geneId,geneSymbol,geneName,AlteredExpression,Biomarker,GeneticVariation,PostTranslationalModification,Therapeutic,diseaseId,diseaseName,score,NumberOfPubmeds,associationType
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",1.0,1.0,1.0,0.0,0.0,19202,Hepatolenticular Degeneration,0.97260683,200,"AlteredExpression, Biomarker, GeneticVariation"
4160,MC4R,melanocortin 4 receptor,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.94,264,"Biomarker, GeneticVariation"
3667,IRS1,insulin receptor substrate 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.907216439,112,"Biomarker, GeneticVariation"
4204,MECP2,methyl CpG binding protein 2,1.0,1.0,1.0,1.0,0.0,35372,Rett Syndrome,0.9,498,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",1.0,1.0,1.0,0.0,0.0,10674,Cystic Fibrosis,0.9,1074,"AlteredExpression, Biomarker, GeneticVariation"
5621,PRNP,prion protein,1.0,1.0,1.0,0.0,0.0,22336,Creutzfeldt-Jakob Syndrome,0.884360623,272,"AlteredExpression, Biomarker, GeneticVariation"
2332,FMR1,fragile X mental retardation 1,1.0,1.0,1.0,0.0,0.0,16667,Fragile X Syndrome,0.880361233,523,"AlteredExpression, Biomarker, GeneticVariation"
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,238198,Gastrointestinal Stromal Tumors,0.879390148,621,"AlteredExpression, Biomarker, GeneticVariation"
4210,MEFV,Mediterranean fever,1.0,1.0,1.0,0.0,0.0,31069,Familial Mediterranean Fever,0.870270925,323,"AlteredExpression, Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,1142166,Brugada Syndrome,0.869105314,183,"Biomarker, GeneticVariation"
1756,DMD,dystrophin,1.0,1.0,1.0,0.0,0.0,13264,"Muscular Dystrophy, Duchenne",0.865413064,510,"AlteredExpression, Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,1.0,1.0,1.0,0.0,0.0,24796,Marfan Syndrome,0.858256352,289,"AlteredExpression, Biomarker, GeneticVariation"
551,AVP,arginine vasopressin,0.0,1.0,1.0,0.0,0.0,687720,"Diabetes Insipidus, Neurogenic",0.855107808,76,"Biomarker, GeneticVariation"
351,APP,amyloid beta (A4) precursor protein,1.0,1.0,1.0,1.0,0.0,2395,Alzheimer Disease,0.852707275,215,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
5314,PKHD1,polycystic kidney and hepatic disease 1 (autosomal recessive),1.0,1.0,1.0,0.0,0.0,85548,"Polycystic Kidney, Autosomal Recessive",0.850728214,60,"AlteredExpression, Biomarker, GeneticVariation"
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",1.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.849717283,161,"AlteredExpression, Biomarker, GeneticVariation"
472,ATM,ATM serine/threonine kinase,1.0,1.0,1.0,0.0,0.0,4135,Ataxia Telangiectasia,0.844353946,371,"AlteredExpression, Biomarker, GeneticVariation"
4221,MEN1,multiple endocrine neoplasia I,1.0,1.0,1.0,0.0,0.0,25267,Multiple Endocrine Neoplasia Type 1,0.843737418,225,"AlteredExpression, Biomarker, GeneticVariation"
443,ASPA,aspartoacylase,0.0,1.0,1.0,0.0,0.0,206307,Canavan Disease,0.839552918,50,"Biomarker, GeneticVariation"
5009,OTC,ornithine carbamoyltransferase,0.0,1.0,1.0,0.0,1.0,268542,Ornithine Carbamoyltransferase Deficiency Disease,0.838731369,71,"Biomarker, GeneticVariation, Therapeutic"
411,ARSB,arylsulfatase B,0.0,1.0,1.0,0.0,0.0,26709,Mucopolysaccharidosis VI,0.837235851,43,"Biomarker, GeneticVariation"
3848,KRT1,"keratin 1, type II",0.0,1.0,1.0,0.0,0.0,79153,"Hyperkeratosis, Epidermolytic",0.833012246,38,"Biomarker, GeneticVariation"
6261,RYR1,ryanodine receptor 1 (skeletal),0.0,1.0,1.0,0.0,0.0,24591,Malignant Hyperthermia,0.831580104,197,"Biomarker, GeneticVariation"
1130,LYST,lysosomal trafficking regulator,0.0,1.0,1.0,0.0,0.0,7965,Chediak-Higashi Syndrome,0.827342155,18,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,1.0,1.0,1.0,0.0,0.0,27831,Neurofibromatosis 1,0.826153872,225,"AlteredExpression, Biomarker, GeneticVariation"
6794,STK11,serine/threonine kinase 11,0.0,1.0,1.0,0.0,0.0,31269,Peutz-Jeghers Syndrome,0.821637865,181,"Biomarker, GeneticVariation"
2717,GLA,"galactosidase, alpha",1.0,1.0,1.0,0.0,0.0,2986,Fabry Disease,0.819539195,237,"AlteredExpression, Biomarker, GeneticVariation"
367,AR,androgen receptor,1.0,1.0,1.0,0.0,0.0,39585,Androgen-Insensitivity Syndrome,0.817503914,148,"AlteredExpression, Biomarker, GeneticVariation"
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",1.0,1.0,1.0,0.0,0.0,19562,von Hippel-Lindau Disease,0.816103697,188,"AlteredExpression, Biomarker, GeneticVariation"
368,ABCC6,"ATP-binding cassette, sub-family C (CFTR/MRP), member 6",1.0,1.0,1.0,0.0,0.0,33847,Pseudoxanthoma Elasticum,0.812244353,117,"AlteredExpression, Biomarker, GeneticVariation"
7454,WAS,Wiskott-Aldrich syndrome,1.0,1.0,1.0,1.0,0.0,43194,Wiskott-Aldrich Syndrome,0.805889613,139,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2158,F9,coagulation factor IX,1.0,1.0,1.0,0.0,0.0,8533,Hemophilia B,0.804609242,291,"AlteredExpression, Biomarker, GeneticVariation"
2670,GFAP,glial fibrillary acidic protein,1.0,1.0,1.0,0.0,0.0,270726,Alexander Disease,0.802117161,92,"AlteredExpression, Biomarker, GeneticVariation"
4137,MAPT,microtubule-associated protein tau,0.0,1.0,1.0,0.0,0.0,338451,Frontotemporal Dementia,0.800853608,343,"Biomarker, GeneticVariation"
4976,OPA1,optic atrophy 1 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,338508,"Optic Atrophy, Autosomal Dominant",0.800375511,115,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,0.0,0.0,18553,"Hamartoma Syndrome, Multiple",0.799169634,195,"AlteredExpression, Biomarker, GeneticVariation"
410,ARSA,arylsulfatase A,1.0,1.0,1.0,0.0,0.0,23522,"Leukodystrophy, Metachromatic",0.793236105,162,"AlteredExpression, Biomarker, GeneticVariation"
3145,HMBS,hydroxymethylbilane synthase,1.0,1.0,1.0,0.0,0.0,162565,"Porphyria, Acute Intermittent",0.7902941,143,"AlteredExpression, Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,1.0,1.0,1.0,1.0,0.0,33300,Progeria,0.783157455,122,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7466,WFS1,Wolfram syndrome 1 (wolframin),0.0,1.0,1.0,0.0,0.0,43207,Wolfram Syndrome,0.78190758,79,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,1.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.78,426,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,1080,Achondroplasia,0.779578366,110,"Biomarker, GeneticVariation"
2548,GAA,"glucosidase, alpha; acid",1.0,1.0,1.0,0.0,1.0,17921,Glycogen Storage Disease Type II,0.775649924,98,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
2131,EXT1,exostosin glycosyltransferase 1,0.0,1.0,1.0,0.0,0.0,15306,"Exostoses, Multiple Hereditary",0.774681282,100,"Biomarker, GeneticVariation"
5354,PLP1,proteolipid protein 1,0.0,1.0,1.0,0.0,0.0,205711,Pelizaeus-Merzbacher Disease,0.77391766,121,"Biomarker, GeneticVariation"
7486,WRN,"Werner syndrome, RecQ helicase-like",1.0,1.0,1.0,0.0,0.0,43119,Werner Syndrome,0.773136244,100,"AlteredExpression, Biomarker, GeneticVariation"
215,ABCD1,"ATP-binding cassette, sub-family D (ALD), member 1",0.0,1.0,1.0,0.0,0.0,162309,Adrenoleukodystrophy,0.772500138,131,"Biomarker, GeneticVariation"
3064,HTT,huntingtin,1.0,1.0,1.0,0.0,0.0,20179,Huntington Disease,0.772303914,228,"AlteredExpression, Biomarker, GeneticVariation"
3251,HPRT1,hypoxanthine phosphoribosyltransferase 1,1.0,1.0,1.0,0.0,0.0,23374,Lesch-Nyhan Syndrome,0.770848141,103,"AlteredExpression, Biomarker, GeneticVariation"
5727,PTCH1,patched 1,0.0,1.0,1.0,0.0,0.0,4779,Basal Cell Nevus Syndrome,0.770203137,104,"Biomarker, GeneticVariation"
1717,DHCR7,7-dehydrocholesterol reductase,0.0,1.0,1.0,0.0,0.0,175694,Smith-Lemli-Opitz Syndrome,0.768883187,82,"Biomarker, GeneticVariation"
2235,FECH,ferrochelatase,0.0,1.0,1.0,0.0,1.0,162568,"Protoporphyria, Erythropoietic",0.768863609,101,"Biomarker, GeneticVariation, Therapeutic"
6519,SLC3A1,"solute carrier family 3 (amino acid transporter heavy chain), member 1",0.0,1.0,1.0,0.0,0.0,10691,Cystinuria,0.767592691,63,"Biomarker, GeneticVariation"
11136,SLC7A9,"solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9",0.0,1.0,1.0,0.0,0.0,10691,Cystinuria,0.767534762,44,"Biomarker, GeneticVariation"
641,BLM,"Bloom syndrome, RecQ helicase-like",1.0,1.0,1.0,0.0,0.0,5859,Bloom Syndrome,0.764885648,64,"AlteredExpression, Biomarker, GeneticVariation"
5080,PAX6,paired box 6,0.0,1.0,1.0,0.0,0.0,3076,Aniridia,0.764735794,140,"Biomarker, GeneticVariation"
6261,RYR1,ryanodine receptor 1 (skeletal),0.0,1.0,1.0,0.0,0.0,751951,"Myopathy, Central Core",0.764072995,88,"Biomarker, GeneticVariation"
538,ATP7A,"ATPase, Cu++ transporting, alpha polypeptide",1.0,1.0,1.0,0.0,0.0,22716,Menkes Kinky Hair Syndrome,0.763937072,83,"AlteredExpression, Biomarker, GeneticVariation"
860,RUNX2,runt-related transcription factor 2,1.0,1.0,1.0,0.0,0.0,8928,Cleidocranial Dysplasia,0.763477022,77,"AlteredExpression, Biomarker, GeneticVariation"
5621,PRNP,prion protein,0.0,1.0,1.0,0.0,0.0,17495,Gerstmann-Straussler-Scheinker Disease,0.760552323,105,"Biomarker, GeneticVariation"
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,1.0,0.0,0.0,39292,Tangier Disease,0.758773301,95,"Biomarker, GeneticVariation"
6559,SLC12A3,"solute carrier family 12 (sodium/chloride transporter), member 3",0.0,1.0,1.0,0.0,0.0,268450,Gitelman Syndrome,0.757954024,47,"Biomarker, GeneticVariation"
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,1.0,0.0,0.0,175704,LEOPARD Syndrome,0.756721944,45,"Biomarker, GeneticVariation"
3423,IDS,iduronate 2-sulfatase,0.0,1.0,1.0,1.0,0.0,26705,Mucopolysaccharidosis II,0.755634684,113,"Biomarker, GeneticVariation, PostTranslationalModification"
5376,PMP22,peripheral myelin protein 22,0.0,1.0,1.0,0.0,0.0,393814,Tomaculous neuropathy,0.755154567,124,"Biomarker, GeneticVariation"
5172,SLC26A4,"solute carrier family 26 (anion exchanger), member 4",0.0,1.0,1.0,0.0,0.0,271829,Pendred syndrome,0.75473465,100,"Biomarker, GeneticVariation"
8878,SQSTM1,sequestosome 1,0.0,1.0,1.0,0.0,0.0,29401,Osteitis Deformans,0.753906476,20,"Biomarker, GeneticVariation"
5979,RET,ret proto-oncogene,0.0,1.0,1.0,1.0,0.0,25269,Multiple Endocrine Neoplasia Type 2b,0.752594128,90,"Biomarker, GeneticVariation, PostTranslationalModification"
2690,GHR,growth hormone receptor,0.0,1.0,1.0,0.0,0.0,271568,Laron Syndrome,0.751353151,75,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,1.0,0.0,0.0,22398,Job Syndrome,0.750962199,59,"Biomarker, GeneticVariation"
3073,HEXA,hexosaminidase A (alpha polypeptide),0.0,1.0,1.0,0.0,0.0,39373,Tay-Sachs Disease,0.750756689,75,"Biomarker, GeneticVariation"
6197,RPS6KA3,"ribosomal protein S6 kinase, 90kDa, polypeptide 3",1.0,1.0,1.0,0.0,0.0,265252,Coffin-Lowry Syndrome,0.750748281,40,"AlteredExpression, Biomarker, GeneticVariation"
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,1.0,0.0,0.0,22595,Darier Disease,0.750406848,30,"Biomarker, GeneticVariation"
4010,LMX1B,"LIM homeobox transcription factor 1, beta",0.0,1.0,1.0,0.0,0.0,27341,Nail-Patella Syndrome,0.750103276,42,"Biomarker, GeneticVariation"
695,BTK,Bruton agammaglobulinemia tyrosine kinase,0.0,1.0,1.0,0.0,0.0,221026,Bruton type agammaglobulinemia,0.750051484,119,"Biomarker, GeneticVariation"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,1264039,"von Willebrand Disease, Type 1",0.749533506,96,"Biomarker, GeneticVariation"
25836,NIPBL,Nipped-B homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,270972,De Lange Syndrome,0.749076217,47,"Biomarker, GeneticVariation"
8518,IKBKAP,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein",0.0,1.0,1.0,0.0,0.0,13364,"Dysautonomia, Familial",0.748225704,41,"Biomarker, GeneticVariation"
846,CASR,calcium-sensing receptor,0.0,1.0,1.0,0.0,0.0,342637,"Hypocalciuric hypercalcemia, familial, type 1",0.748115983,93,"Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,0.0,1.0,1.0,0.0,0.0,23817,Hyperlipoproteinemia Type I,0.747754484,112,"Biomarker, GeneticVariation"
7957,EPM2A,"epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)",1.0,1.0,1.0,0.0,0.0,751783,Lafora Disease,0.747149613,56,"AlteredExpression, Biomarker, GeneticVariation"
4089,SMAD4,SMAD family member 4,0.0,1.0,1.0,0.0,0.0,345893,Juvenile polyposis syndrome,0.747129058,66,"Biomarker, GeneticVariation"
1387,CREBBP,CREB binding protein,0.0,1.0,1.0,0.0,0.0,35934,Rubinstein-Taybi Syndrome,0.74655364,42,"Biomarker, GeneticVariation"
1121,CHM,choroideremia (Rab escort protein 1),0.0,1.0,1.0,0.0,0.0,8525,Choroideremia,0.7459376,51,"Biomarker, GeneticVariation"
55636,CHD7,chromodomain helicase DNA binding protein 7,0.0,1.0,1.0,0.0,0.0,265354,CHARGE Syndrome,0.745847947,84,"Biomarker, GeneticVariation"
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,1.0,0.0,0.0,752347,Lewy Body Disease,0.744227676,22,"Biomarker, GeneticVariation"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,22387,Jervell-Lange Nielsen Syndrome,0.743718595,34,"Biomarker, GeneticVariation"
2138,EYA1,EYA transcriptional coactivator and phosphatase 1,0.0,1.0,1.0,0.0,0.0,265234,Branchio-Oto-Renal Syndrome,0.743669564,42,"Biomarker, GeneticVariation"
2581,GALC,galactosylceramidase,0.0,1.0,1.0,0.0,0.0,23521,"Leukodystrophy, Globoid Cell",0.742700432,67,"Biomarker, GeneticVariation"
3920,LAMP2,lysosomal-associated membrane protein 2,1.0,1.0,1.0,0.0,0.0,878677,Glycogen Storage Disease Type IIb,0.741968536,35,"AlteredExpression, Biomarker, GeneticVariation"
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,1.0,0.0,0.0,1631597,Polymorphic catecholergic ventricular tachycardia,0.741546347,77,"Biomarker, GeneticVariation"
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,1.0,0.0,0.0,1275126,"Periodic fever, familial, autosomal dominant",0.741360905,62,"Biomarker, GeneticVariation"
1311,COMP,cartilage oligomeric matrix protein,0.0,1.0,1.0,0.0,0.0,410538,Pseudoachondroplasia,0.741360905,60,"Biomarker, GeneticVariation"
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,1.0,0.0,0.0,349639,"Leukemia, Myelomonocytic, Juvenile",0.740657972,38,"Biomarker, GeneticVariation"
6949,TCOF1,Treacher Collins-Franceschetti syndrome 1,0.0,1.0,1.0,0.0,0.0,242387,Mandibulofacial Dysostosis,0.740041932,47,"Biomarker, GeneticVariation"
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,1.0,0.0,0.0,22350,"Jaundice, Chronic Idiopathic",0.739984004,29,"Biomarker, GeneticVariation"
3074,HEXB,hexosaminidase B (beta polypeptide),0.0,1.0,1.0,0.0,0.0,36161,Sandhoff Disease,0.739778495,35,"Biomarker, GeneticVariation"
3640,INSL3,insulin-like 3 (Leydig cell),0.0,1.0,1.0,0.0,0.0,10417,Cryptorchidism,0.739523466,31,"Biomarker, GeneticVariation"
34,ACADM,"acyl-CoA dehydrogenase, C-4 to C-12 straight chain",0.0,1.0,1.0,0.0,0.0,220710,Medium chain acyl CoA dehydrogenase deficiency,0.739288992,33,"Biomarker, GeneticVariation"
8910,SGCE,"sarcoglycan, epsilon",0.0,1.0,1.0,0.0,0.0,1834570,Myoclonic dystonia,0.738711302,67,"Biomarker, GeneticVariation"
189,AGXT,alanine-glyoxylate aminotransferase,0.0,1.0,1.0,0.0,0.0,268164,Primary hyperoxaluria type 1,0.738144292,69,"Biomarker, GeneticVariation"
8291,DYSF,dysferlin,0.0,1.0,1.0,0.0,0.0,1850808,Miyoshi myopathy,0.737860788,64,"Biomarker, GeneticVariation"
6899,TBX1,T-box 1,0.0,1.0,1.0,0.0,0.0,12236,DiGeorge Syndrome,0.73780286,48,"Biomarker, GeneticVariation"
6662,SOX9,SRY (sex determining region Y)-box 9,1.0,1.0,1.0,0.0,0.0,1861922,Campomelic Dysplasia,0.737548319,58,"AlteredExpression, Biomarker, GeneticVariation"
5172,SLC26A4,"solute carrier family 26 (anion exchanger), member 4",0.0,1.0,1.0,0.0,0.0,1863752,Enlarged Vestibular Aqueduct,0.73734281,53,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,1868678,"Thanatophoric Dysplasia, Type I",0.737010274,60,"Biomarker, GeneticVariation"
1861,TOR1A,"torsin family 1, member A (torsin A)",0.0,1.0,1.0,0.0,0.0,1851945,Dystonia musculorum deformans type 1,0.736443265,58,"Biomarker, GeneticVariation"
1287,COL4A5,"collagen, type IV, alpha 5",0.0,1.0,1.0,0.0,0.0,1567742,"ALPORT SYNDROME, X-LINKED",0.73615976,71,"Biomarker, GeneticVariation"
10020,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,0.0,1.0,1.0,0.0,0.0,1853926,"Distal myopathy, Nonaka type",0.73615976,57,"Biomarker, GeneticVariation"
6910,TBX5,T-box 5,0.0,1.0,1.0,0.0,0.0,265264,Holt-Oram syndrome,0.735407309,39,"Biomarker, GeneticVariation"
3664,IRF6,interferon regulatory factor 6,0.0,1.0,1.0,0.0,0.0,175697,Van der Woude syndrome,0.735358278,46,"Biomarker, GeneticVariation"
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",1.0,1.0,1.0,0.0,0.0,238198,Gastrointestinal Stromal Tumors,0.735347648,275,"AlteredExpression, Biomarker, GeneticVariation"
2538,G6PC,"glucose-6-phosphatase, catalytic subunit",0.0,1.0,1.0,0.0,0.0,17920,Glycogen Storage Disease Type I,0.734762305,47,"Biomarker, GeneticVariation"
2990,GUSB,"glucuronidase, beta",0.0,1.0,1.0,0.0,0.0,85132,Mucopolysaccharidosis VII,0.734742238,56,"Biomarker, GeneticVariation"
7390,UROS,uroporphyrinogen III synthase,0.0,1.0,1.0,0.0,0.0,162530,"Porphyria, Erythropoietic",0.734713274,47,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,587248,Costello Syndrome,0.734175229,53,"Biomarker, GeneticVariation"
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,1.0,0.0,0.0,1854520,MYH9-Related Disorders,0.733891724,49,"Biomarker, GeneticVariation"
445,ASS1,argininosuccinate synthase 1,0.0,1.0,1.0,0.0,0.0,175683,Citrullinemia,0.73386276,44,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,10273,Craniofacial Dysostosis,0.73386276,41,"Biomarker, GeneticVariation"
686,BTD,biotinidase,0.0,1.0,1.0,0.0,0.0,220754,Biotinidase Deficiency,0.733853863,19,"Biomarker, GeneticVariation"
3081,HGD,"homogentisate 1,2-dioxygenase",0.0,1.0,1.0,0.0,0.0,2066,Alkaptonuria,0.733833796,34,"Biomarker, GeneticVariation"
825,CAPN3,"calpain 3, (p94)",0.0,1.0,1.0,0.0,0.0,1869123,Limb-girdle muscular dystrophy type 2A,0.733608219,54,"Biomarker, GeneticVariation"
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,1.0,0.0,0.0,812437,Oculodentodigital Dysplasia,0.733608219,48,"Biomarker, GeneticVariation"
7299,TYR,tyrosinase,0.0,1.0,1.0,0.0,0.0,268494,Oculocutaneous albinism type 1,0.733324715,48,"Biomarker, GeneticVariation"
657,BMPR1A,"bone morphogenetic protein receptor, type IA",0.0,1.0,1.0,0.0,0.0,345893,Juvenile polyposis syndrome,0.733139272,32,"Biomarker, GeneticVariation"
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,1.0,0.0,0.0,393808,"Charcot-Marie-Tooth disease, X-linked, 1",0.73304121,46,"Biomarker, GeneticVariation"
3931,LCAT,lecithin-cholesterol acyltransferase,0.0,1.0,1.0,0.0,0.0,23195,Lecithin Acyltransferase Deficiency,0.732777773,30,"Biomarker, GeneticVariation"
64840,PORCN,porcupine homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,16395,Focal Dermal Hypoplasia,0.732670813,20,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,0.0,1.0,1.0,0.0,0.0,950121,Denys-Drash Syndrome,0.732494268,29,"Biomarker, GeneticVariation"
2632,GBE1,"glucan (1,4-alpha-), branching enzyme 1",0.0,1.0,1.0,0.0,0.0,17923,Glycogen Storage Disease Type IV,0.732416273,26,"Biomarker, GeneticVariation"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,35828,Romano-Ward Syndrome,0.732132768,26,"Biomarker, GeneticVariation"
8291,DYSF,dysferlin,0.0,1.0,1.0,0.0,0.0,1850889,"Limb-girdle muscular dystrophy, type 2B",0.731623687,42,"Biomarker, GeneticVariation"
5979,RET,ret proto-oncogene,0.0,1.0,1.0,0.0,0.0,25268,Multiple Endocrine Neoplasia Type 2a,0.731124532,396,"Biomarker, GeneticVariation"
4693,NDP,Norrie disease (pseudoglioma),0.0,1.0,1.0,0.0,0.0,266526,Norrie disease,0.730587731,23,"Biomarker, GeneticVariation"
2201,FBN2,fibrillin 2,0.0,1.0,1.0,0.0,0.0,220668,Congenital contractural arachnodactyly,0.7305387,29,"Biomarker, GeneticVariation"
175,AGA,aspartylglucosaminidase,0.0,1.0,1.0,0.0,0.0,268225,Aspartylglucosaminuria,0.730489669,38,"Biomarker, GeneticVariation"
1476,CSTB,cystatin B (stefin B),0.0,1.0,1.0,0.0,0.0,751785,Unverricht-Lundborg Syndrome,0.730206165,37,"Biomarker, GeneticVariation"
6452,SH3BP2,SH3-domain binding protein 2,0.0,1.0,1.0,0.0,0.0,8029,Cherubism,0.729893696,26,"Biomarker, GeneticVariation"
8074,FGF23,fibroblast growth factor 23,0.0,1.0,1.0,0.0,0.0,342642,"Hypophosphatemic Rickets, Autosomal Dominant",0.729639155,34,"Biomarker, GeneticVariation"
2719,GPC3,glypican 3,0.0,1.0,1.0,0.0,0.0,796154,Simpson-Golabi-Behmel syndrome,0.729639155,34,"Biomarker, GeneticVariation"
5076,PAX2,paired box 2,0.0,1.0,1.0,0.0,0.0,1852759,Papillorenal syndrome,0.729355651,33,"Biomarker, GeneticVariation"
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,1.0,0.0,0.0,1845055,ATR-X syndrome,0.729355651,33,"Biomarker, GeneticVariation"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,1.0,0.0,0.0,238357,"Paralysis, Hyperkalemic Periodic",0.729326687,25,"Biomarker, GeneticVariation"
4534,MTM1,myotubularin 1,0.0,1.0,1.0,0.0,0.0,410203,"Myotubular myopathy, X-linked",0.729072146,37,"Biomarker, GeneticVariation"
7508,XPC,"xeroderma pigmentosum, complementation group C",0.0,1.0,1.0,0.0,0.0,2752147,"Xeroderma Pigmentosum, Complementation Group C",0.729072146,33,"Biomarker, GeneticVariation"
7369,UMOD,uromodulin,0.0,1.0,1.0,0.0,0.0,268113,Juvenile gout,0.728788642,31,"Biomarker, GeneticVariation"
7415,VCP,valosin containing protein,0.0,1.0,1.0,0.0,0.0,1833662,Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia,0.728788642,31,"Biomarker, GeneticVariation"
582,BBS1,Bardet-Biedl syndrome 1,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.728759678,25,"Biomarker, GeneticVariation"
201163,FLCN,folliculin,0.0,1.0,1.0,0.0,0.0,346010,Birt-Hogg-Dube Syndrome,0.728505137,31,"Biomarker, GeneticVariation"
6926,TBX3,T-box 3,0.0,1.0,1.0,0.0,0.0,1866994,Ulnar-mammary syndrome,0.728505137,30,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,1833104,"Diabetes Mellitus, Permanent Neonatal",0.728505137,30,"Biomarker, GeneticVariation"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,1.0,0.0,0.0,1833104,"Diabetes Mellitus, Permanent Neonatal",0.728505137,30,"Biomarker, GeneticVariation"
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,1.0,0.0,0.0,272375,Antithrombin III Deficiency,0.728319694,43,"Biomarker, GeneticVariation"
668,FOXL2,forkhead box L2,0.0,1.0,1.0,0.0,0.0,220663,"Blepharophimosis, Ptosis, and Epicanthus Inversus",0.728270663,22,"Biomarker, GeneticVariation"
4541,ND6,"NADH dehydrogenase, subunit 6 (complex I)",0.0,1.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.728085221,8,"Biomarker, GeneticVariation"
1513,CTSK,cathepsin K,0.0,1.0,1.0,0.0,0.0,238402,Pycnodysostosis,0.727938128,29,"Biomarker, GeneticVariation"
5189,PEX1,peroxisomal biogenesis factor 1,0.0,1.0,1.0,0.0,0.0,43459,Zellweger Syndrome,0.7278802,12,"Biomarker, GeneticVariation"
8398,PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent)",0.0,1.0,1.0,0.0,0.0,270724,Infantile Neuroaxonal Dystrophy,0.727654623,27,"Biomarker, GeneticVariation"
9839,ZEB2,zinc finger E-box binding homeobox 2,0.0,1.0,1.0,0.0,0.0,1856113,Mowat-Wilson syndrome,0.727371119,30,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,406709,Hay-Wells syndrome,0.727087614,26,"Biomarker, GeneticVariation"
55612,FERMT1,fermitin family member 1,0.0,1.0,1.0,0.0,0.0,406557,Poikiloderma of Kindler,0.727087614,25,"Biomarker, GeneticVariation"
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,1.0,0.0,0.0,343068,Familial cold urticaria,0.727087614,26,"Biomarker, GeneticVariation"
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,1.0,0.0,0.0,268390,Muckle-Wells syndrome,0.727087614,26,"Biomarker, GeneticVariation"
9211,LGI1,"leucine-rich, glioma inactivated 1",0.0,1.0,1.0,0.0,0.0,1838062,Autosomal Dominant Lateral Temporal Lobe Epilepsy,0.727087614,31,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,1275081,Cardiofaciocutaneous syndrome,0.72680411,26,"Biomarker, GeneticVariation"
2737,GLI3,GLI family zinc finger 3,0.0,1.0,1.0,0.0,0.0,265306,Greig cephalopolysyndactyly syndrome,0.72680411,24,"Biomarker, GeneticVariation"
5476,CTSA,cathepsin A,0.0,1.0,1.0,0.0,0.0,268233,Neuraminidase deficiency with beta-galactosidase deficiency,0.726520605,24,"Biomarker, GeneticVariation"
27019,DNAI1,"dynein, axonemal, intermediate chain 1",0.0,1.0,1.0,0.0,0.0,22521,Kartagener Syndrome,0.726286132,16,"Biomarker, GeneticVariation"
10002,NR2E3,"nuclear receptor subfamily 2, group E, member 3",0.0,1.0,1.0,0.0,0.0,1849394,Enhanced S-Cone Syndrome,0.726237101,22,"Biomarker, GeneticVariation"
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,80024,Piebaldism,0.726237101,22,"Biomarker, GeneticVariation"
50485,SMARCAL1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1",1.0,1.0,1.0,0.0,0.0,877024,Schimke immunoosseous dysplasia,0.726237101,22,"AlteredExpression, Biomarker, GeneticVariation"
9451,EIF2AK3,eukaryotic translation initiation factor 2-alpha kinase 3,0.0,1.0,1.0,0.0,0.0,432217,Wolcott-Rallison syndrome,0.725953596,21,"Biomarker, GeneticVariation"
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,1.0,0.0,0.0,1848533,Ataxia with vitamin E deficiency,0.725953596,25,"Biomarker, GeneticVariation"
51099,ABHD5,abhydrolase domain containing 5,0.0,1.0,1.0,0.0,0.0,268238,Triglyceride storage disease with impaired long-chain fatty acid oxidation,0.725953596,22,"Biomarker, GeneticVariation"
2625,GATA3,GATA binding protein 3,0.0,1.0,1.0,0.0,0.0,1840333,Barakat syndrome,0.725953596,22,"Biomarker, GeneticVariation"
11277,TREX1,three prime repair exonuclease 1,0.0,1.0,1.0,0.0,0.0,796126,Aicardi-Goutieres syndrome,0.725670091,20,"Biomarker, GeneticVariation"
3897,L1CAM,L1 cell adhesion molecule,0.0,1.0,1.0,0.0,0.0,795953,"MASA (Mental Retardation, Aphasia, Shuffling Gait, Adducted Thumbs) Syndrome",0.725670091,20,"Biomarker, GeneticVariation"
779,CACNA1S,"calcium channel, voltage-dependent, L type, alpha 1S subunit",0.0,1.0,1.0,0.0,0.0,3714580,"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1",0.725670091,20,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,268138,"Xeroderma Pigmentosum, Complementation Group D",0.725386587,19,"Biomarker, GeneticVariation"
23230,VPS13A,vacuolar protein sorting 13 homolog A (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,393576,Neuroacanthocytosis,0.725103082,19,"Biomarker, GeneticVariation"
10558,SPTLC1,"serine palmitoyltransferase, long chain base subunit 1",0.0,1.0,1.0,0.0,0.0,20071,Acrodystrophic neuropathy,0.725103082,20,"Biomarker, GeneticVariation"
1594,CYP27B1,"cytochrome P450, family 27, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,268689,"Vitamin D Hydroxylation-Deficient Rickets, Type 1A",0.725103082,20,"Biomarker, GeneticVariation"
286,ANK1,"ankyrin 1, erythrocytic",0.0,1.0,1.0,0.0,0.0,2674218,"Spherocytosis, Type 1",0.725103082,19,"Biomarker, GeneticVariation"
4935,GPR143,G protein-coupled receptor 143,0.0,1.0,1.0,0.0,0.0,342684,Ocular Albinism type 1,0.725103082,18,"Biomarker, GeneticVariation"
3930,LBR,lamin B receptor,0.0,1.0,1.0,0.0,0.0,30779,Pelger-Huet Anomaly,0.725074118,9,"Biomarker, GeneticVariation"
3172,HNF4A,"hepatocyte nuclear factor 4, alpha",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.72496137,141,"Biomarker, GeneticVariation"
6567,SLC16A2,"solute carrier family 16, member 2 (thyroid hormone transporter)",0.0,1.0,1.0,0.0,0.0,795889,Allan-Herndon-Dudley syndrome,0.724819578,20,"Biomarker, GeneticVariation"
2512,FTL,"ferritin, light polypeptide",0.0,1.0,1.0,0.0,0.0,1853578,Neuroferritinopathy,0.724819578,17,"Biomarker, GeneticVariation"
6927,HNF1A,HNF1 homeobox A,0.0,1.0,1.0,0.0,0.0,1838100,"Maturity-Onset Diabetes of the Young, Type 3",0.724819578,17,"Biomarker, GeneticVariation"
6609,SMPD1,"sphingomyelin phosphodiesterase 1, acid lysosomal",0.0,1.0,1.0,0.0,0.0,268243,"Niemann-Pick Disease, Type B",0.724790614,9,"Biomarker, GeneticVariation"
3736,KCNA1,"potassium channel, voltage gated shaker related subfamily A, member 1",0.0,1.0,1.0,0.0,0.0,1719788,"Episodic Ataxia, Type 1",0.724536073,27,"Biomarker, GeneticVariation"
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",0.0,1.0,1.0,0.0,0.0,1832916,Timothy syndrome,0.724536073,17,"Biomarker, GeneticVariation"
1291,COL6A1,"collagen, type VI, alpha 1",0.0,1.0,1.0,0.0,0.0,1834674,Bethlem myopathy,0.724536073,16,"Biomarker, GeneticVariation"
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,1.0,1.0,0.0,0.0,432252,Osteoporosis-pseudoglioma syndrome,0.724536073,16,"Biomarker, GeneticVariation"
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,1.0,0.0,0.0,1860339,Waardenburg syndrome type 2A,0.724536073,16,"Biomarker, GeneticVariation"
2707,GJB3,"gap junction protein, beta 3, 31kDa",0.0,1.0,1.0,0.0,0.0,265961,Erythrokeratodermia Variabilis,0.724536073,16,"Biomarker, GeneticVariation"
2303,FOXC2,forkhead box C2,0.0,1.0,1.0,0.0,0.0,265345,Lymphedema distichiasis syndrome,0.724252569,16,"Biomarker, GeneticVariation"
1947,EFNB1,ephrin-B1,0.0,1.0,1.0,0.0,0.0,220767,Craniofrontonasal dysplasia,0.724252569,15,"Biomarker, GeneticVariation"
8139,GAN,gigaxonin,0.0,1.0,1.0,0.0,0.0,1850386,Giant Axonal Neuropathy,0.724252569,19,"Biomarker, GeneticVariation"
6523,SLC5A1,"solute carrier family 5 (sodium/glucose cotransporter), member 1",0.0,1.0,1.0,0.0,0.0,268186,Glucose-Galactose Malabsorption,0.724252569,15,"Biomarker, GeneticVariation"
55630,SLC39A4,"solute carrier family 39 (zinc transporter), member 4",0.0,1.0,1.0,0.0,0.0,221036,Acrodermatitis enteropathica,0.724252569,18,"Biomarker, GeneticVariation"
4221,MEN1,multiple endocrine neoplasia I,0.0,1.0,1.0,0.0,0.0,1840402,Hyperparathyroidism 1,0.723969064,14,"Biomarker, GeneticVariation"
6584,SLC22A5,"solute carrier family 22 (organic cation/carnitine transporter), member 5",0.0,1.0,1.0,0.0,0.0,342788,Systemic carnitine deficiency,0.723969064,19,"Biomarker, GeneticVariation"
3691,ITGB4,"integrin, beta 4",0.0,1.0,1.0,0.0,0.0,1856934,Epidermolysis bullosa with pyloric atresia,0.723969064,15,"Biomarker, GeneticVariation"
2121,EVC,Ellis van Creveld syndrome,0.0,1.0,1.0,0.0,0.0,13903,Ellis-Van Creveld Syndrome,0.7239401,5,"Biomarker, GeneticVariation"
4125,MAN2B1,"mannosidase, alpha, class 2B, member 1",0.0,1.0,1.0,0.0,0.0,24748,alpha-Mannosidosis,0.723685559,14,"Biomarker, GeneticVariation"
6770,STAR,steroidogenic acute regulatory protein,0.0,1.0,1.0,0.0,0.0,342474,Lipoid congenital adrenal hyperplasia,0.723685559,18,"Biomarker, GeneticVariation"
1674,DES,desmin,0.0,1.0,1.0,0.0,0.0,1832370,"Myopathy, Myofibrillar, Desmin-Related",0.723685559,13,"Biomarker, GeneticVariation"
778,CACNA1F,"calcium channel, voltage-dependent, L type, alpha 1F subunit",0.0,1.0,1.0,0.0,0.0,1848172,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A",0.723685559,13,"Biomarker, GeneticVariation"
6535,SLC6A8,"solute carrier family 6 (neurotransmitter transporter), member 8",0.0,1.0,1.0,0.0,0.0,1845862,"Creatine deficiency, X-linked",0.723685559,19,"Biomarker, GeneticVariation"
57190,SEPN1,"selenoprotein N, 1",0.0,1.0,1.0,0.0,0.0,410180,Rigid spine syndrome,0.723685559,14,"Biomarker, GeneticVariation"
2542,SLC37A4,"solute carrier family 37 (glucose-6-phosphate transporter), member 4",0.0,1.0,1.0,0.0,0.0,268146,Glycogen Storage Disease IB,0.723685559,13,"Biomarker, GeneticVariation"
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,1.0,0.0,0.0,1842090,Platelet Glycoprotein IV Deficiency,0.723685559,14,"Biomarker, GeneticVariation"
7439,BEST1,bestrophin 1,0.0,1.0,1.0,0.0,0.0,2678493,Bestrophinopathy,0.723685559,13,"Biomarker, GeneticVariation"
341640,FREM2,FRAS1 related extracellular matrix protein 2,0.0,1.0,1.0,0.0,0.0,265233,Fraser Syndrome,0.723402055,12,"Biomarker, GeneticVariation"
1293,COL6A3,"collagen, type VI, alpha 3",0.0,1.0,1.0,0.0,0.0,410179,Scleroatonic muscular dystrophy,0.723402055,12,"Biomarker, GeneticVariation"
3908,LAMA2,"laminin, alpha 2",0.0,1.0,1.0,0.0,0.0,1263858,"Muscular dystrophy congenital, merosin negative",0.723402055,14,"Biomarker, GeneticVariation"
7401,CLRN1,clarin 1,0.0,1.0,1.0,0.0,0.0,1568248,"USHER SYNDROME, TYPE IIIA",0.723402055,12,"Biomarker, GeneticVariation"
7172,TPMT,thiopurine S-methyltransferase,0.0,1.0,1.0,0.0,0.0,342801,Thiopurine S methyltranferase deficiency,0.723402055,14,"Biomarker, GeneticVariation"
383,ARG1,arginase 1,0.0,1.0,1.0,0.0,0.0,268548,Hyperargininemia,0.723402055,12,"Biomarker, GeneticVariation"
5213,PFKM,"phosphofructokinase, muscle",0.0,1.0,1.0,0.0,0.0,17926,Glycogen Storage Disease Type VII,0.723167581,10,"Biomarker, GeneticVariation"
23474,ETHE1,ethylmalonic encephalopathy 1,0.0,1.0,1.0,0.0,0.0,1865349,Ethylmalonic encephalopathy,0.72311855,12,"Biomarker, GeneticVariation"
3052,HCCS,holocytochrome c synthase,0.0,1.0,1.0,0.0,0.0,796070,"Microphthalmia, syndromic 7",0.72311855,11,"Biomarker, GeneticVariation"
4948,OCA2,oculocutaneous albinism II,0.0,1.0,1.0,0.0,0.0,268495,Oculocutaneous albinism type 2,0.72311855,16,"Biomarker, GeneticVariation"
6445,SGCG,"sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)",0.0,1.0,1.0,0.0,0.0,410173,"Limb-girdle muscular dystrophy, type 2C",0.72311855,12,"Biomarker, GeneticVariation"
5625,PRODH,proline dehydrogenase (oxidase) 1,0.0,1.0,1.0,0.0,0.0,268529,Hyperprolinemia,0.72311855,12,"Biomarker, GeneticVariation"
3209,HOXA13,homeobox A13,0.0,1.0,1.0,0.0,0.0,1841679,Hand foot uterus syndrome,0.72311855,12,"Biomarker, GeneticVariation"
3913,LAMB2,"laminin, beta 2 (laminin S)",0.0,1.0,1.0,0.0,0.0,1836876,Pierson syndrome,0.72311855,12,"Biomarker, GeneticVariation"
3786,KCNQ3,"potassium channel, voltage gated KQT-like subfamily Q, member 3",0.0,1.0,1.0,0.0,0.0,1852581,Convulsions benign familial neonatal dominant form,0.72311855,13,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,1848213,X-linked periventricular heterotopia,0.72311855,11,"Biomarker, GeneticVariation"
3664,IRF6,interferon regulatory factor 6,0.0,1.0,1.0,0.0,0.0,265259,Popliteal Pterygium Syndrome,0.72311855,11,"Biomarker, GeneticVariation"
26119,LDLRAP1,low density lipoprotein receptor adaptor protein 1,0.0,1.0,1.0,0.0,0.0,1863512,"Hypercholesterolemia, Autosomal Recessive",0.72311855,12,"Biomarker, GeneticVariation"
4488,MSX2,msh homeobox 2,0.0,1.0,1.0,0.0,0.0,1858160,"Craniosynostosis, Type 2",0.722835046,10,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,1300257,"Thanatophoric dysplasia, type 2",0.722835046,10,"Biomarker, GeneticVariation"
2202,EFEMP1,EGF containing fibulin-like extracellular matrix protein 1,0.0,1.0,1.0,0.0,0.0,1832174,Doyne honeycomb retinal dystrophy,0.722835046,10,"Biomarker, GeneticVariation"
340024,SLC6A19,"solute carrier family 6 (neutral amino acid transporter), member 19",0.0,1.0,1.0,0.0,0.0,18609,Hartnup Disease,0.722835046,10,"Biomarker, GeneticVariation"
435,ASL,argininosuccinate lyase,0.0,1.0,1.0,0.0,0.0,268547,Argininosuccinic Aciduria,0.722835046,15,"Biomarker, GeneticVariation"
50945,TBX22,T-box 22,0.0,1.0,1.0,0.0,0.0,1844830,Cleft palate X-linked,0.722835046,12,"Biomarker, GeneticVariation"
9051,PSTPIP1,proline-serine-threonine phosphatase interacting protein 1,0.0,1.0,1.0,0.0,0.0,1858361,"Pyogenic arthritis, pyoderma gangrenosum, and acne",0.722835046,10,"Biomarker, GeneticVariation"
5080,PAX6,paired box 6,0.0,1.0,1.0,0.0,0.0,344559,Peters anomaly,0.722835046,10,"Biomarker, GeneticVariation"
35,ACADS,"acyl-CoA dehydrogenase, C-2 to C-3 short chain",0.0,1.0,1.0,0.0,0.0,342783,Short chain Acyl CoA dehydrogenase deficiency,0.722551541,10,"Biomarker, GeneticVariation"
8200,GDF5,growth differentiation factor 5,0.0,1.0,1.0,0.0,0.0,1862103,Brachydactyly type C,0.722551541,9,"Biomarker, GeneticVariation"
22954,TRIM32,tripartite motif containing 32,0.0,1.0,1.0,0.0,0.0,270968,Limb-girdle muscular dystrophy type 2H,0.722551541,9,"Biomarker, GeneticVariation"
7036,TFR2,transferrin receptor 2,0.0,1.0,1.0,0.0,0.0,1858664,"Hemochromatosis, type 3",0.722551541,11,"Biomarker, GeneticVariation"
1959,EGR2,early growth response 2,0.0,1.0,1.0,0.0,0.0,393818,"Charcot-Marie-Tooth disease, Type 4E",0.722551541,9,"Biomarker, GeneticVariation"
285362,SUMF1,sulfatase modifying factor 1,0.0,1.0,1.0,0.0,0.0,268263,Multiple Sulfatase Deficiency Disease,0.722551541,9,"Biomarker, GeneticVariation"
161742,SPRED1,"sprouty-related, EVH1 domain containing 1",0.0,1.0,1.0,0.0,0.0,1969623,Legius syndrome,0.722551541,11,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,1844696,"Oto-palato-digital syndrome, type 2",0.722551541,10,"Biomarker, GeneticVariation"
57216,VANGL2,VANGL planar cell polarity protein 2,0.0,1.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.722317068,2,"Biomarker, GeneticVariation"
197131,UBR1,ubiquitin protein ligase E3 component n-recognin 1,0.0,1.0,1.0,0.0,0.0,175692,Johanson Blizzard syndrome,0.722268037,8,"Biomarker, GeneticVariation"
6609,SMPD1,"sphingomyelin phosphodiesterase 1, acid lysosomal",0.0,1.0,1.0,0.0,0.0,268242,"Niemann-Pick Disease, Type A",0.722268037,8,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,268362,"Osteogenesis imperfecta, type 3",0.722268037,8,"Biomarker, GeneticVariation"
5340,PLG,plasminogen,0.0,1.0,1.0,0.0,0.0,1968804,"Plasminogen Deficiency, Type I",0.722268037,14,"Biomarker, GeneticVariation"
10560,SLC19A2,"solute carrier family 19 (thiamine transporter), member 2",0.0,1.0,1.0,0.0,0.0,342287,Thiamine responsive megaloblastic anemia syndrome,0.722268037,10,"Biomarker, GeneticVariation"
79813,EHMT1,euchromatic histone-lysine N-methyltransferase 1,0.0,1.0,1.0,0.0,0.0,795833,Kleefstra Syndrome,0.722268037,8,"Biomarker, GeneticVariation"
5307,PITX1,paired-like homeodomain 1,0.0,1.0,1.0,0.0,0.0,9081,Clubfoot,0.722268037,8,"Biomarker, GeneticVariation"
3981,LIG4,"ligase IV, DNA, ATP-dependent",0.0,1.0,1.0,0.0,0.0,1847827,LIG4 Syndrome,0.721984532,8,"Biomarker, GeneticVariation"
10683,DLL3,delta-like 3 (Drosophila),0.0,1.0,1.0,0.0,0.0,265343,Jarcho-Levin syndrome,0.721984532,7,"Biomarker, GeneticVariation"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,1850155,Osteolysis hereditary multicentric,0.721984532,9,"Biomarker, GeneticVariation"
10913,EDAR,ectodysplasin A receptor,0.0,1.0,1.0,0.0,0.0,406702,"Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive",0.721984532,7,"Biomarker, GeneticVariation"
701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,0.0,1.0,1.0,0.0,0.0,1850343,Mosaic variegated aneuploidy syndrome,0.721984532,8,"Biomarker, GeneticVariation"
2073,ERCC5,excision repair cross-complementation group 5,0.0,1.0,1.0,0.0,0.0,268141,"Xeroderma Pigmentosum, Complementation Group G",0.721984532,9,"Biomarker, GeneticVariation"
4158,MC2R,melanocortin 2 receptor (adrenocorticotropic hormone),0.0,1.0,1.0,0.0,0.0,1859974,Familial Glucocorticoid Deficiency 1,0.721984532,10,"Biomarker, GeneticVariation"
3549,IHH,indian hedgehog,0.0,1.0,1.0,0.0,0.0,1862151,Brachydactyly type A1,0.721984532,7,"Biomarker, GeneticVariation"
5167,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,0.0,1.0,1.0,0.0,0.0,1859727,Arterial calcification of infancy,0.721984532,7,"Biomarker, GeneticVariation"
5351,PLOD1,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1",0.0,1.0,1.0,0.0,0.0,268342,Ehlers-Danlos syndrome type 6,0.721984532,12,"Biomarker, GeneticVariation"
760,CA2,carbonic anhydrase II,0.0,1.0,1.0,0.0,0.0,345407,Osteopetrosis with renal tubular acidosis,0.721984532,8,"Biomarker, GeneticVariation"
7915,ALDH5A1,"aldehyde dehydrogenase 5 family, member A1",0.0,1.0,1.0,0.0,0.0,268631,succinic semialdehyde dehydrogenase deficiency,0.721984532,10,"Biomarker, GeneticVariation"
3172,HNF4A,"hepatocyte nuclear factor 4, alpha",0.0,1.0,1.0,0.0,0.0,1852093,"Maturity-Onset Diabetes of the Young, Type 1",0.721701027,7,"Biomarker, GeneticVariation"
7369,UMOD,uromodulin,0.0,1.0,1.0,0.0,0.0,1859040,Medullary Cystic Kidney Disease 2,0.721701027,6,"Biomarker, GeneticVariation"
50617,ATP6V0A4,"ATPase, H+ transporting, lysosomal V0 subunit a4",0.0,1.0,1.0,0.0,0.0,1864498,"Renal tubular acidosis, distal, autosomal recessive",0.721701027,7,"Biomarker, GeneticVariation"
9896,FIG4,FIG4 phosphoinositide 5-phosphatase,0.0,1.0,1.0,0.0,0.0,1970011,"Charcot-Marie-Tooth Disease, Type 4j",0.721701027,6,"Biomarker, GeneticVariation"
54808,DYM,dymeclin,0.0,1.0,1.0,0.0,0.0,265286,Dyggve-Melchior-Clausen syndrome,0.721701027,6,"Biomarker, GeneticVariation"
4072,EPCAM,epithelial cell adhesion molecule,0.0,1.0,1.0,0.0,0.0,2750737,"Diarrhea 5, With Tufting Enteropathy, Congenital",0.721701027,6,"Biomarker, GeneticVariation"
56172,ANKH,ANKH inorganic pyrophosphate transport regulator,0.0,1.0,1.0,0.0,0.0,1852502,"Craniometaphyseal Dysplasia, Autosomal Dominant",0.721701027,6,"Biomarker, GeneticVariation"
8898,MTMR2,myotubularin related protein 2,0.0,1.0,1.0,0.0,0.0,1832399,"Charcot-Marie-Tooth disease, Type 4B1",0.721701027,7,"Biomarker, GeneticVariation"
79628,SH3TC2,SH3 domain and tetratricopeptide repeats 2,0.0,1.0,1.0,0.0,0.0,1866636,"Charcot-Marie-Tooth disease, Type 4C",0.721701027,6,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,220685,Achondrogenesis type 2,0.721701027,7,"Biomarker, GeneticVariation"
23414,ZFPM2,"zinc finger protein, FOG family member 2",0.0,1.0,1.0,0.0,0.0,39685,Tetralogy of Fallot,0.721701027,6,"Biomarker, GeneticVariation"
5191,PEX7,peroxisomal biogenesis factor 7,0.0,1.0,1.0,0.0,0.0,1859133,"Rhizomelic chondrodysplasia punctata, type 1",0.721701027,6,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,1879286,Hereditary bundle branch system defect,0.721701027,6,"Biomarker, GeneticVariation"
4920,ROR2,receptor tyrosine kinase-like orphan receptor 2,0.0,1.0,1.0,0.0,0.0,1849334,"Robinow syndrome, autosomal recessive",0.721701027,8,"Biomarker, GeneticVariation"
8200,GDF5,growth differentiation factor 5,0.0,1.0,1.0,0.0,0.0,265260,"Chondrodysplasia, Grebe type",0.721701027,6,"Biomarker, GeneticVariation"
30061,SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1",0.0,1.0,1.0,0.0,0.0,1853733,"Hemochromatosis, type 4",0.721701027,11,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,1852406,Cutis Gyrata Syndrome of Beare And Stevenson,0.721701027,6,"Biomarker, GeneticVariation"
7021,TFAP2B,transcription factor AP-2 beta (activating enhancer binding protein 2 beta),0.0,1.0,1.0,0.0,0.0,1868570,Char syndrome,0.721701027,7,"Biomarker, GeneticVariation"
23218,NBEAL2,neurobeachin-like 2,0.0,1.0,1.0,0.0,0.0,272302,Gray Platelet Syndrome,0.721417523,5,"Biomarker, GeneticVariation"
7399,USH2A,"Usher syndrome 2A (autosomal recessive, mild)",0.0,1.0,1.0,0.0,0.0,1848634,"Usher syndrome, type 2A",0.721417523,6,"Biomarker, GeneticVariation"
1203,CLN5,"ceroid-lipofuscinosis, neuronal 5",0.0,1.0,1.0,0.0,0.0,1850442,"Ceroid lipofuscinosis, neuronal 5",0.721417523,7,"Biomarker, GeneticVariation"
10999,SLC27A4,"solute carrier family 27 (fatty acid transporter), member 4",0.0,1.0,1.0,0.0,0.0,1837610,Ichthyosis prematurity syndrome,0.721417523,6,"Biomarker, GeneticVariation"
1289,COL5A1,"collagen, type V, alpha 1",0.0,1.0,1.0,0.0,0.0,268335,Ehlers-Danlos syndrome type 1,0.721417523,5,"Biomarker, GeneticVariation"
37,ACADVL,"acyl-CoA dehydrogenase, very long chain",0.0,1.0,1.0,0.0,0.0,342784,VLCAD deficiency,0.721417523,9,"Biomarker, GeneticVariation"
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,1.0,0.0,0.0,391816,Tietz syndrome,0.721417523,5,"Biomarker, GeneticVariation"
10516,FBLN5,fibulin 5,0.0,1.0,1.0,0.0,0.0,268351,"Cutis Laxa, Autosomal Recessive, Type I",0.721417523,5,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,398595,Myeloperoxidase Deficiency,0.721417523,7,"Biomarker, GeneticVariation"
6338,SCNN1B,"sodium channel, non voltage gated 1 beta subunit",0.0,1.0,1.0,0.0,0.0,221043,Liddle Syndrome,0.721417523,7,"Biomarker, GeneticVariation"
3851,KRT4,"keratin 4, type II",0.0,1.0,1.0,0.0,0.0,1721005,"Leukokeratosis, Hereditary Mucosal",0.721417523,5,"Biomarker, GeneticVariation"
8200,GDF5,growth differentiation factor 5,0.0,1.0,1.0,0.0,0.0,1832702,Brachydactyly type A2,0.721417523,5,"Biomarker, GeneticVariation"
617,BCS1L,BC1 (ubiquinol-cytochrome c reductase) synthesis-like,0.0,1.0,1.0,0.0,0.0,1864002,Finnish lethal neonatal metabolic syndrome,0.721417523,5,"Biomarker, GeneticVariation"
9499,MYOT,myotilin,0.0,1.0,1.0,0.0,0.0,1836607,Myotilinopathy,0.721134018,4,"Biomarker, GeneticVariation"
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,1.0,0.0,0.0,1847823,"Charcot-Marie-Tooth disease, Type 2F",0.721134018,4,"Biomarker, GeneticVariation"
5274,SERPINI1,"serpin peptidase inhibitor, clade I (neuroserpin), member 1",0.0,1.0,1.0,0.0,0.0,1858680,Familial encephalopathy with neuroserpin inclusion bodies,0.721134018,5,"Biomarker, GeneticVariation"
7227,TRPS1,trichorhinophalangeal syndrome I,0.0,1.0,1.0,0.0,0.0,432233,Giedion syndrome,0.721134018,4,"Biomarker, GeneticVariation"
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,1.0,0.0,0.0,268362,"Osteogenesis imperfecta, type 3",0.721134018,4,"Biomarker, GeneticVariation"
285590,SH3PXD2B,SH3 and PX domains 2B,0.0,1.0,1.0,0.0,0.0,1855305,Ter Haar syndrome,0.721134018,4,"Biomarker, GeneticVariation"
2617,GARS,glycyl-tRNA synthetase,0.0,1.0,1.0,0.0,0.0,1832274,"Charcot-Marie-Tooth disease, Type 2D",0.721134018,4,"Biomarker, GeneticVariation"
4882,NPR2,natriuretic peptide receptor 2,0.0,1.0,1.0,0.0,0.0,1864356,"Acromesomelic dysplasia, Maroteaux type",0.721134018,4,"Biomarker, GeneticVariation"
1301,COL11A1,"collagen, type XI, alpha 1",0.0,1.0,1.0,0.0,0.0,1858084,"Stickler syndrome, type 2",0.721134018,4,"Biomarker, GeneticVariation"
866,SERPINA6,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6",0.0,1.0,1.0,0.0,0.0,1852529,Corticosteroid-Binding Globulin Deficiency,0.721134018,5,"Biomarker, GeneticVariation"
374654,KIF7,kinesin family member 7,0.0,1.0,1.0,0.0,0.0,796147,Acrocallosal Syndrome,0.721134018,4,"Biomarker, GeneticVariation"
162417,NAGS,N-acetylglutamate synthase,0.0,1.0,1.0,0.0,0.0,268543,N-acetyl glutamate synthetase deficiency,0.721134018,5,"Biomarker, GeneticVariation"
7249,TSC2,tuberous sclerosis 2,0.0,1.0,1.0,0.0,0.0,1860707,Tuberous Sclerosis 2,0.721134018,5,"Biomarker, GeneticVariation"
1289,COL5A1,"collagen, type V, alpha 1",0.0,1.0,1.0,0.0,0.0,268336,Ehlers-Danlos syndrome type 2,0.721134018,4,"Biomarker, GeneticVariation"
4860,PNP,purine nucleoside phosphorylase,0.0,1.0,1.0,0.0,0.0,268125,Purine Nucleoside Phosphorylase Deficiency,0.721134018,7,"Biomarker, GeneticVariation"
79648,MCPH1,microcephalin 1,0.0,1.0,1.0,0.0,0.0,1855081,"Microcephaly, Primary Autosomal Recessive, 1",0.721134018,5,"Biomarker, GeneticVariation"
10577,NPC2,"Niemann-Pick disease, type C2",0.0,1.0,1.0,0.0,0.0,1843366,"Niemann-Pick disease, type C2",0.721134018,8,"Biomarker, GeneticVariation"
3000,GUCY2D,"guanylate cyclase 2D, membrane (retina-specific)",0.0,1.0,1.0,0.0,0.0,1866293,Retinal cone dystrophy 2,0.720850514,3,"Biomarker, GeneticVariation"
2395,FXN,frataxin,0.0,1.0,1.0,0.0,0.0,1856689,Friedreich Ataxia 1,0.720850514,9,"Biomarker, GeneticVariation"
27130,INVS,inversin,0.0,1.0,1.0,0.0,0.0,1865872,Nephronophthisis 2,0.720850514,3,"Biomarker, GeneticVariation"
8322,FZD4,frizzled class receptor 4,0.0,1.0,1.0,0.0,0.0,1851402,Exudative vitreoretinopathy 1,0.720850514,11,"Biomarker, GeneticVariation"
1373,CPS1,"carbamoyl-phosphate synthase 1, mitochondrial",0.0,1.0,1.0,0.0,0.0,751753,Carbamoyl-Phosphate Synthase I Deficiency Disease,0.720850514,11,"Biomarker, GeneticVariation"
845,CASQ2,calsequestrin 2 (cardiac muscle),0.0,1.0,1.0,0.0,0.0,2677794,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2",0.720850514,5,"Biomarker, GeneticVariation"
208,AKT2,v-akt murine thymoma viral oncogene homolog 2,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.720850514,3,"Biomarker, GeneticVariation"
6444,SGCD,"sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)",0.0,1.0,1.0,0.0,0.0,1832525,Limb-girdle muscular dystrophy type 2F,0.720850514,4,"Biomarker, GeneticVariation"
54808,DYM,dymeclin,0.0,1.0,1.0,0.0,0.0,1846431,Smith-McCort Dysplasia,0.720850514,3,"Biomarker, GeneticVariation"
7068,THRB,"thyroid hormone receptor, beta",0.0,1.0,1.0,0.0,0.0,2937288,"Thyroid Hormone Resistance, Generalized, Autosomal Dominant",0.720567009,2,"Biomarker, GeneticVariation"
91147,TMEM67,transmembrane protein 67,0.0,1.0,1.0,0.0,0.0,1846357,Meckel syndrome type 3,0.720567009,2,"Biomarker, GeneticVariation"
79158,GNPTAB,"N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits",0.0,1.0,1.0,0.0,0.0,2673377,Mucolipidosis II Alpha Beta,0.720567009,2,"Biomarker, GeneticVariation"
3239,HOXD13,homeobox D13,0.0,1.0,1.0,0.0,0.0,1861367,Synpolydactyly 1,0.720567009,3,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,1835437,"Platyspondylic Lethal Skeletal Dysplasia, Torrance Type",0.720567009,2,"Biomarker, GeneticVariation"
1643,DDB2,"damage-specific DNA binding protein 2, 48kDa",0.0,1.0,1.0,0.0,0.0,1848411,"Xeroderma Pigmentosum, Complementation Group E",0.720567009,4,"Biomarker, GeneticVariation"
50943,FOXP3,forkhead box P3,0.0,1.0,1.0,0.0,0.0,342288,"Immunodysregulation, Polyendocrinopathy, and Enteropathy, X-Linked",0.720567009,5,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,265251,Oto-Palato-digital syndrome type 1,0.720567009,4,"Biomarker, GeneticVariation"
57165,GJC2,"gap junction protein, gamma 2, 47kDa",0.0,1.0,1.0,0.0,0.0,1837355,"Leukodystrophy, Hypomyelinating, 2",0.720567009,2,"Biomarker, GeneticVariation"
1282,COL4A1,"collagen, type IV, alpha 1",0.0,1.0,1.0,0.0,0.0,1843512,Brain Small Vessel Disease with Hemorrhage,0.720567009,2,"Biomarker, GeneticVariation"
2593,GAMT,guanidinoacetate N-methyltransferase,0.0,1.0,1.0,0.0,0.0,574080,Guanidinoacetate methyltransferase deficiency,0.720567009,5,"Biomarker, GeneticVariation"
6309,SC5D,sterol-C5-desaturase,0.0,1.0,1.0,0.0,0.0,1846421,Lathosterolosis,0.720567009,4,"Biomarker, GeneticVariation"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,1.0,0.0,0.0,2750061,"Hypokalemic Periodic Paralysis, Type 2",0.720567009,2,"Biomarker, GeneticVariation"
23418,CRB1,"crumbs family member 1, photoreceptor morphogenesis associated",0.0,1.0,1.0,0.0,0.0,1838647,Retinitis Pigmentosa 12,0.720567009,2,"Biomarker, GeneticVariation"
121512,FGD4,"FYVE, RhoGEF and PH domain containing 4",0.0,1.0,1.0,0.0,0.0,1836336,"Charcot-Marie-Tooth Disease, Type 4H",0.720567009,3,"Biomarker, GeneticVariation"
51,ACOX1,"acyl-CoA oxidase 1, palmitoyl",0.0,1.0,1.0,0.0,0.0,1849678,Peroxisomal ACYL-COA oxidase deficiency,0.720567009,3,"Biomarker, GeneticVariation"
1300,COL10A1,"collagen, type X, alpha 1",0.0,1.0,1.0,0.0,0.0,265289,Metaphyseal chondrodysplasia Schmid type,0.720567009,4,"Biomarker, GeneticVariation"
54345,SOX18,SRY (sex determining region Y)-box 18,0.0,1.0,1.0,0.0,0.0,1843004,Hypotrichosis-Lymphedema-Telangiectasia Syndrome,0.720567009,3,"Biomarker, GeneticVariation"
6443,SGCB,"sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)",0.0,1.0,1.0,0.0,0.0,1858593,"Limb-girdle muscular dystrophy, type 2E",0.720567009,4,"Biomarker, GeneticVariation"
3373,HYAL1,hyaluronoglucosaminidase 1,0.0,1.0,1.0,0.0,0.0,1291490,Hyaluronidase Deficiency,0.720567009,3,"Biomarker, GeneticVariation"
9499,MYOT,myotilin,0.0,1.0,1.0,0.0,0.0,1866785,"MYOPATHY, SPHEROID BODY",0.720567009,2,"Biomarker, GeneticVariation"
3651,PDX1,pancreatic and duodenal homeobox 1,0.0,1.0,1.0,0.0,0.0,1833382,"Maturity-Onset Diabetes of the Young, Type 4",0.720567009,5,"Biomarker, GeneticVariation"
8200,GDF5,growth differentiation factor 5,0.0,1.0,1.0,0.0,0.0,1856738,Fibular hypoplasia and complex brachydactyly,0.720567009,2,"Biomarker, GeneticVariation"
7476,WNT7A,"wingless-type MMTV integration site family, member 7A",0.0,1.0,1.0,0.0,0.0,1856728,Fuhrmann syndrome,0.720567009,2,"Biomarker, GeneticVariation"
8546,AP3B1,"adaptor-related protein complex 3, beta 1 subunit",0.0,1.0,1.0,0.0,0.0,1842362,Hermansky Pudlak syndrome 2,0.720567009,3,"Biomarker, GeneticVariation"
5429,POLH,"polymerase (DNA directed), eta",0.0,1.0,1.0,0.0,0.0,1848410,"Xeroderma pigmentosum, variant type",0.720567009,5,"Biomarker, GeneticVariation"
2304,FOXE1,forkhead box E1,0.0,1.0,1.0,0.0,0.0,1855794,Bamforth syndrome,0.720567009,5,"Biomarker, GeneticVariation"
2703,GJA8,"gap junction protein, alpha 8, 50kDa",0.0,1.0,1.0,0.0,0.0,1861828,"Cataract, Zonular Pulverulent 1",0.720567009,9,"Biomarker, GeneticVariation"
6496,SIX3,SIX homeobox 3,0.0,1.0,1.0,0.0,0.0,1834877,Holoprosencephaly 2,0.720567009,2,"Biomarker, GeneticVariation"
1184,CLCN5,"chloride channel, voltage-sensitive 5",0.0,1.0,1.0,0.0,0.0,1848336,Dent disease 1,0.720567009,2,"Biomarker, GeneticVariation"
1441,CSF3R,colony stimulating factor 3 receptor (granulocyte),0.0,1.0,1.0,0.0,0.0,543669,"Neutrophilia, Hereditary",0.720567009,2,"Biomarker, GeneticVariation"
2177,FANCD2,"Fanconi anemia, complementation group D2",0.0,1.0,1.0,0.0,0.0,3160738,"FANCONI ANEMIA, COMPLEMENTATION GROUP D2",0.720567009,3,"Biomarker, GeneticVariation"
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,1.0,0.0,0.0,1857277,Donnai-Barrow syndrome,0.720567009,2,"Biomarker, GeneticVariation"
4747,NEFL,"neurofilament, light polypeptide",0.0,1.0,1.0,0.0,0.0,1843225,"Charcot-Marie-Tooth disease, Type 2E",0.720567009,2,"Biomarker, GeneticVariation"
7299,TYR,tyrosinase,0.0,1.0,1.0,0.0,0.0,1847024,Oculocutaneous albinism type 1B,0.720283505,1,"Biomarker, GeneticVariation"
2978,GUCA1A,guanylate cyclase activator 1A (retina),0.0,1.0,1.0,0.0,0.0,1865869,Cone Dystrophy 3,0.720283505,4,"Biomarker, GeneticVariation"
4038,LRP4,low density lipoprotein receptor-related protein 4,0.0,1.0,1.0,0.0,0.0,1859309,Syndactyly Cenani Lenz type,0.720283505,1,"Biomarker, GeneticVariation"
7287,TULP1,tubby like protein 1,0.0,1.0,1.0,0.0,0.0,1838603,Retinitis Pigmentosa 14,0.720283505,1,"Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,1838457,"Fanconi Anemia, Complementation Group D1",0.720283505,1,"Biomarker, GeneticVariation"
51151,SLC45A2,"solute carrier family 45, member 2",0.0,1.0,1.0,0.0,0.0,1847836,"Oculocutaneous Albinism, Type IV",0.720283505,4,"Biomarker, GeneticVariation"
6101,RP1,retinitis pigmentosa 1 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,220701,Retinitis pigmentosa 1,0.720283505,6,"Biomarker, GeneticVariation"
6557,SLC12A1,"solute carrier family 12 (sodium/potassium/chloride transporter), member 1",0.0,1.0,1.0,0.0,0.0,1866495,"Bartter syndrome, antenatal type 1",0.720283505,2,"Biomarker, GeneticVariation"
23746,AIPL1,aryl hydrocarbon receptor interacting protein-like 1,0.0,1.0,1.0,0.0,0.0,1858386,Leber Congenital Amaurosis 4,0.720283505,3,"Biomarker, GeneticVariation"
5626,PROP1,PROP paired-like homeobox 1,0.0,1.0,1.0,0.0,0.0,878683,"Pituitary Hormone Deficiency, Combined, 2",0.720283505,8,"Biomarker, GeneticVariation"
158326,FREM1,FRAS1 related extracellular matrix 1,0.0,1.0,1.0,0.0,0.0,1855425,Marles Greenberg Persaud syndrome,0.720283505,2,"Biomarker, GeneticVariation"
2760,GM2A,GM2 ganglioside activator,0.0,1.0,1.0,0.0,0.0,268275,"Tay-Sachs Disease, AB Variant",0.720283505,3,"Biomarker, GeneticVariation"
8200,GDF5,growth differentiation factor 5,0.0,1.0,1.0,0.0,0.0,1832708,Multiple synostoses syndrome 2,0.720283505,1,"Biomarker, GeneticVariation"
6683,SPAST,spastin,0.0,1.0,1.0,0.0,0.0,1866855,"Spastic paraplegia 4, autosomal dominant",0.720283505,27,"Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,2750785,"Muscular Dystrophy, Congenital, Lmna-Related",0.720283505,1,"Biomarker, GeneticVariation"
60386,SLC25A19,"solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19",0.0,1.0,1.0,0.0,0.0,1846648,Amish lethal microcephaly,0.720283505,1,"Biomarker, GeneticVariation"
5660,PSAP,prosaposin,0.0,1.0,1.0,0.0,0.0,268262,Metachromatic Leukodystrophy due to Saposin B Deficiency,0.720283505,1,"Biomarker, GeneticVariation"
6697,SPR,"sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)",0.0,1.0,1.0,0.0,0.0,268468,"Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency",0.720283505,3,"Biomarker, GeneticVariation"
8443,GNPAT,glyceronephosphate O-acyltransferase,0.0,1.0,1.0,0.0,0.0,1857242,"Rhizomelic chondrodysplasia punctata, type 2",0.720283505,3,"Biomarker, GeneticVariation"
3758,KCNJ1,"potassium channel, inwardly rectifying subfamily J, member 1",0.0,1.0,1.0,0.0,0.0,1855849,"Bartter syndrome, antenatal , type 2",0.720283505,4,"Biomarker, GeneticVariation"
2741,GLRA1,"glycine receptor, alpha 1",0.0,1.0,1.0,0.0,0.0,1835614,Hyperexplexia hereditary,0.720283505,9,"Biomarker, GeneticVariation"
6792,CDKL5,cyclin-dependent kinase-like 5,0.0,1.0,1.0,0.0,0.0,1839333,"Epileptic Encephalopathy, Early Infantile, 2",0.720283505,10,"Biomarker, GeneticVariation"
2998,GYS2,glycogen synthase 2 (liver),0.0,1.0,1.0,0.0,0.0,1855861,"Glycogen Storage Disease 0, Liver",0.720283505,2,"Biomarker, GeneticVariation"
4693,NDP,Norrie disease (pseudoglioma),0.0,1.0,1.0,0.0,0.0,1844579,"Exudative Vitreoretinopathy, Familial, X-Linked Recessive",0.720283505,1,"Biomarker, GeneticVariation"
1296,COL8A2,"collagen, type VIII, alpha 2",0.0,1.0,1.0,0.0,0.0,1850959,"Corneal dystrophy, Fuchs' endothelial, 1",0.720283505,1,"Biomarker, GeneticVariation"
2132,EXT2,exostosin glycosyltransferase 2,0.0,1.0,1.0,0.0,0.0,1851413,"EXOSTOSES, MULTIPLE, TYPE II",0.720283505,7,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,1835398,Sarcoma family syndrome of Li and Fraumeni,0.720283505,20,"Biomarker, GeneticVariation"
26121,PRPF31,pre-mRNA processing factor 31,0.0,1.0,1.0,0.0,0.0,1838601,Retinitis Pigmentosa 11,0.720283505,2,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,1859062,Long Qt Syndrome 3,0.720283505,1,"Biomarker, GeneticVariation"
4292,MLH1,mutL homolog 1,0.0,1.0,1.0,0.0,0.0,1333991,Lynch Syndrome II,0.720283505,1,"Biomarker, GeneticVariation"
6121,RPE65,retinal pigment epithelium-specific protein 65kDa,0.0,1.0,1.0,0.0,0.0,1859844,"Amaurosis congenita of Leber, type 2",0.720283505,1,"Biomarker, GeneticVariation"
1509,CTSD,cathepsin D,0.0,1.0,1.0,0.0,0.0,1864669,"Ceroid Lipofuscinosis, Neuronal, 10",0.72,2,"Biomarker, GeneticVariation"
7170,TPM3,tropomyosin 3,0.0,1.0,1.0,0.0,0.0,1836448,Nemaline myopathy 1,0.72,0,"Biomarker, GeneticVariation"
3075,CFH,complement factor H,0.0,1.0,1.0,0.0,0.0,1853147,"Macular Degeneration, Age-Related, 4",0.72,0,"Biomarker, GeneticVariation"
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,1.0,0.0,0.0,2608087,"Neuronopathy, Distal Hereditary Motor, Type IIB",0.72,0,"Biomarker, GeneticVariation"
4148,MATN3,matrilin 3,0.0,1.0,1.0,0.0,0.0,1846843,"Epiphyseal dysplasia, multiple, 5",0.72,0,"Biomarker, GeneticVariation"
54413,NLGN3,neuroligin 3,0.0,1.0,1.0,0.0,0.0,1845540,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 1",0.72,0,"Biomarker, GeneticVariation"
7038,TG,thyroglobulin,0.0,1.0,1.0,0.0,0.0,342194,Thyroid Dyshormonogenesis 3,0.72,5,"Biomarker, GeneticVariation"
1200,TPP1,tripeptidyl peptidase I,0.0,1.0,1.0,0.0,0.0,1876161,"Ceroid Lipofuscinosis, Neuronal, 2",0.72,0,"Biomarker, GeneticVariation"
5538,PPT1,palmitoyl-protein thioesterase 1,0.0,1.0,1.0,0.0,0.0,1850451,"Ceroid Lipofuscinosis, Neuronal, 1",0.72,4,"Biomarker, GeneticVariation"
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,1837915,"Erythrocytosis, Familial, 2",0.72,0,"Biomarker, GeneticVariation"
4646,MYO6,myosin VI,0.0,1.0,1.0,0.0,0.0,1843028,"Deafness, Autosomal Recessive 37",0.72,0,"Biomarker, GeneticVariation"
10594,PRPF8,pre-mRNA processing factor 8,0.0,1.0,1.0,0.0,0.0,1838702,Retinitis Pigmentosa 13,0.72,2,"Biomarker, GeneticVariation"
5805,PTS,6-pyruvoyltetrahydropterin synthase,0.0,1.0,1.0,0.0,0.0,878676,6-pyruvoyl-tetrahydropterin synthase deficiency,0.72,9,"Biomarker, GeneticVariation"
79147,FKRP,fukutin related protein,0.0,1.0,1.0,0.0,0.0,3150413,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5",0.72,0,"Biomarker, GeneticVariation"
9927,MFN2,mitofusin 2,0.0,1.0,1.0,0.0,0.0,1836485,"Charcot-Marie-Tooth Disease, Axonal, Type 2A2",0.72,0,"Biomarker, GeneticVariation"
6687,SPG7,spastic paraplegia 7 (pure and complicated autosomal recessive),0.0,1.0,1.0,0.0,0.0,1846564,"Spastic Paraplegia 7, Autosomal Recessive",0.72,2,"Biomarker, GeneticVariation"
2672,GFI1,growth factor independent 1 transcription repressor,0.0,1.0,1.0,0.0,0.0,2751288,"Neutropenia, Severe Congenital, Autosomal Dominant 2",0.72,0,"Biomarker, GeneticVariation"
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,0.0,1.0,1.0,0.0,0.0,398788,"Immunodeficiency syndrome, variable",0.72,5,"Biomarker, GeneticVariation"
8803,SUCLA2,"succinate-CoA ligase, ADP-forming, beta subunit",0.0,1.0,1.0,0.0,0.0,2749864,MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA),0.72,2,"Biomarker, GeneticVariation"
64072,CDH23,cadherin-related 23,0.0,1.0,1.0,0.0,0.0,1832394,"Deafness, Autosomal Recessive 12",0.72,0,"Biomarker, GeneticVariation"
7084,TK2,"thymidine kinase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,3149750,MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE),0.72,4,"Biomarker, GeneticVariation"
5308,PITX2,paired-like homeodomain 2,0.0,1.0,1.0,0.0,0.0,3714873,"AXENFELD-RIEGER SYNDROME, TYPE 1",0.72,5,"Biomarker, GeneticVariation"
2162,F13A1,"coagulation factor XIII, A1 polypeptide",0.0,1.0,1.0,0.0,0.0,2750514,"Factor Xiii, A Subunit, Deficiency Of",0.72,1,"Biomarker, GeneticVariation"
4487,MSX1,msh homeobox 1,0.0,1.0,1.0,0.0,0.0,1837210,Orofacial Cleft 5,0.72,0,"Biomarker, GeneticVariation"
3060,HCRT,hypocretin (orexin) neuropeptide precursor,0.0,1.0,1.0,0.0,0.0,1834372,Narcolepsy 1,0.72,1,"Biomarker, GeneticVariation"
256471,MFSD8,major facilitator superfamily domain containing 8,0.0,1.0,1.0,0.0,0.0,1838571,"Ceroid Lipofuscinosis, Neuronal, 7",0.72,5,"Biomarker, GeneticVariation"
117531,TMC1,transmembrane channel-like 1,0.0,1.0,1.0,0.0,0.0,1832978,"Deafness, Autosomal Recessive 7",0.72,0,"Biomarker, GeneticVariation"
1311,COMP,cartilage oligomeric matrix protein,0.0,1.0,1.0,0.0,0.0,1838280,"Epiphyseal dysplasia, multiple, 1",0.72,2,"Biomarker, GeneticVariation"
5456,POU3F4,POU class 3 homeobox 4,0.0,1.0,1.0,0.0,0.0,1844678,Progressive hearing loss stapes fixation,0.72,3,"Biomarker, GeneticVariation"
10381,TUBB3,"tubulin, beta 3 class III",0.0,1.0,1.0,0.0,0.0,2748801,"Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement",0.72,0,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,1858562,"Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip/Palate Syndrome 3",0.72,0,"Biomarker, GeneticVariation"
7546,ZIC2,Zic family member 2,0.0,1.0,1.0,0.0,0.0,1864827,Holoprosencephaly 5,0.72,2,"Biomarker, GeneticVariation"
3691,ITGB4,"integrin, beta 4",0.0,1.0,1.0,0.0,0.0,268374,"Epidermolysis Bullosa, Junctional, Non-Herlitz Type",0.72,0,"Biomarker, GeneticVariation"
3914,LAMB3,"laminin, beta 3",0.0,1.0,1.0,0.0,0.0,268374,"Epidermolysis Bullosa, Junctional, Non-Herlitz Type",0.72,0,"Biomarker, GeneticVariation"
170302,ARX,aristaless related homeobox,0.0,1.0,1.0,0.0,0.0,1846171,"Lissencephaly, X-Linked, 2",0.72,0,"Biomarker, GeneticVariation"
9227,LRAT,lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase),0.0,1.0,1.0,0.0,0.0,2750063,Leber Congenital Amaurosis 14,0.72,1,"Biomarker, GeneticVariation"
58,ACTA1,"actin, alpha 1, skeletal muscle",0.0,1.0,1.0,0.0,0.0,1834336,Nemaline myopathy 3,0.72,0,"Biomarker, GeneticVariation"
7547,ZIC3,Zic family member 3,0.0,1.0,1.0,0.0,0.0,1844020,"Heterotaxy, visceral, X-linked",0.72,0,"Biomarker, GeneticVariation"
1908,EDN3,endothelin 3,0.0,1.0,1.0,0.0,0.0,2750457,"Waardenburg Syndrome, Type 4b",0.72,0,"Biomarker, GeneticVariation"
10312,TCIRG1,"T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3",0.0,1.0,1.0,0.0,0.0,1850127,"Osteopetrosis, Autosomal Recessive 1",0.72,2,"Biomarker, GeneticVariation"
5961,PRPH2,"peripherin 2 (retinal degeneration, slow)",0.0,1.0,1.0,0.0,0.0,1842475,Retinitis Pigmentosa 7,0.72,0,"Biomarker, GeneticVariation"
5339,PLEC,plectin,0.0,1.0,1.0,0.0,0.0,432317,"Epidermolysis bullosa simplex, Ogna type",0.72,1,"Biomarker, GeneticVariation"
83700,JAM3,junctional adhesion molecule 3,0.0,1.0,1.0,0.0,0.0,3151000,"HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS",0.72,1,"Biomarker, GeneticVariation"
6654,SOS1,son of sevenless homolog 1 (Drosophila),0.0,1.0,1.0,0.0,0.0,1853120,Noonan Syndrome 4,0.72,6,"Biomarker, GeneticVariation"
6469,SHH,sonic hedgehog,0.0,1.0,1.0,0.0,0.0,1840529,Holoprosencephaly 3,0.72,0,"Biomarker, GeneticVariation"
50506,DUOX2,dual oxidase 2,0.0,1.0,1.0,0.0,0.0,1846632,Thyroid Dyshormonogenesis 6,0.72,3,"Biomarker, GeneticVariation"
8048,CSRP3,cysteine and glycine-rich protein 3 (cardiac LIM protein),0.0,1.0,1.0,0.0,0.0,1843808,"Cardiomyopathy, Dilated, 1M",0.72,0,"Biomarker, GeneticVariation"
8540,AGPS,alkylglycerone phosphate synthase,0.0,1.0,1.0,0.0,0.0,1838612,"Rhizomelic chondrodysplasia punctata, type 3",0.72,3,"Biomarker, GeneticVariation"
1420,CRYGC,"crystallin, gamma C",0.0,1.0,1.0,0.0,0.0,1852438,"Cataract, Coppock-Like",0.72,3,"Biomarker, GeneticVariation"
7345,UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase),0.0,1.0,1.0,0.0,0.0,3150899,"PARKINSON DISEASE 5, AUTOSOMAL DOMINANT",0.72,0,"Biomarker, GeneticVariation"
11081,KERA,keratocan,0.0,1.0,1.0,0.0,0.0,1857574,Cornea Plana 2,0.72,2,"Biomarker, GeneticVariation"
7827,NPHS2,"nephrosis 2, idiopathic, steroid-resistant (podocin)",0.0,1.0,1.0,0.0,0.0,1868672,"Nephrotic syndrome, idiopathic, steroid-resistant",0.72,11,"Biomarker, GeneticVariation"
259266,ASPM,"asp (abnormal spindle) homolog, microcephaly associated (Drosophila)",0.0,1.0,1.0,0.0,0.0,1837501,"Microcephaly, Primary Autosomal Recessive, 5",0.72,1,"Biomarker, GeneticVariation"
253827,MSRB3,methionine sulfoxide reductase B3,0.0,1.0,1.0,0.0,0.0,2239351,"DEAFNESS, AUTOSOMAL RECESSIVE 74",0.72,1,"Biomarker, GeneticVariation"
148738,HFE2,hemochromatosis type 2 (juvenile),0.0,1.0,1.0,0.0,0.0,1865614,"Hemochromatosis, Type 2A",0.72,3,"Biomarker, GeneticVariation"
1410,CRYAB,"crystallin, alpha B",0.0,1.0,1.0,0.0,0.0,1837317,Alpha-B Crystallinopathy,0.72,0,"Biomarker, GeneticVariation"
1186,CLCN7,"chloride channel, voltage-sensitive 7",0.0,1.0,1.0,0.0,0.0,1969106,"Osteopetrosis, Autosomal Recessive 4",0.72,0,"Biomarker, GeneticVariation"
23095,KIF1B,kinesin family member 1B,0.0,1.0,1.0,0.0,0.0,1861678,"Charcot-Marie-Tooth Disease, Axonal, Type 2a1",0.72,1,"Biomarker, GeneticVariation"
9215,LARGE,like-glycosyltransferase,0.0,1.0,1.0,0.0,0.0,3150414,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6",0.72,0,"Biomarker, GeneticVariation"
1674,DES,desmin,0.0,1.0,1.0,0.0,0.0,1858154,"Cardiomyopathy, Dilated, 1i",0.72,0,"Biomarker, GeneticVariation"
51168,MYO15A,myosin XVA,0.0,1.0,1.0,0.0,0.0,1838263,"Deafness, Autosomal Recessive 3",0.72,3,"Biomarker, GeneticVariation"
6010,RHO,rhodopsin,0.0,1.0,1.0,0.0,0.0,1864869,"Night Blindness, Congenital Stationary, Autosomal Dominant 1",0.72,0,"Biomarker, GeneticVariation"
54982,CLN6,"ceroid-lipofuscinosis, neuronal 6, late infantile, variant",0.0,1.0,1.0,0.0,0.0,1866282,"Ceroid Lipofuscinosis, Neuronal, 6",0.72,0,"Biomarker, GeneticVariation"
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,1.0,1.0,0.0,0.0,1854467,"Spastic paraplegia 13, autosomal dominant",0.72,0,"Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,1854154,"Charcot-Marie-Tooth disease, Type 2B1",0.72,0,"Biomarker, GeneticVariation"
7225,TRPC6,"transient receptor potential cation channel, subfamily C, member 6",0.0,1.0,1.0,0.0,0.0,1858915,Focal Segmental Glomerulosclerosis 2,0.72,3,"Biomarker, GeneticVariation"
7273,TTN,titin,0.0,1.0,1.0,0.0,0.0,1858763,"Cardiomyopathy, Dilated, 1g",0.72,0,"Biomarker, GeneticVariation"
91147,TMEM67,transmembrane protein 67,0.0,1.0,1.0,0.0,0.0,1853153,Joubert syndrome 6,0.72,0,"Biomarker, GeneticVariation"
4593,MUSK,"muscle, skeletal, receptor tyrosine kinase",0.0,1.0,1.0,0.0,0.0,1837091,"Myasthenic syndrome, congenital, type Id",0.72,2,"Biomarker, GeneticVariation"
1145,CHRNE,"cholinergic receptor, nicotinic, epsilon (muscle)",0.0,1.0,1.0,0.0,0.0,1837091,"Myasthenic syndrome, congenital, type Id",0.72,0,"Biomarker, GeneticVariation"
94,ACVRL1,activin A receptor type II-like 1,0.0,1.0,1.0,0.0,0.0,1838163,Osler-rendu-weber syndrome 2,0.72,10,"Biomarker, GeneticVariation"
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,1.0,0.0,0.0,1832243,"Cardiomyopathy, Dilated, 1D",0.72,0,"Biomarker, GeneticVariation"
120892,LRRK2,leucine-rich repeat kinase 2,0.0,1.0,1.0,0.0,0.0,1846862,"PARKINSON DISEASE 8, AUTOSOMAL DOMINANT",0.72,10,"Biomarker, GeneticVariation"
5255,PHKA1,"phosphorylase kinase, alpha 1 (muscle)",0.0,1.0,1.0,0.0,0.0,1845151,"Glycogen Storage Disease, Type IXD",0.72,1,"Biomarker, GeneticVariation"
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,1.0,0.0,0.0,1865020,Short QT Syndrome 1,0.72,0,"Biomarker, GeneticVariation"
653361,NCF1,neutrophil cytosolic factor 1,0.0,1.0,1.0,0.0,0.0,1856251,"Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I",0.72,1,"Biomarker, GeneticVariation"
4607,MYBPC3,"myosin binding protein C, cardiac",0.0,1.0,1.0,0.0,0.0,1861862,"Cardiomyopathy, Familial Hypertrophic, 4",0.72,0,"Biomarker, GeneticVariation"
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,1.0,0.0,0.0,1844376,"Granulomatous Disease, Chronic, X-Linked",0.72,0,"Biomarker, GeneticVariation"
494513,DFNB59,"deafness, autosomal recessive 59",0.0,1.0,1.0,0.0,0.0,1857744,"Deafness, Autosomal Recessive 59",0.72,2,"Biomarker, GeneticVariation"
55775,TDP1,tyrosyl-DNA phosphodiesterase 1,0.0,1.0,1.0,0.0,0.0,1846574,"Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy",0.72,1,"Biomarker, GeneticVariation"
64241,ABCG8,"ATP-binding cassette, sub-family G (WHITE), member 8",0.0,1.0,1.0,0.0,0.0,342907,Sitosterolemia,0.72,2,"Biomarker, GeneticVariation"
64240,ABCG5,"ATP-binding cassette, sub-family G (WHITE), member 5",0.0,1.0,1.0,0.0,0.0,342907,Sitosterolemia,0.72,4,"Biomarker, GeneticVariation"
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,1.0,0.0,0.0,1868595,"PARKINSON DISEASE 1, AUTOSOMAL DOMINANT",0.72,0,"Biomarker, GeneticVariation"
1302,COL11A2,"collagen, type XI, alpha 2",0.0,1.0,1.0,0.0,0.0,1866095,"Deafness, Autosomal Dominant 13",0.72,0,"Biomarker, GeneticVariation"
2626,GATA4,GATA binding protein 4,0.0,1.0,1.0,0.0,0.0,1842778,Atrial septal defect 2,0.72,0,"Biomarker, GeneticVariation"
79147,FKRP,fukutin related protein,0.0,1.0,1.0,0.0,0.0,1846672,"Muscular Dystrophy, Limb-Girdle, Type 2I",0.72,0,"Biomarker, GeneticVariation"
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,1.0,0.0,0.0,2751536,"Cerebral Amyloid Angiopathy, App-Related",0.72,0,"Biomarker, GeneticVariation"
5354,PLP1,proteolipid protein 1,0.0,1.0,1.0,0.0,0.0,1839264,"Spastic paraplegia 2, X-linked",0.72,0,"Biomarker, GeneticVariation"
80184,CEP290,centrosomal protein 290kDa,0.0,1.0,1.0,0.0,0.0,1857780,Joubert syndrome 5,0.72,0,"Biomarker, GeneticVariation"
6010,RHO,rhodopsin,0.0,1.0,1.0,0.0,0.0,3151001,Retinitis Pigmentosa 4,0.72,0,"Biomarker, GeneticVariation"
124590,USH1G,Usher syndrome 1G (autosomal recessive),0.0,1.0,1.0,0.0,0.0,1847089,"Usher Syndrome, Type IG",0.72,2,"Biomarker, GeneticVariation"
3295,HSD17B4,hydroxysteroid (17-beta) dehydrogenase 4,0.0,1.0,1.0,0.0,0.0,342870,Bifunctional peroxisomal enzyme deficiency,0.72,0,"Biomarker, GeneticVariation"
9129,PRPF3,pre-mRNA processing factor 3,0.0,1.0,1.0,0.0,0.0,1832378,Retinitis Pigmentosa 18,0.72,2,"Biomarker, GeneticVariation"
4647,MYO7A,myosin VIIA,0.0,1.0,1.0,0.0,0.0,1838701,"Deafness, Autosomal Recessive 2",0.72,0,"Biomarker, GeneticVariation"
170302,ARX,aristaless related homeobox,0.0,1.0,1.0,0.0,0.0,3463992,"Epileptic Encephalopathy, Early Infantile, 1",0.72,0,"Biomarker, GeneticVariation"
4094,MAF,v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog,0.0,1.0,1.0,0.0,0.0,1857768,"Cataract, Pulverulent, Juvenile-Onset",0.72,2,"Biomarker, GeneticVariation"
5551,PRF1,perforin 1 (pore forming protein),0.0,1.0,1.0,0.0,0.0,1863727,"Hemophagocytic lymphohistiocytosis, familial, 2",0.72,2,"Biomarker, GeneticVariation"
5158,PDE6B,"phosphodiesterase 6B, cGMP-specific, rod, beta",0.0,1.0,1.0,0.0,0.0,1876182,"Night Blindness, Congenital Stationary, Autosomal Dominant 2",0.72,0,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,2673759,"Deafness, Autosomal Recessive 1A",0.72,0,"Biomarker, GeneticVariation"
23554,TSPAN12,tetraspanin 12,0.0,1.0,1.0,0.0,0.0,2750079,Exudative Vitreoretinopathy 5,0.72,3,"Biomarker, GeneticVariation"
55800,SCN3B,"sodium channel, voltage gated, type III beta subunit",0.0,1.0,1.0,0.0,0.0,2751088,Brugada Syndrome 7,0.72,2,"Biomarker, GeneticVariation"
2821,GPI,glucose-6-phosphate isomerase,0.0,1.0,1.0,0.0,0.0,3150730,"HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY",0.72,6,"Biomarker, GeneticVariation"
2934,GSN,gelsolin,0.0,1.0,1.0,0.0,0.0,1622345,Meretoja syndrome,0.72,1,"Biomarker, GeneticVariation"
9215,LARGE,like-glycosyltransferase,0.0,1.0,1.0,0.0,0.0,1837229,"Muscular Dystrophy, Congenital, Type 1D",0.72,0,"Biomarker, GeneticVariation"
65018,PINK1,PTEN induced putative kinase 1,0.0,1.0,1.0,0.0,0.0,1853833,"Parkinson Disease 6, Autosomal Recessive Early-Onset",0.72,17,"Biomarker, GeneticVariation"
859,CAV3,caveolin 3,0.0,1.0,1.0,0.0,0.0,1832567,"Muscular Dystrophy, Limb-Girdle, Type 1C",0.72,0,"Biomarker, GeneticVariation"
220074,LRTOMT,leucine rich transmembrane and O-methyltransferase domain containing,0.0,1.0,1.0,0.0,0.0,1969621,"Deafness, Autosomal Recessive 63",0.72,2,"Biomarker, GeneticVariation"
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,1.0,1.0,0.0,0.0,2750467,"Cardiomyopathy, Familial Hypertrophic, 14",0.72,0,"Biomarker, GeneticVariation"
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,1.0,0.0,0.0,2675212,"Spherocytosis, Type 4",0.72,0,"Biomarker, GeneticVariation"
9499,MYOT,myotilin,0.0,1.0,1.0,0.0,0.0,1834659,"Muscular dystrophy, limb-girdle, type 1A",0.72,0,"Biomarker, GeneticVariation"
21,ABCA3,"ATP-binding cassette, sub-family A (ABC1), member 3",0.0,1.0,1.0,0.0,0.0,1970456,"Surfactant Metabolism Dysfunction, Pulmonary, 3",0.72,1,"Biomarker, GeneticVariation"
5083,PAX9,paired box 9,0.0,1.0,1.0,0.0,0.0,1970291,"Tooth Agenesis, Selective, 3",0.72,1,"Biomarker, GeneticVariation"
9217,VAPB,VAMP (vesicle-associated membrane protein)-associated protein B and C,0.0,1.0,1.0,0.0,0.0,1837728,Amyotrophic Lateral Sclerosis 8,0.72,0,"Biomarker, GeneticVariation"
83605,CCM2,cerebral cavernous malformation 2,0.0,1.0,1.0,0.0,0.0,1864041,Cerebral Cavernous Malformations 2,0.72,2,"Biomarker, GeneticVariation"
246213,SLC17A8,"solute carrier family 17 (vesicular glutamate transporter), member 8",0.0,1.0,1.0,0.0,0.0,1854158,"Deafness, Autosomal Dominant 25",0.72,1,"Biomarker, GeneticVariation"
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,1.0,0.0,0.0,1832931,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 2",0.72,0,"Biomarker, GeneticVariation"
56652,C10orf2,chromosome 10 open reading frame 2,0.0,1.0,1.0,0.0,0.0,1836439,"Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 3",0.72,0,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,1836080,"Stickler Syndrome, Type I, Nonsyndromic Ocular",0.72,0,"Biomarker, GeneticVariation"
57560,IFT80,intraflagellar transport 80,0.0,1.0,1.0,0.0,0.0,1970005,Asphyxiating Thoracic Dystrophy 2,0.72,1,"Biomarker, GeneticVariation"
6324,SCN1B,"sodium channel, voltage gated, type I beta subunit",0.0,1.0,1.0,0.0,0.0,1858672,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",0.72,0,"Biomarker, GeneticVariation"
27232,GNMT,glycine N-methyltransferase,0.0,1.0,1.0,0.0,0.0,1847720,Glycine N-Methyltransferase Deficiency,0.72,2,"Biomarker, GeneticVariation"
3728,JUP,junction plakoglobin,0.0,1.0,1.0,0.0,0.0,1969081,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 12",0.72,1,"Biomarker, GeneticVariation"
8048,CSRP3,cysteine and glycine-rich protein 3 (cardiac LIM protein),0.0,1.0,1.0,0.0,0.0,2677491,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12",0.72,0,"Biomarker, GeneticVariation"
7007,TECTA,tectorin alpha,0.0,1.0,1.0,0.0,0.0,1832187,"Deafness, Autosomal Dominant 12",0.72,8,"Biomarker, GeneticVariation"
117531,TMC1,transmembrane channel-like 1,0.0,1.0,1.0,0.0,0.0,1847626,"Deafness, Autosomal Dominant 36",0.72,0,"Biomarker, GeneticVariation"
4633,MYL2,"myosin, light chain 2, regulatory, cardiac, slow",0.0,1.0,1.0,0.0,0.0,1834460,"Cardiomyopathy, Familial Hypertrophic, 10",0.72,5,"Biomarker, GeneticVariation"
11155,LDB3,LIM domain binding 3,0.0,1.0,1.0,0.0,0.0,1832244,"Cardiomyopathy, Dilated, 1C",0.72,2,"Biomarker, GeneticVariation"
9381,OTOF,otoferlin,0.0,1.0,1.0,0.0,0.0,1832828,"Deafness, Autosomal Recessive 9",0.72,2,"Biomarker, GeneticVariation"
51422,PRKAG2,"protein kinase, AMP-activated, gamma 2 non-catalytic subunit",0.0,1.0,1.0,0.0,0.0,1833236,"Cardiomyopathy, Familial Hypertrophic, 6",0.72,0,"Biomarker, GeneticVariation"
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,1969057,Noonan Syndrome 5,0.72,0,"Biomarker, GeneticVariation"
1767,DNAH5,"dynein, axonemal, heavy chain 5",0.0,1.0,1.0,0.0,0.0,1837618,"Primary ciliary dyskinesia, 3",0.72,0,"Biomarker, GeneticVariation"
7809,BSND,barttin CLCNK-type chloride channel accessory beta subunit,0.0,1.0,1.0,0.0,0.0,1865270,"Bartter Syndrome, Type 4A",0.72,3,"Biomarker, GeneticVariation"
54806,AHI1,Abelson helper integration site 1,0.0,1.0,1.0,0.0,0.0,1837713,Joubert syndrome 3,0.72,4,"Biomarker, GeneticVariation"
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,1.0,0.0,0.0,1861864,"Cardiomyopathy, Familial Hypertrophic, 2",0.72,0,"Biomarker, GeneticVariation"
8701,DNAH11,"dynein, axonemal, heavy chain 11",0.0,1.0,1.0,0.0,0.0,2678473,"Ciliary Dyskinesia, Primary, 7",0.72,2,"Biomarker, GeneticVariation"
6444,SGCD,"sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)",0.0,1.0,1.0,0.0,0.0,1847667,"Cardiomyopathy, Dilated, 1l",0.72,0,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.713376199,173,"Biomarker, GeneticVariation"
5979,RET,ret proto-oncogene,0.0,1.0,1.0,0.0,0.0,31511,Pheochromocytoma,0.703862993,141,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,1.0,1.0,1.0,0.0,0.0,27708,Wilms Tumor,0.701437182,204,"AlteredExpression, Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,1.0,1.0,1.0,0.0,0.0,32463,Polycythemia Vera,0.7,341,"AlteredExpression, Biomarker, GeneticVariation"
4137,MAPT,microtubule-associated protein tau,1.0,1.0,1.0,0.0,0.0,38868,"Supranuclear Palsy, Progressive",0.696619388,108,"AlteredExpression, Biomarker, GeneticVariation"
6928,HNF1B,HNF1 homeobox B,1.0,1.0,1.0,0.0,1.0,11860,"Diabetes Mellitus, Type 2",0.691781039,40,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
2322,FLT3,fms-related tyrosine kinase 3,1.0,1.0,1.0,1.0,0.0,23467,"Leukemia, Myeloid, Acute",0.69,653,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
6390,SDHB,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",0.0,1.0,1.0,0.0,0.0,31511,Pheochromocytoma,0.688241277,81,"Biomarker, GeneticVariation"
4137,MAPT,microtubule-associated protein tau,0.0,1.0,1.0,0.0,0.0,236642,Pick Disease of the Brain,0.682522577,246,"Biomarker, GeneticVariation"
6392,SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein",0.0,1.0,1.0,0.0,0.0,31511,Pheochromocytoma,0.679568492,83,"Biomarker, GeneticVariation"
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,31511,Pheochromocytoma,0.674650852,81,"Biomarker, GeneticVariation"
27032,ATP2C1,"ATPase, Ca++ transporting, type 2C, member 1",1.0,1.0,1.0,0.0,0.0,85106,"Pemphigus, Benign Familial",0.668073785,53,"AlteredExpression, Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",1.0,1.0,1.0,0.0,0.0,40015,Thrombasthenia,0.665131291,35,"AlteredExpression, Biomarker, GeneticVariation"
5979,RET,ret proto-oncogene,0.0,1.0,1.0,0.0,0.0,1833921,Familial medullary thyroid carcinoma,0.66280919,151,"Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,1.0,0.0,23467,"Leukemia, Myeloid, Acute",0.662460644,41,"Biomarker, GeneticVariation, PostTranslationalModification"
4771,NF2,neurofibromin 2 (merlin),0.0,1.0,1.0,0.0,0.0,27832,Neurofibromatosis 2,0.65709234,81,"Biomarker, GeneticVariation"
1593,CYP27A1,"cytochrome P450, family 27, subfamily A, polypeptide 1",1.0,1.0,1.0,0.0,0.0,238052,"Xanthomatosis, Cerebrotendinous",0.656085837,71,"AlteredExpression, Biomarker, GeneticVariation"
3674,ITGA2B,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)",0.0,1.0,1.0,0.0,0.0,40015,Thrombasthenia,0.654971885,51,"Biomarker, GeneticVariation"
5837,PYGM,"phosphorylase, glycogen, muscle",1.0,1.0,1.0,0.0,0.0,17924,Glycogen Storage Disease Type V,0.654424943,35,"AlteredExpression, Biomarker, GeneticVariation"
224,ALDH3A2,"aldehyde dehydrogenase 3 family, member A2",0.0,1.0,1.0,0.0,0.0,37231,Sjogren-Larsson Syndrome,0.65275288,34,"Biomarker, GeneticVariation"
1075,CTSC,cathepsin C,0.0,1.0,1.0,0.0,0.0,30360,Papillon-Lefevre Disease,0.652654818,47,"Biomarker, GeneticVariation"
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,1.0,0.0,0.0,403814,Congenital bilateral aplasia of vas deferens,0.649299033,89,"Biomarker, GeneticVariation"
5644,PRSS1,"protease, serine, 1 (trypsin 1)",0.0,1.0,1.0,0.0,0.0,238339,Hereditary pancreatitis,0.649200971,106,"Biomarker, GeneticVariation"
2643,GCH1,GTP cyclohydrolase 1,0.0,1.0,1.0,0.0,0.0,1851920,"Dystonia, Dopa-responsive",0.648066952,100,"Biomarker, GeneticVariation"
6934,TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box)",1.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.647658039,305,"AlteredExpression, Biomarker, GeneticVariation"
3759,KCNJ2,"potassium channel, inwardly rectifying subfamily J, member 2",0.0,1.0,1.0,0.0,0.0,1563715,Andersen Syndrome,0.647042654,44,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,1861171,Thrombophilia due to Activated Protein C Resistance,0.64664943,94,"Biomarker, GeneticVariation"
7291,TWIST1,twist family bHLH transcription factor 1,0.0,1.0,1.0,0.0,0.0,10278,Craniosynostoses,0.645575612,41,"Biomarker, GeneticVariation"
4952,OCRL,oculocerebrorenal syndrome of Lowe,0.0,1.0,1.0,0.0,0.0,28860,Oculocerebrorenal Syndrome,0.645428519,65,"Biomarker, GeneticVariation"
2492,FSHR,follicle stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,85083,Ovarian Hyperstimulation Syndrome,0.645234179,20,"Biomarker, GeneticVariation"
2160,F11,coagulation factor XI,0.0,1.0,1.0,0.0,0.0,15523,Factor XI Deficiency,0.64512722,35,"Biomarker, GeneticVariation"
959,CD40LG,CD40 ligand,0.0,1.0,1.0,0.0,0.0,398689,"Hyper-IgM Immunodeficiency Syndrome, Type 1",0.644948402,90,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,38644,Sudden Infant Death,0.64482316,23,"Biomarker, GeneticVariation"
64324,NSD1,nuclear receptor binding SET domain protein 1,0.0,1.0,1.0,0.0,0.0,175695,Sotos Syndrome,0.644244981,62,"Biomarker, GeneticVariation"
412,STS,"steroid sulfatase (microsomal), isozyme S",0.0,1.0,1.0,0.0,0.0,79588,"Ichthyosis, X-Linked",0.642162387,71,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,15499,Factor V Deficiency,0.640287087,12,"Biomarker, GeneticVariation"
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,1.0,1.0,0.0,0.0,15503,Factor VII Deficiency,0.639934485,44,"Biomarker, GeneticVariation"
178,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",0.0,1.0,1.0,0.0,0.0,17922,Glycogen Storage Disease Type III,0.639523954,36,"Biomarker, GeneticVariation"
3561,IL2RG,"interleukin 2 receptor, gamma",0.0,1.0,1.0,0.0,0.0,1279481,X-Linked Combined Immunodeficiency Diseases,0.639014873,51,"Biomarker, GeneticVariation"
6473,SHOX,short stature homeobox,0.0,1.0,1.0,0.0,0.0,265309,Leri-Weil syndrome,0.638144292,64,"Biomarker, GeneticVariation"
80025,PANK2,pantothenate kinase 2,0.0,1.0,1.0,0.0,0.0,18523,Pantothenate Kinase-Associated Neurodegeneration,0.637235851,44,"Biomarker, GeneticVariation"
3858,KRT10,"keratin 10, type I",0.0,1.0,1.0,0.0,0.0,79153,"Hyperkeratosis, Epidermolytic",0.636952346,42,"Biomarker, GeneticVariation"
773,CACNA1A,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",0.0,1.0,1.0,0.0,0.0,1720416,Episodic ataxia with nystagmus,0.635358278,47,"Biomarker, GeneticVariation"
122042,RXFP2,relaxin/insulin-like family peptide receptor 2,0.0,1.0,1.0,0.0,0.0,10417,Cryptorchidism,0.635143871,22,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,410529,Hypochondroplasia,0.635025742,53,"Biomarker, GeneticVariation"
1180,CLCN1,"chloride channel, voltage-sensitive 1",0.0,1.0,1.0,0.0,0.0,2936781,Myotonia congenita,0.634742238,52,"Biomarker, GeneticVariation"
79577,CDC73,cell division cycle 73,0.0,1.0,1.0,0.0,0.0,1704981,Hyperparathyroidism 2,0.634458733,51,"Biomarker, GeneticVariation"
2271,FH,fumarate hydratase,0.0,1.0,1.0,0.0,0.0,1708350,Reed's syndrome,0.634175229,51,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,2673196,Lipoprotein Glomerulopathy,0.633989786,33,"Biomarker, GeneticVariation"
3643,INSR,insulin receptor,0.0,1.0,1.0,0.0,0.0,265344,Donohue Syndrome,0.633940755,41,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,1.0,27051,Myocardial Infarction,0.633927213,217,"Biomarker, GeneticVariation, Therapeutic"
2731,GLDC,glycine dehydrogenase (decarboxylating),0.0,1.0,1.0,0.0,0.0,751748,"Hyperglycinemia, Nonketotic",0.633882827,27,"Biomarker, GeneticVariation"
229,ALDOB,"aldolase B, fructose-bisphosphate",0.0,1.0,1.0,0.0,0.0,16751,Fructose Intolerance,0.633824899,13,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,20640,Hypoprothrombinemias,0.633570358,26,"Biomarker, GeneticVariation"
4591,TRIM37,tripartite motif containing 37,0.0,1.0,1.0,0.0,0.0,524582,Mulibrey Nanism,0.633492363,12,"Biomarker, GeneticVariation"
6901,TAZ,tafazzin,0.0,1.0,1.0,0.0,0.0,574083,Barth Syndrome,0.633324715,49,"Biomarker, GeneticVariation"
3897,L1CAM,L1 cell adhesion molecule,0.0,1.0,1.0,0.0,0.0,265216,"Hydrocephalus, X-linked",0.63304121,46,"Biomarker, GeneticVariation"
51119,SBDS,Shwachman-Bodian-Diamond syndrome,0.0,1.0,1.0,0.0,0.0,272170,Shwachman syndrome,0.632757706,45,"Biomarker, GeneticVariation"
1896,EDA,ectodysplasin A,0.0,1.0,1.0,0.0,0.0,162359,"Ectodermal Dysplasia 1, Anhidrotic",0.632757706,45,"Biomarker, GeneticVariation"
4538,ND4,"NADH dehydrogenase, subunit 4 (complex I)",0.0,1.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.63238682,16,"Biomarker, GeneticVariation"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,1264041,"von Willebrand Disease, Type 3",0.632190697,43,"Biomarker, GeneticVariation"
4292,MLH1,mutL homolog 1,0.0,1.0,1.0,0.0,0.0,265325,Turcot syndrome,0.632190697,43,"Biomarker, GeneticVariation"
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",0.0,1.0,1.0,0.0,0.0,1690006,Lattice corneal dystrophy type 1,0.631956223,34,"Biomarker, GeneticVariation"
594,BCKDHB,"branched chain keto acid dehydrogenase E1, beta polypeptide",1.0,1.0,1.0,0.0,0.0,24776,Maple Syrup Urine Disease,0.631869331,10,"AlteredExpression, Biomarker, GeneticVariation"
7454,WAS,Wiskott-Aldrich syndrome,0.0,1.0,1.0,0.0,0.0,1839163,Thrombocytopenia 1,0.631389214,32,"Biomarker, GeneticVariation"
8086,AAAS,"achalasia, adrenocortical insufficiency, alacrimia",0.0,1.0,1.0,0.0,0.0,271742,Achalasia Addisonianism Alacrimia syndrome,0.630489669,40,"Biomarker, GeneticVariation"
4547,MTTP,microsomal triglyceride transfer protein,0.0,1.0,1.0,0.0,0.0,744,Abetalipoproteinemia,0.630460705,29,"Biomarker, GeneticVariation"
1482,NKX2-5,NK2 homeobox 5,0.0,1.0,1.0,0.0,0.0,39685,Tetralogy of Fallot,0.630353257,13,"Biomarker, GeneticVariation"
112476,PRRT2,proline-rich transmembrane protein 2,1.0,1.0,1.0,0.0,0.0,1868682,Familial paroxysmal dystonia,0.630206165,36,"AlteredExpression, Biomarker, GeneticVariation"
593,BCKDHA,"branched chain keto acid dehydrogenase E1, alpha polypeptide",1.0,1.0,1.0,0.0,0.0,24776,Maple Syrup Urine Disease,0.630197267,18,"AlteredExpression, Biomarker, GeneticVariation"
103,ADAR,"adenosine deaminase, RNA-specific",0.0,1.0,1.0,0.0,0.0,406775,Dyschromatosis symmetrica hereditaria 1,0.62992266,35,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,11989,Camurati-Engelmann Syndrome,0.629659222,18,"Biomarker, GeneticVariation"
3859,KRT12,"keratin 12, type I",0.0,1.0,1.0,0.0,0.0,339277,"Corneal Dystrophy, Juvenile Epithelial of Meesmann",0.629552263,15,"Biomarker, GeneticVariation"
843,CASP10,"caspase 10, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.62947378,4,"Biomarker, GeneticVariation"
1756,DMD,dystrophin,1.0,1.0,1.0,0.0,0.0,3714570,Dilated cardiomyopathy 3B,0.629355651,33,"AlteredExpression, Biomarker, GeneticVariation"
3857,KRT9,"keratin 9, type I",0.0,1.0,1.0,0.0,0.0,1721006,"Keratoderma, Palmoplantar, Epidermolytic",0.629355651,38,"Biomarker, GeneticVariation"
23064,SETX,senataxin,0.0,1.0,1.0,0.0,0.0,1853761,"Spinocerebellar ataxia, autosomal recessive 1",0.629355651,33,"Biomarker, GeneticVariation"
7249,TSC2,tuberous sclerosis 2,1.0,1.0,1.0,0.0,0.0,41341,Tuberous Sclerosis,0.629308792,265,"AlteredExpression, Biomarker, GeneticVariation"
182,JAG1,jagged 1,0.0,1.0,1.0,0.0,0.0,39685,Tetralogy of Fallot,0.628935735,8,"Biomarker, GeneticVariation"
1406,CRX,cone-rod homeobox,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.628837673,24,"Biomarker, GeneticVariation"
5205,ATP8B1,"ATPase, aminophospholipid transporter, class I, type 8B, member 1",0.0,1.0,1.0,0.0,0.0,268312,"Cholestasis, progressive familial intrahepatic 1",0.628788642,31,"Biomarker, GeneticVariation"
212,ALAS2,5'-aminolevulinate synthase 2,0.0,1.0,1.0,0.0,0.0,221018,X-linked sideroblastic anemia,0.628788642,37,"Biomarker, GeneticVariation"
2131,EXT1,exostosin glycosyltransferase 1,0.0,1.0,1.0,1.0,0.0,8479,Chondrosarcoma,0.628730714,13,"Biomarker, GeneticVariation, PostTranslationalModification"
2161,F12,coagulation factor XII (Hageman factor),0.0,1.0,1.0,0.0,0.0,15526,Factor XII Deficiency,0.628574235,8,"Biomarker, GeneticVariation"
8085,KMT2D,lysine (K)-specific methyltransferase 2D,0.0,1.0,1.0,0.0,0.0,796004,Kabuki syndrome,0.628554168,22,"Biomarker, GeneticVariation"
26278,SACS,sacsin molecular chaperone,0.0,1.0,1.0,0.0,0.0,1849140,Spastic ataxia Charlevoix-Saguenay type,0.628505137,34,"Biomarker, GeneticVariation"
5373,PMM2,phosphomannomutase 2,0.0,1.0,1.0,0.0,0.0,349653,Congenital disorder of glycosylation type 1A,0.627938128,34,"Biomarker, GeneticVariation"
2639,GCDH,glutaryl-CoA dehydrogenase,0.0,1.0,1.0,0.0,0.0,268595,Glutaric aciduria 1,0.627938128,31,"Biomarker, GeneticVariation"
1584,CYP11B1,"cytochrome P450, family 11, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,268292,Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency,0.627938128,29,"Biomarker, GeneticVariation"
23209,MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1,0.0,1.0,1.0,0.0,0.0,1858854,Megalencephalic leukoencephalopathy with subcortical cysts,0.627938128,29,"Biomarker, GeneticVariation"
132884,EVC2,Ellis van Creveld syndrome 2,0.0,1.0,1.0,0.0,0.0,13903,Ellis-Van Creveld Syndrome,0.6278802,10,"Biomarker, GeneticVariation"
3973,LHCGR,luteinizing hormone/choriogonadotropin receptor,0.0,1.0,1.0,0.0,0.0,342549,Familial Testotoxicosis,0.627703654,21,"Biomarker, GeneticVariation"
501,ALDH7A1,"aldehyde dehydrogenase 7 family, member A1",0.0,1.0,1.0,0.0,0.0,1849508,Pyridoxine-dependent epilepsy,0.627654623,27,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,0.0,1.0,1.0,0.0,0.0,950122,Frasier Syndrome,0.627625659,19,"Biomarker, GeneticVariation"
55654,TMEM127,transmembrane protein 127,0.0,1.0,1.0,0.0,0.0,31511,Pheochromocytoma,0.627469181,10,"Biomarker, GeneticVariation"
6925,TCF4,transcription factor 4,0.0,1.0,1.0,0.0,0.0,1970431,Pitt-Hopkins syndrome,0.627371119,26,"Biomarker, GeneticVariation"
2245,FGD1,"FYVE, RhoGEF and PH domain containing 1",0.0,1.0,1.0,0.0,0.0,175701,Aarskog Syndrome,0.627371119,27,"Biomarker, GeneticVariation"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,1264040,"von Willebrand Disease, Type 2",0.627371119,26,"Biomarker, GeneticVariation"
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,1.0,0.0,0.0,1847501,De Vivo disease,0.627087614,27,"Biomarker, GeneticVariation"
2328,FMO3,flavin containing monooxygenase 3,0.0,1.0,1.0,0.0,0.0,342739,Trimethylaminuria,0.627087614,26,"Biomarker, GeneticVariation"
7276,TTR,transthyretin,0.0,1.0,1.0,0.0,0.0,2751492,"Amyloidosis, Hereditary, Transthyretin-Related",0.62680411,24,"Biomarker, GeneticVariation"
4166,CHST6,carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6,0.0,1.0,1.0,0.0,0.0,1636149,"Macular dystrophy, corneal type 1",0.62680411,25,"Biomarker, GeneticVariation"
10585,POMT1,protein-O-mannosyltransferase 1,0.0,1.0,1.0,0.0,0.0,265221,Walker-Warburg Syndrome,0.62680411,24,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,1.0,0.0,0.0,25149,Medulloblastoma,0.626775146,16,"Biomarker, GeneticVariation"
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",0.0,1.0,1.0,0.0,0.0,1868681,Dystonia 12,0.626520605,23,"Biomarker, GeneticVariation"
10456,HAX1,HCLS1 associated protein X-1,0.0,1.0,1.0,0.0,0.0,1853118,"Neutropenia, Severe Congenital, Autosomal Recessive 3",0.626520605,25,"Biomarker, GeneticVariation"
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,1.0,1.0,0.0,0.0,2751824,"46, XY Disorders of Sex Development",0.626520605,23,"Biomarker, GeneticVariation"
23400,ATP13A2,ATPase type 13A2,0.0,1.0,1.0,0.0,0.0,1847640,Parkinson disease 9,0.626520605,26,"Biomarker, GeneticVariation"
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,1836706,"Hyperthyroidism, Nonautoimmune",0.625953596,21,"Biomarker, GeneticVariation"
4535,ND1,"NADH dehydrogenase, subunit 1 (complex I)",0.0,1.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.625768153,8,"Biomarker, GeneticVariation"
157680,VPS13B,vacuolar protein sorting 13 homolog B (yeast),0.0,1.0,1.0,0.0,0.0,265223,Cohen syndrome,0.625670091,21,"Biomarker, GeneticVariation"
538,ATP7A,"ATPase, Cu++ transporting, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,268353,Occipital horn syndrome,0.625670091,20,"Biomarker, GeneticVariation"
1893,ECM1,extracellular matrix protein 1,0.0,1.0,1.0,0.0,0.0,23795,Lipoid Proteinosis of Urbach and Wiethe,0.625670091,20,"Biomarker, GeneticVariation"
6690,SPINK1,"serine peptidase inhibitor, Kazal type 1",0.0,1.0,1.0,0.0,0.0,1842402,Tropical Calcific Pancreatitis,0.625435618,11,"Biomarker, GeneticVariation"
116085,SLC22A12,"solute carrier family 22 (organic anion/urate transporter), member 12",0.0,1.0,1.0,0.0,0.0,473219,Renal hypouricemia,0.625386587,22,"Biomarker, GeneticVariation"
9289,GPR56,G protein-coupled receptor 56,0.0,1.0,1.0,0.0,0.0,1847352,"Polymicrogyria, Bilateral Frontoparietal",0.625386587,20,"Biomarker, GeneticVariation"
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",0.0,1.0,1.0,0.0,0.0,1275685,Corneal dystrophy Avellino type,0.625386587,19,"Biomarker, GeneticVariation"
113235,SLC46A1,"solute carrier family 46 (folate transporter), member 1",0.0,1.0,1.0,0.0,0.0,342705,"Folate Malabsorption, Hereditary",0.625386587,19,"Biomarker, GeneticVariation"
9241,NOG,noggin,0.0,1.0,1.0,0.0,0.0,1861385,Cushing's symphalangism,0.625386587,19,"Biomarker, GeneticVariation"
5096,PCCB,"propionyl CoA carboxylase, beta polypeptide",0.0,1.0,1.0,0.0,0.0,268579,Propionic Acidemia,0.625103082,21,"Biomarker, GeneticVariation"
164656,TMPRSS6,"transmembrane protease, serine 6",0.0,1.0,1.0,0.0,0.0,85576,Iron-Refractory Iron Deficiency Anemia,0.625103082,18,"Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,432291,Mandibuloacral dysplasia with type A lipodystrophy,0.625103082,19,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,334041,"Osseous Heteroplasia, Progressive",0.624819578,17,"Biomarker, GeneticVariation"
54840,APTX,aprataxin,0.0,1.0,1.0,0.0,0.0,1859598,Early-onset ataxia with oculomotor apraxia and hypoalbuminemia,0.624819578,21,"Biomarker, GeneticVariation"
6690,SPINK1,"serine peptidase inhibitor, Kazal type 1",0.0,1.0,1.0,0.0,0.0,238339,Hereditary pancreatitis,0.624819578,17,"Biomarker, GeneticVariation"
3110,MNX1,motor neuron and pancreas homeobox 1,0.0,1.0,1.0,0.0,0.0,1531773,Currarino triad,0.624819578,18,"Biomarker, GeneticVariation"
285440,CYP4V2,"cytochrome P450, family 4, subfamily V, polypeptide 2",0.0,1.0,1.0,0.0,0.0,1859486,Bietti Crystalline Dystrophy,0.624819578,18,"Biomarker, GeneticVariation"
3248,HPGD,hydroxyprostaglandin dehydrogenase 15-(NAD),0.0,1.0,1.0,0.0,0.0,29411,"Osteoarthropathy, Primary Hypertrophic",0.624790614,9,"Biomarker, GeneticVariation"
1075,CTSC,cathepsin C,0.0,1.0,1.0,0.0,0.0,31106,Aggressive Periodontitis,0.624790614,8,"Biomarker, GeneticVariation"
730,C7,complement component 7,0.0,1.0,1.0,0.0,0.0,1864694,Complement Component 7 Deficiency,0.624634135,5,"Biomarker, GeneticVariation"
5095,PCCA,"propionyl CoA carboxylase, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,268579,Propionic Acidemia,0.624536073,17,"Biomarker, GeneticVariation"
1991,ELANE,"elastase, neutrophil expressed",0.0,1.0,1.0,0.0,0.0,221023,Cyclic neutropenia,0.624536073,16,"Biomarker, GeneticVariation"
3849,KRT2,"keratin 2, type II",0.0,1.0,1.0,0.0,0.0,432306,Ichthyosis Bullosa of Siemens,0.624536073,16,"Biomarker, GeneticVariation"
4867,NPHP1,nephronophthisis 1 (juvenile),0.0,1.0,1.0,0.0,0.0,1855681,"Nephronophthisis, familial juvenile",0.624536073,16,"Biomarker, GeneticVariation"
6928,HNF1B,HNF1 homeobox B,0.0,1.0,1.0,0.0,0.0,431693,Renal cysts and diabetes syndrome,0.624536073,16,"Biomarker, GeneticVariation"
23405,DICER1,"dicer 1, ribonuclease type III",0.0,1.0,1.0,0.0,0.0,1266144,Pleuropulmonary blastoma,0.624536073,16,"Biomarker, GeneticVariation"
4361,MRE11A,MRE11 meiotic recombination 11 homolog A (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,1858391,Ataxia Telangiectasia Like Disorder,0.624536073,17,"Biomarker, GeneticVariation"
3712,IVD,isovaleryl-CoA dehydrogenase,0.0,1.0,1.0,0.0,0.0,268575,"Acidemia, isovaleric",0.624536073,17,"Biomarker, GeneticVariation"
1678,TIMM8A,translocase of inner mitochondrial membrane 8 homolog A (yeast),0.0,1.0,1.0,0.0,0.0,796074,Mohr-Tranebjaerg syndrome,0.624252569,16,"Biomarker, GeneticVariation"
57104,PNPLA2,patatin-like phospholipase domain containing 2,0.0,1.0,1.0,0.0,0.0,1853136,Neutral Lipid Storage Disease with Myopathy,0.624252569,15,"Biomarker, GeneticVariation"
3892,KRT86,"keratin 86, type II",0.0,1.0,1.0,0.0,0.0,546966,Monilethrix,0.624252569,15,"Biomarker, GeneticVariation"
3251,HPRT1,hypoxanthine phosphoribosyltransferase 1,0.0,1.0,1.0,0.0,0.0,268117,"Gout, HPRT-Related",0.624252569,16,"Biomarker, GeneticVariation"
6473,SHOX,short stature homeobox,0.0,1.0,1.0,0.0,0.0,432230,Langer mesomelic dysplasia,0.624252569,15,"Biomarker, GeneticVariation"
54209,TREM2,triggering receptor expressed on myeloid cells 2,0.0,1.0,1.0,0.0,0.0,1857316,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy,0.624252569,16,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,20497,"Hyperostosis, Cortical, Congenital",0.624223604,6,"Biomarker, GeneticVariation"
10166,SLC25A15,solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15,0.0,1.0,1.0,0.0,0.0,268540,HHH syndrome,0.623969064,16,"Biomarker, GeneticVariation"
2290,FOXG1,forkhead box G1,0.0,1.0,1.0,0.0,0.0,3150705,FOXG1 syndrome,0.623969064,14,"Biomarker, GeneticVariation"
1293,COL6A3,"collagen, type VI, alpha 3",0.0,1.0,1.0,0.0,0.0,1834674,Bethlem myopathy,0.623969064,14,"Biomarker, GeneticVariation"
3030,HADHA,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit",0.0,1.0,1.0,0.0,0.0,1969443,Trifunctional Protein Deficiency With Myopathy And Neuropathy,0.623969064,14,"Biomarker, GeneticVariation"
6833,ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",0.0,1.0,1.0,0.0,0.0,1833104,"Diabetes Mellitus, Permanent Neonatal",0.623969064,14,"Biomarker, GeneticVariation"
3766,KCNJ10,"potassium channel, inwardly rectifying subfamily J, member 10",0.0,1.0,1.0,0.0,0.0,2748572,SeSAME syndrome,0.623969064,15,"Biomarker, GeneticVariation"
140803,TRPM6,"transient receptor potential cation channel, subfamily M, member 6",0.0,1.0,1.0,0.0,0.0,1865974,"Hypomagnesemia 1, Intestinal",0.623969064,14,"Biomarker, GeneticVariation"
10165,SLC25A13,"solute carrier family 25 (aspartate/glutamate carrier), member 13",0.0,1.0,1.0,0.0,0.0,1853942,Neonatal-onset citrullinemia type 2,0.623685559,14,"Biomarker, GeneticVariation"
5873,RAB27A,"RAB27A, member RAS oncogene family",0.0,1.0,1.0,0.0,0.0,1868679,Griscelli syndrome type 2,0.623685559,14,"Biomarker, GeneticVariation"
93986,FOXP2,forkhead box P2,0.0,1.0,1.0,0.0,0.0,750927,Developmental verbal dyspraxia,0.623685559,14,"Biomarker, GeneticVariation"
38,ACAT1,acetyl-CoA acetyltransferase 1,0.0,1.0,1.0,0.0,0.0,1536500,Beta ketothiolase deficiency,0.623685559,15,"Biomarker, GeneticVariation"
5395,PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,265325,Turcot syndrome,0.623685559,15,"Biomarker, GeneticVariation"
50964,SOST,sclerostin,0.0,1.0,1.0,0.0,0.0,265301,Sclerosteosis,0.623685559,13,"Biomarker, GeneticVariation"
79577,CDC73,cell division cycle 73,0.0,1.0,1.0,0.0,0.0,1840402,Hyperparathyroidism 1,0.623402055,12,"Biomarker, GeneticVariation"
8838,WISP3,WNT1 inducible signaling pathway protein 3,0.0,1.0,1.0,0.0,0.0,432215,"Arthropathy, progressive pseudorheumatoid, of childhood",0.623402055,12,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,1785148,Rapp-Hodgkin syndrome,0.623402055,13,"Biomarker, GeneticVariation"
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,1.0,0.0,0.0,1864445,Histiocytosis with joint contractures and sensorineural deafness,0.623402055,16,"Biomarker, GeneticVariation"
2512,FTL,"ferritin, light polypeptide",0.0,1.0,1.0,0.0,0.0,1833213,"Hyperferritinemia, hereditary, with congenital cataracts",0.623402055,12,"Biomarker, GeneticVariation"
84295,PHF6,PHD finger protein 6,0.0,1.0,1.0,0.0,0.0,265339,Borjeson-Forssman-Lehmann syndrome,0.623402055,13,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,2020284,"Stickler syndrome, type 1",0.623402055,12,"Biomarker, GeneticVariation"
118429,ANTXR2,anthrax toxin receptor 2,0.0,1.0,1.0,0.0,0.0,2745948,"Hyalinosis, Systemic",0.623402055,12,"Biomarker, GeneticVariation"
157570,ESCO2,establishment of sister chromatid cohesion N-acetyltransferase 2,0.0,1.0,1.0,0.0,0.0,392475,Roberts Syndrome,0.623402055,13,"Biomarker, GeneticVariation"
51128,SAR1B,"secretion associated, Ras related GTPase 1B",0.0,1.0,1.0,0.0,0.0,795956,Chylomicron retention disease,0.62311855,13,"Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,1834653,"Limb-girdle muscular dystrophy, type 1B",0.62311855,11,"Biomarker, GeneticVariation"
25953,PNKD,paroxysmal nonkinesigenic dyskinesia,0.0,1.0,1.0,0.0,0.0,1869117,Paroxysmal nonkinesigenic dyskinesia,0.62311855,12,"Biomarker, GeneticVariation"
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",0.0,1.0,1.0,0.0,0.0,339278,"Corneal dystrophy of Bowman layer, type 1",0.62311855,11,"Biomarker, GeneticVariation"
5921,RASA1,RAS p21 protein activator (GTPase activating protein) 1,0.0,1.0,1.0,0.0,0.0,1842180,Capillary Malformation-Arteriovenous Malformation,0.62311855,12,"Biomarker, GeneticVariation"
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,1.0,0.0,0.0,268363,"Osteogenesis imperfecta, type 4",0.62311855,11,"Biomarker, GeneticVariation"
29914,UBIAD1,UbiA prenyltransferase domain containing 1,0.0,1.0,1.0,0.0,0.0,271287,"Corneal Dystrophy, Crystalline, of Schnyder",0.62311855,11,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,1863204,Propping Zerres syndrome,0.62311855,11,"Biomarker, GeneticVariation"
275,AMT,aminomethyltransferase,0.0,1.0,1.0,0.0,0.0,751748,"Hyperglycinemia, Nonketotic",0.622884077,8,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,2677099,Crouzon Syndrome With Acanthosis Nigricans,0.622835046,10,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,265279,Kniest dysplasia,0.622835046,11,"Biomarker, GeneticVariation"
487,ATP2A1,"ATPase, Ca++ transporting, cardiac muscle, fast twitch 1",1.0,1.0,1.0,0.0,0.0,1832918,Brody myopathy,0.622835046,10,"AlteredExpression, Biomarker, GeneticVariation"
64221,ROBO3,"roundabout, axon guidance receptor, homolog 3 (Drosophila)",0.0,1.0,1.0,0.0,0.0,1846496,"Gaze Palsy, Familial Horizontal, with Progressive Scoliosis",0.622835046,11,"Biomarker, GeneticVariation"
4645,MYO5B,myosin VB,0.0,1.0,1.0,0.0,0.0,341306,Microvillus inclusion disease,0.622835046,12,"Biomarker, GeneticVariation"
8517,IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma",0.0,1.0,1.0,0.0,0.0,1846006,"Ectodermal dysplasia, hypohidrotic, with immune deficiency",0.622835046,10,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.622835046,11,"Biomarker, GeneticVariation"
5880,RAC2,"ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)",0.0,1.0,1.0,0.0,0.0,1842398,Neutrophil Immunodeficiency Syndrome,0.622600572,1,"Biomarker, GeneticVariation"
1188,CLCNKB,"chloride channel, voltage-sensitive Kb",0.0,1.0,1.0,0.0,0.0,1846343,"Bartter syndrome, type 3",0.622551541,10,"Biomarker, GeneticVariation"
8195,MKKS,McKusick-Kaufman syndrome,0.0,1.0,1.0,0.0,0.0,948368,McKusick Kaufman syndrome,0.622551541,9,"Biomarker, GeneticVariation"
7273,TTN,titin,0.0,1.0,1.0,0.0,0.0,1863599,Hereditary Myopathy with Early Respiratory Failure,0.622551541,9,"Biomarker, GeneticVariation"
4351,MPI,mannose phosphate isomerase,0.0,1.0,1.0,0.0,0.0,1865145,Congenital disorder of glycosylation type 1B,0.622551541,13,"Biomarker, GeneticVariation"
26276,VPS33B,vacuolar protein sorting 33 homolog B (yeast),0.0,1.0,1.0,0.0,0.0,1859722,Arthrogryposis renal dysfunction cholestasis syndrome,0.622551541,10,"Biomarker, GeneticVariation"
94137,RP1L1,retinitis pigmentosa 1-like 1,0.0,1.0,1.0,0.0,0.0,3150833,OCCULT MACULAR DYSTROPHY,0.622551541,9,"Biomarker, GeneticVariation"
1292,COL6A2,"collagen, type VI, alpha 2",0.0,1.0,1.0,0.0,0.0,1834674,Bethlem myopathy,0.622551541,9,"Biomarker, GeneticVariation"
9968,MED12,mediator complex subunit 12,0.0,1.0,1.0,0.0,0.0,220769,Opitz-Kaveggia syndrome,0.622551541,9,"Biomarker, GeneticVariation"
8029,CUBN,cubilin (intrinsic factor-cobalamin receptor),0.0,1.0,1.0,0.0,0.0,1306856,Imerslund-Grasbeck syndrome,0.622551541,9,"Biomarker, GeneticVariation"
2617,GARS,glycyl-tRNA synthetase,0.0,1.0,1.0,0.0,0.0,1833308,"Neuronopathy, Distal Hereditary Motor, Type V",0.622551541,9,"Biomarker, GeneticVariation"
1540,CYLD,cylindromatosis (turban tumor syndrome),0.0,1.0,1.0,0.0,0.0,1275122,Trichoepithelioma multiple familial,0.622551541,10,"Biomarker, GeneticVariation"
2710,GK,glycerol kinase,0.0,1.0,1.0,0.0,0.0,268418,Hyperglycerolemia,0.622551541,10,"Biomarker, GeneticVariation"
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,1.0,0.0,0.0,152101,Hypoplastic Left Heart Syndrome,0.622317068,1,"Biomarker, GeneticVariation"
81839,VANGL1,VANGL planar cell polarity protein 1,0.0,1.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.622317068,2,"Biomarker, GeneticVariation"
7498,XDH,xanthine dehydrogenase,0.0,1.0,1.0,0.0,0.0,268118,"Xanthinuria, Type I",0.622268037,8,"Biomarker, GeneticVariation"
54880,BCOR,BCL6 corepressor,0.0,1.0,1.0,0.0,0.0,1846265,"Microphthalmia, syndromic 2",0.622268037,9,"Biomarker, GeneticVariation"
79001,VKORC1,"vitamin K epoxide reductase complex, subunit 1",0.0,1.0,1.0,0.0,0.0,750384,Coumarin Resistance,0.622268037,8,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,265964,Vohwinkel syndrome,0.622268037,8,"Biomarker, GeneticVariation"
10084,PQBP1,polyglutamine binding protein 1,0.0,1.0,1.0,0.0,0.0,796135,Renpenning syndrome 1,0.622268037,10,"Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,1842160,"Myopathy, Myosin Storage",0.622268037,8,"Biomarker, GeneticVariation"
3075,CFH,complement factor H,0.0,1.0,1.0,0.0,0.0,398777,Complement Factor H Deficiency,0.622268037,8,"Biomarker, GeneticVariation"
64127,NOD2,nucleotide-binding oligomerization domain containing 2,0.0,1.0,1.0,0.0,0.0,1836122,"Sarcoidosis, Early-Onset",0.622268037,8,"Biomarker, GeneticVariation"
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,265281,Metatropic dwarfism,0.622268037,8,"Biomarker, GeneticVariation"
30813,VSX1,visual system homeobox 1,0.0,1.0,1.0,0.0,0.0,339284,"Corneal Dystrophy, Posterior Polymorphous, 1",0.622268037,8,"Biomarker, GeneticVariation"
3852,KRT5,"keratin 5, type II",0.0,1.0,1.0,0.0,0.0,432316,Epidermolysis bullosa simplex with mottled pigmentation,0.622268037,8,"Biomarker, GeneticVariation"
113278,SLC52A3,"solute carrier family 52 (riboflavin transporter), member 3",0.0,1.0,1.0,0.0,0.0,796274,Brown-Vialetto-Van Laere syndrome,0.622268037,9,"Biomarker, GeneticVariation"
2811,GP1BA,"glycoprotein Ib (platelet), alpha polypeptide",0.0,1.0,1.0,0.0,0.0,1280798,"Von Willebrand disease, platelet type",0.622268037,8,"Biomarker, GeneticVariation"
477,ATP1A2,"ATPase, Na+/K+ transporting, alpha 2 polypeptide",0.0,1.0,1.0,0.0,0.0,1865322,"Hemiplegic migraine, familial type 2",0.621984532,8,"Biomarker, GeneticVariation"
83959,SLC4A11,"solute carrier family 4, sodium borate transporter, member 11",0.0,1.0,1.0,0.0,0.0,1857572,Corneal dystrophy and perceptive deafness,0.621984532,7,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,2936791,antley-bixler syndrome,0.621984532,7,"Biomarker, GeneticVariation"
2737,GLI3,GLI family zinc finger 3,0.0,1.0,1.0,0.0,0.0,220697,"Polydactyly, Postaxial",0.621984532,7,"Biomarker, GeneticVariation"
5184,PEPD,peptidase D,0.0,1.0,1.0,0.0,0.0,268532,Prolidase Deficiency,0.621984532,11,"Biomarker, GeneticVariation"
6716,SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",0.0,1.0,1.0,0.0,0.0,268297,Pseudovaginal Perineoscrotal Hypospadias,0.621984532,17,"Biomarker, GeneticVariation"
84916,CIRH1A,"cirrhosis, autosomal recessive 1A (cirhin)",0.0,1.0,1.0,0.0,0.0,1858051,North American Indian Childhood Cirrhosis,0.621984532,7,"Biomarker, GeneticVariation"
5972,REN,renin,0.0,1.0,1.0,0.0,0.0,266313,Allanson Pantzar McLeod syndrome,0.621984532,7,"Biomarker, GeneticVariation"
24,ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4",0.0,1.0,1.0,0.0,0.0,1855465,Stargardt disease 1,0.621984532,7,"Biomarker, GeneticVariation"
5741,PTH,parathyroid hormone,0.0,1.0,1.0,0.0,0.0,1832648,Hypoparathyroidism familial isolated,0.621984532,8,"Biomarker, GeneticVariation"
6476,SI,sucrase-isomaltase (alpha-glucosidase),0.0,1.0,1.0,0.0,0.0,1283620,"Sucrase-isomaltase deficiency, congenital",0.621984532,8,"Biomarker, GeneticVariation"
8312,AXIN1,axin 1,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.621984532,8,"Biomarker, GeneticVariation"
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,1.0,0.0,0.0,1849157,"Insulin-Like Growth Factor I, Resistance To",0.621984532,9,"Biomarker, GeneticVariation"
127534,GJB4,"gap junction protein, beta 4, 30.3kDa",0.0,1.0,1.0,0.0,0.0,265961,Erythrokeratodermia Variabilis,0.621984532,7,"Biomarker, GeneticVariation"
8074,FGF23,fibroblast growth factor 23,0.0,1.0,1.0,0.0,0.0,1876187,"Tumoral Calcinosis, Hyperphosphatemic, Familial",0.621984532,7,"Biomarker, GeneticVariation"
124583,CANT1,calcium activated nucleotidase 1,0.0,1.0,1.0,0.0,0.0,432242,Desbuquois syndrome,0.621984532,8,"Biomarker, GeneticVariation"
950,SCARB2,"scavenger receptor class B, member 2",0.0,1.0,1.0,0.0,0.0,751779,"EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH OR WITHOUT RENAL FAILURE",0.621984532,8,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,268363,"Osteogenesis imperfecta, type 4",0.621984532,7,"Biomarker, GeneticVariation"
2896,GRN,granulin,0.0,1.0,1.0,0.0,0.0,1843792,"FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED",0.621984532,8,"Biomarker, GeneticVariation"
56975,FAM20C,"family with sequence similarity 20, member C",0.0,1.0,1.0,0.0,0.0,1850106,Raine syndrome,0.621984532,7,"Biomarker, GeneticVariation"
1836,SLC26A2,"solute carrier family 26 (anion exchanger), member 2",0.0,1.0,1.0,0.0,0.0,1850554,Atelosteogenesis type 2,0.621984532,7,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,0.0,1.0,1.0,0.0,0.0,2931482,Neurofibromatosis-Noonan syndrome,0.621984532,7,"Biomarker, GeneticVariation"
1639,DCTN1,dynactin 1,0.0,1.0,1.0,0.0,0.0,1868594,Perry Syndrome,0.621984532,7,"Biomarker, GeneticVariation"
4621,MYH3,"myosin, heavy chain 3, skeletal muscle, embryonic",0.0,1.0,1.0,0.0,0.0,265224,Freeman-Sheldon syndrome,0.621701027,6,"Biomarker, GeneticVariation"
10568,SLC34A2,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 2",0.0,1.0,1.0,0.0,0.0,155912,Pulmonary Alveolar Microlithiasis,0.621701027,6,"Biomarker, GeneticVariation"
56652,C10orf2,chromosome 10 open reading frame 2,0.0,1.0,1.0,0.0,0.0,1849096,Infantile onset spinocerebellar ataxia,0.621701027,6,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,265293,Frontometaphyseal dysplasia,0.621701027,7,"Biomarker, GeneticVariation"
6524,SLC5A2,"solute carrier family 5 (sodium/glucose cotransporter), member 2",0.0,1.0,1.0,0.0,0.0,17980,"Glycosuria, Renal",0.621701027,6,"Biomarker, GeneticVariation"
54332,GDAP1,ganglioside induced differentiation associated protein 1,0.0,1.0,1.0,0.0,0.0,1859198,"Charcot-Marie-Tooth disease, Type 4A",0.621701027,6,"Biomarker, GeneticVariation"
158,ADSL,adenylosuccinate lyase,0.0,1.0,1.0,0.0,0.0,268126,Adenylosuccinate lyase deficiency,0.621701027,13,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,1.0,0.0,0.0,206711,Pilomatrixoma,0.621701027,6,"Biomarker, GeneticVariation"
6575,SLC20A2,"solute carrier family 20 (phosphate transporter), member 2",0.0,1.0,1.0,0.0,0.0,393590,Idiopathic basal ganglia calcification 1,0.621701027,9,"Biomarker, GeneticVariation"
2688,GH1,growth hormone 1,0.0,1.0,1.0,0.0,0.0,271567,"Isolated Growth Hormone Deficiency, Type II",0.621701027,6,"Biomarker, GeneticVariation"
54332,GDAP1,ganglioside induced differentiation associated protein 1,0.0,1.0,1.0,0.0,0.0,1842983,"Charcot-Marie-Tooth disease, Type 2K",0.621701027,6,"Biomarker, GeneticVariation"
7439,BEST1,bestrophin 1,0.0,1.0,1.0,0.0,0.0,1860406,Vitreoretinochoroidopathy,0.621701027,6,"Biomarker, GeneticVariation"
3998,LMAN1,"lectin, mannose-binding, 1",0.0,1.0,1.0,0.0,0.0,1856883,Familial Multiple Coagulation Factor Deficiency I,0.621701027,7,"Biomarker, GeneticVariation"
10060,ABCC9,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",0.0,1.0,1.0,0.0,0.0,795905,Cantu syndrome,0.621417523,5,"Biomarker, GeneticVariation"
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,1.0,0.0,0.0,1861861,"Cardiomyopathy, Familial Restrictive, 1",0.621417523,5,"Biomarker, GeneticVariation"
80704,SLC19A3,"solute carrier family 19 (thiamine transporter), member 3",1.0,1.0,1.0,0.0,0.0,1843807,"Basal ganglia disease, biotin-responsive",0.621417523,5,"AlteredExpression, Biomarker, GeneticVariation"
50814,NSDHL,NAD(P) dependent steroid dehydrogenase-like,0.0,1.0,1.0,0.0,0.0,265267,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,0.621417523,6,"Biomarker, GeneticVariation"
58,ACTA1,"actin, alpha 1, skeletal muscle",0.0,1.0,1.0,0.0,0.0,546264,Congenital Fiber-Type Disproportion,0.621417523,5,"Biomarker, GeneticVariation"
1075,CTSC,cathepsin C,0.0,1.0,1.0,0.0,0.0,1855627,Keratosis palmoplantaris with periodontopathia and onychogryposis,0.621417523,5,"Biomarker, GeneticVariation"
5091,PC,pyruvate carboxylase,0.0,1.0,1.0,0.0,0.0,34341,Pyruvate Carboxylase Deficiency Disease,0.621417523,6,"Biomarker, GeneticVariation"
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,265280,"Spondylometaphyseal dysplasia, Kozlowski type",0.621417523,5,"Biomarker, GeneticVariation"
56172,ANKH,ANKH inorganic pyrophosphate transport regulator,0.0,1.0,1.0,0.0,0.0,856830,Chondrocalcinosis 2,0.621417523,5,"Biomarker, GeneticVariation"
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,1.0,0.0,0.0,1832661,Anophthalmia with pulmonary hypoplasia,0.621417523,6,"Biomarker, GeneticVariation"
203859,ANO5,anoctamin 5,0.0,1.0,1.0,0.0,0.0,1833736,"Osteogenesis imperfecta, Levin type",0.621417523,5,"Biomarker, GeneticVariation"
1718,DHCR24,24-dehydrocholesterol reductase,0.0,1.0,1.0,0.0,0.0,1865596,Desmosterolosis,0.621417523,5,"Biomarker, GeneticVariation"
2746,GLUD1,glutamate dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,1847555,"Hyperinsulinemic hypoglycemia, familial, 6",0.621417523,8,"Biomarker, GeneticVariation"
11330,CTRC,chymotrypsin C (caldecrin),0.0,1.0,1.0,0.0,0.0,238339,Hereditary pancreatitis,0.621417523,6,"Biomarker, GeneticVariation"
81031,SLC2A10,"solute carrier family 2 (facilitated glucose transporter), member 10",0.0,1.0,1.0,0.0,0.0,1859726,Arterial Tortuosity Syndrome,0.621417523,5,"Biomarker, GeneticVariation"
9927,MFN2,mitofusin 2,0.0,1.0,1.0,0.0,0.0,393807,Hereditary Motor And Sensory Neuropathy VI,0.621417523,5,"Biomarker, GeneticVariation"
5860,QDPR,quinoid dihydropteridine reductase,0.0,1.0,1.0,0.0,0.0,268465,dhpr deficiency,0.621417523,8,"Biomarker, GeneticVariation"
10020,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,0.0,1.0,1.0,0.0,0.0,342853,Sialic Acid Storage Disease,0.621417523,5,"Biomarker, GeneticVariation"
4668,NAGA,"N-acetylgalactosaminidase, alpha-",1.0,1.0,1.0,1.0,0.0,1836544,"Schindler Disease, Type I",0.621417523,7,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2643,GCH1,GTP cyclohydrolase 1,0.0,1.0,1.0,0.0,0.0,268467,"Hyperphenylalaninemia, BH4-Deficient, B",0.621417523,5,"Biomarker, GeneticVariation"
2517,FUCA1,"fucosidase, alpha-L- 1, tissue",0.0,1.0,1.0,0.0,0.0,16788,Fucosidosis,0.621417523,7,"Biomarker, GeneticVariation"
658,BMPR1B,"bone morphogenetic protein receptor, type IB",0.0,1.0,1.0,0.0,0.0,1832702,Brachydactyly type A2,0.621417523,6,"Biomarker, GeneticVariation"
4613,MYCN,v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog,0.0,1.0,1.0,0.0,0.0,796068,Oculodigitoesophagoduodenal syndrome,0.621417523,7,"Biomarker, GeneticVariation"
204,AK2,adenylate kinase 2,0.0,1.0,1.0,0.0,0.0,272167,Reticular dysgenesis,0.621134018,4,"Biomarker, GeneticVariation"
10195,ALG3,"ALG3, alpha-1,3- mannosyltransferase",0.0,1.0,1.0,0.0,0.0,1832736,Congenital disorder of glycosylation type 1D,0.621134018,6,"Biomarker, GeneticVariation"
10436,EMG1,EMG1 N1-specific pseudouridine methyltransferase,0.0,1.0,1.0,0.0,0.0,1859405,Bowen-Conradi syndrome,0.621134018,4,"Biomarker, GeneticVariation"
10020,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,0.0,1.0,1.0,0.0,0.0,1833373,Inclusion body myopathy autosomal recessive,0.621134018,4,"Biomarker, GeneticVariation"
3850,KRT3,"keratin 3, type II",0.0,1.0,1.0,0.0,0.0,339277,"Corneal Dystrophy, Juvenile Epithelial of Meesmann",0.621134018,5,"Biomarker, GeneticVariation"
274,BIN1,bridging integrator 1,0.0,1.0,1.0,0.0,0.0,410204,"Myopathy, Centronuclear, Autosomal Recessive",0.621134018,4,"Biomarker, GeneticVariation"
83990,BRIP1,BRCA1 interacting protein C-terminal helicase 1,0.0,1.0,1.0,0.0,0.0,1836860,"Fanconi Anemia, Complementation Group J",0.621134018,4,"Biomarker, GeneticVariation"
210,ALAD,aminolevulinate dehydratase,0.0,1.0,1.0,0.0,0.0,268328,"Porphyria, Acute Hepatic",0.621134018,4,"Biomarker, GeneticVariation"
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,432227,Brachyolmia Type 3,0.621134018,4,"Biomarker, GeneticVariation"
80208,SPG11,spastic paraplegia 11 (autosomal recessive),0.0,1.0,1.0,0.0,0.0,1858479,"Spastic paraplegia 11, autosomal recessive",0.621134018,5,"Biomarker, GeneticVariation"
788,SLC25A20,"solute carrier family 25 (carnitine/acylcarnitine translocase), member 20",0.0,1.0,1.0,0.0,0.0,342791,Carnitine-Acylcarnitine Translocase Deficiency,0.621134018,6,"Biomarker, GeneticVariation"
27031,NPHP3,nephronophthisis 3 (adolescent),0.0,1.0,1.0,0.0,0.0,2673883,Renal-Hepatic-Pancreatic Dysplasia,0.621134018,4,"Biomarker, GeneticVariation"
3977,LIFR,leukemia inhibitory factor receptor alpha,0.0,1.0,1.0,0.0,0.0,796176,Stuve-Wiedemann syndrome,0.621134018,5,"Biomarker, GeneticVariation"
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,1.0,0.0,0.0,432321,"Epidermolysis bullosa, pretibial",0.621134018,4,"Biomarker, GeneticVariation"
129563,DIS3L2,DIS3 like 3'-5' exoribonuclease 2,0.0,1.0,1.0,0.0,0.0,796113,"Nephroblastomatosis, fetal ascites, macrosomia and Wilms tumor",0.621134018,4,"Biomarker, GeneticVariation"
9663,LPIN2,lipin 2,0.0,1.0,1.0,0.0,0.0,1864997,Majeed syndrome,0.621134018,4,"Biomarker, GeneticVariation"
5831,PYCR1,pyrroline-5-carboxylate reductase 1,0.0,1.0,1.0,0.0,0.0,2751987,"Cutis Laxa, Autosomal Recessive, Type IIB",0.621134018,4,"Biomarker, GeneticVariation"
7476,WNT7A,"wingless-type MMTV integration site family, member 7A",0.0,1.0,1.0,0.0,0.0,1848651,Al Awadi syndrome,0.621134018,4,"Biomarker, GeneticVariation"
554,AVPR2,arginine vasopressin receptor 2,0.0,1.0,1.0,0.0,0.0,1845202,Nephrogenic Syndrome of Inappropriate Antidiuresis,0.621134018,4,"Biomarker, GeneticVariation"
4089,SMAD4,SMAD family member 4,0.0,1.0,1.0,0.0,0.0,1832942,Juvenile Polyposis with Hereditary Hemorrhagic Telangiectasia,0.621134018,4,"Biomarker, GeneticVariation"
5230,PGK1,phosphoglycerate kinase 1,1.0,1.0,1.0,0.0,0.0,1970848,Phosphoglycerate Kinase 1 Deficiency,0.621134018,12,"AlteredExpression, Biomarker, GeneticVariation"
81693,AMN,amnion associated transmembrane protein,0.0,1.0,1.0,0.0,0.0,1306856,Imerslund-Grasbeck syndrome,0.621134018,4,"Biomarker, GeneticVariation"
25978,CHMP2B,charged multivesicular body protein 2B,0.0,1.0,1.0,0.0,0.0,1833296,"Frontotemporal Dementia, Chromosome 3-Linked",0.621134018,4,"Biomarker, GeneticVariation"
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,1.0,0.0,0.0,220722,Cerebrooculofacioskeletal Syndrome 1,0.621134018,4,"Biomarker, GeneticVariation"
2317,FLNB,"filamin B, beta",0.0,1.0,1.0,0.0,0.0,265283,"Atelosteogenesis, type 1",0.621134018,5,"Biomarker, GeneticVariation"
7169,TPM2,tropomyosin 2 (beta),0.0,1.0,1.0,0.0,0.0,1834523,Distal arthrogryposis type 2B,0.621134018,4,"Biomarker, GeneticVariation"
4621,MYH3,"myosin, heavy chain 3, skeletal muscle, embryonic",0.0,1.0,1.0,0.0,0.0,1834523,Distal arthrogryposis type 2B,0.621134018,4,"Biomarker, GeneticVariation"
7136,TNNI2,"troponin I type 2 (skeletal, fast)",0.0,1.0,1.0,0.0,0.0,1834523,Distal arthrogryposis type 2B,0.621134018,5,"Biomarker, GeneticVariation"
4089,SMAD4,SMAD family member 4,0.0,1.0,1.0,0.0,0.0,796081,Growth mental deficiency syndrome of Myhre,0.621134018,4,"Biomarker, GeneticVariation"
113189,CHST14,carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14,0.0,1.0,1.0,0.0,0.0,1866294,"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 1",0.621134018,5,"Biomarker, GeneticVariation"
2244,FGB,fibrinogen beta chain,0.0,1.0,1.0,0.0,0.0,19250,Afibrinogenemia congenital,0.621134018,6,"Biomarker, GeneticVariation"
2692,GHRHR,growth hormone releasing hormone receptor,0.0,1.0,1.0,0.0,0.0,2748571,"Isolated Growth Hormone Deficiency, Type IB",0.620850514,6,"Biomarker, GeneticVariation"
5308,PITX2,paired-like homeodomain 2,0.0,1.0,1.0,0.0,0.0,1842031,"Iridogoniodysgenesis, dominant type",0.620850514,3,"Biomarker, GeneticVariation"
762,CA4,carbonic anhydrase IV,0.0,1.0,1.0,0.0,0.0,1833245,Retinitis Pigmentosa 17,0.620850514,6,"Biomarker, GeneticVariation"
778,CACNA1F,"calcium channel, voltage-dependent, L type, alpha 1F subunit",0.0,1.0,1.0,0.0,0.0,268505,Aland Island Eye Disease,0.620850514,3,"Biomarker, GeneticVariation"
25782,RAB3GAP2,RAB3 GTPase activating protein subunit 2 (non-catalytic),0.0,1.0,1.0,0.0,0.0,796037,Martsolf syndrome,0.620850514,3,"Biomarker, GeneticVariation"
1757,SARDH,sarcosine dehydrogenase,0.0,1.0,1.0,0.0,0.0,268563,Sarcosinemia,0.620850514,3,"Biomarker, GeneticVariation"
2492,FSHR,follicle stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,949595,"Gonadal Dysgenesis, 46,XX",0.620850514,3,"Biomarker, GeneticVariation"
10908,PNPLA6,patatin-like phospholipase domain containing 6,0.0,1.0,1.0,0.0,0.0,2677586,"Spastic Paraplegia 39, Autosomal Recessive",0.620850514,3,"Biomarker, GeneticVariation"
4626,MYH8,"myosin, heavy chain 8, skeletal muscle, perinatal",0.0,1.0,1.0,0.0,0.0,265226,Hecht syndrome,0.620850514,3,"Biomarker, GeneticVariation"
9241,NOG,noggin,0.0,1.0,1.0,0.0,0.0,1861305,NOG-Related-Symphalangism Spectrum Disorder,0.620850514,3,"Biomarker, GeneticVariation"
4998,ORC1,"origin recognition complex, subunit 1",0.0,1.0,1.0,0.0,0.0,1868684,Meier-Gorlin syndrome,0.620850514,6,"Biomarker, GeneticVariation"
3748,KCNC3,"potassium channel, voltage gated Shaw related subfamily C, member 3",0.0,1.0,1.0,0.0,0.0,1854488,Spinocerebellar ataxia 13,0.620850514,4,"Biomarker, GeneticVariation"
1663,DDX11,DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11,0.0,1.0,1.0,0.0,0.0,3150658,WARSAW BREAKAGE SYNDROME,0.620850514,3,"Biomarker, GeneticVariation"
617,BCS1L,BC1 (ubiquinol-cytochrome c reductase) synthesis-like,0.0,1.0,1.0,0.0,0.0,266006,Bjornstad syndrome,0.620850514,3,"Biomarker, GeneticVariation"
2733,GLE1,GLE1 RNA export mediator,0.0,1.0,1.0,0.0,0.0,1854664,Lethal congenital contracture syndrome 1,0.620850514,4,"Biomarker, GeneticVariation"
2248,FGF3,fibroblast growth factor 3,0.0,1.0,1.0,0.0,0.0,1853144,"Deafness, Congenital, with Inner Ear Agenesis, Microtia, and Microdontia",0.620850514,4,"Biomarker, GeneticVariation"
1836,SLC26A2,"solute carrier family 26 (anion exchanger), member 2",0.0,1.0,1.0,0.0,0.0,1847593,"Epiphyseal dysplasia, multiple, 4",0.620850514,3,"Biomarker, GeneticVariation"
84823,LMNB2,lamin B2,0.0,1.0,1.0,0.0,0.0,220989,"Lipodystrophy, Partial, Acquired",0.620850514,3,"Biomarker, GeneticVariation"
415,ARSE,arylsulfatase E (chondrodysplasia punctata 1),0.0,1.0,1.0,0.0,0.0,1844853,"Chondrodysplasia punctata, brachytelephalangic",0.620850514,6,"Biomarker, GeneticVariation"
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",0.0,1.0,1.0,0.0,0.0,1562894,"Corneal dystrophy, Thiel-Behnke type",0.620850514,3,"Biomarker, GeneticVariation"
392255,GDF6,growth differentiation factor 6,0.0,1.0,1.0,0.0,0.0,1861689,Klippel Feil syndrome dominant type,0.620850514,3,"Biomarker, GeneticVariation"
6497,SKI,SKI proto-oncogene,0.0,1.0,1.0,0.0,0.0,1321551,Shprintzen Golberg craniosynostosis,0.620850514,4,"Biomarker, GeneticVariation"
549,AUH,AU RNA binding protein/enoyl-CoA hydratase,0.0,1.0,1.0,0.0,0.0,342727,"3-Methylglutaconic Aciduria, Type I",0.620850514,3,"Biomarker, GeneticVariation"
25793,FBXO7,F-box protein 7,0.0,1.0,1.0,0.0,0.0,1850100,Pallidopyramidal syndrome,0.620850514,4,"Biomarker, GeneticVariation"
5224,PGAM2,phosphoglycerate mutase 2 (muscle),0.0,1.0,1.0,0.0,0.0,268149,Dimauro disease,0.620850514,4,"Biomarker, GeneticVariation"
7879,RAB7A,"RAB7A, member RAS oncogene family",0.0,1.0,1.0,0.0,0.0,1833219,"Charcot-Marie-Tooth disease, Type 2B",0.620850514,4,"Biomarker, GeneticVariation"
5582,PRKCG,"protein kinase C, gamma",0.0,1.0,1.0,0.0,0.0,1854369,Spinocerebellar ataxia 14,0.620850514,4,"Biomarker, GeneticVariation"
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,1.0,1.0,0.0,0.0,432273,Worth syndrome,0.620850514,3,"Biomarker, GeneticVariation"
2317,FLNB,"filamin B, beta",0.0,1.0,1.0,0.0,0.0,432201,Boomerang dysplasia,0.620850514,3,"Biomarker, GeneticVariation"
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,1.0,0.0,0.0,1858673,"Generalized Epilepsy With Febrile Seizures Plus, Type 2",0.620850514,3,"Biomarker, GeneticVariation"
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,1.0,0.0,0.0,1851573,Transient bullous dermolysis of the newborn,0.620850514,3,"Biomarker, GeneticVariation"
11285,B4GALT7,"xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7",0.0,1.0,1.0,0.0,0.0,1869122,"Ehlers-Danlos syndrome, progeroid form",0.620850514,3,"Biomarker, GeneticVariation"
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,1.0,0.0,0.0,2751067,"Parkinsonism-Dystonia, Infantile",0.620850514,3,"Biomarker, GeneticVariation"
4952,OCRL,oculocerebrorenal syndrome of Lowe,0.0,1.0,1.0,0.0,0.0,1845167,Dent Disease 2,0.620850514,3,"Biomarker, GeneticVariation"
201163,FLCN,folliculin,0.0,1.0,1.0,0.0,0.0,1868193,"Pneumothorax, Primary Spontaneous",0.620850514,3,"Biomarker, GeneticVariation"
2161,F12,coagulation factor XII (Hageman factor),0.0,1.0,1.0,0.0,0.0,1857728,Hereditary Angioedema Type III,0.620850514,3,"Biomarker, GeneticVariation"
91147,TMEM67,transmembrane protein 67,0.0,1.0,1.0,0.0,0.0,1857662,COACH syndrome,0.620850514,3,"Biomarker, GeneticVariation"
22,ABCB7,"ATP-binding cassette, sub-family B (MDR/TAP), member 7",0.0,1.0,1.0,0.0,0.0,1845028,"Anemia, sideroblastic spinocerebellar ataxia",0.620850514,5,"Biomarker, GeneticVariation"
7080,NKX2-1,NK2 homeobox 1,0.0,1.0,1.0,0.0,0.0,1970269,"Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress",0.620850514,3,"Biomarker, GeneticVariation"
3872,KRT17,"keratin 17, type I",0.0,1.0,1.0,0.0,0.0,259771,Steatocystoma Multiplex,0.620850514,3,"Biomarker, GeneticVariation"
2055,CLN8,"ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)",0.0,1.0,1.0,0.0,0.0,1864923,"Ceroid lipofuscinosis, neuronal 8",0.620850514,3,"Biomarker, GeneticVariation"
200576,PIKFYVE,"phosphoinositide kinase, FYVE finger containing",0.0,1.0,1.0,0.0,0.0,1562113,"Corneal Dystrophy, Fleck",0.620850514,3,"Biomarker, GeneticVariation"
6469,SHH,sonic hedgehog,0.0,1.0,1.0,0.0,0.0,1840235,Single upper central incisor,0.620850514,3,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,0.0,1.0,1.0,0.0,0.0,1834235,"Neurofibromatosis, Familial Spinal",0.620850514,3,"Biomarker, GeneticVariation"
3236,HOXD10,homeobox D10,0.0,1.0,1.0,0.0,0.0,240912,"Vertical talus, congenital",0.620850514,5,"Biomarker, GeneticVariation"
3034,HAL,histidine ammonia-lyase,0.0,1.0,1.0,0.0,0.0,220992,Histidinemia,0.620850514,3,"Biomarker, GeneticVariation"
389434,IYD,iodotyrosine deiodinase,0.0,1.0,1.0,0.0,0.0,342195,Thyroid Dyshormonogenesis 4,0.620850514,4,"Biomarker, GeneticVariation"
3818,KLKB1,"kallikrein B, plasma (Fletcher factor) 1",0.0,1.0,1.0,0.0,0.0,272339,Prekallikrein Deficiency,0.620850514,5,"Biomarker, GeneticVariation"
2335,FN1,fibronectin 1,0.0,1.0,1.0,0.0,0.0,1866075,Glomerulopathy with fibronectin deposits,0.620850514,4,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,266004,"Knuckle pads, leuconychia and sensorineural deafness",0.620850514,3,"Biomarker, GeneticVariation"
54714,CNGB3,cyclic nucleotide gated channel beta 3,0.0,1.0,1.0,0.0,0.0,1849792,Achromatopsia 3,0.620850514,3,"Biomarker, GeneticVariation"
1146,CHRNG,"cholinergic receptor, nicotinic, gamma (muscle)",0.0,1.0,1.0,0.0,0.0,265261,Multiple pterygium syndrome,0.620850514,5,"Biomarker, GeneticVariation"
80324,PUS1,pseudouridylate synthase 1,0.0,1.0,1.0,0.0,0.0,1838103,Myopathy with lactic acidosis and sideroblastic anemia,0.620850514,4,"Biomarker, GeneticVariation"
7046,TGFBR1,"transforming growth factor, beta receptor 1",0.0,1.0,1.0,0.0,0.0,546476,Keratoacanthoma familial,0.620850514,3,"Biomarker, GeneticVariation"
257,ALX3,ALX homeobox 3,0.0,1.0,1.0,0.0,0.0,1876203,Frontonasal dysplasia,0.620850514,3,"Biomarker, GeneticVariation"
9968,MED12,mediator complex subunit 12,0.0,1.0,1.0,0.0,0.0,796022,Lujan Fryns syndrome,0.620567009,2,"Biomarker, GeneticVariation"
5077,PAX3,paired box 3,0.0,1.0,1.0,0.0,0.0,1852510,Craniofacial deafness hand syndrome,0.620567009,3,"Biomarker, GeneticVariation"
3708,ITPR1,"inositol 1,4,5-trisphosphate receptor, type 1",0.0,1.0,1.0,0.0,0.0,1847725,Spinocerebellar Ataxia 15,0.620567009,3,"Biomarker, GeneticVariation"
7841,MOGS,mannosyl-oligosaccharide glucosidase,0.0,1.0,1.0,0.0,0.0,1853736,"Congenital Disorder Of Glycosylation, Type IIB",0.620567009,2,"Biomarker, GeneticVariation"
9333,TGM5,transglutaminase 5,0.0,1.0,1.0,0.0,0.0,1853354,"Peeling skin syndrome, acral type",0.620567009,2,"Biomarker, GeneticVariation"
51062,ATL1,atlastin GTPase 1,0.0,1.0,1.0,0.0,0.0,2931355,"Spastic paraplegia 3, autosomal dominant",0.620567009,2,"Biomarker, GeneticVariation"
8787,RGS9,regulator of G-protein signaling 9,0.0,1.0,1.0,0.0,0.0,1842073,Prolonged Electroretinal Response Suppression,0.620567009,3,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,1835672,Keratoderma palmoplantar deafness,0.620567009,2,"Biomarker, GeneticVariation"
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,1.0,0.0,0.0,1865643,"Cholestasis, progressive familial intrahepatic 3",0.620567009,3,"Biomarker, GeneticVariation"
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",0.0,1.0,1.0,0.0,0.0,1837974,"Corneal Dystrophy, Lattice Type IIIA",0.620567009,2,"Biomarker, GeneticVariation"
79048,SECISBP2,SECIS binding protein 2,0.0,1.0,1.0,0.0,0.0,1864761,"Thyroid Hormone Metabolism, Abnormal",0.620567009,2,"Biomarker, GeneticVariation"
9526,MPDU1,mannose-P-dolichol utilization defect 1,0.0,1.0,1.0,0.0,0.0,1836669,Congenital disorder of glycosylation type 1F,0.620567009,3,"Biomarker, GeneticVariation"
28982,FLVCR1,feline leukemia virus subgroup C cellular receptor 1,0.0,1.0,1.0,0.0,0.0,1836916,Posterior column ataxia with retinitis pigmentosa,0.620567009,3,"Biomarker, GeneticVariation"
51305,KCNK9,"potassium channel, two pore domain subfamily K, member 9",0.0,1.0,1.0,0.0,0.0,2676770,Birk-Barel Mental Retardation Dysmorphism Syndrome,0.620567009,2,"Biomarker, GeneticVariation"
55145,THAP1,"THAP domain containing, apoptosis associated protein 1",0.0,1.0,1.0,0.0,0.0,1414216,"Dystonia 6, torsion",0.620567009,16,"Biomarker, GeneticVariation"
966,CD59,"CD59 molecule, complement regulatory protein",0.0,1.0,1.0,0.0,0.0,2676767,CD59 Deficiency,0.620567009,3,"Biomarker, GeneticVariation"
3000,GUCY2D,"guanylate cyclase 2D, membrane (retina-specific)",0.0,1.0,1.0,0.0,0.0,2931258,"Amaurosis congenita of Leber, type 1",0.620567009,2,"Biomarker, GeneticVariation"
9401,RECQL4,RecQ protein-like 4,0.0,1.0,1.0,0.0,0.0,265308,Craniosynostosis radial aplasia syndrome,0.620567009,2,"Biomarker, GeneticVariation"
1282,COL4A1,"collagen, type IV, alpha 1",0.0,1.0,1.0,0.0,0.0,2673195,"Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps",0.620567009,2,"Biomarker, GeneticVariation"
7169,TPM2,tropomyosin 2 (beta),0.0,1.0,1.0,0.0,0.0,220662,"Arthrogryposis multiplex congenita, distal type 1",0.620567009,2,"Biomarker, GeneticVariation"
100506658,OCLN,occludin,0.0,1.0,1.0,0.0,0.0,3489725,BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA,0.620567009,2,"Biomarker, GeneticVariation"
1832,DSP,desmoplakin,0.0,1.0,1.0,0.0,0.0,1843292,Skin Fragility-Woolly Hair Syndrome,0.620567009,2,"Biomarker, GeneticVariation"
6786,STIM1,stromal interaction molecule 1,0.0,1.0,1.0,0.0,0.0,2748557,Immune dysfunction with T-cell inactivation due to calcium entry defect 2,0.620567009,2,"Biomarker, GeneticVariation"
4358,MPV17,MpV17 mitochondrial inner membrane protein,0.0,1.0,1.0,0.0,0.0,1850406,Navajo neurohepatopathy,0.620567009,3,"Biomarker, GeneticVariation"
10128,LRPPRC,leucine-rich pentatricopeptide repeat containing,0.0,1.0,1.0,0.0,0.0,1857355,"Leigh syndrome , French Canadian type",0.620567009,2,"Biomarker, GeneticVariation"
147495,APCDD1,adenomatosis polyposis coli down-regulated 1,0.0,1.0,1.0,0.0,0.0,1854310,Hypotrichosis simplex,0.620567009,2,"Biomarker, GeneticVariation"
1001,CDH3,"cadherin 3, type 1, P-cadherin (placental)",0.0,1.0,1.0,0.0,0.0,1857041,"Ectodermal dysplasia, ectrodactyly, and macular dystrophy",0.620567009,2,"Biomarker, GeneticVariation"
326625,MMAB,methylmalonic aciduria (cobalamin deficiency) cblB type,0.0,1.0,1.0,0.0,0.0,1855102,Methylmalonic aciduria cblB type,0.620567009,4,"Biomarker, GeneticVariation"
8398,PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent)",0.0,1.0,1.0,0.0,0.0,2751842,"Dystonia-Parkinsonism, Adult-Onset",0.620567009,2,"Biomarker, GeneticVariation"
3778,KCNMA1,"potassium channel, calcium activated large conductance subfamily M alpha, member 1",0.0,1.0,1.0,0.0,0.0,1836173,Generalized Epilepsy and Paroxysmal Dyskinesia,0.620567009,2,"Biomarker, GeneticVariation"
26154,ABCA12,"ATP-binding cassette, sub-family A (ABC1), member 12",0.0,1.0,1.0,0.0,0.0,1832550,"Lamellar ichthyosis, type 2",0.620567009,2,"Biomarker, GeneticVariation"
3549,IHH,indian hedgehog,0.0,1.0,1.0,0.0,0.0,1843096,Acrocapitofemoral Dysplasia,0.620567009,2,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,1850303,"Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Recessive",0.620567009,2,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,1843851,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",0.620567009,3,"Biomarker, GeneticVariation"
9496,TBX4,T-box 4,0.0,1.0,1.0,0.0,0.0,1840061,Ischiopatellar dysplasia,0.620567009,2,"Biomarker, GeneticVariation"
23096,IQSEC2,IQ motif and Sec7 domain 2,0.0,1.0,1.0,0.0,0.0,2931498,"Mental Retardation, X-Linked 1",0.620567009,3,"Biomarker, GeneticVariation"
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,1.0,0.0,0.0,1842534,Dystonia 18,0.620567009,2,"Biomarker, GeneticVariation"
55650,PIGV,"phosphatidylinositol glycan anchor biosynthesis, class V",0.0,1.0,1.0,0.0,0.0,1855923,Hyperphosphatasia with Mental Retardation,0.620567009,3,"Biomarker, GeneticVariation"
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,1.0,0.0,0.0,1861366,"Syndactyly, type 3",0.620567009,2,"Biomarker, GeneticVariation"
123606,NIPA1,non imprinted in Prader-Willi/Angelman syndrome 1,0.0,1.0,1.0,0.0,0.0,1838192,"Spastic paraplegia 6, autosomal dominant",0.620567009,3,"Biomarker, GeneticVariation"
55157,DARS2,"aspartyl-tRNA synthetase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,1970180,Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation,0.620567009,3,"Biomarker, GeneticVariation"
8292,COLQ,collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase,0.0,1.0,1.0,0.0,1.0,1864233,Endplate Acetylcholinesterase Deficiency,0.620567009,6,"Biomarker, GeneticVariation, Therapeutic"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,265318,"Nevus, Sebaceous of Jadassohn",0.620567009,2,"Biomarker, GeneticVariation"
7140,TNNT3,"troponin T type 3 (skeletal, fast)",0.0,1.0,1.0,0.0,0.0,1834523,Distal arthrogryposis type 2B,0.620567009,3,"Biomarker, GeneticVariation"
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",0.0,1.0,1.0,0.0,0.0,1641846,Groenouw type I corneal dystrophy,0.620567009,2,"Biomarker, GeneticVariation"
56922,MCCC1,methylcrotonoyl-CoA carboxylase 1 (alpha),0.0,1.0,1.0,0.0,0.0,268600,3-methylcrotonyl CoA carboxylase 1 deficiency,0.620567009,5,"Biomarker, GeneticVariation"
4719,NDUFS1,"NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.620567009,2,"Biomarker, GeneticVariation"
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.620567009,2,"Biomarker, GeneticVariation"
2203,FBP1,"fructose-1,6-bisphosphatase 1",0.0,1.0,1.0,0.0,0.0,16756,"Fructose-1,6-Diphosphatase Deficiency",0.620567009,4,"Biomarker, GeneticVariation"
4615,MYD88,myeloid differentiation primary response 88,0.0,1.0,1.0,0.0,0.0,2677092,MYD88 Deficiency,0.620567009,3,"Biomarker, GeneticVariation"
5080,PAX6,paired box 6,0.0,1.0,1.0,0.0,0.0,9363,Coloboma,0.620567009,2,"Biomarker, GeneticVariation"
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,1.0,0.0,0.0,3150943,Long Qt Syndrome 2,0.620567009,2,"Biomarker, GeneticVariation"
6389,SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.620567009,2,"Biomarker, GeneticVariation"
285489,DOK7,docking protein 7,0.0,1.0,1.0,0.0,0.0,1850792,Congenital myasthenic syndrome ib,0.620567009,4,"Biomarker, GeneticVariation"
8813,DPM1,"dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit",0.0,1.0,1.0,0.0,0.0,1837396,Congenital disorder of glycosylation type 1E,0.620567009,4,"Biomarker, GeneticVariation"
9241,NOG,noggin,0.0,1.0,1.0,0.0,0.0,342282,Symphalangism-brachydactyly syndrome,0.620567009,2,"Biomarker, GeneticVariation"
1302,COL11A2,"collagen, type XI, alpha 2",0.0,1.0,1.0,0.0,0.0,1848488,Pierre Robin syndrome with fetal chondrodysplasia,0.620567009,2,"Biomarker, GeneticVariation"
5961,PRPH2,"peripherin 2 (retinal degeneration, slow)",0.0,1.0,1.0,0.0,0.0,2751290,"Choroidal Dystrophy, Central Areolar 2",0.620283505,1,"Biomarker, GeneticVariation"
6595,SMARCA2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",0.0,1.0,1.0,0.0,0.0,1303073,Nicolaides Baraitser syndrome,0.620283505,1,"Biomarker, GeneticVariation"
2688,GH1,growth hormone 1,0.0,1.0,1.0,0.0,0.0,1849779,Kowarski syndrome,0.620283505,1,"Biomarker, GeneticVariation"
27034,ACAD8,"acyl-CoA dehydrogenase family, member 8",0.0,1.0,1.0,0.0,0.0,1969809,Isobutyryl-CoA dehydrogenase deficiency,0.620283505,3,"Biomarker, GeneticVariation"
2259,FGF14,fibroblast growth factor 14,0.0,1.0,1.0,0.0,0.0,1836383,Spinocerebellar ataxia 27,0.620283505,2,"Biomarker, GeneticVariation"
83394,PITPNM3,PITPNM family member 3,0.0,1.0,1.0,0.0,0.0,1832976,Cone-Rod Dystrophy 5,0.620283505,2,"Biomarker, GeneticVariation"
859,CAV3,caveolin 3,0.0,1.0,1.0,0.0,0.0,2678485,Long Qt Syndrome 9,0.620283505,1,"Biomarker, GeneticVariation"
570,BAAT,bile acid CoA:amino acid N-acyltransferase,0.0,1.0,1.0,0.0,0.0,1843139,"Hypercholanemia, Familial",0.620283505,1,"Biomarker, GeneticVariation"
9414,TJP2,tight junction protein 2,0.0,1.0,1.0,0.0,0.0,1843139,"Hypercholanemia, Familial",0.620283505,1,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,432283,Osteoglophonic dwarfism,0.620283505,1,"Biomarker, GeneticVariation"
84930,MASTL,microtubule associated serine/threonine kinase-like,0.0,1.0,1.0,0.0,0.0,1861185,Thrombocytopenia chromosome breakage,0.620283505,1,"Biomarker, GeneticVariation"
346171,ZFP57,ZFP57 zinc finger protein,0.0,1.0,1.0,0.0,0.0,1832386,"Diabetes Mellitus, Transient Neonatal, 1",0.620283505,2,"Biomarker, GeneticVariation"
50674,NEUROG3,neurogenin 3,0.0,1.0,1.0,0.0,0.0,1835888,"Diarrhea 4, Malabsorptive, Congenital",0.620283505,2,"Biomarker, GeneticVariation"
11284,PNKP,polynucleotide kinase 3'-phosphatase,0.0,1.0,1.0,0.0,0.0,3150667,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10",0.620283505,2,"Biomarker, GeneticVariation"
4921,DDR2,discoidin domain receptor tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,1849011,"Spondylometaepiphyseal Dysplasia, Short Limb-Hand Type",0.620283505,1,"Biomarker, GeneticVariation"
9241,NOG,noggin,0.0,1.0,1.0,0.0,0.0,1969652,"BRACHYDACTYLY, TYPE B2",0.620283505,1,"Biomarker, GeneticVariation"
5631,PRPS1,phosphoribosyl pyrophosphate synthetase 1,0.0,1.0,1.0,0.0,0.0,796028,Arts syndrome,0.620283505,1,"Biomarker, GeneticVariation"
5631,PRPS1,phosphoribosyl pyrophosphate synthetase 1,0.0,1.0,1.0,0.0,0.0,1839566,Optic atrophy polyneuropathy deafness,0.620283505,1,"Biomarker, GeneticVariation"
3293,HSD17B3,hydroxysteroid (17-beta) dehydrogenase 3,0.0,1.0,1.0,0.0,0.0,268296,17-Hydroxysteroid Dehydrogenase Deficiency,0.620283505,6,"Biomarker, GeneticVariation"
9640,ZNF592,zinc finger protein 592,0.0,1.0,1.0,0.0,0.0,1847114,"Spinocerebellar ataxia, autosomal recessive 5",0.620283505,1,"Biomarker, GeneticVariation"
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,1.0,1.0,0.0,0.0,2677109,"Leukodystrophy, Hypomyelinating, 4",0.620283505,1,"Biomarker, GeneticVariation"
2072,ERCC4,excision repair cross-complementation group 4,0.0,1.0,1.0,0.0,0.0,1970416,XFE Progeroid Syndrome,0.620283505,1,"Biomarker, GeneticVariation"
401,PHOX2A,paired-like homeobox 2a,0.0,1.0,1.0,0.0,0.0,1865915,"Fibrosis Of Extraocular Muscles, Congenital, 2",0.620283505,2,"Biomarker, GeneticVariation"
23347,SMCHD1,structural maintenance of chromosomes flexible hinge domain containing 1,0.0,1.0,1.0,0.0,0.0,1834671,Facioscapulohumeral Muscular Dystrophy 1B,0.620283505,2,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,1837845,"Sick Sinus Syndrome 1, Autosomal Recessive",0.620283505,1,"Biomarker, GeneticVariation"
335,APOA1,apolipoprotein A-I,0.0,1.0,1.0,0.0,0.0,268389,"Amyloidosis, familial visceral",0.620283505,3,"Biomarker, GeneticVariation"
91869,RFT1,RFT1 homolog (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,2677590,"Congenital Disorder Of Glycosylation, Type In",0.620283505,2,"Biomarker, GeneticVariation"
84572,GNPTG,"N-acetylglucosamine-1-phosphate transferase, gamma subunit",0.0,1.0,1.0,0.0,0.0,1854896,Mucolipidosis III Gamma,0.620283505,2,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,262436,"Cardiac valvular dysplasia, X-linked",0.620283505,1,"Biomarker, GeneticVariation"
5745,PTH1R,parathyroid hormone 1 receptor,0.0,1.0,1.0,0.0,0.0,1859148,"Chondrodysplasia, blomstrand type",0.620283505,1,"Biomarker, GeneticVariation"
25974,MMACHC,"methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria",0.0,1.0,1.0,0.0,0.0,1848561,Methylmalonic acidemia with homocystinuria,0.620283505,2,"Biomarker, GeneticVariation"
55131,RBM28,RNA binding motif protein 28,0.0,1.0,1.0,0.0,0.0,2677535,"Alopecia, Neurologic Defects, and Endocrinopathy Syndrome",0.620283505,2,"Biomarker, GeneticVariation"
3753,KCNE1,"potassium channel, voltage gated subfamily E regulatory beta subunit 1",0.0,1.0,1.0,0.0,0.0,1867904,Long Qt Syndrome 5,0.620283505,1,"Biomarker, GeneticVariation"
10225,CD96,CD96 molecule,0.0,1.0,1.0,0.0,0.0,796095,Opitz trigonocephaly syndrome,0.620283505,1,"Biomarker, GeneticVariation"
3239,HOXD13,homeobox D13,0.0,1.0,1.0,0.0,0.0,1861348,"Syndactyly, type v",0.620283505,2,"Biomarker, GeneticVariation"
2752,GLUL,glutamate-ammonia ligase,0.0,1.0,1.0,0.0,0.0,1864910,"Glutamine deficiency, congenital",0.620283505,1,"Biomarker, GeneticVariation"
169522,KCNV2,"potassium channel, voltage gated modifier subfamily V, member 2",0.0,1.0,1.0,0.0,0.0,1835897,Retinal Cone Dystrophy 3B,0.620283505,2,"Biomarker, GeneticVariation"
6507,SLC1A3,"solute carrier family 1 (glial high affinity glutamate transporter), member 3",0.0,1.0,1.0,0.0,0.0,2675211,"Episodic Ataxia, Type 6",0.620283505,2,"Biomarker, GeneticVariation"
4907,NT5E,"5'-nucleotidase, ecto (CD73)",0.0,1.0,1.0,0.0,0.0,1859372,Calcification of Joints and Arteries,0.620283505,2,"Biomarker, GeneticVariation"
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,1.0,0.0,0.0,432322,"Epidermolysis bullosa dystrophica, Pasini type",0.620283505,1,"Biomarker, GeneticVariation"
23418,CRB1,"crumbs family member 1, photoreceptor morphogenesis associated",0.0,1.0,1.0,0.0,0.0,1868310,Pigmented Paravenous Chorioretinal Atrophy,0.620283505,1,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,268335,Ehlers-Danlos syndrome type 1,0.620283505,1,"Biomarker, GeneticVariation"
51733,UPB1,"ureidopropionase, beta",0.0,1.0,1.0,0.0,0.0,1291512,Beta-Ureidopropionase Deficiency,0.620283505,2,"Biomarker, GeneticVariation"
2776,GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",0.0,1.0,1.0,0.0,0.0,38505,Sturge-Weber Syndrome,0.620283505,2,"Biomarker, GeneticVariation"
843,CASP10,"caspase 10, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,1858968,"Autoimmune Lymphoproliferative Syndrome, Type IIA",0.620283505,1,"Biomarker, GeneticVariation"
4359,MPZ,myelin protein zero,0.0,1.0,1.0,0.0,0.0,1843153,"Charcot-Marie-Tooth disease, Type 2J",0.620283505,1,"Biomarker, GeneticVariation"
51259,TMEM216,transmembrane protein 216,0.0,1.0,1.0,0.0,0.0,1842577,Joubert syndrome 2,0.620283505,1,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,432122,"Trigonocephaly, Nonsyndromic",0.620283505,1,"Biomarker, GeneticVariation"
8398,PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent)",0.0,1.0,1.0,0.0,0.0,1857747,NBIA2B,0.620283505,1,"Biomarker, GeneticVariation"
6555,SLC10A2,"solute carrier family 10 (sodium/bile acid cotransporter), member 2",0.0,1.0,1.0,0.0,0.0,2750087,"Bile Acid Malabsorption, Primary",0.620283505,1,"Biomarker, GeneticVariation"
158326,FREM1,FRAS1 related extracellular matrix 1,0.0,1.0,1.0,0.0,0.0,2750433,Bifid Nose With Or Without Anorectal And Renal Anomalies,0.620283505,1,"Biomarker, GeneticVariation"
3889,KRT83,"keratin 83, type II",0.0,1.0,1.0,0.0,0.0,546966,Monilethrix,0.620283505,2,"Biomarker, GeneticVariation"
57724,EPG5,ectopic P-granules autophagy protein 5 homolog (C. elegans),0.0,1.0,1.0,0.0,0.0,1855772,Absent corpus callosum cataract immunodeficiency,0.620283505,1,"Biomarker, GeneticVariation"
54714,CNGB3,cyclic nucleotide gated channel beta 3,0.0,1.0,1.0,0.0,0.0,1855465,Stargardt disease 1,0.620283505,1,"Biomarker, GeneticVariation"
51196,PLCE1,"phospholipase C, epsilon 1",0.0,1.0,1.0,0.0,0.0,1853124,"NEPHROTIC SYNDROME, TYPE 3",0.620283505,2,"Biomarker, GeneticVariation"
867,CBL,"Cbl proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,3150803,NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA,0.620283505,2,"Biomarker, GeneticVariation"
26277,TINF2,TERF1 (TRF1)-interacting nuclear factor 2,0.0,1.0,1.0,0.0,0.0,1327916,Revesz Debuse syndrome,0.620283505,1,"Biomarker, GeneticVariation"
23133,PHF8,PHD finger protein 8,0.0,1.0,1.0,0.0,0.0,1846055,Siderius X-linked mental retardation syndrome,0.620283505,2,"Biomarker, GeneticVariation"
2301,FOXE3,forkhead box E3,0.0,1.0,1.0,0.0,0.0,1862839,Anterior segment mesenchymal dysgenesis,0.620283505,2,"Biomarker, GeneticVariation"
23229,ARHGEF9,Cdc42 guanine nucleotide exchange factor (GEF) 9,0.0,1.0,1.0,0.0,0.0,1845102,Hyperekplexia and Epilepsy,0.620283505,1,"Biomarker, GeneticVariation"
3209,HOXA13,homeobox A13,0.0,1.0,1.0,0.0,0.0,1867801,"Preaxial deficiency, postaxial polydactyly and hypospadias",0.620283505,2,"Biomarker, GeneticVariation"
2677,GGCX,gamma-glutamyl carboxylase,0.0,1.0,1.0,0.0,0.0,1848534,"Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, 1",0.620283505,1,"Biomarker, GeneticVariation"
5479,PPIB,peptidylprolyl isomerase B (cyclophilin B),0.0,1.0,1.0,0.0,0.0,1850169,"Osteogenesis Imperfecta, Type IX",0.620283505,2,"Biomarker, GeneticVariation"
22845,DOLK,dolichol kinase,0.0,1.0,1.0,0.0,0.0,1835849,"Congenital Disorder Of Glycosylation, Type Im",0.620283505,1,"Biomarker, GeneticVariation"
8450,CUL4B,cullin 4B,0.0,1.0,1.0,0.0,0.0,1845861,"Mental Retardation, X-Linked, With Brachydactyly And Macroglossia",0.620283505,2,"Biomarker, GeneticVariation"
2628,GATM,glycine amidinotransferase (L-arginine:glycine amidinotransferase),0.0,1.0,1.0,0.0,0.0,2675179,Arginine:Glycine Amidinotransferase Deficiency,0.620283505,3,"Biomarker, GeneticVariation"
3141,HLCS,holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase),0.0,1.0,1.0,0.0,0.0,268581,Holocarboxylase Synthetase Deficiency,0.620283505,9,"Biomarker, GeneticVariation"
3028,HSD17B10,hydroxysteroid (17-beta) dehydrogenase 10,0.0,1.0,1.0,0.0,0.0,1845517,"Hydroxyacyl-CoA Dehydrogenase, Type 2, Deficiency",0.620283505,3,"Biomarker, GeneticVariation"
2937,GSS,glutathione synthetase,0.0,1.0,1.0,0.0,0.0,398746,Glutathione synthetase deficiency,0.620283505,1,"Biomarker, GeneticVariation"
283989,TSEN54,TSEN54 tRNA splicing endonuclease subunit,0.0,1.0,1.0,0.0,0.0,1856974,Young McKeever Squier syndrome,0.620283505,1,"Biomarker, GeneticVariation"
3708,ITPR1,"inositol 1,4,5-trisphosphate receptor, type 1",0.0,1.0,1.0,0.0,0.0,1861732,Spinocerebellar Ataxia 29,0.620283505,2,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,1861456,Stiff Skin Syndrome,0.620283505,1,"Biomarker, GeneticVariation"
23322,RPGRIP1L,RPGRIP1-like,0.0,1.0,1.0,0.0,0.0,1857662,COACH syndrome,0.620283505,1,"Biomarker, GeneticVariation"
57545,CC2D2A,coiled-coil and C2 domain containing 2A,0.0,1.0,1.0,0.0,0.0,1857662,COACH syndrome,0.620283505,1,"Biomarker, GeneticVariation"
1497,CTNS,"cystinosin, lysosomal cystine transporter",0.0,1.0,1.0,0.0,0.0,268626,"Cystinosis, Late-Onset Juvenile or Adolescent Nephropathic Type",0.620283505,1,"Biomarker, GeneticVariation"
6495,SIX1,SIX homeobox 1,0.0,1.0,1.0,0.0,0.0,1842124,Branchiootic Syndrome 3,0.620283505,5,"Biomarker, GeneticVariation"
283989,TSEN54,TSEN54 tRNA splicing endonuclease subunit,0.0,1.0,1.0,0.0,0.0,1848526,Pontocerebellar Hypoplasia Type 2A,0.620283505,1,"Biomarker, GeneticVariation"
3759,KCNJ2,"potassium channel, inwardly rectifying subfamily J, member 2",0.0,1.0,1.0,0.0,0.0,1865018,Short QT Syndrome 3,0.620283505,1,"Biomarker, GeneticVariation"
92579,G6PC3,"glucose 6 phosphatase, catalytic, 3",0.0,1.0,1.0,0.0,0.0,2675526,"Neutropenia, Severe Congenital, Autosomal Recessive 4",0.620283505,4,"Biomarker, GeneticVariation"
7010,TEK,"TEK tyrosine kinase, endothelial",0.0,1.0,1.0,0.0,0.0,1838437,"Venous Malformations, Multiple Cutaneous and Mucosal",0.620283505,2,"Biomarker, GeneticVariation"
55640,FLVCR2,"feline leukemia virus subgroup C cellular receptor family, member 2",0.0,1.0,1.0,0.0,0.0,1856972,Encephaloclastic Proliferative Vasculopathy,0.620283505,3,"Biomarker, GeneticVariation"
4595,MUTYH,mutY homolog,0.0,1.0,1.0,0.0,0.0,1837991,"Colorectal Adenomatous Polyposis, Autosomal Recessive",0.620283505,1,"Biomarker, GeneticVariation"
1585,CYP11B2,"cytochrome P450, family 11, subfamily B, polypeptide 2",0.0,1.0,1.0,0.0,0.0,268293,18-Hydroxylase deficiency,0.620283505,1,"Biomarker, GeneticVariation"
729238,SFTPA2,surfactant protein A2,0.0,1.0,1.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.620283505,1,"Biomarker, GeneticVariation"
567,B2M,beta-2-microglobulin,0.0,1.0,1.0,0.0,0.0,1855796,"Hypoproteinemia, Hypercatabolic",0.620283505,1,"Biomarker, GeneticVariation"
3621,ING1,"inhibitor of growth family, member 1",0.0,1.0,1.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.620283505,2,"Biomarker, GeneticVariation"
2694,GIF,gastric intrinsic factor (vitamin B synthesis),0.0,1.0,1.0,0.0,0.0,1394891,Intrinsic Factor Deficiency,0.620283505,2,"Biomarker, GeneticVariation"
5396,PRRX1,paired related homeobox 1,0.0,1.0,1.0,0.0,0.0,1876185,Dysgnathia complex,0.620283505,3,"Biomarker, GeneticVariation"
3848,KRT1,"keratin 1, type II",0.0,1.0,1.0,0.0,0.0,1833030,"Palmoplantar Keratoderma, Nonepidermolytic",0.620283505,1,"Biomarker, GeneticVariation"
26353,HSPB8,heat shock 22kDa protein 8,0.0,1.0,1.0,0.0,0.0,1837552,"Charcot-Marie-Tooth disease, Type 2I",0.620283505,1,"Biomarker, GeneticVariation"
22999,RIMS1,regulating synaptic membrane exocytosis 1,0.0,1.0,1.0,0.0,0.0,1863634,Cone-Rod Dystrophy 7,0.620283505,2,"Biomarker, GeneticVariation"
1103,CHAT,choline O-acetyltransferase,0.0,1.0,1.0,0.0,0.0,393929,Congenital myasthenic syndrome with episodic apnea,0.620283505,3,"Biomarker, GeneticVariation"
1959,EGR2,early growth response 2,0.0,1.0,1.0,0.0,0.0,1843247,"Charcot-Marie-Tooth disease, Type 1D",0.620283505,1,"Biomarker, GeneticVariation"
2733,GLE1,GLE1 RNA export mediator,0.0,1.0,1.0,0.0,0.0,2678471,Lethal Arthrogryposis With Anterior Horn Cell Disease,0.620283505,1,"Biomarker, GeneticVariation"
9791,PTDSS1,phosphatidylserine synthase 1,0.0,1.0,1.0,0.0,0.0,432269,Lenz Majewski hyperostotic dwarfism,0.620283505,1,"Biomarker, GeneticVariation"
5727,PTCH1,patched 1,0.0,1.0,1.0,0.0,0.0,1835820,Holoprosencephaly 7,0.620283505,1,"Biomarker, GeneticVariation"
4720,NDUFS2,"NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase)",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.620283505,2,"Biomarker, GeneticVariation"
80224,NUBPL,nucleotide binding protein-like,0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.620283505,2,"Biomarker, GeneticVariation"
2671,GFER,"growth factor, augmenter of liver regeneration",0.0,1.0,1.0,0.0,0.0,2751320,"Myopathy, Mitochondrial Progressive, With Congenital Cataract, Hearing Loss, And Developmental Delay",0.620283505,1,"Biomarker, GeneticVariation"
131669,UROC1,urocanate hydratase 1,0.0,1.0,1.0,0.0,0.0,268514,Urocanase deficiency,0.620283505,1,"Biomarker, GeneticVariation"
153201,SLC36A2,"solute carrier family 36 (proton/amino acid symporter), member 2",0.0,1.0,1.0,0.0,0.0,268654,Iminoglycinuria,0.620283505,1,"Biomarker, GeneticVariation"
7317,UBA1,ubiquitin-like modifier activating enzyme 1,0.0,1.0,1.0,0.0,0.0,1844934,"Arthrogryposis multiplex congenita, distal, X-linked",0.620283505,2,"Biomarker, GeneticVariation"
9479,MAPK8IP1,mitogen-activated protein kinase 8 interacting protein 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.620283505,1,"Biomarker, GeneticVariation"
5972,REN,renin,0.0,1.0,1.0,0.0,0.0,2751310,"Hyperuricemic Nephropathy, Familial Juvenile 2",0.620283505,1,"Biomarker, GeneticVariation"
3614,IMPDH1,IMP (inosine 5'-monophosphate) dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,1867299,Retinitis Pigmentosa 10,0.620283505,1,"Biomarker, GeneticVariation"
10841,FTCD,formimidoyltransferase cyclodeaminase,0.0,1.0,1.0,0.0,0.0,268609,Glutamate formiminotransferase deficiency,0.620283505,1,"Biomarker, GeneticVariation"
4254,KITLG,KIT ligand,0.0,1.0,1.0,0.0,0.0,1840392,"Hyperpigmentation, Familial Progressive",0.620283505,1,"Biomarker, GeneticVariation"
3930,LBR,lamin B receptor,0.0,1.0,1.0,0.0,0.0,748397,Reynold's syndrome,0.620283505,1,"Biomarker, GeneticVariation"
6389,SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",0.0,1.0,1.0,0.0,0.0,1855008,Mitochondrial Complex II Deficiency,0.620283505,1,"Biomarker, GeneticVariation"
23092,ARHGAP26,Rho GTPase activating protein 26,0.0,1.0,1.0,0.0,0.0,349639,"Leukemia, Myelomonocytic, Juvenile",0.620283505,2,"Biomarker, GeneticVariation"
79840,NHEJ1,nonhomologous end-joining factor 1,0.0,1.0,1.0,0.0,0.0,1969799,"Severe Combined Immunodeficiency with Microcephaly, Growth Retardation, and Sensitivity to Ionizing Radiation",0.620283505,3,"Biomarker, GeneticVariation"
2798,GNRHR,gonadotropin-releasing hormone receptor,0.0,1.0,1.0,0.0,0.0,271582,Fertile eunuch syndrome,0.620283505,1,"Biomarker, GeneticVariation"
974,CD79B,"CD79b molecule, immunoglobulin-associated beta",0.0,1.0,1.0,0.0,0.0,3150207,"AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE",0.62,1,"Biomarker, GeneticVariation"
338917,VSX2,visual system homeobox 2,0.0,1.0,1.0,0.0,0.0,1864720,"Microphthalmia, Isolated 2",0.62,0,"Biomarker, GeneticVariation"
7168,TPM1,tropomyosin 1 (alpha),0.0,1.0,1.0,0.0,0.0,1861863,"Cardiomyopathy, Familial Hypertrophic, 3",0.62,0,"Biomarker, GeneticVariation"
203859,ANO5,anoctamin 5,0.0,1.0,1.0,0.0,0.0,2750076,Miyoshi Muscular Dystrophy 3,0.62,0,"Biomarker, GeneticVariation"
29968,PSAT1,phosphoserine aminotransferase 1,0.0,1.0,1.0,0.0,0.0,1970253,Phosphoserine Aminotransferase Deficiency,0.62,1,"Biomarker, GeneticVariation"
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,1.0,0.0,0.0,2678474,"Cardiomyopathy, Dilated, 2a",0.62,0,"Biomarker, GeneticVariation"
90411,MCFD2,multiple coagulation factor deficiency 2,0.0,1.0,1.0,0.0,0.0,3150889,"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2",0.62,3,"Biomarker, GeneticVariation"
1807,DPYS,dihydropyrimidinase,0.0,1.0,1.0,0.0,0.0,342803,Dihydropyrimidinase Deficiency,0.62,1,"Biomarker, GeneticVariation"
7284,TUFM,"Tu translation elongation factor, mitochondrial",0.0,1.0,1.0,0.0,0.0,1857682,Combined Oxidative Phosphorylation Deficiency 4,0.62,1,"Biomarker, GeneticVariation"
9997,SCO2,SCO2 cytochrome c oxidase assembly protein,0.0,1.0,1.0,0.0,0.0,1858424,"Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency",0.62,0,"Biomarker, GeneticVariation"
55149,MTPAP,mitochondrial poly(A) polymerase,0.0,1.0,1.0,0.0,0.0,3150925,"SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE",0.62,1,"Biomarker, GeneticVariation"
10747,MASP2,mannan-binding lectin serine peptidase 2,0.0,1.0,1.0,0.0,0.0,3151085,MASP2 Deficiency,0.62,1,"Biomarker, GeneticVariation"
10133,OPTN,optineurin,0.0,1.0,1.0,0.0,0.0,3150692,AMYOTROPHIC LATERAL SCLEROSIS 12,0.62,0,"Biomarker, GeneticVariation"
4210,MEFV,Mediterranean fever,0.0,1.0,1.0,0.0,0.0,1851347,"Familial Mediterranean Fever, Autosomal Dominant",0.62,0,"Biomarker, GeneticVariation"
54205,CYCS,"cytochrome c, somatic",0.0,1.0,1.0,0.0,0.0,2677608,Thrombocytopenia 4,0.62,1,"Biomarker, GeneticVariation"
7480,WNT10B,"wingless-type MMTV integration site family, member 10B",0.0,1.0,1.0,0.0,0.0,2749665,Split-Hand/Foot Malformation 6,0.62,1,"Biomarker, GeneticVariation"
7112,TMPO,thymopoietin,0.0,1.0,1.0,0.0,0.0,3151039,"Cardiomyopathy, Dilated, 1t",0.62,1,"Biomarker, GeneticVariation"
5015,OTX2,orthodenticle homeobox 2,0.0,1.0,1.0,0.0,0.0,1864690,"Microphthalmia, Syndromic 5",0.62,0,"Biomarker, GeneticVariation"
123872,DNAAF1,"dynein, axonemal, assembly factor 1",0.0,1.0,1.0,0.0,0.0,2750790,"Ciliary Dyskinesia, Primary, 13",0.62,1,"Biomarker, GeneticVariation"
54332,GDAP1,ganglioside induced differentiation associated protein 1,0.0,1.0,1.0,0.0,0.0,1843183,"Charcot-Marie-Tooth disease, Type 4A, axonal form",0.62,0,"Biomarker, GeneticVariation"
9210,BMP15,bone morphogenetic protein 15,0.0,1.0,1.0,0.0,0.0,1845294,Ovarian Dysgenesis 2,0.62,4,"Biomarker, GeneticVariation"
2688,GH1,growth hormone 1,0.0,1.0,1.0,0.0,0.0,2748571,"Isolated Growth Hormone Deficiency, Type IB",0.62,0,"Biomarker, GeneticVariation"
2677,GGCX,gamma-glutamyl carboxylase,0.0,1.0,1.0,0.0,0.0,1835813,Pseudoxanthoma Elasticum-Like Disorder with Multiple Coagulation Factor Deficiency,0.62,0,"Biomarker, GeneticVariation"
8565,YARS,tyrosyl-tRNA synthetase,0.0,1.0,1.0,0.0,0.0,1842237,"Charcot-Marie-Tooth Disease, Dominant Intermediate C",0.62,1,"Biomarker, GeneticVariation"
79158,GNPTAB,"N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits",0.0,1.0,1.0,0.0,0.0,33788,Pseudo-Hurler polydystrophy,0.62,0,"Biomarker, GeneticVariation"
5078,PAX4,paired box 4,0.0,1.0,1.0,0.0,0.0,2677132,"Maturity-Onset Diabetes Of The Young, Type 9",0.62,1,"Biomarker, GeneticVariation"
22858,ICK,intestinal cell (MAK-like) kinase,0.0,1.0,1.0,0.0,0.0,2675227,Endocrine-Cerebroosteodysplasia,0.62,1,"Biomarker, GeneticVariation"
23322,RPGRIP1L,RPGRIP1-like,0.0,1.0,1.0,0.0,0.0,1969052,"Meckel Syndrome, Type 5",0.62,0,"Biomarker, GeneticVariation"
261734,NPHP4,nephronophthisis 4,0.0,1.0,1.0,0.0,0.0,1846979,Senior-Loken syndrome 4,0.62,0,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,1854416,Macrocephaly Autism Syndrome,0.62,1,"Biomarker, GeneticVariation"
6833,ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",0.0,1.0,1.0,0.0,0.0,271714,"Hypoglycemia, leucine-induced",0.62,0,"Biomarker, GeneticVariation"
80326,WNT10A,"wingless-type MMTV integration site family, member 10A",0.0,1.0,1.0,0.0,0.0,796093,Odontoonychodermal dysplasia,0.62,0,"Biomarker, GeneticVariation"
25839,COG4,component of oligomeric golgi complex 4,0.0,1.0,1.0,0.0,0.0,3150736,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj",0.62,1,"Biomarker, GeneticVariation"
375298,CERKL,ceramide kinase-like,0.0,1.0,1.0,0.0,0.0,1842127,Retinitis Pigmentosa 26,0.62,1,"Biomarker, GeneticVariation"
7414,VCL,vinculin,0.0,1.0,1.0,0.0,0.0,2750459,"Cardiomyopathy, Familial Hypertrophic, 15",0.62,0,"Biomarker, GeneticVariation"
65055,REEP1,receptor accessory protein 1,0.0,1.0,1.0,0.0,0.0,1853247,"Spastic Paraplegia 31, Autosomal Dominant",0.62,2,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,1864852,CATSHL syndrome,0.62,0,"Biomarker, GeneticVariation"
57545,CC2D2A,coiled-coil and C2 domain containing 2A,0.0,1.0,1.0,0.0,0.0,2676788,Joubert Syndrome 9,0.62,0,"Biomarker, GeneticVariation"
1134,CHRNA1,"cholinergic receptor, nicotinic, alpha 1 (muscle)",0.0,1.0,1.0,0.0,0.0,1854678,"MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE",0.62,0,"Biomarker, GeneticVariation"
1146,CHRNG,"cholinergic receptor, nicotinic, gamma (muscle)",0.0,1.0,1.0,0.0,0.0,1854678,"MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE",0.62,0,"Biomarker, GeneticVariation"
1144,CHRND,"cholinergic receptor, nicotinic, delta (muscle)",0.0,1.0,1.0,0.0,0.0,1854678,"MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE",0.62,0,"Biomarker, GeneticVariation"
91624,NEXN,nexilin (F actin binding protein),0.0,1.0,1.0,0.0,0.0,2751084,"Cardiomyopathy, Dilated, 1CC",0.62,0,"Biomarker, GeneticVariation"
347344,ZNF81,zinc finger protein 81,0.0,1.0,1.0,0.0,0.0,1845333,"Mental Retardation, X-Linked 45",0.62,1,"Biomarker, GeneticVariation"
2182,ACSL4,acyl-CoA synthetase long-chain family member 4,0.0,1.0,1.0,0.0,0.0,1845672,"Mental Retardation, X-Linked 63",0.62,1,"Biomarker, GeneticVariation"
84667,HES7,hes family bHLH transcription factor 7,0.0,1.0,1.0,0.0,0.0,3150942,"SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE",0.62,2,"Biomarker, GeneticVariation"
27286,SRPX2,"sushi-repeat containing protein, X-linked 2",0.0,1.0,1.0,0.0,0.0,1845070,"Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia, X-Linked",0.62,1,"Biomarker, GeneticVariation"
389207,GRXCR1,"glutaredoxin, cysteine rich 1",0.0,1.0,1.0,0.0,0.0,1414017,"DEAFNESS, AUTOSOMAL RECESSIVE 25",0.62,2,"Biomarker, GeneticVariation"
147372,CCBE1,collagen and calcium binding EGF domains 1,0.0,1.0,1.0,0.0,0.0,340834,Hennekam lymphangiectasia lymphedema syndrome,0.62,2,"Biomarker, GeneticVariation"
6935,ZEB1,zinc finger E-box binding homeobox 1,0.0,1.0,1.0,0.0,0.0,2750448,"Corneal Dystrophy, Fuchs Endothelial, 6",0.62,1,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,2675750,"Deafness, Autosomal Dominant 3A",0.62,0,"Biomarker, GeneticVariation"
8792,TNFRSF11A,"tumor necrosis factor receptor superfamily, member 11a, NFKB activator",0.0,1.0,1.0,0.0,0.0,2676766,"Osteopetrosis, Autosomal Recessive 7",0.62,1,"Biomarker, GeneticVariation"
6777,STAT5B,signal transducer and activator of transcription 5B,0.0,1.0,1.0,0.0,0.0,1855548,Laron syndrome type 2,0.62,3,"Biomarker, GeneticVariation"
57165,GJC2,"gap junction protein, gamma 2, 47kDa",0.0,1.0,1.0,0.0,0.0,3150732,"LYMPHEDEMA, HEREDITARY, IC",0.62,0,"Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,1.0,0.0,0.0,2676676,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",0.62,0,"Biomarker, GeneticVariation"
79042,TSEN34,TSEN34 tRNA splicing endonuclease subunit,0.0,1.0,1.0,0.0,0.0,2676465,Pontocerebellar Hypoplasia Type 2C,0.62,1,"Biomarker, GeneticVariation"
57165,GJC2,"gap junction protein, gamma 2, 47kDa",0.0,1.0,1.0,0.0,0.0,2750784,"Spastic Paraplegia 44, Autosomal Recessive",0.62,0,"Biomarker, GeneticVariation"
2038,EPB42,erythrocyte membrane protein band 4.2,0.0,1.0,1.0,0.0,0.0,2675192,"Spherocytosis, Type 5",0.62,4,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,1860991,Noonan syndrome 3,0.62,0,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,1853102,Cerebrooculofacioskeletal Syndrome 2,0.62,0,"Biomarker, GeneticVariation"
2542,SLC37A4,"solute carrier family 37 (glucose-6-phosphate transporter), member 4",0.0,1.0,1.0,0.0,0.0,342749,Glycogen Storage Disease IC,0.62,0,"Biomarker, GeneticVariation"
84876,ORAI1,ORAI calcium release-activated calcium modulator 1,0.0,1.0,1.0,0.0,0.0,2748568,Immune dysfunction with T-cell inactivation due to calcium entry defect 1,0.62,0,"Biomarker, GeneticVariation"
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,1863959,"Hyperthyroidism, Familial Gestational",0.62,0,"Biomarker, GeneticVariation"
3033,HADH,hydroxyacyl-CoA dehydrogenase,0.0,1.0,1.0,0.0,0.0,1864948,"Hyperinsulinemic Hypoglycemia, Familial, 4",0.62,0,"Biomarker, GeneticVariation"
8604,SLC25A12,"solute carrier family 25 (aspartate/glutamate carrier), member 12",0.0,1.0,1.0,0.0,0.0,2751855,"Hypomyelination, Global Cerebral",0.62,2,"Biomarker, GeneticVariation"
8671,SLC4A4,"solute carrier family 4 (sodium bicarbonate cotransporter), member 4",0.0,1.0,1.0,0.0,0.0,1970309,"Renal Tubular Acidosis, Proximal, With Ocular Abnormalities And Mental Retardation",0.62,3,"Biomarker, GeneticVariation"
22948,CCT5,"chaperonin containing TCP1, subunit 5 (epsilon)",0.0,1.0,1.0,0.0,0.0,1850395,"Neuropathy, Hereditary Sensory, with Spastic Paraplegia, Autosomal Recessive",0.62,1,"Biomarker, GeneticVariation"
6102,RP2,retinitis pigmentosa 2 (X-linked recessive),0.0,1.0,1.0,0.0,0.0,2681923,Retinitis Pigmentosa 2,0.62,6,"Biomarker, GeneticVariation"
8036,SHOC2,soc-2 suppressor of clear homolog (C. elegans),0.0,1.0,1.0,0.0,0.0,1843181,NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR,0.62,1,"Biomarker, GeneticVariation"
2243,FGA,fibrinogen alpha chain,0.0,1.0,1.0,0.0,0.0,268389,"Amyloidosis, familial visceral",0.62,1,"Biomarker, GeneticVariation"
4069,LYZ,lysozyme,0.0,1.0,1.0,0.0,0.0,268389,"Amyloidosis, familial visceral",0.62,1,"Biomarker, GeneticVariation"
57526,PCDH19,protocadherin 19,0.0,1.0,1.0,0.0,0.0,1848137,"Epilepsy, Female-Restricted, with Mental Retardation",0.62,9,"Biomarker, GeneticVariation"
10060,ABCC9,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",0.0,1.0,1.0,0.0,0.0,1837839,"Cardiomyopathy, Dilated, 1o",0.62,0,"Biomarker, GeneticVariation"
7414,VCL,vinculin,0.0,1.0,1.0,0.0,0.0,1969639,"Cardiomyopathy, Dilated, 1w",0.62,0,"Biomarker, GeneticVariation"
440138,ALG11,"ALG11, alpha-1,2-mannosyltransferase",0.0,1.0,1.0,0.0,0.0,3150913,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip",0.62,2,"Biomarker, GeneticVariation"
9896,FIG4,FIG4 phosphoinositide 5-phosphatase,0.0,1.0,1.0,0.0,0.0,2675491,Amyotrophic Lateral Sclerosis 11,0.62,0,"Biomarker, GeneticVariation"
10142,AKAP9,A kinase (PRKA) anchor protein 9,0.0,1.0,1.0,0.0,0.0,2678483,Long Qt Syndrome 11,0.62,1,"Biomarker, GeneticVariation"
56606,SLC2A9,"solute carrier family 2 (facilitated glucose transporter), member 9",0.0,1.0,1.0,0.0,0.0,2677549,"Hypouricemia, Renal, 2",0.62,3,"Biomarker, GeneticVariation"
8600,TNFSF11,"tumor necrosis factor (ligand) superfamily, member 11",0.0,1.0,1.0,0.0,0.0,1850126,"Osteopetrosis, mild autosomal recessive form",0.62,1,"Biomarker, GeneticVariation"
26275,HIBCH,3-hydroxyisobutyryl-CoA hydrolase,0.0,1.0,1.0,0.0,0.0,342738,Beta-Hydroxyisobutyryl CoA Deacylase Deficiency,0.62,1,"Biomarker, GeneticVariation"
6231,RPS26,ribosomal protein S26,0.0,1.0,1.0,0.0,0.0,2750080,Diamond-Blackfan Anemia 10,0.62,1,"Biomarker, GeneticVariation"
176,ACAN,aggrecan,0.0,1.0,1.0,0.0,0.0,2748544,"Spondyloepimetaphyseal Dysplasia, Aggrecan Type",0.62,0,"Biomarker, GeneticVariation"
64321,SOX17,SRY (sex determining region Y)-box 17,0.0,1.0,1.0,0.0,0.0,3150927,VESICOURETERAL REFLUX 3,0.62,1,"Biomarker, GeneticVariation"
23495,TNFRSF13B,"tumor necrosis factor receptor superfamily, member 13B",0.0,1.0,1.0,0.0,0.0,1836032,Immunoglobulin a deficiency 2,0.62,0,"Biomarker, GeneticVariation"
2672,GFI1,growth factor independent 1 transcription repressor,0.0,1.0,1.0,0.0,0.0,1842930,"Neutropenia, Nonimmune Chronic Idiopathic, Adult",0.62,0,"Biomarker, GeneticVariation"
84100,ARL6,ADP-ribosylation factor-like 6,0.0,1.0,1.0,0.0,0.0,3150808,RETINITIS PIGMENTOSA 55,0.62,0,"Biomarker, GeneticVariation"
64423,INF2,"inverted formin, FH2 and WH2 domain containing",0.0,1.0,1.0,0.0,0.0,2750475,Focal Segmental Glomerulosclerosis 5,0.62,0,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,1851536,"Epiphyseal Dysplasia, Multiple, with Myopia and Conductive Deafness",0.62,0,"Biomarker, GeneticVariation"
1417,CRYBB3,"crystallin, beta B3",0.0,1.0,1.0,0.0,0.0,1857853,"Cataract, Congenital Nuclear, Autosomal Recessive 2",0.62,2,"Biomarker, GeneticVariation"
26227,PHGDH,phosphoglycerate dehydrogenase,0.0,1.0,1.0,0.0,0.0,1866174,Phosphoglycerate Dehydrogenase Deficiency,0.62,1,"Biomarker, GeneticVariation"
6640,SNTA1,"syntrophin, alpha 1",0.0,1.0,1.0,0.0,0.0,2751830,Long Qt Syndrome 12,0.62,2,"Biomarker, GeneticVariation"
23385,NCSTN,nicastrin,0.0,1.0,1.0,0.0,0.0,1840560,"Hidradenitis suppurativa, familial",0.62,2,"Biomarker, GeneticVariation"
2218,FKTN,fukutin,0.0,1.0,1.0,0.0,0.0,2751052,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4",0.62,0,"Biomarker, GeneticVariation"
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,1.0,1.0,0.0,0.0,2751825,Premature Ovarian Failure 7,0.62,0,"Biomarker, GeneticVariation"
4792,NFKBIA,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",0.0,1.0,1.0,0.0,0.0,2677481,"Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant",0.62,1,"Biomarker, GeneticVariation"
84701,COX4I2,cytochrome c oxidase subunit IV isoform 2 (lung),0.0,1.0,1.0,0.0,0.0,2675184,"Exocrine Pancreatic Insufficiency, Dyserythropoietic Anemia, and Calvarial Hyperostosis",0.62,1,"Biomarker, GeneticVariation"
3735,KARS,lysyl-tRNA synthetase,0.0,1.0,1.0,0.0,0.0,3150897,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B",0.62,0,"Biomarker, GeneticVariation"
1837,DTNA,"dystrobrevin, alpha",0.0,1.0,1.0,0.0,0.0,1858725,"Noncompaction of Left Ventricular Myocardium, Familial Isolated, Autosomal Dominant 1",0.62,1,"Biomarker, GeneticVariation"
130557,ZNF513,zinc finger protein 513,0.0,1.0,1.0,0.0,0.0,3150879,RETINITIS PIGMENTOSA 58,0.62,1,"Biomarker, GeneticVariation"
8542,APOL1,"apolipoprotein L, 1",0.0,1.0,1.0,0.0,0.0,2675525,"FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO",0.62,1,"Biomarker, GeneticVariation"
1073,CFL2,cofilin 2 (muscle),0.0,1.0,1.0,0.0,0.0,1853154,Nemaline Myopathy 7,0.62,1,"Biomarker, GeneticVariation"
6135,RPL11,ribosomal protein L11,0.0,1.0,1.0,0.0,0.0,2675512,Diamond-Blackfan Anemia 7,0.62,1,"Biomarker, GeneticVariation"
6326,SCN2A,"sodium channel, voltage gated, type II alpha subunit",0.0,1.0,1.0,0.0,0.0,3150987,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11",0.62,0,"Biomarker, GeneticVariation"
5318,PKP2,plakophilin 2,0.0,1.0,1.0,0.0,0.0,1836906,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 9",0.62,3,"Biomarker, GeneticVariation"
1824,DSC2,desmocollin 2,0.0,1.0,1.0,0.0,0.0,1864850,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 11",0.62,2,"Biomarker, GeneticVariation"
1308,COL17A1,"collagen, type XVII, alpha 1",0.0,1.0,1.0,0.0,0.0,268374,"Epidermolysis Bullosa, Junctional, Non-Herlitz Type",0.62,5,"Biomarker, GeneticVariation"
51251,NT5C3A,"5'-nucleotidase, cytosolic IIIA",0.0,1.0,1.0,0.0,0.0,1849507,"Uridine 5-Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia due to",0.62,2,"Biomarker, GeneticVariation"
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,1.0,0.0,0.0,1856057,"Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type",0.62,1,"Biomarker, GeneticVariation"
5449,POU1F1,POU class 1 homeobox 1,0.0,1.0,1.0,0.0,0.0,2751608,"Pituitary Hormone Deficiency, Combined, 1",0.62,8,"Biomarker, GeneticVariation"
4308,TRPM1,"transient receptor potential cation channel, subfamily M, member 1",0.0,1.0,1.0,0.0,0.0,2750747,CSNB1C,0.62,3,"Biomarker, GeneticVariation"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,1.0,0.0,0.0,1864623,"Diabetes Mellitus, Transient Neonatal, 3",0.62,0,"Biomarker, GeneticVariation"
7168,TPM1,tropomyosin 1 (alpha),0.0,1.0,1.0,0.0,0.0,2678476,"Cardiomyopathy, Dilated, 1y",0.62,0,"Biomarker, GeneticVariation"
83959,SLC4A11,"solute carrier family 4, sodium borate transporter, member 11",0.0,1.0,1.0,0.0,0.0,2750450,"Corneal Dystrophy, Fuchs Endothelial, 4",0.62,0,"Biomarker, GeneticVariation"
8462,KLF11,Kruppel-like factor 11,0.0,1.0,1.0,0.0,0.0,1864839,"Maturity-Onset Diabetes of the Young, Type 7",0.62,1,"Biomarker, GeneticVariation"
7173,TPO,thyroid peroxidase,0.0,1.0,1.0,0.0,0.0,1291299,Thyroid Dyshormonogenesis 2A,0.62,15,"Biomarker, GeneticVariation"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,1865019,Short QT Syndrome 2,0.62,0,"Biomarker, GeneticVariation"
63929,XPNPEP3,"X-prolyl aminopeptidase 3, mitochondrial",0.0,1.0,1.0,0.0,0.0,3150419,NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1,0.62,1,"Biomarker, GeneticVariation"
2273,FHL1,four and a half LIM domains 1,0.0,1.0,1.0,0.0,0.0,2678055,"Myopathy, X-Linked, With Postural Muscle Atrophy",0.62,0,"Biomarker, GeneticVariation"
9131,AIFM1,"apoptosis-inducing factor, mitochondrion-associated, 1",0.0,1.0,1.0,0.0,0.0,3151753,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6,0.62,0,"Biomarker, GeneticVariation"
23064,SETX,senataxin,0.0,1.0,1.0,0.0,0.0,1865409,"Amyotrophic Lateral Sclerosis 4, Juvenile",0.62,0,"Biomarker, GeneticVariation"
9681,DEPDC5,DEP domain containing 5,0.0,1.0,1.0,0.0,0.0,1858477,"Epilepsy, Partial, with Variable Foci",0.62,3,"Biomarker, GeneticVariation"
7369,UMOD,uromodulin,0.0,1.0,1.0,0.0,0.0,1835934,Glomerulocystic Kidney Disease with Hyperuricemia and Isosthenuria,0.62,0,"Biomarker, GeneticVariation"
55624,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",0.0,1.0,1.0,0.0,0.0,3150417,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3",0.62,0,"Biomarker, GeneticVariation"
2067,ERCC1,excision repair cross-complementation group 1,0.0,1.0,1.0,0.0,0.0,1853100,Cerebrooculofacioskeletal Syndrome 4,0.62,1,"Biomarker, GeneticVariation"
287,ANK2,"ankyrin 2, neuronal",0.0,1.0,1.0,0.0,0.0,1970119,"Cardiac Arrhythmia, Ankyrin-B-Related",0.62,1,"Biomarker, GeneticVariation"
83715,ESPN,espin,0.0,1.0,1.0,0.0,0.0,1837007,"DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT",0.62,1,"Biomarker, GeneticVariation"
1369,CPN1,"carboxypeptidase N, polypeptide 1",0.0,1.0,1.0,0.0,0.0,398782,Carboxypeptidase N Deficiency,0.62,1,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,700635,Strudwick syndrome,0.62,0,"Biomarker, GeneticVariation"
7454,WAS,Wiskott-Aldrich syndrome,0.0,1.0,1.0,0.0,0.0,1845987,"Neutropenia, Severe Congenital, X-Linked",0.62,1,"Biomarker, GeneticVariation"
65109,UPF3B,UPF3 regulator of nonsense transcripts homolog B (yeast),0.0,1.0,1.0,0.0,0.0,1970822,"Mental Retardation, X-Linked, Syndromic 14",0.62,1,"Biomarker, GeneticVariation"
9639,ARHGEF10,Rho guanine nucleotide exchange factor (GEF) 10,0.0,1.0,1.0,0.0,0.0,1842357,"Slowed Nerve Conduction Velocity, Autosomal Dominant",0.62,1,"Biomarker, GeneticVariation"
7169,TPM2,tropomyosin 2 (beta),0.0,1.0,1.0,0.0,0.0,1836447,Nemaline myopathy 4,0.62,0,"Biomarker, GeneticVariation"
51259,TMEM216,transmembrane protein 216,0.0,1.0,1.0,0.0,0.0,1864148,Meckel syndrome type 2,0.62,0,"Biomarker, GeneticVariation"
1482,NKX2-5,NK2 homeobox 5,0.0,1.0,1.0,0.0,0.0,2673630,"Hypothyroidism, Congenital, Nongoitrous, 5",0.62,0,"Biomarker, GeneticVariation"
8557,TCAP,titin-cap,0.0,1.0,1.0,0.0,0.0,1843791,"Cardiomyopathy, Dilated, 1N",0.62,0,"Biomarker, GeneticVariation"
5261,PHKG2,"phosphorylase kinase, gamma 2 (testis)",0.0,1.0,1.0,0.0,0.0,2751643,Glycogen Storage Disease IXC,0.62,2,"Biomarker, GeneticVariation"
54361,WNT4,"wingless-type MMTV integration site family, member 4",0.0,1.0,1.0,0.0,0.0,2678492,"Sex Reversal, Female, With Dysgenesis Of Kidneys, Adrenals, And Lungs",0.62,0,"Biomarker, GeneticVariation"
348938,NIPAL4,NIPA-like domain containing 4,0.0,1.0,1.0,0.0,0.0,2677065,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6",0.62,2,"Biomarker, GeneticVariation"
79001,VKORC1,"vitamin K epoxide reductase complex, subunit 1",0.0,1.0,1.0,0.0,0.0,1843832,"Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, Type 2",0.62,1,"Biomarker, GeneticVariation"
30813,VSX1,visual system homeobox 1,0.0,1.0,1.0,0.0,0.0,1835677,Keratoconus 1,0.62,0,"Biomarker, GeneticVariation"
9573,GDF3,growth differentiation factor 3,0.0,1.0,1.0,0.0,0.0,3150967,"KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT",0.62,0,"Biomarker, GeneticVariation"
29071,C1GALT1C1,C1GALT1-specific chaperone 1,0.0,1.0,1.0,0.0,0.0,272137,Tn Syndrome,0.62,1,"Biomarker, GeneticVariation"
78989,COLEC11,collectin sub-family member 11,0.0,1.0,1.0,0.0,0.0,796279,Carnevale syndrome,0.62,1,"Biomarker, GeneticVariation"
6812,STXBP1,syntaxin binding protein 1,0.0,1.0,1.0,0.0,0.0,2677326,"Epileptic Encephalopathy, Early Infantile, 4",0.62,2,"Biomarker, GeneticVariation"
64805,P2RY12,"purinergic receptor P2Y, G-protein coupled, 12",0.0,1.0,1.0,0.0,0.0,1853278,Bleeding Disorder Due To P2RY12 Defect,0.62,1,"Biomarker, GeneticVariation"
2218,FKTN,fukutin,0.0,1.0,1.0,0.0,0.0,1969040,"Muscular Dystrophy, Limb-Girdle, Type 2M",0.62,0,"Biomarker, GeneticVariation"
5352,PLOD2,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2",0.0,1.0,1.0,0.0,0.0,1836602,Bruck syndrome 2,0.62,2,"Biomarker, GeneticVariation"
6491,STIL,SCL/TAL1 interrupting locus,0.0,1.0,1.0,0.0,0.0,2675187,"Microcephaly, Primary Autosomal Recessive, 7",0.62,1,"Biomarker, GeneticVariation"
153201,SLC36A2,"solute carrier family 36 (proton/amino acid symporter), member 2",0.0,1.0,1.0,0.0,0.0,543541,Glycinuria with or without Oxalate Urolithiasis,0.62,0,"Biomarker, GeneticVariation"
5199,CFP,complement factor properdin,0.0,1.0,1.0,0.0,0.0,1839454,"Properdin deficiency, X-linked",0.62,4,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,1845235,"Heterotopia, Periventricular, Ehlers-Danlos Variant",0.62,0,"Biomarker, GeneticVariation"
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,1.0,1.0,0.0,0.0,1854335,"Epilepsy, Nocturnal Frontal Lobe, Type 3",0.62,2,"Biomarker, GeneticVariation"
9573,GDF3,growth differentiation factor 3,0.0,1.0,1.0,0.0,0.0,3150969,"MICROPHTHALMIA, ISOLATED 7",0.62,0,"Biomarker, GeneticVariation"
8242,KDM5C,lysine (K)-specific demethylase 5C,0.0,1.0,1.0,0.0,0.0,1845243,"Mental Retardation, X-Linked, Syndromic, Jarid1c-Related",0.62,3,"Biomarker, GeneticVariation"
80270,HSD3B7,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7",0.0,1.0,1.0,0.0,0.0,1843116,"Bile acid synthesis defect, congenital, 1",0.62,1,"Biomarker, GeneticVariation"
54949,SDHAF2,succinate dehydrogenase complex assembly factor 2,0.0,1.0,1.0,0.0,0.0,1866552,Paragangliomas 2,0.62,1,"Biomarker, GeneticVariation"
4640,MYO1A,myosin IA,0.0,1.0,1.0,0.0,0.0,1842939,"Deafness, Autosomal Dominant 48",0.62,1,"Biomarker, GeneticVariation"
50939,IMPG2,interphotoreceptor matrix proteoglycan 2,0.0,1.0,1.0,0.0,0.0,3150819,RETINITIS PIGMENTOSA 56,0.62,1,"Biomarker, GeneticVariation"
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,1.0,0.0,0.0,268337,Ehlers-Danlos syndrome type 3,0.62,0,"Biomarker, GeneticVariation"
26353,HSPB8,heat shock 22kDa protein 8,0.0,1.0,1.0,0.0,0.0,1834692,"Neuropathy, Distal Hereditary Motor, Type IIA",0.62,0,"Biomarker, GeneticVariation"
2992,GYG1,glycogenin 1,0.0,1.0,1.0,0.0,0.0,3150754,GLYCOGEN STORAGE DISEASE XV,0.62,1,"Biomarker, GeneticVariation"
1340,COX6B1,cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous),0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.62,1,"Biomarker, GeneticVariation"
6439,SFTPB,surfactant protein B,0.0,1.0,1.0,0.0,0.0,1968602,"Surfactant Metabolism Dysfunction, Pulmonary, 1",0.62,1,"Biomarker, GeneticVariation"
54809,SAMD9,sterile alpha motif domain containing 9,0.0,1.0,1.0,0.0,0.0,1864861,"Tumoral Calcinosis, Normophosphatemic, Familial",0.62,1,"Biomarker, GeneticVariation"
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,1.0,0.0,0.0,1969038,"Renal Tubular Acidosis, Distal, With Hemolytic Anemia",0.62,0,"Biomarker, GeneticVariation"
5167,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,0.0,1.0,1.0,0.0,0.0,2750078,"Hypophosphatemic Rickets, Autosomal Recessive, 2",0.62,0,"Biomarker, GeneticVariation"
84153,RNASEH2C,"ribonuclease H2, subunit C",0.0,1.0,1.0,0.0,0.0,1835916,Aicardi-Goutieres Syndrome 3,0.62,3,"Biomarker, GeneticVariation"
2707,GJB3,"gap junction protein, beta 3, 31kDa",0.0,1.0,1.0,0.0,0.0,2675236,"Deafness, Autosomal Dominant 2B",0.62,0,"Biomarker, GeneticVariation"
5961,PRPH2,"peripherin 2 (retinal degeneration, slow)",0.0,1.0,1.0,0.0,0.0,1868569,Patterned dystrophy of retinal pigment epithelium,0.62,0,"Biomarker, GeneticVariation"
7273,TTN,titin,0.0,1.0,1.0,0.0,0.0,1861065,"Cardiomyopathy, Familial Hypertrophic, 9",0.62,2,"Biomarker, GeneticVariation"
57057,TBX20,T-box 20,0.0,1.0,1.0,0.0,0.0,1969657,Atrial Septal Defect 4,0.62,1,"Biomarker, GeneticVariation"
170302,ARX,aristaless related homeobox,0.0,1.0,1.0,0.0,0.0,796244,"Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related",0.62,0,"Biomarker, GeneticVariation"
5663,PSEN1,presenilin 1,0.0,1.0,1.0,0.0,0.0,3160720,"Cardiomyopathy, Dilated, 1u",0.62,0,"Biomarker, GeneticVariation"
7846,TUBA1A,"tubulin, alpha 1a",0.0,1.0,1.0,0.0,0.0,1969029,Lissencephaly 3,0.62,1,"Biomarker, GeneticVariation"
57449,PLEKHG5,"pleckstrin homology domain containing, family G (with RhoGef domain) member 5",0.0,1.0,1.0,0.0,0.0,1970211,"Spinal Muscular Atrophy, Distal, Autosomal Recessive, 4",0.62,0,"Biomarker, GeneticVariation"
100134444,KCNJ18,"potassium channel, inwardly rectifying subfamily J, member 18",0.0,1.0,1.0,0.0,0.0,2750473,"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2",0.62,1,"Biomarker, GeneticVariation"
60,ACTB,"actin, beta",0.0,1.0,1.0,0.0,0.0,1846331,Juvenile-onset dystonia,0.62,0,"Biomarker, GeneticVariation"
9440,MED17,mediator complex subunit 17,0.0,1.0,1.0,0.0,0.0,3150921,"MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY",0.62,1,"Biomarker, GeneticVariation"
10564,ARFGEF2,ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited),0.0,1.0,1.0,0.0,0.0,1842563,"Heterotopia, Periventricular, Autosomal Recessive",0.62,1,"Biomarker, GeneticVariation"
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,1.0,1.0,0.0,0.0,2750466,"Cardiomyopathy, Dilated, 1EE",0.62,0,"Biomarker, GeneticVariation"
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,1.0,0.0,0.0,2751666,Bronchiectasis With Or Without Elevated Sweat Chloride 2,0.62,0,"Biomarker, GeneticVariation"
9897,KIAA0196,KIAA0196,0.0,1.0,1.0,0.0,0.0,1863704,"Spastic paraplegia 8, autosomal dominant",0.62,4,"Biomarker, GeneticVariation"
2034,EPAS1,endothelial PAS domain protein 1,0.0,1.0,1.0,0.0,0.0,2673187,"Erythrocytosis, Familial, 4",0.62,4,"Biomarker, GeneticVariation"
83959,SLC4A11,"solute carrier family 4, sodium borate transporter, member 11",0.0,1.0,1.0,0.0,0.0,1857569,Corneal endothelial dystrophy type 2,0.62,0,"Biomarker, GeneticVariation"
54344,DPM3,dolichyl-phosphate mannosyltransferase polypeptide 3,0.0,1.0,1.0,0.0,0.0,2752007,"Congenital Disorder of Glycosylation, Type Io",0.62,1,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,1858079,Osteoarthritis with Mild Chondrodysplasia,0.62,0,"Biomarker, GeneticVariation"
8985,PLOD3,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3",0.0,1.0,1.0,0.0,0.0,2676285,"Bone Fragility with Contractures, Arterial Rupture, and Deafness",0.62,1,"Biomarker, GeneticVariation"
7287,TULP1,tubby like protein 1,0.0,1.0,1.0,0.0,0.0,3151206,LEBER CONGENITAL AMAUROSIS 15,0.62,0,"Biomarker, GeneticVariation"
1832,DSP,desmoplakin,0.0,1.0,1.0,0.0,0.0,1843896,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 8",0.62,0,"Biomarker, GeneticVariation"
3955,LFNG,LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase,0.0,1.0,1.0,0.0,0.0,1853296,"SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE",0.62,1,"Biomarker, GeneticVariation"
2296,FOXC1,forkhead box C1,0.0,1.0,1.0,0.0,0.0,1866560,Iridogoniodysgenesis type1,0.62,0,"Biomarker, GeneticVariation"
5146,PDE6C,"phosphodiesterase 6C, cGMP-specific, cone, alpha prime",0.0,1.0,1.0,0.0,0.0,2751308,Cone Dystrophy 4,0.62,1,"Biomarker, GeneticVariation"
81857,MED25,mediator complex subunit 25,0.0,1.0,1.0,0.0,0.0,1854150,"Charcot-Marie-Tooth disease, Type 2B2",0.62,1,"Biomarker, GeneticVariation"
10804,GJB6,"gap junction protein, beta 6, 30kDa",0.0,1.0,1.0,0.0,0.0,2675237,"Deafness, Autosomal Dominant 3B",0.62,0,"Biomarker, GeneticVariation"
6718,AKR1D1,"aldo-keto reductase family 1, member D1",0.0,1.0,1.0,0.0,0.0,1856127,"Bile acid synthesis defect, congenital, 2",0.62,3,"Biomarker, GeneticVariation"
2488,FSHB,"follicle stimulating hormone, beta polypeptide",0.0,1.0,1.0,0.0,0.0,1856716,"Follicle-stimulating hormone deficiency, isolated",0.62,1,"Biomarker, GeneticVariation"
8842,PROM1,prominin 1,0.0,1.0,1.0,0.0,0.0,339512,"Macular Dystrophy, Retinal, 2",0.62,0,"Biomarker, GeneticVariation"
5896,RAG1,recombination activating gene 1,0.0,1.0,1.0,0.0,0.0,1835931,"Alpha/Beta T-Cell Lymphopenia with Gamma/Delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity",0.62,0,"Biomarker, GeneticVariation"
79751,SLC25A22,"solute carrier family 25 (mitochondrial carrier: glutamate), member 22",0.0,1.0,1.0,0.0,0.0,270855,"Epileptic Encephalopathy, Early Infantile, 3",0.62,1,"Biomarker, GeneticVariation"
3798,KIF5A,kinesin family member 5A,0.0,1.0,1.0,0.0,0.0,1858712,"Spastic paraplegia 10, autosomal dominant",0.62,5,"Biomarker, GeneticVariation"
3785,KCNQ2,"potassium channel, voltage gated KQT-like subfamily Q, member 2",0.0,1.0,1.0,0.0,0.0,3150986,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7",0.62,0,"Biomarker, GeneticVariation"
9533,POLR1C,"polymerase (RNA) I polypeptide C, 30kDa",0.0,1.0,1.0,0.0,0.0,1855433,"Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive",0.62,1,"Biomarker, GeneticVariation"
1438,CSF2RA,"colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)",0.0,1.0,1.0,0.0,0.0,2677877,"Surfactant Metabolism Dysfunction, Pulmonary, 4",0.62,1,"Biomarker, GeneticVariation"
89884,LHX4,LIM homeobox 4,0.0,1.0,1.0,0.0,0.0,2678408,"Pituitary Hormone Deficiency, Combined, 4",0.62,2,"Biomarker, GeneticVariation"
7466,WFS1,Wolfram syndrome 1 (wolframin),0.0,1.0,1.0,0.0,0.0,1833021,"Deafness, Autosomal Dominant 6",0.62,0,"Biomarker, GeneticVariation"
118813,ZFYVE27,"zinc finger, FYVE domain containing 27",0.0,1.0,1.0,0.0,0.0,1853251,"Spastic Paraplegia 33, Autosomal Dominant",0.62,1,"Biomarker, GeneticVariation"
9992,KCNE2,"potassium channel, voltage gated subfamily E regulatory beta subunit 2",0.0,1.0,1.0,0.0,0.0,3150953,Long Qt Syndrome 6,0.62,0,"Biomarker, GeneticVariation"
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),0.0,1.0,1.0,0.0,0.0,2751295,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5",0.62,1,"Biomarker, GeneticVariation"
2273,FHL1,four and a half LIM domains 1,0.0,1.0,1.0,0.0,0.0,2678061,"Scapuloperoneal Myopathy, X-Linked Dominant",0.62,0,"Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,3495498,"Cardiomyopathy, Familial Hypertrophic, 1",0.62,0,"Biomarker, GeneticVariation"
4040,LRP6,low density lipoprotein receptor-related protein 6,0.0,1.0,1.0,0.0,0.0,1970440,"Coronary Artery Disease, Autosomal Dominant 2",0.62,1,"Biomarker, GeneticVariation"
5459,POU4F3,POU class 4 homeobox 3,0.0,1.0,1.0,0.0,0.0,1865366,"Deafness, Autosomal Dominant 15",0.62,1,"Biomarker, GeneticVariation"
10516,FBLN5,fibulin 5,0.0,1.0,1.0,0.0,0.0,1837187,"Macular Degeneration, Age-Related, 3",0.62,0,"Biomarker, GeneticVariation"
374462,PTPRQ,"protein tyrosine phosphatase, receptor type, Q",0.0,1.0,1.0,0.0,0.0,3150654,"DEAFNESS, AUTOSOMAL RECESSIVE 84A",0.62,1,"Biomarker, GeneticVariation"
170302,ARX,aristaless related homeobox,0.0,1.0,1.0,0.0,0.0,796124,Proud Syndrome,0.62,0,"Biomarker, GeneticVariation"
23171,GPD1L,glycerol-3-phosphate dehydrogenase 1-like,0.0,1.0,1.0,0.0,0.0,2673193,Brugada Syndrome 2,0.62,0,"Biomarker, GeneticVariation"
134430,WDR36,WD repeat domain 36,0.0,1.0,1.0,0.0,0.0,1835933,"Glaucoma 1, Open Angle, G",0.62,1,"Biomarker, GeneticVariation"
1134,CHRNA1,"cholinergic receptor, nicotinic, alpha 1 (muscle)",0.0,1.0,1.0,0.0,0.0,1837122,"Myasthenic Syndrome, Congenital, Fast-Channel",0.62,0,"Biomarker, GeneticVariation"
1145,CHRNE,"cholinergic receptor, nicotinic, epsilon (muscle)",0.0,1.0,1.0,0.0,0.0,1837122,"Myasthenic Syndrome, Congenital, Fast-Channel",0.62,0,"Biomarker, GeneticVariation"
1144,CHRND,"cholinergic receptor, nicotinic, delta (muscle)",0.0,1.0,1.0,0.0,0.0,1837122,"Myasthenic Syndrome, Congenital, Fast-Channel",0.62,0,"Biomarker, GeneticVariation"
2892,GRIA3,"glutamate receptor, ionotropic, AMPA 3",0.0,1.0,1.0,0.0,0.0,2678051,"Mental Retardation, X-Linked 94",0.62,1,"Biomarker, GeneticVariation"
54361,WNT4,"wingless-type MMTV integration site family, member 4",0.0,1.0,1.0,0.0,0.0,2675014,Mullerian Aplasia and Hyperandrogenism,0.62,0,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,266313,Allanson Pantzar McLeod syndrome,0.62,2,"Biomarker, GeneticVariation"
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,1.0,0.0,0.0,266313,Allanson Pantzar McLeod syndrome,0.62,1,"Biomarker, GeneticVariation"
8988,HSPB3,heat shock 27kDa protein 3,0.0,1.0,1.0,0.0,0.0,3150619,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC",0.62,1,"Biomarker, GeneticVariation"
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,1.0,1.0,0.0,0.0,2677903,Mental Retardation And Microcephaly With Pontine And Cerebellar Hypoplasia,0.62,0,"Biomarker, GeneticVariation"
3158,HMGCS2,3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial),0.0,1.0,1.0,0.0,0.0,2751532,3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency,0.62,3,"Biomarker, GeneticVariation"
5889,RAD51C,RAD51 paralog C,0.0,1.0,1.0,0.0,0.0,3150653,"FANCONI ANEMIA, COMPLEMENTATION GROUP O",0.62,0,"Biomarker, GeneticVariation"
1829,DSG2,desmoglein 2,0.0,1.0,1.0,0.0,0.0,1857777,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 10",0.62,2,"Biomarker, GeneticVariation"
925,CD8A,CD8a molecule,0.0,1.0,1.0,0.0,0.0,1837065,"CD8 Deficiency, Familial",0.62,1,"Biomarker, GeneticVariation"
5122,PCSK1,proprotein convertase subtilisin/kexin type 1,0.0,1.0,1.0,0.0,0.0,1833053,Proprotein Convertase 1 3 Deficiency,0.62,2,"Biomarker, GeneticVariation"
3239,HOXD13,homeobox D13,0.0,1.0,1.0,0.0,0.0,220664,"Brachydactyly, Type D",0.62,1,"Biomarker, GeneticVariation"
785,CACNB4,"calcium channel, voltage-dependent, beta 4 subunit",0.0,1.0,1.0,0.0,0.0,1866039,"Episodic Ataxia, Type 5",0.62,1,"Biomarker, GeneticVariation"
4634,MYL3,"myosin, light chain 3, alkali; ventricular, skeletal, slow",0.0,1.0,1.0,0.0,0.0,1837471,"Cardiomyopathy, Familial Hypertrophic, 8",0.62,3,"Biomarker, GeneticVariation"
65217,PCDH15,protocadherin-related 15,0.0,1.0,1.0,0.0,0.0,1836027,"Deafness, Autosomal Recessive 23",0.62,0,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,1834846,"Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1",0.62,0,"Biomarker, GeneticVariation"
9132,KCNQ4,"potassium channel, voltage gated KQT-like subfamily Q, member 4",0.0,1.0,1.0,0.0,0.0,2677637,"Deafness, Autosomal Dominant 2A",0.62,5,"Biomarker, GeneticVariation"
54583,EGLN1,egl-9 family hypoxia-inducible factor 1,0.0,1.0,1.0,0.0,0.0,1853286,"Erythrocytosis, Familial, 3",0.62,2,"Biomarker, GeneticVariation"
7276,TTR,transthyretin,0.0,1.0,1.0,0.0,0.0,2750824,Dystransthyretinemic Euthyroidal Hyperthyroxinemia,0.62,0,"Biomarker, GeneticVariation"
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,1.0,0.0,0.0,2750091,"Cardiomyopathy, Dilated, 1FF",0.62,0,"Biomarker, GeneticVariation"
259236,TMIE,transmembrane inner ear,0.0,1.0,1.0,0.0,0.0,1832992,"Deafness, Autosomal Recessive 6",0.62,1,"Biomarker, GeneticVariation"
1716,DGUOK,deoxyguanosine kinase,0.0,1.0,1.0,0.0,0.0,3151513,MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE),0.62,2,"Biomarker, GeneticVariation"
338917,VSX2,visual system homeobox 2,0.0,1.0,1.0,0.0,0.0,1864721,"Microphthalmia, Isolated, with Coloboma 3",0.62,0,"Biomarker, GeneticVariation"
10913,EDAR,ectodysplasin A receptor,0.0,1.0,1.0,0.0,0.0,1720965,"Ectodermal Dysplasia 3, Anhidrotic",0.62,0,"Biomarker, GeneticVariation"
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,1.0,1.0,0.0,0.0,1855739,"Indifference to Pain, Congenital, Autosomal Recessive",0.62,0,"Biomarker, GeneticVariation"
154881,KCTD7,potassium channel tetramerization domain containing 7,0.0,1.0,1.0,0.0,0.0,2673257,"Epilepsy, Progressive Myoclonic 3",0.62,3,"Biomarker, GeneticVariation"
57545,CC2D2A,coiled-coil and C2 domain containing 2A,0.0,1.0,1.0,0.0,0.0,2676790,"Meckel Syndrome, Type 6",0.62,0,"Biomarker, GeneticVariation"
91147,TMEM67,transmembrane protein 67,0.0,1.0,1.0,0.0,0.0,3150796,NEPHRONOPHTHISIS 11,0.62,0,"Biomarker, GeneticVariation"
3848,KRT1,"keratin 1, type II",0.0,1.0,1.0,0.0,0.0,1843463,"Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis",0.62,0,"Biomarker, GeneticVariation"
50484,RRM2B,ribonucleotide reductase M2 B (TP53 inducible),0.0,1.0,1.0,0.0,0.0,2749861,MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY),0.62,3,"Biomarker, GeneticVariation"
1376,CPT2,carnitine palmitoyltransferase 2,0.0,1.0,1.0,0.0,0.0,1833508,"Carnitine Palmitoyltransferase II Deficiency, Late-Onset",0.62,9,"Biomarker, GeneticVariation"
6100,RP9,retinitis pigmentosa 9 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,1867300,Retinitis Pigmentosa 9,0.62,1,"Biomarker, GeneticVariation"
60529,ALX4,ALX homeobox 4,0.0,1.0,1.0,0.0,0.0,1865044,Parietal Foramina 2,0.62,0,"Biomarker, GeneticVariation"
10518,CIB2,calcium and integrin binding family member 2,0.0,1.0,1.0,0.0,0.0,3553944,"USHER SYNDROME, TYPE IJ",0.62,1,"Biomarker, GeneticVariation"
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,1.0,0.0,0.0,1860752,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7",0.62,0,"Biomarker, GeneticVariation"
3199,HOXA2,homeobox A2,0.0,1.0,1.0,0.0,0.0,2676772,"Microtia, Hearing Impairment, And Cleft Palate",0.62,2,"Biomarker, GeneticVariation"
5913,RAPSN,receptor-associated protein of the synapse,0.0,1.0,1.0,0.0,0.0,1837091,"Myasthenic syndrome, congenital, type Id",0.62,0,"Biomarker, GeneticVariation"
55624,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",0.0,1.0,1.0,0.0,0.0,3150412,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3",0.62,0,"Biomarker, GeneticVariation"
81607,PVRL4,poliovirus receptor-related 4,0.0,1.0,1.0,0.0,0.0,3150807,ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1,0.62,1,"Biomarker, GeneticVariation"
291,SLC25A4,"solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4",0.0,1.0,1.0,0.0,0.0,1836460,"Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 2",0.62,4,"Biomarker, GeneticVariation"
57539,WDR35,WD repeat domain 35,0.0,1.0,1.0,0.0,0.0,3150874,CRANIOECTODERMAL DYSPLASIA 2,0.62,0,"Biomarker, GeneticVariation"
56652,C10orf2,chromosome 10 open reading frame 2,0.0,1.0,1.0,0.0,0.0,1843851,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",0.62,0,"Biomarker, GeneticVariation"
767,CA8,carbonic anhydrase VIII,0.0,1.0,1.0,0.0,0.0,2750509,"Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 3",0.62,1,"Biomarker, GeneticVariation"
7704,ZBTB16,zinc finger and BTB domain containing 16,0.0,1.0,1.0,0.0,0.0,2676231,"Skeletal Defects, Genital Hypoplasia, And Mental Retardation",0.62,1,"Biomarker, GeneticVariation"
29958,DMGDH,dimethylglycine dehydrogenase,0.0,1.0,1.0,0.0,0.0,1853892,Dimethylglycine Dehydrogenase Deficiency,0.62,1,"Biomarker, GeneticVariation"
144165,PRICKLE1,prickle homolog 1 (Drosophila),0.0,1.0,1.0,0.0,0.0,2676254,Prickle1-Related Progressive Myoclonus Epilepsy with Ataxia,0.62,1,"Biomarker, GeneticVariation"
2736,GLI2,GLI family zinc finger 2,0.0,1.0,1.0,0.0,0.0,1835819,Holoprosencephaly 9,0.62,0,"Biomarker, GeneticVariation"
4359,MPZ,myelin protein zero,0.0,1.0,1.0,0.0,0.0,1843075,"Charcot-Marie-Tooth Disease, Dominant Intermediate D",0.62,0,"Biomarker, GeneticVariation"
286676,ILDR1,immunoglobulin-like domain containing receptor 1,0.0,1.0,1.0,0.0,0.0,1864818,"Deafness, Autosomal Recessive 42",0.62,1,"Biomarker, GeneticVariation"
1950,EGF,epidermal growth factor,0.0,1.0,1.0,0.0,0.0,2673648,"Hypomagnesemia 4, Renal",0.62,1,"Biomarker, GeneticVariation"
4647,MYO7A,myosin VIIA,0.0,1.0,1.0,0.0,0.0,1832475,"Deafness, Autosomal Dominant 11",0.62,0,"Biomarker, GeneticVariation"
120227,CYP2R1,"cytochrome P450, family 2, subfamily R, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1838657,"Vitamin D Hydroxylation-Deficient Rickets, Type 1B",0.62,1,"Biomarker, GeneticVariation"
4935,GPR143,G protein-coupled receptor 143,0.0,1.0,1.0,0.0,0.0,3151752,"NYSTAGMUS 6, CONGENITAL, X-LINKED",0.62,0,"Biomarker, GeneticVariation"
29954,POMT2,protein-O-mannosyltransferase 2,0.0,1.0,1.0,0.0,0.0,3150418,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2",0.62,0,"Biomarker, GeneticVariation"
771,CA12,carbonic anhydrase XII,0.0,1.0,1.0,0.0,0.0,1840437,"HYPERCHLORHIDROSIS, ISOLATED",0.62,1,"Biomarker, GeneticVariation"
84839,RAX2,retina and anterior neural fold homeobox 2,0.0,1.0,1.0,0.0,0.0,1835865,Cone-Rod Dystrophy 11,0.62,0,"Biomarker, GeneticVariation"
1896,EDA,ectodysplasin A,0.0,1.0,1.0,0.0,0.0,1970757,"Tooth Agenesis, Selective, X-Linked, 1",0.62,0,"Biomarker, GeneticVariation"
254065,BRWD3,bromodomain and WD repeat domain containing 3,0.0,1.0,1.0,0.0,0.0,1970841,"Mental Retardation, X-Linked 93",0.62,1,"Biomarker, GeneticVariation"
51082,POLR1D,"polymerase (RNA) I polypeptide D, 16kDa",0.0,1.0,1.0,0.0,0.0,3150983,TREACHER COLLINS SYNDROME 2,0.62,1,"Biomarker, GeneticVariation"
54795,TRPM4,"transient receptor potential cation channel, subfamily M, member 4",0.0,1.0,1.0,0.0,0.0,1970298,"Progressive Familial Heart Block, Type Ib",0.62,3,"Biomarker, GeneticVariation"
1414,CRYBB1,"crystallin, beta B1",0.0,1.0,1.0,0.0,0.0,1969062,"Cataract, Congenital Nuclear, Autosomal Recessive 3",0.62,1,"Biomarker, GeneticVariation"
1175,AP2S1,"adaptor-related protein complex 2, sigma 1 subunit",0.0,1.0,1.0,0.0,0.0,1833372,"Familial benign hypercalcemia, type 3",0.62,2,"Biomarker, GeneticVariation"
7134,TNNC1,troponin C type 1 (slow),0.0,1.0,1.0,0.0,0.0,2678475,"Cardiomyopathy, Dilated, 1z",0.62,0,"Biomarker, GeneticVariation"
388939,C2orf71,chromosome 2 open reading frame 71,0.0,1.0,1.0,0.0,0.0,3150691,RETINITIS PIGMENTOSA 54,0.62,2,"Biomarker, GeneticVariation"
5956,OPN1LW,"opsin 1 (cone pigments), long-wave-sensitive",0.0,1.0,1.0,0.0,0.0,339537,Blue cone monochromatism,0.62,0,"Biomarker, GeneticVariation"
2317,FLNB,"filamin B, beta",0.0,1.0,1.0,0.0,0.0,1862414,"ATELOSTEOGENESIS, TYPE III",0.62,1,"Biomarker, GeneticVariation"
8425,LTBP4,latent transforming growth factor beta binding protein 4,0.0,1.0,1.0,0.0,0.0,2750804,"Cutis Laxa With Severe Pulmonary, Gastrointestinal, And Urinary Abnormalities",0.62,1,"Biomarker, GeneticVariation"
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",0.0,1.0,1.0,0.0,0.0,521723,"Corneal dystrophy, epithelial basement membrane",0.62,0,"Biomarker, GeneticVariation"
2700,GJA3,"gap junction protein, alpha 3, 46kDa",0.0,1.0,1.0,0.0,0.0,1866078,"Cataract, Zonular Pulverulent 3",0.62,15,"Biomarker, GeneticVariation"
10484,SEC23A,Sec23 homolog A (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,1843042,Craniolenticulosutural Dysplasia,0.62,1,"Biomarker, GeneticVariation"
71,ACTG1,actin gamma 1,0.0,1.0,1.0,0.0,0.0,1858172,"Deafness, Autosomal Dominant 20",0.62,0,"Biomarker, GeneticVariation"
11281,POU6F2,POU class 6 homeobox 2,0.0,1.0,1.0,0.0,0.0,1832099,Wilms tumor and radial bilateral aplasia,0.62,1,"Biomarker, GeneticVariation"
79068,FTO,fat mass and obesity associated,0.0,1.0,1.0,0.0,0.0,2752001,"Growth Retardation, Developmental Delay, Coarse Facies, And Early Death",0.62,1,"Biomarker, GeneticVariation"
23322,RPGRIP1L,RPGRIP1-like,0.0,1.0,1.0,0.0,0.0,1969053,Joubert Syndrome 7,0.62,0,"Biomarker, GeneticVariation"
57817,HAMP,hepcidin antimicrobial peptide,0.0,1.0,1.0,0.0,0.0,1865616,"Hemochromatosis, Type 2B",0.62,3,"Biomarker, GeneticVariation"
57010,CABP4,calcium binding protein 4,0.0,1.0,1.0,0.0,0.0,1864877,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B",0.62,1,"Biomarker, GeneticVariation"
9056,SLC7A7,"solute carrier family 7 (amino acid transporter light chain, y+L system), member 7",0.0,1.0,1.0,0.0,0.0,268647,Lysinuric Protein Intolerance,0.62,1,"Biomarker, GeneticVariation"
23389,MED13L,mediator complex subunit 13-like,0.0,1.0,1.0,0.0,0.0,1837341,"Transposition of the Great Arteries, Dextro-Looped 1",0.62,1,"Biomarker, GeneticVariation"
5308,PITX2,paired-like homeodomain 2,0.0,1.0,1.0,0.0,0.0,1867155,Ring dermoid of cornea,0.62,0,"Biomarker, GeneticVariation"
2690,GHR,growth hormone receptor,0.0,1.0,1.0,0.0,0.0,1858656,"Short Stature, Idiopathic, Autosomal",0.62,0,"Biomarker, GeneticVariation"
2693,GHSR,growth hormone secretagogue receptor,0.0,1.0,1.0,0.0,0.0,1858656,"Short Stature, Idiopathic, Autosomal",0.62,1,"Biomarker, GeneticVariation"
4747,NEFL,"neurofilament, light polypeptide",0.0,1.0,1.0,0.0,0.0,1843164,"Charcot-Marie-Tooth disease, Type 1F",0.62,0,"Biomarker, GeneticVariation"
6330,SCN4B,"sodium channel, voltage gated, type IV beta subunit",0.0,1.0,1.0,0.0,0.0,2678484,Long Qt Syndrome 10,0.62,2,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,3150970,NOONAN SYNDROME 7,0.62,0,"Biomarker, GeneticVariation"
4653,MYOC,"myocilin, trabecular meshwork inducible glucocorticoid response",0.0,1.0,1.0,0.0,0.0,1842028,"Glaucoma 1, Open Angle, A",0.62,0,"Biomarker, GeneticVariation"
55835,CENPJ,centromere protein J,0.0,1.0,1.0,0.0,0.0,1842109,"Microcephaly, Primary Autosomal Recessive, 6",0.62,1,"Biomarker, GeneticVariation"
538,ATP7A,"ATPase, Cu++ transporting, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,1845359,"Spinal Muscular Atrophy, Distal, X-Linked 3",0.62,0,"Biomarker, GeneticVariation"
10021,HCN4,hyperpolarization activated cyclic nucleotide gated potassium channel 4,0.0,1.0,1.0,0.0,0.0,1834144,"Sick Sinus Syndrome 2, Autosomal Dominant",0.62,2,"Biomarker, GeneticVariation"
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,1.0,0.0,0.0,1834478,Macrothrombocytopenia progressive deafness,0.62,0,"Biomarker, GeneticVariation"
80746,TSEN2,TSEN2 tRNA splicing endonuclease subunit,0.0,1.0,1.0,0.0,0.0,2676466,Pontocerebellar Hypoplasia Type 2B,0.62,1,"Biomarker, GeneticVariation"
346007,EYS,eyes shut homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,1864446,Retinitis Pigmentosa 25,0.62,2,"Biomarker, GeneticVariation"
28976,ACAD9,"acyl-CoA dehydrogenase family, member 9",0.0,1.0,1.0,0.0,0.0,1970173,"Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of",0.62,6,"Biomarker, GeneticVariation"
80184,CEP290,centrosomal protein 290kDa,0.0,1.0,1.0,0.0,0.0,1857779,Senior-Loken Syndrome 6,0.62,0,"Biomarker, GeneticVariation"
7134,TNNC1,troponin C type 1 (slow),0.0,1.0,1.0,0.0,0.0,2750472,"Cardiomyopathy, Familial Hypertrophic, 13",0.62,0,"Biomarker, GeneticVariation"
5063,PAK3,p21 protein (Cdc42/Rac)-activated kinase 3,0.0,1.0,1.0,0.0,0.0,796237,"Mental Retardation, X-Linked 30",0.62,2,"Biomarker, GeneticVariation"
1019,CDK4,cyclin-dependent kinase 4,0.0,1.0,1.0,0.0,0.0,1836892,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3",0.62,3,"Biomarker, GeneticVariation"
1535,CYBA,"cytochrome b-245, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,1856255,"Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative",0.62,5,"Biomarker, GeneticVariation"
1013,CDH15,"cadherin 15, type 1, M-cadherin (myotubule)",0.0,1.0,1.0,0.0,0.0,2675488,"Mental Retardation, Autosomal Dominant 3",0.62,1,"Biomarker, GeneticVariation"
1135,CHRNA2,"cholinergic receptor, nicotinic, alpha 2 (neuronal)",0.0,1.0,1.0,0.0,0.0,1835905,"Epilepsy, Nocturnal Frontal Lobe, Type 4",0.62,1,"Biomarker, GeneticVariation"
5664,PSEN2,presenilin 2,0.0,1.0,1.0,0.0,0.0,1847200,Alzheimer disease type 4,0.62,3,"Biomarker, GeneticVariation"
56945,MRPS22,mitochondrial ribosomal protein S22,0.0,1.0,1.0,0.0,0.0,2673642,Combined Oxidative Phosphorylation Deficiency 5,0.62,1,"Biomarker, GeneticVariation"
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",0.0,1.0,1.0,0.0,0.0,1848805,Thyroid Dyshormonogenesis 1,0.62,3,"Biomarker, GeneticVariation"
652,BMP4,bone morphogenetic protein 4,0.0,1.0,1.0,0.0,0.0,2677434,Orofacial Cleft 11,0.62,0,"Biomarker, GeneticVariation"
2254,FGF9,fibroblast growth factor 9,0.0,1.0,1.0,0.0,0.0,2751826,Multiple Synostoses Syndrome 3,0.62,1,"Biomarker, GeneticVariation"
261734,NPHP4,nephronophthisis 4,0.0,1.0,1.0,0.0,0.0,1847013,Nephronophthisis 4,0.62,0,"Biomarker, GeneticVariation"
6708,SPTA1,"spectrin, alpha, erythrocytic 1",0.0,1.0,1.0,0.0,0.0,520739,"Pyropoikilocytosis, Hereditary",0.62,0,"Biomarker, GeneticVariation"
2623,GATA1,GATA binding protein 1 (globin transcription factor 1),0.0,1.0,1.0,0.0,0.0,1839161,"Thrombocytopenia, Platelet Dysfunction, Hemolysis, and Imbalanced Globin Synthesis",0.62,0,"Biomarker, GeneticVariation"
5296,PIK3R2,"phosphoinositide-3-kinase, regulatory subunit 2 (beta)",0.0,1.0,1.0,0.0,0.0,1863924,Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome,0.62,1,"Biomarker, GeneticVariation"
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,1.0,0.0,0.0,1968550,"Mental Retardation, X-Linked, Syndromic 13",0.62,0,"Biomarker, GeneticVariation"
5889,RAD51C,RAD51 paralog C,0.0,1.0,1.0,0.0,0.0,3150659,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3",0.62,0,"Biomarker, GeneticVariation"
282996,RBM20,RNA binding motif protein 20,0.0,1.0,1.0,0.0,0.0,2750995,"Cardiomyopathy, Dilated, 1DD",0.62,4,"Biomarker, GeneticVariation"
8802,SUCLG1,"succinate-CoA ligase, alpha subunit",0.0,1.0,1.0,0.0,0.0,3151476,MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA),0.62,3,"Biomarker, GeneticVariation"
6566,SLC16A1,"solute carrier family 16 (monocarboxylate transporter), member 1",0.0,1.0,1.0,0.0,0.0,1855577,Erythrocyte Lactate Transporter Defect,0.62,0,"Biomarker, GeneticVariation"
18,ABAT,4-aminobutyrate aminotransferase,0.0,1.0,1.0,0.0,0.0,342708,Gamma aminobutyric acid transaminase deficiency,0.62,1,"Biomarker, GeneticVariation"
11078,TRIOBP,TRIO and F-actin binding protein,0.0,1.0,1.0,0.0,0.0,1853276,"Deafness, Autosomal Recessive 28",0.62,1,"Biomarker, GeneticVariation"
6708,SPTA1,"spectrin, alpha, erythrocytic 1",0.0,1.0,1.0,0.0,0.0,1851741,Elliptocytosis 2,0.62,0,"Biomarker, GeneticVariation"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,1836482,Li-Fraumeni Syndrome 2,0.62,0,"Biomarker, GeneticVariation"
2165,F13B,"coagulation factor XIII, B polypeptide",0.0,1.0,1.0,0.0,0.0,2750481,"Factor XIII, B Subunit, Deficiency Of",0.62,1,"Biomarker, GeneticVariation"
4688,NCF2,neutrophil cytosolic factor 2,0.0,1.0,1.0,0.0,0.0,1856245,"Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type II",0.62,5,"Biomarker, GeneticVariation"
5092,PCBD1,pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha,0.0,1.0,1.0,0.0,0.0,1849700,Hyperphenylalaninemia with primapterinuria,0.62,2,"Biomarker, GeneticVariation"
6569,SLC34A1,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 1",0.0,1.0,1.0,0.0,0.0,2676786,"Nephrolithiasis-Osteoporosis, Hypophosphatemic, 1",0.62,1,"Biomarker, GeneticVariation"
10008,KCNE3,"potassium channel, voltage gated subfamily E regulatory beta subunit 3",0.0,1.0,1.0,0.0,0.0,2751089,Brugada Syndrome 6,0.62,1,"Biomarker, GeneticVariation"
29954,POMT2,protein-O-mannosyltransferase 2,0.0,1.0,1.0,0.0,0.0,3150416,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2",0.62,0,"Biomarker, GeneticVariation"
3762,KCNJ5,"potassium channel, inwardly rectifying subfamily J, member 5",0.0,1.0,1.0,0.0,0.0,3150733,LONG QT SYNDROME 13,0.62,0,"Biomarker, GeneticVariation"
1184,CLCN5,"chloride channel, voltage-sensitive 5",0.0,1.0,1.0,0.0,0.0,1839874,Low Molecular Weight Proteinuria with Hypercalciuria and Nephrocalcinosis,0.62,0,"Biomarker, GeneticVariation"
80207,OPA3,"optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)",0.0,1.0,1.0,0.0,0.0,1833809,"Optic atrophy and cataract, autosomal dominant",0.62,1,"Biomarker, GeneticVariation"
84623,KIRREL3,kin of IRRE like 3 (Drosophila),0.0,1.0,1.0,0.0,0.0,2675487,"Mental Retardation, Autosomal Dominant 4",0.62,1,"Biomarker, GeneticVariation"
64218,SEMA4A,"sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A",0.0,1.0,1.0,0.0,0.0,1853214,Retinitis Pigmentosa 35,0.62,0,"Biomarker, GeneticVariation"
1785,DNM2,dynamin 2,0.0,1.0,1.0,0.0,0.0,1834558,"Myopathy, Centronuclear, Autosomal Dominant",0.62,0,"Biomarker, GeneticVariation"
6440,SFTPC,surfactant protein C,0.0,1.0,1.0,0.0,0.0,1970470,"Surfactant Metabolism Dysfunction, Pulmonary, 2",0.62,5,"Biomarker, GeneticVariation"
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",0.0,1.0,1.0,0.0,0.0,2751938,"Cerebral Palsy, Spastic Quadriplegic, 1",0.62,1,"Biomarker, GeneticVariation"
2296,FOXC1,forkhead box C1,0.0,1.0,1.0,0.0,0.0,2678503,"AXENFELD-RIEGER SYNDROME, TYPE 3",0.62,0,"Biomarker, GeneticVariation"
166785,MMAA,methylmalonic aciduria (cobalamin deficiency) cblA type,0.0,1.0,1.0,0.0,0.0,1855109,Methylmalonic aciduria cblA type,0.62,3,"Biomarker, GeneticVariation"
783,CACNB2,"calcium channel, voltage-dependent, beta 2 subunit",0.0,1.0,1.0,0.0,0.0,2678477,Brugada Syndrome 4,0.62,1,"Biomarker, GeneticVariation"
11232,POLG2,"polymerase (DNA directed), gamma 2, accessory subunit",0.0,1.0,1.0,0.0,0.0,1864668,"Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 4",0.62,1,"Biomarker, GeneticVariation"
135935,NOBOX,NOBOX oogenesis homeobox,0.0,1.0,1.0,0.0,0.0,1969060,Premature Ovarian Failure 5,0.62,2,"Biomarker, GeneticVariation"
9992,KCNE2,"potassium channel, voltage gated subfamily E regulatory beta subunit 2",0.0,1.0,1.0,0.0,0.0,1862394,"Atrial Fibrillation, Familial, 4",0.62,0,"Biomarker, GeneticVariation"
2103,ESRRB,estrogen-related receptor beta,0.0,1.0,1.0,0.0,0.0,1837857,"Deafness, Autosomal Recessive 35",0.62,1,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,1832680,"Cardiomyopathy, Dilated, 1E",0.62,0,"Biomarker, GeneticVariation"
1991,ELANE,"elastase, neutrophil expressed",0.0,1.0,1.0,0.0,0.0,1859966,"Neutropenia, Severe Congenital, Autosomal Dominant 1",0.62,0,"Biomarker, GeneticVariation"
5631,PRPS1,phosphoribosyl pyrophosphate synthetase 1,0.0,1.0,1.0,0.0,0.0,1844677,"Deafness, X-Linked 1",0.62,0,"Biomarker, GeneticVariation"
203,AK1,adenylate kinase 1,0.0,1.0,1.0,0.0,0.0,2675459,"Adenylate Kinase Deficiency, Hemolytic Anemia Due To",0.62,3,"Biomarker, GeneticVariation"
57477,SHROOM4,shroom family member 4,0.0,1.0,1.0,0.0,0.0,1845530,Stocco dos Santos syndrome,0.62,1,"Biomarker, GeneticVariation"
1001,CDH3,"cadherin 3, type 1, P-cadherin (placental)",0.0,1.0,1.0,0.0,0.0,1832162,Juvenile macular degeneration and hypotrichosis,0.62,0,"Biomarker, GeneticVariation"
5250,SLC25A3,"solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3",0.0,1.0,1.0,0.0,0.0,1835845,Mitochondrial Phosphate Carrier Deficiency,0.62,1,"Biomarker, GeneticVariation"
5745,PTH1R,parathyroid hormone 1 receptor,0.0,1.0,1.0,0.0,0.0,265295,Jansen type metaphyseal chondrodysplasia,0.62,0,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,3150914,MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE),0.62,0,"Biomarker, GeneticVariation"
7092,TLL1,tolloid-like 1,0.0,1.0,1.0,0.0,0.0,2751315,Atrial Septal Defect 6,0.62,1,"Biomarker, GeneticVariation"
23020,SNRNP200,small nuclear ribonucleoprotein 200kDa (U5),0.0,1.0,1.0,0.0,0.0,1835895,Retinitis Pigmentosa 33,0.62,5,"Biomarker, GeneticVariation"
30062,RAX,retina and anterior neural fold homeobox,0.0,1.0,1.0,0.0,0.0,1970237,"Microphthalmia, Isolated 3",0.62,1,"Biomarker, GeneticVariation"
4322,MMP13,matrix metallopeptidase 13 (collagenase 3),0.0,1.0,1.0,0.0,0.0,1865832,"Spondyloepimetaphyseal Dysplasia, Missouri Type",0.62,2,"Biomarker, GeneticVariation"
22934,RPIA,ribose 5-phosphate isomerase A,0.0,1.0,1.0,0.0,0.0,1291609,Ribose 5-Phosphate Isomerase Deficiency,0.62,1,"Biomarker, GeneticVariation"
9531,BAG3,BCL2-associated athanogene 3,0.0,1.0,1.0,0.0,0.0,2751831,"Myopathy, Myofibrillar, Bag3-Related",0.62,0,"Biomarker, GeneticVariation"
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,1.0,0.0,0.0,1865290,"Hyperinsulinemic hypoglycemia, familial, 3",0.62,0,"Biomarker, GeneticVariation"
6103,RPGR,retinitis pigmentosa GTPase regulator,0.0,1.0,1.0,0.0,0.0,2749137,"Retinitis Pigmentosa, X-Linked, And Sinorespiratory Infections, With Or Without Deafness",0.62,0,"Biomarker, GeneticVariation"
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,1.0,0.0,0.0,2750732,Noonan Syndrome 6,0.62,0,"Biomarker, GeneticVariation"
128866,CHMP4B,charged multivesicular body protein 4B,0.0,1.0,1.0,0.0,0.0,1854311,"Cataract, posterior polar, 3",0.62,1,"Biomarker, GeneticVariation"
84733,CBX2,chromobox homolog 2,0.0,1.0,1.0,0.0,0.0,2751317,"46, XY Sex Reversal 5",0.62,1,"Biomarker, GeneticVariation"
8635,RNASET2,ribonuclease T2,0.0,1.0,1.0,0.0,0.0,2751843,"Leukoencephalopathy, Cystic, Without Megalencephaly",0.62,1,"Biomarker, GeneticVariation"
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,1.0,0.0,0.0,2673186,"Aortic Aneurysm, Familial Thoracic 6",0.62,0,"Biomarker, GeneticVariation"
27249,MMADHC,"methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria",0.0,1.0,1.0,0.0,0.0,1848552,"Methylmalonic Aciduria and Homocystinuria, CblD Type",0.62,1,"Biomarker, GeneticVariation"
2218,FKTN,fukutin,0.0,1.0,1.0,0.0,0.0,1969024,"Cardiomyopathy, Dilated, 1x",0.62,0,"Biomarker, GeneticVariation"
255738,PCSK9,proprotein convertase subtilisin/kexin type 9,0.0,1.0,1.0,0.0,0.0,1863551,"Hypercholesterolemia, Autosomal Dominant, 3",0.62,2,"Biomarker, GeneticVariation"
768206,PRCD,progressive rod-cone degeneration,0.0,1.0,1.0,0.0,0.0,1864621,Retinitis Pigmentosa 36,0.62,1,"Biomarker, GeneticVariation"
55163,PNPO,pyridoxamine 5'-phosphate oxidase,0.0,1.0,1.0,0.0,0.0,1864723,Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency,0.62,1,"Biomarker, GeneticVariation"
55764,IFT122,intraflagellar transport 122,0.0,1.0,1.0,0.0,0.0,432235,Cranioectodermal Dysplasia,0.62,1,"Biomarker, GeneticVariation"
10939,AFG3L2,AFG3-like AAA ATPase 2,0.0,1.0,1.0,0.0,0.0,1853249,Spinocerebellar ataxia 28,0.62,0,"Biomarker, GeneticVariation"
85476,GFM1,"G elongation factor, mitochondrial 1",0.0,1.0,1.0,0.0,0.0,1836797,Combined Oxidative Phosphorylation Deficiency 1,0.62,2,"Biomarker, GeneticVariation"
6390,SDHB,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",0.0,1.0,1.0,0.0,0.0,1861848,PARAGANGLIOMAS 4,0.62,0,"Biomarker, GeneticVariation"
5019,OXCT1,3-oxoacid CoA transferase 1,0.0,1.0,1.0,0.0,0.0,342792,Succinyl-CoA:3-oxoacid CoA transferase deficiency,0.62,3,"Biomarker, GeneticVariation"
9197,SLC33A1,"solute carrier family 33 (acetyl-CoA transporter), member 1",0.0,1.0,1.0,0.0,0.0,2675528,"Spastic Paraplegia 42, Autosomal Dominant",0.62,0,"Biomarker, GeneticVariation"
203859,ANO5,anoctamin 5,0.0,1.0,1.0,0.0,0.0,1969785,"Muscular Dystrophy, Limb-Girdle, Type 2L",0.62,0,"Biomarker, GeneticVariation"
2027,ENO3,"enolase 3 (beta, muscle)",0.0,1.0,1.0,0.0,0.0,2752027,Glycogen Storage Disease XIII,0.62,1,"Biomarker, GeneticVariation"
29954,POMT2,protein-O-mannosyltransferase 2,0.0,1.0,1.0,0.0,0.0,3150411,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2",0.62,0,"Biomarker, GeneticVariation"
3938,LCT,lactase,0.0,1.0,1.0,0.0,0.0,268179,"Lactase Deficiency, Congenital",0.62,1,"Biomarker, GeneticVariation"
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",0.0,1.0,1.0,0.0,0.0,1838049,"Epilepsy, Nocturnal Frontal Lobe, Type 1",0.62,2,"Biomarker, GeneticVariation"
5903,RANBP2,RAN binding protein 2,0.0,1.0,1.0,0.0,0.0,2675556,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3",0.62,1,"Biomarker, GeneticVariation"
668,FOXL2,forkhead box L2,0.0,1.0,1.0,0.0,0.0,1837008,Premature Ovarian Failure 3,0.62,0,"Biomarker, GeneticVariation"
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",0.0,1.0,1.0,0.0,0.0,1856603,"Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to",0.62,3,"Biomarker, GeneticVariation"
64087,MCCC2,methylcrotonoyl-CoA carboxylase 2 (beta),0.0,1.0,1.0,0.0,0.0,1859499,3-methylcrotonyl CoA carboxylase 2 deficiency,0.62,3,"Biomarker, GeneticVariation"
56997,ADCK3,aarF domain containing kinase 3,0.0,1.0,1.0,0.0,0.0,2677589,"Spinocerebellar Ataxia, Autosomal Recessive 9",0.62,2,"Biomarker, GeneticVariation"
5962,RDX,radixin,0.0,1.0,1.0,0.0,0.0,1970239,"Deafness, Autosomal Recessive, 24",0.62,1,"Biomarker, GeneticVariation"
2779,GNAT1,"guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1",0.0,1.0,1.0,0.0,0.0,1864870,"Night Blindness, Congenital Stationary, Autosomal Dominant 3",0.62,1,"Biomarker, GeneticVariation"
6736,SRY,sex determining region Y,0.0,1.0,1.0,0.0,0.0,2748896,"46,Xy Gonadal Dysgenesis, Complete, Sry-Related",0.62,22,"Biomarker, GeneticVariation"
1639,DCTN1,dynactin 1,0.0,1.0,1.0,0.0,0.0,1843315,"Neuronopathy, Distal Hereditary Motor, Type Viib",0.62,0,"Biomarker, GeneticVariation"
5350,PLN,phospholamban,0.0,1.0,1.0,0.0,0.0,1835928,"Cardiomyopathy, Dilated, 1p",0.62,1,"Biomarker, GeneticVariation"
11315,PARK7,parkinson protein 7,0.0,1.0,1.0,0.0,0.0,1853445,"Parkinson Disease 7, Autosomal Recessive Early-Onset",0.62,4,"Biomarker, GeneticVariation"
4694,NDUFA1,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.62,1,"Biomarker, GeneticVariation"
79133,NDUFAF5,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 5",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.62,0,"Biomarker, GeneticVariation"
55572,FOXRED1,FAD-dependent oxidoreductase domain containing 1,0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.62,1,"Biomarker, GeneticVariation"
25915,NDUFAF3,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 3",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.62,1,"Biomarker, GeneticVariation"
29078,NDUFAF4,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 4",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.62,1,"Biomarker, GeneticVariation"
5660,PSAP,prosaposin,0.0,1.0,1.0,0.0,0.0,1864651,"Gaucher Disease, Atypical, Due To Saposin C Deficiency",0.62,0,"Biomarker, GeneticVariation"
57096,RPGRIP1,retinitis pigmentosa GTPase regulator interacting protein 1,0.0,1.0,1.0,0.0,0.0,2750720,Cone-Rod Dystrophy 13,0.62,0,"Biomarker, GeneticVariation"
859,CAV3,caveolin 3,0.0,1.0,1.0,0.0,0.0,241005,"CREATINE PHOSPHOKINASE, ELEVATED SERUM",0.62,0,"Biomarker, GeneticVariation"
2324,FLT4,fms-related tyrosine kinase 4,0.0,1.0,1.0,0.0,0.0,1865871,"Hemangioma, capillary infantile",0.62,0,"Biomarker, GeneticVariation"
3791,KDR,kinase insert domain receptor,0.0,1.0,1.0,0.0,0.0,1865871,"Hemangioma, capillary infantile",0.62,1,"Biomarker, GeneticVariation"
10585,POMT1,protein-O-mannosyltransferase 1,0.0,1.0,1.0,0.0,0.0,1836373,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1",0.62,0,"Biomarker, GeneticVariation"
345895,RSPH4A,radial spoke head 4 homolog A (Chlamydomonas),0.0,1.0,1.0,0.0,0.0,2675229,"Ciliary Dyskinesia, Primary, 11",0.62,1,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,1838547,Melanoma-Pancreatic Cancer Syndrome,0.62,0,"Biomarker, GeneticVariation"
79188,TMEM43,transmembrane protein 43,0.0,1.0,1.0,0.0,0.0,1858379,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 5",0.62,0,"Biomarker, GeneticVariation"
53630,BCO1,beta-carotene oxygenase 1,0.0,1.0,1.0,0.0,0.0,2676023,"Hypercarotenemia And Vitamin A Deficiency, Autosomal Dominant",0.62,1,"Biomarker, GeneticVariation"
145226,RDH12,retinol dehydrogenase 12 (all-trans/9-cis/11-cis),0.0,1.0,1.0,0.0,0.0,2675186,Leber Congenital Amaurosis 13,0.62,5,"Biomarker, GeneticVariation"
652,BMP4,bone morphogenetic protein 4,0.0,1.0,1.0,0.0,0.0,1864689,"Microphthalmia, Syndromic 6",0.62,0,"Biomarker, GeneticVariation"
26058,GIGYF2,GRB10 interacting GYF protein 2,0.0,1.0,1.0,0.0,0.0,1843211,Parkinson Disease 11,0.62,1,"Biomarker, GeneticVariation"
3033,HADH,hydroxyacyl-CoA dehydrogenase,0.0,1.0,1.0,0.0,0.0,1291230,3-Hydroxyacyl-CoA Dehydrogenase Deficiency,0.62,0,"Biomarker, GeneticVariation"
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,1.0,1.0,0.0,0.0,1843330,Osteopetrosis autosomal dominant type 1,0.62,0,"Biomarker, GeneticVariation"
5173,PDYN,prodynorphin,0.0,1.0,1.0,0.0,0.0,1853250,Spinocerebellar ataxia 23,0.62,4,"Biomarker, GeneticVariation"
24,ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4",0.0,1.0,1.0,0.0,0.0,1858806,Cone-Rod Dystrophy 3,0.62,0,"Biomarker, GeneticVariation"
8831,SYNGAP1,synaptic Ras GTPase activating protein 1,0.0,1.0,1.0,0.0,0.0,2675473,"Mental Retardation, Autosomal Dominant 5",0.62,1,"Biomarker, GeneticVariation"
5080,PAX6,paired box 6,0.0,1.0,1.0,0.0,0.0,1833797,"Optic Nerve Hypoplasia, Bilateral",0.62,0,"Biomarker, GeneticVariation"
8517,IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma",0.0,1.0,1.0,0.0,0.0,1970879,"Atypical Mycobacteriosis, Familial, X-Linked 1",0.62,0,"Biomarker, GeneticVariation"
5313,PKLR,"pyruvate kinase, liver and RBC",0.0,1.0,1.0,0.0,0.0,1863224,"Adenosine Triphosphate, Elevated, Of Erythrocytes",0.62,0,"Biomarker, GeneticVariation"
9368,SLC9A3R1,"solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1",0.0,1.0,1.0,0.0,0.0,2676782,"Nephrolithiasis-Osteoporosis, Hypophosphatemic, 2",0.62,2,"Biomarker, GeneticVariation"
90167,FRMD7,FERM domain containing 7,0.0,1.0,1.0,0.0,0.0,1839580,"Nystagmus 1, congenital, X- linked",0.62,12,"Biomarker, GeneticVariation"
10269,ZMPSTE24,zinc metallopeptidase STE24,0.0,1.0,1.0,0.0,0.0,1837756,Mandibuloacral dysplasia with type B lipodystrophy,0.62,3,"Biomarker, GeneticVariation"
7050,TGIF1,TGFB-induced factor homeobox 1,0.0,1.0,1.0,0.0,0.0,1840528,Holoprosencephaly 4,0.62,2,"Biomarker, GeneticVariation"
121391,KRT74,"keratin 74, type II",0.0,1.0,1.0,0.0,0.0,1860238,"WOOLLY HAIR, AUTOSOMAL DOMINANT",0.62,0,"Biomarker, GeneticVariation"
6092,ROBO2,"roundabout, axon guidance receptor, homolog 2 (Drosophila)",0.0,1.0,1.0,0.0,0.0,1970483,Vesicoureteral Reflux 2,0.62,1,"Biomarker, GeneticVariation"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,1837014,"Atrial Fibrillation, Familial, 3",0.62,0,"Biomarker, GeneticVariation"
1302,COL11A2,"collagen, type XI, alpha 2",0.0,1.0,1.0,0.0,0.0,1864746,"Deafness, Autosomal Recessive 53",0.62,0,"Biomarker, GeneticVariation"
8517,IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma",0.0,1.0,1.0,0.0,0.0,1845073,"Invasive Pneumococcal Disease, Recurrent Isolated, 2",0.62,0,"Biomarker, GeneticVariation"
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,1.0,1.0,0.0,0.0,2676759,"Thrombophilia, Hereditary, Due To Protein C Deficiency, Autosomal Recessive",0.62,0,"Biomarker, GeneticVariation"
8517,IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma",0.0,1.0,1.0,0.0,0.0,1845117,Immunodeficiency without anhidrotic ectodermal dysplasia,0.62,0,"Biomarker, GeneticVariation"
1785,DNM2,dynamin 2,0.0,1.0,1.0,0.0,0.0,1847902,"Charcot-Marie-Tooth Disease, Dominant Intermediate B",0.62,0,"Biomarker, GeneticVariation"
149461,CLDN19,claudin 19,0.0,1.0,1.0,0.0,0.0,1855466,"Hypomagnesemia 5, Renal, with Ocular Involvement",0.62,1,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,1854442,Split-Hand/Foot Malformation 4,0.62,0,"Biomarker, GeneticVariation"
16,AARS,alanyl-tRNA synthetase,0.0,1.0,1.0,0.0,0.0,2750090,"Charcot-Marie-Tooth Disease, Axonal, Type 2n",0.62,2,"Biomarker, GeneticVariation"
81027,TUBB1,"tubulin, beta 1 class VI",0.0,1.0,1.0,0.0,0.0,2751259,"Macrothrombocytopenia, Autosomal Dominant, Tubb1-Related",0.62,1,"Biomarker, GeneticVariation"
10002,NR2E3,"nuclear receptor subfamily 2, group E, member 3",0.0,1.0,1.0,0.0,0.0,1970163,Retinitis Pigmentosa 37,0.62,0,"Biomarker, GeneticVariation"
226,ALDOA,"aldolase A, fructose-bisphosphate",0.0,1.0,1.0,0.0,0.0,272066,Glycogen Storage Disease XII,0.62,3,"Biomarker, GeneticVariation"
4620,MYH2,"myosin, heavy chain 2, skeletal muscle, adult",0.0,1.0,1.0,0.0,0.0,1854106,"Inclusion Body Myopathy 3, Autosomal Dominant",0.62,1,"Biomarker, GeneticVariation"
4629,MYH11,"myosin, heavy chain 11, smooth muscle",0.0,1.0,1.0,0.0,0.0,1851504,"Aortic aneurysm, familial thoracic 4",0.62,1,"Biomarker, GeneticVariation"
10686,CLDN16,claudin 16,0.0,1.0,1.0,0.0,0.0,268448,Hypomagnesemia primary,0.62,3,"Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,1834481,"Cardiomyopathy, Dilated, 1s",0.62,0,"Biomarker, GeneticVariation"
55975,KLHL7,kelch-like family member 7,0.0,1.0,1.0,0.0,0.0,2751986,Retinitis Pigmentosa 42,0.62,1,"Biomarker, GeneticVariation"
23396,PIP5K1C,"phosphatidylinositol-4-phosphate 5-kinase, type I, gamma",0.0,1.0,1.0,0.0,0.0,1969655,Lethal Congenital Contractural Syndrome 3,0.62,1,"Biomarker, GeneticVariation"
3753,KCNE1,"potassium channel, voltage gated subfamily E regulatory beta subunit 1",0.0,1.0,1.0,0.0,0.0,2676723,Jervell And Lange-Nielsen Syndrome 2,0.62,0,"Biomarker, GeneticVariation"
644096,SDHAF1,succinate dehydrogenase complex assembly factor 1,0.0,1.0,1.0,0.0,0.0,1855008,Mitochondrial Complex II Deficiency,0.62,1,"Biomarker, GeneticVariation"
2916,GRM6,"glutamate receptor, metabotropic 6",0.0,1.0,1.0,0.0,0.0,1850362,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B",0.62,2,"Biomarker, GeneticVariation"
392255,GDF6,growth differentiation factor 6,0.0,1.0,1.0,0.0,0.0,2751307,"Microphthalmia, Isolated 4",0.62,0,"Biomarker, GeneticVariation"
54977,SLC25A38,"solute carrier family 25, member 38",0.0,1.0,1.0,0.0,0.0,2673914,"Anemia, Sideroblastic, Pyridoxine-Refractory, Autosomal Recessive",0.62,1,"Biomarker, GeneticVariation"
10102,TSFM,"Ts translation elongation factor, mitochondrial",0.0,1.0,1.0,0.0,0.0,1864840,Combined Oxidative Phosphorylation Deficiency 3,0.62,1,"Biomarker, GeneticVariation"
1674,DES,desmin,0.0,1.0,1.0,0.0,0.0,1867005,"Scapuloperoneal Syndrome, Neurogenic, Kaeser Type",0.62,0,"Biomarker, GeneticVariation"
6927,HNF1A,HNF1 homeobox A,0.0,1.0,1.0,0.0,0.0,2675866,"Diabetes Mellitus, Insulin-Dependent, 20",0.62,0,"Biomarker, GeneticVariation"
4990,SIX6,SIX homeobox 6,0.0,1.0,1.0,0.0,0.0,1859311,"Microphthalmia, Isolated, with Cataract 2",0.62,1,"Biomarker, GeneticVariation"
7068,THRB,"thyroid hormone receptor, beta",0.0,1.0,1.0,0.0,0.0,1840364,"Thyroid Hormone Resistance, Selective Pituitary",0.62,0,"Biomarker, GeneticVariation"
861,RUNX1,runt-related transcription factor 1,0.0,1.0,1.0,0.0,0.0,1832388,"Platelet Disorder, Familial, with Associated Myeloid Malignancy",0.62,1,"Biomarker, GeneticVariation"
25939,SAMHD1,SAM domain and HD domain 1,0.0,1.0,1.0,0.0,0.0,2749659,Aicardi-Goutieres syndrome 5,0.62,1,"Biomarker, GeneticVariation"
390594,KBTBD13,kelch repeat and BTB (POZ) domain containing 13,0.0,1.0,1.0,0.0,0.0,1836472,Nemaline myopathy 6,0.62,1,"Biomarker, GeneticVariation"
5896,RAG1,recombination activating gene 1,0.0,1.0,1.0,0.0,0.0,2673536,Combined Cellular And Humoral Immune Defects With Granulomas,0.62,0,"Biomarker, GeneticVariation"
5897,RAG2,recombination activating gene 2,0.0,1.0,1.0,0.0,0.0,2673536,Combined Cellular And Humoral Immune Defects With Granulomas,0.62,0,"Biomarker, GeneticVariation"
112817,HOGA1,4-hydroxy-2-oxoglutarate aldolase 1,0.0,1.0,1.0,0.0,0.0,3150878,"HYPEROXALURIA, PRIMARY, TYPE III",0.62,1,"Biomarker, GeneticVariation"
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,1.0,1.0,0.0,0.0,1858674,"Generalized Epilepsy With Febrile Seizures Plus, Type 3",0.62,0,"Biomarker, GeneticVariation"
83893,SPATA16,spermatogenesis associated 16,0.0,1.0,1.0,0.0,0.0,403825,Globozoospermia,0.62,1,"Biomarker, GeneticVariation"
200894,ARL13B,ADP-ribosylation factor-like 13B,0.0,1.0,1.0,0.0,0.0,2676771,Joubert Syndrome 8,0.62,1,"Biomarker, GeneticVariation"
64170,CARD9,"caspase recruitment domain family, member 9",0.0,1.0,1.0,0.0,0.0,1859353,"Candidiasis familial chronic mucocutaneous, autosomal recessive",0.62,2,"Biomarker, GeneticVariation"
222662,LHFPL5,lipoma HMGIC fusion partner-like 5,0.0,1.0,1.0,0.0,0.0,1853223,"Deafness, Autosomal Recessive 67",0.62,2,"Biomarker, GeneticVariation"
79784,MYH14,"myosin, heavy chain 14, non-muscle",0.0,1.0,1.0,0.0,0.0,1833503,"Deafness, Autosomal Dominant 4",0.62,0,"Biomarker, GeneticVariation"
88,ACTN2,"actinin, alpha 2",0.0,1.0,1.0,0.0,0.0,2677338,"Cardiomyopathy, Dilated, 1AA",0.62,0,"Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,1855128,"Methylcobalamin Deficiency, CblG Type",0.62,2,"Biomarker, GeneticVariation"
10585,POMT1,protein-O-mannosyltransferase 1,0.0,1.0,1.0,0.0,0.0,3150415,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1",0.62,0,"Biomarker, GeneticVariation"
9573,GDF3,growth differentiation factor 3,0.0,1.0,1.0,0.0,0.0,3150968,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6",0.62,0,"Biomarker, GeneticVariation"
10535,RNASEH2A,"ribonuclease H2, subunit A",0.0,1.0,1.0,0.0,0.0,1835912,Aicardi-Goutieres Syndrome 4,0.62,2,"Biomarker, GeneticVariation"
404672,GTF2H5,"general transcription factor IIH, polypeptide 5",0.0,1.0,1.0,0.0,0.0,1866504,"TRICHOTHIODYSTROPHY, PHOTOSENSITIVE",0.62,1,"Biomarker, GeneticVariation"
7102,TSPAN7,tetraspanin 7,0.0,1.0,1.0,0.0,0.0,1846174,"Mental Retardation, X-Linked 58",0.62,1,"Biomarker, GeneticVariation"
79083,MLPH,melanophilin,0.0,1.0,1.0,0.0,0.0,1836573,Griscelli syndrome type 3,0.62,1,"Biomarker, GeneticVariation"
79983,POF1B,"premature ovarian failure, 1B",0.0,1.0,1.0,0.0,0.0,1845105,Premature Ovarian Failure 2b,0.62,1,"Biomarker, GeneticVariation"
5631,PRPS1,phosphoribosyl pyrophosphate synthetase 1,0.0,1.0,1.0,0.0,0.0,1970827,Phosphoribosylpyrophosphate Synthetase Superactivity,0.62,0,"Biomarker, GeneticVariation"
7227,TRPS1,trichorhinophalangeal syndrome I,0.0,1.0,1.0,0.0,0.0,1860823,"Trichorhinophalangeal Syndrome, Type III",0.62,0,"Biomarker, GeneticVariation"
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,1.0,0.0,0.0,3150644,"BRACHYDACTYLY, TYPE E2",0.62,1,"Biomarker, GeneticVariation"
1187,CLCNKA,"chloride channel, voltage-sensitive Ka",0.0,1.0,1.0,0.0,0.0,2751312,"Bartter Syndrome, Type 4b",0.62,1,"Biomarker, GeneticVariation"
8642,DCHS1,dachsous cadherin-related 1,0.0,1.0,1.0,0.0,0.0,1832390,Van Maldergem Wetzburger Verloes syndrome,0.62,1,"Biomarker, GeneticVariation"
3891,KRT85,"keratin 85, type II",0.0,1.0,1.0,0.0,0.0,1865951,"Ectodermal Dysplasia, Pure Hair-Nail Type",0.62,1,"Biomarker, GeneticVariation"
36,ACADSB,"acyl-CoA dehydrogenase, short/branched chain",0.0,1.0,1.0,0.0,0.0,1864912,2-Methylbutyryl-CoA Dehydrogenase Deficiency,0.62,1,"Biomarker, GeneticVariation"
5913,RAPSN,receptor-associated protein of the synapse,0.0,1.0,1.0,0.0,0.0,1276035,"Pena Shokeir syndrome, type 1",0.62,0,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.616288585,182,"Biomarker, GeneticVariation"
11132,CAPN10,calpain 10,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.616008496,115,"Biomarker, GeneticVariation"
1050,CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.615949658,142,"Biomarker, GeneticVariation"
3949,LDLR,low density lipoprotein receptor,1.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.614893146,146,"AlteredExpression, Biomarker, GeneticVariation"
4854,NOTCH3,notch 3,0.0,1.0,1.0,0.0,0.0,751587,CADASIL,0.613112661,172,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,398623,Thrombophilia,0.59664943,238,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.592905942,76,"AlteredExpression, Biomarker, GeneticVariation"
4287,ATXN3,ataxin 3,1.0,1.0,1.0,0.0,0.0,24408,Machado-Joseph Disease,0.590939759,183,"AlteredExpression, Biomarker, GeneticVariation"
3643,INSR,insulin receptor,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.590225487,106,"Biomarker, GeneticVariation"
3949,LDLR,low density lipoprotein receptor,1.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.588019272,693,"AlteredExpression, Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,1.0,1.0,1.0,1.0,0.0,32580,Adenomatous Polyposis Coli,0.58560962,630,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
4869,NPM1,"nucleophosmin (nucleolar phosphoprotein B23, numatrin)",1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.585496695,266,"AlteredExpression, Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.582954318,43,"Biomarker, GeneticVariation"
2022,ENG,endoglin,1.0,1.0,1.0,0.0,0.0,39445,"Telangiectasia, Hereditary Hemorrhagic",0.574515418,69,"AlteredExpression, Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",1.0,1.0,1.0,0.0,0.0,5283,beta-Thalassemia,0.570361233,315,"AlteredExpression, Biomarker, GeneticVariation"
2157,F8,"coagulation factor VIII, procoagulant component",1.0,1.0,1.0,0.0,0.0,19069,Hemophilia A,0.569977949,189,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,1.0,29463,Osteosarcoma,0.569920287,135,"Biomarker, GeneticVariation, Therapeutic"
1756,DMD,dystrophin,0.0,1.0,1.0,0.0,0.0,917713,Becker muscular dystrophy,0.568450972,198,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.56707308,497,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
4683,NBN,nibrin,1.0,1.0,1.0,0.0,0.0,398791,Nijmegen Breakage Syndrome,0.564142748,104,"AlteredExpression, Biomarker, GeneticVariation"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,23976,Long QT Syndrome,0.563689056,229,"Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,6413,Burkitt Lymphoma,0.562500138,122,"AlteredExpression, Biomarker, GeneticVariation"
6514,SLC2A2,"solute carrier family 2 (facilitated glucose transporter), member 2",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.558149825,30,"Biomarker, GeneticVariation"
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,1.0,0.0,0.0,751122,Severe myoclonic epilepsy of infancy,0.557394294,159,"Biomarker, GeneticVariation"
7337,UBE3A,ubiquitin protein ligase E3A,0.0,1.0,1.0,0.0,0.0,162635,Angelman Syndrome,0.554981437,109,"Biomarker, GeneticVariation"
190,NR0B1,"nuclear receptor subfamily 0, group B, member 1",0.0,1.0,1.0,0.0,0.0,220766,X-linked adrenal hypoplasia congenita,0.554020548,121,"Biomarker, GeneticVariation"
6517,SLC2A4,"solute carrier family 2 (facilitated glucose transporter), member 4",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.551294246,48,"Biomarker, GeneticVariation"
5621,PRNP,prion protein,0.0,1.0,1.0,0.0,0.0,206042,"Insomnia, Fatal Familial",0.547569041,75,"Biomarker, GeneticVariation"
359,AQP2,aquaporin 2 (collecting duct),0.0,1.0,1.0,0.0,1.0,162283,"Diabetes Insipidus, Nephrogenic",0.547445431,58,"Biomarker, GeneticVariation, Therapeutic"
8929,PHOX2B,paired-like homeobox 2b,0.0,1.0,1.0,0.0,0.0,1275808,Congenital central hypoventilation syndrome,0.547314501,81,"Biomarker, GeneticVariation"
8106,PABPN1,"poly(A) binding protein, nuclear 1",1.0,1.0,1.0,0.0,0.0,270952,"Muscular Dystrophy, Oculopharyngeal",0.546447336,72,"AlteredExpression, Biomarker, GeneticVariation"
5979,RET,ret proto-oncogene,0.0,1.0,1.0,0.0,0.0,2931876,Hirschsprung disease 1,0.545154567,124,"Biomarker, GeneticVariation"
6834,SURF1,surfeit 1,0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.544910541,56,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,3494506,"PSEUDOHYPOPARATHYROIDISM, TYPE IA",0.544381393,86,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,476089,Endometrial Carcinoma,0.543786075,111,"Biomarker, GeneticVariation"
355,FAS,Fas cell surface death receptor,0.0,1.0,1.0,0.0,0.0,1328840,Autoimmune Lymphoproliferative Syndrome,0.543296406,80,"Biomarker, GeneticVariation"
114327,EFHC1,EF-hand domain (C-terminal) containing 1,0.0,1.0,1.0,0.0,0.0,270853,"Myoclonic Epilepsy, Juvenile",0.543258544,39,"Biomarker, GeneticVariation"
9401,RECQL4,RecQ protein-like 4,0.0,1.0,1.0,0.0,0.0,32339,Rothmund-Thomson Syndrome,0.541989258,53,"Biomarker, GeneticVariation"
1201,CLN3,"ceroid-lipofuscinosis, neuronal 3",0.0,1.0,1.0,0.0,0.0,751383,Juvenile neuronal ceroid lipofuscinosis,0.540667525,101,"Biomarker, GeneticVariation"
378884,NHLRC1,NHL repeat containing E3 ubiquitin protein ligase 1,1.0,1.0,1.0,0.0,0.0,751783,Lafora Disease,0.540374468,39,"AlteredExpression, Biomarker, GeneticVariation"
2811,GP1BA,"glycoprotein Ib (platelet), alpha polypeptide",0.0,1.0,1.0,0.0,0.0,5129,Bernard-Soulier Syndrome,0.538459034,11,"Biomarker, GeneticVariation"
1497,CTNS,"cystinosin, lysosomal cystine transporter",0.0,1.0,1.0,0.0,0.0,2931187,Cystinosis,0.538311941,30,"Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.538028436,32,"AlteredExpression, Biomarker, GeneticVariation"
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",1.0,1.0,1.0,0.0,0.0,23976,Long QT Syndrome,0.537809384,208,"AlteredExpression, Biomarker, GeneticVariation"
7389,UROD,uroporphyrinogen decarboxylase,0.0,1.0,1.0,0.0,0.0,162566,Porphyria Cutanea Tarda,0.536944104,56,"Biomarker, GeneticVariation"
1180,CLCN1,"chloride channel, voltage-sensitive 1",0.0,1.0,1.0,0.0,0.0,27127,Myotonia Congenita,0.536582604,54,"Biomarker, GeneticVariation"
114798,SLITRK1,"SLIT and NTRK-like family, member 1",0.0,1.0,1.0,0.0,0.0,40517,Tourette Syndrome,0.536133724,19,"Biomarker, GeneticVariation"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,1.0,0.0,35335,Retinoblastoma,0.534148437,273,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2812,GP1BB,"glycoprotein Ib (platelet), beta polypeptide",0.0,1.0,1.0,0.0,0.0,5129,Bernard-Soulier Syndrome,0.534108403,12,"Biomarker, GeneticVariation"
5053,PAH,phenylalanine hydroxylase,0.0,1.0,1.0,0.0,0.0,31485,Phenylketonurias,0.53379388,263,"Biomarker, GeneticVariation"
1629,DBT,dihydrolipoamide branched chain transacylase E2,1.0,1.0,1.0,0.0,0.0,24776,Maple Syrup Urine Disease,0.533286854,17,"AlteredExpression, Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.533177352,1400,"AlteredExpression, Biomarker, GeneticVariation"
773,CACNA1A,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",0.0,1.0,1.0,0.0,0.0,1832884,"Hemiplegic migraine, familial type 1",0.532190697,44,"Biomarker, GeneticVariation"
5376,PMP22,peripheral myelin protein 22,0.0,1.0,1.0,0.0,0.0,270911,"Charcot-Marie-Tooth disease, type IA",0.5310774,58,"Biomarker, GeneticVariation"
1760,DMPK,dystrophia myotonica-protein kinase,1.0,1.0,1.0,0.0,0.0,27126,Myotonic Dystrophy,0.530803822,234,"AlteredExpression, Biomarker, GeneticVariation"
846,CASR,calcium-sensing receptor,0.0,1.0,1.0,0.0,0.0,1832645,"Hyperparathyroidism, Neonatal Severe Primary",0.530489669,37,"Biomarker, GeneticVariation"
7399,USH2A,"Usher syndrome 2A (autosomal recessive, mild)",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.530160061,18,"Biomarker, GeneticVariation"
3952,LEP,leptin,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.53,573,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,2745959,"Spondyloepiphyseal dysplasia, congenita",0.529355651,33,"Biomarker, GeneticVariation"
2175,FANCA,"Fanconi anemia, complementation group A",0.0,1.0,1.0,0.0,0.0,3469521,"FANCONI ANEMIA, COMPLEMENTATION GROUP A",0.529278311,76,"Biomarker, GeneticVariation"
3949,LDLR,low density lipoprotein receptor,0.0,1.0,1.0,0.0,0.0,745103,"HYPERCHOLESTEROLEMIA, FAMILIAL",0.529072146,60,"Biomarker, GeneticVariation"
1371,CPOX,coproporphyrinogen oxidase,0.0,1.0,1.0,0.0,0.0,162531,"Coproporphyria, Hereditary",0.528476173,27,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,265336,"Keratitis, Ichthyosis, and Deafness (KID) Syndrome",0.528221633,29,"Biomarker, GeneticVariation"
5264,PHYH,phytanoyl-CoA 2-hydroxylase,0.0,1.0,1.0,0.0,0.0,34960,Refsum Disease,0.527596695,11,"Biomarker, GeneticVariation"
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,1.0,0.0,0.0,79474,Recessive dystrophic epidermolysis bullosa,0.527577283,62,"Biomarker, GeneticVariation"
5078,PAX4,paired box 4,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.52730446,13,"Biomarker, GeneticVariation"
554,AVPR2,arginine vasopressin receptor 2,0.0,1.0,1.0,0.0,0.0,1563705,"DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED",0.52615976,57,"Biomarker, GeneticVariation"
8820,HESX1,HESX homeobox 1,0.0,1.0,1.0,0.0,0.0,338503,Septo-Optic Dysplasia,0.526043904,26,"Biomarker, GeneticVariation"
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1970109,Aromatase deficiency,0.526002627,17,"Biomarker, GeneticVariation"
3508,IGHMBP2,immunoglobulin mu binding protein 2,1.0,1.0,1.0,0.0,0.0,1858517,Spinal muscular atrophy with respiratory distress 1,0.525670091,21,"AlteredExpression, Biomarker, GeneticVariation"
2798,GNRHR,gonadotropin-releasing hormone receptor,0.0,1.0,1.0,0.0,0.0,271623,Hypogonadotropic hypogonadism,0.525641782,48,"Biomarker, GeneticVariation"
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,1.0,0.0,0.0,342277,"Diabetes Mellitus, Type Ii, Autosomal Dominant",0.525386587,20,"Biomarker, GeneticVariation"
326,AIRE,autoimmune regulator,0.0,1.0,1.0,0.0,0.0,85859,Polyglandular autoimmune syndrome type I,0.525309247,57,"Biomarker, GeneticVariation"
2057,EPOR,erythropoietin receptor,0.0,1.0,1.0,0.0,0.0,152264,"Polycythemia, primary familial and congenital",0.525152113,12,"Biomarker, GeneticVariation"
6899,TBX1,T-box 1,0.0,1.0,1.0,0.0,0.0,220704,Shprintzen syndrome,0.525025742,53,"Biomarker, GeneticVariation"
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,1.0,0.0,0.0,398738,Leukocyte adhesion deficiency type 1,0.524819578,24,"Biomarker, GeneticVariation"
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,1.0,0.0,0.0,1868675,"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE",0.524742238,52,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,265326,BANNAYAN-RILEY-RUVALCABA SYNDROME,0.524742238,52,"Biomarker, GeneticVariation"
773,CACNA1A,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",0.0,1.0,1.0,0.0,0.0,752124,SPINOCEREBELLAR ATAXIA 6,0.524507764,43,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,1193,apert syndrome,0.524458733,51,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,1864436,Muenke Syndrome,0.524252569,15,"Biomarker, GeneticVariation"
4359,MPZ,myelin protein zero,0.0,1.0,1.0,0.0,0.0,393818,"Charcot-Marie-Tooth disease, Type 4E",0.523685559,13,"Biomarker, GeneticVariation"
2072,ERCC4,excision repair cross-complementation group 4,0.0,1.0,1.0,0.0,0.0,268140,"Xeroderma Pigmentosum, Complementation Group F",0.523402055,12,"Biomarker, GeneticVariation"
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,1.0,0.0,0.0,268338,"EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT",0.523373746,39,"Biomarker, GeneticVariation"
4292,MLH1,mutL homolog 1,1.0,1.0,1.0,0.0,0.0,9405,"Colorectal Neoplasms, Hereditary Nonpolyposis",0.523292553,51,"AlteredExpression, Biomarker, GeneticVariation"
7248,TSC1,tuberous sclerosis 1,0.0,1.0,1.0,0.0,0.0,1854465,Tuberous Sclerosis 1,0.523167581,10,"Biomarker, GeneticVariation"
11093,ADAMTS13,"ADAM metallopeptidase with thrombospondin type 1 motif, 13",0.0,1.0,1.0,0.0,0.0,1268935,"THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL",0.523090241,49,"Biomarker, GeneticVariation"
1910,EDNRB,endothelin receptor type B,0.0,1.0,1.0,0.0,0.0,1848519,"Waardenburg syndrome, type 4",0.522835046,10,"Biomarker, GeneticVariation"
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,1.0,0.0,1.0,11860,"Diabetes Mellitus, Type 2",0.522812606,160,"Biomarker, GeneticVariation, Therapeutic"
1302,COL11A2,"collagen, type XI, alpha 2",0.0,1.0,1.0,0.0,0.0,1855310,Megaepiphyseal dwarfism,0.522551541,9,"Biomarker, GeneticVariation"
57192,MCOLN1,mucolipin 1,0.0,1.0,1.0,0.0,0.0,238286,Mucolipidosis Type IV,0.522523232,36,"Biomarker, GeneticVariation"
3425,IDUA,"iduronidase, alpha-L-",0.0,1.0,1.0,0.0,0.0,86795,Hurler Syndrome,0.522523232,37,"Biomarker, GeneticVariation"
7291,TWIST1,twist family bHLH transcription factor 1,0.0,1.0,1.0,0.0,0.0,175699,Saethre-Chotzen Syndrome,0.522474201,44,"Biomarker, GeneticVariation"
5167,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,0.0,1.0,1.0,0.0,0.0,1865343,Ossification of the posterior longitudinal ligament of the spine,0.522317068,1,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,268358,"Osteogenesis imperfecta, type 2A",0.522268037,8,"Biomarker, GeneticVariation"
4143,MAT1A,"methionine adenosyltransferase I, alpha",0.0,1.0,1.0,0.0,0.0,268621,Methionine Adenosyltransferase Deficiency,0.522268037,9,"Biomarker, GeneticVariation"
90,ACVR1,"activin A receptor, type I",0.0,1.0,1.0,0.0,0.0,16037,Fibrodysplasia Ossificans Progressiva,0.522190697,44,"Biomarker, GeneticVariation"
4488,MSX2,msh homeobox 2,0.0,1.0,1.0,0.0,0.0,1868598,Parietal Foramina,0.521984532,7,"Biomarker, GeneticVariation"
11005,SPINK5,"serine peptidase inhibitor, Kazal type 5",0.0,1.0,1.0,0.0,0.0,265962,Netherton Syndrome,0.521907192,43,"Biomarker, GeneticVariation"
3643,INSR,insulin receptor,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.521585338,8,"Biomarker, GeneticVariation"
114902,C1QTNF5,C1q and tumor necrosis factor related protein 5,0.0,1.0,1.0,0.0,0.0,1854065,Late-Onset Retinal Degeneration,0.521417523,5,"Biomarker, GeneticVariation"
3032,HADHB,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit",0.0,1.0,1.0,0.0,0.0,1969443,Trifunctional Protein Deficiency With Myopathy And Neuropathy,0.521417523,6,"Biomarker, GeneticVariation"
4758,NEU1,sialidase 1 (lysosomal sialidase),0.0,1.0,1.0,0.0,0.0,268228,Neuraminidase 1 deficiency,0.521417523,9,"Biomarker, GeneticVariation"
27031,NPHP3,nephronophthisis 3 (adolescent),0.0,1.0,1.0,0.0,0.0,1858392,Nephronophthisis 3,0.521134018,4,"Biomarker, GeneticVariation"
9516,LITAF,lipopolysaccharide-induced TNF factor,1.0,1.0,1.0,0.0,0.0,270913,"Charcot-Marie-Tooth disease, Type 1C",0.521134018,6,"AlteredExpression, Biomarker, GeneticVariation"
9095,TBX19,T-box 19,0.0,1.0,1.0,0.0,0.0,271583,"ACTH Deficiency, Isolated",0.521134018,6,"Biomarker, GeneticVariation"
2071,ERCC3,excision repair cross-complementation group 3,0.0,1.0,1.0,0.0,0.0,268136,"Xeroderma Pigmentosum, Complementation Group B",0.521134018,4,"Biomarker, GeneticVariation"
3868,KRT16,"keratin 16, type I",1.0,1.0,1.0,0.0,0.0,2931923,Hyperkeratosis of the palms and soles and esophageal papillomas,0.521134018,4,"AlteredExpression, Biomarker, GeneticVariation"
249,ALPL,"alkaline phosphatase, liver/bone/kidney",0.0,1.0,1.0,0.0,0.0,268413,"Hypophosphatasia, Adult",0.521134018,24,"Biomarker, GeneticVariation"
4261,CIITA,"class II, major histocompatibility complex, transactivator",0.0,1.0,1.0,0.0,0.0,2931418,Bare lymphocyte syndrome 2,0.520850514,5,"Biomarker, GeneticVariation"
6103,RPGR,retinitis pigmentosa GTPase regulator,0.0,1.0,1.0,0.0,0.0,1845667,Retinitis Pigmentosa 3,0.520850514,3,"Biomarker, GeneticVariation"
5158,PDE6B,"phosphodiesterase 6B, cGMP-specific, rod, beta",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.520685793,10,"Biomarker, GeneticVariation"
84059,GPR98,G protein-coupled receptor 98,0.0,1.0,1.0,0.0,0.0,2931213,"Usher syndrome, type 2C",0.520567009,3,"Biomarker, GeneticVariation"
3299,HSF4,heat shock transcription factor 4,0.0,1.0,1.0,0.0,0.0,1861821,"Cataract, zonular",0.520567009,4,"Biomarker, GeneticVariation"
5376,PMP22,peripheral myelin protein 22,0.0,1.0,1.0,0.0,0.0,3495591,"Charcot-Marie-Tooth Disease, Demyelinating, Type 1e",0.520567009,2,"Biomarker, GeneticVariation"
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,1.0,1.0,0.0,0.0,20074,"INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS",0.520489669,40,"Biomarker, GeneticVariation"
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),0.0,1.0,1.0,0.0,0.0,342687,dopamine beta hydroxylase deficiency,0.520283505,2,"Biomarker, GeneticVariation"
79659,DYNC2H1,"dynein, cytoplasmic 2, heavy chain 1",0.0,1.0,1.0,0.0,0.0,36069,Asphyxiating Thoracic Dystrophy 3,0.520283505,4,"Biomarker, GeneticVariation"
7078,TIMP3,TIMP metallopeptidase inhibitor 3,0.0,1.0,1.0,0.0,0.0,1850938,"Fundus Dystrophy, Pseudoinflammatory, Of Sorsby",0.520283505,6,"Biomarker, GeneticVariation"
4247,MGAT2,"mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase",0.0,1.0,1.0,0.0,0.0,2931008,Congenital disorder of glycosylation type 2A,0.520283505,3,"Biomarker, GeneticVariation"
7018,TF,transferrin,0.0,1.0,1.0,0.0,0.0,521802,Congenital atransferrinemia,0.520283505,4,"Biomarker, GeneticVariation"
1690,COCH,cochlin,0.0,1.0,1.0,0.0,0.0,1832425,"Deafness, Autosomal Dominant 9",0.520283505,9,"Biomarker, GeneticVariation"
55343,SLC35C1,"solute carrier family 35 (GDP-fucose transporter), member C1",0.0,1.0,1.0,0.0,0.0,398739,"Congenital disorder of glycosylation, type 2C",0.520283505,2,"Biomarker, GeneticVariation"
1421,CRYGD,"crystallin, gamma D",0.0,1.0,1.0,0.0,0.0,3540850,"Cataract, Punctate, Progressive Juvenile-Onset",0.52,6,"Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1856439,"Glaucoma 3, Primary Congenital, A",0.52,0,"Biomarker, GeneticVariation"
3098,HK1,hexokinase 1,0.0,1.0,1.0,0.0,0.0,3150343,"HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY",0.52,2,"Biomarker, GeneticVariation"
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,1.0,1.0,0.0,0.0,1866176,Exudative Vitreoretinopathy 4,0.52,0,"Biomarker, GeneticVariation"
8022,LHX3,LIM homeobox 3,0.0,1.0,1.0,0.0,0.0,3489787,Winkelman Bethge Pfeiffer syndrome,0.52,2,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,2674574,"Aortic aneurysm, familial thoracic 3",0.52,0,"Biomarker, GeneticVariation"
79147,FKRP,fukutin related protein,0.0,1.0,1.0,0.0,0.0,1847759,"Muscular Dystrophy, Congenital, 1C",0.52,0,"Biomarker, GeneticVariation"
6017,RLBP1,retinaldehyde binding protein 1,0.0,1.0,1.0,0.0,0.0,1843816,Bothnia Retinal Dystrophy,0.52,0,"Biomarker, GeneticVariation"
26154,ABCA12,"ATP-binding cassette, sub-family A (ABC1), member 12",0.0,1.0,1.0,0.0,0.0,598226,Harlequin type ichthyosis,0.52,0,"Biomarker, GeneticVariation"
4594,MUT,methylmalonyl CoA mutase,0.0,1.0,1.0,0.0,0.0,1855114,Methylmalonic Aciduria due to Methylmalonyl-CoA Mutase Deficiency,0.52,6,"Biomarker, GeneticVariation"
85300,ATCAY,"ataxia, cerebellar, Cayman type",0.0,1.0,1.0,0.0,0.0,1832585,"Cerebellar Ataxia, Cayman Type",0.52,1,"Biomarker, GeneticVariation"
1374,CPT1A,carnitine palmitoyltransferase 1A (liver),0.0,1.0,1.0,0.0,0.0,1829703,Carnitine palmitoyl transferase 1A deficiency,0.52,6,"Biomarker, GeneticVariation"
70,ACTC1,"actin, alpha, cardiac muscle 1",0.0,1.0,1.0,0.0,0.0,2677506,"Cardiomyopathy, Familial Hypertrophic, 11",0.52,0,"Biomarker, GeneticVariation"
6833,ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",0.0,1.0,1.0,0.0,0.0,1835887,"Diabetes Mellitus, Transient Neonatal, 2",0.52,0,"Biomarker, GeneticVariation"
27429,HTRA2,HtrA serine peptidase 2,0.0,1.0,1.0,0.0,0.0,1853202,"PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",0.52,1,"Biomarker, GeneticVariation"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,1.0,0.0,0.0,342646,"Vitamin D-Dependent Rickets, Type 2A",0.52,9,"Biomarker, GeneticVariation"
347733,TUBB2B,"tubulin, beta 2B class IIb",0.0,1.0,1.0,0.0,0.0,3552236,"POLYMICROGYRIA, SYMMETRIC OR ASYMMETRIC",0.52,1,"Biomarker, GeneticVariation"
10682,EBP,emopamil binding protein (sterol isomerase),0.0,1.0,1.0,0.0,0.0,2931843,"Chondrodysplasia punctata 2, X-linked dominant",0.52,5,"Biomarker, GeneticVariation"
51422,PRKAG2,"protein kinase, AMP-activated, gamma 2 non-catalytic subunit",0.0,1.0,1.0,0.0,0.0,1849813,"Glycogen Storage Disease of Heart, Lethal Congenital",0.52,0,"Biomarker, GeneticVariation"
3785,KCNQ2,"potassium channel, voltage gated KQT-like subfamily Q, member 2",0.0,1.0,1.0,0.0,0.0,3149074,"SEIZURES, BENIGN FAMILIAL NEONATAL, 1",0.52,0,"Biomarker, GeneticVariation"
7849,PAX8,paired box 8,0.0,1.0,1.0,0.0,0.0,1869118,"Hypothyroidism, Congenital, Nongoitrous, 2",0.52,3,"Biomarker, GeneticVariation"
79152,FA2H,fatty acid 2-hydroxylase,0.0,1.0,1.0,0.0,0.0,1823105,"SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE",0.52,3,"Biomarker, GeneticVariation"
60506,NYX,nyctalopin,0.0,1.0,1.0,0.0,0.0,3495587,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A",0.52,2,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,1866504,"TRICHOTHIODYSTROPHY, PHOTOSENSITIVE",0.52,0,"Biomarker, GeneticVariation"
4646,MYO6,myosin VI,0.0,1.0,1.0,0.0,0.0,2931767,"Deafness, autosomal dominant nonsyndromic sensorineural 22",0.52,0,"Biomarker, GeneticVariation"
7840,ALMS1,Alstrom syndrome 1,0.0,1.0,1.0,0.0,0.0,268425,Alstrom Syndrome,0.519688186,26,"Biomarker, GeneticVariation"
1836,SLC26A2,"solute carrier family 26 (anion exchanger), member 2",0.0,1.0,1.0,0.0,0.0,220726,Diastrophic dysplasia,0.519639155,34,"Biomarker, GeneticVariation"
7852,CXCR4,chemokine (C-X-C motif) receptor 4,0.0,1.0,1.0,0.0,0.0,472817,WHIM syndrome,0.519355651,33,"Biomarker, GeneticVariation"
5077,PAX3,paired box 3,0.0,1.0,1.0,0.0,0.0,1847800,Waardenburg Syndrome Type 1,0.519355651,33,"Biomarker, GeneticVariation"
2737,GLI3,GLI family zinc finger 3,0.0,1.0,1.0,0.0,0.0,265220,Pallister-Hall Syndrome,0.519092213,18,"Biomarker, GeneticVariation"
2629,GBA,"glucosidase, beta, acid",0.0,1.0,1.0,0.0,0.0,17205,Gaucher Disease,0.51839424,153,"Biomarker, GeneticVariation"
4359,MPZ,myelin protein zero,0.0,1.0,1.0,0.0,0.0,11195,dejerine-sottas disease,0.518221633,29,"Biomarker, GeneticVariation"
6299,SALL1,spalt-like transcription factor 1,0.0,1.0,1.0,0.0,0.0,265246,Townes-Brocks syndrome,0.517938128,28,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,23931,osteogenesis imperfecta tarda,0.517938128,28,"Biomarker, GeneticVariation"
2588,GALNS,galactosamine (N-acetyl)-6-sulfatase,0.0,1.0,1.0,0.0,0.0,86651,"Mucopolysaccharidosis, MPS-IV-A",0.517938128,34,"Biomarker, GeneticVariation"
54903,MKS1,"Meckel syndrome, type 1",0.0,1.0,1.0,0.0,0.0,3714506,Meckel syndrome type 1,0.517752685,11,"Biomarker, GeneticVariation"
5589,PRKCSH,protein kinase C substrate 80K-H,0.0,1.0,1.0,0.0,0.0,158683,Polycystic liver disease,0.517703654,21,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.51742015,18,"Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,410190,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,0.517371119,26,"Biomarker, GeneticVariation"
3931,LCAT,lecithin-cholesterol acyltransferase,0.0,1.0,1.0,0.0,0.0,342895,Fish-eye disease,0.517136645,17,"Biomarker, GeneticVariation"
1736,DKC1,"dyskeratosis congenita 1, dyskerin",0.0,1.0,1.0,0.0,0.0,1148551,"DYSKERATOSIS CONGENITA, X-LINKED",0.517087614,31,"Biomarker, GeneticVariation"
2324,FLT4,fms-related tyrosine kinase 4,0.0,1.0,1.0,0.0,0.0,1704423,Milroy's Disease,0.517087614,25,"Biomarker, GeneticVariation"
4669,NAGLU,"N-acetylglucosaminidase, alpha",0.0,1.0,1.0,0.0,0.0,86648,Mucopolysaccharidosis Type IIIB,0.516520605,28,"Biomarker, GeneticVariation"
4359,MPZ,myelin protein zero,0.0,1.0,1.0,0.0,0.0,270912,"Charcot-Marie-Tooth disease, type IB",0.516237101,22,"Biomarker, GeneticVariation"
249,ALPL,"alkaline phosphatase, liver/bone/kidney",0.0,1.0,1.0,0.0,0.0,268412,"Hypophosphatasia, Infantile",0.515719122,13,"Biomarker, GeneticVariation"
4647,MYO7A,myosin VIIA,0.0,1.0,1.0,0.0,0.0,1568247,"USHER SYNDROME, TYPE I",0.515670091,20,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,33835,Pseudopseudohypoparathyroidism,0.515103082,19,"Biomarker, GeneticVariation"
3159,HMGA1,high mobility group AT-hook 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.514585104,8,"Biomarker, GeneticVariation"
2629,GBA,"glucosidase, beta, acid",0.0,1.0,1.0,0.0,0.0,1961835,"GAUCHER DISEASE, TYPE I",0.514536073,16,"Biomarker, GeneticVariation"
1285,COL4A3,"collagen, type IV, alpha 3 (Goodpasture antigen)",0.0,1.0,1.0,0.0,0.0,1567744,"ALPORT SYNDROME, AUTOSOMAL RECESSIVE",0.514536073,16,"Biomarker, GeneticVariation"
4352,MPL,"MPL proto-oncogene, thrombopoietin receptor",0.0,1.0,1.0,0.0,0.0,1327915,Congenital amegakaryocytic thrombocytopenia,0.514252569,15,"Biomarker, GeneticVariation"
1282,COL4A1,"collagen, type IV, alpha 1",0.0,1.0,1.0,0.0,0.0,1867983,PORENCEPHALY 1,0.514252569,15,"Biomarker, GeneticVariation"
4436,MSH2,mutS homolog 2,1.0,1.0,1.0,0.0,0.0,9405,"Colorectal Neoplasms, Hereditary Nonpolyposis",0.514024283,53,"AlteredExpression, Biomarker, GeneticVariation"
80144,FRAS1,Fraser extracellular matrix complex subunit 1,0.0,1.0,1.0,0.0,0.0,265233,Fraser Syndrome,0.513969064,14,"Biomarker, GeneticVariation"
5251,PHEX,"phosphate regulating endopeptidase homolog, X-linked",0.0,1.0,1.0,0.0,0.0,733682,"HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT",0.513969064,20,"Biomarker, GeneticVariation"
9445,ITM2B,integral membrane protein 2B,0.0,1.0,1.0,0.0,0.0,1861735,"Dementia, familial Danish",0.513969064,14,"Biomarker, GeneticVariation"
100,ADA,adenosine deaminase,0.0,1.0,1.0,0.0,0.0,1863236,"SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE D...",0.513969064,23,"Biomarker, GeneticVariation"
5897,RAG2,recombination activating gene 2,0.0,1.0,1.0,0.0,0.0,1801959,Histiocytic medullary reticulosis,0.513685559,13,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,0.0,1.0,1.0,0.0,0.0,349639,"Leukemia, Myelomonocytic, Juvenile",0.513685559,14,"Biomarker, GeneticVariation"
57167,SALL4,spalt-like transcription factor 4,0.0,1.0,1.0,0.0,0.0,1623209,Duane-radial ray syndrome,0.51311855,11,"Biomarker, GeneticVariation"
1286,COL4A4,"collagen, type IV, alpha 4",0.0,1.0,1.0,0.0,0.0,1567744,"ALPORT SYNDROME, AUTOSOMAL RECESSIVE",0.51311855,11,"Biomarker, GeneticVariation"
4810,NHS,Nance-Horan syndrome (congenital cataracts and dental anomalies),0.0,1.0,1.0,0.0,0.0,796085,Nance-Horan syndrome,0.51311855,11,"Biomarker, GeneticVariation"
11231,SEC63,SEC63 homolog (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,158683,Polycystic liver disease,0.51311855,12,"Biomarker, GeneticVariation"
7305,TYROBP,TYRO protein tyrosine kinase binding protein,0.0,1.0,1.0,0.0,0.0,1857316,Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy,0.51311855,11,"Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,1449563,Primary idiopathic dilated cardiomyopathy,0.512884077,3,"Biomarker, GeneticVariation"
26580,BSCL2,Berardinelli-Seip congenital lipodystrophy 2 (seipin),0.0,1.0,1.0,0.0,0.0,1720863,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2",0.512835046,10,"Biomarker, GeneticVariation"
26503,SLC17A5,"solute carrier family 17 (acidic sugar transporter), member 5",0.0,1.0,1.0,0.0,0.0,1096903,Salla disease,0.512835046,10,"Biomarker, GeneticVariation"
9445,ITM2B,integral membrane protein 2B,0.0,1.0,1.0,0.0,0.0,1867773,"Dementia, familial British",0.512835046,10,"Biomarker, GeneticVariation"
545,ATR,ATR serine/threonine kinase,0.0,1.0,1.0,0.0,0.0,265202,Seckel syndrome 1,0.512835046,10,"Biomarker, GeneticVariation"
4864,NPC1,"Niemann-Pick disease, type C1",0.0,1.0,1.0,0.0,0.0,3179455,"NIEMANN-PICK DISEASE, TYPE C1",0.512835046,26,"Biomarker, GeneticVariation"
2591,GALNT3,polypeptide N-acetylgalactosaminyltransferase 3,0.0,1.0,1.0,0.0,0.0,1876187,"Tumoral Calcinosis, Hyperphosphatemic, Familial",0.512551541,9,"Biomarker, GeneticVariation"
1811,SLC26A3,"solute carrier family 26 (anion exchanger), member 3",0.0,1.0,1.0,0.0,0.0,267662,Congenital chloride diarrhea,0.512551541,11,"Biomarker, GeneticVariation"
10804,GJB6,"gap junction protein, beta 6, 30kDa",0.0,1.0,1.0,0.0,0.0,162361,clouston syndrome,0.512551541,9,"Biomarker, GeneticVariation"
6223,RPS19,ribosomal protein S19,0.0,1.0,1.0,0.0,0.0,2676137,Diamond-Blackfan Anemia 1,0.512268037,15,"Biomarker, GeneticVariation"
6712,SPTBN2,"spectrin, beta, non-erythrocytic 2",0.0,1.0,1.0,0.0,0.0,752123,SPINOCEREBELLAR ATAXIA 5,0.512268037,9,"Biomarker, GeneticVariation"
11146,GLMN,"glomulin, FKBP associated protein",0.0,1.0,1.0,0.0,0.0,1841984,Glomus vagale tumors,0.512268037,8,"Biomarker, GeneticVariation"
9380,GRHPR,glyoxylate reductase/hydroxypyruvate reductase,0.0,1.0,1.0,0.0,0.0,268165,Primary hyperoxaluria type 2,0.512268037,8,"Biomarker, GeneticVariation"
80781,COL18A1,"collagen, type XVIII, alpha 1",0.0,1.0,1.0,0.0,0.0,1849409,Knobloch syndrome,0.511984532,7,"Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,1720860,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2",0.511984532,7,"Biomarker, GeneticVariation"
7273,TTN,titin,0.0,1.0,1.0,0.0,0.0,1838244,"TIBIAL MUSCULAR DYSTROPHY, TARDIVE",0.511984532,7,"Biomarker, GeneticVariation"
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",0.0,1.0,1.0,0.0,0.0,1449842,"PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT",0.511984532,7,"Biomarker, GeneticVariation"
139285,AMER1,APC membrane recruitment protein 1,0.0,1.0,1.0,0.0,0.0,432268,Osteopathia striata cranial sclerosis,0.511701027,7,"Biomarker, GeneticVariation"
3425,IDUA,"iduronidase, alpha-L-",0.0,1.0,1.0,0.0,0.0,26708,Mucopolysaccharidosis V,0.511701027,6,"Biomarker, GeneticVariation"
9990,SLC12A6,"solute carrier family 12 (potassium/chloride transporter), member 6",0.0,1.0,1.0,0.0,0.0,795950,Corpus callosum agenesis neuronopathy,0.511701027,6,"Biomarker, GeneticVariation"
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,3493776,"Hypothyroidism, Congenital, Nongoitrous, 1",0.511701027,6,"Biomarker, GeneticVariation"
3425,IDUA,"iduronidase, alpha-L-",0.0,1.0,1.0,0.0,0.0,86431,Hurler-Scheie syndrome,0.511417523,5,"Biomarker, GeneticVariation"
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,1.0,0.0,0.0,398641,Epstein syndrome,0.511417523,5,"Biomarker, GeneticVariation"
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,1.0,0.0,0.0,1846058,Lubs X-linked mental retardation syndrome,0.511417523,5,"Biomarker, GeneticVariation"
1301,COL11A1,"collagen, type XI, alpha 1",0.0,1.0,1.0,0.0,0.0,265235,Marshall syndrome,0.511417523,5,"Biomarker, GeneticVariation"
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,1.0,0.0,0.0,403445,Fechtner syndrome,0.511417523,5,"Biomarker, GeneticVariation"
3339,HSPG2,heparan sulfate proteoglycan 2,0.0,1.0,1.0,0.0,0.0,36391,Schwartz-Jampel Syndrome,0.511417523,5,"Biomarker, GeneticVariation"
26503,SLC17A5,"solute carrier family 17 (acidic sugar transporter), member 5",0.0,1.0,1.0,0.0,0.0,1096902,INFANTILE SIALIC ACID STORAGE DISEASE,0.511417523,5,"Biomarker, GeneticVariation"
3868,KRT16,"keratin 16, type I",0.0,1.0,1.0,0.0,0.0,1706595,PACHYONYCHIA CONGENITA 1,0.511417523,5,"Biomarker, GeneticVariation"
1352,COX10,COX10 heme A:farnesyltransferase cytochrome c oxidase assembly factor,0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.511134018,4,"Biomarker, GeneticVariation"
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,1.0,0.0,0.0,751038,COCKAYNE SYNDROME B,0.511134018,4,"Biomarker, GeneticVariation"
5309,PITX3,paired-like homeodomain 3,0.0,1.0,1.0,0.0,0.0,1862839,Anterior segment mesenchymal dysgenesis,0.511134018,4,"Biomarker, GeneticVariation"
4868,NPHS1,"nephrosis 1, congenital, Finnish type (nephrin)",0.0,1.0,1.0,0.0,0.0,403399,Finnish congenital nephrotic syndrome,0.511134018,11,"Biomarker, GeneticVariation"
1634,DCN,decorin,0.0,1.0,1.0,0.0,0.0,1864738,"Corneal Dystrophy, Congenital Stromal",0.511134018,4,"Biomarker, GeneticVariation"
57338,JPH3,junctophilin 3,0.0,1.0,1.0,0.0,0.0,1847987,Huntington Disease-Like 2,0.511134018,4,"Biomarker, GeneticVariation"
25861,DFNB31,"deafness, autosomal recessive 31",0.0,1.0,1.0,0.0,0.0,1568249,"USHER SYNDROME, TYPE IID",0.511134018,4,"Biomarker, GeneticVariation"
3242,HPD,4-hydroxyphenylpyruvate dioxygenase,0.0,1.0,1.0,0.0,0.0,268623,Tyrosinemia type III,0.511134018,4,"Biomarker, GeneticVariation"
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,1.0,0.0,0.0,1832334,"Neuropathy, hereditary motor and sensory, LOM type",0.511134018,4,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,25237,Melnick-Needles syndrome,0.511134018,4,"Biomarker, GeneticVariation"
6785,ELOVL4,ELOVL fatty acid elongase 4,0.0,1.0,1.0,0.0,0.0,1838644,Stargardt disease 3,0.511134018,4,"Biomarker, GeneticVariation"
2720,GLB1,"galactosidase, beta 1",0.0,1.0,1.0,0.0,0.0,268272,"GM1-GANGLIOSIDOSIS, TYPE II",0.510850514,3,"Biomarker, GeneticVariation"
1491,CTH,cystathionine gamma-lyase,0.0,1.0,1.0,0.0,0.0,220993,Cystathioninuria,0.510850514,4,"Biomarker, GeneticVariation"
54101,RIPK4,receptor-interacting serine-threonine kinase 4,0.0,1.0,1.0,0.0,0.0,1849718,"Popliteal Pterygium Syndrome, Lethal Type",0.510850514,4,"Biomarker, GeneticVariation"
165918,RNF168,"ring finger protein 168, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,2677792,Riddle Syndrome,0.510850514,3,"Biomarker, GeneticVariation"
9896,FIG4,FIG4 phosphoinositide 5-phosphatase,0.0,1.0,1.0,0.0,0.0,1857663,Yunis Varon syndrome,0.510850514,3,"Biomarker, GeneticVariation"
64093,SMOC1,SPARC related modular calcium binding 1,0.0,1.0,1.0,0.0,0.0,599973,Anophthalmos with limb anomalies,0.510850514,4,"Biomarker, GeneticVariation"
2629,GBA,"glucosidase, beta, acid",0.0,1.0,1.0,0.0,0.0,268250,Acute neuronopathic Gaucher's disease,0.510850514,3,"Biomarker, GeneticVariation"
9742,IFT140,intraflagellar transport 140,0.0,1.0,1.0,0.0,0.0,1849437,Mainzer-Saldino Disease,0.510850514,3,"Biomarker, GeneticVariation"
4256,MGP,matrix Gla protein,0.0,1.0,1.0,0.0,0.0,1855607,Keutel syndrome,0.510850514,4,"Biomarker, GeneticVariation"
10491,CRTAP,cartilage associated protein,0.0,1.0,1.0,0.0,0.0,1853162,Osteogenesis Imperfecta Type VII,0.510567009,4,"Biomarker, GeneticVariation"
7068,THRB,"thyroid hormone receptor, beta",0.0,1.0,1.0,0.0,0.0,3489796,"Thyroid Hormone Resistance, Generalized, Autosomal Recessive",0.510567009,2,"Biomarker, GeneticVariation"
64072,CDH23,cadherin-related 23,0.0,1.0,1.0,0.0,0.0,1832845,"Usher Syndrome, Type ID",0.510567009,2,"Biomarker, GeneticVariation"
2629,GBA,"glucosidase, beta, acid",0.0,1.0,1.0,0.0,0.0,268251,"GAUCHER DISEASE, TYPE III",0.510567009,2,"Biomarker, GeneticVariation"
5311,PKD2,polycystic kidney disease 2 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,2751306,POLYCYSTIC KIDNEY DISEASE 2,0.510567009,8,"Biomarker, GeneticVariation"
2317,FLNB,"filamin B, beta",0.0,1.0,1.0,0.0,0.0,1848934,Spondylocarpotarsal synostosis,0.510567009,3,"Biomarker, GeneticVariation"
9247,GCM2,glial cells missing homolog 2 (Drosophila),0.0,1.0,1.0,0.0,0.0,1832648,Hypoparathyroidism familial isolated,0.510567009,4,"Biomarker, GeneticVariation"
23169,SLC35D1,"solute carrier family 35 (UDP-GlcA/UDP-GalNAc transporter), member D1",0.0,1.0,1.0,0.0,0.0,432194,Schneckenbecken dysplasia,0.510567009,2,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,0.0,1720861,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3",0.510567009,2,"Biomarker, GeneticVariation"
2176,FANCC,"Fanconi anemia, complementation group C",0.0,1.0,1.0,0.0,0.0,3468041,"FANCONI ANEMIA, COMPLEMENTATION GROUP C",0.510567009,2,"Biomarker, GeneticVariation"
3861,KRT14,"keratin 14, type I",0.0,1.0,1.0,0.0,0.0,79295,"EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE",0.510567009,2,"Biomarker, GeneticVariation"
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,1846545,CASPASE 8 DEFICIENCY,0.510567009,2,"Biomarker, GeneticVariation"
89910,UBE3B,ubiquitin protein ligase E3B,0.0,1.0,1.0,0.0,0.0,3808692,BLEPHAROPHIMOSIS-PTOSIS-INTELLECTUAL DISABILITY SYNDROME,0.510567009,2,"Biomarker, GeneticVariation"
249,ALPL,"alkaline phosphatase, liver/bone/kidney",0.0,1.0,1.0,0.0,0.0,220743,"Hypophosphatasia, Childhood",0.510567009,2,"Biomarker, GeneticVariation"
10555,AGPAT2,1-acylglycerol-3-phosphate O-acyltransferase 2,0.0,1.0,1.0,0.0,0.0,1720862,"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1",0.510567009,3,"Biomarker, GeneticVariation"
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,1.0,0.0,0.0,1449843,"PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE",0.510283505,1,"Biomarker, GeneticVariation"
64327,LMBR1,limb development membrane protein 1,0.0,1.0,1.0,0.0,0.0,265559,Acheiropodia,0.510283505,1,"Biomarker, GeneticVariation"
4128,MAOA,monoamine oxidase A,0.0,1.0,1.0,0.0,0.0,796275,Brunner Syndrome,0.510283505,1,"Biomarker, GeneticVariation"
26090,ABHD12,abhydrolase domain containing 12,0.0,1.0,1.0,0.0,0.0,2675204,"Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa, And Cataract",0.510283505,1,"Biomarker, GeneticVariation"
5663,PSEN1,presenilin 1,0.0,1.0,1.0,0.0,0.0,1843013,"Alzheimer disease, familial, type 3",0.510283505,1,"Biomarker, GeneticVariation"
167691,LCA5,Leber congenital amaurosis 5,0.0,1.0,1.0,0.0,0.0,1858301,"Amaurosis congenita of Leber, type 5",0.510283505,1,"Biomarker, GeneticVariation"
7148,TNXB,tenascin XB,0.0,1.0,1.0,0.0,0.0,1848029,Ehlers-Danlos syndrome caused by tenascin-X deficiency,0.510283505,1,"Biomarker, GeneticVariation"
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),0.0,1.0,1.0,0.0,0.0,1291564,Deficiency of aromatic-L-amino-acid decarboxylase,0.510283505,3,"Biomarker, GeneticVariation"
7051,TGM1,transglutaminase 1,0.0,1.0,1.0,0.0,0.0,3536797,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1",0.510283505,8,"Biomarker, GeneticVariation"
9321,TRIP11,thyroid hormone receptor interactor 11,0.0,1.0,1.0,0.0,0.0,265273,Achondrogenesis type 1A,0.510283505,1,"Biomarker, GeneticVariation"
64421,DCLRE1C,DNA cross-link repair 1C,0.0,1.0,1.0,0.0,0.0,1865370,Severe combined immunodeficiency with sensitivity to ionizing radiation,0.510283505,1,"Biomarker, GeneticVariation"
91252,SLC39A13,"solute carrier family 39 (zinc transporter), member 13",0.0,1.0,1.0,0.0,0.0,2676510,"Spondylocheirodysplasia, Ehlers-Danlos Syndrome-Like",0.510283505,1,"Biomarker, GeneticVariation"
1147,CHUK,conserved helix-loop-helix ubiquitous kinase,0.0,1.0,1.0,0.0,0.0,3150891,COCOON SYNDROME,0.510283505,1,"Biomarker, GeneticVariation"
65217,PCDH15,protocadherin-related 15,0.0,1.0,1.0,0.0,0.0,1865885,"Usher Syndrome, Type IF",0.510283505,1,"Biomarker, GeneticVariation"
4724,NDUFS4,"NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.510283505,1,"Biomarker, GeneticVariation"
4726,NDUFS6,"NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.510283505,1,"Biomarker, GeneticVariation"
6261,RYR1,ryanodine receptor 1 (skeletal),0.0,1.0,1.0,0.0,0.0,1850674,MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA,0.510283505,1,"Biomarker, GeneticVariation"
10117,ENAM,enamelin,0.0,1.0,1.0,0.0,0.0,399368,"Amelogenesis Imperfecta, Type IB",0.510283505,1,"Biomarker, GeneticVariation"
3914,LAMB3,"laminin, beta 3",0.0,1.0,1.0,0.0,0.0,79683,Epidermolysis bullosa letalis,0.510283505,1,"Biomarker, GeneticVariation"
6338,SCNN1B,"sodium channel, non voltage gated 1 beta subunit",0.0,1.0,1.0,0.0,0.0,1449843,"PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE",0.51,0,"Biomarker, GeneticVariation"
55806,HR,hair growth associated,0.0,1.0,1.0,0.0,0.0,1859592,Atrichia with Papular Lesions,0.51,0,"Biomarker, GeneticVariation"
4703,NEB,nebulin,0.0,1.0,1.0,0.0,0.0,1850569,Nemaline Myopathy 2,0.51,0,"Biomarker, GeneticVariation"
3679,ITGA7,"integrin, alpha 7",0.0,1.0,1.0,0.0,0.0,2750786,"Muscular Dystrophy, Congenital, Due To Integrin Alpha-7 Deficiency",0.51,0,"Biomarker, GeneticVariation"
8200,GDF5,growth differentiation factor 5,0.0,1.0,1.0,0.0,0.0,3554446,"BRACHYDACTYLY, TYPE A1, C",0.51,0,"Biomarker, GeneticVariation"
23418,CRB1,"crumbs family member 1, photoreceptor morphogenesis associated",0.0,1.0,1.0,0.0,0.0,3151202,LEBER CONGENITAL AMAUROSIS 8,0.51,0,"Biomarker, GeneticVariation"
84343,HPS3,Hermansky-Pudlak syndrome 3,0.0,1.0,1.0,0.0,0.0,1423606,HPS3 GENE,0.51,1,"Biomarker, GeneticVariation"
6935,ZEB1,zinc finger E-box binding homeobox 1,0.0,1.0,1.0,0.0,0.0,1836724,"Corneal Dystrophy, Posterior Polymorphous, 3",0.51,0,"Biomarker, GeneticVariation"
11235,PDCD10,programmed cell death 10,0.0,1.0,1.0,0.0,0.0,1864040,Cerebral Cavernous Malformations 3,0.51,0,"Biomarker, GeneticVariation"
65266,WNK4,WNK lysine deficient protein kinase 4,0.0,1.0,1.0,0.0,0.0,1840390,"Pseudohypoaldosteronism, Type IIb",0.51,3,"Biomarker, GeneticVariation"
57539,WDR35,WD repeat domain 35,0.0,1.0,1.0,0.0,0.0,3279792,SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY,0.51,0,"Biomarker, GeneticVariation"
25861,DFNB31,"deafness, autosomal recessive 31",0.0,1.0,1.0,0.0,0.0,1846839,"Deafness, Autosomal Recessive 31",0.51,0,"Biomarker, GeneticVariation"
161497,STRC,stereocilin,0.0,1.0,1.0,0.0,0.0,1863561,"Deafness, Autosomal Recessive 16",0.51,0,"Biomarker, GeneticVariation"
8557,TCAP,titin-cap,0.0,1.0,1.0,0.0,0.0,1866008,"Muscular Dystrophy, Limb-Girdle, Type 2G",0.51,0,"Biomarker, GeneticVariation"
201294,UNC13D,unc-13 homolog D (C. elegans),0.0,1.0,1.0,0.0,0.0,1837174,"Hemophagocytic lymphohistiocytosis, familial, 3",0.51,0,"Biomarker, GeneticVariation"
6598,SMARCB1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",0.0,1.0,1.0,0.0,0.0,1836327,Rhabdoid Tumor Predisposition Syndrome 1,0.51,0,"Biomarker, GeneticVariation"
2743,GLRB,"glycine receptor, beta",0.0,1.0,1.0,0.0,0.0,3553291,HYPEREKPLEXIA 2,0.51,2,"Biomarker, GeneticVariation"
146183,OTOA,otoancorin,0.0,1.0,1.0,0.0,0.0,1846896,"Deafness, Autosomal Recessive 22",0.51,0,"Biomarker, GeneticVariation"
1453,CSNK1D,"casein kinase 1, delta",0.0,1.0,1.0,0.0,0.0,3808874,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2",0.51,1,"Biomarker, GeneticVariation"
8842,PROM1,prominin 1,0.0,1.0,1.0,0.0,0.0,2677516,Retinitis Pigmentosa 41,0.51,0,"Biomarker, GeneticVariation"
8676,STX11,syntaxin 11,0.0,1.0,1.0,0.0,0.0,1863728,"Hemophagocytic lymphohistiocytosis, familial, 4",0.51,0,"Biomarker, GeneticVariation"
6591,SNAI2,snail family zinc finger 2,0.0,1.0,1.0,0.0,0.0,1837203,"Waardenburg Syndrome, Type 2D",0.51,0,"Biomarker, GeneticVariation"
182,JAG1,jagged 1,0.0,1.0,1.0,0.0,0.0,1956125,ALAGILLE SYNDROME 1,0.51,0,"Biomarker, GeneticVariation"
352909,DNAAF3,"dynein, axonemal, assembly factor 3",0.0,1.0,1.0,0.0,0.0,1847554,"Primary ciliary dyskinesia, 2",0.51,1,"Biomarker, GeneticVariation"
10243,GPHN,gephyrin,0.0,1.0,1.0,0.0,0.0,1854990,"Molybdenum Cofactor Deficiency, Complementation Group C",0.51,1,"Biomarker, GeneticVariation"
3909,LAMA3,"laminin, alpha 3",0.0,1.0,1.0,0.0,0.0,268374,"Epidermolysis Bullosa, Junctional, Non-Herlitz Type",0.51,0,"Biomarker, GeneticVariation"
3918,LAMC2,"laminin, gamma 2",0.0,1.0,1.0,0.0,0.0,268374,"Epidermolysis Bullosa, Junctional, Non-Herlitz Type",0.51,1,"Biomarker, GeneticVariation"
3075,CFH,complement factor H,0.0,1.0,1.0,0.0,0.0,2749604,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1",0.51,0,"Biomarker, GeneticVariation"
6103,RPGR,retinitis pigmentosa GTPase regulator,0.0,1.0,1.0,0.0,0.0,1844776,"Cone-Rod Dystrophy, X-Linked, Type 1",0.51,0,"Biomarker, GeneticVariation"
11280,SCN11A,"sodium channel, voltage gated, type XI alpha subunit",0.0,1.0,1.0,0.0,0.0,3809882,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII",0.51,0,"Biomarker, GeneticVariation"
4284,MIP,major intrinsic protein of lens fiber,0.0,1.0,1.0,0.0,0.0,3809001,"CATARACT 15, MULTIPLE TYPES",0.51,5,"Biomarker, GeneticVariation"
5345,SERPINF2,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2",0.0,1.0,1.0,0.0,0.0,2752081,ALPHA-2-PLASMIN INHIBITOR DEFICIENCY,0.51,1,"Biomarker, GeneticVariation"
55130,ARMC4,armadillo repeat containing 4,0.0,1.0,1.0,0.0,0.0,3809548,"CILIARY DYSKINESIA, PRIMARY, 23",0.51,1,"Biomarker, GeneticVariation"
1605,DAG1,dystroglycan 1 (dystrophin-associated glycoprotein 1),0.0,1.0,1.0,0.0,0.0,3151184,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9",0.51,1,"Biomarker, GeneticVariation"
4644,MYO5A,"myosin VA (heavy chain 12, myoxin)",0.0,1.0,1.0,0.0,0.0,1859194,Griscelli syndrome type 1,0.51,0,"Biomarker, GeneticVariation"
169792,GLIS3,GLIS family zinc finger 3,0.0,1.0,1.0,0.0,0.0,1857775,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",0.51,0,"Biomarker, GeneticVariation"
63925,ZNF335,zinc finger protein 335,0.0,1.0,1.0,0.0,0.0,3554499,"MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE",0.51,1,"Biomarker, GeneticVariation"
153562,MARVELD2,MARVEL domain containing 2,0.0,1.0,1.0,0.0,0.0,1857811,"Deafness, Autosomal Recessive 49",0.51,0,"Biomarker, GeneticVariation"
1954,MEGF8,multiple EGF-like-domains 8,0.0,1.0,1.0,0.0,0.0,3554247,CARPENTER SYNDROME 2,0.51,1,"Biomarker, GeneticVariation"
2055,CLN8,"ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)",0.0,1.0,1.0,0.0,0.0,1838570,"CEROID LIPOFUSCINOSIS, NEURONAL, 8",0.51,0,"Biomarker, GeneticVariation"
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,1.0,0.0,0.0,1864846,"Pigmented Nodular Adrenocortical Disease, Primary, 1",0.51,0,"Biomarker, GeneticVariation"
4983,OPHN1,oligophrenin 1,0.0,1.0,1.0,0.0,0.0,1845366,"Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance",0.51,0,"Biomarker, GeneticVariation"
51778,MYOZ2,myozenin 2,0.0,1.0,1.0,0.0,0.0,3151204,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16",0.51,1,"Biomarker, GeneticVariation"
1411,CRYBA1,"crystallin, beta A1",0.0,1.0,1.0,0.0,0.0,1833229,"Cataract, Congenital Zonular, with Sutural Opacities",0.51,0,"Biomarker, GeneticVariation"
9152,SLC6A5,"solute carrier family 6 (neurotransmitter transporter), member 5",0.0,1.0,1.0,0.0,0.0,3553288,HYPEREKPLEXIA 3,0.51,1,"Biomarker, GeneticVariation"
64175,P3H1,prolyl 3-hydroxylase 1,0.0,1.0,1.0,0.0,0.0,1970458,"Osteogenesis imperfecta, type VIII",0.51,0,"Biomarker, GeneticVariation"
977,CD151,CD151 molecule (Raph blood group),0.0,1.0,1.0,0.0,0.0,1836823,Nephropathy with Pretibial Epidermolysis Bullosa and Deafness,0.51,0,"Biomarker, GeneticVariation"
10083,USH1C,"Usher syndrome 1C (autosomal recessive, severe)",0.0,1.0,1.0,0.0,0.0,1865870,"Deafness, Autosomal Recessive 18",0.51,0,"Biomarker, GeneticVariation"
8200,GDF5,growth differentiation factor 5,0.0,1.0,1.0,0.0,0.0,2930970,Acromesomelic dysplasia,0.51,0,"Biomarker, GeneticVariation"
1302,COL11A2,"collagen, type XI, alpha 2",0.0,1.0,1.0,0.0,0.0,1861481,"Stickler syndrome, type 3",0.51,0,"Biomarker, GeneticVariation"
6442,SGCA,"sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)",0.0,1.0,1.0,0.0,0.0,1842550,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D",0.51,6,"Biomarker, GeneticVariation"
9313,MMP20,matrix metallopeptidase 20,0.0,1.0,1.0,0.0,0.0,2675858,"Amelogenesis Imperfecta, Hypomaturation Type, Iia2",0.51,0,"Biomarker, GeneticVariation"
8456,FOXN1,forkhead box N1,0.0,1.0,1.0,0.0,0.0,1866426,"T-cell immunodeficiency, congenital alopecia and nail dystrophy",0.51,0,"Biomarker, GeneticVariation"
53904,MYO3A,myosin IIIA,0.0,1.0,1.0,0.0,0.0,1846784,"Deafness, Autosomal Recessive 30",0.51,0,"Biomarker, GeneticVariation"
57096,RPGRIP1,retinitis pigmentosa GTPase regulator interacting protein 1,0.0,1.0,1.0,0.0,0.0,1854260,Leber Congenital Amaurosis 6,0.51,0,"Biomarker, GeneticVariation"
1406,CRX,cone-rod homeobox,0.0,1.0,1.0,0.0,0.0,3151192,LEBER CONGENITAL AMAUROSIS 7,0.51,0,"Biomarker, GeneticVariation"
3166,HMX1,H6 family homeobox 1,0.0,1.0,1.0,0.0,0.0,2677500,Oculoauricular Syndrome,0.51,0,"Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,1.0,0.0,0.0,1861195,"Glanzmann Thrombasthenia, Autosomal Dominant",0.51,0,"Biomarker, GeneticVariation"
3674,ITGA2B,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)",0.0,1.0,1.0,0.0,0.0,1861195,"Glanzmann Thrombasthenia, Autosomal Dominant",0.51,0,"Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,3281125,THROMBOCYTHEMIA 3,0.51,0,"Biomarker, GeneticVariation"
50846,DHH,desert hedgehog,0.0,1.0,1.0,0.0,0.0,2751325,"46,Xy Gonadal Dysgenesis, Partial, With Minifascicular Neuropathy",0.51,0,"Biomarker, GeneticVariation"
81846,SBF2,SET binding factor 2,0.0,1.0,1.0,0.0,0.0,1858278,"Charcot-Marie-Tooth disease, Type 4B2",0.51,0,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,162832,"Genes, APC",0.51,0,"Biomarker, GeneticVariation"
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",0.0,1.0,1.0,0.0,0.0,2749942,"EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5",0.51,0,"Biomarker, GeneticVariation"
6011,GRK1,G protein-coupled receptor kinase 1,0.0,1.0,1.0,0.0,0.0,3150678,OGUCHI DISEASE 2,0.51,2,"Biomarker, GeneticVariation"
55835,CENPJ,centromere protein J,0.0,1.0,1.0,0.0,0.0,1826553,PERICENTRIN,0.51,0,"Biomarker, GeneticVariation"
23562,CLDN14,claudin 14,0.0,1.0,1.0,0.0,0.0,3279660,"DEAFNESS, AUTOSOMAL RECESSIVE 29",0.51,2,"Biomarker, GeneticVariation"
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,1.0,0.0,0.0,340978,May-Hegglin anomaly,0.51,0,"Biomarker, GeneticVariation"
23345,SYNE1,"spectrin repeat containing, nuclear envelope 1",0.0,1.0,1.0,0.0,0.0,2751807,Emery-Dreifuss Muscular Dystrophy 4,0.51,1,"Biomarker, GeneticVariation"
23435,TARDBP,TAR DNA binding protein,0.0,1.0,1.0,0.0,0.0,2677565,"AMYOTROPHIC LATERAL SCLEROSIS 10, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA",0.51,9,"Biomarker, GeneticVariation"
81624,DIAPH3,diaphanous-related formin 3,0.0,1.0,1.0,0.0,0.0,1836743,"Auditory Neuropathy, Autosomal Dominant, 1",0.51,0,"Biomarker, GeneticVariation"
84662,GLIS2,GLIS family zinc finger 2,0.0,1.0,1.0,0.0,0.0,1969092,Nephronophthisis 7,0.51,0,"Biomarker, GeneticVariation"
3198,HOXA1,homeobox A1,0.0,1.0,1.0,0.0,0.0,1832215,Athabaskan brainstem dysgenesis,0.51,1,"Biomarker, GeneticVariation"
3814,KISS1,KiSS-1 metastasis-suppressor,0.0,1.0,1.0,0.0,0.0,3541462,HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA,0.51,1,"Biomarker, GeneticVariation"
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,1.0,0.0,0.0,1864887,Cortical Dysplasia-Focal Epilepsy Syndrome,0.51,0,"Biomarker, GeneticVariation"
50937,CDON,"cell adhesion associated, oncogene regulated",0.0,1.0,1.0,0.0,0.0,3280215,HOLOPROSENCEPHALY 11,0.51,1,"Biomarker, GeneticVariation"
3852,KRT5,"keratin 5, type II",0.0,1.0,1.0,0.0,0.0,79295,"EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE",0.51,0,"Biomarker, GeneticVariation"
8291,DYSF,dysferlin,0.0,1.0,1.0,0.0,0.0,1847532,"Myopathy, Distal, with Anterior Tibial Onset",0.51,0,"Biomarker, GeneticVariation"
11234,HPS5,Hermansky-Pudlak syndrome 5,0.0,1.0,1.0,0.0,0.0,1424692,HPS5 GENE,0.51,1,"Biomarker, GeneticVariation"
5194,PEX13,peroxisomal biogenesis factor 13,0.0,1.0,1.0,0.0,0.0,3554001,PEROXISOME BIOGENESIS DISORDER 11B,0.51,1,"Biomarker, GeneticVariation"
2035,EPB41,erythrocyte membrane protein band 4.1,0.0,1.0,1.0,0.0,0.0,2678497,Elliptocytosis 1,0.51,0,"Biomarker, GeneticVariation"
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,1.0,0.0,0.0,2607929,"CARNEY COMPLEX, TYPE 1",0.51,0,"Biomarker, GeneticVariation"
84634,KISS1R,KISS1 receptor,0.0,1.0,1.0,0.0,0.0,3553841,HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA,0.51,0,"Biomarker, GeneticVariation"
3982,LIM2,"lens intrinsic membrane protein 2, 19kDa",0.0,1.0,1.0,0.0,0.0,3809004,CATARACT 19,0.51,1,"Biomarker, GeneticVariation"
4436,MSH2,mutS homolog 2,0.0,1.0,1.0,0.0,0.0,2936783,"Colorectal cancer, hereditary nonpolyposis, type 1",0.51,30,"Biomarker, GeneticVariation"
2664,GDI1,GDP dissociation inhibitor 1,0.0,1.0,1.0,0.0,0.0,1415038,GDP DISSOCIATION INHIBITOR 1,0.51,2,"Biomarker, GeneticVariation"
284119,PTRF,polymerase I and transcript release factor,0.0,1.0,1.0,0.0,0.0,2750069,"Lipodystrophy, Congenital Generalized, Type 4",0.51,0,"Biomarker, GeneticVariation"
1415,CRYBB2,"crystallin, beta B2",0.0,1.0,1.0,0.0,0.0,1832175,"Cataract, Congenital, Cerulean Type, 2",0.51,0,"Biomarker, GeneticVariation"
1908,EDN3,endothelin 3,0.0,1.0,1.0,0.0,0.0,3150975,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4",0.51,0,"Biomarker, GeneticVariation"
80184,CEP290,centrosomal protein 290kDa,0.0,1.0,1.0,0.0,0.0,1857821,Leber Congenital Amaurosis 10,0.51,0,"Biomarker, GeneticVariation"
26277,TINF2,TERF1 (TRF1)-interacting nuclear factor 2,0.0,1.0,1.0,0.0,0.0,3151445,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3",0.51,0,"Biomarker, GeneticVariation"
55806,HR,hair growth associated,0.0,1.0,1.0,0.0,0.0,1859877,ALOPECIA UNIVERSALIS CONGENITA,0.51,3,"Biomarker, GeneticVariation"
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,1.0,0.0,0.0,1858672,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",0.51,0,"Biomarker, GeneticVariation"
5158,PDE6B,"phosphodiesterase 6B, cGMP-specific, rod, beta",0.0,1.0,1.0,0.0,0.0,3151107,RETINITIS PIGMENTOSA 40,0.51,0,"Biomarker, GeneticVariation"
646960,PRSS56,"protease, serine, 56",0.0,1.0,1.0,0.0,0.0,3150757,"MICROPHTHALMIA, ISOLATED 6",0.51,3,"Biomarker, GeneticVariation"
1969,EPHA2,EPH receptor A2,0.0,1.0,1.0,0.0,0.0,1861825,"Cataract, posterior polar, 1",0.51,2,"Biomarker, GeneticVariation"
6708,SPTA1,"spectrin, alpha, erythrocytic 1",0.0,1.0,1.0,0.0,0.0,2678338,"Spherocytosis, Type 3",0.51,0,"Biomarker, GeneticVariation"
50511,SYCP3,synaptonemal complex protein 3,0.0,1.0,1.0,0.0,0.0,232981,Arrest of spermatogenesis,0.51,0,"Biomarker, GeneticVariation"
93,ACVR2B,"activin A receptor, type IIB",0.0,1.0,1.0,0.0,0.0,3151057,"HETEROTAXY, VISCERAL, 4, AUTOSOMAL",0.51,1,"Biomarker, GeneticVariation"
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,1.0,0.0,0.0,1854182,"Parkinson Disease 4, Autosomal Dominant Lewy Body",0.51,0,"Biomarker, GeneticVariation"
3257,HPS1,Hermansky-Pudlak syndrome 1,0.0,1.0,1.0,0.0,0.0,2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,0.51,0,"Biomarker, GeneticVariation"
1910,EDNRB,endothelin receptor type B,0.0,1.0,1.0,0.0,0.0,1838564,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2",0.51,0,"Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,1.0,0.0,0.0,1857854,Proopiomelanocortin Deficiency,0.51,0,"Biomarker, GeneticVariation"
6121,RPE65,retinal pigment epithelium-specific protein 65kDa,0.0,1.0,1.0,0.0,0.0,3151086,Retinitis Pigmentosa 20,0.51,0,"Biomarker, GeneticVariation"
3728,JUP,junction plakoglobin,0.0,1.0,1.0,0.0,0.0,1832600,Naxos disease,0.51,0,"Biomarker, GeneticVariation"
7248,TSC1,tuberous sclerosis 1,1.0,1.0,1.0,0.0,0.0,41341,Tuberous Sclerosis,0.509539195,236,"AlteredExpression, Biomarker, GeneticVariation"
6010,RHO,rhodopsin,1.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.509097005,137,"AlteredExpression, Biomarker, GeneticVariation"
5621,PRNP,prion protein,0.0,1.0,1.0,0.0,0.0,162534,Prion Diseases,0.508922666,424,"Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,2895,"Anemia, Sickle Cell",0.503395611,128,"Biomarker, GeneticVariation"
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,1.0,0.0,0.0,2312,alpha-Thalassemia,0.502972512,206,"Biomarker, GeneticVariation"
6392,SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein",0.0,1.0,1.0,0.0,0.0,30421,Paraganglioma,0.50024702,115,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,23976,Long QT Syndrome,0.499445703,135,"Biomarker, GeneticVariation"
5310,PKD1,polycystic kidney disease 1 (autosomal dominant),1.0,1.0,1.0,0.0,0.0,85413,"Polycystic Kidney, Autosomal Dominant",0.495020261,293,"AlteredExpression, Biomarker, GeneticVariation"
155,ADRB3,adrenoceptor beta 3,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.494664898,126,"Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,1.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.4932175,133,"AlteredExpression, Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,1.0,1.0,1.0,1.0,0.0,2395,Alzheimer Disease,0.49,1132,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,1.0,3873,"Arthritis, Rheumatoid",0.49,485,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
1636,ACE,angiotensin I converting enzyme,1.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.49,513,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",1.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.49,537,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
64127,NOD2,nucleotide-binding oligomerization domain containing 2,1.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.49,617,"AlteredExpression, Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.489729464,55,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,221757,alpha 1-Antitrypsin Deficiency,0.486158361,117,"Biomarker, GeneticVariation"
5167,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.485280283,56,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,29434,Osteogenesis Imperfecta,0.485153812,125,"Biomarker, GeneticVariation"
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.484742238,79,"Biomarker, GeneticVariation"
1589,CYP21A2,"cytochrome P450, family 21, subfamily A, polypeptide 2",0.0,1.0,1.0,0.0,0.0,2936858,Congenital adrenal hyperplasia due to 21 hydroxylase deficiency,0.482910346,155,"Biomarker, GeneticVariation"
7352,UCP3,"uncoupling protein 3 (mitochondrial, proton carrier)",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.482550142,57,"Biomarker, GeneticVariation"
6833,ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.481740417,55,"Biomarker, GeneticVariation"
10644,IGF2BP2,insulin-like growth factor 2 mRNA binding protein 2,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.481056678,86,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.480721448,178,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,1.0,1418,Adenocarcinoma,0.477928964,346,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
27185,DISC1,disrupted in schizophrenia 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.477916077,185,"Biomarker, GeneticVariation"
2395,FXN,frataxin,1.0,1.0,1.0,1.0,0.0,16719,Friedreich Ataxia,0.475141498,131,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3040,HBA2,"hemoglobin, alpha 2",1.0,1.0,1.0,0.0,0.0,2312,alpha-Thalassemia,0.473183658,192,"AlteredExpression, Biomarker, GeneticVariation"
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,1.0,0.0,0.0,17551,Gilbert Disease,0.472812925,50,"Biomarker, GeneticVariation"
5979,RET,ret proto-oncogene,0.0,1.0,1.0,0.0,0.0,238462,"Thyroid cancer, medullary",0.47,370,"Biomarker, GeneticVariation"
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.469939866,116,"AlteredExpression, Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,33806,Pseudohypoparathyroidism,0.468632552,68,"Biomarker, GeneticVariation"
56729,RETN,resistin,1.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.467682022,54,"AlteredExpression, Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,1.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.466069352,92,"AlteredExpression, Biomarker, GeneticVariation"
4771,NF2,neurofibromin 2 (merlin),0.0,1.0,1.0,1.0,0.0,25286,Meningioma,0.465884398,81,"Biomarker, GeneticVariation, PostTranslationalModification"
6103,RPGR,retinitis pigmentosa GTPase regulator,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.465669991,60,"Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,1.0,0.0,0.0,677776,Hereditary Breast and Ovarian Cancer Syndrome,0.465566896,196,"Biomarker, GeneticVariation"
4049,LTA,lymphotoxin alpha,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.463938534,29,"Biomarker, GeneticVariation"
3596,IL13,interleukin 13,1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.458360398,224,"AlteredExpression, Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",1.0,1.0,1.0,0.0,0.0,2312,alpha-Thalassemia,0.456038267,38,"AlteredExpression, Biomarker, GeneticVariation"
5663,PSEN1,presenilin 1,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.454664898,177,"AlteredExpression, Biomarker, GeneticVariation"
4760,NEUROD1,neuronal differentiation 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.452303677,28,"Biomarker, GeneticVariation"
554,AVPR2,arginine vasopressin receptor 2,0.0,1.0,1.0,0.0,0.0,162283,"Diabetes Insipidus, Nephrogenic",0.451463526,66,"Biomarker, GeneticVariation"
5167,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.450944082,34,"Biomarker, GeneticVariation"
3952,LEP,leptin,1.0,1.0,1.0,0.0,1.0,11860,"Diabetes Mellitus, Type 2",0.450563004,60,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3753,KCNE1,"potassium channel, voltage gated subfamily E regulatory beta subunit 1",0.0,1.0,1.0,0.0,0.0,23976,Long QT Syndrome,0.449477529,45,"Biomarker, GeneticVariation"
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.448888891,137,"AlteredExpression, Biomarker, GeneticVariation"
6583,SLC22A4,"solute carrier family 22 (organic cation/zwitterion transporter), member 4",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.448002566,21,"Biomarker, GeneticVariation"
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,221013,"Mastocytosis, Systemic",0.447864859,75,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,1.0,1.0,0.0,919267,Ovarian Neoplasms,0.447416467,54,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
185,AGTR1,"angiotensin II receptor, type 1",1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.447384475,194,"AlteredExpression, Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.447210958,52,"AlteredExpression, Biomarker, GeneticVariation"
5972,REN,renin,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.445135462,380,"Biomarker, GeneticVariation"
3990,LIPC,"lipase, hepatic",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.444706982,16,"Biomarker, GeneticVariation"
6927,HNF1A,HNF1 homeobox A,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.444374446,26,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.443421548,192,"AlteredExpression, Biomarker, GeneticVariation"
2815,GP9,glycoprotein IX (platelet),0.0,1.0,1.0,0.0,0.0,5129,Bernard-Soulier Syndrome,0.442946076,34,"Biomarker, GeneticVariation"
3630,INS,insulin,1.0,1.0,1.0,0.0,1.0,11860,"Diabetes Mellitus, Type 2",0.442612885,2252,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,410189,"Muscular Dystrophy, Emery-Dreifuss",0.442429241,64,"Biomarker, GeneticVariation"
2312,FLG,filaggrin,0.0,1.0,1.0,0.0,0.0,79584,Ichthyosis Vulgaris,0.442145248,55,"Biomarker, GeneticVariation"
6654,SOS1,son of sevenless homolog 1 (Drosophila),0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.441930841,34,"Biomarker, GeneticVariation"
9992,KCNE2,"potassium channel, voltage gated subfamily E regulatory beta subunit 2",0.0,1.0,1.0,0.0,0.0,23976,Long QT Syndrome,0.441675812,39,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,20479,Hyperlipoproteinemia Type III,0.441196184,67,"Biomarker, GeneticVariation"
64127,NOD2,nucleotide-binding oligomerization domain containing 2,0.0,1.0,1.0,0.0,0.0,1861303,Synovitis granulomatous with uveitis and cranial neuropathies,0.4410774,58,"Biomarker, GeneticVariation"
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",1.0,1.0,1.0,1.0,0.0,30567,Parkinson Disease,0.441056678,160,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2956,MSH6,mutS homolog 6,0.0,1.0,1.0,0.0,0.0,9405,"Colorectal Neoplasms, Hereditary Nonpolyposis",0.440943916,17,"Biomarker, GeneticVariation"
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,1.0,0.0,0.0,10324,Crigler-Najjar Syndrome,0.440551013,31,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,1.0,11854,"Diabetes Mellitus, Type 1",0.440090308,850,"Biomarker, GeneticVariation, Therapeutic"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,1.0,0.0,25202,Melanoma,0.439085114,69,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2261,FGFR3,fibroblast growth factor receptor 3,1.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.4385961,68,"AlteredExpression, Biomarker, GeneticVariation"
8517,IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma",0.0,1.0,1.0,0.0,0.0,21171,Incontinentia Pigmenti,0.438176673,50,"Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,677776,Hereditary Breast and Ovarian Cancer Syndrome,0.438066952,99,"Biomarker, GeneticVariation"
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,1.0,0.0,0.0,1959620,Dihydropyrimidine Dehydrogenase Deficiency,0.438056912,38,"Biomarker, GeneticVariation"
4137,MAPT,microtubule-associated protein tau,1.0,1.0,1.0,1.0,0.0,2395,Alzheimer Disease,0.437135246,118,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
10984,KCNQ1OT1,KCNQ1 opposite strand/antisense transcript 1 (non-protein coding),0.0,1.0,1.0,1.0,0.0,4903,Beckwith-Wiedemann Syndrome,0.43675915,42,"Biomarker, GeneticVariation, PostTranslationalModification"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,1.0,0.0,0.0,1708349,"GASTRIC CANCER, HEREDITARY DIFFUSE",0.43664943,96,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.43621123,14,"Biomarker, GeneticVariation"
7249,TSC2,tuberous sclerosis 2,0.0,1.0,1.0,0.0,0.0,751674,Lymphangioleiomyomatosis,0.436072868,32,"Biomarker, GeneticVariation"
1028,CDKN1C,"cyclin-dependent kinase inhibitor 1C (p57, Kip2)",0.0,1.0,1.0,1.0,0.0,4903,Beckwith-Wiedemann Syndrome,0.435428519,63,"Biomarker, GeneticVariation, PostTranslationalModification"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.434800554,148,"Biomarker, GeneticVariation, Therapeutic"
10133,OPTN,optineurin,0.0,1.0,1.0,0.0,0.0,339573,"Glaucoma, Primary Open Angle",0.434791269,44,"Biomarker, GeneticVariation"
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,1.0,0.0,0.0,406810,Carney Complex,0.434664898,87,"Biomarker, GeneticVariation"
5959,RDH5,retinol dehydrogenase 5 (11-cis/9-cis),0.0,1.0,1.0,0.0,0.0,311338,Fundus Albipunctatus,0.434605826,28,"Biomarker, GeneticVariation"
2487,FRZB,frizzled-related protein,0.0,1.0,1.0,0.0,0.0,29408,Osteoarthritis,0.434334146,21,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.433891724,49,"Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,1.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.433747559,50,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
675,BRCA2,"breast cancer 2, early onset",1.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.432835046,116,"AlteredExpression, Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,19045,Hemoglobinopathies,0.432691047,38,"Biomarker, GeneticVariation"
2218,FKTN,fukutin,0.0,1.0,1.0,0.0,0.0,410174,fukuyama muscular dystrophy,0.432474201,44,"Biomarker, GeneticVariation"
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.432222588,21,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.432023437,166,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,4238,Atrial Fibrillation,0.431675646,10,"Biomarker, GeneticVariation"
11277,TREX1,three prime repair exonuclease 1,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.431331286,14,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.431314635,15,"AlteredExpression, Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.431293591,16,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,11881,Diabetic Nephropathies,0.430947346,146,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.430744865,66,"Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.43,2210,"Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.43,1287,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,24796,Marfan Syndrome,0.42985649,27,"Biomarker, GeneticVariation"
2120,ETV6,ets variant 6,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.429552918,45,"Biomarker, GeneticVariation"
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.429449068,206,"Biomarker, GeneticVariation"
5687,PSMA6,"proteasome (prosome, macropain) subunit, alpha type, 6",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.429260028,11,"Biomarker, GeneticVariation"
5663,PSEN1,presenilin 1,0.0,1.0,1.0,0.0,0.0,338451,Frontotemporal Dementia,0.429170208,17,"Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.428563454,113,"Biomarker, GeneticVariation"
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.428487509,14,"Biomarker, GeneticVariation"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,1.0,0.0,0.0,221055,Paramyotonia congenita of Von Eulenburg,0.428221633,29,"Biomarker, GeneticVariation"
2006,ELN,elastin,0.0,1.0,1.0,0.0,0.0,3499,"Aortic Stenosis, Supravalvular",0.428164359,47,"Biomarker, GeneticVariation"
1756,DMD,dystrophin,1.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.428135395,40,"AlteredExpression, Biomarker, GeneticVariation"
1291,COL6A1,"collagen, type VI, alpha 1",0.0,1.0,1.0,0.0,0.0,410179,Scleroatonic muscular dystrophy,0.427987159,20,"Biomarker, GeneticVariation"
3957,LGALS2,"lectin, galactoside-binding, soluble, 2",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.427793474,14,"Biomarker, GeneticVariation"
5498,PPOX,protoporphyrinogen oxidase,0.0,1.0,1.0,0.0,0.0,162532,"Porphyria, Variegate",0.42759735,58,"Biomarker, GeneticVariation"
9607,CARTPT,CART prepropeptide,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.42730446,14,"Biomarker, GeneticVariation"
7273,TTN,titin,1.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.427255918,28,"AlteredExpression, Biomarker, GeneticVariation"
583,BBS2,Bardet-Biedl syndrome 2,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.427235851,43,"Biomarker, GeneticVariation"
1071,CETP,"cholesteryl ester transfer protein, plasma",0.0,1.0,1.0,0.0,0.0,3149462,HYPERALPHALIPOPROTEINEMIA 1,0.427087614,27,"Biomarker, GeneticVariation"
7439,BEST1,bestrophin 1,0.0,1.0,1.0,0.0,0.0,339510,Vitelliform Macular Dystrophy,0.427010274,60,"Biomarker, GeneticVariation"
7276,TTR,transthyretin,0.0,1.0,1.0,0.0,0.0,7286,Carpal Tunnel Syndrome,0.426775146,16,"Biomarker, GeneticVariation"
55109,AGGF1,angiogenic factor with G patch and FHA domains 1,0.0,1.0,1.0,0.0,0.0,22739,Klippel-Trenaunay-Weber Syndrome,0.426618667,8,"Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,1.0,1.0,1.0,0.0,0.0,20474,"Hyperlipidemia, Familial Combined",0.426561394,25,"AlteredExpression, Biomarker, GeneticVariation"
5697,PYY,peptide YY,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.426404915,18,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,268301,Reifenstein syndrome,0.42615976,57,"Biomarker, GeneticVariation"
7012,TERC,telomerase RNA component,0.0,1.0,1.0,0.0,0.0,2874,"Anemia, Aplastic",0.426141966,9,"Biomarker, GeneticVariation"
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,1.0,1.0,0.0,0.0,1833661,Paroxysmal Extreme Pain Disorder,0.425953596,21,"Biomarker, GeneticVariation"
6399,TRAPPC2,trafficking protein particle complex 2,0.0,1.0,1.0,0.0,0.0,3541456,"Spondyloepiphyseal Dysplasia Tarda, X-Linked",0.425953596,22,"Biomarker, GeneticVariation"
51422,PRKAG2,"protein kinase, AMP-activated, gamma 2 non-catalytic subunit",0.0,1.0,1.0,0.0,0.0,43202,Wolff-Parkinson-White Syndrome,0.425924632,12,"Biomarker, GeneticVariation"
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,1.0,0.0,0.0,949658,"Cardiomyopathy, Hypertrophic, Familial",0.425809431,16,"Biomarker, GeneticVariation"
6017,RLBP1,retinaldehyde binding protein 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.425690158,5,"Biomarker, GeneticVariation"
268,AMH,anti-Mullerian hormone,0.0,1.0,1.0,0.0,0.0,1849930,Persistent Mullerian duct syndrome,0.425670091,22,"Biomarker, GeneticVariation"
2592,GALT,galactose-1-phosphate uridylyltransferase,0.0,1.0,1.0,0.0,0.0,268151,GALACTOSEMIA,0.425592751,67,"Biomarker, GeneticVariation"
1298,COL9A2,"collagen, type IX, alpha 2",0.0,1.0,1.0,0.0,0.0,158252,Intervertebral disc disease,0.425484649,3,"Biomarker, GeneticVariation"
26580,BSCL2,Berardinelli-Seip congenital lipodystrophy 2 (seipin),0.0,1.0,1.0,0.0,0.0,2931276,Spastic paraplegia 17,0.425435618,11,"Biomarker, GeneticVariation"
4261,CIITA,"class II, major histocompatibility complex, transactivator",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.425398412,13,"Biomarker, GeneticVariation"
4281,MID1,midline 1,0.0,1.0,1.0,0.0,0.0,2936904,"Opitz GBBB Syndrome, X-Linked",0.425386587,21,"Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,339573,"Glaucoma, Primary Open Angle",0.425386587,19,"Biomarker, GeneticVariation"
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.424987392,18,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,751651,Mitochondrial Diseases,0.424967814,37,"Biomarker, GeneticVariation"
4436,MSH2,mutS homolog 2,0.0,1.0,1.0,0.0,0.0,1321489,Muir-Torre Syndrome,0.424967814,35,"Biomarker, GeneticVariation"
7139,TNNT2,troponin T type 2 (cardiac),1.0,1.0,1.0,0.0,0.0,949658,"Cardiomyopathy, Hypertrophic, Familial",0.424597417,14,"AlteredExpression, Biomarker, GeneticVariation"
1292,COL6A2,"collagen, type VI, alpha 2",0.0,1.0,1.0,0.0,0.0,410179,Scleroatonic muscular dystrophy,0.424252569,15,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,25149,Medulloblastoma,0.424252569,16,"Biomarker, GeneticVariation"
5160,PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1,0.0,1.0,1.0,0.0,0.0,34345,Pyruvate Dehydrogenase Complex Deficiency Disease,0.424252569,27,"Biomarker, GeneticVariation"
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,268285,"Adrenal hyperplasia, congenital, type 5",0.424252569,24,"Biomarker, GeneticVariation"
4795,NFKBIL1,nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1,1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.424186398,9,"AlteredExpression, Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,22603,"Keratosis, Seborrheic",0.4239401,5,"Biomarker, GeneticVariation"
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,1.0,1.0,0.0,878544,Cardiomyopathies,0.423599322,26,"Biomarker, GeneticVariation, PostTranslationalModification"
9244,CRLF1,cytokine receptor-like factor 1,0.0,1.0,1.0,0.0,0.0,1832409,Crisponi syndrome,0.423402055,15,"Biomarker, GeneticVariation"
6023,RMRP,RNA component of mitochondrial RNA processing endoribonuclease,0.0,1.0,1.0,0.0,0.0,220748,Cartilage-hair hypoplasia,0.423324715,47,"Biomarker, GeneticVariation"
5313,PKLR,"pyruvate kinase, liver and RBC",0.0,1.0,1.0,0.0,0.0,340968,Pyruvate Kinase Deficiency of Red Cells,0.42311855,11,"Biomarker, GeneticVariation"
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,1.0,0.0,0.0,268358,"Osteogenesis imperfecta, type 2A",0.42311855,11,"Biomarker, GeneticVariation"
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,1.0,0.0,0.0,18522,Hallermann's Syndrome,0.423089586,2,"Biomarker, GeneticVariation"
283120,H19,"H19, imprinted maternally expressed transcript (non-protein coding)",0.0,1.0,1.0,1.0,0.0,4903,Beckwith-Wiedemann Syndrome,0.422954318,22,"Biomarker, GeneticVariation, PostTranslationalModification"
1890,TYMP,thymidine phosphorylase,0.0,1.0,1.0,0.0,0.0,872218,Mitochondrial neurogastrointestinal encephalopathy syndrome,0.422835046,14,"Biomarker, GeneticVariation"
1355,COX15,cytochrome c oxidase assembly homolog 15 (yeast),0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.422806082,2,"Biomarker, GeneticVariation"
1285,COL4A3,"collagen, type IV, alpha 3 (Goodpasture antigen)",0.0,1.0,1.0,0.0,0.0,241908,"Hematuria, Benign Familial",0.422551541,9,"Biomarker, GeneticVariation"
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,1.0,0.0,0.0,1275114,Epidermolysis Bullosa Pruriginosa,0.422551541,9,"Biomarker, GeneticVariation"
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,1.0,0.0,0.0,2931132,"Crigler Najjar syndrome, type 2",0.422551541,9,"Biomarker, GeneticVariation"
1836,SLC26A2,"solute carrier family 26 (anion exchanger), member 2",0.0,1.0,1.0,0.0,0.0,265274,Achondrogenesis type 1B,0.422551541,9,"Biomarker, GeneticVariation"
5395,PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,9405,"Colorectal Neoplasms, Hereditary Nonpolyposis",0.422407376,6,"Biomarker, GeneticVariation"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,1.0,0.0,0.0,2931826,Potassium aggravated myotonia,0.422268037,8,"Biomarker, GeneticVariation"
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,1.0,0.0,0.0,2609268,GALLBLADDER DISEASE 1,0.422268037,8,"Biomarker, GeneticVariation"
81,ACTN4,"actinin, alpha 4",0.0,1.0,1.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.422181799,18,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.422152835,10,"Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.422132768,28,"Biomarker, GeneticVariation"
2626,GATA4,GATA binding protein 4,0.0,1.0,1.0,0.0,0.0,39685,Tetralogy of Fallot,0.422025321,11,"Biomarker, GeneticVariation"
6121,RPE65,retinal pigment epithelium-specific protein 65kDa,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.421869331,12,"Biomarker, GeneticVariation"
2642,GCGR,glucagon receptor,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.42177078,17,"Biomarker, GeneticVariation"
1834,DSPP,dentin sialophosphoprotein,0.0,1.0,1.0,0.0,0.0,399380,"Dentin dysplasia, type II",0.421701027,6,"Biomarker, GeneticVariation"
26580,BSCL2,Berardinelli-Seip congenital lipodystrophy 2 (seipin),0.0,1.0,1.0,0.0,0.0,1833308,"Neuronopathy, Distal Hereditary Motor, Type V",0.421701027,6,"Biomarker, GeneticVariation"
29929,ALG6,"ALG6, alpha-1,3-glucosyltransferase",0.0,1.0,1.0,0.0,0.0,2930997,Congenital disorder of glycosylation type 1C,0.421701027,9,"Biomarker, GeneticVariation"
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,1.0,0.0,0.0,259810,Hypokalemic distal renal tubular acidosis,0.421623687,41,"Biomarker, GeneticVariation"
4508,ATP6,ATP synthase F0 subunit 6,0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.421565759,24,"Biomarker, GeneticVariation"
4607,MYBPC3,"myosin binding protein C, cardiac",0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.421536307,12,"Biomarker, GeneticVariation"
9469,CHST3,carbohydrate (chondroitin 6) sulfotransferase 3,0.0,1.0,1.0,0.0,0.0,1837657,"Spondyloepiphyseal dysplasia, Omani type",0.421417523,6,"Biomarker, GeneticVariation"
56623,INPP5E,"inositol polyphosphate-5-phosphatase, 72 kDa",0.0,1.0,1.0,0.0,0.0,431399,Agenesis of Cerebellar Vermis,0.421417523,6,"Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,949658,"Cardiomyopathy, Hypertrophic, Familial",0.421253291,15,"Biomarker, GeneticVariation"
6768,ST14,suppression of tumorigenicity 14 (colon carcinoma),0.0,1.0,1.0,0.0,0.0,1835851,"Ichthyosis with hypotrichosis, autosomal recessive",0.421134018,5,"Biomarker, GeneticVariation"
57465,TBC1D24,"TBC1 domain family, member 24",0.0,1.0,1.0,0.0,0.0,917800,"MYOCLONIC EPILEPSY, FAMILIAL INFANTILE",0.421134018,4,"Biomarker, GeneticVariation"
2702,GJA5,"gap junction protein, alpha 5, 40kDa",0.0,1.0,1.0,0.0,0.0,1838539,Atrial Standstill,0.421134018,4,"Biomarker, GeneticVariation"
5979,RET,ret proto-oncogene,0.0,1.0,1.0,0.0,0.0,1275808,Congenital central hypoventilation syndrome,0.421134018,6,"Biomarker, GeneticVariation"
2108,ETFA,"electron-transfer-flavoprotein, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,268596,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,0.421134018,6,"Biomarker, GeneticVariation"
3769,KCNJ13,"potassium channel, inwardly rectifying subfamily J, member 13",0.0,1.0,1.0,0.0,0.0,1860405,Snowflake vitreoretinal degeneration,0.421134018,4,"Biomarker, GeneticVariation"
26040,SETBP1,SET binding protein 1,0.0,1.0,1.0,0.0,0.0,265227,Schinzel-Giedion syndrome,0.421134018,5,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,795998,Jackson-Weiss syndrome,0.421134018,4,"Biomarker, GeneticVariation"
56052,ALG1,"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase",0.0,1.0,1.0,0.0,0.0,2931005,Congenital disorder of glycosylation type 1K,0.421134018,4,"Biomarker, GeneticVariation"
1798,DPAGT1,dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),0.0,1.0,1.0,0.0,0.0,2931004,Congenital disorder of glycosylation type 1J,0.420850514,3,"Biomarker, GeneticVariation"
8625,RFXANK,regulatory factor X-associated ankyrin-containing protein,0.0,1.0,1.0,0.0,0.0,2931418,Bare lymphocyte syndrome 2,0.420850514,4,"Biomarker, GeneticVariation"
79053,ALG8,"ALG8, alpha-1,3-glucosyltransferase",0.0,1.0,1.0,0.0,0.0,2931002,Congenital disorder of glycosylation type 1H,0.420850514,4,"Biomarker, GeneticVariation"
8659,ALDH4A1,"aldehyde dehydrogenase 4 family, member A1",0.0,1.0,1.0,0.0,0.0,2931835,Hyperprolinemia type 2,0.420850514,4,"Biomarker, GeneticVariation"
10653,SPINT2,"serine peptidase inhibitor, Kunitz type, 2",0.0,1.0,1.0,0.0,0.0,267663,"Diarrhea 3, Secretory Sodium, Congenital",0.420850514,3,"Biomarker, GeneticVariation"
3858,KRT10,"keratin 10, type I",0.0,1.0,1.0,0.0,0.0,1843463,"Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis",0.420850514,3,"Biomarker, GeneticVariation"
7054,TH,tyrosine hydroxylase,0.0,1.0,1.0,0.0,0.0,2673535,"Segawa syndrome, autosomal recessive",0.420850514,10,"Biomarker, GeneticVariation"
2109,ETFB,"electron-transfer-flavoprotein, beta polypeptide",0.0,1.0,1.0,0.0,0.0,268596,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,0.420850514,5,"Biomarker, GeneticVariation"
269,AMHR2,"anti-Mullerian hormone receptor, type II",0.0,1.0,1.0,0.0,0.0,1849930,Persistent Mullerian duct syndrome,0.420850514,5,"Biomarker, GeneticVariation"
4728,NDUFS8,"NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase)",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.420850514,3,"Biomarker, GeneticVariation"
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,1868616,Parastremmatic dwarfism,0.420850514,3,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,242292,McCune-Albright Syndrome,0.420773174,38,"Biomarker, GeneticVariation"
3482,IGF2R,insulin-like growth factor 2 receptor,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.420764276,15,"Biomarker, GeneticVariation"
11322,TMC6,transmembrane channel-like 6,0.0,1.0,1.0,0.0,0.0,14522,Epidermodysplasia Verruciformis,0.420686281,12,"Biomarker, GeneticVariation"
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,751335,"SPINAL MUSCULAR ATROPHY, SCAPULOPERONEAL",0.420567009,3,"Biomarker, GeneticVariation"
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,1853710,"Hereditary Motor And Sensory Neuropathy, Type IIC",0.420567009,2,"Biomarker, GeneticVariation"
3887,KRT81,"keratin 81, type II",0.0,1.0,1.0,0.0,0.0,546966,Monilethrix,0.420567009,4,"Biomarker, GeneticVariation"
2657,GDF1,growth differentiation factor 1,0.0,1.0,1.0,0.0,0.0,39685,Tetralogy of Fallot,0.420567009,2,"Biomarker, GeneticVariation"
8647,ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",0.0,1.0,1.0,0.0,0.0,3489789,"Cholestasis, progressive familial intrahepatic 2",0.420567009,2,"Biomarker, GeneticVariation"
79796,ALG9,"ALG9, alpha-1,2-mannosyltransferase",0.0,1.0,1.0,0.0,0.0,2931006,Congenital disorder of glycosylation type 1L,0.420567009,2,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,1275808,Congenital central hypoventilation syndrome,0.420567009,2,"Biomarker, GeneticVariation"
79087,ALG12,"ALG12, alpha-1,6-mannosyltransferase",0.0,1.0,1.0,0.0,0.0,2931001,Congenital disorder of glycosylation type 1G,0.420567009,5,"Biomarker, GeneticVariation"
2121,EVC,Ellis van Creveld syndrome,0.0,1.0,1.0,0.0,0.0,457013,Weyers acrofacial dysostosis,0.420567009,2,"Biomarker, GeneticVariation"
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.420567009,2,"Biomarker, GeneticVariation"
84668,FAM126A,"family with sequence similarity 126, member A",0.0,1.0,1.0,0.0,0.0,1864663,"Leukodystrophy, Hypomyelinating, 5",0.420567009,3,"Biomarker, GeneticVariation"
9733,SART3,squamous cell carcinoma antigen recognized by T cells 3,0.0,1.0,1.0,0.0,0.0,1867981,"Porokeratosis, disseminated superficial actinic 1",0.420567009,2,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,2697932,Loeys-Dietz Syndrome,0.420489669,39,"Biomarker, GeneticVariation"
6899,TBX1,T-box 1,0.0,1.0,1.0,0.0,0.0,1857586,Conotruncal cardiac defects,0.420283505,1,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,1865234,HID Syndrome,0.420283505,1,"Biomarker, GeneticVariation"
6916,TBXAS1,thromboxane A synthase 1 (platelet),0.0,1.0,1.0,0.0,0.0,1856465,Ghosal Hematodiaphyseal Dysplasia,0.420283505,1,"Biomarker, GeneticVariation"
5993,RFX5,"regulatory factor X, 5 (influences HLA class II expression)",0.0,1.0,1.0,0.0,0.0,2931418,Bare lymphocyte syndrome 2,0.420283505,2,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,265269,Lacrimoauriculodentodigital syndrome,0.420283505,1,"Biomarker, GeneticVariation"
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,1.0,0.0,0.0,268130,Oroticaciduria 1,0.420283505,2,"Biomarker, GeneticVariation"
3426,CFI,complement factor I,0.0,1.0,1.0,0.0,0.0,3463916,Complement Factor I Deficiency,0.420283505,1,"Biomarker, GeneticVariation"
23636,NUP62,nucleoporin 62kDa,0.0,1.0,1.0,0.0,0.0,795996,Striatonigral degeneration infantile,0.420283505,1,"Biomarker, GeneticVariation"
176,ACAN,aggrecan,0.0,1.0,1.0,0.0,0.0,3665488,Familial Osteochondritis Dissecans,0.420283505,1,"Biomarker, GeneticVariation"
1834,DSPP,dentin sialophosphoprotein,0.0,1.0,1.0,0.0,0.0,399378,"Dentinogenesis imperfecta, shields type 3",0.420283505,1,"Biomarker, GeneticVariation"
26040,SETBP1,SET binding protein 1,0.0,1.0,1.0,0.0,0.0,349639,"Leukemia, Myelomonocytic, Juvenile",0.420283505,1,"Biomarker, GeneticVariation"
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.420148236,18,"Biomarker, GeneticVariation"
95,ACY1,aminoacylase 1,0.0,1.0,1.0,0.0,0.0,1835922,Aminoacylase 1 deficiency,0.42,2,"Biomarker, GeneticVariation"
8842,PROM1,prominin 1,0.0,1.0,1.0,0.0,0.0,1863534,Stargardt disease 4,0.42,0,"Biomarker, GeneticVariation"
3875,KRT18,"keratin 18, type I",0.0,1.0,1.0,0.0,0.0,1861556,"Cirrhosis, Familial",0.42,1,"Biomarker, GeneticVariation"
3856,KRT8,"keratin 8, type II",0.0,1.0,1.0,0.0,0.0,1861556,"Cirrhosis, Familial",0.42,1,"Biomarker, GeneticVariation"
5309,PITX3,paired-like homeodomain 3,0.0,1.0,1.0,0.0,0.0,1864567,"Cataract, posterior polar, 4",0.42,2,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,376358,Malignant neoplasm of prostate,0.42,1257,"Biomarker, GeneticVariation"
1482,NKX2-5,NK2 homeobox 5,0.0,1.0,1.0,0.0,0.0,3276096,ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS,0.42,0,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,0.0,1.0,1.0,0.0,0.0,3151568,"NEPHROTIC SYNDROME, TYPE 4",0.42,0,"Biomarker, GeneticVariation"
137814,NKX2-6,NK2 homeobox 6,0.0,1.0,1.0,0.0,0.0,1857586,Conotruncal cardiac defects,0.42,1,"Biomarker, GeneticVariation"
2657,GDF1,growth differentiation factor 1,0.0,1.0,1.0,0.0,0.0,1857586,Conotruncal cardiac defects,0.42,0,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,3150617,"Maturity-onset diabetes of the young, type 10",0.42,0,"Biomarker, GeneticVariation"
6855,SYP,synaptophysin,0.0,1.0,1.0,0.0,0.0,3275408,"MENTAL RETARDATION, X-LINKED 96",0.42,1,"Biomarker, GeneticVariation"
70,ACTC1,"actin, alpha, cardiac muscle 1",0.0,1.0,1.0,0.0,0.0,2748552,Atrial Septal Defect 5,0.42,0,"Biomarker, GeneticVariation"
54413,NLGN3,neuroligin 3,0.0,1.0,1.0,0.0,0.0,1845341,"ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1",0.42,0,"Biomarker, GeneticVariation"
79628,SH3TC2,SH3 domain and tetratricopeptide repeats 2,0.0,1.0,1.0,0.0,0.0,3150596,"MONONEUROPATHY OF THE MEDIAN NERVE, MILD",0.42,0,"Biomarker, GeneticVariation"
219844,HYLS1,hydrolethalus syndrome 1,0.0,1.0,1.0,0.0,0.0,1856016,Hydrolethalus Syndrome 1,0.42,1,"Biomarker, GeneticVariation"
1727,CYB5R3,cytochrome b5 reductase 3,0.0,1.0,1.0,0.0,0.0,268193,NADH cytochrome B5 reductase deficiency,0.42,9,"Biomarker, GeneticVariation"
669,BPGM,"2,3-bisphosphoglycerate mutase",0.0,1.0,1.0,0.0,0.0,1412816,BISPHOSPHOGLYCERATE MUTASE,0.42,2,"Biomarker, GeneticVariation"
6663,SOX10,SRY (sex determining region Y)-box 10,0.0,1.0,1.0,0.0,0.0,2750452,"Waardenburg Syndrome, Type 4c",0.42,0,"Biomarker, GeneticVariation"
55997,CFC1,"cripto, FRL-1, cryptic family 1",0.0,1.0,1.0,0.0,0.0,1415817,"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",0.42,1,"Biomarker, GeneticVariation"
5257,PHKB,"phosphorylase kinase, beta",0.0,1.0,1.0,0.0,0.0,543514,Glycogen Storage Disease IXB,0.42,1,"Biomarker, GeneticVariation"
64135,IFIH1,interferon induced with helicase C domain 1,0.0,1.0,1.0,0.0,0.0,1857808,"Diabetes Mellitus, Insulin-Dependent, 19",0.42,2,"Biomarker, GeneticVariation"
2652,OPN1MW,"opsin 1 (cone pigments), medium-wave-sensitive",0.0,1.0,1.0,0.0,0.0,1415024,"COLORBLINDNESS, PARTIAL, DEUTAN SERIES",0.42,0,"Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,751337,Scapuloperoneal muscular dystrophy,0.42,0,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,3149842,MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE),0.42,0,"Biomarker, GeneticVariation"
718,C3,complement component 3,0.0,1.0,1.0,0.0,0.0,1969651,"Macular Degeneration, Age-Related, 9",0.42,0,"Biomarker, GeneticVariation"
1261,CNGA3,cyclic nucleotide gated channel alpha 3,0.0,1.0,1.0,0.0,0.0,1857618,Achromatopsia 2,0.42,6,"Biomarker, GeneticVariation"
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,1.0,0.0,0.0,1864987,"Migraine, Familial Hemiplegic, 3",0.42,0,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,1865070,"Scaphocephaly, Maxillary Retrusion, And Mental Retardation",0.42,0,"Biomarker, GeneticVariation"
6165,RPL35A,ribosomal protein L35a,0.0,1.0,1.0,0.0,0.0,2675859,Diamond-Blackfan Anemia 5,0.42,1,"Biomarker, GeneticVariation"
3664,IRF6,interferon regulatory factor 6,0.0,1.0,1.0,0.0,0.0,1837213,"OROFACIAL CLEFT 6, SUSCEPTIBILITY TO",0.42,0,"Biomarker, GeneticVariation"
9180,OSMR,oncostatin M receptor,0.0,1.0,1.0,0.0,0.0,268398,Amyloidosis IX,0.42,2,"Biomarker, GeneticVariation"
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",0.0,1.0,1.0,0.0,0.0,2678478,Brugada Syndrome 3,0.42,0,"Biomarker, GeneticVariation"
486,FXYD2,FXYD domain containing ion transport regulator 2,0.0,1.0,1.0,0.0,0.0,1835171,"Hypomagnesemia 2, renal",0.42,1,"Biomarker, GeneticVariation"
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,1969056,"LEOPARD syndrome, 2",0.42,0,"Biomarker, GeneticVariation"
6125,RPL5,ribosomal protein L5,0.0,1.0,1.0,0.0,0.0,2931850,Aase Smith syndrome 2,0.42,2,"Biomarker, GeneticVariation"
2255,FGF10,fibroblast growth factor 10,0.0,1.0,1.0,0.0,0.0,265269,Lacrimoauriculodentodigital syndrome,0.42,2,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,265269,Lacrimoauriculodentodigital syndrome,0.42,0,"Biomarker, GeneticVariation"
3053,SERPIND1,"serpin peptidase inhibitor, clade D (heparin cofactor), member 1",0.0,1.0,1.0,0.0,0.0,398626,Heparin Cofactor II Deficiency,0.42,3,"Biomarker, GeneticVariation"
2623,GATA1,GATA binding protein 1 (globin transcription factor 1),0.0,1.0,1.0,0.0,0.0,3550789,"THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA",0.42,0,"Biomarker, GeneticVariation"
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,1.0,0.0,0.0,1843761,"Toenail Dystrophy, Isolated",0.42,0,"Biomarker, GeneticVariation"
4760,NEUROD1,neuronal differentiation 1,0.0,1.0,1.0,0.0,0.0,1853371,"MODY, Type 6",0.42,1,"Biomarker, GeneticVariation"
4838,NODAL,nodal growth differentiation factor,0.0,1.0,1.0,0.0,0.0,3495537,"HETEROTAXY, VISCERAL, 5, AUTOSOMAL",0.42,2,"Biomarker, GeneticVariation"
701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,0.0,1.0,1.0,0.0,0.0,1864389,PREMATURE CHROMATID SEPARATION TRAIT,0.42,0,"Biomarker, GeneticVariation"
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,1.0,0.0,0.0,3275750,ATRIOVENTRICULAR SEPTAL DEFECT 3,0.42,0,"Biomarker, GeneticVariation"
6338,SCNN1B,"sodium channel, non voltage gated 1 beta subunit",0.0,1.0,1.0,0.0,0.0,2749757,Bronchiectasis With Or Without Elevated Sweat Chloride 1,0.42,0,"Biomarker, GeneticVariation"
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,1.0,0.0,0.0,796003,"Mental retardation-hypotonic facies syndrome, x-linked, 1",0.42,0,"Biomarker, GeneticVariation"
859,CAV3,caveolin 3,0.0,1.0,1.0,0.0,0.0,3495498,"Cardiomyopathy, Familial Hypertrophic, 1",0.42,0,"Biomarker, GeneticVariation"
85366,MYLK2,myosin light chain kinase 2,0.0,1.0,1.0,0.0,0.0,3495498,"Cardiomyopathy, Familial Hypertrophic, 1",0.42,1,"Biomarker, GeneticVariation"
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,1.0,1.0,0.0,0.0,1843323,Van Buchem disease type 2,0.42,0,"Biomarker, GeneticVariation"
1413,CRYBA4,"crystallin, beta A4",0.0,1.0,1.0,0.0,0.0,3808012,CATARACT 23,0.42,1,"Biomarker, GeneticVariation"
1834,DSPP,dentin sialophosphoprotein,0.0,1.0,1.0,0.0,0.0,1854146,"Deafness, Autosomal Dominant 39, with Dentinogenesis Imperfecta 1",0.42,0,"Biomarker, GeneticVariation"
2273,FHL1,four and a half LIM domains 1,0.0,1.0,1.0,0.0,0.0,2678027,"Myopathy, Reducing Body, X-Linked, Early-Onset, Severe",0.42,0,"Biomarker, GeneticVariation"
91647,ATPAF2,ATP synthase mitochondrial F1 complex assembly factor 2,0.0,1.0,1.0,0.0,0.0,3276276,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1",0.42,1,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,1835044,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2",0.42,0,"Biomarker, GeneticVariation"
6005,RHAG,Rh-associated glycoprotein,0.0,1.0,1.0,0.0,0.0,1849387,"Rh-Null, Regulator Type",0.42,3,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,3541518,"ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT",0.42,0,"Biomarker, GeneticVariation"
2652,OPN1MW,"opsin 1 (cone pigments), medium-wave-sensitive",0.0,1.0,1.0,0.0,0.0,339537,Blue cone monochromatism,0.42,0,"Biomarker, GeneticVariation"
1639,DCTN1,dynactin 1,0.0,1.0,1.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.42,0,"Biomarker, GeneticVariation"
1296,COL8A2,"collagen, type VIII, alpha 2",0.0,1.0,1.0,0.0,0.0,1852795,"Corneal Dystrophy, Posterior Polymorphous, 2",0.42,0,"Biomarker, GeneticVariation"
3897,L1CAM,L1 cell adhesion molecule,0.0,1.0,1.0,0.0,0.0,1839909,"Corpus Callosum, Partial Agenesis of, X-Linked",0.42,0,"Biomarker, GeneticVariation"
283,ANG,"angiogenin, ribonuclease, RNase A family, 5",0.0,1.0,1.0,0.0,0.0,2678468,Amyotrophic Lateral Sclerosis 9,0.42,3,"Biomarker, GeneticVariation"
23600,AMACR,alpha-methylacyl-CoA racemase,0.0,1.0,1.0,0.0,0.0,1858328,"Bile acid synthesis defect, congenital, 4",0.42,0,"Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1842028,"Glaucoma 1, Open Angle, A",0.42,0,"Biomarker, GeneticVariation"
5256,PHKA2,"phosphorylase kinase, alpha 2 (liver)",0.0,1.0,1.0,0.0,0.0,1418533,"phosphorylase kinase, alpha 2 (liver)",0.42,7,"Biomarker, GeneticVariation"
83552,MFRP,membrane frizzled-related protein,0.0,1.0,1.0,0.0,0.0,1836006,Nanophthalmos 2,0.42,1,"Biomarker, GeneticVariation"
3587,IL10RA,"interleukin 10 receptor, alpha",0.0,1.0,1.0,0.0,0.0,2751053,"Inflammatory Bowel Disease 28, Autosomal Recessive",0.42,2,"Biomarker, GeneticVariation"
27235,COQ2,coenzyme Q2 4-hydroxybenzoate polyprenyltransferase,0.0,1.0,1.0,0.0,0.0,3551954,"COENZYME Q10 DEFICIENCY, PRIMARY, 1",0.42,0,"Biomarker, GeneticVariation"
1184,CLCN5,"chloride channel, voltage-sensitive 5",0.0,1.0,1.0,0.0,0.0,403720,"Nephrolithiasis, X-Linked Recessive, with Renal Failure",0.42,0,"Biomarker, GeneticVariation"
717,C2,complement component 2,0.0,1.0,1.0,0.0,0.0,3150275,COMPLEMENT COMPONENT 2 DEFICIENCY,0.42,2,"Biomarker, GeneticVariation"
83872,HMCN1,hemicentin 1,0.0,1.0,1.0,0.0,0.0,1864205,"Macular Degeneration, Age-Related, 1",0.42,1,"Biomarker, GeneticVariation"
81839,VANGL1,VANGL planar cell polarity protein 1,0.0,1.0,1.0,0.0,0.0,1838568,Sacral defect and anterior sacral meningocele,0.42,0,"Biomarker, GeneticVariation"
4626,MYH8,"myosin, heavy chain 8, skeletal muscle, perinatal",0.0,1.0,1.0,0.0,0.0,1837245,Carney Complex Variant,0.42,0,"Biomarker, GeneticVariation"
64419,MTMR14,myotubularin related protein 14,0.0,1.0,1.0,0.0,0.0,1834558,"Myopathy, Centronuclear, Autosomal Dominant",0.42,1,"Biomarker, GeneticVariation"
3643,INSR,insulin receptor,0.0,1.0,1.0,0.0,0.0,1864952,"Hyperinsulinemic Hypoglycemia, Familial, 5",0.42,0,"Biomarker, GeneticVariation"
3643,INSR,insulin receptor,0.0,1.0,1.0,0.0,0.0,342278,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",0.42,0,"Biomarker, GeneticVariation"
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,1.0,0.0,0.0,270210,"Hyperbilirubinemia, Transient Familial Neonatal",0.42,0,"Biomarker, GeneticVariation"
55687,TRMU,tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase,0.0,1.0,1.0,0.0,0.0,3278664,"LIVER FAILURE, INFANTILE, TRANSIENT",0.42,1,"Biomarker, GeneticVariation"
2158,F9,coagulation factor IX,0.0,1.0,1.0,0.0,0.0,2749016,"Thrombophilia, X-Linked, Due To Factor Ix Defect",0.42,0,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,3665593,"Nevus, Epidermal",0.42,0,"Biomarker, GeneticVariation"
6663,SOX10,SRY (sex determining region Y)-box 10,0.0,1.0,1.0,0.0,0.0,1836727,"Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease",0.42,0,"Biomarker, GeneticVariation"
64218,SEMA4A,"sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A",0.0,1.0,1.0,0.0,0.0,1846529,Cone-Rod Dystrophy 10,0.42,0,"Biomarker, GeneticVariation"
3239,HOXD13,homeobox D13,0.0,1.0,1.0,0.0,0.0,1862102,"Brachydactyly, Type E",0.42,1,"Biomarker, GeneticVariation"
50846,DHH,desert hedgehog,0.0,1.0,1.0,0.0,0.0,1856273,"46,XY Gonadal Dysgenesis, Complete or Partial, DHH-Related",0.42,1,"Biomarker, GeneticVariation"
282808,RAB40AL,"RAB40A, member RAS oncogene family-like",0.0,1.0,1.0,0.0,0.0,1845285,Martin-Probst Deafness-Mental Retardation Syndrome,0.42,1,"Biomarker, GeneticVariation"
5956,OPN1LW,"opsin 1 (cone pigments), long-wave-sensitive",0.0,1.0,1.0,0.0,0.0,1419325,"COLORBLINDNESS, PARTIAL, PROTAN SERIES",0.42,0,"Biomarker, GeneticVariation"
9365,KL,klotho,0.0,1.0,1.0,0.0,0.0,1876187,"Tumoral Calcinosis, Hyperphosphatemic, Familial",0.42,1,"Biomarker, GeneticVariation"
9517,SPTLC2,"serine palmitoyltransferase, long chain base subunit 2",0.0,1.0,1.0,0.0,0.0,3150896,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC",0.42,2,"Biomarker, GeneticVariation"
4148,MATN3,matrilin 3,0.0,1.0,1.0,0.0,0.0,1837481,"Spondyloepimetaphyseal Dysplasia, Matrilin-3 Related",0.42,0,"Biomarker, GeneticVariation"
6794,STK11,serine/threonine kinase 11,0.0,1.0,1.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.42,0,"Biomarker, GeneticVariation"
4359,MPZ,myelin protein zero,0.0,1.0,1.0,0.0,0.0,1837552,"Charcot-Marie-Tooth disease, Type 2I",0.42,0,"Biomarker, GeneticVariation"
5830,PEX5,peroxisomal biogenesis factor 5,0.0,1.0,1.0,0.0,0.0,3550234,PEROXISOME BIOGENESIS DISORDER 2B,0.42,1,"Biomarker, GeneticVariation"
525,ATP6V1B1,"ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1",0.0,1.0,1.0,0.0,0.0,403554,"Renal Tubular Acidosis, Distal, with Progressive Nerve Deafness",0.42,3,"Biomarker, GeneticVariation"
471,ATIC,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,0.0,1.0,1.0,0.0,0.0,1837530,AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency,0.42,1,"Biomarker, GeneticVariation"
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,1.0,0.0,0.0,3278147,GELEOPHYSIC DYSPLASIA 1,0.42,2,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,1835398,Sarcoma family syndrome of Li and Fraumeni,0.42,0,"Biomarker, GeneticVariation"
24,ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4",0.0,1.0,1.0,0.0,0.0,3495438,"Macular Degeneration, Age-Related, 2",0.42,0,"Biomarker, GeneticVariation"
5627,PROS1,protein S (alpha),0.0,1.0,1.0,0.0,0.0,3278211,"THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT",0.42,0,"Biomarker, GeneticVariation"
2811,GP1BA,"glycoprotein Ib (platelet), alpha polypeptide",0.0,1.0,1.0,0.0,0.0,3277076,"BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT",0.42,0,"Biomarker, GeneticVariation"
7003,TEAD1,TEA domain family member 1 (SV40 transcriptional enhancer factor),0.0,1.0,1.0,0.0,0.0,1862382,Sveinsson Chorioretinal Atrophy,0.42,1,"Biomarker, GeneticVariation"
8647,ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",0.0,1.0,1.0,0.0,0.0,2608083,"CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2",0.42,0,"Biomarker, GeneticVariation"
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",0.0,1.0,1.0,0.0,0.0,1854631,"Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy",0.42,0,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,1852092,"Diabetes Mellitus, Insulin-Dependent, 2",0.42,0,"Biomarker, GeneticVariation"
7439,BEST1,bestrophin 1,0.0,1.0,1.0,0.0,0.0,2750789,"Retinitis Pigmentosa, Concentric",0.42,0,"Biomarker, GeneticVariation"
265,AMELX,"amelogenin, X-linked",0.0,1.0,1.0,0.0,0.0,1845052,"Amelogenesis imperfecta, hypoplastic/hypomaturation, X-linked 1",0.42,3,"Biomarker, GeneticVariation"
5447,POR,P450 (cytochrome) oxidoreductase,0.0,1.0,1.0,0.0,0.0,3150099,ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS,0.42,0,"Biomarker, GeneticVariation"
1497,CTNS,"cystinosin, lysosomal cystine transporter",0.0,1.0,1.0,0.0,0.0,2931013,"Cystinosis, ocular nonnephropathic",0.42,0,"Biomarker, GeneticVariation"
8842,PROM1,prominin 1,0.0,1.0,1.0,0.0,0.0,2675210,Cone-Rod Dystrophy 12,0.42,0,"Biomarker, GeneticVariation"
2071,ERCC3,excision repair cross-complementation group 3,0.0,1.0,1.0,0.0,0.0,1866504,"TRICHOTHIODYSTROPHY, PHOTOSENSITIVE",0.42,0,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,3150971,LEOPARD SYNDROME 3,0.42,0,"Biomarker, GeneticVariation"
51114,ZDHHC9,"zinc finger, DHHC-type containing 9",0.0,1.0,1.0,0.0,0.0,3275406,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE",0.42,1,"Biomarker, GeneticVariation"
611,OPN1SW,"opsin 1 (cone pigments), short-wave-sensitive",0.0,1.0,1.0,0.0,0.0,1412770,TRITANOPIA,0.42,2,"Biomarker, GeneticVariation"
4973,OLR1,oxidized low density lipoprotein (lectin-like) receptor 1,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.419424749,10,"Biomarker, GeneticVariation"
346007,EYS,eyes shut homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.419346754,9,"Biomarker, GeneticVariation"
845,CASQ2,calsequestrin 2 (cardiac muscle),0.0,1.0,1.0,0.0,0.0,1631597,Polymorphic catecholergic ventricular tachycardia,0.419072146,33,"Biomarker, GeneticVariation"
5191,PEX7,peroxisomal biogenesis factor 7,0.0,1.0,1.0,0.0,0.0,34960,Refsum Disease,0.418985254,6,"Biomarker, GeneticVariation"
4901,NRL,neural retina leucine zipper,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.41885774,7,"Biomarker, GeneticVariation"
55212,BBS7,Bardet-Biedl syndrome 7,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.418779744,6,"Biomarker, GeneticVariation"
1815,DRD4,dopamine receptor D4,0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.418704858,172,"Biomarker, GeneticVariation"
4537,ND3,"NADH dehydrogenase, subunit 3 (complex I)",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.418701749,4,"Biomarker, GeneticVariation"
4567,TRNL1,tRNA,0.0,1.0,1.0,0.0,0.0,162671,MELAS Syndrome,0.418574235,10,"Biomarker, GeneticVariation"
3291,HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2,0.0,1.0,1.0,0.0,0.0,2936861,Apparent mineralocorticoid excess,0.418505137,33,"Biomarker, GeneticVariation"
213,ALB,albumin,0.0,1.0,1.0,0.0,0.0,342185,"Hyperthyroxinemia, Familial Dysalbuminemic",0.418505137,30,"Biomarker, GeneticVariation"
147138,TMC8,transmembrane channel-like 8,0.0,1.0,1.0,0.0,0.0,14522,Epidermodysplasia Verruciformis,0.418447209,14,"Biomarker, GeneticVariation"
585,BBS4,Bardet-Biedl syndrome 4,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.418447209,12,"Biomarker, GeneticVariation"
51744,CD244,"CD244 molecule, natural killer cell receptor 2B4",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.41829073,4,"Biomarker, GeneticVariation"
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,175704,LEOPARD Syndrome,0.41829073,6,"Biomarker, GeneticVariation"
10165,SLC25A13,"solute carrier family 25 (aspartate/glutamate carrier), member 13",0.0,1.0,1.0,0.0,0.0,1863844,Adult-onset citrullinemia type 2,0.418270663,22,"Biomarker, GeneticVariation"
4598,MVK,mevalonate kinase,0.0,1.0,1.0,0.0,0.0,398691,Hyperimmunoglobulin D with periodic fever,0.418270663,22,"Biomarker, GeneticVariation"
10743,RAI1,retinoic acid induced 1,0.0,1.0,1.0,0.0,0.0,795864,Smith-Magenis Syndrome,0.418221633,35,"Biomarker, GeneticVariation"
7066,THPO,thrombopoietin,0.0,1.0,1.0,0.0,0.0,40028,"Thrombocythemia, Essential",0.418192668,20,"Biomarker, GeneticVariation"
8792,TNFRSF11A,"tumor necrosis factor receptor superfamily, member 11a, NFKB activator",0.0,1.0,1.0,0.0,0.0,29401,Osteitis Deformans,0.418085221,7,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.418085221,8,"Biomarker, GeneticVariation"
3952,LEP,leptin,1.0,1.0,1.0,0.0,0.0,3554224,LEPTIN DEFICIENCY,0.417938128,29,"AlteredExpression, Biomarker, GeneticVariation"
6606,SMN1,"survival of motor neuron 1, telomeric",0.0,1.0,1.0,0.0,0.0,43116,Werdnig-Hoffmann Disease,0.417654623,27,"Biomarker, GeneticVariation"
7168,TPM1,tropomyosin 1 (alpha),0.0,1.0,1.0,0.0,0.0,949658,"Cardiomyopathy, Hypertrophic, Familial",0.417625659,19,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.417517945,334,"AlteredExpression, Biomarker, GeneticVariation"
2584,GALK1,galactokinase 1,0.0,1.0,1.0,0.0,0.0,268155,Deficiency of galactokinase,0.417469181,11,"Biomarker, GeneticVariation"
4607,MYBPC3,"myosin binding protein C, cardiac",0.0,1.0,1.0,0.0,0.0,949658,"Cardiomyopathy, Hypertrophic, Familial",0.417469181,15,"Biomarker, GeneticVariation"
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.417440217,3,"Biomarker, GeneticVariation"
2730,GCLM,"glutamate-cysteine ligase, modifier subunit",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.417440217,3,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,40479,Torsades de Pointes,0.417391186,11,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,0.0,0.0,2874,"Anemia, Aplastic",0.417391186,11,"Biomarker, GeneticVariation"
2720,GLB1,"galactosidase, beta 1",0.0,1.0,1.0,0.0,0.0,86652,Mucopolysaccharidosis Type IVB,0.417371119,26,"Biomarker, GeneticVariation"
51684,SUFU,suppressor of fused homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,25149,Medulloblastoma,0.417313191,9,"Biomarker, GeneticVariation"
1316,KLF6,Kruppel-like factor 6,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.417156712,3,"Biomarker, GeneticVariation"
10461,MERTK,"MER proto-oncogene, tyrosine kinase",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.417107681,11,"Biomarker, GeneticVariation"
7046,TGFBR1,"transforming growth factor, beta receptor 1",0.0,1.0,1.0,0.0,0.0,2697932,Loeys-Dietz Syndrome,0.417087614,26,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,1.0,0.0,0.0,206624,Hepatoblastoma,0.41705865,17,"Biomarker, GeneticVariation"
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.416695907,339,"Biomarker, GeneticVariation"
6514,SLC2A2,"solute carrier family 2 (facilitated glucose transporter), member 2",0.0,1.0,1.0,0.0,0.0,3495427,fanconi-bickel syndrome,0.416520605,23,"Biomarker, GeneticVariation"
5896,RAG1,recombination activating gene 1,0.0,1.0,1.0,0.0,0.0,1801959,Histiocytic medullary reticulosis,0.416520605,23,"Biomarker, GeneticVariation"
6927,HNF1A,HNF1 homeobox A,1.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.416517577,132,"AlteredExpression, Biomarker, GeneticVariation"
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,1.0,0.0,0.0,1704429,Familial hypoalphalipoproteinemia,0.416237101,22,"Biomarker, GeneticVariation"
129880,BBS5,Bardet-Biedl syndrome 5,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.416179172,5,"Biomarker, GeneticVariation"
145226,RDH12,retinol dehydrogenase 12 (all-trans/9-cis/11-cis),0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.415973663,6,"Biomarker, GeneticVariation"
4292,MLH1,mutL homolog 1,0.0,1.0,1.0,0.0,0.0,1321489,Muir-Torre Syndrome,0.415953596,21,"Biomarker, GeneticVariation"
2159,F10,coagulation factor X,0.0,1.0,1.0,0.0,0.0,15519,Factor X Deficiency,0.415895668,5,"Biomarker, GeneticVariation"
4540,ND5,"NADH dehydrogenase, subunit 5 (complex I)",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.415895668,5,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,25286,Meningioma,0.415768153,7,"Biomarker, GeneticVariation"
1747,DLX3,distal-less homeobox 3,0.0,1.0,1.0,0.0,0.0,265333,Tricho-dento-osseous syndrome,0.415719122,12,"Biomarker, GeneticVariation"
7248,TSC1,tuberous sclerosis 1,0.0,1.0,1.0,0.0,0.0,751674,Lymphangioleiomyomatosis,0.415670091,20,"Biomarker, GeneticVariation"
2624,GATA2,GATA binding protein 2,1.0,1.0,1.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.415641127,13,"AlteredExpression, Biomarker, GeneticVariation"
8195,MKKS,McKusick-Kaufman syndrome,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.415641127,11,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.415406654,5,"AlteredExpression, Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,1.0,0.0,0.0,473780,"Thrombocytopenia, Neonatal Alloimmune",0.415406654,5,"Biomarker, GeneticVariation"
57152,SLURP1,secreted LY6/PLAUR domain containing 1,0.0,1.0,1.0,0.0,0.0,25221,Acroerythrokeratoderma,0.415386587,20,"Biomarker, GeneticVariation"
2719,GPC3,glypican 3,0.0,1.0,1.0,0.0,0.0,27708,Wilms Tumor,0.415357623,10,"Biomarker, GeneticVariation"
84100,ARL6,ADP-ribosylation factor-like 6,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.415357623,10,"Biomarker, GeneticVariation"
4978,OPCML,opioid binding protein/cell adhesion molecule-like,1.0,1.0,1.0,1.0,0.0,919267,Ovarian Neoplasms,0.415328659,3,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,1.0,1.0,0.0,0.0,14805,"ERYTHERMALGIA, PRIMARY",0.415103082,18,"Biomarker, GeneticVariation"
4436,MSH2,mutS homolog 2,0.0,1.0,1.0,0.0,0.0,265325,Turcot syndrome,0.415103082,18,"Biomarker, GeneticVariation"
7080,NKX2-1,NK2 homeobox 1,0.0,1.0,1.0,0.0,0.0,393584,"CHOREA, BENIGN HEREDITARY",0.415103082,18,"Biomarker, GeneticVariation"
1540,CYLD,cylindromatosis (turban tumor syndrome),0.0,1.0,1.0,0.0,0.0,1857941,Brooke-Spiegler syndrome,0.415103082,18,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,42514,"Tachycardia, Ventricular",0.414839645,3,"Biomarker, GeneticVariation"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,1.0,0.0,149925,Small Cell Lung Carcinoma,0.414819578,19,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
4070,TACSTD2,tumor-associated calcium signal transducer 2,0.0,1.0,1.0,0.0,0.0,339273,"Corneal dystrophy, gelatinous drop-like",0.414819578,17,"Biomarker, GeneticVariation"
79738,BBS10,Bardet-Biedl syndrome 10,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.414790614,9,"Biomarker, GeneticVariation"
7504,XK,X-linked Kx blood group,0.0,0.0,1.0,0.0,0.0,398568,"Neuroacanthocytosis, Mcleod Type",0.414634135,4,GeneticVariation
10483,SEC23B,Sec23 homolog B (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,1306589,"Congenital dyserythropoietic anemia, type II",0.414536073,17,"Biomarker, GeneticVariation"
427,ASAH1,N-acylsphingosine amidohydrolase (acid ceramidase) 1,0.0,1.0,1.0,0.0,0.0,268255,Farber Lipogranulomatosis,0.414536073,16,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.414375338,230,"AlteredExpression, Biomarker, GeneticVariation"
4512,COX1,cytochrome c oxidase subunit I,0.0,1.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.4143016,8,"Biomarker, GeneticVariation"
6041,RNASEL,"ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)",0.0,1.0,1.0,0.0,0.0,2931456,"Prostate cancer, familial",0.414252569,15,"Biomarker, GeneticVariation"
3643,INSR,insulin receptor,0.0,1.0,1.0,0.0,0.0,271695,Rabson-Mendenhall syndrome,0.414252569,15,"Biomarker, GeneticVariation"
190,NR0B1,"nuclear receptor subfamily 0, group B, member 1",0.0,1.0,1.0,0.0,0.0,1848296,Dosage-sensitive sex reversal,0.414252569,15,"Biomarker, GeneticVariation"
1584,CYP11B1,"cytochrome P450, family 11, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1260386,Glucocorticoid-Remediable Aldosteronism,0.414252569,15,"Biomarker, GeneticVariation"
7020,TFAP2A,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha),0.0,1.0,1.0,0.0,0.0,376524,branchio oculo facial syndrome,0.414252569,15,"Biomarker, GeneticVariation"
6899,TBX1,T-box 1,0.0,1.0,1.0,0.0,0.0,39685,Tetralogy of Fallot,0.414018095,8,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,23234,Legg-Calve-Perthes Disease,0.414018095,6,"Biomarker, GeneticVariation"
10801,9-Sep,septin 9,0.0,1.0,1.0,0.0,0.0,1834304,"AMYOTROPHY, HEREDITARY NEURALGIC",0.413969064,14,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,340493,Paroxysmal ventricular fibrillation,0.413969064,14,"Biomarker, GeneticVariation"
6872,TAF1,"TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa",0.0,1.0,1.0,0.0,0.0,1839130,"Dystonia 3, Torsion, X-Linked",0.413969064,14,"Biomarker, GeneticVariation"
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,0.0,1.0,1.0,0.0,0.0,1853490,22q13.3 deletion syndrome,0.413969064,14,"Biomarker, GeneticVariation"
5961,PRPH2,"peripherin 2 (retinal degeneration, slow)",0.0,1.0,1.0,0.0,0.0,1842914,"MACULAR DYSTROPHY, VITELLIFORM, ADULT-ONSET",0.41373459,5,"Biomarker, GeneticVariation"
2820,GPD2,glycerol-3-phosphate dehydrogenase 2 (mitochondrial),0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.41373459,7,"Biomarker, GeneticVariation"
4598,MVK,mevalonate kinase,0.0,1.0,1.0,0.0,0.0,1959626,Mevalonic aciduria,0.413685559,13,"Biomarker, GeneticVariation"
5604,MAP2K1,mitogen-activated protein kinase kinase 1,0.0,1.0,1.0,0.0,0.0,1275081,Cardiofaciocutaneous syndrome,0.413685559,15,"Biomarker, GeneticVariation"
1641,DCX,doublecortin,0.0,1.0,1.0,0.0,0.0,1848199,"LISSENCEPHALY, X-LINKED, 1",0.413685559,21,"Biomarker, GeneticVariation"
4920,ROR2,receptor tyrosine kinase-like orphan receptor 2,0.0,1.0,1.0,0.0,0.0,1862112,"Brachydactyly, Type B1",0.413685559,13,"Biomarker, GeneticVariation"
2653,GCSH,glycine cleavage system protein H (aminomethyl carrier),0.0,1.0,1.0,0.0,0.0,751748,"Hyperglycinemia, Nonketotic",0.413451086,4,"Biomarker, GeneticVariation"
2627,GATA6,GATA binding protein 6,0.0,1.0,1.0,0.0,0.0,39685,Tetralogy of Fallot,0.413451086,4,"Biomarker, GeneticVariation"
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",0.0,1.0,1.0,0.0,0.0,26267,Mitral Valve Prolapse,0.413451086,4,"Biomarker, GeneticVariation"
1286,COL4A4,"collagen, type IV, alpha 4",0.0,1.0,1.0,0.0,0.0,241908,"Hematuria, Benign Familial",0.413402055,12,"Biomarker, GeneticVariation"
2956,MSH6,mutS homolog 6,0.0,1.0,1.0,0.0,0.0,265325,Turcot syndrome,0.413402055,12,"Biomarker, GeneticVariation"
4352,MPL,"MPL proto-oncogene, thrombopoietin receptor",0.0,1.0,1.0,0.0,0.0,26987,Myelofibrosis,0.413402055,12,"Biomarker, GeneticVariation"
867,CBL,"Cbl proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,349639,"Leukemia, Myelomonocytic, Juvenile",0.413402055,13,"Biomarker, GeneticVariation"
51360,MBTPS2,"membrane-bound transcription factor peptidase, site 2",0.0,1.0,1.0,0.0,0.0,343057,"Keratosis Follicularis Spinulosa Decalvans, X-Linked",0.413402055,12,"Biomarker, GeneticVariation"
64324,NSD1,nuclear receptor binding SET domain protein 1,0.0,1.0,1.0,0.0,0.0,4903,Beckwith-Wiedemann Syndrome,0.413373091,3,"Biomarker, GeneticVariation"
4508,ATP6,ATP synthase F0 subunit 6,0.0,1.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.413167581,3,"Biomarker, GeneticVariation"
1758,DMP1,dentin matrix acidic phosphoprotein 1,0.0,1.0,1.0,0.0,0.0,342643,"Hypophosphatemic Rickets, Autosomal Recessive, 1",0.41311855,11,"Biomarker, GeneticVariation"
9820,CUL7,cullin 7,0.0,1.0,1.0,0.0,0.0,1848862,Miller-McKusick-Malvaux-Syndrome (3M Syndrome),0.41311855,11,"Biomarker, GeneticVariation"
22861,NLRP1,"NLR family, pyrin domain containing 1",0.0,1.0,1.0,0.0,0.0,1847835,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1,0.41311855,11,"Biomarker, GeneticVariation"
9820,CUL7,cullin 7,0.0,1.0,1.0,0.0,0.0,2678312,THREE M SYNDROME 1,0.41311855,12,"Biomarker, GeneticVariation"
6898,TAT,tyrosine aminotransferase,0.0,1.0,1.0,0.0,0.0,268487,"Hypertyrosinemia, Richner-Hanhart type",0.41311855,11,"Biomarker, GeneticVariation"
4535,ND1,"NADH dehydrogenase, subunit 1 (complex I)",0.0,1.0,1.0,0.0,0.0,162671,MELAS Syndrome,0.413089586,3,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,346302,Growth Hormone-Secreting Pituitary Adenoma,0.413089586,4,"Biomarker, GeneticVariation"
23095,KIF1B,kinesin family member 1B,0.0,1.0,1.0,0.0,0.0,31511,Pheochromocytoma,0.413089586,3,"Biomarker, GeneticVariation"
4540,ND5,"NADH dehydrogenase, subunit 5 (complex I)",0.0,1.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.412884077,2,"Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,221054,WELANDER DISTAL MYOPATHY,0.412835046,10,"Biomarker, GeneticVariation"
8892,EIF2B2,"eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa",1.0,1.0,1.0,0.0,0.0,1858991,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER,0.412835046,14,"AlteredExpression, Biomarker, GeneticVariation"
1967,EIF2B1,"eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa",1.0,1.0,1.0,0.0,0.0,1858991,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER,0.412835046,11,"AlteredExpression, Biomarker, GeneticVariation"
8890,EIF2B4,"eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa",1.0,1.0,1.0,0.0,0.0,1858991,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER,0.412835046,11,"AlteredExpression, Biomarker, GeneticVariation"
5605,MAP2K2,mitogen-activated protein kinase kinase 2,0.0,1.0,1.0,0.0,0.0,1275081,Cardiofaciocutaneous syndrome,0.412835046,12,"Biomarker, GeneticVariation"
23111,SPG20,spastic paraplegia 20 (Troyer syndrome),0.0,1.0,1.0,0.0,0.0,393559,"Spastic paraplegia 20, autosomal recessive",0.412835046,10,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,1.0,0.0,0.0,1837475,Insulin-Like Growth Factor I Deficiency,0.412835046,10,"Biomarker, GeneticVariation"
727897,MUC5B,"mucin 5B, oligomeric mucus/gel-forming",0.0,1.0,1.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.412835046,11,"Biomarker, GeneticVariation"
79650,USB1,U6 snRNA biogenesis 1,0.0,1.0,1.0,0.0,0.0,1858723,Poikiloderma with Neutropenia,0.412835046,10,"Biomarker, GeneticVariation"
8792,TNFRSF11A,"tumor necrosis factor receptor superfamily, member 11a, NFKB activator",0.0,1.0,1.0,0.0,0.0,432292,"Polyostotic osteolytic dysplasia, hereditary expansile",0.412835046,10,"Biomarker, GeneticVariation"
2243,FGA,fibrinogen alpha chain,0.0,1.0,1.0,0.0,0.0,19250,Afibrinogenemia congenital,0.412835046,12,"Biomarker, GeneticVariation"
26525,IL36RN,interleukin 36 receptor antagonist,0.0,1.0,1.0,0.0,0.0,343055,Generalized pustular psoriasis,0.412835046,10,"Biomarker, GeneticVariation"
4633,MYL2,"myosin, light chain 2, regulatory, cardiac, slow",0.0,1.0,1.0,0.0,0.0,949658,"Cardiomyopathy, Hypertrophic, Familial",0.412806082,3,"Biomarker, GeneticVariation"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,29463,Osteosarcoma,0.412806082,1,"Biomarker, GeneticVariation"
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.412600572,1,"Biomarker, GeneticVariation"
1258,CNGB1,cyclic nucleotide gated channel beta 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.412600572,3,"Biomarker, GeneticVariation"
5308,PITX2,paired-like homeodomain 2,0.0,1.0,1.0,0.0,0.0,344559,Peters anomaly,0.412600572,1,"Biomarker, GeneticVariation"
1738,DLD,dihydrolipoamide dehydrogenase,0.0,1.0,1.0,0.0,0.0,268193,NADH cytochrome B5 reductase deficiency,0.412551541,12,"Biomarker, GeneticVariation"
2294,FOXF1,forkhead box F1,0.0,1.0,1.0,0.0,0.0,31190,Persistent Fetal Circulation Syndrome,0.412551541,9,"Biomarker, GeneticVariation"
4014,LOR,loricrin,0.0,1.0,1.0,0.0,0.0,1858805,"Vohwinkel Syndrome, Variant Form",0.412551541,9,"Biomarker, GeneticVariation"
6606,SMN1,"survival of motor neuron 1, telomeric",0.0,1.0,1.0,0.0,0.0,152109,Kugelberg-Welander disease,0.412551541,9,"Biomarker, GeneticVariation"
9563,H6PD,hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase),0.0,1.0,1.0,0.0,0.0,1291245,Cortisone reductase deficiency,0.412551541,9,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,1.0,0.0,0.0,268419,Acatalasia,0.412551541,12,"Biomarker, GeneticVariation"
200879,LIPH,"lipase, member H",0.0,1.0,1.0,0.0,0.0,1836672,"Total Hypotrichosis, Mari type",0.412551541,10,"Biomarker, GeneticVariation"
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,1.0,0.0,0.0,1833104,"Diabetes Mellitus, Permanent Neonatal",0.412551541,9,"Biomarker, GeneticVariation"
1161,ERCC8,excision repair cross-complementation group 8,0.0,1.0,1.0,0.0,0.0,751039,COCKAYNE SYNDROME A,0.412551541,9,"Biomarker, GeneticVariation"
6295,SAG,S-antigen; retina and pineal gland (arrestin),0.0,1.0,1.0,0.0,0.0,1306122,Oguchi disease,0.412551541,10,"Biomarker, GeneticVariation"
4595,MUTYH,mutY homolog,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.412522577,1,"Biomarker, GeneticVariation"
440823,MIAT,myocardial infarction associated transcript (non-protein coding),0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.412522577,1,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,0.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.412317068,1,GeneticVariation
8438,RAD54L,RAD54-like (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.412317068,1,"Biomarker, GeneticVariation"
387733,IFITM5,interferon induced transmembrane protein 5,0.0,1.0,1.0,0.0,0.0,1970414,"Osteogenesis Imperfecta, Type V",0.412268037,8,"Biomarker, GeneticVariation"
3872,KRT17,"keratin 17, type I",0.0,1.0,1.0,0.0,0.0,1721007,PACHYONYCHIA CONGENITA 2,0.412268037,8,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,152013,Adenocarcinoma of lung,0.412268037,8,"Biomarker, GeneticVariation"
3655,ITGA6,"integrin, alpha 6",0.0,1.0,1.0,0.0,0.0,1856934,Epidermolysis bullosa with pyloric atresia,0.412268037,8,"Biomarker, GeneticVariation"
11277,TREX1,three prime repair exonuclease 1,0.0,1.0,1.0,0.0,0.0,24145,Chilblain lupus,0.412268037,8,"Biomarker, GeneticVariation"
23592,LEMD3,LEM domain containing 3,0.0,1.0,1.0,0.0,0.0,265514,Buschke-Ollendorff syndrome,0.412268037,8,"Biomarker, GeneticVariation"
5317,PKP1,plakophilin 1,0.0,1.0,1.0,0.0,0.0,1858302,Ectodermal dysplasia/ skin fragility syndrome,0.412268037,8,"Biomarker, GeneticVariation"
8864,PER2,period circadian clock 2,0.0,1.0,1.0,0.0,0.0,1858496,"Advanced Sleep-Phase Syndrome, Familial",0.412268037,8,"Biomarker, GeneticVariation"
22930,RAB3GAP1,RAB3 GTPase activating protein subunit 1 (catalytic),0.0,1.0,1.0,0.0,0.0,1838625,Warburg Sjo Fledelius syndrome,0.412268037,8,"Biomarker, GeneticVariation"
6611,SMS,spermine synthase,0.0,1.0,1.0,0.0,0.0,796160,Snyder Robinson syndrome,0.412268037,8,"Biomarker, GeneticVariation"
4853,NOTCH2,notch 2,0.0,1.0,1.0,0.0,0.0,917715,Hajdu-Cheney Syndrome,0.412268037,9,"Biomarker, GeneticVariation"
145173,B3GALTL,"beta 1,3-galactosyltransferase-like",0.0,1.0,1.0,0.0,0.0,796012,Krause-Kivlin syndrome,0.411984532,8,"Biomarker, GeneticVariation"
6654,SOS1,son of sevenless homolog 1 (Drosophila),0.0,1.0,1.0,0.0,0.0,399440,"Fibromatosis, Gingival, Type 1",0.411984532,7,"Biomarker, GeneticVariation"
6620,SNCB,"synuclein, beta",0.0,1.0,1.0,0.0,0.0,752347,Lewy Body Disease,0.411984532,7,"Biomarker, GeneticVariation"
80207,OPA3,"optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)",0.0,1.0,1.0,0.0,0.0,574084,Costeff optic atrophy syndrome,0.411984532,7,"Biomarker, GeneticVariation"
1471,CST3,cystatin C,0.0,1.0,1.0,0.0,0.0,1527338,"Hereditary cerebral amyloid angiopathy, Icelandic type",0.411984532,8,"Biomarker, GeneticVariation"
112476,PRRT2,proline-rich transmembrane protein 2,0.0,1.0,1.0,0.0,0.0,1865926,"Infantile convulsions and paroxysmal choreoathetosis, familial",0.411984532,7,"Biomarker, GeneticVariation"
4582,MUC1,"mucin 1, cell surface associated",0.0,1.0,1.0,0.0,0.0,1868139,Medullary cystic kidney disease 1,0.411984532,8,"Biomarker, GeneticVariation"
81704,DOCK8,dedicator of cytokinesis 8,0.0,1.0,1.0,0.0,0.0,1968689,"HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE",0.411984532,8,"Biomarker, GeneticVariation"
84627,ZNF469,zinc finger protein 469,0.0,1.0,1.0,0.0,0.0,268344,Ehlers-Danlos syndrome 6B,0.411984532,8,"Biomarker, GeneticVariation"
2720,GLB1,"galactosidase, beta 1",0.0,1.0,1.0,0.0,0.0,268271,"GM1-GANGLIOSIDOSIS, TYPE I",0.411984532,7,"Biomarker, GeneticVariation"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,1.0,0.0,0.0,3714580,"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1",0.411984532,7,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,1856058,"HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY",0.411984532,10,"Biomarker, GeneticVariation"
4601,MXI1,"MAX interactor 1, dimerization protein",0.0,1.0,1.0,0.0,0.0,376358,Malignant neoplasm of prostate,0.411701027,6,"Biomarker, GeneticVariation"
4088,SMAD3,SMAD family member 3,0.0,1.0,1.0,0.0,0.0,3151087,LOEYS-DIETZ SYNDROME 3,0.411701027,7,"Biomarker, GeneticVariation"
80067,DCAF17,DDB1 and CUL4 associated factor 17,0.0,1.0,1.0,0.0,0.0,342286,Woodhouse Sakati syndrome,0.411701027,6,"Biomarker, GeneticVariation"
7012,TERC,telomerase RNA component,0.0,1.0,1.0,0.0,0.0,1851970,"Dyskeratosis Congenita, Autosomal Dominant",0.411701027,6,"Biomarker, GeneticVariation"
1832,DSP,desmoplakin,0.0,1.0,1.0,0.0,0.0,1854063,Cardiomyopathy dilated with Woolly hair and keratoderma,0.411701027,7,"Biomarker, GeneticVariation"
79944,L2HGDH,L-2-hydroxyglutarate dehydrogenase,0.0,1.0,1.0,0.0,0.0,1855995,L-2-HYDROXYGLUTARIC ACIDURIA,0.411701027,9,"Biomarker, GeneticVariation"
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",0.0,1.0,1.0,0.0,0.0,268414,Hyperostosis corticalis deformans juvenilis,0.411701027,6,"Biomarker, GeneticVariation"
7436,VLDLR,very low density lipoprotein receptor,0.0,1.0,1.0,0.0,0.0,394006,Dysequilibrium syndrome,0.411701027,6,"Biomarker, GeneticVariation"
138050,HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,0.0,1.0,1.0,0.0,0.0,86649,"Mucopolysaccharidosis, MPS-III-C",0.411701027,7,"Biomarker, GeneticVariation"
23417,MLYCD,malonyl-CoA decarboxylase,0.0,1.0,1.0,0.0,0.0,342793,Malonic aciduria,0.411701027,6,"Biomarker, GeneticVariation"
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,1.0,1.0,0.0,0.0,1833921,Familial medullary thyroid carcinoma,0.411701027,6,"Biomarker, GeneticVariation"
2799,GNS,glucosamine (N-acetyl)-6-sulfatase,0.0,1.0,1.0,0.0,0.0,86650,"Mucopolysaccharidosis, MPS-III-D",0.411701027,6,"Biomarker, GeneticVariation"
9939,RBM8A,RNA binding motif protein 8A,0.0,1.0,1.0,0.0,0.0,175703,Absent radii and thrombocytopenia,0.411701027,6,"Biomarker, GeneticVariation"
343637,RSPO4,R-spondin 4,0.0,1.0,1.0,0.0,0.0,265998,Anonychia congenita,0.411701027,6,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,1834570,Myoclonic dystonia,0.411701027,6,"Biomarker, GeneticVariation"
3848,KRT1,"keratin 1, type II",0.0,1.0,1.0,0.0,0.0,1721006,"Keratoderma, Palmoplantar, Epidermolytic",0.411701027,6,"Biomarker, GeneticVariation"
331,XIAP,"X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,1845076,"Lymphoproliferative Syndrome, X-Linked, 2",0.411701027,6,"Biomarker, GeneticVariation"
146059,CDAN1,codanin 1,0.0,1.0,1.0,0.0,0.0,271933,"Congenital dyserythropoietic anemia, type I",0.411701027,7,"Biomarker, GeneticVariation"
162514,TRPV3,"transient receptor potential cation channel, subfamily V, member 3",0.0,1.0,1.0,0.0,0.0,2609071,Olmsted syndrome,0.411701027,6,"Biomarker, GeneticVariation"
1591,CYP24A1,"cytochrome P450, family 24, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,268080,"Hypercalcemia, Idiopathic, of Infancy",0.411701027,6,"Biomarker, GeneticVariation"
2317,FLNB,"filamin B, beta",0.0,1.0,1.0,0.0,0.0,1835564,LARSEN SYNDROME,0.411701027,6,"Biomarker, GeneticVariation"
3284,HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",0.0,0.0,1.0,0.0,0.0,342471,3b-Hydroxysteroid Dehydrogenase Deficiency,0.411701027,9,GeneticVariation
10410,IFITM3,interferon induced transmembrane protein 3,0.0,1.0,1.0,0.0,0.0,21400,"Influenza, Human",0.411701027,7,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,1.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.411462061,92,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
10216,PRG4,proteoglycan 4,0.0,1.0,1.0,0.0,0.0,1859690,Jacobs syndrome,0.411417523,6,"Biomarker, GeneticVariation"
6908,TBP,TATA box binding protein,0.0,1.0,1.0,0.0,0.0,1846707,Spinocerebellar Ataxia 17,0.411417523,5,"Biomarker, GeneticVariation"
2299,FOXI1,forkhead box I1,0.0,1.0,1.0,0.0,0.0,1863752,Enlarged Vestibular Aqueduct,0.411417523,5,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,796173,Spondyloperipheral dysplasia short ulna,0.411417523,5,"Biomarker, GeneticVariation"
60495,HPSE2,heparanase 2 (inactive),0.0,1.0,1.0,0.0,0.0,403555,Urofacial syndrome,0.411417523,5,"Biomarker, GeneticVariation"
1028,CDKN1C,"cyclin-dependent kinase inhibitor 1C (p57, Kip2)",0.0,1.0,1.0,0.0,0.0,1846009,"Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies",0.411417523,5,"Biomarker, GeneticVariation"
4771,NF2,neurofibromin 2 (merlin),0.0,1.0,1.0,0.0,0.0,1335929,Schwannomatosis,0.411417523,5,"Biomarker, GeneticVariation"
57679,ALS2,amyotrophic lateral sclerosis 2 (juvenile),0.0,1.0,1.0,0.0,0.0,1853396,Primary lateral sclerosis juvenile,0.411417523,5,"Biomarker, GeneticVariation"
9401,RECQL4,RecQ protein-like 4,0.0,1.0,1.0,0.0,0.0,1849453,Rapadilino syndrome,0.411417523,5,"Biomarker, GeneticVariation"
9780,PIEZO1,piezo-type mechanosensitive ion channel component 1,0.0,1.0,1.0,0.0,0.0,272051,"Xerocytosis, hereditary",0.411417523,6,"Biomarker, GeneticVariation"
3852,KRT5,"keratin 5, type II",0.0,1.0,1.0,0.0,0.0,80333,Weber-Cockayne syndrome,0.411417523,5,"Biomarker, GeneticVariation"
5654,HTRA1,HtrA serine peptidase 1,0.0,1.0,1.0,0.0,0.0,1838577,Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy,0.411417523,6,"Biomarker, GeneticVariation"
84634,KISS1R,KISS1 receptor,0.0,1.0,1.0,0.0,0.0,342543,"Precocious Puberty, Central",0.411417523,5,"Biomarker, GeneticVariation"
166379,BBS12,Bardet-Biedl syndrome 12,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.411417523,5,"Biomarker, GeneticVariation"
6340,SCNN1G,"sodium channel, non voltage gated 1 gamma subunit",0.0,1.0,1.0,0.0,0.0,221043,Liddle Syndrome,0.411417523,5,"Biomarker, GeneticVariation"
1180,CLCN1,"chloride channel, voltage-sensitive 1",0.0,1.0,1.0,0.0,0.0,751360,"Congenital myotonia, autosomal recessive form",0.411417523,5,"Biomarker, GeneticVariation"
1056,CEL,carboxyl ester lipase,0.0,1.0,1.0,0.0,0.0,1853297,"Maturity-Onset Diabetes of the Young, Type 8, with Exocrine Dysfunction",0.411417523,5,"Biomarker, GeneticVariation"
1723,DHODH,dihydroorotate dehydrogenase (quinone),0.0,1.0,1.0,0.0,0.0,265257,Genee-Wiedemann syndrome,0.411417523,5,"Biomarker, GeneticVariation"
1184,CLCN5,"chloride channel, voltage-sensitive 5",0.0,1.0,1.0,0.0,0.0,1845168,"HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE",0.411134018,4,"Biomarker, GeneticVariation"
9076,CLDN1,claudin 1,0.0,1.0,1.0,0.0,0.0,1843355,"Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis",0.411134018,4,"Biomarker, GeneticVariation"
54757,FAM20A,"family with sequence similarity 20, member A",0.0,1.0,1.0,0.0,0.0,2931783,Amelogenesis imperfecta nephrocalcinosis,0.411134018,4,"Biomarker, GeneticVariation"
6606,SMN1,"survival of motor neuron 1, telomeric",0.0,1.0,1.0,0.0,0.0,393538,spinal muscular atrophy type ii,0.411134018,4,"Biomarker, GeneticVariation"
2301,FOXE3,forkhead box E3,0.0,1.0,1.0,0.0,0.0,1853230,"Aphakia, congenital primary",0.411134018,4,"Biomarker, GeneticVariation"
171023,ASXL1,additional sex combs like transcriptional regulator 1,0.0,1.0,1.0,0.0,0.0,796232,Bohring syndrome,0.411134018,4,"Biomarker, GeneticVariation"
4519,CYTB,cytochrome b,0.0,1.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.411134018,4,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,0.0,0.0,1851970,"Dyskeratosis Congenita, Autosomal Dominant",0.411134018,4,"Biomarker, GeneticVariation"
57038,RARS2,"arginyl-tRNA synthetase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,1969084,Pontocerebellar Hypoplasia Type 6,0.411134018,4,"Biomarker, GeneticVariation"
2582,GALE,UDP-galactose-4-epimerase,0.0,1.0,1.0,0.0,0.0,751161,UDPglucose-4-epimerase deficiency,0.411134018,7,"Biomarker, GeneticVariation"
9652,TTC37,tetratricopeptide repeat domain 37,0.0,1.0,1.0,0.0,0.0,1857276,Trichohepatoenteric Syndrome,0.411134018,4,"Biomarker, GeneticVariation"
3636,INPPL1,inositol polyphosphate phosphatase-like 1,0.0,1.0,1.0,0.0,0.0,432219,Opsismodysplasia,0.411134018,4,"Biomarker, GeneticVariation"
7170,TPM3,tropomyosin 3,0.0,1.0,1.0,0.0,0.0,546264,Congenital Fiber-Type Disproportion,0.411134018,4,"Biomarker, GeneticVariation"
8893,EIF2B5,"eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa",0.0,1.0,1.0,0.0,0.0,1858991,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER,0.411134018,9,"Biomarker, GeneticVariation"
25814,ATXN10,ataxin 10,0.0,1.0,1.0,0.0,0.0,1963674,Spinocerebellar Ataxia 10,0.411134018,4,"Biomarker, GeneticVariation"
6341,SCO1,SCO1 cytochrome c oxidase assembly protein,0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.411134018,4,"Biomarker, GeneticVariation"
4513,COX2,cytochrome c oxidase subunit II,0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.411134018,5,"Biomarker, GeneticVariation"
64421,DCLRE1C,DNA cross-link repair 1C,0.0,1.0,1.0,0.0,0.0,1801959,Histiocytic medullary reticulosis,0.411134018,4,"Biomarker, GeneticVariation"
3075,CFH,complement factor H,0.0,1.0,1.0,0.0,0.0,730295,Basal Laminar Drusen,0.411134018,4,"Biomarker, GeneticVariation"
6591,SNAI2,snail family zinc finger 2,0.0,1.0,1.0,0.0,0.0,80024,Piebaldism,0.411134018,4,"Biomarker, GeneticVariation"
4540,ND5,"NADH dehydrogenase, subunit 5 (complex I)",0.0,1.0,1.0,0.0,0.0,162671,MELAS Syndrome,0.411134018,4,"Biomarker, GeneticVariation"
10479,SLC9A6,"solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6",0.0,1.0,1.0,0.0,0.0,2678194,"Mental Retardation, X-Linked, Syndromic, Christianson Type",0.411134018,4,"Biomarker, GeneticVariation"
220202,ATOH7,atonal homolog 7 (Drosophila),0.0,1.0,1.0,0.0,0.0,1857299,"Retinal Nonattachment, Nonsyndromic Congenital",0.411134018,6,"Biomarker, GeneticVariation"
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,1.0,0.0,0.0,238339,Hereditary pancreatitis,0.411134018,4,"Biomarker, GeneticVariation"
6315,ATXN8OS,ATXN8 opposite strand (non-protein coding),0.0,1.0,1.0,0.0,0.0,1837454,Spinocerebellar ataxia 8,0.411134018,4,"Biomarker, GeneticVariation"
30008,EFEMP2,EGF containing fibulin-like extracellular matrix protein 2,0.0,1.0,1.0,0.0,0.0,268351,"Cutis Laxa, Autosomal Recessive, Type I",0.411134018,4,"Biomarker, GeneticVariation"
6390,SDHB,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",0.0,1.0,1.0,0.0,0.0,1847319,Carney-Stratakis Syndrome,0.411134018,4,"Biomarker, GeneticVariation"
6392,SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein",0.0,1.0,1.0,0.0,0.0,1847319,Carney-Stratakis Syndrome,0.411134018,4,"Biomarker, GeneticVariation"
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,1.0,0.0,0.0,11195,dejerine-sottas disease,0.411134018,4,"Biomarker, GeneticVariation"
92344,GORAB,"golgin, RAB6-interacting",0.0,1.0,1.0,0.0,0.0,432255,Gerodermia osteodysplastica,0.411134018,4,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,1851124,"Desmoid disease, hereditary",0.411134018,4,"Biomarker, GeneticVariation"
5521,PPP2R2B,"protein phosphatase 2, regulatory subunit B, beta",0.0,1.0,1.0,0.0,0.0,1858501,Spinocerebellar Ataxia 12,0.411134018,4,"Biomarker, GeneticVariation"
51324,SPG21,"spastic paraplegia 21 (autosomal recessive, Mast syndrome)",0.0,1.0,1.0,0.0,0.0,1855346,MAST Syndrome,0.411134018,4,"Biomarker, GeneticVariation"
114327,EFHC1,EF-hand domain (C-terminal) containing 1,0.0,1.0,1.0,0.0,0.0,14553,"Epilepsy, Absence",0.410850514,3,"Biomarker, GeneticVariation"
4851,NOTCH1,notch 1,0.0,1.0,1.0,0.0,0.0,1260873,Aortic Valve Disease,0.410850514,3,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.410850514,3,"Biomarker, GeneticVariation"
2271,FH,fumarate hydratase,0.0,1.0,1.0,0.0,0.0,342770,Fumarase deficiency,0.410850514,3,"Biomarker, GeneticVariation"
6657,SOX2,SRY (sex determining region Y)-box 2,0.0,1.0,1.0,0.0,0.0,1859773,"Microphthalmia, Syndromic 3",0.410850514,3,"Biomarker, GeneticVariation"
57679,ALS2,amyotrophic lateral sclerosis 2 (juvenile),0.0,1.0,1.0,0.0,0.0,1859807,"Amyotrophic Lateral Sclerosis 2, Juvenile",0.410850514,3,"Biomarker, GeneticVariation"
3155,HMGCL,3-hydroxymethyl-3-methylglutaryl-CoA lyase,0.0,1.0,1.0,0.0,0.0,268601,3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,0.410850514,3,"Biomarker, GeneticVariation"
7474,WNT5A,"wingless-type MMTV integration site family, member 5A",0.0,1.0,1.0,0.0,0.0,265205,"Robinow Syndrome, Autosomal Dominant",0.410850514,3,"Biomarker, GeneticVariation"
2624,GATA2,GATA binding protein 2,0.0,1.0,1.0,0.0,0.0,3279664,Emberger syndrome,0.410850514,3,"Biomarker, GeneticVariation"
4512,COX1,cytochrome c oxidase subunit I,0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.410850514,3,"Biomarker, GeneticVariation"
9343,EFTUD2,elongation factor Tu GTP binding domain containing 2,0.0,1.0,1.0,0.0,0.0,1864652,"Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate",0.410850514,3,"Biomarker, GeneticVariation"
5339,PLEC,plectin,0.0,1.0,1.0,0.0,0.0,2677349,Epidermolysis Bullosa Simplex With Pyloric Atresia,0.410850514,3,"Biomarker, GeneticVariation"
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,1.0,0.0,0.0,265971,Acrokeratosis verruciformis of Hopf,0.410850514,3,"Biomarker, GeneticVariation"
23545,ATP6V0A2,"ATPase, H+ transporting, lysosomal V0 subunit a2",0.0,1.0,1.0,0.0,0.0,406587,Wrinkly skin syndrome,0.410850514,4,"Biomarker, GeneticVariation"
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,1.0,0.0,0.0,20075,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V",0.410850514,4,"Biomarker, GeneticVariation"
8241,RBM10,RNA binding motif protein 10,0.0,1.0,1.0,0.0,0.0,1839463,TARP syndrome,0.410850514,3,"Biomarker, GeneticVariation"
3827,KNG1,kininogen 1,0.0,1.0,1.0,0.0,0.0,272340,Flaujeac factor deficiency,0.410850514,3,"Biomarker, GeneticVariation"
8892,EIF2B2,"eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa",0.0,1.0,1.0,0.0,0.0,1847967,Vanishing White Matter Leukodystrophy with Ovarian Failure,0.410850514,4,"Biomarker, GeneticVariation"
8890,EIF2B4,"eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa",0.0,1.0,1.0,0.0,0.0,1847967,Vanishing White Matter Leukodystrophy with Ovarian Failure,0.410850514,4,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,266313,Allanson Pantzar McLeod syndrome,0.410850514,4,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,265287,Acromicric dysplasia,0.410850514,3,"Biomarker, GeneticVariation"
6888,TALDO1,transaldolase 1,0.0,1.0,1.0,0.0,0.0,1291329,Transaldolase Deficiency,0.410850514,3,"Biomarker, GeneticVariation"
9049,AIP,aryl hydrocarbon receptor interacting protein,0.0,1.0,1.0,0.0,0.0,346302,Growth Hormone-Secreting Pituitary Adenoma,0.410850514,3,"Biomarker, GeneticVariation"
735,C9,complement component 9,0.0,1.0,1.0,0.0,0.0,3151189,C9 Deficiency,0.410850514,3,"Biomarker, GeneticVariation"
6905,TBCE,tubulin folding cofactor E,0.0,1.0,1.0,0.0,0.0,1855840,Hypoparathyroidism-retardation-dysmorphism syndrome,0.410850514,3,"Biomarker, GeneticVariation"
3295,HSD17B4,hydroxysteroid (17-beta) dehydrogenase 4,0.0,1.0,1.0,0.0,0.0,685838,Gonadal dysgenesis XX type deafness,0.410850514,3,"Biomarker, GeneticVariation"
6786,STIM1,stromal interaction molecule 1,0.0,1.0,1.0,0.0,0.0,410207,"MYOPATHY, TUBULAR AGGREGATE",0.410850514,3,"Biomarker, GeneticVariation"
2255,FGF10,fibroblast growth factor 10,0.0,1.0,1.0,0.0,0.0,158667,Aplasia of Lacrimal and Salivary Glands,0.410850514,3,"Biomarker, GeneticVariation"
477,ATP1A2,"ATPase, Na+/K+ transporting, alpha 2 polypeptide",0.0,1.0,1.0,0.0,0.0,338488,Alternating hemiplegia of childhood,0.410850514,3,"Biomarker, GeneticVariation"
2773,GNAI3,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3",0.0,1.0,1.0,0.0,0.0,1865295,Auriculo-condylar syndrome,0.410850514,3,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,1858556,MASS syndrome,0.410850514,3,"Biomarker, GeneticVariation"
1959,EGR2,early growth response 2,0.0,1.0,1.0,0.0,0.0,11195,dejerine-sottas disease,0.410850514,3,"Biomarker, GeneticVariation"
728294,D2HGDH,D-2-hydroxyglutarate dehydrogenase,0.0,1.0,1.0,0.0,0.0,3152055,D-2-HYDROXYGLUTARIC ACIDURIA 1,0.410850514,5,"Biomarker, GeneticVariation"
7012,TERC,telomerase RNA component,0.0,1.0,1.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.410850514,5,"Biomarker, GeneticVariation"
8795,TNFRSF10B,"tumor necrosis factor receptor superfamily, member 10b",0.0,1.0,1.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.410850514,3,"Biomarker, GeneticVariation"
1832,DSP,desmoplakin,0.0,1.0,1.0,0.0,0.0,1864826,"Epidermolysis bullosa, lethal acantholytic",0.410850514,3,"Biomarker, GeneticVariation"
6023,RMRP,RNA component of mitochondrial RNA processing endoribonuclease,0.0,1.0,1.0,0.0,0.0,1846796,Anauxetic dysplasia,0.410850514,3,"Biomarker, GeneticVariation"
5740,PTGIS,prostaglandin I2 (prostacyclin) synthase,0.0,1.0,1.0,0.0,0.0,85580,"Hypertension, Essential",0.410850514,3,"Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,344559,Peters anomaly,0.410850514,3,"Biomarker, GeneticVariation"
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,1.0,0.0,0.0,265210,Weaver syndrome,0.410850514,3,"Biomarker, GeneticVariation"
8243,SMC1A,structural maintenance of chromosomes 1A,0.0,1.0,1.0,0.0,0.0,1802395,Congenital muscular hypertrophy-cerebral syndrome,0.410850514,6,"Biomarker, GeneticVariation"
344,APOC2,apolipoprotein C-II,0.0,1.0,1.0,0.0,0.0,1720779,APOLIPOPROTEIN C-II DEFICIENCY,0.410850514,4,"Biomarker, GeneticVariation"
196527,ANO6,anoctamin 6,0.0,1.0,1.0,0.0,0.0,796149,Scott Syndrome,0.410850514,3,"Biomarker, GeneticVariation"
23503,ZFYVE26,"zinc finger, FYVE domain containing 26",0.0,1.0,1.0,0.0,0.0,1849128,"Spastic paraplegia 15, autosomal recessive",0.410850514,3,"Biomarker, GeneticVariation"
3861,KRT14,"keratin 14, type I",0.0,1.0,1.0,0.0,0.0,79299,Generalized epidermolysis bullosa simplex,0.410850514,3,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,1.0,10346,Crohn Disease,0.410738639,104,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.410708802,132,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.41062191,110,"Biomarker, GeneticVariation"
5295,PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",0.0,1.0,1.0,0.0,0.0,878684,SHORT syndrome,0.410567009,4,"Biomarker, GeneticVariation"
3861,KRT14,"keratin 14, type I",0.0,1.0,1.0,0.0,0.0,406778,Dermatopathia pigmentosa reticularis,0.410567009,2,"Biomarker, GeneticVariation"
732,C8B,"complement component 8, beta polypeptide",0.0,1.0,1.0,0.0,0.0,3151080,"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II",0.410567009,2,"Biomarker, GeneticVariation"
80331,DNAJC5,"DnaJ (Hsp40) homolog, subfamily C, member 5",0.0,1.0,1.0,0.0,0.0,1834207,"CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT",0.410567009,2,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,0.0,2748507,Deficiency of interleukin-1 receptor antagonist,0.410567009,2,"Biomarker, GeneticVariation"
388531,RGS9BP,regulator of G protein signaling 9 binding protein,0.0,1.0,1.0,0.0,0.0,1842073,Prolonged Electroretinal Response Suppression,0.410567009,2,"Biomarker, GeneticVariation"
3795,KHK,ketohexokinase (fructokinase),0.0,1.0,1.0,0.0,0.0,268160,Fructosuria,0.410567009,3,"Biomarker, GeneticVariation"
8481,OFD1,oral-facial-digital syndrome 1,0.0,1.0,1.0,0.0,0.0,1510460,OROFACIODIGITAL SYNDROME I,0.410567009,7,"Biomarker, GeneticVariation"
54982,CLN6,"ceroid-lipofuscinosis, neuronal 6, late infantile, variant",0.0,1.0,1.0,0.0,0.0,22797,Adult neuronal ceroid lipofuscinosis,0.410567009,2,"Biomarker, GeneticVariation"
9241,NOG,noggin,0.0,1.0,1.0,0.0,0.0,1866656,STAPES ANKYLOSIS WITH BROAD THUMB AND TOES,0.410567009,2,"Biomarker, GeneticVariation"
4750,NEK1,NIMA-related kinase 1,0.0,1.0,1.0,0.0,0.0,24507,"Short rib-polydactyly syndrome, Majewski type",0.410567009,3,"Biomarker, GeneticVariation"
168667,BMPER,BMP binding endothelial regulator,0.0,1.0,1.0,0.0,0.0,1842691,Diaphanospondylodysostosis,0.410567009,2,"Biomarker, GeneticVariation"
3835,KIF22,kinesin family member 22,0.0,1.0,1.0,0.0,0.0,1863732,Spondyloepimetaphyseal dysplasia with multiple dislocations,0.410567009,3,"Biomarker, GeneticVariation"
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,1.0,0.0,0.0,750384,Coumarin Resistance,0.410567009,2,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,1563720,HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA,0.410567009,2,"Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,0.0,1.0,0.0,0.0,85261,Proteus Syndrome,0.410567009,2,GeneticVariation
93183,PIGM,"phosphatidylinositol glycan anchor biosynthesis, class M",0.0,1.0,1.0,0.0,0.0,1853205,Glycosylphosphatidylinositol deficiency,0.410567009,2,"Biomarker, GeneticVariation"
3832,KIF11,kinesin family member 11,0.0,1.0,1.0,0.0,0.0,1835265,"Lymphedema, microcephaly and chorioretinopathy syndrome",0.410567009,2,"Biomarker, GeneticVariation"
64788,LMF1,lipase maturation factor 1,0.0,1.0,1.0,0.0,0.0,1855498,Lipase deficiency combined,0.410567009,2,"Biomarker, GeneticVariation"
6261,RYR1,ryanodine receptor 1 (skeletal),0.0,1.0,1.0,0.0,0.0,546264,Congenital Fiber-Type Disproportion,0.410567009,2,"Biomarker, GeneticVariation"
5447,POR,P450 (cytochrome) oxidoreductase,0.0,1.0,1.0,0.0,0.0,1860042,DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY,0.410567009,2,"Biomarker, GeneticVariation"
51715,RAB23,"RAB23, member RAS oncogene family",0.0,1.0,1.0,0.0,0.0,1275078,Acrocephalopolysyndactyly Type II,0.410567009,2,"Biomarker, GeneticVariation"
5651,TMPRSS15,"transmembrane protease, serine 15",0.0,1.0,1.0,0.0,0.0,268416,Enterokinase Deficiency,0.410567009,2,"Biomarker, GeneticVariation"
55605,KIF21A,kinesin family member 21A,0.0,1.0,1.0,0.0,0.0,1851102,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1",0.410567009,4,"Biomarker, GeneticVariation"
51360,MBTPS2,"membrane-bound transcription factor peptidase, site 2",0.0,1.0,1.0,0.0,0.0,1839988,Ichthyosis follicularis atrichia photophobia syndrome,0.410567009,2,"Biomarker, GeneticVariation"
2720,GLB1,"galactosidase, beta 1",0.0,1.0,1.0,0.0,0.0,268273,Adult GM1 gangliosidosis,0.410567009,2,"Biomarker, GeneticVariation"
5818,PVRL1,poliovirus receptor-related 1 (herpesvirus entry mediator C),0.0,1.0,1.0,0.0,0.0,2931488,Zlotogora-Ogur syndrome,0.410567009,3,"Biomarker, GeneticVariation"
6913,TBX15,T-box 15,0.0,1.0,1.0,0.0,0.0,1850040,Pelviscapular dysplasia,0.410567009,2,"Biomarker, GeneticVariation"
7138,TNNT1,"troponin T type 1 (skeletal, slow)",0.0,1.0,1.0,0.0,0.0,1854380,Nemaline myopathy 5,0.410567009,2,"Biomarker, GeneticVariation"
10157,AASS,aminoadipate-semialdehyde synthase,0.0,1.0,1.0,0.0,0.0,268553,Hyperlysinemias,0.410567009,2,"Biomarker, GeneticVariation"
7443,VRK1,vaccinia related kinase 1,0.0,1.0,1.0,0.0,0.0,1843504,Pontocerebellar Hypoplasia Type 1,0.410567009,2,"Biomarker, GeneticVariation"
51816,CECR1,"cat eye syndrome chromosome region, candidate 1",0.0,1.0,1.0,0.0,0.0,31036,Polyarteritis Nodosa,0.410567009,3,"Biomarker, GeneticVariation"
846,CASR,calcium-sensing receptor,0.0,1.0,1.0,0.0,0.0,1832648,Hypoparathyroidism familial isolated,0.410567009,2,"Biomarker, GeneticVariation"
3242,HPD,4-hydroxyphenylpyruvate dioxygenase,0.0,1.0,1.0,0.0,0.0,2931042,Hawkinsinuria,0.410567009,2,"Biomarker, GeneticVariation"
55997,CFC1,"cripto, FRL-1, cryptic family 1",0.0,1.0,1.0,0.0,0.0,13069,Double Outlet Right Ventricle,0.410567009,2,"Biomarker, GeneticVariation"
79092,CARD14,"caspase recruitment domain family, member 14",0.0,1.0,1.0,0.0,0.0,32027,Pityriasis Rubra Pilaris,0.410567009,2,"Biomarker, GeneticVariation"
80025,PANK2,pantothenate kinase 2,0.0,1.0,1.0,0.0,0.0,1846582,"Hypoprebetalipoproteinemia, Acanthocytosis, Retinitis Pigmentosa, And Pallidal Degeneration",0.410567009,2,"Biomarker, GeneticVariation"
2688,GH1,growth hormone 1,0.0,1.0,1.0,0.0,0.0,342573,Pituitary dwarfism 1,0.410567009,2,"Biomarker, GeneticVariation"
29899,GPSM2,G-protein signaling modulator 2,0.0,1.0,1.0,0.0,0.0,1858695,Chudley-Mccullough syndrome,0.410567009,2,"Biomarker, GeneticVariation"
5159,PDGFRB,"platelet-derived growth factor receptor, beta polypeptide",0.0,1.0,1.0,0.0,0.0,432284,"Fibromatosis, Congenital Generalized",0.410567009,2,"Biomarker, GeneticVariation"
5660,PSAP,prosaposin,0.0,1.0,1.0,0.0,0.0,2673635,Combined Saposin Deficiency,0.410567009,2,"Biomarker, GeneticVariation"
7259,TSPYL1,TSPY-like 1,0.0,1.0,1.0,0.0,0.0,1837371,Sudden Infant Death with Dysgenesis of the Testes Syndrome,0.410567009,2,"Biomarker, GeneticVariation"
9342,SNAP29,"synaptosomal-associated protein, 29kDa",0.0,1.0,1.0,0.0,0.0,1836033,"Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome",0.410567009,2,"Biomarker, GeneticVariation"
3852,KRT5,"keratin 5, type II",0.0,1.0,1.0,0.0,0.0,1836284,Epidermolysis Bullosa Simplex with Migratory Circinate Erythema,0.410567009,2,"Biomarker, GeneticVariation"
7252,TSHB,"thyroid stimulating hormone, beta",0.0,1.0,1.0,0.0,0.0,271789,"Hypothyroidism, Congenital, Nongoitrous, 4",0.410567009,2,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,1863753,Limb-mammary syndrome,0.410567009,3,"Biomarker, GeneticVariation"
388939,C2orf71,chromosome 2 open reading frame 71,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.410567009,2,"Biomarker, GeneticVariation"
83706,FERMT3,fermitin family member 3,0.0,1.0,1.0,0.0,0.0,2748536,"Leukocyte Adhesion Deficiency, Type III",0.410567009,2,"Biomarker, GeneticVariation"
54453,RIN2,Ras and Rab interactor 2,0.0,1.0,1.0,0.0,0.0,2751321,"Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis",0.410567009,2,"Biomarker, GeneticVariation"
23479,ISCU,iron-sulfur cluster assembly enzyme,0.0,1.0,1.0,0.0,0.0,1850718,"Myopathy with Lactic Acidosis, Hereditary",0.410567009,2,"Biomarker, GeneticVariation"
7780,SLC30A2,"solute carrier family 30 (zinc transporter), member 2",0.0,0.0,1.0,0.0,0.0,1842486,"Zinc Deficiency, Neonatal, due to Low Breast Milk Zinc",0.410567009,3,GeneticVariation
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,1.0,0.0,0.0,410530,Metachondromatosis,0.410567009,2,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,0.0,1.0,0.0,0.0,1836683,"Czech dysplasia, metatarsal type",0.410567009,2,GeneticVariation
3094,HINT1,histidine triad nucleotide binding protein 1,0.0,1.0,1.0,0.0,0.0,242287,Isaacs Syndrome,0.410567009,2,"Biomarker, GeneticVariation"
9094,UNC119,unc-119 homolog (C. elegans),0.0,0.0,1.0,0.0,0.0,3809768,IMMUNODEFICIENCY 13,0.410567009,2,GeneticVariation
2296,FOXC1,forkhead box C1,0.0,1.0,1.0,0.0,0.0,344559,Peters anomaly,0.410567009,2,"Biomarker, GeneticVariation"
1285,COL4A3,"collagen, type IV, alpha 3 (Goodpasture antigen)",0.0,1.0,1.0,0.0,0.0,1567743,"ALPORT SYNDROME, AUTOSOMAL DOMINANT",0.410567009,2,"Biomarker, GeneticVariation"
2138,EYA1,EYA transcriptional coactivator and phosphatase 1,0.0,1.0,1.0,0.0,0.0,1833691,Otofaciocervical Syndrome,0.410567009,2,"Biomarker, GeneticVariation"
4088,SMAD3,SMAD family member 3,0.0,1.0,1.0,0.0,0.0,2697932,Loeys-Dietz Syndrome,0.410567009,2,"Biomarker, GeneticVariation"
4567,TRNL1,tRNA,0.0,1.0,1.0,0.0,0.0,162666,Mitochondrial Encephalomyopathies,0.410567009,3,"Biomarker, GeneticVariation"
590,BCHE,butyrylcholinesterase,0.0,1.0,1.0,0.0,0.0,1283400,Butyrylcholinesterase deficiency,0.410567009,6,"Biomarker, GeneticVariation"
22856,CHSY1,chondroitin sulfate synthase 1,0.0,1.0,1.0,0.0,0.0,1854466,Temtamy preaxial brachydactyly syndrome,0.410567009,2,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,0.0,1.0,1.0,0.0,0.0,553586,Caf-au-lait macules with pulmonary stenosis,0.410567009,2,"Biomarker, GeneticVariation"
3861,KRT14,"keratin 14, type I",0.0,1.0,1.0,0.0,0.0,343111,Naegeli syndrome,0.410567009,2,"Biomarker, GeneticVariation"
197322,ACSF3,acyl-CoA synthetase family member 3,0.0,1.0,1.0,0.0,0.0,3280314,Combined Malonic and Methylmalonic Aciduria,0.410567009,2,"Biomarker, GeneticVariation"
79827,CLMP,CXADR-like membrane protein,0.0,0.0,1.0,0.0,0.0,21847,Intestinal Pseudo-Obstruction,0.410567009,2,GeneticVariation
85007,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,0.0,0.0,1.0,0.0,0.0,3554344,PHOSPHOHYDROXYLYSINURIA,0.410567009,2,GeneticVariation
10082,GPC6,glypican 6,0.0,1.0,1.0,0.0,0.0,1850318,Omodysplasia type 1,0.410567009,2,"Biomarker, GeneticVariation"
116519,APOA5,apolipoprotein A-V,1.0,1.0,1.0,0.0,0.0,20557,Hypertriglyceridemia,0.410361233,33,"AlteredExpression, Biomarker, GeneticVariation"
63901,FAM111A,"family with sequence similarity 111, member A",0.0,1.0,1.0,0.0,0.0,1865639,Gracile bone dysplasia,0.410283505,1,"Biomarker, GeneticVariation"
51604,PIGT,"phosphatidylinositol glycan anchor biosynthesis, class T",0.0,0.0,1.0,0.0,0.0,3809356,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3,0.410283505,2,GeneticVariation
9968,MED12,mediator complex subunit 12,0.0,0.0,1.0,0.0,0.0,3698541,"Ohdo syndrome, Maat-Kievit-Brunner type",0.410283505,1,GeneticVariation
3659,IRF1,interferon regulatory factor 1,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.410283505,1,"Biomarker, GeneticVariation"
1585,CYP11B2,"cytochrome P450, family 11, subfamily B, polypeptide 2",0.0,1.0,1.0,0.0,0.0,3463917,CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY,0.410283505,1,"Biomarker, GeneticVariation"
7297,TYK2,tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,1969086,Tyrosine Kinase 2 Deficiency,0.410283505,1,"Biomarker, GeneticVariation"
4539,ND4L,"NADH dehydrogenase, subunit 4L (complex I)",0.0,1.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.410283505,2,"Biomarker, GeneticVariation"
246329,STAC3,SH3 and cysteine rich domain 3,0.0,1.0,1.0,0.0,0.0,1850625,Native American myopathy,0.410283505,1,"Biomarker, GeneticVariation"
222546,RFX6,"regulatory factor X, 6",0.0,1.0,1.0,0.0,0.0,2748662,Mitchell-Riley Syndrome,0.410283505,2,"Biomarker, GeneticVariation"
284252,KCTD1,potassium channel tetramerization domain containing 1,0.0,1.0,1.0,0.0,0.0,1867020,Scalp ear nipple syndrome,0.410283505,1,"Biomarker, GeneticVariation"
3973,LHCGR,luteinizing hormone/choriogonadotropin receptor,0.0,1.0,1.0,0.0,0.0,266432,Leydig cell agenesis,0.410283505,1,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,1845146,"Holoprosencephaly, Ectrodactyly, and Bilateral Cleft Lip/Palate",0.410283505,1,"Biomarker, GeneticVariation"
1825,DSC3,desmocollin 3,0.0,1.0,1.0,0.0,0.0,2751292,Hypotrichosis And Recurrent Skin Vesicles,0.410283505,1,"Biomarker, GeneticVariation"
4519,CYTB,cytochrome b,0.0,1.0,1.0,0.0,0.0,1708371,"Cardiomyopathy, infantile histiocytoid",0.410283505,1,"Biomarker, GeneticVariation"
55906,ZC4H2,"zinc finger, C4H2 domain containing",0.0,1.0,1.0,0.0,0.0,796200,Wieacker syndrome,0.410283505,2,"Biomarker, GeneticVariation"
5836,PYGL,"phosphorylase, glycogen, liver",0.0,1.0,1.0,0.0,0.0,17925,Glycogen Storage Disease Type VI,0.410283505,2,"Biomarker, GeneticVariation"
3431,SP110,SP110 nuclear body protein,0.0,1.0,1.0,0.0,0.0,1856128,Hepatic venoocclusive disease with immunodeficiency,0.410283505,1,"Biomarker, GeneticVariation"
5660,PSAP,prosaposin,0.0,1.0,1.0,0.0,0.0,2673266,"Krabbe Disease, Atypical, due to Saposin A Deficiency",0.410283505,1,"Biomarker, GeneticVariation"
343035,RD3,retinal degeneration 3,0.0,1.0,1.0,0.0,0.0,1857743,Leber Congenital Amaurosis 12,0.410283505,1,"Biomarker, GeneticVariation"
1778,DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1",0.0,1.0,1.0,0.0,0.0,1834690,"Spinal Muscular Atrophy, Childhood, Proximal, Autosomal Dominant",0.410283505,1,"Biomarker, GeneticVariation"
26277,TINF2,TERF1 (TRF1)-interacting nuclear factor 2,0.0,1.0,1.0,0.0,0.0,1851970,"Dyskeratosis Congenita, Autosomal Dominant",0.410283505,1,"Biomarker, GeneticVariation"
2138,EYA1,EYA transcriptional coactivator and phosphatase 1,0.0,1.0,1.0,0.0,0.0,1865143,Branchiootic syndrome,0.410283505,1,"Biomarker, GeneticVariation"
4488,MSX2,msh homeobox 2,0.0,1.0,1.0,0.0,0.0,1868597,Parietal Foramina With Cleidocranial Dysplasia,0.410283505,1,"Biomarker, GeneticVariation"
51091,SEPSECS,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase,0.0,1.0,1.0,0.0,0.0,3151140,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2D",0.410283505,1,"Biomarker, GeneticVariation"
4784,NFIX,nuclear factor I/X (CCAAT-binding transcription factor),0.0,0.0,1.0,0.0,0.0,3553660,SOTOS SYNDROME 2,0.410283505,2,GeneticVariation
51371,POMP,proteasome maturation protein,0.0,1.0,1.0,0.0,0.0,1866029,Keratosis Linearis with Ichthyosis Congenita and Sclerosing Keratoderma,0.410283505,1,"Biomarker, GeneticVariation"
1678,TIMM8A,translocase of inner mitochondrial membrane 8 homolog A (yeast),0.0,1.0,1.0,0.0,0.0,1839564,Jensen syndrome,0.410283505,1,"Biomarker, GeneticVariation"
51807,TUBA8,"tubulin, alpha 8",0.0,1.0,1.0,0.0,0.0,2750798,Polymicrogyria With Optic Nerve Hypoplasia,0.410283505,1,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,3279786,ANHAPTOGLOBINEMIA,0.410283505,2,"Biomarker, GeneticVariation"
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,1.0,0.0,0.0,1853392,"Interleukin 2 Receptor, Alpha, Deficiency of",0.410283505,1,"Biomarker, GeneticVariation"
5130,PCYT1A,"phosphate cytidylyltransferase 1, choline, alpha",0.0,1.0,1.0,0.0,0.0,1837073,Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy,0.410283505,2,"Biomarker, GeneticVariation"
50964,SOST,sclerostin,0.0,1.0,1.0,0.0,0.0,2675746,"Craniodiaphyseal Dysplasia, Autosomal Dominant",0.410283505,1,"Biomarker, GeneticVariation"
2627,GATA6,GATA binding protein 6,0.0,1.0,1.0,0.0,0.0,1838780,"Pancreatic Hypoplasia, Congenital, with Diabetes Mellitus and Congenital Heart Disease",0.410283505,1,"Biomarker, GeneticVariation"
10617,STAMBP,STAM binding protein,0.0,1.0,1.0,0.0,0.0,3280296,Microcephaly-capillary malformation syndrome,0.410283505,1,"Biomarker, GeneticVariation"
5293,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta",0.0,0.0,1.0,0.0,0.0,3714976,Activated PI3K-delta Syndrome,0.410283505,1,GeneticVariation
56623,INPP5E,"inositol polyphosphate-5-phosphatase, 72 kDa",0.0,1.0,1.0,0.0,0.0,1857802,MORM syndrome,0.410283505,1,"Biomarker, GeneticVariation"
8891,EIF2B3,"eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa",0.0,0.0,1.0,0.0,0.0,1858991,LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER,0.410283505,4,GeneticVariation
340024,SLC6A19,"solute carrier family 6 (neutral amino acid transporter), member 19",0.0,1.0,1.0,0.0,0.0,543541,Glycinuria with or without Oxalate Urolithiasis,0.410283505,1,"Biomarker, GeneticVariation"
1053,CEBPE,"CCAAT/enhancer binding protein (C/EBP), epsilon",0.0,1.0,1.0,0.0,0.0,398593,Specific Granule Deficiency,0.410283505,1,"Biomarker, GeneticVariation"
6813,STXBP2,syntaxin binding protein 2,0.0,1.0,1.0,0.0,0.0,2751293,"Hemophagocytic Lymphohistiocytosis, Familial, 5",0.410283505,3,"Biomarker, GeneticVariation"
79784,MYH14,"myosin, heavy chain 14, non-muscle",0.0,1.0,1.0,0.0,0.0,3280556,"PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS",0.410283505,1,"Biomarker, GeneticVariation"
7148,TNXB,tenascin XB,0.0,1.0,1.0,0.0,0.0,268337,Ehlers-Danlos syndrome type 3,0.410283505,1,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,1835042,Melanoma astrocytoma syndrome,0.410283505,1,"Biomarker, GeneticVariation"
22868,FASTKD2,FAST kinase domains 2,0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.410283505,1,"Biomarker, GeneticVariation"
5080,PAX6,paired box 6,0.0,1.0,1.0,0.0,0.0,431401,Aniridia cerebellar ataxia mental deficiency,0.410283505,1,"Biomarker, GeneticVariation"
102,ADAM10,ADAM metallopeptidase domain 10,0.0,1.0,1.0,0.0,0.0,406811,Reticulate acropigmentation of Kitamura,0.410283505,1,"Biomarker, GeneticVariation"
1290,COL5A2,"collagen, type V, alpha 2",0.0,1.0,1.0,0.0,0.0,268335,Ehlers-Danlos syndrome type 1,0.410283505,1,"Biomarker, GeneticVariation"
1292,COL6A2,"collagen, type VI, alpha 2",0.0,1.0,1.0,0.0,0.0,1850671,"Myosclerosis, Autosomal Recessive",0.410283505,1,"Biomarker, GeneticVariation"
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,1.0,0.0,0.0,585216,Alpha-Thalassemia Myelodysplasia Syndrome,0.410283505,1,"Biomarker, GeneticVariation"
57511,COG6,component of oligomeric golgi complex 6,0.0,1.0,1.0,0.0,0.0,3553230,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl",0.410283505,1,"Biomarker, GeneticVariation"
3048,HBG2,"hemoglobin, gamma G",0.0,1.0,1.0,0.0,0.0,3151421,"CYANOSIS, TRANSIENT NEONATAL",0.410283505,4,"Biomarker, GeneticVariation"
79651,RHBDF2,rhomboid 5 homolog 2 (Drosophila),0.0,0.0,1.0,0.0,0.0,1835664,Keratosis palmoplantaris with esophageal cancer,0.410283505,2,GeneticVariation
8313,AXIN2,axin 2,0.0,1.0,1.0,0.0,0.0,1837750,Oligodontia-Colorectal Cancer Syndrome,0.410283505,1,"Biomarker, GeneticVariation"
50814,NSDHL,NAD(P) dependent steroid dehydrogenase-like,0.0,1.0,1.0,0.0,0.0,3151781,CK SYNDROME,0.410283505,1,"Biomarker, GeneticVariation"
729,C6,complement component 6,0.0,1.0,1.0,0.0,0.0,2676232,Complement Component 6 Deficiency,0.410283505,1,"Biomarker, GeneticVariation"
6496,SIX3,SIX homeobox 3,0.0,1.0,1.0,0.0,0.0,266484,Schizencephaly,0.410283505,1,"Biomarker, GeneticVariation"
63901,FAM111A,"family with sequence similarity 111, member A",0.0,1.0,1.0,0.0,0.0,265291,Kenny Caffey syndrome,0.410283505,1,"Biomarker, GeneticVariation"
8815,BANF1,barrier to autointegration factor 1,0.0,1.0,1.0,0.0,0.0,3151446,NESTOR-GUILLERMO PROGERIA SYNDROME,0.410283505,2,"Biomarker, GeneticVariation"
9060,PAPSS2,3'-phosphoadenosine 5'-phosphosulfate synthase 2,0.0,1.0,1.0,0.0,0.0,2748515,"Spondyloepimetaphyseal Dysplasia, Pakistani Type",0.410283505,1,"Biomarker, GeneticVariation"
1376,CPT2,carnitine palmitoyltransferase 2,0.0,1.0,1.0,0.0,0.0,1833511,"Carnitine Palmitoyltransferase II Deficiency, Infantile",0.410283505,1,"Biomarker, GeneticVariation"
3730,KAL1,Kallmann syndrome 1 sequence,0.0,1.0,1.0,0.0,0.0,1563719,Kallmann Syndrome 1,0.410283505,10,"Biomarker, GeneticVariation"
4541,ND6,"NADH dehydrogenase, subunit 6 (complex I)",0.0,0.0,1.0,0.0,0.0,162671,MELAS Syndrome,0.410283505,1,GeneticVariation
22909,FAN1,FANCD2/FANCI-associated nuclease 1,0.0,0.0,1.0,0.0,0.0,3553774,"INTERSTITIAL NEPHRITIS, KARYOMEGALIC",0.410283505,1,GeneticVariation
4487,MSX1,msh homeobox 1,0.0,1.0,1.0,0.0,0.0,406735,Witkop syndrome,0.410283505,1,"Biomarker, GeneticVariation"
9935,MAFB,v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B,0.0,1.0,1.0,0.0,0.0,2674705,"Osteolysis, Hereditary, Of Carpal Bones With Or Without Nephropathy",0.410283505,2,"Biomarker, GeneticVariation"
54938,SARS2,"seryl-tRNA synthetase 2, mitochondrial",0.0,0.0,1.0,0.0,0.0,3151209,"HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS",0.410283505,2,GeneticVariation
8893,EIF2B5,"eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa",0.0,1.0,1.0,0.0,0.0,1847967,Vanishing White Matter Leukodystrophy with Ovarian Failure,0.410283505,2,"Biomarker, GeneticVariation"
8622,PDE8B,phosphodiesterase 8B,0.0,1.0,1.0,0.0,0.0,1836694,"Striatal Degeneration, Autosomal Dominant",0.410283505,1,"Biomarker, GeneticVariation"
8643,PTCH2,patched 2,0.0,1.0,1.0,0.0,0.0,25149,Medulloblastoma,0.410283505,1,"Biomarker, GeneticVariation"
8260,NAA10,"N(alpha)-acetyltransferase 10, NatA catalytic subunit",0.0,1.0,1.0,0.0,0.0,3275447,OGDEN SYNDROME,0.410283505,2,"Biomarker, GeneticVariation"
7293,TNFRSF4,"tumor necrosis factor receptor superfamily, member 4",0.0,0.0,1.0,0.0,0.0,3810053,IMMUNODEFICIENCY 16,0.410283505,1,GeneticVariation
579,NKX3-2,NK3 homeobox 2,0.0,1.0,1.0,0.0,0.0,2750066,Spondylo-Megaepiphyseal-Metaphyseal Dysplasia,0.410283505,1,"Biomarker, GeneticVariation"
51135,IRAK4,interleukin-1 receptor-associated kinase 4,0.0,1.0,1.0,0.0,0.0,1843256,IRAK4 Deficiency,0.410283505,1,"Biomarker, GeneticVariation"
128178,EDARADD,EDAR-associated death domain,0.0,1.0,1.0,0.0,0.0,406702,"Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive",0.410283505,1,"Biomarker, GeneticVariation"
8996,NOL3,nucleolar protein 3 (apoptosis repressor with CARD domain),0.0,0.0,1.0,0.0,0.0,3539916,"MYOCLONUS, FAMILIAL CORTICAL",0.410283505,1,GeneticVariation
81794,ADAMTS10,"ADAM metallopeptidase with thrombospondin type 1 motif, 10",0.0,1.0,1.0,0.0,0.0,1869114,WEILL-MARCHESANI SYNDROME 1,0.410283505,2,"Biomarker, GeneticVariation"
10661,KLF1,Kruppel-like factor 1 (erythroid),0.0,0.0,1.0,0.0,0.0,3150926,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV",0.410283505,2,GeneticVariation
4038,LRP4,low density lipoprotein receptor-related protein 4,0.0,1.0,1.0,0.0,0.0,3280402,SCLEROSTEOSIS 2,0.410283505,1,"Biomarker, GeneticVariation"
57217,TTC7A,tetratricopeptide repeat domain 7A,0.0,1.0,1.0,0.0,0.0,220744,"Intestinal Atresia, Multiple",0.410283505,1,"Biomarker, GeneticVariation"
3990,LIPC,"lipase, hepatic",0.0,0.0,1.0,0.0,0.0,3151466,HEPATIC LIPASE DEFICIENCY,0.410283505,2,GeneticVariation
91851,CHRDL1,chordin-like 1,0.0,1.0,1.0,0.0,0.0,344530,Megalocornea,0.410283505,1,"Biomarker, GeneticVariation"
116519,APOA5,apolipoprotein A-V,0.0,1.0,1.0,0.0,0.0,20481,Hyperlipoproteinemia Type V,0.410283505,1,"Biomarker, GeneticVariation"
4668,NAGA,"N-acetylgalactosaminidase, alpha-",0.0,1.0,1.0,0.0,0.0,1836522,KANZAKI DISEASE,0.410283505,1,"Biomarker, GeneticVariation"
80169,CTC1,CTS telomere maintenance complex component 1,0.0,1.0,1.0,0.0,0.0,2677299,Cerebroretinal Microangiopathy with Calcifications and Cysts,0.410283505,3,"Biomarker, GeneticVariation"
91179,SCARF2,"scavenger receptor class F, member 2",0.0,1.0,1.0,0.0,0.0,1833136,Marden Walker like syndrome,0.410283505,1,"Biomarker, GeneticVariation"
55788,LMBRD1,LMBR1 domain containing 1,0.0,1.0,1.0,0.0,0.0,1848578,"Methylmalonic Aciduria and Homocystinuria, CblF Type",0.410283505,1,"Biomarker, GeneticVariation"
710,SERPING1,"serpin peptidase inhibitor, clade G (C1 inhibitor), member 1",0.0,1.0,1.0,0.0,0.0,2717906,"ANGIOEDEMA, HEREDITARY, TYPE I",0.410283505,11,"Biomarker, GeneticVariation"
57167,SALL4,spalt-like transcription factor 4,0.0,1.0,1.0,0.0,0.0,1327918,Oculootoradial syndrome,0.410283505,1,"Biomarker, GeneticVariation"
3239,HOXD13,homeobox D13,0.0,1.0,1.0,0.0,0.0,1853137,Brachydactyly-Syndactyly Syndrome,0.410283505,2,"Biomarker, GeneticVariation"
64327,LMBR1,limb development membrane protein 1,0.0,1.0,1.0,0.0,0.0,1861355,"Syndactyly, Type IV",0.410283505,1,"Biomarker, GeneticVariation"
8905,AP1S2,"adaptor-related protein complex 1, sigma 2 subunit",0.0,1.0,1.0,0.0,0.0,796254,"Mental retardation, X-linked, syndromic 5",0.410283505,3,"Biomarker, GeneticVariation"
3909,LAMA3,"laminin, alpha 3",0.0,1.0,1.0,0.0,0.0,1328355,Laryngo onycho cutaneous syndrome,0.410283505,2,"Biomarker, GeneticVariation"
63982,ANO3,anoctamin 3,0.0,0.0,1.0,0.0,0.0,3554374,DYSTONIA 24,0.410283505,2,GeneticVariation
6023,RMRP,RNA component of mitochondrial RNA processing endoribonuclease,0.0,1.0,1.0,0.0,0.0,1834821,Metaphyseal Dysplasia without Hypotrichosis,0.410283505,1,"Biomarker, GeneticVariation"
92002,FAM58A,"family with sequence similarity 58, member A",0.0,1.0,1.0,0.0,0.0,2678045,"Toe Syndactyly, Telecanthus, and Anogenital and Renal Malformations",0.410283505,1,"Biomarker, GeneticVariation"
6576,SLC25A1,"solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1",0.0,1.0,1.0,0.0,0.0,2746066,2-Hydroxyglutaricaciduria,0.410283505,1,"Biomarker, GeneticVariation"
170691,ADAMTS17,"ADAM metallopeptidase with thrombospondin type 1 motif, 17",0.0,1.0,1.0,0.0,0.0,2750787,Weill-Marchesani-Like Syndrome,0.410283505,1,"Biomarker, GeneticVariation"
50,ACO2,"aconitase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,3281192,INFANTILE CEREBELLAR-RETINAL DEGENERATION,0.410283505,1,"Biomarker, GeneticVariation"
8481,OFD1,oral-facial-digital syndrome 1,0.0,1.0,1.0,0.0,0.0,2749019,Joubert Syndrome 10,0.410283505,1,"Biomarker, GeneticVariation"
54476,RNF216,ring finger protein 216,0.0,1.0,1.0,0.0,0.0,1859305,Cerebellar Ataxia and Hypogonadotropic Hypogonadism,0.410283505,2,"Biomarker, GeneticVariation"
336,APOA2,apolipoprotein A-II,0.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.410283505,1,"Biomarker, GeneticVariation"
617,BCS1L,BC1 (ubiquinol-cytochrome c reductase) synthesis-like,0.0,1.0,1.0,0.0,0.0,1852372,Mitochondrial Complex III Deficiency,0.410283505,1,"Biomarker, GeneticVariation"
1583,CYP11A1,"cytochrome P450, family 11, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,3151055,"ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE",0.410283505,4,"Biomarker, GeneticVariation"
9775,EIF4A3,eukaryotic translation initiation factor 4A3,0.0,1.0,1.0,0.0,0.0,1849348,Richieri Costa Pereira syndrome,0.410283505,1,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,2748545,"QUESTION MARK EARS, ISOLATED",0.410283505,1,"Biomarker, GeneticVariation"
84342,COG8,component of oligomeric golgi complex 8,0.0,1.0,1.0,0.0,0.0,1970021,"Congenital Disorder Of Glycosylation, Type IIH",0.410283505,1,"Biomarker, GeneticVariation"
1719,DHFR,dihydrofolate reductase,0.0,0.0,1.0,0.0,0.0,3151205,Megaloblastic Anemia due to Dihydrofolate Reductase Deficiency,0.410283505,2,GeneticVariation
6017,RLBP1,retinaldehyde binding protein 1,0.0,1.0,1.0,0.0,0.0,311338,Fundus Albipunctatus,0.410283505,1,"Biomarker, GeneticVariation"
25886,POC1A,POC1 centriolar protein A,0.0,0.0,1.0,0.0,0.0,3542022,"SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS",0.410283505,1,GeneticVariation
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,3159322,Brachyolmia Type 2,0.410283505,1,"Biomarker, GeneticVariation"
6305,SBF1,SET binding factor 1,0.0,0.0,1.0,0.0,0.0,3695063,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3",0.410283505,1,GeneticVariation
6891,TAP2,"transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)",0.0,1.0,1.0,0.0,0.0,1858266,"Bare Lymphocyte Syndrome, Type I",0.410283505,1,"Biomarker, GeneticVariation"
6892,TAPBP,TAP binding protein (tapasin),0.0,1.0,1.0,0.0,0.0,1858266,"Bare Lymphocyte Syndrome, Type I",0.410283505,1,"Biomarker, GeneticVariation"
9487,PIGL,"phosphatidylinositol glycan anchor biosynthesis, class L",0.0,1.0,1.0,0.0,0.0,1848392,Zunich neuroectodermal syndrome,0.410283505,1,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,1846129,Terminal Osseous Dysplasia and Pigmentary Defects,0.410283505,1,"Biomarker, GeneticVariation"
256297,PTF1A,"pancreas specific transcription factor, 1a",0.0,1.0,1.0,0.0,0.0,1836780,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",0.410283505,2,"Biomarker, GeneticVariation"
3028,HSD17B10,hydroxysteroid (17-beta) dehydrogenase 10,0.0,1.0,1.0,0.0,0.0,1846168,"Mental Retardation, X-Linked, Syndromic 10",0.410283505,1,"Biomarker, GeneticVariation"
1290,COL5A2,"collagen, type V, alpha 2",0.0,1.0,1.0,0.0,0.0,268336,Ehlers-Danlos syndrome type 2,0.410283505,1,"Biomarker, GeneticVariation"
64327,LMBR1,limb development membrane protein 1,0.0,1.0,1.0,0.0,0.0,1868114,"POLYDACTYLY, PREAXIAL II",0.410283505,1,"Biomarker, GeneticVariation"
5618,PRLR,prolactin receptor,0.0,1.0,1.0,0.0,0.0,20514,Hyperprolactinemia,0.410283505,1,"Biomarker, GeneticVariation"
55084,SOBP,sine oculis binding protein homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,3150924,"MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS",0.410283505,1,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,2752042,"Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi",0.410283505,1,"Biomarker, GeneticVariation"
26249,KLHL3,kelch-like family member 3,0.0,0.0,1.0,0.0,0.0,3469605,"PSEUDOHYPOALDOSTERONISM, TYPE IID",0.410283505,2,GeneticVariation
170692,ADAMTS18,"ADAM metallopeptidase with thrombospondin type 1 motif, 18",0.0,0.0,1.0,0.0,0.0,3809567,"MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS",0.410283505,1,GeneticVariation
4598,MVK,mevalonate kinase,0.0,1.0,1.0,0.0,0.0,1867981,"Porokeratosis, disseminated superficial actinic 1",0.410283505,2,"Biomarker, GeneticVariation"
3852,KRT5,"keratin 5, type II",0.0,0.0,1.0,0.0,0.0,79299,Generalized epidermolysis bullosa simplex,0.410283505,1,GeneticVariation
118,ADD1,adducin 1 (alpha),0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.410280477,92,"Biomarker, GeneticVariation"
137492,VPS37A,vacuolar protein sorting 37 homolog A (S. cerevisiae),0.0,0.0,1.0,0.0,0.0,3539494,"SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE",0.41,1,GeneticVariation
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,0.0,1.0,0.0,0.0,1860896,"Colorectal Cancer, Hereditary Nonpolyposis, Type 6",0.41,0,GeneticVariation
10664,CTCF,CCCTC-binding factor (zinc finger protein),0.0,0.0,1.0,0.0,0.0,3809686,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 21",0.41,1,GeneticVariation
51010,EXOSC3,exosome component 3,0.0,0.0,1.0,0.0,0.0,3553449,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1B",0.41,1,GeneticVariation
117144,CATSPER1,"cation channel, sperm associated 1",0.0,1.0,1.0,0.0,0.0,2751811,Spermatogenic Failure 7,0.41,0,"Biomarker, GeneticVariation"
8867,SYNJ1,synaptojanin 1,0.0,0.0,1.0,0.0,0.0,3809824,"PARKINSON DISEASE 20, EARLY-ONSET",0.41,1,GeneticVariation
4054,LTBP3,latent transforming growth factor beta binding protein 3,0.0,1.0,1.0,0.0,0.0,2751297,"Tooth Agenesis, Selective, 6",0.41,0,"Biomarker, GeneticVariation"
10046,MAMLD1,mastermind-like domain containing 1,0.0,1.0,1.0,0.0,0.0,2677879,"Hypospadias 2, X-Linked",0.41,0,"Biomarker, GeneticVariation"
60528,ELAC2,elaC ribonuclease Z 2,0.0,0.0,1.0,0.0,0.0,3539120,"PROSTATE CANCER, HEREDITARY, 2",0.41,0,GeneticVariation
2979,GUCA1B,guanylate cyclase activator 1B (retina),0.0,0.0,1.0,0.0,0.0,3151190,RETINITIS PIGMENTOSA 48,0.41,1,GeneticVariation
5192,PEX10,peroxisomal biogenesis factor 10,0.0,0.0,1.0,0.0,0.0,3553948,PEROXISOME BIOGENESIS DISORDER 6B,0.41,1,GeneticVariation
9409,PEX16,peroxisomal biogenesis factor 16,0.0,0.0,1.0,0.0,0.0,3553960,PEROXISOME BIOGENESIS DISORDER 8B,0.41,1,GeneticVariation
51761,ATP8A2,"ATPase, aminophospholipid transporter, class I, type 8A, member 2",0.0,0.0,1.0,0.0,0.0,3808977,"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4",0.41,1,GeneticVariation
54968,TMEM70,transmembrane protein 70,0.0,0.0,1.0,0.0,0.0,3279699,"Encephalocardiomyopathy, Mitochondrial, Neonatal, Due To Atp Synthase Deficiency",0.41,1,GeneticVariation
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,0.0,1.0,0.0,0.0,1847406,"Digital Arthropathy-Brachydactyly, Familial",0.41,0,GeneticVariation
147912,SIX5,SIX homeobox 5,0.0,0.0,1.0,0.0,0.0,1970479,BRANCHIOOTORENAL SYNDROME 2,0.41,1,GeneticVariation
5159,PDGFRB,"platelet-derived growth factor receptor, beta polypeptide",0.0,0.0,1.0,0.0,0.0,3554321,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4",0.41,0,GeneticVariation
142680,SLC34A3,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 3",0.0,0.0,1.0,0.0,0.0,342645,Autosomal recessive hypophosphatemic bone disease,0.41,2,GeneticVariation
718,C3,complement component 3,0.0,0.0,1.0,0.0,0.0,2752037,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5",0.41,0,GeneticVariation
5332,PLCB4,"phospholipase C, beta 4",0.0,0.0,1.0,0.0,0.0,3553404,AURICULOCONDYLAR SYNDROME 2,0.41,1,GeneticVariation
6658,SOX3,SRY (sex determining region Y)-box 3,0.0,1.0,1.0,0.0,0.0,342376,Panhypopituitarism X-linked,0.41,0,"Biomarker, GeneticVariation"
285848,PNPLA1,patatin-like phospholipase domain containing 1,0.0,0.0,1.0,0.0,0.0,3554355,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10",0.41,1,GeneticVariation
1409,CRYAA,"crystallin, alpha A",0.0,0.0,1.0,0.0,0.0,1858679,"Cataract, Autosomal Dominant",0.41,5,GeneticVariation
64241,ABCG8,"ATP-binding cassette, sub-family G (WHITE), member 8",0.0,1.0,1.0,0.0,0.0,1969115,Gallbladder Disease 4,0.41,0,"Biomarker, GeneticVariation"
11253,MAN1B1,"mannosidase, alpha, class 1B, member 1",0.0,0.0,1.0,0.0,0.0,3280127,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15",0.41,1,GeneticVariation
84665,MYPN,myopalladin,0.0,0.0,1.0,0.0,0.0,3714995,"CARDIOMYOPATHY, DILATED, 1KK",0.41,3,GeneticVariation
3394,IRF8,interferon regulatory factor 8,0.0,0.0,1.0,0.0,0.0,3808589,"CD11C-POSITIVE/CD1C-POSITIVE DENDRITIC CELL DEFICIENCY, AUTOSOMAL DOMINANT",0.41,0,GeneticVariation
272,AMPD3,adenosine monophosphate deaminase 3,0.0,0.0,1.0,0.0,0.0,2752073,Erythrocyte Amp Deaminase Deficiency,0.41,4,GeneticVariation
51004,COQ6,coenzyme Q6 monooxygenase,0.0,0.0,1.0,0.0,0.0,3553349,"COENZYME Q10 DEFICIENCY, PRIMARY, 6",0.41,1,GeneticVariation
392255,GDF6,growth differentiation factor 6,0.0,0.0,1.0,0.0,0.0,3715164,LEBER CONGENITAL AMAUROSIS 17,0.41,0,GeneticVariation
286077,FAM83H,"family with sequence similarity 83, member H",0.0,1.0,1.0,0.0,0.0,399376,"Amelogenesis Imperfecta, Type III",0.41,0,"Biomarker, GeneticVariation"
7385,UQCRC2,ubiquinol-cytochrome c reductase core protein II,0.0,0.0,1.0,0.0,0.0,3554608,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5",0.41,1,GeneticVariation
1889,ECE1,endothelin converting enzyme 1,0.0,0.0,1.0,0.0,0.0,3151237,"Hirschsprung Disease, Cardiac Defects, and Autonomic Dysfunction",0.41,1,GeneticVariation
4340,MOG,myelin oligodendrocyte glycoprotein,0.0,0.0,1.0,0.0,0.0,3280266,NARCOLEPSY 7,0.41,1,GeneticVariation
4604,MYBPC1,"myosin binding protein C, slow type",0.0,0.0,1.0,0.0,0.0,3280526,"ARTHROGRYPOSIS, DISTAL, TYPE 1B",0.41,1,GeneticVariation
871,SERPINH1,"serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)",0.0,1.0,1.0,0.0,0.0,729264,Preterm Premature Rupture of the Membranes,0.41,0,"Biomarker, GeneticVariation"
158326,FREM1,FRAS1 related extracellular matrix 1,0.0,0.0,1.0,0.0,0.0,3280974,TRIGONOCEPHALY 2,0.41,0,GeneticVariation
11311,VPS45,vacuolar protein sorting 45 homolog (S. cerevisiae),0.0,0.0,1.0,0.0,0.0,3809031,"NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE",0.41,1,GeneticVariation
6938,TCF12,transcription factor 12,0.0,0.0,1.0,0.0,0.0,3715051,CRANIOSYNOSTOSIS 3,0.41,2,GeneticVariation
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,0.0,1.0,0.0,0.0,3281191,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13",0.41,5,GeneticVariation
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,1.0,0.0,0.0,1843898,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4,0.41,0,"Biomarker, GeneticVariation"
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,0.0,1.0,0.0,0.0,1843244,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2",0.41,0,GeneticVariation
60,ACTB,"actin, beta",0.0,0.0,1.0,0.0,0.0,1855722,"Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation",0.41,0,GeneticVariation
843,CASP10,"caspase 10, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.41,0,"Biomarker, GeneticVariation"
1962,EHHADH,"enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase",0.0,0.0,1.0,0.0,0.0,3810100,FANCONI RENOTUBULAR SYNDROME 3,0.41,1,GeneticVariation
6566,SLC16A1,"solute carrier family 16 (monocarboxylate transporter), member 1",0.0,1.0,1.0,0.0,0.0,1864902,"Hyperinsulinemic hypoglycemia, familial, 7",0.41,0,"Biomarker, GeneticVariation"
11141,IL1RAPL1,interleukin 1 receptor accessory protein-like 1,0.0,1.0,1.0,0.0,0.0,796227,"MENTAL RETARDATION, X-LINKED 21",0.41,0,"Biomarker, GeneticVariation"
9842,PLEKHM1,"pleckstrin homology domain containing, family M (with RUN domain) member 1",0.0,1.0,1.0,0.0,0.0,1969093,"Osteopetrosis, Autosomal Recessive 6",0.41,0,"Biomarker, GeneticVariation"
763,CA5A,"carbonic anhydrase VA, mitochondrial",0.0,0.0,1.0,0.0,0.0,3810404,"CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO",0.41,1,GeneticVariation
23594,ORC6,"origin recognition complex, subunit 6",0.0,0.0,1.0,0.0,0.0,3151113,MEIER-GORLIN SYNDROME 3,0.41,1,GeneticVariation
3675,ITGA3,"integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)",0.0,0.0,1.0,0.0,0.0,3553636,"INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL",0.41,1,GeneticVariation
55505,NOP10,NOP10 ribonucleoprotein,0.0,0.0,1.0,0.0,0.0,1857144,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 1",0.41,1,GeneticVariation
57716,PRX,periaxin,0.0,0.0,1.0,0.0,0.0,3540453,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F",0.41,1,GeneticVariation
22861,NLRP1,"NLR family, pyrin domain containing 1",0.0,0.0,1.0,0.0,0.0,3808876,CORNEAL INTRAEPITHELIAL DYSKERATOSIS AND ECTODERMAL DYSPLASIA,0.41,1,GeneticVariation
1615,DARS,aspartyl-tRNA synthetase,0.0,0.0,1.0,0.0,0.0,3809008,HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY,0.41,1,GeneticVariation
191,AHCY,adenosylhomocysteinase,0.0,0.0,1.0,0.0,0.0,3151058,Hypermethioninemia with Deficiency of S-Adenosylhomocysteine Hydrolase,0.41,2,GeneticVariation
60529,ALX4,ALX homeobox 4,0.0,1.0,1.0,0.0,0.0,3150703,FRONTONASAL DYSPLASIA 2,0.41,0,"Biomarker, GeneticVariation"
10345,TRDN,triadin,0.0,0.0,1.0,0.0,0.0,3809536,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS",0.41,1,GeneticVariation
3854,KRT6B,"keratin 6B, type II",0.0,0.0,1.0,0.0,0.0,3714949,PACHYONYCHIA CONGENITA 4,0.41,1,GeneticVariation
3207,HOXA11,homeobox A11,0.0,1.0,1.0,0.0,0.0,1854273,Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia,0.41,1,"Biomarker, GeneticVariation"
1785,DNM2,dynamin 2,0.0,0.0,1.0,0.0,0.0,3809272,LETHAL CONGENITAL CONTRACTURE SYNDROME 5,0.41,0,GeneticVariation
10908,PNPLA6,patatin-like phospholipase domain containing 6,0.0,0.0,1.0,0.0,0.0,1859093,"Chorioretinal Dystrophy, Spinocerebellar Ataxia, and Hypogonadotropic Hypogonadism",0.41,0,GeneticVariation
126326,GIPC3,"GIPC PDZ domain containing family, member 3",0.0,0.0,1.0,0.0,0.0,1866094,"Deafness, Autosomal Recessive 15",0.41,2,GeneticVariation
7681,MKRN3,makorin ring finger protein 3,0.0,0.0,1.0,0.0,0.0,3809199,"PRECOCIOUS PUBERTY, CENTRAL, 2",0.41,1,GeneticVariation
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.41,3,Biomarker
57379,AICDA,activation-induced cytidine deaminase,0.0,0.0,1.0,0.0,0.0,1720956,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2",0.41,2,GeneticVariation
80184,CEP290,centrosomal protein 290kDa,0.0,1.0,1.0,0.0,0.0,1970161,"Meckel Syndrome, Type 4",0.41,0,"Biomarker, GeneticVariation"
2898,GRIK2,"glutamate receptor, ionotropic, kainate 2",0.0,1.0,1.0,0.0,0.0,1970198,"Mental Retardation, Autosomal Recessive 6",0.41,0,"Biomarker, GeneticVariation"
3588,IL10RB,"interleukin 10 receptor, beta",0.0,1.0,1.0,0.0,0.0,2675508,"Inflammatory Bowel Disease 25, Autosomal Recessive",0.41,0,"Biomarker, GeneticVariation"
84433,CARD11,"caspase recruitment domain family, member 11",0.0,0.0,1.0,0.0,0.0,1847973,Persistent Polyclonal B-Cell Lymphocytosis,0.41,1,GeneticVariation
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,0.0,1.0,0.0,0.0,3553859,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12",0.41,0,GeneticVariation
10559,SLC35A1,"solute carrier family 35 (CMP-sialic acid transporter), member A1",0.0,1.0,1.0,0.0,0.0,1970344,"Congenital Disorder Of Glycosylation, Type IIF",0.41,0,"Biomarker, GeneticVariation"
25923,ATL3,atlastin GTPase 3,0.0,0.0,1.0,0.0,0.0,3810194,"NEUROPATHY, HEREDITARY SENSORY, TYPE IF",0.41,1,GeneticVariation
1848,DUSP6,dual specificity phosphatase 6,0.0,0.0,1.0,0.0,0.0,3808981,HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA,0.41,1,GeneticVariation
54704,PDP1,pyruvate dehyrogenase phosphatase catalytic subunit 1,0.0,1.0,1.0,0.0,0.0,1837429,Pyruvate dehydrogenase phosphatase deficiency,0.41,0,"Biomarker, GeneticVariation"
10021,HCN4,hyperpolarization activated cyclic nucleotide gated potassium channel 4,0.0,1.0,1.0,0.0,0.0,2751083,Brugada Syndrome 8,0.41,0,"Biomarker, GeneticVariation"
5885,RAD21,RAD21 homolog (S. pombe),0.0,0.0,1.0,0.0,0.0,3553517,CORNELIA DE LANGE SYNDROME 4,0.41,1,GeneticVariation
123624,AGBL1,ATP/GTP binding protein-like 1,0.0,0.0,1.0,0.0,0.0,3809798,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8",0.41,1,GeneticVariation
28962,OSTM1,osteopetrosis associated transmembrane protein 1,0.0,1.0,1.0,0.0,0.0,1968603,"Osteopetrosis, Autosomal Recessive 5",0.41,0,"Biomarker, GeneticVariation"
6487,ST3GAL3,"ST3 beta-galactoside alpha-2,3-sialyltransferase 3",0.0,0.0,1.0,0.0,0.0,3554316,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15",0.41,0,GeneticVariation
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,36489,Sea-Blue Histiocyte Syndrome,0.41,1,"Biomarker, GeneticVariation"
81545,FBXO38,F-box protein 38,0.0,0.0,1.0,0.0,0.0,3711384,"Distal Hereditary Motor Neuropathy, Type Ii",0.41,1,GeneticVariation
113612,CYP2U1,"cytochrome P450, family 2, subfamily U, polypeptide 1",0.0,0.0,1.0,0.0,0.0,3539507,"SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE",0.41,1,GeneticVariation
83544,DNAL1,"dynein, axonemal, light chain 1",0.0,0.0,1.0,0.0,0.0,3151460,"CILIARY DYSKINESIA, PRIMARY, 16",0.41,1,GeneticVariation
492,ATP2B3,"ATPase, Ca++ transporting, plasma membrane 3",0.0,0.0,1.0,0.0,0.0,796205,"Spinocerebellar Ataxia, X-Linked 1",0.41,1,GeneticVariation
284086,NEK8,NIMA-related kinase 8,0.0,0.0,1.0,0.0,0.0,3151188,NEPHRONOPHTHISIS 9,0.41,1,GeneticVariation
4514,COX3,cytochrome c oxidase III,0.0,0.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.41,1,GeneticVariation
4536,ND2,MTND2,0.0,0.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.41,0,GeneticVariation
9657,IQCB1,IQ motif containing B1,0.0,1.0,1.0,0.0,0.0,1836517,Senior-Loken Syndrome 5,0.41,0,"Biomarker, GeneticVariation"
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,0.0,1.0,0.0,0.0,3280587,"AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE",0.41,1,GeneticVariation
3516,RBPJ,recombination signal binding protein for immunoglobulin kappa J region,0.0,0.0,1.0,0.0,0.0,3553748,ADAMS-OLIVER SYNDROME 3,0.41,1,GeneticVariation
5949,RBP3,"retinol binding protein 3, interstitial",0.0,0.0,1.0,0.0,0.0,3715216,RETINITIS PIGMENTOSA 66,0.41,1,GeneticVariation
8924,HERC2,HECT and RLD domain containing E3 ubiquitin protein ligase 2,0.0,0.0,1.0,0.0,0.0,3809753,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38",0.41,1,GeneticVariation
2521,FUS,FUS RNA binding protein,0.0,1.0,1.0,0.0,0.0,2750729,"Amyotrophic Lateral Sclerosis 6, Autosomal Recessive",0.41,0,"Biomarker, GeneticVariation"
1646,AKR1C2,"aldo-keto reductase family 1, member C2",0.0,0.0,1.0,0.0,0.0,1839840,"Male Pseudohermaphroditism due to Deficiency of Testicular 17,20-Desmolase",0.41,1,GeneticVariation
55703,POLR3B,polymerase (RNA) III (DNA directed) polypeptide B,0.0,0.0,1.0,0.0,0.0,3280644,"LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM",0.41,3,GeneticVariation
5002,SLC22A18,"solute carrier family 22, member 18",0.0,0.0,1.0,0.0,0.0,684249,Carcinoma of lung,0.41,1,GeneticVariation
22995,CEP152,centrosomal protein 152kDa,0.0,0.0,1.0,0.0,0.0,3553886,"MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE",0.41,0,GeneticVariation
658,BMPR1B,"bone morphogenetic protein receptor, type IB",0.0,1.0,1.0,0.0,0.0,1836182,"Chondrodysplasia, acromesomelic, with genital anomalies",0.41,1,"Biomarker, GeneticVariation"
5145,PDE6A,"phosphodiesterase 6A, cGMP-specific, rod, alpha",0.0,0.0,1.0,0.0,0.0,3151139,RETINITIS PIGMENTOSA 43,0.41,2,GeneticVariation
80185,TTI2,TELO2 interacting protein 2,0.0,0.0,1.0,0.0,0.0,3809853,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39",0.41,1,GeneticVariation
10269,ZMPSTE24,zinc metallopeptidase STE24,0.0,1.0,1.0,0.0,0.0,406585,"Tight skin contracture syndrome, lethal",0.41,0,"Biomarker, GeneticVariation"
6597,SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",0.0,1.0,1.0,0.0,0.0,2750074,Rhabdoid Tumor Predisposition Syndrome 2,0.41,0,"Biomarker, GeneticVariation"
26504,CNNM4,cyclin and CBS domain divalent metal cation transport mediator 4,0.0,1.0,1.0,0.0,0.0,1857588,Amaurosis hypertrichosis,0.41,0,"Biomarker, GeneticVariation"
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,0.0,1.0,1.0,0.0,0.0,1843478,Lethal Congenital Contracture Syndrome 2,0.41,0,"Biomarker, GeneticVariation"
1106,CHD2,chromodomain helicase DNA binding protein 2,0.0,0.0,1.0,0.0,0.0,3809278,"EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET",0.41,1,GeneticVariation
285203,EOGT,EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase,0.0,0.0,1.0,0.0,0.0,3809092,ADAMS-OLIVER SYNDROME 4,0.41,1,GeneticVariation
5339,PLEC,plectin,0.0,1.0,1.0,0.0,0.0,3150989,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q",0.41,0,"Biomarker, GeneticVariation"
22891,ZNF365,zinc finger protein 365,0.0,1.0,1.0,0.0,0.0,2700426,"NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO",0.41,0,"Biomarker, GeneticVariation"
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,0.0,1.0,0.0,0.0,3279885,Hereditary Sensory and Autonomic Neuropathy Type Ie,0.41,0,GeneticVariation
3800,KIF5C,kinesin family member 5C,0.0,0.0,1.0,0.0,0.0,3809013,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2",0.41,1,GeneticVariation
1906,EDN1,endothelin 1,0.0,0.0,1.0,0.0,0.0,3810332,AURICULOCONDYLAR SYNDROME 3,0.41,0,GeneticVariation
23568,ARL2BP,ADP-ribosylation factor-like 2 binding protein,0.0,0.0,1.0,0.0,0.0,3809503,RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS,0.41,1,GeneticVariation
10329,TMEM5,transmembrane protein 5,0.0,0.0,1.0,0.0,0.0,3554381,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 10",0.41,1,GeneticVariation
1763,DNA2,DNA replication helicase/nuclease 2,0.0,0.0,1.0,0.0,0.0,3554599,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 6",0.41,1,GeneticVariation
545,ATR,ATR serine/threonine kinase,0.0,0.0,1.0,0.0,0.0,3281203,"CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL",0.41,1,GeneticVariation
57674,RNF213,ring finger protein 213,0.0,0.0,1.0,0.0,0.0,1846689,Moyamoya disease 2,0.41,1,GeneticVariation
6391,SDHC,"succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa",0.0,1.0,1.0,0.0,0.0,1854336,Paragangliomas 3,0.41,0,"Biomarker, GeneticVariation"
55858,TMEM165,transmembrane protein 165,0.0,0.0,1.0,0.0,0.0,3553571,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk",0.41,1,GeneticVariation
80326,WNT10A,"wingless-type MMTV integration site family, member 10A",0.0,0.0,1.0,0.0,0.0,1835492,"Tooth Agenesis, Selective, 4",0.41,0,GeneticVariation
2937,GSS,glutathione synthetase,0.0,1.0,1.0,0.0,0.0,1856399,"Glutathione Synthetase Deficiency of Erythrocytes, Hemolytic Anemia due to",0.41,0,"Biomarker, GeneticVariation"
242,ALOX12B,"arachidonate 12-lipoxygenase, 12R type",0.0,1.0,1.0,0.0,0.0,1855792,"Ichthyosiform erythroderma, Brocq congenital, nonbullous form",0.41,0,"Biomarker, GeneticVariation"
1298,COL9A2,"collagen, type IX, alpha 2",0.0,1.0,1.0,0.0,0.0,1838429,"Epiphyseal dysplasia, multiple, 2",0.41,0,"Biomarker, GeneticVariation"
146057,TTBK2,tau tubulin kinase 2,0.0,1.0,1.0,0.0,0.0,1858351,Spinocerebellar Ataxia 11,0.41,0,"Biomarker, GeneticVariation"
5075,PAX1,paired box 1,0.0,0.0,1.0,0.0,0.0,3714942,OTOFACIOCERVICAL SYNDROME 2,0.41,1,GeneticVariation
3426,CFI,complement factor I,0.0,0.0,1.0,0.0,0.0,2752039,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3",0.41,0,GeneticVariation
54414,SIAE,sialic acid acetylesterase,0.0,0.0,1.0,0.0,0.0,3150797,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6",0.41,1,GeneticVariation
11151,CORO1A,"coronin, actin binding protein, 1A",0.0,0.0,1.0,0.0,0.0,3809383,IMMUNODEFICIENCY 8,0.41,1,GeneticVariation
55526,DHTKD1,dehydrogenase E1 and transketolase domain containing 1,0.0,0.0,1.0,0.0,0.0,1859817,2-AMINOADIPIC 2-OXOADIPIC ACIDURIA,0.41,1,GeneticVariation
5424,POLD1,"polymerase (DNA directed), delta 1, catalytic subunit",0.0,0.0,1.0,0.0,0.0,2675481,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 10",0.41,2,GeneticVariation
80776,B9D2,B9 protein domain 2,0.0,0.0,1.0,0.0,0.0,3280036,"MECKEL SYNDROME, TYPE 10",0.41,1,GeneticVariation
1258,CNGB1,cyclic nucleotide gated channel beta 1,0.0,0.0,1.0,0.0,0.0,3151066,RETINITIS PIGMENTOSA 45,0.41,1,GeneticVariation
8818,DPM2,"dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit",0.0,0.0,1.0,0.0,0.0,3554385,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu",0.41,1,GeneticVariation
84059,GPR98,G protein-coupled receptor 98,0.0,1.0,1.0,0.0,0.0,1858493,"Febrile Convulsions, Familial, 4",0.41,0,"Biomarker, GeneticVariation"
317719,KLHL10,kelch-like family member 10,0.0,0.0,1.0,0.0,0.0,3554453,SPERMATOGENIC FAILURE 11,0.41,1,GeneticVariation
6229,RPS24,ribosomal protein S24,0.0,1.0,1.0,0.0,0.0,1857719,"Anemia, Diamond-Blackfan, 3",0.41,0,"Biomarker, GeneticVariation"
51079,NDUFA13,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13",0.0,1.0,1.0,0.0,0.0,749424,"Thyroid cancer, Hurthle cell",0.41,0,"Biomarker, GeneticVariation"
51135,IRAK4,interleukin-1 receptor-associated kinase 4,0.0,1.0,1.0,0.0,0.0,1835828,"Invasive Pneumococcal Disease, Recurrent Isolated, 1",0.41,0,"Biomarker, GeneticVariation"
1288,COL4A6,"collagen, type IV, alpha 6",0.0,0.0,1.0,0.0,0.0,3806737,"DEAFNESS, X-LINKED 6",0.41,1,GeneticVariation
440435,GPR179,G protein-coupled receptor 179,0.0,0.0,1.0,0.0,0.0,3281215,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E",0.41,2,GeneticVariation
1630,DCC,DCC netrin 1 receptor,0.0,1.0,1.0,0.0,0.0,1834870,MIRROR MOVEMENTS 1,0.41,0,"Biomarker, GeneticVariation"
8517,IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma",0.0,1.0,1.0,0.0,0.0,1845919,"Ectodermal Dysplasia, Anhidrotic, with Immunodeficiency, Osteopetrosis, and Lymphedema",0.41,0,"Biomarker, GeneticVariation"
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,1.0,0.0,0.0,750384,Coumarin Resistance,0.41,0,"Biomarker, GeneticVariation"
2158,F9,coagulation factor IX,0.0,1.0,1.0,0.0,0.0,750384,Coumarin Resistance,0.41,0,"Biomarker, GeneticVariation"
26128,KIAA1279,KIAA1279,0.0,1.0,1.0,0.0,0.0,1836123,Goldberg-Shprintzen megacolon syndrome,0.41,1,"Biomarker, GeneticVariation"
51181,DCXR,dicarbonyl/L-xylulose reductase,0.0,1.0,1.0,0.0,0.0,268162,Pentosuria,0.41,0,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,0.0,1.0,0.0,0.0,3281247,BENT BONE DYSPLASIA SYNDROME,0.41,0,GeneticVariation
7043,TGFB3,"transforming growth factor, beta 3",0.0,0.0,1.0,0.0,0.0,3810012,RIENHOFF SYNDROME,0.41,1,GeneticVariation
81620,CDT1,chromatin licensing and DNA replication factor 1,0.0,0.0,1.0,0.0,0.0,3151120,MEIER-GORLIN SYNDROME 4,0.41,2,GeneticVariation
79188,TMEM43,transmembrane protein 43,0.0,0.0,1.0,0.0,0.0,3553060,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT",0.41,0,GeneticVariation
112744,IL17F,interleukin 17F,0.0,0.0,1.0,0.0,0.0,3151405,"CANDIDIASIS, FAMILIAL, 6",0.41,1,GeneticVariation
23556,PIGN,"phosphatidylinositol glycan anchor biosynthesis, class N",0.0,0.0,1.0,0.0,0.0,3279775,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1,0.41,1,GeneticVariation
779,CACNA1S,"calcium channel, voltage-dependent, L type, alpha 1S subunit",0.0,1.0,1.0,0.0,0.0,2930984,Malignant hyperthermia susceptibility type 5,0.41,0,"Biomarker, GeneticVariation"
63976,PRDM16,PR domain containing 16,0.0,0.0,1.0,0.0,0.0,3809288,LEFT VENTRICULAR NONCOMPACTION 8,0.41,1,GeneticVariation
111,ADCY5,adenylate cyclase 5,0.0,0.0,1.0,0.0,0.0,1847627,"Dyskinesia, Familial, with Facial Myokymia",0.41,1,GeneticVariation
23189,KANK1,KN motif and ankyrin repeat domains 1,0.0,1.0,1.0,0.0,0.0,2752061,"Cerebral Palsy, Spastic Quadriplegic, 2",0.41,0,"Biomarker, GeneticVariation"
29760,BLNK,B-cell linker,0.0,1.0,1.0,0.0,0.0,3150752,"AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE",0.41,0,"Biomarker, GeneticVariation"
731,C8A,"complement component 8, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,3151081,"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I",0.41,0,"Biomarker, GeneticVariation"
10382,TUBB4A,"tubulin, beta 4A class IVa",0.0,0.0,1.0,0.0,0.0,1851943,Dystonia musculorum deformans 4,0.41,0,GeneticVariation
284403,WDR62,WD repeat domain 62,0.0,0.0,1.0,0.0,0.0,1858535,"MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS",0.41,3,GeneticVariation
60681,FKBP10,"FK506 binding protein 10, 65 kDa",0.0,0.0,1.0,0.0,0.0,1850168,Bruck syndrome 1,0.41,1,GeneticVariation
5149,PDE6H,"phosphodiesterase 6H, cGMP-specific, cone, gamma",0.0,1.0,1.0,0.0,0.0,1864900,Retinal Cone Dystrophy 3A,0.41,0,"Biomarker, GeneticVariation"
1181,CLCN2,"chloride channel, voltage-sensitive 2",0.0,0.0,1.0,0.0,0.0,3810242,LEUKOENCEPHALOPATHY WITH ATAXIA,0.41,1,GeneticVariation
29119,CTNNA3,"catenin (cadherin-associated protein), alpha 3",0.0,0.0,1.0,0.0,0.0,3810138,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13",0.41,1,GeneticVariation
2070,EYA4,EYA transcriptional coactivator and phosphatase 4,0.0,1.0,1.0,0.0,0.0,1854368,"Cardiomyopathy, Dilated, 1J",0.41,0,"Biomarker, GeneticVariation"
345,APOC3,apolipoprotein C-III,0.0,0.0,1.0,0.0,0.0,3151467,Apolipoprotein C-III Deficiency,0.41,1,GeneticVariation
24148,PRPF6,pre-mRNA processing factor 6,0.0,0.0,1.0,0.0,0.0,3151434,RETINITIS PIGMENTOSA 60,0.41,1,GeneticVariation
54919,DNAAF5,"dynein, axonemal, assembly factor 5",0.0,0.0,1.0,0.0,0.0,3543825,"CILIARY DYSKINESIA, PRIMARY, 18",0.41,1,GeneticVariation
5604,MAP2K1,mitogen-activated protein kinase kinase 1,0.0,0.0,1.0,0.0,0.0,3809006,CARDIOFACIOCUTANEOUS SYNDROME 3,0.41,2,GeneticVariation
1134,CHRNA1,"cholinergic receptor, nicotinic, alpha 1 (muscle)",0.0,0.0,1.0,0.0,0.0,751885,"MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL",0.41,0,GeneticVariation
1140,CHRNB1,"cholinergic receptor, nicotinic, beta 1 (muscle)",0.0,0.0,1.0,0.0,0.0,751885,"MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL",0.41,2,GeneticVariation
1144,CHRND,"cholinergic receptor, nicotinic, delta (muscle)",0.0,0.0,1.0,0.0,0.0,751885,"MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL",0.41,0,GeneticVariation
6853,SYN1,synapsin I,0.0,1.0,1.0,0.0,0.0,1845343,"Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders",0.41,0,"Biomarker, GeneticVariation"
8822,FGF17,fibroblast growth factor 17,0.0,0.0,1.0,0.0,0.0,3808983,HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA,0.41,1,GeneticVariation
10699,CORIN,"corin, serine peptidase",0.0,0.0,1.0,0.0,0.0,3281288,PREECLAMPSIA/ECLAMPSIA 5,0.41,1,GeneticVariation
9524,TECR,"trans-2,3-enoyl-CoA reductase",0.0,0.0,1.0,0.0,0.0,3151462,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14",0.41,1,GeneticVariation
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,0.0,1.0,0.0,0.0,1970859,"Atypical Mycobacteriosis, Familial, X-Linked 2",0.41,0,GeneticVariation
79809,TTC21B,tetratricopeptide repeat domain 21B,0.0,0.0,1.0,0.0,0.0,3151186,NEPHRONOPHTHISIS 12,0.41,0,GeneticVariation
5663,PSEN1,presenilin 1,0.0,1.0,1.0,0.0,0.0,1843015,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",0.41,0,"Biomarker, GeneticVariation"
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,0.0,1.0,0.0,0.0,1845546,FG SYNDROME 4,0.41,0,GeneticVariation
55737,VPS35,vacuolar protein sorting 35 homolog (S. cerevisiae),0.0,0.0,1.0,0.0,0.0,3280133,PARKINSON DISEASE 17,0.41,1,GeneticVariation
5832,ALDH18A1,"aldehyde dehydrogenase 18 family, member A1",0.0,0.0,1.0,0.0,0.0,268354,De Barsy syndrome,0.41,2,GeneticVariation
1123,CHN1,chimerin 1,0.0,0.0,1.0,0.0,0.0,751083,DUANE RETRACTION SYNDROME 2,0.41,1,GeneticVariation
54928,IMPAD1,inositol monophosphatase domain containing 1,0.0,0.0,1.0,0.0,0.0,3279757,"CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE",0.41,1,GeneticVariation
4359,MPZ,myelin protein zero,0.0,0.0,1.0,0.0,0.0,205713,Hereditary areflexic dystasia,0.41,0,GeneticVariation
4618,MYF6,myogenic factor 6 (herculin),0.0,0.0,1.0,0.0,0.0,3280703,"MYOPATHY, CENTRONUCLEAR, 3",0.41,1,GeneticVariation
9427,ECEL1,endothelin converting enzyme-like 1,0.0,0.0,1.0,0.0,0.0,3554415,"ARTHROGRYPOSIS, DISTAL, TYPE 5D",0.41,4,GeneticVariation
83636,C19orf12,chromosome 19 open reading frame 12,0.0,0.0,1.0,0.0,0.0,3280371,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4,0.41,0,GeneticVariation
51741,WWOX,WW domain containing oxidoreductase,0.0,0.0,1.0,0.0,0.0,3280452,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12",0.41,1,GeneticVariation
9622,KLK4,kallikrein-related peptidase 4,0.0,1.0,1.0,0.0,0.0,1290537,Amelogenesis imperfecta pigmented hypomaturation type,0.41,0,"Biomarker, GeneticVariation"
91662,NLRP12,"NLR family, pyrin domain containing 12",0.0,1.0,1.0,0.0,0.0,2673198,Familial Cold Autoinflammatory Syndrome 2,0.41,0,"Biomarker, GeneticVariation"
1299,COL9A3,"collagen, type IX, alpha 3",0.0,1.0,1.0,0.0,0.0,1832998,"Epiphyseal dysplasia, multiple, 3",0.41,0,"Biomarker, GeneticVariation"
57609,DIP2B,DIP2 disco-interacting protein 2 homolog B (Drosophila),0.0,1.0,1.0,0.0,0.0,1969893,"Mental Retardation, Fra12a Type",0.41,0,"Biomarker, GeneticVariation"
112476,PRRT2,proline-rich transmembrane protein 2,0.0,0.0,1.0,0.0,0.0,1853995,"Convulsions, Benign Familial Infantile, 2",0.41,0,GeneticVariation
9570,GOSR2,golgi SNAP receptor complex member 2,0.0,0.0,1.0,0.0,0.0,3279627,"EPILEPSY, PROGRESSIVE MYOCLONIC 6",0.41,1,GeneticVariation
6469,SHH,sonic hedgehog,0.0,1.0,1.0,0.0,0.0,1968843,"Microphthalmia, Isolated, with Coloboma 5",0.41,0,"Biomarker, GeneticVariation"
1284,COL4A2,"collagen, type IV, alpha 2",0.0,0.0,1.0,0.0,0.0,3280970,PORENCEPHALY 2,0.41,1,GeneticVariation
10749,KIF1C,kinesin family member 1C,0.0,0.0,1.0,0.0,0.0,1969796,"Ataxia, Spastic, 2, Autosomal Recessive",0.41,1,GeneticVariation
2318,FLNC,"filamin C, gamma",0.0,1.0,1.0,0.0,0.0,1836050,"Filaminopathy, autosomal dominant",0.41,0,"Biomarker, GeneticVariation"
2767,GNA11,"guanine nucleotide binding protein (G protein), alpha 11 (Gq class)",0.0,0.0,1.0,0.0,0.0,1840347,"Hypocalciuric hypercalcemia, familial, type 2",0.41,0,GeneticVariation
4891,SLC11A2,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2",0.0,1.0,1.0,0.0,0.0,2673913,"Anemia, Hypochromic Microcytic, With Iron Overload",0.41,0,"Biomarker, GeneticVariation"
344018,FIGLA,folliculogenesis specific basic helix-loop-helix,0.0,1.0,1.0,0.0,0.0,2676742,Premature Ovarian Failure 6,0.41,0,"Biomarker, GeneticVariation"
3703,STT3A,"STT3A, subunit of the oligosaccharyltransferase complex (catalytic)",0.0,0.0,1.0,0.0,0.0,3810062,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw",0.41,1,GeneticVariation
1528,CYB5A,cytochrome b5 type A (microsomal),0.0,1.0,1.0,0.0,0.0,2673427,Methemoglobinemia Type IV,0.41,0,"Biomarker, GeneticVariation"
9197,SLC33A1,"solute carrier family 33 (acetyl-CoA transporter), member 1",0.0,0.0,1.0,0.0,0.0,3280965,"CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION",0.41,0,GeneticVariation
25778,DSTYK,dual serine/threonine and tyrosine protein kinase,0.0,0.0,1.0,0.0,0.0,1835826,"Renal Hypodysplasia, Nonsyndromic, 1",0.41,1,GeneticVariation
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,0.0,1.0,0.0,0.0,3554449,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 19",0.41,0,GeneticVariation
79695,GALNT12,polypeptide N-acetylgalactosaminyltransferase 12,0.0,0.0,1.0,0.0,0.0,1837315,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 1",0.41,2,GeneticVariation
3796,KIF2A,kinesin heavy chain member 2A,0.0,0.0,1.0,0.0,0.0,3809414,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3",0.41,1,GeneticVariation
6635,SNRPE,small nuclear ribonucleoprotein polypeptide E,0.0,0.0,1.0,0.0,0.0,3554409,HYPOTRICHOSIS 11,0.41,1,GeneticVariation
79583,TMEM231,transmembrane protein 231,0.0,0.0,1.0,0.0,0.0,3809352,"MECKEL SYNDROME, TYPE 11",0.41,0,GeneticVariation
11277,TREX1,three prime repair exonuclease 1,0.0,1.0,1.0,0.0,0.0,1860518,"Vasculopathy, Retinal, With Cerebral Leukodystrophy",0.41,0,"Biomarker, GeneticVariation"
4141,MARS,methionyl-tRNA synthetase,0.0,0.0,1.0,0.0,0.0,3809651,INFANTILE LIVER FAILURE SYNDROME 2,0.41,1,GeneticVariation
23236,PLCB1,"phospholipase C, beta 1 (phosphoinositide-specific)",0.0,1.0,1.0,0.0,0.0,3150988,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12",0.41,0,"Biomarker, GeneticVariation"
200205,IBA57,"IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae)",0.0,0.0,1.0,0.0,0.0,3809165,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3,0.41,1,GeneticVariation
57128,LYRM4,LYR motif containing 4,0.0,0.0,1.0,0.0,0.0,3810055,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19,0.41,1,GeneticVariation
55135,WRAP53,"WD repeat containing, antisense to TP53",0.0,0.0,1.0,0.0,0.0,3151442,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3",0.41,1,GeneticVariation
388389,CCDC103,coiled-coil domain containing 103,0.0,0.0,1.0,0.0,0.0,3542550,"CILIARY DYSKINESIA, PRIMARY, 17",0.41,1,GeneticVariation
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,0.0,1.0,0.0,0.0,3809645,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5",0.41,1,GeneticVariation
5165,PDK3,"pyruvate dehydrogenase kinase, isozyme 3",0.0,0.0,1.0,0.0,0.0,3806702,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6",0.41,1,GeneticVariation
5191,PEX7,peroxisomal biogenesis factor 7,0.0,0.0,1.0,0.0,0.0,2749346,"Refsum Disease, Adult, 2",0.41,0,GeneticVariation
57582,KCNT1,"potassium channel, sodium activated subfamily T, member 1",0.0,0.0,1.0,0.0,0.0,3554195,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14",0.41,0,GeneticVariation
259232,NALCN,"sodium leak channel, non selective",0.0,0.0,1.0,0.0,0.0,3809454,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES",0.41,1,GeneticVariation
29940,DSE,dermatan sulfate epimerase,0.0,0.0,1.0,0.0,0.0,3809845,"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 2",0.41,1,GeneticVariation
1687,DFNA5,"deafness, autosomal dominant 5",0.0,1.0,1.0,0.0,0.0,1832932,"Deafness, Autosomal Dominant 5",0.41,0,"Biomarker, GeneticVariation"
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,0.0,1.0,0.0,0.0,3279791,"SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO",0.41,0,GeneticVariation
54716,SLC6A20,"solute carrier family 6 (proline IMINO transporter), member 20",0.0,1.0,1.0,0.0,0.0,543541,Glycinuria with or without Oxalate Urolithiasis,0.41,0,"Biomarker, GeneticVariation"
2187,FANCB,"Fanconi anemia, complementation group B",0.0,1.0,1.0,0.0,0.0,1845292,"Fanconi Anemia, Complementation Group B",0.41,0,"Biomarker, GeneticVariation"
919,CD247,CD247 molecule,0.0,1.0,1.0,0.0,0.0,1857798,Immunodeficiency due to Defect in CD3-Zeta,0.41,0,"Biomarker, GeneticVariation"
57094,CPA6,carboxypeptidase A6,0.0,0.0,1.0,0.0,0.0,3280734,"FEBRILE SEIZURES, FAMILIAL, 11",0.41,0,GeneticVariation
55690,PACS1,phosphofurin acidic cluster sorting protein 1,0.0,0.0,1.0,0.0,0.0,3554343,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 17",0.41,1,GeneticVariation
91624,NEXN,nexilin (F actin binding protein),0.0,0.0,1.0,0.0,0.0,3151267,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20",0.41,0,GeneticVariation
4337,MOCS1,molybdenum cofactor synthesis 1,0.0,0.0,1.0,0.0,0.0,1854988,"Molybdenum Cofactor Deficiency, Complementation Group A",0.41,3,GeneticVariation
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,1.0,0.0,0.0,1857034,"Ehlers-Danlos syndrome, cardiac valvular form",0.41,1,"Biomarker, GeneticVariation"
10295,BCKDK,branched chain ketoacid dehydrogenase kinase,0.0,0.0,1.0,0.0,0.0,3554078,BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY,0.41,2,GeneticVariation
2214,FCGR3A,"Fc fragment of IgG, low affinity IIIa, receptor (CD16a)",0.0,0.0,1.0,0.0,0.0,3810342,IMMUNODEFICIENCY 20,0.41,1,GeneticVariation
55717,WDR11,WD repeat domain 11,0.0,0.0,1.0,0.0,0.0,3540450,HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA,0.41,1,GeneticVariation
3741,KCNA5,"potassium channel, voltage gated shaker related subfamily A, member 5",0.0,1.0,1.0,0.0,0.0,2677106,"Atrial Fibrillation, Familial, 7",0.41,0,"Biomarker, GeneticVariation"
2318,FLNC,"filamin C, gamma",0.0,0.0,1.0,0.0,0.0,3279722,"MYOPATHY, DISTAL, 4",0.41,1,GeneticVariation
91574,C12orf65,chromosome 12 open reading frame 65,0.0,1.0,1.0,0.0,0.0,3150801,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7,0.41,0,"Biomarker, GeneticVariation"
164045,HFM1,"HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae)",0.0,0.0,1.0,0.0,0.0,3810376,PREMATURE OVARIAN FAILURE 9,0.41,1,GeneticVariation
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,1.0,0.0,0.0,2751584,Neurodegeneration Due To Cerebral Folate Transport Deficiency,0.41,0,"Biomarker, GeneticVariation"
1272,CNTN1,contactin 1,0.0,1.0,1.0,0.0,0.0,2675527,"Myopathy, Congenital, Compton-North",0.41,0,"Biomarker, GeneticVariation"
22897,CEP164,centrosomal protein 164kDa,0.0,0.0,1.0,0.0,0.0,3541853,NEPHRONOPHTHISIS 15,0.41,1,GeneticVariation
27315,PGAP2,post-GPI attachment to proteins 2,0.0,0.0,1.0,0.0,0.0,3280153,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3,0.41,2,GeneticVariation
3777,KCNK3,"potassium channel, two pore domain subfamily K, member 3",0.0,0.0,1.0,0.0,0.0,3809198,"PULMONARY HYPERTENSION, PRIMARY, 4",0.41,1,GeneticVariation
726,CAPN5,calpain 5,0.0,0.0,1.0,0.0,0.0,1860404,"VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY",0.41,1,GeneticVariation
6709,SPTAN1,"spectrin, alpha, non-erythrocytic 1",0.0,1.0,1.0,0.0,0.0,3150731,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5",0.41,0,"Biomarker, GeneticVariation"
201973,PRIMPOL,primase and polymerase (DNA-directed),0.0,0.0,1.0,0.0,0.0,3809464,"MYOPIA 22, AUTOSOMAL DOMINANT",0.41,1,GeneticVariation
5826,ABCD4,"ATP-binding cassette, sub-family D (ALD), member 4",0.0,0.0,1.0,0.0,0.0,3553915,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE",0.41,1,GeneticVariation
3181,HNRNPA2B1,heterogeneous nuclear ribonucleoprotein A2/B1,0.0,0.0,1.0,0.0,0.0,3809468,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2,0.41,1,GeneticVariation
51520,LARS,leucyl-tRNA synthetase,0.0,0.0,1.0,0.0,0.0,3809522,INFANTILE LIVER FAILURE SYNDROME 1,0.41,1,GeneticVariation
25914,RTTN,rotatin,0.0,0.0,1.0,0.0,0.0,3553831,POLYMICROGYRIA WITH SEIZURES,0.41,1,GeneticVariation
7098,TLR3,toll-like receptor 3,0.0,0.0,1.0,0.0,0.0,2751803,"HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2",0.41,1,GeneticVariation
2521,FUS,FUS RNA binding protein,0.0,0.0,1.0,0.0,0.0,3539195,"TREMOR, HEREDITARY ESSENTIAL, 4",0.41,0,GeneticVariation
729920,ISPD,isoprenoid synthase domain containing,0.0,0.0,1.0,0.0,0.0,3553330,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7",0.41,0,GeneticVariation
220296,HEPACAM,hepatic and glial cell adhesion molecule,0.0,0.0,1.0,0.0,0.0,3151355,MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A,0.41,0,GeneticVariation
5654,HTRA1,HtrA serine peptidase 1,0.0,1.0,1.0,0.0,0.0,1857813,"Macular Degeneration, Age-Related, 7",0.41,0,"Biomarker, GeneticVariation"
79947,DHDDS,dehydrodolichyl diphosphate synthase,0.0,0.0,1.0,0.0,0.0,3151227,RETINITIS PIGMENTOSA 59,0.41,1,GeneticVariation
23495,TNFRSF13B,"tumor necrosis factor receptor superfamily, member 13B",0.0,0.0,1.0,0.0,0.0,3150354,"IMMUNODEFICIENCY, COMMON VARIABLE, 2",0.41,0,GeneticVariation
8287,USP9Y,"ubiquitin specific peptidase 9, Y-linked",0.0,1.0,1.0,0.0,0.0,1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",0.41,0,"Biomarker, GeneticVariation"
8239,USP9X,"ubiquitin specific peptidase 9, X-linked",0.0,0.0,1.0,0.0,0.0,3806746,"MENTAL RETARDATION, X-LINKED 99",0.41,1,GeneticVariation
6016,RIT1,Ras-like without CAAX 1,0.0,0.0,1.0,0.0,0.0,3809233,NOONAN SYNDROME 8,0.41,1,GeneticVariation
57704,GBA2,"glucosidase, beta (bile acid) 2",0.0,0.0,1.0,0.0,0.0,2828721,"SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE",0.41,2,GeneticVariation
6336,SCN10A,"sodium channel, voltage gated, type X alpha subunit",0.0,0.0,1.0,0.0,0.0,3809893,"EPISODIC PAIN SYNDROME, FAMILIAL, 2",0.41,1,GeneticVariation
84720,PIGO,"phosphatidylinositol glycan anchor biosynthesis, class O",0.0,0.0,1.0,0.0,0.0,3553637,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2,0.41,1,GeneticVariation
1911,PHC1,polyhomeotic homolog 1 (Drosophila),0.0,0.0,1.0,0.0,0.0,3809431,"MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE",0.41,1,GeneticVariation
657,BMPR1A,"bone morphogenetic protein receptor, type IA",0.0,1.0,1.0,0.0,0.0,1864730,"Polyposis Syndrome, Hereditary Mixed, 2",0.41,0,"Biomarker, GeneticVariation"
2178,FANCE,"Fanconi anemia, complementation group E",0.0,1.0,1.0,0.0,0.0,3160739,"FANCONI ANEMIA, COMPLEMENTATION GROUP E",0.41,0,"Biomarker, GeneticVariation"
22931,RAB18,"RAB18, member RAS oncogene family",0.0,0.0,1.0,0.0,0.0,3280203,WARBURG MICRO SYNDROME 3,0.41,1,GeneticVariation
1832,DSP,desmoplakin,0.0,1.0,1.0,0.0,0.0,1852127,Keratosis Palmoplantaris Striata II,0.41,0,"Biomarker, GeneticVariation"
5122,PCSK1,proprotein convertase subtilisin/kexin type 1,0.0,1.0,1.0,0.0,0.0,2676498,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12,0.41,0,"Biomarker, GeneticVariation"
10058,ABCB6,"ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)",0.0,0.0,1.0,0.0,0.0,3281027,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7",0.41,0,GeneticVariation
25821,MTO1,mitochondrial tRNA translation optimization 1,0.0,0.0,1.0,0.0,0.0,3553529,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10,0.41,1,GeneticVariation
3913,LAMB2,"laminin, beta 2 (laminin S)",0.0,0.0,1.0,0.0,0.0,3280113,"NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES",0.41,0,GeneticVariation
55215,FANCI,"Fanconi anemia, complementation group I",0.0,1.0,1.0,0.0,0.0,1836861,"Fanconi Anemia, Complementation Group I",0.41,0,"Biomarker, GeneticVariation"
2811,GP1BA,"glycoprotein Ib (platelet), alpha polypeptide",0.0,1.0,1.0,0.0,0.0,1847711,"NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO",0.41,0,"Biomarker, GeneticVariation"
84282,RNF135,ring finger protein 135,0.0,0.0,1.0,0.0,0.0,3280095,"MACROCEPHALY, MACROSOMIA, FACIAL DYSMORPHISM SYNDROME",0.41,1,GeneticVariation
10058,ABCB6,"ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)",0.0,0.0,1.0,0.0,0.0,3809394,DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3,0.41,0,GeneticVariation
10075,HUWE1,"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,2678046,"Mental Retardation, X-Linked, Syndromic, Turner Type",0.41,0,"Biomarker, GeneticVariation"
78987,CRELD1,cysteine-rich with EGF-like domains 1,0.0,1.0,1.0,0.0,0.0,1853509,"Atrioventricular Septal Defect, Partial, with Heterotaxy Syndrome",0.41,0,"Biomarker, GeneticVariation"
374393,FAM111B,"family with sequence similarity 111, member B",0.0,0.0,1.0,0.0,0.0,3810325,"POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS",0.41,1,GeneticVariation
23414,ZFPM2,"zinc finger protein, FOG family member 2",0.0,1.0,1.0,0.0,0.0,1857781,Diaphragmatic Hernia 3,0.41,0,"Biomarker, GeneticVariation"
92211,CDHR1,cadherin-related family member 1,0.0,1.0,1.0,0.0,0.0,3150912,CONE-ROD DYSTROPHY 15,0.41,0,"Biomarker, GeneticVariation"
84892,POMGNT2,"protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)",0.0,0.0,1.0,0.0,0.0,3553813,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8",0.41,1,GeneticVariation
80347,COASY,CoA synthase,0.0,0.0,1.0,0.0,0.0,3810230,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6,0.41,1,GeneticVariation
4072,EPCAM,epithelial cell adhesion molecule,0.0,1.0,1.0,0.0,0.0,2750471,"Colorectal Cancer, Hereditary Nonpolyposis, Type 8",0.41,0,"Biomarker, GeneticVariation"
55670,PEX26,peroxisomal biogenesis factor 26,0.0,0.0,1.0,0.0,0.0,3539168,PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER),0.41,0,GeneticVariation
4477,MSMB,"microseminoprotein, beta-",0.0,1.0,1.0,0.0,0.0,2677821,"Prostate Cancer, Hereditary, 13",0.41,0,"Biomarker, GeneticVariation"
801,CALM1,"calmodulin 1 (phosphorylase kinase, delta)",0.0,0.0,1.0,0.0,0.0,3554047,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4",0.41,1,GeneticVariation
84839,RAX2,retina and anterior neural fold homeobox 2,0.0,0.0,1.0,0.0,0.0,3151060,"Macular Degeneration, Age-Related, 6",0.41,0,GeneticVariation
3762,KCNJ5,"potassium channel, inwardly rectifying subfamily J, member 5",0.0,0.0,1.0,0.0,0.0,3150933,"HYPERALDOSTERONISM, FAMILIAL, TYPE III",0.41,0,GeneticVariation
51199,NIN,ninein (GSK3B interacting protein),0.0,0.0,1.0,0.0,0.0,3553870,SECKEL SYNDROME 7,0.41,1,GeneticVariation
345193,LRIT3,"leucine-rich repeat, immunoglobulin-like and transmembrane domains 3",0.0,0.0,1.0,0.0,0.0,3554399,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F",0.41,1,GeneticVariation
8452,CUL3,cullin 3,0.0,0.0,1.0,0.0,0.0,3469606,"PSEUDOHYPOALDOSTERONISM, TYPE IIE",0.41,1,GeneticVariation
4117,MAK,male germ cell-associated kinase,0.0,0.0,1.0,0.0,0.0,3280042,RETINITIS PIGMENTOSA 62,0.41,1,GeneticVariation
71,ACTG1,actin gamma 1,0.0,0.0,1.0,0.0,0.0,3281235,BARAITSER-WINTER SYNDROME 2,0.41,0,GeneticVariation
9420,CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1",0.0,0.0,1.0,0.0,0.0,1849115,"Spastic Paraplegia 5a, Autosomal Recessive",0.41,1,GeneticVariation
1981,EIF4G1,"eukaryotic translation initiation factor 4 gamma, 1",0.0,0.0,1.0,0.0,0.0,3280271,PARKINSON DISEASE 18,0.41,1,GeneticVariation
2036,EPB41L1,erythrocyte membrane protein band 4.1-like 1,0.0,0.0,1.0,0.0,0.0,3280285,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 11",0.41,1,GeneticVariation
23090,ZNF423,zinc finger protein 423,0.0,0.0,1.0,0.0,0.0,3539071,NEPHRONOPHTHISIS 14,0.41,1,GeneticVariation
57728,WDR19,WD repeat domain 19,0.0,0.0,1.0,0.0,0.0,3280612,NEPHRONOPHTHISIS 13,0.41,0,GeneticVariation
5015,OTX2,orthodenticle homeobox 2,0.0,0.0,1.0,0.0,0.0,3151440,"PITUITARY HORMONE DEFICIENCY, COMBINED, 6",0.41,0,GeneticVariation
93589,CACNA2D4,"calcium channel, voltage-dependent, alpha 2/delta subunit 4",0.0,1.0,1.0,0.0,0.0,1864849,Retinal Cone Dystrophy 4,0.41,0,"Biomarker, GeneticVariation"
2767,GNA11,"guanine nucleotide binding protein (G protein), alpha 11 (Gq class)",0.0,0.0,1.0,0.0,0.0,3809243,"HYPOCALCEMIA, AUTOSOMAL DOMINANT 2",0.41,0,GeneticVariation
126792,B3GALT6,"UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6",0.0,0.0,1.0,0.0,0.0,3809210,"EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 2",0.41,0,GeneticVariation
776,CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",0.0,0.0,1.0,0.0,0.0,3809609,"PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES",0.41,1,GeneticVariation
10939,AFG3L2,AFG3-like AAA ATPase 2,0.0,0.0,1.0,0.0,0.0,3280977,"SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE",0.41,0,GeneticVariation
4643,MYO1E,myosin IE,0.0,0.0,1.0,0.0,0.0,3279905,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6,0.41,1,GeneticVariation
113246,C12orf57,chromosome 12 open reading frame 57,0.0,0.0,1.0,0.0,0.0,1857512,Temtamy syndrome,0.41,1,GeneticVariation
2624,GATA2,GATA binding protein 2,0.0,0.0,1.0,0.0,0.0,3280030,IMMUNODEFICIENCY 21,0.41,0,GeneticVariation
83452,RAB33B,"RAB33B, member RAS oncogene family",0.0,0.0,1.0,0.0,0.0,3714896,SMITH-MCCORT DYSPLASIA 2,0.41,2,GeneticVariation
1482,NKX2-5,NK2 homeobox 5,0.0,0.0,1.0,0.0,0.0,3280785,VENTRICULAR SEPTAL DEFECT 3,0.41,0,GeneticVariation
3420,IDH3B,isocitrate dehydrogenase 3 (NAD+) beta,0.0,0.0,1.0,0.0,0.0,2675496,Retinitis Pigmentosa 46,0.41,1,GeneticVariation
10667,FARS2,"phenylalanyl-tRNA synthetase 2, mitochondrial",0.0,0.0,1.0,0.0,0.0,3554168,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14,0.41,2,GeneticVariation
55777,MBD5,methyl-CpG binding domain protein 5,0.0,1.0,1.0,0.0,0.0,1969562,"Mental Retardation, Autosomal Dominant 1",0.41,0,"Biomarker, GeneticVariation"
6327,SCN2B,"sodium channel, voltage gated, type II beta subunit",0.0,0.0,1.0,0.0,0.0,3809312,"ATRIAL FIBRILLATION, FAMILIAL, 14",0.41,1,GeneticVariation
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,1.0,0.0,0.0,1850635,"Atrial myxoma, familial",0.41,0,"Biomarker, GeneticVariation"
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,1.0,1.0,0.0,0.0,2675861,"Lipodystrophy, Congenital Generalized, Type 3",0.41,0,"Biomarker, GeneticVariation"
132,ADK,adenosine kinase,0.0,0.0,1.0,0.0,0.0,3280381,HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY,0.41,1,GeneticVariation
5426,POLE,"polymerase (DNA directed), epsilon, catalytic subunit",0.0,0.0,1.0,0.0,0.0,3554460,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 12",0.41,1,GeneticVariation
2774,GNAL,"guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type",0.0,0.0,1.0,0.0,0.0,3554447,DYSTONIA 25,0.41,1,GeneticVariation
126410,CYP4F22,"cytochrome P450, family 4, subfamily F, polypeptide 22",0.0,1.0,1.0,0.0,0.0,1858142,"Lamellar ichthyosis, type 3",0.41,0,"Biomarker, GeneticVariation"
55129,ANO10,anoctamin 10,0.0,0.0,1.0,0.0,0.0,3150998,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10",0.41,1,GeneticVariation
4538,ND4,"NADH dehydrogenase, subunit 4 (complex I)",0.0,0.0,1.0,0.0,0.0,162671,MELAS Syndrome,0.41,0,GeneticVariation
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",0.0,0.0,1.0,0.0,0.0,3151411,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 6",0.41,2,GeneticVariation
9907,AP5Z1,"adaptor-related protein complex 5, zeta 1 subunit",0.0,1.0,1.0,0.0,0.0,3150901,"SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE",0.41,0,"Biomarker, GeneticVariation"
87178,PNPT1,polyribonucleotide nucleotidyltransferase 1,0.0,0.0,1.0,0.0,0.0,1824925,"DEAFNESS, AUTOSOMAL RECESSIVE 70",0.41,0,GeneticVariation
22827,PUF60,poly-U binding splicing factor 60KDa,0.0,0.0,1.0,0.0,0.0,3810023,VERHEIJ SYNDROME,0.41,1,GeneticVariation
55755,CDK5RAP2,CDK5 regulatory subunit associated protein 2,0.0,1.0,1.0,0.0,0.0,1858108,"Microcephaly, Primary Autosomal Recessive, 3",0.41,0,"Biomarker, GeneticVariation"
51062,ATL1,atlastin GTPase 1,0.0,0.0,1.0,0.0,0.0,3150972,"NEUROPATHY, HEREDITARY SENSORY, TYPE ID",0.41,0,GeneticVariation
5144,PDE4D,"phosphodiesterase 4D, cAMP-specific",0.0,0.0,1.0,0.0,0.0,3553250,ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE,0.41,4,GeneticVariation
2200,FBN1,fibrillin 1,0.0,0.0,1.0,0.0,0.0,3280054,GELEOPHYSIC DYSPLASIA 2,0.41,0,GeneticVariation
166336,PRICKLE2,prickle homolog 2 (Drosophila),0.0,0.0,1.0,0.0,0.0,3151194,"EPILEPSY, PROGRESSIVE MYOCLONIC 5",0.41,1,GeneticVariation
440275,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,0.0,0.0,1.0,0.0,0.0,340848,"Hemangiomatosis, familial pulmonary capillary",0.41,1,GeneticVariation
4853,NOTCH2,notch 2,0.0,0.0,1.0,0.0,0.0,1857761,ALAGILLE SYNDROME 2,0.41,1,GeneticVariation
2658,GDF2,growth differentiation factor 2,0.0,0.0,1.0,0.0,0.0,3809710,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5",0.41,1,GeneticVariation
55005,RMND1,required for meiotic nuclear division 1 homolog (S. cerevisiae),0.0,0.0,1.0,0.0,0.0,3554067,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11,0.41,1,GeneticVariation
145873,MESP2,mesoderm posterior basic helix-loop-helix transcription factor 2,0.0,1.0,1.0,0.0,0.0,1837549,"Spondylocostal dysostosis, autosomal recessive",0.41,0,"Biomarker, GeneticVariation"
64446,DNAI2,"dynein, axonemal, intermediate chain 2",0.0,1.0,1.0,0.0,0.0,2676235,"Ciliary Dyskinesia, Primary, 9",0.41,0,"Biomarker, GeneticVariation"
8312,AXIN1,axin 1,0.0,1.0,1.0,0.0,0.0,1842884,Caudal Duplication Anomaly,0.41,0,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,2676832,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1",0.41,0,"Biomarker, GeneticVariation"
27010,TPK1,thiamin pyrophosphokinase 1,0.0,0.0,1.0,0.0,0.0,3280866,THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE),0.41,1,GeneticVariation
6473,SHOX,short stature homeobox,0.0,1.0,1.0,0.0,0.0,1845118,"Short Stature, Idiopathic, X-Linked",0.41,0,"Biomarker, GeneticVariation"
9568,GABBR2,"gamma-aminobutyric acid (GABA) B receptor, 2",0.0,1.0,1.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.41,0,"Biomarker, GeneticVariation"
124404,12-Sep,septin 12,0.0,0.0,1.0,0.0,0.0,3553793,SPERMATOGENIC FAILURE 10,0.41,1,GeneticVariation
57107,PDSS2,"prenyl (decaprenyl) diphosphate synthase, subunit 2",0.0,0.0,1.0,0.0,0.0,3553358,"COENZYME Q10 DEFICIENCY, PRIMARY, 3",0.41,1,GeneticVariation
427,ASAH1,N-acylsphingosine amidohydrolase (acid ceramidase) 1,0.0,0.0,1.0,0.0,0.0,1834569,Jankovic Rivera syndrome,0.41,0,GeneticVariation
29978,UBQLN2,ubiquilin 2,0.0,0.0,1.0,0.0,0.0,3275459,"AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA",0.41,3,GeneticVariation
2737,GLI3,GLI family zinc finger 3,0.0,1.0,1.0,0.0,0.0,1868111,"Polydactyly, preaxial 4",0.41,0,"Biomarker, GeneticVariation"
26012,NSMF,NMDA receptor synaptonuclear signaling and neuronal migration factor,0.0,0.0,1.0,0.0,0.0,3553842,HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA,0.41,2,GeneticVariation
57465,TBC1D24,"TBC1 domain family, member 24",0.0,0.0,1.0,0.0,0.0,3809173,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16",0.41,0,GeneticVariation
3752,KCND3,"potassium channel, voltage gated Shal related subfamily D, member 3",0.0,0.0,1.0,0.0,0.0,1846367,Spinocerebellar ataxia 19,0.41,2,GeneticVariation
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",0.0,0.0,1.0,0.0,0.0,3553788,ALTERNATING HEMIPLEGIA OF CHILDHOOD 2,0.41,0,GeneticVariation
547,KIF1A,kinesin family member 1A,0.0,0.0,1.0,0.0,0.0,3280283,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 9",0.41,0,GeneticVariation
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,0.0,2675112,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4",0.41,0,"Biomarker, GeneticVariation"
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,1.0,0.0,0.0,265287,Acromicric dysplasia,0.41,1,"Biomarker, GeneticVariation"
440,ASNS,asparagine synthetase (glutamine-hydrolyzing),0.0,0.0,1.0,0.0,0.0,3809971,ASPARAGINE SYNTHETASE DEFICIENCY,0.41,1,GeneticVariation
64699,TMPRSS3,"transmembrane protease, serine 3",0.0,1.0,1.0,0.0,0.0,1832827,"Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8",0.41,0,"Biomarker, GeneticVariation"
1730,DIAPH2,diaphanous-related formin 2,0.0,1.0,1.0,0.0,0.0,1845293,Premature Ovarian Failure 2a,0.41,0,"Biomarker, GeneticVariation"
124997,WDR81,WD repeat domain 81,0.0,0.0,1.0,0.0,0.0,2750234,"Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 2",0.41,1,GeneticVariation
81790,RNF170,ring finger protein 170,0.0,0.0,1.0,0.0,0.0,1837015,"Ataxia, Sensory, Autosomal Dominant",0.41,1,GeneticVariation
5784,PTPN14,"protein tyrosine phosphatase, non-receptor type 14",0.0,1.0,1.0,0.0,0.0,3150875,CHOANAL ATRESIA AND LYMPHEDEMA,0.41,0,"Biomarker, GeneticVariation"
8823,FGF16,fibroblast growth factor 16,0.0,0.0,1.0,0.0,0.0,1839728,Metacarpal 4 5 Fusion,0.41,1,GeneticVariation
5269,SERPINB6,"serpin peptidase inhibitor, clade B (ovalbumin), member 6",0.0,1.0,1.0,0.0,0.0,3150704,"DEAFNESS, AUTOSOMAL RECESSIVE 91",0.41,0,"Biomarker, GeneticVariation"
7280,TUBB2A,"tubulin, beta 2A class IIa",0.0,0.0,1.0,0.0,0.0,3810407,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5",0.41,1,GeneticVariation
6134,RPL10,ribosomal protein L10,0.0,0.0,1.0,0.0,0.0,3275438,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 5",0.41,2,GeneticVariation
157657,C8orf37,chromosome 8 open reading frame 37,0.0,0.0,1.0,0.0,0.0,3281045,CONE-ROD DYSTROPHY 16,0.41,1,GeneticVariation
7374,UNG,uracil-DNA glycosylase,0.0,0.0,1.0,0.0,0.0,1720958,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5",0.41,1,GeneticVariation
4976,OPA1,optic atrophy 1 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,1847730,"GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO",0.41,0,"Biomarker, GeneticVariation"
81848,SPRY4,sprouty homolog 4 (Drosophila),0.0,0.0,1.0,0.0,0.0,3808971,HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA,0.41,1,GeneticVariation
10111,RAD50,RAD50 homolog (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,2751318,Nijmegen Breakage Syndrome-Like Disorder,0.41,0,"Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,2675520,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2",0.41,0,"Biomarker, GeneticVariation"
498,ATP5A1,"ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle",0.0,0.0,1.0,0.0,0.0,3808899,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4",0.41,0,GeneticVariation
6597,SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",0.0,0.0,1.0,0.0,0.0,3553249,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 16",0.41,1,GeneticVariation
1938,EEF2,eukaryotic translation elongation factor 2,0.0,0.0,1.0,0.0,0.0,1836395,Spinocerebellar ataxia 26,0.41,1,GeneticVariation
6340,SCNN1G,"sodium channel, non voltage gated 1 gamma subunit",0.0,1.0,1.0,0.0,0.0,2751324,Bronchiectasis With Or Without Elevated Sweat Chloride 3,0.41,0,"Biomarker, GeneticVariation"
6578,SLCO2A1,"solute carrier organic anion transporter family, member 2A1",0.0,0.0,1.0,0.0,0.0,3280800,"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2",0.41,4,GeneticVariation
55812,SPATA7,spermatogenesis associated 7,0.0,1.0,1.0,0.0,0.0,1858677,Leber Congenital Amaurosis 3,0.41,0,"Biomarker, GeneticVariation"
27086,FOXP1,forkhead box P1,0.0,1.0,1.0,0.0,0.0,3150923,MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES,0.41,0,"Biomarker, GeneticVariation"
4689,NCF4,"neutrophil cytosolic factor 4, 40kDa",0.0,0.0,1.0,0.0,0.0,3151409,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III",0.41,1,GeneticVariation
51308,REEP2,receptor accessory protein 2,0.0,0.0,1.0,0.0,0.0,3810160,"SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE",0.41,1,GeneticVariation
3514,IGKC,immunoglobulin kappa constant,0.0,0.0,1.0,0.0,0.0,3279824,Kappa-Chain Deficiency,0.41,1,GeneticVariation
7167,TPI1,triosephosphate isomerase 1,0.0,0.0,1.0,0.0,0.0,1860808,Triosephosphate Isomerase Deficiency,0.41,3,GeneticVariation
79753,SNIP1,Smad nuclear interacting protein 1,0.0,0.0,1.0,0.0,0.0,3281055,"PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM",0.41,1,GeneticVariation
23533,PIK3R5,"phosphoinositide-3-kinase, regulatory subunit 5",0.0,0.0,1.0,0.0,0.0,3554690,ATAXIA-OCULOMOTOR APRAXIA 3,0.41,1,GeneticVariation
56652,C10orf2,chromosome 10 open reading frame 2,0.0,1.0,1.0,0.0,0.0,3151513,MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE),0.41,0,"Biomarker, GeneticVariation"
92667,MGME1,mitochondrial genome maintenance exonuclease 1,0.0,0.0,1.0,0.0,0.0,3554462,MITOCHONDRIAL DNA DEPLETION SYNDROME 11,0.41,1,GeneticVariation
23363,OBSL1,obscurin-like 1,0.0,1.0,1.0,0.0,0.0,2752041,Three M Syndrome 2,0.41,0,"Biomarker, GeneticVariation"
10049,DNAJB6,"DnaJ (Hsp40) homolog, subfamily B, member 6",0.0,0.0,1.0,0.0,0.0,3148763,"Muscular Dystrophy, Limb-Girdle, Type 1E",0.41,2,GeneticVariation
79581,SLC52A2,"solute carrier family 52 (riboflavin transporter), member 2",0.0,0.0,1.0,0.0,0.0,3553538,BROWN-VIALETTO-VAN LAERE SYNDROME 2,0.41,1,GeneticVariation
128178,EDARADD,EDAR-associated death domain,0.0,1.0,1.0,0.0,0.0,1720965,"Ectodermal Dysplasia 3, Anhidrotic",0.41,0,"Biomarker, GeneticVariation"
695,BTK,Bruton agammaglobulinemia tyrosine kinase,0.0,1.0,1.0,0.0,0.0,472813,"Hypogammaglobulinemia and Isolated growth hormone deficiency, X-linked",0.41,0,"Biomarker, GeneticVariation"
846,CASR,calcium-sensing receptor,0.0,0.0,1.0,0.0,0.0,2752062,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8",0.41,0,GeneticVariation
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,0.0,1.0,0.0,0.0,1832855,"Choreoathetosis/Spasticity, Episodic",0.41,0,GeneticVariation
146227,BEAN1,"brain expressed, associated with NEDD4, 1",0.0,1.0,1.0,0.0,0.0,1861736,Spinocerebellar Ataxia 31,0.41,0,"Biomarker, GeneticVariation"
4323,MMP14,matrix metallopeptidase 14 (membrane-inserted),0.0,0.0,1.0,0.0,0.0,432289,Winchester syndrome,0.41,1,GeneticVariation
60684,TRAPPC11,trafficking protein particle complex 11,0.0,0.0,1.0,0.0,0.0,3809236,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2S",0.41,1,GeneticVariation
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,0.0,1.0,0.0,0.0,3151406,SPERMATOGENIC FAILURE 8,0.41,0,GeneticVariation
7056,THBD,thrombomodulin,0.0,0.0,1.0,0.0,0.0,2752036,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6",0.41,0,GeneticVariation
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,0.0,1.0,0.0,0.0,1865285,Megalencephaly cutis marmorata telangiectatica congenita,0.41,0,GeneticVariation
23530,NNT,nicotinamide nucleotide transhydrogenase,0.0,0.0,1.0,0.0,0.0,3553587,GLUCOCORTICOID DEFICIENCY 4,0.41,1,GeneticVariation
23639,LRRC6,leucine rich repeat containing 6,0.0,0.0,1.0,0.0,0.0,3543826,"CILIARY DYSKINESIA, PRIMARY, 19",0.41,1,GeneticVariation
116442,RAB39B,"RAB39B, member RAS oncogene family",0.0,1.0,1.0,0.0,0.0,1846038,"Mental Retardation, X-Linked 72",0.41,0,"Biomarker, GeneticVariation"
5618,PRLR,prolactin receptor,0.0,0.0,1.0,0.0,0.0,3809918,MULTIPLE FIBROADENOMAS OF THE BREAST,0.41,0,GeneticVariation
6598,SMARCB1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",0.0,0.0,1.0,0.0,0.0,3553248,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 15",0.41,1,GeneticVariation
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,0.0,1.0,0.0,0.0,3151088,"MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE",0.41,0,GeneticVariation
5333,PLCD1,"phospholipase C, delta 1",0.0,0.0,1.0,0.0,0.0,544855,Leukonychia totalis,0.41,1,GeneticVariation
30835,CD209,CD209 molecule,0.0,1.0,1.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.41,0,"Biomarker, GeneticVariation"
3431,SP110,SP110 nuclear body protein,0.0,1.0,1.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.41,0,"Biomarker, GeneticVariation"
54888,NSUN2,"NOP2/Sun RNA methyltransferase family, member 2",0.0,0.0,1.0,0.0,0.0,1970199,"Mental Retardation, Autosomal Recessive 5",0.41,1,GeneticVariation
29925,GMPPB,GDP-mannose pyrophosphorylase B,0.0,0.0,1.0,0.0,0.0,3809221,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14",0.41,0,GeneticVariation
6324,SCN1B,"sodium channel, voltage gated, type I beta subunit",0.0,1.0,1.0,0.0,0.0,2748541,Brugada Syndrome 5,0.41,0,"Biomarker, GeneticVariation"
63895,PIEZO2,piezo-type mechanosensitive ion channel component 2,0.0,0.0,1.0,0.0,0.0,1862472,Oculomelic amyoplasia,0.41,0,GeneticVariation
2583,B4GALNT1,"beta-1,4-N-acetyl-galactosaminyl transferase 1",0.0,0.0,1.0,0.0,0.0,1836632,"Spastic paraplegia 26, autosomal recessive",0.41,1,GeneticVariation
1140,CHRNB1,"cholinergic receptor, nicotinic, beta 1 (muscle)",0.0,1.0,1.0,0.0,0.0,1837091,"Myasthenic syndrome, congenital, type Id",0.41,0,"Biomarker, GeneticVariation"
8050,PDHX,"pyruvate dehydrogenase complex, component X",0.0,1.0,1.0,0.0,0.0,1855553,Pyruvate Dehydrogenase E3-Binding Protein Deficiency,0.41,0,"Biomarker, GeneticVariation"
57728,WDR19,WD repeat domain 19,0.0,0.0,1.0,0.0,0.0,3280616,CRANIOECTODERMAL DYSPLASIA 4,0.41,0,GeneticVariation
79934,ADCK4,aarF domain containing kinase 4,0.0,0.0,1.0,0.0,0.0,3809965,"NEPHROTIC SYNDROME, TYPE 9",0.41,1,GeneticVariation
54805,CNNM2,cyclin and CBS domain divalent metal cation transport mediator 2,0.0,0.0,1.0,0.0,0.0,3151295,"HYPOMAGNESEMIA 6, RENAL",0.41,1,GeneticVariation
29926,GMPPA,GDP-mannose pyrophosphorylase A,0.0,0.0,1.0,0.0,0.0,3809738,"ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME",0.41,1,GeneticVariation
3547,IGSF1,"immunoglobulin superfamily, member 1",0.0,0.0,1.0,0.0,0.0,3550963,"HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT",0.41,1,GeneticVariation
116369,SLC26A8,"solute carrier family 26 (anion exchanger), member 8",0.0,0.0,1.0,0.0,0.0,1847540,"Azoospermia, Nonobstructive",0.41,1,GeneticVariation
5167,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,0.0,0.0,1.0,0.0,0.0,3809781,COLE DISEASE,0.41,0,GeneticVariation
286262,TPRN,taperin,0.0,1.0,1.0,0.0,0.0,2750082,"Deafness, Autosomal Recessive 79",0.41,0,"Biomarker, GeneticVariation"
7319,UBE2A,ubiquitin-conjugating enzyme E2A,0.0,0.0,1.0,0.0,0.0,3275464,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE",0.41,1,GeneticVariation
2819,GPD1,glycerol-3-phosphate dehydrogenase 1 (soluble),0.0,0.0,1.0,0.0,0.0,3280953,"HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE",0.41,1,GeneticVariation
2056,EPO,erythropoietin,0.0,1.0,1.0,0.0,0.0,2675471,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2",0.41,0,"Biomarker, GeneticVariation"
6873,TAF2,"TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa",0.0,0.0,1.0,0.0,0.0,3810080,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40",0.41,1,GeneticVariation
1259,CNGA1,cyclic nucleotide gated channel alpha 1,0.0,0.0,1.0,0.0,0.0,3151059,RETINITIS PIGMENTOSA 49,0.41,1,GeneticVariation
4638,MYLK,myosin light chain kinase,0.0,0.0,1.0,0.0,0.0,3151077,"AORTIC ANEURYSM, FAMILIAL THORACIC 7",0.41,1,GeneticVariation
50940,PDE11A,phosphodiesterase 11A,0.0,1.0,1.0,0.0,0.0,1864851,"Pigmented Nodular Adrenocortical Disease, Primary, 2",0.41,0,"Biomarker, GeneticVariation"
1410,CRYAB,"crystallin, alpha B",0.0,0.0,1.0,0.0,0.0,3554649,"CARDIOMYOPATHY, DILATED, 1II",0.41,0,GeneticVariation
56603,CYP26B1,"cytochrome P450, family 26, subfamily B, polypeptide 1",0.0,0.0,1.0,0.0,0.0,3280729,RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES,0.41,1,GeneticVariation
724066,ATXN8,ataxin 8,0.0,1.0,1.0,0.0,0.0,1837454,Spinocerebellar ataxia 8,0.41,0,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,0.0,1.0,0.0,0.0,3809005,CARDIOFACIOCUTANEOUS SYNDROME 2,0.41,0,GeneticVariation
23321,TRIM2,tripartite motif containing 2,0.0,0.0,1.0,0.0,0.0,3809655,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R",0.41,1,GeneticVariation
1729,DIAPH1,diaphanous-related formin 1,0.0,1.0,1.0,0.0,0.0,1852282,"Deafness, Autosomal Dominant 1",0.41,0,"Biomarker, GeneticVariation"
5157,PDGFRL,platelet-derived growth factor receptor-like,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.41,0,"Biomarker, GeneticVariation"
1650,DDOST,dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic),0.0,0.0,1.0,0.0,0.0,3281084,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir",0.41,1,GeneticVariation
3735,KARS,lysyl-tRNA synthetase,0.0,0.0,1.0,0.0,0.0,3151351,"DEAFNESS, AUTOSOMAL RECESSIVE 89",0.41,0,GeneticVariation
29925,GMPPB,GDP-mannose pyrophosphorylase B,0.0,0.0,1.0,0.0,0.0,3714932,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14",0.41,0,GeneticVariation
102,ADAM10,ADAM metallopeptidase domain 10,0.0,0.0,1.0,0.0,0.0,3810041,ALZHEIMER DISEASE 18,0.41,0,GeneticVariation
3702,ITK,IL2-inducible T-cell kinase,0.0,1.0,1.0,0.0,0.0,2751686,"Lymphoproliferative Syndrome, Ebv-Associated, Autosomal, 1",0.41,0,"Biomarker, GeneticVariation"
57094,CPA6,carboxypeptidase A6,0.0,0.0,1.0,0.0,0.0,3280730,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 5",0.41,0,GeneticVariation
5745,PTH1R,parathyroid hormone 1 receptor,0.0,1.0,1.0,0.0,0.0,1852222,"Failure of Tooth Eruption, Primary",0.41,0,"Biomarker, GeneticVariation"
3248,HPGD,hydroxyprostaglandin dehydrogenase 15-(NAD),0.0,0.0,1.0,0.0,0.0,1861514,"DIGITAL CLUBBING, ISOLATED CONGENITAL",0.41,0,GeneticVariation
7291,TWIST1,twist family bHLH transcription factor 1,0.0,1.0,1.0,0.0,0.0,1863370,Saethre-Chotzen Syndrome with Eyelid Anomalies,0.41,1,"Biomarker, GeneticVariation"
125336,LOXHD1,lipoxygenase homology domains 1,0.0,1.0,1.0,0.0,0.0,2746083,"Deafness, Autosomal Recessive 77",0.41,0,"Biomarker, GeneticVariation"
84146,ZNF644,zinc finger protein 644,0.0,0.0,1.0,0.0,0.0,3279997,"MYOPIA 21, AUTOSOMAL DOMINANT",0.41,1,GeneticVariation
11155,LDB3,LIM domain binding 3,0.0,1.0,1.0,0.0,0.0,1836155,"Myopathy, Myofibrillar, Zasp-Related",0.41,0,"Biomarker, GeneticVariation"
56246,MRAP,melanocortin 2 receptor accessory protein,0.0,1.0,1.0,0.0,0.0,1846284,Glucocorticoid Deficiency 2,0.41,0,"Biomarker, GeneticVariation"
778,CACNA1F,"calcium channel, voltage-dependent, L type, alpha 1F subunit",0.0,1.0,1.0,0.0,0.0,1845407,"Cone-Rod Dystrophy, X-Linked, 3",0.41,0,"Biomarker, GeneticVariation"
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,0.0,1.0,0.0,0.0,3279990,"CANDIDIASIS, FAMILIAL, 7",0.41,0,GeneticVariation
113179,ADAT3,"adenosine deaminase, tRNA-specific 3",0.0,0.0,1.0,0.0,0.0,3809039,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36",0.41,1,GeneticVariation
8092,ALX1,ALX homeobox 1,0.0,1.0,1.0,0.0,0.0,3150706,FRONTONASAL DYSPLASIA 3,0.41,0,"Biomarker, GeneticVariation"
4867,NPHP1,nephronophthisis 1 (juvenile),0.0,1.0,1.0,0.0,0.0,1846790,Joubert syndrome 4,0.41,0,"Biomarker, GeneticVariation"
7283,TUBG1,"tubulin, gamma 1",0.0,0.0,1.0,0.0,0.0,3809420,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4",0.41,1,GeneticVariation
7507,XPA,"xeroderma pigmentosum, complementation group A",0.0,0.0,1.0,0.0,0.0,1337030,XPA GENE,0.41,4,GeneticVariation
9179,AP4M1,"adaptor-related protein complex 4, mu 1 subunit",0.0,1.0,1.0,0.0,0.0,2752008,"Spastic Paraplegia-50, Autosomal Recessive",0.41,0,"Biomarker, GeneticVariation"
7355,SLC35A2,"solute carrier family 35 (UDP-galactose transporter), member A2",0.0,0.0,1.0,0.0,0.0,3806688,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm",0.41,2,GeneticVariation
123016,TTC8,tetratricopeptide repeat domain 8,0.0,1.0,1.0,0.0,0.0,3150715,RETINITIS PIGMENTOSA 51,0.41,0,"Biomarker, GeneticVariation"
649,BMP1,bone morphogenetic protein 1,0.0,0.0,1.0,0.0,0.0,3553887,"OSTEOGENESIS IMPERFECTA, TYPE XIII",0.41,3,GeneticVariation
84466,MEGF10,multiple EGF-like-domains 10,0.0,0.0,1.0,0.0,0.0,3280679,"MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET",0.41,1,GeneticVariation
64423,INF2,"inverted formin, FH2 and WH2 domain containing",0.0,0.0,1.0,0.0,0.0,3280845,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E",0.41,0,GeneticVariation
57728,WDR19,WD repeat domain 19,0.0,0.0,1.0,0.0,0.0,3280598,SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY,0.41,0,GeneticVariation
89891,WDR34,WD repeat domain 34,0.0,0.0,1.0,0.0,0.0,3810200,SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY,0.41,2,GeneticVariation
4214,MAP3K1,"mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase",0.0,0.0,1.0,0.0,0.0,3151064,"46,XY SEX REVERSAL 6",0.41,1,GeneticVariation
92335,STRADA,STE20-related kinase adaptor alpha,0.0,1.0,1.0,0.0,0.0,1970203,"Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy",0.41,0,"Biomarker, GeneticVariation"
3861,KRT14,"keratin 14, type I",0.0,0.0,1.0,0.0,0.0,80333,Weber-Cockayne syndrome,0.41,0,GeneticVariation
57582,KCNT1,"potassium channel, sodium activated subfamily T, member 1",0.0,0.0,1.0,0.0,0.0,3554306,"EPILEPSY, NOCTURNAL FRONTAL LOBE, 5",0.41,0,GeneticVariation
28956,LAMTOR2,"late endosomal/lysosomal adaptor, MAPK and MTOR activator 2",0.0,1.0,1.0,0.0,0.0,1835829,Immunodeficiency due to Defect in MAPBP-Interacting Protein,0.41,0,"Biomarker, GeneticVariation"
388551,CEACAM16,carcinoembryonic antigen-related cell adhesion molecule 16,0.0,0.0,1.0,0.0,0.0,3281297,"DEAFNESS, AUTOSOMAL DOMINANT 4B",0.41,1,GeneticVariation
148022,TICAM1,toll-like receptor adaptor molecule 1,0.0,0.0,1.0,0.0,0.0,3553869,"HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4",0.41,1,GeneticVariation
5828,PEX2,peroxisomal biogenesis factor 2,0.0,0.0,1.0,0.0,0.0,3542026,PEROXISOME BIOGENESIS DISORDER 5B,0.41,1,GeneticVariation
5627,PROS1,protein S (alpha),0.0,0.0,1.0,0.0,0.0,3281092,"THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE",0.41,0,GeneticVariation
57709,SLC7A14,"solute carrier family 7, member 14",0.0,0.0,1.0,0.0,0.0,3810380,RETINITIS PIGMENTOSA 68,0.41,1,GeneticVariation
10210,TOPORS,"topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,1835923,Retinitis Pigmentosa 31,0.41,0,"Biomarker, GeneticVariation"
4901,NRL,neural retina leucine zipper,0.0,0.0,1.0,0.0,0.0,1834329,Retinitis Pigmentosa 27,0.41,0,GeneticVariation
3273,HRG,histidine-rich glycoprotein,0.0,0.0,1.0,0.0,0.0,2751090,THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY,0.41,2,GeneticVariation
221421,RSPH9,radial spoke head 9 homolog (Chlamydomonas),0.0,1.0,1.0,0.0,0.0,2675228,"Ciliary Dyskinesia, Primary, 12",0.41,0,"Biomarker, GeneticVariation"
220,ALDH1A3,"aldehyde dehydrogenase 1 family, member A3",0.0,0.0,1.0,0.0,0.0,3554524,"MICROPHTHALMIA, ISOLATED 8",0.41,6,GeneticVariation
2627,GATA6,GATA binding protein 6,0.0,0.0,1.0,0.0,0.0,3280939,ATRIOVENTRICULAR SEPTAL DEFECT 5,0.41,0,GeneticVariation
375790,AGRN,agrin,0.0,0.0,1.0,0.0,0.0,3808739,"MYASTHENIC SYNDROME, CONGENITAL, WITH PRE- AND POSTSYNAPTIC DEFECTS",0.41,3,GeneticVariation
3394,IRF8,interferon regulatory factor 8,0.0,0.0,1.0,0.0,0.0,3808590,"MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE",0.41,0,GeneticVariation
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,1857829,"Heart-hand syndrome, Slovenian type",0.41,0,"Biomarker, GeneticVariation"
51314,NME8,NME/NM23 family member 8,0.0,1.0,1.0,0.0,0.0,1970506,"Ciliary Dyskinesia, Primary, 6",0.41,0,"Biomarker, GeneticVariation"
629,CFB,complement factor B,0.0,0.0,1.0,0.0,0.0,2752038,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4",0.41,2,GeneticVariation
83696,TRAPPC9,trafficking protein particle complex 9,0.0,1.0,1.0,0.0,0.0,2750791,"Mental Retardation, Autosomal Recessive 13",0.41,0,"Biomarker, GeneticVariation"
6487,ST3GAL3,"ST3 beta-galactoside alpha-2,3-sialyltransferase 3",0.0,0.0,1.0,0.0,0.0,1970200,"Mental Retardation, Autosomal Recessive 12",0.41,0,GeneticVariation
7345,UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase),0.0,0.0,1.0,0.0,0.0,3809665,"NEURODEGENERATION WITH OPTIC ATROPHY, CHILDHOOD-ONSET",0.41,0,GeneticVariation
11041,B4GAT1,"beta-1,4-glucuronyltransferase 1",0.0,0.0,1.0,0.0,0.0,3809042,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13",0.41,1,GeneticVariation
27089,UQCRQ,"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa",0.0,0.0,1.0,0.0,0.0,3554607,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4",0.41,1,GeneticVariation
84693,MCEE,methylmalonyl CoA epimerase,0.0,1.0,1.0,0.0,0.0,1855100,Methylmalonyl-CoA Epimerase Deficiency,0.41,0,"Biomarker, GeneticVariation"
8504,PEX3,peroxisomal biogenesis factor 3,0.0,0.0,1.0,0.0,0.0,3553999,PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER),0.41,1,GeneticVariation
79633,FAT4,FAT atypical cadherin 4,0.0,0.0,1.0,0.0,0.0,3809875,VAN MALDERGEM SYNDROME 2,0.41,0,GeneticVariation
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,1.0,0.0,0.0,268371,Epidermolysis Bullosa With Congenital Localized Absence Of Skin And Deformity Of Nails,0.41,0,"Biomarker, GeneticVariation"
6197,RPS6KA3,"ribosomal protein S6 kinase, 90kDa, polypeptide 3",0.0,0.0,1.0,0.0,0.0,796225,"Mental Retardation, X-Linked 19",0.41,0,GeneticVariation
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,0.0,1.0,0.0,0.0,2674321,"Thrombophilia, Hereditary, Due To Protein C Deficiency, Autosomal Dominant",0.41,0,GeneticVariation
3614,IMPDH1,IMP (inosine 5'-monophosphate) dehydrogenase 1,0.0,0.0,1.0,0.0,0.0,1840284,Leber Congenital Amaurosis 11,0.41,0,GeneticVariation
9439,MED23,mediator complex subunit 23,0.0,0.0,1.0,0.0,0.0,3280265,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18",0.41,1,GeneticVariation
987,LRBA,"LPS-responsive vesicle trafficking, beach and anchor containing",0.0,0.0,1.0,0.0,0.0,3553512,"IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY",0.41,1,GeneticVariation
5950,RBP4,"retinol binding protein 4, plasma",0.0,0.0,1.0,0.0,0.0,3554593,"RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME",0.41,1,GeneticVariation
9531,BAG3,BCL2-associated athanogene 3,0.0,0.0,1.0,0.0,0.0,3151293,"CARDIOMYOPATHY, DILATED, 1HH",0.41,0,GeneticVariation
9101,USP8,ubiquitin specific peptidase 8,0.0,1.0,1.0,0.0,0.0,221406,Pituitary ACTH Hypersecretion,0.41,1,"Biomarker, GeneticVariation"
83737,ITCH,itchy E3 ubiquitin protein ligase,0.0,1.0,1.0,0.0,0.0,3150649,"AUTOIMMUNE DISEASE, SYNDROMIC MULTISYSTEM",0.41,0,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,872218,Mitochondrial neurogastrointestinal encephalopathy syndrome,0.41,0,"Biomarker, GeneticVariation"
50615,IL21R,interleukin 21 receptor,0.0,0.0,1.0,0.0,0.0,3554687,IL21R IMMUNODEFICIENCY,0.41,1,GeneticVariation
7991,TUSC3,tumor suppressor candidate 3,0.0,1.0,1.0,0.0,0.0,1970197,"Mental Retardation, Autosomal Recessive 7",0.41,0,"Biomarker, GeneticVariation"
26235,FBXL4,F-box and leucine-rich repeat protein 4,0.0,0.0,1.0,0.0,0.0,3809592,MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE),0.41,1,GeneticVariation
57534,MIB1,mindbomb E3 ubiquitin protein ligase 1,0.0,0.0,1.0,0.0,0.0,3554496,LEFT VENTRICULAR NONCOMPACTION 7,0.41,1,GeneticVariation
26160,IFT172,intraflagellar transport 172,0.0,0.0,1.0,0.0,0.0,3810175,SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY,0.41,1,GeneticVariation
55670,PEX26,peroxisomal biogenesis factor 26,0.0,0.0,1.0,0.0,0.0,3553951,PEROXISOME BIOGENESIS DISORDER 7B,0.41,0,GeneticVariation
3910,LAMA4,"laminin, alpha 4",0.0,0.0,1.0,0.0,0.0,3808935,"CARDIOMYOPATHY, DILATED, 1JJ",0.41,1,GeneticVariation
57449,PLEKHG5,"pleckstrin homology domain containing, family G (with RhoGef domain) member 5",0.0,0.0,1.0,0.0,0.0,3809309,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C",0.41,0,GeneticVariation
5277,PIGA,"phosphatidylinositol glycan anchor biosynthesis, class A",0.0,0.0,1.0,0.0,0.0,3275508,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2,0.41,0,GeneticVariation
1193,CLIC2,chloride intracellular channel 2,0.0,0.0,1.0,0.0,0.0,3550913,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 32",0.41,1,GeneticVariation
6915,TBXA2R,thromboxane A2 receptor,0.0,0.0,1.0,0.0,0.0,3279614,"BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO",0.41,1,GeneticVariation
23395,LARS2,"leucyl-tRNA synthetase 2, mitochondrial",0.0,0.0,1.0,0.0,0.0,3809105,PERRAULT SYNDROME 4,0.41,1,GeneticVariation
121278,TPH2,tryptophan hydroxylase 2,0.0,0.0,1.0,0.0,0.0,2751802,"ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7",0.41,1,GeneticVariation
55214,P3H2,prolyl 3-hydroxylase 2,0.0,0.0,1.0,0.0,0.0,3280346,"MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION",0.41,1,GeneticVariation
84233,TMEM126A,transmembrane protein 126A,0.0,1.0,1.0,0.0,0.0,2751812,Optic Atrophy 7,0.41,0,"Biomarker, GeneticVariation"
85365,ALG2,"ALG2, alpha-1,3/1,6-mannosyltransferase",0.0,1.0,1.0,0.0,0.0,1842836,Congenital disorder of glycosylation type II,0.41,0,"Biomarker, GeneticVariation"
133396,IL31RA,interleukin 31 receptor A,0.0,0.0,1.0,0.0,0.0,3151404,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2",0.41,1,GeneticVariation
735,C9,complement component 9,0.0,0.0,1.0,0.0,0.0,3810042,"MACULAR DEGENERATION, AGE-RELATED, 15",0.41,0,GeneticVariation
57505,AARS2,"alanyl-tRNA synthetase 2, mitochondrial",0.0,0.0,1.0,0.0,0.0,3279793,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8,0.41,0,GeneticVariation
11222,MRPL3,mitochondrial ribosomal protein L3,0.0,0.0,1.0,0.0,0.0,3281234,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9,0.41,1,GeneticVariation
84197,POMK,protein-O-mannose kinase,0.0,0.0,1.0,0.0,0.0,3808964,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12",0.41,1,GeneticVariation
79092,CARD14,"caspase recruitment domain family, member 14",0.0,0.0,1.0,0.0,0.0,1864497,PSORIASIS SUSCEPTIBILITY 2,0.41,0,GeneticVariation
7042,TGFB2,"transforming growth factor, beta 2",0.0,0.0,1.0,0.0,0.0,3553762,LOEYS-DIETZ SYNDROME 4,0.41,1,GeneticVariation
22995,CEP152,centrosomal protein 152kDa,0.0,0.0,1.0,0.0,0.0,3151187,SECKEL SYNDROME 5,0.41,0,GeneticVariation
203286,ANKS6,ankyrin repeat and sterile alpha motif domain containing 6,0.0,0.0,1.0,0.0,0.0,3809320,NEPHRONOPHTHISIS 16,0.41,1,GeneticVariation
1778,DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1",0.0,0.0,1.0,0.0,0.0,3280220,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O",0.41,0,GeneticVariation
3178,HNRNPA1,heterogeneous nuclear ribonucleoprotein A1,0.0,0.0,1.0,0.0,0.0,3809469,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3,0.41,0,GeneticVariation
1471,CST3,cystatin C,0.0,1.0,1.0,0.0,0.0,2677774,"Macular Degeneration, Age-Related, 11",0.41,0,"Biomarker, GeneticVariation"
6499,SKIV2L,superkiller viralicidic activity 2-like (S. cerevisiae),0.0,0.0,1.0,0.0,0.0,3281289,TRICHOHEPATOENTERIC SYNDROME 2,0.41,1,GeneticVariation
55605,KIF21A,kinesin family member 21A,0.0,1.0,1.0,0.0,0.0,2751105,"Fibrosis of Extraocular Muscles, Congenital, 3B",0.41,0,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,0.0,1.0,0.0,0.0,1845902,FG SYNDROME 2,0.41,0,GeneticVariation
23590,PDSS1,"prenyl (decaprenyl) diphosphate synthase, subunit 1",0.0,0.0,1.0,0.0,0.0,3553354,"COENZYME Q10 DEFICIENCY, PRIMARY, 2",0.41,1,GeneticVariation
727,C5,complement component 5,0.0,1.0,1.0,0.0,0.0,343047,Complement component 5 deficiency,0.41,0,"Biomarker, GeneticVariation"
10518,CIB2,calcium and integrin binding family member 2,0.0,0.0,1.0,0.0,0.0,1836199,"Deafness, Autosomal Recessive 48",0.41,0,GeneticVariation
7471,WNT1,"wingless-type MMTV integration site family, member 1",0.0,0.0,1.0,0.0,0.0,3808844,"OSTEOGENESIS IMPERFECTA, TYPE XV",0.41,0,GeneticVariation
148789,B3GALNT2,"beta-1,3-N-acetylgalactosaminyltransferase 2",0.0,0.0,1.0,0.0,0.0,3554638,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11",0.41,1,GeneticVariation
3178,HNRNPA1,heterogeneous nuclear ribonucleoprotein A1,0.0,0.0,1.0,0.0,0.0,3715156,AMYOTROPHIC LATERAL SCLEROSIS 20,0.41,0,GeneticVariation
4159,MC3R,melanocortin 3 receptor,0.0,1.0,1.0,0.0,0.0,2677162,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9,0.41,0,"Biomarker, GeneticVariation"
2273,FHL1,four and a half LIM domains 1,0.0,1.0,1.0,0.0,0.0,2678015,"Myopathy, Reducing Body, X-Linked, Childhood-Onset",0.41,0,"Biomarker, GeneticVariation"
51524,TMEM138,transmembrane protein 138,0.0,0.0,1.0,0.0,0.0,3280906,JOUBERT SYNDROME 16,0.41,1,GeneticVariation
4208,MEF2C,myocyte enhancer factor 2C,0.0,1.0,1.0,0.0,0.0,3150700,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 20",0.41,0,"Biomarker, GeneticVariation"
23529,CLCF1,cardiotrophin-like cytokine factor 1,0.0,0.0,1.0,0.0,0.0,1853198,COLD-INDUCED SWEATING SYNDROME 2,0.41,1,GeneticVariation
10243,GPHN,gephyrin,0.0,1.0,1.0,0.0,0.0,1835614,Hyperexplexia hereditary,0.41,0,"Biomarker, GeneticVariation"
6253,RTN2,reticulon 2,0.0,0.0,1.0,0.0,0.0,1858106,"Spastic paraplegia 12, autosomal dominant",0.41,1,GeneticVariation
2048,EPHB2,EPH receptor B2,0.0,1.0,1.0,0.0,0.0,1863600,PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY,0.41,0,"Biomarker, GeneticVariation"
56616,DIABLO,"diablo, IAP-binding mitochondrial protein",0.0,0.0,1.0,0.0,0.0,3279948,"DEAFNESS, AUTOSOMAL DOMINANT 64",0.41,1,GeneticVariation
83479,DDX59,DEAD (Asp-Glu-Ala-Asp) box polypeptide 59,0.0,0.0,1.0,0.0,0.0,1868118,Orofaciodigital syndrome 5,0.41,1,GeneticVariation
23545,ATP6V0A2,"ATPase, H+ transporting, lysosomal V0 subunit a2",0.0,1.0,1.0,0.0,0.0,268355,"Cutis Laxa, Autosomal Recessive, Type IIA",0.41,0,"Biomarker, GeneticVariation"
51594,NBAS,neuroblastoma amplified sequence,0.0,0.0,1.0,0.0,0.0,3541319,"SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY",0.41,1,GeneticVariation
79977,GRHL2,grainyhead-like 2 (Drosophila),0.0,1.0,1.0,0.0,0.0,1837640,"Deafness, Autosomal Dominant 28",0.41,0,"Biomarker, GeneticVariation"
5648,MASP1,mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),0.0,1.0,1.0,0.0,0.0,796059,Oculopalatoskeletal syndrome,0.41,1,"Biomarker, GeneticVariation"
3759,KCNJ2,"potassium channel, inwardly rectifying subfamily J, member 2",0.0,1.0,1.0,0.0,0.0,42514,"Tachycardia, Ventricular",0.41,1,"Biomarker, GeneticVariation"
6324,SCN1B,"sodium channel, voltage gated, type I beta subunit",0.0,0.0,1.0,0.0,0.0,3809311,"ATRIAL FIBRILLATION, FAMILIAL, 13",0.41,0,GeneticVariation
57465,TBC1D24,"TBC1 domain family, member 24",0.0,0.0,1.0,0.0,0.0,2829265,"DEAFNESS, AUTOSOMAL RECESSIVE 86",0.41,0,GeneticVariation
7700,ZNF141,zinc finger protein 141,0.0,0.0,1.0,0.0,0.0,3808889,"POLYDACTYLY, POSTAXIAL, TYPE A6",0.41,1,GeneticVariation
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,0.0,1.0,0.0,0.0,3554241,"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3",0.41,0,GeneticVariation
5148,PDE6G,"phosphodiesterase 6G, cGMP-specific, rod, gamma",0.0,1.0,1.0,0.0,0.0,3150821,RETINITIS PIGMENTOSA 57,0.41,0,"Biomarker, GeneticVariation"
5729,PTGDR,prostaglandin D2 receptor (DP),0.0,1.0,1.0,0.0,0.0,1846534,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1",0.41,0,"Biomarker, GeneticVariation"
4976,OPA1,optic atrophy 1 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,1852267,Optic atrophy 1 and deafness,0.41,0,"Biomarker, GeneticVariation"
5216,PFN1,profilin 1,0.0,0.0,1.0,0.0,0.0,3553719,AMYOTROPHIC LATERAL SCLEROSIS 18,0.41,1,GeneticVariation
7025,NR2F1,"nuclear receptor subfamily 2, group F, member 1",0.0,0.0,1.0,0.0,0.0,3810363,BOSCH-BOONSTRA OPTIC ATROPHY SYNDROME,0.41,1,GeneticVariation
2629,GBA,"glucosidase, beta, acid",0.0,1.0,1.0,0.0,0.0,1842704,"Gaucher Disease, Perinatal Lethal",0.41,0,"Biomarker, GeneticVariation"
4607,MYBPC3,"myosin binding protein C, cardiac",0.0,0.0,1.0,0.0,0.0,3715165,LEFT VENTRICULAR NONCOMPACTION 10,0.41,0,GeneticVariation
2702,GJA5,"gap junction protein, alpha 5, 40kDa",0.0,0.0,1.0,0.0,0.0,3279693,"ATRIAL FIBRILLATION, FAMILIAL, 11",0.41,0,GeneticVariation
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",0.0,0.0,1.0,0.0,0.0,2677087,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5",0.41,1,GeneticVariation
51360,MBTPS2,"membrane-bound transcription factor peptidase, site 2",0.0,0.0,1.0,0.0,0.0,3806745,"PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED",0.41,0,GeneticVariation
27030,MLH3,mutL homolog 3,0.0,0.0,1.0,0.0,0.0,1858380,"Colorectal Cancer, Hereditary Nonpolyposis, Type 7",0.41,1,GeneticVariation
6389,SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",0.0,0.0,1.0,0.0,0.0,3279992,PARAGANGLIOMAS 5,0.41,0,GeneticVariation
79443,FYCO1,FYVE and coiled-coil domain containing 1,0.0,0.0,1.0,0.0,0.0,1864908,"Cataract, autosomal recessive congenital 2",0.41,1,GeneticVariation
54862,CC2D1A,coiled-coil and C2 domain containing 1A,0.0,1.0,1.0,0.0,0.0,1838023,"Mental Retardation, Autosomal Recessive 3",0.41,0,"Biomarker, GeneticVariation"
79228,THOC6,THO complex 6 homolog (Drosophila),0.0,0.0,1.0,0.0,0.0,3150939,BEAULIEU-BOYCOTT-INNES SYNDROME,0.41,1,GeneticVariation
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,1.0,0.0,0.0,1842342,"Deafness, Autosomal Recessive 39",0.41,0,"Biomarker, GeneticVariation"
11023,VAX1,ventral anterior homeobox 1,0.0,0.0,1.0,0.0,0.0,3553077,"MICROPHTHALMIA, SYNDROMIC 11",0.41,1,GeneticVariation
343641,TGM6,transglutaminase 6,0.0,0.0,1.0,0.0,0.0,1539956,TRANSGLUTAMINASE 6,0.41,2,GeneticVariation
2539,G6PD,glucose-6-phosphate dehydrogenase,0.0,0.0,1.0,0.0,0.0,2720289,"Anemia, Nonspherocytic Hemolytic, Due To G6pd Deficiency",0.41,4,GeneticVariation
8575,PRKRA,"protein kinase, interferon-inducible double stranded RNA dependent activator",0.0,0.0,1.0,0.0,0.0,2677567,Dystonia 16,0.41,1,GeneticVariation
2626,GATA4,GATA binding protein 4,0.0,0.0,1.0,0.0,0.0,3280777,VENTRICULAR SEPTAL DEFECT 1,0.41,0,GeneticVariation
79868,ALG13,"ALG13, UDP-N-acetylglucosaminyltransferase subunit",0.0,0.0,1.0,0.0,0.0,3550904,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Is",0.41,1,GeneticVariation
2997,GYS1,glycogen synthase 1 (muscle),0.0,1.0,1.0,0.0,0.0,1969054,"Glycogen Storage Disease 0, Muscle",0.41,0,"Biomarker, GeneticVariation"
54332,GDAP1,ganglioside induced differentiation associated protein 1,0.0,1.0,1.0,0.0,0.0,1842197,"Charcot-Marie-Tooth Disease, Recessive Intermediate A",0.41,0,"Biomarker, GeneticVariation"
3476,IGBP1,immunoglobulin (CD79A) binding protein 1,0.0,1.0,1.0,0.0,0.0,1845446,"Corpus Callosum, Agenesis of, with Mental Retardation, Ocular Coloboma, and Micrognathia",0.41,0,"Biomarker, GeneticVariation"
2070,EYA4,EYA transcriptional coactivator and phosphatase 4,0.0,1.0,1.0,0.0,0.0,1832476,"Deafness, Autosomal Dominant 10",0.41,0,"Biomarker, GeneticVariation"
51364,ZMYND10,"zinc finger, MYND-type containing 10",0.0,0.0,1.0,0.0,0.0,3809543,"CILIARY DYSKINESIA, PRIMARY, 22",0.41,2,GeneticVariation
6862,T,"T, brachyury homolog (mouse)",0.0,0.0,1.0,0.0,0.0,3810343,SACRAL AGENESIS WITH VERTEBRAL ANOMALIES,0.41,1,GeneticVariation
5831,PYCR1,pyrroline-5-carboxylate reductase 1,0.0,0.0,1.0,0.0,0.0,3280799,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB",0.41,0,GeneticVariation
5322,PLA2G5,"phospholipase A2, group V",0.0,0.0,1.0,0.0,0.0,1856718,"Fleck Retina, Familial Benign",0.41,1,GeneticVariation
54,ACP5,"acid phosphatase 5, tartrate resistant",0.0,0.0,1.0,0.0,0.0,1842763,Combined Immunodeficiency with Autoimmunity and Spondylometaphyseal Dysplasia,0.41,2,GeneticVariation
125972,CALR3,calreticulin 3,0.0,0.0,1.0,0.0,0.0,3151266,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19",0.41,1,GeneticVariation
3054,HCFC1,host cell factor C1,0.0,0.0,1.0,0.0,0.0,796208,"Mental Retardation, X-Linked 3",0.41,1,GeneticVariation
24140,FTSJ1,FtsJ RNA methyltransferase homolog 1 (E. coli),0.0,1.0,1.0,0.0,0.0,796215,"Mental Retardation, X-Linked 9",0.41,0,"Biomarker, GeneticVariation"
93210,PGAP3,post-GPI attachment to proteins 3,0.0,0.0,1.0,0.0,0.0,3810354,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4,0.41,1,GeneticVariation
10265,IRX5,iroquois homeobox 5,0.0,0.0,1.0,0.0,0.0,1970027,"Hypertelorism, Severe, With Midface Prominence, Myopia, Mental Retardation, And Bone Fragility",0.41,1,GeneticVariation
6204,RPS10,ribosomal protein S10,0.0,1.0,1.0,0.0,0.0,2750081,Diamond-Blackfan Anemia 9,0.41,0,"Biomarker, GeneticVariation"
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,0.0,1.0,0.0,0.0,1863659,"DEAFNESS, AUTOSOMAL DOMINANT 17",0.41,0,GeneticVariation
2775,GNAO1,"guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O",0.0,0.0,1.0,0.0,0.0,3809606,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17",0.41,1,GeneticVariation
6795,AURKC,aurora kinase C,0.0,1.0,1.0,0.0,0.0,403812,"Male Infertility with Large-Headed, Multiflagellar, Polyploid Spermatozoa",0.41,0,"Biomarker, GeneticVariation"
103,ADAR,"adenosine deaminase, RNA-specific",0.0,0.0,1.0,0.0,0.0,3539013,AICARDI-GOUTIERES SYNDROME 6,0.41,0,GeneticVariation
405753,DUOXA2,dual oxidase maturation factor 2,0.0,1.0,1.0,0.0,0.0,342196,Thyroid Dyshormonogenesis 5,0.41,0,"Biomarker, GeneticVariation"
29887,SNX10,sorting nexin 10,0.0,0.0,1.0,0.0,0.0,3554478,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8",0.41,2,GeneticVariation
1778,DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1",0.0,0.0,1.0,0.0,0.0,3281202,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 13",0.41,0,GeneticVariation
6326,SCN2A,"sodium channel, voltage gated, type II alpha subunit",0.0,0.0,1.0,0.0,0.0,1843140,"SEIZURES, BENIGN FAMILIAL INFANTILE, 3",0.41,0,GeneticVariation
23299,BICD2,bicaudal D homolog 2 (Drosophila),0.0,0.0,1.0,0.0,0.0,3809049,"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMAL DOMINANT",0.41,3,GeneticVariation
9841,ZBTB24,zinc finger and BTB domain containing 24,0.0,0.0,1.0,0.0,0.0,3279748,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2,0.41,1,GeneticVariation
3371,TNC,tenascin C,0.0,0.0,1.0,0.0,0.0,3810170,"DEAFNESS, AUTOSOMAL DOMINANT 56",0.41,1,GeneticVariation
65125,WNK1,WNK lysine deficient protein kinase 1,0.0,1.0,1.0,0.0,0.0,2752089,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA",0.41,0,"Biomarker, GeneticVariation"
4053,LTBP2,latent transforming growth factor beta binding protein 2,0.0,1.0,1.0,0.0,0.0,2751316,"Glaucoma 3, Primary Congenital, D",0.41,0,"Biomarker, GeneticVariation"
5995,RGR,retinal G protein coupled receptor,0.0,0.0,1.0,0.0,0.0,3151068,RETINITIS PIGMENTOSA 44,0.41,1,GeneticVariation
3590,IL11RA,"interleukin 11 receptor, alpha",0.0,0.0,1.0,0.0,0.0,3280073,CRANIOSYNOSTOSIS AND DENTAL ANOMALIES,0.41,1,GeneticVariation
6731,SRP72,signal recognition particle 72kDa,0.0,0.0,1.0,0.0,0.0,3808553,BONE MARROW FAILURE SYNDROME 1,0.41,1,GeneticVariation
7341,SUMO1,small ubiquitin-like modifier 1,0.0,1.0,1.0,0.0,0.0,1866070,Orofacial Cleft 10,0.41,0,"Biomarker, GeneticVariation"
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,1.0,0.0,0.0,1845336,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 3",0.41,0,"Biomarker, GeneticVariation"
368,ABCC6,"ATP-binding cassette, sub-family C (CFTR/MRP), member 6",0.0,0.0,1.0,0.0,0.0,3276161,"ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2",0.41,0,GeneticVariation
1355,COX15,cytochrome c oxidase assembly homolog 15 (yeast),0.0,0.0,1.0,0.0,0.0,3554534,"CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2",0.41,0,GeneticVariation
6201,RPS7,ribosomal protein S7,0.0,1.0,1.0,0.0,0.0,2675511,Diamond-Blackfan Anemia 8,0.41,0,"Biomarker, GeneticVariation"
176,ACAN,aggrecan,0.0,1.0,1.0,0.0,0.0,1842149,"Spondyloepiphyseal Dysplasia, Kimberley Type",0.41,0,"Biomarker, GeneticVariation"
362,AQP5,aquaporin 5,0.0,0.0,1.0,0.0,0.0,1838359,"Diffuse palmoplantar keratoderma, Bothnian type",0.41,1,GeneticVariation
1131,CHRM3,"cholinergic receptor, muscarinic 3",0.0,1.0,1.0,0.0,0.0,33770,Prune Belly Syndrome,0.41,1,"Biomarker, GeneticVariation"
11213,IRAK3,interleukin-1 receptor-associated kinase 3,0.0,1.0,1.0,0.0,0.0,1970224,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5",0.41,0,"Biomarker, GeneticVariation"
126792,B3GALT6,"UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6",0.0,0.0,1.0,0.0,0.0,432243,Spondyloepimetaphyseal Dysplasia With Joint Laxity,0.41,0,GeneticVariation
9131,AIFM1,"apoptosis-inducing factor, mitochondrion-associated, 1",0.0,0.0,1.0,0.0,0.0,795910,Cowchock syndrome,0.41,0,GeneticVariation
57082,CASC5,cancer susceptibility candidate 5,0.0,0.0,1.0,0.0,0.0,1858516,"Microcephaly, Primary Autosomal Recessive, 4",0.41,1,GeneticVariation
9459,ARHGEF6,Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6,0.0,1.0,1.0,0.0,0.0,1845526,"Mental Retardation, X-Linked 46",0.41,0,"Biomarker, GeneticVariation"
79809,TTC21B,tetratricopeptide repeat domain 21B,0.0,0.0,1.0,0.0,0.0,3151185,SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY,0.41,0,GeneticVariation
2902,GRIN1,"glutamate receptor, ionotropic, N-methyl D-aspartate 1",0.0,0.0,1.0,0.0,0.0,3280282,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 8",0.41,1,GeneticVariation
4338,MOCS2,molybdenum cofactor synthesis 2,0.0,0.0,1.0,0.0,0.0,1854989,"Molybdenum Cofactor Deficiency, Complementation Group B",0.41,2,GeneticVariation
9723,SEMA3E,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E",0.0,1.0,1.0,0.0,0.0,265354,CHARGE Syndrome,0.41,0,"Biomarker, GeneticVariation"
5193,PEX12,peroxisomal biogenesis factor 12,0.0,0.0,1.0,0.0,0.0,3553929,PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER),0.41,0,GeneticVariation
407053,MIR96,microRNA 96,0.0,1.0,1.0,0.0,0.0,1537752,"DEAFNESS, AUTOSOMAL DOMINANT 50",0.41,0,"Biomarker, GeneticVariation"
50489,CD207,"CD207 molecule, langerin",0.0,0.0,1.0,0.0,0.0,3150657,BIRBECK GRANULE DEFICIENCY,0.41,1,GeneticVariation
7415,VCP,valosin containing protein,0.0,0.0,1.0,0.0,0.0,3151403,"AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA",0.41,0,GeneticVariation
27022,FOXD3,forkhead box D3,0.0,1.0,1.0,0.0,0.0,1842979,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1",0.41,0,"Biomarker, GeneticVariation"
6017,RLBP1,retinaldehyde binding protein 1,0.0,1.0,1.0,0.0,0.0,1843815,Newfoundland Rod-Cone Dystrophy,0.41,0,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,2678098,"Hypospadias 1, X-Linked",0.41,0,"Biomarker, GeneticVariation"
10159,ATP6AP2,"ATPase, H+ transporting, lysosomal accessory protein 2",0.0,1.0,1.0,0.0,0.0,1845543,"Mental Retardation, X-Linked, with Epilepsy",0.41,0,"Biomarker, GeneticVariation"
255928,SYT14,synaptotagmin XIV,0.0,0.0,1.0,0.0,0.0,3280226,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11",0.41,1,GeneticVariation
55172,DNAAF2,"dynein, axonemal, assembly factor 2",0.0,1.0,1.0,0.0,0.0,2675867,"Ciliary Dyskinesia, Primary, 10",0.41,0,"Biomarker, GeneticVariation"
131377,KLHL40,kelch-like family member 40,0.0,0.0,1.0,0.0,0.0,3809209,NEMALINE MYOPATHY 8,0.41,1,GeneticVariation
8754,ADAM9,ADAM metallopeptidase domain 9,0.0,1.0,1.0,0.0,0.0,1423873,CONE-ROD DYSTROPHY 9,0.41,0,"Biomarker, GeneticVariation"
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",0.0,0.0,1.0,0.0,0.0,3810400,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19",0.41,0,GeneticVariation
10371,SEMA3A,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A",0.0,0.0,1.0,0.0,0.0,3554021,HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA,0.41,1,GeneticVariation
1436,CSF1R,colony stimulating factor 1 receptor,0.0,0.0,1.0,0.0,0.0,1857300,"Gliosis, Familial Progressive Subcortical",0.41,2,GeneticVariation
7490,WT1,Wilms tumor 1,0.0,0.0,1.0,0.0,0.0,1837026,Meacham Syndrome,0.41,0,GeneticVariation
79644,SRD5A3,steroid 5 alpha-reductase 3,0.0,1.0,1.0,0.0,0.0,3150191,"Coloboma, Ocular, And Ichthyosis, Brain Malformations, And Endocrine Abnormalities",0.41,0,"Biomarker, GeneticVariation"
2563,GABRD,"gamma-aminobutyric acid (GABA) A receptor, delta",0.0,0.0,1.0,0.0,0.0,2751603,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10",0.41,1,GeneticVariation
79583,TMEM231,transmembrane protein 231,0.0,0.0,1.0,0.0,0.0,3554235,JOUBERT SYNDROME 20,0.41,0,GeneticVariation
55636,CHD7,chromodomain helicase DNA binding protein 7,0.0,1.0,1.0,0.0,0.0,1837461,"SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 3",0.41,0,"Biomarker, GeneticVariation"
23301,EHBP1,EH domain binding protein 1,0.0,1.0,1.0,0.0,0.0,2678479,"Prostate Cancer, Hereditary, 12",0.41,0,"Biomarker, GeneticVariation"
51067,YARS2,"tyrosyl-tRNA synthetase 2, mitochondrial",0.0,0.0,1.0,0.0,0.0,3150802,"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2",0.41,2,GeneticVariation
51660,MPC1,mitochondrial pyruvate carrier 1,0.0,0.0,1.0,0.0,0.0,3553607,MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY,0.41,1,GeneticVariation
5649,RELN,reelin,0.0,1.0,1.0,0.0,0.0,796089,Norman Roberts lissencephaly syndrome,0.41,0,"Biomarker, GeneticVariation"
8722,CTSF,cathepsin F,0.0,0.0,1.0,0.0,0.0,3715049,"CEROID LIPOFUSCINOSIS, NEURONAL, 13",0.41,1,GeneticVariation
4091,SMAD6,SMAD family member 6,0.0,0.0,1.0,0.0,0.0,3542024,AORTIC VALVE DISEASE 2,0.41,1,GeneticVariation
5190,PEX6,peroxisomal biogenesis factor 6,0.0,0.0,1.0,0.0,0.0,3553936,PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER),0.41,2,GeneticVariation
8738,CRADD,CASP2 and RIPK1 domain containing adaptor with death domain,0.0,0.0,1.0,0.0,0.0,3281044,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34",0.41,1,GeneticVariation
55112,WDR60,WD repeat domain 60,0.0,0.0,1.0,0.0,0.0,3809691,SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY,0.41,1,GeneticVariation
51293,CD320,CD320 molecule,0.0,1.0,1.0,0.0,0.0,3150900,METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT,0.41,0,"Biomarker, GeneticVariation"
79755,ZNF750,zinc finger protein 750,0.0,1.0,1.0,0.0,0.0,1853258,Seborrhea-Like Dermatitis with Psoriasiform Elements,0.41,0,"Biomarker, GeneticVariation"
2626,GATA4,GATA binding protein 4,0.0,0.0,1.0,0.0,0.0,3280781,ATRIOVENTRICULAR SEPTAL DEFECT 4,0.41,0,GeneticVariation
51124,IER3IP1,immediate early response 3 interacting protein 1,0.0,0.0,1.0,0.0,0.0,3280240,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME",0.41,1,GeneticVariation
8622,PDE8B,phosphodiesterase 8B,0.0,0.0,1.0,0.0,0.0,3280094,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3",0.41,1,GeneticVariation
7381,UQCRB,ubiquinol-cytochrome c reductase binding protein,0.0,1.0,1.0,0.0,0.0,1852372,Mitochondrial Complex III Deficiency,0.41,0,"Biomarker, GeneticVariation"
2189,FANCG,"Fanconi anemia, complementation group G",0.0,0.0,1.0,0.0,0.0,1333532,FANCG GENE,0.41,1,GeneticVariation
2956,MSH6,mutS homolog 6,0.0,0.0,1.0,0.0,0.0,1833477,"Colorectal Cancer, Hereditary Nonpolyposis, Type 5",0.41,3,GeneticVariation
2066,ERBB4,erb-b2 receptor tyrosine kinase 4,0.0,0.0,1.0,0.0,0.0,3715155,AMYOTROPHIC LATERAL SCLEROSIS 19,0.41,1,GeneticVariation
1200,TPP1,tripeptidyl peptidase I,0.0,0.0,1.0,0.0,0.0,1836474,"Spinocerebellar Ataxia, Autosomal Recessive 7",0.41,0,GeneticVariation
57158,JPH2,junctophilin 2,0.0,0.0,1.0,0.0,0.0,3151264,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17",0.41,1,GeneticVariation
6605,SMARCE1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1",0.0,1.0,1.0,0.0,0.0,1333989,"Meningioma, familial",0.41,1,"Biomarker, GeneticVariation"
3853,KRT6A,"keratin 6A, type II",0.0,0.0,1.0,0.0,0.0,3714948,PACHYONYCHIA CONGENITA 3,0.41,9,GeneticVariation
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,1858990,"Beta Thalassemia, Dominant Inclusion Body Type",0.41,0,"Biomarker, GeneticVariation"
57798,GATAD1,GATA zinc finger domain containing 1,0.0,0.0,1.0,0.0,0.0,3553409,"CARDIOMYOPATHY, DILATED, 2B",0.41,1,GeneticVariation
84947,SERAC1,serine active site containing 1,0.0,0.0,1.0,0.0,0.0,3553597,"3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME",0.41,1,GeneticVariation
6870,TACR3,tachykinin receptor 3,0.0,0.0,1.0,0.0,0.0,3553844,HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA,0.41,2,GeneticVariation
26123,TCTN3,tectonic family member 3,0.0,0.0,1.0,0.0,0.0,3553758,JOUBERT SYNDROME 18,0.41,1,GeneticVariation
23259,DDHD2,DDHD domain containing 2,0.0,0.0,1.0,0.0,0.0,3539495,"SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE",0.41,1,GeneticVariation
10342,TFG,TRK-fused gene,0.0,0.0,1.0,0.0,0.0,3714897,"SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE",0.41,0,GeneticVariation
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,1.0,0.0,0.0,2676271,"Cardiomyopathy, Familial Restrictive, 3",0.41,0,"Biomarker, GeneticVariation"
84173,ELMOD3,ELMO/CED-12 domain containing 3,0.0,0.0,1.0,0.0,0.0,2829267,"DEAFNESS, AUTOSOMAL RECESSIVE 88",0.41,1,GeneticVariation
152137,CCDC50,coiled-coil domain containing 50,0.0,1.0,1.0,0.0,0.0,1843895,"Deafness, Autosomal Dominant 44",0.41,0,"Biomarker, GeneticVariation"
1798,DPAGT1,dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),0.0,0.0,1.0,0.0,0.0,3553645,"MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2",0.41,0,GeneticVariation
51206,GP6,glycoprotein VI (platelet),0.0,0.0,1.0,0.0,0.0,3280120,"BLEEDING DISORDER, PLATELET-TYPE, 11",0.41,2,GeneticVariation
124454,EARS2,"glutamyl-tRNA synthetase 2, mitochondrial",0.0,0.0,1.0,0.0,0.0,3554079,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12,0.41,2,GeneticVariation
631,BFSP1,"beaded filament structural protein 1, filensin",0.0,1.0,1.0,0.0,0.0,1969644,"Cataract, Cortical, Juvenile-Onset",0.41,0,"Biomarker, GeneticVariation"
2521,FUS,FUS RNA binding protein,0.0,0.0,1.0,0.0,0.0,1842675,"AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA",0.41,0,GeneticVariation
3651,PDX1,pancreatic and duodenal homeobox 1,0.0,1.0,1.0,0.0,0.0,1850096,"Pancreatic Agenesis, Congenital",0.41,0,"Biomarker, GeneticVariation"
212,ALAS2,5'-aminolevulinate synthase 2,0.0,1.0,1.0,0.0,0.0,2677889,"Protoporphyria, Erythropoietic, X-Linked Dominant",0.41,0,"Biomarker, GeneticVariation"
5915,RARB,"retinoic acid receptor, beta",0.0,0.0,1.0,0.0,0.0,3809803,"MICROPHTHALMIA, SYNDROMIC 12",0.41,1,GeneticVariation
10342,TFG,TRK-fused gene,0.0,0.0,1.0,0.0,0.0,1858338,"Neuropathy, hereditary motor and sensory, Okinawa type",0.41,0,GeneticVariation
60528,ELAC2,elaC ribonuclease Z 2,0.0,0.0,1.0,0.0,0.0,3809526,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17,0.41,0,GeneticVariation
286887,KRT6C,"keratin 6C, type II",0.0,0.0,1.0,0.0,0.0,3810394,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE",0.41,1,GeneticVariation
79728,PALB2,partner and localizer of BRCA2,0.0,1.0,1.0,0.0,0.0,1835817,"Fanconi Anemia, Complementation Group N",0.41,0,"Biomarker, GeneticVariation"
84529,C15orf41,chromosome 15 open reading frame 41,0.0,0.0,1.0,0.0,0.0,3810185,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib",0.41,1,GeneticVariation
60386,SLC25A19,"solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19",0.0,0.0,1.0,0.0,0.0,3150973,THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE),0.41,0,GeneticVariation
1161,ERCC8,excision repair cross-complementation group 8,0.0,0.0,1.0,0.0,0.0,3553298,UV-SENSITIVE SYNDROME 2,0.41,0,GeneticVariation
65250,C5orf42,chromosome 5 open reading frame 42,0.0,0.0,1.0,0.0,0.0,3553264,JOUBERT SYNDROME 17,0.41,1,GeneticVariation
23438,HARS2,"histidyl-tRNA synthetase 2, mitochondrial",0.0,0.0,1.0,0.0,0.0,3554105,PERRAULT SYNDROME 2,0.41,1,GeneticVariation
79621,RNASEH2B,"ribonuclease H2, subunit B",0.0,0.0,1.0,0.0,0.0,3489724,AICARDI-GOUTIERES SYNDROME 2,0.41,2,GeneticVariation
256764,WDR72,WD repeat domain 72,0.0,1.0,1.0,0.0,0.0,2750771,"Amelogenesis Imperfecta, Hypomaturation Type, Iia3",0.41,0,"Biomarker, GeneticVariation"
10060,ABCC9,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",0.0,0.0,1.0,0.0,0.0,3279695,"ATRIAL FIBRILLATION, FAMILIAL, 12",0.41,0,GeneticVariation
8869,ST3GAL5,"ST3 beta-galactoside alpha-2,3-sialyltransferase 5",0.0,1.0,1.0,0.0,0.0,1836824,Amish Infantile Epilepsy Syndrome,0.41,0,"Biomarker, GeneticVariation"
126328,NDUFA11,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.41,0,"Biomarker, GeneticVariation"
91942,NDUFAF2,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 2",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.41,0,"Biomarker, GeneticVariation"
4729,NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",0.0,1.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.41,0,"Biomarker, GeneticVariation"
6218,RPS17,ribosomal protein S17,0.0,1.0,1.0,0.0,0.0,2675860,Diamond-Blackfan Anemia 4,0.41,0,"Biomarker, GeneticVariation"
55780,ERMARD,ER membrane-associated RNA degradation,0.0,0.0,1.0,0.0,0.0,3809872,PERIVENTRICULAR NODULAR HETEROTOPIA 6,0.41,1,GeneticVariation
6342,SCP2,sterol carrier protein 2,0.0,1.0,1.0,0.0,0.0,3150990,LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY,0.41,0,"Biomarker, GeneticVariation"
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,0.0,0.0,1.0,0.0,0.0,3151380,SCHIZOPHRENIA 15,0.41,0,GeneticVariation
713,C1QB,"complement component 1, q subcomponent, B chain",0.0,0.0,1.0,0.0,0.0,3150902,C1q DEFICIENCY,0.41,1,GeneticVariation
714,C1QC,"complement component 1, q subcomponent, C chain",0.0,0.0,1.0,0.0,0.0,3150902,C1q DEFICIENCY,0.41,1,GeneticVariation
6890,TAP1,"transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)",0.0,1.0,1.0,0.0,0.0,1858266,"Bare Lymphocyte Syndrome, Type I",0.41,0,"Biomarker, GeneticVariation"
4093,SMAD9,SMAD family member 9,0.0,0.0,1.0,0.0,0.0,1423690,"PULMONARY HYPERTENSION, PRIMARY, 2",0.41,1,GeneticVariation
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,0.0,1.0,0.0,0.0,3150909,D-2-HYDROXYGLUTARIC ACIDURIA 2,0.41,1,GeneticVariation
10319,LAMC3,"laminin, gamma 3",0.0,0.0,1.0,0.0,0.0,3279875,"CORTICAL MALFORMATIONS, OCCIPITAL",0.41,1,GeneticVariation
10382,TUBB4A,"tubulin, beta 4A class IVa",0.0,0.0,1.0,0.0,0.0,2676244,"Leukodystrophy, Hypomyelinating, 6",0.41,0,GeneticVariation
340990,OTOG,otogelin,0.0,0.0,1.0,0.0,0.0,3554163,"DEAFNESS, AUTOSOMAL RECESSIVE 18B",0.41,1,GeneticVariation
64802,NMNAT1,nicotinamide nucleotide adenylyltransferase 1,0.0,0.0,1.0,0.0,0.0,1837873,"Amaurosis congenita of Leber, type 9",0.41,4,GeneticVariation
8492,PRSS12,"protease, serine, 12 (neurotrypsin, motopsin)",0.0,1.0,1.0,0.0,0.0,1855304,"Mental Retardation, Autosomal Recessive 1",0.41,0,"Biomarker, GeneticVariation"
79783,SUGCT,succinyl-CoA:glutarate-CoA transferase,0.0,0.0,1.0,0.0,0.0,342873,Glutaric Aciduria III,0.41,1,GeneticVariation
30008,EFEMP2,EGF containing fibulin-like extracellular matrix protein 2,0.0,0.0,1.0,0.0,0.0,3280798,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB",0.41,3,GeneticVariation
50484,RRM2B,ribonucleotide reductase M2 B (TP53 inducible),0.0,1.0,1.0,0.0,0.0,2751319,"Progressive External Ophthalmoplegia With Mitochondrial Dna Deletions, Autosomal Dominant, 5",0.41,0,"Biomarker, GeneticVariation"
10461,MERTK,"MER proto-oncogene, tyrosine kinase",0.0,0.0,1.0,0.0,0.0,3151228,RETINITIS PIGMENTOSA 38,0.41,1,GeneticVariation
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,1.0,0.0,0.0,1970712,"Multiple Endocrine Neoplasia, Type IV",0.41,0,"Biomarker, GeneticVariation"
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,0.0,1.0,0.0,0.0,2751681,"NEUROBLASTOMA, SUSCEPTIBILITY TO, 3",0.41,4,GeneticVariation
3035,HARS,histidyl-tRNA synthetase,0.0,0.0,1.0,0.0,0.0,3281066,"USHER SYNDROME, TYPE IIIB",0.41,1,GeneticVariation
5592,PRKG1,"protein kinase, cGMP-dependent, type I",0.0,0.0,1.0,0.0,0.0,3809513,"AORTIC ANEURYSM, FAMILIAL THORACIC 8",0.41,1,GeneticVariation
10369,CACNG2,"calcium channel, voltage-dependent, gamma subunit 2",0.0,0.0,1.0,0.0,0.0,3280284,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 10",0.41,1,GeneticVariation
89765,RSPH1,radial spoke head 1 homolog (Chlamydomonas),0.0,0.0,1.0,0.0,0.0,3809634,"CILIARY DYSKINESIA, PRIMARY, 24",0.41,1,GeneticVariation
1116,CHI3L1,chitinase 3-like 1 (cartilage glycoprotein-39),0.0,1.0,1.0,0.0,0.0,2677770,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7",0.41,0,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,795998,Jackson-Weiss syndrome,0.41,0,"Biomarker, GeneticVariation"
87,ACTN1,"actinin, alpha 1",0.0,0.0,1.0,0.0,0.0,3554663,"BLEEDING DISORDER, PLATELET-TYPE, 15",0.41,2,GeneticVariation
57502,NLGN4X,"neuroligin 4, X-linked",0.0,1.0,1.0,0.0,0.0,1845334,"ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2",0.41,0,"Biomarker, GeneticVariation"
953,ENTPD1,ectonucleoside triphosphate diphosphohydrolase 1,0.0,0.0,1.0,0.0,0.0,3810289,"SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE",0.41,1,GeneticVariation
6866,TAC3,tachykinin 3,0.0,0.0,1.0,0.0,0.0,3553843,HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA,0.41,2,GeneticVariation
8200,GDF5,growth differentiation factor 5,0.0,0.0,1.0,0.0,0.0,3809104,"SYMPHALANGISM, PROXIMAL, 1B",0.41,0,GeneticVariation
24,ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4",0.0,1.0,1.0,0.0,0.0,1866422,Retinitis Pigmentosa 19,0.41,0,"Biomarker, GeneticVariation"
10466,COG5,component of oligomeric golgi complex 5,0.0,1.0,1.0,0.0,0.0,3150876,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi",0.41,0,"Biomarker, GeneticVariation"
958,CD40,"CD40 molecule, TNF receptor superfamily member 5",0.0,0.0,1.0,0.0,0.0,1720957,"IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3",0.41,1,GeneticVariation
284654,RSPO1,R-spondin 1,0.0,1.0,1.0,0.0,0.0,3149931,"PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL",0.41,0,"Biomarker, GeneticVariation"
2626,GATA4,GATA binding protein 4,0.0,0.0,1.0,0.0,0.0,3809858,TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE,0.41,0,GeneticVariation
51185,CRBN,cereblon,0.0,1.0,1.0,0.0,0.0,1843942,"Mental Retardation, Autosomal Recessive 2",0.41,0,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,0.0,1.0,0.0,0.0,3553617,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1",0.41,0,GeneticVariation
3543,IGLL1,immunoglobulin lambda-like polypeptide 1,0.0,0.0,1.0,0.0,0.0,3150750,"AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE",0.41,1,GeneticVariation
11280,SCN11A,"sodium channel, voltage gated, type XI alpha subunit",0.0,0.0,1.0,0.0,0.0,3809899,"EPISODIC PAIN SYNDROME, FAMILIAL, 3",0.41,0,GeneticVariation
29925,GMPPB,GDP-mannose pyrophosphorylase B,0.0,0.0,1.0,0.0,0.0,3809216,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14",0.41,0,GeneticVariation
5605,MAP2K2,mitogen-activated protein kinase kinase 2,0.0,0.0,1.0,0.0,0.0,3809007,CARDIOFACIOCUTANEOUS SYNDROME 4,0.41,3,GeneticVariation
131118,DNAJC19,"DnaJ (Hsp40) homolog, subfamily C, member 19",0.0,1.0,1.0,0.0,0.0,1857776,"3-Methylglutaconic Aciduria, Type V",0.41,0,"Biomarker, GeneticVariation"
1537,CYC1,cytochrome c-1,0.0,0.0,1.0,0.0,0.0,3809553,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6",0.41,1,GeneticVariation
87178,PNPT1,polyribonucleotide nucleotidyltransferase 1,0.0,0.0,1.0,0.0,0.0,3554129,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13,0.41,0,GeneticVariation
8516,ITGA8,"integrin, alpha 8",0.0,0.0,1.0,0.0,0.0,1619700,Renal Adysplasia,0.41,1,GeneticVariation
1749,DLX5,distal-less homeobox 5,0.0,0.0,1.0,0.0,0.0,1857344,Split-Hand/Foot Malformation With Sensorineural Hearing Loss,0.41,1,GeneticVariation
5009,OTC,ornithine carbamoyltransferase,0.0,1.0,1.0,0.0,0.0,220994,Hyperammonemia,0.41,4,"Biomarker, GeneticVariation"
3861,KRT14,"keratin 14, type I",0.0,1.0,1.0,0.0,0.0,1832926,"Epidermolysis Bullosa Simplex, Autosomal Recessive",0.41,0,"Biomarker, GeneticVariation"
121391,KRT74,"keratin 74, type II",0.0,0.0,1.0,0.0,0.0,3151432,HYPOTRICHOSIS 3,0.41,0,GeneticVariation
10892,MALT1,MALT1 paracaspase,0.0,0.0,1.0,0.0,0.0,3809583,IMMUNODEFICIENCY 12,0.41,1,GeneticVariation
871,SERPINH1,"serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)",0.0,0.0,1.0,0.0,0.0,3151211,"OSTEOGENESIS IMPERFECTA, TYPE X",0.41,1,GeneticVariation
7043,TGFB3,"transforming growth factor, beta 3",0.0,1.0,1.0,0.0,0.0,1862511,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 1",0.41,0,"Biomarker, GeneticVariation"
3211,HOXB1,homeobox B1,0.0,0.0,1.0,0.0,0.0,3553625,"FACIAL PARESIS, HEREDITARY CONGENITAL, 3",0.41,1,GeneticVariation
4205,MEF2A,myocyte enhancer factor 2A,0.0,1.0,1.0,0.0,0.0,1842247,"Coronary Artery Disease, Autosomal Dominant, 1",0.41,0,"Biomarker, GeneticVariation"
7187,TRAF3,TNF receptor-associated factor 3,0.0,0.0,1.0,0.0,0.0,3553868,"HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 3",0.41,1,GeneticVariation
8216,LZTR1,leucine-zipper-like transcription regulator 1,0.0,0.0,1.0,0.0,0.0,3810283,SCHWANNOMATOSIS 2,0.41,1,GeneticVariation
55869,HDAC8,histone deacetylase 8,0.0,0.0,1.0,0.0,0.0,3550903,CORNELIA DE LANGE SYNDROME 5,0.41,1,GeneticVariation
9150,CTDP1,"CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1",0.0,1.0,1.0,0.0,0.0,1858726,"Congenital Cataracts, Facial Dysmorphism, And Neuropathy",0.41,0,"Biomarker, GeneticVariation"
51218,GLRX5,glutaredoxin 5,0.0,1.0,1.0,0.0,0.0,2673914,"Anemia, Sideroblastic, Pyridoxine-Refractory, Autosomal Recessive",0.41,0,"Biomarker, GeneticVariation"
5723,PSPH,phosphoserine phosphatase,0.0,0.0,1.0,0.0,0.0,1291463,Deficiency of phosphoserine phosphatase,0.41,1,GeneticVariation
5000,ORC4,"origin recognition complex, subunit 4",0.0,0.0,1.0,0.0,0.0,3151097,MEIER-GORLIN SYNDROME 2,0.41,1,GeneticVariation
990,CDC6,cell division cycle 6,0.0,0.0,1.0,0.0,0.0,3151126,MEIER-GORLIN SYNDROME 5,0.41,1,GeneticVariation
59345,GNB4,"guanine nucleotide binding protein (G protein), beta polypeptide 4",0.0,0.0,1.0,0.0,0.0,3554654,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F",0.41,1,GeneticVariation
3575,IL7R,interleukin 7 receptor,0.0,1.0,1.0,0.0,0.0,1837028,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive",0.41,0,"Biomarker, GeneticVariation"
5788,PTPRC,"protein tyrosine phosphatase, receptor type, C",0.0,1.0,1.0,0.0,0.0,1837028,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive",0.41,0,"Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,1.0,0.0,0.0,2750067,Plasminogen Activator Inhibitor-1 Deficiency,0.41,0,"Biomarker, GeneticVariation"
5080,PAX6,paired box 6,0.0,1.0,1.0,0.0,0.0,155299,Coloboma of optic nerve,0.41,0,"Biomarker, GeneticVariation"
2188,FANCF,"Fanconi anemia, complementation group F",0.0,1.0,1.0,0.0,0.0,1414532,FANCF GENE,0.41,0,"Biomarker, GeneticVariation"
60529,ALX4,ALX homeobox 4,0.0,0.0,1.0,0.0,0.0,3809819,"CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO",0.41,0,GeneticVariation
54463,FAM134B,"family with sequence similarity 134, member B",0.0,1.0,1.0,0.0,0.0,2751092,"Neuropathy, Hereditary Sensory And Autonomic, Type IIB",0.41,0,"Biomarker, GeneticVariation"
11019,LIAS,lipoic acid synthetase,0.0,0.0,1.0,0.0,0.0,3280887,PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY,0.41,1,GeneticVariation
57654,UVSSA,UV-stimulated scaffold protein A,0.0,0.0,1.0,0.0,0.0,3553328,UV-SENSITIVE SYNDROME 3,0.41,1,GeneticVariation
11107,PRDM5,PR domain containing 5,0.0,0.0,1.0,0.0,0.0,3280011,BRITTLE CORNEA SYNDROME 2,0.41,1,GeneticVariation
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,1.0,0.0,0.0,2749477,"Oculodentodigital Dysplasia, Autosomal Recessive",0.41,0,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,2675128,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6",0.41,0,"Biomarker, GeneticVariation"
640,BLK,"BLK proto-oncogene, Src family tyrosine kinase",0.0,1.0,1.0,0.0,0.0,3150618,"Maturity-onset diabetes of the young, type 11",0.41,0,"Biomarker, GeneticVariation"
392255,GDF6,growth differentiation factor 6,0.0,1.0,1.0,0.0,0.0,3150968,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6",0.41,0,"Biomarker, GeneticVariation"
7401,CLRN1,clarin 1,0.0,0.0,1.0,0.0,0.0,3280041,RETINITIS PIGMENTOSA 61,0.41,0,GeneticVariation
547,KIF1A,kinesin family member 1A,0.0,0.0,1.0,0.0,0.0,1835896,"Spastic Paraplegia 30, Autosomal Recessive",0.41,0,GeneticVariation
1376,CPT2,carnitine palmitoyltransferase 2,0.0,1.0,1.0,0.0,0.0,1833518,"Carnitine Palmitoyltransferase II Deficiency, Lethal Neonatal",0.41,0,"Biomarker, GeneticVariation"
8526,DGKE,"diacylglycerol kinase, epsilon 64kDa",0.0,0.0,1.0,0.0,0.0,3554330,"NEPHROTIC SYNDROME, TYPE 7",0.41,1,GeneticVariation
8912,CACNA1H,"calcium channel, voltage-dependent, T type, alpha 1H subunit",0.0,0.0,1.0,0.0,0.0,2749872,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6",0.41,1,GeneticVariation
4909,NTF4,neurotrophin 4,0.0,1.0,1.0,0.0,0.0,2751294,"Glaucoma 1, Open Angle, O",0.41,0,"Biomarker, GeneticVariation"
219736,STOX1,storkhead box 1,0.0,0.0,1.0,0.0,0.0,1836255,Preeclampsia Eclampsia 4,0.41,2,GeneticVariation
5336,PLCG2,"phospholipase C, gamma 2 (phosphatidylinositol-specific)",0.0,0.0,1.0,0.0,0.0,3553961,"AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED",0.41,1,GeneticVariation
2072,ERCC4,excision repair cross-complementation group 4,0.0,0.0,1.0,0.0,0.0,3808988,"FANCONI ANEMIA, COMPLEMENTATION GROUP Q",0.41,0,GeneticVariation
123263,MTFMT,mitochondrial methionyl-tRNA formyltransferase,0.0,0.0,1.0,0.0,0.0,3554182,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15,0.41,2,GeneticVariation
1737,DLAT,dihydrolipoamide S-acetyltransferase,0.0,1.0,1.0,0.0,0.0,1855565,Pyruvate Dehydrogenase E2 Deficiency,0.41,0,"Biomarker, GeneticVariation"
65080,MRPL44,mitochondrial ribosomal protein L44,0.0,0.0,1.0,0.0,0.0,3809339,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16,0.41,1,GeneticVariation
5236,PGM1,phosphoglucomutase 1,0.0,0.0,1.0,0.0,0.0,3554056,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It",0.41,1,GeneticVariation
23345,SYNE1,"spectrin repeat containing, nuclear envelope 1",0.0,1.0,1.0,0.0,0.0,1853116,"Spinocerebellar Ataxia, Autosomal Recessive 8",0.41,0,"Biomarker, GeneticVariation"
4179,CD46,"CD46 molecule, complement regulatory protein",0.0,0.0,1.0,0.0,0.0,2752040,"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2",0.41,4,GeneticVariation
200942,KLHDC8B,kelch domain containing 8B,0.0,1.0,1.0,0.0,0.0,19829,Hodgkin Disease,0.41,0,"Biomarker, GeneticVariation"
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,0.0,1.0,0.0,0.0,3151303,"Obesity, Hyperphagia, and Developmental Delay",0.41,1,GeneticVariation
7827,NPHS2,"nephrosis 2, idiopathic, steroid-resistant (podocin)",1.0,1.0,1.0,0.0,0.0,27726,Nephrotic Syndrome,0.405931697,71,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.403904692,105,"AlteredExpression, Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.39980493,190,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.398969258,57,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.398879116,89,"AlteredExpression, Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.396672258,50,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.393756456,85,"Biomarker, GeneticVariation"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,1.0,0.0,1.0,28754,Obesity,0.393530879,105,"Biomarker, GeneticVariation, Therapeutic"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,1.0,243026,Sepsis,0.393306176,95,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.392915883,175,"AlteredExpression, Biomarker"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),1.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.392007271,52,"AlteredExpression, Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,1.0,1.0,1.0,0.0,0.0,20473,Hyperlipidemias,0.3919975,84,"AlteredExpression, Biomarker, GeneticVariation"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.391175951,76,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.390180617,85,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.39,565,"Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,1.0,1.0,1.0,0.0,0.0,40028,"Thrombocythemia, Essential",0.39,266,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,1.0,598608,Hyperhomocysteinemia,0.39,365,"Biomarker, GeneticVariation, Therapeutic"
3077,HFE,hemochromatosis,1.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.39,609,"AlteredExpression, Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,1.0,1.0,1.0,0.0,0.0,27022,Myeloproliferative Disorders,0.39,274,"AlteredExpression, Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.39,543,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,1.0,0.0,7137,"Carcinoma, Squamous Cell",0.39,622,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
1312,COMT,catechol-O-methyltransferase,1.0,1.0,1.0,1.0,0.0,36341,Schizophrenia,0.39,268,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3075,CFH,complement factor H,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.39,373,"Biomarker, GeneticVariation"
54901,CDKAL1,CDK5 regulatory subunit associated protein 1-like 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.388711302,112,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.387658039,44,"AlteredExpression, Biomarker, GeneticVariation"
10891,PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha",0.0,1.0,1.0,0.0,1.0,11860,"Diabetes Mellitus, Type 2",0.387519355,62,"Biomarker, GeneticVariation, Therapeutic"
1636,ACE,angiotensin I converting enzyme,1.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.385582455,84,"AlteredExpression, Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,1.0,11849,Diabetes Mellitus,0.384518934,1507,"Biomarker, GeneticVariation, Therapeutic"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.383295751,58,"Biomarker, GeneticVariation"
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.383128976,56,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.38280761,35,"AlteredExpression, Biomarker, GeneticVariation"
2100,ESR2,estrogen receptor 2 (ER beta),1.0,1.0,1.0,1.0,1.0,1458155,Breast Neoplasms,0.382670325,50,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
5664,PSEN2,presenilin 2,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.381370997,55,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.381340183,68,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.380715246,47,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.380539573,32,"AlteredExpression, Biomarker, GeneticVariation"
3084,NRG1,neuregulin 1,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.380180309,201,"AlteredExpression, Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",1.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.379189364,55,"AlteredExpression, Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,1.0,1.0,1.0,0.0,1.0,20557,Hypertriglyceridemia,0.378633525,30,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.378166043,32,"AlteredExpression, Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,1.0,1.0,1.0,1.0,0.0,1418,Adenocarcinoma,0.377406996,228,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,3469,Anxiety Disorders,0.376077927,143,"Biomarker, GeneticVariation"
153,ADRB1,adrenoceptor beta 1,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.375924632,35,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,11581,Depressive Disorder,0.375045154,257,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.375027915,47,"AlteredExpression, Biomarker, GeneticVariation"
5053,PAH,phenylalanine hydroxylase,0.0,1.0,1.0,0.0,0.0,751434,Classical phenylketonuria,0.374634135,251,"Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.374510218,377,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
4129,MAOB,monoamine oxidase B,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.37431137,27,"Biomarker, GeneticVariation"
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.373831742,47,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.373715567,108,"AlteredExpression, Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,1.0,1.0,1.0,0.0,0.0,1815,Primary Myelofibrosis,0.371838046,242,"AlteredExpression, Biomarker, GeneticVariation"
6352,CCL5,chemokine (C-C motif) ligand 5,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.369735652,37,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.369451658,44,"Biomarker, GeneticVariation, Therapeutic"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,26640,Mouth Neoplasms,0.369315735,28,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.368742272,31,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,1.0,243026,Sepsis,0.368708592,45,"Biomarker, GeneticVariation, Therapeutic"
5144,PDE4D,"phosphodiesterase 4D, cAMP-specific",0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.368446132,38,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,376358,Malignant neoplasm of prostate,0.367278604,154,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",1.0,1.0,1.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.36707308,984,"AlteredExpression, Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,1.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.367065982,67,"AlteredExpression, Biomarker, GeneticVariation"
7356,SCGB1A1,"secretoglobin, family 1A, member 1 (uteroglobin)",1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.365845071,31,"AlteredExpression, Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.363919444,67,"AlteredExpression, Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.363725105,24,"AlteredExpression, Biomarker, GeneticVariation"
5979,RET,ret proto-oncogene,1.0,1.0,1.0,0.0,0.0,19569,Hirschsprung Disease,0.363550202,163,"AlteredExpression, Biomarker, GeneticVariation"
153,ADRB1,adrenoceptor beta 1,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.36252942,48,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.362439182,232,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,38454,Stroke,0.362422949,37,"AlteredExpression, Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.362119378,47,"Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.361748493,26,"Biomarker, GeneticVariation"
7299,TYR,tyrosinase,0.0,1.0,1.0,0.0,0.0,78918,"Albinism, Oculocutaneous",0.361455284,76,"Biomarker, GeneticVariation"
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.360926943,32,"Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.360163321,51,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.360121878,688,"AlteredExpression, Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.360121878,243,"AlteredExpression, Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.359800748,139,"AlteredExpression, Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.358335268,51,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.358157649,158,"AlteredExpression, Biomarker, GeneticVariation"
1589,CYP21A2,"cytochrome P450, family 21, subfamily A, polypeptide 2",0.0,1.0,1.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.357748348,255,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.357504821,32,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.357143322,30,"AlteredExpression, Biomarker, GeneticVariation"
84062,DTNBP1,dystrobrevin binding protein 1,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.356994667,131,"AlteredExpression, Biomarker, GeneticVariation"
1535,CYBA,"cytochrome b-245, alpha polypeptide",1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.356625832,28,"AlteredExpression, Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.356565143,64,"Biomarker, GeneticVariation"
3732,CD82,CD82 molecule,1.0,1.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.356320965,116,"AlteredExpression, Biomarker, Therapeutic"
5241,PGR,progesterone receptor,1.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.356195235,43,"AlteredExpression, Biomarker, GeneticVariation"
6760,SS18,"synovial sarcoma translocation, chromosome 18",1.0,1.0,1.0,0.0,0.0,39101,"Sarcoma, Synovial",0.355557344,134,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,1.0,0.0,7097,Carcinoma,0.355487743,928,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
348,APOE,apolipoprotein E,1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.355225771,315,"AlteredExpression, Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,1.0,11581,Depressive Disorder,0.354764758,153,"Biomarker, GeneticVariation, Therapeutic"
6606,SMN1,"survival of motor neuron 1, telomeric",1.0,1.0,1.0,0.0,0.0,26847,"Muscular Atrophy, Spinal",0.354591025,559,"AlteredExpression, Biomarker, GeneticVariation"
3567,IL5,interleukin 5,1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.354541454,105,"AlteredExpression, Biomarker, GeneticVariation"
2213,FCGR2B,"Fc fragment of IgG, low affinity IIb, receptor (CD32)",1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.354054713,32,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.353734324,21,"AlteredExpression, Biomarker, GeneticVariation"
120892,LRRK2,leucine-rich repeat kinase 2,1.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.353247375,242,"AlteredExpression, Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.352396861,224,"AlteredExpression, Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,1.0,1.0,1.0,1.0,0.0,24121,Lung Neoplasms,0.352120189,40,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,1.0,36341,Schizophrenia,0.351815152,27,"Biomarker, GeneticVariation, Therapeutic"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,1.0,11881,Diabetic Nephropathies,0.35145414,36,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,1.0,4153,Atherosclerosis,0.351384066,53,"Biomarker, GeneticVariation, Therapeutic"
672,BRCA1,"breast cancer 1, early onset",1.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.351262843,209,"AlteredExpression, Biomarker, GeneticVariation"
4878,NPPA,natriuretic peptide A,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.351170147,33,"Biomarker, GeneticVariation, Therapeutic"
7099,TLR4,toll-like receptor 4,0.0,1.0,1.0,0.0,0.0,243026,Sepsis,0.350866087,42,"Biomarker, GeneticVariation"
26191,PTPN22,"protein tyrosine phosphatase, non-receptor type 22 (lymphoid)",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.350503026,137,"Biomarker, GeneticVariation"
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",1.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.350320122,34,"AlteredExpression, Biomarker, GeneticVariation"
2312,FLG,filaggrin,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.350041576,170,"Biomarker, GeneticVariation"
3291,HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2,1.0,1.0,1.0,1.0,0.0,20538,Hypertension,0.349605532,47,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,1.0,0.0,1.0,21655,Insulin Resistance,0.349390148,22,"Biomarker, GeneticVariation, Therapeutic"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.349087065,32,"Biomarker, GeneticVariation"
8202,NCOA3,nuclear receptor coactivator 3,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.349001638,26,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
387715,ARMS2,age-related maculopathy susceptibility 2,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.348975783,173,"Biomarker, GeneticVariation"
3952,LEP,leptin,1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.348804049,37,"AlteredExpression, Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.34879564,20,"AlteredExpression, Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.348598051,26,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.34853654,428,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2332,FMR1,fragile X mental retardation 1,0.0,1.0,1.0,0.0,0.0,1839780,Fragile X Tremor Ataxia Syndrome,0.348087674,118,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.348051597,23,"AlteredExpression, Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,1.0,30567,Parkinson Disease,0.347640089,20,"Biomarker, GeneticVariation, Therapeutic"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.34761308,33,"AlteredExpression, Biomarker"
5077,PAX3,paired box 3,0.0,1.0,1.0,0.0,0.0,206655,"Rhabdomyosarcoma, Alveolar",0.346739738,97,"Biomarker, GeneticVariation"
2212,FCGR2A,"Fc fragment of IgG, low affinity IIa, receptor (CD32)",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.346174024,22,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.345876256,200,"AlteredExpression, Biomarker, GeneticVariation"
64127,NOD2,nucleotide-binding oligomerization domain containing 2,1.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.345857232,167,"AlteredExpression, Biomarker, GeneticVariation"
6356,CCL11,chemokine (C-C motif) ligand 11,1.0,1.0,1.0,0.0,1.0,4096,Asthma,0.345607504,22,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
59272,ACE2,angiotensin I converting enzyme 2,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.345352963,32,"Biomarker, GeneticVariation, Therapeutic"
4068,SH2D1A,SH2 domain containing 1A,0.0,1.0,1.0,0.0,0.0,549463,X-Linked Lymphoproliferative Syndrome,0.344636589,114,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.34445293,32,"AlteredExpression, Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.343722011,19,"AlteredExpression, Biomarker, GeneticVariation"
1910,EDNRB,endothelin receptor type B,0.0,1.0,1.0,0.0,0.0,19569,Hirschsprung Disease,0.343631869,41,"Biomarker, GeneticVariation"
3651,PDX1,pancreatic and duodenal homeobox 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.343582349,43,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,30193,Pain,0.343523933,26,"Biomarker, GeneticVariation"
4842,NOS1,nitric oxide synthase 1 (neuronal),1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.342879417,20,"AlteredExpression, Biomarker, GeneticVariation"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.342526326,39,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.341982492,237,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.34158892,15,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.341560445,18,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",1.0,1.0,1.0,0.0,1.0,29408,Osteoarthritis,0.341470791,43,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3481,IGF2,insulin-like growth factor 2,1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.341344254,54,"AlteredExpression, Biomarker, GeneticVariation"
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,1.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.341056678,137,"AlteredExpression, Biomarker, GeneticVariation"
6607,SMN2,"survival of motor neuron 2, centromeric",1.0,1.0,1.0,1.0,1.0,26847,"Muscular Atrophy, Spinal",0.34089413,553,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
4159,MC3R,melanocortin 3 receptor,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.340776268,38,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.3402392,61,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.340121878,16,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,1.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.340102788,42,"AlteredExpression, Biomarker, GeneticVariation"
8660,IRS2,insulin receptor substrate 2,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.340102299,27,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,1.0,11860,"Diabetes Mellitus, Type 2",0.340077421,267,"Biomarker, GeneticVariation, Therapeutic"
8200,GDF5,growth differentiation factor 5,1.0,1.0,1.0,0.0,0.0,29408,Osteoarthritis,0.339975273,32,"AlteredExpression, Biomarker, GeneticVariation"
3075,CFH,complement factor H,0.0,1.0,1.0,0.0,0.0,2931788,Atypical Hemolytic Uremic Syndrome,0.339866042,91,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.339407776,30,"Biomarker, GeneticVariation"
5122,PCSK1,proprotein convertase subtilisin/kexin type 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.339358745,34,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,1.0,1.0,1.0,1458155,Breast Neoplasms,0.33926827,508,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,1839259,"Bulbo-Spinal Atrophy, X-Linked",0.339172662,131,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.339165871,26,"AlteredExpression, Biomarker, GeneticVariation"
875,CBS,cystathionine-beta-synthase,0.0,1.0,1.0,0.0,0.0,598608,Hyperhomocysteinemia,0.338870219,44,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.338372308,17,"Biomarker, GeneticVariation"
9378,NRXN1,neurexin 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.337814196,34,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.337629242,28,"Biomarker, GeneticVariation"
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.337550758,23,"Biomarker, GeneticVariation"
3567,IL5,interleukin 5,1.0,1.0,1.0,0.0,0.0,14457,Eosinophilia,0.337462082,66,"AlteredExpression, Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",1.0,1.0,1.0,0.0,0.0,40136,Thyroid Neoplasms,0.337371119,97,"AlteredExpression, Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.337334568,65,"Biomarker, GeneticVariation"
5310,PKD1,polycystic kidney disease 1 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,22680,Polycystic Kidney Diseases,0.33691514,51,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.3362991,56,"AlteredExpression, Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.336240195,24,"Biomarker, GeneticVariation"
10232,MSLN,mesothelin,1.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.336134212,31,"AlteredExpression, Biomarker"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,1.0,242350,Erectile Dysfunction,0.33595669,24,"Biomarker, GeneticVariation, Therapeutic"
154,ADRB2,"adrenoceptor beta 2, surface",1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.335766924,197,"AlteredExpression, Biomarker, GeneticVariation"
153,ADRB1,adrenoceptor beta 1,0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.335488231,15,"Biomarker, GeneticVariation"
3816,KLK1,kallikrein 1,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.3354392,20,"Biomarker, GeneticVariation, Therapeutic"
1636,ACE,angiotensin I converting enzyme,1.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.335170951,147,"AlteredExpression, Biomarker, GeneticVariation"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",1.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.334970742,12,"AlteredExpression, Biomarker, GeneticVariation"
6638,SNRPN,small nuclear ribonucleoprotein polypeptide N,0.0,1.0,1.0,0.0,0.0,32897,Prader-Willi Syndrome,0.334890474,70,"Biomarker, GeneticVariation"
624,BDKRB2,bradykinin receptor B2,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.334871703,17,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",1.0,1.0,1.0,0.0,0.0,38644,Sudden Infant Death,0.334794196,14,"AlteredExpression, Biomarker, GeneticVariation"
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),1.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.334793708,16,"AlteredExpression, Biomarker, GeneticVariation"
1827,RCAN1,regulator of calcineurin 1,1.0,1.0,0.0,1.0,0.0,13080,Down Syndrome,0.334774618,39,"AlteredExpression, Biomarker, PostTranslationalModification"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,1.0,0.0,7097,Carcinoma,0.334634135,264,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
613,BCR,breakpoint cluster region,1.0,1.0,1.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.334634135,476,"AlteredExpression, Biomarker, GeneticVariation"
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.334403732,11,"AlteredExpression, Biomarker, GeneticVariation"
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,20437,Hypercalcemia,0.334381393,93,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.333992713,6,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.333992713,14,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.333738173,17,"AlteredExpression, Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",1.0,1.0,1.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.333738173,17,"AlteredExpression, Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,1.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.333614744,194,"AlteredExpression, Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,1.0,21368,Inflammation,0.333581694,14,"Biomarker, GeneticVariation, Therapeutic"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,1.0,18801,Heart Failure,0.333356606,34,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.333200128,24,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.333099527,119,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.333064693,14,"AlteredExpression, Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.332867592,26,"Biomarker, GeneticVariation"
3674,ITGA2B,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)",0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.33268215,13,"Biomarker, GeneticVariation"
65018,PINK1,PTEN induced putative kinase 1,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.332358733,91,"Biomarker, GeneticVariation"
659,BMPR2,"bone morphogenetic protein receptor, type II (serine/threonine kinase)",0.0,1.0,1.0,0.0,0.0,3714844,"PULMONARY HYPERTENSION, PRIMARY, 1",0.332113356,83,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.332095562,35,"AlteredExpression, Biomarker, GeneticVariation"
2703,GJA8,"gap junction protein, alpha 8, 50kDa",0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.332046531,37,"Biomarker, GeneticVariation"
1814,DRD3,dopamine receptor D3,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.331965508,114,"AlteredExpression, Biomarker, GeneticVariation"
4879,NPPB,natriuretic peptide B,1.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.331754129,15,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.331733574,22,"Biomarker, GeneticVariation"
5506,PPP1R3A,"protein phosphatase 1, regulatory subunit 3A",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.331371586,15,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.331010086,19,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,1.0,1.0,1.0,1.0,0.0,14859,Esophageal Neoplasms,0.33088306,23,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
4879,NPPB,natriuretic peptide B,1.0,1.0,0.0,0.0,0.0,242698,"Ventricular Dysfunction, Left",0.330180617,10,"AlteredExpression, Biomarker"
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.330110542,17,"Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,1.0,0.0,0.0,1140680,Malignant neoplasm of ovary,0.33,1376,"Biomarker, GeneticVariation"
79068,FTO,fat mass and obesity associated,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.33,307,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.33,247,"Biomarker, GeneticVariation"
332,BIRC5,baculoviral IAP repeat containing 5,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.329975107,10,"AlteredExpression, Biomarker, GeneticVariation"
889,KRIT1,"KRIT1, ankyrin repeat containing",0.0,1.0,1.0,0.0,0.0,2919945,Cavernous hemangioma of brain,0.329894351,63,"Biomarker, GeneticVariation"
4340,MOG,myelin oligodendrocyte glycoprotein,0.0,1.0,0.0,0.0,0.0,14072,"Encephalomyelitis, Autoimmune, Experimental",0.32984532,81,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.329798561,16,"AlteredExpression, Biomarker, GeneticVariation"
7097,TLR2,toll-like receptor 2,1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.329769597,10,"AlteredExpression, Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,1.0,0.0,25500,Mesothelioma,0.329729464,38,"Biomarker, GeneticVariation, PostTranslationalModification"
1834,DSPP,dentin sialophosphoprotein,0.0,1.0,1.0,0.0,0.0,11436,Dentinogenesis Imperfecta,0.329729464,35,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.329564088,10,"AlteredExpression, Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,1.0,9319,Colitis,0.329532851,65,"Biomarker, Therapeutic"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.329362175,189,"Biomarker, GeneticVariation"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",1.0,1.0,1.0,0.0,1.0,9404,Colorectal Neoplasms,0.329359067,16,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.329133002,20,"Biomarker, GeneticVariation"
4852,NPY,neuropeptide Y,0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.329005487,20,"Biomarker, GeneticVariation"
2020,EN2,engrailed homeobox 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.328976523,13,"Biomarker, GeneticVariation"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",1.0,1.0,1.0,0.0,1.0,85207,"Diabetes, Gestational",0.328792058,13,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",1.0,1.0,1.0,0.0,0.0,22665,Kidney Neoplasms,0.328771502,22,"AlteredExpression, Biomarker, GeneticVariation"
4881,NPR1,natriuretic peptide receptor 1,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.328615024,13,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.328409514,15,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.328019272,312,"AlteredExpression, Biomarker"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,1.0,27051,Myocardial Infarction,0.327636995,11,"Biomarker, GeneticVariation, Therapeutic"
3667,IRS1,insulin receptor substrate 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.327489903,34,"Biomarker, GeneticVariation"
3779,KCNMB1,potassium channel subfamily M regulatory beta subunit 1,1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.327275496,8,"AlteredExpression, Biomarker, GeneticVariation"
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.327255429,27,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.327226465,24,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.327197501,7,"Biomarker, GeneticVariation"
861,RUNX1,runt-related transcription factor 1,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.326991725,379,"AlteredExpression, Biomarker, GeneticVariation"
2332,FMR1,fragile X mental retardation 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.326795867,35,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.326786482,9,"Biomarker, GeneticVariation"
1409,CRYAA,"crystallin, alpha A",0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.326659944,21,"Biomarker, GeneticVariation"
23435,TARDBP,TAR DNA binding protein,0.0,1.0,1.0,1.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.326375196,283,"Biomarker, GeneticVariation, PostTranslationalModification"
94025,MUC16,"mucin 16, cell surface associated",1.0,1.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.326298445,20,"AlteredExpression, Biomarker, Therapeutic"
185,AGTR1,"angiotensin II receptor, type 1",1.0,1.0,1.0,0.0,1.0,18801,Heart Failure,0.326297956,14,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
210,ALAD,aminolevulinate dehydratase,0.0,1.0,1.0,0.0,0.0,23176,Lead Poisoning,0.326219473,10,"Biomarker, GeneticVariation"
6439,SFTPB,surfactant protein B,0.0,1.0,1.0,0.0,0.0,24115,Lung Diseases,0.326121899,26,"Biomarker, GeneticVariation"
114907,FBXO32,F-box protein 32,1.0,1.0,0.0,0.0,0.0,26846,Muscular Atrophy,0.326043904,25,"AlteredExpression, Biomarker"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,1.0,18801,Heart Failure,0.325788875,29,"Biomarker, GeneticVariation, Therapeutic"
1191,CLU,clusterin,1.0,1.0,0.0,1.0,1.0,33578,Prostatic Neoplasms,0.325702472,10,"AlteredExpression, Biomarker, PostTranslationalModification, Therapeutic"
5979,RET,ret proto-oncogene,1.0,1.0,1.0,0.0,0.0,40136,Thyroid Neoplasms,0.32564797,111,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.325502832,137,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.325496962,9,"AlteredExpression, Biomarker, GeneticVariation"
476,ATP1A1,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.325369447,7,"AlteredExpression, Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.325369447,10,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,34069,Pulmonary Fibrosis,0.325016845,35,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.324469414,9,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.324264393,14,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.324083421,134,"AlteredExpression, Biomarker, GeneticVariation"
23411,SIRT1,sirtuin 1,0.0,1.0,1.0,0.0,1.0,28754,Obesity,0.324038817,28,"Biomarker, GeneticVariation, Therapeutic"
3990,LIPC,"lipase, hepatic",0.0,1.0,1.0,0.0,0.0,20473,Hyperlipidemias,0.323902405,8,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.323853596,55,"AlteredExpression, Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.323853374,12,"Biomarker, GeneticVariation"
712,C1QA,"complement component 1, q subcomponent, A chain",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.323853374,10,"Biomarker, GeneticVariation"
1773,DNASE1,deoxyribonuclease I,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.323726348,17,"Biomarker, GeneticVariation"
5376,PMP22,peripheral myelin protein 22,0.0,1.0,1.0,0.0,0.0,11195,dejerine-sottas disease,0.323706281,33,"Biomarker, GeneticVariation"
9378,NRXN1,neurexin 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.323648353,21,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,1.0,0.0,17638,Glioma,0.32364711,267,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.323491875,14,"Biomarker, GeneticVariation"
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",1.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.323302175,207,"AlteredExpression, Biomarker, GeneticVariation"
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.323237334,16,"Biomarker, GeneticVariation"
177,AGER,advanced glycosylation end product-specific receptor,1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.32305238,11,"AlteredExpression, Biomarker, GeneticVariation"
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,33375,Prolactinoma,0.32304121,51,Biomarker
8517,IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma",0.0,1.0,1.0,0.0,0.0,2930820,"Incontinentia pigmenti, familial male-lethal type",0.32304121,46,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,1.0,149721,"Hypertrophy, Left Ventricular",0.322924865,8,"Biomarker, GeneticVariation, Therapeutic"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),1.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.32284687,10,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5727,PTCH1,patched 1,0.0,1.0,1.0,0.0,0.0,25149,Medulloblastoma,0.322728742,37,"Biomarker, GeneticVariation"
490,ATP2B1,"ATPase, Ca++ transporting, plasma membrane 1",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.322670325,15,"Biomarker, GeneticVariation"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.322641361,10,"Biomarker, GeneticVariation, Therapeutic"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.322641361,11,"AlteredExpression, Biomarker, GeneticVariation"
8647,ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",0.0,1.0,1.0,0.0,0.0,8370,Cholestasis,0.322572263,33,"Biomarker, GeneticVariation"
267012,DAOA,D-amino acid oxidase activator,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.322483705,59,"AlteredExpression, Biomarker, GeneticVariation"
150,ADRA2A,adrenoceptor alpha 2A,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.322357856,8,"Biomarker, GeneticVariation"
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.322357856,9,"Biomarker, GeneticVariation"
6649,SOD3,"superoxide dismutase 3, extracellular",1.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.322279861,7,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,17636,Glioblastoma,0.32215208,356,"AlteredExpression, Biomarker, GeneticVariation"
133,ADM,adrenomedullin,1.0,1.0,0.0,0.0,0.0,243026,Sepsis,0.32207484,11,"AlteredExpression, Biomarker"
6690,SPINK1,"serine peptidase inhibitor, Kazal type 1",0.0,1.0,1.0,0.0,0.0,30305,Pancreatitis,0.322052619,77,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.322025321,14,"Biomarker, GeneticVariation, Therapeutic"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,26640,Mouth Neoplasms,0.321996357,7,"AlteredExpression, Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.32197629,22,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,1.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.3218203,23,"AlteredExpression, Biomarker"
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.321585338,6,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.321539904,214,"Biomarker, GeneticVariation"
1909,EDNRA,endothelin receptor type A,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.321458312,13,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,1.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.321433751,109,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3107,HLA-C,"major histocompatibility complex, class I, C",1.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.321337155,149,"AlteredExpression, Biomarker, GeneticVariation"
6310,ATXN1,ataxin 1,0.0,1.0,1.0,0.0,0.0,752120,SPINOCEREBELLAR ATAXIA 1,0.321262843,75,"Biomarker, GeneticVariation"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.321227435,350,"Biomarker, GeneticVariation"
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.321125776,18,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,220658,PFEIFFER SYNDROME,0.321105709,31,"Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,0.0,1.0,1.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.321047781,16,"Biomarker, GeneticVariation"
2078,ERG,v-ets avian erythroblastosis virus E26 oncogene homolog,1.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.321027714,31,"AlteredExpression, Biomarker"
5747,PTK2,protein tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.321018817,8,"Biomarker, GeneticVariation"
7039,TGFA,"transforming growth factor, alpha",1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.32099875,25,"AlteredExpression, Biomarker"
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.320891302,10,"Biomarker, GeneticVariation"
5741,PTH,parathyroid hormone,0.0,1.0,1.0,0.0,1.0,29456,Osteoporosis,0.320871236,31,"Biomarker, GeneticVariation, Therapeutic"
7852,CXCR4,chemokine (C-X-C motif) receptor 4,1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.320747318,195,"AlteredExpression, Biomarker, GeneticVariation"
4879,NPPB,natriuretic peptide B,1.0,1.0,1.0,0.0,1.0,18801,Heart Failure,0.320686281,26,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3106,HLA-B,"major histocompatibility complex, class I, B",1.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.320683254,110,"AlteredExpression, Biomarker, GeneticVariation"
6492,SIM1,single-minded family bHLH transcription factor 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.320636762,13,"Biomarker, GeneticVariation"
121278,TPH2,tryptophan hydroxylase 2,0.0,1.0,1.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.320587731,22,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,85580,"Hypertension, Essential",0.3205387,29,"Biomarker, GeneticVariation"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.320529803,9,"AlteredExpression, Biomarker, GeneticVariation"
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,20514,Hyperprolactinemia,0.320460705,33,Biomarker
181,AGRP,agouti related neuropeptide,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.320353257,15,"Biomarker, GeneticVariation"
25,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",1.0,1.0,1.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.320246032,1319,"AlteredExpression, Biomarker, GeneticVariation"
3156,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,1.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.320197267,14,"AlteredExpression, Biomarker, GeneticVariation"
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",1.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.320168303,7,"AlteredExpression, Biomarker, GeneticVariation"
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.320090308,6,"AlteredExpression, Biomarker, GeneticVariation"
335,APOA1,apolipoprotein A-I,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.320040789,7,"Biomarker, GeneticVariation"
213,ALB,albumin,0.0,1.0,0.0,0.0,1.0,11881,Diabetic Nephropathies,0.31992266,39,"Biomarker, Therapeutic"
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,1.0,0.0,0.0,409818,"Chronic infantile neurological, cutaneous and articular syndrome",0.31992266,35,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,1.0,0.0,5695,Urinary Bladder Neoplasms,0.319884799,6,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.319835279,9,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.319786248,14,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",1.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.319757284,7,"AlteredExpression, Biomarker, GeneticVariation"
4148,MATN3,matrilin 3,0.0,1.0,1.0,0.0,0.0,29408,Osteoarthritis,0.319708253,11,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.319679289,6,"Biomarker, GeneticVariation"
6338,SCNN1B,"sodium channel, non voltage gated 1 beta subunit",1.0,1.0,1.0,0.0,0.0,10674,Cystic Fibrosis,0.319679289,4,"AlteredExpression, Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,1.0,0.0,38356,Stomach Neoplasms,0.319630258,13,"Biomarker, GeneticVariation, PostTranslationalModification"
23621,BACE1,beta-site APP-cleaving enzyme 1,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.319596312,71,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,162557,"Liver Failure, Acute",0.319424749,13,"AlteredExpression, Biomarker, GeneticVariation"
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,85681,Hyperphosphatemia,0.319355651,35,Biomarker
3643,INSR,insulin receptor,1.0,1.0,0.0,0.0,0.0,20459,Hyperinsulinism,0.319326687,27,"AlteredExpression, Biomarker"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.319300831,186,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.319268759,11,"AlteredExpression, Biomarker"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.319219239,12,"Biomarker, GeneticVariation"
3663,IRF5,interferon regulatory factor 5,1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.319205915,93,"AlteredExpression, Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.31885774,10,"Biomarker, GeneticVariation"
4878,NPPA,natriuretic peptide A,0.0,1.0,1.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.318779744,11,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,24115,Lung Diseases,0.318574235,10,"Biomarker, GeneticVariation"
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.318505137,33,Biomarker
147409,DSG4,desmoglein 4,0.0,1.0,1.0,0.0,0.0,20678,Hypotrichosis,0.318418245,6,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.31829073,8,"Biomarker, GeneticVariation"
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.31829073,8,"Biomarker, GeneticVariation"
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,20503,"Hyperparathyroidism, Secondary",0.318221633,32,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,1.0,0.0,1.0,27051,Myocardial Infarction,0.318212735,7,"Biomarker, GeneticVariation, Therapeutic"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,4763,Barrett Esophagus,0.318212735,9,"AlteredExpression, Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.318189641,90,"Biomarker, GeneticVariation"
4879,NPPB,natriuretic peptide B,1.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.31813474,8,"AlteredExpression, Biomarker"
4879,NPPB,natriuretic peptide B,1.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.31813474,8,"AlteredExpression, Biomarker"
4137,MAPT,microtubule-associated protein tau,0.0,1.0,1.0,0.0,0.0,497327,Dementia,0.318092941,110,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,1.0,11884,Diabetic Retinopathy,0.318007226,8,"Biomarker, GeneticVariation, Therapeutic"
4692,NDN,"necdin, melanoma antigen (MAGE) family member",0.0,1.0,0.0,0.0,0.0,32897,Prader-Willi Syndrome,0.317938128,28,Biomarker
10269,ZMPSTE24,zinc metallopeptidase STE24,0.0,1.0,0.0,0.0,0.0,33300,Progeria,0.317938128,29,Biomarker
9997,SCO2,SCO2 cytochrome c oxidase assembly protein,0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.317909164,19,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.317851236,7,"AlteredExpression, Biomarker"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,24115,Lung Diseases,0.317801716,8,"Biomarker, GeneticVariation"
1535,CYBA,"cytochrome b-245, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.317723721,4,"Biomarker, GeneticVariation"
5048,PAFAH1B1,"platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)",0.0,1.0,1.0,0.0,0.0,431375,Classical Lissencephaly,0.317654623,30,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,1.0,1.0,0.0,0.0,1.0,21368,Inflammation,0.317567731,5,"AlteredExpression, Biomarker, Therapeutic"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.317469181,14,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,1.0,1.0,1.0,0.0,0.0,35126,Reperfusion Injury,0.317362222,6,"AlteredExpression, Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.317313191,12,Biomarker
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.317313191,14,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,270611,Brain Injuries,0.317156712,8,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,16059,Fibrosis,0.317156712,7,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.317029686,10,"AlteredExpression, Biomarker"
149233,IL23R,interleukin 23 receptor,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.317026658,91,"Biomarker, GeneticVariation"
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,1.0,0.0,1.0,7786,Brain Ischemia,0.316951203,30,"Biomarker, GeneticVariation, Therapeutic"
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,1.0,0.0,0.0,33687,Proteinuria,0.316951203,5,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,1.0,24121,Lung Neoplasms,0.316936028,146,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.316824177,10,"Biomarker, GeneticVariation"
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.31680411,27,Biomarker
10814,CPLX2,complexin 2,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.316540672,8,"Biomarker, GeneticVariation"
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.316520605,25,Biomarker
2969,GTF2I,general transcription factor IIi,0.0,1.0,0.0,0.0,0.0,175702,Williams Syndrome,0.316520605,23,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,11881,Diabetic Nephropathies,0.316491641,17,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,38358,Stomach Ulcer,0.316462677,13,"AlteredExpression, Biomarker"
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.316462677,9,Biomarker
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.3163797,96,"AlteredExpression, Biomarker, GeneticVariation"
595,CCND1,cyclin D1,0.0,1.0,1.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.316257167,7,"Biomarker, GeneticVariation"
639,PRDM1,"PR domain containing 1, with ZNF domain",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.316051658,6,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,34069,Pulmonary Fibrosis,0.316051658,11,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.316051658,7,"Biomarker, GeneticVariation"
4897,NRCAM,neuronal cell adhesion molecule,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.316051658,6,"Biomarker, GeneticVariation"
3606,IL18,interleukin 18,0.0,1.0,1.0,0.0,1.0,524620,Metabolic Syndrome X,0.316051658,10,"Biomarker, GeneticVariation, Therapeutic"
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.315973663,6,"Biomarker, GeneticVariation, Therapeutic"
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,1.0,0.0,0.0,22650,Kidney Calculi,0.315973663,9,"Biomarker, GeneticVariation"
1869,E2F1,E2F transcription factor 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.315953596,22,Biomarker
353,APRT,adenine phosphoribosyltransferase,1.0,1.0,1.0,0.0,0.0,3665382,ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY,0.315953596,24,"AlteredExpression, Biomarker, GeneticVariation"
23411,SIRT1,sirtuin 1,1.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.315924632,12,"AlteredExpression, Biomarker"
6502,SKP2,"S-phase kinase-associated protein 2, E3 ubiquitin protein ligase",1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.315924632,13,"AlteredExpression, Biomarker"
6311,ATXN2,ataxin 2,1.0,1.0,1.0,0.0,0.0,752121,SPINOCEREBELLAR ATAXIA 2,0.315876256,56,"AlteredExpression, Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,15695,Fatty Liver,0.315690158,6,"Biomarker, GeneticVariation"
9569,GTF2IRD1,GTF2I repeat domain containing 1,0.0,1.0,0.0,0.0,0.0,175702,Williams Syndrome,0.315670091,20,Biomarker
959,CD40LG,CD40 ligand,1.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.315612163,6,"AlteredExpression, Biomarker"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.315607248,118,"AlteredExpression, Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,11875,Diabetic Angiopathies,0.315484649,6,"Biomarker, GeneticVariation"
2702,GJA5,"gap junction protein, alpha 5, 40kDa",0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.315484649,7,"Biomarker, GeneticVariation, Therapeutic"
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.315435618,12,"Biomarker, GeneticVariation"
10911,UTS2,urotensin 2,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.315406654,6,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.315406654,4,"Biomarker, GeneticVariation"
84676,TRIM63,"tripartite motif containing 63, E3 ubiquitin protein ligase",1.0,1.0,0.0,0.0,0.0,26846,Muscular Atrophy,0.315357623,13,"AlteredExpression, Biomarker"
4088,SMAD3,SMAD family member 3,0.0,1.0,1.0,0.0,0.0,29408,Osteoarthritis,0.315357623,11,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,1.0,1.0,0.0,24121,Lung Neoplasms,0.315328659,5,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
4973,OLR1,oxidized low density lipoprotein (lectin-like) receptor 1,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.315201144,5,"Biomarker, GeneticVariation"
5145,PDE6A,"phosphodiesterase 6A, cGMP-specific, rod, alpha",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.315201144,6,"Biomarker, GeneticVariation"
1909,EDNRA,endothelin receptor type A,0.0,1.0,1.0,0.0,0.0,520679,"Sleep Apnea, Obstructive",0.315201144,4,"Biomarker, GeneticVariation"
8828,NRP2,neuropilin 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.315123149,1,"Biomarker, GeneticVariation"
7439,BEST1,bestrophin 1,0.0,1.0,1.0,0.0,0.0,2745945,"MACULAR DYSTROPHY, VITELLIFORM",0.315103082,18,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.315045154,5,"AlteredExpression, Biomarker, Therapeutic"
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",1.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.315045154,3,"AlteredExpression, Biomarker"
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.315045154,5,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,24115,Lung Diseases,0.314868609,14,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.314868609,14,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,1.0,18800,Cardiomegaly,0.314839645,5,"Biomarker, GeneticVariation, Therapeutic"
3552,IL1A,"interleukin 1, alpha",0.0,1.0,1.0,0.0,0.0,270611,Brain Injuries,0.314839645,4,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,1.0,34063,Pulmonary Edema,0.314839645,3,"Biomarker, GeneticVariation, Therapeutic"
5339,PLEC,plectin,0.0,1.0,0.0,0.0,0.0,2931072,Epidermolysa bullosa simplex and limb girdle muscular dystrophy,0.314819578,17,Biomarker
2305,FOXM1,forkhead box M1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.314819578,18,Biomarker
6778,STAT6,"signal transducer and activator of transcription 6, interleukin-4 induced",0.0,1.0,1.0,0.0,1.0,11615,"Dermatitis, Atopic",0.314790614,10,"Biomarker, GeneticVariation, Therapeutic"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,1.0,21655,Insulin Resistance,0.314634135,7,"Biomarker, GeneticVariation, Therapeutic"
23411,SIRT1,sirtuin 1,0.0,1.0,1.0,0.0,1.0,21655,Insulin Resistance,0.314634135,6,"Biomarker, GeneticVariation, Therapeutic"
3606,IL18,interleukin 18,0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.314634135,4,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.314634135,8,"Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.314634135,4,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,33581,Prostatitis,0.314634135,3,"Biomarker, GeneticVariation"
477,ATP1A2,"ATPase, Na+/K+ transporting, alpha 2 polypeptide",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.314634135,5,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,1925,Albuminuria,0.314634135,4,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,1.0,270611,Brain Injuries,0.314634135,5,"Biomarker, GeneticVariation, Therapeutic"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,1.0,0.0,1.0,23890,Liver Cirrhosis,0.314634135,4,"Biomarker, GeneticVariation, Therapeutic"
3990,LIPC,"lipase, hepatic",0.0,1.0,1.0,0.0,0.0,20476,Hyperlipoproteinemias,0.314634135,3,"Biomarker, GeneticVariation"
4886,NPY1R,neuropeptide Y receptor Y1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.314634135,3,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,1.0,236736,Cocaine-Related Disorders,0.314634135,13,"Biomarker, GeneticVariation, Therapeutic"
3572,IL6ST,interleukin 6 signal transducer,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.314585104,9,"Biomarker, GeneticVariation"
5310,PKD1,polycystic kidney disease 1 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,3149841,POLYCYSTIC KIDNEY DISEASE 1,0.314585104,33,"Biomarker, GeneticVariation"
4724,NDUFS4,"NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.314507109,8,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.3143016,12,"Biomarker, GeneticVariation, Therapeutic"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.3143016,9,"Biomarker, GeneticVariation"
23411,SIRT1,sirtuin 1,0.0,1.0,1.0,0.0,1.0,524620,Metabolic Syndrome X,0.3143016,8,"Biomarker, GeneticVariation, Therapeutic"
55054,ATG16L1,autophagy related 16-like 1 (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.314249541,96,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.313995,115,"Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,0.0,1.0,1.0,0.0,0.0,15695,Fatty Liver,0.313969064,17,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.3139401,8,"Biomarker, GeneticVariation"
2539,G6PD,glucose-6-phosphate dehydrogenase,1.0,1.0,1.0,0.0,0.0,2939465,Glucosephosphate Dehydrogenase Deficiency,0.313914244,187,"AlteredExpression, Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.31373459,7,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.313711496,93,"AlteredExpression, Biomarker, GeneticVariation"
4745,NELL1,NEL-like 1 (chicken),1.0,1.0,0.0,0.0,0.0,10278,Craniosynostoses,0.313656595,5,"AlteredExpression, Biomarker"
1889,ECE1,endothelin converting enzyme 1,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.313656595,7,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),1.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.313656595,7,"AlteredExpression, Biomarker"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.313451086,7,"Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.313402055,14,Biomarker
3643,INSR,insulin receptor,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.313402055,14,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,1.0,243026,Sepsis,0.313373091,6,"Biomarker, Therapeutic"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.313373091,7,Biomarker
898,CCNE1,cyclin E1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.313373091,7,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.313373091,9,"AlteredExpression, Biomarker, Therapeutic"
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.31335896,174,"AlteredExpression, Biomarker, GeneticVariation"
5080,PAX6,paired box 6,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.313167581,5,"Biomarker, GeneticVariation"
1363,CPE,carboxypeptidase E,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.313167581,6,"Biomarker, GeneticVariation"
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,1.0,0.0,0.0,30193,Pain,0.313167581,8,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.313145782,219,"AlteredExpression, Biomarker, GeneticVariation"
7468,WHSC1,Wolf-Hirschhorn syndrome candidate 1,0.0,1.0,1.0,0.0,0.0,1956097,Wolf-Hirschhorn Syndrome,0.31311855,11,"Biomarker, GeneticVariation"
4647,MYO7A,myosin VIIA,0.0,1.0,1.0,0.0,0.0,2931206,"Usher syndrome, type 1B",0.31311855,11,"Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,1.0,20538,Hypertension,0.313089586,6,"Biomarker, Therapeutic"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.313089586,4,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,38358,Stomach Ulcer,0.312884077,3,"Biomarker, GeneticVariation"
155,ADRB3,adrenoceptor beta 3,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.312884077,6,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.31288381,174,"Biomarker, GeneticVariation"
4968,OGG1,8-oxoguanine DNA glycosylase,1.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.312806082,3,"AlteredExpression, Biomarker, GeneticVariation"
2131,EXT1,exostosin glycosyltransferase 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.312806082,1,"Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,0.0,1.0,1.0,0.0,0.0,11882,Diabetic Neuropathies,0.312806082,2,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.312635406,109,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.312600572,4,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.312600572,5,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.312600572,3,"Biomarker, GeneticVariation"
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,1.0,0.0,1.0,27051,Myocardial Infarction,0.312600572,8,"Biomarker, GeneticVariation, Therapeutic"
6285,S100B,S100 calcium binding protein B,0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.312600572,4,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.312597122,135,"AlteredExpression, Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,1.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.312522577,9,"AlteredExpression, Biomarker, Therapeutic"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),1.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.312522577,5,"AlteredExpression, Biomarker, Therapeutic"
6548,SLC9A1,"solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1",0.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.312522577,3,"Biomarker, Therapeutic"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,18800,Cardiomegaly,0.312522577,3,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,1.0,270611,Brain Injuries,0.312522577,3,"Biomarker, Therapeutic"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.312522577,3,"AlteredExpression, Biomarker"
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.312522577,3,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,1.0,21368,Inflammation,0.312522577,3,"Biomarker, Therapeutic"
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.312522577,3,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.312522577,5,Biomarker
6256,RXRA,"retinoid X receptor, alpha",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.312522577,2,"Biomarker, GeneticVariation"
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",1.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.312522577,1,"AlteredExpression, Biomarker"
2911,GRM1,"glutamate receptor, metabotropic 1",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.312522577,3,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),1.0,1.0,0.0,0.0,1.0,20541,"Hypertension, Portal",0.312522577,4,"AlteredExpression, Biomarker, Therapeutic"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.312522577,3,"AlteredExpression, Biomarker"
1012,CDH13,cadherin 13,0.0,1.0,0.0,1.0,0.0,24121,Lung Neoplasms,0.312522577,3,"Biomarker, PostTranslationalModification"
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",1.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.312522577,3,"AlteredExpression, Biomarker"
5077,PAX3,paired box 3,1.0,1.0,0.0,0.0,1.0,27794,Neural Tube Defects,0.312522577,3,"AlteredExpression, Biomarker, Therapeutic"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,0.0,0.0,0.0,35328,Retinal Vein Occlusion,0.312522577,3,"AlteredExpression, Biomarker"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.312439348,196,"AlteredExpression, Biomarker, GeneticVariation"
26191,PTPN22,"protein tyrosine phosphatase, non-receptor type 22 (lymphoid)",0.0,1.0,1.0,0.0,0.0,4364,Autoimmune Diseases,0.31240051,149,"Biomarker, GeneticVariation"
32,ACACB,acetyl-CoA carboxylase beta,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.312317068,3,"Biomarker, GeneticVariation"
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.312317068,3,"Biomarker, GeneticVariation"
3952,LEP,leptin,0.0,1.0,1.0,0.0,1.0,21655,Insulin Resistance,0.312317068,4,"Biomarker, GeneticVariation, Therapeutic"
5295,PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.312317068,3,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,35126,Reperfusion Injury,0.312317068,6,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,15934,Fetal Growth Retardation,0.312317068,3,"Biomarker, GeneticVariation"
10891,PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.312317068,1,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,600518,Choroidal Neovascularization,0.312317068,3,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,26640,Mouth Neoplasms,0.312317068,3,"Biomarker, GeneticVariation"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,1.0,30193,Pain,0.312317068,3,"Biomarker, GeneticVariation, Therapeutic"
1812,DRD1,dopamine receptor D1,0.0,1.0,1.0,0.0,1.0,30567,Parkinson Disease,0.312317068,4,"Biomarker, GeneticVariation, Therapeutic"
4137,MAPT,microtubule-associated protein tau,0.0,1.0,1.0,0.0,0.0,25261,Memory Disorders,0.312317068,4,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,15967,Fever,0.312317068,6,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,13386,"Dyskinesia, Drug-Induced",0.312317068,5,"Biomarker, GeneticVariation"
54551,MAGEL2,melanoma antigen family L2,0.0,1.0,0.0,0.0,0.0,32897,Prader-Willi Syndrome,0.312268037,8,Biomarker
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,1.0,34069,Pulmonary Fibrosis,0.312268037,11,"Biomarker, Therapeutic"
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.312268037,10,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.312267281,391,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,1.0,9319,Colitis,0.311984532,9,"Biomarker, Therapeutic"
4155,MBP,myelin basic protein,0.0,1.0,0.0,0.0,0.0,11303,Demyelinating Diseases,0.311984532,9,Biomarker
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,0.0,0.0,0.0,20433,Hyperbilirubinemia,0.311984532,10,Biomarker
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.311984532,8,Biomarker
81,ACTN4,"actinin, alpha 4",0.0,1.0,1.0,0.0,0.0,333497,Segmental glomerulosclerosis,0.311984532,9,"Biomarker, GeneticVariation"
7299,TYR,tyrosinase,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.311880748,216,"AlteredExpression, Biomarker, GeneticVariation"
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,1.0,0.0,0.0,8370,Cholestasis,0.311701027,11,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.311701027,8,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,12715,Iron Metabolism Disorders,0.311701027,8,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,1.0,11881,Diabetic Nephropathies,0.311701027,7,"Biomarker, Therapeutic"
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,1.0,0.0,0.0,1867403,"Pyloric Stenosis, Infantile Hypertrophic 1",0.311701027,6,"Biomarker, GeneticVariation"
2626,GATA4,GATA binding protein 4,0.0,1.0,1.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.311701027,7,"Biomarker, GeneticVariation"
93664,CADPS2,Ca++-dependent secretion activator 2,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.311701027,6,Biomarker
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,35455,Rhinitis,0.311701027,8,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,1.0,18801,Heart Failure,0.311701027,11,"Biomarker, Therapeutic"
9031,BAZ1B,"bromodomain adjacent to zinc finger domain, 1B",0.0,1.0,0.0,0.0,0.0,175702,Williams Syndrome,0.311701027,7,Biomarker
3066,HDAC2,histone deacetylase 2,0.0,1.0,0.0,0.0,1.0,24117,"Pulmonary Disease, Chronic Obstructive",0.311701027,10,"Biomarker, Therapeutic"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,1.0,20538,Hypertension,0.311417523,7,"Biomarker, Therapeutic"
6285,S100B,S100 calcium binding protein B,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.311417523,5,Biomarker
5367,PMCH,pro-melanin-concentrating hormone,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.311417523,7,Biomarker
9509,ADAMTS2,"ADAM metallopeptidase with thrombospondin type 1 motif, 2",0.0,1.0,0.0,0.0,0.0,2700425,"Ehlers-Danlos Syndrome, Type VII, Autosomal Recessive",0.311417523,5,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,1.0,993582,"Arthritis, Experimental",0.311417523,15,"Biomarker, Therapeutic"
3320,HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.311417523,7,Biomarker
6314,ATXN7,ataxin 7,0.0,1.0,1.0,0.0,0.0,752125,spinocerebellar ataxia-7,0.311340183,40,"Biomarker, GeneticVariation"
6495,SIX1,SIX homeobox 1,0.0,1.0,1.0,0.0,0.0,265234,Branchio-Oto-Renal Syndrome,0.311253291,14,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.311246847,151,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.311239734,235,"AlteredExpression, Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,243026,Sepsis,0.311134018,7,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.311134018,6,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.311134018,7,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.311134018,6,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,1.0,11175,Dehydration,0.311134018,6,"Biomarker, Therapeutic"
231,AKR1B1,"aldo-keto reductase family 1, member B1 (aldose reductase)",0.0,1.0,0.0,0.0,1.0,86543,Cataract,0.311134018,8,"Biomarker, Therapeutic"
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.311134018,6,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.311134018,5,Biomarker
9971,NR1H4,"nuclear receptor subfamily 1, group H, member 4",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.311134018,5,Biomarker
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,18790,Heart Arrest,0.311134018,6,"AlteredExpression, Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.311134018,6,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.311134018,6,Biomarker
6569,SLC34A1,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 1",0.0,1.0,0.0,0.0,0.0,20438,Hypercalciuria,0.311134018,6,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,1.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.311134018,7,"Biomarker, GeneticVariation"
23236,PLCB1,"phospholipase C, beta 1 (phosphoinositide-specific)",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.311134018,5,Biomarker
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,40038,Thromboembolism,0.311050235,171,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.310928242,76,"AlteredExpression, Biomarker, GeneticVariation"
6364,CCL20,chemokine (C-C motif) ligand 20,0.0,1.0,0.0,0.0,1.0,9324,"Colitis, Ulcerative",0.310850514,5,"Biomarker, Therapeutic"
652,BMP4,bone morphogenetic protein 4,0.0,1.0,0.0,0.0,0.0,33375,Prolactinoma,0.310850514,5,Biomarker
1395,CRHR2,corticotropin releasing hormone receptor 2,0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.310850514,5,Biomarker
1399,CRKL,v-crk avian sarcoma virus CT10 oncogene homolog-like,0.0,1.0,0.0,0.0,0.0,12236,DiGeorge Syndrome,0.310850514,4,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,1.0,9319,Colitis,0.310850514,6,"Biomarker, Therapeutic"
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.310850514,5,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,34069,Pulmonary Fibrosis,0.310850514,5,"Biomarker, GeneticVariation"
26960,NBEA,neurobeachin,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.310850514,4,Biomarker
2,A2M,alpha-2-macroglobulin,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.310850514,4,Biomarker
10788,IQGAP2,IQ motif containing GTPase activating protein 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.310850514,3,Biomarker
3929,LBP,lipopolysaccharide binding protein,0.0,1.0,0.0,0.0,1.0,28754,Obesity,0.310850514,4,"Biomarker, Therapeutic"
5193,PEX12,peroxisomal biogenesis factor 12,0.0,1.0,0.0,0.0,0.0,43459,Zellweger Syndrome,0.310850514,4,Biomarker
3339,HSPG2,heparan sulfate proteoglycan 2,0.0,1.0,0.0,0.0,0.0,1857100,Dyssegmental dysplasia,0.310850514,3,Biomarker
8100,IFT88,intraflagellar transport 88,0.0,1.0,0.0,0.0,0.0,85548,"Polycystic Kidney, Autosomal Recessive",0.310850514,5,Biomarker
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),0.0,1.0,0.0,0.0,1.0,30567,Parkinson Disease,0.310850514,7,"Biomarker, Therapeutic"
4891,SLC11A2,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2",0.0,1.0,0.0,0.0,0.0,162316,"Anemia, Iron-Deficiency",0.310850514,5,Biomarker
1909,EDNRA,endothelin receptor type A,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.310850514,5,Biomarker
493856,CISD2,CDGSH iron sulfur domain 2,0.0,1.0,0.0,0.0,0.0,1858028,Wolfram Syndrome 2,0.310850514,3,Biomarker
8714,ABCC3,"ATP-binding cassette, sub-family C (CFTR/MRP), member 3",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.310567009,4,Biomarker
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,1.0,0.0,0.0,1864498,"Renal tubular acidosis, distal, autosomal recessive",0.310567009,2,"Biomarker, GeneticVariation"
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.310567009,4,Biomarker
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.310567009,4,Biomarker
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.310567009,4,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.310567009,4,Biomarker
156,ADRBK1,"adrenergic, beta, receptor kinase 1",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.310567009,4,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.310567009,9,Biomarker
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.310567009,4,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,1.0,20538,Hypertension,0.310567009,5,"Biomarker, Therapeutic"
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.310567009,5,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,162872,"Aortic Aneurysm, Thoracic",0.310567009,4,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,162872,"Aortic Aneurysm, Thoracic",0.310567009,4,"Biomarker, GeneticVariation"
51094,ADIPOR1,adiponectin receptor 1,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.310567009,3,Biomarker
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,1.0,34069,Pulmonary Fibrosis,0.310567009,4,"Biomarker, Therapeutic"
3764,KCNJ8,"potassium channel, inwardly rectifying subfamily J, member 8",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.310567009,4,Biomarker
28964,GIT1,G protein-coupled receptor kinase interacting ArfGAP 1,0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.310567009,2,"Biomarker, GeneticVariation"
348980,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.310567009,4,"Biomarker, GeneticVariation"
4504,MT3,metallothionein 3,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.310567009,3,"Biomarker, Therapeutic"
2180,ACSL1,acyl-CoA synthetase long-chain family member 1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.310567009,4,Biomarker
2878,GPX3,glutathione peroxidase 3 (plasma),0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.310567009,4,Biomarker
3099,HK2,hexokinase 2,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.310567009,4,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,1.0,242422,Parkinsonian Disorders,0.310567009,6,"Biomarker, Therapeutic"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.310567009,5,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,1.0,993582,"Arthritis, Experimental",0.310567009,7,"Biomarker, Therapeutic"
4323,MMP14,matrix metallopeptidase 14 (membrane-inserted),0.0,1.0,0.0,0.0,0.0,162871,"Aortic Aneurysm, Abdominal",0.310567009,3,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.310567009,14,Biomarker
6529,SLC6A1,"solute carrier family 6 (neurotransmitter transporter), member 1",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.310567009,3,Biomarker
6671,SP4,Sp4 transcription factor,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.310567009,2,Biomarker
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,0.0,0.0,0.0,853897,Diabetic Cardiomyopathies,0.310567009,4,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,242350,Erectile Dysfunction,0.310283505,3,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,1.0,7786,Brain Ischemia,0.310283505,4,"Biomarker, Therapeutic"
3605,IL17A,interleukin 17A,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.310283505,2,Biomarker
3218,HOXB8,homeobox B8,0.0,1.0,0.0,0.0,0.0,40953,Trichotillomania,0.310283505,2,Biomarker
6247,RS1,retinoschisin 1,0.0,1.0,1.0,0.0,0.0,3714753,"RETINOSCHISIS 1, X-LINKED, JUVENILE",0.310283505,10,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,0.0,0.0,0.0,12739,Disseminated Intravascular Coagulation,0.310283505,3,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.310283505,3,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.310283505,3,"Biomarker, GeneticVariation"
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.310283505,4,Biomarker
133,ADM,adrenomedullin,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.310283505,5,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.310283505,3,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.310283505,3,Biomarker
1269,CNR2,cannabinoid receptor 2 (macrophage),0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.310283505,2,Biomarker
587,BCAT2,"branched chain amino-acid transaminase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,24776,Maple Syrup Urine Disease,0.310283505,1,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,0.0,0.0,1.0,6625,Cachexia,0.310283505,3,"Biomarker, Therapeutic"
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.310283505,3,Biomarker
158326,FREM1,FRAS1 related extracellular matrix 1,0.0,1.0,0.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.310283505,1,Biomarker
2626,GATA4,GATA binding protein 4,0.0,1.0,0.0,0.0,1.0,27051,Myocardial Infarction,0.310283505,3,"Biomarker, Therapeutic"
6869,TACR1,tachykinin receptor 1,0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.310283505,1,"Biomarker, GeneticVariation"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.310283505,2,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.310283505,3,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,1565489,Renal Insufficiency,0.310283505,3,Biomarker
3066,HDAC2,histone deacetylase 2,0.0,1.0,0.0,0.0,1.0,14175,Endometriosis,0.310283505,3,"Biomarker, Therapeutic"
4744,NEFH,"neurofilament, heavy polypeptide",0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.310283505,1,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,1.0,20541,"Hypertension, Portal",0.310283505,3,"Biomarker, Therapeutic"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,20473,Hyperlipidemias,0.310283505,3,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.310283505,3,Biomarker
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",0.0,1.0,1.0,0.0,0.0,1857253,Dicarboxylicaminoaciduria,0.310283505,1,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.310283505,3,Biomarker
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,1.0,993582,"Arthritis, Experimental",0.310283505,4,"Biomarker, Therapeutic"
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",0.0,1.0,1.0,0.0,0.0,19151,Hepatic Encephalopathy,0.310283505,2,"Biomarker, GeneticVariation"
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,1.0,1.0,0.0,0.0,19151,Hepatic Encephalopathy,0.310283505,2,"Biomarker, GeneticVariation"
6356,CCL11,chemokine (C-C motif) ligand 11,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.310283505,4,Biomarker
6361,CCL17,chemokine (C-C motif) ligand 17,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.310283505,3,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.310283505,3,Biomarker
2660,MSTN,myostatin,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.310283505,2,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.310283505,5,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.310283505,4,Biomarker
6336,SCN10A,"sodium channel, voltage gated, type X alpha subunit",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.310283505,3,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.310283505,4,Biomarker
1910,EDNRB,endothelin receptor type B,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.310283505,4,Biomarker
4093,SMAD9,SMAD family member 9,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.310283505,2,Biomarker
3284,HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.310283505,3,Biomarker
6770,STAR,steroidogenic acute regulatory protein,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.310283505,3,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.310283505,5,Biomarker
2833,CXCR3,chemokine (C-X-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,38454,Stroke,0.310283505,2,Biomarker
1374,CPT1A,carnitine palmitoyltransferase 1A (liver),0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.310283505,3,Biomarker
1910,EDNRB,endothelin receptor type B,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.310283505,3,Biomarker
7056,THBD,thrombomodulin,0.0,1.0,0.0,0.0,0.0,35222,"Respiratory Distress Syndrome, Adult",0.310283505,2,Biomarker
23600,AMACR,alpha-methylacyl-CoA racemase,0.0,1.0,1.0,0.0,0.0,3280428,Alpha-Methylacyl-CoA Racemase Deficiency,0.310283505,1,"Biomarker, GeneticVariation"
1742,DLG4,"discs, large homolog 4 (Drosophila)",0.0,1.0,0.0,0.0,0.0,175702,Williams Syndrome,0.310283505,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.310283505,4,Biomarker
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.310251513,99,"Biomarker, GeneticVariation"
367,AR,androgen receptor,1.0,1.0,1.0,0.0,1.0,33578,Prostatic Neoplasms,0.310033857,216,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
590,BCHE,butyrylcholinesterase,0.0,1.0,1.0,0.0,0.0,1412756,BUTYRYLCHOLINESTERASE,0.31,18,"Biomarker, GeneticVariation"
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.31,2,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.31,2,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,1835698,"Keratitis, hereditary",0.31,0,Biomarker
7273,TTN,titin,0.0,1.0,0.0,0.0,0.0,1837342,"Muscular Dystrophy, Limb-Girdle, Type 2J",0.31,0,Biomarker
5562,PRKAA1,"protein kinase, AMP-activated, alpha 1 catalytic subunit",0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.31,2,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.31,2,Biomarker
6720,SREBF1,sterol regulatory element binding transcription factor 1,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.31,2,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,20550,Hyperthyroidism,0.31,2,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,1.0,20550,Hyperthyroidism,0.31,2,"Biomarker, Therapeutic"
2243,FGA,fibrinogen alpha chain,0.0,1.0,0.0,0.0,0.0,34065,Pulmonary Embolism,0.31,2,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.31,3,Biomarker
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,37929,Spinal Cord Injuries,0.31,2,Biomarker
361,AQP4,aquaporin 4,0.0,1.0,0.0,0.0,0.0,37929,Spinal Cord Injuries,0.31,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,37929,Spinal Cord Injuries,0.31,2,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,37929,Spinal Cord Injuries,0.31,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,37929,Spinal Cord Injuries,0.31,1,Biomarker
3291,HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2,0.0,1.0,1.0,0.0,0.0,1415737,hydroxysteroid (11-beta) dehydrogenase 2,0.31,6,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,242350,Erectile Dysfunction,0.31,1,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,242350,Erectile Dysfunction,0.31,1,Biomarker
1909,EDNRA,endothelin receptor type A,0.0,1.0,0.0,0.0,0.0,242350,Erectile Dysfunction,0.31,2,Biomarker
4886,NPY1R,neuropeptide Y receptor Y1,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.31,2,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,1.0,242488,Acute Lung Injury,0.31,2,"Biomarker, Therapeutic"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,1.0,242488,Acute Lung Injury,0.31,2,"Biomarker, Therapeutic"
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,1.0,242488,Acute Lung Injury,0.31,2,"Biomarker, Therapeutic"
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,10692,Cystitis,0.31,2,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.31,2,Biomarker
1427,CRYGS,"crystallin, gamma S",0.0,1.0,1.0,0.0,0.0,3805410,"CATARACT 20, MULTIPLE TYPES",0.31,1,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.31,2,Biomarker
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.31,2,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.31,2,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,3,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,4,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.31,3,"Biomarker, Therapeutic"
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,3,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,2,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,2,Biomarker
1958,EGR1,early growth response 1,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,2,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,2,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,2,Biomarker
5599,MAPK8,mitogen-activated protein kinase 8,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,2,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,7,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,4,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.31,2,"Biomarker, Therapeutic"
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.31,2,"Biomarker, Therapeutic"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.31,2,"Biomarker, Therapeutic"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,2,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,8,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,3,Biomarker
6401,SELE,selectin E,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.31,3,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.31,5,"Biomarker, Therapeutic"
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.31,2,"Biomarker, Therapeutic"
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.31,2,Biomarker
1649,DDIT3,DNA-damage-inducible transcript 3,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.31,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.31,2,Biomarker
2147,F2,coagulation factor II (thrombin),0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.31,1,Biomarker
10763,NES,nestin,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.31,2,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.31,1,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.31,2,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,36982,"Shock, Hemorrhagic",0.31,2,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,36982,"Shock, Hemorrhagic",0.31,2,Biomarker
6548,SLC9A1,"solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1",0.0,1.0,0.0,0.0,0.0,36982,"Shock, Hemorrhagic",0.31,2,Biomarker
2253,FGF8,fibroblast growth factor 8 (androgen-induced),0.0,1.0,0.0,0.0,0.0,12236,DiGeorge Syndrome,0.31,1,Biomarker
7046,TGFBR1,"transforming growth factor, beta receptor 1",0.0,1.0,1.0,0.0,0.0,2931764,Furlong syndrome,0.31,0,"Biomarker, GeneticVariation"
898,CCNE1,cyclin E1,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.31,2,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,1.0,38358,Stomach Ulcer,0.31,2,"Biomarker, Therapeutic"
1145,CHRNE,"cholinergic receptor, nicotinic, epsilon (muscle)",0.0,1.0,1.0,0.0,0.0,751885,"MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL",0.31,0,"Biomarker, GeneticVariation"
5897,RAG2,recombination activating gene 2,0.0,1.0,0.0,0.0,0.0,1832322,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive",0.31,0,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,178324,Vascular System Injuries,0.31,2,Biomarker
26762,HAVCR1,hepatitis A virus cellular receptor 1,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.31,2,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,26766,Multiple Organ Failure,0.31,2,Biomarker
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.31,2,Biomarker
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.31,2,Biomarker
51083,GAL,galanin/GMAP prepropeptide,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.31,2,Biomarker
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,0.0,0.0,1.0,20538,Hypertension,0.31,2,"Biomarker, Therapeutic"
2740,GLP1R,glucagon-like peptide 1 receptor,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.31,2,Biomarker
11255,HRH3,histamine receptor H3,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.31,1,Biomarker
5580,PRKCD,"protein kinase C, delta",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.31,3,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.31,2,Biomarker
9351,SLC9A3R2,"solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.31,2,Biomarker
3077,HFE,hemochromatosis,0.0,1.0,1.0,0.0,0.0,1384665,HFE GENE,0.31,7,"Biomarker, GeneticVariation"
5601,MAPK9,mitogen-activated protein kinase 9,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.31,2,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,1.0,18800,Cardiomegaly,0.31,16,"Biomarker, Therapeutic"
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.31,1,Biomarker
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,1.0,18800,Cardiomegaly,0.31,2,"Biomarker, Therapeutic"
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.31,2,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.31,2,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,1.0,18800,Cardiomegaly,0.31,5,"Biomarker, Therapeutic"
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,1.0,18800,Cardiomegaly,0.31,7,"Biomarker, Therapeutic"
5578,PRKCA,"protein kinase C, alpha",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.31,2,Biomarker
5579,PRKCB,"protein kinase C, beta",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.31,2,Biomarker
51548,SIRT6,sirtuin 6,0.0,1.0,0.0,0.0,1.0,18800,Cardiomegaly,0.31,1,"Biomarker, Therapeutic"
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,2,Biomarker
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,5,Biomarker
902,CCNH,cyclin H,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,1,Biomarker
1019,CDK4,cyclin-dependent kinase 4,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,2,Biomarker
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,2,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,1,Biomarker
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,0.0,0.0,1.0,24668,"Mammary Neoplasms, Experimental",0.31,2,"Biomarker, Therapeutic"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,3,Biomarker
4012,LNPEP,leucyl/cystinyl aminopeptidase,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,2,Biomarker
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,1,Biomarker
6051,RNPEP,arginyl aminopeptidase (aminopeptidase B),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,1,Biomarker
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.31,4,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,42373,Vascular Diseases,0.31,1,Biomarker
210,ALAD,aminolevulinate dehydratase,0.0,1.0,0.0,0.0,0.0,162533,"Porphyrias, Hepatic",0.31,3,Biomarker
6833,ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",0.0,1.0,1.0,0.0,0.0,2931832,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1",0.31,0,"Biomarker, GeneticVariation"
6285,S100B,S100 calcium binding protein B,0.0,1.0,0.0,0.0,0.0,18944,Hematoma,0.31,2,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,600467,Neurogenic Inflammation,0.31,6,Biomarker
6869,TACR1,tachykinin receptor 1,0.0,1.0,0.0,0.0,0.0,600467,Neurogenic Inflammation,0.31,3,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,600467,Neurogenic Inflammation,0.31,2,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,3150974,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3",0.31,2,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,6434,Burns,0.31,2,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,36983,"Shock, Septic",0.31,2,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,403823,Asthenozoospermia,0.31,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,220708,VATER association,0.31,1,Biomarker
6346,CCL1,chemokine (C-C motif) ligand 1,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.31,2,Biomarker
6354,CCL7,chemokine (C-C motif) ligand 7,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.31,2,Biomarker
38,ACAT1,acetyl-CoA acetyltransferase 1,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.31,1,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.31,2,Biomarker
3156,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.31,2,Biomarker
6721,SREBF2,sterol regulatory element binding transcription factor 2,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.31,2,Biomarker
3988,LIPA,"lipase A, lysosomal acid, cholesterol esterase",0.0,1.0,1.0,0.0,0.0,1416865,LYSOSOMAL ACID LIPASE DEFICIENCY,0.31,2,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,282612,Prostatic Intraepithelial Neoplasia,0.31,2,Biomarker
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,0.0,0.0,1.0,282612,Prostatic Intraepithelial Neoplasia,0.31,2,"Biomarker, Therapeutic"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,1866558,"Neural tube defect, folate-sensitive",0.31,0,Biomarker
427,ASAH1,N-acylsphingosine amidohydrolase (acid ceramidase) 1,0.0,1.0,1.0,0.0,0.0,1412573,FARBER LIPOGRANULOMATOSIS,0.31,0,"Biomarker, GeneticVariation"
2157,F8,"coagulation factor VIII, procoagulant component",0.0,1.0,1.0,0.0,0.0,1366370,HEMOPHILIA A,0.31,59,"Biomarker, GeneticVariation"
1439,CSF2RB,"colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)",0.0,1.0,0.0,0.0,0.0,1968602,"Surfactant Metabolism Dysfunction, Pulmonary, 1",0.31,0,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,1.0,270611,Brain Injuries,0.31,3,"Biomarker, Therapeutic"
3659,IRF1,interferon regulatory factor 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.31,2,Biomarker
5530,PPP3CA,"protein phosphatase 3, catalytic subunit, alpha isozyme",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.31,2,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.31,4,Biomarker
7097,TLR2,toll-like receptor 2,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.31,2,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.31,2,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.31,2,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,1.0,270611,Brain Injuries,0.31,2,"Biomarker, Therapeutic"
359,AQP2,aquaporin 2 (collecting duct),0.0,1.0,1.0,0.0,0.0,1563706,"DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL",0.31,14,"Biomarker, GeneticVariation"
4909,NTF4,neurotrophin 4,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.31,1,Therapeutic
8864,PER2,period circadian clock 2,0.0,1.0,1.0,0.0,0.0,3807327,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1",0.31,1,"Biomarker, GeneticVariation"
7080,NKX2-1,NK2 homeobox 1,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.31,3,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.31,2,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.31,2,Biomarker
383,ARG1,arginase 1,0.0,1.0,0.0,0.0,0.0,37116,Silicosis,0.31,2,Biomarker
6352,CCL5,chemokine (C-C motif) ligand 5,0.0,1.0,0.0,0.0,0.0,20500,Hyperoxaluria,0.31,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,3949,Asbestosis,0.31,2,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.31,2,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.31,2,Biomarker
6569,SLC34A1,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 1",0.0,1.0,0.0,0.0,0.0,85682,Hypophosphatemia,0.31,2,Biomarker
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,0.0,0.0,1.0,3811,"Arrhythmias, Cardiac",0.31,3,"Biomarker, Therapeutic"
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.31,3,Biomarker
952,CD38,CD38 molecule,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.31,2,Biomarker
5534,PPP3R1,"protein phosphatase 3, regulatory subunit B, alpha",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.31,1,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.31,2,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,1.0,27051,Myocardial Infarction,0.31,2,"Biomarker, Therapeutic"
3291,HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.31,1,Biomarker
5350,PLN,phospholamban,0.0,1.0,0.0,0.0,1.0,27051,Myocardial Infarction,0.31,3,"Biomarker, Therapeutic"
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.31,1,Biomarker
4487,MSX1,msh homeobox 1,0.0,1.0,1.0,0.0,0.0,3489529,"TOOTH AGENESIS, SELECTIVE, 1",0.31,0,"Biomarker, GeneticVariation"
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.31,2,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.31,2,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.31,3,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,1.0,1527311,Brain Edema,0.31,2,"Biomarker, Therapeutic"
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,1527311,Brain Edema,0.31,2,Biomarker
6285,S100B,S100 calcium binding protein B,0.0,1.0,0.0,0.0,0.0,1527311,Brain Edema,0.31,2,Biomarker
5329,PLAUR,"plasminogen activator, urokinase receptor",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.31,2,Biomarker
18,ABAT,4-aminobutyrate aminotransferase,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.31,2,"Biomarker, Therapeutic"
210,ALAD,aminolevulinate dehydratase,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.31,2,Biomarker
328,APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.31,2,Biomarker
1136,CHRNA3,"cholinergic receptor, nicotinic, alpha 3 (neuronal)",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.31,2,Biomarker
1814,DRD3,dopamine receptor D3,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.31,2,"Biomarker, Therapeutic"
4358,MPV17,MpV17 mitochondrial inner membrane protein,0.0,1.0,0.0,0.0,0.0,3151513,MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE),0.31,0,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,20476,Hyperlipoproteinemias,0.31,2,Biomarker
3861,KRT14,"keratin 14, type I",0.0,1.0,1.0,0.0,0.0,3715082,"EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1",0.31,0,"Biomarker, GeneticVariation"
5727,PTCH1,patched 1,0.0,1.0,1.0,0.0,0.0,2751544,"BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1",0.31,0,"Biomarker, GeneticVariation"
6658,SOX3,SRY (sex determining region Y)-box 3,0.0,1.0,0.0,0.0,0.0,2678223,"Mental Retardation, X-Linked, With Panhypopituitarism",0.31,0,Biomarker
6710,SPTB,"spectrin, beta, erythrocytic",0.0,1.0,1.0,0.0,0.0,1420387,"SPECTRIN, BETA, ERYTHROCYTIC",0.31,5,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,1412481,APOLIPOPROTEIN E,0.31,0,"Biomarker, GeneticVariation"
242,ALOX12B,"arachidonate 12-lipoxygenase, 12R type",0.0,1.0,1.0,0.0,0.0,1855789,Self-Healing Collodion Baby,0.31,4,"Biomarker, GeneticVariation"
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,1.0,43251,Wounds and Injuries,0.31,2,"Biomarker, Therapeutic"
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,1.0,43251,Wounds and Injuries,0.31,2,"Biomarker, Therapeutic"
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,27708,Wilms Tumor,0.31,1,Biomarker
2752,GLUL,glutamate-ammonia ligase,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.31,2,Biomarker
3033,HADH,hydroxyacyl-CoA dehydrogenase,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.31,2,Biomarker
79661,NEIL1,nei endonuclease VIII-like 1 (E. coli),0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.31,2,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.31,2,Biomarker
567,B2M,beta-2-microglobulin,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.31,3,Biomarker
1191,CLU,clusterin,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.31,6,Biomarker
2671,GFER,"growth factor, augmenter of liver regeneration",0.0,1.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.31,1,"Biomarker, Therapeutic"
26762,HAVCR1,hepatitis A virus cellular receptor 1,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.31,10,Biomarker
3934,LCN2,lipocalin 2,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.31,4,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.31,2,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.31,4,"Biomarker, Therapeutic"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.31,4,"Biomarker, Therapeutic"
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,151699,Intracranial Hemorrhages,0.31,5,Biomarker
623,BDKRB1,bradykinin receptor B1,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.31,2,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,1.0,30193,Pain,0.31,3,"Biomarker, Therapeutic"
1186,CLCN7,"chloride channel, voltage-sensitive 7",0.0,1.0,1.0,0.0,0.0,3179239,"OSTEOPETROSIS, AUTOSOMAL DOMINANT 2",0.31,0,"Biomarker, GeneticVariation"
70,ACTC1,"actin, alpha, cardiac muscle 1",0.0,1.0,1.0,0.0,0.0,3150681,"CARDIOMYOPATHY, DILATED, 1R",0.31,0,"Biomarker, GeneticVariation"
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,20598,Hypocalcemia,0.31,3,Biomarker
57107,PDSS2,"prenyl (decaprenyl) diphosphate synthase, subunit 2",0.0,1.0,0.0,0.0,0.0,3551954,"COENZYME Q10 DEFICIENCY, PRIMARY, 1",0.31,0,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,0.0,0.0,1.0,242422,Parkinsonian Disorders,0.31,4,"Biomarker, Therapeutic"
211,ALAS1,5'-aminolevulinate synthase 1,0.0,1.0,0.0,0.0,0.0,32708,Porphyrias,0.31,2,Biomarker
2159,F10,coagulation factor X,0.0,1.0,1.0,0.0,0.0,1414497,COAGULATION FACTOR X,0.31,13,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
148,ADRA1A,adrenoceptor alpha 1A,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
155,ADRB3,adrenoceptor beta 3,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
8639,AOC3,"amine oxidase, copper containing 3",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,4,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
623,BDKRB1,bradykinin receptor B1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,4,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,4,"Biomarker, Therapeutic"
6376,CX3CL1,chemokine (C-X3-C motif) ligand 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
1535,CYBA,"cytochrome b-245, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,4,"Biomarker, Therapeutic"
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,4,Biomarker
2936,GSR,glutathione reductase,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,5,"Biomarker, Therapeutic"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,5,"Biomarker, Therapeutic"
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,3,"Biomarker, Therapeutic"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,4,Biomarker
3643,INSR,insulin receptor,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,5,Biomarker
3667,IRS1,insulin receptor substrate 1,0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,3,"Biomarker, Therapeutic"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,5,"Biomarker, Therapeutic"
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,9,Biomarker
5105,PCK1,phosphoenolpyruvate carboxykinase 1 (soluble),0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
5126,PCSK2,proprotein convertase subtilisin/kexin type 2,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
3651,PDX1,pancreatic and duodenal homeobox 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,4,Biomarker
5313,PKLR,"pyruvate kinase, liver and RBC",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,4,Biomarker
10891,PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha",0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,3,"Biomarker, Therapeutic"
5580,PRKCD,"protein kinase C, delta",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,5,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,2,"Biomarker, Therapeutic"
6514,SLC2A2,"solute carrier family 2 (facilitated glucose transporter), member 2",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
6517,SLC2A4,"solute carrier family 2 (facilitated glucose transporter), member 4",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,5,Biomarker
6550,SLC9A3,"solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,3,"Biomarker, Therapeutic"
6720,SREBF1,sterol regulatory element binding transcription factor 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,2,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,8,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.31,2,"Biomarker, Therapeutic"
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.31,3,Biomarker
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,1864205,"Macular Degeneration, Age-Related, 1",0.31,0,Biomarker
5579,PRKCB,"protein kinase C, beta",0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.31,2,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,11882,Diabetic Neuropathies,0.31,2,Biomarker
3643,INSR,insulin receptor,0.0,1.0,0.0,0.0,0.0,11882,Diabetic Neuropathies,0.31,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,11882,Diabetic Neuropathies,0.31,2,Biomarker
374654,KIF7,kinesin family member 7,0.0,1.0,1.0,0.0,0.0,3279899,HYDROLETHALUS SYNDROME 2,0.31,0,"Biomarker, GeneticVariation"
153,ADRB1,adrenoceptor beta 1,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.31,1,Biomarker
100506742,CASP12,caspase 12 (gene/pseudogene),0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.31,2,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.31,2,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.31,2,"Biomarker, Therapeutic"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.31,2,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.31,3,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.31,5,"Biomarker, Therapeutic"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.31,2,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.31,6,"Biomarker, Therapeutic"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.31,3,"Biomarker, Therapeutic"
5350,PLN,phospholamban,0.0,1.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.31,2,"Biomarker, Therapeutic"
6403,SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.31,2,Biomarker
6546,SLC8A1,"solute carrier family 8 (sodium/calcium exchanger), member 1",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.31,3,Biomarker
6652,SORD,sorbitol dehydrogenase,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.31,2,Biomarker
894,CCND2,cyclin D2,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.31,1,Biomarker
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.31,1,"Biomarker, Therapeutic"
2678,GGT1,gamma-glutamyltransferase 1,0.0,1.0,0.0,0.0,0.0,268524,Glutathionuria,0.31,0,Biomarker
10804,GJB6,"gap junction protein, beta 6, 30kDa",0.0,1.0,0.0,0.0,0.0,2673759,"Deafness, Autosomal Recessive 1A",0.31,0,Biomarker
11255,HRH3,histamine receptor H3,0.0,1.0,0.0,0.0,0.0,2622,Amnesia,0.31,2,Biomarker
1634,DCN,decorin,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.31,1,Biomarker
5294,PIK3CG,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma",0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.31,2,Biomarker
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
288,ANK3,"ankyrin 3, node of Ranvier (ankyrin G)",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
361,AQP4,aquaporin 4,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
8678,BECN1,"beclin 1, autophagy related",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,2,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,3,Biomarker
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,2,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
4208,MEF2C,myocyte enhancer factor 2C,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,2,Biomarker
2185,PTK2B,protein tyrosine kinase 2 beta,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
6546,SLC8A1,"solute carrier family 8 (sodium/calcium exchanger), member 1",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,2,Biomarker
6547,SLC8A3,"solute carrier family 8 (sodium/calcium exchanger), member 3",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,2,Biomarker
6640,SNTA1,"syntrophin, alpha 1",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
6714,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
6754,SSTR4,somatostatin receptor 4,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.31,1,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.31,2,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.31,2,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.31,2,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.31,3,Biomarker
3596,IL13,interleukin 13,0.0,0.0,0.0,0.0,1.0,993582,"Arthritis, Experimental",0.31,2,Therapeutic
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.31,5,Biomarker
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.31,2,Biomarker
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",0.0,1.0,0.0,0.0,1.0,993582,"Arthritis, Experimental",0.31,2,"Biomarker, Therapeutic"
100506742,CASP12,caspase 12 (gene/pseudogene),0.0,1.0,0.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.31,2,Biomarker
2560,GABRB1,"gamma-aminobutyric acid (GABA) A receptor, beta 1",0.0,1.0,0.0,0.0,0.0,19151,Hepatic Encephalopathy,0.31,1,Biomarker
25794,FSCN2,"fascin actin-bundling protein 2, retinal",0.0,1.0,0.0,0.0,0.0,1842816,Retinitis Pigmentosa 30,0.31,0,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.31,2,Biomarker
2,A2M,alpha-2-macroglobulin,0.0,1.0,0.0,0.0,0.0,206669,"Adenoma, Liver Cell",0.31,1,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.31,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,162871,"Aortic Aneurysm, Abdominal",0.31,1,Biomarker
7057,THBS1,thrombospondin 1,0.0,1.0,0.0,0.0,0.0,11884,Diabetic Retinopathy,0.31,1,Biomarker
167465,ZNF366,zinc finger protein 366,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.31,2,Biomarker
55624,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",0.0,1.0,1.0,0.0,0.0,3151519,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3",0.31,0,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,242706,Hyperoxia,0.31,3,Biomarker
5879,RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.31,2,Biomarker
7837,PXDN,peroxidasin,0.0,1.0,1.0,0.0,0.0,3151617,"SCLEROCORNEA, AUTOSOMAL RECESSIVE",0.31,1,"Biomarker, GeneticVariation"
55054,ATG16L1,autophagy related 16-like 1 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,1970207,Inflammatory Bowel Disease 10,0.31,0,Biomarker
9060,PAPSS2,3'-phosphoadenosine 5'-phosphosulfate synthase 2,0.0,1.0,1.0,0.0,0.0,2748516,Spondylodysplasia And Premature Pubarche,0.31,1,"Biomarker, GeneticVariation"
133,ADM,adrenomedullin,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,1,Biomarker
623,BDKRB1,bradykinin receptor B1,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,4,Biomarker
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,4,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,1.0,20429,Hyperalgesia,0.31,4,"Biomarker, Therapeutic"
887,CCKBR,cholecystokinin B receptor,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,2,Biomarker
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,3,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,1.0,20429,Hyperalgesia,0.31,4,"Biomarker, Therapeutic"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,8,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,0.0,0.0,1.0,20429,Hyperalgesia,0.31,6,"Biomarker, Therapeutic"
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,4,Biomarker
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,2,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,1.0,20429,Hyperalgesia,0.31,4,"Biomarker, Therapeutic"
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,2,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.31,2,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.31,2,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.31,2,Biomarker
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,1.0,0.0,0.0,0.0,376618,Endotoxemia,0.31,2,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,376618,Endotoxemia,0.31,3,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.31,6,Biomarker
1394,CRHR1,corticotropin releasing hormone receptor 1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.31,2,Biomarker
655,BMP7,bone morphogenetic protein 7,0.0,1.0,0.0,0.0,1.0,15802,Femoral Fractures,0.31,2,"Biomarker, Therapeutic"
2184,FAH,fumarylacetoacetate hydrolase (fumarylacetoacetase),0.0,1.0,1.0,0.0,0.0,1414525,"TYROSINEMIA, TYPE I",0.31,8,"Biomarker, GeneticVariation"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.31,2,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.31,3,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.31,3,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,32231,Pleurisy,0.31,3,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,32231,Pleurisy,0.31,2,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,333355,Mucositis,0.31,2,Biomarker
133,ADM,adrenomedullin,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.31,3,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.31,2,Biomarker
1373,CPS1,"carbamoyl-phosphate synthase 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.31,2,Biomarker
5168,ENPP2,ectonucleotide pyrophosphatase/phosphodiesterase 2,0.0,1.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.31,3,"Biomarker, Therapeutic"
2690,GHR,growth hormone receptor,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.31,2,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.31,3,"Biomarker, Therapeutic"
3586,IL10,interleukin 10,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.31,10,Therapeutic
3694,ITGB6,"integrin, beta 6",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.31,2,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.31,2,Biomarker
3958,LGALS3,"lectin, galactoside-binding, soluble, 3",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.31,2,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.31,3,"Biomarker, Therapeutic"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.31,3,Biomarker
5159,PDGFRB,"platelet-derived growth factor receptor, beta polypeptide",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.31,3,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.31,2,"Biomarker, Therapeutic"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.31,4,"Biomarker, Therapeutic"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.31,2,"Biomarker, Therapeutic"
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,1.0,878773,"Urinary Bladder, Overactive",0.31,3,"Biomarker, Therapeutic"
64805,P2RY12,"purinergic receptor P2Y, G-protein coupled, 12",0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.31,2,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,1.0,40053,Thrombosis,0.31,7,"Biomarker, Therapeutic"
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,1.0,35222,"Respiratory Distress Syndrome, Adult",0.31,3,"Biomarker, Therapeutic"
8192,CLPP,caseinolytic mitochondrial matrix peptidase proteolytic subunit,0.0,1.0,1.0,0.0,0.0,3808414,PERRAULT SYNDROME 3,0.31,1,"Biomarker, GeneticVariation"
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.31,2,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.31,5,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.31,2,Biomarker
4942,OAT,ornithine aminotransferase,0.0,1.0,1.0,0.0,0.0,1417917,ORNITHINE AMINOTRANSFERASE,0.31,5,"Biomarker, GeneticVariation"
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,20544,"Hypertension, Renal",0.31,2,Biomarker
6354,CCL7,chemokine (C-C motif) ligand 7,0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.31,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.31,2,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.31,2,Biomarker
7056,THBD,thrombomodulin,0.0,1.0,1.0,0.0,0.0,3280976,Thrombophilia due to Thrombomodulin Defect,0.31,0,"Biomarker, GeneticVariation"
375790,AGRN,agrin,0.0,1.0,0.0,0.0,0.0,1850792,Congenital myasthenic syndrome ib,0.31,0,Biomarker
6448,SGSH,N-sulfoglucosamine sulfohydrolase,0.0,1.0,1.0,0.0,0.0,1420015,"MUCOPOLYSACCHARIDOSIS, TYPE IIIA",0.31,13,"Biomarker, GeneticVariation"
26050,SLITRK5,"SLIT and NTRK-like family, member 5",0.0,1.0,0.0,0.0,0.0,28768,Obsessive-Compulsive Disorder,0.31,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,11156,Deficiency Diseases,0.31,2,Biomarker
6529,SLC6A1,"solute carrier family 6 (neurotransmitter transporter), member 1",0.0,1.0,0.0,0.0,1.0,38587,Substance Withdrawal Syndrome,0.31,2,"Biomarker, Therapeutic"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.30969064,158,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.309574784,127,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),1.0,1.0,1.0,0.0,0.0,13080,Down Syndrome,0.309372035,56,"AlteredExpression, Biomarker, GeneticVariation"
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,1.0,0.0,0.0,20433,Hyperbilirubinemia,0.308705565,107,"Biomarker, GeneticVariation"
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,1.0,0.0,0.0,878682,Deficiency of ferroxidase,0.307938128,28,"Biomarker, GeneticVariation"
174,AFP,alpha-fetoprotein,1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.307838656,388,"AlteredExpression, Biomarker, GeneticVariation"
11093,ADAMTS13,"ADAM metallopeptidase with thrombospondin type 1 motif, 13",1.0,1.0,1.0,0.0,0.0,34155,"Purpura, Thrombotic Thrombocytopenic",0.307471634,141,"AlteredExpression, Biomarker, GeneticVariation"
4297,KMT2A,lysine (K)-specific methyltransferase 2A,1.0,1.0,1.0,0.0,0.0,23418,Leukemia,0.307427637,327,"AlteredExpression, Biomarker, GeneticVariation"
6690,SPINK1,"serine peptidase inhibitor, Kazal type 1",0.0,1.0,1.0,0.0,0.0,149521,"Pancreatitis, Chronic",0.307288042,98,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.306908259,94,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.306729864,78,"AlteredExpression, Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.306536989,70,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,85390,Li-Fraumeni Syndrome,0.306079378,282,"Biomarker, GeneticVariation"
1822,ATN1,atrophin 1,1.0,1.0,1.0,0.0,0.0,751781,Dentatorubral-pallidoluysian atrophy,0.305953596,21,"AlteredExpression, Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.30586026,109,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.305499634,59,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.304288531,242,"AlteredExpression, Biomarker, GeneticVariation"
64127,NOD2,nucleotide-binding oligomerization domain containing 2,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.303875728,105,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,41296,Tuberculosis,0.3038178,69,"Biomarker, GeneticVariation"
4126,MANBA,"mannosidase, beta A, lysosomal",0.0,1.0,1.0,0.0,0.0,342849,beta-Mannosidosis,0.303685559,13,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,1.0,0.0,38356,Stomach Neoplasms,0.303625799,43,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,1.0,0.0,0.0,30305,Pancreatitis,0.303476367,59,"Biomarker, GeneticVariation"
64374,SIL1,SIL1 nucleotide exchange factor,0.0,1.0,1.0,0.0,0.0,24814,marinesco-sjogren syndrome,0.303402055,12,"Biomarker, GeneticVariation"
26191,PTPN22,"protein tyrosine phosphatase, non-receptor type 22 (lymphoid)",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.303112107,119,"Biomarker, GeneticVariation"
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.30299625,78,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.302967286,68,"Biomarker, GeneticVariation"
4016,LOXL1,lysyl oxidase-like 1,0.0,1.0,1.0,0.0,0.0,206368,Exfoliation Syndrome,0.302800511,64,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,1861172,Venous Thromboembolism,0.302793502,49,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.302654818,56,"Biomarker, GeneticVariation"
282617,IFNL3,"interferon, lambda 3",0.0,1.0,1.0,0.0,0.0,19196,Hepatitis C,0.302438945,237,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.302438945,1572,"Biomarker, GeneticVariation"
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,1.0,0.0,0.0,1328840,Autoimmune Lymphoproliferative Syndrome,0.302268037,8,"Biomarker, GeneticVariation"
5644,PRSS1,"protease, serine, 1 (trypsin 1)",0.0,1.0,1.0,0.0,0.0,30305,Pancreatitis,0.302098556,77,"Biomarker, GeneticVariation"
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.301752512,138,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.301752512,130,"Biomarker, GeneticVariation"
23569,PADI4,"peptidyl arginine deiminase, type IV",1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.301744976,72,"AlteredExpression, Biomarker, GeneticVariation"
11315,PARK7,parkinson protein 7,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.301727671,51,"Biomarker, GeneticVariation"
51684,SUFU,suppressor of fused homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,4779,Basal Cell Nevus Syndrome,0.301417523,5,"Biomarker, GeneticVariation"
117581,TWIST2,twist family bHLH transcription factor 2,0.0,1.0,1.0,0.0,0.0,1744559,Facial ectodermal dysplasia,0.301134018,4,"Biomarker, GeneticVariation"
2266,FGG,fibrinogen gamma chain,0.0,1.0,1.0,0.0,0.0,19250,Afibrinogenemia congenital,0.301134018,4,"Biomarker, GeneticVariation"
10083,USH1C,"Usher syndrome 1C (autosomal recessive, severe)",0.0,1.0,1.0,0.0,0.0,1848604,"Usher Syndrome, Type IC",0.300850514,3,"Biomarker, GeneticVariation"
1749,DLX5,distal-less homeobox 5,0.0,1.0,1.0,0.0,0.0,2931019,Split hand foot deformity 1,0.300850514,3,"Biomarker, GeneticVariation"
2299,FOXI1,forkhead box I1,0.0,1.0,1.0,0.0,0.0,271829,Pendred syndrome,0.300850514,3,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.300570506,202,"AlteredExpression, Biomarker, GeneticVariation"
23426,GRIP1,glutamate receptor interacting protein 1,0.0,1.0,1.0,0.0,0.0,265233,Fraser Syndrome,0.300567009,2,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.300415745,77,"Biomarker, GeneticVariation"
55806,HR,hair growth associated,0.0,1.0,1.0,0.0,0.0,2750815,Marie Unna Hereditary Hypotrichosis 1,0.300283505,1,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,1869115,WEILL-MARCHESANI SYNDROME 2,0.300283505,1,"Biomarker, GeneticVariation"
3918,LAMC2,"laminin, gamma 2",0.0,1.0,1.0,0.0,0.0,79683,Epidermolysis bullosa letalis,0.300283505,1,"Biomarker, GeneticVariation"
6340,SCNN1G,"sodium channel, non voltage gated 1 gamma subunit",0.0,1.0,1.0,0.0,0.0,1449843,"PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE",0.3,0,"Biomarker, GeneticVariation"
27185,DISC1,disrupted in schizophrenia 1,0.0,1.0,1.0,0.0,0.0,1858050,SCHIZOPHRENIA 9,0.3,0,"Biomarker, GeneticVariation"
2780,GNAT2,"guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2",0.0,1.0,1.0,0.0,0.0,1841721,Achromatopsia 4,0.3,0,"Biomarker, GeneticVariation"
57017,COQ9,coenzyme Q9,0.0,1.0,1.0,0.0,0.0,3553374,"COENZYME Q10 DEFICIENCY, PRIMARY, 5",0.3,0,"Biomarker, GeneticVariation"
89781,HPS4,Hermansky-Pudlak syndrome 4,0.0,1.0,1.0,0.0,0.0,3484357,HERMANSKY-PUDLAK SYNDROME 4,0.3,0,"Biomarker, GeneticVariation"
85366,MYLK2,myosin light chain kinase 2,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.3,1,"Biomarker, GeneticVariation"
92749,DRC1,dynein regulatory complex subunit 1,0.0,1.0,1.0,0.0,0.0,3809087,"CILIARY DYSKINESIA, PRIMARY, 21",0.3,0,"Biomarker, GeneticVariation"
5828,PEX2,peroxisomal biogenesis factor 2,0.0,1.0,1.0,0.0,0.0,3553940,PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER),0.3,0,"Biomarker, GeneticVariation"
3566,IL4R,interleukin 4 receptor,0.0,1.0,1.0,0.0,0.0,1869116,"ASTHMA, SUSCEPTIBILITY TO",0.3,0,"Biomarker, GeneticVariation"
1524,CX3CR1,chemokine (C-X3-C motif) receptor 1,0.0,1.0,1.0,0.0,0.0,3151079,"MACULAR DEGENERATION, AGE-RELATED, 12",0.3,0,"Biomarker, GeneticVariation"
65125,WNK1,WNK lysine deficient protein kinase 1,0.0,1.0,1.0,0.0,0.0,1840391,"Pseudohypoaldosteronism, Type IIc",0.3,0,"Biomarker, GeneticVariation"
29851,ICOS,inducible T-cell co-stimulator,0.0,1.0,1.0,0.0,0.0,3149378,"IMMUNODEFICIENCY, COMMON VARIABLE, 1",0.3,0,"Biomarker, GeneticVariation"
4791,NFKB2,nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100),0.0,1.0,1.0,0.0,0.0,3149378,"IMMUNODEFICIENCY, COMMON VARIABLE, 1",0.3,0,"Biomarker, GeneticVariation"
339829,CCDC39,coiled-coil domain containing 39,0.0,1.0,1.0,0.0,0.0,3151136,"CILIARY DYSKINESIA, PRIMARY, 14",0.3,0,"Biomarker, GeneticVariation"
161582,DYX1C1,dyslexia susceptibility 1 candidate 1,0.0,1.0,1.0,0.0,0.0,3809641,"CILIARY DYSKINESIA, PRIMARY, 25",0.3,0,"Biomarker, GeneticVariation"
90678,LRSAM1,leucine rich repeat and sterile alpha motif containing 1,0.0,1.0,1.0,0.0,0.0,3280797,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P",0.3,0,"Biomarker, GeneticVariation"
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,3553382,CORTISONE REDUCTASE DEFICIENCY 2,0.3,0,"Biomarker, GeneticVariation"
84062,DTNBP1,dystrobrevin binding protein 1,0.0,1.0,1.0,0.0,0.0,3279756,HERMANSKY-PUDLAK SYNDROME 7,0.3,0,"Biomarker, GeneticVariation"
1120,CHKB,choline kinase beta,0.0,1.0,1.0,0.0,0.0,1865233,"Muscular Dystrophy, Congenital, Megaconial Type",0.3,0,"Biomarker, GeneticVariation"
22941,SHANK2,SH3 and multiple ankyrin repeat domains 2,0.0,1.0,1.0,0.0,0.0,3150693,"AUTISM, SUSCEPTIBILITY TO, 17",0.3,0,"Biomarker, GeneticVariation"
4001,LMNB1,lamin B1,0.0,1.0,1.0,0.0,0.0,1868512,"Leukodystrophy, Demyelinating, Adult-Onset, Autosomal Dominant",0.3,0,"Biomarker, GeneticVariation"
79803,HPS6,Hermansky-Pudlak syndrome 6,0.0,1.0,1.0,0.0,0.0,1425796,HPS6 GENE,0.3,0,"Biomarker, GeneticVariation"
388552,BLOC1S3,"biogenesis of lysosomal organelles complex-1, subunit 3",0.0,1.0,1.0,0.0,0.0,1538326,"BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 3",0.3,0,"Biomarker, GeneticVariation"
128637,TBC1D20,"TBC1 domain family, member 20",0.0,1.0,1.0,0.0,0.0,3810265,WARBURG MICRO SYNDROME 4,0.3,0,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,40038,Thromboembolism,0.299993556,108,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.299513017,172,"Biomarker, GeneticVariation"
4292,MLH1,mutL homolog 1,1.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.299456807,71,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
5999,RGS4,regulator of G-protein signaling 4,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.299369981,50,"AlteredExpression, Biomarker, GeneticVariation"
6390,SDHB,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",0.0,1.0,1.0,0.0,0.0,30421,Paraganglioma,0.299310269,117,"Biomarker, GeneticVariation"
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,0.0,1.0,1.0,0.0,0.0,18213,Graves Disease,0.299114079,87,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.298998222,62,"Biomarker, GeneticVariation"
929,CD14,CD14 molecule,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.298460177,59,"Biomarker, GeneticVariation"
2629,GBA,"glucosidase, beta, acid",0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.298402249,49,"Biomarker, GeneticVariation"
6387,CXCL12,chemokine (C-X-C motif) ligand 12,0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.298037988,117,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,1.0,0.0,38356,Stomach Neoplasms,0.298031852,39,"Biomarker, GeneticVariation, PostTranslationalModification"
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.297783448,121,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.297748348,63,"AlteredExpression, Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.297397107,40,"AlteredExpression, Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.296932934,107,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.296413557,143,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.296279033,80,"AlteredExpression, Biomarker, GeneticVariation"
1815,DRD4,dopamine receptor D4,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.296221105,73,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.295966564,77,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,11884,Diabetic Retinopathy,0.295693807,77,"AlteredExpression, Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,1.0,1956346,Coronary Artery Disease,0.295487809,67,"Biomarker, GeneticVariation, Therapeutic"
4830,NME1,NME/NM23 nucleoside diphosphate kinase 1,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.295225771,254,"AlteredExpression, Biomarker"
5371,PML,promyelocytic leukemia,1.0,1.0,1.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.295225771,402,"AlteredExpression, Biomarker, GeneticVariation"
5914,RARA,"retinoic acid receptor, alpha",1.0,1.0,1.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.295225771,372,"AlteredExpression, Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,1.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.294890474,98,"AlteredExpression, Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.294490136,55,"Biomarker, GeneticVariation, PostTranslationalModification"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.294462149,80,"Biomarker, GeneticVariation"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.294381393,133,"Biomarker, GeneticVariation"
4137,MAPT,microtubule-associated protein tau,1.0,1.0,1.0,0.0,0.0,949664,Tauopathies,0.294341814,194,"AlteredExpression, Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,4943,Behcet Syndrome,0.294265537,70,"Biomarker, GeneticVariation"
2312,FLG,filaggrin,0.0,1.0,1.0,0.0,0.0,13595,Eczema,0.293900854,165,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.293669564,58,"Biomarker, GeneticVariation"
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.293530879,94,"Biomarker, GeneticVariation"
6653,SORL1,"sortilin-related receptor, L(DLR class) A repeats containing",1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.29349438,41,"AlteredExpression, Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.293386059,79,"AlteredExpression, Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,1.0,1.0,1.0,0.0,1.0,4153,Atherosclerosis,0.292798561,117,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.292790086,70,"Biomarker, GeneticVariation"
238,ALK,anaplastic lymphoma receptor tyrosine kinase,1.0,1.0,1.0,0.0,0.0,206180,"Lymphoma, Large-Cell, Anaplastic",0.292703194,273,"AlteredExpression, Biomarker, GeneticVariation"
4607,MYBPC3,"myosin binding protein C, cardiac",0.0,1.0,1.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.292652763,66,"Biomarker, GeneticVariation"
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),1.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.292564509,59,"AlteredExpression, Biomarker, GeneticVariation"
7276,TTR,transthyretin,1.0,1.0,1.0,0.0,0.0,206245,"Amyloid Neuropathies, Familial",0.292524442,150,"AlteredExpression, Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,1.0,0.0,0.0,24301,"Lymphoma, Follicular",0.292292174,346,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.292113356,107,"AlteredExpression, Biomarker"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",1.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.292065199,66,"AlteredExpression, Biomarker, GeneticVariation"
1756,DMD,dystrophin,1.0,1.0,1.0,0.0,1.0,26850,Muscular Dystrophies,0.291675646,451,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3417,IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.291264627,246,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.290500583,84,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,1.0,0.0,7097,Carcinoma,0.290275917,80,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
1861,TOR1A,"torsin family 1, member A (torsin A)",1.0,1.0,1.0,0.0,0.0,13421,Dystonia,0.290207374,147,"AlteredExpression, Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",1.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.290180617,101,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.290180617,42,"Biomarker, GeneticVariation"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",1.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.28995504,63,"AlteredExpression, Biomarker, GeneticVariation"
79068,FTO,fat mass and obesity associated,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.28984532,106,"Biomarker, GeneticVariation"
5241,PGR,progesterone receptor,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.289610846,89,"AlteredExpression, Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,1.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.289474923,67,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.289418357,40,"Biomarker, GeneticVariation"
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.289356372,135,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,1.0,1.0,1.0,1.0,0.0,27651,Neoplasms,0.289212529,115,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
4137,MAPT,microtubule-associated protein tau,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.289104526,50,"Biomarker, GeneticVariation"
4255,MGMT,O-6-methylguanine-DNA methyltransferase,1.0,1.0,1.0,1.0,0.0,17636,Glioblastoma,0.289071084,203,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
169026,SLC30A8,"solute carrier family 30 (zinc transporter), member 8",0.0,1.0,1.0,0.0,1.0,11860,"Diabetes Mellitus, Type 2",0.288994806,119,"Biomarker, GeneticVariation, Therapeutic"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.288947559,232,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,1261473,Sarcoma,0.288877232,169,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.28874205,318,"Biomarker, GeneticVariation"
5888,RAD51,RAD51 recombinase,0.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.288711302,80,"Biomarker, GeneticVariation"
1071,CETP,"cholesteryl ester transfer protein, plasma",0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.288683211,46,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.288438478,53,"AlteredExpression, Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.287941544,49,"Biomarker, GeneticVariation"
6775,STAT4,signal transducer and activator of transcription 4,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.287890625,54,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.287658039,69,"AlteredExpression, Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),1.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.287658039,106,"AlteredExpression, Biomarker, GeneticVariation"
6775,STAT4,signal transducer and activator of transcription 4,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.287274585,57,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.286894418,60,"Biomarker, GeneticVariation"
4436,MSH2,mutS homolog 2,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.286457262,40,"AlteredExpression, Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,1.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.285944932,91,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,398623,Thrombophilia,0.285563787,122,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.285358278,84,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.285309247,67,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.285281156,33,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",1.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.284996778,75,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.28469408,50,"AlteredExpression, Biomarker, GeneticVariation"
3087,HHEX,hematopoietically expressed homeobox,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.284458733,99,"Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",1.0,1.0,1.0,1.0,1.0,27651,Neoplasms,0.284420383,47,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.284146264,49,"Biomarker, GeneticVariation"
126,ADH1C,"alcohol dehydrogenase 1C (class I), gamma polypeptide",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.283608219,64,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,1.0,38356,Stomach Neoplasms,0.283463399,35,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.283218799,121,"AlteredExpression, Biomarker"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.282983282,48,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.282904799,61,"AlteredExpression, Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",1.0,1.0,1.0,1.0,0.0,7097,Carcinoma,0.282847914,91,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
629,CFB,complement factor B,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.282728742,52,"Biomarker, GeneticVariation"
472,ATM,ATM serine/threonine kinase,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.282670325,42,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.282612885,120,"Biomarker, GeneticVariation"
4613,MYCN,v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog,1.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.282612885,666,"AlteredExpression, Biomarker, GeneticVariation"
862,RUNX1T1,"runt-related transcription factor 1; translocated to, 1 (cyclin D-related)",0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.282612885,262,"Biomarker, GeneticVariation"
4137,MAPT,microtubule-associated protein tau,0.0,1.0,1.0,1.0,0.0,524851,Neurodegenerative Diseases,0.282463586,161,"Biomarker, GeneticVariation, PostTranslationalModification"
354,KLK3,kallikrein-related peptidase 3,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.282288758,72,"AlteredExpression, Biomarker, GeneticVariation"
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.281829918,141,"Biomarker, GeneticVariation"
11200,CHEK2,checkpoint kinase 2,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.281819811,53,"AlteredExpression, Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,3850,Arteriosclerosis,0.281585338,276,"Biomarker, GeneticVariation"
3107,HLA-C,"major histocompatibility complex, class I, C",1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.281311219,56,"AlteredExpression, Biomarker, GeneticVariation"
2212,FCGR2A,"Fc fragment of IgG, low affinity IIa, receptor (CD32)",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.281164511,45,"Biomarker, GeneticVariation"
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,1.0,0.0,0.0,79294,Epidermolysis Bullosa Dystrophica,0.281126819,94,"Biomarker, GeneticVariation"
718,C3,complement component 3,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.281086516,41,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,36202,Sarcoidosis,0.281066449,50,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,302592,Cervix carcinoma,0.280853608,260,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.280842826,91,"AlteredExpression, Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.280704949,49,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.280255195,58,"AlteredExpression, Biomarker, GeneticVariation"
149233,IL23R,interleukin 23 receptor,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.280166904,54,"Biomarker, GeneticVariation"
960,CD44,CD44 molecule (Indian blood group),1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.280090308,222,"AlteredExpression, Biomarker"
3630,INS,insulin,1.0,1.0,1.0,0.0,0.0,20459,Hyperinsulinism,0.279884799,393,"AlteredExpression, Biomarker, GeneticVariation"
2896,GRN,granulin,0.0,1.0,1.0,0.0,0.0,497327,Dementia,0.279769009,44,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.279408486,58,"AlteredExpression, Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.279355651,53,"Biomarker, GeneticVariation"
149233,IL23R,interleukin 23 receptor,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.279345843,60,"Biomarker, GeneticVariation"
590,BCHE,butyrylcholinesterase,0.0,1.0,1.0,1.0,0.0,2395,Alzheimer Disease,0.279336946,48,"Biomarker, GeneticVariation, PostTranslationalModification"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.279267848,67,"Biomarker, GeneticVariation"
7185,TRAF1,TNF receptor-associated factor 1,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.279209431,40,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,525045,Mood Disorders,0.279120266,86,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.279044226,112,"AlteredExpression, Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.278778345,56,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.278769448,39,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,1.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.278699543,142,"AlteredExpression, Biomarker, GeneticVariation"
4683,NBN,nibrin,0.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.278505137,44,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,1861172,Venous Thromboembolism,0.278428015,29,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,1.0,0.0,9375,Colonic Neoplasms,0.277764898,63,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.277588353,65,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.277567731,51,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.277077806,60,"Biomarker, GeneticVariation"
7466,WFS1,Wolfram syndrome 1 (wolframin),0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.27680411,48,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.276773746,66,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.276088608,98,"Biomarker, GeneticVariation"
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.275152113,40,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.275103082,54,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.275074118,33,"Biomarker, GeneticVariation"
3575,IL7R,interleukin 7 receptor,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.274986315,38,"Biomarker, GeneticVariation"
3630,INS,insulin,1.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.274839645,249,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5979,RET,ret proto-oncogene,1.0,1.0,1.0,0.0,0.0,27662,Multiple Endocrine Neoplasia,0.274788896,149,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.274720605,87,"AlteredExpression, Biomarker, GeneticVariation"
2332,FMR1,fragile X mental retardation 1,0.0,1.0,1.0,0.0,0.0,85215,Primary Ovarian Insufficiency,0.274662677,71,"Biomarker, GeneticVariation"
221895,JAZF1,JAZF zinc finger 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.274536073,40,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.274510425,34,"AlteredExpression, Biomarker, GeneticVariation"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.274418818,35,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,1.0,0.0,38356,Stomach Neoplasms,0.27438291,37,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3375,IAPP,islet amyloid polypeptide,1.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.273812652,76,"AlteredExpression, Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.273773006,117,"AlteredExpression, Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.272941583,76,"Biomarker, GeneticVariation"
149233,IL23R,interleukin 23 receptor,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.272825726,41,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.272522577,28,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.272522577,35,"Biomarker, GeneticVariation"
3630,INS,insulin,1.0,1.0,0.0,0.0,0.0,271650,Glucose Intolerance,0.272522577,250,"AlteredExpression, Biomarker"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.272414219,47,"Biomarker, GeneticVariation"
4359,MPZ,myelin protein zero,0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.272236866,132,"Biomarker, GeneticVariation"
25,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",1.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.272197221,173,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.272169064,89,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.272034118,80,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.271916307,27,"Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.271914523,90,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.271846721,42,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,3714514,Infection,0.271831369,25,"AlteredExpression, Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,16059,Fibrosis,0.271831369,28,"AlteredExpression, Biomarker, GeneticVariation"
387129,NPSR1,neuropeptide S receptor 1,1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.271663233,36,"AlteredExpression, Biomarker, GeneticVariation"
5376,PMP22,peripheral myelin protein 22,0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.271502209,164,"Biomarker, GeneticVariation"
10855,HPSE,heparanase,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.271369535,91,"AlteredExpression, Biomarker"
7099,TLR4,toll-like receptor 4,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.270996696,39,"Biomarker, GeneticVariation"
94,ACVRL1,activin A receptor type II-like 1,1.0,1.0,1.0,0.0,0.0,39445,"Telangiectasia, Hereditary Hemorrhagic",0.27094913,60,"AlteredExpression, Biomarker, GeneticVariation"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.270566098,64,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,1.0,1.0,1.0,1.0,0.0,1418,Adenocarcinoma,0.270498466,103,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
5311,PKD2,polycystic kidney disease 2 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,85413,"Polycystic Kidney, Autosomal Dominant",0.270143103,180,"Biomarker, GeneticVariation"
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.27007855,73,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.27004812,58,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,38325,Stevens-Johnson Syndrome,0.270007986,78,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,0.0,1.0,0.0,1.0,21655,Insulin Resistance,0.27,43,"GeneticVariation, Therapeutic"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.27,316,Biomarker
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.27,246,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,1.0,20456,Hyperglycemia,0.27,369,"Biomarker, Therapeutic"
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,524620,Metabolic Syndrome X,0.27,438,Biomarker
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,1.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.27,79,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,32914,Pre-Eclampsia,0.269570764,19,"Biomarker, GeneticVariation"
1610,DAO,D-amino-acid oxidase,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.269530631,40,"AlteredExpression, Biomarker, GeneticVariation"
3077,HFE,hemochromatosis,0.0,1.0,1.0,0.0,0.0,162566,Porphyria Cutanea Tarda,0.269423183,30,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,1.0,0.0,17638,Glioma,0.269422376,111,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.269049218,147,"Biomarker, GeneticVariation"
2913,GRM3,"glutamate receptor, metabotropic 3",1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.269013141,35,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.26885439,96,"Biomarker, GeneticVariation"
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.268474119,35,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,1.0,3873,"Arthritis, Rheumatoid",0.268298062,46,"Biomarker, GeneticVariation, Therapeutic"
4595,MUTYH,mutY homolog,1.0,1.0,1.0,0.0,0.0,32580,Adenomatous Polyposis Coli,0.268229453,78,"AlteredExpression, Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.267846102,165,"AlteredExpression, Biomarker, GeneticVariation"
5133,PDCD1,programmed cell death 1,1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.267468104,34,"AlteredExpression, Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.267299967,60,"Biomarker, GeneticVariation"
2,A2M,alpha-2-macroglobulin,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.266949637,25,"Biomarker, GeneticVariation"
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.266880539,46,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,1.0,0.0,5586,Bipolar Disorder,0.266831508,48,"Biomarker, GeneticVariation, PostTranslationalModification"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.266774068,36,"Biomarker, GeneticVariation"
56999,ADAMTS9,"ADAM metallopeptidase with thrombospondin type 1 motif, 9",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.266743639,27,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.266625998,47,"Biomarker, GeneticVariation"
7253,TSHR,thyroid stimulating hormone receptor,1.0,1.0,1.0,0.0,0.0,18213,Graves Disease,0.266390229,118,"AlteredExpression, Biomarker, GeneticVariation"
10858,CYP46A1,"cytochrome P450, family 46, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.265893614,24,"Biomarker, GeneticVariation"
3949,LDLR,low density lipoprotein receptor,1.0,1.0,1.0,0.0,1.0,4153,Atherosclerosis,0.265852184,131,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3593,IL12B,interleukin 12B,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.265718045,36,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.265168342,80,"AlteredExpression, Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.265101028,29,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",1.0,0.0,1.0,0.0,0.0,809,"Abortion, Habitual",0.265045154,29,"AlteredExpression, GeneticVariation"
5444,PON1,paraoxonase 1,1.0,1.0,1.0,0.0,1.0,7222,Cardiovascular Diseases,0.26476947,52,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
4041,LRP5,low density lipoprotein receptor-related protein 5,1.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.264711541,33,"AlteredExpression, Biomarker, GeneticVariation"
6387,CXCL12,chemokine (C-X-C motif) ligand 12,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.264681282,104,"AlteredExpression, Biomarker"
5621,PRNP,prion protein,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.264661533,36,"Biomarker, GeneticVariation"
3077,HFE,hemochromatosis,0.0,1.0,1.0,0.0,0.0,392514,Hereditary hemochromatosis,0.264634135,428,"Biomarker, GeneticVariation"
65018,PINK1,PTEN induced putative kinase 1,0.0,1.0,1.0,0.0,0.0,242422,Parkinsonian Disorders,0.26454487,75,"Biomarker, GeneticVariation"
1471,CST3,cystatin C,1.0,1.0,1.0,0.0,1.0,2395,Alzheimer Disease,0.264505055,30,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.2644986,45,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,28768,Obsessive-Compulsive Disorder,0.264485476,38,"Biomarker, GeneticVariation"
63892,THADA,thyroid adenoma associated,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.264426571,27,"Biomarker, GeneticVariation"
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,1.0,0.0,0.0,29434,Osteogenesis Imperfecta,0.264328846,153,"Biomarker, GeneticVariation"
3664,IRF6,interferon regulatory factor 6,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.26381102,31,"Biomarker, GeneticVariation"
846,CASR,calcium-sensing receptor,0.0,1.0,1.0,0.0,0.0,20437,Hypercalcemia,0.263734979,53,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.263703572,24,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.263626066,23,"AlteredExpression, Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,1.0,149721,"Hypertrophy, Left Ventricular",0.263585443,49,"Biomarker, GeneticVariation, Therapeutic"
4255,MGMT,O-6-methylguanine-DNA methyltransferase,1.0,1.0,1.0,0.0,0.0,17638,Glioma,0.263584636,124,"AlteredExpression, Biomarker, GeneticVariation"
975,CD81,CD81 molecule,1.0,1.0,1.0,0.0,0.0,19196,Hepatitis C,0.263500505,45,"AlteredExpression, Biomarker, GeneticVariation"
2214,FCGR3A,"Fc fragment of IgG, low affinity IIIa, receptor (CD16a)",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.263429453,39,"Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.263400489,37,"AlteredExpression, Biomarker, GeneticVariation"
717,C2,complement component 2,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.263371037,24,"Biomarker, GeneticVariation"
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.263351458,34,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.26293203,35,"Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.262719578,29,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.262665832,63,"Biomarker, GeneticVariation"
5644,PRSS1,"protease, serine, 1 (trypsin 1)",0.0,1.0,1.0,0.0,0.0,149521,"Pancreatitis, Chronic",0.262617289,73,"Biomarker, GeneticVariation"
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.26252942,44,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.262436073,27,"AlteredExpression, Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,1.0,0.0,0.0,346153,"Breast Cancer, Familial",0.262317068,257,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.262042849,71,"AlteredExpression, Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.262041871,59,"AlteredExpression, Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",1.0,1.0,1.0,0.0,0.0,32914,Pre-Eclampsia,0.262003033,21,"AlteredExpression, Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.261898028,36,"AlteredExpression, Biomarker, GeneticVariation"
2623,GATA1,GATA binding protein 1 (globin transcription factor 1),1.0,1.0,1.0,0.0,0.0,13080,Down Syndrome,0.261895267,78,"AlteredExpression, Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,85580,"Hypertension, Essential",0.261842987,145,"Biomarker, GeneticVariation"
4853,NOTCH2,notch 2,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.261825999,25,"Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.261797524,22,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.261446875,64,"AlteredExpression, Biomarker"
6716,SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.261302055,24,"AlteredExpression, Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),1.0,1.0,1.0,0.0,1.0,4153,Atherosclerosis,0.261141838,60,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.261131157,99,"Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.26112551,32,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,376358,Malignant neoplasm of prostate,0.260936495,80,"Biomarker, GeneticVariation"
6041,RNASEL,"ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.260813041,21,"AlteredExpression, Biomarker, GeneticVariation"
4153,MBL2,"mannose-binding lectin (protein C) 2, soluble",0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.260574341,42,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.260512844,170,"Biomarker, GeneticVariation"
2896,GRN,granulin,0.0,1.0,1.0,0.0,0.0,751072,Frontotemporal Lobar Degeneration,0.260425464,139,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.260085326,44,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.260078383,52,"Biomarker, GeneticVariation"
1861,TOR1A,"torsin family 1, member A (torsin A)",0.0,1.0,1.0,0.0,0.0,393593,Dystonic Disorders,0.260063964,140,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.26000782,52,"AlteredExpression, Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.259929336,38,"Biomarker, GeneticVariation"
2555,GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.259830786,46,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.259753279,63,"AlteredExpression, Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,1.0,1.0,1.0,0.0,0.0,32914,Pre-Eclampsia,0.259480456,18,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,4114,Astrocytoma,0.259381754,138,"AlteredExpression, Biomarker, GeneticVariation"
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,1.0,0.0,1.0,242422,Parkinsonian Disorders,0.259343726,78,"Biomarker, GeneticVariation, Therapeutic"
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.259333363,32,"Biomarker, GeneticVariation"
5649,RELN,reelin,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.25923579,52,"AlteredExpression, Biomarker, GeneticVariation"
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,1.0,0.0,0.0,149521,"Pancreatitis, Chronic",0.259137239,60,"Biomarker, GeneticVariation"
4153,MBL2,"mannose-binding lectin (protein C) 2, soluble",1.0,1.0,1.0,0.0,0.0,3714514,Infection,0.259012974,21,"AlteredExpression, Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.259000828,38,"AlteredExpression, Biomarker, GeneticVariation"
345611,IRGM,"immunity-related GTPase family, M",0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.258795318,41,"Biomarker, GeneticVariation"
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,1.0,0.0,0.0,14550,"Epilepsies, Myoclonic",0.258729958,25,"Biomarker, GeneticVariation"
4544,MTNR1B,melatonin receptor 1B,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.258462294,41,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.258212469,22,"AlteredExpression, Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.258198856,31,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,1.0,0.0,7138,"Carcinoma, Transitional Cell",0.258169085,95,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3630,INS,insulin,1.0,1.0,0.0,0.0,0.0,20615,Hypoglycemia,0.258166813,168,"AlteredExpression, Biomarker"
3107,HLA-C,"major histocompatibility complex, class I, C",0.0,1.0,1.0,0.0,0.0,3872,"Arthritis, Psoriatic",0.258149825,33,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,0.0,0.0,14170,Endometrial Neoplasms,0.25811343,28,"AlteredExpression, Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,1.0,21368,Inflammation,0.257985427,22,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
57817,HAMP,hepcidin antimicrobial peptide,1.0,1.0,1.0,0.0,0.0,282193,Iron Overload,0.257680071,96,"AlteredExpression, Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.257632824,29,"Biomarker, GeneticVariation"
148738,HFE2,hemochromatosis type 2 (juvenile),0.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.257575385,33,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.257555318,44,"AlteredExpression, Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.257476346,25,"Biomarker, GeneticVariation"
94103,ORMDL3,ORMDL sphingolipid biosynthesis regulator 3,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.257456279,39,"Biomarker, GeneticVariation"
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.257358217,58,"Biomarker, GeneticVariation"
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.257328276,40,"Biomarker, GeneticVariation"
2321,FLT1,fms-related tyrosine kinase 1,1.0,1.0,1.0,0.0,0.0,32914,Pre-Eclampsia,0.257312436,20,"AlteredExpression, Biomarker, GeneticVariation"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,1.0,0.0,0.0,27404,Narcolepsy,0.257250281,40,"Biomarker, GeneticVariation"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.257064838,23,"Biomarker, GeneticVariation"
4137,MAPT,microtubule-associated protein tau,1.0,1.0,1.0,0.0,0.0,242422,Parkinsonian Disorders,0.256850113,86,"AlteredExpression, Biomarker, GeneticVariation"
3040,HBA2,"hemoglobin, alpha 2",1.0,1.0,1.0,0.0,0.0,5283,beta-Thalassemia,0.256769357,141,"AlteredExpression, Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.256752858,23,"AlteredExpression, Biomarker, GeneticVariation"
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.256752369,19,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,18798,"Heart Defects, Congenital",0.256732303,28,"Biomarker, GeneticVariation"
2272,FHIT,fragile histidine triad,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.25671419,69,"AlteredExpression, Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.256576313,38,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.256507215,47,"Biomarker, GeneticVariation"
4851,NOTCH1,notch 1,0.0,1.0,1.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.256398472,110,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.256392824,39,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.256284888,21,"AlteredExpression, Biomarker, GeneticVariation"
57817,HAMP,hepcidin antimicrobial peptide,1.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.256253651,72,"AlteredExpression, Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,85220,Cerebral Amyloid Angiopathy,0.256174679,56,"Biomarker, GeneticVariation"
6696,SPP1,secreted phosphoprotein 1,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.256095389,129,"AlteredExpression, Biomarker"
3949,LDLR,low density lipoprotein receptor,0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.256027586,82,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.25600236,30,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.255981805,38,"AlteredExpression, Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.255873869,20,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.255687131,77,"AlteredExpression, Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.25547886,131,"Biomarker, GeneticVariation"
4352,MPL,"MPL proto-oncogene, thrombopoietin receptor",1.0,1.0,1.0,0.0,0.0,40028,"Thrombocythemia, Essential",0.25545168,50,"AlteredExpression, Biomarker, GeneticVariation"
1536,CYBB,"cytochrome b-245, beta polypeptide",1.0,1.0,1.0,0.0,0.0,18203,"Granulomatous Disease, Chronic",0.255313973,102,"AlteredExpression, Biomarker, GeneticVariation"
24,ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4",0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.255304587,75,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,1.0,0.0,7137,"Carcinoma, Squamous Cell",0.255229842,25,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.255180811,33,"AlteredExpression, Biomarker"
5727,PTCH1,patched 1,0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.254995368,19,"Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.254946337,26,"AlteredExpression, Biomarker, GeneticVariation"
5172,SLC26A4,"solute carrier family 26 (anion exchanger), member 4",0.0,1.0,1.0,0.0,0.0,1384666,Hearing Loss,0.254846321,20,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,1.0,11849,Diabetes Mellitus,0.254454073,72,"Biomarker, GeneticVariation, Therapeutic"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.254308765,25,"AlteredExpression, Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.254248075,64,"Biomarker, GeneticVariation"
7350,UCP1,"uncoupling protein 1 (mitochondrial, proton carrier)",0.0,1.0,1.0,0.0,1.0,28754,Obesity,0.254248075,66,"Biomarker, GeneticVariation, Therapeutic"
2308,FOXO1,forkhead box O1,0.0,1.0,1.0,0.0,0.0,206655,"Rhabdomyosarcoma, Alveolar",0.254052929,104,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.254024283,20,"Biomarker, GeneticVariation"
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",0.0,1.0,1.0,0.0,0.0,40336,Tobacco Use Disorder,0.254024283,20,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.253975252,27,"Biomarker, GeneticVariation"
7128,TNFAIP3,"tumor necrosis factor, alpha-induced protein 3",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.25387719,35,"Biomarker, GeneticVariation"
3077,HFE,hemochromatosis,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.253741267,18,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.2537212,25,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.253563426,102,"AlteredExpression, Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.253525076,58,"Biomarker, GeneticVariation"
2177,FANCD2,"Fanconi anemia, complementation group D2",1.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.253485919,105,"AlteredExpression, Biomarker"
3456,IFNB1,"interferon, beta 1, fibroblast",0.0,1.0,1.0,0.0,1.0,26769,Multiple Sclerosis,0.25342523,149,"Biomarker, GeneticVariation, Therapeutic"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,346153,"Breast Cancer, Familial",0.25334789,180,"Biomarker, GeneticVariation"
3664,IRF6,interferon regulatory factor 6,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.252997712,26,"Biomarker, GeneticVariation"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.252678301,18,"AlteredExpression, Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,836924,Thrombocytosis,0.252382649,44,"Biomarker, GeneticVariation"
367,AR,androgen receptor,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.25232521,35,"AlteredExpression, Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.252324721,26,"AlteredExpression, Biomarker, GeneticVariation"
6792,CDKL5,cyclin-dependent kinase-like 5,0.0,1.0,1.0,0.0,0.0,35372,Rett Syndrome,0.252235556,59,"Biomarker, GeneticVariation"
6757,SSX2,"synovial sarcoma, X breakpoint 2",0.0,1.0,1.0,0.0,0.0,39101,"Sarcoma, Synovial",0.252155289,123,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.252108042,66,"Biomarker, GeneticVariation"
3416,IDE,insulin-degrading enzyme,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.251658673,22,"Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.251611108,50,"AlteredExpression, Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.251601722,28,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.251589575,50,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",1.0,1.0,1.0,0.0,0.0,85084,Motor Neuron Disease,0.251414495,75,"AlteredExpression, Biomarker, GeneticVariation"
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.25137468,24,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.251346204,18,"Biomarker, GeneticVariation"
129787,TMEM18,transmembrane protein 18,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.251325649,29,"Biomarker, GeneticVariation"
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.251170147,23,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,1.0,1.0,1.0,0.0,0.0,30319,Panic Disorder,0.251170147,22,"AlteredExpression, Biomarker, GeneticVariation"
710,SERPING1,"serpin peptidase inhibitor, clade G (C1 inhibitor), member 1",0.0,1.0,1.0,0.0,1.0,19243,"Angioedemas, Hereditary",0.251050235,132,"Biomarker, GeneticVariation, Therapeutic"
6223,RPS19,ribosomal protein S19,1.0,1.0,1.0,0.0,0.0,1260899,"Anemia, Diamond-Blackfan",0.251012373,92,"AlteredExpression, Biomarker, GeneticVariation"
2646,GCKR,glucokinase (hexokinase 4) regulator,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.250993113,30,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.250936651,32,"AlteredExpression, Biomarker, GeneticVariation"
2074,ERCC6,excision repair cross-complementation group 6,1.0,1.0,1.0,0.0,0.0,9207,Cockayne Syndrome,0.250896517,62,"AlteredExpression, Biomarker, GeneticVariation"
3663,IRF5,interferon regulatory factor 5,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.250886643,22,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.250818033,54,"AlteredExpression, Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.250722733,19,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
4607,MYBPC3,"myosin binding protein C, cardiac",0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.250718994,58,"Biomarker, GeneticVariation"
2078,ERG,v-ets avian erythroblastosis virus E26 oncogene homolog,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.250702666,33,"Biomarker, GeneticVariation"
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.250661555,43,"AlteredExpression, Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,1.0,1.0,1.0,0.0,0.0,23267,Leiomyoma,0.250632591,35,"AlteredExpression, Biomarker, GeneticVariation"
3077,HFE,hemochromatosis,0.0,1.0,1.0,0.0,0.0,19196,Hepatitis C,0.250631614,28,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.25047384,100,"Biomarker, GeneticVariation"
6310,ATXN1,ataxin 1,1.0,1.0,1.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.25037805,53,"AlteredExpression, Biomarker, GeneticVariation"
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.250377073,34,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.25029067,21,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.250233719,17,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,1.0,1.0,1.0,0.0,0.0,23418,Leukemia,0.250163155,23,"AlteredExpression, Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.250083865,92,"AlteredExpression, Biomarker"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,1.0,19163,Hepatitis B,0.249917512,50,"Biomarker, GeneticVariation, Therapeutic"
255738,PCSK9,proprotein convertase subtilisin/kexin type 9,0.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.249889036,49,"Biomarker, GeneticVariation"
6275,S100A4,S100 calcium binding protein A4,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.249887252,116,"AlteredExpression, Biomarker"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.249852152,33,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2132,EXT2,exostosin glycosyltransferase 2,0.0,1.0,1.0,0.0,0.0,15306,"Exostoses, Multiple Hereditary",0.249614917,71,"Biomarker, GeneticVariation"
3684,ITGAM,"integrin, alpha M (complement component 3 receptor 3 subunit)",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.249448564,29,"Biomarker, GeneticVariation"
3480,IGF1R,insulin-like growth factor 1 receptor,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.249334174,22,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.249285143,27,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7113,TMPRSS2,"transmembrane protease, serine 2",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.249256179,21,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,1.0,1.0,1.0,1.0,0.0,14170,Endometrial Neoplasms,0.249206171,18,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,1.0,0.0,0.0,16382,Flushing,0.249144993,46,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.248980106,18,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.248969425,69,"Biomarker, GeneticVariation"
5172,SLC26A4,"solute carrier family 26 (anion exchanger), member 4",0.0,1.0,1.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.248881555,35,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.248881555,27,"Biomarker, GeneticVariation"
2162,F13A1,"coagulation factor XIII, A1 polypeptide",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.248823627,18,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.248804537,45,"AlteredExpression, Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.248747098,33,"AlteredExpression, Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",1.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.248725565,23,"AlteredExpression, Biomarker, GeneticVariation"
1524,CX3CR1,chemokine (C-X3-C motif) receptor 1,0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.248725077,25,"Biomarker, GeneticVariation"
7166,TPH1,tryptophan hydroxylase 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.248696601,19,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.248667637,13,"Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.248627015,37,"Biomarker, GeneticVariation"
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.248528953,53,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,12236,DiGeorge Syndrome,0.248520056,25,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.248499989,43,"AlteredExpression, Biomarker, GeneticVariation"
2896,GRN,granulin,0.0,1.0,1.0,0.0,0.0,338451,Frontotemporal Dementia,0.24842021,115,"Biomarker, GeneticVariation"
659,BMPR2,"bone morphogenetic protein receptor, type II (serine/threonine kinase)",0.0,1.0,1.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.248364554,43,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",1.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.248363577,22,"AlteredExpression, Biomarker, GeneticVariation"
3558,IL2,interleukin 2,0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.248342215,113,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",1.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.248315035,38,"AlteredExpression, Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.248306138,16,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,1.0,7097,Carcinoma,0.248287048,42,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
23274,CLEC16A,"C-type lectin domain family 16, member A",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.248285582,20,"Biomarker, GeneticVariation"
3486,IGFBP3,insulin-like growth factor binding protein 3,1.0,1.0,1.0,1.0,1.0,33578,Prostatic Neoplasms,0.248200156,19,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.248122161,17,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.248122161,18,"AlteredExpression, Biomarker, GeneticVariation"
4928,NUP98,nucleoporin 98kDa,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.248070368,77,"AlteredExpression, Biomarker, GeneticVariation"
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.247973114,18,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,10278,Craniosynostoses,0.247942854,78,"Biomarker, GeneticVariation"
149233,IL23R,interleukin 23 receptor,0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.24793298,38,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.247844792,95,"AlteredExpression, Biomarker, GeneticVariation"
120892,LRRK2,leucine-rich repeat kinase 2,0.0,1.0,1.0,0.0,0.0,242422,Parkinsonian Disorders,0.247786864,74,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.24772747,48,"Biomarker, GeneticVariation"
2006,ELN,elastin,0.0,1.0,1.0,0.0,0.0,175702,Williams Syndrome,0.247688313,83,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.247687825,84,"Biomarker, GeneticVariation"
1234,CCR5,chemokine (C-C motif) receptor 5 (gene/pseudogene),0.0,1.0,1.0,0.0,0.0,19196,Hepatitis C,0.247669542,23,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.247649964,45,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,11881,Diabetic Nephropathies,0.247620511,30,"Biomarker, GeneticVariation"
23274,CLEC16A,"C-type lectin domain family 16, member A",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.247542028,26,"Biomarker, GeneticVariation"
7018,TF,transferrin,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.247484099,15,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,1.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.247328598,18,"AlteredExpression, Biomarker, GeneticVariation"
4650,MYO9B,myosin IXB,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.247308531,21,"Biomarker, GeneticVariation"
1191,CLU,clusterin,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.247180528,26,"Biomarker, GeneticVariation"
2643,GCH1,GTP cyclohydrolase 1,0.0,1.0,1.0,0.0,0.0,13421,Dystonia,0.247132963,50,"Biomarker, GeneticVariation"
1136,CHRNA3,"cholinergic receptor, nicotinic, alpha 3 (neuronal)",0.0,1.0,1.0,0.0,0.0,40336,Tobacco Use Disorder,0.24707308,17,"Biomarker, GeneticVariation"
9231,DLG5,"discs, large homolog 5 (Drosophila)",0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.246898,29,"Biomarker, GeneticVariation"
65266,WNK4,WNK lysine deficient protein kinase 4,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.246848481,37,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.246811597,21,"AlteredExpression, Biomarker, GeneticVariation"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.24674993,45,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.246642483,32,"Biomarker, GeneticVariation"
5979,RET,ret proto-oncogene,0.0,1.0,1.0,0.0,0.0,206693,"Carcinoma, Medullary",0.246584555,21,"Biomarker, GeneticVariation"
182,JAG1,jagged 1,0.0,1.0,1.0,0.0,0.0,85280,Alagille Syndrome,0.246525331,70,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,1.0,11881,Diabetic Nephropathies,0.24649539,53,"Biomarker, GeneticVariation, Therapeutic"
958,CD40,"CD40 molecule, TNF receptor superfamily member 5",1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.246486493,28,"AlteredExpression, Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.246479061,26,"AlteredExpression, Biomarker, PostTranslationalModification"
7099,TLR4,toll-like receptor 4,1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.246466914,50,"AlteredExpression, Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,162674,"Ophthalmoplegia, Chronic Progressive External",0.246458506,32,"Biomarker, GeneticVariation"
25970,SH2B1,SH2B adaptor protein 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.246358978,32,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.24635057,18,"Biomarker, GeneticVariation"
2158,F9,coagulation factor IX,0.0,1.0,1.0,0.0,0.0,19069,Hemophilia A,0.246348297,79,"Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,271694,"Lipodystrophy, Familial Partial",0.246192796,78,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,27404,Narcolepsy,0.246124993,25,"Biomarker, GeneticVariation"
2056,EPO,erythropoietin,1.0,1.0,0.0,0.0,1.0,2871,Anemia,0.245976116,169,"AlteredExpression, Biomarker, Therapeutic"
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,1.0,0.0,0.0,9952,"Seizures, Febrile",0.245949425,46,"Biomarker, GeneticVariation"
875,CBS,cystathionine-beta-synthase,0.0,1.0,1.0,0.0,0.0,19880,Homocystinuria,0.245937767,79,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.245831296,74,"AlteredExpression, Biomarker, GeneticVariation"
54829,ASPN,asporin,1.0,1.0,1.0,0.0,0.0,29408,Osteoarthritis,0.245714463,26,"AlteredExpression, Biomarker, GeneticVariation"
238,ALK,anaplastic lymphoma receptor tyrosine kinase,1.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.245654751,89,"AlteredExpression, Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,1.0,1.0,1.0,0.0,0.0,20473,Hyperlipidemias,0.245635979,30,"AlteredExpression, Biomarker, GeneticVariation"
5329,PLAUR,"plasminogen activator, urokinase receptor",1.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.245599583,16,"AlteredExpression, Biomarker"
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,524910,"Hepatitis C, Chronic",0.245438071,134,"Biomarker, Therapeutic"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.245423038,25,"AlteredExpression, Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,1.0,33578,Prostatic Neoplasms,0.245345043,25,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.245303444,31,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.245245027,16,"Biomarker, GeneticVariation"
2010,EMD,emerin,0.0,1.0,1.0,0.0,0.0,410189,"Muscular Dystrophy, Emery-Dreifuss",0.245235323,64,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,34067,Pulmonary Emphysema,0.245174634,109,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.245167032,13,"Biomarker, GeneticVariation"
83990,BRIP1,BRCA1 interacting protein C-terminal helicase 1,0.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.245077867,46,"Biomarker, GeneticVariation"
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,1.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.24506897,29,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,42373,Vascular Diseases,0.244979805,65,"Biomarker, GeneticVariation"
3606,IL18,interleukin 18,1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.244971397,41,"AlteredExpression, Biomarker, GeneticVariation"
2067,ERCC1,excision repair cross-complementation group 1,1.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.244920093,116,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.244913468,31,"AlteredExpression, Biomarker, GeneticVariation"
26191,PTPN22,"protein tyrosine phosphatase, non-receptor type 22 (lymphoid)",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.244843882,45,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.244814429,36,"AlteredExpression, Biomarker, GeneticVariation"
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,1.0,0.0,0.0,20456,Hyperglycemia,0.244803748,76,"Biomarker, GeneticVariation"
4549,RNR1,s-rRNA,0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.244756013,19,"Biomarker, GeneticVariation"
3552,IL1A,"interleukin 1, alpha",0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.244756013,17,"Biomarker, GeneticVariation"
4481,MSR1,macrophage scavenger receptor 1,0.0,1.0,1.0,0.0,0.0,376358,Malignant neoplasm of prostate,0.244727704,31,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.244650031,18,"AlteredExpression, Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,1.0,1.0,0.0,27651,Neoplasms,0.244494529,20,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,3872,"Arthritis, Psoriatic",0.244403899,32,"Biomarker, GeneticVariation"
51752,ERAP1,endoplasmic reticulum aminopeptidase 1,0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.244383832,50,"Biomarker, GeneticVariation"
30009,TBX21,T-box 21,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.244267976,13,"Biomarker, GeneticVariation"
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,1.0,0.0,0.0,342276,Mason-Type Diabetes,0.244020548,120,"Biomarker, GeneticVariation"
2130,EWSR1,EWS RNA-binding protein 1,0.0,1.0,0.0,0.0,0.0,553580,"Sarcoma, Ewing",0.244020548,121,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.244014412,42,"AlteredExpression, Biomarker, GeneticVariation"
2176,FANCC,"Fanconi anemia, complementation group C",1.0,1.0,1.0,0.0,0.0,15625,Fanconi Anemia,0.243895795,63,"AlteredExpression, Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",1.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.243800006,18,"AlteredExpression, Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.243750486,20,"AlteredExpression, Biomarker, GeneticVariation"
6559,SLC12A3,"solute carrier family 12 (sodium/chloride transporter), member 3",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.243729931,26,"Biomarker, GeneticVariation"
332,BIRC5,baculoviral IAP repeat containing 5,1.0,1.0,1.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.243701944,32,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.243573452,19,"AlteredExpression, Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.243525398,37,"AlteredExpression, Biomarker, GeneticVariation"
472,ATM,ATM serine/threonine kinase,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.24351374,70,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.243445938,17,"Biomarker, GeneticVariation"
3593,IL12B,interleukin 12B,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.243367943,17,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.243327809,57,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,35328,Retinal Vein Occlusion,0.243289948,17,"Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.243270858,48,"AlteredExpression, Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,1.0,22658,Kidney Diseases,0.243240428,27,"Biomarker, GeneticVariation, Therapeutic"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.243221827,52,"AlteredExpression, Biomarker"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.24316341,34,"Biomarker, GeneticVariation"
6469,SHH,sonic hedgehog,0.0,1.0,1.0,0.0,0.0,79541,Holoprosencephaly,0.243074245,66,"Biomarker, GeneticVariation"
3852,KRT5,"keratin 5, type II",0.0,1.0,1.0,0.0,0.0,79298,Epidermolysis Bullosa Simplex,0.243045281,56,"Biomarker, GeneticVariation"
5625,PRODH,proline dehydrogenase (oxidase) 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.243035407,24,"Biomarker, GeneticVariation"
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.242995762,59,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,1.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.242966798,50,"AlteredExpression, Biomarker, GeneticVariation"
2592,GALT,galactose-1-phosphate uridylyltransferase,1.0,1.0,1.0,0.0,0.0,16952,Galactosemias,0.242966309,50,"AlteredExpression, Biomarker, GeneticVariation"
720,C4A,complement component 4A (Rodgers blood group),1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.242957412,25,"AlteredExpression, Biomarker, GeneticVariation"
257194,NEGR1,neuronal growth regulator 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.242956923,21,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.242938322,51,"AlteredExpression, Biomarker"
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.24285143,30,"AlteredExpression, Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.242821977,16,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,1.0,0.0,0.0,19080,Hemorrhage,0.242644455,13,"Biomarker, GeneticVariation"
2641,GCG,glucagon,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.242564676,80,"Biomarker, GeneticVariation"
51131,PHF11,PHD finger protein 11,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.242517429,16,"Biomarker, GeneticVariation"
7128,TNFAIP3,"tumor necrosis factor, alpha-induced protein 3",1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.242497362,28,"AlteredExpression, Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,13080,Down Syndrome,0.242468398,17,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,1.0,0.0,1.0,38356,Stomach Neoplasms,0.242438945,16,"Biomarker, GeneticVariation, Therapeutic"
79047,KCTD15,potassium channel tetramerization domain containing 15,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.242389914,19,"Biomarker, GeneticVariation"
3425,IDUA,"iduronidase, alpha-L-",0.0,1.0,1.0,0.0,1.0,23786,Mucopolysaccharidosis I,0.24228166,83,"Biomarker, GeneticVariation, Therapeutic"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.242213857,32,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,1.0,0.0,27627,Neoplasm Metastasis,0.242203665,80,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
132789,GNPDA2,glucosamine-6-phosphate deaminase 2,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.24210641,17,"Biomarker, GeneticVariation"
3730,KAL1,Kallmann syndrome 1 sequence,0.0,1.0,1.0,0.0,0.0,162809,Kallmann Syndrome,0.242096217,65,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,5684,Malignant neoplasm of bladder,0.242095729,57,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,40136,Thyroid Neoplasms,0.24208732,45,"AlteredExpression, Biomarker, GeneticVariation"
4018,LPA,"lipoprotein, Lp(a)",1.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.241988769,52,"AlteredExpression, Biomarker, GeneticVariation"
5241,PGR,progesterone receptor,1.0,1.0,1.0,0.0,0.0,14170,Endometrial Neoplasms,0.241971464,14,"AlteredExpression, Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.241901389,23,"Biomarker, GeneticVariation"
5318,PKP2,plakophilin 2,0.0,1.0,1.0,0.0,0.0,349788,Arrhythmogenic Right Ventricular Dysplasia,0.241873568,51,"Biomarker, GeneticVariation"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,1.0,0.0,0.0,36421,"Scleroderma, Systemic",0.241773874,24,"Biomarker, GeneticVariation"
23400,ATP13A2,ATPase type 13A2,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.241666915,13,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.24166562,85,"AlteredExpression, Biomarker"
7298,TYMS,thymidylate synthetase,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.24163844,17,"AlteredExpression, Biomarker, GeneticVariation"
7052,TGM2,transglutaminase 2,0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.241636656,81,Biomarker
4018,LPA,"lipoprotein, Lp(a)",1.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.241598306,40,"AlteredExpression, Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.241589575,49,"Biomarker, GeneticVariation"
2719,GPC3,glypican 3,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.241578727,61,"AlteredExpression, Biomarker"
3558,IL2,interleukin 2,0.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.241489074,117,"Biomarker, GeneticVariation, Therapeutic"
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",1.0,1.0,1.0,0.0,1.0,33578,Prostatic Neoplasms,0.241482938,18,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.241461406,13,"Biomarker, GeneticVariation"
640,BLK,"BLK proto-oncogene, Src family tyrosine kinase",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.241441339,27,"Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.241441339,27,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.241433907,24,"AlteredExpression, Biomarker"
3569,IL6,interleukin 6,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.241433907,27,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.241383899,18,"AlteredExpression, Biomarker, GeneticVariation"
5649,RELN,reelin,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.241363832,27,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",1.0,1.0,1.0,0.0,1.0,21368,Inflammation,0.241354935,16,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,20550,Hyperthyroidism,0.241266259,55,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,1.0,1.0,1.0,1.0,1.0,4153,Atherosclerosis,0.241158323,37,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.241150403,24,"AlteredExpression, Biomarker, GeneticVariation"
472,ATM,ATM serine/threonine kinase,1.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.241149914,16,"AlteredExpression, Biomarker, GeneticVariation"
1201,CLN3,"ceroid-lipofuscinosis, neuronal 3",1.0,1.0,1.0,0.0,0.0,27877,Neuronal Ceroid-Lipofuscinoses,0.241002821,37,"AlteredExpression, Biomarker, GeneticVariation"
6833,ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",0.0,1.0,1.0,0.0,0.0,2931834,Congenital Hyperinsulinism,0.240913168,68,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.240894396,16,"Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.24087433,29,"Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.240866898,21,"AlteredExpression, Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,1.0,1.0,1458155,Breast Neoplasms,0.240837934,16,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
1812,DRD1,dopamine receptor D1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.240796335,24,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,4238,Atrial Fibrillation,0.240738406,12,"Biomarker, GeneticVariation"
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.240738406,14,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,17154,"Gastritis, Atrophic",0.240718339,23,"Biomarker, GeneticVariation"
23495,TNFRSF13B,"tumor necrosis factor receptor superfamily, member 13B",0.0,1.0,1.0,0.0,0.0,9447,Common Variable Immunodeficiency,0.240698761,45,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,1.0,1.0,1.0,1.0,0.0,7097,Carcinoma,0.240611869,24,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
30061,SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1",0.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.240611869,24,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.240583393,21,"AlteredExpression, Biomarker, GeneticVariation"
2175,FANCA,"Fanconi anemia, complementation group A",1.0,1.0,1.0,0.0,0.0,15625,Fanconi Anemia,0.240580632,74,"AlteredExpression, Biomarker, GeneticVariation"
2561,GABRB2,"gamma-aminobutyric acid (GABA) A receptor, beta 2",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.240562349,19,"Biomarker, GeneticVariation"
159296,NKX2-3,NK2 homeobox 3,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.240561861,18,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.240532897,11,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.240483866,12,"Biomarker, GeneticVariation"
2313,FLI1,"Fli-1 proto-oncogene, ETS transcription factor",0.0,1.0,1.0,0.0,0.0,553580,"Sarcoma, Ewing",0.24038402,102,"Biomarker, GeneticVariation"
153,ADRB1,adrenoceptor beta 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.240356351,14,"Biomarker, GeneticVariation"
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.24030732,23,"Biomarker, GeneticVariation"
54790,TET2,tet methylcytosine dioxygenase 2,0.0,1.0,1.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.240296639,67,"Biomarker, GeneticVariation"
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.240278356,15,"Biomarker, GeneticVariation"
23600,AMACR,alpha-methylacyl-CoA racemase,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.240270925,14,"AlteredExpression, Biomarker, GeneticVariation"
6349,CCL3L1,chemokine (C-C motif) ligand 3-like 1,0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.240180294,27,"Biomarker, GeneticVariation"
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,0.0,1.0,1.0,0.0,0.0,677607,Hashimoto Disease,0.240171886,11,"Biomarker, GeneticVariation"
6756,SSX1,"synovial sarcoma, X breakpoint 1",1.0,1.0,1.0,0.0,0.0,39101,"Sarcoma, Synovial",0.240161205,56,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.240149546,93,"Biomarker, GeneticVariation"
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",0.0,1.0,1.0,0.0,0.0,43094,Weight Gain,0.240121878,15,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,40336,Tobacco Use Disorder,0.240121878,14,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.240121878,13,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.240121878,14,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.240100515,100,"Biomarker, GeneticVariation"
9856,KIAA0319,KIAA0319,0.0,1.0,1.0,0.0,0.0,476254,Dyslexia,0.240053268,33,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.240013623,76,"AlteredExpression, Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,162871,"Aortic Aneurysm, Abdominal",0.23999534,21,"AlteredExpression, Biomarker, GeneticVariation"
6366,CCL21,chemokine (C-C motif) ligand 21,1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.239916857,16,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.23989679,26,"Biomarker, GeneticVariation"
3861,KRT14,"keratin 14, type I",0.0,1.0,1.0,0.0,0.0,79298,Epidermolysis Bullosa Simplex,0.2398777,54,"Biomarker, GeneticVariation"
4487,MSX1,msh homeobox 1,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.239867826,26,"Biomarker, GeneticVariation"
7012,TERC,telomerase RNA component,0.0,1.0,1.0,0.0,0.0,265965,Dyskeratosis Congenita,0.239839839,24,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,10674,Cystic Fibrosis,0.239838862,14,"AlteredExpression, Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,1.0,1956346,Coronary Artery Disease,0.239798728,44,"Biomarker, GeneticVariation, Therapeutic"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.239789831,17,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.23976798,106,Biomarker
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,39743,Thanatophoric Dysplasia,0.239750186,54,"Biomarker, GeneticVariation"
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.239604877,17,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.239555357,16,"AlteredExpression, Biomarker, GeneticVariation"
857,CAV1,"caveolin 1, caveolae protein, 22kDa",1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.23952737,19,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.239449375,18,"AlteredExpression, Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.239427843,16,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,1.0,26769,Multiple Sclerosis,0.239378812,21,"Biomarker, GeneticVariation, Therapeutic"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,1.0,0.0,0.0,35579,Rickets,0.239300817,24,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.239271853,9,"Biomarker, GeneticVariation"
23788,MTCH2,mitochondrial carrier 2,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.239222333,16,"Biomarker, GeneticVariation"
6387,CXCL12,chemokine (C-X-C motif) ligand 12,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.239165871,17,"AlteredExpression, Biomarker, GeneticVariation"
1806,DPYD,dihydropyrimidine dehydrogenase,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.239116351,22,"AlteredExpression, Biomarker, GeneticVariation"
345,APOC3,apolipoprotein C-III,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.239095796,22,"Biomarker, GeneticVariation"
57817,HAMP,hepcidin antimicrobial peptide,1.0,1.0,0.0,0.0,0.0,2871,Anemia,0.23905615,62,"AlteredExpression, Biomarker"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.238969258,40,"AlteredExpression, Biomarker, GeneticVariation"
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,1.0,1.0,1.0,1.0,0.0,24121,Lung Neoplasms,0.23891133,23,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.238910353,11,"AlteredExpression, Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.238899183,48,"AlteredExpression, Biomarker, GeneticVariation"
1316,KLF6,Kruppel-like factor 6,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.238882366,13,"AlteredExpression, Biomarker, GeneticVariation"
24,ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.238870219,39,"Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.238832358,16,"AlteredExpression, Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,14518,Toxic Epidermal Necrolysis,0.238812458,51,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.238734296,20,"AlteredExpression, Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.238714718,46,"AlteredExpression, Biomarker"
4824,NKX3-1,NK3 homeobox 1,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.238627825,24,"AlteredExpression, Biomarker, GeneticVariation"
2720,GLB1,"galactosidase, beta 1",0.0,1.0,1.0,0.0,0.0,85131,"Gangliosidosis, GM1",0.238518105,66,"Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.238499334,12,"Biomarker, GeneticVariation"
351,APP,amyloid beta (A4) precursor protein,1.0,1.0,1.0,0.0,0.0,497327,Dementia,0.23845128,30,"AlteredExpression, Biomarker, GeneticVariation"
3952,LEP,leptin,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.238422316,23,"AlteredExpression, Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,1.0,0.0,0.0,32914,Pre-Eclampsia,0.238421339,10,"Biomarker, GeneticVariation"
773,CACNA1A,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",1.0,1.0,1.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.238372796,25,"AlteredExpression, Biomarker, GeneticVariation"
6338,SCNN1B,"sodium channel, non voltage gated 1 beta subunit",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.238372308,15,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",1.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.238361627,62,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5771,PTPN2,"protein tyrosine phosphatase, non-receptor type 2",0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.238322788,20,"Biomarker, GeneticVariation"
332,BIRC5,baculoviral IAP repeat containing 5,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.238315357,15,"AlteredExpression, Biomarker, GeneticVariation"
5328,PLAU,"plasminogen activator, urokinase",1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.238292529,85,"AlteredExpression, Biomarker"
595,CCND1,cyclin D1,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.238187842,12,"Biomarker, GeneticVariation"
5888,RAD51,RAD51 recombinase,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.238109847,13,"Biomarker, GeneticVariation"
3908,LAMA2,"laminin, alpha 2",1.0,1.0,1.0,0.0,0.0,26850,Muscular Dystrophies,0.23808978,29,"AlteredExpression, Biomarker, GeneticVariation"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),1.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.238037988,91,"AlteredExpression, Biomarker"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,32461,Polycythemia,0.238020194,41,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,18133,Graft vs Host Disease,0.237961289,19,"Biomarker, GeneticVariation"
79728,PALB2,partner and localizer of BRCA2,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.237904338,11,"AlteredExpression, Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,1.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.23788151,84,"Biomarker, GeneticVariation"
26121,PRPF31,pre-mRNA processing factor 31,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.237847065,27,"Biomarker, GeneticVariation"
3949,LDLR,low density lipoprotein receptor,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.237765165,45,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.237748348,11,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7391,USF1,upstream transcription factor 1,1.0,1.0,1.0,0.0,0.0,20474,"Hyperlipidemia, Familial Combined",0.237707725,29,"AlteredExpression, Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.237620833,16,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,149931,Migraine Disorders,0.237550758,14,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,19196,Hepatitis C,0.237501727,31,"Biomarker, GeneticVariation"
30813,VSX1,visual system homeobox 1,0.0,1.0,1.0,0.0,0.0,22578,Keratoconus,0.237501727,23,"Biomarker, GeneticVariation"
965,CD58,CD58 molecule,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.237472275,15,"Biomarker, GeneticVariation"
4049,LTA,lymphotoxin alpha,0.0,1.0,1.0,0.0,0.0,243026,Sepsis,0.237472275,15,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.237413051,72,"AlteredExpression, Biomarker"
64127,NOD2,nucleotide-binding oligomerization domain containing 2,0.0,1.0,1.0,0.0,0.0,36202,Sarcoidosis,0.237394768,15,"Biomarker, GeneticVariation"
361,AQP4,aquaporin 4,1.0,1.0,1.0,0.0,0.0,27873,Neuromyelitis Optica,0.237355123,57,"AlteredExpression, Biomarker, GeneticVariation"
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.237345249,25,"Biomarker, GeneticVariation"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",1.0,1.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.237326159,47,"AlteredExpression, Biomarker, Therapeutic"
5346,PLIN1,perilipin 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.237325182,32,"Biomarker, GeneticVariation"
3811,KIR3DL1,"killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1",0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.237276151,43,"Biomarker, GeneticVariation"
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,1.0,0.0,0.0,27947,Neutropenia,0.23722712,49,"Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,1.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.237216439,96,"AlteredExpression, Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.237140228,25,"AlteredExpression, Biomarker, GeneticVariation"
7292,TNFSF4,"tumor necrosis factor (ligand) superfamily, member 4",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.237139739,21,"Biomarker, GeneticVariation"
30835,CD209,CD209 molecule,0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.237139739,19,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.237062721,32,"AlteredExpression, Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,5779,Blood Coagulation Disorders,0.237061744,24,"Biomarker, GeneticVariation"
2272,FHIT,fragile histidine triad,1.0,1.0,1.0,1.0,0.0,24121,Lung Neoplasms,0.236955762,25,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2100,ESR2,estrogen receptor 2 (ER beta),1.0,1.0,1.0,1.0,0.0,14175,Endometriosis,0.236906243,21,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,1.0,1418,Adenocarcinoma,0.236877279,19,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.236856235,22,"Biomarker, GeneticVariation"
5770,PTPN1,"protein tyrosine phosphatase, non-receptor type 1",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.236807204,23,"Biomarker, GeneticVariation"
161582,DYX1C1,dyslexia susceptibility 1 candidate 1,0.0,1.0,1.0,0.0,0.0,476254,Dyslexia,0.236729697,29,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.236643293,16,"AlteredExpression, Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.236524676,36,"AlteredExpression, Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,1.0,0.0,17638,Glioma,0.236524188,31,"Biomarker, GeneticVariation, PostTranslationalModification"
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.23651529,10,"AlteredExpression, Biomarker, GeneticVariation"
84735,CNDP1,carnosine dipeptidase 1 (metallopeptidase M20 family),0.0,1.0,1.0,0.0,0.0,11881,Diabetic Nephropathies,0.236495224,18,"Biomarker, GeneticVariation"
9173,IL1RL1,interleukin 1 receptor-like 1,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.236445704,23,"Biomarker, GeneticVariation"
1950,EGF,epidermal growth factor,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.236388753,25,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.236387776,10,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.236367709,24,"Biomarker, GeneticVariation"
2100,ESR2,estrogen receptor 2 (ER beta),1.0,1.0,1.0,0.0,1.0,33578,Prostatic Neoplasms,0.236359789,17,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,31212,Personality Disorders,0.236338256,14,"Biomarker, GeneticVariation"
8301,PICALM,phosphatidylinositol binding clathrin assembly protein,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.236289225,18,"Biomarker, GeneticVariation"
5744,PTHLH,parathyroid hormone-like hormone,1.0,1.0,0.0,0.0,0.0,20437,Hypercalcemia,0.236250069,64,"AlteredExpression, Biomarker"
4023,LPL,lipoprotein lipase,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.236240195,28,"Biomarker, GeneticVariation"
2322,FLT3,fms-related tyrosine kinase 3,0.0,1.0,1.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.236220616,45,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.236131451,85,"Biomarker, GeneticVariation"
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.236093102,44,"Biomarker, GeneticVariation"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.23605524,13,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,1.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.23605524,16,"AlteredExpression, Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.236005721,17,"Biomarker, GeneticVariation"
1991,ELANE,"elastase, neutrophil expressed",0.0,1.0,1.0,0.0,0.0,27947,Neutropenia,0.235977734,20,"Biomarker, GeneticVariation"
57502,NLGN4X,"neuroligin 4, X-linked",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.235957178,26,"Biomarker, GeneticVariation"
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.23595669,21,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.235888081,52,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",1.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.235751669,32,"AlteredExpression, Biomarker, GeneticVariation"
7030,TFE3,transcription factor binding to IGHM enhancer 3,1.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.235740988,74,"AlteredExpression, Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,1.0,1.0,1.0,0.0,1.0,9375,Colonic Neoplasms,0.235665265,14,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5788,PTPRC,"protein tyrosine phosphatase, receptor type, C",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.23564471,15,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,38358,Stomach Ulcer,0.235644221,13,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,15695,Fatty Liver,0.235566226,17,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,25517,Metabolic Diseases,0.235515411,91,Biomarker
6387,CXCL12,chemokine (C-X-C motif) ligand 12,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.235509275,11,"AlteredExpression, Biomarker, GeneticVariation"
60528,ELAC2,elaC ribonuclease Z 2,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.235509275,11,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.235487743,11,"Biomarker, GeneticVariation"
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.235487743,13,"Biomarker, GeneticVariation"
1589,CYP21A2,"cytochrome P450, family 21, subfamily A, polypeptide 2",0.0,1.0,1.0,0.0,0.0,852654,21-hydroxylase deficiency,0.235438071,125,"Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,1.0,1.0,1.0,0.0,0.0,242339,Dyslipidemias,0.235419133,35,"AlteredExpression, Biomarker, GeneticVariation"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,1.0,0.0,0.0,2931834,Congenital Hyperinsulinism,0.235399067,53,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.235390169,28,"AlteredExpression, Biomarker, GeneticVariation"
5021,OXTR,oxytocin receptor,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.235389681,22,"Biomarker, GeneticVariation"
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.235361205,17,"AlteredExpression, Biomarker, GeneticVariation"
864,RUNX3,runt-related transcription factor 3,1.0,1.0,1.0,1.0,0.0,38356,Stomach Neoplasms,0.23533273,20,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7036,TFR2,transferrin receptor 2,0.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.235292107,45,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.235272041,60,"AlteredExpression, Biomarker, GeneticVariation"
4629,MYH11,"myosin, heavy chain 11, smooth muscle",0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.235231907,90,"Biomarker, GeneticVariation"
768,CA9,carbonic anhydrase IX,1.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.235225771,11,"AlteredExpression, Biomarker"
23327,NEDD4L,"neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.235155696,18,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.235155207,18,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,11881,Diabetic Nephropathies,0.235107153,30,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.235106665,23,"Biomarker, GeneticVariation"
1186,CLCN7,"chloride channel, voltage-sensitive 7",0.0,1.0,1.0,0.0,0.0,29454,Osteopetrosis,0.235058122,35,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.235049225,20,"AlteredExpression, Biomarker, GeneticVariation"
3596,IL13,interleukin 13,1.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.235008603,40,"AlteredExpression, Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.235000194,25,"AlteredExpression, Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.234999217,12,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,1.0,0.0,1418,Adenocarcinoma,0.234881577,47,"Biomarker, GeneticVariation, PostTranslationalModification"
5277,PIGA,"phosphatidylinositol glycan anchor biosynthesis, class A",0.0,1.0,1.0,0.0,0.0,24790,Paroxysmal nocturnal hemoglobinuria,0.234871062,123,"Biomarker, GeneticVariation"
6609,SMPD1,"sphingomyelin phosphodiesterase 1, acid lysosomal",1.0,1.0,1.0,0.0,0.0,28064,Niemann-Pick Diseases,0.234832546,54,"AlteredExpression, Biomarker, GeneticVariation"
7291,TWIST1,twist family bHLH transcription factor 1,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.234832546,54,"AlteredExpression, Biomarker"
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.234814752,11,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,11633,Dermatomyositis,0.234794196,15,"Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,3125,Anorexia Nervosa,0.234666682,15,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.234656,67,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,1.0,1.0,1.0,0.0,0.0,24299,Lymphoma,0.234627036,56,"AlteredExpression, Biomarker, GeneticVariation"
2539,G6PD,glucose-6-phosphate dehydrogenase,0.0,1.0,1.0,0.0,0.0,2878,"Anemia, Hemolytic",0.234627036,56,"Biomarker, GeneticVariation"
1535,CYBA,"cytochrome b-245, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.234588687,18,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,30920,Peptic Ulcer,0.234588198,12,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,235974,Pancreatic Carcinoma,0.234587558,122,"Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.23456862,35,"AlteredExpression, Biomarker, GeneticVariation"
6311,ATXN2,ataxin 2,0.0,1.0,1.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.23456862,37,"Biomarker, GeneticVariation"
1816,DRD5,dopamine receptor D5,0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.234490136,25,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.234461661,24,"AlteredExpression, Biomarker, GeneticVariation"
6361,CCL17,chemokine (C-C motif) ligand 17,1.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.234433185,23,"AlteredExpression, Biomarker"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.234403732,12,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.234383177,16,"Biomarker, GeneticVariation"
613,BCR,breakpoint cluster region,0.0,1.0,1.0,0.0,0.0,5699,Blast Crisis,0.234381393,86,"Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,15625,Fanconi Anemia,0.234372496,62,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.234363599,41,"AlteredExpression, Biomarker, GeneticVariation"
6794,STK11,serine/threonine kinase 11,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.234334635,29,"AlteredExpression, Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.234294501,62,"AlteredExpression, Biomarker"
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.234294501,63,"AlteredExpression, Biomarker, GeneticVariation"
91752,ZNF804A,zinc finger protein 804A,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.234294012,54,"Biomarker, GeneticVariation"
3593,IL12B,interleukin 12B,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.234255663,19,"Biomarker, GeneticVariation"
23385,NCSTN,nicastrin,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.234226698,11,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.23420712,32,"Biomarker, GeneticVariation"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",1.0,1.0,1.0,0.0,1.0,4153,Atherosclerosis,0.234198711,16,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
55024,BANK1,B-cell scaffold protein with ankyrin repeats 1,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.234177667,16,"Biomarker, GeneticVariation"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.234157601,36,"Biomarker, GeneticVariation"
26191,PTPN22,"protein tyrosine phosphatase, non-receptor type 22 (lymphoid)",0.0,1.0,1.0,0.0,0.0,18213,Graves Disease,0.234128637,21,"Biomarker, GeneticVariation"
5617,PRL,prolactin,0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.234097888,87,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.234060027,52,"AlteredExpression, Biomarker, GeneticVariation"
7827,NPHS2,"nephrosis 2, idiopathic, steroid-resistant (podocin)",0.0,1.0,1.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.234030575,38,"Biomarker, GeneticVariation"
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.233973135,31,"AlteredExpression, Biomarker, GeneticVariation"
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.233972646,18,"AlteredExpression, Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.233944171,22,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
6314,ATXN7,ataxin 7,1.0,1.0,1.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.233943682,16,"AlteredExpression, Biomarker, GeneticVariation"
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,1540912,Hypereosinophilic Syndrome,0.233924104,36,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.233903549,44,"Biomarker, GeneticVariation"
85480,TSLP,thymic stromal lymphopoietin,1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.233874585,35,"AlteredExpression, Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.233865687,16,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,151779,"Melanoma, Cutaneous Malignant",0.233863415,78,"Biomarker, GeneticVariation"
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,1.0,1.0,0.0,1.0,0.0,33578,Prostatic Neoplasms,0.233837212,15,"AlteredExpression, Biomarker, PostTranslationalModification"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.233816168,11,"Biomarker, GeneticVariation"
10320,IKZF1,IKAROS family zinc finger 1 (Ikaros),1.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.23379659,37,"AlteredExpression, Biomarker, GeneticVariation"
6928,HNF1B,HNF1 homeobox B,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.233787204,9,"AlteredExpression, Biomarker, GeneticVariation"
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.233787204,10,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.233756456,69,"AlteredExpression, Biomarker"
246,ALOX15,arachidonate 15-lipoxygenase,1.0,1.0,1.0,0.0,1.0,4153,Atherosclerosis,0.233689142,22,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
7056,THBD,thrombomodulin,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.233688653,13,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,0.0,1.0,0.0,27627,Neoplasm Metastasis,0.233669564,45,"AlteredExpression, Biomarker, PostTranslationalModification"
3162,HMOX1,heme oxygenase (decycling) 1,1.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.233611147,17,"AlteredExpression, Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,0.0,1.0,1.0,0.0,0.0,20473,Hyperlipidemias,0.233561627,22,"Biomarker, GeneticVariation"
4049,LTA,lymphotoxin alpha,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.233532663,15,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,24299,Lymphoma,0.233532663,14,"Biomarker, GeneticVariation"
3172,HNF4A,"hepatocyte nuclear factor 4, alpha",0.0,1.0,0.0,0.0,0.0,342276,Mason-Type Diabetes,0.233530879,83,Biomarker
288,ANK3,"ankyrin 3, node of Ranvier (ankyrin G)",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.233463565,36,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.23345418,11,"Biomarker, GeneticVariation"
3205,HOXA9,homeobox A9,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.233415023,50,"AlteredExpression, Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.233376185,9,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,1925,Albuminuria,0.233376185,11,"Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,23418,Leukemia,0.233356606,30,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.233356118,21,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,1.0,1.0,0.0,1.0,1.0,5695,Urinary Bladder Neoplasms,0.233299167,21,"AlteredExpression, Biomarker, PostTranslationalModification, Therapeutic"
2623,GATA1,GATA binding protein 1 (globin transcription factor 1),1.0,1.0,1.0,0.0,0.0,23462,"Leukemia, Megakaryoblastic, Acute",0.233250791,55,"AlteredExpression, Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,3125,Anorexia Nervosa,0.233249647,14,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.233171652,23,"AlteredExpression, Biomarker, GeneticVariation"
2707,GJB3,"gap junction protein, beta 3, 31kDa",0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.233170675,11,"Biomarker, GeneticVariation"
79001,VKORC1,"vitamin K epoxide reductase complex, subunit 1",0.0,1.0,1.0,0.0,0.0,19080,Hemorrhage,0.233170675,10,"Biomarker, GeneticVariation"
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.233160483,57,Biomarker
2932,GSK3B,glycogen synthase kinase 3 beta,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.233093169,15,"AlteredExpression, Biomarker, GeneticVariation"
56244,BTNL2,butyrophilin-like 2 (MHC class II associated),1.0,1.0,1.0,0.0,0.0,36202,Sarcoidosis,0.233073102,22,"AlteredExpression, Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.233073102,24,"AlteredExpression, Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.233072613,19,"Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.233043649,13,"Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.233043649,11,"Biomarker, GeneticVariation"
7043,TGFB3,"transforming growth factor, beta 3",0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.233043649,16,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,13581,Ectopia Lentis,0.233024071,34,"Biomarker, GeneticVariation"
2166,FAAH,fatty acid amide hydrolase,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.233023582,27,"Biomarker, GeneticVariation"
5744,PTHLH,parathyroid hormone-like hormone,1.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.233015662,19,"AlteredExpression, Biomarker, PostTranslationalModification"
5053,PAH,phenylalanine hydroxylase,0.0,1.0,1.0,0.0,0.0,751435,Hyperphenylalaninemia,0.232984592,102,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.232945587,25,"Biomarker, GeneticVariation"
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.232859184,12,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.232859184,9,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,1.0,1418,Adenocarcinoma,0.232838628,23,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.23281905,41,"AlteredExpression, Biomarker"
6326,SCN2A,"sodium channel, voltage gated, type II alpha subunit",0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.232740566,33,"Biomarker, GeneticVariation"
5997,RGS2,regulator of G-protein signaling 2,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.232711114,18,"Biomarker, GeneticVariation, Therapeutic"
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.232703194,10,"Biomarker, GeneticVariation"
332,BIRC5,baculoviral IAP repeat containing 5,1.0,1.0,1.0,0.0,1.0,24121,Lung Neoplasms,0.232703194,11,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
6037,RNASE3,"ribonuclease, RNase A family, 3",1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.232682638,19,"AlteredExpression, Biomarker, GeneticVariation"
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",1.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.232633119,19,"AlteredExpression, Biomarker, GeneticVariation"
8842,PROM1,prominin 1,1.0,1.0,0.0,1.0,0.0,17636,Glioblastoma,0.232593473,55,"AlteredExpression, Biomarker, PostTranslationalModification"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.232584088,27,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",1.0,1.0,1.0,0.0,1.0,33578,Prostatic Neoplasms,0.232575679,13,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,0.0,0.0,265965,Dyskeratosis Congenita,0.232555612,24,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.232555124,15,"Biomarker, GeneticVariation"
6583,SLC22A4,"solute carrier family 22 (organic cation/zwitterion transporter), member 4",0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.232555124,16,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,34065,Pulmonary Embolism,0.232554635,14,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,948480,Coronary Restenosis,0.232554635,15,"Biomarker, GeneticVariation"
121278,TPH2,tryptophan hydroxylase 2,0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.232505604,19,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.232497684,11,"AlteredExpression, Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,1.0,33578,Prostatic Neoplasms,0.232477617,25,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,152013,Adenocarcinoma of lung,0.232445892,73,"Biomarker, GeneticVariation"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.232436995,47,"AlteredExpression, Biomarker, GeneticVariation"
4255,MGMT,O-6-methylguanine-DNA methyltransferase,0.0,1.0,1.0,0.0,0.0,6118,Brain Neoplasms,0.232378578,28,"Biomarker, GeneticVariation"
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.232321139,16,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.232309969,55,"AlteredExpression, Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,1.0,1.0,1.0,0.0,0.0,23418,Leukemia,0.232281005,48,"AlteredExpression, Biomarker, GeneticVariation"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.232271619,18,"AlteredExpression, Biomarker, GeneticVariation"
4864,NPC1,"Niemann-Pick disease, type C1",0.0,1.0,1.0,0.0,0.0,220756,"Niemann-Pick Disease, Type C",0.232260449,58,"Biomarker, GeneticVariation"
319100,TAAR6,trace amine associated receptor 6,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.232193624,10,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,18133,Graft vs Host Disease,0.232193135,8,"Biomarker, GeneticVariation"
1950,EGF,epidermal growth factor,1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.232165149,16,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7153,TOP2A,topoisomerase (DNA) II alpha 170kDa,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.232165149,16,"AlteredExpression, Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.23216466,9,"AlteredExpression, Biomarker, GeneticVariation"
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,1.0,0.0,0.0,14548,"Epilepsy, Generalized",0.232115629,17,"Biomarker, GeneticVariation"
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.232113356,79,Biomarker
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.232086665,11,"AlteredExpression, Biomarker, GeneticVariation"
100,ADA,adenosine deaminase,0.0,1.0,1.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.232085047,105,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.231988603,25,"AlteredExpression, Biomarker, GeneticVariation"
117156,SCGB3A2,"secretoglobin, family 3A, member 2",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.231988114,11,"Biomarker, GeneticVariation"
6790,AURKA,aurora kinase A,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.231959639,15,"AlteredExpression, Biomarker, GeneticVariation"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",1.0,1.0,0.0,0.0,1.0,17638,Glioma,0.231939572,31,"AlteredExpression, Biomarker, Therapeutic"
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",1.0,1.0,1.0,0.0,1.0,40136,Thyroid Neoplasms,0.231910608,23,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,16059,Fibrosis,0.231881155,9,"AlteredExpression, Biomarker, GeneticVariation"
1950,EGF,epidermal growth factor,1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.231869986,46,"AlteredExpression, Biomarker, GeneticVariation"
3663,IRF5,interferon regulatory factor 5,0.0,1.0,1.0,0.0,0.0,36421,"Scleroderma, Systemic",0.2318606,13,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,162809,Kallmann Syndrome,0.231841022,36,"Biomarker, GeneticVariation"
128674,PROKR2,prokineticin receptor 2,0.0,1.0,1.0,0.0,0.0,162809,Kallmann Syndrome,0.231812058,25,"Biomarker, GeneticVariation"
857,CAV1,"caveolin 1, caveolae protein, 22kDa",1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.23174296,52,"AlteredExpression, Biomarker"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,1140680,Malignant neoplasm of ovary,0.23169344,53,"Biomarker, GeneticVariation"
6247,RS1,retinoschisin 1,0.0,1.0,1.0,0.0,0.0,152439,Retinoschisis,0.231676134,16,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.231675646,9,"Biomarker, GeneticVariation"
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.231675646,12,"Biomarker, GeneticVariation"
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,1.0,0.0,0.0,85220,Cerebral Amyloid Angiopathy,0.231627103,20,"Biomarker, GeneticVariation"
7019,TFAM,"transcription factor A, mitochondrial",0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.231626126,8,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.231598139,15,"AlteredExpression, Biomarker, GeneticVariation"
6714,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.231598139,14,"AlteredExpression, Biomarker"
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,1.0,1.0,0.0,0.0,9952,"Seizures, Febrile",0.231577584,21,"Biomarker, GeneticVariation"
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,1.0,0.0,0.0,4509,Azoospermia,0.231557029,32,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,79218,"Fibromatosis, Aggressive",0.231508486,44,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,24115,Lung Diseases,0.231508486,44,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.2314991,13,"Biomarker, GeneticVariation"
773,CACNA1A,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",0.0,1.0,1.0,0.0,0.0,4134,Ataxia,0.231479522,36,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.231470136,10,"AlteredExpression, Biomarker, GeneticVariation"
6716,SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",0.0,1.0,1.0,0.0,0.0,2937421,Prostatic Hyperplasia,0.231470136,9,"Biomarker, GeneticVariation"
4072,EPCAM,epithelial cell adhesion molecule,0.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.231430491,44,"Biomarker, GeneticVariation"
1378,CR1,complement component (3b/4b) receptor 1 (Knops blood group),0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.231420617,11,"Biomarker, GeneticVariation"
2100,ESR2,estrogen receptor 2 (ER beta),1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.23139263,14,"AlteredExpression, Biomarker, GeneticVariation"
6317,SERPINB3,"serpin peptidase inhibitor, clade B (ovalbumin), member 3",1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.231343599,21,"AlteredExpression, Biomarker"
7412,VCAM1,vascular cell adhesion molecule 1,1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.231323043,29,"AlteredExpression, Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.231314635,13,"AlteredExpression, Biomarker, GeneticVariation"
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",1.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.231314635,13,"AlteredExpression, Biomarker, GeneticVariation"
3440,IFNA2,"interferon, alpha 2",0.0,1.0,1.0,0.0,1.0,19196,Hepatitis C,0.231311874,75,"Biomarker, GeneticVariation, Therapeutic"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,1.0,0.0,0.0,11849,Diabetes Mellitus,0.231274012,37,"Biomarker, GeneticVariation"
3614,IMPDH1,IMP (inosine 5'-monophosphate) dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.231265115,12,"Biomarker, GeneticVariation"
695,BTK,Bruton agammaglobulinemia tyrosine kinase,0.0,1.0,1.0,0.0,1.0,1768,Agammaglobulinemia,0.23118712,13,"Biomarker, GeneticVariation, Therapeutic"
51473,DCDC2,doublecortin domain containing 2,0.0,1.0,1.0,0.0,0.0,476254,Dyslexia,0.231166565,17,"Biomarker, GeneticVariation"
30061,SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1",0.0,1.0,1.0,0.0,0.0,282193,Iron Overload,0.231146498,38,"Biomarker, GeneticVariation"
1736,DKC1,"dyskeratosis congenita 1, dyskerin",1.0,1.0,1.0,0.0,0.0,265965,Dyskeratosis Congenita,0.231118022,33,"AlteredExpression, Biomarker, GeneticVariation"
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,1.0,1.0,0.0,0.0,14804,Erythromelalgia,0.231089058,26,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.231089058,28,"AlteredExpression, Biomarker"
5327,PLAT,"plasminogen activator, tissue",1.0,1.0,1.0,0.0,1.0,38454,Stroke,0.23108857,79,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
7941,PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)",1.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.231039539,26,"AlteredExpression, Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",1.0,1.0,0.0,1.0,0.0,30297,Pancreatic Neoplasms,0.23103113,12,"AlteredExpression, Biomarker, PostTranslationalModification"
5617,PRL,prolactin,1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.231010575,17,"AlteredExpression, Biomarker, GeneticVariation"
434,ASIP,agouti signaling protein,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.231010086,13,"Biomarker, GeneticVariation"
27436,EML4,echinoderm microtubule associated protein like 4,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.230979338,75,Biomarker
51151,SLC45A2,"solute carrier family 45, member 2",0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.23088306,17,"Biomarker, GeneticVariation"
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,1.0,0.0,0.0,524851,Neurodegenerative Diseases,0.230854585,22,"Biomarker, GeneticVariation"
3667,IRS1,insulin receptor substrate 1,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.230853608,10,"Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.230853608,10,"Biomarker, GeneticVariation"
116519,APOA5,apolipoprotein A-V,1.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.230834029,25,"AlteredExpression, Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.230805065,21,"AlteredExpression, Biomarker, GeneticVariation"
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,1.0,0.0,0.0,1126,"Acidosis, Renal Tubular",0.230747626,12,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,1.0,1.0,0.0,38356,Stomach Neoplasms,0.230747626,11,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.230747626,12,"AlteredExpression, Biomarker"
5268,SERPINB5,"serpin peptidase inhibitor, clade B (ovalbumin), member 5",1.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.230747626,11,"AlteredExpression, Biomarker, PostTranslationalModification"
7490,WT1,Wilms tumor 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.230747626,10,"AlteredExpression, Biomarker"
3481,IGF2,insulin-like growth factor 2,0.0,1.0,1.0,0.0,0.0,4903,Beckwith-Wiedemann Syndrome,0.230744865,65,"Biomarker, GeneticVariation"
80339,PNPLA3,patatin-like phospholipase domain containing 3,0.0,1.0,1.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.230744865,66,"Biomarker, GeneticVariation"
59067,IL21,interleukin 21,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.230677551,16,"Biomarker, GeneticVariation"
2492,FSHR,follicle stimulating hormone receptor,1.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.230677551,20,"AlteredExpression, Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.230657484,36,"Biomarker, GeneticVariation"
353143,LCE3B,late cornified envelope 3B,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.23062852,24,"Biomarker, GeneticVariation"
353144,LCE3C,late cornified envelope 3C,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.23062852,24,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.230608941,49,"Biomarker, GeneticVariation"
406906,MIR122,microRNA 122,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.230608941,47,"AlteredExpression, Biomarker"
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.230542116,11,"AlteredExpression, Biomarker, GeneticVariation"
6696,SPP1,secreted phosphoprotein 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.230493085,17,"AlteredExpression, Biomarker"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.230464121,9,"AlteredExpression, Biomarker"
6340,SCNN1G,"sodium channel, non voltage gated 1 gamma subunit",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.230443077,12,"Biomarker, GeneticVariation"
6886,TAL1,T-cell acute lymphocytic leukemia 1,0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.230412329,73,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,1.0,0.0,0.0,2936349,"Plaque, Amyloid",0.230412329,73,"Biomarker, GeneticVariation"
7704,ZBTB16,zinc finger and BTB domain containing 16,0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.230412329,72,Biomarker
659,BMPR2,"bone morphogenetic protein receptor, type II (serine/threonine kinase)",0.0,1.0,1.0,0.0,0.0,152171,Idiopathic Pulmonary Hypertension,0.230334989,107,"Biomarker, GeneticVariation"
79577,CDC73,cell division cycle 73,1.0,1.0,1.0,0.0,0.0,30521,Parathyroid Neoplasms,0.230238545,22,"AlteredExpression, Biomarker, GeneticVariation"
2332,FMR1,fragile X mental retardation 1,0.0,1.0,1.0,0.0,0.0,3714756,Intellectual Disability,0.230238545,25,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.230237568,13,"Biomarker, GeneticVariation"
85363,TRIM5,tripartite motif containing 5,1.0,1.0,1.0,0.0,1.0,19693,HIV Infections,0.230197922,46,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
55876,GSDMB,gasdermin B,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.230188537,19,"Biomarker, GeneticVariation"
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.230188537,22,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,1510455,Acrocephalosyndactylia,0.230180617,12,"Biomarker, GeneticVariation"
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,1.0,0.0,0.0,598608,Hyperhomocysteinemia,0.230159573,14,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.230139506,27,"Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",1.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.230110542,15,"AlteredExpression, Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.230110542,20,"AlteredExpression, Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,28768,Obsessive-Compulsive Disorder,0.230110542,16,"Biomarker, GeneticVariation"
7068,THRB,"thyroid hormone receptor, beta",0.0,1.0,1.0,0.0,0.0,2940786,Thyroid Hormone Resistance Syndrome,0.230090963,40,"Biomarker, GeneticVariation"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,1.0,0.0,0.0,158981,Neonatal diabetes mellitus,0.230051484,106,"Biomarker, GeneticVariation"
4352,MPL,"MPL proto-oncogene, thrombopoietin receptor",1.0,1.0,1.0,0.0,0.0,836924,Thrombocytosis,0.230033035,23,"AlteredExpression, Biomarker, GeneticVariation"
4477,MSMB,"microseminoprotein, beta-",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.230003583,12,"Biomarker, GeneticVariation"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.229975107,8,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.229975107,9,"Biomarker, GeneticVariation"
2100,ESR2,estrogen receptor 2 (ER beta),1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.229926076,14,"AlteredExpression, Biomarker"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.229926076,17,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
6101,RP1,retinitis pigmentosa 1 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.229888381,11,"Biomarker, GeneticVariation"
3362,HTR6,"5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.229827037,17,"Biomarker, GeneticVariation"
1200,TPP1,tripeptidyl peptidase I,1.0,1.0,1.0,0.0,0.0,27877,Neuronal Ceroid-Lipofuscinoses,0.229778495,31,"AlteredExpression, Biomarker, GeneticVariation"
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.229749042,12,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,29458,"Osteoporosis, Postmenopausal",0.229670558,13,"Biomarker, GeneticVariation"
8604,SLC25A12,"solute carrier family 25 (aspartate/glutamate carrier), member 12",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.229621527,15,"Biomarker, GeneticVariation"
8600,TNFSF11,"tumor necrosis factor (ligand) superfamily, member 11",1.0,1.0,1.0,0.0,1.0,29456,Osteoporosis,0.229593052,16,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3606,IL18,interleukin 18,1.0,1.0,1.0,0.0,0.0,36202,Sarcoidosis,0.229593052,11,"AlteredExpression, Biomarker, GeneticVariation"
3122,HLA-DRA,"major histocompatibility complex, class II, DR alpha",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.229592563,9,"Biomarker, GeneticVariation"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,376358,Malignant neoplasm of prostate,0.229572497,21,"Biomarker, GeneticVariation"
6121,RPE65,retinal pigment epithelium-specific protein 65kDa,0.0,1.0,1.0,0.0,1.0,456909,Blindness,0.229564088,9,"Biomarker, GeneticVariation, Therapeutic"
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,23467,"Leukemia, Myeloid, Acute",0.229561815,70,"Biomarker, Therapeutic"
4089,SMAD4,SMAD family member 4,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.229515057,15,"AlteredExpression, Biomarker, GeneticVariation"
6794,STK11,serine/threonine kinase 11,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.229515057,15,"AlteredExpression, Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,1.0,0.0,0.0,948089,Acute Coronary Syndrome,0.229514568,9,"Biomarker, GeneticVariation"
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.229514568,9,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.229503887,54,"AlteredExpression, Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.229466026,22,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.229465537,12,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.229436573,11,"Biomarker, GeneticVariation"
5241,PGR,progesterone receptor,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.229416995,30,"AlteredExpression, Biomarker"
26580,BSCL2,Berardinelli-Seip congenital lipodystrophy 2 (seipin),0.0,1.0,1.0,0.0,0.0,221032,"Lipodystrophy, Congenital Generalized",0.229416995,27,"Biomarker, GeneticVariation"
2898,GRIK2,"glutamate receptor, ionotropic, kainate 2",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.229387542,10,"Biomarker, GeneticVariation"
5588,PRKCQ,"protein kinase C, theta",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.229387054,13,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.229367476,29,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.229359067,12,"AlteredExpression, Biomarker"
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.229359067,14,"AlteredExpression, Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.229358578,9,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.229358578,12,"Biomarker, GeneticVariation"
8915,BCL10,B-cell CLL/lymphoma 10,1.0,1.0,1.0,0.0,0.0,242647,"Lymphoma, B-Cell, Marginal Zone",0.229339655,61,"AlteredExpression, Biomarker, GeneticVariation"
8647,ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",0.0,1.0,1.0,0.0,0.0,8372,"Cholestasis, Intrahepatic",0.229309547,14,"Biomarker, GeneticVariation"
3077,HFE,hemochromatosis,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.229309059,8,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,42109,Urticaria,0.229309059,8,"Biomarker, GeneticVariation"
1161,ERCC8,excision repair cross-complementation group 8,0.0,1.0,1.0,0.0,0.0,9207,Cockayne Syndrome,0.22928948,29,"Biomarker, GeneticVariation"
64127,NOD2,nucleotide-binding oligomerization domain containing 2,0.0,1.0,1.0,0.0,0.0,3872,"Arthritis, Psoriatic",0.229260028,11,"Biomarker, GeneticVariation"
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.229260028,16,"Biomarker, GeneticVariation"
3456,IFNB1,"interferon, beta 1, fibroblast",1.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.22924045,37,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,40136,Thyroid Neoplasms,0.229231064,9,"Biomarker, GeneticVariation"
613,BCR,breakpoint cluster region,1.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.229220383,52,"AlteredExpression, Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.229191419,44,Biomarker
779,CACNA1S,"calcium channel, voltage-dependent, L type, alpha 1S subunit",0.0,1.0,1.0,0.0,0.0,238358,Hypokalemic Periodic Paralysis,0.229191419,41,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",1.0,1.0,1.0,0.0,0.0,13080,Down Syndrome,0.229191419,43,"AlteredExpression, Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,1.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.229182033,19,"AlteredExpression, Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.229153557,13,"Biomarker, GeneticVariation"
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,1.0,0.0,0.0,85580,"Hypertension, Essential",0.229141899,44,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,242422,Parkinsonian Disorders,0.229104526,17,"Biomarker, GeneticVariation"
4729,NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.229104038,9,"Biomarker, GeneticVariation"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",1.0,1.0,1.0,0.0,1.0,1458155,Breast Neoplasms,0.229075562,13,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3105,HLA-A,"major histocompatibility complex, class I, A",0.0,1.0,1.0,0.0,0.0,38325,Stevens-Johnson Syndrome,0.229054518,14,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.229054518,12,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.229014873,53,"AlteredExpression, Biomarker, GeneticVariation"
4647,MYO7A,myosin VIIA,0.0,1.0,1.0,0.0,0.0,271097,Usher Syndromes,0.229005976,27,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,27686,"Neovascularization, Pathologic",0.228947559,10,"AlteredExpression, Biomarker, GeneticVariation"
7035,TFPI,tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor),0.0,0.0,1.0,0.0,1.0,42487,Venous Thrombosis,0.228947559,8,"GeneticVariation, Therapeutic"
7066,THPO,thrombopoietin,1.0,1.0,1.0,0.0,0.0,836924,Thrombocytosis,0.22887895,33,"AlteredExpression, Biomarker, GeneticVariation"
3565,IL4,interleukin 4,1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.228849497,18,"AlteredExpression, Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,28768,Obsessive-Compulsive Disorder,0.228849497,16,"Biomarker, GeneticVariation"
4241,MFI2,antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.228821022,18,"AlteredExpression, Biomarker, GeneticVariation"
5645,PRSS2,"protease, serine, 2 (trypsin 2)",1.0,1.0,1.0,0.0,0.0,149521,"Pancreatitis, Chronic",0.228820533,10,"AlteredExpression, Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,1.0,11884,Diabetic Retinopathy,0.228820533,10,"Biomarker, GeneticVariation, Therapeutic"
57142,RTN4,reticulon 4,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.228820533,13,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.228800466,27,"Biomarker, GeneticVariation"
857,CAV1,"caveolin 1, caveolae protein, 22kDa",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.228792058,11,"AlteredExpression, Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.228771502,20,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.228771014,12,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.22874205,7,"Biomarker, GeneticVariation"
3785,KCNQ2,"potassium channel, voltage gated KQT-like subfamily Q, member 2",0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.228702404,40,"Biomarker, GeneticVariation"
114781,BTBD9,BTB (POZ) domain containing 9,0.0,1.0,1.0,0.0,0.0,35258,Restless Legs Syndrome,0.228693019,12,"Biomarker, GeneticVariation"
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,1.0,0.0,0.0,85207,"Diabetes, Gestational",0.228684777,26,"Biomarker, GeneticVariation"
8929,PHOX2B,paired-like homeobox 2b,0.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.22867344,31,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,7795,Diffuse Cerebral Sclerosis of Schilder,0.228644476,28,"Biomarker, GeneticVariation"
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.228643988,18,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",1.0,1.0,1.0,0.0,0.0,24530,Malaria,0.228643988,17,"AlteredExpression, Biomarker, GeneticVariation"
846,CASR,calcium-sensing receptor,1.0,1.0,1.0,0.0,0.0,20502,Hyperparathyroidism,0.228615512,20,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.228565993,21,"AlteredExpression, Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.228537029,11,"AlteredExpression, Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.22853654,9,"Biomarker, GeneticVariation"
3952,LEP,leptin,0.0,1.0,1.0,0.0,1.0,43094,Weight Gain,0.22853654,10,"Biomarker, GeneticVariation, Therapeutic"
56606,SLC2A9,"solute carrier family 2 (facilitated glucose transporter), member 9",0.0,1.0,1.0,0.0,0.0,18099,Gout,0.22853654,9,"Biomarker, GeneticVariation"
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,1.0,1.0,0.0,0.0,16658,"Fractures, Bone",0.22853654,9,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,236969,Substance-Related Disorders,0.22853654,9,"Biomarker, GeneticVariation"
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,1.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.22853654,11,"Biomarker, GeneticVariation"
1285,COL4A3,"collagen, type IV, alpha 3 (Goodpasture antigen)",0.0,1.0,1.0,0.0,0.0,27706,"Nephritis, Hereditary",0.228508553,11,"Biomarker, GeneticVariation"
1950,EGF,epidermal growth factor,1.0,1.0,1.0,0.0,0.0,17636,Glioblastoma,0.228476828,58,"AlteredExpression, Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,1.0,1.0,0.0,0.0,0.0,27708,Wilms Tumor,0.228427797,66,"AlteredExpression, Biomarker"
1804,DPP6,dipeptidyl-peptidase 6,0.0,1.0,1.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.228409514,10,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,10073,Coronary Vasospasm,0.228311452,23,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,1.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.228303044,11,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2099,ESR1,estrogen receptor 1,1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.228303044,12,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
5468,PPARG,peroxisome proliferator-activated receptor gamma,1.0,1.0,1.0,0.0,1.0,40136,Thyroid Neoplasms,0.228254013,17,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,1.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.228253524,7,"Biomarker, GeneticVariation"
5362,PLXNA2,plexin A2,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.228253524,8,"Biomarker, GeneticVariation"
4311,MME,membrane metallo-endopeptidase,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.228225049,8,"AlteredExpression, Biomarker"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,1.0,1.0,1.0,1.0,1.0,24121,Lung Neoplasms,0.228225049,12,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
945,CD33,CD33 molecule,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.228164359,50,"AlteredExpression, Biomarker, GeneticVariation"
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.228154974,20,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.22812601,11,"Biomarker, GeneticVariation"
9966,TNFSF15,"tumor necrosis factor (ligand) superfamily, member 15",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.228076979,16,"Biomarker, GeneticVariation"
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),1.0,1.0,1.0,0.0,1.0,398625,Protein C Deficiency,0.228048503,18,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
1950,EGF,epidermal growth factor,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.228027948,27,"AlteredExpression, Biomarker, GeneticVariation"
10555,AGPAT2,1-acylglycerol-3-phosphate O-acyltransferase 2,1.0,1.0,1.0,0.0,0.0,221032,"Lipodystrophy, Congenital Generalized",0.227999472,21,"AlteredExpression, Biomarker, GeneticVariation"
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,19569,Hirschsprung Disease,0.227949953,22,"Biomarker, GeneticVariation"
2798,GNRHR,gonadotropin-releasing hormone receptor,0.0,1.0,1.0,0.0,0.0,20619,Hypogonadism,0.227892025,10,"Biomarker, GeneticVariation"
7051,TGM1,transglutaminase 1,0.0,1.0,1.0,0.0,0.0,79154,"Ichthyosis, Lamellar",0.227880855,46,"Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.227880855,49,"Biomarker, GeneticVariation"
326,AIRE,autoimmune regulator,0.0,1.0,1.0,0.0,0.0,3494489,"Autoimmune polyendocrinopathy syndrome, type 1",0.227860788,63,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.227842505,10,"AlteredExpression, Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.227822438,24,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,149931,Migraine Disorders,0.227793474,13,"Biomarker, GeneticVariation"
4908,NTF3,neurotrophin 3,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.227793474,14,"Biomarker, GeneticVariation"
7173,TPO,thyroid peroxidase,0.0,1.0,1.0,0.0,0.0,10308,Congenital Hypothyroidism,0.227773896,39,"Biomarker, GeneticVariation"
4170,MCL1,myeloid cell leukemia 1,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.227773896,39,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),1.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.22776451,10,"AlteredExpression, Biomarker, GeneticVariation"
7555,CNBP,"CCHC-type zinc finger, nucleic acid binding protein",0.0,1.0,1.0,0.0,0.0,27126,Myotonic Dystrophy,0.227675345,47,"Biomarker, GeneticVariation"
3952,LEP,leptin,1.0,1.0,0.0,0.0,1.0,21368,Inflammation,0.227658039,8,"AlteredExpression, Biomarker, Therapeutic"
4481,MSR1,macrophage scavenger receptor 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.227658039,8,"Biomarker, GeneticVariation"
845,CASQ2,calsequestrin 2 (cardiac muscle),0.0,1.0,1.0,0.0,0.0,42514,"Tachycardia, Ventricular",0.227658039,8,"Biomarker, GeneticVariation"
9429,ABCG2,"ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.227658039,8,"AlteredExpression, Biomarker, GeneticVariation"
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.227636995,13,"Biomarker, GeneticVariation"
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.227636995,12,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,7273,Carotid Artery Diseases,0.227636995,11,"Biomarker, GeneticVariation"
4513,COX2,cytochrome c oxidase subunit II,0.0,1.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.227598005,83,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.22759735,48,"AlteredExpression, Biomarker, GeneticVariation"
4221,MEN1,multiple endocrine neoplasia I,1.0,1.0,1.0,0.0,0.0,206754,Neuroendocrine Tumors,0.227568386,38,"AlteredExpression, Biomarker, GeneticVariation"
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.227559,11,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.227559,10,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.227559,10,"AlteredExpression, Biomarker, GeneticVariation"
153,ADRB1,adrenoceptor beta 1,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.227559,12,"Biomarker, GeneticVariation"
326,AIRE,autoimmune regulator,0.0,1.0,1.0,0.0,0.0,85409,"Polyendocrinopathies, Autoimmune",0.22750997,18,"Biomarker, GeneticVariation"
81608,FIP1L1,factor interacting with PAPOLA and CPSF1,0.0,1.0,1.0,0.0,0.0,1540912,Hypereosinophilic Syndrome,0.227490391,38,"Biomarker, GeneticVariation"
3676,ITGA4,"integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)",1.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.227481494,14,"AlteredExpression, Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.227481005,10,"AlteredExpression, Biomarker, GeneticVariation"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",1.0,1.0,1.0,0.0,1.0,21368,Inflammation,0.22745253,8,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3817,KLK2,kallikrein-related peptidase 2,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.22745253,8,"AlteredExpression, Biomarker, GeneticVariation"
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.22745253,8,"AlteredExpression, Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.22745253,9,"AlteredExpression, Biomarker, GeneticVariation"
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.22745253,8,"Biomarker, GeneticVariation"
943,TNFRSF8,"tumor necrosis factor receptor superfamily, member 8",1.0,1.0,1.0,0.0,0.0,19829,Hodgkin Disease,0.227432463,24,"AlteredExpression, Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.227431974,16,"AlteredExpression, Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,856761,Budd-Chiari Syndrome,0.227431974,15,"Biomarker, GeneticVariation"
3417,IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",0.0,1.0,1.0,0.0,0.0,28945,Oligodendroglioma,0.227411908,32,"Biomarker, GeneticVariation"
274,BIN1,bridging integrator 1,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.227353491,11,"Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,24535,"Malaria, Falciparum",0.227353491,11,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.227325015,8,"Biomarker, GeneticVariation"
54413,NLGN3,neuroligin 3,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.227304948,19,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.227304948,22,"Biomarker, GeneticVariation"
6657,SOX2,SRY (sex determining region Y)-box 2,0.0,1.0,1.0,0.0,0.0,3119,Anophthalmos,0.227304948,22,"Biomarker, GeneticVariation"
6775,STAT4,signal transducer and activator of transcription 4,0.0,1.0,1.0,0.0,0.0,36421,"Scleroderma, Systemic",0.22730446,15,"Biomarker, GeneticVariation"
6649,SOD3,"superoxide dismutase 3, extracellular",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.227275496,8,"Biomarker, GeneticVariation"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.22724702,9,"Biomarker, GeneticVariation"
8243,SMC1A,structural maintenance of chromosomes 1A,0.0,1.0,1.0,0.0,0.0,270972,De Lange Syndrome,0.227226953,20,"Biomarker, GeneticVariation"
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",1.0,1.0,1.0,0.0,0.0,242422,Parkinsonian Disorders,0.227206887,37,"AlteredExpression, Biomarker, GeneticVariation"
1188,CLCNKB,"chloride channel, voltage-sensitive Kb",0.0,1.0,1.0,0.0,0.0,4775,Bartter Syndrome,0.227148958,20,"Biomarker, GeneticVariation"
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.22714847,14,"Biomarker, GeneticVariation"
6348,CCL3,chemokine (C-C motif) ligand 3,1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.227128403,30,"AlteredExpression, Biomarker, GeneticVariation"
6934,TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box)",1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.227119994,14,"AlteredExpression, Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.227119994,14,"AlteredExpression, Biomarker"
10019,SH2B3,SH2B adaptor protein 3,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.227069986,9,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.227059305,53,"AlteredExpression, Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,1.0,1.0,1.0,0.0,0.0,11849,Diabetes Mellitus,0.227050408,29,"AlteredExpression, Biomarker, GeneticVariation"
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.227041511,11,"Biomarker, GeneticVariation"
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",1.0,1.0,1.0,0.0,1.0,3873,"Arthritis, Rheumatoid",0.227021444,19,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
60675,PROK2,prokineticin 2,0.0,1.0,1.0,0.0,0.0,162809,Kallmann Syndrome,0.227021444,18,"Biomarker, GeneticVariation"
2324,FLT4,fms-related tyrosine kinase 4,1.0,1.0,1.0,0.0,0.0,24236,Lymphedema,0.227021444,22,"AlteredExpression, Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.227001377,36,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.22699248,14,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.226972413,27,"Biomarker, GeneticVariation"
5582,PRKCG,"protein kinase C, gamma",0.0,1.0,1.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.226972413,27,"Biomarker, GeneticVariation"
5077,PAX3,paired box 3,0.0,1.0,1.0,0.0,0.0,3266898,Waardenburg Syndrome,0.226952346,44,"Biomarker, GeneticVariation"
4507,MTAP,methylthioadenosine phosphorylase,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.22694296,15,"AlteredExpression, Biomarker, GeneticVariation"
5310,PKD1,polycystic kidney disease 1 (autosomal dominant),1.0,1.0,1.0,0.0,0.0,10709,Cysts,0.226923382,37,"AlteredExpression, Biomarker, GeneticVariation"
1785,DNM2,dynamin 2,0.0,1.0,1.0,0.0,0.0,752282,"Myopathies, Structural, Congenital",0.226923382,34,"Biomarker, GeneticVariation"
50943,FOXP3,forkhead box P3,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.226922893,28,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.226914485,13,"AlteredExpression, Biomarker, GeneticVariation"
54806,AHI1,Abelson helper integration site 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.226864965,9,"Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.22683649,12,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,1.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.226836001,9,"AlteredExpression, Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.226795867,36,"AlteredExpression, Biomarker, GeneticVariation"
1071,CETP,"cholesteryl ester transfer protein, plasma",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.226786482,8,"Biomarker, GeneticVariation"
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",1.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.226746837,43,"AlteredExpression, Biomarker, GeneticVariation"
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.22672677,60,Biomarker
55294,FBXW7,"F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.22668842,21,"Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.22668842,22,"Biomarker, GeneticVariation"
51750,RTEL1,regulator of telomere elongation helicase 1,0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.22668842,19,"Biomarker, GeneticVariation"
4534,MTM1,myotubularin 1,0.0,1.0,1.0,0.0,0.0,752282,"Myopathies, Structural, Congenital",0.226639877,36,"Biomarker, GeneticVariation"
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.226630492,7,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.226590358,36,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.226561394,28,"Biomarker, GeneticVariation"
3169,FOXA1,forkhead box A1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.226552985,12,"AlteredExpression, Biomarker"
3084,NRG1,neuregulin 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.226552985,11,"AlteredExpression, Biomarker"
3952,LEP,leptin,0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.226541327,44,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.22653243,18,"Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.226502977,7,"Biomarker, GeneticVariation"
4128,MAOA,monoamine oxidase A,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.226502977,7,"Biomarker, GeneticVariation"
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.226502977,9,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,1.0,11881,Diabetic Nephropathies,0.226492296,53,"Biomarker, GeneticVariation, Therapeutic"
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,10308,Congenital Hypothyroidism,0.226483399,25,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.226483399,25,"Biomarker, GeneticVariation, Therapeutic"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.226453946,14,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.226453946,12,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,0.0,1.0,1.0,0.0,0.0,206727,Nerve Sheath Neoplasms,0.226434368,37,"Biomarker, GeneticVariation"
65078,RTN4R,reticulon 4 receptor,1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.226425471,6,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,11057,"Hearing Loss, Sudden",0.226424982,6,"Biomarker, GeneticVariation"
219771,CCNY,cyclin Y,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.226424982,6,"Biomarker, GeneticVariation"
6496,SIX3,SIX homeobox 3,0.0,1.0,1.0,0.0,0.0,79541,Holoprosencephaly,0.226405404,25,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,23343,Leprosy,0.226404915,19,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,29463,Osteosarcoma,0.22637644,14,"AlteredExpression, Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.226375951,12,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,32927,Precancerous Conditions,0.226355884,30,"Biomarker, GeneticVariation"
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,1.0,1.0,1.0,0.0,1418,Adenocarcinoma,0.226327409,23,"Biomarker, GeneticVariation, PostTranslationalModification"
2776,GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.22632692,21,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.22632692,21,"AlteredExpression, Biomarker, GeneticVariation"
55145,THAP1,"THAP domain containing, apoptosis associated protein 1",0.0,1.0,1.0,0.0,0.0,13421,Dystonia,0.226306853,34,"Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",1.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.226297956,8,"AlteredExpression, Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.226277889,29,"Biomarker, GeneticVariation"
7052,TGM2,transglutaminase 2,1.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.226269481,10,"AlteredExpression, Biomarker, PostTranslationalModification"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.226269481,11,"AlteredExpression, Biomarker, GeneticVariation"
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,1.0,0.0,1.0,24121,Lung Neoplasms,0.226269481,12,"Biomarker, GeneticVariation, Therapeutic"
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,1.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.226248925,18,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
51561,IL23A,"interleukin 23, alpha subunit p19",0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.226228858,34,"Biomarker, GeneticVariation"
356,FASLG,"Fas ligand (TNF superfamily, member 6)",1.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.226219961,11,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.226219473,8,"Biomarker, GeneticVariation"
56729,RETN,resistin,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.226219473,8,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.226219473,7,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.226219473,9,"Biomarker, GeneticVariation"
126,ADH1C,"alcohol dehydrogenase 1C (class I), gamma polypeptide",0.0,1.0,1.0,0.0,0.0,26640,Mouth Neoplasms,0.226219473,7,"Biomarker, GeneticVariation"
4153,MBL2,"mannose-binding lectin (protein C) 2, soluble",0.0,1.0,1.0,0.0,0.0,151526,Premature Birth,0.226219473,7,"Biomarker, GeneticVariation"
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",1.0,1.0,1.0,0.0,0.0,23418,Leukemia,0.226199894,26,"AlteredExpression, Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,1.0,151744,Myocardial Ischemia,0.226170442,13,"Biomarker, GeneticVariation, Therapeutic"
7124,TNF,tumor necrosis factor,1.0,1.0,0.0,0.0,0.0,17638,Glioma,0.226130796,50,"AlteredExpression, Biomarker"
213,ALB,albumin,1.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.226101832,49,"AlteredExpression, Biomarker"
7038,TG,thyroglobulin,0.0,1.0,1.0,0.0,0.0,18021,Goiter,0.226101832,43,"Biomarker, GeneticVariation"
940,CD28,CD28 molecule,1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.226101832,42,"AlteredExpression, Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,1.0,0.0,1.0,11860,"Diabetes Mellitus, Type 2",0.226092447,11,"Biomarker, GeneticVariation, Therapeutic"
1030,CDKN2B,"cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.22607238,24,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.226063971,11,"AlteredExpression, Biomarker, GeneticVariation"
3586,IL10,interleukin 10,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.226063971,11,"AlteredExpression, Biomarker, GeneticVariation"
1421,CRYGD,"crystallin, gamma D",0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.226043904,25,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.226043904,24,"AlteredExpression, Biomarker"
5429,POLH,"polymerase (DNA directed), eta",0.0,1.0,1.0,0.0,0.0,43346,Xeroderma Pigmentosum,0.226043904,26,"Biomarker, GeneticVariation"
940,CD28,CD28 molecule,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.225994385,27,"Biomarker, GeneticVariation"
1890,TYMP,thymidine phosphorylase,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.225985976,10,"AlteredExpression, Biomarker"
5058,PAK1,p21 protein (Cdc42/Rac)-activated kinase 1,1.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.225985976,10,"AlteredExpression, Biomarker, PostTranslationalModification"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,41327,"Tuberculosis, Pulmonary",0.225965421,16,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,6625,Cachexia,0.225887426,16,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.225886937,8,"Biomarker, GeneticVariation"
3605,IL17A,interleukin 17A,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.225876256,57,Biomarker
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,1.0,1.0,0.0,0.0,85541,"Epilepsy, Frontal Lobe",0.225858462,10,"Biomarker, GeneticVariation"
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.225837906,20,"Biomarker, GeneticVariation"
1017,CDK2,cyclin-dependent kinase 2,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.225818328,40,"AlteredExpression, Biomarker, GeneticVariation"
3952,LEP,leptin,1.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.225809431,17,"AlteredExpression, Biomarker, GeneticVariation"
3105,HLA-A,"major histocompatibility complex, class I, A",0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.225808942,10,"Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.225808942,7,"Biomarker, GeneticVariation"
3914,LAMB3,"laminin, beta 3",0.0,1.0,1.0,0.0,0.0,79301,"Epidermolysis Bullosa, Junctional",0.225789364,31,"Biomarker, GeneticVariation"
83990,BRIP1,BRCA1 interacting protein C-terminal helicase 1,0.0,1.0,1.0,0.0,0.0,15625,Fanconi Anemia,0.225789364,30,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.225759911,20,"Biomarker, GeneticVariation"
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.225731436,17,"AlteredExpression, Biomarker"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.225730947,8,"Biomarker, GeneticVariation"
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,1.0,0.0,1.0,4352,Autistic Disorder,0.22571088,28,"Biomarker, GeneticVariation, Therapeutic"
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.22571088,23,"Biomarker, GeneticVariation"
9518,GDF15,growth differentiation factor 15,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.225702472,9,"AlteredExpression, Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.225702472,9,"AlteredExpression, Biomarker"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.225681916,15,"Biomarker, GeneticVariation"
3439,IFNA1,"interferon, alpha 1",0.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.225641782,55,"Biomarker, GeneticVariation, Therapeutic"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.225592751,58,Biomarker
3554,IL1R1,"interleukin 1 receptor, type I",1.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.225574957,7,"AlteredExpression, Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,33975,Psychotic Disorders,0.225554402,17,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,6118,Brain Neoplasms,0.225554402,21,"Biomarker, GeneticVariation"
54899,PXK,PX domain containing serine/threonine kinase,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.225525438,9,"Biomarker, GeneticVariation"
8764,TNFRSF14,"tumor necrosis factor receptor superfamily, member 14",1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.225525438,11,"AlteredExpression, Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,37198,"Sinus Thrombosis, Intracranial",0.225525438,10,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.225525438,10,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.225496962,9,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,206708,Cervical Intraepithelial Neoplasia,0.225476407,13,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,1.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.225476407,17,"AlteredExpression, Biomarker, GeneticVariation"
1890,TYMP,thymidine phosphorylase,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.225447931,15,"AlteredExpression, Biomarker"
10855,HPSE,heparanase,1.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.225447931,15,"AlteredExpression, Biomarker"
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,1.0,0.0,0.0,3714756,Intellectual Disability,0.225447931,17,"Biomarker, GeneticVariation"
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.225418967,8,"AlteredExpression, Biomarker, GeneticVariation"
332,BIRC5,baculoviral IAP repeat containing 5,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.225418967,7,"AlteredExpression, Biomarker"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.225418967,9,"Biomarker, GeneticVariation"
898,CCNE1,cyclin E1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.225418967,9,"AlteredExpression, Biomarker"
7424,VEGFC,vascular endothelial growth factor C,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.225418967,8,"AlteredExpression, Biomarker"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.225398412,13,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.225369447,10,"Biomarker, GeneticVariation"
5972,REN,renin,0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.225358278,50,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.225349381,23,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.225349381,25,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,1.0,0.0,0.0,948089,Acute Coronary Syndrome,0.225320417,16,"Biomarker, GeneticVariation"
8929,PHOX2B,paired-like homeobox 2b,0.0,1.0,1.0,0.0,0.0,19569,Hirschsprung Disease,0.225320417,15,"Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,24299,Lymphoma,0.225319928,9,"Biomarker, GeneticVariation"
4211,MEIS1,Meis homeobox 1,0.0,1.0,1.0,0.0,0.0,35258,Restless Legs Syndrome,0.225319928,9,"Biomarker, GeneticVariation"
4485,MST1,macrophage stimulating 1 (hepatocyte growth factor-like),0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.225319928,10,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.225291452,9,"AlteredExpression, Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,1512419,Hereditary Melanoma,0.225280938,82,"Biomarker, GeneticVariation"
4261,CIITA,"class II, major histocompatibility complex, transactivator",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.225270897,16,"Biomarker, GeneticVariation"
1436,CSF1R,colony stimulating factor 1 receptor,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.225251319,39,"AlteredExpression, Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.225231907,89,"Biomarker, GeneticVariation"
7507,XPA,"xeroderma pigmentosum, complementation group A",0.0,1.0,1.0,0.0,0.0,43346,Xeroderma Pigmentosum,0.225222355,30,"Biomarker, GeneticVariation"
5594,MAPK1,mitogen-activated protein kinase 1,1.0,1.0,0.0,1.0,0.0,27627,Neoplasm Metastasis,0.225222355,31,"AlteredExpression, Biomarker, PostTranslationalModification"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,10200,Cough,0.225221866,25,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.225213457,9,"AlteredExpression, Biomarker, GeneticVariation"
7050,TGIF1,TGFB-induced factor homeobox 1,0.0,1.0,1.0,0.0,0.0,79541,Holoprosencephaly,0.225193391,19,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.225192902,18,"AlteredExpression, Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.225192902,16,"Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,856761,Budd-Chiari Syndrome,0.225192902,17,"Biomarker, GeneticVariation"
1812,DRD1,dopamine receptor D1,0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.225192902,13,"Biomarker, GeneticVariation"
5594,MAPK1,mitogen-activated protein kinase 1,1.0,1.0,1.0,1.0,0.0,7137,"Carcinoma, Squamous Cell",0.225164426,15,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,36202,Sarcoidosis,0.225163938,4,"Biomarker, GeneticVariation"
114609,TIRAP,toll-interleukin 1 receptor (TIR) domain containing adaptor protein,0.0,1.0,1.0,0.0,0.0,41296,Tuberculosis,0.225163938,8,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,40136,Thyroid Neoplasms,0.225163938,10,"Biomarker, GeneticVariation"
10599,SLCO1B1,"solute carrier organic anion transporter family, member 1B1",0.0,1.0,1.0,0.0,0.0,26848,Muscular Diseases,0.225143871,21,"Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.225135462,7,"AlteredExpression, Biomarker"
5328,PLAU,"plasminogen activator, urokinase",1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.225135462,8,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,1.0,1.0,24121,Lung Neoplasms,0.225085943,11,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
121278,TPH2,tryptophan hydroxylase 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.225036423,7,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.225036423,10,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,19829,Hodgkin Disease,0.225036423,8,"Biomarker, GeneticVariation"
6121,RPE65,retinal pigment epithelium-specific protein 65kDa,0.0,1.0,0.0,0.0,0.0,339527,Leber Congenital Amaurosis,0.225025742,54,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.225025742,54,Biomarker
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.225007948,8,"AlteredExpression, Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.224987392,17,"Biomarker, GeneticVariation"
5081,PAX7,paired box 7,0.0,1.0,1.0,0.0,0.0,206655,"Rhabdomyosarcoma, Alveolar",0.224967814,36,"Biomarker, GeneticVariation"
4018,LPA,"lipoprotein, Lp(a)",1.0,1.0,1.0,0.0,0.0,38454,Stroke,0.224958917,14,"AlteredExpression, Biomarker, GeneticVariation"
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.224958428,10,"Biomarker, GeneticVariation"
59067,IL21,interleukin 21,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.224938361,24,"Biomarker, GeneticVariation"
3605,IL17A,interleukin 17A,1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.224929953,7,"AlteredExpression, Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,3714514,Infection,0.224929953,7,"AlteredExpression, Biomarker, GeneticVariation"
10481,HOXB13,homeobox B13,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.224929953,7,"AlteredExpression, Biomarker, GeneticVariation"
2218,FKTN,fukutin,1.0,1.0,1.0,0.0,0.0,26850,Muscular Dystrophies,0.224909397,17,"AlteredExpression, Biomarker, GeneticVariation"
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.224909397,17,"Biomarker, GeneticVariation"
345,APOC3,apolipoprotein C-III,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.224909397,15,"Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,1.0,1.0,0.0,1.0,0.0,9404,Colorectal Neoplasms,0.224880922,13,"AlteredExpression, Biomarker, PostTranslationalModification"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.224880922,16,"AlteredExpression, Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.224802438,9,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,1.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.224753407,10,"AlteredExpression, Biomarker, GeneticVariation"
861,RUNX1,runt-related transcription factor 1,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.224753407,10,"Biomarker, GeneticVariation"
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",0.0,1.0,1.0,0.0,0.0,85541,"Epilepsy, Frontal Lobe",0.224753407,14,"Biomarker, GeneticVariation"
1021,CDK6,cyclin-dependent kinase 6,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.224752919,7,"Biomarker, GeneticVariation"
2643,GCH1,GTP cyclohydrolase 1,0.0,1.0,1.0,0.0,0.0,30193,Pain,0.224752919,9,"Biomarker, GeneticVariation"
1071,CETP,"cholesteryl ester transfer protein, plasma",0.0,1.0,1.0,0.0,0.0,20473,Hyperlipidemias,0.224752919,10,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.224724443,6,"AlteredExpression, Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",1.0,1.0,1.0,1.0,1.0,27651,Neoplasms,0.224724443,12,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification, Therapeutic"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.224724443,6,"Biomarker, GeneticVariation"
2152,F3,"coagulation factor III (thromboplastin, tissue factor)",1.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.224724443,7,"AlteredExpression, Biomarker, GeneticVariation"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.224724443,8,"Biomarker, GeneticVariation"
2688,GH1,growth hormone 1,1.0,1.0,0.0,0.0,0.0,32019,Pituitary Neoplasms,0.224713274,45,"AlteredExpression, Biomarker"
1440,CSF3,colony stimulating factor 3 (granulocyte),1.0,1.0,1.0,0.0,1.0,27947,Neutropenia,0.224713274,56,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.224674924,7,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.224674924,7,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.224664898,87,"AlteredExpression, Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.224655345,27,"Biomarker, GeneticVariation"
3952,LEP,leptin,1.0,1.0,1.0,0.0,0.0,20459,Hyperinsulinism,0.224655345,29,"AlteredExpression, Biomarker, GeneticVariation"
4221,MEN1,multiple endocrine neoplasia I,0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.224654857,24,"Biomarker, GeneticVariation"
159296,NKX2-3,NK2 homeobox 3,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.224625893,13,"Biomarker, GeneticVariation"
1071,CETP,"cholesteryl ester transfer protein, plasma",0.0,1.0,1.0,0.0,0.0,242339,Dyslipidemias,0.224625893,15,"Biomarker, GeneticVariation"
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",1.0,1.0,1.0,0.0,0.0,13080,Down Syndrome,0.224625893,13,"AlteredExpression, Biomarker, GeneticVariation"
5896,RAG1,recombination activating gene 1,0.0,1.0,1.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.224618139,30,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.224605826,30,"Biomarker, GeneticVariation"
84894,LINGO1,leucine rich repeat and Ig domain containing 1,0.0,1.0,1.0,0.0,0.0,270736,Essential Tremor,0.224605826,27,"Biomarker, GeneticVariation"
10161,LPAR6,lysophosphatidic acid receptor 6,0.0,1.0,1.0,0.0,0.0,20678,Hypotrichosis,0.224597417,12,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.224596929,6,"AlteredExpression, Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,34885,Rectal Neoplasms,0.224596929,8,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.224576862,21,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.224547898,12,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,4364,Autoimmune Diseases,0.224527831,29,"Biomarker, GeneticVariation"
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.224518934,7,"Biomarker, GeneticVariation"
2157,F8,"coagulation factor VIII, procoagulant component",1.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.224518934,7,"AlteredExpression, Biomarker, GeneticVariation"
4942,OAT,ornithine aminotransferase,0.0,1.0,1.0,0.0,0.0,18425,Gyrate Atrophy,0.224507764,43,"Biomarker, GeneticVariation"
6792,CDKL5,cyclin-dependent kinase-like 5,0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.2244788,35,"Biomarker, GeneticVariation"
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.224469414,9,"Biomarker, GeneticVariation"
60468,BACH2,"BTB and CNC homology 1, basic leucine zipper transcription factor 2",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.224469414,8,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,4943,Behcet Syndrome,0.224420383,11,"Biomarker, GeneticVariation"
1030,CDKN2B,"cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)",0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.224420383,15,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.224420383,13,"Biomarker, GeneticVariation"
1535,CYBA,"cytochrome b-245, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.224420383,15,"Biomarker, GeneticVariation"
8000,PSCA,prostate stem cell antigen,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.224391419,6,"Biomarker, GeneticVariation"
81037,CLPTM1L,CLPTM1-like,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.224391419,7,"Biomarker, GeneticVariation"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,0.0,24809,Marijuana Abuse,0.224371352,20,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.224342877,21,"AlteredExpression, Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.224342877,20,"AlteredExpression, Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,22603,"Keratosis, Seborrheic",0.224342877,15,"Biomarker, GeneticVariation"
3593,IL12B,interleukin 12B,0.0,1.0,1.0,0.0,0.0,3872,"Arthritis, Psoriatic",0.224342388,10,"Biomarker, GeneticVariation"
2194,FASN,fatty acid synthase,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.224313913,12,"AlteredExpression, Biomarker"
5468,PPARG,peroxisome proliferator-activated receptor gamma,1.0,1.0,1.0,0.0,1.0,38356,Stomach Neoplasms,0.224313424,7,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,1.0,0.0,0.0,32914,Pre-Eclampsia,0.224313424,5,"Biomarker, GeneticVariation"
2956,MSH6,mutS homolog 6,0.0,1.0,1.0,0.0,0.0,14170,Endometrial Neoplasms,0.224313424,7,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,43251,Wounds and Injuries,0.224313424,7,"AlteredExpression, Biomarker, GeneticVariation"
1136,CHRNA3,"cholinergic receptor, nicotinic, alpha 3 (neuronal)",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.224313424,7,"Biomarker, GeneticVariation"
65125,WNK1,WNK lysine deficient protein kinase 1,1.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.224293357,21,"AlteredExpression, Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,1.0,1.0,1.0,0.0,1.0,242339,Dyslipidemias,0.224215362,20,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,32580,Adenomatous Polyposis Coli,0.224195295,35,"AlteredExpression, Biomarker, GeneticVariation"
6854,SYN2,synapsin II,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.224186398,8,"Biomarker, GeneticVariation"
2067,ERCC1,excision repair cross-complementation group 1,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.22418591,8,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,1.0,7786,Brain Ischemia,0.22418591,8,"Biomarker, GeneticVariation, Therapeutic"
3798,KIF5A,kinesin family member 5A,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.22418591,7,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.22418591,7,"Biomarker, GeneticVariation"
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.224175229,56,Biomarker
1649,DDIT3,DNA-damage-inducible transcript 3,0.0,1.0,1.0,0.0,0.0,206634,"Liposarcoma, Myxoid",0.224175229,50,"Biomarker, GeneticVariation"
85480,TSLP,thymic stromal lymphopoietin,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.224166331,28,"Biomarker, GeneticVariation"
4128,MAOA,monoamine oxidase A,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.224136879,12,"Biomarker, GeneticVariation"
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,1.0,0.0,0.0,19337,Heroin Dependence,0.224136879,13,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.224107915,7,"Biomarker, GeneticVariation"
7356,SCGB1A1,"secretoglobin, family 1A, member 1 (uteroglobin)",1.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.224107915,7,"AlteredExpression, Biomarker, GeneticVariation"
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,1.0,0.0,0.0,18671,Head and Neck Neoplasms,0.224107915,7,"Biomarker, GeneticVariation"
4522,MTHFD1,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase",0.0,1.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.224107915,5,"Biomarker, GeneticVariation"
4221,MEN1,multiple endocrine neoplasia I,0.0,1.0,1.0,0.0,0.0,17150,Gastrinoma,0.224088336,26,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,5779,Blood Coagulation Disorders,0.224087848,22,"Biomarker, GeneticVariation"
1116,CHI3L1,chitinase 3-like 1 (cartilage glycoprotein-39),0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.224058884,8,"Biomarker, GeneticVariation"
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.224038817,26,"Biomarker, GeneticVariation"
2115,ETV1,ets variant 1,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.224030408,9,"AlteredExpression, Biomarker, GeneticVariation"
595,CCND1,cyclin D1,1.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.224030408,11,"AlteredExpression, Biomarker"
6367,CCL22,chemokine (C-C motif) ligand 22,1.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.224030408,10,"AlteredExpression, Biomarker"
4851,NOTCH1,notch 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.224030408,11,"AlteredExpression, Biomarker"
6776,STAT5A,signal transducer and activator of transcription 5A,1.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.224030408,10,"AlteredExpression, Biomarker, PostTranslationalModification"
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,1.0,0.0,0.0,23470,"Leukemia, Myeloid",0.223989786,37,"Biomarker, GeneticVariation"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,0.0,0.0,29463,Osteosarcoma,0.223940755,41,"AlteredExpression, Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,1.0,0.0,0.0,1206,Acromegaly,0.223911791,37,"Biomarker, GeneticVariation"
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,1.0,0.0,0.0,4782,Basal Ganglia Diseases,0.223902405,7,"Biomarker, GeneticVariation"
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.223902405,7,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.223902405,8,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,236969,Substance-Related Disorders,0.223902405,7,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.223902405,7,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.223902405,7,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.223902405,8,"Biomarker, GeneticVariation"
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.223902405,7,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,2170,Alopecia,0.223902405,7,"Biomarker, GeneticVariation"
865,CBFB,"core-binding factor, beta subunit",0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.223891724,50,"Biomarker, GeneticVariation"
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.22386276,42,Biomarker
3662,IRF4,interferon regulatory factor 4,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.223853374,12,"Biomarker, GeneticVariation"
4485,MST1,macrophage stimulating 1 (hepatocyte growth factor-like),1.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.223775379,12,"AlteredExpression, Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.223775379,9,"Biomarker, GeneticVariation"
3426,CFI,complement factor I,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.223775379,11,"Biomarker, GeneticVariation"
57167,SALL4,spalt-like transcription factor 4,0.0,1.0,1.0,0.0,0.0,13261,Duane Retraction Syndrome,0.223746904,9,"Biomarker, GeneticVariation"
55145,THAP1,"THAP domain containing, apoptosis associated protein 1",0.0,1.0,1.0,0.0,0.0,393593,Dystonic Disorders,0.223706281,33,"Biomarker, GeneticVariation"
552,AVPR1A,arginine vasopressin receptor 1A,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.223697384,7,"Biomarker, GeneticVariation"
5108,PCM1,pericentriolar material 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.223697384,7,"Biomarker, GeneticVariation"
135,ADORA2A,adenosine A2a receptor,0.0,1.0,1.0,0.0,0.0,30319,Panic Disorder,0.223697384,8,"Biomarker, GeneticVariation"
1030,CDKN2B,"cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)",0.0,1.0,1.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.223628286,33,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,1.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.223628286,33,"Biomarker, GeneticVariation, Therapeutic"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,1.0,3850,Arteriosclerosis,0.223608219,49,"Biomarker, Therapeutic"
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,40136,Thyroid Neoplasms,0.223570358,19,"Biomarker, GeneticVariation"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.22356987,13,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,1.0,0.0,26764,Multiple Myeloma,0.223550291,31,"Biomarker, PostTranslationalModification"
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,1.0,0.0,0.0,13720,Ehlers-Danlos Syndrome,0.223550291,30,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.223541394,8,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,4943,Behcet Syndrome,0.223491875,9,"Biomarker, GeneticVariation"
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.223491875,13,"Biomarker, GeneticVariation"
221458,KIF6,kinesin family member 6,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.223491875,9,"Biomarker, GeneticVariation"
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.223491875,9,"Biomarker, GeneticVariation"
1291,COL6A1,"collagen, type VI, alpha 1",0.0,1.0,1.0,0.0,0.0,26850,Muscular Dystrophies,0.223463399,9,"Biomarker, GeneticVariation"
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.223463399,7,"AlteredExpression, Biomarker"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.223463399,10,"AlteredExpression, Biomarker"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,32285,Pneumonia,0.223442844,18,"Biomarker, GeneticVariation"
7172,TPMT,thiopurine S-methyltransferase,0.0,1.0,1.0,0.0,0.0,23530,Leukopenia,0.223422777,32,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.22341388,11,"Biomarker, GeneticVariation"
328,APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.22341388,8,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,35309,Retinal Diseases,0.223373746,41,"Biomarker, GeneticVariation"
1908,EDN3,endothelin 3,0.0,1.0,1.0,0.0,0.0,19569,Hirschsprung Disease,0.223364849,17,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.223335885,11,"AlteredExpression, Biomarker, GeneticVariation"
241,ALOX5AP,arachidonate 5-lipoxygenase-activating protein,0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.223286365,10,"Biomarker, GeneticVariation"
5966,REL,v-rel avian reticuloendotheliosis viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.223286365,11,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,38358,Stomach Ulcer,0.223286365,10,"Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,0.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.223286365,12,"Biomarker, GeneticVariation"
6794,STK11,serine/threonine kinase 11,1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.223257889,7,"AlteredExpression, Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,686353,"Muscular Dystrophies, Limb-Girdle",0.223237823,20,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.223237823,23,"AlteredExpression, Biomarker"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.223208859,15,"AlteredExpression, Biomarker, GeneticVariation"
5329,PLAUR,"plasminogen activator, urokinase receptor",1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.223208859,16,"AlteredExpression, Biomarker"
3593,IL12B,interleukin 12B,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.22320837,11,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.223179894,8,"AlteredExpression, Biomarker"
6752,SSTR2,somatostatin receptor 2,1.0,1.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.223179894,10,"AlteredExpression, Biomarker, Therapeutic"
22943,DKK1,dickkopf WNT signaling pathway inhibitor 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.223179894,7,"AlteredExpression, Biomarker"
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.223179894,8,"AlteredExpression, Biomarker, GeneticVariation"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,0.0,1.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.223170675,10,GeneticVariation
3458,IFNG,"interferon, gamma",1.0,1.0,1.0,0.0,0.0,2874,"Anemia, Aplastic",0.223159339,16,"AlteredExpression, Biomarker, GeneticVariation"
4018,LPA,"lipoprotein, Lp(a)",0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.223159339,17,"Biomarker, GeneticVariation"
11330,CTRC,chymotrypsin C (caldecrin),0.0,1.0,1.0,0.0,0.0,149521,"Pancreatitis, Chronic",0.223159339,14,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.223139272,31,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,948089,Acute Coronary Syndrome,0.223130375,9,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,36202,Sarcoidosis,0.223130375,6,"Biomarker, GeneticVariation"
1576,CYP3A4,"cytochrome P450, family 3, subfamily A, polypeptide 4",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.223130375,10,"AlteredExpression, Biomarker, GeneticVariation"
50941,IBD5,inflammatory bowel disease 5,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.223110308,22,"Biomarker, GeneticVariation"
23418,CRB1,"crumbs family member 1, photoreceptor morphogenesis associated",0.0,1.0,1.0,0.0,0.0,339527,Leber Congenital Amaurosis,0.223090241,38,"Biomarker, GeneticVariation"
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.223090241,38,"Biomarker, GeneticVariation"
6240,RRM1,ribonucleotide reductase M1,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.223090241,39,"Biomarker, GeneticVariation"
59272,ACE2,angiotensin I converting enzyme 2,1.0,1.0,1.0,0.0,1.0,11881,Diabetic Nephropathies,0.223081344,14,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
4018,LPA,"lipoprotein, Lp(a)",1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.223061277,32,"AlteredExpression, Biomarker, GeneticVariation"
3439,IFNA1,"interferon, alpha 1",0.0,1.0,1.0,0.0,1.0,19163,Hepatitis B,0.22304121,47,"Biomarker, GeneticVariation, Therapeutic"
846,CASR,calcium-sensing receptor,1.0,1.0,1.0,0.0,0.0,20626,Hypoparathyroidism,0.223032313,21,"AlteredExpression, Biomarker, GeneticVariation"
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,1.0,0.0,0.0,149931,Migraine Disorders,0.223032313,23,"Biomarker, GeneticVariation"
9927,MFN2,mitofusin 2,0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.223004004,49,"Biomarker, GeneticVariation"
3394,IRF8,interferon regulatory factor 8,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.22300286,8,"Biomarker, GeneticVariation"
7297,TYK2,tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.22300286,8,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.22300286,7,"Biomarker, GeneticVariation"
152,ADRA2C,adrenoceptor alpha 2C,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.22300286,10,"Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.22300286,10,"Biomarker, GeneticVariation"
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.22300286,8,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,0.0,1.0,1.0,0.0,0.0,162678,Neurofibromatoses,0.222983282,31,"Biomarker, GeneticVariation"
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,1.0,0.0,0.0,19196,Hepatitis C,0.222974385,7,"Biomarker, GeneticVariation"
5251,PHEX,"phosphate regulating endopeptidase homolog, X-linked",0.0,1.0,1.0,0.0,0.0,3536983,Familial Hypophosphatemic Rickets,0.222954318,22,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,17638,Glioma,0.222954318,20,"AlteredExpression, Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.222953829,14,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,162872,"Aortic Aneurysm, Thoracic",0.222953829,15,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,22104,Irritable Bowel Syndrome,0.222953829,15,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.222925354,14,"AlteredExpression, Biomarker"
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.222924865,7,"Biomarker, GeneticVariation"
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,1.0,0.0,0.0,162871,"Aortic Aneurysm, Abdominal",0.222924865,7,"Biomarker, GeneticVariation"
90865,IL33,interleukin 33,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.222904799,24,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.22289639,7,"AlteredExpression, Biomarker"
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",1.0,1.0,1.0,0.0,1.0,27651,Neoplasms,0.22289639,7,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
581,BAX,BCL2-associated X protein,1.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.22289639,7,"AlteredExpression, Biomarker, Therapeutic"
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.22289639,7,"AlteredExpression, Biomarker, GeneticVariation"
1869,E2F1,E2F transcription factor 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.22289639,7,"AlteredExpression, Biomarker"
3725,JUN,jun proto-oncogene,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.22289639,7,"AlteredExpression, Biomarker"
4288,MKI67,marker of proliferation Ki-67,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.22289639,9,"AlteredExpression, Biomarker"
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.22284687,6,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,1.0,30297,Pancreatic Neoplasms,0.22284687,8,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,17924,Glycogen Storage Disease Type V,0.22284687,5,"Biomarker, GeneticVariation"
2572,GAD2,"glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)",1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.22284687,5,"AlteredExpression, Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.222806737,38,"Biomarker, GeneticVariation"
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.222768875,7,"AlteredExpression, Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.222768875,8,"Biomarker, GeneticVariation"
1585,CYP11B2,"cytochrome P450, family 11, subfamily B, polypeptide 2",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.222758094,129,"Biomarker, GeneticVariation"
8647,ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",1.0,1.0,1.0,0.0,0.0,268312,"Cholestasis, progressive familial intrahepatic 1",0.222757706,46,"AlteredExpression, Biomarker, GeneticVariation"
4594,MUT,methylmalonyl CoA mutase,0.0,1.0,1.0,0.0,0.0,268583,Methylmalonic acidemia,0.222757706,46,"Biomarker, GeneticVariation"
10019,SH2B3,SH2B adaptor protein 3,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.222719356,7,"Biomarker, GeneticVariation"
54106,TLR9,toll-like receptor 9,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.222719356,8,"Biomarker, GeneticVariation"
2184,FAH,fumarylacetoacetate hydrolase (fumarylacetoacetase),0.0,1.0,1.0,0.0,0.0,268483,Tyrosinemias,0.222699778,30,"Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",1.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.222699778,29,"AlteredExpression, Biomarker"
7046,TGFBR1,"transforming growth factor, beta receptor 1",1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.22269088,6,"AlteredExpression, Biomarker, GeneticVariation"
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.22269088,11,"Biomarker, GeneticVariation"
7508,XPC,"xeroderma pigmentosum, complementation group C",1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.22269088,7,"AlteredExpression, Biomarker, GeneticVariation"
4851,NOTCH1,notch 1,1.0,1.0,1.0,0.0,0.0,24299,Lymphoma,0.222670813,21,"AlteredExpression, Biomarker, GeneticVariation"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,85390,Li-Fraumeni Syndrome,0.222670813,20,"Biomarker, GeneticVariation"
2113,ETS1,v-ets avian erythroblastosis virus E26 oncogene homolog 1,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.222670325,14,"Biomarker, GeneticVariation"
598,BCL2L1,BCL2-like 1,1.0,1.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.222641849,15,"AlteredExpression, Biomarker, Therapeutic"
6401,SELE,selectin E,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.222641361,9,"Biomarker, GeneticVariation"
1890,TYMP,thymidine phosphorylase,1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.222612885,6,"AlteredExpression, Biomarker"
3162,HMOX1,heme oxygenase (decycling) 1,1.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.222612885,7,"AlteredExpression, Biomarker"
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.222612885,5,"AlteredExpression, Biomarker"
847,CAT,catalase,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.22259233,11,"Biomarker, GeneticVariation"
345,APOC3,apolipoprotein C-III,0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.222584088,25,"Biomarker, GeneticVariation"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.222543299,22,"AlteredExpression, Biomarker, GeneticVariation"
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",1.0,1.0,1.0,0.0,0.0,14553,"Epilepsy, Absence",0.222514335,10,"AlteredExpression, Biomarker, GeneticVariation"
57192,MCOLN1,mucolipin 1,0.0,1.0,1.0,0.0,0.0,26697,Mucolipidoses,0.222485371,7,"Biomarker, GeneticVariation"
6934,TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box)",0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.222485371,5,"Biomarker, GeneticVariation"
1356,CP,ceruloplasmin (ferroxidase),1.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.222485371,5,"AlteredExpression, Biomarker, GeneticVariation"
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.222485371,9,"AlteredExpression, Biomarker, GeneticVariation"
5048,PAFAH1B1,"platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)",0.0,1.0,1.0,0.0,0.0,266463,Lissencephaly,0.222474201,44,"Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,1.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.22243634,12,"AlteredExpression, Biomarker, GeneticVariation"
7137,TNNI3,troponin I type 3 (cardiac),1.0,1.0,1.0,0.0,0.0,7196,"Cardiomyopathy, Restrictive",0.22243634,11,"AlteredExpression, Biomarker, GeneticVariation"
3592,IL12A,interleukin 12A,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.222435851,8,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,0.0,1.0,1.0,0.0,0.0,34885,Rectal Neoplasms,0.222435851,9,"Biomarker, GeneticVariation"
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.222435851,7,"Biomarker, GeneticVariation"
3566,IL4R,interleukin 4 receptor,0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.222435851,6,"Biomarker, GeneticVariation"
5465,PPARA,peroxisome proliferator-activated receptor alpha,1.0,1.0,1.0,0.0,1.0,242339,Dyslipidemias,0.222416273,29,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
7157,TP53,tumor protein p53,1.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.222416273,28,"AlteredExpression, Biomarker"
8434,RECK,reversion-inducing-cysteine-rich protein with kazal motifs,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.222416273,28,"AlteredExpression, Biomarker"
10117,ENAM,enamelin,0.0,1.0,1.0,0.0,0.0,2452,Amelogenesis Imperfecta,0.222416273,27,"Biomarker, GeneticVariation"
3075,CFH,complement factor H,0.0,1.0,1.0,0.0,0.0,17662,"Glomerulonephritis, Membranoproliferative",0.222416273,26,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",1.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.222407376,6,"AlteredExpression, Biomarker, GeneticVariation"
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.222407376,7,"AlteredExpression, Biomarker, GeneticVariation"
2335,FN1,fibronectin 1,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.222387309,21,"AlteredExpression, Biomarker"
5467,PPARD,peroxisome proliferator-activated receptor delta,0.0,1.0,1.0,0.0,1.0,28754,Obesity,0.22238682,14,"Biomarker, GeneticVariation, Therapeutic"
5915,RARB,"retinoic acid receptor, beta",1.0,1.0,0.0,1.0,0.0,7137,"Carcinoma, Squamous Cell",0.222358345,13,"AlteredExpression, Biomarker, PostTranslationalModification"
219771,CCNY,cyclin Y,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.222357856,4,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.222357856,6,"Biomarker, GeneticVariation"
383,ARG1,arginase 1,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.222308825,12,"Biomarker, GeneticVariation"
1235,CCR6,chemokine (C-C motif) receptor 6,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.222308825,14,"Biomarker, GeneticVariation"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,1.0,0.0,0.0,42870,Vitamin D Deficiency,0.222308825,15,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.222279861,6,"Biomarker, GeneticVariation"
7100,TLR5,toll-like receptor 5,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.22223083,9,"Biomarker, GeneticVariation"
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,1.0,0.0,1.0,27051,Myocardial Infarction,0.22223083,45,"Biomarker, GeneticVariation, Therapeutic"
1071,CETP,"cholesteryl ester transfer protein, plasma",1.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.22223083,10,"AlteredExpression, Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.222201866,9,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,43251,Wounds and Injuries,0.222201866,5,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.222201866,5,"Biomarker, GeneticVariation"
7486,WRN,"Werner syndrome, RecQ helicase-like",0.0,1.0,1.0,0.0,0.0,231341,"Aging, Premature",0.222190697,44,"Biomarker, GeneticVariation"
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,1.0,0.0,1.0,23530,Leukopenia,0.222190697,47,"Biomarker, GeneticVariation, Therapeutic"
7369,UMOD,uromodulin,0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.222181799,20,"Biomarker, GeneticVariation"
921,CD5,CD5 molecule,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.222152835,11,"Biomarker, GeneticVariation"
3107,HLA-C,"major histocompatibility complex, class I, C",0.0,1.0,1.0,0.0,0.0,38325,Stevens-Johnson Syndrome,0.222152347,7,"Biomarker, GeneticVariation"
2189,FANCG,"Fanconi anemia, complementation group G",1.0,1.0,1.0,0.0,0.0,15625,Fanconi Anemia,0.222132768,26,"AlteredExpression, Biomarker, GeneticVariation"
6615,SNAI1,snail family zinc finger 1,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.222132768,28,"AlteredExpression, Biomarker"
3458,IFNG,"interferon, gamma",1.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.222132768,28,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,0.0,0.0,0.0,2871,Anemia,0.222103804,20,"AlteredExpression, Biomarker"
340273,ABCB5,"ATP-binding cassette, sub-family B (MDR/TAP), member 5",1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.222103804,16,"AlteredExpression, Biomarker, GeneticVariation"
8091,HMGA2,high mobility group AT-hook 2,1.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.222103804,19,"AlteredExpression, Biomarker"
7337,UBE3A,ubiquitin protein ligase E3A,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.222103316,13,"Biomarker, GeneticVariation"
23187,PHLDB1,"pleckstrin homology-like domain, family B, member 1",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.222103316,12,"Biomarker, GeneticVariation"
4292,MLH1,mutL homolog 1,1.0,1.0,1.0,1.0,0.0,919267,Ovarian Neoplasms,0.22207484,11,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.222074352,5,"Biomarker, GeneticVariation"
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.222074352,4,"Biomarker, GeneticVariation"
4193,MDM2,"MDM2 proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.222054285,19,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.222054285,20,"Biomarker, GeneticVariation"
4547,MTTP,microsomal triglyceride transfer protein,0.0,1.0,1.0,0.0,0.0,15695,Fatty Liver,0.222025321,11,"Biomarker, GeneticVariation"
7128,TNFAIP3,"tumor necrosis factor, alpha-induced protein 3",0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.222025321,11,"Biomarker, GeneticVariation"
5172,SLC26A4,"solute carrier family 26 (anion exchanger), member 4",0.0,1.0,1.0,0.0,0.0,18021,Goiter,0.222005254,30,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.222005254,27,"Biomarker, GeneticVariation"
3596,IL13,interleukin 13,0.0,1.0,1.0,0.0,0.0,2607914,"Rhinitis, Allergic",0.222005254,26,"Biomarker, GeneticVariation"
9,NAT1,N-acetyltransferase 1 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.221996357,6,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,1.0,1.0,1.0,0.0,0.0,32914,Pre-Eclampsia,0.221996357,6,"AlteredExpression, Biomarker, GeneticVariation"
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.221996357,5,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,4936,Mental Disorders,0.221956223,36,"Biomarker, GeneticVariation"
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),1.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.221947326,12,"AlteredExpression, Biomarker, GeneticVariation"
5972,REN,renin,1.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.221927259,28,"AlteredExpression, Biomarker, GeneticVariation"
4221,MEN1,multiple endocrine neoplasia I,0.0,1.0,1.0,0.0,0.0,21670,Insulinoma,0.221927259,26,"Biomarker, GeneticVariation"
2521,FUS,FUS RNA binding protein,0.0,1.0,1.0,0.0,0.0,206634,"Liposarcoma, Myxoid",0.221878228,35,"Biomarker, GeneticVariation"
682,BSG,basigin (Ok blood group),0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.221878228,35,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),1.0,1.0,0.0,0.0,1.0,17638,Glioma,0.221878228,34,"AlteredExpression, Biomarker, Therapeutic"
3558,IL2,interleukin 2,1.0,1.0,0.0,0.0,1.0,23418,Leukemia,0.221878228,35,"AlteredExpression, Biomarker, Therapeutic"
1811,SLC26A3,"solute carrier family 26 (anion exchanger), member 3",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.221868842,6,"Biomarker, GeneticVariation"
923,CD6,CD6 molecule,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.221868842,7,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,11875,Diabetic Angiopathies,0.221868842,7,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.221868842,8,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.221868842,6,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.221868842,8,"Biomarker, GeneticVariation"
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",0.0,1.0,1.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.221849264,27,"Biomarker, GeneticVariation"
7980,TFPI2,tissue factor pathway inhibitor 2,0.0,1.0,0.0,1.0,0.0,27627,Neoplasm Metastasis,0.221849264,25,"Biomarker, PostTranslationalModification"
1869,E2F1,E2F transcription factor 1,0.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.2218203,15,"Biomarker, GeneticVariation, Therapeutic"
8431,NR0B2,"nuclear receptor subfamily 0, group B, member 2",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.221819811,9,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.221819811,11,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,1.0,0.0,1.0,11860,"Diabetes Mellitus, Type 2",0.221819811,15,"Biomarker, GeneticVariation, Therapeutic"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,1.0,0.0,0.0,40136,Thyroid Neoplasms,0.221791336,11,"AlteredExpression, Biomarker, GeneticVariation"
6422,SFRP1,secreted frizzled-related protein 1,1.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.221791336,8,"AlteredExpression, Biomarker, PostTranslationalModification"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,340274,"Hypertension, Pregnancy-Induced",0.221790847,4,"Biomarker, GeneticVariation"
1806,DPYD,dihydropyrimidine dehydrogenase,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.221790847,8,"AlteredExpression, Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.221790847,6,"Biomarker, GeneticVariation"
6606,SMN1,"survival of motor neuron 1, telomeric",0.0,1.0,1.0,0.0,0.0,700595,Spinal Muscular Atrophies of Childhood,0.221790847,6,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,5138,Berylliosis,0.221790847,8,"Biomarker, GeneticVariation"
4092,SMAD7,SMAD family member 7,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.221790847,4,"Biomarker, GeneticVariation"
6775,STAT4,signal transducer and activator of transcription 4,0.0,1.0,1.0,0.0,0.0,1527336,Sjogren's Syndrome,0.221790847,6,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,36983,"Shock, Septic",0.221790847,6,"AlteredExpression, Biomarker, GeneticVariation"
153,ADRB1,adrenoceptor beta 1,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.221790847,5,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.221790847,7,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,18939,Hematologic Diseases,0.221790847,5,"Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.221790847,6,"Biomarker, GeneticVariation"
2243,FGA,fibrinogen alpha chain,0.0,1.0,1.0,0.0,0.0,1861172,Venous Thromboembolism,0.221790847,4,"Biomarker, GeneticVariation"
2811,GP1BA,"glycoprotein Ib (platelet), alpha polypeptide",0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.221790847,6,"Biomarker, GeneticVariation"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.22177078,21,"Biomarker, GeneticVariation"
2629,GBA,"glucosidase, beta, acid",0.0,1.0,1.0,0.0,0.0,752347,Lewy Body Disease,0.221741816,11,"Biomarker, GeneticVariation"
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,1.0,0.0,0.0,40479,Torsades de Pointes,0.221692785,21,"Biomarker, GeneticVariation"
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,1.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.221692785,16,"Biomarker, GeneticVariation"
1767,DNAH5,"dynein, axonemal, heavy chain 5",0.0,1.0,1.0,0.0,0.0,22521,Kartagener Syndrome,0.221692785,17,"Biomarker, GeneticVariation"
3988,LIPA,"lipase A, lysosomal acid, cholesterol esterase",0.0,1.0,1.0,0.0,0.0,8384,Cholesterol Ester Storage Disease,0.221672718,34,"Biomarker, GeneticVariation"
3292,HSD17B1,hydroxysteroid (17-beta) dehydrogenase 1,1.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.221663821,8,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,22593,Keratosis,0.221663821,9,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,19187,"Hepatitis, Alcoholic",0.221663821,10,"Biomarker, GeneticVariation"
5617,PRL,prolactin,0.0,1.0,0.0,0.0,1.0,32019,Pituitary Neoplasms,0.221623687,44,"Biomarker, Therapeutic"
2034,EPAS1,endothelial PAS domain protein 1,1.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.22161479,17,"AlteredExpression, Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,22596,"Keratoderma, Palmoplantar",0.22161479,19,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,1.0,206698,Cholangiocarcinoma,0.22161479,18,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
26277,TINF2,TERF1 (TRF1)-interacting nuclear factor 2,0.0,1.0,1.0,0.0,0.0,265965,Dyskeratosis Congenita,0.22161479,15,"Biomarker, GeneticVariation"
3718,JAK3,Janus kinase 3,0.0,1.0,1.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.221586481,44,"Biomarker, GeneticVariation"
3990,LIPC,"lipase, hepatic",0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.221585338,6,"Biomarker, GeneticVariation"
629,CFB,complement factor B,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.221585338,5,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.221585338,9,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.221585338,6,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,19080,Hemorrhage,0.221585338,6,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,0.0,1.0,0.0,1.0,700359,Organophosphate Poisoning,0.221585338,8,"GeneticVariation, Therapeutic"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,1.0,0.0,0.0,5138,Berylliosis,0.221585338,9,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,1925,Albuminuria,0.221585338,8,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,0.0,1.0,0.0,1.0,4238,Atrial Fibrillation,0.221585338,6,"GeneticVariation, Therapeutic"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.221585338,6,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,22665,Kidney Neoplasms,0.221585338,5,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,852077,"Blood Coagulation Disorders, Inherited",0.221585338,6,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.221585338,6,"Biomarker, GeneticVariation"
1019,CDK4,cyclin-dependent kinase 4,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.221536795,17,"AlteredExpression, Biomarker"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",1.0,1.0,0.0,0.0,1.0,27819,Neuroblastoma,0.221536795,17,"AlteredExpression, Biomarker, Therapeutic"
958,CD40,"CD40 molecule, TNF receptor superfamily member 5",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.221536307,10,"Biomarker, GeneticVariation"
7097,TLR2,toll-like receptor 2,0.0,1.0,1.0,0.0,0.0,23343,Leprosy,0.221536307,10,"Biomarker, GeneticVariation"
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.221536307,9,"Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.221536307,13,"Biomarker, GeneticVariation"
3249,HPN,hepsin,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.221507831,9,"AlteredExpression, Biomarker, GeneticVariation"
6623,SNCG,"synuclein, gamma (breast cancer-specific protein 1)",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.221507831,9,"AlteredExpression, Biomarker"
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,0.0,1.0,0.0,0.0,85298,"Death, Sudden, Cardiac",0.221470136,9,GeneticVariation
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,0.0,1.0,0.0,0.0,85298,"Death, Sudden, Cardiac",0.221470136,9,GeneticVariation
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.221458312,9,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,34069,Pulmonary Fibrosis,0.221458312,13,"AlteredExpression, Biomarker, GeneticVariation"
7248,TSC1,tuberous sclerosis 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.221340183,41,Biomarker
2130,EWSR1,EWS RNA-binding protein 1,0.0,1.0,1.0,0.0,0.0,206663,"Neuroectodermal Tumors, Primitive",0.221340183,41,"Biomarker, GeneticVariation"
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,1.0,41408,Turner Syndrome,0.221340183,41,"Biomarker, Therapeutic"
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.221311219,33,Biomarker
4729,NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.221302322,7,"AlteredExpression, Biomarker, GeneticVariation"
200879,LIPH,"lipase, member H",0.0,1.0,1.0,0.0,0.0,20678,Hypotrichosis,0.221253291,15,"Biomarker, GeneticVariation"
7054,TH,tyrosine hydroxylase,0.0,1.0,1.0,0.0,0.0,13421,Dystonia,0.221253291,16,"Biomarker, GeneticVariation"
6557,SLC12A1,"solute carrier family 12 (sodium/potassium/chloride transporter), member 1",0.0,1.0,1.0,0.0,0.0,4775,Bartter Syndrome,0.221253291,15,"Biomarker, GeneticVariation"
1116,CHI3L1,chitinase 3-like 1 (cartilage glycoprotein-39),1.0,1.0,1.0,0.0,0.0,17636,Glioblastoma,0.221253291,16,"AlteredExpression, Biomarker, GeneticVariation"
9211,LGI1,"leucine-rich, glioma inactivated 1",1.0,1.0,0.0,0.0,0.0,17638,Glioma,0.221253291,14,"AlteredExpression, Biomarker"
70,ACTC1,"actin, alpha, cardiac muscle 1",0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.221252802,11,"Biomarker, GeneticVariation"
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.221252802,11,"Biomarker, GeneticVariation"
4864,NPC1,"Niemann-Pick disease, type C1",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.221252802,9,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.221252802,12,"Biomarker, GeneticVariation"
3732,CD82,CD82 molecule,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.221224327,8,"AlteredExpression, Biomarker"
2852,GPER1,G protein-coupled estrogen receptor 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.221224327,8,"AlteredExpression, Biomarker"
57661,PHRF1,PHD and ring finger domains 1,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.221174807,8,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.221174807,8,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.221174807,11,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.221174807,10,"Biomarker, GeneticVariation"
3146,HMGB1,high mobility group box 1,1.0,1.0,1.0,0.0,0.0,243026,Sepsis,0.221125776,17,"AlteredExpression, Biomarker, GeneticVariation"
4900,NRGN,"neurogranin (protein kinase C substrate, RC3)",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.221125776,15,"Biomarker, GeneticVariation"
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,1.0,0.0,0.0,2931834,Congenital Hyperinsulinism,0.221125776,15,"Biomarker, GeneticVariation"
1756,DMD,dystrophin,0.0,1.0,1.0,0.0,1.0,878544,Cardiomyopathies,0.221105709,35,"Biomarker, GeneticVariation, Therapeutic"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,2931404,Albright's hereditary osteodystrophy,0.221105709,34,"Biomarker, GeneticVariation"
5972,REN,renin,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.221105709,35,"Biomarker, GeneticVariation"
22854,NTNG1,netrin G1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.221096812,5,"Biomarker, GeneticVariation"
2688,GH1,growth hormone 1,0.0,1.0,1.0,0.0,0.0,1206,Acromegaly,0.221056678,46,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,4114,Astrocytoma,0.221047781,16,"Biomarker, GeneticVariation"
859,CAV3,caveolin 3,0.0,1.0,1.0,0.0,0.0,686353,"Muscular Dystrophies, Limb-Girdle",0.221027714,32,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.221018817,9,"Biomarker, GeneticVariation"
10491,CRTAP,cartilage associated protein,0.0,1.0,1.0,0.0,0.0,29434,Osteogenesis Imperfecta,0.22099875,22,"Biomarker, GeneticVariation"
64175,P3H1,prolyl 3-hydroxylase 1,0.0,1.0,1.0,0.0,0.0,29434,Osteogenesis Imperfecta,0.22099875,22,"Biomarker, GeneticVariation"
199713,NLRP7,"NLR family, pyrin domain containing 7",0.0,1.0,1.0,0.0,0.0,20217,Hydatidiform Mole,0.22099875,22,"Biomarker, GeneticVariation"
5595,MAPK3,mitogen-activated protein kinase 3,1.0,1.0,0.0,1.0,0.0,27627,Neoplasm Metastasis,0.220969786,16,"AlteredExpression, Biomarker, PostTranslationalModification"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.220969297,11,"Biomarker, GeneticVariation"
5078,PAX4,paired box 4,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.220969297,7,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.220969297,11,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,0.0,0.0,1.0,38356,Stomach Neoplasms,0.220940822,10,"AlteredExpression, Biomarker, Therapeutic"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,0.0,1.0,0.0,919267,Ovarian Neoplasms,0.220940822,8,"AlteredExpression, Biomarker, PostTranslationalModification"
1969,EPHA2,EPH receptor A2,1.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.220940822,8,"AlteredExpression, Biomarker"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,13384,Dyskinesias,0.220940822,8,"Biomarker, GeneticVariation"
581,BAX,BCL2-associated X protein,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.220940822,8,"AlteredExpression, Biomarker"
4363,ABCC1,"ATP-binding cassette, sub-family C (CFTR/MRP), member 1",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.220940822,8,"AlteredExpression, Biomarker"
8493,PPM1D,"protein phosphatase, Mg2+/Mn2+ dependent, 1D",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.220940822,7,"AlteredExpression, Biomarker"
5915,RARB,"retinoic acid receptor, beta",1.0,1.0,0.0,1.0,1.0,1458155,Breast Neoplasms,0.220940822,8,"AlteredExpression, Biomarker, PostTranslationalModification, Therapeutic"
4129,MAOB,monoamine oxidase B,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.220920267,15,"Biomarker, GeneticVariation"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,1.0,0.0,0.0,524909,"Hepatitis B, Chronic",0.220920267,15,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,243026,Sepsis,0.220891302,8,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,2895,"Anemia, Sickle Cell",0.220891302,8,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,33975,Psychotic Disorders,0.220871236,24,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,4364,Autoimmune Diseases,0.220871236,26,"Biomarker, GeneticVariation"
3662,IRF4,interferon regulatory factor 4,0.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.220871236,24,"Biomarker, GeneticVariation"
3596,IL13,interleukin 13,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.220842272,15,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,948089,Acute Coronary Syndrome,0.220813307,7,"Biomarker, GeneticVariation"
3559,IL2RA,"interleukin 2 receptor, alpha",1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.220793241,24,"AlteredExpression, Biomarker, GeneticVariation"
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,1.0,0.0,0.0,2316212,Cryopyrin-Associated Periodic Syndromes,0.220773174,40,"Biomarker, GeneticVariation"
9126,SMC3,structural maintenance of chromosomes 3,0.0,1.0,1.0,0.0,0.0,270972,De Lange Syndrome,0.220764276,12,"Biomarker, GeneticVariation"
1311,COMP,cartilage oligomeric matrix protein,1.0,1.0,1.0,0.0,0.0,29408,Osteoarthritis,0.220764276,13,"AlteredExpression, Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.22074421,30,"Biomarker, GeneticVariation"
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,1.0,0.0,0.0,23465,"Leukemia, Monocytic, Acute",0.22074421,30,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.220735312,6,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.220735312,7,"AlteredExpression, Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,1.0,1.0,1.0,0.0,0.0,32019,Pituitary Neoplasms,0.220735312,8,"AlteredExpression, Biomarker, GeneticVariation"
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,1.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.220735312,9,"AlteredExpression, Biomarker, GeneticVariation"
2006,ELN,elastin,0.0,1.0,1.0,0.0,0.0,10495,Cutis Laxa,0.220715246,21,"Biomarker, GeneticVariation"
2057,EPOR,erythropoietin receptor,0.0,1.0,1.0,0.0,0.0,32461,Polycythemia,0.220715246,22,"Biomarker, GeneticVariation"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,1.0,0.0,0.0,238358,Hypokalemic Periodic Paralysis,0.220715246,22,"Biomarker, GeneticVariation"
3251,HPRT1,hypoxanthine phosphoribosyltransferase 1,0.0,1.0,1.0,0.0,0.0,740394,Hyperuricemia,0.220715246,20,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,0.0,0.0,206692,"Carcinoma, Lobular",0.220686281,15,"AlteredExpression, Biomarker, GeneticVariation"
10084,PQBP1,polyglutamine binding protein 1,0.0,1.0,1.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.220686281,12,"Biomarker, GeneticVariation"
3077,HFE,hemochromatosis,0.0,1.0,1.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.220685793,5,"Biomarker, GeneticVariation"
3176,HNMT,histamine N-methyltransferase,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.220685793,7,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,31099,Periodontitis,0.220685793,9,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,6267,Bronchiectasis,0.220685793,8,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.220685793,6,"Biomarker, GeneticVariation"
5445,PON2,paraoxonase 2,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.220685793,8,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.220685793,7,"Biomarker, GeneticVariation"
4830,NME1,NME/NM23 nucleoside diphosphate kinase 1,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.220657317,6,"AlteredExpression, Biomarker"
6714,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",1.0,1.0,0.0,1.0,0.0,9375,Colonic Neoplasms,0.220657317,7,"AlteredExpression, Biomarker, PostTranslationalModification"
2152,F3,"coagulation factor III (thromboplastin, tissue factor)",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.220657317,6,"AlteredExpression, Biomarker"
6615,SNAI1,snail family zinc finger 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.220657317,7,"AlteredExpression, Biomarker"
6591,SNAI2,snail family zinc finger 2,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.220657317,6,"AlteredExpression, Biomarker"
51741,WWOX,WW domain containing oxidoreductase,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.220657317,6,"AlteredExpression, Biomarker"
6696,SPP1,secreted phosphoprotein 1,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.220657317,8,"AlteredExpression, Biomarker"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.220636762,14,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.220636762,15,"Biomarker, GeneticVariation"
6720,SREBF1,sterol regulatory element binding transcription factor 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.220636762,16,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.220607798,6,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.220607798,7,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.220607798,8,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,7785,Cerebral Infarction,0.220607798,8,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.220558767,15,"Biomarker, GeneticVariation"
2912,GRM2,"glutamate receptor, metabotropic 2",1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.220558767,14,"AlteredExpression, Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,1.0,151744,Myocardial Ischemia,0.2205387,34,"Biomarker, GeneticVariation, Therapeutic"
4179,CD46,"CD46 molecule, complement regulatory protein",0.0,1.0,1.0,0.0,0.0,25007,Measles,0.220489669,38,"Biomarker, GeneticVariation"
55636,CHD7,chromodomain helicase DNA binding protein 7,0.0,1.0,1.0,0.0,0.0,162809,Kallmann Syndrome,0.220480772,11,"Biomarker, GeneticVariation"
355,FAS,Fas cell surface death receptor,0.0,1.0,1.0,0.0,0.0,4364,Autoimmune Diseases,0.220480772,16,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,1.0,0.0,0.0,17638,Glioma,0.220480772,13,"AlteredExpression, Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,27022,Myeloproliferative Disorders,0.220460705,30,"Biomarker, GeneticVariation"
3000,GUCY2D,"guanylate cyclase 2D, membrane (retina-specific)",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.220460705,28,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.220451808,7,"AlteredExpression, Biomarker, GeneticVariation"
50506,DUOX2,dual oxidase 2,1.0,1.0,1.0,0.0,0.0,10308,Congenital Hypothyroidism,0.220431741,19,"AlteredExpression, Biomarker, GeneticVariation"
1890,TYMP,thymidine phosphorylase,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.220431741,22,"AlteredExpression, Biomarker"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.220402777,12,"AlteredExpression, Biomarker"
1116,CHI3L1,chitinase 3-like 1 (cartilage glycoprotein-39),1.0,1.0,0.0,0.0,0.0,17638,Glioma,0.220402777,12,"AlteredExpression, Biomarker"
386653,IL31,interleukin 31,1.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.220402777,14,"AlteredExpression, Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,0.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.220402777,14,"Biomarker, GeneticVariation"
3952,LEP,leptin,1.0,1.0,0.0,0.0,0.0,85207,"Diabetes, Gestational",0.220402777,14,"AlteredExpression, Biomarker"
64241,ABCG8,"ATP-binding cassette, sub-family G (WHITE), member 8",0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.220402288,7,"Biomarker, GeneticVariation"
3560,IL2RB,"interleukin 2 receptor, beta",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.220402288,10,"Biomarker, GeneticVariation"
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,0.0,1.0,1.0,0.0,1.0,18133,Graft vs Host Disease,0.220402288,9,"Biomarker, GeneticVariation, Therapeutic"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.220402288,5,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.220373813,5,"AlteredExpression, Biomarker"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.220373813,6,"AlteredExpression, Biomarker, GeneticVariation"
6423,SFRP2,secreted frizzled-related protein 2,0.0,1.0,0.0,1.0,0.0,9404,Colorectal Neoplasms,0.220373813,7,"Biomarker, PostTranslationalModification"
7367,UGT2B17,"UDP glucuronosyltransferase 2 family, polypeptide B17",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.220373813,5,"AlteredExpression, Biomarker, GeneticVariation"
83990,BRIP1,BRCA1 interacting protein C-terminal helicase 1,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.220373813,5,"Biomarker, GeneticVariation"
23136,EPB41L3,erythrocyte membrane protein band 4.1-like 3,0.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.220373813,4,"Biomarker, GeneticVariation, PostTranslationalModification"
5915,RARB,"retinoic acid receptor, beta",1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.220373813,6,"AlteredExpression, Biomarker"
864,RUNX3,runt-related transcription factor 3,1.0,1.0,0.0,1.0,0.0,24121,Lung Neoplasms,0.220373813,6,"AlteredExpression, Biomarker, PostTranslationalModification"
56729,RETN,resistin,0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.220353257,14,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.220324293,7,"Biomarker, GeneticVariation"
2539,G6PD,glucose-6-phosphate dehydrogenase,0.0,1.0,1.0,0.0,0.0,15702,Favism,0.220304226,22,"Biomarker, GeneticVariation"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.220304226,24,"Biomarker, GeneticVariation"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,1.0,0.0,1.0,15695,Fatty Liver,0.220275262,14,"Biomarker, GeneticVariation, Therapeutic"
887,CCKBR,cholecystokinin B receptor,0.0,1.0,1.0,0.0,0.0,30319,Panic Disorder,0.220275262,13,"Biomarker, GeneticVariation"
1832,DSP,desmoplakin,0.0,1.0,1.0,0.0,0.0,349788,Arrhythmogenic Right Ventricular Dysplasia,0.22026702,25,"Biomarker, GeneticVariation"
4179,CD46,"CD46 molecule, complement regulatory protein",0.0,1.0,1.0,0.0,0.0,2931788,Atypical Hemolytic Uremic Syndrome,0.220255195,30,"Biomarker, GeneticVariation"
1234,CCR5,chemokine (C-C motif) receptor 5 (gene/pseudogene),0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.220246298,3,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.220246298,6,"Biomarker, GeneticVariation"
5925,RB1,retinoblastoma 1,0.0,1.0,1.0,1.0,0.0,2239176,"Carcinoma, Hepatocellular",0.220226231,23,"Biomarker, GeneticVariation, PostTranslationalModification"
4155,MBP,myelin basic protein,0.0,1.0,0.0,0.0,0.0,14072,"Encephalomyelitis, Autoimmune, Experimental",0.220206165,39,Biomarker
338,APOB,apolipoprotein B,0.0,1.0,1.0,0.0,0.0,1704417,Hyperlipoproteinemia Type II,0.220206165,36,"Biomarker, GeneticVariation"
8912,CACNA1H,"calcium channel, voltage-dependent, T type, alpha 1H subunit",0.0,1.0,1.0,0.0,0.0,14553,"Epilepsy, Absence",0.220197267,10,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,1.0,0.0,0.0,11849,Diabetes Mellitus,0.220197267,11,"Biomarker, GeneticVariation"
2321,FLT1,fms-related tyrosine kinase 1,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.220197267,12,"AlteredExpression, Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.220197267,11,"AlteredExpression, Biomarker, GeneticVariation"
23095,KIF1B,kinesin family member 1B,0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.220177855,64,"Biomarker, GeneticVariation"
5741,PTH,parathyroid hormone,0.0,1.0,1.0,0.0,0.0,221002,"Hyperparathyroidism, Primary",0.220177855,63,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.220168303,6,"AlteredExpression, Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,1.0,0.0,0.0,14170,Endometrial Neoplasms,0.220168303,6,"AlteredExpression, Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.220168303,7,"Biomarker, GeneticVariation"
64170,CARD9,"caspase recruitment domain family, member 9",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.220118784,6,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.220118784,5,"Biomarker, GeneticVariation"
4589,MUC7,"mucin 7, secreted",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.220118784,5,"Biomarker, GeneticVariation"
79258,MMEL1,membrane metallo-endopeptidase-like 1,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.220118784,8,"Biomarker, GeneticVariation"
5788,PTPRC,"protein tyrosine phosphatase, receptor type, C",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.220118784,8,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,7282,Carotid Stenosis,0.220118784,6,"Biomarker, GeneticVariation"
64805,P2RY12,"purinergic receptor P2Y, G-protein coupled, 12",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.220118784,5,"Biomarker, GeneticVariation"
79001,VKORC1,"vitamin K epoxide reductase complex, subunit 1",0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.220118784,5,"Biomarker, GeneticVariation"
145741,C2CD4A,C2 calcium-dependent domain containing 4A,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.220118784,5,"Biomarker, GeneticVariation"
4879,NPPB,natriuretic peptide B,1.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.220090308,5,"AlteredExpression, Biomarker"
27030,MLH3,mutL homolog 3,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.220090308,4,"AlteredExpression, Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.220090308,5,"AlteredExpression, Biomarker, GeneticVariation"
4593,MUSK,"muscle, skeletal, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,26896,Myasthenia Gravis,0.220090308,5,Biomarker
6285,S100B,S100 calcium binding protein B,1.0,1.0,0.0,0.0,1.0,270611,Brain Injuries,0.220090308,6,"AlteredExpression, Biomarker, Therapeutic"
2875,GPT,glutamic-pyruvate transaminase (alanine aminotransferase),1.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.220090308,5,"AlteredExpression, Biomarker"
2150,F2RL1,coagulation factor II (thrombin) receptor-like 1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.220090308,6,Biomarker
3146,HMGB1,high mobility group box 1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.220090308,9,Biomarker
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.220090308,5,"Biomarker, GeneticVariation, PostTranslationalModification"
3952,LEP,leptin,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.220090308,5,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.220090308,5,"Biomarker, GeneticVariation"
23411,SIRT1,sirtuin 1,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.220090308,5,"AlteredExpression, Biomarker"
6768,ST14,suppression of tumorigenicity 14 (colon carcinoma),1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.220090308,5,"AlteredExpression, Biomarker"
332,BIRC5,baculoviral IAP repeat containing 5,1.0,1.0,1.0,0.0,1.0,9375,Colonic Neoplasms,0.220090308,6,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
580,BARD1,BRCA1 associated RING domain 1,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.220090308,4,"AlteredExpression, Biomarker, GeneticVariation"
1806,DPYD,dihydropyrimidine dehydrogenase,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.220090308,5,"AlteredExpression, Biomarker"
2876,GPX1,glutathione peroxidase 1,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.220090308,4,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.220069753,14,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.220069753,13,"Biomarker, GeneticVariation"
1584,CYP11B1,"cytochrome P450, family 11, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.220061999,30,"Biomarker, GeneticVariation"
8924,HERC2,HECT and RLD domain containing E3 ubiquitin protein ligase 2,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.220040789,3,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,37116,Silicosis,0.220040789,4,"Biomarker, GeneticVariation"
8644,AKR1C3,"aldo-keto reductase family 1, member C3",0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.220040789,6,"Biomarker, GeneticVariation"
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",1.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.220040789,7,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,6625,Cachexia,0.220020722,21,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.22,291,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.22,970,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.22,2572,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,36220,"Sarcoma, Kaposi",0.219991758,10,"AlteredExpression, Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.219991758,13,"Biomarker, GeneticVariation"
2048,EPHB2,EPH receptor B2,0.0,1.0,1.0,0.0,0.0,376358,Malignant neoplasm of prostate,0.219971691,28,"Biomarker, GeneticVariation"
3486,IGFBP3,insulin-like growth factor binding protein 3,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.219962794,5,"AlteredExpression, Biomarker, GeneticVariation"
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,1.0,0.0,1.0,243026,Sepsis,0.219962794,6,"Biomarker, GeneticVariation, Therapeutic"
6340,SCNN1G,"sodium channel, non voltage gated 1 gamma subunit",1.0,1.0,1.0,0.0,0.0,10674,Cystic Fibrosis,0.219962794,4,"AlteredExpression, Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,0.0,1.0,1.0,0.0,0.0,30305,Pancreatitis,0.219942727,20,"Biomarker, GeneticVariation"
3309,HSPA5,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.219942727,20,"AlteredExpression, Biomarker, GeneticVariation"
6010,RHO,rhodopsin,0.0,1.0,1.0,0.0,0.0,35304,Retinal Degeneration,0.21992266,36,"Biomarker, GeneticVariation"
92140,MTDH,metadherin,1.0,1.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.21992266,35,"AlteredExpression, Biomarker, Therapeutic"
118,ADD1,adducin 1 (alpha),0.0,1.0,1.0,0.0,0.0,85580,"Hypertension, Essential",0.21992266,35,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.219913763,12,"Biomarker, GeneticVariation"
100133941,CD24,CD24 molecule,1.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.219913763,10,"AlteredExpression, Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,1.0,242339,Dyslipidemias,0.219913763,13,"Biomarker, GeneticVariation, Therapeutic"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",1.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.219893696,27,"AlteredExpression, Biomarker"
5468,PPARG,peroxisome proliferator-activated receptor gamma,1.0,1.0,1.0,0.0,1.0,30297,Pancreatic Neoplasms,0.219884799,6,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
1577,CYP3A5,"cytochrome P450, family 3, subfamily A, polypeptide 5",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.219884799,4,"Biomarker, GeneticVariation"
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.219884799,5,"Biomarker, GeneticVariation"
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,1.0,0.0,0.0,42514,"Tachycardia, Ventricular",0.219884799,6,"Biomarker, GeneticVariation"
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),1.0,1.0,1.0,0.0,1.0,1861172,Venous Thromboembolism,0.219884799,6,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
4214,MAP3K1,"mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.219884799,5,"Biomarker, GeneticVariation"
354,KLK3,kallikrein-related peptidase 3,0.0,1.0,1.0,0.0,0.0,2937421,Prostatic Hyperplasia,0.219884799,5,"Biomarker, GeneticVariation"
5966,REL,v-rel avian reticuloendotheliosis viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,19829,Hodgkin Disease,0.219884799,4,"AlteredExpression, Biomarker, GeneticVariation"
3758,KCNJ1,"potassium channel, inwardly rectifying subfamily J, member 1",0.0,1.0,1.0,0.0,0.0,4775,Bartter Syndrome,0.219864732,19,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.219835768,13,"AlteredExpression, Biomarker"
1958,EGR1,early growth response 1,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.219835768,12,"AlteredExpression, Biomarker"
375056,MIA3,"melanoma inhibitory activity family, member 3",0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.219835279,6,"Biomarker, GeneticVariation"
221692,PHACTR1,phosphatase and actin regulator 1,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.219835279,7,"Biomarker, GeneticVariation"
2701,GJA4,"gap junction protein, alpha 4, 37kDa",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.219835279,7,"Biomarker, GeneticVariation"
4633,MYL2,"myosin, light chain 2, regulatory, cardiac, slow",0.0,1.0,1.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.219835279,7,"Biomarker, GeneticVariation"
1136,CHRNA3,"cholinergic receptor, nicotinic, alpha 3 (neuronal)",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.219835279,5,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,11884,Diabetic Retinopathy,0.219835279,7,"Biomarker, GeneticVariation"
255738,PCSK9,proprotein convertase subtilisin/kexin type 9,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.219786248,13,"Biomarker, GeneticVariation"
10758,TRAF3IP2,TRAF3 interacting protein 2,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.219786248,11,"Biomarker, GeneticVariation"
137196,CCDC26,CCDC26 long non-coding RNA,0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.219786248,10,"Biomarker, GeneticVariation"
642,BLMH,bleomycin hydrolase,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.219757284,5,"Biomarker, GeneticVariation"
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.219757284,5,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,18671,Head and Neck Neoplasms,0.219757284,8,"AlteredExpression, Biomarker, GeneticVariation"
7341,SUMO1,small ubiquitin-like modifier 1,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.219757284,5,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.219737217,20,"Biomarker, GeneticVariation"
10046,MAMLD1,mastermind-like domain containing 1,0.0,1.0,1.0,0.0,0.0,848558,Hypospadias,0.219708253,10,"Biomarker, GeneticVariation"
3198,HOXA1,homeobox A1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.219708253,11,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,1.0,7222,Cardiovascular Diseases,0.219708253,11,"Biomarker, GeneticVariation, Therapeutic"
10468,FST,follistatin,0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.219708253,10,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.219679289,4,"Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,1.0,0.0,0.0,40034,Thrombocytopenia,0.219679289,5,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.219679289,4,"Biomarker, GeneticVariation"
2067,ERCC1,excision repair cross-complementation group 1,1.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.219679289,5,"AlteredExpression, Biomarker, GeneticVariation"
7516,XRCC2,X-ray repair complementing defective repair in Chinese hamster cells 2,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.219679289,5,"Biomarker, GeneticVariation"
2162,F13A1,"coagulation factor XIII, A1 polypeptide",0.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.219679289,5,"Biomarker, GeneticVariation"
335,APOA1,apolipoprotein A-I,1.0,1.0,1.0,0.0,0.0,38454,Stroke,0.219679289,5,"AlteredExpression, Biomarker, GeneticVariation"
3195,TLX1,T-cell leukemia homeobox 1,0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.219639155,35,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.219639155,34,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.219630258,11,"Biomarker, GeneticVariation"
3952,LEP,leptin,1.0,1.0,1.0,0.0,0.0,15695,Fatty Liver,0.219630258,13,"AlteredExpression, Biomarker, GeneticVariation"
3791,KDR,kinase insert domain receptor,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.219630258,11,"AlteredExpression, Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,1.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.219581227,18,"AlteredExpression, Biomarker"
5604,MAP2K1,mitogen-activated protein kinase kinase 1,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.219581227,17,"AlteredExpression, Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,10481,Cushing Syndrome,0.219581227,20,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.219581227,19,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.219581227,17,"AlteredExpression, Biomarker"
3381,IBSP,integrin-binding sialoprotein,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.219581227,17,Biomarker
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.219552263,11,"AlteredExpression, Biomarker"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.219552263,11,"AlteredExpression, Biomarker"
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),1.0,1.0,0.0,0.0,1.0,7137,"Carcinoma, Squamous Cell",0.219552263,11,"AlteredExpression, Biomarker, Therapeutic"
25865,PRKD2,protein kinase D2,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.219551775,4,"Biomarker, GeneticVariation"
1512,CTSH,cathepsin H,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.219551775,5,"Biomarker, GeneticVariation"
683,BST1,bone marrow stromal cell antigen 1,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.219551775,4,"Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.219551775,6,"Biomarker, GeneticVariation"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,1.0,0.0,0.0,42109,Urticaria,0.219551775,5,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.219551775,5,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.219551775,6,"Biomarker, GeneticVariation"
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.219551775,6,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.219551775,5,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.219551775,5,"Biomarker, GeneticVariation"
9049,AIP,aryl hydrocarbon receptor interacting protein,0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.219502744,13,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,0.0,1.0,1.0,0.0,0.0,32927,Precancerous Conditions,0.219502744,12,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",1.0,1.0,1.0,0.0,0.0,27947,Neutropenia,0.219502744,11,"AlteredExpression, Biomarker, GeneticVariation"
111,ADCY5,adenylate cyclase 5,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.219502744,11,"Biomarker, GeneticVariation"
10718,NRG3,neuregulin 3,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.219502744,10,"Biomarker, GeneticVariation"
355,FAS,Fas cell surface death receptor,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.219502744,11,"Biomarker, GeneticVariation"
10144,FAM13A,"family with sequence similarity 13, member A",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.219502744,10,"Biomarker, GeneticVariation"
7341,SUMO1,small ubiquitin-like modifier 1,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.21947378,4,"Biomarker, GeneticVariation"
323,APBB2,"amyloid beta (A4) precursor protein-binding, family B, member 2",0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.21947378,3,"Biomarker, GeneticVariation"
27328,PCDH11X,protocadherin 11 X-linked,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.21947378,3,"Biomarker, GeneticVariation"
6607,SMN2,"survival of motor neuron 2, centromeric",0.0,1.0,1.0,0.0,0.0,700595,Spinal Muscular Atrophies of Childhood,0.21947378,4,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,1.0,1.0,1.0,0.0,0.0,26766,Multiple Organ Failure,0.21947378,6,"AlteredExpression, Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,832,Abruptio Placentae,0.21947378,3,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21947378,7,"Biomarker, GeneticVariation"
3741,KCNA5,"potassium channel, voltage gated shaker related subfamily A, member 5",0.0,1.0,1.0,0.0,0.0,4238,Atrial Fibrillation,0.21947378,4,"Biomarker, GeneticVariation"
434,ASIP,agouti signaling protein,0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21947378,3,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.21947378,6,"Biomarker, GeneticVariation"
1583,CYP11A1,"cytochrome P450, family 11, subfamily A, polypeptide 1",1.0,1.0,1.0,0.0,0.0,14170,Endometrial Neoplasms,0.21947378,5,"AlteredExpression, Biomarker, GeneticVariation"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.21947378,5,"Biomarker, GeneticVariation"
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.21947378,5,"Biomarker, GeneticVariation"
1071,CETP,"cholesteryl ester transfer protein, plasma",0.0,1.0,1.0,0.0,0.0,20557,Hypertriglyceridemia,0.21947378,5,"Biomarker, GeneticVariation"
5027,P2RX7,"purinergic receptor P2X, ligand gated ion channel, 7",0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.219424749,11,"Biomarker, GeneticVariation"
161742,SPRED1,"sprouty-related, EVH1 domain containing 1",0.0,1.0,1.0,0.0,0.0,27831,Neurofibromatosis 1,0.219424749,8,"Biomarker, GeneticVariation"
9210,BMP15,bone morphogenetic protein 15,0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.219424749,9,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.219404682,26,"Biomarker, GeneticVariation, Therapeutic"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.219404682,26,"Biomarker, GeneticVariation"
1232,CCR3,chemokine (C-C motif) receptor 3,1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.219404682,27,"AlteredExpression, Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.219375718,17,"AlteredExpression, Biomarker, GeneticVariation"
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",1.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.219375718,17,"AlteredExpression, Biomarker, GeneticVariation"
5961,PRPH2,"peripherin 2 (retinal degeneration, slow)",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.219367476,27,"Biomarker, GeneticVariation"
5376,PMP22,peripheral myelin protein 22,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.219355651,35,Biomarker
3371,TNC,tenascin C,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.219346754,7,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.219346754,9,"Biomarker, GeneticVariation"
2584,GALK1,galactokinase 1,0.0,1.0,1.0,0.0,0.0,16952,Galactosemias,0.219346754,11,"Biomarker, GeneticVariation"
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.219326687,25,Biomarker
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.219326687,24,"AlteredExpression, Biomarker"
6720,SREBF1,sterol regulatory element binding transcription factor 1,1.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.219297723,18,"AlteredExpression, Biomarker"
27232,GNMT,glycine N-methyltransferase,1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.219297723,15,"AlteredExpression, Biomarker, GeneticVariation"
3855,KRT7,"keratin 7, type II",1.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.219268759,9,"AlteredExpression, Biomarker"
5744,PTHLH,parathyroid hormone-like hormone,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.219268759,10,"AlteredExpression, Biomarker"
3315,HSPB1,heat shock 27kDa protein 1,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.219268759,9,"AlteredExpression, Biomarker"
26330,GAPDHS,"glyceraldehyde-3-phosphate dehydrogenase, spermatogenic",0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.21926827,4,"Biomarker, GeneticVariation"
3596,IL13,interleukin 13,0.0,1.0,1.0,0.0,0.0,20523,"Hypersensitivity, Immediate",0.21926827,6,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,43094,Weight Gain,0.21926827,4,"Biomarker, GeneticVariation"
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",0.0,1.0,1.0,0.0,0.0,43094,Weight Gain,0.21926827,4,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,1.0,33687,Proteinuria,0.21926827,9,"Biomarker, GeneticVariation, Therapeutic"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,22876,"Obstetric Labor, Premature",0.21926827,6,"Biomarker, GeneticVariation"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.21926827,4,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,27726,Nephrotic Syndrome,0.21926827,5,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,6434,Burns,0.21926827,6,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,6434,Burns,0.21926827,5,"Biomarker, GeneticVariation"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.21926827,5,"Biomarker, GeneticVariation"
3976,LIF,leukemia inhibitory factor,0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.21926827,5,"Biomarker, GeneticVariation"
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,1.0,0.0,0.0,26640,Mouth Neoplasms,0.21926827,5,"Biomarker, GeneticVariation"
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,1.0,0.0,0.0,23055,Laryngeal Neoplasms,0.21926827,4,"Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,0.0,1.0,1.0,0.0,0.0,20557,Hypertriglyceridemia,0.21926827,4,"Biomarker, GeneticVariation"
2646,GCKR,glucokinase (hexokinase 4) regulator,0.0,1.0,1.0,0.0,0.0,20557,Hypertriglyceridemia,0.21926827,4,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.21926827,5,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.21926827,4,"Biomarker, GeneticVariation"
2539,G6PD,glucose-6-phosphate dehydrogenase,0.0,1.0,1.0,0.0,0.0,19054,Hemolysis,0.21926827,6,"Biomarker, GeneticVariation"
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.21926827,4,"Biomarker, GeneticVariation"
2243,FGA,fibrinogen alpha chain,0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.21926827,5,"Biomarker, GeneticVariation"
10318,TNIP1,TNFAIP3 interacting protein 1,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.219219239,10,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.219219239,12,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.219219239,12,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.219219239,11,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.219219239,10,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,1.0,0.0,1.0,11854,"Diabetes Mellitus, Type 1",0.219219239,10,"Biomarker, GeneticVariation, Therapeutic"
3949,LDLR,low density lipoprotein receptor,0.0,1.0,1.0,0.0,0.0,20473,Hyperlipidemias,0.219170208,19,"Biomarker, GeneticVariation"
5771,PTPN2,"protein tyrosine phosphatase, non-receptor type 2",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.219141244,8,"Biomarker, GeneticVariation"
3135,HLA-G,"major histocompatibility complex, class I, G",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.219141244,8,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.219141244,9,"Biomarker, GeneticVariation"
1585,CYP11B2,"cytochrome P450, family 11, subfamily B, polypeptide 2",0.0,1.0,1.0,0.0,0.0,20428,Hyperaldosteronism,0.219141244,11,"Biomarker, GeneticVariation"
6387,CXCL12,chemokine (C-X-C motif) ligand 12,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.219141244,9,"Biomarker, GeneticVariation"
10752,CHL1,cell adhesion molecule L1-like,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.219141244,7,"Biomarker, GeneticVariation"
7226,TRPM2,"transient receptor potential cation channel, subfamily M, member 2",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.219141244,8,"Biomarker, GeneticVariation"
2056,EPO,erythropoietin,0.0,1.0,1.0,0.0,1.0,26986,Myelodysplastic Syndromes,0.219121177,25,"Biomarker, GeneticVariation, Therapeutic"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.219121177,25,"Biomarker, GeneticVariation"
29851,ICOS,inducible T-cell co-stimulator,0.0,1.0,1.0,0.0,0.0,9447,Common Variable Immunodeficiency,0.219092213,16,"Biomarker, GeneticVariation"
23418,CRB1,"crumbs family member 1, photoreceptor morphogenesis associated",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.219092213,17,"Biomarker, GeneticVariation"
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,1.0,0.0,0.0,349639,"Leukemia, Myelomonocytic, Juvenile",0.219092213,15,"Biomarker, GeneticVariation"
8030,CCDC6,coiled-coil domain containing 6,0.0,1.0,1.0,0.0,0.0,238463,"Thyroid cancer, papillary",0.219072146,32,"Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.219072146,33,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.219063249,10,"AlteredExpression, Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.219063249,8,"AlteredExpression, Biomarker, GeneticVariation"
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,1.0,0.0,0.0,3119,Anophthalmos,0.219063249,7,"Biomarker, GeneticVariation"
4613,MYCN,v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.219043182,24,Biomarker
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.219043182,25,"Biomarker, GeneticVariation"
3909,LAMA3,"laminin, alpha 3",0.0,1.0,1.0,0.0,0.0,79301,"Epidermolysis Bullosa, Junctional",0.219014218,15,"Biomarker, GeneticVariation"
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,1.0,0.0,0.0,37889,"Spherocytosis, Hereditary",0.219014218,16,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,3486,Aortic Aneurysm,0.219014218,17,"Biomarker, GeneticVariation"
1410,CRYAB,"crystallin, alpha B",0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.219014218,16,"Biomarker, GeneticVariation"
238,ALK,anaplastic lymphoma receptor tyrosine kinase,1.0,1.0,1.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.219014218,17,"AlteredExpression, Biomarker, GeneticVariation"
6285,S100B,S100 calcium binding protein B,1.0,1.0,0.0,0.0,0.0,13080,Down Syndrome,0.219014218,16,"AlteredExpression, Biomarker"
1630,DCC,DCC netrin 1 receptor,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.218985254,9,"AlteredExpression, Biomarker, GeneticVariation"
4288,MKI67,marker of proliferation Ki-67,1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.218985254,8,"AlteredExpression, Biomarker"
4879,NPPB,natriuretic peptide B,1.0,1.0,0.0,0.0,0.0,7222,Cardiovascular Diseases,0.218985254,9,"AlteredExpression, Biomarker"
3897,L1CAM,L1 cell adhesion molecule,0.0,1.0,1.0,0.0,0.0,19569,Hirschsprung Disease,0.218985254,7,"Biomarker, GeneticVariation"
1474,CST6,cystatin E/M,1.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.218985254,8,"AlteredExpression, Biomarker, PostTranslationalModification"
2118,ETV4,ets variant 4,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.218985254,9,"AlteredExpression, Biomarker"
3458,IFNG,"interferon, gamma",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.218985254,9,"AlteredExpression, Biomarker, GeneticVariation"
65217,PCDH15,protocadherin-related 15,0.0,1.0,1.0,0.0,0.0,271097,Usher Syndromes,0.218985254,9,"Biomarker, GeneticVariation"
3899,AFF3,"AF4/FMR2 family, member 3",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.218935735,8,"Biomarker, GeneticVariation"
7056,THBD,thrombomodulin,0.0,1.0,1.0,0.0,0.0,398623,Thrombophilia,0.218935735,9,"Biomarker, GeneticVariation"
580,BARD1,BRCA1 associated RING domain 1,0.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.218935735,10,"Biomarker, GeneticVariation"
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.218935735,7,"Biomarker, GeneticVariation"
80332,ADAM33,ADAM metallopeptidase domain 33,0.0,1.0,1.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.218886704,17,"Biomarker, GeneticVariation"
2194,FASN,fatty acid synthase,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.218886704,17,"Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,0.0,1.0,1.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21885774,8,"Biomarker, GeneticVariation"
10318,TNIP1,TNFAIP3 interacting protein 1,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.21885774,9,"Biomarker, GeneticVariation"
467,ATF3,activating transcription factor 3,0.0,1.0,1.0,0.0,0.0,848558,Hypospadias,0.21885774,6,"Biomarker, GeneticVariation"
6247,RS1,retinoschisin 1,0.0,1.0,1.0,0.0,0.0,271091,Juvenile X-Linked Retinoschisis,0.218809364,50,"Biomarker, GeneticVariation"
28444,IGHV3-21,immunoglobulin heavy variable 3-21,1.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.218808709,16,"AlteredExpression, Biomarker, GeneticVariation"
4397,MS,multiple sclerosis,0.0,1.0,0.0,0.0,0.0,26769,Multiple Sclerosis,0.218788642,31,Biomarker
7276,TTR,transthyretin,0.0,1.0,1.0,0.0,0.0,740340,"Amyloidosis, Familial",0.218788642,33,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,1.0,0.0,0.0,4943,Behcet Syndrome,0.218779744,7,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,1.0,0.0,0.0,11849,Diabetes Mellitus,0.218779744,9,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,38358,Stomach Ulcer,0.218779744,7,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.218779744,6,"Biomarker, GeneticVariation"
7412,VCAM1,vascular cell adhesion molecule 1,1.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.218779744,8,"AlteredExpression, Biomarker, GeneticVariation"
9685,CLINT1,clathrin interactor 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.218779744,5,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.218759678,23,"Biomarker, GeneticVariation"
79870,BAALC,"brain and acute leukemia, cytoplasmic",1.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.218759678,24,"AlteredExpression, Biomarker"
3753,KCNE1,"potassium channel, voltage gated subfamily E regulatory beta subunit 1",0.0,1.0,1.0,0.0,0.0,22387,Jervell-Lange Nielsen Syndrome,0.218730714,16,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",1.0,1.0,0.0,0.0,0.0,10346,Crohn Disease,0.218730714,16,"AlteredExpression, Biomarker"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.218730714,17,"AlteredExpression, Biomarker"
5816,PVALB,parvalbumin,1.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.218730714,15,"AlteredExpression, Biomarker"
4089,SMAD4,SMAD family member 4,0.0,1.0,1.0,0.0,0.0,235974,Pancreatic Carcinoma,0.218711302,66,"Biomarker, GeneticVariation"
6696,SPP1,secreted phosphoprotein 1,1.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.218701749,7,"AlteredExpression, Biomarker"
26154,ABCA12,"ATP-binding cassette, sub-family A (ABC1), member 12",0.0,1.0,1.0,0.0,0.0,79154,"Ichthyosis, Lamellar",0.218701749,7,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.218701749,8,"AlteredExpression, Biomarker, GeneticVariation"
2346,FOLH1,folate hydrolase (prostate-specific membrane antigen) 1,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.218701749,9,"AlteredExpression, Biomarker"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",1.0,1.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.218701749,11,"AlteredExpression, Biomarker, Therapeutic"
9076,CLDN1,claudin 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.218701749,7,"AlteredExpression, Biomarker"
2114,ETS2,v-ets avian erythroblastosis virus E26 oncogene homolog 2,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.218701749,8,"AlteredExpression, Biomarker"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.218701749,7,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,0.0,1.0,0.0,24121,Lung Neoplasms,0.218701749,8,"AlteredExpression, Biomarker, PostTranslationalModification"
301,ANXA1,annexin A1,1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.218701749,8,"AlteredExpression, Biomarker, GeneticVariation"
3929,LBP,lipopolysaccharide binding protein,0.0,1.0,1.0,0.0,0.0,243026,Sepsis,0.21865223,7,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.21865223,7,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.21865223,6,"Biomarker, GeneticVariation"
26191,PTPN22,"protein tyrosine phosphatase, non-receptor type 22 (lymphoid)",0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.21865223,10,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,19337,Heroin Dependence,0.21865223,8,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.21865223,8,"Biomarker, GeneticVariation"
115352,FCRL3,Fc receptor-like 3,0.0,1.0,1.0,0.0,0.0,18213,Graves Disease,0.21865223,7,"Biomarker, GeneticVariation"
7038,TG,thyroglobulin,0.0,1.0,1.0,0.0,0.0,920350,"Thyroiditis, Autoimmune",0.218603199,14,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.218603199,16,"Biomarker, GeneticVariation"
1380,CR2,complement component (3d/Epstein Barr virus) receptor 2,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.218574235,6,"Biomarker, GeneticVariation"
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.218574235,6,"Biomarker, GeneticVariation"
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.218574235,9,"Biomarker, GeneticVariation, Therapeutic"
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",0.0,1.0,1.0,0.0,0.0,270853,"Myoclonic Epilepsy, Juvenile",0.218574235,6,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.218574235,6,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.218574235,6,"AlteredExpression, Biomarker, GeneticVariation"
3596,IL13,interleukin 13,0.0,1.0,1.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.218574235,9,"Biomarker, GeneticVariation"
4852,NPY,neuropeptide Y,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.218574235,8,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.218574235,9,"AlteredExpression, Biomarker, GeneticVariation"
30062,RAX,retina and anterior neural fold homeobox,0.0,1.0,1.0,0.0,0.0,3119,Anophthalmos,0.218574235,8,"Biomarker, GeneticVariation"
3440,IFNA2,"interferon, alpha 2",0.0,1.0,1.0,0.0,1.0,19163,Hepatitis B,0.218525204,16,"Biomarker, GeneticVariation, Therapeutic"
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.218505137,31,Biomarker
10481,HOXB13,homeobox B13,0.0,1.0,1.0,0.0,0.0,376358,Malignant neoplasm of prostate,0.218505137,30,"Biomarker, GeneticVariation"
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.218505137,31,Biomarker
23600,AMACR,alpha-methylacyl-CoA racemase,0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.21849624,6,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,11849,Diabetes Mellitus,0.21849624,7,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.21849624,8,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.21849624,8,"AlteredExpression, Biomarker, GeneticVariation"
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,1.0,0.0,0.0,38358,Stomach Ulcer,0.21849624,7,"AlteredExpression, Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",1.0,1.0,1.0,0.0,1.0,7137,"Carcinoma, Squamous Cell",0.21849624,9,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.21849624,9,"Biomarker, GeneticVariation"
57526,PCDH19,protocadherin 19,0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.218476173,21,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.218476173,22,Biomarker
4005,LMO2,LIM domain only 2 (rhombotin-like 1),0.0,1.0,1.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.218476173,22,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,1.0,0.0,27819,Neuroblastoma,0.218476173,22,"Biomarker, PostTranslationalModification"
5879,RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.218476173,22,"AlteredExpression, Biomarker"
260431,COPD,"Pulmonary disease, chronic obstructive, severe early-onset",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.218476173,22,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,0.0,0.0,0.0,206180,"Lymphoma, Large-Cell, Anaplastic",0.218447209,13,"AlteredExpression, Biomarker"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.218447209,14,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,1.0,1.0,1.0,0.0,0.0,25500,Mesothelioma,0.218418245,7,"AlteredExpression, Biomarker, GeneticVariation"
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,1.0,0.0,1.0,0.0,5695,Urinary Bladder Neoplasms,0.218418245,6,"Biomarker, PostTranslationalModification"
177,AGER,advanced glycosylation end product-specific receptor,1.0,1.0,1.0,0.0,0.0,11875,Diabetic Angiopathies,0.218418245,7,"AlteredExpression, Biomarker, GeneticVariation"
5069,PAPPA,"pregnancy-associated plasma protein A, pappalysin 1",1.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.218418245,7,"AlteredExpression, Biomarker"
1414,CRYBB1,"crystallin, beta B1",0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.218418245,5,"Biomarker, GeneticVariation"
1012,CDH13,cadherin 13,1.0,1.0,0.0,1.0,0.0,2239176,"Carcinoma, Hepatocellular",0.218418245,5,"AlteredExpression, Biomarker, PostTranslationalModification"
5655,KLK10,kallikrein-related peptidase 10,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.218418245,6,"AlteredExpression, Biomarker"
4853,NOTCH2,notch 2,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.218418245,6,"Biomarker, GeneticVariation"
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",1.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.218418245,7,"AlteredExpression, Biomarker, Therapeutic"
5595,MAPK3,mitogen-activated protein kinase 3,1.0,1.0,1.0,1.0,0.0,7137,"Carcinoma, Squamous Cell",0.218418245,7,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.218418245,5,"Biomarker, GeneticVariation"
640,BLK,"BLK proto-oncogene, Src family tyrosine kinase",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.218368725,10,"Biomarker, GeneticVariation"
5771,PTPN2,"protein tyrosine phosphatase, non-receptor type 2",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.218368725,7,"Biomarker, GeneticVariation"
7096,TLR1,toll-like receptor 1,0.0,1.0,1.0,0.0,0.0,23343,Leprosy,0.218368725,5,"Biomarker, GeneticVariation"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.218368725,9,"Biomarker, GeneticVariation"
2215,FCGR3B,"Fc fragment of IgG, low affinity IIIb, receptor (CD16b)",0.0,1.0,1.0,0.0,0.0,24143,Lupus Nephritis,0.218368725,8,"Biomarker, GeneticVariation"
8542,APOL1,"apolipoprotein L, 1",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.218368725,5,"Biomarker, GeneticVariation"
2532,ACKR1,atypical chemokine receptor 1 (Duffy blood group),0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.218319694,15,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,0.0,1.0,1.0,0.0,0.0,23418,Leukemia,0.218319694,16,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.21829073,4,"Biomarker, GeneticVariation"
100,ADA,adenosine deaminase,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.21829073,4,"Biomarker, GeneticVariation"
57194,ATP10A,"ATPase, class V, type 10A",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.21829073,5,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.21829073,7,"Biomarker, GeneticVariation"
4689,NCF4,"neutrophil cytosolic factor 4, 40kDa",0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.21829073,5,"Biomarker, GeneticVariation"
3952,LEP,leptin,0.0,1.0,1.0,0.0,1.0,28756,"Obesity, Morbid",0.218270663,23,"Biomarker, GeneticVariation, Therapeutic"
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,1.0,1.0,0.0,0.0,1623,Adrenal Insufficiency,0.218270663,22,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.218270663,23,"Biomarker, GeneticVariation"
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",1.0,1.0,1.0,0.0,0.0,32019,Pituitary Neoplasms,0.218241699,15,"AlteredExpression, Biomarker, GeneticVariation"
326,AIRE,autoimmune regulator,0.0,1.0,1.0,0.0,0.0,6840,Candidiasis,0.218241699,14,"Biomarker, GeneticVariation"
80271,ITPKC,inositol-trisphosphate 3-kinase C,0.0,1.0,1.0,0.0,0.0,26691,Mucocutaneous Lymph Node Syndrome,0.218241699,13,"Biomarker, GeneticVariation"
2122,MECOM,MDS1 and EVI1 complex locus,0.0,1.0,1.0,0.0,0.0,23470,"Leukemia, Myeloid",0.218221633,30,"Biomarker, GeneticVariation"
2538,G6PC,"glucose-6-phosphatase, catalytic subunit",0.0,1.0,0.0,0.0,0.0,2919796,Hepatorenal form of glycogen storage disease,0.218221633,29,Biomarker
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.218212735,7,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.218212735,7,"Biomarker, GeneticVariation"
2056,EPO,erythropoietin,0.0,1.0,1.0,0.0,1.0,22661,"Kidney Failure, Chronic",0.218192668,21,"Biomarker, GeneticVariation, Therapeutic"
8074,FGF23,fibroblast growth factor 23,0.0,1.0,1.0,0.0,0.0,85681,Hyperphosphatemia,0.218192668,20,"Biomarker, GeneticVariation"
9997,SCO2,SCO2 cytochrome c oxidase assembly protein,0.0,1.0,1.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.218163704,11,"Biomarker, GeneticVariation"
212,ALAS2,5'-aminolevulinate synthase 2,1.0,1.0,1.0,0.0,0.0,2896,"Anemia, Sideroblastic",0.218163704,15,"AlteredExpression, Biomarker, GeneticVariation"
5657,PRTN3,proteinase 3,1.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.218163704,12,"AlteredExpression, Biomarker"
4599,MX1,MX dynamin-like GTPase 1,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.218163704,14,Biomarker
5897,RAG2,recombination activating gene 2,0.0,1.0,1.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.218155462,25,"Biomarker, GeneticVariation"
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",1.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21813474,6,"AlteredExpression, Biomarker, GeneticVariation"
5328,PLAU,"plasminogen activator, urokinase",1.0,1.0,1.0,0.0,0.0,4096,Asthma,0.21813474,5,"AlteredExpression, Biomarker, GeneticVariation"
79444,BIRC7,baculoviral IAP repeat containing 7,1.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21813474,4,"AlteredExpression, Biomarker"
3678,ITGA5,"integrin, alpha 5 (fibronectin receptor, alpha polypeptide)",1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21813474,6,"AlteredExpression, Biomarker"
5594,MAPK1,mitogen-activated protein kinase 1,1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21813474,6,"AlteredExpression, Biomarker"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21813474,6,"AlteredExpression, Biomarker, GeneticVariation"
177,AGER,advanced glycosylation end product-specific receptor,1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21813474,6,"AlteredExpression, Biomarker, GeneticVariation"
7372,UMPS,uridine monophosphate synthetase,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21813474,7,"AlteredExpression, Biomarker"
10395,DLC1,DLC1 Rho GTPase activating protein,1.0,1.0,1.0,1.0,0.0,27651,Neoplasms,0.21813474,6,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
572,BAD,BCL2-associated agonist of cell death,1.0,1.0,0.0,1.0,0.0,33578,Prostatic Neoplasms,0.21813474,6,"AlteredExpression, Biomarker, PostTranslationalModification"
8842,PROM1,prominin 1,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21813474,6,"AlteredExpression, Biomarker"
374,AREG,amphiregulin,1.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21813474,6,"AlteredExpression, Biomarker, Therapeutic"
4854,NOTCH3,notch 3,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21813474,5,"AlteredExpression, Biomarker"
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21813474,6,Biomarker
7001,PRDX2,peroxiredoxin 2,1.0,1.0,0.0,0.0,0.0,13080,Down Syndrome,0.21813474,4,"AlteredExpression, Biomarker"
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.21813474,6,"AlteredExpression, Biomarker, GeneticVariation"
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21813474,6,Biomarker
2212,FCGR2A,"Fc fragment of IgG, low affinity IIa, receptor (CD32)",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.218085221,6,"Biomarker, GeneticVariation"
28,ABO,"ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)",0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.218085221,5,"Biomarker, GeneticVariation"
11262,SP140,SP140 nuclear body protein,1.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.218085221,5,"AlteredExpression, Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.218085221,8,"Biomarker, GeneticVariation"
56606,SLC2A9,"solute carrier family 2 (facilitated glucose transporter), member 9",0.0,1.0,1.0,0.0,0.0,740394,Hyperuricemia,0.218085221,8,"Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,149931,Migraine Disorders,0.218085221,7,"Biomarker, GeneticVariation"
8929,PHOX2B,paired-like homeobox 2b,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.218085221,6,"Biomarker, GeneticVariation"
5126,PCSK2,proprotein convertase subtilisin/kexin type 2,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.218085221,6,"Biomarker, GeneticVariation"
3113,HLA-DPA1,"major histocompatibility complex, class II, DP alpha 1",0.0,1.0,1.0,0.0,0.0,524909,"Hepatitis B, Chronic",0.218085221,6,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,20514,Hyperprolactinemia,0.218085221,6,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,17658,Glomerulonephritis,0.21803619,16,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,2726,Amyloidosis,0.21803619,15,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,0.0,1.0,1.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.21803619,15,"Biomarker, GeneticVariation"
6462,SHBG,sex hormone-binding globulin,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21803619,13,"Biomarker, GeneticVariation"
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.218007226,5,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.218007226,6,"AlteredExpression, Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,34885,Rectal Neoplasms,0.218007226,7,"Biomarker, GeneticVariation"
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,1.0,0.0,0.0,162566,Porphyria Cutanea Tarda,0.218007226,4,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.218007226,6,"Biomarker, GeneticVariation"
5789,PTPRD,"protein tyrosine phosphatase, receptor type, D",0.0,1.0,1.0,0.0,0.0,35258,Restless Legs Syndrome,0.218007226,4,"Biomarker, GeneticVariation"
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",1.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.218007226,8,"AlteredExpression, Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.218007226,4,"Biomarker, GeneticVariation"
5604,MAP2K1,mitogen-activated protein kinase kinase 1,0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.218007226,6,"Biomarker, GeneticVariation"
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,40156,Thyrotoxicosis,0.217958195,13,"Biomarker, GeneticVariation"
176,ACAN,aggrecan,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.217958195,12,"Biomarker, GeneticVariation"
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.217958195,15,"Biomarker, GeneticVariation"
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,268312,"Cholestasis, progressive familial intrahepatic 1",0.217938128,29,Biomarker
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",0.0,1.0,1.0,0.0,0.0,85580,"Hypertension, Essential",0.217938128,28,"Biomarker, GeneticVariation"
2100,ESR2,estrogen receptor 2 (ER beta),1.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.217929231,5,"AlteredExpression, Biomarker, GeneticVariation"
6402,SELL,selectin L,0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.217929231,3,"Biomarker, GeneticVariation"
2272,FHIT,fragile histidine triad,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217929231,4,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,16065,"Fibrous Dysplasia, Polyostotic",0.217929231,7,"Biomarker, GeneticVariation"
25894,PLEKHG4,"pleckstrin homology domain containing, family G (with RhoGef domain) member 4",0.0,1.0,1.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.217929231,5,"Biomarker, GeneticVariation"
6401,SELE,selectin E,0.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.217929231,3,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.217929231,5,"Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.217909164,21,Biomarker
7248,TSC1,tuberous sclerosis 1,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.217909164,19,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,11848,Diabetes Insipidus,0.217909164,22,Biomarker
2178,FANCE,"Fanconi anemia, complementation group E",0.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.2178802,10,Biomarker
2033,EP300,E1A binding protein p300,0.0,1.0,1.0,0.0,0.0,35934,Rubinstein-Taybi Syndrome,0.2178802,10,"Biomarker, GeneticVariation"
1420,CRYGC,"crystallin, gamma C",0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.2178802,12,"Biomarker, GeneticVariation"
2705,GJB1,"gap junction protein, beta 1, 32kDa",1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.2178802,11,"AlteredExpression, Biomarker"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.2178802,13,"AlteredExpression, Biomarker"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.217851236,4,"Biomarker, GeneticVariation"
2272,FHIT,fragile histidine triad,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.217851236,5,"AlteredExpression, Biomarker, GeneticVariation"
1718,DHCR24,24-dehydrocholesterol reductase,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.217851236,5,"Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.217851236,4,"AlteredExpression, Biomarker"
2247,FGF2,fibroblast growth factor 2 (basic),1.0,1.0,0.0,0.0,1.0,23890,Liver Cirrhosis,0.217851236,5,"AlteredExpression, Biomarker, Therapeutic"
2591,GALNT3,polypeptide N-acetylgalactosaminyltransferase 3,0.0,1.0,1.0,0.0,0.0,6663,Calcinosis,0.217851236,5,"Biomarker, GeneticVariation"
153090,DAB2IP,DAB2 interacting protein,1.0,1.0,1.0,1.0,0.0,33578,Prostatic Neoplasms,0.217851236,3,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
2932,GSK3B,glycogen synthase kinase 3 beta,1.0,1.0,0.0,1.0,0.0,33578,Prostatic Neoplasms,0.217851236,5,"AlteredExpression, Biomarker, PostTranslationalModification"
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.217851236,5,"AlteredExpression, Biomarker"
8000,PSCA,prostate stem cell antigen,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.217851236,5,"AlteredExpression, Biomarker"
27173,SLC39A1,"solute carrier family 39 (zinc transporter), member 1",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.217851236,5,"AlteredExpression, Biomarker"
7366,UGT2B15,"UDP glucuronosyltransferase 2 family, polypeptide B15",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217851236,5,"AlteredExpression, Biomarker, GeneticVariation"
463,ZFHX3,zinc finger homeobox 3,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217851236,4,"Biomarker, GeneticVariation"
50943,FOXP3,forkhead box P3,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.217851236,4,"AlteredExpression, Biomarker"
25800,SLC39A6,"solute carrier family 39 (zinc transporter), member 6",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.217851236,5,Biomarker
6926,TBX3,T-box 3,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.217851236,5,"AlteredExpression, Biomarker"
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.217851236,6,"AlteredExpression, Biomarker, GeneticVariation"
868,CBLB,"Cbl proto-oncogene B, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.217801716,5,"Biomarker, GeneticVariation"
22808,MRAS,muscle RAS oncogene homolog,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.217801716,5,"Biomarker, GeneticVariation"
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,1.0,0.0,0.0,37199,Sinusitis,0.217801716,7,"Biomarker, GeneticVariation"
3676,ITGA4,"integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.217801716,4,"Biomarker, GeneticVariation"
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.217801716,7,"Biomarker, GeneticVariation"
2876,GPX1,glutathione peroxidase 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.217801716,6,"Biomarker, GeneticVariation"
84159,ARID5B,AT rich interactive domain 5B (MRF1-like),0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.217801716,6,"Biomarker, GeneticVariation"
1824,DSC2,desmocollin 2,1.0,1.0,1.0,0.0,0.0,349788,Arrhythmogenic Right Ventricular Dysplasia,0.217793474,16,"AlteredExpression, Biomarker, GeneticVariation"
64135,IFIH1,interferon induced with helicase C domain 1,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.217752685,12,"Biomarker, GeneticVariation"
3570,IL6R,interleukin 6 receptor,0.0,1.0,1.0,0.0,1.0,3873,"Arthritis, Rheumatoid",0.217752685,14,"Biomarker, GeneticVariation, Therapeutic"
93986,FOXP2,forkhead box P2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.217752685,12,"Biomarker, GeneticVariation"
10109,ARPC2,"actin related protein 2/3 complex, subunit 2, 34kDa",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.217723721,2,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.217723721,4,"Biomarker, GeneticVariation"
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),1.0,1.0,1.0,0.0,1.0,243026,Sepsis,0.217723721,7,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
4953,ODC1,ornithine decarboxylase 1,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.217723721,6,"AlteredExpression, Biomarker, GeneticVariation"
51752,ERAP1,endoplasmic reticulum aminopeptidase 1,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.217723721,4,"Biomarker, GeneticVariation"
6403,SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.217723721,6,"Biomarker, GeneticVariation"
5621,PRNP,prion protein,0.0,1.0,1.0,0.0,0.0,19202,Hepatolenticular Degeneration,0.217723721,2,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,30305,Pancreatitis,0.217723721,5,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.217723721,3,"Biomarker, GeneticVariation"
197,AHSG,alpha-2-HS-glycoprotein,0.0,1.0,1.0,0.0,0.0,6663,Calcinosis,0.217723721,6,"Biomarker, GeneticVariation"
4193,MDM2,"MDM2 proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217723721,6,"Biomarker, GeneticVariation"
6356,CCL11,chemokine (C-C motif) ligand 11,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.217723721,3,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,1.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.217723721,6,"AlteredExpression, Biomarker, GeneticVariation"
9993,DGCR2,DiGeorge syndrome critical region gene 2,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.217723721,3,"Biomarker, GeneticVariation"
4255,MGMT,O-6-methylguanine-DNA methyltransferase,0.0,1.0,1.0,0.0,0.0,23418,Leukemia,0.217723721,5,"Biomarker, GeneticVariation"
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.217723721,3,"Biomarker, GeneticVariation"
3667,IRS1,insulin receptor substrate 1,0.0,1.0,1.0,0.0,0.0,11849,Diabetes Mellitus,0.217703654,20,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.217703654,19,"Biomarker, GeneticVariation"
4598,MVK,mevalonate kinase,0.0,1.0,1.0,0.0,0.0,342731,Mevalonate Kinase Deficiency,0.217703654,23,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,1.0,22116,Ischemia,0.21767469,12,"Biomarker, GeneticVariation, Therapeutic"
115650,TNFRSF13C,"tumor necrosis factor receptor superfamily, member 13C",0.0,1.0,1.0,0.0,0.0,9447,Common Variable Immunodeficiency,0.21767469,10,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,1.0,0.0,0.0,27708,Wilms Tumor,0.21767469,11,"Biomarker, GeneticVariation"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,1.0,25202,Melanoma,0.217654623,28,"Biomarker, Therapeutic"
7248,TSC1,tuberous sclerosis 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.217654623,28,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.217645726,5,"AlteredExpression, Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,27726,Nephrotic Syndrome,0.217645726,6,"AlteredExpression, Biomarker, GeneticVariation"
472,ATM,ATM serine/threonine kinase,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217645726,4,"AlteredExpression, Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",1.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.217645726,5,"AlteredExpression, Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,1.0,1.0,1.0,0.0,0.0,206624,Hepatoblastoma,0.217625659,19,"AlteredExpression, Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,1.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.217625659,20,"AlteredExpression, Biomarker"
5663,PSEN1,presenilin 1,0.0,1.0,1.0,0.0,0.0,236642,Pick Disease of the Brain,0.217625659,19,"Biomarker, GeneticVariation"
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),1.0,1.0,0.0,0.0,1.0,23903,Liver Neoplasms,0.217625659,20,"AlteredExpression, Biomarker, Therapeutic"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.217625659,20,Biomarker
7124,TNF,tumor necrosis factor,1.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.217596695,12,"AlteredExpression, Biomarker"
1727,CYB5R3,cytochrome b5 reductase 3,1.0,1.0,1.0,0.0,0.0,25637,Methemoglobinemia,0.217596695,12,"AlteredExpression, Biomarker, GeneticVariation"
3958,LGALS3,"lectin, galactoside-binding, soluble, 3",1.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.217596695,11,"AlteredExpression, Biomarker"
7424,VEGFC,vascular endothelial growth factor C,1.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.217596695,11,"AlteredExpression, Biomarker"
5256,PHKA2,"phosphorylase kinase, alpha 2 (liver)",0.0,1.0,1.0,0.0,0.0,17919,Glycogen Storage Disease,0.217596695,10,"Biomarker, GeneticVariation"
8671,SLC4A4,"solute carrier family 4 (sodium bicarbonate cotransporter), member 4",0.0,1.0,1.0,0.0,0.0,1126,"Acidosis, Renal Tubular",0.217567731,3,"Biomarker, GeneticVariation"
5594,MAPK1,mitogen-activated protein kinase 1,1.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.217567731,4,"AlteredExpression, Biomarker, PostTranslationalModification"
5621,PRNP,prion protein,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.217567731,4,"AlteredExpression, Biomarker, GeneticVariation"
332,BIRC5,baculoviral IAP repeat containing 5,1.0,1.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.217567731,7,"AlteredExpression, Biomarker, Therapeutic"
10381,TUBB3,"tubulin, beta 3 class III",0.0,1.0,0.0,1.0,0.0,919267,Ovarian Neoplasms,0.217567731,3,"Biomarker, PostTranslationalModification"
2623,GATA1,GATA binding protein 1 (globin transcription factor 1),0.0,1.0,1.0,0.0,0.0,40034,Thrombocytopenia,0.217567731,4,"Biomarker, GeneticVariation"
1647,GADD45A,"growth arrest and DNA-damage-inducible, alpha",1.0,1.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.217567731,4,"AlteredExpression, Biomarker, Therapeutic"
8829,NRP1,neuropilin 1,1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.217567731,3,"AlteredExpression, Biomarker"
8313,AXIN2,axin 2,0.0,1.0,1.0,1.0,0.0,9404,Colorectal Neoplasms,0.217567731,3,"Biomarker, GeneticVariation, PostTranslationalModification"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,1.0,0.0,0.0,27746,Nerve Degeneration,0.217567731,5,"Biomarker, GeneticVariation"
3397,ID1,"inhibitor of DNA binding 1, dominant negative helix-loop-helix protein",1.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.217567731,4,"AlteredExpression, Biomarker"
8754,ADAM9,ADAM metallopeptidase domain 9,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.217567731,3,"AlteredExpression, Biomarker"
2264,FGFR4,fibroblast growth factor receptor 4,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217567731,3,"Biomarker, GeneticVariation"
3667,IRS1,insulin receptor substrate 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217567731,3,"Biomarker, GeneticVariation"
25818,KLK5,kallikrein-related peptidase 5,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217567731,3,"AlteredExpression, Biomarker, GeneticVariation"
5329,PLAUR,"plasminogen activator, urokinase receptor",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.217567731,4,"AlteredExpression, Biomarker"
8412,BCAR3,breast cancer anti-estrogen resistance 3,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.217567731,4,"AlteredExpression, Biomarker"
3488,IGFBP5,insulin-like growth factor binding protein 5,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.217567731,4,"AlteredExpression, Biomarker, GeneticVariation"
182,JAG1,jagged 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.217567731,4,"AlteredExpression, Biomarker"
3875,KRT18,"keratin 18, type I",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.217567731,4,"AlteredExpression, Biomarker"
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.217567731,3,"AlteredExpression, Biomarker"
2074,ERCC6,excision repair cross-complementation group 6,1.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.217567731,3,"AlteredExpression, Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,35242,Respiratory Tract Diseases,0.217518212,6,"Biomarker, GeneticVariation"
8613,PPAP2B,phosphatidic acid phosphatase type 2B,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.217518212,5,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,35235,Respiratory Syncytial Virus Infections,0.217518212,6,"Biomarker, GeneticVariation"
6470,SHMT1,serine hydroxymethyltransferase 1 (soluble),0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.217518212,5,"Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.217518212,5,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,26896,Myasthenia Gravis,0.217518212,7,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,41466,Typhoid Fever,0.217518212,4,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.217518212,6,"Biomarker, GeneticVariation"
114904,C1QTNF6,C1q and tumor necrosis factor related protein 6,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.217518212,5,"Biomarker, GeneticVariation"
246778,IL27,interleukin 27,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.217518212,5,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,23470,"Leukemia, Myeloid",0.217518212,5,"Biomarker, GeneticVariation"
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.217518212,5,"Biomarker, GeneticVariation"
1581,CYP7A1,"cytochrome P450, family 7, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,1.0,20443,Hypercholesterolemia,0.217518212,6,"Biomarker, GeneticVariation, Therapeutic"
3574,IL7,interleukin 7,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.217469181,11,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,28756,"Obesity, Morbid",0.217469181,13,"Biomarker, GeneticVariation"
135138,PACRG,PARK2 co-regulated,0.0,1.0,1.0,0.0,0.0,23343,Leprosy,0.217469181,10,"Biomarker, GeneticVariation"
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,1.0,0.0,0.0,23343,Leprosy,0.217469181,10,"Biomarker, GeneticVariation"
80339,PNPLA3,patatin-like phospholipase domain containing 3,0.0,1.0,1.0,0.0,0.0,23896,"Liver Diseases, Alcoholic",0.217469181,10,"Biomarker, GeneticVariation"
54664,TMEM106B,transmembrane protein 106B,0.0,1.0,1.0,0.0,0.0,751072,Frontotemporal Lobar Degeneration,0.217469181,11,"Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,0.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.217469181,12,"Biomarker, GeneticVariation"
1584,CYP11B1,"cytochrome P450, family 11, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,20428,Hyperaldosteronism,0.217440217,5,"Biomarker, GeneticVariation"
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.217440217,2,"Biomarker, GeneticVariation"
2558,GABRA5,"gamma-aminobutyric acid (GABA) A receptor, alpha 5",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.217440217,4,"Biomarker, GeneticVariation"
4049,LTA,lymphotoxin alpha,0.0,1.0,1.0,0.0,0.0,3872,"Arthritis, Psoriatic",0.217440217,3,"Biomarker, GeneticVariation"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.217440217,4,"Biomarker, GeneticVariation"
6218,RPS17,ribosomal protein S17,0.0,1.0,1.0,0.0,0.0,1260899,"Anemia, Diamond-Blackfan",0.217391186,9,"Biomarker, GeneticVariation"
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.217391186,10,"Biomarker, GeneticVariation"
5521,PPP2R2B,"protein phosphatase 2, regulatory subunit B, beta",0.0,1.0,1.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.217391186,12,"Biomarker, GeneticVariation"
875,CBS,cystathionine-beta-synthase,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.217391186,10,"Biomarker, GeneticVariation"
6352,CCL5,chemokine (C-C motif) ligand 5,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.217391186,10,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,0.0,1.0,1.0,0.0,0.0,31511,Pheochromocytoma,0.217391186,11,"Biomarker, GeneticVariation"
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,19243,"Angioedemas, Hereditary",0.217371119,27,Biomarker
6663,SOX10,SRY (sex determining region Y)-box 10,0.0,1.0,1.0,0.0,0.0,1848519,"Waardenburg syndrome, type 4",0.217371119,26,"Biomarker, GeneticVariation"
25978,CHMP2B,charged multivesicular body protein 2B,0.0,1.0,0.0,0.0,0.0,338451,Frontotemporal Dementia,0.217371119,26,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.217371119,26,"Biomarker, GeneticVariation"
8013,NR4A3,"nuclear receptor subfamily 4, group A, member 3",0.0,1.0,1.0,0.0,0.0,1275278,"Chondrosarcoma, Extraskeletal Myxoid",0.217371119,26,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.217371119,27,Biomarker
11093,ADAMTS13,"ADAM metallopeptidase with thrombospondin type 1 motif, 13",0.0,1.0,0.0,0.0,0.0,2717961,Thrombotic Microangiopathies,0.217371119,28,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.217362222,2,"Biomarker, GeneticVariation"
7372,UMPS,uridine monophosphate synthetase,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.217362222,6,"AlteredExpression, Biomarker, GeneticVariation"
167691,LCA5,Leber congenital amaurosis 5,0.0,1.0,1.0,0.0,0.0,456909,Blindness,0.217362222,3,"Biomarker, GeneticVariation"
5627,PROS1,protein S (alpha),1.0,1.0,1.0,0.0,0.0,600433,Activated Protein C Resistance,0.217362222,4,"AlteredExpression, Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.217362222,4,"AlteredExpression, Biomarker, GeneticVariation"
54205,CYCS,"cytochrome c, somatic",0.0,1.0,1.0,0.0,0.0,40034,Thrombocytopenia,0.217362222,2,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.217362222,4,"AlteredExpression, Biomarker, GeneticVariation"
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.217362222,3,"Biomarker, GeneticVariation"
3486,IGFBP3,insulin-like growth factor binding protein 3,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.217362222,4,"Biomarker, GeneticVariation"
7507,XPA,"xeroderma pigmentosum, complementation group A",0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.217362222,2,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,20507,Hyperplasia,0.217362222,4,"Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217362222,4,"AlteredExpression, Biomarker, GeneticVariation"
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.217362222,4,"Biomarker, GeneticVariation"
7163,TPD52,tumor protein D52,1.0,0.0,1.0,0.0,1.0,33578,Prostatic Neoplasms,0.217362222,3,"AlteredExpression, GeneticVariation, Therapeutic"
846,CASR,calcium-sensing receptor,1.0,1.0,1.0,0.0,0.0,20598,Hypocalcemia,0.217362222,5,"AlteredExpression, Biomarker, GeneticVariation"
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.217362222,4,"AlteredExpression, Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.217362222,4,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.217362222,5,"Biomarker, GeneticVariation"
5327,PLAT,"plasminogen activator, tissue",1.0,1.0,1.0,0.0,1.0,40053,Thrombosis,0.217362222,7,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5627,PROS1,protein S (alpha),0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.217362222,4,"Biomarker, GeneticVariation"
6403,SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.217362222,4,"Biomarker, GeneticVariation"
1535,CYBA,"cytochrome b-245, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,18203,"Granulomatous Disease, Chronic",0.217342155,18,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,1.0,0.0,1.0,22116,Ischemia,0.217342155,18,"Biomarker, GeneticVariation, Therapeutic"
2321,FLT1,fms-related tyrosine kinase 1,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.217342155,19,"AlteredExpression, Biomarker"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,1.0,23418,Leukemia,0.217342155,18,"Biomarker, Therapeutic"
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,243026,Sepsis,0.217313191,11,"Biomarker, Therapeutic"
3725,JUN,jun proto-oncogene,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.217313191,11,"AlteredExpression, Biomarker"
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,1.0,0.0,0.0,42875,Vitamin E Deficiency,0.217313191,11,"Biomarker, GeneticVariation"
5328,PLAU,"plasminogen activator, urokinase",1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.217313191,10,"AlteredExpression, Biomarker"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.217313191,14,"AlteredExpression, Biomarker"
1123,CHN1,chimerin 1,0.0,1.0,1.0,0.0,0.0,13261,Duane Retraction Syndrome,0.217313191,8,"Biomarker, GeneticVariation"
6834,SURF1,surfeit 1,0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.217284882,35,"Biomarker, GeneticVariation"
64240,ABCG5,"ATP-binding cassette, sub-family G (WHITE), member 5",0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.217234707,4,"Biomarker, GeneticVariation"
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.217234707,4,"Biomarker, GeneticVariation"
3912,LAMB1,"laminin, beta 1",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.217234707,4,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,1.0,4153,Atherosclerosis,0.217234707,6,"Biomarker, GeneticVariation, Therapeutic"
1577,CYP3A5,"cytochrome P450, family 3, subfamily A, polypeptide 5",0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.217234707,5,"Biomarker, GeneticVariation"
875,CBS,cystathionine-beta-synthase,0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.217234707,3,"Biomarker, GeneticVariation"
55289,ACOXL,acyl-CoA oxidase-like,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.217234707,4,"Biomarker, GeneticVariation"
1071,CETP,"cholesteryl ester transfer protein, plasma",0.0,1.0,1.0,0.0,0.0,20476,Hyperlipoproteinemias,0.217234707,6,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.217234707,3,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,1.0,26640,Mouth Neoplasms,0.217234707,6,"Biomarker, GeneticVariation, Therapeutic"
4254,KITLG,KIT ligand,0.0,1.0,1.0,0.0,0.0,39590,Testicular Neoplasms,0.217234707,4,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,27947,Neutropenia,0.217234707,5,"Biomarker, GeneticVariation"
4507,MTAP,methylthioadenosine phosphorylase,0.0,1.0,1.0,0.0,0.0,27960,Nevus,0.217234707,4,"Biomarker, GeneticVariation"
169792,GLIS3,GLIS family zinc finger 3,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.217234707,4,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,29458,"Osteoporosis, Postmenopausal",0.217234707,5,"Biomarker, GeneticVariation"
3107,HLA-C,"major histocompatibility complex, class I, C",0.0,1.0,1.0,0.0,0.0,524909,"Hepatitis B, Chronic",0.217234707,4,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.217234707,5,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,34069,Pulmonary Fibrosis,0.217185676,13,"Biomarker, GeneticVariation"
6948,TCN2,transcobalamin II,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.217156712,3,"Biomarker, GeneticVariation"
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),1.0,0.0,1.0,0.0,1.0,19080,Hemorrhage,0.217156712,6,"AlteredExpression, GeneticVariation, Therapeutic"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,5138,Berylliosis,0.217156712,2,"Biomarker, GeneticVariation"
9429,ABCG2,"ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.217156712,5,"Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.217156712,4,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,33687,Proteinuria,0.217156712,4,"Biomarker, GeneticVariation"
7299,TYR,tyrosinase,0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.217156712,2,"Biomarker, GeneticVariation"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.217156712,2,"Biomarker, GeneticVariation"
9132,KCNQ4,"potassium channel, voltage gated KQT-like subfamily Q, member 4",0.0,1.0,1.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.217156712,2,"Biomarker, GeneticVariation"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.217156712,4,"Biomarker, GeneticVariation"
54106,TLR9,toll-like receptor 9,0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.217156712,4,"Biomarker, GeneticVariation"
3952,LEP,leptin,0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.217156712,4,"Biomarker, GeneticVariation"
5888,RAD51,RAD51 recombinase,1.0,1.0,1.0,0.0,0.0,18671,Head and Neck Neoplasms,0.217156712,4,"AlteredExpression, Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.217156712,4,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.217156712,3,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.217156712,3,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,948480,Coronary Restenosis,0.217156712,3,"Biomarker, GeneticVariation"
3269,HRH1,histamine receptor H1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.217156712,4,"Biomarker, GeneticVariation"
5376,PMP22,peripheral myelin protein 22,1.0,1.0,1.0,0.0,0.0,27888,Hereditary Sensory and Motor Neuropathy,0.217136645,19,"AlteredExpression, Biomarker, GeneticVariation"
3439,IFNA1,"interferon, alpha 1",0.0,1.0,1.0,0.0,1.0,23890,Liver Cirrhosis,0.217136645,19,"Biomarker, GeneticVariation, Therapeutic"
2641,GCG,glucagon,0.0,1.0,1.0,0.0,1.0,28754,Obesity,0.217136645,19,"Biomarker, GeneticVariation, Therapeutic"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.217136645,19,"Biomarker, GeneticVariation"
337,APOA4,apolipoprotein A-IV,0.0,1.0,1.0,0.0,1.0,4153,Atherosclerosis,0.217107681,10,"Biomarker, GeneticVariation, Therapeutic"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.217107681,9,"Biomarker, GeneticVariation"
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.217107681,10,"Biomarker, GeneticVariation"
2746,GLUD1,glutamate dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,20459,Hyperinsulinism,0.217107681,9,"Biomarker, GeneticVariation"
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.217107681,8,"Biomarker, GeneticVariation"
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",1.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.217107681,11,"AlteredExpression, Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.217087614,26,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.217087614,27,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.217087614,36,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,1.0,3469,Anxiety Disorders,0.217087614,26,"Biomarker, Therapeutic"
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.217087614,26,"Biomarker, Therapeutic"
2776,GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",0.0,1.0,1.0,0.0,0.0,220633,Uveal melanoma,0.217087614,25,"Biomarker, GeneticVariation"
3853,KRT6A,"keratin 6A, type II",0.0,1.0,1.0,0.0,0.0,265334,Pachyonychia Congenita,0.21705865,17,"Biomarker, GeneticVariation"
57697,FANCM,"Fanconi anemia, complementation group M",1.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.21705865,16,"AlteredExpression, Biomarker"
7957,EPM2A,"epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)",0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.21705865,17,Biomarker
5191,PEX7,peroxisomal biogenesis factor 7,1.0,1.0,1.0,0.0,0.0,282529,"Chondrodysplasia Punctata, Rhizomelic",0.21705865,16,"AlteredExpression, Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,206677,Adenomatous Polyps,0.21705865,17,"Biomarker, GeneticVariation"
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,1.0,1.0,1.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.217029686,9,"AlteredExpression, Biomarker, GeneticVariation"
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",1.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.217029686,10,"AlteredExpression, Biomarker"
6752,SSTR2,somatostatin receptor 2,0.0,1.0,0.0,0.0,0.0,206754,Neuroendocrine Tumors,0.217029686,9,Biomarker
1508,CTSB,cathepsin B,1.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.217029686,8,"AlteredExpression, Biomarker"
7020,TFAP2A,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha),1.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.217029686,9,"AlteredExpression, Biomarker, Therapeutic"
2810,SFN,stratifin,1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.217029686,8,"AlteredExpression, Biomarker"
6324,SCN1B,"sodium channel, voltage gated, type I beta subunit",0.0,1.0,1.0,0.0,0.0,9952,"Seizures, Febrile",0.217029686,9,"Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.217029686,10,Biomarker
6535,SLC6A8,"solute carrier family 6 (neurotransmitter transporter), member 8",0.0,1.0,1.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.217029686,8,"Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,0.0,1.0,1.0,0.0,0.0,1862596,"Hypobetalipoproteinemia, Familial",0.217010274,60,"Biomarker, GeneticVariation"
375611,SLC26A5,"solute carrier family 26 (anion exchanger), member 5",0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.216951203,4,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.216951203,4,"Biomarker, GeneticVariation"
328,APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.216951203,4,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,0.0,20523,"Hypersensitivity, Immediate",0.216951203,5,"Biomarker, GeneticVariation"
3791,KDR,kinase insert domain receptor,0.0,1.0,1.0,0.0,0.0,27686,"Neovascularization, Pathologic",0.216951203,4,"Biomarker, GeneticVariation"
57412,AS3MT,arsenite methyltransferase,0.0,0.0,1.0,0.0,1.0,311375,Arsenic Poisoning,0.216951203,4,"GeneticVariation, Therapeutic"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,40034,Thrombocytopenia,0.216951203,3,"Biomarker, GeneticVariation"
28,ABO,"ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)",0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.216951203,3,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,0.0,1.0,0.0,1.0,26766,Multiple Organ Failure,0.216951203,4,"GeneticVariation, Therapeutic"
2876,GPX1,glutathione peroxidase 1,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.216951203,4,"Biomarker, GeneticVariation"
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.216951203,4,"Biomarker, GeneticVariation"
3596,IL13,interleukin 13,0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.216951203,4,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.216951203,5,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.216951203,4,"Biomarker, GeneticVariation"
3592,IL12A,interleukin 12A,0.0,1.0,1.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.216951203,3,"Biomarker, GeneticVariation"
6356,CCL11,chemokine (C-C motif) ligand 11,0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.216951203,4,"Biomarker, GeneticVariation"
434,ASIP,agouti signaling protein,0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.216951203,3,"Biomarker, GeneticVariation"
7299,TYR,tyrosinase,0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.216951203,3,"Biomarker, GeneticVariation"
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.216951203,4,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.216951203,4,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,0.0,1.0,0.0,1.0,333641,Atrophy,0.216951203,4,"GeneticVariation, Therapeutic"
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,1.0,0.0,0.0,35455,Rhinitis,0.216951203,4,"Biomarker, GeneticVariation"
2693,GHSR,growth hormone secretagogue receptor,0.0,0.0,1.0,0.0,1.0,1973,Alcoholism,0.216951203,4,"GeneticVariation, Therapeutic"
5588,PRKCQ,"protein kinase C, theta",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.216951203,3,"Biomarker, GeneticVariation"
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,1.0,0.0,0.0,1861172,Venous Thromboembolism,0.216951203,4,"Biomarker, GeneticVariation"
2580,GAK,cyclin G associated kinase,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.216951203,3,"Biomarker, GeneticVariation"
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.216951203,5,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.216951203,4,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.216951203,4,"Biomarker, GeneticVariation"
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.216951203,4,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,948480,Coronary Restenosis,0.216951203,3,"Biomarker, GeneticVariation"
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,1.0,0.0,0.0,31347,Pharyngeal Neoplasms,0.216951203,4,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,20544,"Hypertension, Renal",0.216951203,4,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,7273,Carotid Artery Diseases,0.216951203,3,"Biomarker, GeneticVariation"
6387,CXCL12,chemokine (C-X-C motif) ligand 12,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.216902172,11,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,162872,"Aortic Aneurysm, Thoracic",0.216902172,10,"Biomarker, GeneticVariation"
3704,ITPA,inosine triphosphatase (nucleoside triphosphate pyrophosphatase),0.0,1.0,1.0,0.0,1.0,2878,"Anemia, Hemolytic",0.216902172,9,"Biomarker, GeneticVariation, Therapeutic"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,1.0,0.0,1.0,20473,Hyperlipidemias,0.216902172,11,"Biomarker, GeneticVariation, Therapeutic"
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,1.0,0.0,0.0,18799,Heart Diseases,0.216902172,10,"Biomarker, GeneticVariation"
1394,CRHR1,corticotropin releasing hormone receptor 1,0.0,1.0,1.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.216902172,8,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.216902172,11,"Biomarker, GeneticVariation"
1893,ECM1,extracellular matrix protein 1,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.216824177,7,"Biomarker, GeneticVariation"
201163,FLCN,folliculin,0.0,1.0,1.0,0.0,0.0,32326,Pneumothorax,0.216824177,9,"Biomarker, GeneticVariation"
7472,WNT2,wingless-type MMTV integration site family member 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.216824177,7,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,271051,Macular Edema,0.216824177,10,"Biomarker, GeneticVariation"
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,1.0,0.0,0.0,268318,Intrahepatic Cholestasis of Pregnancy,0.21680411,24,"Biomarker, GeneticVariation"
6103,RPGR,retinitis pigmentosa GTPase regulator,0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.216775146,17,Biomarker
57190,SEPN1,"selenoprotein N, 1",0.0,1.0,1.0,0.0,0.0,26850,Muscular Dystrophies,0.216746182,8,"Biomarker, GeneticVariation"
4771,NF2,neurofibromin 2 (merlin),0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.216746182,14,Biomarker
1021,CDK6,cyclin-dependent kinase 6,1.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.216746182,7,"AlteredExpression, Biomarker"
10987,COPS5,COP9 signalosome subunit 5,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.216746182,8,"AlteredExpression, Biomarker"
146059,CDAN1,codanin 1,0.0,1.0,1.0,0.0,0.0,2876,"Anemia, Dyserythropoietic, Congenital",0.216746182,7,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.216746182,9,"AlteredExpression, Biomarker"
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.216746182,9,"Biomarker, GeneticVariation"
8301,PICALM,phosphatidylinositol binding clathrin assembly protein,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.216746182,8,"Biomarker, GeneticVariation"
384,ARG2,arginase 2,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.216618667,7,"Biomarker, GeneticVariation"
5144,PDE4D,"phosphodiesterase 4D, cAMP-specific",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.216618667,9,"Biomarker, GeneticVariation"
4868,NPHS1,"nephrosis 1, congenital, Finnish type (nephrin)",0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.216618667,9,"Biomarker, GeneticVariation"
10347,ABCA7,"ATP-binding cassette, sub-family A (ABC1), member 7",0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.216618667,9,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,3165,Anthracosis,0.216618667,8,"Biomarker, GeneticVariation"
3667,IRS1,insulin receptor substrate 1,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.216618667,9,"Biomarker, GeneticVariation"
7369,UMOD,uromodulin,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.216618667,8,"Biomarker, GeneticVariation"
929,CD14,CD14 molecule,0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.216618667,10,"Biomarker, GeneticVariation"
80339,PNPLA3,patatin-like phospholipase domain containing 3,0.0,1.0,1.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.216618667,7,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.216618667,9,"Biomarker, GeneticVariation"
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.216618667,10,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.216569636,17,"Biomarker, GeneticVariation"
7249,TSC2,tuberous sclerosis 2,0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.216569636,16,"Biomarker, GeneticVariation"
1184,CLCN5,"chloride channel, voltage-sensitive 5",0.0,1.0,1.0,0.0,0.0,878681,Dent Disease,0.216569636,19,"Biomarker, GeneticVariation"
4128,MAOA,monoamine oxidase A,0.0,1.0,1.0,0.0,0.0,3431,Antisocial Personality Disorder,0.216569636,18,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,206698,Cholangiocarcinoma,0.216569636,18,"Biomarker, GeneticVariation"
2110,ETFDH,electron-transferring-flavoprotein dehydrogenase,0.0,1.0,1.0,0.0,0.0,268596,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,0.216569636,16,"Biomarker, GeneticVariation"
799,CALCR,calcitonin receptor,0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.216540672,7,"Biomarker, GeneticVariation"
5083,PAX9,paired box 9,0.0,1.0,1.0,0.0,0.0,399352,Anodontia,0.216540672,8,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,3486,Aortic Aneurysm,0.216540672,9,"Biomarker, GeneticVariation"
7021,TFAP2B,transcription factor AP-2 beta (activating enhancer binding protein 2 beta),0.0,1.0,1.0,0.0,0.0,13274,"Ductus Arteriosus, Patent",0.216540672,8,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,20456,Hyperglycemia,0.216540672,6,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.216520605,25,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,19202,Hepatolenticular Degeneration,0.216520605,24,Biomarker
100,ADA,adenosine deaminase,0.0,1.0,0.0,0.0,0.0,392607,Severe combined immunodeficiency due to adenosine deaminase deficiency,0.216520605,23,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,406704,Ectrodactyly-cleft lip/palate syndrome,0.216520605,24,"Biomarker, GeneticVariation"
3918,LAMC2,"laminin, gamma 2",0.0,1.0,1.0,0.0,0.0,79301,"Epidermolysis Bullosa, Junctional",0.216491641,15,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,0.0,1.0,0.0,262584,"Carcinoma, Small Cell",0.216491641,15,"Biomarker, PostTranslationalModification"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.216491641,15,Biomarker
959,CD40LG,CD40 ligand,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.216491641,16,Biomarker
5015,OTX2,orthodenticle homeobox 2,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.216491641,15,Biomarker
958,CD40,"CD40 molecule, TNF receptor superfamily member 5",0.0,1.0,0.0,0.0,0.0,272236,Hyper-IgM Immunodeficiency Syndrome,0.216491641,14,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,1.0,0.0,0.0,162635,Angelman Syndrome,0.216491641,14,"Biomarker, GeneticVariation"
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,1.0,524851,Neurodegenerative Diseases,0.216491641,15,"Biomarker, Therapeutic"
3934,LCN2,lipocalin 2,0.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.216491641,16,"Biomarker, GeneticVariation"
6591,SNAI2,snail family zinc finger 2,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.216491641,16,"AlteredExpression, Biomarker"
3567,IL5,interleukin 5,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.216491641,15,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,0.0,271694,"Lipodystrophy, Familial Partial",0.216491641,15,"Biomarker, GeneticVariation"
2078,ERG,v-ets avian erythroblastosis virus E26 oncogene homolog,1.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.216491641,15,"AlteredExpression, Biomarker"
8788,DLK1,delta-like 1 homolog (Drosophila),1.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.216462677,6,"AlteredExpression, Biomarker"
2625,GATA3,GATA binding protein 3,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.216462677,7,"AlteredExpression, Biomarker, GeneticVariation"
5745,PTH1R,parathyroid hormone 1 receptor,1.0,1.0,1.0,0.0,0.0,14084,Enchondromatosis,0.216462677,5,"AlteredExpression, Biomarker, GeneticVariation"
3371,TNC,tenascin C,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.216462677,8,Biomarker
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,1.0,0.0,0.0,2878,"Anemia, Hemolytic",0.216462677,6,"Biomarker, GeneticVariation"
23095,KIF1B,kinesin family member 1B,0.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.216462677,7,"Biomarker, GeneticVariation"
196,AHR,aryl hydrocarbon receptor,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.216462677,9,"AlteredExpression, Biomarker"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.216462677,8,"Biomarker, GeneticVariation"
374291,NDUFS7,"NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)",1.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.216462677,5,"AlteredExpression, Biomarker, GeneticVariation"
4056,LTC4S,leukotriene C4 synthase,1.0,1.0,1.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.216335162,11,"AlteredExpression, Biomarker, GeneticVariation"
3172,HNF4A,"hepatocyte nuclear factor 4, alpha",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.216335162,7,"Biomarker, GeneticVariation"
64240,ABCG5,"ATP-binding cassette, sub-family G (WHITE), member 5",0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.216335162,8,"Biomarker, GeneticVariation"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,1.0,0.0,0.0,36202,Sarcoidosis,0.216335162,8,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,23283,"Leishmaniasis, Cutaneous",0.216335162,8,"Biomarker, GeneticVariation"
1490,CTGF,connective tissue growth factor,0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.216335162,9,"Biomarker, GeneticVariation"
3949,LDLR,low density lipoprotein receptor,0.0,1.0,1.0,0.0,0.0,242339,Dyslipidemias,0.216335162,9,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,1565489,Renal Insufficiency,0.216335162,9,"Biomarker, GeneticVariation"
4938,OAS1,"2'-5'-oligoadenylate synthetase 1, 40/46kDa",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.216335162,6,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.216335162,8,"Biomarker, GeneticVariation"
2524,FUT2,fucosyltransferase 2 (secretor status included),0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.216335162,7,"Biomarker, GeneticVariation"
1378,CR1,complement component (3b/4b) receptor 1 (Knops blood group),0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.216335162,8,"Biomarker, GeneticVariation"
6326,SCN2A,"sodium channel, voltage gated, type II alpha subunit",0.0,1.0,1.0,0.0,0.0,9952,"Seizures, Febrile",0.216335162,6,"Biomarker, GeneticVariation"
2334,AFF2,"AF4/FMR2 family, member 2",0.0,1.0,1.0,0.0,0.0,16667,Fragile X Syndrome,0.216286132,15,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,0.0,1.0,1.0,0.0,0.0,206115,WAGR Syndrome,0.216286132,14,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,162871,"Aortic Aneurysm, Abdominal",0.216286132,18,"Biomarker, GeneticVariation"
4891,SLC11A2,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2",0.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.216257167,8,"Biomarker, GeneticVariation"
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,1.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.216257167,7,"Biomarker, GeneticVariation"
4317,MMP8,matrix metallopeptidase 8 (neutrophil collagenase),1.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.216257167,7,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,80178,Spinal Dysraphism,0.216257167,5,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.216257167,10,"Biomarker, GeneticVariation"
27185,DISC1,disrupted in schizophrenia 1,0.0,1.0,1.0,0.0,0.0,236792,Asperger Syndrome,0.216257167,5,"Biomarker, GeneticVariation"
3762,KCNJ5,"potassium channel, inwardly rectifying subfamily J, member 5",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.216237101,24,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.216237101,23,Biomarker
2272,FHIT,fragile histidine triad,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.216237101,23,Biomarker
4193,MDM2,"MDM2 proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.216237101,23,"Biomarker, GeneticVariation"
26291,FGF21,fibroblast growth factor 21,0.0,1.0,0.0,0.0,1.0,28754,Obesity,0.216237101,23,"Biomarker, Therapeutic"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,699791,STOMACH CARCINOMA,0.216237101,22,"Biomarker, GeneticVariation"
196,AHR,aryl hydrocarbon receptor,0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.216237101,23,"Biomarker, GeneticVariation"
4128,MAOA,monoamine oxidase A,0.0,1.0,1.0,0.0,0.0,4936,Mental Disorders,0.216208136,15,"Biomarker, GeneticVariation"
613,BCR,breakpoint cluster region,0.0,1.0,1.0,0.0,0.0,27022,Myeloproliferative Disorders,0.216208136,14,"Biomarker, GeneticVariation"
4583,MUC2,"mucin 2, oligomeric mucus/gel-forming",1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.216208136,15,"AlteredExpression, Biomarker"
2260,FGFR1,fibroblast growth factor receptor 1,1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.216208136,14,"AlteredExpression, Biomarker"
5241,PGR,progesterone receptor,1.0,1.0,0.0,0.0,0.0,25286,Meningioma,0.216208136,16,"AlteredExpression, Biomarker"
3458,IFNG,"interferon, gamma",1.0,1.0,1.0,0.0,0.0,23281,Leishmaniasis,0.216179172,8,"AlteredExpression, Biomarker, GeneticVariation"
2162,F13A1,"coagulation factor XIII, A1 polypeptide",0.0,1.0,1.0,0.0,0.0,15530,Factor XIII Deficiency,0.216179172,6,"Biomarker, GeneticVariation"
23236,PLCB1,"phospholipase C, beta 1 (phosphoinositide-specific)",0.0,1.0,1.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.216179172,7,"Biomarker, GeneticVariation"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,1.0,0.0,5695,Urinary Bladder Neoplasms,0.216179172,6,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
332,BIRC5,baculoviral IAP repeat containing 5,1.0,1.0,1.0,0.0,1.0,7134,"Carcinoma, Renal Cell",0.216179172,7,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3934,LCN2,lipocalin 2,1.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.216179172,9,"AlteredExpression, Biomarker"
7099,TLR4,toll-like receptor 4,1.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.216179172,7,"AlteredExpression, Biomarker, GeneticVariation"
2984,GUCY2C,guanylate cyclase 2C,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.216179172,6,"AlteredExpression, Biomarker"
7273,TTN,titin,0.0,1.0,1.0,0.0,0.0,751336,Distal Myopathies,0.216179172,5,"Biomarker, GeneticVariation"
2182,ACSL4,acyl-CoA synthetase long-chain family member 4,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.216179172,6,"AlteredExpression, Biomarker"
3491,CYR61,"cysteine-rich, angiogenic inducer, 61",1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.216179172,5,"AlteredExpression, Biomarker"
3294,HSD17B2,hydroxysteroid (17-beta) dehydrogenase 2,1.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.216179172,7,"AlteredExpression, Biomarker"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,34013,"Puberty, Precocious",0.216179172,7,"Biomarker, GeneticVariation"
3315,HSPB1,heat shock 27kDa protein 1,1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.216179172,7,"AlteredExpression, Biomarker"
1719,DHFR,dihydrofolate reductase,1.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.216179172,5,"AlteredExpression, Biomarker"
23592,LEMD3,LEM domain containing 3,0.0,1.0,1.0,0.0,0.0,25239,Melorheostosis,0.216179172,4,"Biomarker, GeneticVariation"
1829,DSG2,desmoglein 2,0.0,1.0,1.0,0.0,0.0,349788,Arrhythmogenic Right Ventricular Dysplasia,0.216121411,21,"Biomarker, GeneticVariation"
10111,RAD50,RAD50 homolog (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.216051658,6,"Biomarker, GeneticVariation"
118429,ANTXR2,anthrax toxin receptor 2,0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.216051658,6,"Biomarker, GeneticVariation"
311,ANXA11,annexin A11,0.0,1.0,1.0,0.0,0.0,36202,Sarcoidosis,0.216051658,6,"Biomarker, GeneticVariation"
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.216051658,7,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.216051658,8,"Biomarker, GeneticVariation"
7804,LRP8,"low density lipoprotein receptor-related protein 8, apolipoprotein e receptor",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.216051658,5,"Biomarker, GeneticVariation"
23025,UNC13A,unc-13 homolog A (C. elegans),0.0,1.0,1.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.216051658,7,"Biomarker, GeneticVariation"
9732,DOCK4,dedicator of cytokinesis 4,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.216051658,5,"Biomarker, GeneticVariation"
2739,GLO1,glyoxalase I,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.216051658,5,"Biomarker, GeneticVariation"
4889,NPY5R,neuropeptide Y receptor Y5,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.216051658,6,"Biomarker, GeneticVariation"
10758,TRAF3IP2,TRAF3 interacting protein 2,0.0,1.0,1.0,0.0,0.0,3872,"Arthritis, Psoriatic",0.216051658,5,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,2895,"Anemia, Sickle Cell",0.216051658,6,"Biomarker, GeneticVariation"
7412,VCAM1,vascular cell adhesion molecule 1,1.0,1.0,1.0,0.0,0.0,2895,"Anemia, Sickle Cell",0.216051658,8,"AlteredExpression, Biomarker, GeneticVariation"
5981,RFC1,"replication factor C (activator 1) 1, 145kDa",0.0,1.0,1.0,0.0,0.0,29463,Osteosarcoma,0.216051658,6,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,7785,Cerebral Infarction,0.216051658,7,"Biomarker, GeneticVariation"
4792,NFKBIA,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",0.0,1.0,1.0,0.0,0.0,19829,Hodgkin Disease,0.216051658,5,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,22116,Ischemia,0.216002627,15,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,0.0,4364,Autoimmune Diseases,0.216002627,17,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.216002627,15,"Biomarker, GeneticVariation"
472,ATM,ATM serine/threonine kinase,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.216002627,14,"Biomarker, GeneticVariation"
79001,VKORC1,"vitamin K epoxide reductase complex, subunit 1",0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.215973663,5,"Biomarker, GeneticVariation"
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,1.0,0.0,1.0,4153,Atherosclerosis,0.215973663,7,"Biomarker, GeneticVariation, Therapeutic"
5447,POR,P450 (cytochrome) oxidoreductase,0.0,1.0,1.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.215973663,7,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,17658,Glomerulonephritis,0.215973663,7,"Biomarker, GeneticVariation"
55748,CNDP2,CNDP dipeptidase 2 (metallopeptidase M20 family),0.0,1.0,1.0,0.0,0.0,11881,Diabetic Nephropathies,0.215973663,4,"Biomarker, GeneticVariation"
3856,KRT8,"keratin 8, type II",0.0,1.0,1.0,0.0,1.0,23890,Liver Cirrhosis,0.215973663,6,"Biomarker, GeneticVariation, Therapeutic"
9947,MAGEC1,melanoma antigen family C1,1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.215973663,6,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,4698,Balkan Nephropathy,0.215973663,5,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.215973663,6,"Biomarker, GeneticVariation"
30835,CD209,CD209 molecule,0.0,1.0,1.0,0.0,0.0,41327,"Tuberculosis, Pulmonary",0.215973663,6,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.215973663,5,"Biomarker, GeneticVariation"
123016,TTC8,tetratricopeptide repeat domain 8,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.215973663,5,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,35305,Retinal Detachment,0.215973663,5,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.215973663,5,"Biomarker, GeneticVariation"
23495,TNFRSF13B,"tumor necrosis factor receptor superfamily, member 13B",1.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.215973663,7,"AlteredExpression, Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,42510,Ventricular Fibrillation,0.215965421,18,"Biomarker, GeneticVariation"
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.215953596,21,"Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,0.0,1.0,1.0,0.0,0.0,35412,Rhabdomyosarcoma,0.215953596,21,"Biomarker, GeneticVariation"
121278,TPH2,tryptophan hydroxylase 2,0.0,1.0,1.0,0.0,0.0,11581,Depressive Disorder,0.215953596,22,"Biomarker, GeneticVariation"
2010,EMD,emerin,0.0,1.0,1.0,0.0,0.0,751337,Scapuloperoneal muscular dystrophy,0.215953596,23,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.215953596,22,Biomarker
6598,SMARCB1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",0.0,1.0,0.0,0.0,0.0,1335929,Schwannomatosis,0.215953596,22,Biomarker
23451,SF3B1,"splicing factor 3b, subunit 1, 155kDa",0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.215953596,21,Biomarker
859,CAV3,caveolin 3,0.0,1.0,1.0,0.0,0.0,1838254,"Rippling muscle disease, 1",0.215953596,21,"Biomarker, GeneticVariation"
4143,MAT1A,"methionine adenosyltransferase I, alpha",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.215953596,22,Biomarker
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",0.0,1.0,0.0,0.0,0.0,162635,Angelman Syndrome,0.215953596,22,Biomarker
4830,NME1,NME/NM23 nucleoside diphosphate kinase 1,0.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.215953596,21,"Biomarker, GeneticVariation"
859,CAV3,caveolin 3,0.0,1.0,1.0,0.0,0.0,1853698,Rippling muscle disease,0.215953596,21,"Biomarker, GeneticVariation"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,349639,"Leukemia, Myelomonocytic, Juvenile",0.215953596,21,Biomarker
5320,PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid)",1.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.215924632,14,"AlteredExpression, Biomarker"
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,1.0,0.0,0.0,23448,"Leukemia, Lymphoid",0.215924632,14,"Biomarker, GeneticVariation"
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),1.0,1.0,0.0,0.0,1.0,23890,Liver Cirrhosis,0.215924632,14,"AlteredExpression, Biomarker, Therapeutic"
9021,SOCS3,suppressor of cytokine signaling 3,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.215924632,13,"AlteredExpression, Biomarker"
3569,IL6,interleukin 6,1.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.215924632,12,"AlteredExpression, Biomarker"
407035,MIR31,microRNA 31,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.215924632,14,Biomarker
2707,GJB3,"gap junction protein, beta 3, 31kDa",0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.215924632,13,"Biomarker, GeneticVariation"
30061,SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1",1.0,1.0,1.0,0.0,0.0,2871,Anemia,0.215895668,4,"AlteredExpression, Biomarker, GeneticVariation"
1471,CST3,cystatin C,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.215895668,7,Biomarker
7430,EZR,ezrin,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.215895668,6,"AlteredExpression, Biomarker"
5328,PLAU,"plasminogen activator, urokinase",1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.215895668,5,"AlteredExpression, Biomarker"
22914,KLRK1,"killer cell lectin-like receptor subfamily K, member 1",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.215895668,6,Biomarker
3934,LCN2,lipocalin 2,0.0,1.0,0.0,0.0,1.0,27651,Neoplasms,0.215895668,6,"Biomarker, Therapeutic"
796,CALCA,calcitonin-related polypeptide alpha,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215895668,5,"AlteredExpression, Biomarker"
5443,POMC,proopiomelanocortin,1.0,1.0,0.0,0.0,0.0,221406,Pituitary ACTH Hypersecretion,0.215895668,4,"AlteredExpression, Biomarker"
10232,MSLN,mesothelin,1.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.215895668,5,"AlteredExpression, Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.215895668,8,"AlteredExpression, Biomarker"
55294,FBXW7,"F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase",1.0,1.0,0.0,0.0,0.0,17638,Glioma,0.215895668,3,"AlteredExpression, Biomarker"
3856,KRT8,"keratin 8, type II",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215895668,5,"AlteredExpression, Biomarker"
5594,MAPK1,mitogen-activated protein kinase 1,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.215895668,7,"AlteredExpression, Biomarker"
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.215895668,6,"AlteredExpression, Biomarker"
3858,KRT10,"keratin 10, type I",1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.215895668,6,"AlteredExpression, Biomarker"
8792,TNFRSF11A,"tumor necrosis factor receptor superfamily, member 11a, NFKB activator",1.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.215895668,4,"AlteredExpression, Biomarker"
11168,PSIP1,PC4 and SFRS1 interacting protein 1,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.215895668,6,"AlteredExpression, Biomarker, GeneticVariation"
8837,CFLAR,CASP8 and FADD-like apoptosis regulator,1.0,1.0,0.0,0.0,0.0,19829,Hodgkin Disease,0.215895668,4,"AlteredExpression, Biomarker"
6775,STAT4,signal transducer and activator of transcription 4,0.0,1.0,1.0,0.0,0.0,4943,Behcet Syndrome,0.215768153,6,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,2871,Anemia,0.215768153,5,"Biomarker, GeneticVariation"
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.215768153,5,"Biomarker, GeneticVariation"
10320,IKZF1,IKAROS family zinc finger 1 (Ikaros),0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.215768153,6,"Biomarker, GeneticVariation"
11173,ADAMTS7,"ADAM metallopeptidase with thrombospondin type 1 motif, 7",0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.215768153,6,"Biomarker, GeneticVariation"
117289,TAGAP,T-cell activation RhoGTPase activating protein,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.215768153,8,"Biomarker, GeneticVariation"
7189,TRAF6,"TNF receptor-associated factor 6, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.215768153,8,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,25312,Meningomyelocele,0.215768153,6,"Biomarker, GeneticVariation"
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.215768153,7,"Biomarker, GeneticVariation"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.215768153,6,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,8149,Chlamydia Infections,0.215768153,7,"Biomarker, GeneticVariation"
55905,RNF114,ring finger protein 114,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.215768153,6,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,24301,"Lymphoma, Follicular",0.215768153,5,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,1.0,27051,Myocardial Infarction,0.215768153,8,"Biomarker, GeneticVariation, Therapeutic"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215768153,5,"Biomarker, GeneticVariation"
5727,PTCH1,patched 1,0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.215768153,6,"Biomarker, GeneticVariation"
64135,IFIH1,interferon induced with helicase C domain 1,0.0,1.0,1.0,0.0,0.0,18213,Graves Disease,0.215768153,4,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.215768153,5,"Biomarker, GeneticVariation"
2212,FCGR2A,"Fc fragment of IgG, low affinity IIa, receptor (CD32)",0.0,1.0,1.0,0.0,0.0,26691,Mucocutaneous Lymph Node Syndrome,0.215768153,5,"Biomarker, GeneticVariation"
10363,HMG20A,high mobility group 20A,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.215768153,5,"Biomarker, GeneticVariation"
5605,MAP2K2,mitogen-activated protein kinase kinase 2,0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.215768153,6,"Biomarker, GeneticVariation"
26011,TENM4,teneurin transmembrane protein 4,0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.215768153,5,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.215719122,14,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,3469,Anxiety Disorders,0.215719122,13,"Biomarker, GeneticVariation"
6899,TBX1,T-box 1,0.0,1.0,1.0,0.0,0.0,18798,"Heart Defects, Congenital",0.215719122,14,"Biomarker, GeneticVariation"
1030,CDKN2B,"cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)",0.0,1.0,1.0,0.0,0.0,24299,Lymphoma,0.215719122,14,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,21846,Intestinal Polyps,0.215719122,16,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.215719122,13,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.215719122,13,"Biomarker, GeneticVariation"
3440,IFNA2,"interferon, alpha 2",0.0,1.0,1.0,0.0,1.0,25202,Melanoma,0.215719122,31,"Biomarker, GeneticVariation, Therapeutic"
3078,CFHR1,complement factor H-related 1,0.0,1.0,1.0,0.0,0.0,2931788,Atypical Hemolytic Uremic Syndrome,0.215719122,13,"Biomarker, GeneticVariation"
25978,CHMP2B,charged multivesicular body protein 2B,0.0,1.0,1.0,0.0,0.0,751072,Frontotemporal Lobar Degeneration,0.215719122,12,"Biomarker, GeneticVariation"
2289,FKBP5,FK506 binding protein 5,0.0,1.0,1.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.215719122,13,"Biomarker, GeneticVariation"
57679,ALS2,amyotrophic lateral sclerosis 2 (juvenile),0.0,1.0,1.0,0.0,0.0,2931441,"Hereditary spastic paralysis, infantile onset ascending",0.215719122,12,"Biomarker, GeneticVariation"
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.215690158,3,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,1.0,5695,Urinary Bladder Neoplasms,0.215690158,5,"Biomarker, GeneticVariation, Therapeutic"
847,CAT,catalase,1.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.215690158,5,"AlteredExpression, Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,17658,Glomerulonephritis,0.215690158,5,"Biomarker, GeneticVariation"
721,C4B,complement component 4B (Chido blood group),0.0,1.0,1.0,0.0,0.0,4364,Autoimmune Diseases,0.215690158,6,"Biomarker, GeneticVariation"
438,ASMT,acetylserotonin O-methyltransferase,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215690158,5,"Biomarker, GeneticVariation"
22871,NLGN1,neuroligin 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215690158,5,"Biomarker, GeneticVariation"
9037,SEMA5A,"sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215690158,3,"Biomarker, GeneticVariation"
2067,ERCC1,excision repair cross-complementation group 1,1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.215690158,6,"AlteredExpression, Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.215690158,6,"Biomarker, GeneticVariation"
2876,GPX1,glutathione peroxidase 1,1.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.215690158,5,"AlteredExpression, Biomarker, GeneticVariation"
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,1.0,1.0,0.0,0.0,18817,"Heart Septal Defects, Atrial",0.215690158,3,"Biomarker, GeneticVariation"
2995,GYPC,glycophorin C (Gerbich blood group),0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.215690158,3,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,11581,Depressive Disorder,0.215670091,21,"Biomarker, GeneticVariation"
25939,SAMHD1,SAM domain and HD domain 1,0.0,1.0,0.0,0.0,0.0,796126,Aicardi-Goutieres syndrome,0.215670091,20,Biomarker
6098,ROS1,"ROS proto-oncogene 1 , receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.215670091,20,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,175693,Silver-Russell Syndrome,0.215670091,20,Biomarker
3439,IFNA1,"interferon, alpha 1",0.0,1.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.215670091,23,"Biomarker, Therapeutic"
8028,MLLT10,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.215670091,20,Biomarker
3868,KRT16,"keratin 16, type I",0.0,1.0,1.0,0.0,0.0,265334,Pachyonychia Congenita,0.215641127,12,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,0.0,25517,Metabolic Diseases,0.215641127,12,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",1.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.215641127,13,"AlteredExpression, Biomarker, GeneticVariation"
4292,MLH1,mutL homolog 1,0.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.215641127,13,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.215641127,13,"AlteredExpression, Biomarker"
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",0.0,1.0,1.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.215641127,12,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.215641127,12,Biomarker
23532,PRAME,preferentially expressed antigen in melanoma,1.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.215641127,13,"AlteredExpression, Biomarker"
23586,DDX58,DEAD (Asp-Glu-Ala-Asp) box polypeptide 58,1.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.215641127,13,"AlteredExpression, Biomarker"
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.215641127,12,"Biomarker, GeneticVariation"
8600,TNFSF11,"tumor necrosis factor (ligand) superfamily, member 11",0.0,1.0,1.0,0.0,0.0,29454,Osteopetrosis,0.215612163,4,"Biomarker, GeneticVariation"
960,CD44,CD44 molecule (Indian blood group),1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.215612163,5,"AlteredExpression, Biomarker"
2520,GAST,gastrin,1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.215612163,4,"AlteredExpression, Biomarker"
6647,SOD1,"superoxide dismutase 1, soluble",1.0,1.0,1.0,0.0,1.0,7786,Brain Ischemia,0.215612163,5,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),1.0,1.0,0.0,0.0,1.0,22658,Kidney Diseases,0.215612163,5,"AlteredExpression, Biomarker, Therapeutic"
81,ACTN4,"actinin, alpha 4",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.215612163,5,Biomarker
10232,MSLN,mesothelin,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.215612163,5,Biomarker
10232,MSLN,mesothelin,1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.215612163,5,"AlteredExpression, Biomarker"
3651,PDX1,pancreatic and duodenal homeobox 1,1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.215612163,6,"AlteredExpression, Biomarker"
701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,1.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.215612163,4,"AlteredExpression, Biomarker, GeneticVariation"
9156,EXO1,exonuclease 1,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.215612163,4,"Biomarker, GeneticVariation"
6422,SFRP1,secreted frizzled-related protein 1,1.0,1.0,0.0,1.0,0.0,9404,Colorectal Neoplasms,0.215612163,6,"AlteredExpression, Biomarker, PostTranslationalModification"
10320,IKZF1,IKAROS family zinc finger 1 (Ikaros),1.0,1.0,0.0,0.0,0.0,24299,Lymphoma,0.215612163,5,"AlteredExpression, Biomarker"
3691,ITGB4,"integrin, beta 4",0.0,1.0,1.0,0.0,0.0,14527,Epidermolysis Bullosa,0.215612163,4,"Biomarker, GeneticVariation"
6850,SYK,spleen tyrosine kinase,1.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.215612163,3,"AlteredExpression, Biomarker"
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215612163,5,Biomarker
7431,VIM,vimentin,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215612163,5,"AlteredExpression, Biomarker"
1230,CCR1,chemokine (C-C motif) receptor 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.215612163,3,Biomarker
1540,CYLD,cylindromatosis (turban tumor syndrome),1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.215612163,3,"AlteredExpression, Biomarker"
5747,PTK2,protein tyrosine kinase 2,1.0,1.0,0.0,1.0,0.0,17636,Glioblastoma,0.215612163,5,"AlteredExpression, Biomarker, PostTranslationalModification"
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,1.0,7222,Cardiovascular Diseases,0.215612163,5,"Biomarker, Therapeutic"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.215612163,5,"AlteredExpression, Biomarker"
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215612163,4,"AlteredExpression, Biomarker"
5300,PIN1,"peptidylprolyl cis/trans isomerase, NIMA-interacting 1",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215612163,6,"AlteredExpression, Biomarker"
9971,NR1H4,"nuclear receptor subfamily 1, group H, member 4",0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.215612163,5,"Biomarker, GeneticVariation"
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,1.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.215612163,5,"Biomarker, GeneticVariation"
6338,SCNN1B,"sodium channel, non voltage gated 1 beta subunit",0.0,1.0,1.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.215612163,3,"Biomarker, GeneticVariation"
5747,PTK2,protein tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.215612163,5,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,2871,Anemia,0.215484649,3,"Biomarker, GeneticVariation"
3593,IL12B,interleukin 12B,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.215484649,5,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,243026,Sepsis,0.215484649,5,"Biomarker, GeneticVariation"
57608,KIAA1462,KIAA1462,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.215484649,4,"Biomarker, GeneticVariation"
3988,LIPA,"lipase A, lysosomal acid, cholesterol esterase",0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.215484649,4,"Biomarker, GeneticVariation"
1378,CR1,complement component (3b/4b) receptor 1 (Knops blood group),0.0,1.0,1.0,0.0,0.0,24535,"Malaria, Falciparum",0.215484649,6,"Biomarker, GeneticVariation"
7367,UGT2B17,"UDP glucuronosyltransferase 2 family, polypeptide B17",0.0,1.0,1.0,0.0,0.0,18133,Graft vs Host Disease,0.215484649,5,"Biomarker, GeneticVariation"
10610,ST6GALNAC2,"ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2",0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.215484649,3,"Biomarker, GeneticVariation"
2067,ERCC1,excision repair cross-complementation group 1,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.215484649,4,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,37198,"Sinus Thrombosis, Intracranial",0.215484649,6,"Biomarker, GeneticVariation"
886,CCKAR,cholecystokinin A receptor,0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.215484649,4,"Biomarker, GeneticVariation"
1814,DRD3,dopamine receptor D3,0.0,1.0,1.0,0.0,0.0,40517,Tourette Syndrome,0.215484649,5,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.215484649,7,"Biomarker, GeneticVariation"
919,CD247,CD247 molecule,0.0,1.0,1.0,0.0,0.0,36421,"Scleroderma, Systemic",0.215484649,4,"Biomarker, GeneticVariation"
3710,ITPR3,"inositol 1,4,5-trisphosphate receptor, type 3",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.215484649,3,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.215484649,6,"Biomarker, GeneticVariation"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.215484649,3,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.215484649,5,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,29458,"Osteoporosis, Postmenopausal",0.215484649,6,"Biomarker, GeneticVariation"
339145,FAM92B,"family with sequence similarity 92, member B",0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.215484649,4,"Biomarker, GeneticVariation"
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.215484649,5,"Biomarker, GeneticVariation"
958,CD40,"CD40 molecule, TNF receptor superfamily member 5",0.0,1.0,1.0,0.0,0.0,26691,Mucocutaneous Lymph Node Syndrome,0.215484649,5,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.215484649,7,"Biomarker, GeneticVariation"
5629,PROX1,prospero homeobox 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.215484649,6,"Biomarker, GeneticVariation"
1739,DLG1,"discs, large homolog 1 (Drosophila)",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.215484649,5,"Biomarker, GeneticVariation"
2901,GRIK5,"glutamate receptor, ionotropic, kainate 5",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.215484649,5,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.215484649,5,"Biomarker, GeneticVariation"
57817,HAMP,hepcidin antimicrobial peptide,0.0,1.0,1.0,0.0,0.0,5283,beta-Thalassemia,0.215435618,12,"Biomarker, GeneticVariation"
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,1.0,0.0,0.0,162872,"Aortic Aneurysm, Thoracic",0.215435618,12,"Biomarker, GeneticVariation"
23284,LPHN3,latrophilin 3,0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.215435618,12,"Biomarker, GeneticVariation"
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.215435618,12,"Biomarker, GeneticVariation"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.215435618,12,"Biomarker, GeneticVariation"
3552,IL1A,"interleukin 1, alpha",0.0,1.0,1.0,0.0,0.0,11633,Dermatomyositis,0.215406654,3,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,11633,Dermatomyositis,0.215406654,3,"Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.215406654,5,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.215406654,4,"Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,1.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.215406654,6,"AlteredExpression, Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.215406654,5,"AlteredExpression, Biomarker, GeneticVariation"
1187,CLCNKA,"chloride channel, voltage-sensitive Ka",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.215406654,3,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,3949,Asbestosis,0.215406654,2,"Biomarker, GeneticVariation"
5110,PCMT1,protein-L-isoaspartate (D-aspartate) O-methyltransferase,0.0,1.0,1.0,0.0,0.0,80178,Spinal Dysraphism,0.215406654,3,"Biomarker, GeneticVariation"
1746,DLX2,distal-less homeobox 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215406654,2,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215406654,2,"Biomarker, GeneticVariation"
4139,MARK1,MAP/microtubule affinity-regulating kinase 1,1.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215406654,2,"AlteredExpression, Biomarker, GeneticVariation"
405,ARNT,aryl hydrocarbon receptor nuclear translocator,1.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.215406654,3,"AlteredExpression, Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,205770,"Papilloma, Choroid Plexus",0.215406654,3,"Biomarker, GeneticVariation"
6712,SPTBN2,"spectrin, beta, non-erythrocytic 2",0.0,1.0,1.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.215406654,4,"Biomarker, GeneticVariation"
259197,NCR3,natural cytotoxicity triggering receptor 3,0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.215406654,3,"Biomarker, GeneticVariation"
4153,MBL2,"mannose-binding lectin (protein C) 2, soluble",0.0,1.0,1.0,0.0,0.0,85207,"Diabetes, Gestational",0.215406654,2,"Biomarker, GeneticVariation"
201163,FLCN,folliculin,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.215386587,20,Biomarker
1540,CYLD,cylindromatosis (turban tumor syndrome),0.0,1.0,1.0,0.0,0.0,1305968,Familial cylindromatosis,0.215386587,20,"Biomarker, GeneticVariation"
213,ALB,albumin,0.0,1.0,0.0,0.0,1.0,20538,Hypertension,0.215386587,20,"Biomarker, Therapeutic"
8101,CLLS2,Disrupted in B-cell neoplasia,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.215386587,19,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,699791,STOMACH CARCINOMA,0.215386587,19,"Biomarker, GeneticVariation"
2641,GCG,glucagon,0.0,1.0,1.0,0.0,1.0,20456,Hyperglycemia,0.215386587,21,"Biomarker, GeneticVariation, Therapeutic"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.215386587,20,Biomarker
134430,WDR36,WD repeat domain 36,0.0,1.0,1.0,0.0,0.0,339573,"Glaucoma, Primary Open Angle",0.215386587,19,"Biomarker, GeneticVariation"
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,524909,"Hepatitis B, Chronic",0.215386587,25,"Biomarker, Therapeutic"
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,0.0,0.0,0.0,2931838,Familial HDL deficiency,0.215386587,19,Biomarker
4869,NPM1,"nucleophosmin (nucleolar phosphoprotein B23, numatrin)",0.0,1.0,1.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.215386587,20,"Biomarker, GeneticVariation"
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,1.0,1.0,0.0,0.0,14553,"Epilepsy, Absence",0.215357623,10,"Biomarker, GeneticVariation"
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.215357623,10,Biomarker
55120,FANCL,"Fanconi anemia, complementation group L",0.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.215357623,10,Biomarker
7273,TTN,titin,0.0,1.0,1.0,0.0,0.0,26848,Muscular Diseases,0.215357623,10,"Biomarker, GeneticVariation"
7173,TPO,thyroid peroxidase,0.0,1.0,1.0,0.0,0.0,18021,Goiter,0.215357623,13,"Biomarker, GeneticVariation"
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",0.0,1.0,0.0,0.0,0.0,13421,Dystonia,0.215357623,10,Biomarker
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,0.0,0.0,0.0,24299,Lymphoma,0.215357623,12,"AlteredExpression, Biomarker"
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.215357623,11,"AlteredExpression, Biomarker"
3785,KCNQ2,"potassium channel, voltage gated KQT-like subfamily Q, member 2",0.0,1.0,1.0,0.0,0.0,270851,"Epilepsy, Benign Neonatal",0.215357623,11,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,4114,Astrocytoma,0.215357623,11,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",1.0,1.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.215357623,12,"AlteredExpression, Biomarker, Therapeutic"
648,BMI1,"BMI1 proto-oncogene, polycomb ring finger",1.0,1.0,0.0,0.0,0.0,17638,Glioma,0.215357623,10,"AlteredExpression, Biomarker"
4582,MUC1,"mucin 1, cell surface associated",0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.215357623,11,Biomarker
286077,FAM83H,"family with sequence similarity 83, member H",0.0,1.0,1.0,0.0,0.0,2452,Amelogenesis Imperfecta,0.215357623,11,"Biomarker, GeneticVariation"
4983,OPHN1,oligophrenin 1,0.0,1.0,1.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.215357623,10,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,1.0,1.0,0.0,0.0,0.0,23281,Leishmaniasis,0.215328659,5,"AlteredExpression, Biomarker"
1118,CHIT1,chitinase 1 (chitotriosidase),1.0,1.0,1.0,0.0,0.0,17205,Gaucher Disease,0.215328659,3,"AlteredExpression, Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.215328659,4,"AlteredExpression, Biomarker, GeneticVariation"
55743,CHFR,"checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase",0.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.215328659,3,"Biomarker, PostTranslationalModification"
83998,REG4,"regenerating islet-derived family, member 4",1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
5329,PLAUR,"plasminogen activator, urokinase receptor",1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.215328659,4,"AlteredExpression, Biomarker"
6648,SOD2,"superoxide dismutase 2, mitochondrial",1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.215328659,5,"AlteredExpression, Biomarker"
4288,MKI67,marker of proliferation Ki-67,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.215328659,4,Biomarker
8626,TP63,tumor protein p63,1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.215328659,3,"AlteredExpression, Biomarker"
55630,SLC39A4,"solute carrier family 39 (zinc transporter), member 4",0.0,1.0,1.0,0.0,0.0,1197,Acrodermatitis,0.215328659,8,"Biomarker, GeneticVariation"
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.215328659,2,"AlteredExpression, Biomarker"
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.215328659,4,"Biomarker, GeneticVariation"
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,1.0,0.0,9404,Colorectal Neoplasms,0.215328659,2,"Biomarker, PostTranslationalModification"
8991,SELENBP1,selenium binding protein 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.215328659,2,Biomarker
8074,FGF23,fibroblast growth factor 23,0.0,1.0,1.0,0.0,0.0,6663,Calcinosis,0.215328659,4,"Biomarker, GeneticVariation"
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.215328659,4,"Biomarker, GeneticVariation"
4879,NPPB,natriuretic peptide B,1.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.215328659,4,"AlteredExpression, Biomarker"
2118,ETV4,ets variant 4,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
3490,IGFBP7,insulin-like growth factor binding protein 7,1.0,1.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.215328659,3,"AlteredExpression, Biomarker, Therapeutic"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.215328659,4,"AlteredExpression, Biomarker"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.215328659,3,"AlteredExpression, Biomarker"
240,ALOX5,arachidonate 5-lipoxygenase,1.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.215328659,5,"AlteredExpression, Biomarker, GeneticVariation"
4316,MMP7,"matrix metallopeptidase 7 (matrilysin, uterine)",1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
1259,CNGA1,cyclic nucleotide gated channel alpha 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.215328659,4,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",1.0,1.0,0.0,0.0,1.0,30567,Parkinson Disease,0.215328659,6,"AlteredExpression, Biomarker, Therapeutic"
573,BAG1,BCL2-associated athanogene,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
650,BMP2,bone morphogenetic protein 2,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
1825,DSC3,desmocollin 3,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,3,"AlteredExpression, Biomarker"
2057,EPOR,erythropoietin receptor,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,4,Biomarker
3490,IGFBP7,insulin-like growth factor binding protein 7,0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.215328659,4,"Biomarker, Therapeutic"
4194,MDM4,"MDM4, p53 regulator",1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,4,"AlteredExpression, Biomarker, GeneticVariation"
92140,MTDH,metadherin,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
5245,PHB,prohibitin,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,3,"Biomarker, GeneticVariation"
9821,RB1CC1,RB1-inducible coiled-coil 1,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,4,"Biomarker, GeneticVariation"
8614,STC2,stanniocalcin 2,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215328659,3,"AlteredExpression, Biomarker"
598,BCL2L1,BCL2-like 1,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
4170,MCL1,myeloid cell leukemia 1,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.215328659,4,"AlteredExpression, Biomarker"
5950,RBP4,"retinol binding protein 4, plasma",1.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.215328659,2,"AlteredExpression, Biomarker"
3725,JUN,jun proto-oncogene,1.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.215328659,4,"AlteredExpression, Biomarker"
2799,GNS,glucosamine (N-acetyl)-6-sulfatase,0.0,1.0,1.0,0.0,0.0,26706,Mucopolysaccharidosis III,0.215328659,4,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,7273,Carotid Artery Diseases,0.215328659,4,"Biomarker, GeneticVariation"
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,1.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.215328659,2,"Biomarker, GeneticVariation"
3908,LAMA2,"laminin, alpha 2",0.0,1.0,1.0,0.0,0.0,699743,Congenital muscular dystrophy,0.215309247,54,"Biomarker, GeneticVariation"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,1.0,26769,Multiple Sclerosis,0.215201144,4,"Biomarker, GeneticVariation, Therapeutic"
8000,PSCA,prostate stem cell antigen,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.215201144,5,"Biomarker, GeneticVariation"
3687,ITGAX,"integrin, alpha X (complement component 3 receptor 4 subunit)",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.215201144,2,"Biomarker, GeneticVariation"
121260,SLC15A4,"solute carrier family 15 (oligopeptide transporter), member 4",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.215201144,4,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,1175175,Severe Acute Respiratory Syndrome,0.215201144,3,"Biomarker, GeneticVariation"
639,PRDM1,"PR domain containing 1, with ZNF domain",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.215201144,5,"Biomarker, GeneticVariation"
8490,RGS5,regulator of G-protein signaling 5,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.215201144,4,"Biomarker, GeneticVariation, Therapeutic"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,751967,"Multiple Sclerosis, Relapsing-Remitting",0.215201144,3,"Biomarker, GeneticVariation"
7252,TSHB,"thyroid stimulating hormone, beta",0.0,1.0,1.0,0.0,0.0,20676,Hypothyroidism,0.215201144,5,"Biomarker, GeneticVariation"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,1.0,0.0,0.0,24299,Lymphoma,0.215201144,4,"Biomarker, GeneticVariation"
64135,IFIH1,interferon induced with helicase C domain 1,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.215201144,3,"Biomarker, GeneticVariation"
4792,NFKBIA,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.215201144,4,"Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,3495559,"Arthritis, Juvenile",0.215201144,4,"Biomarker, GeneticVariation"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.215201144,5,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,24314,Lymphoproliferative Disorders,0.215201144,5,"Biomarker, GeneticVariation"
332,BIRC5,baculoviral IAP repeat containing 5,0.0,1.0,1.0,0.0,1.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.215201144,5,"Biomarker, GeneticVariation, Therapeutic"
1815,DRD4,dopamine receptor D4,0.0,1.0,1.0,0.0,0.0,40188,Tic Disorders,0.215201144,4,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215201144,5,"Biomarker, GeneticVariation"
2557,GABRA4,"gamma-aminobutyric acid (GABA) A receptor, alpha 4",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215201144,2,"Biomarker, GeneticVariation"
22941,SHANK2,SH3 and multiple ankyrin repeat domains 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215201144,4,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.215201144,4,"Biomarker, GeneticVariation"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.215201144,3,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,162429,Malnutrition,0.215201144,4,"Biomarker, GeneticVariation"
9672,SDC3,syndecan 3,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.215201144,2,"Biomarker, GeneticVariation"
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.215201144,4,"Biomarker, GeneticVariation"
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),0.0,1.0,1.0,0.0,0.0,42900,Vitiligo,0.215201144,3,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,27092,Myopia,0.215201144,3,"Biomarker, GeneticVariation"
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.215201144,5,"Biomarker, GeneticVariation"
4015,LOX,lysyl oxidase,0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.215201144,3,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,29458,"Osteoporosis, Postmenopausal",0.215201144,5,"Biomarker, GeneticVariation"
388125,C2CD4B,C2 calcium-dependent domain containing 4B,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.215201144,3,"Biomarker, GeneticVariation"
3098,HK1,hexokinase 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.215201144,5,"Biomarker, GeneticVariation"
5579,PRKCB,"protein kinase C, beta",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.215201144,4,"Biomarker, GeneticVariation"
2993,GYPA,glycophorin A (MNS blood group),0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.215201144,4,"Biomarker, GeneticVariation"
2906,GRIN2D,"glutamate receptor, ionotropic, N-methyl D-aspartate 2D",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.215201144,4,"Biomarker, GeneticVariation"
4923,NTSR1,neurotensin receptor 1 (high affinity),0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.215201144,4,"Biomarker, GeneticVariation"
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.215201144,3,"Biomarker, GeneticVariation"
7168,TPM1,tropomyosin 1 (alpha),0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.215192902,17,"Biomarker, GeneticVariation"
135,ADORA2A,adenosine A2a receptor,0.0,1.0,1.0,0.0,0.0,3469,Anxiety Disorders,0.215152113,12,"Biomarker, GeneticVariation"
27347,STK39,serine threonine kinase 39,0.0,1.0,1.0,0.0,1.0,20538,Hypertension,0.215152113,11,"Biomarker, GeneticVariation, Therapeutic"
51752,ERAP1,endoplasmic reticulum aminopeptidase 1,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.215152113,10,"Biomarker, GeneticVariation"
2066,ERBB4,erb-b2 receptor tyrosine kinase 4,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.215152113,10,"Biomarker, GeneticVariation"
2767,GNA11,"guanine nucleotide binding protein (G protein), alpha 11 (Gq class)",0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.215152113,11,"Biomarker, GeneticVariation"
2737,GLI3,GLI family zinc finger 3,0.0,1.0,1.0,0.0,0.0,152427,Polydactyly,0.215152113,11,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.215152113,11,"AlteredExpression, Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.215152113,12,"Biomarker, GeneticVariation"
7296,TXNRD1,thioredoxin reductase 1,0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.215123149,1,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.215123149,4,"Biomarker, GeneticVariation"
5649,RELN,reelin,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.215123149,4,"AlteredExpression, Biomarker, GeneticVariation"
5534,PPP3R1,"protein phosphatase 3, regulatory subunit B, alpha",0.0,1.0,1.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.215123149,3,"Biomarker, GeneticVariation"
5788,PTPRC,"protein tyrosine phosphatase, receptor type, C",0.0,1.0,1.0,0.0,0.0,19196,Hepatitis C,0.215123149,2,"Biomarker, GeneticVariation"
23022,PALLD,"palladin, cytoskeletal associated protein",1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.215123149,3,"AlteredExpression, Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",1.0,1.0,1.0,0.0,0.0,30848,Penile Induration,0.215123149,4,"AlteredExpression, Biomarker, GeneticVariation"
8792,TNFRSF11A,"tumor necrosis factor receptor superfamily, member 11a, NFKB activator",0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.215123149,2,"Biomarker, GeneticVariation"
3284,HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",0.0,1.0,1.0,0.0,0.0,848558,Hypospadias,0.215123149,1,"Biomarker, GeneticVariation"
6401,SELE,selectin E,0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.215123149,2,"Biomarker, GeneticVariation"
1670,DEFA5,"defensin, alpha 5, Paneth cell-specific",0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.215123149,1,"Biomarker, GeneticVariation"
843,CASP10,"caspase 10, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.215123149,1,"Biomarker, GeneticVariation"
116987,AGAP1,"ArfGAP with GTPase domain, ankyrin repeat and PH domain 1",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215123149,1,"Biomarker, GeneticVariation"
1745,DLX1,distal-less homeobox 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215123149,1,"Biomarker, GeneticVariation"
2918,GRM8,"glutamate receptor, metabotropic 8",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215123149,2,"Biomarker, GeneticVariation"
3105,HLA-A,"major histocompatibility complex, class I, A",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.215123149,2,"Biomarker, GeneticVariation"
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.215123149,4,"Biomarker, GeneticVariation"
3291,HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.215123149,2,"Biomarker, GeneticVariation"
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.215123149,4,"Biomarker, GeneticVariation"
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,1.0,0.0,0.0,11884,Diabetic Retinopathy,0.215123149,4,"Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.215123149,3,"Biomarker, GeneticVariation"
3981,LIG4,"ligase IV, DNA, ATP-dependent",0.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.215123149,2,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.215123149,4,"Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,32962,Pregnancy Complications,0.215123149,3,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,11603,Dermatitis,0.215123149,2,"Biomarker, GeneticVariation"
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,1.0,0.0,0.0,7785,Cerebral Infarction,0.215123149,1,"Biomarker, GeneticVariation"
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",1.0,1.0,1.0,0.0,0.0,10674,Cystic Fibrosis,0.215123149,5,"AlteredExpression, Biomarker, GeneticVariation"
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,1.0,0.0,0.0,10674,Cystic Fibrosis,0.215123149,1,"Biomarker, GeneticVariation"
4323,MMP14,matrix metallopeptidase 14 (membrane-inserted),0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.215123149,2,"Biomarker, GeneticVariation"
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,1.0,1.0,0.0,1.0,20619,Hypogonadism,0.215123149,4,"Biomarker, GeneticVariation, Therapeutic"
2316,FLNA,"filamin A, alpha",0.0,1.0,0.0,0.0,0.0,1868720,Periventricular Nodular Heterotopia,0.215103082,19,Biomarker
1594,CYP27B1,"cytochrome P450, family 27, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,35579,Rickets,0.215103082,19,Biomarker
60498,IGAN1,IgA nephropathy,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.215103082,18,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.215103082,18,Biomarker
2194,FASN,fatty acid synthase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.215103082,20,Biomarker
4602,MYB,v-myb avian myeloblastosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.215103082,19,Biomarker
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,0.0,0.0,0.0,2700265,Waardenburg syndrome type 2,0.215103082,19,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.215103082,19,Biomarker
6208,RPS14,ribosomal protein S14,0.0,1.0,0.0,0.0,0.0,740302,5q- syndrome,0.215103082,18,Biomarker
79577,CDC73,cell division cycle 73,0.0,1.0,1.0,0.0,0.0,687150,parathyroid cancer,0.215074773,45,"Biomarker, GeneticVariation"
3872,KRT17,"keratin 17, type I",0.0,1.0,1.0,0.0,0.0,265334,Pachyonychia Congenita,0.215074118,10,"Biomarker, GeneticVariation"
2023,ENO1,"enolase 1, (alpha)",1.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.215074118,10,"AlteredExpression, Biomarker"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,85261,Proteus Syndrome,0.215074118,12,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.215074118,11,"Biomarker, GeneticVariation"
5309,PITX3,paired-like homeodomain 3,0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.215074118,10,"Biomarker, GeneticVariation"
10553,HTATIP2,"HIV-1 Tat interactive protein 2, 30kDa",1.0,1.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.215074118,9,"AlteredExpression, Biomarker, Therapeutic"
2821,GPI,glucose-6-phosphate isomerase,0.0,1.0,1.0,0.0,0.0,2878,"Anemia, Hemolytic",0.215074118,9,"Biomarker, GeneticVariation"
54474,KRT20,"keratin 20, type I",1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.215074118,11,"AlteredExpression, Biomarker"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,85655,Polymyositis,0.215074118,11,"Biomarker, GeneticVariation"
3606,IL18,interleukin 18,1.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.215074118,9,"AlteredExpression, Biomarker, GeneticVariation"
50943,FOXP3,forkhead box P3,1.0,1.0,0.0,0.0,0.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.215074118,10,"AlteredExpression, Biomarker"
4853,NOTCH2,notch 2,0.0,1.0,1.0,0.0,0.0,85280,Alagille Syndrome,0.215074118,9,"Biomarker, GeneticVariation"
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,1.0,0.0,0.0,23479,"Leukemia, Myelomonocytic, Acute",0.215074118,11,"Biomarker, GeneticVariation"
1440,CSF3,colony stimulating factor 3 (granulocyte),1.0,1.0,0.0,0.0,1.0,5695,Urinary Bladder Neoplasms,0.215045154,4,"AlteredExpression, Biomarker, Therapeutic"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.215045154,8,"AlteredExpression, Biomarker"
2263,FGFR2,fibroblast growth factor receptor 2,1.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.215045154,4,"AlteredExpression, Biomarker, PostTranslationalModification"
3725,JUN,jun proto-oncogene,1.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.215045154,3,"AlteredExpression, Biomarker, PostTranslationalModification"
5595,MAPK3,mitogen-activated protein kinase 3,1.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.215045154,3,"AlteredExpression, Biomarker, PostTranslationalModification"
387,RHOA,ras homolog family member A,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.215045154,4,Biomarker
7291,TWIST1,twist family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.215045154,3,Biomarker
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.215045154,3,Biomarker
1965,EIF2S1,"eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa",1.0,1.0,0.0,1.0,0.0,2395,Alzheimer Disease,0.215045154,3,"AlteredExpression, Biomarker, PostTranslationalModification"
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.215045154,3,Biomarker
7291,TWIST1,twist family bHLH transcription factor 1,0.0,1.0,1.0,0.0,0.0,1510455,Acrocephalosyndactylia,0.215045154,4,"Biomarker, GeneticVariation"
7010,TEK,"TEK tyrosine kinase, endothelial",1.0,1.0,0.0,0.0,0.0,27686,"Neovascularization, Pathologic",0.215045154,3,"AlteredExpression, Biomarker"
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.215045154,3,"AlteredExpression, Biomarker"
387,RHOA,ras homolog family member A,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.215045154,3,"AlteredExpression, Biomarker"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.215045154,2,Biomarker
1647,GADD45A,"growth arrest and DNA-damage-inducible, alpha",1.0,0.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.215045154,2,"AlteredExpression, Therapeutic"
5595,MAPK3,mitogen-activated protein kinase 3,1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
25803,SPDEF,SAM pointed domain containing ETS transcription factor,1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.215045154,2,"AlteredExpression, Biomarker"
5277,PIGA,"phosphatidylinositol glycan anchor biosynthesis, class A",0.0,1.0,1.0,0.0,0.0,19050,"Hemoglobinuria, Paroxysmal",0.215045154,4,"Biomarker, GeneticVariation"
8600,TNFSF11,"tumor necrosis factor (ligand) superfamily, member 11",0.0,1.0,0.0,0.0,0.0,2382,Alveolar Bone Loss,0.215045154,3,Biomarker
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.215045154,2,"Biomarker, GeneticVariation"
23600,AMACR,alpha-methylacyl-CoA racemase,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
6790,AURKA,aurora kinase A,0.0,1.0,0.0,1.0,0.0,9404,Colorectal Neoplasms,0.215045154,2,"Biomarker, PostTranslationalModification"
64374,SIL1,SIL1 nucleotide exchange factor,0.0,1.0,1.0,0.0,0.0,37952,Spinocerebellar Degenerations,0.215045154,2,"Biomarker, GeneticVariation"
4879,NPPB,natriuretic peptide B,1.0,1.0,0.0,0.0,0.0,242707,"Ventricular Dysfunction, Right",0.215045154,4,"AlteredExpression, Biomarker"
6608,SMO,"smoothened, frizzled class receptor",1.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.215045154,3,"AlteredExpression, Biomarker, GeneticVariation"
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,270611,Brain Injuries,0.215045154,3,"Biomarker, Therapeutic"
595,CCND1,cyclin D1,1.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.215045154,4,"AlteredExpression, Biomarker"
3481,IGF2,insulin-like growth factor 2,1.0,1.0,0.0,0.0,0.0,15934,Fetal Growth Retardation,0.215045154,4,"AlteredExpression, Biomarker"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),1.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.215045154,3,"AlteredExpression, Biomarker"
5069,PAPPA,"pregnancy-associated plasma protein A, pappalysin 1",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.215045154,3,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.215045154,3,Biomarker
6502,SKP2,"S-phase kinase-associated protein 2, E3 ubiquitin protein ligase",1.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.215045154,3,Biomarker
10551,AGR2,anterior gradient 2,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
301,ANXA1,annexin A1,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,1.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"Biomarker, PostTranslationalModification"
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,1.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"Biomarker, PostTranslationalModification"
7430,EZR,ezrin,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,4,"AlteredExpression, Biomarker"
2650,GCNT1,"glucosaminyl (N-acetyl) transferase 1, core 2",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,2,"Biomarker, GeneticVariation"
10481,HOXB13,homeobox B13,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,5,"AlteredExpression, Biomarker"
1902,LPAR1,lysophosphatidic acid receptor 1,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
4292,MLH1,mutL homolog 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"Biomarker, GeneticVariation"
4502,MT2A,metallothionein 2A,1.0,1.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.215045154,3,"AlteredExpression, Biomarker, Therapeutic"
4585,MUC4,"mucin 4, cell surface associated",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,Biomarker
9,NAT1,N-acetyltransferase 1 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"Biomarker, GeneticVariation"
6019,RLN2,relaxin 2,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",1.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"AlteredExpression, Biomarker, GeneticVariation"
10333,TLR6,toll-like receptor 6,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"Biomarker, GeneticVariation"
7372,UMPS,uridine monophosphate synthetase,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,2,"AlteredExpression, Biomarker"
10451,VAV3,vav 3 guanine nucleotide exchange factor,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
7432,VIP,vasoactive intestinal peptide,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.215045154,4,"Biomarker, GeneticVariation"
64241,ABCG8,"ATP-binding cassette, sub-family G (WHITE), member 8",0.0,1.0,1.0,0.0,0.0,242216,Gallstones,0.215045154,3,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,9405,"Colorectal Neoplasms, Hereditary Nonpolyposis",0.215045154,3,"Biomarker, GeneticVariation"
563,AZGP1,"alpha-2-glycoprotein 1, zinc-binding",1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.215045154,2,"AlteredExpression, Biomarker"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,20615,Hypoglycemia,0.215045154,3,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.215045154,3,"Biomarker, GeneticVariation"
54739,XAF1,XIAP associated factor 1,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,1.0,0.0,0.0,27125,Myotonia,0.215045154,3,"Biomarker, GeneticVariation"
208,AKT2,v-akt murine thymoma viral oncogene homolog 2,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
23705,CADM1,cell adhesion molecule 1,0.0,1.0,1.0,1.0,0.0,1458155,Breast Neoplasms,0.215045154,2,"Biomarker, GeneticVariation, PostTranslationalModification"
1003,CDH5,"cadherin 5, type 2 (vascular endothelium)",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215045154,3,Biomarker
2274,FHL2,four and a half LIM domains 2,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215045154,2,"AlteredExpression, Biomarker"
3161,HMMR,hyaluronan-mediated motility receptor (RHAMM),1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215045154,2,"AlteredExpression, Biomarker"
3162,HMOX1,heme oxygenase (decycling) 1,1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.215045154,3,"AlteredExpression, Biomarker, GeneticVariation"
10855,HPSE,heparanase,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
1902,LPAR1,lysophosphatidic acid receptor 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
6470,SHMT1,serine hydroxymethyltransferase 1 (soluble),1.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.215045154,3,"AlteredExpression, Biomarker, GeneticVariation"
6935,ZEB1,zinc finger E-box binding homeobox 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.215045154,3,"AlteredExpression, Biomarker"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.215045154,3,"Biomarker, GeneticVariation"
6441,SFTPD,surfactant protein D,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.215045154,4,"AlteredExpression, Biomarker"
7276,TTR,transthyretin,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.215045154,4,"AlteredExpression, Biomarker"
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,1.0,20649,Hypotension,0.215045154,7,"Biomarker, Therapeutic"
816,CAMK2B,calcium/calmodulin-dependent protein kinase II beta,1.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.215045154,3,"AlteredExpression, Biomarker"
4598,MVK,mevalonate kinase,0.0,1.0,1.0,0.0,0.0,15967,Fever,0.215045154,3,"Biomarker, GeneticVariation"
8837,CFLAR,CASP8 and FADD-like apoptosis regulator,1.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.215045154,3,"AlteredExpression, Biomarker"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,1.0,0.0,0.0,2170,Alopecia,0.215045154,4,"Biomarker, GeneticVariation"
2638,GC,group-specific component (vitamin D binding protein),1.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.215045154,4,"AlteredExpression, Biomarker"
1269,CNR2,cannabinoid receptor 2 (macrophage),1.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.215045154,2,"AlteredExpression, Biomarker"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.215025742,53,"Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,1.0,0.0,0.0,4943,Behcet Syndrome,0.21491764,3,"Biomarker, GeneticVariation"
400935,IL17REL,interleukin 17 receptor E-like,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21491764,2,"Biomarker, GeneticVariation"
8807,IL18RAP,interleukin 18 receptor accessory protein,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21491764,3,"Biomarker, GeneticVariation"
6401,SELE,selectin E,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.21491764,3,"Biomarker, GeneticVariation"
4602,MYB,v-myb avian myeloblastosis viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.21491764,3,"Biomarker, GeneticVariation"
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.21491764,4,"Biomarker, GeneticVariation"
79722,ANKRD55,ankyrin repeat domain 55,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21491764,4,"Biomarker, GeneticVariation"
4794,NFKBIE,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21491764,3,"Biomarker, GeneticVariation"
54899,PXK,PX domain containing serine/threonine kinase,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21491764,3,"Biomarker, GeneticVariation"
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.21491764,3,"Biomarker, GeneticVariation"
3758,KCNJ1,"potassium channel, inwardly rectifying subfamily J, member 1",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.21491764,4,"Biomarker, GeneticVariation"
4261,CIITA,"class II, major histocompatibility complex, transactivator",0.0,1.0,1.0,0.0,0.0,1403,Addison Disease,0.21491764,2,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21491764,5,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,11609,Drug Eruptions,0.21491764,4,"Biomarker, GeneticVariation"
375056,MIA3,"melanoma inhibitory activity family, member 3",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.21491764,3,"Biomarker, GeneticVariation"
10019,SH2B3,SH2B adaptor protein 3,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.21491764,2,"Biomarker, GeneticVariation"
1814,DRD3,dopamine receptor D3,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.21491764,3,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21491764,4,"Biomarker, GeneticVariation"
6870,TACR3,tachykinin receptor 3,0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.21491764,2,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,2949,"Aneurysm, Dissecting",0.21491764,5,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,27765,Nervous System Diseases,0.21491764,4,"Biomarker, GeneticVariation"
941,CD80,CD80 molecule,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.21491764,3,"Biomarker, GeneticVariation"
155,ADRB3,adrenoceptor beta 3,0.0,1.0,1.0,0.0,0.0,20473,Hyperlipidemias,0.21491764,3,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,1.0,0.0,0.0,11882,Diabetic Neuropathies,0.21491764,3,"Biomarker, GeneticVariation"
5995,RGR,retinal G protein coupled receptor,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.21491764,4,"Biomarker, GeneticVariation"
84142,FAM175A,"family with sequence similarity 175, member A",0.0,1.0,1.0,0.0,0.0,6142,Malignant neoplasm breast,0.21491764,3,"Biomarker, GeneticVariation"
6356,CCL11,chemokine (C-C motif) ligand 11,0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.21491764,2,"Biomarker, GeneticVariation"
7297,TYK2,tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.21491764,3,"Biomarker, GeneticVariation"
5184,PEPD,peptidase D,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21491764,2,"Biomarker, GeneticVariation"
23780,APOL2,"apolipoprotein L, 2",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.21491764,3,"Biomarker, GeneticVariation"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.21491764,4,"Biomarker, GeneticVariation"
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.21491764,4,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.214868609,11,"Biomarker, GeneticVariation"
23586,DDX58,DEAD (Asp-Glu-Ala-Asp) box polypeptide 58,0.0,1.0,1.0,0.0,0.0,19196,Hepatitis C,0.214868609,11,"Biomarker, GeneticVariation"
2006,ELN,elastin,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.214868609,10,"Biomarker, GeneticVariation"
7292,TNFSF4,"tumor necrosis factor (ligand) superfamily, member 4",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.214868609,9,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.214868609,11,"Biomarker, GeneticVariation"
4160,MC4R,melanocortin 4 receptor,0.0,1.0,1.0,0.0,0.0,20505,Hyperphagia,0.214868609,11,"Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,1.0,0.0,0.0,10072,Coronary Thrombosis,0.214868609,11,"Biomarker, GeneticVariation"
23607,CD2AP,CD2-associated protein,0.0,1.0,1.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.214868609,9,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.214868609,10,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,1.0,0.0,1.0,11854,"Diabetes Mellitus, Type 1",0.214868609,10,"Biomarker, GeneticVariation, Therapeutic"
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,1.0,0.0,0.0,28945,Oligodendroglioma,0.214868609,11,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,25500,Mesothelioma,0.214839645,2,"Biomarker, GeneticVariation"
54822,TRPM7,"transient receptor potential cation channel, subfamily M, member 7",0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.214839645,1,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.214839645,2,"Biomarker, GeneticVariation"
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.214839645,4,"AlteredExpression, Biomarker, GeneticVariation"
4089,SMAD4,SMAD family member 4,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.214839645,2,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",1.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.214839645,4,"AlteredExpression, Biomarker, GeneticVariation"
2255,FGF10,fibroblast growth factor 10,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.214839645,3,"Biomarker, GeneticVariation"
3482,IGF2R,insulin-like growth factor 2 receptor,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.214839645,3,"Biomarker, GeneticVariation"
219736,STOX1,storkhead box 1,1.0,1.0,1.0,0.0,0.0,32914,Pre-Eclampsia,0.214839645,2,"AlteredExpression, Biomarker, GeneticVariation"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,1.0,0.0,0.0,7097,Carcinoma,0.214839645,3,"Biomarker, GeneticVariation"
56244,BTNL2,butyrophilin-like 2 (MHC class II associated),0.0,1.0,1.0,0.0,0.0,5138,Berylliosis,0.214839645,1,"Biomarker, GeneticVariation"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.214839645,3,"AlteredExpression, Biomarker, GeneticVariation"
6690,SPINK1,"serine peptidase inhibitor, Kazal type 1",0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.214839645,3,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,1.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.214839645,3,"AlteredExpression, Biomarker, GeneticVariation"
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.214839645,3,"Biomarker, GeneticVariation"
4868,NPHS1,"nephrosis 1, congenital, Finnish type (nephrin)",1.0,1.0,1.0,0.0,1.0,33687,Proteinuria,0.214839645,5,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,1.0,0.0,0.0,473527,Hypoalphalipoproteinemias,0.214839645,2,"Biomarker, GeneticVariation"
335,APOA1,apolipoprotein A-I,0.0,1.0,1.0,0.0,0.0,473527,Hypoalphalipoproteinemias,0.214839645,2,"Biomarker, GeneticVariation"
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.214839645,2,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,22876,"Obstetric Labor, Premature",0.214839645,3,"Biomarker, GeneticVariation"
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,1.0,0.0,0.0,18800,Cardiomegaly,0.214839645,3,"Biomarker, GeneticVariation"
635,BHMT,betaine--homocysteine S-methyltransferase,0.0,1.0,1.0,0.0,0.0,832,Abruptio Placentae,0.214839645,1,"Biomarker, GeneticVariation"
56729,RETN,resistin,1.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.214839645,3,"AlteredExpression, Biomarker, GeneticVariation"
3569,IL6,interleukin 6,1.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.214839645,3,"AlteredExpression, Biomarker, GeneticVariation"
3753,KCNE1,"potassium channel, voltage gated subfamily E regulatory beta subunit 1",0.0,1.0,1.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.214839645,2,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,16978,Gallbladder Neoplasms,0.214839645,4,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,6118,Brain Neoplasms,0.214839645,3,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.214839645,3,"Biomarker, GeneticVariation"
6716,SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",0.0,1.0,1.0,0.0,0.0,14170,Endometrial Neoplasms,0.214839645,3,"Biomarker, GeneticVariation"
6770,STAR,steroidogenic acute regulatory protein,1.0,1.0,1.0,0.0,0.0,14170,Endometrial Neoplasms,0.214839645,3,"AlteredExpression, Biomarker, GeneticVariation"
2780,GNAT2,"guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2",0.0,1.0,1.0,0.0,0.0,9398,Color Vision Defects,0.214839645,2,"Biomarker, GeneticVariation"
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,1.0,0.0,1.0,27651,Neoplasms,0.214839645,3,"Biomarker, GeneticVariation, Therapeutic"
335,APOA1,apolipoprotein A-I,0.0,1.0,1.0,0.0,1.0,21368,Inflammation,0.214839645,3,"Biomarker, GeneticVariation, Therapeutic"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,1.0,0.0,1.0,21368,Inflammation,0.214839645,3,"Biomarker, GeneticVariation, Therapeutic"
10544,PROCR,"protein C receptor, endothelial",0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.214839645,3,"Biomarker, GeneticVariation"
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",0.0,1.0,1.0,0.0,1.0,21368,Inflammation,0.214839645,3,"Biomarker, GeneticVariation, Therapeutic"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.214839645,2,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.214839645,2,"Biomarker, GeneticVariation"
6817,SULT1A1,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.214839645,3,"Biomarker, GeneticVariation"
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),1.0,1.0,1.0,0.0,0.0,27626,Neoplasm Invasiveness,0.214839645,3,"AlteredExpression, Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.214839645,2,"Biomarker, GeneticVariation"
1812,DRD1,dopamine receptor D1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.214839645,1,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.214839645,1,"Biomarker, GeneticVariation"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.214839645,3,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,40336,Tobacco Use Disorder,0.214839645,3,"Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,1.0,0.0,0.0,3714514,Infection,0.214839645,4,"Biomarker, GeneticVariation"
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,1.0,1.0,0.0,0.0,27889,Hereditary Sensory and Autonomic Neuropathies,0.214839645,2,"Biomarker, GeneticVariation"
2941,GSTA4,glutathione S-transferase alpha 4,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.214839645,2,"Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.214839645,2,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.214839645,2,"Biomarker, GeneticVariation"
3283,HSD3B1,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1",0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.214839645,2,"Biomarker, GeneticVariation"
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,0.0,1.0,0.0,1.0,2937358,Cerebral Hemorrhage,0.214839645,3,"GeneticVariation, Therapeutic"
51156,SERPINA10,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10",0.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.214839645,2,"Biomarker, GeneticVariation"
3570,IL6R,interleukin 6 receptor,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.214839645,3,"Biomarker, GeneticVariation"
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,1.0,0.0,1.0,40053,Thrombosis,0.214839645,6,"Biomarker, GeneticVariation, Therapeutic"
7056,THBD,thrombomodulin,0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.214839645,4,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.214839645,3,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,7273,Carotid Artery Diseases,0.214839645,2,"Biomarker, GeneticVariation"
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.214819578,18,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,1.0,22116,Ischemia,0.214819578,19,"Biomarker, Therapeutic"
595,CCND1,cyclin D1,0.0,1.0,1.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.214819578,18,"Biomarker, GeneticVariation"
406950,MIR16-1,microRNA 16-1,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.214819578,17,Biomarker
332,BIRC5,baculoviral IAP repeat containing 5,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.214819578,17,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.214819578,18,"Biomarker, GeneticVariation"
4830,NME1,NME/NM23 nucleoside diphosphate kinase 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.214819578,18,Biomarker
6121,RPE65,retinal pigment epithelium-specific protein 65kDa,0.0,1.0,1.0,0.0,0.0,854723,Retinal Dystrophies,0.214819578,18,"Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,1231,"ACTH Syndrome, Ectopic",0.214819578,21,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,20615,Hypoglycemia,0.214819578,17,Biomarker
3938,LCT,lactase,0.0,1.0,1.0,0.0,0.0,268181,"Lactose Intolerance, Adult Type",0.214819578,17,"Biomarker, GeneticVariation"
598,BCL2L1,BCL2-like 1,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.214790614,10,"AlteredExpression, Biomarker"
2213,FCGR2B,"Fc fragment of IgG, low affinity IIb, receptor (CD32)",1.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.214790614,9,"AlteredExpression, Biomarker"
5879,RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",1.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.214790614,9,"AlteredExpression, Biomarker, GeneticVariation"
3090,HIC1,hypermethylated in cancer 1,0.0,1.0,0.0,1.0,0.0,25149,Medulloblastoma,0.214790614,8,"Biomarker, PostTranslationalModification"
80184,CEP290,centrosomal protein 290kDa,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.214790614,8,"Biomarker, GeneticVariation"
2582,GALE,UDP-galactose-4-epimerase,0.0,1.0,0.0,0.0,0.0,16952,Galactosemias,0.214790614,8,Biomarker
64324,NSD1,nuclear receptor binding SET domain protein 1,1.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.214790614,8,"AlteredExpression, Biomarker"
11141,IL1RAPL1,interleukin 1 receptor accessory protein-like 1,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.214790614,9,Biomarker
6720,SREBF1,sterol regulatory element binding transcription factor 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.214703888,14,"Biomarker, GeneticVariation"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.214634135,3,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,4782,Basal Ganglia Diseases,0.214634135,7,"Biomarker, GeneticVariation"
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,1.0,0.0,0.0,85298,"Death, Sudden, Cardiac",0.214634135,3,"Biomarker, GeneticVariation"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,0.0,1.0,0.0,1.0,21655,Insulin Resistance,0.214634135,4,"GeneticVariation, Therapeutic"
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.214634135,3,"Biomarker, GeneticVariation"
10460,TACC3,"transforming, acidic coiled-coil containing protein 3",0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.214634135,3,"Biomarker, GeneticVariation"
25780,RASGRP3,RAS guanyl releasing protein 3 (calcium and DAG-regulated),0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.214634135,2,"Biomarker, GeneticVariation"
23743,BHMT2,betaine--homocysteine S-methyltransferase 2,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.214634135,3,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.214634135,4,"Biomarker, GeneticVariation"
6401,SELE,selectin E,0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.214634135,3,"Biomarker, GeneticVariation"
945,CD33,CD33 molecule,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.214634135,3,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,21295,"Infant, Premature, Diseases",0.214634135,2,"Biomarker, GeneticVariation"
55759,WDR12,WD repeat domain 12,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.214634135,2,"Biomarker, GeneticVariation"
3606,IL18,interleukin 18,0.0,1.0,1.0,0.0,0.0,20523,"Hypersensitivity, Immediate",0.214634135,3,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,85183,"Neoplasms, Second Primary",0.214634135,2,"Biomarker, GeneticVariation"
3516,RBPJ,recombination signal binding protein for immunoglobulin kappa J region,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.214634135,3,"Biomarker, GeneticVariation"
200734,SPRED2,"sprouty-related, EVH1 domain containing 2",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.214634135,3,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,1828,Agricultural Workers' Diseases,0.214634135,3,"Biomarker, GeneticVariation"
6817,SULT1A1,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1",0.0,1.0,1.0,0.0,0.0,42076,Urologic Neoplasms,0.214634135,2,"Biomarker, GeneticVariation"
590,BCHE,butyrylcholinesterase,0.0,1.0,1.0,0.0,1.0,700359,Organophosphate Poisoning,0.214634135,8,"Biomarker, GeneticVariation, Therapeutic"
2812,GP1BB,"glycoprotein Ib (platelet), beta polypeptide",0.0,1.0,1.0,0.0,0.0,40034,Thrombocytopenia,0.214634135,3,"Biomarker, GeneticVariation"
3674,ITGA2B,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)",0.0,1.0,1.0,0.0,0.0,40034,Thrombocytopenia,0.214634135,3,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,5138,Berylliosis,0.214634135,3,"Biomarker, GeneticVariation"
51141,INSIG2,insulin induced gene 2,0.0,1.0,1.0,0.0,0.0,43094,Weight Gain,0.214634135,3,"Biomarker, GeneticVariation"
79728,PALB2,partner and localizer of BRCA2,0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.214634135,2,"Biomarker, GeneticVariation"
6447,SCG5,secretogranin V (7B2 protein),0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.214634135,3,"Biomarker, GeneticVariation"
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.214634135,2,"Biomarker, GeneticVariation"
2161,F12,coagulation factor XII (Hageman factor),0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.214634135,3,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,28797,Occupational Diseases,0.214634135,3,"Biomarker, GeneticVariation"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,28797,Occupational Diseases,0.214634135,6,"Biomarker, GeneticVariation"
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,0.0,1.0,1.0,0.0,0.0,28797,Occupational Diseases,0.214634135,3,"Biomarker, GeneticVariation"
4522,MTHFD1,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase",0.0,1.0,1.0,0.0,0.0,832,Abruptio Placentae,0.214634135,2,"Biomarker, GeneticVariation"
7827,NPHS2,"nephrosis 2, idiopathic, steroid-resistant (podocin)",0.0,1.0,1.0,0.0,0.0,1925,Albuminuria,0.214634135,3,"Biomarker, GeneticVariation"
2356,FPGS,folylpolyglutamate synthase,0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.214634135,2,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,6434,Burns,0.214634135,3,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,6434,Burns,0.214634135,3,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.214634135,2,"Biomarker, GeneticVariation"
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.214634135,2,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.214634135,2,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.214634135,2,"Biomarker, GeneticVariation"
463,ZFHX3,zinc finger homeobox 3,0.0,1.0,1.0,0.0,0.0,4238,Atrial Fibrillation,0.214634135,3,"Biomarker, GeneticVariation"
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.214634135,3,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.214634135,3,"Biomarker, GeneticVariation"
4985,OPRD1,"opioid receptor, delta 1",0.0,1.0,1.0,0.0,0.0,236969,Substance-Related Disorders,0.214634135,3,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.214634135,3,"Biomarker, GeneticVariation"
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.214634135,3,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.214634135,3,"Biomarker, GeneticVariation"
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.214634135,3,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.214634135,3,"Biomarker, GeneticVariation"
6522,SLC4A2,"solute carrier family 4 (anion exchanger), member 2",0.0,1.0,1.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.214634135,3,"Biomarker, GeneticVariation"
6689,SPIB,Spi-B transcription factor (Spi-1/PU.1 related),0.0,1.0,1.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.214634135,2,"Biomarker, GeneticVariation"
8807,IL18RAP,interleukin 18 receptor accessory protein,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.214634135,3,"Biomarker, GeneticVariation"
221692,PHACTR1,phosphatase and actin regulator 1,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.214634135,2,"Biomarker, GeneticVariation"
55759,WDR12,WD repeat domain 12,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.214634135,2,"Biomarker, GeneticVariation"
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.214634135,3,"Biomarker, GeneticVariation"
1395,CRHR2,corticotropin releasing hormone receptor 2,0.0,0.0,1.0,0.0,1.0,21368,Inflammation,0.214634135,3,"GeneticVariation, Therapeutic"
22853,LMTK2,lemur tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.214634135,2,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,28960,Oligospermia,0.214634135,3,"Biomarker, GeneticVariation"
1008,CDH10,"cadherin 10, type 2 (T2-cadherin)",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.214634135,2,"Biomarker, GeneticVariation"
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,1.0,0.0,0.0,40336,Tobacco Use Disorder,0.214634135,5,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.214634135,4,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.214634135,4,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,26640,Mouth Neoplasms,0.214634135,3,"Biomarker, GeneticVariation"
7512,XPNPEP2,"X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound",0.0,1.0,1.0,0.0,0.0,2994,Angioedema,0.214634135,2,"Biomarker, GeneticVariation"
60468,BACH2,"BTB and CNC homology 1, basic leucine zipper transcription factor 2",0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.214634135,2,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,7772,Intracranial Arteriovenous Malformations,0.214634135,2,"Biomarker, GeneticVariation"
4254,KITLG,KIT ligand,0.0,1.0,1.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.214634135,2,"Biomarker, GeneticVariation"
1301,COL11A1,"collagen, type XI, alpha 1",0.0,1.0,1.0,0.0,0.0,21818,Intervertebral Disc Displacement,0.214634135,2,"Biomarker, GeneticVariation"
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,1.0,0.0,0.0,20473,Hyperlipidemias,0.214634135,2,"Biomarker, GeneticVariation"
10133,OPTN,optineurin,0.0,1.0,1.0,0.0,0.0,29401,Osteitis Deformans,0.214634135,2,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.214634135,3,"Biomarker, GeneticVariation"
8398,PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent)",0.0,1.0,1.0,0.0,0.0,27960,Nevus,0.214634135,2,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,16059,Fibrosis,0.214634135,3,"Biomarker, GeneticVariation"
969,CD69,CD69 molecule,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.214634135,2,"Biomarker, GeneticVariation"
1235,CCR6,chemokine (C-C motif) receptor 6,0.0,1.0,1.0,0.0,0.0,42900,Vitiligo,0.214634135,2,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,18671,Head and Neck Neoplasms,0.214634135,3,"Biomarker, GeneticVariation"
23743,BHMT2,betaine--homocysteine S-methyltransferase 2,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.214634135,3,"Biomarker, GeneticVariation"
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.214634135,3,"Biomarker, GeneticVariation"
3483,IGFALS,"insulin-like growth factor binding protein, acid labile subunit",0.0,1.0,1.0,0.0,0.0,18273,Growth Disorders,0.214634135,4,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,30849,Penile Neoplasms,0.214634135,3,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,221204,Osteolysis,0.214634135,3,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.214634135,3,"Biomarker, GeneticVariation"
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.214634135,3,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.214634135,4,"Biomarker, GeneticVariation, Therapeutic"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,42109,Urticaria,0.214634135,2,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.214634135,2,"Biomarker, GeneticVariation"
1814,DRD3,dopamine receptor D3,0.0,1.0,1.0,0.0,1.0,236736,Cocaine-Related Disorders,0.214634135,7,"Biomarker, GeneticVariation, Therapeutic"
79694,MANEA,"mannosidase, endo-alpha",0.0,1.0,1.0,0.0,0.0,236736,Cocaine-Related Disorders,0.214634135,2,"Biomarker, GeneticVariation"
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,1.0,0.0,1.0,236736,Cocaine-Related Disorders,0.214634135,6,"Biomarker, GeneticVariation, Therapeutic"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.214634135,3,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,333355,Mucositis,0.214634135,2,"Biomarker, GeneticVariation"
3592,IL12A,interleukin 12A,0.0,0.0,1.0,0.0,1.0,23903,Liver Neoplasms,0.214634135,3,"GeneticVariation, Therapeutic"
80832,APOL4,"apolipoprotein L, 4",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.214634135,2,"Biomarker, GeneticVariation"
2931,GSK3A,glycogen synthase kinase 3 alpha,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.214634135,3,"Biomarker, GeneticVariation"
1234,CCR5,chemokine (C-C motif) receptor 5 (gene/pseudogene),0.0,1.0,1.0,0.0,0.0,43124,West Nile Fever,0.214634135,2,"Biomarker, GeneticVariation"
8322,FZD4,frizzled class receptor 4,0.0,1.0,1.0,0.0,0.0,35309,Retinal Diseases,0.214634135,3,"Biomarker, GeneticVariation"
635,BHMT,betaine--homocysteine S-methyltransferase,0.0,1.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.214634135,2,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,1.0,0.0,0.0,79487,Helicobacter Infections,0.214634135,3,"Biomarker, GeneticVariation"
1814,DRD3,dopamine receptor D3,0.0,1.0,1.0,0.0,0.0,21122,Impulse Control Disorders,0.214634135,5,"Biomarker, GeneticVariation"
2166,FAAH,fatty acid amide hydrolase,0.0,1.0,1.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.214634135,2,"Biomarker, GeneticVariation"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.214585104,8,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.214585104,12,"Biomarker, GeneticVariation"
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,1.0,0.0,0.0,2584620,"Thrombophilia, hereditary",0.214585104,9,"Biomarker, GeneticVariation"
3643,INSR,insulin receptor,0.0,1.0,1.0,0.0,0.0,271650,Glucose Intolerance,0.214585104,9,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.214585104,9,"Biomarker, GeneticVariation"
590,BCHE,butyrylcholinesterase,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.214585104,9,"Biomarker, GeneticVariation"
133522,PPARGC1B,"peroxisome proliferator-activated receptor gamma, coactivator 1 beta",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.214585104,8,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.214585104,10,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.214585104,10,"Biomarker, GeneticVariation"
2661,GDF9,growth differentiation factor 9,0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.214585104,9,"Biomarker, GeneticVariation"
3558,IL2,interleukin 2,0.0,1.0,1.0,0.0,1.0,23903,Liver Neoplasms,0.214585104,10,"Biomarker, GeneticVariation, Therapeutic"
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.214536073,16,"Biomarker, GeneticVariation"
2188,FANCF,"Fanconi anemia, complementation group F",0.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.214536073,16,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,3486,Aortic Aneurysm,0.214536073,17,Biomarker
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.214536073,17,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,22568,Keratitis,0.214536073,16,"Biomarker, GeneticVariation"
57096,RPGRIP1,retinitis pigmentosa GTPase regulator interacting protein 1,0.0,1.0,1.0,0.0,0.0,339527,Leber Congenital Amaurosis,0.214536073,16,"Biomarker, GeneticVariation"
140821,RSS,Russell Silver syndrome,0.0,1.0,0.0,0.0,0.0,175693,Silver-Russell Syndrome,0.214536073,16,Biomarker
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",0.0,1.0,1.0,0.0,0.0,338488,Alternating hemiplegia of childhood,0.214536073,16,"Biomarker, GeneticVariation"
79058,ASPSCR1,"alveolar soft part sarcoma chromosome region, candidate 1",0.0,1.0,1.0,0.0,0.0,206657,"Sarcoma, Alveolar Soft Part",0.214536073,16,"Biomarker, GeneticVariation"
80025,PANK2,pantothenate kinase 2,0.0,1.0,0.0,0.0,0.0,2931845,Neurodegeneration with brain iron accumulation (NBIA),0.214536073,16,Biomarker
6657,SOX2,SRY (sex determining region Y)-box 2,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.214536073,16,Biomarker
2767,GNA11,"guanine nucleotide binding protein (G protein), alpha 11 (Gq class)",0.0,1.0,0.0,0.0,0.0,220633,Uveal melanoma,0.214536073,17,Biomarker
2624,GATA2,GATA binding protein 2,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.214536073,16,"Biomarker, GeneticVariation"
1741,DLG3,"discs, large homolog 3 (Drosophila)",0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.214536073,16,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.214507109,8,"AlteredExpression, Biomarker"
2950,GSTP1,glutathione S-transferase pi 1,1.0,1.0,0.0,0.0,0.0,282612,Prostatic Intraepithelial Neoplasia,0.214507109,9,"AlteredExpression, Biomarker"
4292,MLH1,mutL homolog 1,1.0,1.0,0.0,0.0,0.0,24299,Lymphoma,0.214507109,8,"AlteredExpression, Biomarker"
27185,DISC1,disrupted in schizophrenia 1,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.214507109,7,Biomarker
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,751336,Distal Myopathies,0.214507109,7,"Biomarker, GeneticVariation"
1051,CEBPB,"CCAAT/enhancer binding protein (C/EBP), beta",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.214507109,8,Biomarker
2752,GLUL,glutamate-ammonia ligase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.214507109,9,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.214507109,9,"AlteredExpression, Biomarker"
6720,SREBF1,sterol regulatory element binding transcription factor 1,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.214507109,8,"AlteredExpression, Biomarker"
10537,UBD,ubiquitin D,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.214507109,8,"AlteredExpression, Biomarker"
2520,GAST,gastrin,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.214507109,9,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.214507109,9,Biomarker
4763,NF1,neurofibromin 1,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.214507109,10,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,334634,"Lymphoma, Mantle-Cell",0.214507109,7,Biomarker
57096,RPGRIP1,retinitis pigmentosa GTPase regulator interacting protein 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.214507109,7,"Biomarker, GeneticVariation"
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.214507109,9,Biomarker
5444,PON1,paraoxonase 1,1.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.214507109,8,"AlteredExpression, Biomarker, GeneticVariation"
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.214507109,9,Biomarker
1441,CSF3R,colony stimulating factor 3 receptor (granulocyte),0.0,1.0,1.0,0.0,0.0,1853118,"Neutropenia, Severe Congenital, Autosomal Recessive 3",0.214458733,51,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.2143016,10,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,1.0,22658,Kidney Diseases,0.2143016,8,"Biomarker, GeneticVariation, Therapeutic"
6272,SORT1,sortilin 1,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.2143016,9,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,1.0,23283,"Leishmaniasis, Cutaneous",0.2143016,10,"Biomarker, GeneticVariation, Therapeutic"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,23283,"Leishmaniasis, Cutaneous",0.2143016,9,"Biomarker, GeneticVariation"
3558,IL2,interleukin 2,0.0,1.0,1.0,0.0,1.0,27651,Neoplasms,0.2143016,9,"Biomarker, GeneticVariation, Therapeutic"
4792,NFKBIA,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",0.0,1.0,1.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.2143016,8,"Biomarker, GeneticVariation, Therapeutic"
1149,CIDEA,cell death-inducing DFFA-like effector a,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.2143016,8,"Biomarker, GeneticVariation"
10878,CFHR3,complement factor H-related 3,0.0,1.0,1.0,0.0,0.0,2931788,Atypical Hemolytic Uremic Syndrome,0.2143016,8,"Biomarker, GeneticVariation"
3426,CFI,complement factor I,0.0,1.0,1.0,0.0,0.0,2931788,Atypical Hemolytic Uremic Syndrome,0.2143016,8,"Biomarker, GeneticVariation"
4868,NPHS1,"nephrosis 1, congenital, Finnish type (nephrin)",1.0,1.0,1.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.2143016,9,"AlteredExpression, Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.2143016,7,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.2143016,10,"Biomarker, GeneticVariation"
4160,MC4R,melanocortin 4 receptor,0.0,1.0,1.0,0.0,0.0,20459,Hyperinsulinism,0.2143016,9,"Biomarker, GeneticVariation"
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.2143016,9,"Biomarker, GeneticVariation"
9734,HDAC9,histone deacetylase 9,0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.2143016,7,"Biomarker, GeneticVariation"
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,1.0,0.0,0.0,13902,"Elliptocytosis, Hereditary",0.2143016,8,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,85109,Corneal Neovascularization,0.214252569,16,Biomarker
1714,DGCR,DiGeorge syndrome chromosome region,0.0,1.0,0.0,0.0,0.0,12236,DiGeorge Syndrome,0.214252569,15,Biomarker
3378,IBD2,inflammatory bowel disease 2,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.214252569,15,"Biomarker, GeneticVariation"
335,APOA1,apolipoprotein A-I,1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.214252569,16,"AlteredExpression, Biomarker"
5538,PPT1,palmitoyl-protein thioesterase 1,0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.214252569,17,Biomarker
3600,IL15,interleukin 15,0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.214252569,15,Biomarker
3239,HOXD13,homeobox D13,0.0,1.0,1.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.214252569,16,"Biomarker, GeneticVariation"
4781,NFIB,nuclear factor I/B,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.214252569,16,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.214252569,16,Biomarker
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,1.0,23903,Liver Neoplasms,0.214252569,16,"Biomarker, Therapeutic"
5079,PAX5,paired box 5,0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.214252569,16,"Biomarker, GeneticVariation"
64109,CRLF2,cytokine receptor-like factor 2,1.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.214252569,15,"AlteredExpression, Biomarker"
8314,BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),0.0,1.0,0.0,0.0,0.0,220633,Uveal melanoma,0.214252569,15,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,376545,Hematologic Neoplasms,0.214252569,16,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,1.0,0.0,0.0,272187,Congenital leukocyte adherence deficiency,0.214224259,43,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,35412,Rhabdomyosarcoma,0.214223604,6,Biomarker
374,AREG,amphiregulin,0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.214223604,6,Biomarker
1191,CLU,clusterin,1.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.214223604,6,"AlteredExpression, Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,20540,"Hypertension, Malignant",0.214223604,7,"Biomarker, GeneticVariation"
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.214223604,6,"Biomarker, GeneticVariation"
8575,PRKRA,"protein kinase, interferon-inducible double stranded RNA dependent activator",0.0,1.0,1.0,0.0,0.0,13421,Dystonia,0.214223604,7,"Biomarker, GeneticVariation"
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,40038,Thromboembolism,0.214223604,7,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,1.0,1.0,0.0,0.0,0.0,17168,Gastroesophageal Reflux,0.214223604,8,"AlteredExpression, Biomarker"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.214223604,7,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.214223604,8,"Biomarker, Therapeutic"
7980,TFPI2,tissue factor pathway inhibitor 2,0.0,1.0,0.0,1.0,0.0,2239176,"Carcinoma, Hepatocellular",0.214223604,6,"Biomarker, PostTranslationalModification"
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",1.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.214223604,6,"AlteredExpression, Biomarker"
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",0.0,1.0,0.0,0.0,0.0,242422,Parkinsonian Disorders,0.214223604,6,Biomarker
1993,ELAVL2,ELAV like neuron-specific RNA binding protein 2,1.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.214223604,8,"AlteredExpression, Biomarker"
22954,TRIM32,tripartite motif containing 32,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.214223604,7,"Biomarker, GeneticVariation"
11009,IL24,interleukin 24,1.0,1.0,0.0,0.0,1.0,24121,Lung Neoplasms,0.214223604,9,"AlteredExpression, Biomarker, Therapeutic"
157,ADRBK2,"adrenergic, beta, receptor kinase 2",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.214223604,7,"Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,20302,Hydrophthalmos,0.214038817,27,"Biomarker, GeneticVariation"
345611,IRGM,"immunity-related GTPase family, M",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.214018095,8,"Biomarker, GeneticVariation"
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,1.0,0.0,0.0,152013,Adenocarcinoma of lung,0.214018095,7,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,206681,"Adenocarcinoma, Clear Cell",0.214018095,8,"Biomarker, GeneticVariation"
8575,PRKRA,"protein kinase, interferon-inducible double stranded RNA dependent activator",0.0,1.0,1.0,0.0,0.0,393593,Dystonic Disorders,0.214018095,7,"Biomarker, GeneticVariation"
81037,CLPTM1L,CLPTM1-like,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.214018095,7,"Biomarker, GeneticVariation"
25978,CHMP2B,charged multivesicular body protein 2B,0.0,1.0,1.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.214018095,6,"Biomarker, GeneticVariation"
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,1.0,0.0,0.0,10481,Cushing Syndrome,0.214018095,8,"Biomarker, GeneticVariation"
1471,CST3,cystatin C,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.214018095,8,"Biomarker, GeneticVariation"
79054,TRPM8,"transient receptor potential cation channel, subfamily M, member 8",0.0,1.0,1.0,0.0,0.0,149931,Migraine Disorders,0.214018095,6,"Biomarker, GeneticVariation"
5649,RELN,reelin,0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.214018095,8,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.213969064,14,Biomarker
4163,MCC,mutated in colorectal cancers,0.0,1.0,1.0,0.0,0.0,32580,Adenomatous Polyposis Coli,0.213969064,15,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,684249,Carcinoma of lung,0.213969064,14,"Biomarker, GeneticVariation"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,1.0,7097,Carcinoma,0.213969064,15,"Biomarker, Therapeutic"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,1275081,Cardiofaciocutaneous syndrome,0.213969064,15,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.213969064,15,Biomarker
79092,CARD14,"caspase recruitment domain family, member 14",0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.213969064,15,"Biomarker, GeneticVariation"
1406,CRX,cone-rod homeobox,0.0,1.0,1.0,0.0,0.0,339527,Leber Congenital Amaurosis,0.213969064,15,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,0.0,0.0,0.0,2931401,Long QT syndrome type 3,0.213969064,15,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.213969064,17,Biomarker
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,0.0,346302,Growth Hormone-Secreting Pituitary Adenoma,0.213969064,16,Biomarker
6261,RYR1,ryanodine receptor 1 (skeletal),0.0,1.0,1.0,0.0,0.0,270962,Minicore Myopathy with External Ophthalmoplegia,0.213969064,14,"Biomarker, GeneticVariation"
8031,NCOA4,nuclear receptor coactivator 4,0.0,1.0,1.0,0.0,0.0,238463,"Thyroid cancer, papillary",0.213969064,14,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,220658,PFEIFFER SYNDROME,0.213969064,14,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,0.0,0.0,1.0,11880,Diabetic Ketoacidosis,0.213969064,15,"Biomarker, Therapeutic"
57007,ACKR3,atypical chemokine receptor 3,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.213969064,14,Biomarker
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.213969064,16,Biomarker
406928,MIR137,microRNA 137,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.213969064,14,"Biomarker, GeneticVariation"
948,CD36,CD36 molecule (thrombospondin receptor),1.0,1.0,0.0,0.0,0.0,10068,Coronary Disease,0.2139401,5,"AlteredExpression, Biomarker"
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,1.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.2139401,7,"AlteredExpression, Biomarker"
9971,NR1H4,"nuclear receptor subfamily 1, group H, member 4",1.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.2139401,8,"AlteredExpression, Biomarker"
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,1.0,0.0,0.0,11849,Diabetes Mellitus,0.2139401,6,"Biomarker, GeneticVariation"
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.2139401,5,Biomarker
2321,FLT1,fms-related tyrosine kinase 1,0.0,1.0,0.0,0.0,1.0,7134,"Carcinoma, Renal Cell",0.2139401,7,"Biomarker, Therapeutic"
2187,FANCB,"Fanconi anemia, complementation group B",0.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.2139401,5,Biomarker
859,CAV3,caveolin 3,0.0,1.0,1.0,0.0,0.0,38644,Sudden Infant Death,0.2139401,5,"Biomarker, GeneticVariation"
3574,IL7,interleukin 7,0.0,1.0,0.0,0.0,0.0,24312,Lymphopenia,0.2139401,7,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.2139401,5,"AlteredExpression, Biomarker"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),1.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.2139401,6,"AlteredExpression, Biomarker"
9518,GDF15,growth differentiation factor 15,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.2139401,6,Biomarker
5909,RAP1GAP,RAP1 GTPase activating protein,1.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.2139401,5,"AlteredExpression, Biomarker"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.2139401,6,"AlteredExpression, Biomarker"
6999,TDO2,"tryptophan 2,3-dioxygenase",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.2139401,5,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,206727,Nerve Sheath Neoplasms,0.2139401,7,"Biomarker, GeneticVariation"
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.2139401,6,Biomarker
3484,IGFBP1,insulin-like growth factor binding protein 1,1.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.2139401,7,"AlteredExpression, Biomarker"
317782,CELIAC2,celiac disease 2,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.2139401,6,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,24115,Lung Diseases,0.2139401,6,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.2139401,7,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,1.0,524851,Neurodegenerative Diseases,0.2139401,6,"Biomarker, Therapeutic"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",1.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.2139401,6,"AlteredExpression, Biomarker"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,18799,Heart Diseases,0.2139401,7,"Biomarker, GeneticVariation"
1436,CSF1R,colony stimulating factor 1 receptor,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.2139401,7,Biomarker
8831,SYNGAP1,synaptic Ras GTPase activating protein 1,0.0,1.0,1.0,0.0,0.0,3714756,Intellectual Disability,0.2139401,7,"Biomarker, GeneticVariation"
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.2139401,7,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.2139401,7,"AlteredExpression, Biomarker"
2898,GRIK2,"glutamate receptor, ionotropic, kainate 2",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.2139401,6,Biomarker
84628,NTNG2,netrin G2,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.2139401,5,"Biomarker, GeneticVariation"
274,BIN1,bridging integrator 1,0.0,1.0,1.0,0.0,0.0,752282,"Myopathies, Structural, Congenital",0.2139401,5,"Biomarker, GeneticVariation"
6448,SGSH,N-sulfoglucosamine sulfohydrolase,0.0,1.0,1.0,0.0,0.0,26706,Mucopolysaccharidosis III,0.2139401,6,"Biomarker, GeneticVariation"
1612,DAPK1,death-associated protein kinase 1,1.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.2139401,7,"AlteredExpression, Biomarker"
50615,IL21R,interleukin 21 receptor,0.0,1.0,1.0,0.0,1.0,24141,"Lupus Erythematosus, Systemic",0.21373459,6,"Biomarker, GeneticVariation, Therapeutic"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,11875,Diabetic Angiopathies,0.21373459,7,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.21373459,6,"Biomarker, GeneticVariation"
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.21373459,6,"Biomarker, GeneticVariation"
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,1.0,0.0,0.0,3469,Anxiety Disorders,0.21373459,5,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.21373459,7,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,17658,Glomerulonephritis,0.21373459,7,"Biomarker, GeneticVariation"
5966,REL,v-rel avian reticuloendotheliosis viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.21373459,6,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,15230,Exanthema,0.21373459,6,"Biomarker, GeneticVariation"
1867,DYX1,dyslexia susceptibility 1,0.0,1.0,1.0,0.0,0.0,476254,Dyslexia,0.21373459,5,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.21373459,8,"Biomarker, GeneticVariation"
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.21373459,5,"Biomarker, GeneticVariation"
1520,CTSS,cathepsin S,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.21373459,6,"Biomarker, GeneticVariation"
23216,TBC1D1,"TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.21373459,6,"Biomarker, GeneticVariation"
7172,TPMT,thiopurine S-methyltransferase,0.0,1.0,1.0,0.0,0.0,27947,Neutropenia,0.21373459,6,"Biomarker, GeneticVariation"
3084,NRG1,neuregulin 1,0.0,1.0,1.0,0.0,0.0,19569,Hirschsprung Disease,0.21373459,6,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,27059,Myocarditis,0.21373459,7,"Biomarker, GeneticVariation"
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.21373459,6,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",1.0,1.0,1.0,0.0,1.0,19693,HIV Infections,0.21373459,6,"AlteredExpression, Biomarker, GeneticVariation, Therapeutic"
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.21373459,6,"Biomarker, GeneticVariation"
4035,LRP1,low density lipoprotein receptor-related protein 1,0.0,1.0,1.0,0.0,0.0,149931,Migraine Disorders,0.21373459,5,"Biomarker, GeneticVariation"
63976,PRDM16,PR domain containing 16,0.0,1.0,1.0,0.0,0.0,149931,Migraine Disorders,0.21373459,5,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.21373459,7,"Biomarker, GeneticVariation"
10891,PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha",0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.21373459,7,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.21373459,7,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.21373459,7,"Biomarker, GeneticVariation"
2213,FCGR2B,"Fc fragment of IgG, low affinity IIb, receptor (CD32)",0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.21373459,5,"Biomarker, GeneticVariation"
1375,CPT1B,carnitine palmitoyltransferase 1B (muscle),0.0,1.0,1.0,0.0,0.0,27404,Narcolepsy,0.21373459,5,"Biomarker, GeneticVariation"
114902,C1QTNF5,C1q and tumor necrosis factor related protein 5,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.21373459,6,"Biomarker, GeneticVariation"
2335,FN1,fibronectin 1,0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.213685559,14,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,1.0,0.0,1.0,11581,Depressive Disorder,0.213685559,14,"Biomarker, GeneticVariation, Therapeutic"
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,1.0,1.0,0.0,0.0,85215,Primary Ovarian Insufficiency,0.213685559,13,"Biomarker, GeneticVariation"
56606,SLC2A9,"solute carrier family 2 (facilitated glucose transporter), member 9",0.0,1.0,1.0,0.0,0.0,473219,Renal hypouricemia,0.213685559,15,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,497406,Overweight,0.213685559,14,"Biomarker, GeneticVariation"
378884,NHLRC1,NHL repeat containing E3 ubiquitin protein ligase 1,0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.213685559,14,Biomarker
9365,KL,klotho,0.0,1.0,0.0,0.0,0.0,231341,"Aging, Premature",0.213685559,14,Biomarker
4359,MPZ,myelin protein zero,0.0,1.0,1.0,0.0,0.0,27888,Hereditary Sensory and Motor Neuropathy,0.213685559,13,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,345893,Juvenile polyposis syndrome,0.213685559,13,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.213685559,14,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.213685559,14,Biomarker
9817,KEAP1,kelch-like ECH-associated protein 1,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.213685559,13,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,1.0,36572,Seizures,0.213685559,16,"Biomarker, GeneticVariation, Therapeutic"
100188832,AUTS1,"Autism, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.213685559,13,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.213685559,13,"Biomarker, Therapeutic"
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",0.0,1.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.213685559,14,"Biomarker, Therapeutic"
260328,ALRH,Allergic rhinitis,0.0,1.0,0.0,0.0,0.0,2607914,"Rhinitis, Allergic",0.213685559,13,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.213685559,14,Biomarker
5324,PLAG1,pleiomorphic adenoma gene 1,0.0,1.0,1.0,0.0,0.0,1260965,Lipoblastoma,0.213685559,14,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.213685559,13,Biomarker
317,APAF1,apoptotic peptidase activating factor 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.213656595,4,Biomarker
1593,CYP27A1,"cytochrome P450, family 27, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.213656595,5,Biomarker
54209,TREM2,triggering receptor expressed on myeloid cells 2,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.213656595,6,"AlteredExpression, Biomarker, GeneticVariation"
2678,GGT1,gamma-glutamyltransferase 1,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.213656595,6,"AlteredExpression, Biomarker"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.213656595,6,"AlteredExpression, Biomarker"
6736,SRY,sex determining region Y,0.0,1.0,1.0,0.0,0.0,2748895,Ovotesticular Disorders of Sex Development,0.213656595,5,"Biomarker, GeneticVariation"
8600,TNFSF11,"tumor necrosis factor (ligand) superfamily, member 11",1.0,1.0,1.0,0.0,0.0,266929,Chronic Periodontitis,0.213656595,6,"AlteredExpression, Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,38525,Subarachnoid Hemorrhage,0.213656595,5,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,5283,beta-Thalassemia,0.213656595,5,Biomarker
657,BMPR1A,"bone morphogenetic protein receptor, type IA",0.0,1.0,1.0,0.0,0.0,18553,"Hamartoma Syndrome, Multiple",0.213656595,4,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,0.0,0.0,0.0,282612,Prostatic Intraepithelial Neoplasia,0.213656595,6,Biomarker
915,CD3D,"CD3d molecule, delta (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.213656595,6,Biomarker
406874,DYX8,dyslexia susceptibility 8,0.0,1.0,0.0,0.0,0.0,476254,Dyslexia,0.213656595,4,Biomarker
10908,PNPLA6,patatin-like phospholipase domain containing 6,0.0,1.0,1.0,0.0,0.0,85084,Motor Neuron Disease,0.213656595,4,"Biomarker, GeneticVariation"
1191,CLU,clusterin,1.0,1.0,0.0,0.0,1.0,25202,Melanoma,0.213656595,4,"AlteredExpression, Biomarker, Therapeutic"
7980,TFPI2,tissue factor pathway inhibitor 2,0.0,1.0,0.0,1.0,0.0,25202,Melanoma,0.213656595,4,"Biomarker, PostTranslationalModification"
2194,FASN,fatty acid synthase,1.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.213656595,6,"AlteredExpression, Biomarker"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.213656595,5,"Biomarker, GeneticVariation"
7249,TSC2,tuberous sclerosis 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.213656595,6,"Biomarker, GeneticVariation"
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,0.0,1.0,0.0,1973,Alcoholism,0.213656595,5,"Biomarker, PostTranslationalModification"
147912,SIX5,SIX homeobox 5,0.0,1.0,1.0,0.0,0.0,265234,Branchio-Oto-Renal Syndrome,0.213656595,4,"Biomarker, GeneticVariation"
5879,RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.213656595,5,"AlteredExpression, Biomarker"
9409,PEX16,peroxisomal biogenesis factor 16,0.0,1.0,1.0,0.0,0.0,43459,Zellweger Syndrome,0.213656595,4,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,0.0,1.0,1.0,0.0,0.0,20502,Hyperparathyroidism,0.213656595,5,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.213656595,5,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.213656595,6,Biomarker
6696,SPP1,secreted phosphoprotein 1,1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.213656595,6,"AlteredExpression, Biomarker"
54903,MKS1,"Meckel syndrome, type 1",0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.213656595,4,"Biomarker, GeneticVariation"
1755,DMBT1,deleted in malignant brain tumors 1,0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.213656595,4,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,1.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.213656595,5,"AlteredExpression, Biomarker"
5465,PPARA,peroxisome proliferator-activated receptor alpha,1.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.213656595,5,"AlteredExpression, Biomarker"
2243,FGA,fibrinogen alpha chain,0.0,1.0,1.0,0.0,0.0,1733,Afibrinogenemia,0.213656595,5,"Biomarker, GeneticVariation"
8242,KDM5C,lysine (K)-specific demethylase 5C,0.0,1.0,1.0,0.0,0.0,3714756,Intellectual Disability,0.213656595,6,"Biomarker, GeneticVariation"
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.213656595,5,Biomarker
406903,MIR10B,microRNA 10b,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213656595,5,"AlteredExpression, Biomarker"
4904,YBX1,Y box binding protein 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213656595,6,"AlteredExpression, Biomarker"
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,1.0,0.0,24121,Lung Neoplasms,0.213656595,6,"Biomarker, PostTranslationalModification"
27232,GNMT,glycine N-methyltransferase,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.213656595,6,Biomarker
6855,SYP,synaptophysin,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.213656595,6,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,1.0,1.0,1.0,0.0,0.0,29463,Osteosarcoma,0.213656595,6,"AlteredExpression, Biomarker, GeneticVariation"
4629,MYH11,"myosin, heavy chain 11, smooth muscle",1.0,1.0,0.0,0.0,0.0,23479,"Leukemia, Myelomonocytic, Acute",0.213656595,5,"AlteredExpression, Biomarker"
8021,NUP214,nucleoporin 214kDa,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.213656595,5,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,1.0,0.0,0.0,14869,"Esophagitis, Peptic",0.213656595,6,"Biomarker, GeneticVariation"
23095,KIF1B,kinesin family member 1B,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.213451086,5,"Biomarker, GeneticVariation"
29119,CTNNA3,"catenin (cadherin-associated protein), alpha 3",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.213451086,4,"Biomarker, GeneticVariation"
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.213451086,5,"Biomarker, GeneticVariation"
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,1.0,0.0,0.0,26010,Microphthalmos,0.213451086,4,"Biomarker, GeneticVariation"
3654,IRAK1,interleukin-1 receptor-associated kinase 1,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.213451086,5,"Biomarker, GeneticVariation"
10020,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,0.0,1.0,1.0,0.0,0.0,238190,"Myositis, Inclusion Body",0.213451086,6,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,1.0,34067,Pulmonary Emphysema,0.213451086,5,"Biomarker, GeneticVariation, Therapeutic"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.213451086,8,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,32927,Precancerous Conditions,0.213451086,6,"Biomarker, GeneticVariation"
5467,PPARD,peroxisome proliferator-activated receptor delta,0.0,1.0,1.0,0.0,0.0,15695,Fatty Liver,0.213451086,6,"Biomarker, GeneticVariation"
63870,PSORS5,psoriasis susceptibility 5,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.213451086,5,"Biomarker, GeneticVariation"
63869,PSORS6,psoriasis susceptibility 6,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.213451086,4,"Biomarker, GeneticVariation"
28,ABO,"ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)",0.0,1.0,1.0,0.0,0.0,13295,Duodenal Ulcer,0.213451086,4,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,0.0,23283,"Leishmaniasis, Cutaneous",0.213451086,5,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,0.0,1.0,1.0,0.0,0.0,6118,Brain Neoplasms,0.213451086,6,"Biomarker, GeneticVariation"
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,1.0,0.0,0.0,6118,Brain Neoplasms,0.213451086,6,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.213451086,6,"Biomarker, GeneticVariation"
2917,GRM7,"glutamate receptor, metabotropic 7",0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.213451086,5,"Biomarker, GeneticVariation"
412,STS,"steroid sulfatase (microsomal), isozyme S",0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.213451086,4,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,1565489,Renal Insufficiency,0.213451086,6,"Biomarker, GeneticVariation"
54806,AHI1,Abelson helper integration site 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.213451086,4,"Biomarker, GeneticVariation"
721,C4B,complement component 4B (Chido blood group),0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.213451086,6,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.213451086,4,"Biomarker, GeneticVariation"
6869,TACR1,tachykinin receptor 1,0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.213451086,4,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.213451086,4,"Biomarker, GeneticVariation"
3075,CFH,complement factor H,0.0,1.0,1.0,0.0,0.0,25303,Meningococcal Infections,0.213451086,4,"Biomarker, GeneticVariation"
146057,TTBK2,tau tubulin kinase 2,0.0,1.0,1.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.213451086,5,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.213451086,6,"Biomarker, GeneticVariation"
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),0.0,1.0,1.0,0.0,0.0,1456784,Paranoid Disorders,0.213451086,4,"Biomarker, GeneticVariation"
4902,NRTN,neurturin,0.0,1.0,1.0,0.0,0.0,19569,Hirschsprung Disease,0.213451086,5,"Biomarker, GeneticVariation"
3105,HLA-A,"major histocompatibility complex, class I, A",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.213451086,5,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,1.0,0.0,1.0,17638,Glioma,0.213451086,6,"Biomarker, GeneticVariation, Therapeutic"
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.213451086,6,"Biomarker, GeneticVariation"
2979,GUCA1B,guanylate cyclase activator 1B (retina),0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.213451086,4,"Biomarker, GeneticVariation"
5949,RBP3,"retinol binding protein 3, interstitial",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.213451086,4,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,85580,"Hypertension, Essential",0.213451086,4,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.213451086,6,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.213451086,6,"Biomarker, GeneticVariation"
1909,EDNRA,endothelin receptor type A,0.0,1.0,1.0,0.0,0.0,149931,Migraine Disorders,0.213451086,4,"Biomarker, GeneticVariation"
5502,PPP1R1A,"protein phosphatase 1, regulatory (inhibitor) subunit 1A",0.0,1.0,1.0,0.0,1.0,18801,Heart Failure,0.213451086,5,"Biomarker, GeneticVariation, Therapeutic"
3552,IL1A,"interleukin 1, alpha",0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.213451086,7,"Biomarker, GeneticVariation"
55259,CASC1,cancer susceptibility candidate 1,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.213451086,6,"Biomarker, GeneticVariation"
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.213451086,5,"Biomarker, GeneticVariation"
84547,PGBD1,piggyBac transposable element derived 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.213451086,5,"Biomarker, GeneticVariation"
8991,SELENBP1,selenium binding protein 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.213451086,4,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,23418,Leukemia,0.213451086,6,"Biomarker, GeneticVariation"
1120,CHKB,choline kinase beta,0.0,1.0,1.0,0.0,0.0,27404,Narcolepsy,0.213451086,4,"Biomarker, GeneticVariation"
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.213451086,4,"Biomarker, GeneticVariation"
10002,NR2E3,"nuclear receptor subfamily 2, group E, member 3",0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.21341388,8,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,11581,Depressive Disorder,0.213402055,12,"Biomarker, GeneticVariation"
29072,SETD2,SET domain containing 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.213402055,14,Biomarker
930,CD19,CD19 molecule,0.0,1.0,0.0,0.0,0.0,9447,Common Variable Immunodeficiency,0.213402055,13,Biomarker
7535,ZAP70,zeta-chain (TCR) associated protein kinase 70kDa,0.0,1.0,0.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.213402055,12,Biomarker
2584,GALK1,galactokinase 1,0.0,1.0,0.0,0.0,0.0,86543,Cataract,0.213402055,12,Biomarker
3954,LETM1,leucine zipper-EF-hand containing transmembrane protein 1,0.0,1.0,0.0,0.0,0.0,1956097,Wolf-Hirschhorn Syndrome,0.213402055,12,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.213402055,15,"Biomarker, Therapeutic"
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.213402055,12,"Biomarker, GeneticVariation"
57379,AICDA,activation-induced cytidine deaminase,0.0,1.0,1.0,0.0,0.0,272236,Hyper-IgM Immunodeficiency Syndrome,0.213402055,12,"Biomarker, GeneticVariation"
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,29928,Ovarian Diseases,0.213402055,13,"Biomarker, GeneticVariation"
3667,IRS1,insulin receptor substrate 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.213402055,13,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.213402055,12,Biomarker
7098,TLR3,toll-like receptor 3,0.0,1.0,0.0,0.0,0.0,276226,"Encephalitis, Herpes Simplex",0.213402055,12,Biomarker
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,1.0,30193,Pain,0.213402055,15,"Biomarker, Therapeutic"
7054,TH,tyrosine hydroxylase,0.0,1.0,1.0,0.0,0.0,242422,Parkinsonian Disorders,0.213402055,12,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.213402055,13,Biomarker
8091,HMGA2,high mobility group AT-hook 2,0.0,1.0,0.0,0.0,0.0,3489413,"LIPOMATOSIS, MULTIPLE",0.213402055,12,Biomarker
213,ALB,albumin,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.213402055,13,"Biomarker, GeneticVariation"
378938,MALAT1,metastasis associated lung adenocarcinoma transcript 1 (non-protein coding),0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.213402055,12,Biomarker
407006,MIR221,microRNA 221,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.213402055,13,Biomarker
6440,SFTPC,surfactant protein C,0.0,1.0,1.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.213402055,12,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,1.0,1261473,Sarcoma,0.213402055,16,"Biomarker, Therapeutic"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,1.0,0.0,0.0,2931833,"HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2",0.213402055,12,"Biomarker, GeneticVariation"
10892,MALT1,MALT1 paracaspase,0.0,1.0,1.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.213402055,12,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,1.0,39101,"Sarcoma, Synovial",0.213402055,12,"Biomarker, Therapeutic"
1282,COL4A1,"collagen, type IV, alpha 1",0.0,1.0,0.0,0.0,0.0,3714587,Porencephaly,0.213402055,12,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,1.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.213402055,12,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.213402055,13,Biomarker
4508,ATP6,ATP synthase F0 subunit 6,0.0,1.0,1.0,0.0,0.0,1328349,Neuropathy ataxia and retinis pigmentosa,0.213402055,12,"Biomarker, GeneticVariation"
100310785,ALL1,"Leukemia, acute lymphocytic, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.213402055,12,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,1.0,32617,Polyuria,0.213402055,13,"Biomarker, Therapeutic"
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.213402055,12,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,23281,Leishmaniasis,0.213373091,5,Biomarker
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.213373091,5,"AlteredExpression, Biomarker"
307,ANXA4,annexin A4,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.213373091,4,Biomarker
6423,SFRP2,secreted frizzled-related protein 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.213373091,3,Biomarker
182,JAG1,jagged 1,0.0,1.0,1.0,0.0,0.0,18798,"Heart Defects, Congenital",0.213373091,3,"Biomarker, GeneticVariation"
51129,ANGPTL4,angiopoietin-like 4,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.213373091,5,"AlteredExpression, Biomarker"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.213373091,3,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,0.0,0.0,0.0,10314,Cri-du-Chat Syndrome,0.213373091,3,"AlteredExpression, Biomarker"
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,1.0,0.0,0.0,25517,Metabolic Diseases,0.213373091,5,"Biomarker, GeneticVariation"
50484,RRM2B,ribonucleotide reductase M2 B (TP53 inducible),0.0,1.0,1.0,0.0,0.0,751651,Mitochondrial Diseases,0.213373091,4,"Biomarker, GeneticVariation"
57817,HAMP,hepcidin antimicrobial peptide,1.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.213373091,4,"AlteredExpression, Biomarker"
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.213373091,5,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,6625,Cachexia,0.213373091,4,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.213373091,4,Biomarker
1436,CSF1R,colony stimulating factor 1 receptor,0.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.213373091,5,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,1.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.213373091,3,"AlteredExpression, Biomarker"
6343,SCT,secretin,0.0,1.0,1.0,0.0,1.0,4352,Autistic Disorder,0.213373091,7,"Biomarker, GeneticVariation, Therapeutic"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),1.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.213373091,5,"AlteredExpression, Biomarker"
8031,NCOA4,nuclear receptor coactivator 4,0.0,1.0,1.0,0.0,0.0,40136,Thyroid Neoplasms,0.213373091,5,"Biomarker, GeneticVariation"
5830,PEX5,peroxisomal biogenesis factor 5,0.0,1.0,1.0,0.0,0.0,43459,Zellweger Syndrome,0.213373091,4,"Biomarker, GeneticVariation"
392255,GDF6,growth differentiation factor 6,0.0,1.0,1.0,0.0,0.0,22738,Klippel-Feil Syndrome,0.213373091,3,"Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.213373091,5,"AlteredExpression, Biomarker"
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.213373091,4,"Biomarker, GeneticVariation"
2878,GPX3,glutathione peroxidase 3 (plasma),1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.213373091,4,"AlteredExpression, Biomarker"
27241,BBS9,Bardet-Biedl syndrome 9,1.0,1.0,0.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.213373091,3,"AlteredExpression, Biomarker"
8313,AXIN2,axin 2,0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.213373091,5,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.213373091,5,"AlteredExpression, Biomarker"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.213373091,5,"Biomarker, Therapeutic"
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.213373091,4,Biomarker
482,ATP1B2,"ATPase, Na+/K+ transporting, beta 2 polypeptide",0.0,1.0,0.0,1.0,0.0,17638,Glioma,0.213373091,3,"Biomarker, PostTranslationalModification"
23746,AIPL1,aryl hydrocarbon receptor interacting protein-like 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.213373091,4,"Biomarker, GeneticVariation"
6295,SAG,S-antigen; retina and pineal gland (arrestin),0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.213373091,4,"Biomarker, GeneticVariation"
2101,ESRRA,estrogen-related receptor alpha,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213373091,5,Biomarker
407006,MIR221,microRNA 221,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213373091,5,Biomarker
8648,NCOA1,nuclear receptor coactivator 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213373091,5,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213373091,5,"AlteredExpression, Biomarker"
7039,TGFA,"transforming growth factor, alpha",1.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.213373091,4,"AlteredExpression, Biomarker"
6688,SPI1,Spi-1 proto-oncogene,1.0,1.0,0.0,0.0,1.0,23470,"Leukemia, Myeloid",0.213373091,4,"AlteredExpression, Biomarker, Therapeutic"
3105,HLA-A,"major histocompatibility complex, class I, A",1.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.213373091,5,"AlteredExpression, Biomarker"
1591,CYP24A1,"cytochrome P450, family 24, subfamily A, polypeptide 1",1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.213373091,4,"AlteredExpression, Biomarker"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.213373091,7,Biomarker
51741,WWOX,WW domain containing oxidoreductase,1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.213373091,4,"AlteredExpression, Biomarker"
7080,NKX2-1,NK2 homeobox 1,0.0,1.0,1.0,0.0,0.0,8489,Chorea,0.213373091,4,"Biomarker, GeneticVariation"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.213373091,5,"AlteredExpression, Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,7785,Cerebral Infarction,0.213373091,4,"Biomarker, GeneticVariation"
5583,PRKCH,"protein kinase C, eta",0.0,1.0,1.0,0.0,0.0,7785,Cerebral Infarction,0.213373091,3,"Biomarker, GeneticVariation"
6948,TCN2,transcobalamin II,0.0,1.0,0.0,0.0,0.0,2888,"Anemia, Megaloblastic",0.213373091,4,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.213373091,5,Biomarker
10801,9-Sep,septin 9,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.213373091,4,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.213324715,47,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.213324715,47,"Biomarker, GeneticVariation"
4584,MUC3A,"mucin 3A, cell surface associated",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.213167581,3,"Biomarker, GeneticVariation"
94103,ORMDL3,ORMDL sphingolipid biosynthesis regulator 3,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.213167581,3,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,79731,"Lymphoma, B-Cell",0.213167581,5,"Biomarker, GeneticVariation"
7941,PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.213167581,5,"Biomarker, GeneticVariation"
221895,JAZF1,JAZF zinc finger 1,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.213167581,3,"Biomarker, GeneticVariation"
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,1.0,0.0,0.0,20179,Huntington Disease,0.213167581,3,"Biomarker, GeneticVariation"
64170,CARD9,"caspase recruitment domain family, member 9",0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.213167581,3,"Biomarker, GeneticVariation"
3593,IL12B,interleukin 12B,0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.213167581,3,"Biomarker, GeneticVariation"
864,RUNX3,runt-related transcription factor 3,0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.213167581,3,"Biomarker, GeneticVariation"
7827,NPHS2,"nephrosis 2, idiopathic, steroid-resistant (podocin)",0.0,1.0,1.0,0.0,0.0,27720,Nephrosis,0.213167581,5,"Biomarker, GeneticVariation"
50511,SYCP3,synaptonemal complex protein 3,0.0,1.0,1.0,0.0,0.0,4509,Azoospermia,0.213167581,3,"Biomarker, GeneticVariation"
1376,CPT2,carnitine palmitoyltransferase 2,0.0,1.0,1.0,0.0,0.0,26848,Muscular Diseases,0.213167581,5,"Biomarker, GeneticVariation"
10678,B3GNT2,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.213167581,3,"Biomarker, GeneticVariation"
3118,HLA-DQA2,"major histocompatibility complex, class II, DQ alpha 2",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.213167581,5,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.213167581,5,"Biomarker, GeneticVariation"
81037,CLPTM1L,CLPTM1-like,0.0,1.0,1.0,0.0,0.0,152013,Adenocarcinoma of lung,0.213167581,5,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,8149,Chlamydia Infections,0.213167581,5,"Biomarker, GeneticVariation"
6324,SCN1B,"sodium channel, voltage gated, type I beta subunit",0.0,1.0,1.0,0.0,0.0,1142166,Brugada Syndrome,0.213167581,4,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,42373,Vascular Diseases,0.213167581,5,"Biomarker, GeneticVariation"
79001,VKORC1,"vitamin K epoxide reductase complex, subunit 1",0.0,1.0,1.0,0.0,0.0,42373,Vascular Diseases,0.213167581,4,"Biomarker, GeneticVariation"
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),0.0,1.0,1.0,0.0,0.0,268495,Oculocutaneous albinism type 2,0.213167581,3,"Biomarker, GeneticVariation"
1555,CYP2B6,"cytochrome P450, family 2, subfamily B, polypeptide 6",0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.213167581,4,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,598608,Hyperhomocysteinemia,0.213167581,6,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.213167581,4,"Biomarker, GeneticVariation"
7297,TYK2,tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.213167581,4,"Biomarker, GeneticVariation"
125893,ZNF816,zinc finger protein 816,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.213167581,3,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,23283,"Leishmaniasis, Cutaneous",0.213167581,4,"Biomarker, GeneticVariation"
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,1.0,0.0,0.0,8313,"Cholangitis, Sclerosing",0.213167581,4,"Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.213167581,5,"Biomarker, GeneticVariation"
2876,GPX1,glutathione peroxidase 1,0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.213167581,3,"Biomarker, GeneticVariation"
2185,PTK2B,protein tyrosine kinase 2 beta,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.213167581,3,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,23532,"Leukoplakia, Oral",0.213167581,3,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.213167581,3,"Biomarker, GeneticVariation"
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.213167581,4,"Biomarker, GeneticVariation"
94313,AUTS5,"Autism, susceptibility to, 5",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.213167581,3,"Biomarker, GeneticVariation"
83943,IMMP2L,IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.213167581,3,"Biomarker, GeneticVariation"
5579,PRKCB,"protein kinase C, beta",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.213167581,4,"Biomarker, GeneticVariation"
6804,STX1A,syntaxin 1A (brain),0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.213167581,3,"Biomarker, GeneticVariation"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,19337,Heroin Dependence,0.213167581,4,"Biomarker, GeneticVariation"
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.213167581,4,"Biomarker, GeneticVariation"
1075,CTSC,cathepsin C,0.0,1.0,1.0,0.0,0.0,31090,Periodontal Diseases,0.213167581,5,"Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,1.0,0.0,0.0,24809,Marijuana Abuse,0.213167581,3,"Biomarker, GeneticVariation"
6103,RPGR,retinitis pigmentosa GTPase regulator,0.0,1.0,1.0,0.0,0.0,854723,Retinal Dystrophies,0.213167581,5,"Biomarker, GeneticVariation"
389421,LIN28B,lin-28 homolog B (C. elegans),0.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.213167581,3,"Biomarker, GeneticVariation"
6833,ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.213167581,5,"Biomarker, GeneticVariation"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,1.0,0.0,0.0,27127,Myotonia Congenita,0.213167581,5,"Biomarker, GeneticVariation"
337,APOA4,apolipoprotein A-IV,0.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.213167581,5,"Biomarker, GeneticVariation"
5445,PON2,paraoxonase 2,0.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.213167581,5,"Biomarker, GeneticVariation"
998,CDC42,cell division cycle 42,1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.213167581,5,"AlteredExpression, Biomarker, GeneticVariation"
3577,CXCR1,chemokine (C-X-C motif) receptor 1,0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.213167581,3,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,1.0,0.0,1.0,11884,Diabetic Retinopathy,0.213167581,5,"Biomarker, GeneticVariation, Therapeutic"
2638,GC,group-specific component (vitamin D binding protein),0.0,1.0,1.0,0.0,0.0,18213,Graves Disease,0.213167581,3,"Biomarker, GeneticVariation"
51151,SLC45A2,"solute carrier family 45, member 2",0.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.213167581,4,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,206646,"Fibromatosis, Abdominal",0.213167581,5,"Biomarker, GeneticVariation"
117289,TAGAP,T-cell activation RhoGTPase activating protein,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.213167581,4,"Biomarker, GeneticVariation"
2559,GABRA6,"gamma-aminobutyric acid (GABA) A receptor, alpha 6",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.213167581,4,"Biomarker, GeneticVariation"
3094,HINT1,histidine triad nucleotide binding protein 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.213167581,4,"Biomarker, GeneticVariation"
5291,PIK3CB,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.213167581,4,"Biomarker, GeneticVariation"
8787,RGS9,regulator of G-protein signaling 9,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.213167581,3,"Biomarker, GeneticVariation"
1053,CEBPE,"CCAAT/enhancer binding protein (C/EBP), epsilon",0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.213167581,4,"Biomarker, GeneticVariation"
3613,IMPA2,inositol(myo)-1(or 4)-monophosphatase 2,0.0,1.0,1.0,0.0,0.0,9952,"Seizures, Febrile",0.213167581,3,"Biomarker, GeneticVariation"
6955,TRA,T cell receptor alpha locus,0.0,1.0,1.0,0.0,0.0,27404,Narcolepsy,0.213167581,3,"Biomarker, GeneticVariation"
1816,DRD5,dopamine receptor D5,0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.213167581,5,"Biomarker, GeneticVariation"
2672,GFI1,growth factor independent 1 transcription repressor,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.213167581,4,"Biomarker, GeneticVariation"
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,1.0,0.0,1.0,20619,Hypogonadism,0.213167581,7,"Biomarker, GeneticVariation, Therapeutic"
2625,GATA3,GATA binding protein 3,0.0,1.0,1.0,0.0,0.0,19829,Hodgkin Disease,0.213167581,4,"Biomarker, GeneticVariation"
51196,PLCE1,"phospholipase C, epsilon 1",0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21311855,11,"Biomarker, GeneticVariation"
5546,PRCC,papillary renal cell carcinoma (translocation-associated),0.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21311855,11,"Biomarker, GeneticVariation"
5889,RAD51C,RAD51 paralog C,0.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.21311855,11,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.21311855,15,Biomarker
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21311855,12,Biomarker
2152,F3,"coagulation factor III (thromboplastin, tissue factor)",0.0,1.0,0.0,0.0,0.0,12739,Disseminated Intravascular Coagulation,0.21311855,14,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.21311855,11,"Biomarker, GeneticVariation"
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,1.0,0.0,0.0,26918,Mycobacterium Infections,0.21311855,12,"Biomarker, GeneticVariation"
4284,MIP,major intrinsic protein of lens fiber,0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.21311855,11,"Biomarker, GeneticVariation"
2632,GBE1,"glucan (1,4-alpha-), branching enzyme 1",1.0,1.0,1.0,0.0,0.0,1849722,"Polyglucosan Body Disease, Adult Form",0.21311855,11,"AlteredExpression, Biomarker, GeneticVariation"
30835,CD209,CD209 molecule,0.0,1.0,1.0,0.0,0.0,11311,Dengue,0.21311855,11,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21311855,11,Biomarker
3954,LETM1,leucine zipper-EF-hand containing transmembrane protein 1,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21311855,11,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,19189,"Hepatitis, Chronic",0.21311855,12,"Biomarker, Therapeutic"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21311855,14,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.21311855,12,"Biomarker, GeneticVariation"
3320,HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21311855,12,Biomarker
406988,MIR205,microRNA 205,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21311855,12,Biomarker
5829,PXN,paxillin,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21311855,12,Biomarker
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.21311855,12,"Biomarker, Therapeutic"
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,282193,Iron Overload,0.21311855,12,Biomarker
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,1.0,0.0,0.0,6845,"Candidiasis, Chronic Mucocutaneous",0.21311855,11,"Biomarker, GeneticVariation"
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,1.0,0.0,0.0,23931,osteogenesis imperfecta tarda,0.21311855,11,"Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.21311855,12,Biomarker
164656,TMPRSS6,"transmembrane protease, serine 6",0.0,1.0,1.0,0.0,0.0,162316,"Anemia, Iron-Deficiency",0.21311855,12,"Biomarker, GeneticVariation"
9365,KL,klotho,0.0,1.0,0.0,0.0,0.0,85681,Hyperphosphatemia,0.21311855,12,Biomarker
8036,SHOC2,soc-2 suppressor of clear homolog (C. elegans),0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.21311855,12,"Biomarker, GeneticVariation"
4291,MLF1,myeloid leukemia factor 1,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21311855,11,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.213110308,23,"Biomarker, GeneticVariation"
1181,CLCN2,"chloride channel, voltage-sensitive 2",0.0,1.0,1.0,0.0,0.0,14553,"Epilepsy, Absence",0.213089586,2,"Biomarker, GeneticVariation"
864,RUNX3,runt-related transcription factor 3,0.0,1.0,0.0,1.0,0.0,14859,Esophageal Neoplasms,0.213089586,4,"Biomarker, PostTranslationalModification"
8837,CFLAR,CASP8 and FADD-like apoptosis regulator,1.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.213089586,3,"AlteredExpression, Biomarker"
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.213089586,3,Biomarker
4582,MUC1,"mucin 1, cell surface associated",1.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.213089586,2,"AlteredExpression, Biomarker"
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,1.0,0.0,1.0,0.0,25500,Mesothelioma,0.213089586,4,"Biomarker, PostTranslationalModification"
170682,SLEH1,systemic lupus erythematosus with hemolytic anemia 1,1.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.213089586,2,"AlteredExpression, Biomarker"
406938,MIR146A,microRNA 146a,1.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.213089586,4,"AlteredExpression, Biomarker, GeneticVariation"
55676,SLC30A6,"solute carrier family 30 (zinc transporter), member 6",0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.213089586,3,Biomarker
284,ANGPT1,angiopoietin 1,1.0,1.0,0.0,0.0,1.0,243026,Sepsis,0.213089586,4,"AlteredExpression, Biomarker, Therapeutic"
57007,ACKR3,atypical chemokine receptor 3,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.213089586,3,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,1.0,7097,Carcinoma,0.213089586,4,"Biomarker, Therapeutic"
5465,PPARA,peroxisome proliferator-activated receptor alpha,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.213089586,4,"AlteredExpression, Biomarker"
6277,S100A6,S100 calcium binding protein A6,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.213089586,4,"AlteredExpression, Biomarker"
6623,SNCG,"synuclein, gamma (breast cancer-specific protein 1)",0.0,1.0,0.0,1.0,0.0,7097,Carcinoma,0.213089586,4,"Biomarker, PostTranslationalModification"
10653,SPINT2,"serine peptidase inhibitor, Kunitz type, 2",1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.213089586,4,"AlteredExpression, Biomarker"
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.213089586,4,"Biomarker, GeneticVariation"
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.213089586,3,"AlteredExpression, Biomarker"
9308,CD83,CD83 molecule,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.213089586,4,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,1.0,6272,Bronchiolitis Obliterans,0.213089586,3,"Biomarker, GeneticVariation, Therapeutic"
23171,GPD1L,glycerol-3-phosphate dehydrogenase 1-like,0.0,1.0,1.0,0.0,0.0,38644,Sudden Infant Death,0.213089586,2,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,1.0,33860,Psoriasis,0.213089586,3,"Biomarker, GeneticVariation, Therapeutic"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,1.0,13295,Duodenal Ulcer,0.213089586,3,"Biomarker, GeneticVariation, Therapeutic"
115761,ARL11,ADP-ribosylation factor-like 11,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.213089586,2,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,41296,Tuberculosis,0.213089586,3,"Biomarker, GeneticVariation"
3982,LIM2,"lens intrinsic membrane protein 2, 19kDa",0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.213089586,2,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,17531,Giant Lymph Node Hyperplasia,0.213089586,4,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),1.0,1.0,1.0,0.0,0.0,271650,Glucose Intolerance,0.213089586,3,"AlteredExpression, Biomarker, GeneticVariation"
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,1.0,0.0,0.0,85568,Buruli Ulcer,0.213089586,2,"Biomarker, GeneticVariation"
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.213089586,5,Biomarker
7112,TMPO,thymopoietin,0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.213089586,2,"Biomarker, GeneticVariation"
1673,DEFB4A,"defensin, beta 4A",1.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.213089586,3,"AlteredExpression, Biomarker"
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",1.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.213089586,4,"AlteredExpression, Biomarker"
6275,S100A4,S100 calcium binding protein A4,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.213089586,2,Biomarker
3161,HMMR,hyaluronan-mediated motility receptor (RHAMM),0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.213089586,2,Biomarker
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,0.0,0.0,0.0,22610,Kernicterus,0.213089586,4,Biomarker
64131,XYLT1,xylosyltransferase I,0.0,1.0,0.0,0.0,0.0,33847,Pseudoxanthoma Elasticum,0.213089586,2,Biomarker
655,BMP7,bone morphogenetic protein 7,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.213089586,5,"AlteredExpression, Biomarker"
26298,EHF,ets homologous factor,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.213089586,4,"AlteredExpression, Biomarker"
2925,GRPR,gastrin-releasing peptide receptor,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.213089586,4,"AlteredExpression, Biomarker"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.213089586,4,"Biomarker, GeneticVariation"
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",1.0,1.0,0.0,0.0,0.0,206754,Neuroendocrine Tumors,0.213089586,3,"AlteredExpression, Biomarker"
7248,TSC1,tuberous sclerosis 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.213089586,4,"Biomarker, GeneticVariation"
2157,F8,"coagulation factor VIII, procoagulant component",0.0,1.0,1.0,0.0,0.0,398623,Thrombophilia,0.213089586,3,"Biomarker, GeneticVariation"
7248,TSC1,tuberous sclerosis 1,0.0,1.0,1.0,0.0,0.0,37769,"Spasms, Infantile",0.213089586,4,"Biomarker, GeneticVariation"
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.213089586,3,Biomarker
7345,UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase),1.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.213089586,2,"AlteredExpression, Biomarker"
7356,SCGB1A1,"secretoglobin, family 1A, member 1 (uteroglobin)",0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.213089586,4,Biomarker
5173,PDYN,prodynorphin,1.0,1.0,0.0,0.0,0.0,13384,Dyskinesias,0.213089586,3,"AlteredExpression, Biomarker"
5195,PEX14,peroxisomal biogenesis factor 14,0.0,1.0,0.0,0.0,0.0,43459,Zellweger Syndrome,0.213089586,2,Biomarker
595,CCND1,cyclin D1,1.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.213089586,4,"AlteredExpression, Biomarker"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,17636,Glioblastoma,0.213089586,2,"Biomarker, GeneticVariation"
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,1.0,0.0,0.0,28840,Ocular Hypertension,0.213089586,2,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,0.0,1.0,1.0,0.0,0.0,19562,von Hippel-Lindau Disease,0.213089586,2,"Biomarker, GeneticVariation"
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.213089586,3,"Biomarker, GeneticVariation"
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.213089586,4,Biomarker
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.213089586,3,"AlteredExpression, Biomarker"
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.213089586,4,"AlteredExpression, Biomarker"
5731,PTGER1,"prostaglandin E receptor 1 (subtype EP1), 42kDa",1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.213089586,4,"AlteredExpression, Biomarker"
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,1.0,0.0,1418,Adenocarcinoma,0.213089586,5,"Biomarker, PostTranslationalModification"
83593,RASSF5,Ras association (RalGDS/AF-6) domain family member 5,0.0,1.0,0.0,1.0,0.0,27819,Neuroblastoma,0.213089586,2,"Biomarker, PostTranslationalModification"
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",1.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.213089586,2,"AlteredExpression, Biomarker"
2520,GAST,gastrin,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.213089586,4,"AlteredExpression, Biomarker"
3383,ICAM1,intercellular adhesion molecule 1,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.213089586,4,"AlteredExpression, Biomarker"
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.213089586,5,"Biomarker, Therapeutic"
1475,CSTA,cystatin A (stefin A),1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.213089586,3,"AlteredExpression, Biomarker"
7473,WNT3,"wingless-type MMTV integration site family, member 3",1.0,1.0,0.0,0.0,0.0,334634,"Lymphoma, Mantle-Cell",0.213089586,2,"AlteredExpression, Biomarker"
3553,IL1B,"interleukin 1, beta",1.0,1.0,0.0,0.0,0.0,6287,Bronchopulmonary Dysplasia,0.213089586,4,"AlteredExpression, Biomarker"
9901,SRGAP3,SLIT-ROBO Rho GTPase activating protein 3,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.213089586,4,Biomarker
10551,AGR2,anterior gradient 2,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213089586,4,"AlteredExpression, Biomarker"
400500,BCAR4,breast cancer anti-estrogen resistance 4 (non-protein coding),1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213089586,3,"AlteredExpression, Biomarker"
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213089586,4,"AlteredExpression, Biomarker"
2879,GPX4,glutathione peroxidase 4,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.213089586,2,"Biomarker, GeneticVariation"
2886,GRB7,growth factor receptor-bound protein 7,1.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.213089586,5,"AlteredExpression, Biomarker, Therapeutic"
6425,SFRP5,secreted frizzled-related protein 5,0.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.213089586,3,"Biomarker, PostTranslationalModification"
5002,SLC22A18,"solute carrier family 22, member 18",0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.213089586,3,"Biomarker, GeneticVariation"
7057,THBS1,thrombospondin 1,1.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.213089586,4,"AlteredExpression, Biomarker, Therapeutic"
55809,TRERF1,transcriptional regulating factor 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.213089586,3,Biomarker
6548,SLC9A1,"solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1",1.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.213089586,3,"AlteredExpression, Biomarker"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,1.0,0.0,26764,Multiple Myeloma,0.213089586,2,"Biomarker, PostTranslationalModification"
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,1.0,0.0,0.0,42109,Urticaria,0.213089586,3,"Biomarker, GeneticVariation"
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.213089586,4,Biomarker
4319,MMP10,matrix metallopeptidase 10 (stromelysin 2),1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.213089586,3,"AlteredExpression, Biomarker"
5111,PCNA,proliferating cell nuclear antigen,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.213089586,4,"AlteredExpression, Biomarker"
5740,PTGIS,prostaglandin I2 (prostacyclin) synthase,0.0,1.0,1.0,0.0,1.0,24121,Lung Neoplasms,0.213089586,3,"Biomarker, GeneticVariation, Therapeutic"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.213089586,4,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,162316,"Anemia, Iron-Deficiency",0.213089586,6,Biomarker
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",0.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.213089586,4,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.213089586,5,"AlteredExpression, Biomarker"
7014,TERF2,telomeric repeat binding factor 2,1.0,1.0,0.0,0.0,0.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.213089586,2,"AlteredExpression, Biomarker"
374,AREG,amphiregulin,0.0,1.0,0.0,0.0,1.0,7137,"Carcinoma, Squamous Cell",0.213089586,3,"Biomarker, Therapeutic"
3065,HDAC1,histone deacetylase 1,1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.213089586,3,"AlteredExpression, Biomarker"
3678,ITGA5,"integrin, alpha 5 (fibronectin receptor, alpha polypeptide)",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.213089586,4,Biomarker
1471,CST3,cystatin C,1.0,1.0,0.0,0.0,0.0,25286,Meningioma,0.213089586,2,"AlteredExpression, Biomarker"
1476,CSTB,cystatin B (stefin B),1.0,1.0,0.0,0.0,0.0,25286,Meningioma,0.213089586,2,"AlteredExpression, Biomarker"
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",1.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.213089586,2,"AlteredExpression, Biomarker"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",1.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.213089586,4,"AlteredExpression, Biomarker"
865,CBFB,"core-binding factor, beta subunit",1.0,1.0,0.0,0.0,0.0,23479,"Leukemia, Myelomonocytic, Acute",0.213089586,4,"AlteredExpression, Biomarker"
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.213089586,3,Biomarker
4330,MN1,meningioma (disrupted in balanced translocation) 1,1.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.213089586,4,"AlteredExpression, Biomarker"
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",1.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.213089586,3,"AlteredExpression, Biomarker"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,1141890,Congenital long QT syndrome,0.21304121,46,"Biomarker, GeneticVariation"
50514,1-Dec,deleted in esophageal cancer 1,0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.212884077,3,"Biomarker, GeneticVariation"
5133,PDCD1,programmed cell death 1,0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.212884077,3,"Biomarker, GeneticVariation"
149628,PYHIN1,"pyrin and HIN domain family, member 1",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.212884077,2,"Biomarker, GeneticVariation"
1947,EFNB1,ephrin-B1,0.0,1.0,1.0,0.0,0.0,10278,Craniosynostoses,0.212884077,4,"Biomarker, GeneticVariation"
54887,UHRF1BP1,UHRF1 binding protein 1,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.212884077,2,"Biomarker, GeneticVariation"
3566,IL4R,interleukin 4 receptor,0.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.212884077,3,"Biomarker, GeneticVariation"
4048,LTA4H,leukotriene A4 hydrolase,0.0,1.0,1.0,0.0,0.0,4153,Atherosclerosis,0.212884077,3,"Biomarker, GeneticVariation"
10228,STX6,syntaxin 6,0.0,1.0,1.0,0.0,0.0,38868,"Supranuclear Palsy, Progressive",0.212884077,2,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,10073,Coronary Vasospasm,0.212884077,2,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,1.0,0.0,0.0,4509,Azoospermia,0.212884077,2,"Biomarker, GeneticVariation"
9464,HAND2,heart and neural crest derivatives expressed 2,0.0,1.0,1.0,0.0,0.0,18798,"Heart Defects, Congenital",0.212884077,4,"Biomarker, GeneticVariation"
51530,ZC3HC1,"zinc finger, C3HC-type containing 1",0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.212884077,3,"Biomarker, GeneticVariation"
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.212884077,4,"Biomarker, GeneticVariation"
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,1.0,0.0,0.0,2171,Alopecia Areata,0.212884077,3,"Biomarker, GeneticVariation"
84159,ARID5B,AT rich interactive domain 5B (MRF1-like),0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.212884077,4,"Biomarker, GeneticVariation"
2638,GC,group-specific component (vitamin D binding protein),0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.212884077,3,"Biomarker, GeneticVariation"
7297,TYK2,tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.212884077,3,"Biomarker, GeneticVariation"
4734,NEDD4,"neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,22548,Keloid,0.212884077,3,"Biomarker, GeneticVariation"
5727,PTCH1,patched 1,0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212884077,4,"Biomarker, GeneticVariation"
116519,APOA5,apolipoprotein A-V,0.0,1.0,1.0,0.0,0.0,20479,Hyperlipoproteinemia Type III,0.212884077,3,"Biomarker, GeneticVariation"
210,ALAD,aminolevulinate dehydratase,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.212884077,2,"Biomarker, GeneticVariation"
1215,CMA1,"chymase 1, mast cell",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.212884077,4,"Biomarker, GeneticVariation"
348932,SLC6A18,"solute carrier family 6 (neutral amino acid transporter), member 18",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.212884077,3,"Biomarker, GeneticVariation"
23274,CLEC16A,"C-type lectin domain family 16, member A",0.0,1.0,1.0,0.0,0.0,1403,Addison Disease,0.212884077,2,"Biomarker, GeneticVariation"
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,1.0,1.0,0.0,0.0,40038,Thromboembolism,0.212884077,4,"Biomarker, GeneticVariation"
9365,KL,klotho,0.0,1.0,1.0,0.0,0.0,20437,Hypercalcemia,0.212884077,4,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,1.0,30201,"Pain, Postoperative",0.212884077,3,"Biomarker, GeneticVariation, Therapeutic"
54414,SIAE,sialic acid acetylesterase,0.0,1.0,1.0,0.0,0.0,4364,Autoimmune Diseases,0.212884077,2,"Biomarker, GeneticVariation"
4200,ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial",0.0,1.0,1.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.212884077,2,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.212884077,3,"Biomarker, GeneticVariation"
163702,IFNLR1,"interferon, lambda receptor 1",0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.212884077,3,"Biomarker, GeneticVariation"
9232,PTTG1,pituitary tumor-transforming 1,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.212884077,3,"Biomarker, GeneticVariation"
8000,PSCA,prostate stem cell antigen,0.0,1.0,1.0,0.0,0.0,13295,Duodenal Ulcer,0.212884077,2,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,3949,Asbestosis,0.212884077,2,"Biomarker, GeneticVariation"
1019,CDK4,cyclin-dependent kinase 4,0.0,1.0,1.0,0.0,0.0,6118,Brain Neoplasms,0.212884077,4,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,6118,Brain Neoplasms,0.212884077,3,"Biomarker, GeneticVariation"
4485,MST1,macrophage stimulating 1 (hepatocyte growth factor-like),0.0,1.0,1.0,0.0,0.0,8313,"Cholangitis, Sclerosing",0.212884077,3,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,22665,Kidney Neoplasms,0.212884077,4,"Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,24301,"Lymphoma, Follicular",0.212884077,3,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,0.0,1.0,1.0,0.0,0.0,24301,"Lymphoma, Follicular",0.212884077,3,"Biomarker, GeneticVariation"
139189,DGKK,"diacylglycerol kinase, kappa",0.0,1.0,1.0,0.0,0.0,848558,Hypospadias,0.212884077,2,"Biomarker, GeneticVariation"
5284,PIGR,polymeric immunoglobulin receptor,0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.212884077,2,"Biomarker, GeneticVariation"
8741,TNFSF13,"tumor necrosis factor (ligand) superfamily, member 13",0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.212884077,3,"Biomarker, GeneticVariation"
9365,KL,klotho,0.0,1.0,1.0,0.0,0.0,6663,Calcinosis,0.212884077,4,"Biomarker, GeneticVariation"
8315,BRAP,BRCA1 associated protein,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.212884077,2,"Biomarker, GeneticVariation"
2915,GRM5,"glutamate receptor, metabotropic 5",0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.212884077,3,"Biomarker, GeneticVariation"
55014,STX17,syntaxin 17,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.212884077,2,"Biomarker, GeneticVariation"
6581,SLC22A3,"solute carrier family 22 (organic cation transporter), member 3",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212884077,4,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212884077,2,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212884077,4,"Biomarker, GeneticVariation"
5617,PRL,prolactin,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212884077,3,"Biomarker, GeneticVariation"
139411,PTCHD1,patched domain containing 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212884077,3,"Biomarker, GeneticVariation"
6535,SLC6A8,"solute carrier family 6 (neurotransmitter transporter), member 8",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212884077,2,"Biomarker, GeneticVariation"
8128,ST8SIA2,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212884077,3,"Biomarker, GeneticVariation"
27347,STK39,serine threonine kinase 39,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212884077,2,"Biomarker, GeneticVariation"
8831,SYNGAP1,synaptic Ras GTPase activating protein 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212884077,3,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.212884077,4,"Biomarker, GeneticVariation"
4887,NPY2R,neuropeptide Y receptor Y2,0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.212884077,2,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,25303,Meningococcal Infections,0.212884077,2,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.212884077,3,"Biomarker, GeneticVariation"
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.212884077,4,"Biomarker, GeneticVariation"
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",0.0,1.0,1.0,0.0,0.0,270736,Essential Tremor,0.212884077,3,"Biomarker, GeneticVariation"
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",0.0,1.0,1.0,0.0,0.0,4114,Astrocytoma,0.212884077,4,"Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,1.0,0.0,0.0,7124,"Carcinoma, Intraductal, Noninfiltrating",0.212884077,4,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,39103,Synovitis,0.212884077,3,"Biomarker, GeneticVariation"
4436,MSH2,mutS homolog 2,0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.212884077,3,"Biomarker, GeneticVariation"
2255,FGF10,fibroblast growth factor 10,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.212884077,4,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,1.0,0.0,0.0,32285,Pneumonia,0.212884077,2,"Biomarker, GeneticVariation"
56946,C11orf30,chromosome 11 open reading frame 30,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.212884077,4,"Biomarker, GeneticVariation"
6279,S100A8,S100 calcium binding protein A8,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.212884077,4,"Biomarker, GeneticVariation"
3122,HLA-DRA,"major histocompatibility complex, class II, DR alpha",0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.212884077,3,"Biomarker, GeneticVariation"
100359403,PARK16,Parkinson disease 16 (susceptibility),0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.212884077,4,"Biomarker, GeneticVariation"
57369,GJD2,"gap junction protein, delta 2, 36kDa",0.0,1.0,1.0,0.0,0.0,27092,Myopia,0.212884077,4,"Biomarker, GeneticVariation"
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,1.0,0.0,0.0,29408,Osteoarthritis,0.212884077,3,"Biomarker, GeneticVariation"
27324,TOX3,TOX high mobility group box family member 3,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.212884077,4,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,42109,Urticaria,0.212884077,4,"Biomarker, GeneticVariation"
4544,MTNR1B,melatonin receptor 1B,0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.212884077,2,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.212884077,4,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.212884077,3,"Biomarker, GeneticVariation"
5741,PTH,parathyroid hormone,0.0,1.0,1.0,0.0,1.0,29458,"Osteoporosis, Postmenopausal",0.212884077,4,"Biomarker, GeneticVariation, Therapeutic"
60468,BACH2,"BTB and CNC homology 1, basic leucine zipper transcription factor 2",0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.212884077,3,"Biomarker, GeneticVariation"
10239,AP3S2,"adaptor-related protein complex 3, sigma 2 subunit",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212884077,2,"Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.212884077,2,"Biomarker, GeneticVariation"
222698,NKAPL,NFKB activating protein-like,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.212884077,2,"Biomarker, GeneticVariation"
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.212884077,3,"Biomarker, GeneticVariation"
90139,TSPAN18,tetraspanin 18,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.212884077,2,"Biomarker, GeneticVariation"
5032,P2RY11,"purinergic receptor P2Y, G-protein coupled, 11",0.0,1.0,1.0,0.0,0.0,27404,Narcolepsy,0.212884077,2,"Biomarker, GeneticVariation"
6616,SNAP25,"synaptosomal-associated protein, 25kDa",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.212884077,3,"Biomarker, GeneticVariation"
6671,SP4,Sp4 transcription factor,0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.212884077,2,"Biomarker, GeneticVariation"
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.212884077,3,"Biomarker, GeneticVariation"
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,1.0,0.0,0.0,162557,"Liver Failure, Acute",0.212884077,3,"Biomarker, GeneticVariation"
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,1.0,0.0,0.0,19829,Hodgkin Disease,0.212884077,2,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,1.0,26846,Muscular Atrophy,0.212835046,11,"Biomarker, Therapeutic"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,1.0,7134,"Carcinoma, Renal Cell",0.212835046,11,"Biomarker, Therapeutic"
3852,KRT5,"keratin 5, type II",0.0,1.0,0.0,0.0,0.0,3714534,dowling-degos disease,0.212835046,10,Biomarker
1394,CRHR1,corticotropin releasing hormone receptor 1,0.0,1.0,1.0,0.0,0.0,3469,Anxiety Disorders,0.212835046,12,"Biomarker, GeneticVariation"
594857,NPS,neuropeptide S,0.0,1.0,1.0,0.0,1.0,3469,Anxiety Disorders,0.212835046,12,"Biomarker, GeneticVariation, Therapeutic"
2161,F12,coagulation factor XII (Hageman factor),0.0,1.0,1.0,0.0,0.0,19243,"Angioedemas, Hereditary",0.212835046,11,"Biomarker, GeneticVariation"
4321,MMP12,matrix metallopeptidase 12 (macrophage elastase),0.0,1.0,1.0,0.0,0.0,34067,Pulmonary Emphysema,0.212835046,10,"Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,1.0,20538,Hypertension,0.212835046,78,"Biomarker, Therapeutic"
213,ALB,albumin,0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.212835046,11,"Biomarker, GeneticVariation"
940,CD28,CD28 molecule,0.0,1.0,1.0,0.0,0.0,4364,Autoimmune Diseases,0.212835046,12,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.212835046,11,Biomarker
10547,PSORS4,psoriasis susceptibility 4,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.212835046,10,Biomarker
6278,S100A7,S100 calcium binding protein A7,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.212835046,11,"Biomarker, GeneticVariation"
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.212835046,11,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,3809250,ESTROGEN RESISTANCE,0.212835046,11,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,0.0,0.0,0.0,265313,Weill-Marchesani Syndrome,0.212835046,10,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.212835046,10,Biomarker
406913,MIR126,microRNA 126,0.0,1.0,0.0,0.0,1.0,7131,"Carcinoma, Non-Small-Cell Lung",0.212835046,11,"Biomarker, Therapeutic"
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.212835046,13,"Biomarker, Therapeutic"
8878,SQSTM1,sequestosome 1,0.0,1.0,1.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.212835046,11,"Biomarker, GeneticVariation"
2588,GALNS,galactosamine (N-acetyl)-6-sulfatase,0.0,1.0,1.0,0.0,0.0,26707,Mucopolysaccharidosis IV,0.212835046,10,"Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,1.0,0.0,1.0,37769,"Spasms, Infantile",0.212835046,30,"Biomarker, GeneticVariation, Therapeutic"
100507436,MICA,MHC class I polypeptide-related sequence A,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212835046,11,"Biomarker, GeneticVariation"
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212835046,10,Biomarker
8431,NR0B2,"nuclear receptor subfamily 0, group B, member 2",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212835046,11,Biomarker
5189,PEX1,peroxisomal biogenesis factor 1,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.212835046,11,Biomarker
5241,PGR,progesterone receptor,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.212835046,11,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.212835046,11,Biomarker
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.212835046,11,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,1.0,0.0,1.0,27947,Neutropenia,0.212835046,12,"Biomarker, GeneticVariation, Therapeutic"
10939,AFG3L2,AFG3-like AAA ATPase 2,0.0,1.0,0.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.212835046,11,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.212835046,10,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.212835046,11,Biomarker
3020,H3F3A,"H3 histone, family 3A",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.212835046,12,"Biomarker, GeneticVariation"
9365,KL,klotho,0.0,1.0,0.0,0.0,0.0,3850,Arteriosclerosis,0.212835046,11,Biomarker
5293,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta",0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.212835046,10,Biomarker
2248,FGF3,fibroblast growth factor 3,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212835046,11,Biomarker
79147,FKRP,fukutin related protein,0.0,1.0,0.0,0.0,0.0,265221,Walker-Warburg Syndrome,0.212835046,10,Biomarker
2539,G6PD,glucose-6-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,2882,"Anemia, Hemolytic, Congenital Nonspherocytic",0.212835046,12,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,1.0,26764,Multiple Myeloma,0.212835046,13,"Biomarker, Therapeutic"
5741,PTH,parathyroid hormone,0.0,1.0,1.0,0.0,0.0,20438,Hypercalciuria,0.212835046,11,"Biomarker, GeneticVariation"
1113,CHGA,chromogranin A (parathyroid secretory protein 1),0.0,1.0,0.0,0.0,0.0,31511,Pheochromocytoma,0.212835046,11,Biomarker
7054,TH,tyrosine hydroxylase,0.0,1.0,0.0,0.0,0.0,31511,Pheochromocytoma,0.212835046,11,Biomarker
1462,VCAN,versican,0.0,1.0,1.0,0.0,0.0,1840452,Hyaloideoretinal degeneration of Wagner,0.212835046,10,"Biomarker, GeneticVariation"
864,RUNX3,runt-related transcription factor 3,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.212835046,11,Biomarker
2152,F3,"coagulation factor III (thromboplastin, tissue factor)",0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.212835046,11,Biomarker
4256,MGP,matrix Gla protein,1.0,1.0,0.0,0.0,0.0,42345,Varicose Veins,0.212806082,1,"AlteredExpression, Biomarker"
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,1.0,26846,Muscular Atrophy,0.212806082,3,"Biomarker, Therapeutic"
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,1.0,35304,Retinal Degeneration,0.212806082,2,"Biomarker, Therapeutic"
2662,GDF10,growth differentiation factor 10,0.0,1.0,0.0,1.0,0.0,25500,Mesothelioma,0.212806082,1,"Biomarker, PostTranslationalModification"
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),1.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.212806082,2,"AlteredExpression, Biomarker"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,25500,Mesothelioma,0.212806082,3,"Biomarker, GeneticVariation"
200931,SLC51A,"solute carrier family 51, alpha subunit",1.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.212806082,3,"AlteredExpression, Biomarker"
123264,SLC51B,"solute carrier family 51, beta subunit",1.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.212806082,3,"AlteredExpression, Biomarker"
1580,CYP4B1,"cytochrome P450, family 4, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.212806082,2,"Biomarker, GeneticVariation"
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212806082,2,Biomarker
54474,KRT20,"keratin 20, type I",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212806082,3,Biomarker
116135,LRRC3B,leucine rich repeat containing 3B,0.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.212806082,1,"Biomarker, PostTranslationalModification"
5793,PTPRG,"protein tyrosine phosphatase, receptor type, G",0.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.212806082,1,"Biomarker, PostTranslationalModification"
54739,XAF1,XIAP associated factor 1,0.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.212806082,2,"Biomarker, PostTranslationalModification"
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,1.0,20179,Huntington Disease,0.212806082,3,"Biomarker, Therapeutic"
1381,CRABP1,cellular retinoic acid binding protein 1,1.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.212806082,1,"AlteredExpression, Biomarker"
3315,HSPB1,heat shock 27kDa protein 1,1.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.212806082,3,"AlteredExpression, Biomarker"
1959,EGR2,early growth response 2,0.0,1.0,0.0,0.0,0.0,35372,Rett Syndrome,0.212806082,1,Biomarker
1808,DPYSL2,dihydropyrimidinase-like 2,0.0,1.0,0.0,1.0,0.0,2395,Alzheimer Disease,0.212806082,3,"Biomarker, PostTranslationalModification"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,1.0,22116,Ischemia,0.212806082,4,"Biomarker, Therapeutic"
8572,PDLIM4,PDZ and LIM domain 4,0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.212806082,1,"Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.212806082,7,"Biomarker, GeneticVariation"
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,85109,Corneal Neovascularization,0.212806082,3,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",1.0,1.0,1.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.212806082,3,"AlteredExpression, Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.212806082,2,Biomarker
5921,RASA1,RAS p21 protein activator (GTPase activating protein) 1,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212806082,3,"AlteredExpression, Biomarker"
3925,STMN1,stathmin 1,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212806082,3,"AlteredExpression, Biomarker"
7170,TPM3,tropomyosin 3,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212806082,4,Biomarker
5655,KLK10,kallikrein-related peptidase 10,0.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.212806082,3,"Biomarker, GeneticVariation"
8991,SELENBP1,selenium binding protein 1,1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.212806082,2,"AlteredExpression, Biomarker"
6502,SKP2,"S-phase kinase-associated protein 2, E3 ubiquitin protein ligase",1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.212806082,2,"AlteredExpression, Biomarker"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",1.0,1.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.212806082,3,"AlteredExpression, Biomarker, Therapeutic"
11009,IL24,interleukin 24,0.0,1.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.212806082,2,"Biomarker, Therapeutic"
8854,ALDH1A2,"aldehyde dehydrogenase 1 family, member A2",0.0,1.0,1.0,0.0,0.0,25312,Meningomyelocele,0.212806082,1,"Biomarker, GeneticVariation"
8842,PROM1,prominin 1,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212806082,4,"Biomarker, GeneticVariation"
7097,TLR2,toll-like receptor 2,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212806082,3,"Biomarker, GeneticVariation"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,1.0,9404,Colorectal Neoplasms,0.212806082,3,"Biomarker, Therapeutic"
80317,ZKSCAN3,zinc finger with KRAB and SCAN domains 3,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212806082,1,Biomarker
2101,ESRRA,estrogen-related receptor alpha,0.0,1.0,0.0,0.0,1.0,25517,Metabolic Diseases,0.212806082,3,"Biomarker, Therapeutic"
3934,LCN2,lipocalin 2,1.0,1.0,0.0,0.0,0.0,5283,beta-Thalassemia,0.212806082,2,"AlteredExpression, Biomarker"
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,1.0,1.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.212806082,2,"Biomarker, GeneticVariation"
60,ACTB,"actin, beta",0.0,1.0,1.0,0.0,0.0,13421,Dystonia,0.212806082,1,"Biomarker, GeneticVariation"
3727,JUND,jun D proto-oncogene,1.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.212806082,1,"AlteredExpression, Biomarker"
2981,GUCA2B,guanylate cyclase activator 2B (uroguanylin),0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.212806082,1,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,1.0,282612,Prostatic Intraepithelial Neoplasia,0.212806082,3,"Biomarker, Therapeutic"
5292,PIM1,"Pim-1 proto-oncogene, serine/threonine kinase",1.0,1.0,0.0,0.0,0.0,282612,Prostatic Intraepithelial Neoplasia,0.212806082,2,"AlteredExpression, Biomarker"
3958,LGALS3,"lectin, galactoside-binding, soluble, 3",1.0,1.0,0.0,0.0,1.0,27697,Nephritis,0.212806082,2,"AlteredExpression, Biomarker, Therapeutic"
4015,LOX,lysyl oxidase,1.0,1.0,0.0,0.0,0.0,19202,Hepatolenticular Degeneration,0.212806082,2,"AlteredExpression, Biomarker"
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,11881,Diabetic Nephropathies,0.212806082,2,"Biomarker, GeneticVariation"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.212806082,3,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.212806082,3,Biomarker
8600,TNFSF11,"tumor necrosis factor (ligand) superfamily, member 11",0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.212806082,2,Biomarker
23414,ZFPM2,"zinc finger protein, FOG family member 2",0.0,1.0,1.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.212806082,2,"Biomarker, GeneticVariation"
10804,GJB6,"gap junction protein, beta 6, 30kDa",0.0,1.0,1.0,0.0,0.0,13575,Ectodermal Dysplasia,0.212806082,2,"Biomarker, GeneticVariation"
6356,CCL11,chemokine (C-C motif) ligand 11,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.212806082,2,Biomarker
6352,CCL5,chemokine (C-C motif) ligand 5,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.212806082,2,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",1.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.212806082,3,"AlteredExpression, Biomarker"
51738,GHRL,ghrelin/obestatin prepropeptide,1.0,1.0,0.0,0.0,1.0,6625,Cachexia,0.212806082,3,"AlteredExpression, Biomarker, Therapeutic"
3236,HOXD10,homeobox D10,0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.212806082,2,"Biomarker, GeneticVariation"
2152,F3,"coagulation factor III (thromboplastin, tissue factor)",1.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.212806082,3,"AlteredExpression, Biomarker"
2263,FGFR2,fibroblast growth factor receptor 2,1.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.212806082,2,"AlteredExpression, Biomarker"
941,CD80,CD80 molecule,1.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.212806082,2,"AlteredExpression, Biomarker"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.212806082,3,"AlteredExpression, Biomarker"
10481,HOXB13,homeobox B13,1.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.212806082,1,"AlteredExpression, Biomarker"
5078,PAX4,paired box 4,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.212806082,1,Biomarker
55504,TNFRSF19,"tumor necrosis factor receptor superfamily, member 19",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.212806082,1,Biomarker
6447,SCG5,secretogranin V (7B2 protein),1.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.212806082,1,"AlteredExpression, Biomarker"
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,1.0,27651,Neoplasms,0.212806082,3,"Biomarker, Therapeutic"
2923,PDIA3,"protein disulfide isomerase family A, member 3",0.0,1.0,0.0,0.0,1.0,27651,Neoplasms,0.212806082,3,"Biomarker, Therapeutic"
8863,PER3,period circadian clock 3,1.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.212806082,1,"AlteredExpression, Biomarker"
55256,ADI1,acireductone dioxygenase 1,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,1,"AlteredExpression, Biomarker"
467,ATF3,activating transcription factor 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,3,Biomarker
894,CCND2,cyclin D2,0.0,1.0,0.0,1.0,0.0,33578,Prostatic Neoplasms,0.212806082,2,"Biomarker, PostTranslationalModification"
1576,CYP3A4,"cytochrome P450, family 3, subfamily A, polypeptide 4",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,3,Biomarker
9420,CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,2,"Biomarker, GeneticVariation"
55840,EAF2,ELL associated factor 2,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
3169,FOXA1,forkhead box A1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,3,Biomarker
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,3,Biomarker
3558,IL2,interleukin 2,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,2,"Biomarker, GeneticVariation"
4023,LPL,lipoprotein lipase,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,2,"Biomarker, GeneticVariation"
11178,LZTS1,"leucine zipper, putative tumor suppressor 1",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,2,"Biomarker, GeneticVariation"
8202,NCOA3,nuclear receptor coactivator 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,4,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,3,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,3,"Biomarker, GeneticVariation"
56924,PAK6,p21 protein (Cdc42/Rac)-activated kinase 6,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,2,"AlteredExpression, Biomarker"
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
7079,TIMP4,TIMP metallopeptidase inhibitor 4,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212806082,2,Biomarker
7298,TYMS,thymidylate synthetase,1.0,1.0,0.0,0.0,0.0,206754,Neuroendocrine Tumors,0.212806082,2,"AlteredExpression, Biomarker"
1072,CFL1,cofilin 1 (non-muscle),0.0,1.0,1.0,0.0,0.0,80178,Spinal Dysraphism,0.212806082,1,"Biomarker, GeneticVariation"
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",1.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.212806082,2,"AlteredExpression, Biomarker"
1719,DHFR,dihydrofolate reductase,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212806082,1,"Biomarker, GeneticVariation"
1959,EGR2,early growth response 2,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.212806082,1,Biomarker
221037,JMJD1C,jumonji domain containing 1C,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.212806082,1,Biomarker
221035,REEP3,receptor accessory protein 3,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.212806082,1,Biomarker
7328,UBE2H,ubiquitin-conjugating enzyme E2H,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212806082,1,"Biomarker, GeneticVariation"
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212806082,2,Biomarker
64399,HHIP,hedgehog interacting protein,0.0,1.0,0.0,1.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212806082,1,"Biomarker, PostTranslationalModification"
83597,RTP3,receptor (chemosensory) transporter protein 3,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212806082,1,Biomarker
9353,SLIT2,slit homolog 2 (Drosophila),0.0,1.0,0.0,1.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212806082,1,"Biomarker, PostTranslationalModification"
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.212806082,3,"AlteredExpression, Biomarker"
3600,IL15,interleukin 15,1.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.212806082,3,"AlteredExpression, Biomarker"
3371,TNC,tenascin C,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.212806082,2,Biomarker
2067,ERCC1,excision repair cross-complementation group 1,1.0,1.0,0.0,0.0,0.0,39590,Testicular Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
113235,SLC46A1,"solute carrier family 46 (folate transporter), member 1",0.0,1.0,1.0,0.0,0.0,24523,Malabsorption Syndromes,0.212806082,3,"Biomarker, GeneticVariation"
2202,EFEMP1,EGF containing fibulin-like extracellular matrix protein 1,1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.212806082,3,"AlteredExpression, Biomarker"
3791,KDR,kinase insert domain receptor,1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.212806082,3,"AlteredExpression, Biomarker"
3856,KRT8,"keratin 8, type II",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.212806082,3,Biomarker
91147,TMEM67,transmembrane protein 67,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.212806082,1,"Biomarker, GeneticVariation"
27113,BBC3,BCL2 binding component 3,0.0,1.0,1.0,0.0,0.0,6413,Burkitt Lymphoma,0.212806082,1,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.212806082,3,Biomarker
51176,LEF1,lymphoid enhancer-binding factor 1,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
8549,LGR5,leucine-rich repeat containing G protein-coupled receptor 5,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212806082,3,Biomarker
27035,NOX1,NADPH oxidase 1,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212806082,2,"AlteredExpression, Biomarker"
8434,RECK,reversion-inducing-cysteine-rich protein with kazal motifs,0.0,1.0,0.0,1.0,0.0,9375,Colonic Neoplasms,0.212806082,1,"Biomarker, PostTranslationalModification"
6876,TAGLN,transgelin,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212806082,2,"AlteredExpression, Biomarker"
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212806082,2,"AlteredExpression, Biomarker"
396,ARHGDIA,Rho GDP dissociation inhibitor (GDI) alpha,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.212806082,3,Biomarker
2056,EPO,erythropoietin,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.212806082,2,"AlteredExpression, Biomarker"
8772,FADD,Fas (TNFRSF6)-associated via death domain,0.0,1.0,1.0,0.0,0.0,27627,Neoplasm Metastasis,0.212806082,3,"Biomarker, GeneticVariation"
4192,MDK,midkine (neurite growth-promoting factor 2),0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.212806082,2,Biomarker
7153,TOP2A,topoisomerase (DNA) II alpha 170kDa,1.0,1.0,0.0,0.0,0.0,17638,Glioma,0.212806082,3,"AlteredExpression, Biomarker"
255520,ELMOD2,ELMO/CED-12 domain containing 2,0.0,1.0,0.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.212806082,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,1.0,1800706,Idiopathic Pulmonary Fibrosis,0.212806082,1,"Biomarker, Therapeutic"
10084,PQBP1,polyglutamine binding protein 1,0.0,1.0,1.0,0.0,0.0,25958,Microcephaly,0.212806082,4,"Biomarker, GeneticVariation"
5328,PLAU,"plasminogen activator, urokinase",1.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.212806082,2,"AlteredExpression, Biomarker"
6259,RYK,receptor-like tyrosine kinase,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.212806082,2,"Biomarker, GeneticVariation"
3572,IL6ST,interleukin 6 signal transducer,1.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.212806082,3,"AlteredExpression, Biomarker"
5176,SERPINF1,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1",1.0,1.0,0.0,0.0,1.0,42164,Uveitis,0.212806082,3,"AlteredExpression, Biomarker, Therapeutic"
6401,SELE,selectin E,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.212806082,2,Biomarker
64324,NSD1,nuclear receptor binding SET domain protein 1,0.0,1.0,1.0,0.0,0.0,3714756,Intellectual Disability,0.212806082,2,"Biomarker, GeneticVariation"
25,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",0.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.212806082,3,"Biomarker, PostTranslationalModification"
652,BMP4,bone morphogenetic protein 4,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,Biomarker
56946,C11orf30,chromosome 11 open reading frame 30,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
1436,CSF1R,colony stimulating factor 1 receptor,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,Biomarker
54567,DLL4,delta-like 4 (Drosophila),1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
2249,FGF4,fibroblast growth factor 4,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
2305,FOXM1,forkhead box M1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
3014,H2AFX,"H2A histone family, member X",0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,"Biomarker, GeneticVariation"
3756,KCNH1,"potassium channel, voltage gated eag related subfamily H, member 1",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,2,"AlteredExpression, Biomarker"
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
10499,NCOA2,nuclear receptor coactivator 2,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
10397,NDRG1,N-myc downstream regulated 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
4855,NOTCH4,notch 4,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,4,"AlteredExpression, Biomarker"
5047,PAEP,progestagen-associated endometrial protein,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212806082,3,Biomarker
2495,FTH1,"ferritin, heavy polypeptide 1",0.0,1.0,0.0,0.0,0.0,282193,Iron Overload,0.212806082,3,Biomarker
81029,WNT5B,"wingless-type MMTV integration site family, member 5B",1.0,1.0,0.0,0.0,0.0,23267,Leiomyoma,0.212806082,1,"AlteredExpression, Biomarker"
55904,KMT2E,lysine (K)-specific methyltransferase 2E,0.0,1.0,0.0,0.0,0.0,23470,"Leukemia, Myeloid",0.212806082,2,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,1.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.212806082,2,"AlteredExpression, Biomarker"
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,1.0,0.0,24121,Lung Neoplasms,0.212806082,3,"Biomarker, PostTranslationalModification"
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212806082,5,"AlteredExpression, Biomarker"
634,CEACAM1,carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein),1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
2202,EFEMP1,EGF containing fibulin-like extracellular matrix protein 1,0.0,1.0,0.0,1.0,0.0,24121,Lung Neoplasms,0.212806082,2,"Biomarker, PostTranslationalModification"
2697,GJA1,"gap junction protein, alpha 1, 43kDa",1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
1326,MAP3K8,mitogen-activated protein kinase kinase kinase 8,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212806082,2,"AlteredExpression, Biomarker"
1432,MAPK14,mitogen-activated protein kinase 14,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212806082,3,"AlteredExpression, Biomarker"
4854,NOTCH3,notch 3,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212806082,2,Biomarker
2678,GGT1,gamma-glutamyltransferase 1,1.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.212806082,2,"AlteredExpression, Biomarker"
6340,SCNN1G,"sodium channel, non voltage gated 1 gamma subunit",0.0,1.0,1.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.212806082,3,"Biomarker, GeneticVariation"
2277,FIGF,c-fos induced growth factor (vascular endothelial growth factor D),1.0,1.0,0.0,0.0,0.0,751674,Lymphangioleiomyomatosis,0.212806082,3,"AlteredExpression, Biomarker"
4118,MAL,"mal, T-cell differentiation protein",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.212806082,2,Biomarker
8202,NCOA3,nuclear receptor coactivator 3,1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.212806082,2,"AlteredExpression, Biomarker"
7249,TSC2,tuberous sclerosis 2,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.212806082,2,Biomarker
2335,FN1,fibronectin 1,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.212806082,2,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,17662,"Glomerulonephritis, Membranoproliferative",0.212806082,1,Biomarker
338442,HCAR2,hydroxycarboxylic acid receptor 2,1.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.212806082,1,"AlteredExpression, Biomarker"
1514,CTSL,cathepsin L,1.0,1.0,0.0,0.0,0.0,25286,Meningioma,0.212806082,2,"AlteredExpression, Biomarker"
4669,NAGLU,"N-acetylglucosaminidase, alpha",0.0,1.0,1.0,0.0,0.0,26706,Mucopolysaccharidosis III,0.212806082,2,"Biomarker, GeneticVariation"
6103,RPGR,retinitis pigmentosa GTPase regulator,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.212806082,2,"Biomarker, GeneticVariation"
9499,MYOT,myotilin,0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.212806082,1,"Biomarker, GeneticVariation"
701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,0.0,1.0,1.0,0.0,0.0,206656,"Rhabdomyosarcoma, Embryonal",0.212806082,2,"Biomarker, GeneticVariation"
355,FAS,Fas cell surface death receptor,1.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.212806082,3,"AlteredExpression, Biomarker"
2252,FGF7,fibroblast growth factor 7,0.0,1.0,0.0,0.0,0.0,2937421,Prostatic Hyperplasia,0.212806082,3,Biomarker
4838,NODAL,nodal growth differentiation factor,0.0,1.0,1.0,0.0,0.0,79541,Holoprosencephaly,0.212806082,3,"Biomarker, GeneticVariation"
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,1.0,0.0,0.0,19158,Hepatitis,0.212806082,4,"Biomarker, GeneticVariation"
2308,FOXO1,forkhead box O1,0.0,1.0,1.0,1.0,0.0,23467,"Leukemia, Myeloid, Acute",0.212806082,3,"Biomarker, GeneticVariation, PostTranslationalModification"
9103,FCGR2C,"Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)",0.0,1.0,1.0,0.0,0.0,398650,"Purpura, Thrombocytopenic, Idiopathic",0.212806082,1,"Biomarker, GeneticVariation"
2245,FGD1,"FYVE, RhoGEF and PH domain containing 1",0.0,1.0,1.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.212806082,1,"Biomarker, GeneticVariation"
641339,ZNF674,zinc finger protein 674,0.0,1.0,1.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.212806082,1,"Biomarker, GeneticVariation"
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.212797839,12,"Biomarker, GeneticVariation"
6833,ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",0.0,1.0,1.0,0.0,0.0,158981,Neonatal diabetes mellitus,0.212757706,45,"Biomarker, GeneticVariation"
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.212600572,3,"Biomarker, GeneticVariation"
11178,LZTS1,"leucine zipper, putative tumor suppressor 1",0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.212600572,2,"Biomarker, GeneticVariation"
3579,CXCR2,chemokine (C-X-C motif) receptor 2,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.212600572,2,"Biomarker, GeneticVariation"
1611,DAP,death-associated protein,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.212600572,2,"Biomarker, GeneticVariation"
2768,GNA12,guanine nucleotide binding protein (G protein) alpha 12,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.212600572,2,"Biomarker, GeneticVariation"
23308,ICOSLG,inducible T-cell co-stimulator ligand,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.212600572,2,"Biomarker, GeneticVariation"
7128,TNFAIP3,"tumor necrosis factor, alpha-induced protein 3",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.212600572,3,"Biomarker, GeneticVariation"
8740,TNFSF14,"tumor necrosis factor (ligand) superfamily, member 14",0.0,1.0,1.0,0.0,0.0,26769,Multiple Sclerosis,0.212600572,3,"Biomarker, GeneticVariation"
10019,SH2B3,SH2B adaptor protein 3,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.212600572,2,"Biomarker, GeneticVariation"
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",0.0,1.0,1.0,0.0,0.0,85215,Primary Ovarian Insufficiency,0.212600572,1,"Biomarker, GeneticVariation"
24,ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4",0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.212600572,1,"Biomarker, GeneticVariation"
9935,MAFB,v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.212600572,1,"Biomarker, GeneticVariation"
5727,PTCH1,patched 1,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.212600572,3,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.212600572,3,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.212600572,3,"Biomarker, GeneticVariation"
23607,CD2AP,CD2-associated protein,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.212600572,3,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.212600572,3,"Biomarker, GeneticVariation"
3552,IL1A,"interleukin 1, alpha",0.0,1.0,1.0,0.0,0.0,3165,Anthracosis,0.212600572,1,"Biomarker, GeneticVariation"
196527,ANO6,anoctamin 6,0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.212600572,2,"Biomarker, GeneticVariation"
7850,IL1R2,"interleukin 1 receptor, type II",0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.212600572,2,"Biomarker, GeneticVariation"
4336,MOBP,myelin-associated oligodendrocyte basic protein,0.0,1.0,1.0,0.0,0.0,38868,"Supranuclear Palsy, Progressive",0.212600572,1,"Biomarker, GeneticVariation"
6121,RPE65,retinal pigment epithelium-specific protein 65kDa,0.0,1.0,1.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.212600572,4,"Biomarker, GeneticVariation"
1719,DHFR,dihydrofolate reductase,0.0,1.0,1.0,0.0,0.0,16412,Folic Acid Deficiency,0.212600572,2,"Biomarker, GeneticVariation"
9518,GDF15,growth differentiation factor 15,0.0,1.0,1.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.212600572,1,"Biomarker, GeneticVariation"
270,AMPD1,adenosine monophosphate deaminase 1,0.0,1.0,1.0,0.0,0.0,26848,Muscular Diseases,0.212600572,3,"Biomarker, GeneticVariation"
23564,DDAH2,dimethylarginine dimethylaminohydrolase 2,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.212600572,3,"Biomarker, GeneticVariation"
10019,SH2B3,SH2B adaptor protein 3,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.212600572,2,"Biomarker, GeneticVariation"
29086,BABAM1,BRISC and BRCA1 A complex member 1,0.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.212600572,1,"Biomarker, GeneticVariation"
306,ANXA3,annexin A3,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.212600572,2,"Biomarker, GeneticVariation"
122618,PLD4,"phospholipase D family, member 4",0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.212600572,2,"Biomarker, GeneticVariation"
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,1.0,0.0,0.0,9376,Colonic Polyps,0.212600572,2,"Biomarker, GeneticVariation"
6795,AURKC,aurora kinase C,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.212600572,3,"Biomarker, GeneticVariation"
2488,FSHB,"follicle stimulating hormone, beta polypeptide",0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.212600572,3,"Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.212600572,1,"Biomarker, GeneticVariation"
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.212600572,1,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.212600572,2,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,35235,Respiratory Syncytial Virus Infections,0.212600572,3,"Biomarker, GeneticVariation"
2643,GCH1,GTP cyclohydrolase 1,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.212600572,3,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,32927,Precancerous Conditions,0.212600572,2,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,32927,Precancerous Conditions,0.212600572,4,"Biomarker, GeneticVariation"
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,1.0,1.0,0.0,0.0,19087,Hemorrhagic Disorders,0.212600572,3,"Biomarker, GeneticVariation"
2262,GPC5,glypican 5,0.0,1.0,1.0,0.0,1.0,27726,Nephrotic Syndrome,0.212600572,1,"Biomarker, GeneticVariation, Therapeutic"
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,1.0,1.0,0.0,0.0,40038,Thromboembolism,0.212600572,3,"Biomarker, GeneticVariation"
4018,LPA,"lipoprotein, Lp(a)",0.0,1.0,1.0,0.0,0.0,40038,Thromboembolism,0.212600572,3,"Biomarker, GeneticVariation"
4049,LTA,lymphotoxin alpha,0.0,1.0,1.0,0.0,0.0,23343,Leprosy,0.212600572,2,"Biomarker, GeneticVariation"
4057,LTF,lactotransferrin,0.0,0.0,1.0,0.0,1.0,11991,Diarrhea,0.212600572,2,"GeneticVariation, Therapeutic"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,242992,Multiple Chemical Sensitivity,0.212600572,2,"Biomarker, GeneticVariation"
64478,CSMD1,CUB and Sushi multiple domains 1,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.212600572,2,"Biomarker, GeneticVariation"
84648,LCE3D,late cornified envelope 3D,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.212600572,4,"Biomarker, GeneticVariation"
5271,SERPINB8,"serpin peptidase inhibitor, clade B (ovalbumin), member 8",0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.212600572,2,"Biomarker, GeneticVariation"
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,1.0,0.0,0.0,23014,Language Development Disorders,0.212600572,5,"Biomarker, GeneticVariation"
9378,NRXN1,neurexin 1,0.0,1.0,1.0,0.0,0.0,23014,Language Development Disorders,0.212600572,3,"Biomarker, GeneticVariation"
1816,DRD5,dopamine receptor D5,0.0,1.0,1.0,0.0,0.0,5747,Blepharospasm,0.212600572,1,"Biomarker, GeneticVariation"
9855,FARP2,"FERM, RhoGEF and pleckstrin domain protein 2",0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.212600572,1,"Biomarker, GeneticVariation"
5934,RBL2,retinoblastoma-like 2,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.212600572,2,"Biomarker, GeneticVariation"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,1.0,0.0,0.0,41948,Uremia,0.212600572,3,"Biomarker, GeneticVariation"
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,1.0,0.0,0.0,920350,"Thyroiditis, Autoimmune",0.212600572,2,"Biomarker, GeneticVariation"
1299,COL9A3,"collagen, type IX, alpha 3",0.0,1.0,1.0,0.0,0.0,158252,Intervertebral disc disease,0.212600572,1,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.212600572,3,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.212600572,4,"Biomarker, GeneticVariation"
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.212600572,6,"Biomarker, GeneticVariation"
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,1.0,0.0,1.0,23890,Liver Cirrhosis,0.212600572,3,"Biomarker, GeneticVariation, Therapeutic"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,1856061,Methylenetetrahydrofolate reductase deficiency,0.212600572,2,"Biomarker, GeneticVariation"
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,1.0,0.0,0.0,13274,"Ductus Arteriosus, Patent",0.212600572,2,"Biomarker, GeneticVariation"
5740,PTGIS,prostaglandin I2 (prostacyclin) synthase,0.0,1.0,1.0,0.0,0.0,13274,"Ductus Arteriosus, Patent",0.212600572,1,"Biomarker, GeneticVariation"
2152,F3,"coagulation factor III (thromboplastin, tissue factor)",0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.212600572,2,"Biomarker, GeneticVariation"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.212600572,2,"Biomarker, GeneticVariation"
51129,ANGPTL4,angiopoietin-like 4,0.0,1.0,1.0,0.0,0.0,242339,Dyslipidemias,0.212600572,3,"Biomarker, GeneticVariation"
842,CASP9,"caspase 9, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212600572,3,"Biomarker, GeneticVariation"
2255,FGF10,fibroblast growth factor 10,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212600572,2,"Biomarker, GeneticVariation"
222546,RFX6,"regulatory factor X, 6",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212600572,2,"Biomarker, GeneticVariation"
440822,PIWIL3,piwi-like RNA-mediated gene silencing 3,0.0,1.0,1.0,0.0,0.0,28960,Oligospermia,0.212600572,1,"Biomarker, GeneticVariation"
143689,PIWIL4,piwi-like RNA-mediated gene silencing 4,0.0,1.0,1.0,0.0,0.0,28960,Oligospermia,0.212600572,1,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,80178,Spinal Dysraphism,0.212600572,1,"Biomarker, GeneticVariation"
25828,TXN2,thioredoxin 2,0.0,1.0,1.0,0.0,0.0,80178,Spinal Dysraphism,0.212600572,1,"Biomarker, GeneticVariation"
18,ABAT,4-aminobutyrate aminotransferase,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,2,"Biomarker, GeneticVariation"
40,ASIC2,acid sensing (proton gated) ion channel 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,2,"Biomarker, GeneticVariation"
2876,GPX1,glutathione peroxidase 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
3237,HOXD11,homeobox D11,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
3352,HTR1D,"5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,2,"Biomarker, GeneticVariation"
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
170572,HTR3C,"5-hydroxytryptamine (serotonin) receptor 3C, ionotropic",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
3361,HTR5A,"5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
3927,LASP1,LIM and SH3 protein 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
140733,MACROD2,MACRO domain containing 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,2,"Biomarker, GeneticVariation"
4129,MAOB,monoamine oxidase B,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,3,"Biomarker, GeneticVariation"
4642,MYO1D,myosin ID,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
4862,NPAS2,neuronal PAS domain protein 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
64324,NSD1,nuclear receptor binding SET domain protein 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,2,"Biomarker, GeneticVariation"
5187,PER1,period circadian clock 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
5307,PITX1,paired-like homeodomain 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
64221,ROBO3,"roundabout, axon guidance receptor, homolog 3 (Drosophila)",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
54538,ROBO4,"roundabout, axon guidance receptor, homolog 4 (Drosophila)",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
6134,RPL10,ribosomal protein L10,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,2,"Biomarker, GeneticVariation"
26470,SEZ6L2,seizure related 6 homolog (mouse)-like 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
27044,SND1,staphylococcal nuclease and tudor domain containing 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212600572,1,"Biomarker, GeneticVariation"
2185,PTK2B,protein tyrosine kinase 2 beta,0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.212600572,2,"Biomarker, GeneticVariation"
7507,XPA,"xeroderma pigmentosum, complementation group A",0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.212600572,4,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212600572,2,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,1.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.212600572,2,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.212600572,2,"Biomarker, GeneticVariation"
7046,TGFBR1,"transforming growth factor, beta receptor 1",0.0,1.0,1.0,0.0,0.0,2949,"Aneurysm, Dissecting",0.212600572,3,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,1.0,85129,Bronchial Hyperreactivity,0.212600572,3,"Biomarker, GeneticVariation, Therapeutic"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,27708,Wilms Tumor,0.212600572,1,"Biomarker, GeneticVariation"
875,CBS,cystathionine-beta-synthase,0.0,1.0,1.0,0.0,0.0,162429,Malnutrition,0.212600572,2,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.212600572,5,"Biomarker, GeneticVariation"
8764,TNFRSF14,"tumor necrosis factor receptor superfamily, member 14",0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.212600572,2,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,2893,"Anemia, Refractory",0.212600572,2,"Biomarker, GeneticVariation"
51196,PLCE1,"phospholipase C, epsilon 1",0.0,1.0,1.0,0.0,0.0,19100,Severe Dengue,0.212600572,2,"Biomarker, GeneticVariation"
51196,PLCE1,"phospholipase C, epsilon 1",0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.212600572,2,"Biomarker, GeneticVariation"
57531,HACE1,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1,0.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.212600572,1,"Biomarker, GeneticVariation"
54620,FBXL19,F-box and leucine-rich repeat protein 19,0.0,1.0,1.0,0.0,0.0,3872,"Arthritis, Psoriatic",0.212600572,2,"Biomarker, GeneticVariation"
4210,MEFV,Mediterranean fever,0.0,1.0,1.0,0.0,0.0,3872,"Arthritis, Psoriatic",0.212600572,2,"Biomarker, GeneticVariation"
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,1.0,0.0,0.0,17665,"Glomerulonephritis, Membranous",0.212600572,3,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.212600572,4,"Biomarker, GeneticVariation"
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,1.0,0.0,0.0,27889,Hereditary Sensory and Autonomic Neuropathies,0.212600572,2,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,85179,Eosinophilia-Myalgia Syndrome,0.212600572,1,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,1.0,2622,Amnesia,0.212600572,3,"Biomarker, GeneticVariation, Therapeutic"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.212600572,3,"Biomarker, GeneticVariation"
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.212600572,3,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.212600572,3,"Biomarker, GeneticVariation"
5017,OVOL1,ovo-like zinc finger 1,0.0,1.0,1.0,0.0,0.0,11615,"Dermatitis, Atopic",0.212600572,3,"Biomarker, GeneticVariation"
5923,RASGRF1,Ras protein-specific guanine nucleotide-releasing factor 1,0.0,1.0,1.0,0.0,0.0,27092,Myopia,0.212600572,3,"Biomarker, GeneticVariation"
153090,DAB2IP,DAB2 interacting protein,0.0,1.0,1.0,0.0,0.0,162871,"Aortic Aneurysm, Abdominal",0.212600572,1,"Biomarker, GeneticVariation"
57761,TRIB3,tribbles pseudokinase 3,0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.212600572,2,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.212600572,4,"Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.212600572,4,"Biomarker, GeneticVariation"
5617,PRL,prolactin,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.212600572,2,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.212600572,3,"Biomarker, GeneticVariation"
54986,ULK4,unc-51 like kinase 4,0.0,1.0,1.0,0.0,0.0,26764,Multiple Myeloma,0.212600572,1,"Biomarker, GeneticVariation"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,1.0,0.0,0.0,42109,Urticaria,0.212600572,2,"Biomarker, GeneticVariation"
3176,HNMT,histamine N-methyltransferase,0.0,1.0,1.0,0.0,0.0,42109,Urticaria,0.212600572,3,"Biomarker, GeneticVariation"
4835,NQO2,"NAD(P)H dehydrogenase, quinone 2",0.0,1.0,1.0,0.0,0.0,1824,Agranulocytosis,0.212600572,1,"Biomarker, GeneticVariation"
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.212600572,3,"Biomarker, GeneticVariation"
5079,PAX5,paired box 5,0.0,1.0,1.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.212600572,3,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,9081,Clubfoot,0.212600572,1,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,1.0,20459,Hyperinsulinism,0.212600572,2,"Biomarker, GeneticVariation, Therapeutic"
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.212600572,3,"Biomarker, GeneticVariation"
1471,CST3,cystatin C,0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.212600572,2,"Biomarker, GeneticVariation"
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.212600572,2,"Biomarker, GeneticVariation"
100507436,MICA,MHC class I polypeptide-related sequence A,0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.212600572,2,"Biomarker, GeneticVariation"
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.212600572,3,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.212600572,2,"Biomarker, GeneticVariation"
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,1.0,0.0,0.0,14548,"Epilepsy, Generalized",0.212600572,2,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,0.0,1.0,1.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.212600572,4,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,23903,Liver Neoplasms,0.212600572,3,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,1.0,0.0,0.0,34734,Raynaud Disease,0.212600572,1,"Biomarker, GeneticVariation"
894,CCND2,cyclin D2,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212600572,2,"Biomarker, GeneticVariation"
355,FAS,Fas cell surface death receptor,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212600572,3,"Biomarker, GeneticVariation"
2888,GRB14,growth factor receptor-bound protein 14,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212600572,2,"Biomarker, GeneticVariation"
55600,ITLN1,intelectin 1 (galactofuranose binding),0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212600572,3,"Biomarker, GeneticVariation"
10296,MAEA,macrophage erythroblast attacher,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212600572,2,"Biomarker, GeneticVariation"
4825,NKX6-1,NK6 homeobox 1,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212600572,3,"Biomarker, GeneticVariation"
5080,PAX6,paired box 6,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212600572,3,"Biomarker, GeneticVariation"
7325,UBE2E2,ubiquitin-conjugating enzyme E2E 2,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212600572,1,"Biomarker, GeneticVariation"
9559,VPS26A,vacuolar protein sorting 26 homolog A (S. pombe),0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212600572,2,"Biomarker, GeneticVariation"
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.212600572,3,"Biomarker, GeneticVariation"
5062,PAK2,p21 protein (Cdc42/Rac)-activated kinase 2,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.212600572,2,"Biomarker, GeneticVariation"
8028,MLLT10,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10",0.0,1.0,1.0,0.0,0.0,25286,Meningioma,0.212600572,1,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,21122,Impulse Control Disorders,0.212600572,5,"Biomarker, GeneticVariation"
2067,ERCC1,excision repair cross-complementation group 1,0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.212600572,1,"Biomarker, GeneticVariation"
3875,KRT18,"keratin 18, type I",0.0,1.0,1.0,0.0,0.0,162557,"Liver Failure, Acute",0.212600572,1,"Biomarker, GeneticVariation"
3856,KRT8,"keratin 8, type II",0.0,1.0,1.0,0.0,0.0,162557,"Liver Failure, Acute",0.212600572,1,"Biomarker, GeneticVariation"
3459,IFNGR1,interferon gamma receptor 1,0.0,1.0,1.0,0.0,0.0,19163,Hepatitis B,0.212600572,2,"Biomarker, GeneticVariation"
23562,CLDN14,claudin 14,0.0,1.0,1.0,0.0,0.0,22650,Kidney Calculi,0.212600572,1,"Biomarker, GeneticVariation"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.212600572,2,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,206064,Microvascular Angina,0.212600572,1,"Biomarker, GeneticVariation"
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.212551541,9,"Biomarker, GeneticVariation"
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.212551541,10,Biomarker
9365,KL,klotho,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.212551541,9,"Biomarker, GeneticVariation"
710,SERPING1,"serpin peptidase inhibitor, clade G (C1 inhibitor), member 1",0.0,1.0,0.0,0.0,1.0,2931758,Acquired angioedema,0.212551541,10,"Biomarker, Therapeutic"
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.212551541,9,Biomarker
140805,HT,Hashimoto thyroiditis,0.0,1.0,1.0,0.0,0.0,677607,Hashimoto Disease,0.212551541,9,"Biomarker, GeneticVariation"
64919,BCL11B,B-cell CLL/lymphoma 11B (zinc finger protein),0.0,1.0,1.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.212551541,10,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.212551541,9,Biomarker
7750,ZMYM2,"zinc finger, MYM-type 2",0.0,1.0,0.0,0.0,0.0,27022,Myeloproliferative Disorders,0.212551541,10,Biomarker
4005,LMO2,LIM domain only 2 (rhombotin-like 1),0.0,1.0,0.0,0.0,0.0,23492,"Leukemia, T-Cell",0.212551541,9,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.212551541,10,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.212551541,10,Biomarker
1019,CDK4,cyclin-dependent kinase 4,0.0,1.0,0.0,0.0,1.0,23827,Liposarcoma,0.212551541,10,"Biomarker, Therapeutic"
199713,NLRP7,"NLR family, pyrin domain containing 7",0.0,1.0,1.0,0.0,0.0,3463897,"HYDATIDIFORM MOLE, RECURRENT, 1",0.212551541,9,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,1.0,1.0,1.0,0.0,0.0,32002,Pituitary Diseases,0.212551541,9,"AlteredExpression, Biomarker, GeneticVariation"
283120,H19,"H19, imprinted maternally expressed transcript (non-protein coding)",0.0,1.0,0.0,0.0,0.0,175693,Silver-Russell Syndrome,0.212551541,10,Biomarker
1033,CDKN3,cyclin-dependent kinase inhibitor 3,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212551541,9,"Biomarker, GeneticVariation"
29126,CD274,CD274 molecule,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212551541,10,Biomarker
2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212551541,11,Biomarker
364,AQP7,aquaporin 7,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.212551541,10,Biomarker
3020,H3F3A,"H3 histone, family 3A",0.0,1.0,1.0,0.0,0.0,17636,Glioblastoma,0.212551541,10,"Biomarker, GeneticVariation"
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.212551541,10,Biomarker
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,1.0,17636,Glioblastoma,0.212551541,10,"Biomarker, Therapeutic"
84181,CHD6,chromodomain helicase DNA binding protein 6,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.212551541,9,Biomarker
213,ALB,albumin,1.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.212551541,10,"AlteredExpression, Biomarker"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.212551541,9,Biomarker
5291,PIK3CB,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta",0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.212551541,9,Biomarker
5294,PIK3CG,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma",0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.212551541,9,Biomarker
6462,SHBG,sex hormone-binding globulin,0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.212551541,10,"Biomarker, GeneticVariation"
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.212551541,11,Biomarker
29954,POMT2,protein-O-mannosyltransferase 2,0.0,1.0,0.0,0.0,0.0,265221,Walker-Warburg Syndrome,0.212551541,9,Biomarker
3667,IRS1,insulin receptor substrate 1,0.0,1.0,1.0,0.0,0.0,20459,Hyperinsulinism,0.212551541,9,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.212551541,11,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.212551541,13,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.212551541,10,Biomarker
5447,POR,P450 (cytochrome) oxidoreductase,0.0,1.0,1.0,0.0,0.0,2350233,Antley-Bixler Syndrome Phenotype,0.212522577,4,"Biomarker, GeneticVariation"
581,BAX,BCL2-associated X protein,1.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
6317,SERPINB3,"serpin peptidase inhibitor, clade B (ovalbumin), member 3",1.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
331,XIAP,"X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase",1.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
6862,T,"T, brachyury homolog (mouse)",1.0,1.0,0.0,0.0,0.0,8487,Chordoma,0.212522577,3,"AlteredExpression, Biomarker"
2272,FHIT,fragile histidine triad,1.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.212522577,2,"AlteredExpression, Biomarker"
55600,ITLN1,intelectin 1 (galactofuranose binding),1.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.212522577,1,"AlteredExpression, Biomarker"
84700,MYO18B,myosin XVIIIB,1.0,0.0,0.0,0.0,1.0,25500,Mesothelioma,0.212522577,1,"AlteredExpression, Therapeutic"
204,AK2,adenylate kinase 2,0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.212522577,1,"Biomarker, GeneticVariation"
182,JAG1,jagged 1,0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.212522577,1,"Biomarker, GeneticVariation"
65217,PCDH15,protocadherin-related 15,0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.212522577,2,"Biomarker, GeneticVariation"
330,BIRC3,baculoviral IAP repeat containing 3,1.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
2100,ESR2,estrogen receptor 2 (ER beta),1.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
2876,GPX1,glutathione peroxidase 1,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
5646,PRSS3,"protease, serine, 3",0.0,1.0,0.0,1.0,0.0,5695,Urinary Bladder Neoplasms,0.212522577,1,"Biomarker, PostTranslationalModification"
1890,TYMP,thymidine phosphorylase,1.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.212522577,3,"AlteredExpression, Biomarker"
196,AHR,aryl hydrocarbon receptor,1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
10550,ARL6IP5,ADP-ribosylation factor-like 6 interacting protein 5,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
329,BIRC2,baculoviral IAP repeat containing 2,1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
1000,CDH2,"cadherin 2, type 1, N-cadherin (neuronal)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,Biomarker
1365,CLDN3,claudin 3,1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
131566,DCBLD2,"discoidin, CUB and LCCL domain containing 2",0.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.212522577,1,"Biomarker, PostTranslationalModification"
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
1839,HBEGF,heparin-binding EGF-like growth factor,1.0,0.0,0.0,0.0,1.0,38356,Stomach Neoplasms,0.212522577,2,"AlteredExpression, Therapeutic"
3814,KISS1,KiSS-1 metastasis-suppressor,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,Biomarker
5655,KLK10,kallikrein-related peptidase 10,1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
8190,MIA,melanoma inhibitory activity,1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
4319,MMP10,matrix metallopeptidase 10 (stromelysin 2),1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,3,Biomarker
5328,PLAU,"plasminogen activator, urokinase",1.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,1.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"Biomarker, PostTranslationalModification"
6138,RPL15,ribosomal protein L15,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,Biomarker
51741,WWOX,WW domain containing oxidoreductase,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",1.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.212522577,4,"AlteredExpression, Biomarker"
7225,TRPC6,"transient receptor potential cation channel, subfamily C, member 6",1.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.212522577,2,"AlteredExpression, Biomarker"
64805,P2RY12,"purinergic receptor P2Y, G-protein coupled, 12",1.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.212522577,1,"AlteredExpression, Biomarker"
64695,SLEB3,systemic lupus erythematosus susceptibility 3,1.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.212522577,1,"AlteredExpression, Biomarker"
2166,FAAH,fatty acid amide hydrolase,1.0,1.0,0.0,0.0,0.0,20179,Huntington Disease,0.212522577,2,"AlteredExpression, Biomarker"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.212522577,2,Biomarker
2248,FGF3,fibroblast growth factor 3,0.0,1.0,0.0,0.0,0.0,8924,Cleft Lip,0.212522577,2,Biomarker
2252,FGF7,fibroblast growth factor 7,0.0,1.0,0.0,0.0,0.0,8924,Cleft Lip,0.212522577,2,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",1.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.212522577,3,"AlteredExpression, Biomarker"
356,FASLG,"Fas ligand (TNF superfamily, member 6)",1.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.212522577,2,"AlteredExpression, Biomarker"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,242788,"Breast Neoplasms, Male",0.212522577,2,"Biomarker, GeneticVariation"
1839,HBEGF,heparin-binding EGF-like growth factor,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.212522577,2,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.212522577,4,"Biomarker, Therapeutic"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.212522577,4,"Biomarker, Therapeutic"
498,ATP5A1,"ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle",0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.212522577,2,Biomarker
7782,SLC30A4,"solute carrier family 30 (zinc transporter), member 4",0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.212522577,1,Biomarker
4057,LTF,lactotransferrin,0.0,1.0,0.0,0.0,1.0,29456,Osteoporosis,0.212522577,2,"Biomarker, Therapeutic"
7035,TFPI,tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor),1.0,1.0,0.0,0.0,0.0,600433,Activated Protein C Resistance,0.212522577,2,"AlteredExpression, Biomarker"
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.212522577,2,Biomarker
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,1.0,0.0,0.0,18798,"Heart Defects, Congenital",0.212522577,1,"Biomarker, GeneticVariation"
1356,CP,ceruloplasmin (ferroxidase),1.0,1.0,0.0,0.0,0.0,32914,Pre-Eclampsia,0.212522577,1,"AlteredExpression, Biomarker"
3624,INHBA,"inhibin, beta A",1.0,1.0,0.0,0.0,0.0,32914,Pre-Eclampsia,0.212522577,2,"AlteredExpression, Biomarker"
5177,PEE1,preeclampsia/eclampsia 1,0.0,1.0,1.0,0.0,0.0,32914,Pre-Eclampsia,0.212522577,1,"Biomarker, GeneticVariation"
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212522577,2,Biomarker
2167,FABP4,"fatty acid binding protein 4, adipocyte",1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212522577,2,"AlteredExpression, Biomarker"
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212522577,2,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212522577,3,"AlteredExpression, Biomarker"
5618,PRLR,prolactin receptor,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212522577,3,Biomarker
6662,SOX9,SRY (sex determining region Y)-box 9,1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212522577,2,"AlteredExpression, Biomarker"
8848,TSC22D1,"TSC22 domain family, member 1",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212522577,2,Biomarker
7534,YWHAZ,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta",1.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.212522577,2,"AlteredExpression, Biomarker"
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
4072,EPCAM,epithelial cell adhesion molecule,1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
6648,SOD2,"superoxide dismutase 2, mitochondrial",1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
7015,TERT,telomerase reverse transcriptase,1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
7298,TYMS,thymidylate synthetase,1.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
331,XIAP,"X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.212522577,2,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,38358,Stomach Ulcer,0.212522577,4,Biomarker
5274,SERPINI1,"serpin peptidase inhibitor, clade I (neuroserpin), member 1",0.0,1.0,1.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.212522577,2,"Biomarker, GeneticVariation"
5196,PF4,platelet factor 4,0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.212522577,8,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,31030,Periapical Periodontitis,0.212522577,1,Biomarker
5349,FXYD3,FXYD domain containing ion transport regulator 3,1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
5909,RAP1GAP,RAP1 GTPase activating protein,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212522577,2,Biomarker
6751,SSTR1,somatostatin receptor 1,1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
7980,TFPI2,tissue factor pathway inhibitor 2,1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
7249,TSC2,tuberous sclerosis 2,1.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
10666,CD226,CD226 molecule,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
2041,EPHA1,EPH receptor A1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,Biomarker
51466,EVL,Enah/Vasp-like,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,3,"Biomarker, GeneticVariation"
201163,FLCN,folliculin,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
2356,FPGS,folylpolyglutamate synthase,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
79695,GALNT12,polypeptide N-acetylgalactosaminyltransferase 12,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
2626,GATA4,GATA binding protein 4,0.0,1.0,0.0,1.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"Biomarker, PostTranslationalModification"
140628,GATA5,GATA binding protein 5,0.0,1.0,0.0,1.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"Biomarker, PostTranslationalModification"
8836,GGH,"gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)",1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
3791,KDR,kinase insert domain receptor,1.0,0.0,0.0,0.0,1.0,9404,Colorectal Neoplasms,0.212522577,2,"AlteredExpression, Therapeutic"
4288,MKI67,marker of proliferation Ki-67,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,1,Biomarker
54894,RNF43,ring finger protein 43,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,Biomarker
6424,SFRP4,secreted frizzled-related protein 4,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
6425,SFRP5,secreted frizzled-related protein 5,0.0,1.0,0.0,1.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"Biomarker, PostTranslationalModification"
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
64321,SOX17,SRY (sex determining region Y)-box 17,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
11171,STRAP,serine/threonine kinase receptor associated protein,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
7083,TK1,"thymidine kinase 1, soluble",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,1.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
7374,UNG,uracil-DNA glycosylase,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
3357,HTR2B,"5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled",1.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.212522577,3,"AlteredExpression, Biomarker"
3606,IL18,interleukin 18,1.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.212522577,2,"AlteredExpression, Biomarker"
5465,PPARA,peroxisome proliferator-activated receptor alpha,1.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.212522577,2,"AlteredExpression, Therapeutic"
6236,RRAD,Ras-related associated with diabetes,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.212522577,1,Biomarker
1129,CHRM2,"cholinergic receptor, muscarinic 2",0.0,1.0,0.0,0.0,1.0,5697,"Urinary Bladder, Neurogenic",0.212522577,2,"Biomarker, Therapeutic"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),1.0,0.0,0.0,0.0,1.0,24305,"Lymphoma, Non-Hodgkin",0.212522577,4,"AlteredExpression, Therapeutic"
356,FASLG,"Fas ligand (TNF superfamily, member 6)",1.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.212522577,2,"AlteredExpression, Biomarker"
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",1.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.212522577,2,"AlteredExpression, Biomarker"
1432,MAPK14,mitogen-activated protein kinase 14,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.212522577,2,Biomarker
9499,MYOT,myotilin,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.212522577,1,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.212522577,2,"AlteredExpression, Therapeutic"
3592,IL12A,interleukin 12A,1.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.212522577,2,"AlteredExpression, Biomarker"
2152,F3,"coagulation factor III (thromboplastin, tissue factor)",0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.212522577,2,Biomarker
2981,GUCA2B,guanylate cyclase activator 2B (uroguanylin),0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.212522577,1,Biomarker
7015,TERT,telomerase reverse transcriptase,1.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
7472,WNT2,wingless-type MMTV integration site family member 2,0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.212522577,2,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.212522577,2,Biomarker
7490,WT1,Wilms tumor 1,1.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.212522577,2,"AlteredExpression, Biomarker"
5465,PPARA,peroxisome proliferator-activated receptor alpha,1.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.212522577,2,"AlteredExpression, Biomarker"
9992,KCNE2,"potassium channel, voltage gated subfamily E regulatory beta subunit 2",0.0,1.0,1.0,0.0,0.0,4238,Atrial Fibrillation,0.212522577,1,"Biomarker, GeneticVariation"
4879,NPPB,natriuretic peptide B,1.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.212522577,2,"AlteredExpression, Biomarker"
6401,SELE,selectin E,1.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.212522577,2,"AlteredExpression, Biomarker"
7450,VWF,von Willebrand factor,1.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.212522577,2,"AlteredExpression, Biomarker"
10232,MSLN,mesothelin,1.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.212522577,3,"AlteredExpression, Biomarker"
2670,GFAP,glial fibrillary acidic protein,1.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.212522577,2,"AlteredExpression, Biomarker"
4017,LOXL2,lysyl oxidase-like 2,1.0,1.0,0.0,0.0,0.0,19202,Hepatolenticular Degeneration,0.212522577,1,"AlteredExpression, Biomarker"
2736,GLI2,GLI family zinc finger 2,1.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.212522577,2,"AlteredExpression, Biomarker"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,270611,Brain Injuries,0.212522577,4,"Biomarker, GeneticVariation"
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,1.0,270611,Brain Injuries,0.212522577,2,"Biomarker, Therapeutic"
8742,TNFSF12,"tumor necrosis factor (ligand) superfamily, member 12",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.212522577,2,Biomarker
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,1.0,270611,Brain Injuries,0.212522577,2,"Biomarker, Therapeutic"
4192,MDK,midkine (neurite growth-promoting factor 2),1.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.212522577,1,"AlteredExpression, Biomarker"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",1.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.212522577,2,"AlteredExpression, Biomarker"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,1.0,20507,Hyperplasia,0.212522577,2,"Biomarker, Therapeutic"
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.212522577,2,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.212522577,2,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,1.0,0.0,0.0,20507,Hyperplasia,0.212522577,2,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),1.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.212522577,4,"AlteredExpression, Biomarker"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.212522577,2,"Biomarker, GeneticVariation"
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,1.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.212522577,1,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,37116,Silicosis,0.212522577,2,"Biomarker, GeneticVariation"
9817,KEAP1,kelch-like ECH-associated protein 1,0.0,1.0,1.0,0.0,0.0,16978,Gallbladder Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
3567,IL5,interleukin 5,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.212522577,1,Biomarker
3605,IL17A,interleukin 17A,1.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.212522577,2,"AlteredExpression, Biomarker"
51176,LEF1,lymphoid enhancer-binding factor 1,0.0,1.0,1.0,0.0,0.0,36503,Sebaceous Gland Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
153,ADRB1,adrenoceptor beta 1,0.0,1.0,1.0,0.0,0.0,242973,Ventricular Dysfunction,0.212522577,1,"Biomarker, GeneticVariation"
3627,CXCL10,chemokine (C-X-C motif) ligand 10,1.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.212522577,2,"AlteredExpression, Biomarker"
4283,CXCL9,chemokine (C-X-C motif) ligand 9,1.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.212522577,2,"AlteredExpression, Biomarker"
954,ENTPD2,ectonucleoside triphosphate diphosphohydrolase 2,1.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.212522577,1,"AlteredExpression, Biomarker"
10397,NDRG1,N-myc downstream regulated 1,1.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.212522577,3,Biomarker
2149,F2R,coagulation factor II (thrombin) receptor,0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.212522577,2,"Biomarker, GeneticVariation"
5806,PTX3,"pentraxin 3, long",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.212522577,2,Biomarker
387,RHOA,ras homolog family member A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.212522577,2,Biomarker
132,ADK,adenosine kinase,1.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.212522577,2,"AlteredExpression, Biomarker"
1958,EGR1,early growth response 1,1.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.212522577,2,"AlteredExpression, Biomarker"
4879,NPPB,natriuretic peptide B,1.0,1.0,0.0,0.0,1.0,7193,"Cardiomyopathy, Dilated",0.212522577,3,"AlteredExpression, Biomarker, Therapeutic"
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.212522577,2,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,42065,Urogenital Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
1645,AKR1C1,"aldo-keto reductase family 1, member C1",1.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
8644,AKR1C3,"aldo-keto reductase family 1, member C3",1.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",1.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
2033,EP300,E1A binding protein p300,1.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
3206,HOXA10,homeobox A10,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.212522577,2,Biomarker
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",1.0,0.0,0.0,0.0,1.0,14170,Endometrial Neoplasms,0.212522577,2,"AlteredExpression, Therapeutic"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",1.0,0.0,0.0,0.0,1.0,151744,Myocardial Ischemia,0.212522577,2,"AlteredExpression, Therapeutic"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,1.0,27051,Myocardial Infarction,0.212522577,2,"Biomarker, Therapeutic"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",1.0,1.0,0.0,0.0,0.0,20452,Hyperemia,0.212522577,2,"AlteredExpression, Biomarker"
153,ADRB1,adrenoceptor beta 1,0.0,1.0,1.0,0.0,0.0,20452,Hyperemia,0.212522577,1,"Biomarker, GeneticVariation"
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.212522577,2,Biomarker
1386,ATF2,activating transcription factor 2,1.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
847,CAT,catalase,1.0,0.0,0.0,0.0,1.0,27651,Neoplasms,0.212522577,2,"AlteredExpression, Therapeutic"
10495,ENOX2,ecto-NOX disulfide-thiol exchanger 2,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.212522577,2,Biomarker
9446,GSTO1,glutathione S-transferase omega 1,0.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
3297,HSF1,heat shock transcription factor 1,1.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
9,NAT1,N-acetyltransferase 1 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,27651,Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.212522577,2,Biomarker
177,AGER,advanced glycosylation end product-specific receptor,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
623,BDKRB1,bradykinin receptor B1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
2833,CXCR3,chemokine (C-X-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
2149,F2R,coagulation factor II (thrombin) receptor,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
3620,IDO1,"indoleamine 2,3-dioxygenase 1",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
3934,LCN2,lipocalin 2,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
1241,LTB4R,leukotriene B4 receptor,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
4057,LTF,lactotransferrin,0.0,1.0,0.0,0.0,1.0,21368,Inflammation,0.212522577,2,"Biomarker, Therapeutic"
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,3,Biomarker
5329,PLAUR,"plasminogen activator, urokinase receptor",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.212522577,2,Biomarker
7349,UCN,urocortin,1.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.212522577,2,"AlteredExpression, Therapeutic"
154,ADRB2,"adrenoceptor beta 2, surface",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
384,ARG2,arginase 2,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
563,AZGP1,"alpha-2-glycoprotein 1, zinc-binding",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
567,B2M,beta-2-microglobulin,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
658,BMPR1B,"bone morphogenetic protein receptor, type IB",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
928,CD9,CD9 molecule,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
1012,CDH13,cadherin 13,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,Biomarker
1366,CLDN7,claudin 7,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
8895,CPNE3,copine III,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,Biomarker
6376,CX3CL1,chemokine (C-X3-C motif) ligand 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,Biomarker
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
64816,CYP3A43,"cytochrome P450, family 3, subfamily A, polypeptide 43",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
1605,DAG1,dystroglycan 1 (dystrophin-associated glycoprotein 1),1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
51181,DCXR,dicarbonyl/L-xylulose reductase,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
8667,EIF3H,"eukaryotic translation initiation factor 3, subunit H",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
1647,GADD45A,"growth arrest and DNA-damage-inducible, alpha",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
2690,GHR,growth hormone receptor,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,Biomarker
9687,GREB1,growth regulation by estrogen in breast cancer 1,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
2938,GSTA1,glutathione S-transferase alpha 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
3283,HSD3B1,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
3284,HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
7184,HSP90B1,"heat shock protein 90kDa beta (Grp94), member 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,Biomarker
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,3,"Biomarker, GeneticVariation"
3603,IL16,interleukin 16,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,Biomarker
54756,IL17RD,interleukin 17 receptor D,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
3606,IL18,interleukin 18,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
3708,ITPR1,"inositol 1,4,5-trisphosphate receptor, type 1",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
3728,JUP,junction plakoglobin,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
606293,KLKP1,kallikrein pseudogene 1,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
3915,LAMC1,"laminin, gamma 1 (formerly LAMB2)",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
4437,MSH3,mutS homolog 3,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
10499,NCOA2,nuclear receptor coactivator 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
83259,PCDH11Y,protocadherin 11 Y-linked,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,Biomarker
5420,PODXL,podocalyxin-like,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"Biomarker, GeneticVariation"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,Biomarker
5567,PRKACB,"protein kinase, cAMP-dependent, catalytic, beta",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,Biomarker
5590,PRKCZ,"protein kinase C, zeta",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,Biomarker
23635,SSBP2,single-stranded DNA binding protein 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,Biomarker
7178,TPT1,"tumor protein, translationally-controlled 1",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
7298,TYMS,thymidylate synthetase,1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
8409,UXT,"ubiquitously-expressed, prefoldin-like chaperone",1.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
1116,CHI3L1,chitinase 3-like 1 (cartilage glycoprotein-39),0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.212522577,2,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",1.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.212522577,8,"AlteredExpression, Biomarker"
885,CCK,cholecystokinin,0.0,1.0,0.0,0.0,0.0,242216,Gallstones,0.212522577,2,Biomarker
8089,YEATS4,YEATS domain containing 4,1.0,0.0,0.0,0.0,1.0,23827,Liposarcoma,0.212522577,2,"AlteredExpression, Therapeutic"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,29422,Osteochondrodysplasias,0.212522577,2,"Biomarker, GeneticVariation"
1297,COL9A1,"collagen, type IX, alpha 1",0.0,1.0,1.0,0.0,0.0,29422,Osteochondrodysplasias,0.212522577,2,"Biomarker, GeneticVariation"
3339,HSPG2,heparan sulfate proteoglycan 2,0.0,1.0,1.0,0.0,0.0,29422,Osteochondrodysplasias,0.212522577,3,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,1.0,1.0,0.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.212522577,1,"AlteredExpression, Biomarker"
361,AQP4,aquaporin 4,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.212522577,1,Biomarker
23705,CADM1,cell adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212522577,1,"Biomarker, GeneticVariation"
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",1.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.212522577,1,"AlteredExpression, Biomarker"
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.212522577,1,Biomarker
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.212522577,1,Biomarker
5175,PECAM1,platelet/endothelial cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.212522577,1,Biomarker
8626,TP63,tumor protein p63,1.0,1.0,0.0,0.0,0.0,206720,"Neoplasms, Squamous Cell",0.212522577,2,"AlteredExpression, Biomarker"
7248,TSC1,tuberous sclerosis 1,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.212522577,2,Biomarker
2810,SFN,stratifin,0.0,1.0,0.0,1.0,0.0,26640,Mouth Neoplasms,0.212522577,2,"Biomarker, PostTranslationalModification"
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212522577,2,Biomarker
90,ACVR1,"activin A receptor, type I",0.0,1.0,1.0,0.0,0.0,27122,Myositis Ossificans,0.212522577,1,"Biomarker, GeneticVariation"
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,43251,Wounds and Injuries,0.212522577,2,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,43251,Wounds and Injuries,0.212522577,2,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,1.0,1.0,0.0,0.0,0.0,43251,Wounds and Injuries,0.212522577,2,"AlteredExpression, Biomarker"
4057,LTF,lactotransferrin,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.212522577,2,Biomarker
2056,EPO,erythropoietin,1.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
2057,EPOR,erythropoietin receptor,1.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
5460,POU5F1,POU class 5 homeobox 1,0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.212522577,2,Biomarker
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",0.0,1.0,1.0,0.0,0.0,1535893,Orthostatic Intolerance,0.212522577,2,"Biomarker, GeneticVariation"
50511,SYCP3,synaptonemal complex protein 3,0.0,1.0,1.0,0.0,0.0,809,"Abortion, Habitual",0.212522577,1,"Biomarker, GeneticVariation"
6659,SOX4,SRY (sex determining region Y)-box 4,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.212522577,2,Biomarker
2072,ERCC4,excision repair cross-complementation group 4,1.0,1.0,0.0,0.0,0.0,39590,Testicular Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
335,APOA1,apolipoprotein A-I,1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.212522577,2,"AlteredExpression, Biomarker"
56287,GKN1,gastrokine 1,1.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.212522577,2,"AlteredExpression, Biomarker"
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.212522577,2,Biomarker
7367,UGT2B17,"UDP glucuronosyltransferase 2 family, polypeptide B17",0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.212522577,1,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,20557,Hypertriglyceridemia,0.212522577,2,"Biomarker, GeneticVariation"
5360,PLTP,phospholipid transfer protein,1.0,1.0,0.0,0.0,0.0,20557,Hypertriglyceridemia,0.212522577,1,"AlteredExpression, Biomarker"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,4114,Astrocytoma,0.212522577,2,"Biomarker, GeneticVariation"
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,20625,Hyponatremia,0.212522577,2,Biomarker
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212522577,2,"Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212522577,2,"Biomarker, GeneticVariation"
342371,ATXN1L,ataxin 1-like,1.0,0.0,0.0,0.0,1.0,87012,Spinocerebellar Ataxias,0.212522577,2,"AlteredExpression, Therapeutic"
8678,BECN1,"beclin 1, autophagy related",1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212522577,2,Biomarker
3725,JUN,jun proto-oncogene,1.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212522577,3,"AlteredExpression, Biomarker"
4171,MCM2,minichromosome maintenance complex component 2,1.0,0.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.212522577,2,"AlteredExpression, Therapeutic"
6566,SLC16A1,"solute carrier family 16 (monocarboxylate transporter), member 1",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212522577,2,Biomarker
160728,SLC5A8,"solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.212522577,3,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,1.0,0.0,9375,Colonic Neoplasms,0.212522577,1,"Biomarker, PostTranslationalModification"
1280,COL2A1,"collagen, type II, alpha 1",1.0,1.0,0.0,0.0,0.0,39103,Synovitis,0.212522577,2,"AlteredExpression, Biomarker"
2057,EPOR,erythropoietin receptor,1.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.212522577,2,"AlteredExpression, Biomarker"
284,ANGPT1,angiopoietin 1,1.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.212522577,3,"AlteredExpression, Biomarker"
3162,HMOX1,heme oxygenase (decycling) 1,1.0,0.0,0.0,0.0,1.0,16059,Fibrosis,0.212522577,2,"AlteredExpression, Therapeutic"
3953,LEPR,leptin receptor,1.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.212522577,2,"AlteredExpression, Biomarker"
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.212522577,2,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",1.0,1.0,0.0,0.0,0.0,334634,"Lymphoma, Mantle-Cell",0.212522577,1,"AlteredExpression, Biomarker"
2932,GSK3B,glycogen synthase kinase 3 beta,1.0,1.0,0.0,0.0,0.0,334634,"Lymphoma, Mantle-Cell",0.212522577,1,"AlteredExpression, Biomarker"
80326,WNT10A,"wingless-type MMTV integration site family, member 10A",1.0,1.0,0.0,0.0,0.0,334634,"Lymphoma, Mantle-Cell",0.212522577,1,"AlteredExpression, Biomarker"
3420,IDH3B,isocitrate dehydrogenase 3 (NAD+) beta,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.212522577,1,"Biomarker, GeneticVariation"
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.212522577,2,Biomarker
5915,RARB,"retinoic acid receptor, beta",0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.212522577,2,Biomarker
2876,GPX1,glutathione peroxidase 1,1.0,0.0,0.0,0.0,1.0,30567,Parkinson Disease,0.212522577,2,"AlteredExpression, Therapeutic"
4217,MAP3K5,mitogen-activated protein kinase kinase kinase 5,1.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.212522577,2,"AlteredExpression, Biomarker"
1687,DFNA5,"deafness, autosomal dominant 5",0.0,1.0,1.0,0.0,0.0,1384666,Hearing Loss,0.212522577,2,"Biomarker, GeneticVariation"
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.212522577,2,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.212522577,2,Biomarker
81704,DOCK8,dedicator of cytokinesis 8,0.0,1.0,1.0,0.0,0.0,3714756,Intellectual Disability,0.212522577,1,"Biomarker, GeneticVariation"
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,1.0,0.0,0.0,3714756,Intellectual Disability,0.212522577,1,"Biomarker, GeneticVariation"
597,BCL2A1,BCL2-related protein A1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,3,"AlteredExpression, Biomarker"
659,BMPR2,"bone morphogenetic protein receptor, type II (serine/threonine kinase)",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
1063,CENPF,"centromere protein F, 350/400kDa",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
1910,EDNRB,endothelin receptor type B,1.0,0.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.212522577,2,"AlteredExpression, Therapeutic"
1938,EEF2,eukaryotic translation elongation factor 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
2202,EFEMP1,EGF containing fibulin-like extracellular matrix protein 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
51466,EVL,Enah/Vasp-like,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
10457,GPNMB,glycoprotein (transmembrane) nmb,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
3280,HES1,hes family bHLH transcription factor 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,3,"AlteredExpression, Biomarker"
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
4118,MAL,"mal, T-cell differentiation protein",1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,1,"AlteredExpression, Biomarker"
80306,MED28,mediator complex subunit 28,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
406938,MIR146A,microRNA 146a,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
406989,MIR206,microRNA 206,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
407007,MIR222,microRNA 222,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
4311,MME,membrane metallo-endopeptidase,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
9611,NCOR1,nuclear receptor corepressor 1,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
8204,NRIP1,nuclear receptor interacting protein 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
133522,PPARGC1B,"peroxisome proliferator-activated receptor gamma, coactivator 1 beta",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
9055,PRC1,protein regulator of cytokinesis 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
5935,RBM3,"RNA binding motif (RNP1, RRM) protein 3",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
7980,TFPI2,tissue factor pathway inhibitor 2,0.0,1.0,0.0,1.0,0.0,1458155,Breast Neoplasms,0.212522577,2,"Biomarker, PostTranslationalModification"
9839,ZEB2,zinc finger E-box binding homeobox 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.212522577,2,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.212522577,4,Biomarker
9588,PRDX6,peroxiredoxin 6,1.0,1.0,0.0,0.0,0.0,13080,Down Syndrome,0.212522577,2,"AlteredExpression, Biomarker"
2205,FCER1A,"Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide",0.0,1.0,0.0,0.0,0.0,42109,Urticaria,0.212522577,3,Biomarker
335,APOA1,apolipoprotein A-I,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
348,APOE,apolipoprotein E,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,3,"AlteredExpression, Biomarker"
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,"Biomarker, GeneticVariation"
153090,DAB2IP,DAB2 interacting protein,0.0,1.0,0.0,1.0,0.0,24121,Lung Neoplasms,0.212522577,2,"Biomarker, PostTranslationalModification"
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,Biomarker
2520,GAST,gastrin,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,3,Biomarker
3458,IFNG,"interferon, gamma",0.0,0.0,1.0,0.0,1.0,24121,Lung Neoplasms,0.212522577,2,"GeneticVariation, Therapeutic"
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
10266,RAMP2,receptor (G protein-coupled) activity modifying protein 2,0.0,1.0,0.0,1.0,0.0,24121,Lung Neoplasms,0.212522577,1,"Biomarker, PostTranslationalModification"
6091,ROBO1,"roundabout, axon guidance receptor, homolog 1 (Drosophila)",0.0,1.0,0.0,1.0,0.0,24121,Lung Neoplasms,0.212522577,1,"Biomarker, PostTranslationalModification"
7037,TFRC,transferrin receptor,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
7099,TLR4,toll-like receptor 4,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.212522577,2,"AlteredExpression, Biomarker"
249,ALPL,"alkaline phosphatase, liver/bone/kidney",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.212522577,2,Biomarker
1906,EDN1,endothelin 1,1.0,0.0,0.0,0.0,1.0,20649,Hypotension,0.212522577,3,"AlteredExpression, Therapeutic"
6285,S100B,S100 calcium binding protein B,1.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.212522577,2,"AlteredExpression, Biomarker"
2247,FGF2,fibroblast growth factor 2 (basic),1.0,1.0,0.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.212522577,2,"AlteredExpression, Biomarker"
1050,CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",1.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.212522577,3,"AlteredExpression, Biomarker"
1410,CRYAB,"crystallin, alpha B",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.212522577,2,Biomarker
6363,CCL19,chemokine (C-C motif) ligand 19,1.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.212522577,1,"AlteredExpression, Biomarker"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.212522577,2,Biomarker
5728,PTEN,phosphatase and tensin homolog,1.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.212522577,2,"AlteredExpression, Biomarker"
5245,PHB,prohibitin,1.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.212522577,2,"AlteredExpression, Biomarker"
405,ARNT,aryl hydrocarbon receptor nuclear translocator,0.0,1.0,0.0,1.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.212522577,2,"Biomarker, PostTranslationalModification"
22807,IKZF2,IKAROS family zinc finger 2 (Helios),1.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.212522577,2,"AlteredExpression, Biomarker"
1576,CYP3A4,"cytochrome P450, family 3, subfamily A, polypeptide 4",1.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.212522577,1,"AlteredExpression, Biomarker"
10210,TOPORS,"topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.212522577,2,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.212522577,2,Biomarker
2212,FCGR2A,"Fc fragment of IgG, low affinity IIa, receptor (CD32)",1.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.212522577,2,"AlteredExpression, Biomarker"
2621,GAS6,growth arrest-specific 6,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.212522577,4,Biomarker
10461,MERTK,"MER proto-oncogene, tyrosine kinase",0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.212522577,1,Biomarker
5196,PF4,platelet factor 4,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.212522577,5,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.212522577,2,Biomarker
2746,GLUD1,glutamate dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,220994,Hyperammonemia,0.212522577,2,"Biomarker, GeneticVariation"
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,1.0,0.0,0.0,15967,Fever,0.212522577,2,"Biomarker, GeneticVariation"
55806,HR,hair growth associated,0.0,1.0,1.0,0.0,0.0,2170,Alopecia,0.212522577,2,"Biomarker, GeneticVariation"
6862,T,"T, brachyury homolog (mouse)",0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.212522577,1,Biomarker
1052,CEBPD,"CCAAT/enhancer binding protein (C/EBP), delta",0.0,1.0,0.0,1.0,0.0,23467,"Leukemia, Myeloid, Acute",0.212522577,1,"Biomarker, PostTranslationalModification"
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,1.0,0.0,0.0,20621,Hypokalemia,0.212522577,3,"Biomarker, GeneticVariation"
925,CD8A,CD8a molecule,0.0,1.0,0.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.212522577,1,Biomarker
7139,TNNT2,troponin T type 2 (cardiac),1.0,1.0,0.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.212522577,2,"AlteredExpression, Biomarker"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,7273,Carotid Artery Diseases,0.212522577,1,"Biomarker, GeneticVariation"
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,1.0,1.0,23487,"Leukemia, Promyelocytic, Acute",0.212522577,3,"Biomarker, PostTranslationalModification, Therapeutic"
2184,FAH,fumarylacetoacetate hydrolase (fumarylacetoacetase),0.0,1.0,1.0,0.0,0.0,268490,Tyrosinemia type I,0.212474201,44,"Biomarker, GeneticVariation"
6262,RYR2,ryanodine receptor 2 (cardiac),1.0,1.0,1.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.212407376,5,"AlteredExpression, Biomarker, GeneticVariation"
8701,DNAH11,"dynein, axonemal, heavy chain 11",0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.212317068,1,"Biomarker, GeneticVariation"
55219,TMEM57,transmembrane protein 57,0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.212317068,1,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,1.0,0.0,1.0,5944,"Bone Diseases, Metabolic",0.212317068,2,"GeneticVariation, Therapeutic"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,17178,Gastrointestinal Diseases,0.212317068,1,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,29396,"Ossification, Heterotopic",0.212317068,1,"Biomarker, GeneticVariation"
170679,PSORS1C1,psoriasis susceptibility 1 candidate 1,0.0,1.0,1.0,0.0,0.0,4943,Behcet Syndrome,0.212317068,2,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,35242,Respiratory Tract Diseases,0.212317068,1,"Biomarker, GeneticVariation"
131,ADH7,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide",0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
9940,DLEC1,deleted in lung and esophageal cancer 1,0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
2206,MS4A2,"membrane-spanning 4-domains, subfamily A, member 2",0.0,1.0,1.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.212317068,2,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,30922,Peptic Ulcer Hemorrhage,0.212317068,1,"Biomarker, GeneticVariation"
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,1.0,0.0,0.0,30922,Peptic Ulcer Hemorrhage,0.212317068,1,"Biomarker, GeneticVariation"
23274,CLEC16A,"C-type lectin domain family 16, member A",0.0,1.0,1.0,0.0,0.0,162538,IgA Deficiency,0.212317068,1,"Biomarker, GeneticVariation"
64135,IFIH1,interferon induced with helicase C domain 1,0.0,1.0,1.0,0.0,0.0,162538,IgA Deficiency,0.212317068,1,"Biomarker, GeneticVariation"
1001,CDH3,"cadherin 3, type 1, P-cadherin (placental)",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.212317068,1,"Biomarker, GeneticVariation"
7850,IL1R2,"interleukin 1 receptor, type II",0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.212317068,1,"Biomarker, GeneticVariation"
23046,KIF21B,kinesin family member 21B,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.212317068,2,"Biomarker, GeneticVariation"
4046,LSP1,lymphocyte-specific protein 1,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.212317068,1,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,17205,Gaucher Disease,0.212317068,1,"Biomarker, GeneticVariation"
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,0.0,1.0,1.0,0.0,0.0,25500,Mesothelioma,0.212317068,2,"Biomarker, GeneticVariation"
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,1.0,0.0,0.0,25500,Mesothelioma,0.212317068,1,"Biomarker, GeneticVariation"
23562,CLDN14,claudin 14,0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.212317068,2,"Biomarker, GeneticVariation"
494513,DFNB59,"deafness, autosomal recessive 59",0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.212317068,2,"Biomarker, GeneticVariation"
9381,OTOF,otoferlin,0.0,1.0,1.0,0.0,0.0,11053,Deafness,0.212317068,2,"Biomarker, GeneticVariation"
1832,DSP,desmoplakin,0.0,1.0,1.0,0.0,0.0,85298,"Death, Sudden, Cardiac",0.212317068,2,"Biomarker, GeneticVariation"
4607,MYBPC3,"myosin binding protein C, cardiac",0.0,1.0,1.0,0.0,0.0,85298,"Death, Sudden, Cardiac",0.212317068,2,"Biomarker, GeneticVariation"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.212317068,2,"Biomarker, GeneticVariation"
4160,MC4R,melanocortin 4 receptor,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.212317068,1,"Biomarker, GeneticVariation"
3164,NR4A1,"nuclear receptor subfamily 4, group A, member 1",0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.212317068,2,"Biomarker, GeneticVariation"
8013,NR4A3,"nuclear receptor subfamily 4, group A, member 3",0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.212317068,2,"Biomarker, GeneticVariation"
5360,PLTP,phospholipid transfer protein,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.212317068,2,"Biomarker, GeneticVariation"
57761,TRIB3,tribbles pseudokinase 3,0.0,1.0,1.0,0.0,0.0,21655,Insulin Resistance,0.212317068,2,"Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.212317068,2,"Biomarker, GeneticVariation"
81037,CLPTM1L,CLPTM1-like,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
119391,GSTO2,glutathione S-transferase omega 2,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
108,ADCY2,adenylate cyclase 2 (brain),0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.212317068,2,"Biomarker, GeneticVariation"
9547,CXCL14,chemokine (C-X-C motif) ligand 14,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.212317068,2,"Biomarker, GeneticVariation"
8989,TRPA1,"transient receptor potential cation channel, subfamily A, member 1",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.212317068,2,"Biomarker, GeneticVariation"
134430,WDR36,WD repeat domain 36,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.212317068,1,"Biomarker, GeneticVariation"
637,BID,BH3 interacting domain death agonist,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
4588,MUC6,"mucin 6, oligomeric mucus/gel-forming",0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
51196,PLCE1,"phospholipase C, epsilon 1",0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
26137,ZBTB20,zinc finger and BTB domain containing 20,0.0,1.0,1.0,0.0,0.0,38356,Stomach Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,42594,Vestibular Diseases,0.212317068,1,"Biomarker, GeneticVariation"
2954,GSTZ1,glutathione S-transferase zeta 1,0.0,1.0,1.0,0.0,0.0,42594,Vestibular Diseases,0.212317068,1,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,42594,Vestibular Diseases,0.212317068,1,"Biomarker, GeneticVariation"
23274,CLEC16A,"C-type lectin domain family 16, member A",0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.212317068,1,"Biomarker, GeneticVariation"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,1.0,0.0,1.0,11875,Diabetic Angiopathies,0.212317068,2,"GeneticVariation, Therapeutic"
4638,MYLK,myosin light chain kinase,0.0,1.0,1.0,0.0,0.0,242488,Acute Lung Injury,0.212317068,2,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,24694,Mandibular Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.212317068,1,"Biomarker, GeneticVariation"
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.212317068,2,"Biomarker, GeneticVariation"
10588,MTHFS,"5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)",0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.212317068,2,"Biomarker, GeneticVariation"
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.212317068,2,"Biomarker, GeneticVariation"
10253,SPRY2,sprouty homolog 2 (Drosophila),0.0,1.0,1.0,0.0,0.0,8924,Cleft Lip,0.212317068,2,"Biomarker, GeneticVariation"
6356,CCL11,chemokine (C-C motif) ligand 11,0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.212317068,2,"Biomarker, GeneticVariation"
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.212317068,3,"Biomarker, GeneticVariation"
3552,IL1A,"interleukin 1, alpha",0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.212317068,2,"Biomarker, GeneticVariation"
81027,TUBB1,"tubulin, beta 1 class VI",0.0,1.0,1.0,0.0,0.0,948089,Acute Coronary Syndrome,0.212317068,2,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.212317068,2,"Biomarker, GeneticVariation"
6582,SLC22A2,"solute carrier family 22 (organic cation transporter), member 2",0.0,0.0,1.0,0.0,1.0,22658,Kidney Diseases,0.212317068,2,"GeneticVariation, Therapeutic"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,35126,Reperfusion Injury,0.212317068,9,"Biomarker, GeneticVariation"
2041,EPHA1,EPH receptor A1,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.212317068,2,"Biomarker, GeneticVariation"
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.212317068,2,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,3165,Anthracosis,0.212317068,1,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,0.0,3165,Anthracosis,0.212317068,1,"Biomarker, GeneticVariation"
9451,EIF2AK3,eukaryotic translation initiation factor 2-alpha kinase 3,0.0,1.0,1.0,0.0,0.0,38868,"Supranuclear Palsy, Progressive",0.212317068,1,"Biomarker, GeneticVariation"
760,CA2,carbonic anhydrase II,0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.212317068,2,"Biomarker, GeneticVariation"
155,ADRB3,adrenoceptor beta 3,0.0,1.0,1.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.212317068,1,"Biomarker, GeneticVariation"
1215,CMA1,"chymase 1, mast cell",0.0,1.0,1.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.212317068,2,"Biomarker, GeneticVariation"
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,1.0,0.0,0.0,18798,"Heart Defects, Congenital",0.212317068,2,"Biomarker, GeneticVariation"
23294,ANKS1A,ankyrin repeat and sterile alpha motif domain containing 1A,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.212317068,1,"Biomarker, GeneticVariation"
84439,HHIPL1,HHIP-like 1,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.212317068,1,"Biomarker, GeneticVariation"
64968,MRPS6,mitochondrial ribosomal protein S6,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.212317068,2,"Biomarker, GeneticVariation"
6943,TCF21,transcription factor 21,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.212317068,2,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.212317068,2,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,1.0,0.0,0.0,20523,"Hypersensitivity, Immediate",0.212317068,2,"Biomarker, GeneticVariation"
2206,MS4A2,"membrane-spanning 4-domains, subfamily A, member 2",0.0,1.0,1.0,0.0,0.0,20523,"Hypersensitivity, Immediate",0.212317068,2,"Biomarker, GeneticVariation"
7941,PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)",0.0,1.0,1.0,0.0,0.0,20523,"Hypersensitivity, Immediate",0.212317068,2,"Biomarker, GeneticVariation"
308,ANXA5,annexin A5,0.0,0.0,1.0,0.0,1.0,32914,Pre-Eclampsia,0.212317068,2,"GeneticVariation, Therapeutic"
9,NAT1,N-acetyltransferase 1 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,28796,"Dermatitis, Occupational",0.212317068,1,"Biomarker, GeneticVariation"
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,28796,"Dermatitis, Occupational",0.212317068,1,"Biomarker, GeneticVariation"
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.212317068,2,"Biomarker, GeneticVariation"
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,0.0,1.0,1.0,0.0,0.0,2171,Alopecia Areata,0.212317068,1,"Biomarker, GeneticVariation"
64375,IKZF4,IKAROS family zinc finger 4 (Eos),0.0,1.0,1.0,0.0,0.0,2171,Alopecia Areata,0.212317068,1,"Biomarker, GeneticVariation"
25824,PRDX5,peroxiredoxin 5,0.0,1.0,1.0,0.0,0.0,2171,Alopecia Areata,0.212317068,1,"Biomarker, GeneticVariation"
55014,STX17,syntaxin 17,0.0,1.0,1.0,0.0,0.0,2171,Alopecia Areata,0.212317068,1,"Biomarker, GeneticVariation"
79465,ULBP3,UL16 binding protein 3,0.0,1.0,1.0,0.0,0.0,2171,Alopecia Areata,0.212317068,1,"Biomarker, GeneticVariation"
8631,SKAP1,src kinase associated phosphoprotein 1,0.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
25976,TIPARP,TCDD-inducible poly(ADP-ribose) polymerase,0.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,1.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.212317068,1,"Biomarker, GeneticVariation"
914,CD2,CD2 molecule,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.212317068,2,"Biomarker, GeneticVariation"
54826,GIN1,gypsy retrotransposon integrase 1,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.212317068,2,"Biomarker, GeneticVariation"
3394,IRF8,interferon regulatory factor 8,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.212317068,2,"Biomarker, GeneticVariation"
5453,POU3F1,POU class 3 homeobox 1,0.0,1.0,1.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.212317068,2,"Biomarker, GeneticVariation"
3483,IGFALS,"insulin-like growth factor binding protein, acid labile subunit",0.0,1.0,1.0,0.0,0.0,34012,"Puberty, Delayed",0.212317068,3,"Biomarker, GeneticVariation"
3814,KISS1,KiSS-1 metastasis-suppressor,0.0,1.0,1.0,0.0,0.0,34012,"Puberty, Delayed",0.212317068,2,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,34012,"Puberty, Delayed",0.212317068,2,"Biomarker, GeneticVariation"
54822,TRPM7,"transient receptor potential cation channel, subfamily M, member 7",0.0,1.0,1.0,0.0,0.0,9376,Colonic Polyps,0.212317068,1,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,311375,Arsenic Poisoning,0.212317068,2,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,311375,Arsenic Poisoning,0.212317068,3,"Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,1.0,0.0,0.0,19080,Hemorrhage,0.212317068,2,"Biomarker, GeneticVariation"
64805,P2RY12,"purinergic receptor P2Y, G-protein coupled, 12",0.0,1.0,1.0,0.0,0.0,19080,Hemorrhage,0.212317068,2,"Biomarker, GeneticVariation"
668,FOXL2,forkhead box L2,0.0,1.0,1.0,0.0,0.0,22548,Keloid,0.212317068,1,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.212317068,2,"Biomarker, GeneticVariation"
1577,CYP3A5,"cytochrome P450, family 3, subfamily A, polypeptide 5",0.0,0.0,1.0,0.0,1.0,235032,Neurotoxicity Syndromes,0.212317068,1,"GeneticVariation, Therapeutic"
135,ADORA2A,adenosine A2a receptor,0.0,1.0,1.0,0.0,0.0,21603,Sleep Initiation and Maintenance Disorders,0.212317068,2,"Biomarker, GeneticVariation"
2212,FCGR2A,"Fc fragment of IgG, low affinity IIa, receptor (CD32)",0.0,1.0,1.0,0.0,0.0,40034,Thrombocytopenia,0.212317068,2,"Biomarker, GeneticVariation"
2815,GP9,glycoprotein IX (platelet),0.0,1.0,1.0,0.0,0.0,40034,Thrombocytopenia,0.212317068,2,"Biomarker, GeneticVariation"
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,1.0,1.0,0.0,0.0,14550,"Epilepsies, Myoclonic",0.212317068,1,"Biomarker, GeneticVariation"
2730,GCLM,"glutamate-cysteine ligase, modifier subunit",0.0,1.0,1.0,0.0,0.0,5138,Berylliosis,0.212317068,1,"Biomarker, GeneticVariation"
3973,LHCGR,luteinizing hormone/choriogonadotropin receptor,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.212317068,2,"Biomarker, GeneticVariation"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,0.0,43094,Weight Gain,0.212317068,2,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,43094,Weight Gain,0.212317068,1,"Biomarker, GeneticVariation"
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212317068,3,"Biomarker, GeneticVariation"
2494,NR5A2,"nuclear receptor subfamily 5, group A, member 2",0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
2030,SLC29A1,"solute carrier family 29 (equilibrative nucleoside transporter), member 1",0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,0.0,1.0,1.0,0.0,0.0,30297,Pancreatic Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
4363,ABCC1,"ATP-binding cassette, sub-family C (CFTR/MRP), member 1",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
405,ARNT,aryl hydrocarbon receptor nuclear translocator,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
59345,GNB4,"guanine nucleotide binding protein (G protein), beta polypeptide 4",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
2879,GPX4,glutathione peroxidase 4,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,3,"Biomarker, GeneticVariation"
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
5795,PTPRJ,"protein tyrosine phosphatase, receptor type, J",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
85415,RHPN2,"rhophilin, Rho GTPase binding protein 2",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
54822,TRPM7,"transient receptor potential cation channel, subfamily M, member 7",0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
7296,TXNRD1,thioredoxin reductase 1,0.0,1.0,1.0,0.0,0.0,9404,Colorectal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
4128,MAOA,monoamine oxidase A,0.0,1.0,1.0,0.0,0.0,33054,Prenatal Exposure Delayed Effects,0.212317068,2,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,33687,Proteinuria,0.212317068,5,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,32310,"Pneumonia, Viral",0.212317068,1,"Biomarker, GeneticVariation"
4363,ABCC1,"ATP-binding cassette, sub-family C (CFTR/MRP), member 1",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.212317068,1,"Biomarker, GeneticVariation"
875,CBS,cystathionine-beta-synthase,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.212317068,2,"Biomarker, GeneticVariation"
1908,EDN3,endothelin 3,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.212317068,2,"Biomarker, GeneticVariation"
2811,GP1BA,"glycoprotein Ib (platelet), alpha polypeptide",0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.212317068,2,"Biomarker, GeneticVariation"
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,1.0,0.0,0.0,37199,Sinusitis,0.212317068,2,"Biomarker, GeneticVariation"
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,1.0,0.0,0.0,32927,Precancerous Conditions,0.212317068,2,"Biomarker, GeneticVariation"
383,ARG1,arginase 1,0.0,1.0,1.0,0.0,0.0,32927,Precancerous Conditions,0.212317068,2,"Biomarker, GeneticVariation"
4607,MYBPC3,"myosin binding protein C, cardiac",0.0,1.0,1.0,0.0,0.0,18800,Cardiomegaly,0.212317068,2,"Biomarker, GeneticVariation"
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,1.0,0.0,0.0,424295,Hyperkinesis,0.212317068,3,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,28797,Occupational Diseases,0.212317068,2,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,28797,Occupational Diseases,0.212317068,2,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,1925,Albuminuria,0.212317068,2,"Biomarker, GeneticVariation"
635,BHMT,betaine--homocysteine S-methyltransferase,0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.212317068,1,"Biomarker, GeneticVariation"
367,AR,androgen receptor,0.0,1.0,1.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.212317068,2,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.212317068,2,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,376634,Craniofacial Abnormalities,0.212317068,6,"Biomarker, GeneticVariation"
135,ADORA2A,adenosine A2a receptor,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,1,"Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,2,"Biomarker, GeneticVariation"
409,ARRB2,"arrestin, beta 2",0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,2,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,2,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,3,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,2,"Biomarker, GeneticVariation"
4886,NPY1R,neuropeptide Y receptor Y1,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,1,"Biomarker, GeneticVariation"
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,2,"Biomarker, GeneticVariation"
128674,PROKR2,prokineticin receptor 2,0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,1,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.212317068,2,"Biomarker, GeneticVariation"
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.212317068,2,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.212317068,2,"Biomarker, GeneticVariation"
6720,SREBF1,sterol regulatory element binding transcription factor 1,0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.212317068,2,"Biomarker, GeneticVariation"
3782,KCNN3,"potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3",0.0,1.0,1.0,0.0,0.0,4238,Atrial Fibrillation,0.212317068,1,"Biomarker, GeneticVariation"
56955,MEPE,matrix extracellular phosphoglycoprotein,0.0,1.0,1.0,0.0,0.0,16658,"Fractures, Bone",0.212317068,2,"Biomarker, GeneticVariation"
5741,PTH,parathyroid hormone,0.0,0.0,1.0,0.0,1.0,16658,"Fractures, Bone",0.212317068,2,"GeneticVariation, Therapeutic"
6711,SPTBN1,"spectrin, beta, non-erythrocytic 1",0.0,1.0,1.0,0.0,0.0,16658,"Fractures, Bone",0.212317068,2,"Biomarker, GeneticVariation"
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,1.0,0.0,0.0,16658,"Fractures, Bone",0.212317068,2,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,19202,Hepatolenticular Degeneration,0.212317068,2,"Biomarker, GeneticVariation"
81037,CLPTM1L,CLPTM1-like,0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.212317068,2,"Biomarker, GeneticVariation"
3852,KRT5,"keratin 5, type II",0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.212317068,2,"Biomarker, GeneticVariation"
51151,SLC45A2,"solute carrier family 45, member 2",0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.212317068,2,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.212317068,2,"Biomarker, GeneticVariation"
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,1.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.212317068,1,"Biomarker, GeneticVariation"
54620,FBXL19,F-box and leucine-rich repeat protein 19,0.0,1.0,1.0,0.0,0.0,33860,Psoriasis,0.212317068,1,"Biomarker, GeneticVariation"
650,BMP2,bone morphogenetic protein 2,0.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.212317068,1,"Biomarker, GeneticVariation"
64506,CPEB1,cytoplasmic polyadenylation element binding protein 1,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.212317068,1,"Biomarker, GeneticVariation"
29949,IL19,interleukin 19,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.212317068,1,"Biomarker, GeneticVariation"
8302,KLRC4,"killer cell lectin-like receptor subfamily C, member 4",0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.212317068,1,"Biomarker, GeneticVariation"
23547,LILRA4,"leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4",0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.212317068,1,"Biomarker, GeneticVariation"
5423,POLB,"polymerase (DNA directed), beta",0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.212317068,1,"Biomarker, GeneticVariation"
11073,TOPBP1,topoisomerase (DNA) II binding protein 1,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.212317068,1,"Biomarker, GeneticVariation"
115352,FCRL3,Fc receptor-like 3,0.0,1.0,1.0,0.0,0.0,920350,"Thyroiditis, Autoimmune",0.212317068,1,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.212317068,3,"Biomarker, GeneticVariation"
729230,CCR2,chemokine (C-C motif) receptor 2,0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.212317068,2,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.212317068,2,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,1.0,20517,Hypersensitivity,0.212317068,3,"Biomarker, GeneticVariation, Therapeutic"
3606,IL18,interleukin 18,0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.212317068,2,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,20517,Hypersensitivity,0.212317068,2,"Biomarker, GeneticVariation"
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",0.0,1.0,1.0,0.0,0.0,236969,Substance-Related Disorders,0.212317068,2,"Biomarker, GeneticVariation"
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,1.0,0.0,0.0,236969,Substance-Related Disorders,0.212317068,2,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,38814,Sunburn,0.212317068,1,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,15934,Fetal Growth Retardation,0.212317068,2,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,15934,Fetal Growth Retardation,0.212317068,2,"Biomarker, GeneticVariation"
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,1.0,0.0,0.0,15934,Fetal Growth Retardation,0.212317068,2,"Biomarker, GeneticVariation"
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.212317068,2,"Biomarker, GeneticVariation"
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.212317068,2,"Biomarker, GeneticVariation"
5069,PAPPA,"pregnancy-associated plasma protein A, pappalysin 1",0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.212317068,2,"Biomarker, GeneticVariation"
5617,PRL,prolactin,0.0,1.0,1.0,0.0,0.0,21361,"Infertility, Female",0.212317068,2,"Biomarker, GeneticVariation"
23274,CLEC16A,"C-type lectin domain family 16, member A",0.0,1.0,1.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.212317068,1,"Biomarker, GeneticVariation"
79258,MMEL1,membrane metallo-endopeptidase-like 1,0.0,1.0,1.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.212317068,1,"Biomarker, GeneticVariation"
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,0.0,1.0,1.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.212317068,1,"Biomarker, GeneticVariation"
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,1.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.212317068,1,"Biomarker, GeneticVariation"
10018,BCL2L11,BCL2-like 11 (apoptosis facilitator),0.0,1.0,1.0,0.0,0.0,8313,"Cholangitis, Sclerosing",0.212317068,1,"Biomarker, GeneticVariation"
6790,AURKA,aurora kinase A,0.0,1.0,1.0,0.0,0.0,22665,Kidney Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,22665,Kidney Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.212317068,2,"Biomarker, GeneticVariation"
3759,KCNJ2,"potassium channel, inwardly rectifying subfamily J, member 2",0.0,1.0,1.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.212317068,3,"Biomarker, GeneticVariation"
4878,NPPA,natriuretic peptide A,0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.212317068,2,"Biomarker, GeneticVariation"
4088,SMAD3,SMAD family member 3,0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.212317068,2,"Biomarker, GeneticVariation"
7057,THBS1,thrombospondin 1,0.0,1.0,1.0,0.0,0.0,23890,Liver Cirrhosis,0.212317068,2,"Biomarker, GeneticVariation"
55740,ENAH,enabled homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.212317068,2,"Biomarker, GeneticVariation"
3673,ITGA2,"integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)",0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.212317068,2,"Biomarker, GeneticVariation"
3684,ITGAM,"integrin, alpha M (complement component 3 receptor 3 subunit)",0.0,1.0,1.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.212317068,2,"Biomarker, GeneticVariation"
7185,TRAF1,TNF receptor-associated factor 1,0.0,1.0,1.0,0.0,0.0,13274,"Ductus Arteriosus, Patent",0.212317068,1,"Biomarker, GeneticVariation"
8453,CUL2,cullin 2,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.212317068,2,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,14170,Endometrial Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,14170,Endometrial Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
4878,NPPA,natriuretic peptide A,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.212317068,2,"Biomarker, GeneticVariation"
6401,SELE,selectin E,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.212317068,2,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,772,"Abnormalities, Multiple",0.212317068,1,"Biomarker, GeneticVariation"
140,ADORA3,adenosine A3 receptor,0.0,0.0,1.0,0.0,1.0,27051,Myocardial Infarction,0.212317068,2,"GeneticVariation, Therapeutic"
153090,DAB2IP,DAB2 interacting protein,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.212317068,1,"Biomarker, GeneticVariation"
8204,NRIP1,nuclear receptor interacting protein 1,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.212317068,1,"Biomarker, GeneticVariation"
100,ADA,adenosine deaminase,0.0,0.0,1.0,0.0,1.0,20452,Hyperemia,0.212317068,3,"GeneticVariation, Therapeutic"
3990,LIPC,"lipase, hepatic",0.0,1.0,1.0,0.0,0.0,20452,Hyperemia,0.212317068,1,"Biomarker, GeneticVariation"
3442,IFNA5,"interferon, alpha 5",0.0,0.0,1.0,0.0,1.0,25202,Melanoma,0.212317068,2,"GeneticVariation, Therapeutic"
4600,MX2,MX dynamin-like GTPase 2,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.212317068,1,"Biomarker, GeneticVariation"
4647,MYO7A,myosin VIIA,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.212317068,2,"Biomarker, GeneticVariation"
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.212317068,2,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.212317068,3,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.212317068,2,"Biomarker, GeneticVariation"
7018,TF,transferrin,0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.212317068,1,"Biomarker, GeneticVariation"
55829,VIMP,VCP-interacting membrane protein,0.0,1.0,1.0,0.0,0.0,21368,Inflammation,0.212317068,2,"Biomarker, GeneticVariation"
5360,PLTP,phospholipid transfer protein,0.0,1.0,1.0,0.0,0.0,242339,Dyslipidemias,0.212317068,2,"Biomarker, GeneticVariation"
6790,AURKA,aurora kinase A,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
60526,C2orf43,chromosome 2 open reading frame 43,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
54535,CCHCR1,coiled-coil alpha-helical rod protein 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
1488,CTBP2,C-terminal binding protein 2,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
23301,EHBP1,EH domain binding protein 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
116113,FOXP4,forkhead box P4,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
221895,JAZF1,JAZF zinc finger 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
3977,LIFR,leukemia inhibitory factor receptor alpha,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
12,SERPINA3,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3",0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
6387,CXCL12,chemokine (C-X-C motif) ligand 12,0.0,1.0,1.0,0.0,0.0,27626,Neoplasm Invasiveness,0.212317068,2,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,1.0,0.0,0.0,27626,Neoplasm Invasiveness,0.212317068,3,"Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,1.0,0.0,0.0,27626,Neoplasm Invasiveness,0.212317068,2,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,27626,Neoplasm Invasiveness,0.212317068,4,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,27626,Neoplasm Invasiveness,0.212317068,5,"Biomarker, GeneticVariation"
6854,SYN2,synapsin II,0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.212317068,2,"Biomarker, GeneticVariation"
26277,TINF2,TERF1 (TRF1)-interacting nuclear factor 2,0.0,1.0,1.0,0.0,0.0,5956,Bone Marrow Diseases,0.212317068,2,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,1565489,Renal Insufficiency,0.212317068,3,"Biomarker, GeneticVariation"
8912,CACNA1H,"calcium channel, voltage-dependent, T type, alpha 1H subunit",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
1007,CDH9,"cadherin 9, type 2 (T1-cadherin)",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
1610,DAO,D-amino-acid oxidase,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
1717,DHCR7,7-dehydrocholesterol reductase,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,2,"Biomarker, GeneticVariation"
9228,DLGAP2,"discs, large (Drosophila) homolog-associated protein 2",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,2,"Biomarker, GeneticVariation"
2555,GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,2,"Biomarker, GeneticVariation"
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,2,"Biomarker, GeneticVariation"
3481,IGF2,insulin-like growth factor 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,2,"Biomarker, GeneticVariation"
4908,NTF3,neurotrophin 3,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,2,"Biomarker, GeneticVariation"
4909,NTF4,neurotrophin 4,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,3,"Biomarker, GeneticVariation"
200150,PLD5,"phospholipase D family, member 5",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
11281,POU6F2,POU class 6 homeobox 2,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
5618,PRLR,prolactin receptor,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
9013,TAF1C,"TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
23078,VWA8,von Willebrand factor A domain containing 8,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.212317068,1,"Biomarker, GeneticVariation"
843,CASP10,"caspase 10, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
2066,ERBB4,erb-b2 receptor tyrosine kinase 4,0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
2321,FLT1,fms-related tyrosine kinase 1,0.0,1.0,1.0,0.0,0.0,37286,Skin Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
57480,PLEKHG1,"pleckstrin homology domain containing, family G (with RhoGef domain) member 1",0.0,1.0,1.0,0.0,0.0,40336,Tobacco Use Disorder,0.212317068,2,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,342257,Diabetes Complications,0.212317068,2,"Biomarker, GeneticVariation"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,1.0,0.0,0.0,43096,Weight Loss,0.212317068,2,"Biomarker, GeneticVariation"
134,ADORA1,adenosine A1 receptor,0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212317068,1,"Biomarker, GeneticVariation"
135,ADORA2A,adenosine A2a receptor,0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212317068,1,"Biomarker, GeneticVariation"
10800,CYSLTR1,cysteinyl leukotriene receptor 1,0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212317068,2,"Biomarker, GeneticVariation"
2207,FCER1G,"Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide",0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212317068,2,"Biomarker, GeneticVariation"
3305,HSPA1L,heat shock 70kDa protein 1-like,0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212317068,2,"Biomarker, GeneticVariation"
4056,LTC4S,leukotriene C4 synthase,0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212317068,2,"Biomarker, GeneticVariation"
2206,MS4A2,"membrane-spanning 4-domains, subfamily A, member 2",0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212317068,3,"Biomarker, GeneticVariation"
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212317068,4,"Biomarker, GeneticVariation"
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,1.0,0.0,0.0,13182,Drug Hypersensitivity,0.212317068,1,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.212317068,2,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,1.0,0.0,0.0,79153,"Hyperkeratosis, Epidermolytic",0.212317068,1,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.212317068,2,"Biomarker, GeneticVariation"
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.212317068,2,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,13604,Edema,0.212317068,2,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,13604,Edema,0.212317068,2,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,26640,Mouth Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,1.0,0.0,0.0,2949,"Aneurysm, Dissecting",0.212317068,2,"Biomarker, GeneticVariation"
5226,PGD,phosphogluconate dehydrogenase,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.212317068,2,"Biomarker, GeneticVariation"
590,BCHE,butyrylcholinesterase,0.0,1.0,1.0,0.0,0.0,522224,Paralysis,0.212317068,10,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.212317068,2,"Biomarker, GeneticVariation"
131,ADH7,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide",0.0,1.0,1.0,0.0,0.0,23055,Laryngeal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,151526,Premature Birth,0.212317068,2,"Biomarker, GeneticVariation"
4057,LTF,lactotransferrin,0.0,0.0,1.0,0.0,1.0,151526,Premature Birth,0.212317068,2,"GeneticVariation, Therapeutic"
10878,CFHR3,complement factor H-related 3,0.0,1.0,1.0,0.0,0.0,25303,Meningococcal Infections,0.212317068,1,"Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,162429,Malnutrition,0.212317068,1,"Biomarker, GeneticVariation"
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,1.0,1.0,0.0,0.0,17612,"Glaucoma, Open-Angle",0.212317068,1,"Biomarker, GeneticVariation"
858,CAV2,caveolin 2,0.0,1.0,1.0,0.0,0.0,17612,"Glaucoma, Open-Angle",0.212317068,1,"Biomarker, GeneticVariation"
2673,GFPT1,glutamine--fructose-6-phosphate transaminase 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.212317068,2,"Biomarker, GeneticVariation"
3215,HOXB5,homeobox B5,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.212317068,1,"Biomarker, GeneticVariation"
1233,CCR4,chemokine (C-C motif) receptor 4,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.212317068,1,"Biomarker, GeneticVariation"
2113,ETS1,v-ets avian erythroblastosis virus E26 oncogene homolog 1,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.212317068,1,"Biomarker, GeneticVariation"
23308,ICOSLG,inducible T-cell co-stimulator ligand,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.212317068,1,"Biomarker, GeneticVariation"
864,RUNX3,runt-related transcription factor 3,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.212317068,1,"Biomarker, GeneticVariation"
57178,ZMIZ1,"zinc finger, MIZ-type containing 1",0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.212317068,1,"Biomarker, GeneticVariation"
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,1.0,0.0,0.0,2792,Anaphylaxis,0.212317068,1,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,30193,Pain,0.212317068,2,"Biomarker, GeneticVariation"
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,0.0,1.0,0.0,1.0,30193,Pain,0.212317068,2,"GeneticVariation, Therapeutic"
4986,OPRK1,"opioid receptor, kappa 1",0.0,1.0,1.0,0.0,0.0,30193,Pain,0.212317068,2,"Biomarker, GeneticVariation"
55729,ATF7IP,activating transcription factor 7 interacting protein,0.0,1.0,1.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.212317068,1,"Biomarker, GeneticVariation"
1761,DMRT1,doublesex and mab-3 related transcription factor 1,0.0,1.0,1.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.212317068,1,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,24809,Marijuana Abuse,0.212317068,1,"Biomarker, GeneticVariation"
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,1.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.212317068,3,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.212317068,3,"Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,1.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.212317068,2,"Biomarker, GeneticVariation"
4193,MDM2,"MDM2 proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.212317068,2,"Biomarker, GeneticVariation"
161742,SPRED1,"sprouty-related, EVH1 domain containing 1",0.0,1.0,1.0,0.0,0.0,221263,Cafe-au-Lait Spots,0.212317068,2,"Biomarker, GeneticVariation"
55729,ATF7IP,activating transcription factor 7 interacting protein,0.0,1.0,1.0,0.0,0.0,39590,Testicular Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
1761,DMRT1,doublesex and mab-3 related transcription factor 1,0.0,1.0,1.0,0.0,0.0,39590,Testicular Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,1.0,0.0,0.0,677050,Manganese Poisoning,0.212317068,2,"Biomarker, GeneticVariation"
1435,CSF1,colony stimulating factor 1 (macrophage),0.0,1.0,1.0,0.0,0.0,29401,Osteitis Deformans,0.212317068,1,"Biomarker, GeneticVariation"
81501,DCSTAMP,dendrocyte expressed seven transmembrane protein,0.0,1.0,1.0,0.0,0.0,29401,Osteitis Deformans,0.212317068,1,"Biomarker, GeneticVariation"
23165,NUP205,nucleoporin 205kDa,0.0,1.0,1.0,0.0,0.0,29401,Osteitis Deformans,0.212317068,1,"Biomarker, GeneticVariation"
5371,PML,promyelocytic leukemia,0.0,1.0,1.0,0.0,0.0,29401,Osteitis Deformans,0.212317068,1,"Biomarker, GeneticVariation"
79890,RIN3,Ras and Rab interactor 3,0.0,1.0,1.0,0.0,0.0,29401,Osteitis Deformans,0.212317068,1,"Biomarker, GeneticVariation"
135,ADORA2A,adenosine A2a receptor,0.0,1.0,1.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.212317068,1,"Biomarker, GeneticVariation"
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,1.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.212317068,1,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,1.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.212317068,2,"Biomarker, GeneticVariation"
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,1.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.212317068,2,"Biomarker, GeneticVariation"
10747,MASP2,mannan-binding lectin serine peptidase 2,0.0,1.0,1.0,0.0,0.0,155862,"Pneumonia, Pneumococcal",0.212317068,2,"Biomarker, GeneticVariation"
1636,ACE,angiotensin I converting enzyme,0.0,1.0,1.0,0.0,0.0,1418,Adenocarcinoma,0.212317068,2,"Biomarker, GeneticVariation"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,1.0,0.0,0.0,20557,Hypertriglyceridemia,0.212317068,2,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,27947,Neutropenia,0.212317068,2,"Biomarker, GeneticVariation"
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,1.0,0.0,0.0,42514,"Tachycardia, Ventricular",0.212317068,2,"Biomarker, GeneticVariation"
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,20625,Hyponatremia,0.212317068,1,"Biomarker, GeneticVariation"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,1.0,0.0,0.0,3872,"Arthritis, Psoriatic",0.212317068,1,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212317068,2,"Biomarker, GeneticVariation"
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212317068,2,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212317068,2,"Biomarker, GeneticVariation"
3486,IGFBP3,insulin-like growth factor binding protein 3,0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212317068,2,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212317068,2,"Biomarker, GeneticVariation"
3976,LIF,leukemia inhibitory factor,0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212317068,2,"Biomarker, GeneticVariation"
7037,TFRC,transferrin receptor,0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212317068,2,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,786,"Abortion, Spontaneous",0.212317068,2,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,1.0,0.0,0.0,9375,Colonic Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,1.0,0.0,0.0,34013,"Puberty, Precocious",0.212317068,2,"Biomarker, GeneticVariation"
1535,CYBA,"cytochrome b-245, alpha polypeptide",0.0,1.0,1.0,0.0,0.0,18799,Heart Diseases,0.212317068,2,"Biomarker, GeneticVariation"
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,1.0,0.0,0.0,18939,Hematologic Diseases,0.212317068,1,"Biomarker, GeneticVariation"
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,1.0,0.0,0.0,85179,Eosinophilia-Myalgia Syndrome,0.212317068,1,"Biomarker, GeneticVariation"
3552,IL1A,"interleukin 1, alpha",0.0,1.0,1.0,0.0,0.0,8495,Chorioamnionitis,0.212317068,2,"Biomarker, GeneticVariation"
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,1.0,0.0,0.0,16470,Food Hypersensitivity,0.212317068,1,"Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.212317068,1,"Biomarker, GeneticVariation"
3107,HLA-C,"major histocompatibility complex, class I, C",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.212317068,2,"Biomarker, GeneticVariation"
3593,IL12B,interleukin 12B,0.0,0.0,1.0,0.0,1.0,17638,Glioma,0.212317068,2,"GeneticVariation, Therapeutic"
29949,IL19,interleukin 19,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.212317068,1,"Biomarker, GeneticVariation"
50604,IL20,interleukin 20,0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.212317068,1,"Biomarker, GeneticVariation"
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,1.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.212317068,2,"Biomarker, GeneticVariation"
27086,FOXP1,forkhead box P1,0.0,1.0,1.0,0.0,0.0,42900,Vitiligo,0.212317068,1,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,1.0,0.0,0.0,18671,Head and Neck Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
7298,TYMS,thymidylate synthetase,0.0,1.0,1.0,0.0,0.0,18671,Head and Neck Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.212317068,2,"Biomarker, GeneticVariation"
10588,MTHFS,"5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)",0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.212317068,2,"Biomarker, GeneticVariation"
5727,PTCH1,patched 1,0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.212317068,2,"Biomarker, GeneticVariation"
10253,SPRY2,sprouty homolog 2 (Drosophila),0.0,1.0,1.0,0.0,0.0,8925,Cleft Palate,0.212317068,2,"Biomarker, GeneticVariation"
84282,RNF135,ring finger protein 135,0.0,1.0,1.0,0.0,0.0,18273,Growth Disorders,0.212317068,2,"Biomarker, GeneticVariation"
4638,MYLK,myosin light chain kinase,0.0,1.0,1.0,0.0,0.0,32285,Pneumonia,0.212317068,2,"Biomarker, GeneticVariation"
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,1.0,0.0,0.0,32285,Pneumonia,0.212317068,2,"Biomarker, GeneticVariation"
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,1.0,0.0,0.0,1861172,Venous Thromboembolism,0.212317068,2,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,1861172,Venous Thromboembolism,0.212317068,2,"Biomarker, GeneticVariation"
3303,HSPA1A,heat shock 70kDa protein 1A,0.0,0.0,1.0,0.0,1.0,30567,Parkinson Disease,0.212317068,2,"GeneticVariation, Therapeutic"
345,APOC3,apolipoprotein C-III,0.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.212317068,2,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,0.0,1.0,0.0,1.0,1384666,Hearing Loss,0.212317068,2,"GeneticVariation, Therapeutic"
4067,LYN,"LYN proto-oncogene, Src family tyrosine kinase",0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.212317068,2,"Biomarker, GeneticVariation"
5890,RAD51B,RAD51 paralog B,0.0,1.0,1.0,0.0,0.0,1458155,Breast Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,0.0,1.0,0.0,1.0,18801,Heart Failure,0.212317068,1,"GeneticVariation, Therapeutic"
8635,RNASET2,ribonuclease T2,0.0,1.0,1.0,0.0,0.0,18213,Graves Disease,0.212317068,1,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,1.0,0.0,0.0,4763,Barrett Esophagus,0.212317068,2,"Biomarker, GeneticVariation"
1814,DRD3,dopamine receptor D3,0.0,1.0,1.0,0.0,0.0,20429,Hyperalgesia,0.212317068,2,"Biomarker, GeneticVariation"
5350,PLN,phospholamban,0.0,1.0,1.0,0.0,0.0,242698,"Ventricular Dysfunction, Left",0.212317068,2,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,1.0,0.0,0.0,1175,Acquired Immunodeficiency Syndrome,0.212317068,2,"Biomarker, GeneticVariation"
9446,GSTO1,glutathione S-transferase omega 1,0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.212317068,2,"Biomarker, GeneticVariation"
3304,HSPA1B,heat shock 70kDa protein 1B,0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.212317068,2,"Biomarker, GeneticVariation"
3554,IL1R1,"interleukin 1 receptor, type I",0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.212317068,2,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.212317068,3,"Biomarker, GeneticVariation"
9365,KL,klotho,0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.212317068,2,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,37274,Skin Diseases,0.212317068,2,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.212317068,2,"Biomarker, GeneticVariation"
3105,HLA-A,"major histocompatibility complex, class I, A",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.212317068,2,"Biomarker, GeneticVariation"
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.212317068,1,"Biomarker, GeneticVariation"
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.212317068,1,"Biomarker, GeneticVariation"
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.212317068,2,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,0.0,1.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.212317068,2,"GeneticVariation, Therapeutic"
3875,KRT18,"keratin 18, type I",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.212317068,2,"Biomarker, GeneticVariation"
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.212317068,2,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.212317068,6,"Biomarker, GeneticVariation"
6439,SFTPB,surfactant protein B,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.212317068,2,"Biomarker, GeneticVariation"
9607,CARTPT,CART prepropeptide,0.0,0.0,1.0,0.0,1.0,236736,Cocaine-Related Disorders,0.212317068,2,"GeneticVariation, Therapeutic"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,0.0,236736,Cocaine-Related Disorders,0.212317068,3,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,236736,Cocaine-Related Disorders,0.212317068,1,"Biomarker, GeneticVariation"
4852,NPY,neuropeptide Y,0.0,1.0,1.0,0.0,0.0,236736,Cocaine-Related Disorders,0.212317068,2,"Biomarker, GeneticVariation"
4887,NPY2R,neuropeptide Y receptor Y2,0.0,1.0,1.0,0.0,0.0,236736,Cocaine-Related Disorders,0.212317068,1,"Biomarker, GeneticVariation"
4986,OPRK1,"opioid receptor, kappa 1",0.0,1.0,1.0,0.0,0.0,236736,Cocaine-Related Disorders,0.212317068,3,"Biomarker, GeneticVariation"
5173,PDYN,prodynorphin,0.0,1.0,1.0,0.0,0.0,236736,Cocaine-Related Disorders,0.212317068,4,"Biomarker, GeneticVariation"
6870,TACR3,tachykinin receptor 3,0.0,1.0,1.0,0.0,0.0,236736,Cocaine-Related Disorders,0.212317068,1,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,0.0,1.0,0.0,1.0,34530,Radiation Injuries,0.212317068,3,"GeneticVariation, Therapeutic"
1019,CDK4,cyclin-dependent kinase 4,0.0,1.0,1.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.212317068,3,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,1.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.212317068,2,"Biomarker, GeneticVariation"
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,1.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.212317068,2,"Biomarker, GeneticVariation"
5241,PGR,progesterone receptor,0.0,1.0,1.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.212317068,2,"Biomarker, GeneticVariation"
1291,COL6A1,"collagen, type VI, alpha 1",0.0,1.0,1.0,0.0,0.0,1865343,Ossification of the posterior longitudinal ligament of the spine,0.212317068,1,"Biomarker, GeneticVariation"
392255,GDF6,growth differentiation factor 6,0.0,1.0,1.0,0.0,0.0,9363,Coloboma,0.212317068,1,"Biomarker, GeneticVariation"
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.212317068,2,"Biomarker, GeneticVariation"
7979,SHFM1,split hand/foot malformation (ectrodactyly) type 1,0.0,1.0,1.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.212317068,2,"Biomarker, GeneticVariation"
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,1.0,0.0,0.0,25261,Memory Disorders,0.212317068,2,"Biomarker, GeneticVariation"
163486,DENND1B,DENN/MADD domain containing 1B,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.212317068,1,"Biomarker, GeneticVariation"
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.212317068,1,"Biomarker, GeneticVariation"
64167,ERAP2,endoplasmic reticulum aminopeptidase 2,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.212317068,1,"Biomarker, GeneticVariation"
4088,SMAD3,SMAD family member 3,0.0,1.0,1.0,0.0,0.0,10346,Crohn Disease,0.212317068,1,"Biomarker, GeneticVariation"
2165,F13B,"coagulation factor XIII, B polypeptide",0.0,1.0,1.0,0.0,0.0,42487,Venous Thrombosis,0.212317068,1,"Biomarker, GeneticVariation"
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,1.0,0.0,0.0,428977,Bradycardia,0.212317068,2,"Biomarker, GeneticVariation"
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,1.0,0.0,0.0,11603,Dermatitis,0.212317068,2,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,34734,Raynaud Disease,0.212317068,1,"Biomarker, GeneticVariation"
875,CBS,cystathionine-beta-synthase,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212317068,2,"Biomarker, GeneticVariation"
83795,KCNK16,"potassium channel, two pore domain subfamily K, member 16",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212317068,1,"Biomarker, GeneticVariation"
9861,PSMD6,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 6",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212317068,1,"Biomarker, GeneticVariation"
6480,ST6GAL1,"ST6 beta-galactosamide alpha-2,6-sialyltranferase 1",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212317068,1,"Biomarker, GeneticVariation"
60685,ZFAND3,"zinc finger, AN1-type domain 3",0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.212317068,1,"Biomarker, GeneticVariation"
2099,ESR1,estrogen receptor 1,0.0,1.0,1.0,0.0,0.0,242656,Disease Progression,0.212317068,2,"Biomarker, GeneticVariation"
1154,CISH,cytokine inducible SH2-containing protein,0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.212317068,1,"Biomarker, GeneticVariation"
4763,NF1,neurofibromin 1,0.0,1.0,1.0,0.0,0.0,23186,Learning Disorders,0.212317068,2,"Biomarker, GeneticVariation"
84282,RNF135,ring finger protein 135,0.0,1.0,1.0,0.0,0.0,23186,Learning Disorders,0.212317068,2,"Biomarker, GeneticVariation"
3594,IL12RB1,"interleukin 12 receptor, beta 1",0.0,1.0,1.0,0.0,0.0,26919,"Mycobacterium Infections, Nontuberculous",0.212317068,1,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,27659,"Neoplasms, Experimental",0.212317068,2,"Biomarker, GeneticVariation"
1577,CYP3A5,"cytochrome P450, family 3, subfamily A, polypeptide 5",0.0,1.0,1.0,0.0,0.0,40053,Thrombosis,0.212317068,2,"Biomarker, GeneticVariation"
1373,CPS1,"carbamoyl-phosphate synthase 1, mitochondrial",0.0,1.0,1.0,0.0,0.0,220994,Hyperammonemia,0.212317068,3,"Biomarker, GeneticVariation"
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,1.0,0.0,0.0,35309,Retinal Diseases,0.212317068,2,"Biomarker, GeneticVariation"
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,1.0,0.0,0.0,15967,Fever,0.212317068,2,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,15967,Fever,0.212317068,4,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,1.0,0.0,0.0,15967,Fever,0.212317068,4,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.212317068,1,"Biomarker, GeneticVariation"
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.212317068,1,"Biomarker, GeneticVariation"
7546,ZIC2,Zic family member 2,0.0,1.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.212317068,2,"Biomarker, GeneticVariation"
3459,IFNGR1,interferon gamma receptor 1,0.0,1.0,1.0,0.0,0.0,79487,Helicobacter Infections,0.212317068,1,"Biomarker, GeneticVariation"
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,1.0,0.0,1.0,40822,Tremor,0.212317068,5,"Biomarker, GeneticVariation, Therapeutic"
84627,ZNF469,zinc finger protein 469,0.0,1.0,1.0,0.0,0.0,10034,Corneal Diseases,0.212317068,2,"Biomarker, GeneticVariation"
735,C9,complement component 9,0.0,1.0,1.0,0.0,0.0,242383,Macular Degeneration,0.212317068,2,"Biomarker, GeneticVariation"
1814,DRD3,dopamine receptor D3,0.0,1.0,1.0,0.0,0.0,13386,"Dyskinesia, Drug-Induced",0.212317068,2,"Biomarker, GeneticVariation"
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.212317068,2,"Biomarker, GeneticVariation"
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.212317068,2,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,3496,Aortic Rupture,0.212317068,2,"Biomarker, GeneticVariation"
1641,DCX,doublecortin,0.0,1.0,1.0,0.0,0.0,1955870,Classical Lissencephalies and Subcortical Band Heterotopias,0.212317068,1,"Biomarker, GeneticVariation"
5048,PAFAH1B1,"platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)",0.0,1.0,1.0,0.0,0.0,1955870,Classical Lissencephalies and Subcortical Band Heterotopias,0.212317068,1,"Biomarker, GeneticVariation"
2122,MECOM,MDS1 and EVI1 complex locus,0.0,1.0,1.0,0.0,0.0,27439,Nasopharyngeal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
55504,TNFRSF19,"tumor necrosis factor receptor superfamily, member 19",0.0,1.0,1.0,0.0,0.0,27439,Nasopharyngeal Neoplasms,0.212317068,1,"Biomarker, GeneticVariation"
3352,HTR1D,"5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled",0.0,1.0,1.0,0.0,0.0,28768,Obsessive-Compulsive Disorder,0.212317068,2,"Biomarker, GeneticVariation"
3108,HLA-DMA,"major histocompatibility complex, class II, DM alpha",0.0,1.0,1.0,0.0,0.0,11616,"Dermatitis, Contact",0.212317068,1,"Biomarker, GeneticVariation"
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,1.0,1.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.212317068,2,"Biomarker, GeneticVariation"
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.212317068,1,"Biomarker, GeneticVariation"
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",0.0,1.0,1.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.212317068,2,"Biomarker, GeneticVariation"
4852,NPY,neuropeptide Y,0.0,1.0,1.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.212317068,2,"Biomarker, GeneticVariation"
4887,NPY2R,neuropeptide Y receptor Y2,0.0,1.0,1.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.212317068,1,"Biomarker, GeneticVariation"
5820,PVT1,Pvt1 oncogene (non-protein coding),0.0,1.0,1.0,0.0,0.0,19829,Hodgkin Disease,0.212317068,1,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.212308825,12,"Biomarker, GeneticVariation"
1524,CX3CR1,chemokine (C-X3-C motif) receptor 1,0.0,1.0,1.0,0.0,0.0,10068,Coronary Disease,0.212268037,8,"Biomarker, GeneticVariation"
406991,MIR21,microRNA 21,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.212268037,8,Biomarker
5727,PTCH1,patched 1,0.0,1.0,0.0,0.0,0.0,35412,Rhabdomyosarcoma,0.212268037,9,Biomarker
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,1.0,0.0,0.0,39231,Tachycardia,0.212268037,9,"Biomarker, GeneticVariation"
5817,PVR,poliovirus receptor,0.0,1.0,0.0,0.0,0.0,32371,Poliomyelitis,0.212268037,9,Biomarker
64072,CDH23,cadherin-related 23,0.0,1.0,1.0,0.0,0.0,2931208,"Usher syndrome, type 1D",0.212268037,8,"Biomarker, GeneticVariation"
1834,DSPP,dentin sialophosphoprotein,0.0,1.0,1.0,0.0,0.0,2973527,Dentinogenesis imperfecta - Shield's type II,0.212268037,8,"Biomarker, GeneticVariation"
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,1.0,1.0,0.0,0.0,14544,Epilepsy,0.212268037,9,"Biomarker, GeneticVariation"
7248,TSC1,tuberous sclerosis 1,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.212268037,10,Biomarker
6662,SOX9,SRY (sex determining region Y)-box 9,0.0,1.0,0.0,0.0,0.0,31900,Pierre Robin Syndrome,0.212268037,8,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,2267227,Bulimia Nervosa,0.212268037,8,"Biomarker, GeneticVariation"
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.212268037,9,Biomarker
27436,EML4,echinoderm microtubule associated protein like 4,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.212268037,9,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,1.0,0.0,0.0,152013,Adenocarcinoma of lung,0.212268037,8,"Biomarker, GeneticVariation"
10344,CCL26,chemokine (C-C motif) ligand 26,0.0,1.0,0.0,0.0,0.0,341106,Eosinophilic Esophagitis,0.212268037,8,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.212268037,9,"Biomarker, GeneticVariation"
7249,TSC2,tuberous sclerosis 2,0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.212268037,11,Biomarker
474,ATOH1,atonal homolog 1 (Drosophila),0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.212268037,8,Biomarker
23532,PRAME,preferentially expressed antigen in melanoma,0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.212268037,8,Biomarker
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,1.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.212268037,9,"AlteredExpression, Biomarker, GeneticVariation, PostTranslationalModification"
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,20505,Hyperphagia,0.212268037,9,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.212268037,14,"Biomarker, Therapeutic"
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,1291245,Cortisone reductase deficiency,0.212268037,8,"Biomarker, GeneticVariation"
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,1.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.212268037,9,"Biomarker, GeneticVariation"
7979,SHFM1,split hand/foot malformation (ectrodactyly) type 1,0.0,1.0,0.0,0.0,0.0,2931019,Split hand foot deformity 1,0.212268037,8,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,265325,Turcot syndrome,0.212268037,9,Biomarker
4194,MDM4,"MDM4, p53 regulator",0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.212268037,9,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,14173,Endometrial Hyperplasia,0.212268037,9,Biomarker
54361,WNT4,"wingless-type MMTV integration site family, member 4",0.0,1.0,0.0,0.0,0.0,1698581,MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME,0.212268037,8,Biomarker
64423,INF2,"inverted formin, FH2 and WH2 domain containing",0.0,1.0,1.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.212268037,8,"Biomarker, GeneticVariation"
51129,ANGPTL4,angiopoietin-like 4,0.0,1.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.212268037,9,"Biomarker, Therapeutic"
5268,SERPINB5,"serpin peptidase inhibitor, clade B (ovalbumin), member 5",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.212268037,9,Biomarker
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.212268037,10,Biomarker
5077,PAX3,paired box 3,0.0,1.0,0.0,0.0,0.0,1261473,Sarcoma,0.212268037,8,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,587248,Costello Syndrome,0.212268037,9,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,1.0,0.0,0.0,18801,Heart Failure,0.212268037,9,"Biomarker, GeneticVariation"
6011,GRK1,G protein-coupled receptor kinase 1,0.0,1.0,1.0,0.0,0.0,1306122,Oguchi disease,0.212268037,8,"Biomarker, GeneticVariation"
174,AFP,alpha-fetoprotein,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.212268037,9,Biomarker
861,RUNX1,runt-related transcription factor 1,0.0,1.0,0.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.212268037,10,Biomarker
27184,DISC2,disrupted in schizophrenia 2 (non-protein coding),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.212268037,8,Biomarker
5921,RASA1,RAS p21 protein activator (GTPase activating protein) 1,0.0,1.0,0.0,0.0,0.0,3857,Arteriovenous Malformations,0.212268037,9,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,1.0,162557,"Liver Failure, Acute",0.212268037,9,"Biomarker, Therapeutic"
4167,MCDR1,"macular dystrophy, retinal, 1 (North Carolina type)",0.0,1.0,1.0,0.0,0.0,730294,"Macular dystrophy, retinal, 1, North Carolina type",0.212268037,8,"Biomarker, GeneticVariation"
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,1.0,23467,"Leukemia, Myeloid, Acute",0.212268037,9,"Biomarker, Therapeutic"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.211984532,7,Biomarker
6657,SOX2,SRY (sex determining region Y)-box 2,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.211984532,7,Biomarker
145226,RDH12,retinol dehydrogenase 12 (all-trans/9-cis/11-cis),0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.211984532,7,Biomarker
4583,MUC2,"mucin 2, oligomeric mucus/gel-forming",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.211984532,8,Biomarker
9049,AIP,aryl hydrocarbon receptor interacting protein,0.0,1.0,0.0,0.0,0.0,33375,Prolactinoma,0.211984532,7,Biomarker
3284,HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",0.0,1.0,1.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.211984532,8,"Biomarker, GeneticVariation"
6387,CXCL12,chemokine (C-X-C motif) ligand 12,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.211984532,8,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,1.0,0.0,0.0,3469,Anxiety Disorders,0.211984532,9,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,1206,Acromegaly,0.211984532,7,"Biomarker, GeneticVariation"
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,20540,"Hypertension, Malignant",0.211984532,8,Biomarker
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.211984532,8,Biomarker
1908,EDN3,endothelin 3,0.0,1.0,0.0,0.0,0.0,1848519,"Waardenburg syndrome, type 4",0.211984532,8,Biomarker
3973,LHCGR,luteinizing hormone/choriogonadotropin receptor,1.0,1.0,1.0,0.0,0.0,860158,Leydig Cell Hypoplasia,0.211984532,7,"AlteredExpression, Biomarker, GeneticVariation"
6444,SGCD,"sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)",0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.211984532,8,"Biomarker, GeneticVariation"
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,17658,Glomerulonephritis,0.211984532,8,"Biomarker, GeneticVariation"
10049,DNAJB6,"DnaJ (Hsp40) homolog, subfamily B, member 6",0.0,1.0,1.0,0.0,0.0,686353,"Muscular Dystrophies, Limb-Girdle",0.211984532,7,"Biomarker, GeneticVariation"
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,0.0,0.0,0.0,1275081,Cardiofaciocutaneous syndrome,0.211984532,8,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,1.0,0.0,1.0,32463,Polycythemia Vera,0.211984532,8,"Biomarker, GeneticVariation, Therapeutic"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,17168,Gastroesophageal Reflux,0.211984532,7,Biomarker
51176,LEF1,lymphoid enhancer-binding factor 1,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.211984532,8,Biomarker
1427,CRYGS,"crystallin, gamma S",0.0,1.0,1.0,0.0,0.0,86543,Cataract,0.211984532,8,"Biomarker, GeneticVariation"
64802,NMNAT1,nicotinamide nucleotide adenylyltransferase 1,0.0,1.0,1.0,0.0,0.0,339527,Leber Congenital Amaurosis,0.211984532,7,"Biomarker, GeneticVariation"
55812,SPATA7,spermatogenesis associated 7,0.0,1.0,0.0,0.0,0.0,339527,Leber Congenital Amaurosis,0.211984532,7,Biomarker
30829,IBD3,inflammatory bowel disease 3,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.211984532,7,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.211984532,8,Biomarker
23532,PRAME,preferentially expressed antigen in melanoma,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.211984532,7,Biomarker
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.211984532,7,Biomarker
7227,TRPS1,trichorhinophalangeal syndrome I,0.0,1.0,1.0,0.0,0.0,23003,Langer-Giedion Syndrome,0.211984532,8,"Biomarker, GeneticVariation"
1585,CYP11B2,"cytochrome P450, family 11, subfamily B, polypeptide 2",0.0,1.0,0.0,0.0,0.0,20595,Hypoaldosteronism,0.211984532,8,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211984532,8,Biomarker
2305,FOXM1,forkhead box M1,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211984532,9,Biomarker
3799,KIF5B,kinesin family member 5B,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211984532,7,Biomarker
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211984532,8,Biomarker
8434,RECK,reversion-inducing-cysteine-rich protein with kazal motifs,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211984532,7,Biomarker
7249,TSC2,tuberous sclerosis 2,0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.211984532,8,"Biomarker, GeneticVariation"
5077,PAX3,paired box 3,0.0,1.0,1.0,0.0,0.0,80178,Spinal Dysraphism,0.211984532,10,"Biomarker, GeneticVariation"
282553,AUTS8,"Autism, susceptibility to, 8",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.211984532,7,Biomarker
11141,IL1RAPL1,interleukin 1 receptor accessory protein-like 1,0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.211984532,7,"Biomarker, GeneticVariation"
5173,PDYN,prodynorphin,0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.211984532,9,"Biomarker, GeneticVariation"
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.211984532,9,Biomarker
57016,AKR1B10,"aldo-keto reductase family 1, member B10 (aldose reductase)",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.211984532,8,Biomarker
1050,CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.211984532,9,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,1.0,27765,Nervous System Diseases,0.211984532,8,"Biomarker, Therapeutic"
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.211984532,8,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,1838539,Atrial Standstill,0.211984532,7,"Biomarker, GeneticVariation"
50818,DYT10,dystonia 10,0.0,1.0,0.0,0.0,0.0,1868682,Familial paroxysmal dystonia,0.211984532,7,Biomarker
60529,ALX4,ALX homeobox 4,0.0,1.0,1.0,0.0,0.0,1868598,Parietal Foramina,0.211984532,7,"Biomarker, GeneticVariation"
145226,RDH12,retinol dehydrogenase 12 (all-trans/9-cis/11-cis),0.0,1.0,1.0,0.0,0.0,854723,Retinal Dystrophies,0.211984532,8,"Biomarker, GeneticVariation"
8504,PEX3,peroxisomal biogenesis factor 3,0.0,1.0,1.0,0.0,0.0,43459,Zellweger Syndrome,0.211984532,7,"Biomarker, GeneticVariation"
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.211984532,8,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,1.0,23290,"Leishmaniasis, Visceral",0.211984532,9,"Biomarker, Therapeutic"
25,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,596263,Carcinogenesis,0.211984532,7,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,2874,"Anemia, Aplastic",0.211984532,13,"Biomarker, Therapeutic"
79944,L2HGDH,L-2-hydroxyglutarate dehydrogenase,0.0,1.0,1.0,0.0,0.0,2746066,2-Hydroxyglutaricaciduria,0.211984532,10,"Biomarker, GeneticVariation"
344,APOC2,apolipoprotein C-II,0.0,1.0,1.0,0.0,0.0,23817,Hyperlipoproteinemia Type I,0.211984532,7,"Biomarker, GeneticVariation"
2973,GTS,Gilles de la Tourette syndrome,0.0,1.0,0.0,0.0,0.0,40517,Tourette Syndrome,0.211984532,7,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.211984532,8,"Biomarker, GeneticVariation"
406892,MIR100,microRNA 100,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211984532,8,Biomarker
1583,CYP11A1,"cytochrome P450, family 11, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,1623,Adrenal Insufficiency,0.211984532,7,"Biomarker, GeneticVariation"
2290,FOXG1,forkhead box G1,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.211984532,7,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.211984532,8,"Biomarker, GeneticVariation"
6778,STAT6,"signal transducer and activator of transcription 6, interleukin-4 induced",0.0,1.0,0.0,0.0,0.0,1266119,Solitary Fibrous Tumors,0.211984532,7,Biomarker
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.211984532,9,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.211984532,8,Biomarker
2218,FKTN,fukutin,0.0,1.0,0.0,0.0,0.0,265221,Walker-Warburg Syndrome,0.211984532,7,Biomarker
55624,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",0.0,1.0,0.0,0.0,0.0,265221,Walker-Warburg Syndrome,0.211984532,7,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.211984532,7,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.211984532,7,Biomarker
2120,ETV6,ets variant 6,0.0,1.0,0.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.211984532,9,Biomarker
6929,TCF3,transcription factor 3,0.0,1.0,1.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.211984532,8,"Biomarker, GeneticVariation"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.211984532,8,Biomarker
4149,MAX,MYC associated factor X,0.0,1.0,0.0,0.0,0.0,31511,Pheochromocytoma,0.211984532,7,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,1.0,23903,Liver Neoplasms,0.211984532,7,"Biomarker, Therapeutic"
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.211984532,8,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,1.0,23903,Liver Neoplasms,0.211984532,8,"Biomarker, Therapeutic"
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.211984532,8,Biomarker
7434,VIPR2,vasoactive intestinal peptide receptor 2,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.211984532,7,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,42384,Vasculitis,0.211984532,8,Biomarker
1495,CTNNA1,"catenin (cadherin-associated protein), alpha 1, 102kDa",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.211984532,7,Biomarker
367,AR,androgen receptor,0.0,1.0,0.0,0.0,0.0,2931395,"Bulbospinal neuronopathy, X-linked recessive",0.211984532,7,Biomarker
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,1.0,0.0,0.0,1141890,Congenital long QT syndrome,0.211907192,42,"Biomarker, GeneticVariation"
7401,CLRN1,clarin 1,0.0,1.0,1.0,0.0,0.0,271097,Usher Syndromes,0.211898295,18,"Biomarker, GeneticVariation"
113278,SLC52A3,"solute carrier family 52 (riboflavin transporter), member 3",0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.211701027,6,"Biomarker, GeneticVariation"
1406,CRX,cone-rod homeobox,0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.211701027,7,Biomarker
9581,PREPL,prolyl endopeptidase-like,0.0,1.0,0.0,0.0,0.0,1848030,Hypotonia-Cystinuria Syndrome,0.211701027,6,Biomarker
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.211701027,6,Biomarker
7307,U2AF1,U2 small nuclear RNA auxiliary factor 1,0.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.211701027,6,Biomarker
8314,BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.211701027,7,Biomarker
5325,PLAGL1,pleiomorphic adenoma gene-like 1,1.0,1.0,1.0,0.0,0.0,1832386,"Diabetes Mellitus, Transient Neonatal, 1",0.211701027,6,"AlteredExpression, Biomarker, GeneticVariation"
8481,OFD1,oral-facial-digital syndrome 1,0.0,1.0,1.0,0.0,0.0,2931426,Orofaciodigital syndrome type1,0.211701027,6,"Biomarker, GeneticVariation"
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.211701027,7,Biomarker
6928,HNF1B,HNF1 homeobox B,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.211701027,6,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,1.0,0.0,0.0,768,Congenital Abnormalities,0.211701027,6,"Biomarker, GeneticVariation"
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,22658,Kidney Diseases,0.211701027,6,"Biomarker, Therapeutic"
242,ALOX12B,"arachidonate 12-lipoxygenase, 12R type",0.0,1.0,0.0,0.0,0.0,79154,"Ichthyosis, Lamellar",0.211701027,7,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.211701027,8,Biomarker
3691,ITGB4,"integrin, beta 4",0.0,1.0,0.0,0.0,0.0,266159,Pyloric Atresia,0.211701027,8,Biomarker
84464,SLX4,SLX4 structure-specific endonuclease subunit,0.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.211701027,7,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,1.0,0.0,0.0,17601,Glaucoma,0.211701027,7,"Biomarker, GeneticVariation"
4512,COX1,cytochrome c oxidase subunit I,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.211701027,7,Biomarker
5947,RBP1,"retinol binding protein 1, cellular",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.211701027,7,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,2932715,Pseudohypoparathyroidism Type 1B,0.211701027,6,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,40028,"Thrombocythemia, Essential",0.211701027,7,"Biomarker, Therapeutic"
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,0.0,0.0,0.0,34067,Pulmonary Emphysema,0.211701027,6,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,26827,Muscle Hypotonia,0.211701027,7,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.211701027,8,Biomarker
10269,ZMPSTE24,zinc metallopeptidase STE24,0.0,1.0,0.0,0.0,0.0,23787,Lipodystrophy,0.211701027,7,Biomarker
81704,DOCK8,dedicator of cytokinesis 8,0.0,1.0,0.0,0.0,0.0,22398,Job Syndrome,0.211701027,6,Biomarker
103,ADAR,"adenosine deaminase, RNA-specific",0.0,1.0,0.0,0.0,0.0,796126,Aicardi-Goutieres syndrome,0.211701027,6,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,3665358,Galactorrhea,0.211701027,7,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.211701027,7,Biomarker
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,35579,Rickets,0.211701027,7,Biomarker
9896,FIG4,FIG4 phosphoinositide 5-phosphatase,0.0,1.0,0.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.211701027,6,Biomarker
9227,LRAT,lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase),0.0,1.0,0.0,0.0,0.0,339527,Leber Congenital Amaurosis,0.211701027,6,Biomarker
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,24301,"Lymphoma, Follicular",0.211701027,7,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,1.0,0.0,0.0,10200,Cough,0.211701027,7,"Biomarker, GeneticVariation"
929,CD14,CD14 molecule,0.0,1.0,0.0,0.0,0.0,13595,Eczema,0.211701027,6,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,1.0,151744,Myocardial Ischemia,0.211701027,7,"Biomarker, Therapeutic"
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.211701027,8,"Biomarker, GeneticVariation"
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,31099,Periodontitis,0.211701027,7,Biomarker
2194,FASN,fatty acid synthase,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.211701027,9,Biomarker
5294,PIK3CG,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma",0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.211701027,6,Biomarker
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,302592,Cervix carcinoma,0.211701027,6,"Biomarker, GeneticVariation"
6750,SST,somatostatin,0.0,1.0,0.0,0.0,1.0,27651,Neoplasms,0.211701027,7,"Biomarker, Therapeutic"
7528,YY1,YY1 transcription factor,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.211701027,7,Biomarker
1012,CDH13,cadherin 13,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211701027,6,Biomarker
4601,MXI1,"MAX interactor 1, dimerization protein",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.211701027,6,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.211701027,7,Biomarker
9189,ZBED1,"zinc finger, BED-type containing 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.211701027,7,Biomarker
7374,UNG,uracil-DNA glycosylase,0.0,1.0,0.0,0.0,0.0,272236,Hyper-IgM Immunodeficiency Syndrome,0.211701027,6,Biomarker
5315,PKM,"pyruvate kinase, muscle",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.211701027,7,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,14130,Endocrine System Diseases,0.211701027,8,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,1.0,27765,Nervous System Diseases,0.211701027,7,"Biomarker, Therapeutic"
7080,NKX2-1,NK2 homeobox 1,0.0,1.0,1.0,0.0,0.0,24115,Lung Diseases,0.211701027,7,"Biomarker, GeneticVariation"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.211701027,7,Biomarker
8148,TAF15,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa",0.0,1.0,1.0,0.0,0.0,1275278,"Chondrosarcoma, Extraskeletal Myxoid",0.211701027,6,"Biomarker, GeneticVariation"
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,2878,"Anemia, Hemolytic",0.211701027,7,Biomarker
648,BMI1,"BMI1 proto-oncogene, polycomb ring finger",0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.211701027,7,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,1.0,17636,Glioblastoma,0.211701027,6,"Biomarker, Therapeutic"
864,RUNX3,runt-related transcription factor 3,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.211701027,7,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.211701027,7,Biomarker
100528024,DEL11P13,"Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome",0.0,1.0,0.0,0.0,0.0,206115,WAGR Syndrome,0.211701027,6,Biomarker
6927,HNF1A,HNF1 homeobox A,0.0,1.0,1.0,0.0,0.0,20615,Hypoglycemia,0.211701027,6,"Biomarker, GeneticVariation"
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.211701027,10,Biomarker
9518,GDF15,growth differentiation factor 15,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211701027,6,Biomarker
406947,MIR155,microRNA 155,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211701027,7,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.211701027,6,Biomarker
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",0.0,1.0,0.0,0.0,1.0,17638,Glioma,0.211701027,7,"Biomarker, Therapeutic"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,1.0,1261473,Sarcoma,0.211701027,7,"Biomarker, Therapeutic"
3860,KRT13,"keratin 13, type I",0.0,1.0,0.0,0.0,0.0,1721005,"Leukokeratosis, Hereditary Mucosal",0.211701027,6,Biomarker
23314,SATB2,SATB homeobox 2,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.211701027,8,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,1.0,0.0,0.0,32285,Pneumonia,0.211701027,7,"Biomarker, GeneticVariation"
90865,IL33,interleukin 33,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.211701027,7,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.211701027,6,Biomarker
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,1.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.211701027,7,"Biomarker, GeneticVariation"
1435,CSF1,colony stimulating factor 1 (macrophage),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.211701027,7,Biomarker
5324,PLAG1,pleiomorphic adenoma gene 1,0.0,1.0,0.0,0.0,0.0,1519176,"Salivary Gland Adenoma, Pleomorphic",0.211701027,6,Biomarker
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.211701027,7,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.211701027,6,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.211701027,7,Biomarker
2722,GLC1B,"glaucoma 1, open angle, B (adult-onset)",0.0,1.0,0.0,0.0,0.0,339573,"Glaucoma, Primary Open Angle",0.211701027,6,Biomarker
2641,GCG,glucagon,0.0,1.0,0.0,0.0,0.0,20459,Hyperinsulinism,0.211701027,7,Biomarker
3861,KRT14,"keratin 14, type I",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.211701027,7,Biomarker
54657,UGT1A4,"UDP glucuronosyltransferase 1 family, polypeptide A4",0.0,1.0,1.0,0.0,0.0,10324,Crigler-Najjar Syndrome,0.211701027,6,"Biomarker, GeneticVariation"
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.211701027,7,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.211701027,7,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.211701027,6,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.211701027,7,Biomarker
4654,MYOD1,myogenic differentiation 1,1.0,1.0,0.0,0.0,0.0,206656,"Rhabdomyosarcoma, Embryonal",0.211701027,6,"AlteredExpression, Biomarker"
23451,SF3B1,"splicing factor 3b, subunit 1, 155kDa",0.0,1.0,1.0,0.0,0.0,220633,Uveal melanoma,0.211701027,6,"Biomarker, GeneticVariation"
6010,RHO,rhodopsin,0.0,1.0,1.0,0.0,0.0,339535,"Night blindness, congenital stationary",0.211701027,6,"Biomarker, GeneticVariation"
3684,ITGAM,"integrin, alpha M (complement component 3 receptor 3 subunit)",1.0,1.0,0.0,1.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.211701027,6,"AlteredExpression, Biomarker, PostTranslationalModification"
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,1.0,1.0,0.0,0.0,392784,Dermatofibrosarcoma Protuberans,0.211623687,41,"Biomarker, GeneticVariation"
773,CACNA1A,"calcium channel, voltage-dependent, P/Q type, alpha 1A subunit",0.0,1.0,0.0,0.0,0.0,14553,"Epilepsy, Absence",0.211417523,5,Biomarker
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,0.0,0.0,0.0,19880,Homocystinuria,0.211417523,5,Biomarker
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,1970482,Potocki-Lupski syndrome,0.211417523,6,Biomarker
3691,ITGB4,"integrin, beta 4",0.0,1.0,1.0,0.0,0.0,79301,"Epidermolysis Bullosa, Junctional",0.211417523,6,"Biomarker, GeneticVariation"
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",0.0,1.0,0.0,0.0,1.0,279626,Esophageal Squamous Cell Carcinoma,0.211417523,6,"Biomarker, Therapeutic"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.211417523,6,"AlteredExpression, Biomarker, GeneticVariation"
3663,IRF5,interferon regulatory factor 5,0.0,1.0,1.0,0.0,0.0,9324,"Colitis, Ulcerative",0.211417523,6,"Biomarker, GeneticVariation"
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,1.0,35304,Retinal Degeneration,0.211417523,5,"Biomarker, Therapeutic"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.211417523,7,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.211417523,8,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.211417523,6,Biomarker
6519,SLC3A1,"solute carrier family 3 (amino acid transporter heavy chain), member 1",0.0,1.0,0.0,0.0,0.0,1848030,Hypotonia-Cystinuria Syndrome,0.211417523,5,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.211417523,6,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.211417523,6,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,221357,Brachydactyly,0.211417523,6,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,1.0,0.0,0.0,11849,Diabetes Mellitus,0.211417523,6,"Biomarker, GeneticVariation"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.211417523,6,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.211417523,6,Biomarker
7086,TKT,transketolase,0.0,1.0,0.0,0.0,0.0,349464,Korsakoff Syndrome,0.211417523,5,Biomarker
3776,KCNK2,"potassium channel, two pore domain subfamily K, member 2",0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.211417523,6,Biomarker
8314,BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.211417523,7,Biomarker
84925,DIRC2,disrupted in renal carcinoma 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.211417523,5,Biomarker
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.211417523,5,Biomarker
55193,PBRM1,polybromo 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.211417523,7,Biomarker
6299,SALL1,spalt-like transcription factor 1,0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.211417523,6,Biomarker
59344,ALOXE3,arachidonate lipoxygenase 3,0.0,1.0,0.0,0.0,0.0,79154,"Ichthyosis, Lamellar",0.211417523,6,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,1862941,"Amyotrophic Lateral Sclerosis, Sporadic",0.211417523,5,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,1.0,22116,Ischemia,0.211417523,6,"Biomarker, Therapeutic"
2707,GJB3,"gap junction protein, beta 3, 31kDa",0.0,1.0,0.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.211417523,6,Biomarker
10481,HOXB13,homeobox B13,0.0,1.0,1.0,0.0,0.0,2931456,"Prostate cancer, familial",0.211417523,5,"Biomarker, GeneticVariation"
54209,TREM2,triggering receptor expressed on myeloid cells 2,0.0,1.0,0.0,0.0,0.0,497327,Dementia,0.211417523,5,Biomarker
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.211417523,6,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,1.0,14544,Epilepsy,0.211417523,7,"Biomarker, Therapeutic"
7337,UBE3A,ubiquitin protein ligase E3A,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.211417523,6,Biomarker
170474,HFM,Hemifacial microsomia,0.0,1.0,0.0,0.0,0.0,265240,Goldenhar Syndrome,0.211417523,5,Biomarker
5012,OTSC1,otosclerosis 1,0.0,1.0,0.0,0.0,0.0,29899,Otosclerosis,0.211417523,5,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,1.0,0.0,0.0,10276,Craniopharyngioma,0.211417523,5,"Biomarker, GeneticVariation"
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.211417523,6,Biomarker
2067,ERCC1,excision repair cross-complementation group 1,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.211417523,6,Biomarker
653361,NCF1,neutrophil cytosolic factor 1,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.211417523,7,Biomarker
5340,PLG,plasminogen,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.211417523,6,Biomarker
5994,RFXAP,regulatory factor X-associated protein,0.0,1.0,0.0,0.0,0.0,2931418,Bare lymphocyte syndrome 2,0.211417523,5,Biomarker
4004,LMO1,LIM domain only 1 (rhombotin 1),0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.211417523,6,Biomarker
4602,MYB,v-myb avian myeloblastosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.211417523,5,Biomarker
84295,PHF6,PHD finger protein 6,0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.211417523,5,Biomarker
7361,UGT1A,"UDP glucuronosyltransferase 1 family, polypeptide A complex locus",0.0,1.0,1.0,0.0,0.0,17551,Gilbert Disease,0.211417523,5,"Biomarker, GeneticVariation"
2774,GNAL,"guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type",0.0,1.0,1.0,0.0,0.0,13421,Dystonia,0.211417523,6,"Biomarker, GeneticVariation"
65217,PCDH15,protocadherin-related 15,0.0,1.0,0.0,0.0,0.0,2931210,"Usher syndrome, type 1F",0.211417523,5,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,1.0,20437,Hypercalcemia,0.211417523,7,"Biomarker, Therapeutic"
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,1134719,"Carcinoma, Ductal, Breast",0.211417523,7,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,1134719,"Carcinoma, Ductal, Breast",0.211417523,5,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.211417523,6,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,1.0,0.0,0.0,4364,Autoimmune Diseases,0.211417523,6,"Biomarker, GeneticVariation"
1181,CLCN2,"chloride channel, voltage-sensitive 2",0.0,1.0,1.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.211417523,5,"Biomarker, GeneticVariation"
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,1.0,15695,Fatty Liver,0.211417523,8,"Biomarker, Therapeutic"
5921,RASA1,RAS p21 protein activator (GTPase activating protein) 1,0.0,1.0,0.0,0.0,0.0,38505,Sturge-Weber Syndrome,0.211417523,5,Biomarker
2774,GNAL,"guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type",0.0,1.0,1.0,0.0,0.0,393593,Dystonic Disorders,0.211417523,6,"Biomarker, GeneticVariation"
4221,MEN1,multiple endocrine neoplasia I,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.211417523,5,Biomarker
359825,PSORS9,psoriasis susceptibility 9,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.211417523,5,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.211417523,6,Biomarker
7439,BEST1,bestrophin 1,0.0,1.0,1.0,0.0,0.0,1842914,"MACULAR DYSTROPHY, VITELLIFORM, ADULT-ONSET",0.211417523,5,"Biomarker, GeneticVariation"
4089,SMAD4,SMAD family member 4,0.0,1.0,1.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.211417523,5,"Biomarker, GeneticVariation"
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.211417523,6,Biomarker
9420,CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,37773,"Spastic Paraplegia, Hereditary",0.211417523,6,Biomarker
11192,DYX3,dyslexia susceptibility 3,0.0,1.0,0.0,0.0,0.0,476254,Dyslexia,0.211417523,5,Biomarker
3816,KLK1,kallikrein 1,0.0,1.0,0.0,0.0,1.0,27051,Myocardial Infarction,0.211417523,6,"Biomarker, Therapeutic"
51010,EXOSC3,exosome component 3,0.0,1.0,1.0,0.0,0.0,1843504,Pontocerebellar Hypoplasia Type 1,0.211417523,5,"Biomarker, GeneticVariation"
81794,ADAMTS10,"ADAM metallopeptidase with thrombospondin type 1 motif, 10",0.0,1.0,1.0,0.0,0.0,265313,Weill-Marchesani Syndrome,0.211417523,5,"Biomarker, GeneticVariation"
405,ARNT,aryl hydrocarbon receptor nuclear translocator,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.211417523,5,Biomarker
374,AREG,amphiregulin,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211417523,6,Biomarker
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211417523,5,"Biomarker, GeneticVariation"
406937,MIR145,microRNA 145,0.0,1.0,0.0,0.0,1.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211417523,6,"Biomarker, Therapeutic"
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211417523,5,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,346302,Growth Hormone-Secreting Pituitary Adenoma,0.211417523,6,Biomarker
4978,OPCML,opioid binding protein/cell adhesion molecule-like,0.0,1.0,1.0,0.0,0.0,1140680,Malignant neoplasm of ovary,0.211417523,5,"Biomarker, GeneticVariation"
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,1.0,0.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.211417523,6,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.211417523,5,Biomarker
158,ADSL,adenylosuccinate lyase,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.211417523,5,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.211417523,6,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.211417523,11,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,40100,Thymoma,0.211417523,6,Biomarker
5116,PCNT,pericentrin,0.0,1.0,1.0,0.0,0.0,432246,"Microcephalic Osteodysplastic Primordial Dwarfism, Type II",0.211417523,5,"Biomarker, GeneticVariation"
7249,TSC2,tuberous sclerosis 2,0.0,1.0,0.0,0.0,0.0,37769,"Spasms, Infantile",0.211417523,6,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,14072,"Encephalomyelitis, Autoimmune, Experimental",0.211417523,6,"Biomarker, Therapeutic"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,206093,Neuroectodermal Tumors,0.211417523,6,Biomarker
2159,F10,coagulation factor X,0.0,1.0,0.0,0.0,0.0,5779,Blood Coagulation Disorders,0.211417523,6,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.211417523,6,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.211417523,5,"Biomarker, GeneticVariation"
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.211417523,5,Biomarker
81622,UNC93B1,unc-93 homolog B1 (C. elegans),0.0,1.0,0.0,0.0,0.0,276226,"Encephalitis, Herpes Simplex",0.211417523,5,Biomarker
213,ALB,albumin,0.0,1.0,1.0,0.0,0.0,239981,Hypoalbuminemia,0.211417523,6,"Biomarker, GeneticVariation"
7306,TYRP1,tyrosinase-related protein 1,0.0,1.0,0.0,0.0,0.0,2931599,Oculocutaneous albinism type 3,0.211417523,5,Biomarker
4595,MUTYH,mutY homolog,0.0,1.0,1.0,0.0,0.0,699791,STOMACH CARCINOMA,0.211417523,5,"Biomarker, GeneticVariation"
5909,RAP1GAP,RAP1 GTPase activating protein,0.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.211417523,6,Biomarker
5828,PEX2,peroxisomal biogenesis factor 2,0.0,1.0,0.0,0.0,0.0,43459,Zellweger Syndrome,0.211417523,6,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.211417523,6,"Biomarker, GeneticVariation"
7056,THBD,thrombomodulin,0.0,1.0,0.0,0.0,0.0,2931788,Atypical Hemolytic Uremic Syndrome,0.211417523,5,Biomarker
2335,FN1,fibronectin 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.211417523,6,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,14356,Enterocolitis,0.211417523,6,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.211417523,6,Biomarker
5190,PEX6,peroxisomal biogenesis factor 6,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.211417523,5,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.211417523,6,Biomarker
4323,MMP14,matrix metallopeptidase 14 (membrane-inserted),0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.211417523,6,Biomarker
6790,AURKA,aurora kinase A,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.211417523,6,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,1.0,2874,"Anemia, Aplastic",0.211417523,7,"Biomarker, Therapeutic"
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.211417523,6,Biomarker
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,1.0,0.0,0.0,2746066,2-Hydroxyglutaricaciduria,0.211417523,5,"Biomarker, GeneticVariation"
4319,MMP10,matrix metallopeptidase 10 (stromelysin 2),0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211417523,5,Biomarker
6667,SP1,Sp1 transcription factor,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211417523,6,Biomarker
284403,WDR62,WD repeat domain 62,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.211417523,6,Biomarker
4763,NF1,neurofibromin 1,0.0,1.0,0.0,0.0,0.0,1261473,Sarcoma,0.211417523,6,Biomarker
84140,FAM161A,"family with sequence similarity 161, member A",0.0,1.0,0.0,0.0,0.0,35334,Retinitis Pigmentosa,0.211417523,5,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.211417523,6,"Biomarker, GeneticVariation"
4665,NAB2,NGFI-A binding protein 2 (EGR1 binding protein 2),0.0,1.0,0.0,0.0,0.0,1266119,Solitary Fibrous Tumors,0.211417523,5,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.211417523,5,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.211417523,9,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.211417523,6,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.211417523,6,Biomarker
3605,IL17A,interleukin 17A,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.211417523,6,Biomarker
5949,RBP3,"retinol binding protein 3, interstitial",0.0,1.0,1.0,0.0,0.0,42164,Uveitis,0.211417523,6,"Biomarker, GeneticVariation"
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.211417523,6,Biomarker
10483,SEC23B,Sec23 homolog B (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,2876,"Anemia, Dyserythropoietic, Congenital",0.211417523,6,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.211417523,6,"Biomarker, GeneticVariation"
338567,KCNK18,"potassium channel, two pore domain subfamily K, member 18",0.0,1.0,0.0,0.0,0.0,149931,Migraine Disorders,0.211417523,5,Biomarker
9759,HDAC4,histone deacetylase 4,0.0,1.0,0.0,0.0,0.0,2931817,Chromosome 2q37 deletion syndrome,0.211417523,5,Biomarker
192142,RLS1,"Restless legs syndrome, susceptibility to",0.0,1.0,0.0,0.0,0.0,35258,Restless Legs Syndrome,0.211417523,5,Biomarker
2305,FOXM1,forkhead box M1,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.211417523,6,"Biomarker, GeneticVariation"
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,24121,Lung Neoplasms,0.211417523,6,"Biomarker, GeneticVariation"
3342,HTC2,"hypertrichosis 2 (generalized, congenital)",0.0,1.0,1.0,0.0,0.0,1855900,Hypertrichosis congenital generalized X-linked,0.211417523,5,"Biomarker, GeneticVariation"
3949,LDLR,low density lipoprotein receptor,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.211417523,8,Biomarker
6720,SREBF1,sterol regulatory element binding transcription factor 1,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.211417523,5,Biomarker
3713,IVL,involucrin,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.211417523,6,Biomarker
5979,RET,ret proto-oncogene,0.0,1.0,0.0,0.0,0.0,1609433,Hereditary renal agenesis,0.211417523,5,Biomarker
3439,IFNA1,"interferon, alpha 1",0.0,1.0,0.0,0.0,1.0,23903,Liver Neoplasms,0.211417523,6,"Biomarker, Therapeutic"
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.211417523,6,Biomarker
169792,GLIS3,GLIS family zinc finger 3,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.211417523,6,"Biomarker, GeneticVariation"
5205,ATP8B1,"ATPase, aminophospholipid transporter, class I, type 8B, member 1",0.0,1.0,0.0,0.0,0.0,8372,"Cholestasis, Intrahepatic",0.211417523,6,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.211417523,6,"Biomarker, GeneticVariation"
2591,GALNT3,polypeptide N-acetylgalactosaminyltransferase 3,0.0,1.0,0.0,0.0,0.0,85681,Hyperphosphatemia,0.211417523,6,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.211417523,6,Biomarker
241,ALOX5AP,arachidonate 5-lipoxygenase-activating protein,0.0,1.0,0.0,0.0,0.0,7785,Cerebral Infarction,0.211417523,5,Biomarker
3062,HCRTR2,hypocretin (orexin) receptor 2,0.0,1.0,0.0,0.0,0.0,27404,Narcolepsy,0.211417523,6,Biomarker
8200,GDF5,growth differentiation factor 5,0.0,1.0,1.0,0.0,0.0,1861385,Cushing's symphalangism,0.211417523,5,"Biomarker, GeneticVariation"
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.211417523,6,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,1840452,Hyaloideoretinal degeneration of Wagner,0.211417523,6,"Biomarker, GeneticVariation"
1978,EIF4EBP1,eukaryotic translation initiation factor 4E binding protein 1,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.211417523,6,"Biomarker, GeneticVariation"
3456,IFNB1,"interferon, beta 1, fibroblast",0.0,1.0,0.0,0.0,1.0,19163,Hepatitis B,0.211417523,6,"Biomarker, Therapeutic"
1050,CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",1.0,1.0,0.0,0.0,1.0,23487,"Leukemia, Promyelocytic, Acute",0.211417523,6,"AlteredExpression, Biomarker, Therapeutic"
7056,THBD,thrombomodulin,0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.211417523,6,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,1.0,20619,Hypogonadism,0.211417523,6,"Biomarker, Therapeutic"
64421,DCLRE1C,DNA cross-link repair 1C,0.0,1.0,1.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.211409281,18,"Biomarker, GeneticVariation"
1832,DSP,desmoplakin,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.211331286,17,"Biomarker, GeneticVariation"
100038247,PTLS,Potocki-Lupski syndrome,0.0,1.0,0.0,0.0,0.0,1970482,Potocki-Lupski syndrome,0.211134018,4,Biomarker
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.211134018,4,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,1863051,Alzheimer disease type 2,0.211134018,4,Biomarker
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.211134018,5,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.211134018,6,Biomarker
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.211134018,5,Biomarker
5309,PITX3,paired-like homeodomain 3,0.0,1.0,0.0,0.0,0.0,26010,Microphthalmos,0.211134018,4,Biomarker
6898,TAT,tyrosine aminotransferase,0.0,1.0,0.0,0.0,0.0,268483,Tyrosinemias,0.211134018,4,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,11581,Depressive Disorder,0.211134018,5,"Biomarker, GeneticVariation"
5816,PVALB,parvalbumin,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.211134018,4,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.211134018,5,Biomarker
7052,TGM2,transglutaminase 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.211134018,5,Biomarker
10683,DLL3,delta-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.211134018,4,Biomarker
1269,CNR2,cannabinoid receptor 2 (macrophage),0.0,1.0,0.0,0.0,1.0,4153,Atherosclerosis,0.211134018,4,"Biomarker, Therapeutic"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.211134018,5,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.211134018,5,Biomarker
3854,KRT6B,"keratin 6B, type II",0.0,1.0,1.0,0.0,0.0,265334,Pachyonychia Congenita,0.211134018,4,"Biomarker, GeneticVariation"
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.211134018,5,Biomarker
6559,SLC12A3,"solute carrier family 12 (sodium/chloride transporter), member 3",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.211134018,5,Biomarker
10216,PRG4,proteoglycan 4,0.0,1.0,0.0,0.0,0.0,31046,Pericarditis,0.211134018,5,Biomarker
1958,EGR1,early growth response 1,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.211134018,5,Biomarker
9365,KL,klotho,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.211134018,5,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.211134018,4,Biomarker
9607,CARTPT,CART prepropeptide,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.211134018,5,Biomarker
1395,CRHR2,corticotropin releasing hormone receptor 2,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.211134018,5,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,1.0,3469,Anxiety Disorders,0.211134018,5,"Biomarker, Therapeutic"
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,0.0,0.0,0.0,1970431,Pitt-Hopkins syndrome,0.211134018,4,Biomarker
9378,NRXN1,neurexin 1,0.0,1.0,0.0,0.0,0.0,1970431,Pitt-Hopkins syndrome,0.211134018,4,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,41956,Ureteral Obstruction,0.211134018,5,Biomarker
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,0.0,0.0,0.0,497327,Dementia,0.211134018,4,Biomarker
1915,EEF1A1,eukaryotic translation elongation factor 1 alpha 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.211134018,5,Biomarker
1106,CHD2,chromodomain helicase DNA binding protein 2,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.211134018,4,Biomarker
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.211134018,5,Biomarker
57468,SLC12A5,"solute carrier family 12 (potassium/chloride transporter), member 5",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.211134018,6,Biomarker
8831,SYNGAP1,synaptic Ras GTPase activating protein 1,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.211134018,4,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,282550,Persian Gulf Syndrome,0.211134018,5,Biomarker
4436,MSH2,mutS homolog 2,0.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.211134018,5,"Biomarker, GeneticVariation"
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.211134018,4,Biomarker
5589,PRKCSH,protein kinase C substrate 80K-H,0.0,1.0,0.0,0.0,0.0,22680,Polycystic Kidney Diseases,0.211134018,5,Biomarker
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,0.0,0.0,0.0,19625,"Histiocytosis, Sinus",0.211134018,4,Biomarker
2309,FOXO3,forkhead box O3,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.211134018,4,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.211134018,5,"Biomarker, GeneticVariation"
9943,OXSR1,oxidative stress responsive 1,0.0,1.0,0.0,0.0,1.0,20538,Hypertension,0.211134018,5,"Biomarker, Therapeutic"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,3706,Arachnodactyly,0.211134018,5,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.211134018,5,Biomarker
54113,VUR,Vesicoureteral reflux,0.0,1.0,0.0,0.0,0.0,42580,Vesico-Ureteral Reflux,0.211134018,4,Biomarker
9533,POLR1C,"polymerase (RNA) I polypeptide C, 30kDa",0.0,1.0,0.0,0.0,0.0,242387,Mandibulofacial Dysostosis,0.211134018,4,Biomarker
51082,POLR1D,"polymerase (RNA) I polypeptide D, 16kDa",0.0,1.0,0.0,0.0,0.0,242387,Mandibulofacial Dysostosis,0.211134018,4,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,1.0,0.0,0.0,162872,"Aortic Aneurysm, Thoracic",0.211134018,4,"Biomarker, GeneticVariation"
7538,ZFP36,ZFP36 ring finger protein,1.0,1.0,0.0,0.0,0.0,3864,Arthritis,0.211134018,5,"AlteredExpression, Biomarker"
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.211134018,5,Biomarker
9997,SCO2,SCO2 cytochrome c oxidase assembly protein,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.211134018,4,"Biomarker, GeneticVariation"
6949,TCOF1,Treacher Collins-Franceschetti syndrome 1,0.0,1.0,1.0,0.0,0.0,376634,Craniofacial Abnormalities,0.211134018,5,"Biomarker, GeneticVariation"
1594,CYP27B1,"cytochrome P450, family 27, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,20437,Hypercalcemia,0.211134018,5,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,20437,Hypercalcemia,0.211134018,5,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.211134018,6,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,1.0,22661,"Kidney Failure, Chronic",0.211134018,5,"Biomarker, Therapeutic"
79621,RNASEH2B,"ribonuclease H2, subunit B",0.0,1.0,1.0,0.0,0.0,796126,Aicardi-Goutieres syndrome,0.211134018,4,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.211134018,5,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,43119,Werner Syndrome,0.211134018,4,Biomarker
23345,SYNE1,"spectrin repeat containing, nuclear envelope 1",0.0,1.0,0.0,0.0,0.0,410189,"Muscular Dystrophy, Emery-Dreifuss",0.211134018,4,Biomarker
26291,FGF21,fibroblast growth factor 21,0.0,1.0,0.0,0.0,1.0,15695,Fatty Liver,0.211134018,5,"Biomarker, Therapeutic"
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.211134018,4,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.211134018,5,Biomarker
63894,VIPAS39,"VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog",0.0,1.0,0.0,0.0,0.0,1859722,Arthrogryposis renal dysfunction cholestasis syndrome,0.211134018,4,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,1.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.211134018,5,"Biomarker, GeneticVariation"
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.211134018,5,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.211134018,5,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.211134018,5,Biomarker
353,APRT,adenine phosphoribosyltransferase,0.0,1.0,0.0,0.0,0.0,451641,Urolithiasis,0.211134018,5,Biomarker
4436,MSH2,mutS homolog 2,0.0,1.0,1.0,0.0,0.0,27831,Neurofibromatosis 1,0.211134018,4,"Biomarker, GeneticVariation"
10908,PNPLA6,patatin-like phospholipase domain containing 6,0.0,1.0,0.0,0.0,0.0,37773,"Spastic Paraplegia, Hereditary",0.211134018,5,Biomarker
4221,MEN1,multiple endocrine neoplasia I,0.0,1.0,0.0,0.0,0.0,17689,Glucagonoma,0.211134018,5,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.211134018,6,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,340288,"Angina, Stable",0.211134018,5,Biomarker
1967,EIF2B1,"eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa",0.0,1.0,0.0,0.0,0.0,1847967,Vanishing White Matter Leukodystrophy with Ovarian Failure,0.211134018,4,Biomarker
338442,HCAR2,hydroxycarboxylic acid receptor 2,0.0,1.0,0.0,0.0,0.0,16382,Flushing,0.211134018,5,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,25202,Melanoma,0.211134018,6,"Biomarker, Therapeutic"
2057,EPOR,erythropoietin receptor,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.211134018,4,Biomarker
5605,MAP2K2,mitogen-activated protein kinase kinase 2,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.211134018,4,Biomarker
25913,POT1,protection of telomeres 1,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.211134018,4,"Biomarker, GeneticVariation"
5312,PKD3,polycystic kidney disease 3 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,85413,"Polycystic Kidney, Autosomal Dominant",0.211134018,4,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,1.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.211134018,5,"Biomarker, Therapeutic"
1432,MAPK14,mitogen-activated protein kinase 14,0.0,1.0,0.0,0.0,1.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.211134018,5,"Biomarker, Therapeutic"
558,AXL,AXL receptor tyrosine kinase,0.0,1.0,0.0,0.0,1.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211134018,5,"Biomarker, Therapeutic"
972,CD74,"CD74 molecule, major histocompatibility complex, class II invariant chain",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211134018,5,Biomarker
928,CD9,CD9 molecule,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211134018,5,Biomarker
1113,CHGA,chromogranin A (parathyroid secretory protein 1),0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211134018,5,Biomarker
2026,ENO2,"enolase 2 (gamma, neuronal)",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211134018,5,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211134018,4,"Biomarker, GeneticVariation"
2254,FGF9,fibroblast growth factor 9,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211134018,4,Biomarker
5829,PXN,paxillin,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.211134018,4,Biomarker
632,BGLAP,bone gamma-carboxyglutamate (gla) protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.211134018,5,Biomarker
5293,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.211134018,5,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.211134018,4,"Biomarker, Therapeutic"
3569,IL6,interleukin 6,0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.211134018,5,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,1565489,Renal Insufficiency,0.211134018,6,Biomarker
10986,IGAD1,immunoglobulin A (IgA) deficiency susceptibility 1,0.0,1.0,0.0,0.0,0.0,2931161,Immunoglobulin a deficiency 1,0.211134018,4,Biomarker
2270,FGS2,FG syndrome 2,0.0,1.0,0.0,0.0,0.0,220769,Opitz-Kaveggia syndrome,0.211134018,4,Biomarker
5077,PAX3,paired box 3,0.0,1.0,1.0,0.0,0.0,79661,Klein-Waardenburg syndrome,0.211134018,4,"Biomarker, GeneticVariation"
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.211134018,5,Biomarker
152330,CNTN4,contactin 4,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.211134018,5,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.211134018,5,Biomarker
54715,RBFOX1,"RNA binding protein, fox-1 homolog (C. elegans) 1",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.211134018,5,Biomarker
7046,TGFBR1,"transforming growth factor, beta receptor 1",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.211134018,4,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,23801,Lipomatosis,0.211134018,4,Biomarker
80326,WNT10A,"wingless-type MMTV integration site family, member 10A",0.0,1.0,0.0,0.0,0.0,1857069,Schopf-Schulz-Passarge Syndrome,0.211134018,4,Biomarker
5726,TAS2R38,"taste receptor, type 2, member 38",0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.211134018,4,Biomarker
3930,LBR,lamin B receptor,0.0,1.0,1.0,0.0,0.0,2931048,HEM dysplasia,0.211134018,4,"Biomarker, GeneticVariation"
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.211134018,4,Biomarker
100124700,HOTAIR,HOX transcript antisense RNA,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.211134018,4,Biomarker
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.211134018,5,Biomarker
5914,RARA,"retinoic acid receptor, alpha",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.211134018,5,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.211134018,5,Biomarker
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.211134018,7,Biomarker
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.211134018,5,Biomarker
32,ACACB,acetyl-CoA carboxylase beta,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.211134018,5,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.211134018,5,Biomarker
57152,SLURP1,secreted LY6/PLAUR domain containing 1,0.0,1.0,0.0,0.0,0.0,22596,"Keratoderma, Palmoplantar",0.211134018,4,Biomarker
3659,IRF1,interferon regulatory factor 1,0.0,1.0,1.0,0.0,0.0,699791,STOMACH CARCINOMA,0.211134018,5,"Biomarker, GeneticVariation"
7170,TPM3,tropomyosin 3,0.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.211134018,5,Biomarker
5190,PEX6,peroxisomal biogenesis factor 6,0.0,1.0,1.0,0.0,0.0,43459,Zellweger Syndrome,0.211134018,4,"Biomarker, GeneticVariation"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,0.0,0.0,0.0,751882,"Myasthenic Syndromes, Congenital",0.211134018,5,Biomarker
6657,SOX2,SRY (sex determining region Y)-box 2,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.211134018,4,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.211134018,4,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.211134018,7,Biomarker
80025,PANK2,pantothenate kinase 2,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.211134018,6,Biomarker
5192,PEX10,peroxisomal biogenesis factor 10,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.211134018,5,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.211134018,4,Biomarker
1523,CUX1,cut-like homeobox 1,1.0,1.0,1.0,0.0,0.0,596263,Carcinogenesis,0.211134018,4,"AlteredExpression, Biomarker, GeneticVariation"
4513,COX2,cytochrome c oxidase subunit II,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.211134018,5,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.211134018,4,Biomarker
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,1.0,0.0,0.0,27819,Neuroblastoma,0.211134018,5,"Biomarker, GeneticVariation"
3417,IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",0.0,1.0,0.0,0.0,0.0,345905,Intrahepatic cholangiocarcinoma,0.211134018,5,Biomarker
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,0.0,0.0,0.0,345905,Intrahepatic cholangiocarcinoma,0.211134018,5,Biomarker
1296,COL8A2,"collagen, type VIII, alpha 2",0.0,1.0,0.0,0.0,0.0,339284,"Corneal Dystrophy, Posterior Polymorphous, 1",0.211134018,4,Biomarker
6663,SOX10,SRY (sex determining region Y)-box 10,0.0,1.0,0.0,0.0,0.0,2700265,Waardenburg syndrome type 2,0.211134018,4,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,221043,Liddle Syndrome,0.211134018,5,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.211134018,5,"Biomarker, Therapeutic"
847,CAT,catalase,0.0,1.0,1.0,0.0,1.0,27627,Neoplasm Metastasis,0.211134018,7,"Biomarker, GeneticVariation, Therapeutic"
1000,CDH2,"cadherin 2, type 1, N-cadherin (neuronal)",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,5,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,4,Biomarker
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,5,Biomarker
9846,GAB2,GRB2-associated binding protein 2,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,5,Biomarker
406986,MIR203A,microRNA 203a,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,5,Biomarker
407009,MIR224,microRNA 224,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,5,Biomarker
8648,NCOA1,nuclear receptor coactivator 1,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,4,Biomarker
5621,PRNP,prion protein,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,5,Biomarker
25800,SLC39A6,"solute carrier family 39 (zinc transporter), member 6",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,5,Biomarker
25816,TNFAIP8,"tumor necrosis factor, alpha-induced protein 8",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.211134018,4,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.211134018,5,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.211134018,4,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.211134018,5,Biomarker
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.211134018,4,Biomarker
4998,ORC1,"origin recognition complex, subunit 1",0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.211134018,4,Biomarker
8900,CCNA1,cyclin A1,0.0,1.0,0.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.211134018,5,Biomarker
252842,AAT1,"Aortic aneurysm, familial thoracic 1",0.0,1.0,1.0,0.0,0.0,345050,"Aortic Aneurysm, Familial Thoracic 1",0.211134018,4,"Biomarker, GeneticVariation"
974,CD79B,"CD79b molecule, immunoglobulin-associated beta",0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.211134018,5,Biomarker
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.211134018,5,Biomarker
9378,NRXN1,neurexin 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.211134018,5,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.211134018,4,Biomarker
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,587248,Costello Syndrome,0.211134018,5,Biomarker
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,0.0,0.0,0.0,587248,Costello Syndrome,0.211134018,5,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,1328840,Autoimmune Lymphoproliferative Syndrome,0.211134018,4,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,1.0,0.0,0.0,1328840,Autoimmune Lymphoproliferative Syndrome,0.211134018,4,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.211134018,5,Biomarker
3084,NRG1,neuregulin 1,0.0,1.0,0.0,0.0,1.0,18801,Heart Failure,0.211134018,4,"Biomarker, Therapeutic"
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,1.0,1175,Acquired Immunodeficiency Syndrome,0.211134018,5,"Biomarker, Therapeutic"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,23470,"Leukemia, Myeloid",0.211134018,4,Biomarker
1637,DCR,Down syndrome chromosome region,0.0,1.0,0.0,0.0,0.0,13080,Down Syndrome,0.211134018,4,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.211134018,8,Biomarker
6657,SOX2,SRY (sex determining region Y)-box 2,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.211134018,5,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,23895,Liver Diseases,0.211134018,5,"Biomarker, GeneticVariation"
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,20459,Hyperinsulinism,0.211134018,7,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.211134018,5,Biomarker
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),0.0,1.0,0.0,0.0,0.0,31511,Pheochromocytoma,0.211134018,5,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,31511,Pheochromocytoma,0.211134018,4,"Biomarker, GeneticVariation"
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.211134018,5,Biomarker
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.211134018,5,Biomarker
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,1.0,0.0,0.0,20981,Immunoblastic Lymphadenopathy,0.211134018,5,"Biomarker, GeneticVariation"
387,RHOA,ras homolog family member A,0.0,1.0,1.0,0.0,0.0,20981,Immunoblastic Lymphadenopathy,0.211134018,4,"Biomarker, GeneticVariation"
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,10346,Crohn Disease,0.211134018,4,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,10346,Crohn Disease,0.211134018,4,Biomarker
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.211134018,5,Biomarker
64324,NSD1,nuclear receptor binding SET domain protein 1,0.0,1.0,0.0,0.0,0.0,265210,Weaver syndrome,0.211134018,4,Biomarker
7941,PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)",0.0,1.0,1.0,0.0,0.0,38454,Stroke,0.211134018,5,"Biomarker, GeneticVariation"
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.211134018,5,Biomarker
10815,CPLX1,complexin 1,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.211134018,5,Biomarker
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.211134018,5,"Biomarker, GeneticVariation"
3417,IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.211134018,5,"Biomarker, GeneticVariation"
6261,RYR1,ryanodine receptor 1 (skeletal),0.0,1.0,0.0,0.0,0.0,752282,"Myopathies, Structural, Congenital",0.211134018,4,Biomarker
29072,SETD2,SET domain containing 2,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.211134018,4,Biomarker
5116,PCNT,pericentrin,0.0,1.0,0.0,0.0,0.0,265202,Seckel syndrome 1,0.211134018,4,Biomarker
2707,GJB3,"gap junction protein, beta 3, 31kDa",0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.211134018,4,"Biomarker, GeneticVariation"
27074,LAMP3,lysosomal-associated membrane protein 3,0.0,1.0,1.0,0.0,0.0,21400,"Influenza, Human",0.211134018,5,"Biomarker, GeneticVariation"
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,0.0,0.0,1.0,162557,"Liver Failure, Acute",0.211134018,4,"Biomarker, Therapeutic"
26040,SETBP1,SET binding protein 1,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.211134018,4,"Biomarker, GeneticVariation"
1021,CDK6,cyclin-dependent kinase 6,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.211134018,5,Biomarker
6455,SH3GL1,SH3-domain GRB2-like 1,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.211134018,4,"Biomarker, GeneticVariation"
51067,YARS2,"tyrosyl-tRNA synthetase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,1838103,Myopathy with lactic acidosis and sideroblastic anemia,0.211134018,4,"Biomarker, GeneticVariation"
91252,SLC39A13,"solute carrier family 39 (zinc transporter), member 13",0.0,1.0,0.0,0.0,0.0,13720,Ehlers-Danlos Syndrome,0.211134018,4,Biomarker
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.211134018,6,Biomarker
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,0.0,0.0,0.0,26847,"Muscular Atrophy, Spinal",0.211134018,5,Biomarker
846,CASR,calcium-sensing receptor,0.0,1.0,1.0,0.0,0.0,342345,"Hypercalciuric Hypocalcemia, Familial",0.211056678,39,"Biomarker, GeneticVariation"
50966,ECA1,"epilepsy, childhood absence 1",0.0,1.0,0.0,0.0,0.0,14553,"Epilepsy, Absence",0.210850514,3,Biomarker
8629,JRK,Jrk homolog (mouse),0.0,1.0,0.0,0.0,0.0,14553,"Epilepsy, Absence",0.210850514,4,Biomarker
4998,ORC1,"origin recognition complex, subunit 1",0.0,1.0,0.0,0.0,0.0,13336,Dwarfism,0.210850514,4,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,14859,Esophageal Neoplasms,0.210850514,3,"Biomarker, GeneticVariation"
4323,MMP14,matrix metallopeptidase 14 (membrane-inserted),0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.210850514,4,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210850514,3,"Biomarker, GeneticVariation"
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210850514,4,Biomarker
1235,CCR6,chemokine (C-C motif) receptor 6,0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.210850514,4,Biomarker
5158,PDE6B,"phosphodiesterase 6B, cGMP-specific, rod, beta",0.0,1.0,1.0,0.0,0.0,35304,Retinal Degeneration,0.210850514,6,"Biomarker, GeneticVariation"
1495,CTNNA1,"catenin (cadherin-associated protein), alpha 1, 102kDa",0.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.210850514,4,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,1.0,25500,Mesothelioma,0.210850514,4,"Biomarker, Therapeutic"
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,7099,Carcinoma in Situ,0.210850514,5,Biomarker
1581,CYP7A1,"cytochrome P450, family 7, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.210850514,5,Biomarker
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.210850514,4,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.210850514,4,Biomarker
4217,MAP3K5,mitogen-activated protein kinase kinase kinase 5,0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.210850514,4,Biomarker
2303,FOXC2,forkhead box C2,0.0,1.0,1.0,0.0,0.0,238261,"Lymphedema, Hereditary, II",0.210850514,3,"Biomarker, GeneticVariation"
646960,PRSS56,"protease, serine, 56",0.0,1.0,0.0,0.0,0.0,26010,Microphthalmos,0.210850514,3,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.210850514,4,Biomarker
1269,CNR2,cannabinoid receptor 2 (macrophage),0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.210850514,3,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.210850514,4,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.210850514,4,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,11581,Depressive Disorder,0.210850514,4,"Biomarker, GeneticVariation"
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210850514,4,"Biomarker, GeneticVariation"
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,1.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210850514,3,"Biomarker, GeneticVariation"
2138,EYA1,EYA transcriptional coactivator and phosphatase 1,0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.210850514,4,Biomarker
2332,FMR1,fragile X mental retardation 1,0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.210850514,4,Biomarker
9021,SOCS3,suppressor of cytokine signaling 3,0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.210850514,4,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210850514,5,Biomarker
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,0.0,0.0,0.0,206624,Hepatoblastoma,0.210850514,4,Biomarker
8622,PDE8B,phosphodiesterase 8B,0.0,1.0,0.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.210850514,4,Biomarker
5697,PYY,peptide YY,0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.210850514,4,Biomarker
2328,FMO3,flavin containing monooxygenase 3,0.0,1.0,1.0,0.0,1.0,32580,Adenomatous Polyposis Coli,0.210850514,3,"Biomarker, GeneticVariation, Therapeutic"
2739,GLO1,glyoxalase I,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.210850514,4,Biomarker
56955,MEPE,matrix extracellular phosphoglycoprotein,0.0,1.0,0.0,0.0,0.0,29442,Osteomalacia,0.210850514,4,Biomarker
4668,NAGA,"N-acetylgalactosaminidase, alpha-",0.0,1.0,0.0,0.0,0.0,338473,Neuroaxonal Dystrophies,0.210850514,4,Biomarker
84466,MEGF10,multiple EGF-like-domains 10,0.0,1.0,1.0,0.0,0.0,26848,Muscular Diseases,0.210850514,3,"Biomarker, GeneticVariation"
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,0.0,0.0,0.0,20757,Ichthyosis,0.210850514,4,Biomarker
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,2931456,"Prostate cancer, familial",0.210850514,3,"Biomarker, GeneticVariation"
1827,RCAN1,regulator of calcineurin 1,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.210850514,4,Biomarker
406938,MIR146A,microRNA 146a,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.210850514,3,"Biomarker, GeneticVariation"
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,2931758,Acquired angioedema,0.210850514,4,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210850514,4,Biomarker
214,ALCAM,activated leukocyte cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210850514,4,Biomarker
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210850514,5,Biomarker
998,CDC42,cell division cycle 42,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210850514,4,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,7097,Carcinoma,0.210850514,4,"Biomarker, Therapeutic"
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210850514,4,Biomarker
5037,PEBP1,phosphatidylethanolamine binding protein 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210850514,4,Biomarker
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210850514,6,Biomarker
6895,TARBP2,TAR (HIV-1) RNA binding protein 2,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210850514,4,Biomarker
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210850514,4,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210850514,4,Biomarker
653361,NCF1,neutrophil cytosolic factor 1,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210850514,4,Biomarker
151056,PLB1,phospholipase B1,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210850514,3,Biomarker
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,0.0,0.0,0.0,27873,Neuromyelitis Optica,0.210850514,4,Biomarker
3913,LAMB2,"laminin, beta 2 (laminin S)",0.0,1.0,0.0,0.0,0.0,268747,"Mesangial sclerosis, diffuse",0.210850514,4,Biomarker
6663,SOX10,SRY (sex determining region Y)-box 10,0.0,1.0,1.0,0.0,0.0,1866425,Yemenite deaf-blind hypopigmentation syndrome,0.210850514,3,"Biomarker, GeneticVariation"
10008,KCNE3,"potassium channel, voltage gated subfamily E regulatory beta subunit 3",0.0,1.0,1.0,0.0,0.0,238357,"Paralysis, Hyperkalemic Periodic",0.210850514,3,"Biomarker, GeneticVariation"
3915,LAMC1,"laminin, gamma 1 (formerly LAMB2)",0.0,1.0,0.0,0.0,0.0,877015,Pelvic Organ Prolapse,0.210850514,3,Biomarker
2624,GATA2,GATA binding protein 2,0.0,1.0,1.0,0.0,0.0,3463824,MYELODYSPLASTIC SYNDROME,0.210850514,3,"Biomarker, GeneticVariation"
196,AHR,aryl hydrocarbon receptor,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.210850514,3,"Biomarker, GeneticVariation"
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.210850514,3,"Biomarker, GeneticVariation"
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.210850514,4,Biomarker
6750,SST,somatostatin,0.0,1.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.210850514,4,"Biomarker, Therapeutic"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,34067,Pulmonary Emphysema,0.210850514,3,Biomarker
3694,ITGB6,"integrin, beta 6",0.0,1.0,0.0,0.0,0.0,34067,Pulmonary Emphysema,0.210850514,3,Biomarker
7056,THBD,thrombomodulin,0.0,1.0,0.0,0.0,1.0,12739,Disseminated Intravascular Coagulation,0.210850514,4,"Biomarker, Therapeutic"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.210850514,3,Biomarker
6098,ROS1,"ROS proto-oncogene 1 , receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.210850514,4,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.210850514,4,Biomarker
6336,SCN10A,"sodium channel, voltage gated, type X alpha subunit",0.0,1.0,0.0,0.0,0.0,1142166,Brugada Syndrome,0.210850514,3,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,5283,beta-Thalassemia,0.210850514,4,"Biomarker, Therapeutic"
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,22398,Job Syndrome,0.210850514,4,Biomarker
5189,PEX1,peroxisomal biogenesis factor 1,0.0,1.0,1.0,0.0,0.0,282527,"Refsum Disease, Infantile",0.210850514,3,"Biomarker, GeneticVariation"
5828,PEX2,peroxisomal biogenesis factor 2,0.0,1.0,1.0,0.0,0.0,282527,"Refsum Disease, Infantile",0.210850514,3,"Biomarker, GeneticVariation"
4868,NPHS1,"nephrosis 1, congenital, Finnish type (nephrin)",0.0,1.0,0.0,0.0,0.0,3501848,"Nephrosis, congenital",0.210850514,5,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.210850514,3,"Biomarker, Therapeutic"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.210850514,4,Biomarker
4023,LPL,lipoprotein lipase,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.210850514,4,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.210850514,4,"Biomarker, Therapeutic"
4720,NDUFS2,"NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase)",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.210850514,3,Biomarker
4635,MYL4,"myosin, light chain 4, alkali; atrial, embryonic",0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.210850514,4,Biomarker
3575,IL7R,interleukin 7 receptor,0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.210850514,3,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.210850514,4,Biomarker
5771,PTPN2,"protein tyrosine phosphatase, non-receptor type 2",0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.210850514,3,Biomarker
6899,TBX1,T-box 1,0.0,1.0,1.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210850514,5,"Biomarker, GeneticVariation"
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.210850514,5,Biomarker
149233,IL23R,interleukin 23 receptor,0.0,1.0,0.0,0.0,0.0,23343,Leprosy,0.210850514,3,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,20437,Hypercalcemia,0.210850514,4,Biomarker
7249,TSC2,tuberous sclerosis 2,0.0,1.0,0.0,0.0,0.0,1854465,Tuberous Sclerosis 1,0.210850514,3,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.210850514,5,Biomarker
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,0.0,0.0,0.0,26896,Myasthenia Gravis,0.210850514,4,Biomarker
2253,FGF8,fibroblast growth factor 8 (androgen-induced),0.0,1.0,0.0,0.0,0.0,162809,Kallmann Syndrome,0.210850514,3,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,282612,Prostatic Intraepithelial Neoplasia,0.210850514,5,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,31154,Peritonitis,0.210850514,4,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,1275081,Cardiofaciocutaneous syndrome,0.210850514,4,"Biomarker, GeneticVariation"
57379,AICDA,activation-induced cytidine deaminase,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.210850514,4,Biomarker
85480,TSLP,thymic stromal lymphopoietin,0.0,1.0,1.0,0.0,0.0,341106,Eosinophilic Esophagitis,0.210850514,3,"Biomarker, GeneticVariation"
64919,BCL11B,B-cell CLL/lymphoma 11B (zinc finger protein),0.0,1.0,0.0,0.0,0.0,24299,Lymphoma,0.210850514,4,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,0.0,0.0,0.0,24299,Lymphoma,0.210850514,4,Biomarker
10628,TXNIP,thioredoxin interacting protein,0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.210850514,4,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.210850514,4,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.210850514,4,Biomarker
2067,ERCC1,excision repair cross-complementation group 1,1.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.210850514,4,"AlteredExpression, Biomarker"
5366,PMAIP1,phorbol-12-myristate-13-acetate-induced protein 1,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.210850514,4,Biomarker
11151,CORO1A,"coronin, actin binding protein, 1A",0.0,1.0,0.0,0.0,0.0,41296,Tuberculosis,0.210850514,4,Biomarker
8671,SLC4A4,"solute carrier family 4 (sodium bicarbonate cotransporter), member 4",0.0,1.0,0.0,0.0,0.0,86543,Cataract,0.210850514,4,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,86543,Cataract,0.210850514,3,Biomarker
170302,ARX,aristaless related homeobox,0.0,1.0,1.0,0.0,0.0,796250,Partington X-linked mental retardation syndrome,0.210850514,3,"Biomarker, GeneticVariation"
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,1.0,0.0,0.0,3276228,ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE,0.210850514,3,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.210850514,3,Biomarker
885,CCK,cholecystokinin,0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.210850514,4,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,21846,Intestinal Polyps,0.210850514,6,Biomarker
7538,ZFP36,ZFP36 ring finger protein,0.0,1.0,0.0,0.0,0.0,6625,Cachexia,0.210850514,5,Biomarker
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,0.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.210850514,4,Biomarker
3614,IMPDH1,IMP (inosine 5'-monophosphate) dehydrogenase 1,0.0,1.0,1.0,0.0,0.0,339527,Leber Congenital Amaurosis,0.210850514,3,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.210850514,4,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210850514,4,Biomarker
7504,XK,X-linked Kx blood group,0.0,1.0,1.0,0.0,0.0,393576,Neuroacanthocytosis,0.210850514,4,"Biomarker, GeneticVariation"
5663,PSEN1,presenilin 1,0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.210850514,3,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.210850514,5,"Biomarker, GeneticVariation"
64170,CARD9,"caspase recruitment domain family, member 9",0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.210850514,4,"Biomarker, GeneticVariation"
50942,IBD6,inflammatory bowel disease 6,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.210850514,3,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.210850514,4,"Biomarker, GeneticVariation"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.210850514,4,Biomarker
2200,FBN1,fibrillin 1,0.0,1.0,0.0,0.0,0.0,1321551,Shprintzen Golberg craniosynostosis,0.210850514,3,Biomarker
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.210850514,4,Biomarker
6790,AURKA,aurora kinase A,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210850514,4,Biomarker
9846,GAB2,GRB2-associated binding protein 2,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.210850514,4,"Biomarker, GeneticVariation"
26227,PHGDH,phosphoglycerate dehydrogenase,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210850514,3,Biomarker
5537,PPP6C,"protein phosphatase 6, catalytic subunit",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210850514,4,Biomarker
9869,SETDB1,"SET domain, bifurcated 1",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210850514,3,Biomarker
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,25149,Medulloblastoma,0.210850514,3,"Biomarker, GeneticVariation"
1755,DMBT1,deleted in malignant brain tumors 1,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.210850514,3,Biomarker
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,0.0,0.0,1.0,25149,Medulloblastoma,0.210850514,4,"Biomarker, Therapeutic"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.210850514,4,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,1.0,0.0,0.0,242339,Dyslipidemias,0.210850514,4,"Biomarker, GeneticVariation"
55743,CHFR,"checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210850514,3,Biomarker
4854,NOTCH3,notch 3,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210850514,4,Biomarker
5478,PPIA,peptidylprolyl isomerase A (cyclophilin A),0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210850514,4,Biomarker
7345,UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase),0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210850514,4,Biomarker
3092,HIP1,huntingtin interacting protein 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210850514,3,Biomarker
246778,IL27,interleukin 27,0.0,1.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.210850514,3,"Biomarker, Therapeutic"
5074,PAWR,"PRKC, apoptosis, WT1, regulator",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210850514,4,Biomarker
8647,ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",0.0,1.0,0.0,0.0,0.0,33774,Pruritus,0.210850514,4,Biomarker
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210850514,5,Biomarker
2290,FOXG1,forkhead box G1,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210850514,3,Biomarker
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,2448,Ameloblastoma,0.210850514,3,"Biomarker, GeneticVariation"
6755,SSTR5,somatostatin receptor 5,0.0,1.0,0.0,0.0,0.0,346302,Growth Hormone-Secreting Pituitary Adenoma,0.210850514,3,Biomarker
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,206754,Neuroendocrine Tumors,0.210850514,3,Biomarker
2560,GABRB1,"gamma-aminobutyric acid (GABA) A receptor, beta 1",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.210850514,3,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210850514,4,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210850514,4,Biomarker
54719,RNANC,"Retinal nonattachment, nonsyndromic congenital",0.0,1.0,0.0,0.0,0.0,1857299,"Retinal Nonattachment, Nonsyndromic Congenital",0.210850514,3,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,32019,Pituitary Neoplasms,0.210850514,4,Biomarker
9782,MATR3,matrin 3,0.0,1.0,1.0,0.0,0.0,751336,Distal Myopathies,0.210850514,3,"Biomarker, GeneticVariation"
387,RHOA,ras homolog family member A,0.0,1.0,1.0,0.0,0.0,79774,"Lymphoma, T-Cell, Peripheral",0.210850514,4,"Biomarker, GeneticVariation"
5696,PSMB8,"proteasome (prosome, macropain) subunit, beta type, 8",0.0,1.0,1.0,0.0,0.0,3278560,CANDLE syndrome,0.210850514,4,"Biomarker, GeneticVariation"
2626,GATA4,GATA binding protein 4,0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.210850514,3,"Biomarker, GeneticVariation"
1442,CSH1,chorionic somatomammotropin hormone 1 (placental lactogen),0.0,1.0,0.0,0.0,0.0,175693,Silver-Russell Syndrome,0.210850514,3,Biomarker
51,ACOX1,"acyl-CoA oxidase 1, palmitoyl",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,4,Biomarker
9510,ADAMTS1,"ADAM metallopeptidase with thrombospondin type 1 motif, 1",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,3,Biomarker
196528,ARID2,"AT rich interactive domain 2 (ARID, RFX-like)",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,4,Biomarker
472,ATM,ATM serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,4,Biomarker
7832,BTG2,"BTG family, member 2",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,3,Biomarker
5218,CDK14,cyclin-dependent kinase 14,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,3,Biomarker
1509,CTSD,cathepsin D,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,4,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,3,Biomarker
9681,DEPDC5,DEP domain containing 5,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,3,"Biomarker, GeneticVariation"
3156,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,5,Biomarker
8660,IRS2,insulin receptor substrate 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,4,Biomarker
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,4,Biomarker
4489,MT1A,metallothionein 1A,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,5,Biomarker
5230,PGK1,phosphoglycerate kinase 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,4,Biomarker
6241,RRM2,ribonucleotide reductase M2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,4,Biomarker
2810,SFN,stratifin,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210850514,4,Biomarker
1491,CTH,cystathionine gamma-lyase,0.0,1.0,1.0,0.0,0.0,268616,Gamma-cystathionase deficiency,0.210850514,3,"Biomarker, GeneticVariation"
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,1.0,14556,"Epilepsy, Temporal Lobe",0.210850514,4,"Biomarker, Therapeutic"
5160,PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1,0.0,1.0,0.0,0.0,0.0,1125,"Acidosis, Lactic",0.210850514,4,Biomarker
10083,USH1C,"Usher syndrome 1C (autosomal recessive, severe)",0.0,1.0,0.0,0.0,0.0,2931207,"Usher syndrome, type 1C",0.210850514,3,Biomarker
100048912,CDKN2B-AS1,CDKN2B antisense RNA 1,0.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.210850514,3,"Biomarker, GeneticVariation"
100048912,CDKN2B-AS1,CDKN2B antisense RNA 1,0.0,1.0,0.0,0.0,0.0,17612,"Glaucoma, Open-Angle",0.210850514,3,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.210850514,4,Biomarker
1066,CES1,carboxylesterase 1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210850514,3,Biomarker
406991,MIR21,microRNA 21,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210850514,4,Biomarker
4808,NHLH2,nescient helix loop helix 2,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210850514,4,Biomarker
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210850514,4,Biomarker
1727,CYB5R3,cytochrome b5 reductase 3,0.0,1.0,0.0,0.0,0.0,10520,Cyanosis,0.210850514,4,Biomarker
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,1.0,0.0,0.0,0.0,376532,"Epilepsy, Rolandic",0.210850514,4,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,4775,Bartter Syndrome,0.210850514,6,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,1.0,20541,"Hypertension, Portal",0.210850514,4,"Biomarker, Therapeutic"
1471,CST3,cystatin C,0.0,1.0,0.0,0.0,0.0,268393,"Cerebral Amyloid Angiopathy, Familial",0.210850514,4,Biomarker
2,A2M,alpha-2-macroglobulin,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.210850514,3,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.210850514,4,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,2932716,Pseudohypoparathyroidism Type 1C,0.210850514,3,"Biomarker, GeneticVariation"
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",0.0,1.0,0.0,0.0,0.0,2878,"Anemia, Hemolytic",0.210850514,3,Biomarker
57096,RPGRIP1,retinitis pigmentosa GTPase regulator interacting protein 1,0.0,1.0,0.0,0.0,0.0,854723,Retinal Dystrophies,0.210850514,4,Biomarker
5825,ABCD3,"ATP-binding cassette, sub-family D (ALD), member 3",0.0,1.0,0.0,0.0,0.0,43459,Zellweger Syndrome,0.210850514,3,Biomarker
3295,HSD17B4,hydroxysteroid (17-beta) dehydrogenase 4,0.0,1.0,0.0,0.0,0.0,43459,Zellweger Syndrome,0.210850514,3,Biomarker
8575,PRKRA,"protein kinase, interferon-inducible double stranded RNA dependent activator",0.0,1.0,0.0,0.0,0.0,242422,Parkinsonian Disorders,0.210850514,3,Biomarker
4610,MYCL,v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog,0.0,1.0,0.0,0.0,1.0,149925,Small Cell Lung Carcinoma,0.210850514,3,"Biomarker, Therapeutic"
629,CFB,complement factor B,0.0,1.0,0.0,0.0,0.0,2931788,Atypical Hemolytic Uremic Syndrome,0.210850514,3,Biomarker
4853,NOTCH2,notch 2,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210850514,4,Biomarker
1410,CRYAB,"crystallin, alpha B",0.0,1.0,1.0,0.0,0.0,524851,Neurodegenerative Diseases,0.210850514,4,"Biomarker, GeneticVariation"
5193,PEX12,peroxisomal biogenesis factor 12,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.210850514,3,Biomarker
3206,HOXA10,homeobox A10,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210850514,3,Biomarker
3439,IFNA1,"interferon, alpha 1",0.0,1.0,0.0,0.0,1.0,1418,Adenocarcinoma,0.210850514,4,"Biomarker, Therapeutic"
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.210850514,4,Biomarker
65018,PINK1,PTEN induced putative kinase 1,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.210850514,4,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,85655,Polymyositis,0.210850514,4,Biomarker
1806,DPYD,dihydropyrimidine dehydrogenase,1.0,1.0,1.0,0.0,0.0,27947,Neutropenia,0.210850514,4,"AlteredExpression, Biomarker, GeneticVariation"
177,AGER,advanced glycosylation end product-specific receptor,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.210850514,4,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.210850514,4,Biomarker
3064,HTT,huntingtin,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.210850514,4,Biomarker
2737,GLI3,GLI family zinc finger 3,0.0,1.0,0.0,0.0,0.0,796147,Acrocallosal Syndrome,0.210850514,3,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.210850514,4,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,521607,Peritoneal Fibrosis,0.210850514,4,Biomarker
728294,D2HGDH,D-2-hydroxyglutarate dehydrogenase,0.0,1.0,1.0,0.0,0.0,2746066,2-Hydroxyglutaricaciduria,0.210850514,3,"Biomarker, GeneticVariation"
6929,TCF3,transcription factor 3,0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.210850514,5,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,1.0,0.0,0.0,7222,Cardiovascular Diseases,0.210850514,4,"Biomarker, GeneticVariation"
4953,ODC1,ornithine decarboxylase 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.210850514,4,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,1.0,0.0,0.0,3665593,"Nevus, Epidermal",0.210850514,3,"Biomarker, GeneticVariation"
27286,SRPX2,"sushi-repeat containing protein, X-linked 2",0.0,1.0,1.0,0.0,0.0,1845668,Perisylvian syndrome,0.210850514,3,"Biomarker, GeneticVariation"
10318,TNIP1,TNFAIP3 interacting protein 1,0.0,1.0,1.0,0.0,0.0,36421,"Scleroderma, Systemic",0.210850514,3,"Biomarker, GeneticVariation"
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,0.0,0.0,0.0,27889,Hereditary Sensory and Autonomic Neuropathies,0.210850514,3,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,2622,Amnesia,0.210850514,4,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210850514,4,Biomarker
1192,CLIC1,chloride intracellular channel 1,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210850514,4,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.210850514,5,"Biomarker, Therapeutic"
2258,FGF13,fibroblast growth factor 13,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210850514,4,Biomarker
407007,MIR222,microRNA 222,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210850514,3,Biomarker
5478,PPIA,peptidylprolyl isomerase A (cyclophilin A),0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210850514,4,Biomarker
5629,PROX1,prospero homeobox 1,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210850514,4,Biomarker
6197,RPS6KA3,"ribosomal protein S6 kinase, 90kDa, polypeptide 3",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210850514,4,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.210850514,5,Biomarker
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,1.0,0.0,0.0,0.0,751072,Frontotemporal Lobar Degeneration,0.210850514,4,Biomarker
5347,PLK1,polo-like kinase 1,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210850514,3,Biomarker
8493,PPM1D,"protein phosphatase, Mg2+/Mn2+ dependent, 1D",0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210850514,3,Biomarker
55717,WDR11,WD repeat domain 11,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210850514,3,Biomarker
653509,SFTPA1,surfactant protein A1,0.0,1.0,1.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.210850514,3,"Biomarker, GeneticVariation"
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.210850514,5,Biomarker
1978,EIF4EBP1,eukaryotic translation initiation factor 4E binding protein 1,0.0,1.0,0.0,0.0,0.0,334634,"Lymphoma, Mantle-Cell",0.210850514,3,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,1261473,Sarcoma,0.210850514,4,Biomarker
9094,UNC119,unc-119 homolog (C. elegans),0.0,1.0,0.0,0.0,0.0,35334,Retinitis Pigmentosa,0.210850514,3,Biomarker
317,APAF1,apoptotic peptidase activating factor 1,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.210850514,3,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.210850514,4,Biomarker
3868,KRT16,"keratin 16, type I",0.0,1.0,0.0,0.0,0.0,1833030,"Palmoplantar Keratoderma, Nonepidermolytic",0.210850514,3,Biomarker
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.210850514,5,Biomarker
1232,CCR3,chemokine (C-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.210850514,4,Biomarker
335,APOA1,apolipoprotein A-I,1.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210850514,4,"AlteredExpression, Biomarker"
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",1.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210850514,4,"AlteredExpression, Biomarker"
3320,HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210850514,4,Biomarker
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),1.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.210850514,4,"AlteredExpression, Biomarker, GeneticVariation"
10527,IPO7,importin 7,1.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210850514,4,"AlteredExpression, Biomarker"
7273,TTN,titin,0.0,1.0,0.0,0.0,0.0,340427,Familial dilated cardiomyopathy,0.210850514,4,Biomarker
1116,CHI3L1,chitinase 3-like 1 (cartilage glycoprotein-39),0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210850514,4,Biomarker
1191,CLU,clusterin,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210850514,4,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210850514,5,Biomarker
1257,CNC2,"Carney complex type 2, multiple neoplasia and lentiginosis",0.0,1.0,0.0,0.0,0.0,406810,Carney Complex,0.210850514,3,Biomarker
23096,IQSEC2,IQ motif and Sec7 domain 2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210850514,3,Biomarker
112476,PRRT2,proline-rich transmembrane protein 2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210850514,4,Biomarker
22941,SHANK2,SH3 and multiple ankyrin repeat domains 2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210850514,4,Biomarker
353,APRT,adenine phosphoribosyltransferase,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210850514,4,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.210850514,4,"Biomarker, Therapeutic"
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210850514,5,Biomarker
11009,IL24,interleukin 24,0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.210850514,5,"Biomarker, Therapeutic"
7025,NR2F1,"nuclear receptor subfamily 2, group F, member 1",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210850514,4,Biomarker
100506658,OCLN,occludin,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210850514,4,Biomarker
5605,MAP2K2,mitogen-activated protein kinase kinase 2,0.0,1.0,0.0,0.0,0.0,587248,Costello Syndrome,0.210850514,4,Biomarker
55036,CCDC40,coiled-coil domain containing 40,0.0,1.0,0.0,0.0,0.0,22521,Kartagener Syndrome,0.210850514,3,Biomarker
352909,DNAAF3,"dynein, axonemal, assembly factor 3",0.0,1.0,0.0,0.0,0.0,22521,Kartagener Syndrome,0.210850514,3,Biomarker
1366,CLDN7,claudin 7,0.0,1.0,0.0,0.0,0.0,677886,Ovarian epithelial cancer,0.210850514,4,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210850514,4,Biomarker
5294,PIK3CG,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210850514,4,Biomarker
2624,GATA2,GATA binding protein 2,0.0,1.0,0.0,0.0,0.0,24236,Lymphedema,0.210850514,4,Biomarker
729920,ISPD,isoprenoid synthase domain containing,0.0,1.0,0.0,0.0,0.0,265221,Walker-Warburg Syndrome,0.210850514,4,Biomarker
4088,SMAD3,SMAD family member 3,0.0,1.0,0.0,0.0,0.0,23267,Leiomyoma,0.210850514,3,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.210850514,12,Biomarker
23436,CELA3B,"chymotrypsin-like elastase family, member 3B",0.0,1.0,0.0,0.0,0.0,267963,Exocrine Pancreatic Insufficiency,0.210850514,4,Biomarker
11152,WDR45,WD repeat domain 45,0.0,1.0,0.0,0.0,0.0,2931845,Neurodegeneration with brain iron accumulation (NBIA),0.210850514,4,Biomarker
23400,ATP13A2,ATPase type 13A2,0.0,1.0,0.0,0.0,0.0,27877,Neuronal Ceroid-Lipofuscinoses,0.210850514,4,Biomarker
26504,CNNM4,cyclin and CBS domain divalent metal cation transport mediator 4,0.0,1.0,1.0,0.0,0.0,3495589,JALILI SYNDROME,0.210850514,4,"Biomarker, GeneticVariation"
942,CD86,CD86 molecule,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.210850514,4,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,42963,Vomiting,0.210850514,4,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,42109,Urticaria,0.210850514,4,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,1824,Agranulocytosis,0.210850514,4,"Biomarker, Therapeutic"
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,1.0,24121,Lung Neoplasms,0.210850514,6,"Biomarker, Therapeutic"
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210850514,4,Biomarker
5449,POU1F1,POU class 1 homeobox 1,0.0,1.0,1.0,0.0,0.0,13338,"Dwarfism, Pituitary",0.210850514,3,"Biomarker, GeneticVariation"
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.210850514,4,"Biomarker, GeneticVariation"
729230,CCR2,chemokine (C-C motif) receptor 2,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.210850514,4,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,1.0,23895,Liver Diseases,0.210850514,6,"Biomarker, Therapeutic"
1436,CSF1R,colony stimulating factor 1 receptor,0.0,1.0,0.0,0.0,0.0,270612,Leukoencephalopathies,0.210850514,4,Biomarker
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,1.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.210850514,4,"AlteredExpression, Biomarker"
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.210850514,4,"Biomarker, GeneticVariation"
54790,TET2,tet methylcytosine dioxygenase 2,0.0,1.0,1.0,0.0,0.0,20981,Immunoblastic Lymphadenopathy,0.210850514,3,"Biomarker, GeneticVariation"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210850514,3,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210850514,3,Biomarker
3952,LEP,leptin,0.0,1.0,1.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210850514,4,"Biomarker, GeneticVariation"
302,ANXA2,annexin A2,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210850514,4,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210850514,3,Biomarker
10399,GNB2L1,"guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210850514,4,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,7137,"Carcinoma, Squamous Cell",0.210850514,4,"Biomarker, Therapeutic"
8481,OFD1,oral-facial-digital syndrome 1,0.0,1.0,0.0,0.0,0.0,1846175,"Simpson-Golabi-Behmel Syndrome, Type 2",0.210850514,3,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,11603,Dermatitis,0.210850514,4,Biomarker
8100,IFT88,intraflagellar transport 88,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210850514,3,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210850514,5,Biomarker
1432,MAPK14,mitogen-activated protein kinase 14,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210850514,4,Biomarker
9971,NR1H4,"nuclear receptor subfamily 1, group H, member 4",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210850514,6,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210850514,4,Biomarker
114609,TIRAP,toll-interleukin 1 receptor (TIR) domain containing adaptor protein,0.0,1.0,1.0,0.0,0.0,24530,Malaria,0.210850514,4,"Biomarker, GeneticVariation"
100329170,SCZD13,schizophrenia 13,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210850514,3,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,2697932,Loeys-Dietz Syndrome,0.210850514,3,Biomarker
286530,P2RY8,"purinergic receptor P2Y, G-protein coupled, 8",1.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.210850514,3,"AlteredExpression, Biomarker, GeneticVariation"
4015,LOX,lysyl oxidase,0.0,1.0,1.0,0.0,0.0,29463,Osteosarcoma,0.210850514,3,"Biomarker, GeneticVariation"
7262,PHLDA2,"pleckstrin homology-like domain, family A, member 2",0.0,1.0,0.0,0.0,1.0,29463,Osteosarcoma,0.210850514,3,"Biomarker, Therapeutic"
6710,SPTB,"spectrin, beta, erythrocytic",0.0,1.0,0.0,0.0,0.0,13902,"Elliptocytosis, Hereditary",0.210850514,4,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.210850514,4,Biomarker
367,AR,androgen receptor,1.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210850514,3,"AlteredExpression, Biomarker"
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210850514,4,Biomarker
7153,TOP2A,topoisomerase (DNA) II alpha 170kDa,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210850514,4,Biomarker
3454,IFNAR1,"interferon (alpha, beta and omega) receptor 1",0.0,1.0,0.0,0.0,0.0,42769,Virus Diseases,0.210850514,4,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.210850514,4,"Biomarker, GeneticVariation"
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210850514,3,Biomarker
5816,PVALB,parvalbumin,0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210850514,4,Biomarker
1738,DLD,dihydrolipoamide dehydrogenase,0.0,1.0,0.0,0.0,0.0,23264,Leigh Disease,0.210850514,3,Biomarker
9896,FIG4,FIG4 phosphoinositide 5-phosphatase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210850514,4,Biomarker
9990,SLC12A6,"solute carrier family 12 (potassium/chloride transporter), member 6",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210850514,5,Biomarker
90411,MCFD2,multiple coagulation factor deficiency 2,0.0,1.0,0.0,0.0,0.0,1856883,Familial Multiple Coagulation Factor Deficiency I,0.210850514,3,Biomarker
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,0.0,1.0,0.0,0.0,0.0,343057,"Keratosis Follicularis Spinulosa Decalvans, X-Linked",0.210850514,3,Biomarker
2619,GAS1,growth arrest-specific 1,0.0,1.0,0.0,0.0,0.0,79541,Holoprosencephaly,0.210850514,3,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.210850514,4,Biomarker
928,CD9,CD9 molecule,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210850514,4,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210850514,4,Biomarker
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210850514,3,Biomarker
11040,PIM2,"Pim-2 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210850514,4,Biomarker
10125,RASGRP1,RAS guanyl releasing protein 1 (calcium and DAG-regulated),0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210850514,3,Biomarker
54904,WHSC1L1,Wolf-Hirschhorn syndrome candidate 1-like 1,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210850514,3,"Biomarker, GeneticVariation"
3455,IFNAR2,"interferon (alpha, beta and omega) receptor 2",0.0,1.0,1.0,0.0,0.0,19163,Hepatitis B,0.210850514,3,"Biomarker, GeneticVariation"
3588,IL10RB,"interleukin 10 receptor, beta",0.0,1.0,1.0,0.0,0.0,19163,Hepatitis B,0.210850514,3,"Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,206734,Hemangioblastoma,0.210850514,4,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,16508,"Foot Deformities, Congenital",0.210850514,4,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,13264,"Muscular Dystrophy, Duchenne",0.210850514,4,Biomarker
366,AQP9,aquaporin 9,0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.210850514,3,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.210850514,4,Biomarker
2664,GDI1,GDP dissociation inhibitor 1,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.210850514,5,Biomarker
2322,FLT3,fms-related tyrosine kinase 3,0.0,1.0,1.0,0.0,0.0,23449,ACUTE LYMPHOCYTIC LEUKEMIA,0.210773174,38,"Biomarker, GeneticVariation"
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,158266,Intervertebral Disc Degeneration,0.210567009,2,Biomarker
51305,KCNK9,"potassium channel, two pore domain subfamily K, member 9",0.0,1.0,0.0,0.0,0.0,14553,"Epilepsy, Absence",0.210567009,2,Biomarker
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,22783,Vulvar Lichen Sclerosus,0.210567009,3,Biomarker
51752,ERAP1,endoplasmic reticulum aminopeptidase 1,0.0,1.0,0.0,0.0,0.0,4943,Behcet Syndrome,0.210567009,2,Biomarker
659,BMPR2,"bone morphogenetic protein receptor, type II (serine/threonine kinase)",0.0,1.0,0.0,0.0,0.0,34091,Pulmonary Veno-Occlusive Disease,0.210567009,2,Biomarker
10800,CYSLTR1,cysteinyl leukotriene receptor 1,1.0,1.0,1.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.210567009,4,"AlteredExpression, Biomarker, GeneticVariation"
57105,CYSLTR2,cysteinyl leukotriene receptor 2,0.0,1.0,1.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.210567009,3,"Biomarker, GeneticVariation"
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,0.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.210567009,2,Biomarker
6915,TBXA2R,thromboxane A2 receptor,0.0,1.0,1.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.210567009,3,"Biomarker, GeneticVariation"
4170,MCL1,myeloid cell leukemia 1,0.0,1.0,0.0,0.0,0.0,79773,"Lymphoma, T-Cell, Cutaneous",0.210567009,2,Biomarker
7072,TIA1,TIA1 cytotoxic granule-associated RNA binding protein,0.0,1.0,1.0,0.0,0.0,221054,WELANDER DISTAL MYOPATHY,0.210567009,2,"Biomarker, GeneticVariation"
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210567009,3,Biomarker
811,CALR,calreticulin,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210567009,3,Biomarker
3861,KRT14,"keratin 14, type I",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210567009,3,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210567009,3,Biomarker
5052,PRDX1,peroxiredoxin 1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210567009,3,Biomarker
2810,SFN,stratifin,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210567009,3,Biomarker
25800,SLC39A6,"solute carrier family 39 (zinc transporter), member 6",0.0,1.0,1.0,0.0,1.0,279626,Esophageal Squamous Cell Carcinoma,0.210567009,2,"Biomarker, GeneticVariation, Therapeutic"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210567009,4,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.210567009,3,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.210567009,4,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.210567009,3,Biomarker
4901,NRL,neural retina leucine zipper,0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.210567009,2,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.210567009,7,Biomarker
3562,IL3,interleukin 3,0.0,1.0,0.0,0.0,1.0,2871,Anemia,0.210567009,4,"Biomarker, Therapeutic"
5770,PTPN1,"protein tyrosine phosphatase, non-receptor type 1",0.0,1.0,0.0,0.0,0.0,79731,"Lymphoma, B-Cell",0.210567009,2,Biomarker
5961,PRPH2,"peripherin 2 (retinal degeneration, slow)",0.0,1.0,0.0,0.0,0.0,339510,Vitelliform Macular Dystrophy,0.210567009,2,Biomarker
1958,EGR1,early growth response 1,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.210567009,2,Biomarker
2719,GPC3,glypican 3,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.210567009,3,Biomarker
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,0.0,1.0,0.0,0.0,0.0,311277,"Obesity, Abdominal",0.210567009,3,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.210567009,3,Biomarker
57061,HYMAI,hydatidiform mole associated and imprinted (non-protein coding),1.0,1.0,0.0,0.0,0.0,1832386,"Diabetes Mellitus, Transient Neonatal, 1",0.210567009,2,"AlteredExpression, Biomarker"
22,ABCB7,"ATP-binding cassette, sub-family B (MDR/TAP), member 7",0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.210567009,3,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.210567009,3,Biomarker
489,ATP2A3,"ATPase, Ca++ transporting, ubiquitous",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.210567009,3,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.210567009,3,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,1.0,26769,Multiple Sclerosis,0.210567009,4,"Biomarker, Therapeutic"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,23798,Lipoma,0.210567009,3,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.210567009,3,Biomarker
346171,ZFP57,ZFP57 zinc finger protein,0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.210567009,3,Biomarker
2735,GLI1,GLI family zinc finger 1,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210567009,3,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210567009,2,Biomarker
3486,IGFBP3,insulin-like growth factor binding protein 3,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210567009,3,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,1.0,5695,Urinary Bladder Neoplasms,0.210567009,4,"Biomarker, Therapeutic"
11127,KIF3A,kinesin family member 3A,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.210567009,2,"Biomarker, GeneticVariation"
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.210567009,3,Biomarker
7078,TIMP3,TIMP metallopeptidase inhibitor 3,0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.210567009,2,Biomarker
56287,GKN1,gastrokine 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.210567009,3,Biomarker
6938,TCF12,transcription factor 12,0.0,1.0,0.0,0.0,0.0,10278,Craniosynostoses,0.210567009,2,Biomarker
2902,GRIN1,"glutamate receptor, ionotropic, N-methyl D-aspartate 1",0.0,1.0,1.0,0.0,0.0,33975,Psychotic Disorders,0.210567009,3,"Biomarker, GeneticVariation"
6786,STIM1,stromal interaction molecule 1,0.0,1.0,1.0,0.0,0.0,1861451,Stormorken Syndrome,0.210567009,2,"Biomarker, GeneticVariation"
3403,IDDM4,insulin-dependent diabetes mellitus 4,0.0,1.0,0.0,0.0,0.0,1838261,"Diabetes Mellitus, Insulin-Dependent, 4",0.210567009,2,Biomarker
1776,DNASE1L3,deoxyribonuclease I-like 3,0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.210567009,2,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,1.0,0.0,0.0,242350,Erectile Dysfunction,0.210567009,3,"Biomarker, GeneticVariation"
6597,SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",0.0,1.0,0.0,0.0,0.0,262584,"Carcinoma, Small Cell",0.210567009,3,Biomarker
2182,ACSL4,acyl-CoA synthetase long-chain family member 4,0.0,1.0,1.0,0.0,0.0,11581,Depressive Disorder,0.210567009,2,"Biomarker, GeneticVariation"
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.210567009,3,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,20179,Huntington Disease,0.210567009,3,Biomarker
216,ALDH1A1,"aldehyde dehydrogenase 1 family, member A1",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210567009,3,Biomarker
353,APRT,adenine phosphoribosyltransferase,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210567009,3,Biomarker
1508,CTSB,cathepsin B,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210567009,3,Biomarker
6927,HNF1A,HNF1 homeobox A,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210567009,2,Biomarker
768,CA9,carbonic anhydrase IX,0.0,1.0,0.0,0.0,0.0,1176475,"Carcinoma, Ductal",0.210567009,3,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,7786,Brain Ischemia,0.210567009,3,"Biomarker, GeneticVariation"
6495,SIX1,SIX homeobox 1,0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.210567009,3,Biomarker
1184,CLCN5,"chloride channel, voltage-sensitive 5",0.0,1.0,1.0,0.0,0.0,3536983,Familial Hypophosphatemic Rickets,0.210567009,2,"Biomarker, GeneticVariation"
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.210567009,3,Biomarker
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.210567009,3,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.210567009,3,Biomarker
3304,HSPA1B,heat shock 70kDa protein 1B,0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.210567009,2,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.210567009,4,Biomarker
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.210567009,3,Biomarker
567,B2M,beta-2-microglobulin,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210567009,5,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210567009,3,Biomarker
26762,HAVCR1,hepatitis A virus cellular receptor 1,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210567009,9,Biomarker
9365,KL,klotho,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210567009,3,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210567009,3,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210567009,3,Biomarker
1385,CREB1,cAMP responsive element binding protein 1,0.0,1.0,0.0,0.0,0.0,1266127,"Histiocytoma, Angiomatoid Fibrous",0.210567009,2,Biomarker
5734,PTGER4,prostaglandin E receptor 4 (subtype EP4),0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.210567009,2,"Biomarker, GeneticVariation"
9755,TBKBP1,TBK1 binding protein 1,0.0,1.0,1.0,0.0,0.0,38013,"Spondylitis, Ankylosing",0.210567009,2,"Biomarker, GeneticVariation"
2122,MECOM,MDS1 and EVI1 complex locus,0.0,1.0,0.0,0.0,0.0,23448,"Leukemia, Lymphoid",0.210567009,3,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,36420,"Scleroderma, Localized",0.210567009,3,Biomarker
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.210567009,3,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.210567009,3,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.210567009,3,Biomarker
100528023,PPR1,Photoparoxysmal response 1,0.0,1.0,0.0,0.0,0.0,1868677,PHOTOPAROXYSMAL RESPONSE 1,0.210567009,2,Biomarker
92344,GORAB,"golgin, RAB6-interacting",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.210567009,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.210567009,3,Biomarker
2548,GAA,"glucosidase, alpha; acid",0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.210567009,3,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.210567009,3,Biomarker
84466,MEGF10,multiple EGF-like-domains 10,0.0,1.0,0.0,0.0,0.0,11168,Deglutition Disorders,0.210567009,2,Biomarker
10305,MMDK,"Mesomelic dysplasia, Kantaputra type",0.0,1.0,0.0,0.0,0.0,1835009,Kantaputra Gorlin syndrome,0.210567009,2,Biomarker
1804,DPP6,dipeptidyl-peptidase 6,0.0,1.0,0.0,0.0,0.0,340493,Paroxysmal ventricular fibrillation,0.210567009,2,Biomarker
6710,SPTB,"spectrin, beta, erythrocytic",0.0,1.0,0.0,0.0,0.0,37889,"Spherocytosis, Hereditary",0.210567009,4,Biomarker
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",0.0,1.0,0.0,0.0,1.0,21841,Intestinal Neoplasms,0.210567009,3,"Biomarker, Therapeutic"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.210567009,3,Biomarker
4583,MUC2,"mucin 2, oligomeric mucus/gel-forming",0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.210567009,3,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,18798,"Heart Defects, Congenital",0.210567009,2,"Biomarker, GeneticVariation"
84830,ADTRP,androgen-dependent TFPI-regulating protein,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.210567009,2,"Biomarker, GeneticVariation"
7189,TRAF6,"TNF receptor-associated factor 6, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.210567009,2,Biomarker
7086,TKT,transketolase,0.0,1.0,0.0,0.0,0.0,43121,Wernicke Encephalopathy,0.210567009,3,Biomarker
1030,CDKN2B,"cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)",0.0,1.0,0.0,0.0,0.0,17601,Glaucoma,0.210567009,2,Biomarker
1576,CYP3A4,"cytochrome P450, family 3, subfamily A, polypeptide 4",0.0,1.0,0.0,0.0,0.0,19196,Hepatitis C,0.210567009,3,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,2453,Amenorrhea,0.210567009,3,Biomarker
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,1.0,0.0,0.0,497327,Dementia,0.210567009,3,"Biomarker, GeneticVariation"
1674,DES,desmin,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210567009,3,Biomarker
3852,KRT5,"keratin 5, type II",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210567009,3,Biomarker
3963,LGALS7,"lectin, galactoside-binding, soluble, 7",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210567009,3,Biomarker
4256,MGP,matrix Gla protein,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210567009,4,Biomarker
5315,PKM,"pyruvate kinase, muscle",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210567009,3,Biomarker
5764,PTN,pleiotrophin,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210567009,3,Biomarker
2316,FLNA,"filamin A, alpha",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210567009,2,Biomarker
4208,MEF2C,myocyte enhancer factor 2C,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210567009,3,Biomarker
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210567009,3,Biomarker
57282,SLC4A10,"solute carrier family 4, sodium bicarbonate transporter, member 10",0.0,1.0,0.0,0.0,1.0,14544,Epilepsy,0.210567009,3,"Biomarker, Therapeutic"
4487,MSX1,msh homeobox 1,0.0,1.0,0.0,0.0,0.0,399352,Anodontia,0.210567009,2,Biomarker
4337,MOCS1,molybdenum cofactor synthesis 1,0.0,1.0,0.0,0.0,0.0,268119,Molybdenum cofactor deficiency,0.210567009,2,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.210567009,3,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.210567009,4,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.210567009,3,"Biomarker, Therapeutic"
100124415,EKD2,Episodic kinesigenic dyskinesia 2,0.0,1.0,0.0,0.0,0.0,1970238,Episodic Kinesigenic Dyskinesia 2,0.210567009,2,Biomarker
2625,GATA3,GATA binding protein 3,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210567009,3,Biomarker
2737,GLI3,GLI family zinc finger 3,0.0,1.0,0.0,0.0,0.0,342418,Hypothalamic hamartomas,0.210567009,2,Biomarker
7535,ZAP70,zeta-chain (TCR) associated protein kinase 70kDa,0.0,1.0,1.0,0.0,0.0,2931299,ZAP70 deficiency,0.210567009,6,"Biomarker, GeneticVariation"
990,CDC6,cell division cycle 6,0.0,1.0,0.0,0.0,0.0,1868684,Meier-Gorlin syndrome,0.210567009,3,Biomarker
54982,CLN6,"ceroid-lipofuscinosis, neuronal 6, late infantile, variant",0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.210567009,3,Biomarker
3605,IL17A,interleukin 17A,0.0,1.0,1.0,0.0,0.0,18133,Graft vs Host Disease,0.210567009,3,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.210567009,3,Biomarker
2332,FMR1,fragile X mental retardation 1,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.210567009,3,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.210567009,3,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,40028,"Thrombocythemia, Essential",0.210567009,2,Biomarker
3417,IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",0.0,1.0,1.0,0.0,0.0,18916,Hemangioma,0.210567009,2,"Biomarker, GeneticVariation"
7015,TERT,telomerase reverse transcriptase,0.0,1.0,1.0,0.0,0.0,1846142,Hoyeraal Hreidarsson syndrome,0.210567009,2,"Biomarker, GeneticVariation"
5831,PYCR1,pyrroline-5-carboxylate reductase 1,0.0,1.0,0.0,0.0,0.0,10495,Cutis Laxa,0.210567009,3,Biomarker
1415,CRYBB2,"crystallin, beta B2",0.0,1.0,0.0,0.0,0.0,344523,Cerulean cataract,0.210567009,2,Biomarker
5320,PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid)",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210567009,2,Biomarker
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.210567009,3,Biomarker
5604,MAP2K1,mitogen-activated protein kinase kinase 1,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.210567009,2,Biomarker
2810,SFN,stratifin,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.210567009,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.210567009,3,Biomarker
7508,XPC,"xeroderma pigmentosum, complementation group C",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.210567009,2,Biomarker
2335,FN1,fibronectin 1,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210567009,4,Biomarker
1501,CTNND2,"catenin (cadherin-associated protein), delta 2",0.0,1.0,0.0,0.0,0.0,10314,Cri-du-Chat Syndrome,0.210567009,2,Biomarker
3020,H3F3A,"H3 histone, family 3A",0.0,1.0,0.0,0.0,0.0,206638,Giant Cell Tumor of Bone,0.210567009,2,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.210567009,3,Biomarker
4193,MDM2,"MDM2 proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.210567009,3,Biomarker
2110,ETFDH,electron-transferring-flavoprotein dehydrogenase,0.0,1.0,0.0,0.0,0.0,25517,Metabolic Diseases,0.210567009,3,Biomarker
4088,SMAD3,SMAD family member 3,0.0,1.0,0.0,0.0,0.0,3486,Aortic Aneurysm,0.210567009,2,Biomarker
3988,LIPA,"lipase A, lysosomal acid, cholesterol esterase",0.0,1.0,0.0,0.0,0.0,2936797,Lysosomal acid lipase deficiency,0.210567009,2,Biomarker
969,CD69,CD69 molecule,0.0,1.0,0.0,0.0,1.0,3864,Arthritis,0.210567009,3,"Biomarker, Therapeutic"
3417,IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",0.0,1.0,0.0,0.0,0.0,14084,Enchondromatosis,0.210567009,3,Biomarker
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,0.0,0.0,0.0,14084,Enchondromatosis,0.210567009,3,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.210567009,3,"Biomarker, Therapeutic"
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.210567009,3,Biomarker
4729,NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.210567009,2,Biomarker
84676,TRIM63,"tripartite motif containing 63, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,1.0,878544,Cardiomyopathies,0.210567009,3,"Biomarker, GeneticVariation, Therapeutic"
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.210567009,3,Biomarker
2253,FGF8,fibroblast growth factor 8 (androgen-induced),0.0,1.0,1.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210567009,3,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,1.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210567009,5,"AlteredExpression, Biomarker"
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210567009,5,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.210567009,3,Biomarker
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.210567009,2,Biomarker
8678,BECN1,"beclin 1, autophagy related",0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.210567009,3,Biomarker
25792,CIZ1,CDKN1A interacting zinc finger protein 1,0.0,1.0,1.0,0.0,0.0,13421,Dystonia,0.210567009,3,"Biomarker, GeneticVariation"
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,1.0,40038,Thromboembolism,0.210567009,3,"Biomarker, Therapeutic"
10981,RAB32,"RAB32, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,23343,Leprosy,0.210567009,2,Biomarker
93986,FOXP2,forkhead box P2,0.0,1.0,0.0,0.0,0.0,3635,Apraxias,0.210567009,3,Biomarker
114086,DBA2,Diamond-Blackfan anemia 2,0.0,1.0,1.0,0.0,0.0,1260899,"Anemia, Diamond-Blackfan",0.210567009,2,"Biomarker, GeneticVariation"
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",0.0,1.0,0.0,0.0,1.0,20437,Hypercalcemia,0.210567009,3,"Biomarker, Therapeutic"
8600,TNFSF11,"tumor necrosis factor (ligand) superfamily, member 11",0.0,1.0,0.0,0.0,0.0,20437,Hypercalcemia,0.210567009,3,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.210567009,10,Biomarker
6352,CCL5,chemokine (C-C motif) ligand 5,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.210567009,3,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,1.0,17658,Glomerulonephritis,0.210567009,3,"Biomarker, Therapeutic"
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.210567009,4,Biomarker
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.210567009,3,Biomarker
2984,GUCY2C,guanylate cyclase 2C,0.0,1.0,0.0,0.0,0.0,11991,Diarrhea,0.210567009,3,Biomarker
4089,SMAD4,SMAD family member 4,0.0,1.0,0.0,0.0,0.0,1134719,"Carcinoma, Ductal, Breast",0.210567009,3,Biomarker
493753,COA5,cytochrome c oxidase assembly factor 5,0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.210567009,2,"Biomarker, GeneticVariation"
2833,CXCR3,chemokine (C-X-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.210567009,3,Biomarker
5175,PECAM1,platelet/endothelial cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.210567009,3,Biomarker
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,1.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.210567009,2,"Biomarker, GeneticVariation"
23224,SYNE2,"spectrin repeat containing, nuclear envelope 2",0.0,1.0,0.0,0.0,0.0,410189,"Muscular Dystrophy, Emery-Dreifuss",0.210567009,2,Biomarker
1181,CLCN2,"chloride channel, voltage-sensitive 2",0.0,1.0,0.0,0.0,0.0,270853,"Myoclonic Epilepsy, Juvenile",0.210567009,2,Biomarker
50715,EJM2,"epilepsy, juvenile myoclonic 2",0.0,1.0,0.0,0.0,0.0,270853,"Myoclonic Epilepsy, Juvenile",0.210567009,2,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,24299,Lymphoma,0.210567009,3,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,1.0,0.0,0.0,24299,Lymphoma,0.210567009,3,"Biomarker, GeneticVariation"
10062,NR1H3,"nuclear receptor subfamily 1, group H, member 3",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.210567009,3,Biomarker
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.210567009,3,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.210567009,3,Biomarker
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.210567009,3,Biomarker
4288,MKI67,marker of proliferation Ki-67,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210567009,3,Biomarker
55350,VNN3,vanin 3,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210567009,2,Biomarker
3240,HP,haptoglobin,0.0,1.0,1.0,0.0,0.0,18995,Hemochromatosis,0.210567009,3,"Biomarker, GeneticVariation"
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,17168,Gastroesophageal Reflux,0.210567009,3,Biomarker
72,ACTG2,"actin, gamma 2, smooth muscle, enteric",0.0,1.0,1.0,0.0,0.0,1608393,Megacystis microcolon intestinal hypoperistalsis syndrome,0.210567009,2,"Biomarker, GeneticVariation"
916,CD3E,"CD3e molecule, epsilon (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.210567009,3,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.210567009,3,Biomarker
10861,SLC26A1,"solute carrier family 26 (anion exchanger), member 1",0.0,1.0,0.0,0.0,0.0,20500,Hyperoxaluria,0.210567009,3,Biomarker
406913,MIR126,microRNA 126,0.0,1.0,0.0,0.0,0.0,345967,"Mesothelioma, Malignant",0.210567009,2,Biomarker
136647,MPLKIP,M-phase specific PLK1 interacting protein,0.0,1.0,0.0,0.0,0.0,1955934,Trichothiodystrophy Syndromes,0.210567009,2,Biomarker
646960,PRSS56,"protease, serine, 56",0.0,1.0,0.0,0.0,0.0,17605,"Glaucoma, Angle-Closure",0.210567009,2,Biomarker
347733,TUBB2B,"tubulin, beta 2B class IIb",0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.210567009,3,Biomarker
51715,RAB23,"RAB23, member RAS oncogene family",0.0,1.0,1.0,0.0,0.0,796281,CARPENTER SYNDROME 1,0.210567009,3,"Biomarker, GeneticVariation"
6905,TBCE,tubulin folding cofactor E,0.0,1.0,0.0,0.0,0.0,265291,Kenny Caffey syndrome,0.210567009,3,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.210567009,2,Biomarker
2006,ELN,elastin,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210567009,3,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210567009,3,Biomarker
3021,H3F3B,"H3 histone, family 3B (H3.3B)",0.0,1.0,0.0,0.0,0.0,8441,Chondroblastoma,0.210567009,2,Biomarker
1816,DRD5,dopamine receptor D5,0.0,1.0,0.0,0.0,0.0,2930898,Benign essential blepharospasm,0.210567009,2,Biomarker
4137,MAPT,microtubule-associated protein tau,0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.210567009,2,Biomarker
7100,TLR5,toll-like receptor 5,0.0,1.0,0.0,0.0,0.0,23241,Legionnaires' Disease,0.210567009,2,Biomarker
117193,THMA,Tibial hemimelia,0.0,1.0,0.0,0.0,0.0,265633,Absence of Tibia,0.210567009,2,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,23492,"Leukemia, T-Cell",0.210567009,3,Biomarker
6596,HLTF,helicase-like transcription factor,0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.210567009,2,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.210567009,2,Biomarker
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,32461,Polycythemia,0.210567009,3,Biomarker
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,32461,Polycythemia,0.210567009,4,"Biomarker, GeneticVariation"
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,1.0,23890,Liver Cirrhosis,0.210567009,3,"Biomarker, Therapeutic"
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,278601,Inflammatory Breast Neoplasms,0.210567009,3,Biomarker
79017,GGCT,gamma-glutamylcyclotransferase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210567009,3,Biomarker
7941,PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210567009,3,Biomarker
54768,HYDIN,"HYDIN, axonemal central pair apparatus protein",0.0,1.0,0.0,0.0,0.0,20255,Hydrocephalus,0.210567009,3,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,1.0,0.0,0.0,340288,"Angina, Stable",0.210567009,3,"Biomarker, GeneticVariation"
6584,SLC22A5,"solute carrier family 22 (organic cation/carnitine transporter), member 5",0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.210567009,2,Biomarker
4487,MSX1,msh homeobox 1,0.0,1.0,0.0,0.0,0.0,1956097,Wolf-Hirschhorn Syndrome,0.210567009,2,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.210567009,5,"Biomarker, GeneticVariation"
3486,IGFBP3,insulin-like growth factor binding protein 3,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.210567009,3,Biomarker
22,ABCB7,"ATP-binding cassette, sub-family B (MDR/TAP), member 7",0.0,1.0,1.0,0.0,0.0,2896,"Anemia, Sideroblastic",0.210567009,4,"Biomarker, GeneticVariation"
51218,GLRX5,glutaredoxin 5,0.0,1.0,0.0,0.0,0.0,2896,"Anemia, Sideroblastic",0.210567009,3,Biomarker
54977,SLC25A38,"solute carrier family 25, member 38",0.0,1.0,0.0,0.0,0.0,2896,"Anemia, Sideroblastic",0.210567009,3,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.210567009,4,Biomarker
6821,SUOX,sulfite oxidase,0.0,1.0,1.0,0.0,0.0,2931746,SULFOCYSTEINURIA,0.210567009,6,"Biomarker, GeneticVariation"
450087,ADHD1,"Attention deficit-hyperactivity disorder, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.210567009,2,Biomarker
79068,FTO,fat mass and obesity associated,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210567009,2,Biomarker
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210567009,2,Biomarker
56925,LXN,latexin,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210567009,2,Biomarker
4217,MAP3K5,mitogen-activated protein kinase kinase kinase 5,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.210567009,2,"Biomarker, GeneticVariation"
5133,PDCD1,programmed cell death 1,0.0,1.0,0.0,0.0,1.0,25202,Melanoma,0.210567009,3,"Biomarker, Therapeutic"
7001,PRDX2,peroxiredoxin 2,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210567009,2,Biomarker
26503,SLC17A5,"solute carrier family 17 (acidic sugar transporter), member 5",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210567009,3,Biomarker
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",0.0,1.0,0.0,0.0,1.0,25202,Melanoma,0.210567009,3,"Biomarker, Therapeutic"
4610,MYCL,v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.210567009,3,Biomarker
23532,PRAME,preferentially expressed antigen in melanoma,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.210567009,3,Biomarker
5727,PTCH1,patched 1,0.0,1.0,0.0,0.0,0.0,206663,"Neuroectodermal Tumors, Primitive",0.210567009,3,Biomarker
4340,MOG,myelin oligodendrocyte glycoprotein,0.0,1.0,0.0,0.0,0.0,11303,Demyelinating Diseases,0.210567009,3,Biomarker
1808,DPYSL2,dihydropyrimidinase-like 2,0.0,1.0,1.0,0.0,0.0,36349,"Schizophrenia, Paranoid",0.210567009,2,"Biomarker, GeneticVariation"
64132,XYLT2,xylosyltransferase II,0.0,1.0,1.0,0.0,0.0,33847,Pseudoxanthoma Elasticum,0.210567009,2,"Biomarker, GeneticVariation"
9510,ADAMTS1,"ADAM metallopeptidase with thrombospondin type 1 motif, 1",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210567009,2,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210567009,3,Biomarker
1845,DUSP3,dual specificity phosphatase 3,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210567009,3,Biomarker
3956,LGALS1,"lectin, galactoside-binding, soluble, 1",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210567009,3,Biomarker
693223,MIR638,microRNA 638,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210567009,2,Biomarker
4320,MMP11,matrix metallopeptidase 11 (stromelysin 3),0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210567009,2,Biomarker
8202,NCOA3,nuclear receptor coactivator 3,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210567009,3,Biomarker
6236,RRAD,Ras-related associated with diabetes,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210567009,2,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,6267,Bronchiectasis,0.210567009,3,Biomarker
406991,MIR21,microRNA 21,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210567009,2,Biomarker
4804,NGFR,nerve growth factor receptor,0.0,1.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.210567009,4,"Biomarker, Therapeutic"
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210567009,3,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210567009,2,Biomarker
5176,SERPINF1,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1",0.0,1.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.210567009,3,"Biomarker, Therapeutic"
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",0.0,1.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.210567009,4,"Biomarker, Therapeutic"
3925,STMN1,stathmin 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210567009,2,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,0.0,0.0,0.0,27121,Myositis,0.210567009,2,Biomarker
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,0.0,1.0,0.0,0.0,0.0,41834,Erythema,0.210567009,3,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210567009,7,Biomarker
2897,GRIK1,"glutamate receptor, ionotropic, kainate 1",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210567009,3,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210567009,4,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.210567009,3,"Biomarker, Therapeutic"
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.210567009,3,"Biomarker, Therapeutic"
57468,SLC12A5,"solute carrier family 12 (potassium/chloride transporter), member 5",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210567009,3,Biomarker
6750,SST,somatostatin,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.210567009,5,"Biomarker, Therapeutic"
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210567009,4,Biomarker
2194,FASN,fatty acid synthase,0.0,1.0,0.0,0.0,1.0,23827,Liposarcoma,0.210567009,3,"Biomarker, Therapeutic"
23706,IBGC1,idiopathic basal ganglia calcification 1,0.0,1.0,0.0,0.0,0.0,393590,Idiopathic basal ganglia calcification 1,0.210567009,2,Biomarker
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,1.0,1.0,0.0,0.0,220769,Opitz-Kaveggia syndrome,0.210567009,2,"Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,206754,Neuroendocrine Tumors,0.210567009,3,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,1.0,0.0,0.0,1140680,Malignant neoplasm of ovary,0.210567009,2,"Biomarker, GeneticVariation"
205428,C3orf58,chromosome 3 open reading frame 58,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210567009,3,Biomarker
1600,DAB1,"Dab, reelin signal transducer, homolog 1 (Drosophila)",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210567009,2,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210567009,3,Biomarker
8242,KDM5C,lysine (K)-specific demethylase 5C,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210567009,2,Biomarker
3912,LAMB1,"laminin, beta 1",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210567009,2,Biomarker
54551,MAGEL2,melanoma antigen family L2,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210567009,2,Biomarker
7436,VLDLR,very low density lipoprotein receptor,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210567009,2,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.210567009,2,Biomarker
2736,GLI2,GLI family zinc finger 2,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.210567009,3,Biomarker
3848,KRT1,"keratin 1, type II",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.210567009,3,Biomarker
1839,HBEGF,heparin-binding EGF-like growth factor,0.0,1.0,0.0,0.0,1.0,520459,"Enterocolitis, Necrotizing",0.210567009,3,"Biomarker, Therapeutic"
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.210567009,3,Biomarker
23418,CRB1,"crumbs family member 1, photoreceptor morphogenesis associated",0.0,1.0,0.0,0.0,0.0,154832,Retinal Telangiectasis,0.210567009,3,Biomarker
3764,KCNJ8,"potassium channel, inwardly rectifying subfamily J, member 8",0.0,1.0,0.0,0.0,0.0,42510,Ventricular Fibrillation,0.210567009,2,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.210567009,3,Biomarker
2550,GABBR1,"gamma-aminobutyric acid (GABA) B receptor, 1",0.0,1.0,1.0,0.0,0.0,1973,Alcoholism,0.210567009,3,"Biomarker, GeneticVariation"
27232,GNMT,glycine N-methyltransferase,0.0,1.0,0.0,0.0,0.0,19189,"Hepatitis, Chronic",0.210567009,2,Biomarker
760,CA2,carbonic anhydrase II,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,3,Biomarker
873,CBR1,carbonyl reductase 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,2,Biomarker
80381,CD276,CD276 molecule,0.0,1.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.210567009,2,"Biomarker, Therapeutic"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,2,Biomarker
2203,FBP1,"fructose-1,6-bisphosphatase 1",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,2,Biomarker
10468,FST,follistatin,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,3,Biomarker
3083,HGFAC,HGF activator,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,3,Biomarker
8826,IQGAP1,IQ motif containing GTPase activating protein 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,2,Biomarker
3660,IRF2,interferon regulatory factor 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,2,Biomarker
9757,KMT2B,lysine (K)-specific methyltransferase 2B,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,3,Biomarker
4598,MVK,mevalonate kinase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,3,Biomarker
7001,PRDX2,peroxiredoxin 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,3,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,2,Biomarker
6319,SCD,stearoyl-CoA desaturase (delta-9-desaturase),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,3,Biomarker
6775,STAT4,signal transducer and activator of transcription 4,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210567009,2,"Biomarker, GeneticVariation"
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.210567009,2,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,14072,"Encephalomyelitis, Autoimmune, Experimental",0.210567009,3,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,1.0,14072,"Encephalomyelitis, Autoimmune, Experimental",0.210567009,3,"Biomarker, Therapeutic"
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,20635,Hypopituitarism,0.210567009,3,Biomarker
11311,VPS45,vacuolar protein sorting 45 homolog (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,1853118,"Neutropenia, Severe Congenital, Autosomal Recessive 3",0.210567009,2,"Biomarker, GeneticVariation"
2677,GGCX,gamma-glutamyl carboxylase,0.0,1.0,1.0,0.0,0.0,5779,Blood Coagulation Disorders,0.210567009,3,"Biomarker, GeneticVariation"
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,0.0,0.0,0.0,5779,Blood Coagulation Disorders,0.210567009,3,Biomarker
79001,VKORC1,"vitamin K epoxide reductase complex, subunit 1",0.0,1.0,1.0,0.0,0.0,5779,Blood Coagulation Disorders,0.210567009,3,"Biomarker, GeneticVariation"
9687,GREB1,growth regulation by estrogen in breast cancer 1,0.0,1.0,1.0,0.0,0.0,14175,Endometriosis,0.210567009,2,"Biomarker, GeneticVariation"
7026,NR2F2,"nuclear receptor subfamily 2, group F, member 2",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210567009,3,Biomarker
5734,PTGER4,prostaglandin E receptor 4 (subtype EP4),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210567009,3,Biomarker
6750,SST,somatostatin,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210567009,3,Biomarker
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.210567009,3,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210567009,3,Biomarker
9970,NR1I3,"nuclear receptor subfamily 1, group I, member 3",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210567009,3,Biomarker
5105,PCK1,phosphoenolpyruvate carboxykinase 1 (soluble),0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210567009,3,Biomarker
6580,SLC22A1,"solute carrier family 22 (organic cation transporter), member 1",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210567009,2,Biomarker
412,STS,"steroid sulfatase (microsomal), isozyme S",0.0,1.0,0.0,0.0,1.0,28754,Obesity,0.210567009,3,"Biomarker, Therapeutic"
7436,VLDLR,very low density lipoprotein receptor,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210567009,2,Biomarker
100379198,ECT,centralopathic epilepsy,0.0,1.0,0.0,0.0,0.0,376532,"Epilepsy, Rolandic",0.210567009,2,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.210567009,3,"Biomarker, GeneticVariation"
1270,CNTF,ciliary neurotrophic factor,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.210567009,2,Biomarker
3295,HSD17B4,hydroxysteroid (17-beta) dehydrogenase 4,0.0,1.0,0.0,0.0,0.0,282528,Peroxisomal Disorders,0.210567009,4,Biomarker
64778,FNDC3B,fibronectin type III domain containing 3B,0.0,1.0,1.0,0.0,0.0,22578,Keratoconus,0.210567009,2,"Biomarker, GeneticVariation"
2308,FOXO1,forkhead box O1,0.0,1.0,1.0,0.0,0.0,22578,Keratoconus,0.210567009,2,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.210567009,3,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,1.0,0.0,0.0,30193,Pain,0.210567009,4,"Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,1.0,30193,Pain,0.210567009,5,"Biomarker, Therapeutic"
843,CASP10,"caspase 10, apoptosis-related cysteine peptidase",0.0,1.0,1.0,0.0,0.0,699791,STOMACH CARCINOMA,0.210567009,2,"Biomarker, GeneticVariation"
3170,FOXA2,forkhead box A2,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.210567009,3,Biomarker
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.210567009,3,Biomarker
6338,SCNN1B,"sodium channel, non voltage gated 1 beta subunit",0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.210567009,3,Biomarker
50951,MMVP1,myxomatous mitral valve prolapse 1,0.0,1.0,0.0,0.0,0.0,26267,Mitral Valve Prolapse,0.210567009,2,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,1.0,10072,Coronary Thrombosis,0.210567009,5,"Biomarker, Therapeutic"
11128,POLR3A,"polymerase (RNA) III (DNA directed) polypeptide A, 155kDa",0.0,1.0,1.0,0.0,0.0,2676243,"Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism",0.210567009,6,"Biomarker, GeneticVariation"
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,2878,"Anemia, Hemolytic",0.210567009,5,"Biomarker, Therapeutic"
23601,CLEC5A,"C-type lectin domain family 5, member A",0.0,1.0,1.0,0.0,1.0,19100,Severe Dengue,0.210567009,3,"Biomarker, GeneticVariation, Therapeutic"
4277,MICB,MHC class I polypeptide-related sequence B,0.0,1.0,1.0,0.0,0.0,19100,Severe Dengue,0.210567009,3,"Biomarker, GeneticVariation"
5194,PEX13,peroxisomal biogenesis factor 13,0.0,1.0,0.0,0.0,0.0,43459,Zellweger Syndrome,0.210567009,3,Biomarker
55670,PEX26,peroxisomal biogenesis factor 26,0.0,1.0,0.0,0.0,0.0,43459,Zellweger Syndrome,0.210567009,2,Biomarker
4658,MYP2,"myopia 2 (high grade, autosomal dominant)",0.0,1.0,0.0,0.0,0.0,1834531,Myopia 2,0.210567009,2,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.210567009,3,Biomarker
2992,GYG1,glycogenin 1,0.0,1.0,0.0,0.0,0.0,17919,Glycogen Storage Disease,0.210567009,3,Biomarker
619394,SPOAN,"spastic paraplegia, optic atrophy, and neuropathy",0.0,1.0,0.0,0.0,0.0,1836010,"Spastic Paraplegia, Optic Atrophy, and Neuropathy",0.210567009,2,Biomarker
718,C3,complement component 3,0.0,1.0,0.0,0.0,0.0,2931788,Atypical Hemolytic Uremic Syndrome,0.210567009,2,Biomarker
8526,DGKE,"diacylglycerol kinase, epsilon 64kDa",0.0,1.0,0.0,0.0,0.0,2931788,Atypical Hemolytic Uremic Syndrome,0.210567009,3,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210567009,2,Biomarker
5292,PIM1,"Pim-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210567009,2,Biomarker
5371,PML,promyelocytic leukemia,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210567009,3,Biomarker
8434,RECK,reversion-inducing-cysteine-rich protein with kazal motifs,0.0,1.0,0.0,0.0,1.0,17636,Glioblastoma,0.210567009,3,"Biomarker, Therapeutic"
864,RUNX3,runt-related transcription factor 3,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210567009,2,Biomarker
26136,TES,testin LIM domain protein,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210567009,3,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,23896,"Liver Diseases, Alcoholic",0.210567009,2,Biomarker
2147,F2,coagulation factor II (thrombin),0.0,1.0,0.0,0.0,0.0,85605,Liver Failure,0.210567009,3,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,5967,Bone Neoplasms,0.210567009,3,Biomarker
5131,PDB1,Paget disease of bone 1,0.0,1.0,0.0,0.0,0.0,29401,Osteitis Deformans,0.210567009,2,Biomarker
10008,KCNE3,"potassium channel, voltage gated subfamily E regulatory beta subunit 3",0.0,1.0,0.0,0.0,0.0,3714580,"HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1",0.210567009,2,Biomarker
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,1.0,0.0,0.0,0.0,150055,Chronic Pain,0.210567009,3,Biomarker
7681,MKRN3,makorin ring finger protein 3,0.0,1.0,0.0,0.0,0.0,342543,"Precocious Puberty, Central",0.210567009,2,Biomarker
5194,PEX13,peroxisomal biogenesis factor 13,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.210567009,3,Biomarker
5195,PEX14,peroxisomal biogenesis factor 14,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.210567009,4,Biomarker
9409,PEX16,peroxisomal biogenesis factor 16,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.210567009,3,Biomarker
55670,PEX26,peroxisomal biogenesis factor 26,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.210567009,2,Biomarker
8504,PEX3,peroxisomal biogenesis factor 3,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.210567009,3,Biomarker
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),0.0,1.0,0.0,0.0,0.0,2940,Aneurysm,0.210567009,2,Biomarker
634,CEACAM1,carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein),0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210567009,3,Biomarker
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210567009,3,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210567009,3,Biomarker
8991,SELENBP1,selenium binding protein 1,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210567009,3,Biomarker
6934,TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box)",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210567009,3,Biomarker
406986,MIR203A,microRNA 203a,0.0,1.0,0.0,0.0,1.0,596263,Carcinogenesis,0.210567009,2,"Biomarker, Therapeutic"
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.210567009,3,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.210567009,2,Biomarker
4826,NNAT,neuronatin,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.210567009,2,Biomarker
780896,ACTD,Acetabular dysplasia,0.0,1.0,0.0,0.0,0.0,1306065,DEVELOPMENTAL DYSPLASIA OF THE HIP 1,0.210567009,2,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,85655,Polymyositis,0.210567009,3,Biomarker
8660,IRS2,insulin receptor substrate 2,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.210567009,3,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.210567009,3,Biomarker
1814,DRD3,dopamine receptor D3,0.0,1.0,0.0,0.0,1.0,26650,Movement Disorders,0.210567009,3,"Biomarker, Therapeutic"
57670,KIAA1549,KIAA1549,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.210567009,3,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.210567009,3,Biomarker
5457,POU4F1,POU class 4 homeobox 1,0.0,1.0,0.0,0.0,0.0,206708,Cervical Intraepithelial Neoplasia,0.210567009,2,Biomarker
768,CA9,carbonic anhydrase IX,0.0,1.0,0.0,0.0,0.0,7124,"Carcinoma, Intraductal, Noninfiltrating",0.210567009,2,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,7124,"Carcinoma, Intraductal, Noninfiltrating",0.210567009,2,Biomarker
5087,PBX1,pre-B-cell leukemia homeobox 1,0.0,1.0,1.0,0.0,0.0,6413,Burkitt Lymphoma,0.210567009,4,"Biomarker, GeneticVariation"
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,17665,"Glomerulonephritis, Membranous",0.210567009,7,Biomarker
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,0.0,0.0,0.0,17665,"Glomerulonephritis, Membranous",0.210567009,3,Biomarker
4358,MPV17,MpV17 mitochondrial inner membrane protein,0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.210567009,2,Biomarker
10232,MSLN,mesothelin,0.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.210567009,3,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.210567009,3,Biomarker
11156,PTP4A3,"protein tyrosine phosphatase type IVA, member 3",0.0,1.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.210567009,2,"Biomarker, Therapeutic"
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,18799,Heart Diseases,0.210567009,3,"Biomarker, Therapeutic"
126393,HSPB6,"heat shock protein, alpha-crystallin-related, B6",0.0,1.0,1.0,0.0,1.0,18799,Heart Diseases,0.210567009,3,"Biomarker, GeneticVariation, Therapeutic"
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.210567009,3,Biomarker
7137,TNNI3,troponin I type 3 (cardiac),0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.210567009,3,Biomarker
170679,PSORS1C1,psoriasis susceptibility 1 candidate 1,0.0,1.0,0.0,0.0,0.0,36421,"Scleroderma, Systemic",0.210567009,2,Biomarker
388,RHOB,ras homolog family member B,0.0,1.0,0.0,0.0,0.0,36421,"Scleroderma, Systemic",0.210567009,2,Biomarker
2018,EMX2,empty spiracles homeobox 2,0.0,1.0,0.0,0.0,0.0,2931870,Familial schizencephaly,0.210567009,2,Biomarker
10516,FBLN5,fibulin 5,0.0,1.0,0.0,0.0,0.0,2931134,"Cutis laxa, recessive",0.210567009,3,Biomarker
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,0.0,0.0,0.0,221043,Liddle Syndrome,0.210567009,3,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,2,Biomarker
1719,DHFR,dihydrofolate reductase,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,2,Biomarker
406920,MIR130B,microRNA 130b,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,3,Biomarker
406957,MIR181C,microRNA 181c,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,3,Biomarker
406979,MIR19A,microRNA 19a,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,3,Biomarker
407029,MIR30A,microRNA 30a,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,3,Biomarker
442915,MIR370,microRNA 370,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,3,Biomarker
574506,MIR503,microRNA 503,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,3,Biomarker
4638,MYLK,myosin light chain kinase,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,3,Biomarker
5008,OSM,oncostatin M,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,2,Biomarker
5287,PIK3C2B,"phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,2,Biomarker
55630,SLC39A4,"solute carrier family 39 (zinc transporter), member 4",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,3,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210567009,3,Biomarker
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,0.0,0.0,0.0,20555,Hypertrichosis,0.210567009,3,Biomarker
4602,MYB,v-myb avian myeloblastosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210567009,3,Biomarker
3925,STMN1,stathmin 1,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210567009,3,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210567009,3,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.210567009,3,Biomarker
431708,MDD1,Major depressive disorder,0.0,1.0,0.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.210567009,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.210567009,3,"Biomarker, GeneticVariation"
4170,MCL1,myeloid cell leukemia 1,0.0,1.0,0.0,0.0,0.0,1261473,Sarcoma,0.210567009,2,Biomarker
55812,SPATA7,spermatogenesis associated 7,0.0,1.0,0.0,0.0,0.0,35334,Retinitis Pigmentosa,0.210567009,2,Biomarker
6401,SELE,selectin E,0.0,1.0,1.0,0.0,0.0,85580,"Hypertension, Essential",0.210567009,2,"Biomarker, GeneticVariation"
6821,SUOX,sulfite oxidase,0.0,1.0,0.0,0.0,0.0,268624,Sulfite oxidase deficiency,0.210567009,2,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210567009,3,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210567009,3,Biomarker
6369,CCL24,chemokine (C-C motif) ligand 24,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210567009,3,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,206669,"Adenoma, Liver Cell",0.210567009,3,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,206669,"Adenoma, Liver Cell",0.210567009,3,Biomarker
27306,HPGDS,hematopoietic prostaglandin D synthase,0.0,1.0,1.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.210567009,2,"Biomarker, GeneticVariation"
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.210567009,2,Biomarker
6336,SCN10A,"sodium channel, voltage gated, type X alpha subunit",0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.210567009,3,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.210567009,3,Biomarker
284382,ACTL9,actin-like 9,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.210567009,2,Biomarker
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.210567009,3,Biomarker
10661,KLF1,Kruppel-like factor 1 (erythroid),0.0,1.0,1.0,0.0,0.0,2876,"Anemia, Dyserythropoietic, Congenital",0.210567009,2,"Biomarker, GeneticVariation"
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,1.0,30567,Parkinson Disease,0.210567009,4,"Biomarker, Therapeutic"
3990,LIPC,"lipase, hepatic",0.0,1.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.210567009,3,"Biomarker, GeneticVariation"
650,BMP2,bone morphogenetic protein 2,0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.210567009,3,Biomarker
2208,FCER2,"Fc fragment of IgE, low affinity II, receptor for (CD23)",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210567009,2,Biomarker
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210567009,3,Biomarker
4193,MDM2,"MDM2 proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.210567009,3,"Biomarker, GeneticVariation"
4953,ODC1,ornithine decarboxylase 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210567009,3,Biomarker
7528,YY1,YY1 transcription factor,0.0,1.0,1.0,0.0,0.0,19693,HIV Infections,0.210567009,3,"Biomarker, GeneticVariation"
1218,CMD1B,"cardiomyopathy, dilated 1B (autosomal dominant)",0.0,1.0,0.0,0.0,0.0,340427,Familial dilated cardiomyopathy,0.210567009,2,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210567009,2,Biomarker
567,B2M,beta-2-microglobulin,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.210567009,3,Biomarker
983,CDK1,cyclin-dependent kinase 1,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.210567009,2,Biomarker
8085,KMT2D,lysine (K)-specific methyltransferase 2D,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.210567009,2,Biomarker
6502,SKP2,"S-phase kinase-associated protein 2, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.210567009,2,Biomarker
4208,MEF2C,myocyte enhancer factor 2C,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210567009,3,Biomarker
139411,PTCHD1,patched domain containing 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210567009,2,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210567009,3,Biomarker
6873,TAF2,"TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210567009,3,Biomarker
9510,ADAMTS1,"ADAM metallopeptidase with thrombospondin type 1 motif, 1",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,2,Biomarker
972,CD74,"CD74 molecule, major histocompatibility complex, class II invariant chain",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,3,Biomarker
1364,CLDN4,claudin 4,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,2,Biomarker
3456,IFNB1,"interferon, beta 1, fibroblast",0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.210567009,3,"Biomarker, Therapeutic"
5609,MAP2K7,mitogen-activated protein kinase kinase 7,1.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,3,"AlteredExpression, Biomarker"
406913,MIR126,microRNA 126,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,3,Biomarker
406988,MIR205,microRNA 205,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,3,Biomarker
442909,MIR342,microRNA 342,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,3,Biomarker
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.210567009,3,"Biomarker, Therapeutic"
6199,RPS6KB2,"ribosomal protein S6 kinase, 70kDa, polypeptide 2",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,2,Biomarker
6423,SFRP2,secreted frizzled-related protein 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,2,Biomarker
6518,SLC2A5,"solute carrier family 2 (facilitated glucose/fructose transporter), member 5",0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.210567009,2,"Biomarker, Therapeutic"
7480,WNT10B,"wingless-type MMTV integration site family, member 10B",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210567009,2,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,23860,Listeriosis,0.210567009,3,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,149931,Migraine Disorders,0.210567009,3,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,18681,Headache,0.210567009,3,Biomarker
9518,GDF15,growth differentiation factor 15,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210567009,3,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,1.0,0.0,0.0,1.0,18801,Heart Failure,0.210567009,3,"Biomarker, Therapeutic"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210567009,3,Biomarker
84159,ARID5B,AT rich interactive domain 5B (MRF1-like),0.0,1.0,0.0,0.0,0.0,18213,Graves Disease,0.210567009,2,Biomarker
10678,B3GNT2,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2",0.0,1.0,0.0,0.0,0.0,18213,Graves Disease,0.210567009,2,Biomarker
6422,SFRP1,secreted frizzled-related protein 1,0.0,1.0,0.0,0.0,0.0,23267,Leiomyoma,0.210567009,2,Biomarker
26040,SETBP1,SET binding protein 1,0.0,1.0,0.0,0.0,0.0,1292772,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",0.210567009,2,Biomarker
5368,PNOC,prepronociceptin,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.210567009,4,Biomarker
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.210567009,3,Biomarker
57817,HAMP,hepcidin antimicrobial peptide,0.0,1.0,1.0,0.0,0.0,5411,Biliary Atresia,0.210567009,2,"Biomarker, GeneticVariation"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,1.0,242596,"Neoplasm, Residual",0.210567009,3,"Biomarker, Therapeutic"
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,1.0,242596,"Neoplasm, Residual",0.210567009,3,"Biomarker, Therapeutic"
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,1.0,20542,"Hypertension, Pulmonary",0.210567009,3,"Biomarker, Therapeutic"
3357,HTR2B,"5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled",0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.210567009,3,Biomarker
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.210567009,3,Biomarker
56547,MMP26,matrix metallopeptidase 26,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.210567009,2,Biomarker
6010,RHO,rhodopsin,0.0,1.0,0.0,0.0,0.0,311338,Fundus Albipunctatus,0.210567009,2,Biomarker
664,BNIP3,BCL2/adenovirus E1B 19kDa interacting protein 3,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.210567009,2,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,26764,Multiple Myeloma,0.210567009,4,"Biomarker, Therapeutic"
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.210567009,2,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,39101,"Sarcoma, Synovial",0.210567009,3,Biomarker
100188812,RLS3,Restless legs syndrome 3,0.0,1.0,0.0,0.0,0.0,35258,Restless Legs Syndrome,0.210567009,2,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,1824,Agranulocytosis,0.210567009,4,Biomarker
2701,GJA4,"gap junction protein, alpha 4, 37kDa",0.0,1.0,1.0,0.0,0.0,18923,Hemangiosarcoma,0.210567009,3,"Biomarker, GeneticVariation"
3791,KDR,kinase insert domain receptor,0.0,1.0,1.0,0.0,0.0,18923,Hemangiosarcoma,0.210567009,3,"Biomarker, GeneticVariation"
5335,PLCG1,"phospholipase C, gamma 1",0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.210567009,2,Biomarker
4254,KITLG,KIT ligand,0.0,1.0,0.0,0.0,0.0,27430,Nasal Polyps,0.210567009,2,Biomarker
7051,TGM1,transglutaminase 1,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.210567009,2,Biomarker
201163,FLCN,folliculin,0.0,1.0,0.0,0.0,0.0,18552,Hamartoma,0.210567009,3,Biomarker
64778,FNDC3B,fibronectin type III domain containing 3B,0.0,1.0,1.0,0.0,0.0,339573,"Glaucoma, Primary Open Angle",0.210567009,2,"Biomarker, GeneticVariation"
3320,HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",0.0,1.0,0.0,0.0,0.0,206180,"Lymphoma, Large-Cell, Anaplastic",0.210567009,3,Biomarker
4953,ODC1,ornithine decarboxylase 1,0.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.210567009,3,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.210567009,3,Biomarker
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),0.0,1.0,0.0,0.0,0.0,31511,Pheochromocytoma,0.210567009,3,Biomarker
3439,IFNA1,"interferon, alpha 1",0.0,1.0,0.0,0.0,1.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.210567009,3,"Biomarker, Therapeutic"
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.210567009,3,Biomarker
3195,TLX1,T-cell leukemia homeobox 1,0.0,1.0,0.0,0.0,0.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.210567009,3,Biomarker
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,0.0,1.0,1.0,0.0,0.0,20981,Immunoblastic Lymphadenopathy,0.210567009,2,"Biomarker, GeneticVariation"
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210567009,3,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210567009,3,Biomarker
5551,PRF1,perforin 1 (pore forming protein),0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210567009,3,Biomarker
360,AQP3,aquaporin 3 (Gill blood group),0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210567009,2,Biomarker
2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210567009,3,Biomarker
3066,HDAC2,histone deacetylase 2,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210567009,2,Biomarker
3963,LGALS7,"lectin, galactoside-binding, soluble, 7",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210567009,3,Biomarker
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,1861537,Orofacial Cleft 1,0.210567009,2,"Biomarker, GeneticVariation"
57492,ARID1B,AT rich interactive domain 1B (SWI1-like),0.0,1.0,0.0,0.0,0.0,265338,Coffin-Siris syndrome,0.210567009,3,Biomarker
9971,NR1H4,"nuclear receptor subfamily 1, group H, member 4",0.0,1.0,0.0,0.0,0.0,10346,Crohn Disease,0.210567009,3,Biomarker
4018,LPA,"lipoprotein, Lp(a)",0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.210567009,3,Biomarker
2296,FOXC1,forkhead box C1,0.0,1.0,0.0,0.0,0.0,10964,Dandy-Walker Syndrome,0.210567009,2,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.210567009,4,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.210567009,3,Biomarker
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,1.0,0.0,0.0,0.0,271694,"Lipodystrophy, Familial Partial",0.210567009,3,Biomarker
54433,GAR1,GAR1 ribonucleoprotein,0.0,1.0,0.0,0.0,0.0,265965,Dyskeratosis Congenita,0.210567009,3,Biomarker
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",0.0,1.0,0.0,0.0,0.0,948480,Coronary Restenosis,0.210567009,3,Biomarker
2520,GAST,gastrin,0.0,1.0,0.0,0.0,0.0,30920,Peptic Ulcer,0.210567009,3,Biomarker
640,BLK,"BLK proto-oncogene, Src family tyrosine kinase",0.0,1.0,1.0,0.0,0.0,26691,Mucocutaneous Lymph Node Syndrome,0.210567009,2,"Biomarker, GeneticVariation"
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,38454,Stroke,0.210567009,3,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,23903,Liver Neoplasms,0.210567009,3,"Biomarker, Therapeutic"
2272,FHIT,fragile histidine triad,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210567009,3,Biomarker
10468,FST,follistatin,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210567009,2,Biomarker
9970,NR1I3,"nuclear receptor subfamily 1, group I, member 3",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210567009,6,Biomarker
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210567009,3,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,1.0,0.0,23903,Liver Neoplasms,0.210567009,3,"Biomarker, PostTranslationalModification"
467,ATF3,activating transcription factor 3,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.210567009,3,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.210567009,3,Biomarker
718,C3,complement component 3,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.210567009,3,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.210567009,2,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,17185,Gastrointestinal Neoplasms,0.210567009,3,Biomarker
1947,EFNB1,ephrin-B1,0.0,1.0,0.0,0.0,0.0,20534,Hypertelorism,0.210567009,3,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210567009,3,Biomarker
5021,OXTR,oxytocin receptor,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210567009,3,Biomarker
387032,ZKSCAN4,zinc finger with KRAB and SCAN domains 4,0.0,1.0,1.0,0.0,0.0,36341,Schizophrenia,0.210567009,2,"Biomarker, GeneticVariation"
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,30328,"Panniculitis, Nodular Nonsuppurative",0.210567009,3,Biomarker
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,25286,Meningioma,0.210567009,3,Biomarker
6608,SMO,"smoothened, frizzled class receptor",0.0,1.0,1.0,0.0,0.0,25286,Meningioma,0.210567009,2,"Biomarker, GeneticVariation"
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,524909,"Hepatitis B, Chronic",0.210567009,3,Biomarker
22978,NT5C2,"5'-nucleotidase, cytosolic II",0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.210567009,3,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,85207,"Diabetes, Gestational",0.210567009,3,Biomarker
4952,OCRL,oculocerebrorenal syndrome of Lowe,0.0,1.0,0.0,0.0,0.0,1848336,Dent disease 1,0.210567009,2,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.210567009,3,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,1.0,7785,Cerebral Infarction,0.210567009,8,"Biomarker, Therapeutic"
55904,KMT2E,lysine (K)-specific methyltransferase 2E,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210567009,3,Biomarker
8877,SPHK1,sphingosine kinase 1,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210567009,3,Biomarker
7306,TYRP1,tyrosinase-related protein 1,0.0,1.0,1.0,0.0,0.0,342683,Rufous oculocutaneous albinism,0.210567009,3,"Biomarker, GeneticVariation"
7473,WNT3,"wingless-type MMTV integration site family, member 3",0.0,1.0,1.0,0.0,0.0,2931216,Tetra-amelia autosomal recessive,0.210567009,2,"Biomarker, GeneticVariation"
1109,AKR1C4,"aldo-keto reductase family 1, member C4",0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210567009,2,Biomarker
22854,NTNG1,netrin G1,0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210567009,2,Biomarker
84628,NTNG2,netrin G2,0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210567009,2,Biomarker
137682,NDUFAF6,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6",0.0,1.0,0.0,0.0,0.0,23264,Leigh Disease,0.210567009,2,Biomarker
4722,NDUFS3,"NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)",0.0,1.0,0.0,0.0,0.0,23264,Leigh Disease,0.210567009,2,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,2717961,Thrombotic Microangiopathies,0.210567009,3,Biomarker
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210567009,3,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210567009,3,"Biomarker, GeneticVariation"
1964,EIF1AX,"eukaryotic translation initiation factor 1A, X-linked",0.0,1.0,0.0,0.0,0.0,220633,Uveal melanoma,0.210567009,2,Biomarker
604,BCL6,B-cell CLL/lymphoma 6,0.0,1.0,0.0,0.0,0.0,79772,"Lymphoma, T-Cell",0.210567009,3,Biomarker
5610,EIF2AK2,eukaryotic translation initiation factor 2-alpha kinase 2,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.210567009,3,Biomarker
3665,IRF7,interferon regulatory factor 7,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.210567009,3,Biomarker
9636,ISG15,ISG15 ubiquitin-like modifier,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.210567009,3,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,1.0,162557,"Liver Failure, Acute",0.210567009,4,"Biomarker, Therapeutic"
57045,TWSG1,twisted gastrulation BMP signaling modulator 1,0.0,1.0,0.0,0.0,0.0,79541,Holoprosencephaly,0.210567009,3,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.210567009,3,Biomarker
5158,PDE6B,"phosphodiesterase 6B, cGMP-specific, rod, beta",0.0,1.0,1.0,0.0,0.0,339535,"Night blindness, congenital stationary",0.210567009,3,"Biomarker, GeneticVariation"
302,ANXA2,annexin A2,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210567009,3,Biomarker
51510,CHMP5,charged multivesicular body protein 5,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210567009,3,Biomarker
30845,EHD3,EH-domain containing 3,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210567009,2,Biomarker
5457,POU4F1,POU class 4 homeobox 1,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210567009,3,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210567009,3,Biomarker
7249,TSC2,tuberous sclerosis 2,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210567009,3,Biomarker
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,19163,Hepatitis B,0.210567009,3,Biomarker
3816,KLK1,kallikrein 1,0.0,1.0,0.0,0.0,1.0,853897,Diabetic Cardiomyopathies,0.210567009,2,"Biomarker, Therapeutic"
3683,ITGAL,"integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.210567009,3,Biomarker
3687,ITGAX,"integrin, alpha X (complement component 3 receptor 4 subunit)",1.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.210567009,2,"AlteredExpression, Biomarker"
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.210567009,2,Biomarker
23229,ARHGEF9,Cdc42 guanine nucleotide exchange factor (GEF) 9,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.210567009,3,Biomarker
7592,ZNF41,zinc finger protein 41,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.210567009,2,Biomarker
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,1.0,0.0,0.0,38644,Sudden Infant Death,0.210529803,6,"Biomarker, GeneticVariation"
1785,DNM2,dynamin 2,0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.210431741,19,"Biomarker, GeneticVariation"
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,42345,Varicose Veins,0.210283505,2,Biomarker
63895,PIEZO2,piezo-type mechanosensitive ion channel component 2,0.0,1.0,1.0,0.0,0.0,220666,Gordon syndrome,0.210283505,1,"Biomarker, GeneticVariation"
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,1.0,158266,Intervertebral Disc Degeneration,0.210283505,2,"Biomarker, Therapeutic"
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,17178,Gastrointestinal Diseases,0.210283505,2,Biomarker
9254,CACNA2D2,"calcium channel, voltage-dependent, alpha 2/delta subunit 2",0.0,1.0,0.0,0.0,0.0,14553,"Epilepsy, Absence",0.210283505,2,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,22783,Vulvar Lichen Sclerosus,0.210283505,2,Biomarker
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,1.0,0.0,0.0,0.0,282512,Landau-Kleffner Syndrome,0.210283505,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,268318,Intrahepatic Cholestasis of Pregnancy,0.210283505,2,Biomarker
1230,CCR1,chemokine (C-C motif) receptor 1,0.0,1.0,0.0,0.0,0.0,4943,Behcet Syndrome,0.210283505,2,Biomarker
4256,MGP,matrix Gla protein,0.0,1.0,0.0,0.0,0.0,1260873,Aortic Valve Disease,0.210283505,1,Biomarker
7038,TG,thyroglobulin,0.0,1.0,1.0,0.0,0.0,13336,Dwarfism,0.210283505,2,"Biomarker, GeneticVariation"
440275,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,0.0,1.0,0.0,0.0,0.0,34091,Pulmonary Veno-Occlusive Disease,0.210283505,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,35242,Respiratory Tract Diseases,0.210283505,2,Biomarker
25,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.210283505,2,Biomarker
246,ALOX15,arachidonate 15-lipoxygenase,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.210283505,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,14859,Esophageal Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
3958,LGALS3,"lectin, galactoside-binding, soluble, 3",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.210283505,1,Biomarker
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.210283505,2,Biomarker
406937,MIR145,microRNA 145,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.210283505,1,Biomarker
27030,MLH3,mutL homolog 3,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.210283505,1,Biomarker
2810,SFN,stratifin,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.210283505,2,Biomarker
7345,UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase),0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.210283505,2,Biomarker
1482,NKX2-5,NK2 homeobox 5,0.0,0.0,1.0,0.0,0.0,685889,Splenic Hypoplasia,0.210283505,1,GeneticVariation
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.210283505,3,"Biomarker, GeneticVariation"
30009,TBX21,T-box 21,0.0,1.0,1.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.210283505,2,"Biomarker, GeneticVariation"
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,79773,"Lymphoma, T-Cell, Cutaneous",0.210283505,1,Biomarker
3000,GUCY2D,"guanylate cyclase 2D, membrane (retina-specific)",0.0,1.0,0.0,0.0,0.0,1832976,Cone-Rod Dystrophy 5,0.210283505,1,Biomarker
930,CD19,CD19 molecule,0.0,1.0,0.0,0.0,0.0,1768,Agammaglobulinemia,0.210283505,2,Biomarker
973,CD79A,"CD79a molecule, immunoglobulin-associated alpha",0.0,1.0,0.0,0.0,0.0,1768,Agammaglobulinemia,0.210283505,1,Biomarker
3543,IGLL1,immunoglobulin lambda-like polypeptide 1,0.0,1.0,0.0,0.0,0.0,1768,Agammaglobulinemia,0.210283505,1,Biomarker
56262,LRRC8A,"leucine rich repeat containing 8 family, member A",0.0,1.0,0.0,0.0,0.0,1768,Agammaglobulinemia,0.210283505,1,Biomarker
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,Biomarker
701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,Biomarker
1072,CFL1,cofilin 1 (non-muscle),0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,Biomarker
1381,CRABP1,cellular retinoic acid binding protein 1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,1,Biomarker
1387,CREBBP,CREB binding protein,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,Biomarker
55294,FBXW7,"F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,Biomarker
3146,HMGB1,high mobility group box 1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,Biomarker
3880,KRT19,"keratin 19, type I",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,Biomarker
494335,MIR423,microRNA 423,0.0,1.0,1.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,"Biomarker, GeneticVariation"
25816,TNFAIP8,"tumor necrosis factor, alpha-induced protein 8",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,1,Biomarker
7168,TPM1,tropomyosin 1 (alpha),0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,Biomarker
1890,TYMP,thymidine phosphorylase,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.210283505,2,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,0.0,0.0,1.0,26846,Muscular Atrophy,0.210283505,2,"Biomarker, Therapeutic"
10370,CITED2,"Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2",0.0,1.0,0.0,0.0,1.0,26846,Muscular Atrophy,0.210283505,1,"Biomarker, Therapeutic"
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,0.0,0.0,0.0,26846,Muscular Atrophy,0.210283505,2,Biomarker
58484,NLRC4,"NLR family, CARD domain containing 4",0.0,1.0,0.0,0.0,0.0,1096155,Macrophage Activation Syndrome,0.210283505,1,Biomarker
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,1.0,0.0,0.0,0.0,2930896,"Congenital thrombotic disease, due to Protein C deficiency",0.210283505,1,Biomarker
8419,BFSP2,"beaded filament structural protein 2, phakinin",0.0,1.0,0.0,0.0,0.0,1858679,"Cataract, Autosomal Dominant",0.210283505,1,Biomarker
4284,MIP,major intrinsic protein of lens fiber,0.0,1.0,0.0,0.0,0.0,1858679,"Cataract, Autosomal Dominant",0.210283505,1,Biomarker
145270,PRIMA1,proline rich membrane anchor 1,0.0,1.0,0.0,0.0,0.0,26850,Muscular Dystrophies,0.210283505,1,Biomarker
1670,DEFA5,"defensin, alpha 5, Paneth cell-specific",0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.210283505,2,Biomarker
8624,PSMG1,"proteasome (prosome, macropain) assembly chaperone 1",0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.210283505,2,Biomarker
8767,RIPK2,receptor-interacting serine-threonine kinase 2,0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.210283505,1,Biomarker
9049,AIP,aryl hydrocarbon receptor interacting protein,0.0,1.0,0.0,0.0,0.0,1306214,ACTH-Secreting Pituitary Adenoma,0.210283505,1,Biomarker
54806,AHI1,Abelson helper integration site 1,0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.210283505,1,Biomarker
64802,NMNAT1,nicotinamide nucleotide adenylyltransferase 1,0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.210283505,1,Biomarker
84839,RAX2,retina and anterior neural fold homeobox 2,0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.210283505,1,Biomarker
23322,RPGRIP1L,RPGRIP1-like,0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.210283505,1,Biomarker
2165,F13B,"coagulation factor XIII, B polypeptide",0.0,1.0,1.0,0.0,0.0,15530,Factor XIII Deficiency,0.210283505,2,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.210283505,2,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,1.0,0.0,0.0,79731,"Lymphoma, B-Cell",0.210283505,2,"Biomarker, GeneticVariation"
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,1852093,"Maturity-Onset Diabetes of the Young, Type 1",0.210283505,1,Biomarker
4066,LYL1,lymphoblastic leukemia associated hematopoiesis regulator 1,0.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.210283505,1,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.210283505,2,Biomarker
2246,FGF1,fibroblast growth factor 1 (acidic),0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.210283505,2,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.210283505,2,Biomarker
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,40156,Thyrotoxicosis,0.210283505,1,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,35412,Rhabdomyosarcoma,0.210283505,1,Biomarker
5395,PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,35412,Rhabdomyosarcoma,0.210283505,1,Biomarker
5757,PTMA,"prothymosin, alpha",0.0,1.0,0.0,0.0,0.0,35412,Rhabdomyosarcoma,0.210283505,1,Biomarker
26519,TIMM10,translocase of inner mitochondrial membrane 10 homolog (yeast),0.0,1.0,0.0,0.0,0.0,35412,Rhabdomyosarcoma,0.210283505,1,Biomarker
1593,CYP27A1,"cytochrome P450, family 27, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.210283505,1,Biomarker
1958,EGR1,early growth response 1,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.210283505,2,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,1.0,0.0,1.0,8370,Cholestasis,0.210283505,2,"GeneticVariation, Therapeutic"
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,1.0,8370,Cholestasis,0.210283505,2,"Biomarker, Therapeutic"
9963,SLC23A1,"solute carrier family 23 (ascorbic acid transporter), member 1",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.210283505,2,Biomarker
9962,SLC23A2,"solute carrier family 23 (ascorbic acid transporter), member 2",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.210283505,2,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.210283505,3,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,1136321,HIV-Associated Lipodystrophy Syndrome,0.210283505,2,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,25289,Meningitis,0.210283505,2,Biomarker
23691,NNO1,nanophthalmos 1,0.0,1.0,0.0,0.0,0.0,1838502,Nanophthalmos 1,0.210283505,1,Biomarker
785,CACNB4,"calcium channel, voltage-dependent, beta 4 subunit",0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.210283505,1,Biomarker
4864,NPC1,"Niemann-Pick disease, type C1",0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.210283505,2,Biomarker
3309,HSPA5,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",0.0,1.0,0.0,0.0,0.0,1846707,Spinocerebellar Ataxia 17,0.210283505,2,Biomarker
3312,HSPA8,heat shock 70kDa protein 8,0.0,1.0,0.0,0.0,0.0,1846707,Spinocerebellar Ataxia 17,0.210283505,2,Biomarker
492,ATP2B3,"ATPase, Ca++ transporting, plasma membrane 3",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.210283505,1,Biomarker
776,CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.210283505,3,Biomarker
5757,PTMA,"prothymosin, alpha",0.0,1.0,0.0,0.0,1.0,1430,Adenoma,0.210283505,2,"Biomarker, Therapeutic"
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",0.0,1.0,1.0,0.0,0.0,1430,Adenoma,0.210283505,2,"Biomarker, GeneticVariation"
5027,P2RX7,"purinergic receptor P2X, ligand gated ion channel, 7",0.0,1.0,0.0,0.0,0.0,26769,Multiple Sclerosis,0.210283505,2,Biomarker
6775,STAT4,signal transducer and activator of transcription 4,0.0,1.0,0.0,0.0,0.0,26769,Multiple Sclerosis,0.210283505,2,Biomarker
1374,CPT1A,carnitine palmitoyltransferase 1A (liver),0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.210283505,2,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210283505,2,Biomarker
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210283505,2,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,5695,Urinary Bladder Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
4016,LOXL1,lysyl oxidase-like 1,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210283505,1,Biomarker
84171,LOXL4,lysyl oxidase-like 4,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210283505,1,Biomarker
5447,POR,P450 (cytochrome) oxidoreductase,0.0,1.0,1.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210283505,2,"Biomarker, GeneticVariation"
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210283505,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.210283505,2,Biomarker
282617,IFNL3,"interferon, lambda 3",0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.210283505,2,Biomarker
3880,KRT19,"keratin 19, type I",0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.210283505,2,"Biomarker, GeneticVariation"
4319,MMP10,matrix metallopeptidase 10 (stromelysin 2),0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.210283505,1,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.210283505,2,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,1.0,4096,Asthma,0.210283505,2,"Biomarker, Therapeutic"
6701,SPRR2B,small proline-rich protein 2B,0.0,1.0,1.0,0.0,0.0,4096,Asthma,0.210283505,2,"Biomarker, GeneticVariation"
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,1.0,34065,Pulmonary Embolism,0.210283505,10,"Biomarker, Therapeutic"
7056,THBD,thrombomodulin,0.0,1.0,0.0,0.0,0.0,34065,Pulmonary Embolism,0.210283505,2,Biomarker
335,APOA1,apolipoprotein A-I,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.210283505,3,Biomarker
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.210283505,2,Biomarker
79633,FAT4,FAT atypical cadherin 4,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.210283505,1,Biomarker
3958,LGALS3,"lectin, galactoside-binding, soluble, 3",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.210283505,2,Biomarker
4502,MT2A,metallothionein 2A,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.210283505,2,Biomarker
4869,NPM1,"nucleophosmin (nucleolar phosphoprotein B23, numatrin)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.210283505,2,Biomarker
5915,RARB,"retinoic acid receptor, beta",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.210283505,2,Biomarker
84654,SPZ1,spermatogenic leucine zipper 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.210283505,2,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,1.0,38356,Stomach Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
650,BMP2,bone morphogenetic protein 2,0.0,1.0,0.0,0.0,0.0,10278,Craniosynostoses,0.210283505,2,Biomarker
57539,WDR35,WD repeat domain 35,0.0,1.0,0.0,0.0,0.0,10278,Craniosynostoses,0.210283505,2,Biomarker
1816,DRD5,dopamine receptor D5,0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.210283505,2,Biomarker
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.210283505,2,Biomarker
8991,SELENBP1,selenium binding protein 1,0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.210283505,1,Biomarker
6616,SNAP25,"synaptosomal-associated protein, 25kDa",0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.210283505,2,Biomarker
916,CD3E,"CD3e molecule, epsilon (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.210283505,2,Biomarker
4436,MSH2,mutS homolog 2,0.0,1.0,0.0,0.0,0.0,1861975,"Cafe au lait spots, multiple",0.210283505,1,Biomarker
3166,HMX1,H6 family homeobox 1,0.0,1.0,0.0,0.0,0.0,26010,Microphthalmos,0.210283505,2,Biomarker
64802,NMNAT1,nicotinamide nucleotide adenylyltransferase 1,0.0,1.0,0.0,0.0,0.0,29124,Optic Atrophy,0.210283505,1,Biomarker
8837,CFLAR,CASP8 and FADD-like apoptosis regulator,0.0,1.0,0.0,0.0,0.0,1955906,"Lymphoma, Extranodal NK-T-Cell",0.210283505,1,Biomarker
343637,RSPO4,R-spondin 4,0.0,1.0,1.0,0.0,0.0,3277900,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4",0.210283505,2,"Biomarker, GeneticVariation"
306,ANXA3,annexin A3,0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.210283505,1,Biomarker
1445,CSK,c-src tyrosine kinase,0.0,1.0,1.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.210283505,1,"Biomarker, GeneticVariation"
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,242350,Erectile Dysfunction,0.210283505,6,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,242341,Sexual Infantilism,0.210283505,1,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,262584,"Carcinoma, Small Cell",0.210283505,2,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,262584,"Carcinoma, Small Cell",0.210283505,2,Biomarker
7864,SCLC1,small cell cancer of the lung,0.0,1.0,0.0,0.0,0.0,262584,"Carcinoma, Small Cell",0.210283505,1,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,0.0,0.0,1.0,524988,Schnitzler Syndrome,0.210283505,2,"Biomarker, Therapeutic"
1055,CECR,cat eye syndrome chromosome region,0.0,1.0,0.0,0.0,0.0,265493,Schmid-Fraccaro syndrome,0.210283505,2,Biomarker
3242,HPD,4-hydroxyphenylpyruvate dioxygenase,0.0,1.0,0.0,0.0,0.0,268483,Tyrosinemias,0.210283505,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.210283505,2,Biomarker
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,1.0,0.0,0.0,11581,Depressive Disorder,0.210283505,3,"Biomarker, GeneticVariation"
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.210283505,5,Biomarker
158326,FREM1,FRAS1 related extracellular matrix 1,0.0,1.0,0.0,0.0,0.0,221363,Bifid nose,0.210283505,2,Biomarker
9131,AIFM1,"apoptosis-inducing factor, mitochondrion-associated, 1",0.0,1.0,0.0,0.0,0.0,20179,Huntington Disease,0.210283505,2,Biomarker
1827,RCAN1,regulator of calcineurin 1,0.0,1.0,0.0,0.0,0.0,20179,Huntington Disease,0.210283505,1,Biomarker
95,ACY1,aminoacylase 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,2,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,2,Biomarker
10950,BTG3,"BTG family, member 3",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,1,Biomarker
835,CASP2,"caspase 2, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,7134,"Carcinoma, Renal Cell",0.210283505,2,"Biomarker, Therapeutic"
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,2,Biomarker
4771,NF2,neurofibromin 2 (merlin),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,2,Biomarker
5058,PAK1,p21 protein (Cdc42/Rac)-activated kinase 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,2,Biomarker
11236,RNF139,ring finger protein 139,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,1,Biomarker
54790,TET2,tet methylcytosine dioxygenase 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,2,Biomarker
8633,UNC5C,unc-5 homolog C (C. elegans),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.210283505,1,Biomarker
114293,ANBC,Aneurysmal bone cysts,0.0,1.0,0.0,0.0,0.0,152244,"Bone Cysts, Aneurysmal",0.210283505,1,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,2793,Anaplasia,0.210283505,2,Biomarker
3417,IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",0.0,1.0,0.0,0.0,0.0,936248,Chondroma,0.210283505,2,Biomarker
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,0.0,0.0,0.0,936248,Chondroma,0.210283505,2,Biomarker
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,0.0,1.0,0.0,0.0,1.0,7786,Brain Ischemia,0.210283505,2,"Biomarker, Therapeutic"
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.210283505,2,Biomarker
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.210283505,2,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.210283505,2,Biomarker
2539,G6PD,glucose-6-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,18203,"Granulomatous Disease, Chronic",0.210283505,2,Biomarker
3269,HRH1,histamine receptor H1,0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.210283505,2,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.210283505,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,948089,Acute Coronary Syndrome,0.210283505,2,"Biomarker, GeneticVariation"
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,29434,Osteogenesis Imperfecta,0.210283505,2,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.210283505,2,"Biomarker, GeneticVariation"
1558,CYP2C8,"cytochrome P450, family 2, subfamily C, polypeptide 8",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210283505,1,Biomarker
406967,MIR192,microRNA 192,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210283505,2,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,1.0,22658,Kidney Diseases,0.210283505,2,"Biomarker, Therapeutic"
4867,NPHP1,nephronophthisis 1 (juvenile),0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210283505,2,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210283505,2,Biomarker
23322,RPGRIP1L,RPGRIP1-like,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210283505,2,Biomarker
9899,SV2B,synaptic vesicle glycoprotein 2B,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210283505,1,Biomarker
79809,TTC21B,tetratricopeptide repeat domain 21B,0.0,1.0,1.0,0.0,0.0,22658,Kidney Diseases,0.210283505,2,"Biomarker, GeneticVariation"
65125,WNK1,WNK lysine deficient protein kinase 1,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.210283505,2,Biomarker
8081,AD5,Alzheimer disease 5,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.210283505,1,Biomarker
801,CALM1,"calmodulin 1 (phosphorylase kinase, delta)",0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.210283505,2,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,1.0,2395,Alzheimer Disease,0.210283505,2,"Biomarker, Therapeutic"
22976,PAXIP1,PAX interacting (with transcription-activation domain) protein 1,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.210283505,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,42749,Viremia,0.210283505,2,"Biomarker, Therapeutic"
10225,CD96,CD96 molecule,0.0,1.0,1.0,0.0,0.0,796232,Bohring syndrome,0.210283505,1,"Biomarker, GeneticVariation"
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,0.0,206624,Hepatoblastoma,0.210283505,2,Biomarker
4001,LMNB1,lamin B1,0.0,1.0,0.0,0.0,0.0,205711,Pelizaeus-Merzbacher Disease,0.210283505,1,Biomarker
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,0.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.210283505,2,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,1.0,16667,Fragile X Syndrome,0.210283505,2,"Biomarker, Therapeutic"
1605,DAG1,dystroglycan 1 (dystrophin-associated glycoprotein 1),0.0,1.0,0.0,0.0,0.0,23092,Lassa Fever,0.210283505,2,Biomarker
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,684337,"Neuroectodermal Tumors, Primitive, Peripheral",0.210283505,2,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,28756,"Obesity, Morbid",0.210283505,2,"Biomarker, GeneticVariation"
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,524910,"Hepatitis C, Chronic",0.210283505,2,Biomarker
2326,FMO1,flavin containing monooxygenase 1,0.0,1.0,0.0,0.0,0.0,1862941,"Amyotrophic Lateral Sclerosis, Sporadic",0.210283505,1,Biomarker
885,CCK,cholecystokinin,0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.210283505,3,Biomarker
72,ACTG2,"actin, gamma 2, smooth muscle, enteric",0.0,1.0,1.0,0.0,0.0,266833,"Visceral Myopathy, Familial",0.210283505,1,"Biomarker, GeneticVariation"
134,ADORA1,adenosine A1 receptor,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.210283505,2,Biomarker
140,ADORA3,adenosine A3 receptor,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.210283505,2,Biomarker
968,CD68,CD68 molecule,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.210283505,2,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.210283505,3,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.210283505,2,Biomarker
55651,NHP2,NHP2 ribonucleoprotein,0.0,1.0,0.0,0.0,0.0,3502105,"Dyskeratosis Congenita, Autosomal Recessive",0.210283505,1,Biomarker
55505,NOP10,NOP10 ribonucleoprotein,0.0,1.0,0.0,0.0,0.0,3502105,"Dyskeratosis Congenita, Autosomal Recessive",0.210283505,1,Biomarker
1592,CYP26A1,"cytochrome P450, family 26, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,32580,Adenomatous Polyposis Coli,0.210283505,1,Biomarker
64333,ARHGAP9,Rho GTPase activating protein 9,0.0,1.0,1.0,0.0,0.0,10073,Coronary Vasospasm,0.210283505,1,"Biomarker, GeneticVariation"
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,243026,Sepsis,0.210283505,2,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,243026,Sepsis,0.210283505,2,Biomarker
7471,WNT1,"wingless-type MMTV integration site family, member 1",0.0,1.0,1.0,0.0,0.0,29456,Osteoporosis,0.210283505,1,"Biomarker, GeneticVariation"
302,ANXA2,annexin A2,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.210283505,2,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.210283505,2,Biomarker
5034,P4HB,"prolyl 4-hydroxylase, beta polypeptide",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.210283505,2,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.210283505,1,Biomarker
54503,ZDHHC13,"zinc finger, DHHC-type containing 13",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.210283505,2,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.210283505,2,Biomarker
2555,GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.210283505,2,Biomarker
2918,GRM8,"glutamate receptor, metabotropic 8",0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.210283505,1,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.210283505,2,Biomarker
50944,SHANK1,SH3 and multiple ankyrin repeat domains 1,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.210283505,2,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,19061,Hemolytic-Uremic Syndrome,0.210283505,2,Biomarker
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,1.0,0.0,0.0,36631,Seminoma,0.210283505,1,"Biomarker, GeneticVariation"
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,36631,Seminoma,0.210283505,1,"Biomarker, GeneticVariation"
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,1.0,0.0,0.0,0.0,949595,"Gonadal Dysgenesis, 46,XX",0.210283505,2,Biomarker
339453,TMEM240,transmembrane protein 240,0.0,1.0,1.0,0.0,0.0,1843891,Spinocerebellar ataxia 21,0.210283505,1,"Biomarker, GeneticVariation"
6905,TBCE,tubulin folding cofactor E,0.0,1.0,0.0,0.0,0.0,1855648,"Kenny-Caffey syndrome, Type 1",0.210283505,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,339143,Graves Ophthalmopathy,0.210283505,2,Biomarker
116519,APOA5,apolipoprotein A-V,0.0,1.0,0.0,0.0,0.0,20480,Hyperlipoproteinemia Type IV,0.210283505,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.210283505,2,Biomarker
10367,MICU1,mitochondrial calcium uptake 1,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.210283505,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.210283505,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.210283505,2,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.210283505,2,Biomarker
203286,ANKS6,ankyrin repeat and sterile alpha motif domain containing 6,0.0,1.0,0.0,0.0,0.0,37221,Situs Inversus,0.210283505,1,Biomarker
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),0.0,1.0,0.0,0.0,0.0,79294,Epidermolysis Bullosa Dystrophica,0.210283505,1,Biomarker
6832,SUPV3L1,"suppressor of var1, 3-like 1 (S. cerevisiae)",0.0,1.0,0.0,0.0,0.0,20757,Ichthyosis,0.210283505,1,Biomarker
2271,FH,fumarate hydratase,0.0,1.0,0.0,0.0,0.0,2936826,Fumaric aciduria,0.210283505,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,2931456,"Prostate cancer, familial",0.210283505,2,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.210283505,2,Biomarker
1889,ECE1,endothelin converting enzyme 1,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.210283505,2,Biomarker
1909,EDNRA,endothelin receptor type A,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.210283505,2,Biomarker
2767,GNA11,"guanine nucleotide binding protein (G protein), alpha 11 (Gq class)",0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.210283505,2,Biomarker
3200,HOXA3,homeobox A3,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.210283505,2,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.210283505,2,Biomarker
9839,ZEB2,zinc finger E-box binding homeobox 2,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.210283505,2,Biomarker
64240,ABCG5,"ATP-binding cassette, sub-family G (WHITE), member 5",0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.210283505,3,Biomarker
325,APCS,"amyloid P component, serum",0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.210283505,2,Biomarker
9518,GDF15,growth differentiation factor 15,0.0,1.0,1.0,0.0,0.0,1956346,Coronary Artery Disease,0.210283505,2,"Biomarker, GeneticVariation"
3654,IRAK1,interleukin-1 receptor-associated kinase 1,0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.210283505,2,Biomarker
10221,TRIB1,tribbles pseudokinase 1,0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.210283505,2,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,0.0,162770,"Hypertrophy, Right Ventricular",0.210283505,2,Biomarker
4208,MEF2C,myocyte enhancer factor 2C,0.0,1.0,1.0,0.0,0.0,38273,Stereotypic Movement Disorder,0.210283505,2,"Biomarker, GeneticVariation"
5883,RAD9A,RAD9 homolog A (S. pombe),0.0,1.0,0.0,0.0,0.0,85183,"Neoplasms, Second Primary",0.210283505,1,Biomarker
780922,SPD3,Synpolydactyly 3,0.0,1.0,0.0,0.0,0.0,1853255,Synpolydactyly 3,0.210283505,1,Biomarker
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,17601,Glaucoma,0.210283505,1,Biomarker
4638,MYLK,myosin light chain kinase,0.0,1.0,0.0,0.0,0.0,17601,Glaucoma,0.210283505,1,Biomarker
8671,SLC4A4,"solute carrier family 4 (sodium bicarbonate cotransporter), member 4",0.0,1.0,0.0,0.0,0.0,17601,Glaucoma,0.210283505,2,Biomarker
23424,TDRD7,tudor domain containing 7,0.0,1.0,0.0,0.0,0.0,17601,Glaucoma,0.210283505,1,Biomarker
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,1.0,0.0,0.0,0.0,37052,Sick Sinus Syndrome,0.210283505,1,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,19196,Hepatitis C,0.210283505,2,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,2453,Amenorrhea,0.210283505,2,Biomarker
11151,CORO1A,"coronin, actin binding protein, 1A",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
2202,EFEMP1,EGF containing fibulin-like extracellular matrix protein 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
5045,FURIN,furin (paired basic amino acid cleaving enzyme),0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,3,Biomarker
3572,IL6ST,interleukin 6 signal transducer,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
4254,KITLG,KIT ligand,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
4023,LPL,lipoprotein lipase,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
4692,NDN,"necdin, melanoma antigen (MAGE) family member",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
23569,PADI4,"peptidyl arginine deiminase, type IV",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
10769,PLK2,polo-like kinase 2,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
5725,PTBP1,polypyrimidine tract binding protein 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
6319,SCD,stearoyl-CoA desaturase (delta-9-desaturase),0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,3,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,3,Biomarker
6446,SGK1,serum/glucocorticoid regulated kinase 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
7091,TLE4,transducin-like enhancer of split 4,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
9540,TP53I3,tumor protein p53 inducible protein 3,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
7227,TRPS1,trichorhinophalangeal syndrome I,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.210283505,2,Biomarker
64644,GINGF2,"gingival fibromatosis, hereditary, 2",0.0,1.0,0.0,0.0,0.0,399440,"Fibromatosis, Gingival, Type 1",0.210283505,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210283505,3,Biomarker
8514,KCNAB2,"potassium channel, voltage gated subfamily A regulatory beta subunit 2",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210283505,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,1.0,14544,Epilepsy,0.210283505,1,"Biomarker, Therapeutic"
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210283505,2,Biomarker
6507,SLC1A3,"solute carrier family 1 (glial high affinity glutamate transporter), member 3",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210283505,2,Biomarker
112755,STX1B,syntaxin 1B,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210283505,1,Biomarker
7296,TXNRD1,thioredoxin reductase 1,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.210283505,2,Biomarker
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,1.0,0.0,0.0,0.0,2171,Alopecia Areata,0.210283505,2,Biomarker
4283,CXCL9,chemokine (C-X-C motif) ligand 9,0.0,1.0,0.0,0.0,0.0,2171,Alopecia Areata,0.210283505,2,Biomarker
10243,GPHN,gephyrin,0.0,1.0,0.0,0.0,0.0,268119,Molybdenum cofactor deficiency,0.210283505,1,Biomarker
4338,MOCS2,molybdenum cofactor synthesis 2,0.0,1.0,1.0,0.0,0.0,268119,Molybdenum cofactor deficiency,0.210283505,1,"Biomarker, GeneticVariation"
374,AREG,amphiregulin,0.0,1.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
10395,DLC1,DLC1 Rho GTPase activating protein,0.0,1.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
2194,FASN,fatty acid synthase,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.210283505,2,Biomarker
4831,NME2,NME/NM23 nucleoside diphosphate kinase 2,0.0,1.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.210283505,1,Biomarker
5889,RAD51C,RAD51 paralog C,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.210283505,2,Biomarker
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",0.0,1.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
6597,SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.210283505,3,Biomarker
23213,SULF1,sulfatase 1,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.210283505,1,Biomarker
156,ADRBK1,"adrenergic, beta, receptor kinase 1",0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,1,Biomarker
6355,CCL8,chemokine (C-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,2,Biomarker
160364,CLEC12A,"C-type lectin domain family 12, member A",0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,2,Biomarker
1509,CTSD,cathepsin D,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,2,Biomarker
2289,FKBP5,FK506 binding protein 5,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,2,Biomarker
2870,GRK6,G protein-coupled receptor kinase 6,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,1,Biomarker
3239,HOXD13,homeobox D13,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,2,Biomarker
22806,IKZF3,IKAROS family zinc finger 3 (Aiolos),0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,2,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,2,Biomarker
81567,TXNDC5,thioredoxin domain containing 5 (endoplasmic reticulum),0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.210283505,2,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,4936,Mental Disorders,0.210283505,2,Biomarker
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",0.0,1.0,1.0,0.0,0.0,1832466,CAPOS syndrome,0.210283505,1,"Biomarker, GeneticVariation"
60502,CPAT1,"cerebral palsy, ataxic 1",0.0,1.0,0.0,0.0,0.0,3496054,"Cerebral Palsy, Ataxic, Autosomal Recessive",0.210283505,1,Biomarker
11231,SEC63,SEC63 homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,22680,Polycystic Kidney Diseases,0.210283505,2,Biomarker
3090,HIC1,hypermethylated in cancer 1,0.0,1.0,0.0,0.0,0.0,32584,Polyps,0.210283505,1,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,1271219,Ectopia pupillae,0.210283505,1,Biomarker
5000,ORC4,"origin recognition complex, subunit 4",0.0,1.0,0.0,0.0,0.0,1868684,Meier-Gorlin syndrome,0.210283505,2,Biomarker
5604,MAP2K1,mitogen-activated protein kinase kinase 1,0.0,1.0,0.0,0.0,0.0,23443,"Leukemia, Hairy Cell",0.210283505,1,Biomarker
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,10276,Craniopharyngioma,0.210283505,1,"Biomarker, GeneticVariation"
114798,SLITRK1,"SLIT and NTRK-like family, member 1",0.0,1.0,0.0,0.0,0.0,40953,Trichotillomania,0.210283505,1,Biomarker
26040,SETBP1,SET binding protein 1,0.0,1.0,1.0,0.0,0.0,3463824,MYELODYSPLASTIC SYNDROME,0.210283505,1,"Biomarker, GeneticVariation"
100188340,AOS,Adams-Oliver syndrome,0.0,1.0,0.0,0.0,0.0,265268,Adams Oliver syndrome,0.210283505,1,Biomarker
114568,NMTC1,Nonmedullary thyroid carcinoma 1,0.0,1.0,0.0,0.0,0.0,1853488,"Thyroid Carcinoma, Nonmedullary 1",0.210283505,1,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.210283505,2,"Biomarker, GeneticVariation"
161582,DYX1C1,dyslexia susceptibility 1 candidate 1,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.210283505,1,Biomarker
2879,GPX4,glutathione peroxidase 4,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.210283505,3,Biomarker
4193,MDM2,"MDM2 proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.210283505,1,"Biomarker, GeneticVariation"
339345,NANOS2,nanos homolog 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.210283505,2,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,1.0,0.0,0.0,21364,"Infertility, Male",0.210283505,1,"Biomarker, GeneticVariation"
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,1.0,0.0,0.0,18916,Hemangioma,0.210283505,1,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,18916,Hemangioma,0.210283505,2,Biomarker
8837,CFLAR,CASP8 and FADD-like apoptosis regulator,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.210283505,2,Biomarker
1616,DAXX,death-domain associated protein,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.210283505,2,Biomarker
4072,EPCAM,epithelial cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.210283505,2,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
4792,NFKBIA,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",0.0,1.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.210283505,2,Biomarker
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
6387,CXCL12,chemokine (C-X-C motif) ligand 12,0.0,1.0,0.0,0.0,0.0,266929,Chronic Periodontitis,0.210283505,2,Biomarker
23098,SARM1,sterile alpha and TIR motif containing 1,0.0,1.0,0.0,0.0,0.0,35235,Respiratory Syncytial Virus Infections,0.210283505,1,Biomarker
148022,TICAM1,toll-like receptor adaptor molecule 1,0.0,1.0,0.0,0.0,0.0,35235,Respiratory Syncytial Virus Infections,0.210283505,1,Biomarker
9895,TECPR2,tectonin beta-propeller repeat containing 2,0.0,1.0,0.0,0.0,0.0,37771,"Paraparesis, Spastic",0.210283505,1,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,34067,Pulmonary Emphysema,0.210283505,1,Biomarker
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,0.0,0.0,1.0,12739,Disseminated Intravascular Coagulation,0.210283505,4,"Biomarker, Therapeutic"
391051,UOX,"urate oxidase, pseudogene",0.0,1.0,0.0,0.0,1.0,41364,Tumor Lysis Syndrome,0.210283505,2,"Biomarker, Therapeutic"
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,1.0,13404,Dyspnea,0.210283505,2,"Biomarker, Therapeutic"
2703,GJA8,"gap junction protein, alpha 8, 50kDa",0.0,1.0,0.0,0.0,0.0,1861829,Cataract microcornea syndrome,0.210283505,2,Biomarker
57016,AKR1B10,"aldo-keto reductase family 1, member B10 (aldose reductase)",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,2,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,1,Biomarker
652,BMP4,bone morphogenetic protein 4,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,2,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,2,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,1.0,9404,Colorectal Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
1719,DHFR,dihydrofolate reductase,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,2,Biomarker
26585,GREM1,"gremlin 1, DAN family BMP antagonist",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,2,Biomarker
5424,POLD1,"polymerase (DNA directed), delta 1, catalytic subunit",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,2,Biomarker
8741,TNFSF13,"tumor necrosis factor (ligand) superfamily, member 13",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,2,Biomarker
11197,WIF1,WNT inhibitory factor 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,2,Biomarker
148266,ZNF569,zinc finger protein 569,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.210283505,2,Biomarker
2641,GCG,glucagon,0.0,1.0,0.0,0.0,1.0,9319,Colitis,0.210283505,2,"Biomarker, Therapeutic"
3726,JUNB,jun B proto-oncogene,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.210283505,2,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,38525,Subarachnoid Hemorrhage,0.210283505,2,Biomarker
389036,ACT,actin-like protein (ACT) gene,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
246,ALOX15,arachidonate 15-lipoxygenase,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
492,ATP2B3,"ATPase, Ca++ transporting, plasma membrane 3",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
1490,CTGF,connective tissue growth factor,0.0,1.0,1.0,0.0,0.0,20538,Hypertension,0.210283505,2,"Biomarker, GeneticVariation"
2641,GCG,glucagon,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
3357,HTR2B,"5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,3,Biomarker
8870,IER3,immediate early response 3,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
84876,ORAI1,ORAI calcium release-activated calcium modulator 1,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
7222,TRPC3,"transient receptor potential cation channel, subfamily C, member 3",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
7224,TRPC5,"transient receptor potential cation channel, subfamily C, member 5",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.210283505,2,Biomarker
7349,UCN,urocortin,0.0,1.0,0.0,0.0,1.0,20538,Hypertension,0.210283505,2,"Biomarker, Therapeutic"
5424,POLD1,"polymerase (DNA directed), delta 1, catalytic subunit",0.0,1.0,0.0,0.0,0.0,23787,Lipodystrophy,0.210283505,1,Biomarker
135656,DPCR1,diffuse panbronchiolitis critical region 1,0.0,1.0,0.0,0.0,0.0,878555,Diffuse panbronchiolitis,0.210283505,2,Biomarker
846,CASR,calcium-sensing receptor,0.0,0.0,1.0,0.0,0.0,3715128,"HYPOCALCEMIA, AUTOSOMAL DOMINANT 1",0.210283505,1,GeneticVariation
8830,PTLAH,patella aplasia-hypoplasia,0.0,1.0,0.0,0.0,0.0,1868577,Absent patella,0.210283505,1,Biomarker
25,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.210283505,2,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.210283505,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.210283505,6,Biomarker
8942,KYNU,kynureninase,0.0,1.0,0.0,0.0,0.0,268474,Hydroxykynureninuria,0.210283505,1,Biomarker
23493,HEY2,hes-related family bHLH transcription factor with YRPW motif 2,0.0,1.0,0.0,0.0,0.0,1142166,Brugada Syndrome,0.210283505,1,Biomarker
55572,FOXRED1,FAD-dependent oxidoreductase domain containing 1,0.0,1.0,1.0,0.0,0.0,751651,Mitochondrial Diseases,0.210283505,2,"Biomarker, GeneticVariation"
92667,MGME1,mitochondrial genome maintenance exonuclease 1,0.0,1.0,0.0,0.0,0.0,751651,Mitochondrial Diseases,0.210283505,1,Biomarker
80224,NUBPL,nucleotide binding protein-like,0.0,1.0,0.0,0.0,0.0,751651,Mitochondrial Diseases,0.210283505,2,Biomarker
6341,SCO1,SCO1 cytochrome c oxidase assembly protein,0.0,1.0,0.0,0.0,0.0,751651,Mitochondrial Diseases,0.210283505,2,Biomarker
7036,TFR2,transferrin receptor 2,0.0,1.0,0.0,0.0,0.0,5283,beta-Thalassemia,0.210283505,1,Biomarker
5277,PIGA,"phosphatidylinositol glycan anchor biosynthesis, class A",0.0,1.0,0.0,0.0,0.0,1853205,Glycosylphosphatidylinositol deficiency,0.210283505,2,Biomarker
6497,SKI,SKI proto-oncogene,0.0,1.0,0.0,0.0,0.0,3486,Aortic Aneurysm,0.210283505,1,Biomarker
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,0.0,0.0,0.0,1852197,Major Affective Disorder 1,0.210283505,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,3864,Arthritis,0.210283505,2,Biomarker
4594,MUT,methylmalonyl CoA mutase,0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.210283505,2,Biomarker
10568,SLC34A2,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 2",0.0,1.0,0.0,0.0,0.0,1864873,Testicular Microlithiasis,0.210283505,1,Biomarker
1910,EDNRB,endothelin receptor type B,0.0,1.0,0.0,0.0,0.0,1838099,ABCD syndrome,0.210283505,1,Biomarker
55670,PEX26,peroxisomal biogenesis factor 26,0.0,1.0,0.0,0.0,0.0,282527,"Refsum Disease, Infantile",0.210283505,2,Biomarker
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,0.0,0.0,0.0,14084,Enchondromatosis,0.210283505,2,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,1.0,42373,Vascular Diseases,0.210283505,2,"Biomarker, Therapeutic"
5311,PKD2,polycystic kidney disease 2 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,42373,Vascular Diseases,0.210283505,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,42373,Vascular Diseases,0.210283505,2,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,24305,"Lymphoma, Non-Hodgkin",0.210283505,2,"Biomarker, Therapeutic"
873,CBR1,carbonyl reductase 1,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.210283505,2,"Biomarker, GeneticVariation"
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.210283505,2,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.210283505,2,"Biomarker, Therapeutic"
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.210283505,3,Biomarker
5563,PRKAA2,"protein kinase, AMP-activated, alpha 2 catalytic subunit",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.210283505,2,Biomarker
54968,TMEM70,transmembrane protein 70,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.210283505,2,Biomarker
2548,GAA,"glucosidase, alpha; acid",0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.210283505,2,Biomarker
9429,ABCG2,"ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)",0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.210283505,1,Biomarker
4849,CNOT3,"CCR4-NOT transcription complex, subunit 3",0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.210283505,1,Biomarker
6134,RPL10,ribosomal protein L10,0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.210283505,1,Biomarker
6125,RPL5,ribosomal protein L5,0.0,1.0,0.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.210283505,1,Biomarker
1749,DLX5,distal-less homeobox 5,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,4,Biomarker
1750,DLX6,distal-less homeobox 6,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,2,Biomarker
2138,EYA1,EYA transcriptional coactivator and phosphatase 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,1,Biomarker
9569,GTF2IRD1,GTF2I repeat domain containing 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,1,Biomarker
3339,HSPG2,heparan sulfate proteoglycan 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,1,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,2,Biomarker
4488,MSX2,msh homeobox 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,2,Biomarker
860,RUNX2,runt-related transcription factor 2,0.0,1.0,1.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,2,"Biomarker, GeneticVariation"
6662,SOX9,SRY (sex determining region Y)-box 9,0.0,1.0,1.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,2,"Biomarker, GeneticVariation"
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,2,Biomarker
7227,TRPS1,trichorhinophalangeal syndrome I,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,2,Biomarker
30813,VSX1,visual system homeobox 1,0.0,1.0,1.0,0.0,0.0,376634,Craniofacial Abnormalities,0.210283505,1,"Biomarker, GeneticVariation"
2,A2M,alpha-2-macroglobulin,0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.210283505,2,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.210283505,2,Biomarker
659,BMPR2,"bone morphogenetic protein receptor, type II (serine/threonine kinase)",0.0,1.0,0.0,0.0,0.0,206081,Hyperandrogenism,0.210283505,1,Biomarker
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,1.0,0.0,0.0,0.0,32768,"Neuralgia, Postherpetic",0.210283505,1,Biomarker
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,1.0,0.0,0.0,0.0,32768,"Neuralgia, Postherpetic",0.210283505,1,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.210283505,2,Biomarker
2067,ERCC1,excision repair cross-complementation group 1,0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.210283505,2,Biomarker
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.210283505,1,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.210283505,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.210283505,1,Biomarker
64240,ABCG5,"ATP-binding cassette, sub-family G (WHITE), member 5",0.0,1.0,0.0,0.0,0.0,43325,Xanthomatosis,0.210283505,2,Biomarker
3764,KCNJ8,"potassium channel, inwardly rectifying subfamily J, member 8",0.0,1.0,1.0,0.0,0.0,38644,Sudden Infant Death,0.210283505,1,"Biomarker, GeneticVariation"
6342,SCP2,sterol carrier protein 2,0.0,1.0,0.0,0.0,0.0,13421,Dystonia,0.210283505,1,Biomarker
84947,SERAC1,serine active site containing 1,0.0,1.0,0.0,0.0,0.0,13421,Dystonia,0.210283505,1,Biomarker
2161,F12,coagulation factor XII (Hageman factor),0.0,1.0,0.0,0.0,0.0,40038,Thromboembolism,0.210283505,2,Biomarker
2621,GAS6,growth arrest-specific 6,0.0,1.0,0.0,0.0,0.0,40038,Thromboembolism,0.210283505,1,Biomarker
5627,PROS1,protein S (alpha),0.0,1.0,0.0,0.0,0.0,40038,Thromboembolism,0.210283505,2,Biomarker
7051,TGM1,transglutaminase 1,0.0,1.0,0.0,0.0,0.0,13238,Dry Eye Syndromes,0.210283505,2,Biomarker
975,CD81,CD81 molecule,0.0,1.0,0.0,0.0,0.0,9447,Common Variable Immunodeficiency,0.210283505,1,Biomarker
931,MS4A1,"membrane-spanning 4-domains, subfamily A, member 1",0.0,1.0,0.0,0.0,0.0,9447,Common Variable Immunodeficiency,0.210283505,1,Biomarker
57369,GJD2,"gap junction protein, delta 2, 36kDa",0.0,1.0,1.0,0.0,0.0,34951,Refractive Errors,0.210283505,2,"Biomarker, GeneticVariation"
7227,TRPS1,trichorhinophalangeal syndrome I,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.210283505,2,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,19112,Hemorrhoids,0.210283505,1,Biomarker
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,18834,Heartburn,0.210283505,2,Biomarker
799,CALCR,calcitonin receptor,0.0,1.0,0.0,0.0,1.0,20437,Hypercalcemia,0.210283505,2,"Biomarker, Therapeutic"
83844,USP26,ubiquitin specific peptidase 26,0.0,1.0,0.0,0.0,0.0,1384583,Sertoli Cell-Only Syndrome,0.210283505,1,Biomarker
57716,PRX,periaxin,0.0,1.0,1.0,0.0,0.0,27888,Hereditary Sensory and Motor Neuropathy,0.210283505,1,"Biomarker, GeneticVariation"
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.210283505,2,Biomarker
968,CD68,CD68 molecule,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.210283505,1,Biomarker
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.210283505,1,Biomarker
50507,NOX4,NADPH oxidase 4,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.210283505,2,Biomarker
5076,PAX2,paired box 2,0.0,1.0,1.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.210283505,2,"Biomarker, GeneticVariation"
929,CD14,CD14 molecule,0.0,1.0,0.0,0.0,0.0,11991,Diarrhea,0.210283505,2,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,0.0,0.0,1.0,11991,Diarrhea,0.210283505,2,"Biomarker, Therapeutic"
4645,MYO5B,myosin VB,0.0,1.0,0.0,0.0,0.0,11991,Diarrhea,0.210283505,2,Biomarker
5697,PYY,peptide YY,0.0,1.0,0.0,0.0,1.0,11991,Diarrhea,0.210283505,2,"Biomarker, Therapeutic"
1969,EPHA2,EPH receptor A2,0.0,1.0,0.0,0.0,0.0,175704,LEOPARD Syndrome,0.210283505,2,Biomarker
573,BAG1,BCL2-associated athanogene,0.0,1.0,0.0,0.0,0.0,1134719,"Carcinoma, Ductal, Breast",0.210283505,1,Biomarker
5268,SERPINB5,"serpin peptidase inhibitor, clade B (ovalbumin), member 5",0.0,1.0,0.0,0.0,0.0,1134719,"Carcinoma, Ductal, Breast",0.210283505,2,Biomarker
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,0.0,0.0,0.0,282612,Prostatic Intraepithelial Neoplasia,0.210283505,2,Biomarker
5376,PMP22,peripheral myelin protein 22,0.0,1.0,0.0,0.0,0.0,30554,Paresthesia,0.210283505,2,Biomarker
64135,IFIH1,interferon induced with helicase C domain 1,0.0,1.0,0.0,0.0,0.0,796126,Aicardi-Goutieres syndrome,0.210283505,2,Biomarker
2737,GLI3,GLI family zinc finger 3,0.0,1.0,0.0,0.0,0.0,162835,Hypopigmentation,0.210283505,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,1.0,41341,Tuberous Sclerosis,0.210283505,2,"Biomarker, Therapeutic"
2717,GLA,"galactosidase, alpha",0.0,1.0,0.0,0.0,1.0,2985,Angiokeratoma,0.210283505,2,"Biomarker, Therapeutic"
3858,KRT10,"keratin 10, type I",0.0,1.0,0.0,0.0,0.0,3665704,Congenital reticular ichthyosiform erythroderma,0.210283505,1,Biomarker
384,ARG2,arginase 2,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.210283505,1,Biomarker
4854,NOTCH3,notch 3,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.210283505,2,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.210283505,2,Biomarker
567,B2M,beta-2-microglobulin,0.0,1.0,0.0,0.0,1.0,4364,Autoimmune Diseases,0.210283505,2,"Biomarker, Therapeutic"
2157,F8,"coagulation factor VIII, procoagulant component",0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.210283505,2,Biomarker
2091,FBL,fibrillarin,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.210283505,4,Biomarker
5949,RBP3,"retinol binding protein 3, interstitial",0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.210283505,3,Biomarker
7293,TNFRSF4,"tumor necrosis factor receptor superfamily, member 4",0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.210283505,2,Biomarker
785,CACNB4,"calcium channel, voltage-dependent, beta 4 subunit",0.0,1.0,0.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.210283505,1,Biomarker
846,CASR,calcium-sensing receptor,0.0,1.0,1.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.210283505,1,"Biomarker, GeneticVariation"
10321,CRISP3,cysteine-rich secretory protein 3,0.0,1.0,0.0,0.0,0.0,32987,"Pregnancy, Ectopic",0.210283505,1,Biomarker
8081,AD5,Alzheimer disease 5,0.0,1.0,0.0,0.0,0.0,1865868,Alzheimer Disease 5,0.210283505,1,Biomarker
10683,DLL3,delta-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,36439,Scoliosis,0.210283505,2,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.210283505,2,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.210283505,2,Biomarker
5566,PRKACA,"protein kinase, cAMP-dependent, catalytic, alpha",0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.210283505,2,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,22353,"Jaundice, Neonatal",0.210283505,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,22672,"Kidney Tubular Necrosis, Acute",0.210283505,2,Biomarker
785,CACNB4,"calcium channel, voltage-dependent, beta 4 subunit",0.0,1.0,1.0,0.0,0.0,270853,"Myoclonic Epilepsy, Juvenile",0.210283505,2,"Biomarker, GeneticVariation"
4867,NPHP1,nephronophthisis 1 (juvenile),0.0,1.0,0.0,0.0,0.0,403553,Senior Loken Syndrome,0.210283505,1,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,0.0,0.0,1.0,24299,Lymphoma,0.210283505,2,"Biomarker, Therapeutic"
5880,RAC2,"ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)",0.0,1.0,0.0,0.0,0.0,24299,Lymphoma,0.210283505,2,Biomarker
1282,COL4A1,"collagen, type IV, alpha 1",0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.210283505,2,Biomarker
2621,GAS6,growth arrest-specific 6,0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.210283505,2,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.210283505,2,Biomarker
3816,KLK1,kallikrein 1,0.0,1.0,0.0,0.0,1.0,11881,Diabetic Nephropathies,0.210283505,2,"Biomarker, Therapeutic"
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.210283505,2,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,2726,Amyloidosis,0.210283505,2,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.210283505,2,Biomarker
3169,FOXA1,forkhead box A1,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.210283505,2,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.210283505,2,Biomarker
51547,SIRT7,sirtuin 7,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.210283505,1,Biomarker
7494,XBP1,X-box binding protein 1,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.210283505,2,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.210283505,2,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.210283505,2,Biomarker
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.210283505,2,Biomarker
5925,RB1,retinoblastoma 1,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.210283505,2,Biomarker
6240,RRM1,ribonucleotide reductase M1,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.210283505,1,Biomarker
7015,TERT,telomerase reverse transcriptase,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.210283505,2,Biomarker
7153,TOP2A,topoisomerase (DNA) II alpha 170kDa,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.210283505,1,Biomarker
1475,CSTA,cystatin A (stefin A),0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.210283505,1,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.210283505,2,Biomarker
257641,NPCA1,Nasopharyngeal carcinoma 1,0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.210283505,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.210283505,2,Biomarker
29785,CYP2S1,"cytochrome P450, family 2, subfamily S, polypeptide 1",0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210283505,1,Biomarker
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210283505,2,Biomarker
7889,PSORS3,psoriasis susceptibility 3,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210283505,1,Biomarker
65245,PSORS7,psoriasis susceptibility 7,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210283505,1,Biomarker
140454,PSORS8,psoriasis susceptibility 8,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210283505,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210283505,2,Biomarker
8876,VNN1,vanin 1,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210283505,1,Biomarker
8875,VNN2,vanin 2,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.210283505,1,Biomarker
2030,SLC29A1,"solute carrier family 29 (equilibrative nucleoside transporter), member 1",0.0,1.0,1.0,0.0,0.0,586323,Alcohol Withdrawal Seizures,0.210283505,1,"Biomarker, GeneticVariation"
8216,LZTR1,leucine-zipper-like transcription regulator 1,0.0,1.0,0.0,0.0,0.0,1335929,Schwannomatosis,0.210283505,1,Biomarker
654,BMP6,bone morphogenetic protein 6,0.0,1.0,0.0,0.0,0.0,18995,Hemochromatosis,0.210283505,2,Biomarker
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,0.0,0.0,0.0,600260,"Lung Diseases, Obstructive",0.210283505,2,Biomarker
18,ABAT,4-aminobutyrate aminotransferase,0.0,1.0,0.0,0.0,0.0,17168,Gastroesophageal Reflux,0.210283505,1,Biomarker
59330,GER,Gastroesophageal reflux,0.0,1.0,0.0,0.0,0.0,17168,Gastroesophageal Reflux,0.210283505,1,Biomarker
84565,LCS1,lymphedema-cholestasis syndrome 1,0.0,1.0,0.0,0.0,0.0,268314,Aagenaes syndrome,0.210283505,1,Biomarker
2208,FCER2,"Fc fragment of IgE, low affinity II, receptor for (CD23)",0.0,1.0,0.0,0.0,0.0,14038,Encephalitis,0.210283505,1,Biomarker
465,ATD,asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome),0.0,1.0,0.0,0.0,0.0,265275,Jeune syndrome,0.210283505,1,Biomarker
90427,BMF,Bcl2 modifying factor,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.210283505,2,Biomarker
406935,MIR143,microRNA 143,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.210283505,2,Biomarker
5527,PPP2R5C,"protein phosphatase 2, regulatory subunit B', gamma",0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.210283505,1,Biomarker
652,BMP4,bone morphogenetic protein 4,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.210283505,2,Biomarker
2006,ELN,elastin,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.210283505,2,Biomarker
7490,WT1,Wilms tumor 1,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.210283505,2,Biomarker
4038,LRP4,low density lipoprotein receptor-related protein 4,0.0,1.0,0.0,0.0,0.0,39075,Syndactyly,0.210283505,2,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,86543,Cataract,0.210283505,1,Biomarker
23424,TDRD7,tudor domain containing 7,0.0,1.0,0.0,0.0,0.0,86543,Cataract,0.210283505,1,Biomarker
860,RUNX2,runt-related transcription factor 2,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.210283505,2,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.210283505,2,Biomarker
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.210283505,2,Biomarker
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.210283505,2,Biomarker
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.210283505,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.210283505,2,Biomarker
7052,TGM2,transglutaminase 2,0.0,1.0,0.0,0.0,1.0,6118,Brain Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
1288,COL4A6,"collagen, type IV, alpha 6",0.0,1.0,0.0,0.0,0.0,1839884,"Leiomyomatosis, esophageal and vulval, with nephropathy",0.210283505,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,0.0,1.0,0.0,1.0,20545,"Hypertension, Renovascular",0.210283505,2,"GeneticVariation, Therapeutic"
7273,TTN,titin,0.0,1.0,1.0,0.0,0.0,2673677,"Myopathy, Early-Onset, with Fatal Cardiomyopathy",0.210283505,1,"Biomarker, GeneticVariation"
1301,COL11A1,"collagen, type XI, alpha 1",0.0,1.0,1.0,0.0,0.0,17605,"Glaucoma, Angle-Closure",0.210283505,2,"Biomarker, GeneticVariation"
144100,PLEKHA7,"pleckstrin homology domain containing, family A member 7",0.0,1.0,1.0,0.0,0.0,17605,"Glaucoma, Angle-Closure",0.210283505,2,"Biomarker, GeneticVariation"
1778,DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1",0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.210283505,2,Biomarker
3800,KIF5C,kinesin family member 5C,0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.210283505,2,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.210283505,2,Biomarker
7283,TUBG1,"tubulin, gamma 1",0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.210283505,2,Biomarker
3719,JBS,Jacobsen syndrome,0.0,1.0,0.0,0.0,0.0,795841,Jacobsen Distal 11q Deletion Syndrome,0.210283505,1,Biomarker
9844,ELMO1,engulfment and cell motility 1,0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.210283505,1,Biomarker
4745,NELL1,NEL-like 1 (chicken),0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.210283505,1,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.210283505,2,Biomarker
729230,CCR2,chemokine (C-C motif) receptor 2,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
1051,CEBPB,"CCAAT/enhancer binding protein (C/EBP), beta",0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
1215,CMA1,"chymase 1, mast cell",0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,3,Biomarker
57105,CYSLTR2,cysteinyl leukotriene receptor 2,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
2246,FGF1,fibroblast growth factor 1 (acidic),0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
2252,FGF7,fibroblast growth factor 7,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,1,Biomarker
26585,GREM1,"gremlin 1, DAN family BMP antagonist",0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.210283505,2,Biomarker
9075,CLDN2,claudin 2,0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.210283505,1,Biomarker
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.210283505,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,1.0,0.0,0.0,30305,Pancreatitis,0.210283505,1,"Biomarker, GeneticVariation"
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.210283505,2,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,21846,Intestinal Polyps,0.210283505,2,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,15672,Fatigue,0.210283505,2,"Biomarker, Therapeutic"
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,15672,Fatigue,0.210283505,2,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,0.0,1.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.210283505,1,GeneticVariation
10861,SLC26A1,"solute carrier family 26 (anion exchanger), member 1",0.0,1.0,0.0,0.0,0.0,451641,Urolithiasis,0.210283505,3,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,1.0,14868,Esophagitis,0.210283505,1,"Biomarker, Therapeutic"
4508,ATP6,ATP synthase F0 subunit 6,0.0,1.0,0.0,0.0,0.0,271650,Glucose Intolerance,0.210283505,2,Biomarker
5919,RARRES2,retinoic acid receptor responder (tazarotene induced) 2,0.0,1.0,0.0,0.0,0.0,271650,Glucose Intolerance,0.210283505,2,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,6625,Cachexia,0.210283505,2,Biomarker
4574,TRNS1,tRNA,0.0,1.0,0.0,0.0,0.0,162671,MELAS Syndrome,0.210283505,1,Biomarker
26127,FGFR1OP2,FGFR1 oncogene partner 2,0.0,1.0,0.0,0.0,0.0,27022,Myeloproliferative Disorders,0.210283505,2,Biomarker
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.210283505,2,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.210283505,2,Biomarker
1978,EIF4EBP1,eukaryotic translation initiation factor 4E binding protein 1,0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.210283505,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,1.0,22665,Kidney Neoplasms,0.210283505,5,"Biomarker, Therapeutic"
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.210283505,1,Biomarker
8085,KMT2D,lysine (K)-specific methyltransferase 2D,0.0,1.0,0.0,0.0,0.0,24301,"Lymphoma, Follicular",0.210283505,2,Biomarker
4977,OPA2,optic atrophy 2 (obscure),0.0,1.0,0.0,0.0,0.0,1839576,"Optic atrophy, X-linked",0.210283505,1,Biomarker
171089,DYX5,dyslexia susceptibility 5,0.0,1.0,0.0,0.0,0.0,476254,Dyslexia,0.210283505,1,Biomarker
10370,CITED2,"Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2",0.0,1.0,0.0,0.0,0.0,18816,Heart Septal Defects,0.210283505,1,Biomarker
982,CDB2,corneal dystrophy of Bowman layer type II (Thiel-Behnke),0.0,1.0,0.0,0.0,0.0,1562894,"Corneal dystrophy, Thiel-Behnke type",0.210283505,1,Biomarker
1269,CNR2,cannabinoid receptor 2 (macrophage),0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.210283505,2,Biomarker
2321,FLT1,fms-related tyrosine kinase 1,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.210283505,2,Biomarker
3291,HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.210283505,2,Biomarker
3875,KRT18,"keratin 18, type I",0.0,1.0,0.0,0.0,1.0,23890,Liver Cirrhosis,0.210283505,2,"Biomarker, Therapeutic"
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,1.0,23890,Liver Cirrhosis,0.210283505,2,"Biomarker, Therapeutic"
574045,HNP1,Hypertensive nephropathy,0.0,1.0,0.0,0.0,0.0,848548,Hypertensive Nephropathy,0.210283505,1,Biomarker
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,1.0,0.0,0.0,0.0,18054,"Gonadal Dysgenesis, 46,XY",0.210283505,4,Biomarker
11280,SCN11A,"sodium channel, voltage gated, type XI alpha subunit",0.0,1.0,1.0,0.0,0.0,2768,"Pain Insensitivity, Congenital",0.210283505,2,"Biomarker, GeneticVariation"
50941,IBD5,inflammatory bowel disease 5,0.0,1.0,0.0,0.0,0.0,1853438,Inflammatory Bowel Disease 5,0.210283505,1,Biomarker
728,C5AR1,complement component 5a receptor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
929,CD14,CD14 molecule,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
3078,CFHR1,complement factor H-related 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
10878,CFHR3,complement factor H-related 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
3484,IGFBP1,insulin-like growth factor binding protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
7096,TLR1,toll-like receptor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.210283505,2,Biomarker
10161,LPAR6,lysophosphatidic acid receptor 6,0.0,1.0,0.0,0.0,0.0,1854310,Hypotrichosis simplex,0.210283505,2,Biomarker
7050,TGIF1,TGFB-induced factor homeobox 1,0.0,1.0,0.0,0.0,0.0,1854310,Hypotrichosis simplex,0.210283505,1,Biomarker
100301525,DUH2,Dyschromatosis universalis hereditaria 2,0.0,1.0,0.0,0.0,0.0,2675183,Dyschromatosis Universalis Hereditaria 2,0.210283505,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,8677,"Bronchitis, Chronic",0.210283505,2,Biomarker
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,0.0,1.0,1.0,0.0,0.0,2931332,Telomeric 22q13 Monosomy Syndrome,0.210283505,2,"Biomarker, GeneticVariation"
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,340288,"Angina, Stable",0.210283505,2,Biomarker
2317,FLNB,"filamin B, beta",0.0,1.0,0.0,0.0,0.0,2931648,"Larsen syndrome, dominant type",0.210283505,2,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.210283505,2,Biomarker
5664,PSEN2,presenilin 2,0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.210283505,1,Biomarker
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.210283505,1,Biomarker
5973,RENBP,renin binding protein,0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.210283505,2,Biomarker
6389,SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.210283505,1,Biomarker
50608,IBD4,inflammatory bowel disease 4,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.210283505,1,Biomarker
57042,IBD7,inflammatory bowel disease 7,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.210283505,1,Biomarker
170595,IBD8,inflammatory bowel disease 8,0.0,1.0,1.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.210283505,1,"Biomarker, GeneticVariation"
8876,VNN1,vanin 1,0.0,1.0,0.0,0.0,1.0,21390,Inflammatory Bowel Diseases,0.210283505,2,"Biomarker, Therapeutic"
2006,ELN,elastin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.210283505,2,Biomarker
2246,FGF1,fibroblast growth factor 1 (acidic),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.210283505,2,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,1.0,151744,Myocardial Ischemia,0.210283505,3,"Biomarker, Therapeutic"
3146,HMGB1,high mobility group box 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.210283505,2,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.210283505,2,Biomarker
3717,JAK2,Janus kinase 2,0.0,1.0,1.0,0.0,0.0,151744,Myocardial Ischemia,0.210283505,3,"Biomarker, GeneticVariation"
1432,MAPK14,mitogen-activated protein kinase 14,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.210283505,2,Biomarker
6403,SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.210283505,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.210283505,2,Biomarker
53834,FGFRL1,fibroblast growth factor receptor-like 1,0.0,1.0,0.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.210283505,2,Biomarker
7490,WT1,Wilms tumor 1,0.0,1.0,0.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.210283505,2,Biomarker
8678,BECN1,"beclin 1, autophagy related",0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.210283505,2,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,1.0,27051,Myocardial Infarction,0.210283505,2,"Biomarker, Therapeutic"
53345,TM6SF2,transmembrane 6 superfamily member 2,0.0,1.0,1.0,0.0,0.0,27051,Myocardial Infarction,0.210283505,1,"Biomarker, GeneticVariation"
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,0.0,0.0,0.0,37268,Skin Abnormalities,0.210283505,2,Biomarker
2678,GGT1,gamma-glutamyltransferase 1,0.0,1.0,0.0,0.0,0.0,31099,Periodontitis,0.210283505,2,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,16382,Flushing,0.210283505,2,Biomarker
450088,ADHD2,"Attention deficit-hyperactivity disorder, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.210283505,1,Biomarker
2245,FGD1,"FYVE, RhoGEF and PH domain containing 1",0.0,1.0,1.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.210283505,1,"Biomarker, GeneticVariation"
5789,PTPRD,"protein tyrosine phosphatase, receptor type, D",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.210283505,1,Biomarker
116071,BATF2,"basic leucine zipper transcription factor, ATF-like 2",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,2,Biomarker
1028,CDKN1C,"cyclin-dependent kinase inhibitor 1C (p57, Kip2)",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,2,Biomarker
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,1,Biomarker
2739,GLO1,glyoxalase I,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,1,Biomarker
2913,GRM3,"glutamate receptor, metabotropic 3",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,2,Biomarker
10013,HDAC6,histone deacetylase 6,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,2,Biomarker
4293,MAP3K9,mitogen-activated protein kinase kinase kinase 9,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,1,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,2,Biomarker
5796,PTPRK,"protein tyrosine phosphatase, receptor type, K",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,3,Biomarker
25797,QPCT,glutaminyl-peptide cyclotransferase,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,2,Biomarker
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,2,Biomarker
9610,RIN1,Ras and Rab interactor 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,2,Biomarker
6392,SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,1,Biomarker
6494,SIPA1,signal-induced proliferation-associated 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,1,Biomarker
8295,TRRAP,transformation/transcription domain-associated protein,0.0,1.0,1.0,0.0,0.0,25202,Melanoma,0.210283505,1,"Biomarker, GeneticVariation"
58189,WFDC1,WAP four-disulfide core domain 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.210283505,2,Biomarker
203286,ANKS6,ankyrin repeat and sterile alpha motif domain containing 6,0.0,1.0,0.0,0.0,0.0,85413,"Polycystic Kidney, Autosomal Dominant",0.210283505,2,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,85413,"Polycystic Kidney, Autosomal Dominant",0.210283505,2,Biomarker
29,ABR,active BCR-related,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.210283505,1,Biomarker
6281,S100A10,S100 calcium binding protein A10,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.210283505,1,Biomarker
6277,S100A6,S100 calcium binding protein A6,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.210283505,1,Biomarker
92335,STRADA,STE20-related kinase adaptor alpha,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.210283505,1,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,1.0,0.0,0.0,152018,ESOPHAGEAL CARCINOMA,0.210283505,1,"Biomarker, GeneticVariation"
6608,SMO,"smoothened, frizzled class receptor",0.0,1.0,0.0,0.0,0.0,206663,"Neuroectodermal Tumors, Primitive",0.210283505,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,432291,Mandibuloacral dysplasia with type A lipodystrophy,0.210283505,1,Biomarker
55806,HR,hair growth associated,0.0,1.0,0.0,0.0,0.0,263505,Alopecia universalis,0.210283505,1,Biomarker
1319,CORD1,cone rod dystrophy 1 (autosomal dominant),0.0,1.0,1.0,0.0,0.0,1833564,Cone-Rod Dystrophy 1,0.210283505,1,"Biomarker, GeneticVariation"
6905,TBCE,tubulin folding cofactor E,0.0,1.0,0.0,0.0,0.0,29464,Osteosclerosis,0.210283505,2,Biomarker
5162,PDHB,pyruvate dehydrogenase (lipoamide) beta,0.0,1.0,0.0,0.0,0.0,34345,Pyruvate Dehydrogenase Complex Deficiency Disease,0.210283505,2,Biomarker
2335,FN1,fibronectin 1,0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.210283505,2,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.210283505,2,Biomarker
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.210283505,2,Biomarker
4068,SH2D1A,SH2 domain containing 1A,0.0,1.0,0.0,0.0,0.0,24314,Lymphoproliferative Disorders,0.210283505,2,Biomarker
25792,CIZ1,CDKN1A interacting zinc finger protein 1,0.0,1.0,0.0,0.0,0.0,1865819,"Cervical Dystonia, Primary",0.210283505,1,Biomarker
406,ARNTL,aryl hydrocarbon receptor nuclear translocator-like,0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.210283505,2,Biomarker
768,CA9,carbonic anhydrase IX,0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.210283505,1,Biomarker
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,242339,Dyslipidemias,0.210283505,2,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,"Biomarker, Therapeutic"
1540,CYLD,cylindromatosis (turban tumor syndrome),0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,Biomarker
2946,GSTM2,glutathione S-transferase mu 2 (muscle),0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,Biomarker
3570,IL6R,interleukin 6 receptor,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,1,Biomarker
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,Biomarker
23028,KDM1A,lysine (K)-specific demethylase 1A,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,1,Biomarker
4504,MT3,metallothionein 3,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,Biomarker
25878,MXRA5,matrix-remodelling associated 5,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,1,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,Biomarker
4826,NNAT,neuronatin,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,Biomarker
5052,PRDX1,peroxiredoxin 1,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,Biomarker
54458,PRR13,proline rich 13,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,1.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,"Biomarker, Therapeutic"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,3,"Biomarker, GeneticVariation"
6855,SYP,synaptophysin,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,2,Biomarker
55829,VIMP,VCP-interacting membrane protein,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.210283505,1,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,206704,"Carcinoma, Large Cell",0.210283505,1,Biomarker
8854,ALDH1A2,"aldehyde dehydrogenase 1 family, member A2",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,1,Biomarker
664,BNIP3,BCL2/adenovirus E1B 19kDa interacting protein 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,1,Biomarker
811,CALR,calreticulin,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
10263,CDK2AP2,cyclin-dependent kinase 2 associated protein 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
1387,CREBBP,CREB binding protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
1474,CST6,cystatin E/M,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,1,Biomarker
30008,EFEMP2,EGF containing fibulin-like extracellular matrix protein 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
2678,GGT1,gamma-glutamyltransferase 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
27232,GNMT,glycine N-methyltransferase,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
84818,IL17RC,interleukin 17 receptor C,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
11009,IL24,interleukin 24,0.0,1.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
9968,MED12,mediator complex subunit 12,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,"Biomarker, GeneticVariation"
8648,NCOA1,nuclear receptor coactivator 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
8829,NRP1,neuropilin 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
7001,PRDX2,peroxiredoxin 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
5621,PRNP,prion protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
101669767,SCHLAP1,SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
6783,SULT1E1,"sulfotransferase family 1E, estrogen-preferring, member 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
23671,TMEFF2,transmembrane protein with EGF-like and two follistatin-like domains 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,Biomarker
7110,TMF1,TATA element modulatory factor 1,0.0,1.0,1.0,0.0,0.0,33578,Prostatic Neoplasms,0.210283505,2,"Biomarker, GeneticVariation"
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,20505,Hyperphagia,0.210283505,2,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,33774,Pruritus,0.210283505,2,Biomarker
2182,ACSL4,acyl-CoA synthetase long-chain family member 4,0.0,1.0,0.0,0.0,0.0,41834,Erythema,0.210283505,1,Biomarker
2488,FSHB,"follicle stimulating hormone, beta polypeptide",0.0,1.0,1.0,0.0,0.0,28960,Oligospermia,0.210283505,2,"Biomarker, GeneticVariation"
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
135,ADORA2A,adenosine A2a receptor,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
249,ALPL,"alkaline phosphatase, liver/bone/kidney",0.0,0.0,1.0,0.0,1.0,36572,Seizures,0.210283505,2,"GeneticVariation, Therapeutic"
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.210283505,4,"Biomarker, Therapeutic"
885,CCK,cholecystokinin,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.210283505,2,"Biomarker, Therapeutic"
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,7,Biomarker
1812,DRD1,dopamine receptor D1,0.0,1.0,1.0,0.0,0.0,36572,Seizures,0.210283505,3,"Biomarker, GeneticVariation"
1813,DRD2,dopamine receptor D2,0.0,1.0,1.0,0.0,1.0,36572,Seizures,0.210283505,4,"Biomarker, GeneticVariation, Therapeutic"
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.210283505,2,"Biomarker, Therapeutic"
2572,GAD2,"glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,3,Biomarker
8777,MPDZ,multiple PDZ domain protein,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
93183,PIGM,"phosphatidylinositol glycan anchor biosynthesis, class M",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
11284,PNKP,polynucleotide kinase 3'-phosphatase,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,1,Biomarker
54715,RBFOX1,"RNA binding protein, fox-1 homolog (C. elegans) 1",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
6925,TCF4,transcription factor 4,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.210283505,2,Biomarker
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,1565489,Renal Insufficiency,0.210283505,2,Biomarker
93985,FGS3,FG syndrome 3,0.0,1.0,0.0,0.0,0.0,220769,Opitz-Kaveggia syndrome,0.210283505,1,Biomarker
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,220769,Opitz-Kaveggia syndrome,0.210283505,1,"Biomarker, GeneticVariation"
1616,DAXX,death-domain associated protein,0.0,1.0,0.0,0.0,0.0,206754,Neuroendocrine Tumors,0.210283505,2,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,206754,Neuroendocrine Tumors,0.210283505,2,Biomarker
6751,SSTR1,somatostatin receptor 1,0.0,1.0,0.0,0.0,0.0,206754,Neuroendocrine Tumors,0.210283505,2,Biomarker
6753,SSTR3,somatostatin receptor 3,0.0,1.0,0.0,0.0,0.0,206754,Neuroendocrine Tumors,0.210283505,2,Biomarker
57379,AICDA,activation-induced cytidine deaminase,0.0,1.0,0.0,0.0,0.0,5699,Blast Crisis,0.210283505,2,Biomarker
57172,CAMK1G,calcium/calmodulin-dependent protein kinase IG,0.0,1.0,1.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.210283505,2,"Biomarker, GeneticVariation"
959,CD40LG,CD40 ligand,0.0,1.0,0.0,0.0,1.0,2736,Amyotrophic Lateral Sclerosis,0.210283505,1,"Biomarker, Therapeutic"
51163,DBR1,debranching RNA lariats 1,0.0,1.0,0.0,0.0,1.0,2736,Amyotrophic Lateral Sclerosis,0.210283505,1,"Biomarker, Therapeutic"
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",0.0,1.0,0.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.210283505,2,Biomarker
6529,SLC6A1,"solute carrier family 6 (neurotransmitter transporter), member 1",0.0,1.0,0.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.210283505,1,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,1.0,0.0,0.0,80178,Spinal Dysraphism,0.210283505,2,"Biomarker, GeneticVariation"
1119,CHKA,choline kinase alpha,0.0,1.0,0.0,0.0,0.0,80178,Spinal Dysraphism,0.210283505,1,Biomarker
5130,PCYT1A,"phosphate cytidylyltransferase 1, choline, alpha",0.0,1.0,1.0,0.0,0.0,80178,Spinal Dysraphism,0.210283505,1,"Biomarker, GeneticVariation"
133,ADM,adrenomedullin,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
114788,CSMD3,CUB and Sushi multiple domains 3,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
9855,FARP2,"FERM, RhoGEF and pleckstrin domain protein 2",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
2550,GABBR1,"gamma-aminobutyric acid (GABA) B receptor, 1",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
9568,GABBR2,"gamma-aminobutyric acid (GABA) B receptor, 2",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
3069,HDLBP,high density lipoprotein binding protein,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
23178,PASK,PAS domain containing serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
57575,PCDH10,protocadherin 10,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
5141,PDE4A,"phosphodiesterase 4A, cAMP-specific",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
5294,PIK3CG,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
5551,PRF1,perforin 1 (pore forming protein),0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
116442,RAB39B,"RAB39B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
6091,ROBO1,"roundabout, axon guidance receptor, homolog 1 (Drosophila)",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
6092,ROBO2,"roundabout, axon guidance receptor, homolog 2 (Drosophila)",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
192683,SCAMP5,secretory carrier membrane protein 5,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
50944,SHANK1,SH3 and multiple ankyrin repeat domains 1,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",0.0,1.0,1.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,"Biomarker, GeneticVariation"
285195,SLC9A9,"solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
54221,SNTG2,"syntrophin, gamma 2",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
29091,STXBP6,syntaxin binding protein 6 (amisyn),0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,2,Biomarker
10771,ZMYND11,"zinc finger, MYND-type containing 11",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.210283505,1,Biomarker
4137,MAPT,microtubule-associated protein tau,0.0,1.0,0.0,0.0,0.0,1850077,Progressive supranuclear palsy atypical,0.210283505,1,Biomarker
360,AQP3,aquaporin 3 (Gill blood group),0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.210283505,2,Biomarker
2993,GYPA,glycophorin A (MNS blood group),0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.210283505,1,Biomarker
4953,ODC1,ornithine decarboxylase 1,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.210283505,3,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.210283505,2,Biomarker
203286,ANKS6,ankyrin repeat and sterile alpha motif domain containing 6,0.0,1.0,0.0,0.0,0.0,1691228,"Kidney Diseases, Cystic",0.210283505,2,Biomarker
91147,TMEM67,transmembrane protein 67,0.0,1.0,0.0,0.0,0.0,1691228,"Kidney Diseases, Cystic",0.210283505,2,Biomarker
93,ACVR2B,"activin A receptor, type IIB",0.0,1.0,0.0,0.0,0.0,3178805,Heterotaxy Syndrome,0.210283505,2,Biomarker
9119,KRT75,"keratin 75, type II",0.0,1.0,1.0,0.0,0.0,549150,Pseudofolliculitis Barbae,0.210283505,1,"Biomarker, GeneticVariation"
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,162309,Adrenoleukodystrophy,0.210283505,2,"Biomarker, GeneticVariation"
23512,SUZ12,SUZ12 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,206727,Nerve Sheath Neoplasms,0.210283505,2,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,18566,"Hand Deformities, Congenital",0.210283505,2,Biomarker
2720,GLB1,"galactosidase, beta 1",0.0,1.0,0.0,0.0,0.0,26707,Mucopolysaccharidosis IV,0.210283505,3,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,3869,"Arthritis, Infectious",0.210283505,2,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,42842,Vitamin A Deficiency,0.210283505,2,Biomarker
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,40100,Thymoma,0.210283505,2,Biomarker
80169,CTC1,CTS telomere maintenance complex component 1,0.0,1.0,0.0,0.0,0.0,154832,Retinal Telangiectasis,0.210283505,2,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,19337,Heroin Dependence,0.210283505,2,Biomarker
472,ATM,ATM serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,79774,"Lymphoma, T-Cell, Peripheral",0.210283505,2,Biomarker
2534,FYN,"FYN proto-oncogene, Src family tyrosine kinase",0.0,1.0,0.0,0.0,0.0,79774,"Lymphoma, T-Cell, Peripheral",0.210283505,1,Biomarker
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,0.0,0.0,0.0,79774,"Lymphoma, T-Cell, Peripheral",0.210283505,3,Biomarker
54790,TET2,tet methylcytosine dioxygenase 2,0.0,1.0,0.0,0.0,0.0,79774,"Lymphoma, T-Cell, Peripheral",0.210283505,3,Biomarker
9702,CEP57,centrosomal protein 57kDa,0.0,1.0,0.0,0.0,0.0,1850343,Mosaic variegated aneuploidy syndrome,0.210283505,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,1855310,Megaepiphyseal dwarfism,0.210283505,1,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,152427,Polydactyly,0.210283505,1,Biomarker
3176,HNMT,histamine N-methyltransferase,0.0,1.0,0.0,0.0,0.0,35455,Rhinitis,0.210283505,1,Biomarker
3269,HRH1,histamine receptor H1,0.0,1.0,0.0,0.0,0.0,35455,Rhinitis,0.210283505,2,Biomarker
6915,TBXA2R,thromboxane A2 receptor,0.0,1.0,1.0,0.0,0.0,35455,Rhinitis,0.210283505,2,"Biomarker, GeneticVariation"
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,37928,Spinal Cord Diseases,0.210283505,1,Biomarker
3026,HABP2,hyaluronan binding protein 2,0.0,1.0,0.0,0.0,0.0,398623,Thrombophilia,0.210283505,1,Biomarker
51156,SERPINA10,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10",0.0,1.0,0.0,0.0,0.0,398623,Thrombophilia,0.210283505,1,Biomarker
3053,SERPIND1,"serpin peptidase inhibitor, clade D (heparin cofactor), member 1",0.0,1.0,0.0,0.0,0.0,398623,Thrombophilia,0.210283505,2,Biomarker
8851,CDK5R1,"cyclin-dependent kinase 5, regulatory subunit 1 (p35)",0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.210283505,2,Biomarker
3456,IFNB1,"interferon, beta 1, fibroblast",0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.210283505,2,Biomarker
11277,TREX1,three prime repair exonuclease 1,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.210283505,2,Biomarker
9992,KCNE2,"potassium channel, voltage gated subfamily E regulatory beta subunit 2",0.0,1.0,0.0,0.0,0.0,42510,Ventricular Fibrillation,0.210283505,1,Biomarker
2657,GDF1,growth differentiation factor 1,0.0,1.0,0.0,0.0,0.0,13069,Double Outlet Right Ventricle,0.210283505,2,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,10481,Cushing Syndrome,0.210283505,2,Biomarker
5108,PCM1,pericentriolar material 1,0.0,1.0,0.0,0.0,0.0,238463,"Thyroid cancer, papillary",0.210283505,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,1858558,"Rheumatoid Arthritis, Systemic Juvenile",0.210283505,1,Biomarker
9968,MED12,mediator complex subunit 12,0.0,1.0,0.0,0.0,0.0,206650,Fibroadenoma,0.210283505,1,Biomarker
57688,ZSWIM6,"zinc finger, SWIM-type containing 6",0.0,1.0,1.0,0.0,0.0,1863616,Acromelic Frontonasal Dysostosis,0.210283505,1,"Biomarker, GeneticVariation"
3565,IL4,interleukin 4,1.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.210283505,2,"AlteredExpression, Biomarker"
3567,IL5,interleukin 5,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.210283505,2,Biomarker
2678,GGT1,gamma-glutamyltransferase 1,0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.210283505,2,Biomarker
50833,TAS2R16,"taste receptor, type 2, member 16",0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.210283505,2,Biomarker
27063,ANKRD1,ankyrin repeat domain 1 (cardiac muscle),0.0,1.0,1.0,0.0,0.0,36400,Scimitar Syndrome,0.210283505,1,"Biomarker, GeneticVariation"
171157,SHFM5,split hand/foot malformation (ectrodactyly) type 5,0.0,1.0,0.0,0.0,0.0,2931019,Split hand foot deformity 1,0.210283505,1,Biomarker
79659,DYNC2H1,"dynein, cytoplasmic 2, heavy chain 1",0.0,1.0,0.0,0.0,0.0,36996,Short Rib-Polydactyly Syndrome,0.210283505,1,Biomarker
93986,FOXP2,forkhead box P2,0.0,1.0,0.0,0.0,0.0,175693,Silver-Russell Syndrome,0.210283505,1,Biomarker
2332,FMR1,fragile X mental retardation 1,0.0,1.0,0.0,0.0,0.0,2749127,"Primary Ovarian Insufficiency, Fragile X-Associated",0.210283505,2,Biomarker
3295,HSD17B4,hydroxysteroid (17-beta) dehydrogenase 4,0.0,1.0,0.0,0.0,0.0,37769,"Spasms, Infantile",0.210283505,1,Biomarker
6442,SGCA,"sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)",0.0,1.0,0.0,0.0,0.0,2936331,Sarcoglycanopathies,0.210283505,1,Biomarker
57509,MTUS1,microtubule associated tumor suppressor 1,0.0,1.0,1.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,1,"Biomarker, GeneticVariation"
325,APCS,"amyloid P component, serum",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
735,C9,complement component 9,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
1052,CEBPD,"CCAAT/enhancer binding protein (C/EBP), delta",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
8667,EIF3H,"eukaryotic translation initiation factor 3, subunit H",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,1,Biomarker
9518,GDF15,growth differentiation factor 15,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
2658,GDF2,growth differentiation factor 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
3148,HMGB2,high mobility group box 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,1,Biomarker
3417,IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
58508,KMT2C,lysine (K)-specific methyltransferase 2C,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
8720,MBTPS1,"membrane-bound transcription factor peptidase, site 1",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
693200,MIR615,microRNA 615,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,1,Biomarker
51085,MLXIPL,MLX interacting protein-like,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
7376,NR1H2,"nuclear receptor subfamily 1, group H, member 2",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
11315,PARK7,parkinson protein 7,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
2923,PDIA3,"protein disulfide isomerase family A, member 3",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
6194,RPS6,ribosomal protein S6,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
6197,RPS6KA3,"ribosomal protein S6 kinase, 90kDa, polypeptide 3",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,1,Biomarker
6514,SLC2A2,"solute carrier family 2 (facilitated glucose transporter), member 2",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
83932,SPRTN,SprT-like N-terminal domain,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,1,Biomarker
8407,TAGLN2,transgelin 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
7054,TH,tyrosine hydroxylase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
8805,TRIM24,tripartite motif containing 24,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,2,Biomarker
7571,ZNF23,zinc finger protein 23,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.210283505,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,1531773,Currarino triad,0.210283505,1,Biomarker
200879,LIPH,"lipase, member H",0.0,1.0,0.0,0.0,0.0,345427,"Woolly hair, congenital",0.210283505,2,Biomarker
25792,CIZ1,CDKN1A interacting zinc finger protein 1,0.0,1.0,0.0,0.0,0.0,553580,"Sarcoma, Ewing",0.210283505,1,Biomarker
4015,LOX,lysyl oxidase,0.0,1.0,0.0,0.0,0.0,268351,"Cutis Laxa, Autosomal Recessive, Type I",0.210283505,1,Biomarker
6792,CDKL5,cyclin-dependent kinase-like 5,0.0,1.0,0.0,0.0,0.0,162635,Angelman Syndrome,0.210283505,2,Biomarker
4868,NPHS1,"nephrosis 1, congenital, Finnish type (nephrin)",0.0,1.0,0.0,0.0,0.0,27721,"Nephrosis, Lipoid",0.210283505,2,Biomarker
2912,GRM2,"glutamate receptor, metabotropic 2",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.210283505,2,Biomarker
4887,NPY2R,neuropeptide Y receptor Y2,0.0,1.0,0.0,0.0,1.0,14556,"Epilepsy, Temporal Lobe",0.210283505,2,"Biomarker, Therapeutic"
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.210283505,2,Biomarker
57468,SLC12A5,"solute carrier family 12 (potassium/chloride transporter), member 5",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.210283505,2,Biomarker
9353,SLIT2,slit homolog 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.210283505,1,Biomarker
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.210283505,2,Biomarker
4567,TRNL1,tRNA,0.0,1.0,1.0,0.0,0.0,1125,"Acidosis, Lactic",0.210283505,2,"Biomarker, GeneticVariation"
868,CBLB,"Cbl proto-oncogene B, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,14072,"Encephalomyelitis, Autoimmune, Experimental",0.210283505,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,2675904,"Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation, and Obesity Syndrome",0.210283505,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,282548,Leukostasis,0.210283505,2,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,1.0,282548,Leukostasis,0.210283505,2,"Biomarker, Therapeutic"
1675,CFD,complement factor D (adipsin),0.0,1.0,0.0,0.0,0.0,25303,Meningococcal Infections,0.210283505,1,Biomarker
1645,AKR1C1,"aldo-keto reductase family 1, member C1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
1646,AKR1C2,"aldo-keto reductase family 1, member C2",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
8644,AKR1C3,"aldo-keto reductase family 1, member C3",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
9547,CXCL14,chemokine (C-X-C motif) ligand 14,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
23405,DICER1,"dicer 1, ribonuclease type III",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,1,Biomarker
100188863,ENDO1,"Endometriosis, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,1,Biomarker
3065,HDAC1,histone deacetylase 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
3620,IDO1,"indoleamine 2,3-dioxygenase 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
687,KLF9,Kruppel-like factor 9,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
406991,MIR21,microRNA 21,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,1,Biomarker
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
10562,OLFM4,olfactomedin 4,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,1,Biomarker
5069,PAPPA,"pregnancy-associated plasma protein A, pappalysin 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
5076,PAX2,paired box 2,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,1,Biomarker
59350,RXFP1,relaxin/insulin-like family peptide receptor 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
6876,TAGLN,transgelin,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
10628,TXNIP,thioredoxin interacting protein,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.210283505,2,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,20488,Hypernatremia,0.210283505,3,Biomarker
54499,TMCO1,transmembrane and coiled-coil domains 1,0.0,1.0,0.0,0.0,0.0,17612,"Glaucoma, Open-Angle",0.210283505,1,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.210283505,3,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.210283505,2,Biomarker
1719,DHFR,dihydrofolate reductase,0.0,1.0,1.0,0.0,0.0,27765,Nervous System Diseases,0.210283505,2,"Biomarker, GeneticVariation"
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.210283505,2,Biomarker
5179,PENK,proenkephalin,0.0,1.0,0.0,0.0,1.0,27765,Nervous System Diseases,0.210283505,2,"Biomarker, Therapeutic"
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.210283505,2,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.210283505,2,Biomarker
54,ACP5,"acid phosphatase 5, tartrate resistant",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210283505,2,Biomarker
8644,AKR1C3,"aldo-keto reductase family 1, member C3",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210283505,2,Biomarker
8522,GAS7,growth arrest-specific 7,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210283505,1,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.210283505,2,"Biomarker, GeneticVariation"
3485,IGFBP2,"insulin-like growth factor binding protein 2, 36kDa",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210283505,2,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.210283505,2,Biomarker
5209,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.210283505,2,"Biomarker, GeneticVariation"
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,0.0,0.0,0.0,38506,Stuttering,0.210283505,1,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,40411,Tongue Neoplasms,0.210283505,2,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,40411,Tongue Neoplasms,0.210283505,3,Biomarker
331,XIAP,"X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.210283505,2,Biomarker
387357,THEMIS,thymocyte selection associated,0.0,1.0,1.0,0.0,0.0,7570,Celiac Disease,0.210283505,2,"Biomarker, GeneticVariation"
80271,ITPKC,inositol-trisphosphate 3-kinase C,0.0,1.0,0.0,0.0,0.0,10051,Coronary Aneurysm,0.210283505,1,Biomarker
51268,PIPOX,pipecolic acid oxidase,0.0,1.0,0.0,0.0,0.0,282528,Peroxisomal Disorders,0.210283505,2,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,26936,Mycoplasma Infections,0.210283505,1,Biomarker
79719,AAGAB,alpha- and gamma-adaptin binding protein,0.0,1.0,0.0,0.0,0.0,22596,"Keratoderma, Palmoplantar",0.210283505,2,Biomarker
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.210283505,2,Biomarker
360,AQP3,aquaporin 3 (Gill blood group),0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.210283505,2,Biomarker
2810,SFN,stratifin,0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.210283505,2,Biomarker
53341,MHAC,microhydranencephaly,0.0,1.0,0.0,0.0,0.0,1857977,Microhydranencephaly,0.210283505,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,30193,Pain,0.210283505,4,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.210283505,6,Biomarker
5368,PNOC,prepronociceptin,0.0,1.0,0.0,0.0,1.0,30193,Pain,0.210283505,2,"Biomarker, Therapeutic"
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.210283505,3,Biomarker
8989,TRPA1,"transient receptor potential cation channel, subfamily A, member 1",0.0,1.0,0.0,0.0,0.0,30193,Pain,0.210283505,2,Biomarker
5069,PAPPA,"pregnancy-associated plasma protein A, pappalysin 1",0.0,1.0,0.0,0.0,0.0,2965,"Angina, Unstable",0.210283505,2,Biomarker
56729,RETN,resistin,0.0,1.0,0.0,0.0,0.0,403447,"Renal Insufficiency, Chronic",0.210283505,2,Biomarker
338,APOB,apolipoprotein B,0.0,1.0,0.0,0.0,0.0,1704299,"Hypobetalipoproteinemia, Familial, Apolipoprotein B",0.210283505,4,Biomarker
57096,RPGRIP1,retinitis pigmentosa GTPase regulator interacting protein 1,0.0,1.0,0.0,0.0,0.0,28738,"Nystagmus, Pathologic",0.210283505,1,Biomarker
7799,PRDM2,"PR domain containing 2, with ZNF domain",0.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.210283505,1,Biomarker
9446,GSTO1,glutathione S-transferase omega 1,0.0,1.0,1.0,0.0,0.0,24115,Lung Diseases,0.210283505,1,"Biomarker, GeneticVariation"
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.210283505,2,Biomarker
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.210283505,2,Biomarker
6299,SALL1,spalt-like transcription factor 1,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.210283505,3,Biomarker
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,1.0,0.0,0.0,13384,Dyskinesias,0.210283505,2,"Biomarker, GeneticVariation"
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,1.0,0.0,0.0,13384,Dyskinesias,0.210283505,1,"Biomarker, GeneticVariation"
84152,PPP1R1B,"protein phosphatase 1, regulatory (inhibitor) subunit 1B",0.0,1.0,0.0,0.0,1.0,13384,Dyskinesias,0.210283505,2,"Biomarker, Therapeutic"
10801,9-Sep,septin 9,0.0,1.0,0.0,0.0,0.0,221759,Brachial Plexus Neuritis,0.210283505,2,Biomarker
10342,TFG,TRK-fused gene,0.0,1.0,0.0,0.0,0.0,1275278,"Chondrosarcoma, Extraskeletal Myxoid",0.210283505,1,Biomarker
4221,MEN1,multiple endocrine neoplasia I,0.0,1.0,0.0,0.0,0.0,11993,Vipoma,0.210283505,2,Biomarker
780915,CHNG3,"Hypothyroidism, congenital, nongoitrous, 3",0.0,1.0,0.0,0.0,0.0,2940785,"Hypothyroidism, Congenital, Nongoitrous, 3",0.210283505,1,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,745744,End Stage Liver Disease,0.210283505,2,Biomarker
26503,SLC17A5,"solute carrier family 17 (acidic sugar transporter), member 5",0.0,1.0,0.0,0.0,0.0,342853,Sialic Acid Storage Disease,0.210283505,1,Biomarker
5192,PEX10,peroxisomal biogenesis factor 10,0.0,1.0,0.0,0.0,0.0,43459,Zellweger Syndrome,0.210283505,3,Biomarker
5824,PEX19,peroxisomal biogenesis factor 19,0.0,1.0,0.0,0.0,0.0,43459,Zellweger Syndrome,0.210283505,1,Biomarker
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,242422,Parkinsonian Disorders,0.210283505,2,Biomarker
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",0.0,1.0,0.0,0.0,1.0,242422,Parkinsonian Disorders,0.210283505,2,"Biomarker, Therapeutic"
170,AFA,ankyloblepharon filiforme adnatum,0.0,1.0,0.0,0.0,0.0,1862866,Ankyloblepharon filiforme adnatum cleft palate,0.210283505,1,Biomarker
3855,KRT7,"keratin 7, type II",0.0,1.0,0.0,0.0,0.0,1510502,"Adenoma, Oxyphilic",0.210283505,1,Biomarker
5816,PVALB,parvalbumin,0.0,1.0,0.0,0.0,0.0,1510502,"Adenoma, Oxyphilic",0.210283505,1,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,0.0,0.0,0.0,206729,Neurofibrosarcoma,0.210283505,1,Biomarker
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.210283505,2,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.210283505,2,Biomarker
4603,MYBL1,v-myb avian myeloblastosis viral oncogene homolog-like 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.210283505,2,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.210283505,2,Biomarker
1152,CKB,"creatine kinase, brain",0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.210283505,2,Biomarker
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,85269,"Plasma Cell Granuloma, Pulmonary",0.210283505,2,Biomarker
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,10417,Cryptorchidism,0.210283505,1,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210283505,2,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210283505,1,Biomarker
1848,DUSP6,dual specificity phosphatase 6,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210283505,1,Biomarker
2195,FAT1,FAT atypical cadherin 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210283505,1,Biomarker
23462,HEY1,hes-related family bHLH transcription factor with YRPW motif 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210283505,2,Biomarker
8358,HIST1H3B,"histone cluster 1, H3b",0.0,1.0,1.0,0.0,0.0,17636,Glioblastoma,0.210283505,2,"Biomarker, GeneticVariation"
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,17636,Glioblastoma,0.210283505,2,"Biomarker, Therapeutic"
182,JAG1,jagged 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210283505,2,Biomarker
3714,JAG2,jagged 2,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210283505,2,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210283505,2,Biomarker
346288,14-Sep,septin 14,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.210283505,1,Biomarker
7052,TGM2,transglutaminase 2,0.0,1.0,0.0,0.0,1.0,17636,Glioblastoma,0.210283505,3,"Biomarker, Therapeutic"
429,ASCL1,achaete-scute family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,1275808,Congenital central hypoventilation syndrome,0.210283505,1,Biomarker
1908,EDN3,endothelin 3,0.0,1.0,0.0,0.0,0.0,1275808,Congenital central hypoventilation syndrome,0.210283505,2,Biomarker
58484,NLRC4,"NLR family, CARD domain containing 4",0.0,1.0,0.0,0.0,0.0,14356,Enterocolitis,0.210283505,1,Biomarker
3973,LHCGR,luteinizing hormone/choriogonadotropin receptor,0.0,1.0,0.0,0.0,0.0,36875,Disorders of Sex Development,0.210283505,2,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,5967,Bone Neoplasms,0.210283505,2,Biomarker
10269,ZMPSTE24,zinc metallopeptidase STE24,0.0,1.0,0.0,0.0,0.0,917990,Acro-Osteolysis,0.210283505,3,Biomarker
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,1815,Primary Myelofibrosis,0.210283505,2,Biomarker
894,CCND2,cyclin D2,0.0,1.0,0.0,0.0,0.0,1863924,Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome,0.210283505,1,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,1863924,Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome,0.210283505,2,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,376670,"Pancreatitis, Alcoholic",0.210283505,1,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,524851,Neurodegenerative Diseases,0.210283505,2,"Biomarker, Therapeutic"
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.210283505,2,Biomarker
9446,GSTO1,glutathione S-transferase omega 1,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.210283505,2,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.210283505,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.210283505,4,Biomarker
54902,TTC19,tetratricopeptide repeat domain 19,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.210283505,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,1.0,14866,Esophageal Stenosis,0.210283505,1,"Biomarker, Therapeutic"
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,0.0,0.0,0.0,42870,Vitamin D Deficiency,0.210283505,1,Biomarker
4598,MVK,mevalonate kinase,0.0,1.0,0.0,0.0,0.0,3862,Arthralgia,0.210283505,2,Biomarker
2253,FGF8,fibroblast growth factor 8 (androgen-induced),0.0,1.0,0.0,0.0,0.0,2936346,22q11 Deletion Syndrome,0.210283505,1,Biomarker
5828,PEX2,peroxisomal biogenesis factor 2,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.210283505,3,Biomarker
2984,GUCY2C,guanylate cyclase 2C,0.0,1.0,1.0,0.0,0.0,2939175,Meconium ileus,0.210283505,1,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,2,Biomarker
760,CA2,carbonic anhydrase II,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,2,Biomarker
1152,CKB,"creatine kinase, brain",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,2,Biomarker
1592,CYP26A1,"cytochrome P450, family 26, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,1,Biomarker
9420,CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,1,Biomarker
780,DDR1,discoidin domain receptor tyrosine kinase 1,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,2,Biomarker
2254,FGF9,fibroblast growth factor 9,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,2,Biomarker
3312,HSPA8,heat shock 70kDa protein 8,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,2,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,2,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,1.0,1418,Adenocarcinoma,0.210283505,2,"Biomarker, Therapeutic"
5587,PRKD1,protein kinase D1,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,1,Biomarker
5915,RARB,"retinoic acid receptor, beta",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,2,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.210283505,2,Biomarker
132158,GLYCTK,glycerate kinase,0.0,1.0,1.0,0.0,0.0,342765,D-Glyceric aciduria,0.210283505,1,"Biomarker, GeneticVariation"
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.210283505,2,Biomarker
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,0.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.210283505,1,Biomarker
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,0.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.210283505,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,1.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.210283505,2,"Biomarker, GeneticVariation"
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.210283505,3,Biomarker
5048,PAFAH1B1,"platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)",1.0,1.0,0.0,0.0,0.0,596263,Carcinogenesis,0.210283505,2,"AlteredExpression, Biomarker"
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.210283505,2,Biomarker
57492,ARID1B,AT rich interactive domain 1B (SWI1-like),0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.210283505,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.210283505,1,Biomarker
11200,CHEK2,checkpoint kinase 2,0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.210283505,2,Biomarker
3456,IFNB1,"interferon, beta 1, fibroblast",0.0,1.0,0.0,0.0,1.0,27819,Neuroblastoma,0.210283505,2,"Biomarker, Therapeutic"
7869,SEMA3B,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B",0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.210283505,1,Biomarker
114,ADCY8,adenylate cyclase 8 (brain),0.0,1.0,0.0,0.0,0.0,525045,Mood Disorders,0.210283505,1,Biomarker
126133,ALDH16A1,"aldehyde dehydrogenase 16 family, member A1",0.0,1.0,0.0,0.0,0.0,740394,Hyperuricemia,0.210283505,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,85655,Polymyositis,0.210283505,2,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.210283505,1,Biomarker
2200,FBN1,fibrillin 1,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.210283505,1,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.210283505,2,Biomarker
5292,PIM1,"Pim-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,34186,Pyelonephritis,0.210283505,1,Biomarker
10367,MICU1,mitochondrial calcium uptake 1,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.210283505,1,Biomarker
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.210283505,2,Biomarker
867,CBL,"Cbl proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.210283505,1,Biomarker
81704,DOCK8,dedicator of cytokinesis 8,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.210283505,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.210283505,4,Biomarker
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.210283505,2,Biomarker
6535,SLC6A8,"solute carrier family 6 (neurotransmitter transporter), member 8",0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.210283505,2,Biomarker
90,ACVR1,"activin A receptor, type I",0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.210283505,1,Biomarker
9113,LATS1,large tumor suppressor kinase 1,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.210283505,1,Biomarker
26524,LATS2,large tumor suppressor kinase 2,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.210283505,1,Biomarker
4853,NOTCH2,notch 2,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.210283505,2,Biomarker
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.210283505,2,Biomarker
5157,PDGFRL,platelet-derived growth factor receptor-like,0.0,1.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.210283505,2,"Biomarker, GeneticVariation"
2302,FOXJ1,forkhead box J1,0.0,1.0,0.0,0.0,0.0,2607914,"Rhinitis, Allergic",0.210283505,1,Biomarker
51057,WDPCP,WD repeat containing planar cell polarity effector,0.0,1.0,0.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.210283505,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,1.0,11882,Diabetic Neuropathies,0.210283505,2,"Biomarker, Therapeutic"
4908,NTF3,neurotrophin 3,0.0,1.0,0.0,0.0,1.0,11882,Diabetic Neuropathies,0.210283505,2,"Biomarker, Therapeutic"
3945,LDHB,lactate dehydrogenase B,0.0,1.0,0.0,0.0,0.0,7124,"Carcinoma, Intraductal, Noninfiltrating",0.210283505,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,24143,Lupus Nephritis,0.210283505,2,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.210283505,1,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.210283505,2,Biomarker
7948,PBCRA1,progressive bifocal chorioretinal atrophy 1,0.0,1.0,0.0,0.0,0.0,1833321,"Chorioretinal atrophy, progressive bifocal",0.210283505,1,Biomarker
80144,FRAS1,Fraser extracellular matrix complex subunit 1,0.0,1.0,0.0,0.0,0.0,24433,Macrostomia,0.210283505,1,Biomarker
2073,ERCC5,excision repair cross-complementation group 5,0.0,1.0,0.0,0.0,0.0,220722,Cerebrooculofacioskeletal Syndrome 1,0.210283505,1,Biomarker
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.210283505,2,Biomarker
10269,ZMPSTE24,zinc metallopeptidase STE24,0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.210283505,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.210283505,2,Biomarker
4089,SMAD4,SMAD family member 4,0.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.210283505,2,Biomarker
873,CBR1,carbonyl reductase 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.210283505,2,Biomarker
1592,CYP26A1,"cytochrome P450, family 26, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.210283505,1,Biomarker
1670,DEFA5,"defensin, alpha 5, Paneth cell-specific",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.210283505,2,Biomarker
2203,FBP1,"fructose-1,6-bisphosphatase 1",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.210283505,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.210283505,2,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,796031,Malouf syndrome,0.210283505,1,"Biomarker, GeneticVariation"
1469,CST1,cystatin SN,0.0,1.0,0.0,0.0,0.0,18621,"Rhinitis, Allergic, Seasonal",0.210283505,1,Biomarker
1675,CFD,complement factor D (adipsin),0.0,1.0,1.0,0.0,0.0,398764,Complement Factor D Deficiency,0.210283505,1,"Biomarker, GeneticVariation"
1357,CPA1,carboxypeptidase A1 (pancreatic),0.0,1.0,0.0,0.0,0.0,149521,"Pancreatitis, Chronic",0.210283505,1,Biomarker
51360,MBTPS2,"membrane-bound transcription factor peptidase, site 2",0.0,1.0,1.0,0.0,0.0,3275579,IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME,0.210283505,1,"Biomarker, GeneticVariation"
57104,PNPLA2,patatin-like phospholipase domain containing 2,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.210283505,3,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.210283505,2,Biomarker
55997,CFC1,"cripto, FRL-1, cryptic family 1",0.0,1.0,0.0,0.0,0.0,40761,Transposition of Great Vessels,0.210283505,1,Biomarker
2657,GDF1,growth differentiation factor 1,0.0,1.0,0.0,0.0,0.0,40761,Transposition of Great Vessels,0.210283505,1,Biomarker
2187,FANCB,"Fanconi anemia, complementation group B",0.0,1.0,0.0,0.0,0.0,2931228,"VACTERL association with hydrocephaly, X-linked",0.210283505,1,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,85548,"Polycystic Kidney, Autosomal Recessive",0.210283505,2,Biomarker
3848,KRT1,"keratin 1, type II",0.0,1.0,0.0,0.0,0.0,1840296,"Ichthyosis hystrix, Curth Macklin type",0.210283505,1,Biomarker
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,1.0,0.0,0.0,1.0,2622,Amnesia,0.210283505,2,"Biomarker, Therapeutic"
2776,GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",0.0,1.0,1.0,0.0,0.0,235752,Port-Wine Stain,0.210283505,1,"Biomarker, GeneticVariation"
5921,RASA1,RAS p21 protein activator (GTPase activating protein) 1,0.0,1.0,0.0,0.0,0.0,235752,Port-Wine Stain,0.210283505,2,Biomarker
1072,CFL1,cofilin 1 (non-muscle),0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,2,Biomarker
27436,EML4,echinoderm microtubule associated protein like 4,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,3,Biomarker
2877,GPX2,glutathione peroxidase 2 (gastrointestinal),0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,1,Biomarker
406899,MIR106A,microRNA 106a,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,2,Biomarker
406910,MIR125A,microRNA 125a,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,2,Biomarker
574033,MIR18B,microRNA 18b,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,2,Biomarker
406974,MIR197,microRNA 197,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,2,Biomarker
693223,MIR638,microRNA 638,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,2,Biomarker
407053,MIR96,microRNA 96,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,2,Biomarker
407055,MIR99A,microRNA 99a,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,2,Biomarker
5395,PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,2,Biomarker
101669767,SCHLAP1,SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding),0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.210283505,1,Biomarker
1109,AKR1C4,"aldo-keto reductase family 1, member C4",0.0,1.0,0.0,0.0,0.0,1456784,Paranoid Disorders,0.210283505,1,Biomarker
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,0.0,0.0,0.0,1456784,Paranoid Disorders,0.210283505,2,Biomarker
2891,GRIA2,"glutamate receptor, ionotropic, AMPA 2",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.210283505,2,Biomarker
57468,SLC12A5,"solute carrier family 12 (potassium/chloride transporter), member 5",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.210283505,1,Biomarker
1889,ECE1,endothelin converting enzyme 1,0.0,1.0,0.0,0.0,0.0,19569,Hirschsprung Disease,0.210283505,2,Biomarker
50947,BHD,Beukes familial hip dysplasia,0.0,1.0,0.0,0.0,0.0,1840572,"Hip Dysplasia, Beukes Type",0.210283505,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,27059,Myocarditis,0.210283505,2,Biomarker
90,ACVR1,"activin A receptor, type I",0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210283505,3,Biomarker
347,APOD,apolipoprotein D,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210283505,1,Biomarker
8358,HIST1H3B,"histone cluster 1, H3b",0.0,1.0,1.0,0.0,0.0,17638,Glioma,0.210283505,2,"Biomarker, GeneticVariation"
4603,MYBL1,v-myb avian myeloblastosis viral oncogene homolog-like 1,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210283505,2,Biomarker
6098,ROS1,"ROS proto-oncogene 1 , receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210283505,2,Biomarker
7494,XBP1,X-box binding protein 1,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.210283505,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.210283505,2,Biomarker
431709,MDD2,Major depressive disorder 2,0.0,1.0,0.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.210283505,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.210283505,2,Biomarker
3659,IRF1,interferon regulatory factor 1,0.0,1.0,0.0,0.0,0.0,740302,5q- syndrome,0.210283505,1,Biomarker
3796,KIF2A,kinesin heavy chain member 2A,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.210283505,1,Biomarker
3800,KIF5C,kinesin family member 5C,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.210283505,1,Biomarker
10733,PLK4,polo-like kinase 4,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.210283505,1,Biomarker
11284,PNKP,polynucleotide kinase 3'-phosphatase,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.210283505,1,Biomarker
9411,ARHGAP29,Rho GTPase activating protein 29,0.0,1.0,0.0,0.0,0.0,334634,"Lymphoma, Mantle-Cell",0.210283505,1,Biomarker
1977,EIF4E,eukaryotic translation initiation factor 4E,0.0,1.0,0.0,0.0,0.0,334634,"Lymphoma, Mantle-Cell",0.210283505,2,Biomarker
54556,ING3,"inhibitor of growth family, member 3",0.0,1.0,1.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.210283505,2,"Biomarker, GeneticVariation"
3236,HOXD10,homeobox D10,0.0,1.0,0.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.210283505,2,Biomarker
3814,KISS1,KiSS-1 metastasis-suppressor,0.0,1.0,0.0,0.0,1.0,1168401,"Carcinoma, squamous cell of head and neck",0.210283505,1,"Biomarker, Therapeutic"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,265318,"Nevus, Sebaceous of Jadassohn",0.210283505,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,1261473,Sarcoma,0.210283505,2,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,1.0,1261473,Sarcoma,0.210283505,2,"Biomarker, Therapeutic"
55534,MAML3,mastermind-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,1261473,Sarcoma,0.210283505,1,Biomarker
481,ATP1B1,"ATPase, Na+/K+ transporting, beta 1 polypeptide",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.210283505,1,Biomarker
1889,ECE1,endothelin converting enzyme 1,0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.210283505,1,Biomarker
51320,MEX3C,mex-3 RNA binding family member C,0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.210283505,1,Biomarker
8490,RGS5,regulator of G-protein signaling 5,0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.210283505,1,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,1.0,0.0,0.0,3850,Arteriosclerosis,0.210283505,2,"Biomarker, GeneticVariation"
777643,GLC1M,"glaucoma 1, open angle, M (juvenile-onset)",0.0,1.0,0.0,0.0,0.0,1864653,"Glaucoma 1, Open Angle, M",0.210283505,1,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,238198,Gastrointestinal Stromal Tumors,0.210283505,1,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.210283505,2,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.210283505,1,Biomarker
84181,CHD6,chromodomain helicase DNA binding protein 6,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.210283505,1,Biomarker
2033,EP300,E1A binding protein p300,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.210283505,2,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,7138,"Carcinoma, Transitional Cell",0.210283505,2,"Biomarker, Therapeutic"
3486,IGFBP3,insulin-like growth factor binding protein 3,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.210283505,2,Biomarker
9611,NCOR1,nuclear receptor corepressor 1,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.210283505,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,1.0,7138,"Carcinoma, Transitional Cell",0.210283505,2,"Biomarker, Therapeutic"
374654,KIF7,kinesin family member 7,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.210283505,1,Biomarker
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.210283505,2,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210283505,2,Biomarker
6354,CCL7,chemokine (C-C motif) ligand 7,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210283505,2,Biomarker
959,CD40LG,CD40 ligand,0.0,1.0,1.0,0.0,0.0,32285,Pneumonia,0.210283505,2,"Biomarker, GeneticVariation"
2919,CXCL1,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210283505,2,Biomarker
6374,CXCL5,chemokine (C-X-C motif) ligand 5,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210283505,2,Biomarker
2833,CXCR3,chemokine (C-X-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210283505,2,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210283505,2,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.210283505,2,Biomarker
8379,MAD1L1,MAD1 mitotic arrest deficient-like 1 (yeast),0.0,1.0,1.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.210283505,1,"Biomarker, GeneticVariation"
5307,PITX1,paired-like homeodomain 1,0.0,1.0,0.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.210283505,1,Biomarker
55159,RFWD3,ring finger and WD repeat domain 3,0.0,1.0,1.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.210283505,1,"Biomarker, GeneticVariation"
6369,CCL24,chemokine (C-C motif) ligand 24,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.210283505,2,Biomarker
2833,CXCR3,chemokine (C-X-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.210283505,2,Biomarker
981,CDAN3,"congenital dyserythropoietic anemia, type III",0.0,1.0,0.0,0.0,0.0,2876,"Anemia, Dyserythropoietic, Congenital",0.210283505,1,Biomarker
5959,RDH5,retinol dehydrogenase 5 (11-cis/9-cis),0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.210283505,2,Biomarker
397,ARHGDIB,Rho GDP dissociation inhibitor (GDI) beta,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210283505,2,Biomarker
9531,BAG3,BCL2-associated athanogene 3,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210283505,1,Biomarker
581,BAX,BCL2-associated X protein,1.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210283505,2,"AlteredExpression, Biomarker"
330,BIRC3,baculoviral IAP repeat containing 3,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210283505,2,Biomarker
5702,PSMC3,"proteasome (prosome, macropain) 26S subunit, ATPase, 3",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.210283505,2,Biomarker
7303,TYS,sclerotylosis,0.0,1.0,1.0,0.0,0.0,406767,Sclerotylosis,0.210283505,1,"Biomarker, GeneticVariation"
55806,HR,hair growth associated,0.0,1.0,0.0,0.0,0.0,2931059,Marie Unna congenital hypotrichosis,0.210283505,1,Biomarker
7035,TFPI,tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor),0.0,1.0,0.0,0.0,1.0,1883,Airway Obstruction,0.210283505,2,"Biomarker, Therapeutic"
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210283505,2,Biomarker
1509,CTSD,cathepsin D,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210283505,2,Biomarker
6372,CXCL6,chemokine (C-X-C motif) ligand 6,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210283505,1,Biomarker
10085,EDIL3,EGF-like repeats and discoidin I-like domains 3,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210283505,2,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210283505,2,Biomarker
5352,PLOD2,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210283505,2,Biomarker
7980,TFPI2,tissue factor pathway inhibitor 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210283505,1,Biomarker
7052,TGM2,transglutaminase 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210283505,2,Biomarker
23321,TRIM2,tripartite motif containing 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.210283505,1,Biomarker
1213,CLTC,"clathrin, heavy chain (Hc)",0.0,1.0,1.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.210283505,2,"Biomarker, GeneticVariation"
5170,PDPK1,3-phosphoinositide dependent protein kinase 1,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.210283505,1,Biomarker
6198,RPS6KB1,"ribosomal protein S6 kinase, 70kDa, polypeptide 1",0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.210283505,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.210283505,2,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,162871,"Aortic Aneurysm, Abdominal",0.210283505,2,Biomarker
1583,CYP11A1,"cytochrome P450, family 11, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,2751824,"46, XY Disorders of Sex Development",0.210283505,2,Biomarker
3973,LHCGR,luteinizing hormone/choriogonadotropin receptor,0.0,1.0,0.0,0.0,0.0,2751824,"46, XY Disorders of Sex Development",0.210283505,2,Biomarker
3159,HMGA1,high mobility group AT-hook 1,0.0,1.0,1.0,0.0,0.0,524620,Metabolic Syndrome X,0.210283505,1,"Biomarker, GeneticVariation"
3929,LBP,lipopolysaccharide binding protein,0.0,1.0,0.0,0.0,0.0,524620,Metabolic Syndrome X,0.210283505,1,Biomarker
79661,NEIL1,nei endonuclease VIII-like 1 (E. coli),0.0,1.0,0.0,0.0,0.0,524620,Metabolic Syndrome X,0.210283505,2,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,524620,Metabolic Syndrome X,0.210283505,2,Biomarker
27089,UQCRQ,"ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa",0.0,1.0,0.0,0.0,0.0,1852372,Mitochondrial Complex III Deficiency,0.210283505,1,Biomarker
113278,SLC52A3,"solute carrier family 52 (riboflavin transporter), member 3",0.0,1.0,0.0,0.0,0.0,30442,"Bulbar Palsy, Progressive",0.210283505,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,11884,Diabetic Retinopathy,0.210283505,2,Biomarker
26005,C2CD3,C2 calcium-dependent domain containing 3,0.0,1.0,0.0,0.0,0.0,29294,Orofaciodigital Syndromes,0.210283505,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,1.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,"Biomarker, GeneticVariation"
10752,CHL1,cell adhesion molecule L1-like,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
10522,DEAF1,DEAF1 transcription factor,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,1,Biomarker
1778,DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
11160,ERLIN2,ER lipid raft associated 2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
9759,HDAC4,histone deacetylase 4,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
284058,KANSL1,KAT8 regulatory NSL complex subunit 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
55180,LINS,lines homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
11253,MAN1B1,"mannosidase, alpha, class 1B, member 1",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
23389,MED13L,mediator complex subunit 13-like,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
26040,SETBP1,SET binding protein 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
80185,TTI2,TELO2 interacting protein 2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.210283505,2,Biomarker
51129,ANGPTL4,angiopoietin-like 4,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
9582,APOBEC3B,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,3,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
958,CD40,"CD40 molecule, TNF receptor superfamily member 5",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
8065,CUL5,cullin 5,0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
2921,CXCL3,chemokine (C-X-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
1649,DDIT3,DNA-damage-inducible transcript 3,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
3692,EIF6,eukaryotic translation initiation factor 6,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
2050,EPHB4,EPH receptor B4,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
2255,FGF10,fibroblast growth factor 10,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
10468,FST,follistatin,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
3002,GZMB,"granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
26508,HEYL,hes-related family bHLH transcription factor with YRPW motif-like,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
3273,HRG,histidine-rich glycoprotein,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
7087,ICAM5,"intercellular adhesion molecule 5, telencephalin",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
10660,LBX1,ladybird homeobox 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
4017,LOXL2,lysyl oxidase-like 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,1,Biomarker
4240,MFGE8,milk fat globule-EGF factor 8 protein,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
406996,MIR214,microRNA 214,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
407013,MIR24-2,microRNA 24-2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,1,Biomarker
9801,MRPL19,mitochondrial ribosomal protein L19,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
4504,MT3,metallothionein 3,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
26227,PHGDH,phosphoglycerate dehydrogenase,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
5292,PIM1,"Pim-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
8438,RAD54L,RAD54-like (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,1,Biomarker
9154,SLC28A1,"solute carrier family 28 (concentrative nucleoside transporter), member 1",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
81031,SLC2A10,"solute carrier family 2 (facilitated glucose transporter), member 10",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,1,Biomarker
3925,STMN1,stathmin 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,3,Biomarker
10381,TUBB3,"tubulin, beta 3 class III",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.210283505,2,Biomarker
3159,HMGA1,high mobility group AT-hook 1,0.0,1.0,0.0,0.0,0.0,23269,Leiomyosarcoma,0.210283505,2,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,23269,Leiomyosarcoma,0.210283505,2,Biomarker
5604,MAP2K1,mitogen-activated protein kinase kinase 1,0.0,1.0,0.0,0.0,0.0,587248,Costello Syndrome,0.210283505,2,Biomarker
317773,MGR6,"Migraine, several forms",0.0,1.0,0.0,0.0,0.0,149931,Migraine Disorders,0.210283505,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,19212,Hepatorenal Syndrome,0.210283505,1,Biomarker
92749,DRC1,dynein regulatory complex subunit 1,0.0,1.0,0.0,0.0,0.0,22521,Kartagener Syndrome,0.210283505,1,Biomarker
161582,DYX1C1,dyslexia susceptibility 1 candidate 1,0.0,1.0,0.0,0.0,0.0,22521,Kartagener Syndrome,0.210283505,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
554,AVPR2,arginine vasopressin receptor 2,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
2053,EPHX2,"epoxide hydrolase 2, cytoplasmic",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,1,Biomarker
2628,GATM,glycine amidinotransferase (L-arginine:glycine amidinotransferase),0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,1,Biomarker
50507,NOX4,NADPH oxidase 4,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
4881,NPR1,natriuretic peptide receptor 1,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
5170,PDPK1,3-phosphoinositide dependent protein kinase 1,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,3,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.210283505,2,Biomarker
8820,HESX1,HESX homeobox 1,0.0,1.0,0.0,0.0,0.0,2930844,Hypopituitarism and septooptic 'dysplasia',0.210283505,1,Biomarker
50976,GRD2,"Graves disease, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,18213,Graves Disease,0.210283505,1,Biomarker
6750,SST,somatostatin,0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.210283505,1,Biomarker
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,0.0,0.0,0.0,549567,Pigmentation Disorders,0.210283505,2,Biomarker
1269,CNR2,cannabinoid receptor 2 (macrophage),0.0,1.0,0.0,0.0,1.0,20429,Hyperalgesia,0.210283505,3,"Biomarker, Therapeutic"
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.210283505,2,Biomarker
440275,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.210283505,1,Biomarker
2629,GBA,"glucosidase, beta, acid",0.0,1.0,1.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.210283505,1,"Biomarker, GeneticVariation"
7166,TPH1,tryptophan hydroxylase 1,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.210283505,2,Biomarker
27161,AGO2,argonaute RISC catalytic component 2,0.0,1.0,0.0,0.0,0.0,23470,"Leukemia, Myeloid",0.210283505,1,Biomarker
3066,HDAC2,histone deacetylase 2,0.0,1.0,0.0,0.0,0.0,23470,"Leukemia, Myeloid",0.210283505,1,Biomarker
7001,PRDX2,peroxiredoxin 2,0.0,1.0,0.0,0.0,1.0,23470,"Leukemia, Myeloid",0.210283505,1,"Biomarker, Therapeutic"
9034,CCRL2,chemokine (C-C motif) receptor-like 2,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.210283505,2,Biomarker
9308,CD83,CD83 molecule,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.210283505,2,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,1.0,0.0,0.0,18794,Heart Block,0.210283505,2,"Biomarker, GeneticVariation"
6336,SCN10A,"sodium channel, voltage gated, type X alpha subunit",0.0,1.0,0.0,0.0,0.0,18794,Heart Block,0.210283505,2,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,26764,Multiple Myeloma,0.210283505,4,"Biomarker, Therapeutic"
23532,PRAME,preferentially expressed antigen in melanoma,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.210283505,2,Biomarker
23384,SPECC1L,sperm antigen with calponin homology and coiled-coil domains 1-like,0.0,1.0,1.0,0.0,0.0,1838348,Oculomaxillofacial dysostosis,0.210283505,2,"Biomarker, GeneticVariation"
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,13080,Down Syndrome,0.210283505,2,Biomarker
450097,RLS2,Restless legs syndrome 2,0.0,1.0,0.0,0.0,0.0,35258,Restless Legs Syndrome,0.210283505,1,Biomarker
100188813,RLS4,Restless legs syndrome 4,0.0,1.0,0.0,0.0,0.0,35258,Restless Legs Syndrome,0.210283505,1,Biomarker
100188839,RLS5,"Restless legs syndrome, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,35258,Restless Legs Syndrome,0.210283505,1,Biomarker
100302512,RLS6,"Restless legs syndrome, susceptibility to, 6",0.0,1.0,0.0,0.0,0.0,35258,Restless Legs Syndrome,0.210283505,1,Biomarker
6869,TACR1,tachykinin receptor 1,0.0,1.0,0.0,0.0,0.0,42963,Vomiting,0.210283505,2,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,42109,Urticaria,0.210283505,2,Biomarker
63895,PIEZO2,piezo-type mechanosensitive ion channel component 2,0.0,1.0,1.0,0.0,0.0,796033,Marden-Walker syndrome,0.210283505,1,"Biomarker, GeneticVariation"
9547,CXCL14,chemokine (C-X-C motif) ligand 14,0.0,1.0,0.0,0.0,1.0,24121,Lung Neoplasms,0.210283505,1,"Biomarker, Therapeutic"
780,DDR1,discoidin domain receptor tyrosine kinase 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,2,Biomarker
9940,DLEC1,deleted in lung and esophageal cancer 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,1,Biomarker
9046,DOK2,"docking protein 2, 56kDa",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,1,Biomarker
79930,DOK3,docking protein 3,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,1,Biomarker
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,2,Biomarker
5609,MAP2K7,mitogen-activated protein kinase kinase 7,1.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,2,"AlteredExpression, Biomarker"
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,3,Biomarker
5519,PPP2R1B,"protein phosphatase 2, regulatory subunit A, beta",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,1,Biomarker
9588,PRDX6,peroxiredoxin 6,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,2,Biomarker
10253,SPRY2,sprouty homolog 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,2,Biomarker
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,2,Biomarker
7011,TEP1,telomerase-associated protein 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,2,Biomarker
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.210283505,2,Biomarker
5460,POU5F1,POU class 5 homeobox 1,0.0,1.0,0.0,0.0,0.0,2931618,Gestational Trophoblastic Disease,0.210283505,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,5940,Bone Diseases,0.210283505,2,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,30312,Pancytopenia,0.210283505,3,"Biomarker, Therapeutic"
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,30312,Pancytopenia,0.210283505,2,"Biomarker, Therapeutic"
5787,PTPRB,"protein tyrosine phosphatase, receptor type, B",0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.210283505,1,Biomarker
7010,TEK,"TEK tyrosine kinase, endothelial",0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.210283505,2,Biomarker
2138,EYA1,EYA transcriptional coactivator and phosphatase 1,0.0,1.0,0.0,0.0,0.0,18777,"Hearing Loss, Conductive",0.210283505,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.210283505,2,Biomarker
93659,CGB5,"chorionic gonadotropin, beta polypeptide 5",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.210283505,2,Biomarker
2549,GAB1,GRB2-associated binding protein 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.210283505,2,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.210283505,2,"Biomarker, GeneticVariation"
5120,PCOS1,polycystic ovary syndrome 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.210283505,1,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.210283505,2,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.210283505,2,Biomarker
9420,CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.210283505,1,Biomarker
27306,HPGDS,hematopoietic prostaglandin D synthase,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.210283505,2,Biomarker
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,0.0,0.0,1.0,0.0,1.0,23895,Liver Diseases,0.210283505,2,"GeneticVariation, Therapeutic"
7295,TXN,thioredoxin,0.0,1.0,0.0,0.0,1.0,23895,Liver Diseases,0.210283505,2,"Biomarker, Therapeutic"
26137,ZBTB20,zinc finger and BTB domain containing 20,0.0,1.0,0.0,0.0,0.0,796121,Primrose syndrome,0.210283505,1,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.210283505,1,Biomarker
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.210283505,2,Biomarker
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,18552,Hamartoma,0.210283505,1,Biomarker
26249,KLHL3,kelch-like family member 3,0.0,1.0,0.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.210283505,2,Biomarker
65125,WNK1,WNK lysine deficient protein kinase 1,0.0,1.0,0.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.210283505,2,Biomarker
65266,WNK4,WNK lysine deficient protein kinase 4,0.0,1.0,0.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.210283505,2,Biomarker
3407,IDDM8,insulin-dependent diabetes mellitus 8,0.0,1.0,0.0,0.0,0.0,1833218,"Diabetes Mellitus, Insulin-Dependent, 8",0.210283505,1,Biomarker
10320,IKZF1,IKAROS family zinc finger 1 (Ikaros),0.0,1.0,0.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.210283505,2,Biomarker
772,CACD,central areolar choroidal dystrophy,0.0,1.0,0.0,0.0,0.0,1536451,Choroidal dystrophy central areolar,0.210283505,1,Biomarker
2200,FBN1,fibrillin 1,0.0,1.0,0.0,0.0,0.0,20459,Hyperinsulinism,0.210283505,1,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,20459,Hyperinsulinism,0.210283505,3,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,14474,Ependymoma,0.210283505,2,Biomarker
7291,TWIST1,twist family bHLH transcription factor 1,1.0,1.0,0.0,0.0,0.0,206180,"Lymphoma, Large-Cell, Anaplastic",0.210283505,1,"AlteredExpression, Biomarker"
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,1.0,1.0,0.0,0.0,85650,Purpura Fulminans,0.210283505,2,"Biomarker, GeneticVariation"
7909,HEMC,"hemangioma, capillary, hereditary",0.0,1.0,0.0,0.0,0.0,1865871,"Hemangioma, capillary infantile",0.210283505,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.210283505,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.210283505,2,Biomarker
6469,SHH,sonic hedgehog,0.0,1.0,0.0,0.0,0.0,9363,Coloboma,0.210283505,1,Biomarker
340024,SLC6A19,"solute carrier family 6 (neutral amino acid transporter), member 19",0.0,1.0,0.0,0.0,0.0,268654,Iminoglycinuria,0.210283505,1,Biomarker
3973,LHCGR,luteinizing hormone/choriogonadotropin receptor,0.0,1.0,1.0,0.0,0.0,23601,Leydig Cell Tumor,0.210283505,3,"Biomarker, GeneticVariation"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,0.0,0.0,0.0,31511,Pheochromocytoma,0.210283505,1,Biomarker
4128,MAOA,monoamine oxidase A,0.0,1.0,0.0,0.0,0.0,31511,Pheochromocytoma,0.210283505,1,Biomarker
654,BMP6,bone morphogenetic protein 6,0.0,1.0,0.0,0.0,0.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.210283505,1,Biomarker
3897,L1CAM,L1 cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,3537,Aphasia,0.210283505,2,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210283505,1,Biomarker
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210283505,2,Biomarker
2938,GSTA1,glutathione S-transferase alpha 1,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210283505,1,Biomarker
5467,PPARD,peroxisome proliferator-activated receptor delta,0.0,1.0,0.0,0.0,1.0,400966,Non-alcoholic Fatty Liver Disease,0.210283505,2,"Biomarker, Therapeutic"
53345,TM6SF2,transmembrane 6 superfamily member 2,0.0,1.0,1.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210283505,1,"Biomarker, GeneticVariation"
7494,XBP1,X-box binding protein 1,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.210283505,2,Biomarker
308,ANXA5,annexin A5,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210283505,2,Biomarker
9582,APOBEC3B,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210283505,1,Biomarker
1457,CSNK2A1,"casein kinase 2, alpha 1 polypeptide",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210283505,2,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210283505,2,Biomarker
90417,KNSTRN,kinetochore-localized astrin/SPAG5 binding protein,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210283505,1,Biomarker
4014,LOR,loricrin,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210283505,2,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210283505,1,Biomarker
23410,SIRT3,sirtuin 3,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.210283505,2,Biomarker
7012,TERC,telomerase RNA component,0.0,1.0,0.0,0.0,1.0,7137,"Carcinoma, Squamous Cell",0.210283505,2,"Biomarker, Therapeutic"
4963,OFC1,orofacial cleft 1,0.0,1.0,0.0,0.0,0.0,1861537,Orofacial Cleft 1,0.210283505,1,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,265338,Coffin-Siris syndrome,0.210283505,2,Biomarker
6598,SMARCB1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",0.0,1.0,0.0,0.0,0.0,265338,Coffin-Siris syndrome,0.210283505,1,Biomarker
6605,SMARCE1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1",0.0,1.0,0.0,0.0,0.0,265338,Coffin-Siris syndrome,0.210283505,2,Biomarker
2358,FPR2,formyl peptide receptor 2,0.0,1.0,0.0,0.0,0.0,10346,Crohn Disease,0.210283505,1,Biomarker
3952,LEP,leptin,0.0,1.0,1.0,0.0,0.0,20443,Hypercholesterolemia,0.210283505,2,"Biomarker, GeneticVariation"
8013,NR4A3,"nuclear receptor subfamily 4, group A, member 3",0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.210283505,2,Biomarker
4683,NBN,nibrin,0.0,1.0,0.0,0.0,0.0,38362,Stomatitis,0.210283505,1,Biomarker
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,0.0,1.0,1.0,0.0,0.0,38362,Stomatitis,0.210283505,2,"Biomarker, GeneticVariation"
1131,CHRM3,"cholinergic receptor, muscarinic 3",0.0,1.0,0.0,0.0,0.0,5686,Urinary Bladder Diseases,0.210283505,1,Biomarker
1828,DSG1,desmoglein 1,0.0,1.0,0.0,0.0,0.0,11603,Dermatitis,0.210283505,1,Biomarker
81858,SHARPIN,SHANK-associated RH domain interactor,0.0,1.0,0.0,0.0,0.0,11603,Dermatitis,0.210283505,2,Biomarker
7538,ZFP36,ZFP36 ring finger protein,0.0,1.0,0.0,0.0,0.0,11603,Dermatitis,0.210283505,2,Biomarker
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,0.0,1.0,0.0,0.0,0.0,23465,"Leukemia, Monocytic, Acute",0.210283505,1,Biomarker
158326,FREM1,FRAS1 related extracellular matrix 1,0.0,1.0,0.0,0.0,0.0,1609433,Hereditary renal agenesis,0.210283505,2,Biomarker
4322,MMP13,matrix metallopeptidase 13 (collagenase 3),0.0,1.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.210283505,2,"Biomarker, Therapeutic"
79600,TCTN1,tectonic family member 1,0.0,1.0,0.0,0.0,0.0,431399,Agenesis of Cerebellar Vermis,0.210283505,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,1.0,38454,Stroke,0.210283505,5,"Biomarker, Therapeutic"
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,0.0,1.0,0.0,1.0,38454,Stroke,0.210283505,2,"GeneticVariation, Therapeutic"
302,ANXA2,annexin A2,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210283505,2,Biomarker
117159,DCD,dermcidin,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210283505,2,Biomarker
1948,EFNB2,ephrin-B2,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210283505,2,Biomarker
2878,GPX3,glutathione peroxidase 3 (plasma),0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210283505,2,Biomarker
3054,HCFC1,host cell factor C1,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210283505,1,Biomarker
3875,KRT18,"keratin 18, type I",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210283505,3,Biomarker
3856,KRT8,"keratin 8, type II",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.210283505,3,Biomarker
407021,MIR29A,microRNA 29a,0.0,1.0,0.0,0.0,1.0,23903,Liver Neoplasms,0.210283505,2,"Biomarker, Therapeutic"
489,ATP2A3,"ATPase, Ca++ transporting, ubiquitous",0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.210283505,2,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.210283505,2,Biomarker
100188782,NIDDM4,"Diabetes mellitus, noninsulin-dependent",0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.210283505,1,Biomarker
5066,PAM,peptidylglycine alpha-amidating monooxygenase,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.210283505,1,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,17185,Gastrointestinal Neoplasms,0.210283505,2,Biomarker
85480,TSLP,thymic stromal lymphopoietin,0.0,1.0,0.0,0.0,0.0,17662,"Glomerulonephritis, Membranoproliferative",0.210283505,2,Biomarker
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210283505,2,Biomarker
4538,ND4,"NADH dehydrogenase, subunit 4 (complex I)",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210283505,2,Biomarker
6377,SCZD1,schizophrenia disorder 1,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210283505,1,Biomarker
63944,SCZD10,schizophrenia disorder 10 (periodic catatonia),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210283505,1,Biomarker
6378,SCZD2,schizophrenia disorder 2,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210283505,1,Biomarker
51150,SDF4,stromal cell derived factor 4,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210283505,2,Biomarker
7057,THBS1,thrombospondin 1,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.210283505,2,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,15696,"Fatty Liver, Alcoholic",0.210283505,2,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,1.0,0.0,0.0,25286,Meningioma,0.210283505,1,"Biomarker, GeneticVariation"
210,ALAD,aminolevulinate dehydratase,0.0,1.0,0.0,0.0,0.0,25286,Meningioma,0.210283505,1,Biomarker
10674,DURS1,Duane retraction syndrome 1,0.0,1.0,0.0,0.0,0.0,13261,Duane Retraction Syndrome,0.210283505,1,Biomarker
100310786,ALL2,"Leukemia, acute lymphoblastic, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.210283505,1,Biomarker
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.210283505,2,Biomarker
3233,HOXD4,homeobox D4,0.0,1.0,1.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.210283505,1,"Biomarker, GeneticVariation"
7468,WHSC1,Wolf-Hirschhorn syndrome candidate 1,0.0,1.0,0.0,0.0,1.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.210283505,1,"Biomarker, Therapeutic"
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,32617,Polyuria,0.210283505,2,Biomarker
63982,ANO3,anoctamin 3,0.0,1.0,1.0,0.0,0.0,9952,"Seizures, Febrile",0.210283505,1,"Biomarker, GeneticVariation"
112755,STX1B,syntaxin 1B,0.0,1.0,0.0,0.0,0.0,9952,"Seizures, Febrile",0.210283505,1,Biomarker
387569,ACF,Asymmetric crying facies (Cayler cardiofacial syndrome),0.0,1.0,0.0,0.0,0.0,431406,Cayler cardiofacial syndrome,0.210283505,1,Biomarker
2138,EYA1,EYA transcriptional coactivator and phosphatase 1,0.0,1.0,0.0,0.0,0.0,431406,Cayler cardiofacial syndrome,0.210283505,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,8479,Chondrosarcoma,0.210283505,1,Biomarker
54880,BCOR,BCL6 corepressor,0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.210283505,2,Biomarker
648,BMI1,"BMI1 proto-oncogene, polycomb ring finger",0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.210283505,1,Biomarker
85417,CCNB3,cyclin B3,0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.210283505,2,Biomarker
1965,EIF2S1,"eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa",0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.210283505,2,Biomarker
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.210283505,2,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.210283505,1,Biomarker
2914,GRM4,"glutamate receptor, metabotropic 4",0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.210283505,2,Biomarker
407050,MIR93,microRNA 93,0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.210283505,2,Biomarker
6469,SHH,sonic hedgehog,0.0,1.0,0.0,0.0,0.0,1868114,"POLYDACTYLY, PREAXIAL II",0.210283505,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,85207,"Diabetes, Gestational",0.210283505,2,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.210283505,2,"Biomarker, Therapeutic"
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.210283505,3,"Biomarker, Therapeutic"
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,343755,HIV Wasting Syndrome,0.210283505,2,Biomarker
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,0.0,0.0,0.0,29423,Osteochondroma,0.210283505,2,Biomarker
270,AMPD1,adenosine monophosphate deaminase 1,0.0,1.0,0.0,0.0,0.0,151786,Muscle Weakness,0.210283505,2,Biomarker
9499,MYOT,myotilin,0.0,1.0,0.0,0.0,0.0,151786,Muscle Weakness,0.210283505,2,Biomarker
5376,PMP22,peripheral myelin protein 22,0.0,1.0,0.0,0.0,0.0,151786,Muscle Weakness,0.210283505,2,Biomarker
366,AQP9,aquaporin 9,0.0,1.0,0.0,0.0,1.0,23418,Leukemia,0.210283505,2,"Biomarker, Therapeutic"
329,BIRC2,baculoviral IAP repeat containing 2,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210283505,2,Biomarker
54541,DDIT4,DNA-damage-inducible transcript 4,0.0,1.0,0.0,0.0,1.0,23418,Leukemia,0.210283505,1,"Biomarker, Therapeutic"
2246,FGF1,fibroblast growth factor 1 (acidic),0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210283505,2,Biomarker
2305,FOXM1,forkhead box M1,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210283505,2,Biomarker
8202,NCOA3,nuclear receptor coactivator 3,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210283505,2,Biomarker
55512,SMPD3,"sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)",0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.210283505,2,Biomarker
1719,DHFR,dihydrofolate reductase,0.0,1.0,0.0,0.0,0.0,2888,"Anemia, Megaloblastic",0.210283505,2,Biomarker
255239,ANKK1,ankyrin repeat and kinase domain containing 1,0.0,1.0,0.0,0.0,0.0,23015,Language Disorders,0.210283505,1,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,0.0,0.0,0.0,23015,Language Disorders,0.210283505,1,Biomarker
6352,CCL5,chemokine (C-C motif) ligand 5,0.0,1.0,0.0,0.0,0.0,19187,"Hepatitis, Alcoholic",0.210283505,2,Biomarker
4938,OAS1,"2'-5'-oligoadenylate synthetase 1, 40/46kDa",0.0,1.0,0.0,0.0,0.0,42769,Virus Diseases,0.210283505,2,Biomarker
1969,EPHA2,EPH receptor A2,0.0,1.0,0.0,0.0,0.0,28326,Noonan Syndrome,0.210283505,2,Biomarker
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,1.0,0.0,0.0,0.0,40822,Tremor,0.210283505,2,Biomarker
55034,MOCOS,molybdenum cofactor sulfurase,0.0,1.0,1.0,0.0,0.0,1863688,"Xanthinuria, Type II",0.210283505,3,"Biomarker, GeneticVariation"
5396,PRRX1,paired related homeobox 1,0.0,1.0,0.0,0.0,0.0,3494422,Retrognathia,0.210283505,1,Biomarker
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,0.0,0.0,0.0,14848,Esophageal Achalasia,0.210283505,1,Biomarker
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,0.0,0.0,0.0,14848,Esophageal Achalasia,0.210283505,1,Biomarker
22995,CEP152,centrosomal protein 152kDa,0.0,1.0,0.0,0.0,0.0,265202,Seckel syndrome 1,0.210283505,1,Biomarker
10815,CPLX1,complexin 1,0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210283505,2,Biomarker
10814,CPLX2,complexin 2,0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210283505,2,Biomarker
2898,GRIK2,"glutamate receptor, ionotropic, kainate 2",0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.210283505,2,"Biomarker, GeneticVariation"
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210283505,3,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210283505,2,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210283505,1,Biomarker
6869,TACR1,tachykinin receptor 1,0.0,1.0,1.0,0.0,0.0,5586,Bipolar Disorder,0.210283505,1,"Biomarker, GeneticVariation"
7222,TRPC3,"transient receptor potential cation channel, subfamily C, member 3",0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.210283505,2,Biomarker
3718,JAK3,Janus kinase 3,0.0,1.0,0.0,0.0,0.0,349639,"Leukemia, Myelomonocytic, Juvenile",0.210283505,1,Biomarker
2623,GATA1,GATA binding protein 1 (globin transcription factor 1),0.0,1.0,0.0,0.0,0.0,1860788,Transient Myeloproliferative Disorder of Down Syndrome,0.210283505,2,Biomarker
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.210283505,1,"Biomarker, GeneticVariation"
79133,NDUFAF5,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 5",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.210283505,1,"Biomarker, GeneticVariation"
4695,NDUFA2,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa",0.0,1.0,0.0,0.0,0.0,23264,Leigh Disease,0.210283505,1,Biomarker
91942,NDUFAF2,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 2",0.0,1.0,0.0,0.0,0.0,23264,Leigh Disease,0.210283505,1,Biomarker
51204,TACO1,translational activator of mitochondrially encoded cytochrome c oxidase I,0.0,1.0,0.0,0.0,0.0,23264,Leigh Disease,0.210283505,2,Biomarker
201163,FLCN,folliculin,0.0,1.0,0.0,0.0,0.0,346255,"Oncocytoma, renal",0.210283505,2,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
4363,ABCC1,"ATP-binding cassette, sub-family C (CFTR/MRP), member 1",0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,"Biomarker, GeneticVariation"
338,APOB,apolipoprotein B,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
410,ARSA,arylsulfatase A,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,"Biomarker, GeneticVariation"
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,"Biomarker, GeneticVariation"
1780,DYNC1I1,"dynein, cytoplasmic 1, intermediate chain 1",0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,"Biomarker, GeneticVariation"
100126572,GJE1,"gap junction protein, epsilon 1, 23kDa",0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,"Biomarker, GeneticVariation"
2876,GPX1,glutathione peroxidase 1,0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,"Biomarker, GeneticVariation"
3439,IFNA1,"interferon, alpha 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,1.0,31117,Peripheral Nervous System Diseases,0.210283505,2,"Biomarker, Therapeutic"
4644,MYO5A,"myosin VA (heavy chain 12, myoxin)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
65018,PINK1,PTEN induced putative kinase 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
57716,PRX,periaxin,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
5689,PSMB1,"proteasome (prosome, macropain) subunit, beta type, 1",0.0,1.0,1.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,"Biomarker, GeneticVariation"
5783,PTPN13,"protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
23221,RHOBTB2,Rho-related BTB domain containing 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,Biomarker
6584,SLC22A5,"solute carrier family 22 (organic cation/carnitine transporter), member 5",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
30812,SOX8,SRY (sex determining region Y)-box 8,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,Biomarker
6925,TCF4,transcription factor 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
65125,WNK1,WNK lysine deficient protein kinase 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.210283505,2,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,206656,"Rhabdomyosarcoma, Embryonal",0.210283505,2,Biomarker
170593,UVM2,"Melanoma, uveal, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,220633,Uveal melanoma,0.210283505,1,Biomarker
387,RHOA,ras homolog family member A,0.0,1.0,1.0,0.0,0.0,79772,"Lymphoma, T-Cell",0.210283505,1,"Biomarker, GeneticVariation"
64135,IFIH1,interferon induced with helicase C domain 1,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.210283505,2,Biomarker
3434,IFIT1,interferon-induced protein with tetratricopeptide repeats 1,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.210283505,2,Biomarker
91543,RSAD2,radical S-adenosyl methionine domain containing 2,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.210283505,2,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,3496,Aortic Rupture,0.210283505,2,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,1.0,7682,Central Nervous System Diseases,0.210283505,2,"Biomarker, Therapeutic"
2671,GFER,"growth factor, augmenter of liver regeneration",0.0,1.0,0.0,0.0,1.0,162557,"Liver Failure, Acute",0.210283505,2,"Biomarker, Therapeutic"
51164,DCTN4,dynactin 4 (p62),0.0,1.0,0.0,0.0,0.0,10674,Cystic Fibrosis,0.210283505,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,2937421,Prostatic Hyperplasia,0.210283505,2,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.210283505,2,Biomarker
3002,GZMB,"granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)",0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.210283505,2,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.210283505,2,Biomarker
308,ANXA5,annexin A5,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,2,Biomarker
23365,ARHGEF12,Rho guanine nucleotide exchange factor (GEF) 12,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,1,Biomarker
1471,CST3,cystatin C,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,2,Biomarker
8847,DLEU2,deleted in lymphocytic leukemia 2 (non-protein coding),0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,2,Biomarker
2274,FHL2,four and a half LIM domains 2,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,2,Biomarker
4026,LPP,LIM domain containing preferred translocation partner in lipoma,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,1,Biomarker
4066,LYL1,lymphoblastic leukemia associated hematopoiesis regulator 1,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,1,Biomarker
5997,RGS2,regulator of G-protein signaling 2,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,2,Biomarker
6279,S100A8,S100 calcium binding protein A8,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,2,Biomarker
7204,TRIO,trio Rho guanine nucleotide exchange factor,0.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.210283505,2,"Biomarker, GeneticVariation"
335,APOA1,apolipoprotein A-I,0.0,1.0,0.0,0.0,1.0,853897,Diabetic Cardiomyopathies,0.210283505,1,"Biomarker, Therapeutic"
3630,INS,insulin,0.0,1.0,0.0,0.0,1.0,853897,Diabetic Cardiomyopathies,0.210283505,2,"Biomarker, Therapeutic"
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,1.0,0.0,0.0,3151201,MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME,0.210283505,1,"Biomarker, GeneticVariation"
3218,HOXB8,homeobox B8,0.0,1.0,0.0,0.0,0.0,28768,Obsessive-Compulsive Disorder,0.210283505,2,Biomarker
8197,CHED1,corneal endothelial dystrophy 1 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1852555,"CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT",0.210283505,1,Biomarker
10411,RAPGEF3,Rap guanine nucleotide exchange factor (GEF) 3,0.0,1.0,0.0,0.0,0.0,24117,"Pulmonary Disease, Chronic Obstructive",0.210283505,1,Biomarker
79633,FAT4,FAT atypical cadherin 4,0.0,1.0,0.0,0.0,0.0,1832390,Van Maldergem Wetzburger Verloes syndrome,0.210283505,2,Biomarker
791229,MACOM,"macrophthalmia, colobomatous, with microcornea",0.0,1.0,0.0,0.0,0.0,1865286,"Macrophthalmia, Colobomatous, with Microcornea",0.210283505,1,Biomarker
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.210283505,3,Biomarker
4986,OPRK1,"opioid receptor, kappa 1",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.210283505,3,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,1.0,38587,Substance Withdrawal Syndrome,0.210283505,5,"Biomarker, Therapeutic"
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,7273,Carotid Artery Diseases,0.210283505,2,Biomarker
1053,CEBPE,"CCAAT/enhancer binding protein (C/EBP), epsilon",0.0,1.0,0.0,0.0,1.0,23487,"Leukemia, Promyelocytic, Acute",0.210283505,2,"Biomarker, Therapeutic"
150,ADRA2A,adrenoceptor alpha 2A,0.0,1.0,0.0,0.0,0.0,30319,Panic Disorder,0.210283505,2,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,20619,Hypogonadism,0.210283505,2,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,20619,Hypogonadism,0.210283505,2,Biomarker
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,0.0,0.0,0.0,20619,Hypogonadism,0.210283505,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,1.0,19829,Hodgkin Disease,0.210283505,2,"Biomarker, Therapeutic"
5770,PTPN1,"protein tyrosine phosphatase, non-receptor type 1",0.0,1.0,0.0,0.0,0.0,19829,Hodgkin Disease,0.210283505,1,Biomarker
7374,UNG,uracil-DNA glycosylase,0.0,1.0,0.0,0.0,0.0,5859,Bloom Syndrome,0.210283505,2,Biomarker
285489,DOK7,docking protein 7,0.0,1.0,0.0,0.0,0.0,1276035,"Pena Shokeir syndrome, type 1",0.210283505,1,Biomarker
79742,CXorf36,chromosome X open reading frame 36,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.210283505,1,Biomarker
116442,RAB39B,"RAB39B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.210283505,1,Biomarker
65109,UPF3B,UPF3 regulator of nonsense transcripts homolog B (yeast),0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.210283505,2,Biomarker
7552,ZNF711,zinc finger protein 711,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.210283505,2,Biomarker
2896,GRN,granulin,0.0,1.0,1.0,0.0,0.0,282513,"Aphasia, Primary Progressive",0.210197267,11,"Biomarker, GeneticVariation"
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,18814,"Heart Rupture, Post-Infarction",0.21,1,Biomarker
338334,CHDS1,"Coronary heart disease, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,10068,Coronary Disease,0.21,0,Biomarker
387584,CHDS2,"Coronary heart disease, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,10068,Coronary Disease,0.21,0,Biomarker
387573,CHDS3,"Coronary heart disease, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,10068,Coronary Disease,0.21,0,Biomarker
387585,CHDS4,"Coronary heart disease, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,10068,Coronary Disease,0.21,0,Biomarker
100188836,CHDS8,"Coronary heart disease, susceptibility to, 8",0.0,1.0,0.0,0.0,0.0,10068,Coronary Disease,0.21,0,Biomarker
100188877,CHDS9,"Coronary heart disease, suscpetibility to, 9",0.0,1.0,0.0,0.0,0.0,10068,Coronary Disease,0.21,0,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,10068,Coronary Disease,0.21,2,Therapeutic
3779,KCNMB1,potassium channel subfamily M regulatory beta subunit 1,0.0,1.0,0.0,0.0,0.0,1837739,"Hypertension, Diastolic, Resistance to",0.21,0,Biomarker
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",0.0,1.0,0.0,0.0,0.0,270726,Alexander Disease,0.21,0,Biomarker
10911,UTS2,urotensin 2,0.0,1.0,0.0,0.0,0.0,13473,Eating Disorders,0.21,1,Biomarker
54110,RP29,retinitis pigmentosa 29 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,2677325,Retinitis Pigmentosa 29,0.21,0,Biomarker
1805,DPT,dermatopontin,0.0,1.0,0.0,0.0,0.0,42345,Varicose Veins,0.21,1,Biomarker
3371,TNC,tenascin C,0.0,1.0,0.0,0.0,0.0,42345,Varicose Veins,0.21,1,Biomarker
619537,VV,varicose veins,0.0,1.0,0.0,0.0,0.0,42345,Varicose Veins,0.21,0,Biomarker
29123,ANKRD11,ankyrin repeat domain 11,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
552,AVPR1A,arginine vasopressin receptor 1A,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
205428,C3orf58,chromosome 3 open reading frame 58,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
95681,CEP41,centrosomal protein 41kDa,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
57680,CHD8,chromodomain helicase DNA binding protein 8,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
1153,CIRBP,cold inducible RNA binding protein,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,4,Biomarker
79742,CXorf36,chromosome X open reading frame 36,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,2,Biomarker
1718,DHCR24,24-dehydrocholesterol reductase,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
1734,DIO2,"deiodinase, iodothyronine, type II",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
1735,DIO3,"deiodinase, iodothyronine, type III",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
1742,DLG4,"discs, large homolog 4 (Drosophila)",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
1745,DLX1,distal-less homeobox 1,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
57628,DPP10,dipeptidyl-peptidase 10 (non-functional),0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
1804,DPP6,dipeptidyl-peptidase 6,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,2,Biomarker
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,2,Biomarker
1815,DRD4,dopamine receptor D4,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
27086,FOXP1,forkhead box P1,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
9248,GPR50,G protein-coupled receptor 50,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
2969,GTF2I,general transcription factor IIi,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
23462,HEY1,hes-related family bHLH transcription factor with YRPW motif 1,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
3077,HFE,hemochromatosis,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
11141,IL1RAPL1,interleukin 1 receptor accessory protein-like 1,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
3720,JARID2,"jumonji, AT rich interactive domain 2",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
10319,LAMC3,"laminin, gamma 3",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
54674,LRRN3,leucine rich repeat neuronal 3,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
347731,LRRTM3,leucine rich repeat transmembrane neuronal 3,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
4208,MEF2C,myocyte enhancer factor 2C,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
619554,MIR486-1,microRNA 486-1,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
57496,MKL2,MKL/myocardin-like 2,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
4543,MTNR1A,melatonin receptor 1A,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
4544,MTNR1B,melatonin receptor 1B,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
57502,NLGN4X,"neuroligin 4, X-linked",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
9378,NRXN1,neurexin 1,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
9379,NRXN2,neurexin 2,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
4923,NTSR1,neurotensin receptor 1 (high affinity),0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
5021,OXTR,oxytocin receptor,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
5101,PCDH9,protocadherin 9,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
139411,PTCHD1,patched domain containing 1,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,2,Biomarker
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
5649,RELN,reelin,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
6323,SCN1A,"sodium channel, voltage gated, type I alpha subunit",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
6433,SFSWAP,"splicing factor, suppressor of white-apricot family",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,2,Biomarker
6567,SLC16A2,"solute carrier family 16, member 2 (thyroid hormone transporter)",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
54221,SNTG2,"syntrophin, gamma 2",0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
6660,SOX5,SRY (sex determining region Y)-box 5,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
6662,SOX9,SRY (sex determining region Y)-box 9,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
6907,TBL1X,transducin (beta)-like 1X-linked,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
151531,UPP2,uridine phosphorylase 2,0.0,1.0,0.0,0.0,0.0,8074,"Child Development Disorders, Pervasive",0.21,1,Biomarker
100188837,AD13,Alzheimer disease-13,0.0,1.0,0.0,0.0,0.0,1970147,Alzheimer Disease 13,0.21,0,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,0.0,0.0,0.0,1.0,2931245,Bone Marrow failure syndromes,0.21,1,Therapeutic
2150,F2RL1,coagulation factor II (thrombin) receptor-like 1,0.0,1.0,0.0,0.0,0.0,17160,Gastroenteritis,0.21,1,Biomarker
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
632,BGLAP,bone gamma-carboxyglutamate (gla) protein,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
729,C6,complement component 6,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
80781,COL18A1,"collagen, type XVIII, alpha 1",0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
2209,FCGR1A,"Fc fragment of IgG, high affinity Ia, receptor (CD64)",0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
3357,HTR2B,"5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled",0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,4,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
3717,JAK2,Janus kinase 2,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
3934,LCN2,lipocalin 2,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
4046,LSP1,lymphocyte-specific protein 1,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
9450,LY86,lymphocyte antigen 86,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
5777,PTPN6,"protein tyrosine phosphatase, non-receptor type 6",0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
11035,RIPK3,receptor-interacting serine-threonine kinase 3,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
6693,SPN,sialophorin,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,18824,Heart Valve Diseases,0.21,1,Biomarker
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,0.0,85128,"Cardiac Output, High",0.21,1,Biomarker
29123,ANKRD11,ankyrin repeat domain 11,0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
80169,CTC1,CTS telomere maintenance complex component 1,0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
1593,CYP27A1,"cytochrome P450, family 27, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
120227,CYP2R1,"cytochrome P450, family 2, subfamily R, polypeptide 1",0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
1717,DHCR7,7-dehydrocholesterol reductase,0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
2638,GC,group-specific component (vitamin D binding protein),0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
3778,KCNMA1,"potassium channel, calcium activated large conductance subfamily M alpha, member 1",0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,5944,"Bone Diseases, Metabolic",0.21,1,Biomarker
10464,PIBF1,progesterone immunomodulatory binding factor 1,0.0,1.0,0.0,0.0,0.0,821,"Abortion, Threatened",0.21,1,Biomarker
885,CCK,cholecystokinin,0.0,0.0,0.0,0.0,1.0,17178,Gastrointestinal Diseases,0.21,1,Therapeutic
57680,CHD8,chromodomain helicase DNA binding protein 8,0.0,1.0,0.0,0.0,0.0,17178,Gastrointestinal Diseases,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,17178,Gastrointestinal Diseases,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,17178,Gastrointestinal Diseases,0.21,1,Biomarker
2520,GAST,gastrin,0.0,1.0,0.0,0.0,0.0,17178,Gastrointestinal Diseases,0.21,1,Biomarker
9817,KEAP1,kelch-like ECH-associated protein 1,0.0,1.0,0.0,0.0,0.0,17178,Gastrointestinal Diseases,0.21,1,Biomarker
4638,MYLK,myosin light chain kinase,0.0,1.0,0.0,0.0,0.0,17178,Gastrointestinal Diseases,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,17178,Gastrointestinal Diseases,0.21,1,Biomarker
1165,SCAR2,"spinocerebellar ataxia, autosomal recessive 2",0.0,1.0,0.0,0.0,0.0,1859298,"Spinocerebellar Ataxia, Autosomal Recessive 2",0.21,0,Biomarker
60681,FKBP10,"FK506 binding protein 10, 65 kDa",0.0,1.0,0.0,0.0,0.0,1853147,"Macular Degeneration, Age-Related, 4",0.21,0,Biomarker
1441,CSF3R,colony stimulating factor 3 receptor (granulocyte),0.0,1.0,0.0,0.0,0.0,23518,Leukocytosis,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,23518,Leukocytosis,0.21,1,Biomarker
100190929,IBD15,Inflammatory bowel disease-15,0.0,1.0,0.0,0.0,0.0,2677094,Inflammatory Bowel Disease 15,0.21,0,Biomarker
619471,PPR3,photoparoxysmal response 3,0.0,1.0,0.0,0.0,0.0,1835966,Photoparoxysmal Response 3,0.21,0,Biomarker
23713,DFNB27,"deafness, autosomal recessive 27",0.0,1.0,0.0,0.0,0.0,1853941,"Deafness, Autosomal Recessive 27",0.21,0,Biomarker
497231,CLN9,"ceroid-lipofuscinosis, neuronal 9",0.0,1.0,0.0,0.0,0.0,1836841,"Ceroid lipofuscinosis, neuronal 9",0.21,0,Biomarker
100192306,JAWAD,Microcephaly with digital anomalies,0.0,1.0,0.0,0.0,0.0,796063,Microcephaly with Mental Retardation and Digital Anomalies,0.21,0,Biomarker
5251,PHEX,"phosphate regulating endopeptidase homolog, X-linked",0.0,1.0,0.0,0.0,0.0,27709,Nephrocalcinosis,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,27709,Nephrocalcinosis,0.21,1,Biomarker
10861,SLC26A1,"solute carrier family 26 (anion exchanger), member 1",0.0,1.0,0.0,0.0,0.0,27709,Nephrocalcinosis,0.21,1,Biomarker
100529229,FAME3,"Epilepsy, familial adult myoclonic, 3",0.0,1.0,0.0,0.0,0.0,3150860,"Epilepsy, Familial Adult Myoclonic, 3",0.21,0,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,27497,Nausea,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,27497,Nausea,0.21,3,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,27497,Nausea,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,27497,Nausea,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,27497,Nausea,0.21,1,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,27497,Nausea,0.21,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,4093,Asthenia,0.21,1,Biomarker
865,CBFB,"core-binding factor, beta subunit",0.0,1.0,0.0,0.0,0.0,29396,"Ossification, Heterotopic",0.21,1,Biomarker
26229,B3GAT3,"beta-1,3-glucuronyltransferase 3",0.0,0.0,1.0,0.0,0.0,3278404,"MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, CRANIOFACIAL DYSMORPHISM, AND CONGENITAL HEART DEFECTS",0.21,1,GeneticVariation
128674,PROKR2,prokineticin receptor 2,0.0,0.0,1.0,0.0,0.0,3550478,HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA,0.21,3,GeneticVariation
2253,FGF8,fibroblast growth factor 8 (androgen-induced),0.0,0.0,1.0,0.0,0.0,3552574,HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA,0.21,2,GeneticVariation
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,877172,"Hematoma, Epidural, Spinal",0.21,2,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,9421,Coma,0.21,1,Biomarker
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,9421,Coma,0.21,1,Therapeutic
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,9421,Coma,0.21,3,Biomarker
335,APOA1,apolipoprotein A-I,0.0,1.0,0.0,0.0,0.0,4943,Behcet Syndrome,0.21,1,Biomarker
338,APOB,apolipoprotein B,0.0,1.0,0.0,0.0,0.0,4943,Behcet Syndrome,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,4943,Behcet Syndrome,0.21,1,Biomarker
3683,ITGAL,"integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)",0.0,1.0,0.0,0.0,0.0,4943,Behcet Syndrome,0.21,1,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,4943,Behcet Syndrome,0.21,1,Biomarker
8302,KLRC4,"killer cell lectin-like receptor subfamily C, member 4",0.0,1.0,0.0,0.0,0.0,4943,Behcet Syndrome,0.21,1,Biomarker
100188845,CODA,Cavitary optic disc anomalies,0.0,1.0,0.0,0.0,0.0,1969063,Cavitary Optic Disc Anomalies,0.21,0,Biomarker
1404,HAPLN1,hyaluronan and proteoglycan link protein 1,0.0,1.0,0.0,0.0,0.0,13336,Dwarfism,0.21,1,Biomarker
10733,PLK4,polo-like kinase 4,0.0,1.0,0.0,0.0,0.0,13336,Dwarfism,0.21,1,Biomarker
54361,WNT4,"wingless-type MMTV integration site family, member 4",0.0,1.0,0.0,0.0,0.0,13336,Dwarfism,0.21,1,Biomarker
100190985,IS5,"scoliosis, idiopathic, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,2677107,"SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 5",0.21,0,Biomarker
100188819,HDLCQ6,High density lipoprotein cholesterol level QTL 6,0.0,1.0,0.0,0.0,0.0,1853096,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6,0.21,0,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,1853096,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6,0.21,0,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,0.0,0.0,0.0,751955,Brain Infarction,0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,0.0,0.0,0.0,1.0,751955,Brain Infarction,0.21,1,Therapeutic
2840,GPR17,G protein-coupled receptor 17,0.0,0.0,0.0,0.0,1.0,751955,Brain Infarction,0.21,1,Therapeutic
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,751955,Brain Infarction,0.21,1,Therapeutic
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,751955,Brain Infarction,0.21,1,Biomarker
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,0.0,0.0,0.0,206146,Myocardial Stunning,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,206146,Myocardial Stunning,0.21,1,Biomarker
5350,PLN,phospholamban,0.0,1.0,0.0,0.0,0.0,206146,Myocardial Stunning,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,206146,Myocardial Stunning,0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,18418,Gynecomastia,0.21,2,Biomarker
4429,MRXS7,"mental retardation, X-linked, syndromic 7",0.0,1.0,0.0,0.0,0.0,1846170,Mental retardation X-linked syndromic 7,0.21,0,Biomarker
3405,IDDM6,insulin-dependent diabetes mellitus 6,0.0,1.0,0.0,0.0,0.0,1866041,"Diabetes Mellitus, Insulin-Dependent, 6",0.21,0,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,2350233,Antley-Bixler Syndrome Phenotype,0.21,1,Biomarker
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,32273,Pneumoconiosis,0.21,1,Biomarker
715,C1R,"complement component 1, r subcomponent",0.0,1.0,0.0,0.0,0.0,3150274,COMPLEMENT COMPONENT C1r/C1s DEFICIENCY,0.21,0,Biomarker
210,ALAD,aminolevulinate dehydratase,0.0,1.0,0.0,0.0,0.0,751859,"Lead Poisoning, Nervous System",0.21,1,Biomarker
425,ARVD4,arrhythmogenic right ventricular dysplasia 4,0.0,1.0,0.0,0.0,0.0,1865881,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 4",0.21,0,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,35242,Respiratory Tract Diseases,0.21,1,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,35242,Respiratory Tract Diseases,0.21,1,Biomarker
5184,PEPD,peptidase D,0.0,1.0,0.0,0.0,0.0,35242,Respiratory Tract Diseases,0.21,1,Biomarker
83706,FERMT3,fermitin family member 3,0.0,1.0,0.0,0.0,0.0,29454,Osteopetrosis,0.21,1,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
11214,AKAP13,A kinase (PRKA) anchor protein 13,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
360,AQP3,aquaporin 3 (Gill blood group),0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
27113,BBC3,BCL2 binding component 3,0.0,0.0,0.0,0.0,1.0,14859,Esophageal Neoplasms,0.21,1,Therapeutic
597,BCL2A1,BCL2-related protein A1,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,2,Biomarker
1012,CDH13,cadherin 13,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
1410,CRYAB,"crystallin, alpha B",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
1592,CYP26A1,"cytochrome P450, family 26, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
2788,GNG7,"guanine nucleotide binding protein (G protein), gamma 7",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
4215,MAP3K3,mitogen-activated protein kinase kinase kinase 3,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
220972,8-Mar,"membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
406985,MIR200C,microRNA 200c,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
4495,MT1G,metallothionein 1G,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
7001,PRDX2,peroxiredoxin 2,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
6049,RNF6,ring finger protein (C3H2C3 type) 6,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,0,Biomarker
56475,RPRM,"reprimo, TP53 dependent G2 arrest mediator candidate",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
148867,SLC30A7,"solute carrier family 30 (zinc transporter), member 7",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
6591,SNAI2,snail family zinc finger 2,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
6750,SST,somatostatin,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
7052,TGM2,transglutaminase 2,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
7168,TPM1,tropomyosin 1 (alpha),0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
7171,TPM4,tropomyosin 4,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
7284,TUFM,"Tu translation elongation factor, mitochondrial",0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
11197,WIF1,WNT inhibitory factor 1,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,1,Biomarker
51741,WWOX,WW domain containing oxidoreductase,0.0,1.0,0.0,0.0,0.0,14859,Esophageal Neoplasms,0.21,0,Biomarker
1814,DRD3,dopamine receptor D3,0.0,1.0,0.0,0.0,0.0,4782,Basal Ganglia Diseases,0.21,1,Biomarker
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,4782,Basal Ganglia Diseases,0.21,1,Biomarker
10367,MICU1,mitochondrial calcium uptake 1,0.0,1.0,0.0,0.0,0.0,4782,Basal Ganglia Diseases,0.21,1,Biomarker
8622,PDE8B,phosphodiesterase 8B,0.0,1.0,0.0,0.0,0.0,4782,Basal Ganglia Diseases,0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,4782,Basal Ganglia Diseases,0.21,1,Biomarker
80704,SLC19A3,"solute carrier family 19 (thiamine transporter), member 3",0.0,1.0,0.0,0.0,0.0,4782,Basal Ganglia Diseases,0.21,1,Biomarker
128178,EDARADD,EDAR-associated death domain,0.0,0.0,1.0,0.0,0.0,3541517,"ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT",0.21,0,GeneticVariation
100415896,ASRT8,"Asthma-related traits, susceptibility to, 8",0.0,1.0,0.0,0.0,0.0,2750782,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8",0.21,0,Biomarker
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,0.0,1.0,0.0,0.0,1866079,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1,0.21,0,GeneticVariation
1285,COL4A3,"collagen, type IV, alpha 3 (Goodpasture antigen)",0.0,1.0,0.0,0.0,0.0,2931254,"Alport syndrome, recessive type",0.21,0,Biomarker
1286,COL4A4,"collagen, type IV, alpha 4",0.0,1.0,0.0,0.0,0.0,2931254,"Alport syndrome, recessive type",0.21,0,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,0.0,0.0,0.0,428791,"Aortic Valve, Calcification of",0.21,1,Biomarker
6574,SLC20A1,"solute carrier family 20 (phosphate transporter), member 1",0.0,1.0,0.0,0.0,0.0,428791,"Aortic Valve, Calcification of",0.21,1,Biomarker
1232,CCR3,chemokine (C-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.21,1,Biomarker
10631,POSTN,"periostin, osteoblast specific factor",0.0,1.0,0.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.21,1,Biomarker
11251,PTGDR2,prostaglandin D2 receptor 2,0.0,1.0,0.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.21,1,Biomarker
5732,PTGER2,"prostaglandin E receptor 2 (subtype EP2), 53kDa",0.0,1.0,0.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.21,1,Biomarker
5739,PTGIR,prostaglandin I2 (prostacyclin) receptor (IP),0.0,1.0,0.0,0.0,0.0,1319853,"Asthma, Aspirin-Induced",0.21,1,Biomarker
4964,OFC2,orofacial cleft 2,0.0,1.0,0.0,0.0,0.0,1864323,Orofacial Cleft 2,0.21,0,Biomarker
64321,SOX17,SRY (sex determining region Y)-box 17,0.0,1.0,0.0,0.0,0.0,232910,Teratogenesis,0.21,1,Biomarker
735,C9,complement component 9,0.0,1.0,0.0,0.0,0.0,15456,Facial Dermatoses,0.21,1,Biomarker
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,35238,Respiratory System Abnormalities,0.21,1,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,35238,Respiratory System Abnormalities,0.21,1,Biomarker
7043,TGFB3,"transforming growth factor, beta 3",0.0,1.0,0.0,0.0,0.0,35238,Respiratory System Abnormalities,0.21,1,Biomarker
100462724,OFC9,Orofacial cleft 9,0.0,1.0,0.0,0.0,0.0,1835894,Orofacial Cleft 9,0.21,0,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,0.0,0.0,0.0,1855456,PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL,0.21,0,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,1855456,PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL,0.21,0,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,1855456,PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL,0.21,0,Biomarker
7910,PFBI,Plasmodium falciparum blood infection levels,0.0,1.0,0.0,0.0,0.0,1855456,PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL,0.21,0,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,1855456,PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL,0.21,0,Biomarker
374569,ASPG,asparaginase,0.0,1.0,0.0,0.0,0.0,8350,Cholelithiasis,0.21,1,Biomarker
100196910,POROK2,"Porokeratosis, palmar, plantar, and disseminated 1",0.0,1.0,0.0,0.0,0.0,1867982,Porokeratosis punctata palmaris et plantaris,0.21,0,Biomarker
2641,GCG,glucagon,0.0,1.0,0.0,0.0,0.0,39239,"Tachycardia, Sinus",0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,7781,Intracranial Embolism and Thrombosis,0.21,2,Therapeutic
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,7781,Intracranial Embolism and Thrombosis,0.21,1,Therapeutic
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
84962,AJUBA,ajuba LIM protein,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
482,ATP1B2,"ATPase, Na+/K+ transporting, beta 2 polypeptide",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
567,B2M,beta-2-microglobulin,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
645,BLVRB,biliverdin reductase B,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
759,CA1,carbonic anhydrase I,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
760,CA2,carbonic anhydrase II,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
829,CAPZA1,"capping protein (actin filament) muscle Z-line, alpha 1",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
1192,CLIC1,chloride intracellular channel 1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
1476,CSTB,cystatin B (stefin B),0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
2033,EP300,E1A binding protein p300,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,2,Biomarker
2195,FAT1,FAT atypical cadherin 1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
2196,FAT2,FAT atypical cadherin 2,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
120114,FAT3,FAT atypical cadherin 3,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
79633,FAT4,FAT atypical cadherin 4,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
2280,FKBP1A,"FK506 binding protein 1A, 12kDa",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
2665,GDI2,GDP dissociation inhibitor 2,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
2739,GLO1,glyoxalase I,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
9446,GSTO1,glutathione S-transferase omega 1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
8342,HIST1H2BM,"histone cluster 1, H2bm",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
3309,HSPA5,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
7403,KDM6A,lysine (K)-specific demethylase 6A,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
58508,KMT2C,lysine (K)-specific methyltransferase 2C,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
8085,KMT2D,lysine (K)-specific methyltransferase 2D,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
3860,KRT13,"keratin 13, type I",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
3872,KRT17,"keratin 17, type I",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
4085,MAD2L1,MAD2 mitotic arrest deficient-like 1 (yeast),0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
4853,NOTCH2,notch 2,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
4854,NOTCH3,notch 3,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
5216,PFN1,profilin 1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
5720,PSME1,"proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
5721,PSME2,"proteasome (prosome, macropain) activator subunit 2 (PA28 beta)",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
6317,SERPINB3,"serpin peptidase inhibitor, clade B (ovalbumin), member 3",0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
6876,TAGLN,transgelin,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
340061,TMEM173,transmembrane protein 173,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
7169,TPM2,tropomyosin 2 (beta),0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
84817,TXNDC17,thioredoxin domain containing 17,0.0,1.0,0.0,0.0,0.0,279626,Esophageal Squamous Cell Carcinoma,0.21,1,Biomarker
100188848,FMTLE,"Epilepsy, familial mesial temporal lobe",0.0,1.0,0.0,0.0,0.0,1968848,"Epilepsy, Familial Mesial Temporal Lobe",0.21,0,Biomarker
270,AMPD1,adenosine monophosphate deaminase 1,0.0,1.0,0.0,0.0,0.0,26846,Muscular Atrophy,0.21,1,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,0.0,0.0,0.0,1.0,26846,Muscular Atrophy,0.21,1,Therapeutic
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,0.0,0.0,0.0,1.0,26846,Muscular Atrophy,0.21,1,Therapeutic
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,26846,Muscular Atrophy,0.21,1,Biomarker
25937,WWTR1,WW domain containing transcription regulator 1,0.0,0.0,0.0,0.0,1.0,26846,Muscular Atrophy,0.21,1,Therapeutic
3341,HTC1,"hypertrichosis 1 (universalis, congenital)",0.0,1.0,0.0,0.0,0.0,235864,Congenital hypertrichosis lanuginosa,0.21,0,Biomarker
317714,DYT15,"dystonia 15, myoclonic",0.0,1.0,0.0,0.0,0.0,1843786,"Dystonia 15, myoclonic",0.21,0,Biomarker
8163,CDR3,Cerebellar degeneration-related autoantigen-3,0.0,1.0,0.0,0.0,0.0,1865782,CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3,0.21,0,Biomarker
3565,IL4,interleukin 4,0.0,0.0,0.0,0.0,1.0,41307,"Tuberculosis, Bovine",0.21,1,Therapeutic
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,6849,"Candidiasis, Oral",0.21,1,Therapeutic
122,ADFN,albinism-deafness syndrome,0.0,1.0,0.0,0.0,0.0,1845068,Albinism deafness syndrome,0.21,0,Biomarker
4750,NEK1,NIMA-related kinase 1,0.0,1.0,0.0,0.0,0.0,1417671,NEVER IN MITOSIS GENE A-RELATED KINASE 1,0.21,0,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,1858679,"Cataract, Autosomal Dominant",0.21,0,Biomarker
717,C2,complement component 2,0.0,1.0,0.0,0.0,0.0,11633,Dermatomyositis,0.21,1,Biomarker
735,C9,complement component 9,0.0,1.0,0.0,0.0,0.0,11633,Dermatomyositis,0.21,1,Biomarker
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,0.0,0.0,0.0,11633,Dermatomyositis,0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,26850,Muscular Dystrophies,0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,26850,Muscular Dystrophies,0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,8031,Chest Pain,0.21,1,Biomarker
383,ARG1,arginase 1,0.0,1.0,0.0,0.0,0.0,23281,Leishmaniasis,0.21,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,23281,Leishmaniasis,0.21,1,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,23281,Leishmaniasis,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,23281,Leishmaniasis,0.21,1,Biomarker
8784,TNFRSF18,"tumor necrosis factor receptor superfamily, member 18",0.0,1.0,0.0,0.0,0.0,23281,Leishmaniasis,0.21,1,Biomarker
100188843,MAFD5,Major affective disorder 5,0.0,1.0,0.0,0.0,0.0,1970944,Major Affective Disorder 5,0.21,0,Biomarker
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,340274,"Hypertension, Pregnancy-Induced",0.21,1,Biomarker
121775,CHDM,Chordoma,0.0,1.0,0.0,0.0,0.0,8487,Chordoma,0.21,0,Biomarker
3577,CXCR1,chemokine (C-X-C motif) receptor 1,0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21,1,Biomarker
1671,DEFA6,"defensin, alpha 6, Paneth cell-specific",0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21,1,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21,1,Biomarker
100529151,IBD11,Inflammatory bowel disease 11,0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21,0,Biomarker
10320,IKZF1,IKAROS family zinc finger 1 (Ikaros),0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21,1,Biomarker
3575,IL7R,interleukin 7 receptor,0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21,1,Biomarker
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,9324,"Colitis, Ulcerative",0.21,1,Therapeutic
10747,MASP2,mannan-binding lectin serine peptidase 2,0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21,1,Biomarker
639,PRDM1,"PR domain containing 1, with ZNF domain",0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21,1,Biomarker
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,9324,"Colitis, Ulcerative",0.21,1,Biomarker
652,BMP4,bone morphogenetic protein 4,0.0,1.0,0.0,0.0,0.0,1306214,ACTH-Secreting Pituitary Adenoma,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,1306214,ACTH-Secreting Pituitary Adenoma,0.21,0,Biomarker
9101,USP8,ubiquitin specific peptidase 8,0.0,1.0,0.0,0.0,0.0,1306214,ACTH-Secreting Pituitary Adenoma,0.21,1,Biomarker
57560,IFT80,intraflagellar transport 80,0.0,1.0,0.0,0.0,0.0,35304,Retinal Degeneration,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,1.0,35304,Retinal Degeneration,0.21,2,"Biomarker, Therapeutic"
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,0.0,0.0,0.0,17205,Gaucher Disease,0.21,1,Biomarker
4899,NRF1,nuclear respiratory factor 1,0.0,1.0,0.0,0.0,0.0,6079,Bowen's Disease,0.21,1,Biomarker
10891,PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha",0.0,1.0,0.0,0.0,0.0,6079,Bowen's Disease,0.21,1,Biomarker
7019,TFAM,"transcription factor A, mitochondrial",0.0,1.0,0.0,0.0,0.0,6079,Bowen's Disease,0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.21,1,Biomarker
374569,ASPG,asparaginase,0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.21,1,Biomarker
2936,GSR,glutathione reductase,0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.21,1,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,0.0,0.0,0.0,1.0,2871,Anemia,0.21,1,Therapeutic
3558,IL2,interleukin 2,0.0,0.0,0.0,0.0,1.0,2871,Anemia,0.21,1,Therapeutic
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.21,1,Biomarker
5617,PRL,prolactin,0.0,0.0,0.0,0.0,1.0,2871,Anemia,0.21,1,Therapeutic
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.21,2,Biomarker
51312,SLC25A37,"solute carrier family 25 (mitochondrial iron transporter), member 37",0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.21,1,Biomarker
113235,SLC46A1,"solute carrier family 46 (folate transporter), member 1",0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.21,1,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,2871,Anemia,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,79731,"Lymphoma, B-Cell",0.21,1,Therapeutic
55840,EAF2,ELL associated factor 2,0.0,1.0,0.0,0.0,0.0,79731,"Lymphoma, B-Cell",0.21,1,Biomarker
406935,MIR143,microRNA 143,0.0,1.0,0.0,0.0,0.0,79731,"Lymphoma, B-Cell",0.21,1,Biomarker
406937,MIR145,microRNA 145,0.0,1.0,0.0,0.0,0.0,79731,"Lymphoma, B-Cell",0.21,1,Biomarker
100415942,DEL2P21,Hypotonia-cystinuria syndrome,0.0,1.0,0.0,0.0,0.0,1848030,Hypotonia-Cystinuria Syndrome,0.21,0,Biomarker
55512,SMPD3,"sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)",0.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.21,1,Biomarker
8877,SPHK1,sphingosine kinase 1,0.0,1.0,0.0,0.0,0.0,26986,Myelodysplastic Syndromes,0.21,1,Biomarker
9759,HDAC4,histone deacetylase 4,0.0,1.0,0.0,0.0,0.0,221357,Brachydactyly,0.21,1,Biomarker
4089,SMAD4,SMAD family member 4,0.0,1.0,0.0,0.0,0.0,221357,Brachydactyly,0.21,1,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,42138,Uterine Neoplasms,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,42138,Uterine Neoplasms,0.21,1,Therapeutic
3159,HMGA1,high mobility group AT-hook 1,0.0,1.0,0.0,0.0,0.0,42138,Uterine Neoplasms,0.21,1,Biomarker
3624,INHBA,"inhibin, beta A",0.0,1.0,0.0,0.0,0.0,42138,Uterine Neoplasms,0.21,1,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,42138,Uterine Neoplasms,0.21,1,Biomarker
8842,PROM1,prominin 1,0.0,1.0,0.0,0.0,0.0,42138,Uterine Neoplasms,0.21,1,Biomarker
4088,SMAD3,SMAD family member 3,0.0,1.0,0.0,0.0,0.0,42138,Uterine Neoplasms,0.21,1,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
1734,DIO2,"deiodinase, iodothyronine, type II",0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
23741,EID1,EP300 interacting inhibitor of differentiation 1,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,2,Biomarker
2934,GSN,gelsolin,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
4831,NME2,NME/NM23 nucleoside diphosphate kinase 2,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
56034,PDGFC,platelet derived growth factor C,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
5241,PGR,progesterone receptor,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
94274,PPP1R14A,"protein phosphatase 1, regulatory (inhibitor) subunit 14A",0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
22827,PUF60,poly-U binding splicing factor 60KDa,0.0,0.0,0.0,0.0,1.0,25500,Mesothelioma,0.21,1,Therapeutic
54716,SLC6A20,"solute carrier family 6 (proline IMINO transporter), member 20",0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
6850,SYK,spleen tyrosine kinase,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
7296,TXNRD1,thioredoxin reductase 1,0.0,1.0,0.0,0.0,0.0,25500,Mesothelioma,0.21,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,0.0,0.0,0.0,1.0,11053,Deafness,0.21,2,Therapeutic
776,CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",0.0,1.0,0.0,0.0,0.0,11053,Deafness,0.21,1,Biomarker
83715,ESPN,espin,0.0,1.0,0.0,0.0,0.0,11053,Deafness,0.21,2,Biomarker
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,0.0,0.0,0.0,11053,Deafness,0.21,1,Biomarker
5077,PAX3,paired box 3,0.0,1.0,0.0,0.0,0.0,11053,Deafness,0.21,1,Biomarker
5424,POLD1,"polymerase (DNA directed), delta 1, catalytic subunit",0.0,1.0,0.0,0.0,0.0,11053,Deafness,0.21,1,Biomarker
84947,SERAC1,serine active site containing 1,0.0,1.0,0.0,0.0,0.0,11053,Deafness,0.21,1,Biomarker
4089,SMAD4,SMAD family member 4,0.0,1.0,0.0,0.0,0.0,11053,Deafness,0.21,1,Biomarker
170532,OTSC3,otosclerosis 3,0.0,1.0,0.0,0.0,0.0,1842353,Otosclerosis 3,0.21,0,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,85298,"Death, Sudden, Cardiac",0.21,1,Biomarker
79188,TMEM43,transmembrane protein 43,0.0,1.0,0.0,0.0,0.0,85298,"Death, Sudden, Cardiac",0.21,1,Biomarker
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,0.0,0.0,0.0,18674,Craniocerebral Trauma,0.21,1,Biomarker
4813,NIDDM2,"non-insulin-dependent diabetes mellitus (common, type 2) 2",0.0,1.0,0.0,0.0,0.0,1832387,"Diabetes Mellitus, Noninsulin-Dependent, 2",0.21,0,Biomarker
644,BLVRA,biliverdin reductase A,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
6354,CCL7,chemokine (C-C motif) ligand 7,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
9420,CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
1582,CYP8B1,"cytochrome P450, family 8, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
9002,F2RL3,coagulation factor II (thrombin) receptor-like 3,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
2243,FGA,fibrinogen alpha chain,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
5603,MAPK13,mitogen-activated protein kinase 13,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,2,Biomarker
1432,MAPK14,mitogen-activated protein kinase 14,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,2,Biomarker
406920,MIR130B,microRNA 130b,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
406961,MIR185,microRNA 185,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
406965,MIR190A,microRNA 190a,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
407000,MIR218-1,microRNA 218-1,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
407012,MIR24-1,microRNA 24-1,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
407019,MIR27B,microRNA 27b,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
442905,MIR337,microRNA 337,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
494323,MIR361,microRNA 361,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
494326,MIR377,microRNA 377,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
693121,MIR411,microRNA 411,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
100126309,MIR875,microRNA 875,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
407055,MIR99A,microRNA 99a,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
406884,MIRLET7B,microRNA let-7b,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
406891,MIRLET7I,microRNA let-7i,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,8370,Cholestasis,0.21,1,Therapeutic
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,3,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
7376,NR1H2,"nuclear receptor subfamily 1, group H, member 2",0.0,0.0,0.0,0.0,1.0,8370,Cholestasis,0.21,1,Therapeutic
10062,NR1H3,"nuclear receptor subfamily 1, group H, member 3",0.0,0.0,0.0,0.0,1.0,8370,Cholestasis,0.21,1,Therapeutic
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
5962,RDX,radixin,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,2,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
6615,SNAI1,snail family zinc finger 1,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,8370,Cholestasis,0.21,1,Biomarker
494148,DFNB55,"deafness, autosomal recessive 55",0.0,1.0,0.0,0.0,0.0,1864962,"Deafness, autosomal recessive 55",0.21,0,Biomarker
337991,DFNB38,"deafness, autosomal recessive 38",0.0,1.0,0.0,0.0,0.0,1842381,"Deafness, Autosomal Recessive 38",0.21,0,Biomarker
718,C3,complement component 3,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
1363,CPE,carboxypeptidase E,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
1489,CTF1,cardiotrophin 1,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
2878,GPX3,glutathione peroxidase 3 (plasma),0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
3159,HMGA1,high mobility group AT-hook 1,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,1.0,21655,Insulin Resistance,0.21,2,"Biomarker, Therapeutic"
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
3483,IGFALS,"insulin-like growth factor binding protein, acid labile subunit",0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
3485,IGFBP2,"insulin-like growth factor binding protein 2, 36kDa",0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
79661,NEIL1,nei endonuclease VIII-like 1 (E. coli),0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
5563,PRKAA2,"protein kinase, AMP-activated, alpha 2 catalytic subunit",0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
6517,SLC2A4,"solute carrier family 2 (facilitated glucose transporter), member 4",0.0,0.0,0.0,0.0,1.0,21655,Insulin Resistance,0.21,1,Therapeutic
6721,SREBF2,sterol regulatory element binding transcription factor 2,0.0,1.0,0.0,0.0,0.0,21655,Insulin Resistance,0.21,1,Biomarker
412,STS,"steroid sulfatase (microsomal), isozyme S",0.0,0.0,0.0,0.0,1.0,21655,Insulin Resistance,0.21,1,Therapeutic
7952,TNDM,"diabetes mellitus, transient neonatal",0.0,1.0,0.0,0.0,0.0,1832386,"Diabetes Mellitus, Transient Neonatal, 1",0.21,0,Biomarker
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,20550,Hyperthyroidism,0.21,1,Biomarker
9607,CARTPT,CART prepropeptide,0.0,1.0,0.0,0.0,0.0,20550,Hyperthyroidism,0.21,1,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,20550,Hyperthyroidism,0.21,1,Biomarker
2936,GSR,glutathione reductase,0.0,1.0,0.0,0.0,0.0,20550,Hyperthyroidism,0.21,1,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,20550,Hyperthyroidism,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,20550,Hyperthyroidism,0.21,1,Biomarker
55811,ADCY10,adenylate cyclase 10 (soluble),0.0,1.0,0.0,0.0,0.0,342639,"Hypercalciuria, Absorptive, 2",0.21,0,Biomarker
10269,ZMPSTE24,zinc metallopeptidase STE24,0.0,1.0,0.0,0.0,0.0,1136321,HIV-Associated Lipodystrophy Syndrome,0.21,1,Biomarker
731,C8A,"complement component 8, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,25289,Meningitis,0.21,1,Biomarker
732,C8B,"complement component 8, beta polypeptide",0.0,1.0,0.0,0.0,0.0,25289,Meningitis,0.21,1,Biomarker
57582,KCNT1,"potassium channel, sodium activated subfamily T, member 1",0.0,1.0,0.0,0.0,0.0,14547,"Epilepsies, Partial",0.21,1,Biomarker
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,34139,"Purine-Pyrimidine Metabolism, Inborn Errors",0.21,2,Biomarker
372,ARCN1,archain 1,0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.21,1,Biomarker
9254,CACNA2D2,"calcium channel, voltage-dependent, alpha 2/delta subunit 2",0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.21,1,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.21,1,Biomarker
1960,EGR3,early growth response 3,0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.21,1,Biomarker
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.21,1,Biomarker
2557,GABRA4,"gamma-aminobutyric acid (GABA) A receptor, alpha 4",0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.21,1,Biomarker
348980,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.21,1,Biomarker
131669,UROC1,urocanate hydratase 1,0.0,1.0,0.0,0.0,0.0,4134,Ataxia,0.21,1,Biomarker
8259,INDX,"Immunoneurologic syndrome X-linked, of Wood, Black, and Norbury",0.0,1.0,0.0,0.0,0.0,1848144,Woods Black Norbury syndrome,0.21,0,Biomarker
64069,ATOD1,"Dermatitis, atopic",0.0,1.0,0.0,0.0,0.0,1864155,"Dermatitis, Atopic, 1",0.21,0,Biomarker
117187,ATOD3,"Dermatitis, atopic, 3",0.0,1.0,0.0,0.0,0.0,1864155,"Dermatitis, Atopic, 1",0.21,0,Biomarker
117188,ATOD5,"Dermatitis, atopic, 5",0.0,1.0,0.0,0.0,0.0,1864155,"Dermatitis, Atopic, 1",0.21,0,Biomarker
114477,ATOD6,"Dermatitis, atopic, 6",0.0,1.0,0.0,0.0,0.0,1864155,"Dermatitis, Atopic, 1",0.21,0,Biomarker
2312,FLG,filaggrin,0.0,1.0,0.0,0.0,0.0,1864155,"Dermatitis, Atopic, 1",0.21,0,Biomarker
506,ATP5B,"ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide",0.0,1.0,0.0,0.0,0.0,1846707,Spinocerebellar Ataxia 17,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,1846707,Spinocerebellar Ataxia 17,0.21,1,Biomarker
10525,HYOU1,hypoxia up-regulated 1,0.0,1.0,0.0,0.0,0.0,1846707,Spinocerebellar Ataxia 17,0.21,1,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,0.0,0.0,0.0,1846707,Spinocerebellar Ataxia 17,0.21,1,Biomarker
5034,P4HB,"prolyl 4-hydroxylase, beta polypeptide",0.0,1.0,0.0,0.0,0.0,1846707,Spinocerebellar Ataxia 17,0.21,1,Biomarker
2923,PDIA3,"protein disulfide isomerase family A, member 3",0.0,1.0,0.0,0.0,0.0,1846707,Spinocerebellar Ataxia 17,0.21,1,Biomarker
9429,ABCG2,"ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.21,1,Biomarker
476,ATP1A1,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.21,2,Biomarker
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.21,1,Biomarker
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.21,1,Biomarker
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.21,1,Biomarker
6948,TCN2,transcobalamin II,0.0,1.0,0.0,0.0,0.0,1430,Adenoma,0.21,1,Biomarker
140560,LI5,Lamellar ichthyosis 5,0.0,1.0,0.0,0.0,0.0,1847849,"Ichthyosis, Lamellar, 5",0.21,0,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,2936791,antley-bixler syndrome,0.21,0,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,26769,Multiple Sclerosis,0.21,1,Biomarker
4162,MCAM,melanoma cell adhesion molecule,0.0,0.0,0.0,0.0,1.0,26769,Multiple Sclerosis,0.21,1,Therapeutic
100271694,MS2,"Multiple sclerosis, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,26769,Multiple Sclerosis,0.21,0,Biomarker
100271695,MS3,"Multiple sclerosis, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,26769,Multiple Sclerosis,0.21,0,Biomarker
100271696,MS4,"Multiple sclerosis, susceptiblity to, 4",0.0,1.0,0.0,0.0,0.0,26769,Multiple Sclerosis,0.21,0,Biomarker
192676,DFNA43,"deafness, autosomal dominant 43",0.0,1.0,0.0,0.0,0.0,1842108,"Deafness, Autosomal Dominant 43",0.21,0,Biomarker
23314,SATB2,SATB homeobox 2,0.0,1.0,0.0,0.0,0.0,1970095,"Cleft Palate, Isolated, And Mental Retardation",0.21,0,Biomarker
7314,UBB,ubiquitin B,0.0,1.0,0.0,0.0,0.0,1970095,"Cleft Palate, Isolated, And Mental Retardation",0.21,0,Biomarker
431709,MDD2,Major depressive disorder 2,0.0,1.0,0.0,0.0,0.0,1837529,Major Depressive Disorder 2,0.21,0,Biomarker
153,ADRB1,adrenoceptor beta 1,0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.21,1,Biomarker
4508,ATP6,ATP synthase F0 subunit 6,0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.21,1,Biomarker
547,KIF1A,kinesin family member 1A,0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.21,1,Biomarker
3799,KIF5B,kinesin family member 5B,0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.21,1,Biomarker
9970,NR1I3,"nuclear receptor subfamily 1, group I, member 3",0.0,1.0,0.0,0.0,0.0,11849,Diabetes Mellitus,0.21,1,Biomarker
267,AMFR,"autocrine motility factor receptor, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
9582,APOBEC3B,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
360,AQP3,aquaporin 3 (Gill blood group),0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
57412,AS3MT,arsenite methyltransferase,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
55252,ASXL2,additional sex combs like transcriptional regulator 2,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
472,ATM,ATM serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
2186,BPTF,bromodomain PHD finger transcription factor,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
100270680,CASC11,cancer susceptibility candidate 11 (non-protein coding),0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,0,Biomarker
898,CCNE1,cyclin E1,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
84181,CHD6,chromodomain helicase DNA binding protein 6,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
1387,CREBBP,CREB binding protein,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
2026,ENO2,"enolase 2 (gamma, neuronal)",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
2033,EP300,E1A binding protein p300,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
2072,ERCC4,excision repair cross-complementation group 4,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
9700,ESPL1,extra spindle pole bodies homolog 1 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
2175,FANCA,"Fanconi anemia, complementation group A",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
10979,FERMT2,fermitin family member 2,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
2954,GSTZ1,glutathione S-transferase zeta 1,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
9759,HDAC4,histone deacetylase 4,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
7403,KDM6A,lysine (K)-specific demethylase 6A,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
58508,KMT2C,lysine (K)-specific methyltransferase 2C,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
3868,KRT16,"keratin 16, type I",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
3978,LIG1,"ligase I, DNA, ATP-dependent",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
4108,MAGEA9,melanoma antigen family A9,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
4489,MT1A,metallothionein 1A,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
4502,MT2A,metallothionein 2A,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,2,Biomarker
4504,MT3,metallothionein 3,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
9611,NCOR1,nuclear receptor corepressor 1,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
5423,POLB,"polymerase (DNA directed), beta",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
387,RHOA,ras homolog family member A,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
8243,SMC1A,structural maintenance of chromosomes 1A,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
27127,SMC1B,structural maintenance of chromosomes 1B,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
6714,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,2,Biomarker
10735,STAG2,stromal antigen 2,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,3,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
7364,UGT2B7,"UDP glucuronosyltransferase 2 family, polypeptide B7",0.0,1.0,0.0,0.0,0.0,5695,Urinary Bladder Neoplasms,0.21,1,Biomarker
1003,CDH5,"cadherin 5, type 2 (vascular endothelium)",0.0,0.0,0.0,0.0,1.0,232347,No-Reflow Phenomenon,0.21,1,Therapeutic
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,0.0,0.0,0.0,1.0,232347,No-Reflow Phenomenon,0.21,1,Therapeutic
3728,JUP,junction plakoglobin,0.0,0.0,0.0,0.0,1.0,232347,No-Reflow Phenomenon,0.21,1,Therapeutic
374569,ASPG,asparaginase,0.0,1.0,0.0,0.0,0.0,18965,Hematuria,0.21,1,Biomarker
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,0.0,0.0,0.0,1.0,18965,Hematuria,0.21,1,Therapeutic
4010,LMX1B,"LIM homeobox transcription factor 1, beta",0.0,1.0,0.0,0.0,0.0,18965,Hematuria,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,18965,Hematuria,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,18965,Hematuria,0.21,2,Biomarker
64644,GINGF2,"gingival fibromatosis, hereditary, 2",0.0,1.0,0.0,0.0,0.0,1854181,"Fibromatosis, Gingival, 2",0.21,0,Biomarker
7201,TRHR,thyrotropin-releasing hormone receptor,0.0,1.0,0.0,0.0,0.0,2940786,Thyroid Hormone Resistance Syndrome,0.21,1,Biomarker
117192,MNRI,"meningioma, radiation-induced",0.0,1.0,0.0,0.0,0.0,1853554,Radiation induced meningioma,0.21,0,Biomarker
57762,NS2,Noonan syndrome 2,0.0,1.0,0.0,0.0,0.0,1854469,Noonan Syndrome 2,0.21,0,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,8311,Cholangitis,0.21,1,Biomarker
4080,MAA,microphthalmia or anophthalmia and associated anomalies,0.0,1.0,0.0,0.0,0.0,796016,"Microphthalmia, syndromic 1",0.21,0,Biomarker
632,BGLAP,bone gamma-carboxyglutamate (gla) protein,0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.21,1,Biomarker
222256,CDHR3,cadherin-related family member 3,0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.21,1,Biomarker
1767,DNAH5,"dynein, axonemal, heavy chain 5",0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.21,1,Biomarker
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.21,1,Biomarker
3291,HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2,0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.21,1,Biomarker
5515,PPP2CA,"protein phosphatase 2, catalytic subunit, alpha isozyme",0.0,1.0,0.0,0.0,0.0,4096,Asthma,0.21,1,Biomarker
847,CAT,catalase,0.0,0.0,0.0,0.0,1.0,34065,Pulmonary Embolism,0.21,1,Therapeutic
153090,DAB2IP,DAB2 interacting protein,0.0,1.0,0.0,0.0,0.0,34065,Pulmonary Embolism,0.21,1,Biomarker
10461,MERTK,"MER proto-oncogene, tyrosine kinase",0.0,0.0,0.0,0.0,1.0,34065,Pulmonary Embolism,0.21,1,Therapeutic
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,1.0,34065,Pulmonary Embolism,0.21,6,"Biomarker, Therapeutic"
6915,TBXA2R,thromboxane A2 receptor,0.0,1.0,0.0,0.0,0.0,34065,Pulmonary Embolism,0.21,1,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,34065,Pulmonary Embolism,0.21,1,Biomarker
8137,HYD2,hypodontia 2 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,1865092,"Tooth Agenesis, Selective, 2",0.21,0,Biomarker
29777,ABT1,activator of basal transcription 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
27034,ACAD8,"acyl-CoA dehydrogenase family, member 8",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
70,ACTC1,"actin, alpha, cardiac muscle 1",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
153,ADRB1,adrenoceptor beta 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
174,AFP,alpha-fetoprotein,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8644,AKR1C3,"aldo-keto reductase family 1, member C3",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
220,ALDH1A3,"aldehyde dehydrogenase 1 family, member A3",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
501,ALDH7A1,"aldehyde dehydrogenase 7 family, member A1",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
229,ALDOB,"aldolase B, fructose-bisphosphate",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
308,ANXA5,annexin A5,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
374,AREG,amphiregulin,0.0,1.0,0.0,0.0,1.0,38356,Stomach Neoplasms,0.21,3,"Biomarker, Therapeutic"
84364,ARFGAP2,ADP-ribosylation factor GTPase activating protein 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,3,Biomarker
9212,AURKB,aurora kinase B,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
645,BLVRB,biliverdin reductase B,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
650,BMP2,bone morphogenetic protein 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
655,BMP7,bone morphogenetic protein 7,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
664,BNIP3,BCL2/adenovirus E1B 19kDa interacting protein 3,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
23246,BOP1,block of proliferation 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
51501,C11orf73,chromosome 11 open reading frame 73,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
759,CA1,carbonic anhydrase I,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,2,Biomarker
760,CA2,carbonic anhydrase II,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
55739,CARKD,carbohydrate kinase domain containing,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
10574,CCT7,"chaperonin containing TCP1, subunit 7 (eta)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1019,CDK4,cyclin-dependent kinase 4,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1032,CDKN2D,"cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1152,CKB,"creatine kinase, brain",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1182,CLCN3,"chloride channel, voltage-sensitive 3",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1201,CLN3,"ceroid-lipofuscinosis, neuronal 3",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
10330,CNPY2,canopy FGF signaling regulator 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
50813,COPS7A,COP9 signalosome subunit 7A,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
29894,CPSF1,"cleavage and polyadenylation specific factor 1, 160kDa",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1469,CST1,cystatin SN,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8530,CST7,cystatin F (leukocystatin),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1496,CTNNA2,"catenin (cadherin-associated protein), alpha 2",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1075,CTSC,cathepsin C,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1514,CTSL,cathepsin L,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,2,Biomarker
1642,DDB1,"damage-specific DNA binding protein 1, 127kDa",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1674,DES,desmin,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1798,DPAGT1,dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
10148,EBI3,Epstein-Barr virus induced 3,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1892,ECHS1,"enoyl CoA hydratase, short chain, 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1915,EEF1A1,eukaryotic translation elongation factor 1 alpha 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1917,EEF1A2,eukaryotic translation elongation factor 1 alpha 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
79852,EPHX3,epoxide hydrolase 3,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
56915,EXOSC5,exosome component 5,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
2149,F2R,coagulation factor II (thrombin) receptor,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3992,FADS1,fatty acid desaturase 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
23201,FAM168A,"family with sequence similarity 168, member A",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
2203,FBP1,"fructose-1,6-bisphosphatase 1",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8857,FCGBP,Fc fragment of IgG binding protein,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
2266,FGG,fibrinogen gamma chain,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
27145,FILIP1,filamin A interacting protein 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
2286,FKBP2,"FK506 binding protein 2, 13kDa",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
79187,FSD1,fibronectin type III and SPRY domain containing 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
10468,FST,follistatin,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
2534,FYN,"FYN proto-oncogene, Src family tyrosine kinase",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
1647,GADD45A,"growth arrest and DNA-damage-inducible, alpha",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
2737,GLI3,GLI family zinc finger 3,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
51292,GMPR2,guanosine monophosphate reductase 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
26585,GREM1,"gremlin 1, DAN family BMP antagonist",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3191,HNRNPL,heterogeneous nuclear ribonucleoprotein L,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3199,HOXA2,homeobox A2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
59340,HRH4,histamine receptor H4,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3312,HSPA8,heat shock 70kDa protein 8,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,2,Biomarker
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,0.0,0.0,0.0,1.0,38356,Stomach Neoplasms,0.21,1,Therapeutic
3384,ICAM2,intercellular adhesion molecule 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3400,ID4,"inhibitor of DNA binding 4, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3420,IDH3B,isocitrate dehydrogenase 3 (NAD+) beta,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3490,IGFBP7,insulin-like growth factor binding protein 7,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3570,IL6R,interleukin 6 receptor,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3621,ING1,"inhibitor of growth family, member 1",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8660,IRS2,insulin receptor substrate 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3678,ITGA5,"integrin, alpha 5 (fibronectin receptor, alpha polypeptide)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8516,ITGA8,"integrin, alpha 8",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
84634,KISS1R,KISS1 receptor,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
58508,KMT2C,lysine (K)-specific methyltransferase 2C,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
3856,KRT8,"keratin 8, type II",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4074,M6PR,mannose-6-phosphate receptor (cation dependent),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5599,MAPK8,mitogen-activated protein kinase 8,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4139,MARK1,MAP/microtubule affinity-regulating kinase 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
125997,MBD3L2,methyl-CpG binding domain protein 3-like 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4291,MLF1,myeloid leukemia factor 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
28998,MRPL13,mitochondrial ribosomal protein L13,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
64963,MRPS11,mitochondrial ribosomal protein S11,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
28973,MRPS18B,mitochondrial ribosomal protein S18B,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
10232,MSLN,mesothelin,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4487,MSX1,msh homeobox 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
9788,MTSS1,metastasis suppressor 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4599,MX1,MX dynamin-like GTPase 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
51594,NBAS,neuroblastoma amplified sequence,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4695,NDUFA2,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4719,NDUFS1,"NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
10528,NOP56,NOP56 ribonucleoprotein,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
4907,NT5E,"5'-nucleotidase, ecto (CD73)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5036,PA2G4,"proliferation-associated 2G4, 38kDa",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5160,PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5223,PGAM1,phosphoglycerate mutase 1 (brain),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5325,PLAGL1,pleiomorphic adenoma gene-like 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
123,PLIN2,perilipin 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
51728,POLR3K,"polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8611,PPAP2A,phosphatidic acid phosphatase type 2A,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5478,PPIA,peptidylprolyl isomerase A (cyclophilin A),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5480,PPIC,peptidylprolyl isomerase C (cyclophilin C),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5518,PPP2R1A,"protein phosphatase 2, regulatory subunit A, alpha",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5524,PPP2R4,"protein phosphatase 2A activator, regulatory subunit 4",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
25824,PRDX5,peroxiredoxin 5,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5550,PREP,prolyl endopeptidase,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5564,PRKAB1,"protein kinase, AMP-activated, beta 1 non-catalytic subunit",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5579,PRKCB,"protein kinase C, beta",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
27339,PRPF19,pre-mRNA processing factor 19,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
53635,PTOV1,prostate tumor overexpressed 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5792,PTPRF,"protein tyrosine phosphatase, receptor type, F",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
80324,PUS1,pseudouridylate synthase 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5886,RAD23A,RAD23 homolog A (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
57610,RANBP10,RAN binding protein 10,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5918,RARRES1,retinoic acid receptor responder (tazarotene induced) 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5947,RBP1,"retinol binding protein 1, cellular",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,2,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5997,RGS2,regulator of G-protein signaling 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
54894,RNF43,ring finger protein 43,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6095,RORA,RAR-related orphan receptor A,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6137,RPL13,ribosomal protein L13,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6141,RPL18,ribosomal protein L18,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6209,RPS15,ribosomal protein S15,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6223,RPS19,ribosomal protein S19,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6227,RPS21,ribosomal protein S21,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6231,RPS26,ribosomal protein S26,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6194,RPS6,ribosomal protein S6,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
9136,RRP9,"ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast)",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6257,RXRB,"retinoid X receptor, beta",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
9805,SCRN1,secernin 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8991,SELENBP1,selenium binding protein 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,2,Biomarker
26135,SERBP1,SERPINE1 mRNA binding protein 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
5055,SERPINB2,"serpin peptidase inhibitor, clade B (ovalbumin), member 2",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6615,SNAI1,snail family zinc finger 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6628,SNRPB,small nuclear ribonucleoprotein polypeptides B and B1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
27131,SNX5,sorting nexin 5,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6700,SPRR2A,small proline-rich protein 2A,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6721,SREBF2,sterol regulatory element binding transcription factor 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8802,SUCLG1,"succinate-CoA ligase, alpha subunit",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8189,SYMPK,symplekin,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8148,TAF15,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
6926,TBX3,T-box 3,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
7022,TFAP2C,transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma),0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
7056,THBD,thrombomodulin,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
7078,TIMP3,TIMP metallopeptidase inhibitor 3,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
9725,TMEM63A,transmembrane protein 63A,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
8744,TNFSF9,"tumor necrosis factor (ligand) superfamily, member 9",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
7170,TPM3,tropomyosin 3,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
10131,TRAP1,TNF receptor-associated protein 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
84790,TUBA1C,"tubulin, alpha 1c",0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
51035,UBXN1,UBX domain protein 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
80328,ULBP2,UL16 binding protein 2,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
81605,URM1,ubiquitin related modifier 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
9277,WDR46,WD repeat domain 46,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
11197,WIF1,WNT inhibitory factor 1,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
90338,ZNF160,zinc finger protein 160,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
7730,ZNF177,zinc finger protein 177,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
84527,ZNF559,zinc finger protein 559,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
51042,ZNF593,zinc finger protein 593,0.0,1.0,0.0,0.0,0.0,38356,Stomach Neoplasms,0.21,1,Biomarker
27241,BBS9,Bardet-Biedl syndrome 9,0.0,1.0,0.0,0.0,0.0,10278,Craniosynostoses,0.21,1,Biomarker
2077,ERF,Ets2 repressor factor,0.0,1.0,0.0,0.0,0.0,10278,Craniosynostoses,0.21,1,Biomarker
55764,IFT122,intraflagellar transport 122,0.0,1.0,0.0,0.0,0.0,10278,Craniosynostoses,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,0.0,0.0,0.0,1.0,39231,Tachycardia,0.21,1,Therapeutic
51083,GAL,galanin/GMAP prepropeptide,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
2641,GCG,glucagon,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
6343,SCT,secretin,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
10451,VAV3,vav 3 guanine nucleotide exchange factor,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,39231,Tachycardia,0.21,1,Biomarker
3406,IDDM7,insulin-dependent diabetes mellitus 7,0.0,1.0,0.0,0.0,0.0,1838259,"Diabetes Mellitus, Insulin-Dependent, 7",0.21,0,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.21,1,Biomarker
10815,CPLX1,complexin 1,0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.21,1,Biomarker
10814,CPLX2,complexin 2,0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.21,1,Biomarker
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.21,1,Biomarker
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.21,1,Biomarker
5816,PVALB,parvalbumin,0.0,1.0,0.0,0.0,0.0,33975,Psychotic Disorders,0.21,1,Biomarker
553194,MYP9,myopia 9,0.0,1.0,0.0,0.0,0.0,1836504,Myopia 9,0.21,0,Biomarker
780904,PSS,Potocki-Shaffer syndrome,0.0,1.0,0.0,0.0,0.0,1832588,Potocki-Shaffer syndrome,0.21,0,Biomarker
25939,SAMHD1,SAM domain and HD domain 1,0.0,0.0,1.0,0.0,0.0,3280721,CHILBLAIN LUPUS 2,0.21,0,GeneticVariation
404713,SSD,Speech-sound disorder,0.0,1.0,0.0,0.0,0.0,1838022,Speech-Sound Disorder,0.21,0,Biomarker
713,C1QB,"complement component 1, q subcomponent, B chain",0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
718,C3,complement component 3,0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
720,C4A,complement component 4A (Rodgers blood group),0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
727,C5,complement component 5,0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
731,C8A,"complement component 8, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
732,C8B,"complement component 8, beta polypeptide",0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
735,C9,complement component 9,0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,2,Biomarker
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
1675,CFD,complement factor D (adipsin),0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,2,Biomarker
3075,CFH,complement factor H,0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
57724,EPG5,ectopic P-granules autophagy protein 5 homolog (C. elegans),0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
8547,FCN3,ficolin (collagen/fibrinogen domain containing) 3,0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
7535,ZAP70,zeta-chain (TCR) associated protein kinase 70kDa,0.0,1.0,0.0,0.0,0.0,21051,Immunologic Deficiency Syndromes,0.21,1,Biomarker
4292,MLH1,mutL homolog 1,0.0,1.0,0.0,0.0,0.0,1861975,"Cafe au lait spots, multiple",0.21,0,Biomarker
8056,ECB2,"erythrocytosis, autosomal recessive benign 2",0.0,1.0,0.0,0.0,0.0,1837915,"Erythrocytosis, Familial, 2",0.21,0,Biomarker
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,0.0,0.0,0.0,26010,Microphthalmos,0.21,1,Biomarker
5015,OTX2,orthodenticle homeobox 2,0.0,1.0,0.0,0.0,0.0,22360,Jaw Abnormalities,0.21,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,22360,Jaw Abnormalities,0.21,1,Biomarker
5424,POLD1,"polymerase (DNA directed), delta 1, catalytic subunit",0.0,1.0,0.0,0.0,0.0,22360,Jaw Abnormalities,0.21,1,Biomarker
6608,SMO,"smoothened, frizzled class receptor",0.0,1.0,0.0,0.0,0.0,22360,Jaw Abnormalities,0.21,1,Biomarker
57045,TWSG1,twisted gastrulation BMP signaling modulator 1,0.0,1.0,0.0,0.0,0.0,22360,Jaw Abnormalities,0.21,1,Biomarker
177,AGER,advanced glycosylation end product-specific receptor,0.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.21,1,Biomarker
284,ANGPT1,angiopoietin 1,0.0,0.0,0.0,0.0,1.0,20564,Hypertrophy,0.21,1,Therapeutic
4508,ATP6,ATP synthase F0 subunit 6,0.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.21,1,Biomarker
4512,COX1,cytochrome c oxidase subunit I,0.0,0.0,0.0,0.0,1.0,20564,Hypertrophy,0.21,1,Therapeutic
1390,CREM,cAMP responsive element modulator,0.0,0.0,0.0,0.0,1.0,20564,Hypertrophy,0.21,1,Therapeutic
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,20564,Hypertrophy,0.21,1,Therapeutic
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.21,2,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.21,1,Biomarker
6013,RLN1,relaxin 1,0.0,1.0,0.0,0.0,0.0,20564,Hypertrophy,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,0.0,0.0,0.0,1.0,20564,Hypertrophy,0.21,1,Therapeutic
10059,DNM1L,dynamin 1-like,0.0,1.0,0.0,0.0,0.0,29124,Optic Atrophy,0.21,1,Biomarker
4722,NDUFS3,"NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)",0.0,1.0,0.0,0.0,0.0,29124,Optic Atrophy,0.21,1,Biomarker
476,ATP1A1,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",0.0,1.0,0.0,0.0,0.0,42594,Vestibular Diseases,0.21,1,Biomarker
83715,ESPN,espin,0.0,1.0,0.0,0.0,0.0,42594,Vestibular Diseases,0.21,1,Biomarker
729330,OC90,otoconin 90,0.0,1.0,0.0,0.0,0.0,42594,Vestibular Diseases,0.21,1,Biomarker
100190928,SLEB12,"Systemic lupus erythematosus, susceptibility to, 12",0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.21,0,Biomarker
100196918,SLEB13,"Systemic lupus erythematosus, susceptibility to, 13",0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.21,0,Biomarker
100322878,SLEB14,"Systemic lupus erythematosus, susceptiblity to, 14",0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.21,0,Biomarker
100379200,SLEB15,"Systemic lupus erthematosus, susceptibility to, 15",0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.21,0,Biomarker
404714,SLEB4,"systemic lupus erythematosus, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.21,0,Biomarker
100188798,SLEB5,"Systemic lupus erythematosus, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.21,0,Biomarker
100188803,SLEB7,"Systemic lupus erythematosus, susceptibility to, 7",0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.21,0,Biomarker
100188804,SLEB8,"Systemic lupus erythematosus, susceptibility to, 8",0.0,1.0,0.0,0.0,0.0,24141,"Lupus Erythematosus, Systemic",0.21,0,Biomarker
84335,AKT1S1,AKT1 substrate 1 (proline-rich),0.0,0.0,0.0,0.0,1.0,37929,Spinal Cord Injuries,0.21,1,Therapeutic
5027,P2RX7,"purinergic receptor P2X, ligand gated ion channel, 7",0.0,0.0,0.0,0.0,1.0,37929,Spinal Cord Injuries,0.21,1,Therapeutic
6647,SOD1,"superoxide dismutase 1, soluble",0.0,0.0,0.0,0.0,1.0,37929,Spinal Cord Injuries,0.21,1,Therapeutic
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,24689,Mandibular Diseases,0.21,1,Biomarker
10269,ZMPSTE24,zinc metallopeptidase STE24,0.0,1.0,0.0,0.0,0.0,24689,Mandibular Diseases,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,11875,Diabetic Angiopathies,0.21,1,Biomarker
445,ASS1,argininosuccinate synthase 1,0.0,0.0,0.0,0.0,1.0,11875,Diabetic Angiopathies,0.21,1,Therapeutic
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,16427,Follicular Cyst,0.21,1,Biomarker
115019,SLC26A9,"solute carrier family 26 (anion exchanger), member 9",0.0,1.0,0.0,0.0,0.0,21843,Intestinal Obstruction,0.21,1,Biomarker
11254,SLC6A14,"solute carrier family 6 (amino acid transporter), member 14",0.0,1.0,0.0,0.0,0.0,21843,Intestinal Obstruction,0.21,1,Biomarker
6550,SLC9A3,"solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3",0.0,1.0,0.0,0.0,0.0,21843,Intestinal Obstruction,0.21,1,Biomarker
116443,GRIN3A,"glutamate receptor, ionotropic, N-methyl-D-aspartate 3A",0.0,1.0,0.0,0.0,0.0,242350,Erectile Dysfunction,0.21,1,Biomarker
6462,SHBG,sex hormone-binding globulin,0.0,1.0,0.0,0.0,0.0,242350,Erectile Dysfunction,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,0.0,0.0,0.0,1.0,242350,Erectile Dysfunction,0.21,1,Therapeutic
1884,EBR3,"epidermolysis bullosa 3, progressiva",0.0,1.0,0.0,0.0,0.0,268368,Epidermolysis Bullosa Dystrophica Neurotrophica,0.21,0,Biomarker
332,BIRC5,baculoviral IAP repeat containing 5,0.0,1.0,0.0,0.0,0.0,262584,"Carcinoma, Small Cell",0.21,1,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,262584,"Carcinoma, Small Cell",0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,0.0,0.0,0.0,1.0,262584,"Carcinoma, Small Cell",0.21,1,Therapeutic
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,0.0,0.0,0.0,262584,"Carcinoma, Small Cell",0.21,1,Biomarker
791122,KTWS,Klippel-Trenaunay-Weber syndrome,0.0,1.0,0.0,0.0,0.0,22739,Klippel-Trenaunay-Weber Syndrome,0.21,0,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,32045,Placenta Diseases,0.21,1,Biomarker
5652,PRSS8,"protease, serine, 8",0.0,0.0,0.0,0.0,1.0,32045,Placenta Diseases,0.21,1,Therapeutic
10653,SPINT2,"serine peptidase inhibitor, Kunitz type, 2",0.0,1.0,0.0,0.0,0.0,32045,Placenta Diseases,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,32045,Placenta Diseases,0.21,1,Biomarker
54,ACP5,"acid phosphatase 5, tartrate resistant",0.0,1.0,0.0,0.0,0.0,20503,"Hyperparathyroidism, Secondary",0.21,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,20503,"Hyperparathyroidism, Secondary",0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,20503,"Hyperparathyroidism, Secondary",0.21,1,Biomarker
406216,ATFB1,"Atrial fibrillation, familial 1",0.0,1.0,0.0,0.0,0.0,1843687,"Atrial fibrillation, familial 1",0.21,0,Biomarker
2702,GJA5,"gap junction protein, alpha 5, 40kDa",0.0,1.0,0.0,0.0,0.0,1843687,"Atrial fibrillation, familial 1",0.21,0,Biomarker
53368,MDC1B,"Muscular dystrophy, congenital, 1B",0.0,1.0,0.0,0.0,0.0,1858118,"Muscular Dystrophy, Congenital, 1B",0.21,0,Biomarker
1881,EBM,"epidermolysis bullosa, macular type",0.0,1.0,0.0,0.0,0.0,795974,"Bullous Dystrophy, Hereditary Macular Type",0.21,0,Biomarker
84061,MAGT1,magnesium transporter 1,0.0,1.0,0.0,0.0,0.0,2678034,"Mental Retardation, X-Linked 95",0.21,0,Biomarker
100526741,DEL8Q13,Mesomelia-synostoses syndrome,0.0,1.0,0.0,0.0,0.0,1838162,Mesomelia-synostoses syndrome,0.21,0,Biomarker
9333,TGM5,transglutaminase 5,0.0,1.0,0.0,0.0,0.0,1849193,Peeling Skin Syndrome,0.21,0,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
23705,CADM1,cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
1816,DRD5,dopamine receptor D5,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
2495,FTH1,"ferritin, heavy polypeptide 1",0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
2512,FTL,"ferritin, light polypeptide",0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
2739,GLO1,glyoxalase I,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
2782,GNB1,"guanine nucleotide binding protein (G protein), beta polypeptide 1",0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
2931,GSK3A,glycogen synthase kinase 3 alpha,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
5649,RELN,reelin,0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
6616,SNAP25,"synaptosomal-associated protein, 25kDa",0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,11581,Depressive Disorder,0.21,1,Biomarker
7446,AVSD1,atrioventricular septal defect 1,0.0,1.0,0.0,0.0,0.0,1389016,Atrioventricular Canal Defect,0.21,0,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,19326,"Hernia, Ventral",0.21,1,Biomarker
56616,DIABLO,"diablo, IAP-binding mitochondrial protein",0.0,1.0,0.0,0.0,0.0,20179,Huntington Disease,0.21,1,Biomarker
51447,IP6K2,inositol hexakisphosphate kinase 2,0.0,1.0,0.0,0.0,0.0,20179,Huntington Disease,0.21,1,Biomarker
11132,CAPN10,calpain 10,0.0,1.0,0.0,0.0,0.0,1832544,"Diabetes Mellitus, Noninsulin-Dependent, 1",0.21,0,Biomarker
4812,NIDDM1,"non-insulin-dependent diabetes mellitus (common, type 2) 1",0.0,1.0,0.0,0.0,0.0,1832544,"Diabetes Mellitus, Noninsulin-Dependent, 1",0.21,0,Biomarker
90,ACVR1,"activin A receptor, type I",0.0,1.0,0.0,0.0,0.0,242488,Acute Lung Injury,0.21,1,Biomarker
335,APOA1,apolipoprotein A-I,0.0,0.0,0.0,0.0,1.0,242488,Acute Lung Injury,0.21,1,Therapeutic
429,ASCL1,achaete-scute family bHLH transcription factor 1,0.0,0.0,0.0,0.0,1.0,242488,Acute Lung Injury,0.21,1,Therapeutic
847,CAT,catalase,0.0,0.0,0.0,0.0,1.0,242488,Acute Lung Injury,0.21,1,Therapeutic
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,242488,Acute Lung Injury,0.21,1,Biomarker
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,242488,Acute Lung Injury,0.21,1,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,0.0,0.0,0.0,242488,Acute Lung Injury,0.21,1,Biomarker
9173,IL1RL1,interleukin 1 receptor-like 1,0.0,0.0,0.0,0.0,1.0,242488,Acute Lung Injury,0.21,1,Therapeutic
7031,TFF1,trefoil factor 1,0.0,1.0,0.0,0.0,0.0,242488,Acute Lung Injury,0.21,1,Biomarker
7032,TFF2,trefoil factor 2,0.0,1.0,0.0,0.0,0.0,242488,Acute Lung Injury,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,242488,Acute Lung Injury,0.21,1,Biomarker
7295,TXN,thioredoxin,0.0,0.0,0.0,0.0,1.0,242488,Acute Lung Injury,0.21,1,Therapeutic
3589,IL11,interleukin 11,0.0,0.0,0.0,0.0,1.0,10692,Cystitis,0.21,1,Therapeutic
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,10692,Cystitis,0.21,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,10692,Cystitis,0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
79026,AHNAK,AHNAK nucleoprotein,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
11214,AKAP13,A kinase (PRKA) anchor protein 13,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
210,ALAD,aminolevulinate dehydratase,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
142685,ASB15,ankyrin repeat and SOCS box containing 15,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
822,CAPG,"capping protein (actin filament), gelsolin-like",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
84433,CARD11,"caspase recruitment domain family, member 11",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
1265,CNN2,calponin 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
10404,CPQ,carboxypeptidase Q,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
8738,CRADD,CASP2 and RIPK1 domain containing adaptor with death domain,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
1410,CRYAB,"crystallin, alpha B",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
114788,CSMD3,CUB and Sushi multiple domains 3,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,2,Biomarker
1509,CTSD,cathepsin D,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
9820,CUL7,cullin 7,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
144132,DNHD1,dynein heavy chain domain 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
1938,EEF2,eukaryotic translation elongation factor 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
158584,FAAH2,fatty acid amide hydrolase 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
374393,FAM111B,"family with sequence similarity 111, member B",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
56776,FMN2,formin 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
8790,FPGT,fucose-1-phosphate guanylyltransferase,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
2886,GRB7,growth factor receptor-bound protein 7,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
3035,HARS,histidyl-tRNA synthetase,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
3778,KCNMA1,"potassium channel, calcium activated large conductance subfamily M alpha, member 1",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
8242,KDM5C,lysine (K)-specific demethylase 5C,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
9817,KEAP1,kelch-like ECH-associated protein 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
3882,KRT32,"keratin 32, type I",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
3856,KRT8,"keratin 8, type II",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
3897,L1CAM,L1 cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
3945,LDHB,lactate dehydrogenase B,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
81562,LMAN2L,"lectin, mannose-binding 2-like",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
53353,LRP1B,low density lipoprotein receptor-related protein 1B,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
120892,LRRK2,leucine-rich repeat kinase 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
4074,M6PR,mannose-6-phosphate receptor (cation dependent),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
8028,MLLT10,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
343930,MSGN1,mesogenin 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
4585,MUC4,"mucin 4, cell surface associated",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
89795,NAV3,neuron navigator 3,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
91662,NLRP12,"NLR family, pyrin domain containing 12",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
283092,OR4C13,"olfactory receptor, family 4, subfamily C, member 13",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
5162,PDHB,pyruvate dehydrogenase (lipoamide) beta,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
23042,PDXDC1,pyridoxal-dependent decarboxylase domain containing 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
5230,PGK1,phosphoglycerate kinase 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
55367,PIDD1,p53-induced death domain protein 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
25953,PNKD,paroxysmal nonkinesigenic dyskinesia,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
23532,PRAME,preferentially expressed antigen in melanoma,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
9045,RPL14,ribosomal protein L14,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
6261,RYR1,ryanodine receptor 1 (skeletal),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
50944,SHANK1,SH3 and multiple ankyrin repeat domains 1,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
6526,SLC5A3,"solute carrier family 5 (sodium/myo-inositol cotransporter), member 3",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
57731,SPTBN4,"spectrin, beta, non-erythrocytic 4",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
23224,SYNE2,"spectrin repeat containing, nuclear envelope 2",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
8407,TAGLN2,transgelin 2,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
6921,TCEB1,"transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
284013,VMO1,vitelline membrane outer layer 1 homolog (chicken),0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
25844,YIPF3,"Yip1 domain family, member 3",0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
9745,ZNF536,zinc finger protein 536,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
91661,ZNF765,zinc finger protein 765,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
91752,ZNF804A,zinc finger protein 804A,0.0,1.0,0.0,0.0,0.0,7134,"Carcinoma, Renal Cell",0.21,1,Biomarker
148,ADRA1A,adrenoceptor alpha 1A,0.0,1.0,0.0,0.0,0.0,600519,Ventricular Remodeling,0.21,1,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,600519,Ventricular Remodeling,0.21,1,Biomarker
4087,SMAD2,SMAD family member 2,0.0,1.0,0.0,0.0,0.0,600519,Ventricular Remodeling,0.21,1,Biomarker
4088,SMAD3,SMAD family member 3,0.0,1.0,0.0,0.0,0.0,600519,Ventricular Remodeling,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,600519,Ventricular Remodeling,0.21,1,Biomarker
875,CBS,cystathionine-beta-synthase,0.0,0.0,1.0,0.0,0.0,1439329,CYSTATHIONINE BETA-SYNTHASE,0.21,25,GeneticVariation
8231,CND,Corneal dermoids,0.0,1.0,0.0,0.0,0.0,1844671,Dermoids of cornea,0.21,0,Biomarker
387583,SPG25,"spastic paraplegia 25 (autosomal recessive, with disc herniation)",0.0,1.0,0.0,0.0,0.0,2936860,"Spastic paraplegia 25, autosomal recessive",0.21,0,Biomarker
9722,NOS1AP,nitric oxide synthase 1 (neuronal) adaptor protein,0.0,1.0,0.0,0.0,0.0,1857828,"QT INTERVAL, VARIATION IN",0.21,0,Biomarker
100379215,QTV,"QT interval, variation in",0.0,1.0,0.0,0.0,0.0,1857828,"QT INTERVAL, VARIATION IN",0.21,0,Biomarker
497657,ANIB3,"aneurysm, intracranial berry 3",0.0,1.0,0.0,0.0,0.0,1836757,"Aneurysm, Intracranial Berry, 3",0.21,0,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
4791,NFKB2,nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100),0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
5966,REL,v-rel avian reticuloendotheliosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
5971,RELB,v-rel avian reticuloendotheliosis viral oncogene homolog B,0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,18843,Heat Stroke,0.21,1,Biomarker
100188809,HPC7,"Prostate cancer, hereditary, 7",0.0,1.0,0.0,0.0,0.0,1853195,"Prostate Cancer, Hereditary, 7",0.21,0,Biomarker
2253,FGF8,fibroblast growth factor 8 (androgen-induced),0.0,1.0,0.0,0.0,0.0,8924,Cleft Lip,0.21,1,Biomarker
2254,FGF9,fibroblast growth factor 9,0.0,1.0,0.0,0.0,0.0,8924,Cleft Lip,0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,8924,Cleft Lip,0.21,1,Biomarker
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,0.0,0.0,0.0,8924,Cleft Lip,0.21,1,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,8924,Cleft Lip,0.21,1,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,8924,Cleft Lip,0.21,1,Biomarker
117190,HPE6,holoprosencephaly 6,0.0,1.0,0.0,0.0,0.0,1853830,Holoprosencephaly 6,0.21,0,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,1176475,"Carcinoma, Ductal",0.21,1,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,1176475,"Carcinoma, Ductal",0.21,1,Biomarker
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,0.0,0.0,1176475,"Carcinoma, Ductal",0.21,1,Biomarker
1287,COL4A5,"collagen, type IV, alpha 5",0.0,1.0,0.0,0.0,0.0,86533,"Leiomyoma, Epithelioid",0.21,1,Biomarker
1288,COL4A6,"collagen, type IV, alpha 6",0.0,1.0,0.0,0.0,0.0,86533,"Leiomyoma, Epithelioid",0.21,1,Biomarker
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,2936350,"Plaque, Atherosclerotic",0.21,3,Biomarker
682,BSG,basigin (Ok blood group),0.0,1.0,0.0,0.0,0.0,2936350,"Plaque, Atherosclerotic",0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,2936350,"Plaque, Atherosclerotic",0.21,1,Biomarker
768,CA9,carbonic anhydrase IX,0.0,1.0,0.0,0.0,0.0,2793,Anaplasia,0.21,1,Biomarker
1243,CMM,cutaneous malignant melanoma/dysplastic nevus,0.0,1.0,0.0,0.0,0.0,1835047,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
474388,CMM4,"Melanoma, cutaneous malignant, 4",0.0,1.0,0.0,0.0,0.0,1835047,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),0.0,1.0,0.0,0.0,0.0,1835047,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,1835047,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
619379,SPG29,spastic paraplegia 29 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1857855,"Spastic paraplegia 29, autosomal dominant",0.21,0,Biomarker
83552,MFRP,membrane frizzled-related protein,0.0,1.0,0.0,0.0,0.0,1970236,"Microphthalmia, Posterior, With Retinitis Pigmentosa, Foveoschisis, And Optic Disc Drusen",0.21,0,Biomarker
2157,F8,"coagulation factor VIII, procoagulant component",0.0,0.0,0.0,0.0,1.0,272325,"Factor 8 deficiency, acquired",0.21,1,Therapeutic
1583,CYP11A1,"cytochrome P450, family 11, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,342474,Lipoid congenital adrenal hyperplasia,0.21,1,Biomarker
9382,COG1,component of oligomeric golgi complex 1,0.0,1.0,0.0,0.0,0.0,2931011,"Congenital disorder of glycosylation, type 2G",0.21,0,Biomarker
176,ACAN,aggrecan,0.0,1.0,0.0,0.0,0.0,238288,"Muscular Dystrophy, Facioscapulohumeral",0.21,1,Biomarker
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",0.0,1.0,0.0,0.0,0.0,238288,"Muscular Dystrophy, Facioscapulohumeral",0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,238288,"Muscular Dystrophy, Facioscapulohumeral",0.21,1,Biomarker
1634,DCN,decorin,0.0,1.0,0.0,0.0,0.0,238288,"Muscular Dystrophy, Facioscapulohumeral",0.21,1,Biomarker
2006,ELN,elastin,0.0,1.0,0.0,0.0,0.0,238288,"Muscular Dystrophy, Facioscapulohumeral",0.21,1,Biomarker
2953,GSTT2,glutathione S-transferase theta 2 (gene/pseudogene),0.0,1.0,0.0,0.0,0.0,238288,"Muscular Dystrophy, Facioscapulohumeral",0.21,1,Biomarker
3304,HSPA1B,heat shock 70kDa protein 1B,0.0,1.0,0.0,0.0,0.0,238288,"Muscular Dystrophy, Facioscapulohumeral",0.21,1,Biomarker
3308,HSPA4,heat shock 70kDa protein 4,0.0,1.0,0.0,0.0,0.0,238288,"Muscular Dystrophy, Facioscapulohumeral",0.21,1,Biomarker
4060,LUM,lumican,0.0,1.0,0.0,0.0,0.0,238288,"Muscular Dystrophy, Facioscapulohumeral",0.21,1,Biomarker
54115,PTOS2,"Ptosis, hereditary congenital 2",0.0,1.0,0.0,0.0,0.0,1846128,"Ptosis, Hereditary Congenital 2",0.21,0,Biomarker
128178,EDARADD,EDAR-associated death domain,0.0,0.0,1.0,0.0,0.0,3539920,"ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",0.21,0,GeneticVariation
710,SERPING1,"serpin peptidase inhibitor, clade G (C1 inhibitor), member 1",0.0,1.0,0.0,0.0,0.0,1852700,"Complement Component 4, Partial Deficiency Of",0.21,0,Biomarker
1828,DSG1,desmoglein 1,0.0,1.0,0.0,0.0,0.0,2931122,Keratosis palmoplantaris striata 1,0.21,0,Biomarker
3848,KRT1,"keratin 1, type II",0.0,1.0,0.0,0.0,0.0,2931122,Keratosis palmoplantaris striata 1,0.21,0,Biomarker
120,ADD3,adducin 3 (gamma),0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
213,ALB,albumin,0.0,0.0,0.0,0.0,1.0,7786,Brain Ischemia,0.21,1,Therapeutic
41,ASIC1,acid sensing (proton gated) ion channel 1,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
27113,BBC3,BCL2 binding component 3,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
842,CASP9,"caspase 9, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,2,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
1233,CCR4,chemokine (C-C motif) receptor 4,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
1051,CEBPB,"CCAAT/enhancer binding protein (C/EBP), beta",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
1128,CHRM1,"cholinergic receptor, muscarinic 1",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
54205,CYCS,"cytochrome c, somatic",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
56616,DIABLO,"diablo, IAP-binding mitochondrial protein",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
8655,DYNLL1,"dynein, light chain, LC8-type 1",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
1958,EGR1,early growth response 1,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,0.0,0.0,0.0,1.0,7786,Brain Ischemia,0.21,1,Therapeutic
3588,IL10RB,"interleukin 10 receptor, beta",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
3594,IL12RB1,"interleukin 12 receptor, beta 1",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
23765,IL17RA,interleukin 17 receptor A,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
5604,MAP2K1,mitogen-activated protein kinase kinase 1,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
4792,NFKBIA,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,7786,Brain Ischemia,0.21,4,Therapeutic
5925,RB1,retinoblastoma 1,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,0.0,0.0,0.0,1.0,7786,Brain Ischemia,0.21,1,Therapeutic
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,3,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,7786,Brain Ischemia,0.21,1,Biomarker
156,ADRBK1,"adrenergic, beta, receptor kinase 1",0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.21,1,Biomarker
1295,COL8A1,"collagen, type VIII, alpha 1",0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.21,1,Biomarker
9314,KLF4,Kruppel-like factor 4 (gut),0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.21,1,Biomarker
1317,SLC31A1,"solute carrier family 31 (copper transporter), member 1",0.0,1.0,0.0,0.0,0.0,768,Congenital Abnormalities,0.21,1,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,2931672,"Cerebral hemorrhage with amyloidosis, hereditary, Dutch type",0.21,2,Biomarker
23529,CLCF1,cardiotrophin-like cytokine factor 1,0.0,1.0,0.0,0.0,0.0,1848947,Cold-Induced Sweating Syndrome 1,0.21,0,Biomarker
4128,MAOA,monoamine oxidase A,0.0,1.0,0.0,0.0,0.0,1285261,Fetal Nutrition Disorders,0.21,1,Biomarker
171157,SHFM5,split hand/foot malformation (ectrodactyly) type 5,0.0,1.0,0.0,0.0,0.0,1847622,Split-Hand/Foot Malformation 5,0.21,0,Biomarker
882,CCAL1,"chondrocalcinosis 1 (calcium pyrophosphate-deposition disease, early onset osteoarthritis)",0.0,1.0,0.0,0.0,0.0,1833499,Chondrocalcinosis 1,0.21,0,Biomarker
23414,ZFPM2,"zinc finger protein, FOG family member 2",0.0,0.0,1.0,0.0,0.0,1857586,Conotruncal cardiac defects,0.21,0,GeneticVariation
2627,GATA6,GATA binding protein 6,0.0,0.0,1.0,0.0,0.0,1857586,Conotruncal cardiac defects,0.21,0,GeneticVariation
55997,CFC1,"cripto, FRL-1, cryptic family 1",0.0,1.0,0.0,0.0,0.0,1857586,Conotruncal cardiac defects,0.21,0,Biomarker
100270799,IBD25,Inflammatory bowel disease-25,0.0,1.0,0.0,0.0,0.0,2675508,"Inflammatory Bowel Disease 25, Autosomal Recessive",0.21,0,Biomarker
5072,PARK3,"Parkinson disease 3 (autosomal dominant, Lewy body)",0.0,1.0,0.0,0.0,0.0,1865581,"Parkinson Disease 3, Autosomal Dominant Lewy Body",0.21,0,Biomarker
1558,CYP2C8,"cytochrome P450, family 2, subfamily C, polypeptide 8",0.0,1.0,0.0,0.0,0.0,35410,Rhabdomyolysis,0.21,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,35410,Rhabdomyolysis,0.21,1,Biomarker
23694,MRX73,"mental retardation, X-linked 73",0.0,1.0,0.0,0.0,0.0,1845860,"Mental Retardation, X-Linked 73",0.21,0,Biomarker
470,ATHS,atherosclerosis susceptibility (lipoprotein associated),0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.21,0,Biomarker
4864,NPC1,"Niemann-Pick disease, type C1",0.0,0.0,0.0,0.0,1.0,4153,Atherosclerosis,0.21,1,Therapeutic
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.21,1,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,4153,Atherosclerosis,0.21,1,Biomarker
8201,MLRL,Myeloid leukemia-related gene (myeloid tumor suppressor),0.0,1.0,0.0,0.0,0.0,1832510,MYELOID TUMOR SUPPRESSOR,0.21,0,Biomarker
100188773,CFSS,craniofacioskeletal syndrome,0.0,1.0,0.0,0.0,0.0,2678036,Craniofacioskeletal Syndrome,0.21,0,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,32001,Pituitary Apoplexy,0.21,2,Biomarker
56172,ANKH,ANKH inorganic pyrophosphate transport regulator,0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.21,1,Biomarker
4038,LRP4,low density lipoprotein receptor-related protein 4,0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.21,1,Biomarker
4487,MSX1,msh homeobox 1,0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.21,1,Biomarker
5308,PITX2,paired-like homeodomain 2,0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.21,1,Biomarker
860,RUNX2,runt-related transcription factor 2,0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.21,1,Biomarker
91252,SLC39A13,"solute carrier family 39 (zinc transporter), member 13",0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.21,2,Biomarker
6926,TBX3,T-box 3,0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.21,1,Biomarker
54499,TMCO1,transmembrane and coiled-coil domains 1,0.0,1.0,0.0,0.0,0.0,40427,Tooth Abnormalities,0.21,1,Biomarker
619407,MSSD,"syndactyly, mesoaxial synostotic, with phalangeal reduction",0.0,1.0,0.0,0.0,0.0,1836206,"Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction",0.21,0,Biomarker
444,ASPH,aspartate beta-hydroxylase,0.0,0.0,1.0,0.0,0.0,1832167,"Ectopia Lentis, Spontaneous Filtering Blebs, and Craniofacial Dysmorphism",0.21,1,GeneticVariation
4891,SLC11A2,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2",0.0,0.0,1.0,0.0,0.0,3806153,"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1",0.21,3,GeneticVariation
4378,MRX14,"mental retardation, X-linked 14",0.0,1.0,0.0,0.0,0.0,796220,"Mental retardation, X-linked 14",0.21,0,Biomarker
71,ACTG1,actin gamma 1,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
397,ARHGDIB,Rho GDP dissociation inhibitor (GDI) beta,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
832,CAPZB,"capping protein (actin filament) muscle Z-line, beta",0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
1152,CKB,"creatine kinase, brain",0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
1158,CKM,"creatine kinase, muscle",0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
2934,GSN,gelsolin,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
3312,HSPA8,heat shock 70kDa protein 8,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
3945,LDHB,lactate dehydrogenase B,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
2923,PDIA3,"protein disulfide isomerase family A, member 3",0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
5689,PSMB1,"proteasome (prosome, macropain) subunit, beta type, 1",0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
338382,RAB7B,"RAB7B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,0.0,0.0,0.0,1.0,948089,Acute Coronary Syndrome,0.21,1,Therapeutic
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
7171,TPM4,tropomyosin 4,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
84790,TUBA1C,"tubulin, alpha 1c",0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
7414,VCL,vinculin,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,948089,Acute Coronary Syndrome,0.21,1,Biomarker
367,AR,androgen receptor,0.0,1.0,0.0,0.0,0.0,242788,"Breast Neoplasms, Male",0.21,2,Biomarker
5890,RAD51B,RAD51 paralog B,0.0,1.0,0.0,0.0,0.0,242788,"Breast Neoplasms, Male",0.21,1,Biomarker
27324,TOX3,TOX high mobility group box family member 3,0.0,1.0,0.0,0.0,0.0,242788,"Breast Neoplasms, Male",0.21,1,Biomarker
57007,ACKR3,atypical chemokine receptor 3,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
147,ADRA1B,adrenoceptor alpha 1B,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
301,ANXA1,annexin A1,0.0,0.0,0.0,0.0,1.0,22658,Kidney Diseases,0.21,1,Therapeutic
793,CALB1,"calbindin 1, 28kDa",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,2,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
1191,CLU,clusterin,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,3,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,22658,Kidney Diseases,0.21,1,Therapeutic
1489,CTF1,cardiotrophin 1,0.0,0.0,0.0,0.0,1.0,22658,Kidney Diseases,0.21,1,Therapeutic
1509,CTSD,cathepsin D,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
2243,FGA,fibrinogen alpha chain,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,2,Biomarker
2628,GATM,glycine amidinotransferase (L-arginine:glycine amidinotransferase),0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
84662,GLIS2,GLIS family zinc finger 2,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
3207,HOXA11,homeobox A11,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
3237,HOXD11,homeobox D11,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
55764,IFT122,intraflagellar transport 122,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
90865,IL33,interleukin 33,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
406991,MIR21,microRNA 21,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
4601,MXI1,"MAX interactor 1, dimerization protein",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
284086,NEK8,NIMA-related kinase 8,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
4881,NPR1,natriuretic peptide receptor 1,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,0.0,0.0,0.0,1.0,22658,Kidney Diseases,0.21,1,Therapeutic
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,2,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
8437,RASAL1,RAS protein activator like 1 (GAP1 like),0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
9104,RGN,regucalcin,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
10736,SIX2,SIX homeobox 2,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
55244,SLC47A1,"solute carrier family 47 (multidrug and toxin extrusion), member 1",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
11136,SLC7A9,"solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
7015,TERT,telomerase reverse transcriptase,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
7020,TFAP2A,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha),0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
7033,TFF3,trefoil factor 3 (intestinal),0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
27283,TINAG,tubulointerstitial nephritis antigen,0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
54361,WNT4,"wingless-type MMTV integration site family, member 4",0.0,1.0,0.0,0.0,0.0,22658,Kidney Diseases,0.21,1,Biomarker
84335,AKT1S1,AKT1 substrate 1 (proline-rich),0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
1026,CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
2919,CXCL1,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
1946,EFNA5,ephrin-A5,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
1948,EFNB2,ephrin-B2,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
83939,EIF2A,"eukaryotic translation initiation factor 2A, 65kDa",0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
2113,ETS1,v-ets avian erythroblastosis virus E26 oncogene homolog 1,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
2252,FGF7,fibroblast growth factor 7,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
2277,FIGF,c-fos induced growth factor (vascular endothelial growth factor D),0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
2520,GAST,gastrin,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,0.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.21,1,Therapeutic
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,0.0,0.0,0.0,0.0,1.0,35126,Reperfusion Injury,0.21,1,Therapeutic
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,2,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
3592,IL12A,interleukin 12A,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,5,Biomarker
3678,ITGA5,"integrin, alpha 5 (fibronectin receptor, alpha polypeptide)",0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
5601,MAPK9,mitogen-activated protein kinase 9,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,2,Biomarker
5320,PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid)",0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
7015,TERT,telomerase reverse transcriptase,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
7057,THBS1,thrombospondin 1,0.0,1.0,0.0,0.0,0.0,35126,Reperfusion Injury,0.21,1,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,546127,"Mercury Poisoning, Nervous System",0.21,1,Biomarker
8422,MEHMO,"mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly and obesity syndrome",0.0,1.0,0.0,0.0,0.0,1846278,MEHMO syndrome,0.21,0,Biomarker
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,0.0,0.0,0.0,3152204,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8",0.21,1,Biomarker
780901,NYS5,"Nystagmus 5, infantile periodic alternating",0.0,1.0,0.0,0.0,0.0,1845116,"Nystagmus 5, Infantile Periodic Alternating",0.21,0,Biomarker
3795,KHK,ketohexokinase (fructokinase),0.0,0.0,1.0,0.0,0.0,1416630,"FRUCTOSURIA, ESSENTIAL",0.21,1,GeneticVariation
8009,LALL,Lymphomatous acute lymphoblastic leukemia,0.0,1.0,0.0,0.0,0.0,1855472,"Lymphoblastic Leukemia, Acute, with Lymphomatous Features",0.21,0,Biomarker
9420,CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,2931356,"Spastic paraplegia type 5A, recessive",0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,37316,Sleep Deprivation,0.21,1,Biomarker
780912,AD10,Alzheimer disease-10,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,0,Biomarker
64851,AD6,Alzheimer disease 6,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,0,Biomarker
353128,AD8,Alzheimer disease 8,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,0,Biomarker
450086,AD9,Alzheimer disease 9,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,0,Biomarker
267,AMFR,"autocrine motility factor receptor, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,1,Biomarker
23237,ARC,activity-regulated cytoskeleton-associated protein,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,1,Biomarker
3952,LEP,leptin,0.0,0.0,0.0,0.0,1.0,2395,Alzheimer Disease,0.21,1,Therapeutic
51338,MS4A4A,"membrane-spanning 4-domains, subfamily A, member 4A",0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,1,Biomarker
5697,PYY,peptide YY,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,1,Biomarker
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,1,Biomarker
1200,TPP1,tripeptidyl peptidase I,0.0,1.0,0.0,0.0,0.0,2395,Alzheimer Disease,0.21,1,Biomarker
4901,NRL,neural retina leucine zipper,0.0,1.0,0.0,0.0,0.0,28077,Night Blindness,0.21,2,Biomarker
8026,DGS2,DiGeorge syndrome/velocardiofacial syndrome complex 2,0.0,1.0,0.0,0.0,0.0,1832431,Digeorge Syndrome/Velocardiofacial Syndrome Complex 2,0.21,0,Biomarker
22909,FAN1,FANCD2/FANCI-associated nuclease 1,0.0,1.0,0.0,0.0,0.0,2931118,Megalocytic interstitial nephritis,0.21,1,Biomarker
727716,SCAX4,"spinocerebellar ataxia, X-linked 4",0.0,1.0,0.0,0.0,0.0,1844933,"Spinocerebellar ataxia, X-linked, 4",0.21,0,Biomarker
100188795,AD11,Alzheimer disease-11,0.0,1.0,0.0,0.0,0.0,1853360,Alzheimer Disease 11,0.21,0,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,19699,HIV Seropositivity,0.21,1,Biomarker
57379,AICDA,activation-induced cytidine deaminase,0.0,1.0,0.0,0.0,0.0,23448,"Leukemia, Lymphoid",0.21,1,Biomarker
81037,CLPTM1L,CLPTM1-like,0.0,1.0,0.0,0.0,0.0,23448,"Leukemia, Lymphoid",0.21,1,Biomarker
26034,IPCEF1,interaction protein for cytohesin exchange factors 1,0.0,1.0,0.0,0.0,0.0,23448,"Leukemia, Lymphoid",0.21,1,Biomarker
4066,LYL1,lymphoblastic leukemia associated hematopoiesis regulator 1,0.0,1.0,0.0,0.0,0.0,23448,"Leukemia, Lymphoid",0.21,1,Biomarker
25913,POT1,protection of telomeres 1,0.0,1.0,0.0,0.0,0.0,23448,"Leukemia, Lymphoid",0.21,2,Biomarker
7015,TERT,telomerase reverse transcriptase,0.0,1.0,0.0,0.0,0.0,23448,"Leukemia, Lymphoid",0.21,1,Biomarker
552,AVPR1A,arginine vasopressin receptor 1A,0.0,1.0,0.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.21,1,Biomarker
554,AVPR2,arginine vasopressin receptor 2,0.0,1.0,0.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.21,1,Biomarker
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",0.0,1.0,0.0,0.0,0.0,1627,"Adrenal Hyperplasia, Congenital",0.21,1,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,2675470,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3",0.21,0,Biomarker
100302720,CTRCT34,"Cataract, autosomal recessive congenital 3",0.0,1.0,0.0,0.0,0.0,2751822,"Cataract, Autosomal Recessive Congenital 3",0.21,0,Biomarker
780903,HHT3,Osler-Rendu-Weber syndrome 3,0.0,1.0,0.0,0.0,0.0,1832774,Osler-rendu-weber syndrome 3,0.21,0,Biomarker
2629,GBA,"glucosidase, beta, acid",0.0,1.0,0.0,0.0,0.0,1856476,"Gaucher Disease, Type Iiic",0.21,0,Biomarker
791254,EDS8,"Ehlers-Danlos syndrome, type VIII",0.0,1.0,0.0,0.0,0.0,268347,"Ehlers-Danlos Syndrome, Type VIII",0.21,0,Biomarker
100196912,MAFD8,"Major affective disorder-8, susceptibility to",0.0,1.0,0.0,0.0,0.0,2700439,Major Affective Disorder 8,0.21,0,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,0.0,0.0,0.0,20474,"Hyperlipidemia, Familial Combined",0.21,1,Biomarker
28515,HYPLIP2,"hyperlipidemia, combined, 2",0.0,1.0,0.0,0.0,0.0,20474,"Hyperlipidemia, Familial Combined",0.21,0,Biomarker
100422910,MIR2861,microRNA 2861,0.0,1.0,0.0,0.0,0.0,3150680,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15,0.21,0,Biomarker
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,0.0,0.0,0.0,1.0,749098,"Hematoma, Subdural, Acute",0.21,1,Therapeutic
8103,PAPA2,"postaxial polydactyly, type A2",0.0,1.0,0.0,0.0,0.0,1865883,"Polydactyly, Postaxial, Type A2",0.21,0,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,0.0,0.0,0.0,1.0,36429,Sclerosis,0.21,1,Therapeutic
29764,DDU,dermo-distortive urticaria,0.0,1.0,0.0,0.0,0.0,1852145,Familial dermographism,0.21,0,Biomarker
100188868,HPC15,"Prostate cancer, hereditary, 15",0.0,1.0,0.0,0.0,0.0,2677771,"Prostate Cancer, Hereditary, 15",0.21,0,Biomarker
779,CACNA1S,"calcium channel, voltage-dependent, L type, alpha 1S subunit",0.0,1.0,0.0,0.0,0.0,2749982,"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
3778,KCNMA1,"potassium channel, calcium activated large conductance subfamily M alpha, member 1",0.0,1.0,0.0,0.0,0.0,28756,"Obesity, Morbid",0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,5683,Urinary Bladder Calculi,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,36420,"Scleroderma, Localized",0.21,1,Therapeutic
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,36420,"Scleroderma, Localized",0.21,1,Biomarker
283120,H19,"H19, imprinted maternally expressed transcript (non-protein coding)",0.0,1.0,0.0,0.0,0.0,19188,"Hepatitis, Animal",0.21,1,Biomarker
3934,LCN2,lipocalin 2,0.0,1.0,0.0,0.0,0.0,19188,"Hepatitis, Animal",0.21,1,Biomarker
7033,TFF3,trefoil factor 3 (intestinal),0.0,1.0,0.0,0.0,0.0,19188,"Hepatitis, Animal",0.21,1,Biomarker
10537,UBD,ubiquitin D,0.0,1.0,0.0,0.0,0.0,19188,"Hepatitis, Animal",0.21,1,Biomarker
724110,SPG34,spastic paraplegia 34 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,2677897,"Spastic Paraplegia 34, X-Linked",0.21,0,Biomarker
6608,SMO,"smoothened, frizzled class receptor",0.0,1.0,0.0,0.0,0.0,24954,Maxillary Neoplasms,0.21,1,Biomarker
5052,PRDX1,peroxiredoxin 1,0.0,0.0,0.0,0.0,1.0,36323,Schistosomiasis,0.21,1,Therapeutic
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,1.0,0.0,0.0,0.0,36323,Schistosomiasis,0.21,1,Biomarker
7078,TIMP3,TIMP metallopeptidase inhibitor 3,0.0,1.0,0.0,0.0,0.0,36323,Schistosomiasis,0.21,1,Biomarker
10386,MHW1,Mental health wellness 1,0.0,1.0,0.0,0.0,0.0,1863621,MENTAL HEALTH WELLNESS 1,0.21,0,Biomarker
3694,ITGB6,"integrin, beta 6",0.0,1.0,0.0,0.0,0.0,524910,"Hepatitis C, Chronic",0.21,1,Biomarker
139189,DGKK,"diacylglycerol kinase, kappa",0.0,1.0,0.0,0.0,0.0,1845672,"Mental Retardation, X-Linked 63",0.21,0,Biomarker
57789,MTBSX,"Mycobacterium tuberculosis, susceptibility to infection by",0.0,1.0,0.0,0.0,0.0,1866629,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, X-LINKED",0.21,0,Biomarker
1709,DFNB17,"deafness, autosomal recessive 17",0.0,1.0,0.0,0.0,0.0,1864276,"Deafness, Autosomal Recessive 17",0.21,0,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,2,Biomarker
9131,AIFM1,"apoptosis-inducing factor, mitochondrion-associated, 1",0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,1,Therapeutic
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
384,ARG2,arginase 2,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
468,ATF4,activating transcription factor 4,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
9474,ATG5,autophagy related 5,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
10533,ATG7,autophagy related 7,0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,1,Therapeutic
596,BCL2,B-cell CLL/lymphoma 2,0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,2,Therapeutic
613,BCR,breakpoint cluster region,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
831,CAST,calpastatin,0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,1,Therapeutic
847,CAT,catalase,0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,2,Therapeutic
959,CD40LG,CD40 ligand,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
998,CDC42,cell division cycle 42,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
1489,CTF1,cardiotrophin 1,0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,1,Therapeutic
1508,CTSB,cathepsin B,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,2,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
29952,DPP7,dipeptidyl-peptidase 7,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
2170,FABP3,"fatty acid binding protein 3, muscle and heart",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
2628,GATM,glycine amidinotransferase (L-arginine:glycine amidinotransferase),0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
26762,HAVCR1,hepatitis A virus cellular receptor 1,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
3146,HMGB1,high mobility group box 1,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,2,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,2,Biomarker
3605,IL17A,interleukin 17A,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,3,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,2,Therapeutic
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
3875,KRT18,"keratin 18, type I",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
3958,LGALS3,"lectin, galactoside-binding, soluble, 3",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
4023,LPL,lipoprotein lipase,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
4255,MGMT,O-6-methylguanine-DNA methyltransferase,0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,1,Therapeutic
406967,MIR192,microRNA 192,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
4613,MYCN,v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,1,Therapeutic
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,2,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
5621,PRNP,prion protein,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
22827,PUF60,poly-U binding splicing factor 60KDa,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
1317,SLC31A1,"solute carrier family 31 (copper transporter), member 1",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,1,Therapeutic
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,1.0,27540,Necrosis,0.21,2,"Biomarker, Therapeutic"
6649,SOD3,"superoxide dismutase 3, extracellular",0.0,0.0,0.0,0.0,1.0,27540,Necrosis,0.21,1,Therapeutic
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
6915,TBXA2R,thromboxane A2 receptor,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,3,Biomarker
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,0.0,0.0,0.0,27540,Necrosis,0.21,1,Biomarker
1394,CRHR1,corticotropin releasing hormone receptor 1,0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.21,1,Biomarker
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.21,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.21,1,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.21,1,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,0.0,0.0,0.0,1.0,3123,Anorexia,0.21,1,Therapeutic
90226,UCN2,urocortin 2,0.0,1.0,0.0,0.0,0.0,3123,Anorexia,0.21,1,Biomarker
81863,CTPL1,"cataract, pulverulent (autosomal recessive, early-onset)",0.0,1.0,0.0,0.0,0.0,1854003,"Cataract, Autosomal Recessive, Early-Onset, Pulverulent",0.21,0,Biomarker
3412,IDDM13,insulin-dependent diabetes mellitus 13,0.0,1.0,0.0,0.0,0.0,1832474,"Diabetes Mellitus, Insulin-Dependent, 13",0.21,0,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.21,1,Biomarker
100188775,LOAS,"Leber optic atrophy, susceptibility to",0.0,1.0,0.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.21,0,Biomarker
9227,LRAT,lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase),0.0,1.0,0.0,0.0,0.0,917796,"Optic Atrophy, Hereditary, Leber",0.21,2,Biomarker
1747,DLX3,distal-less homeobox 3,0.0,1.0,0.0,0.0,0.0,1863012,"Amelogenesis Imperfecta, Type IV",0.21,0,Biomarker
100188785,ITC1,"hypertrichosis universalis congenita, Ambras type",0.0,1.0,0.0,0.0,0.0,1840362,Ambras syndrome,0.21,0,Biomarker
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,1,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,2,Biomarker
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,1,Biomarker
1158,CKM,"creatine kinase, muscle",0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,1,Biomarker
2833,CXCR3,chemokine (C-X-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,1,Biomarker
54205,CYCS,"cytochrome c, somatic",0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,1,Biomarker
5601,MAPK9,mitogen-activated protein kinase 9,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,22116,Ischemia,0.21,2,Therapeutic
6275,S100A4,S100 calcium binding protein A4,0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,1,Biomarker
871,SERPINH1,"serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)",0.0,1.0,0.0,0.0,0.0,22116,Ischemia,0.21,1,Biomarker
100233158,BMIQ14,Body mass index QTL14,0.0,1.0,0.0,0.0,0.0,2675914,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14,0.21,0,Biomarker
4657,MYP1,myopia 1 (X-linked),0.0,1.0,0.0,0.0,0.0,1839612,Myopia 1,0.21,0,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,206658,Smooth Muscle Tumor,0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,162674,"Ophthalmoplegia, Chronic Progressive External",0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,162674,"Ophthalmoplegia, Chronic Progressive External",0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,162674,"Ophthalmoplegia, Chronic Progressive External",0.21,1,Biomarker
3303,HSPA1A,heat shock 70kDa protein 1A,0.0,0.0,0.0,0.0,1.0,282507,Heat Stress Disorders,0.21,1,Therapeutic
140906,SPG18,spastic paraplegia 18 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,2749936,"Spastic Paraplegia 18, Autosomal Recessive",0.21,0,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,1860228,"ZINC, ELEVATED PLASMA",0.21,0,Biomarker
100188792,MAFD3,"Major affective disorder 3, early onset",0.0,1.0,0.0,0.0,0.0,1864994,Major Affective Disorder 3,0.21,0,Biomarker
84735,CNDP1,carnosine dipeptidase 1 (metallopeptidase M20 family),0.0,1.0,0.0,0.0,0.0,27854,Neurologic Manifestations,0.21,1,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,0.0,0.0,0.0,1.0,27854,Neurologic Manifestations,0.21,1,Therapeutic
5309,PITX3,paired-like homeodomain 3,0.0,1.0,0.0,0.0,0.0,27854,Neurologic Manifestations,0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.21,1,Biomarker
1674,DES,desmin,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.21,1,Biomarker
1910,EDNRB,endothelin receptor type B,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.21,1,Biomarker
10855,HPSE,heparanase,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.21,1,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,27720,Nephrosis,0.21,2,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,0.0,0.0,0.0,1.0,27720,Nephrosis,0.21,1,Therapeutic
10804,GJB6,"gap junction protein, beta 6, 30kDa",0.0,1.0,0.0,0.0,0.0,2675750,"Deafness, Autosomal Dominant 3A",0.21,0,Biomarker
65014,CMD1K,"cardiomyopathy, dilated 1K (autosomal dominant)",0.0,1.0,0.0,0.0,0.0,1854159,"Cardiomyopathy, Dilated, 1K",0.21,0,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,0.0,0.0,0.0,32580,Adenomatous Polyposis Coli,0.21,1,Biomarker
26585,GREM1,"gremlin 1, DAN family BMP antagonist",0.0,1.0,0.0,0.0,0.0,32580,Adenomatous Polyposis Coli,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,32580,Adenomatous Polyposis Coli,0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,0.0,0.0,0.0,1.0,37579,Soft Tissue Neoplasms,0.21,1,Therapeutic
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,37579,Soft Tissue Neoplasms,0.21,1,Therapeutic
7124,TNF,tumor necrosis factor,0.0,0.0,0.0,0.0,1.0,37579,Soft Tissue Neoplasms,0.21,2,Therapeutic
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,43049,Water Intoxication,0.21,8,Biomarker
10911,UTS2,urotensin 2,0.0,1.0,0.0,0.0,0.0,43049,Water Intoxication,0.21,1,Biomarker
392255,GDF6,growth differentiation factor 6,0.0,1.0,0.0,0.0,0.0,1852521,"Spondylocostal Dysostosis 4, Autosomal Dominant",0.21,0,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,243026,Sepsis,0.21,1,Biomarker
3579,CXCR2,chemokine (C-X-C motif) receptor 2,0.0,1.0,0.0,0.0,0.0,243026,Sepsis,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,243026,Sepsis,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,243026,Sepsis,0.21,1,Biomarker
724074,DFNY1,"deafness, Y-linked 1",0.0,1.0,0.0,0.0,0.0,1824927,"DEAFNESS, Y-LINKED 1",0.21,0,Biomarker
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,0.0,0.0,0.0,2936861,Apparent mineralocorticoid excess,0.21,1,Biomarker
7085,TKCR,"torticollis, keloids, cryptorchidism and renal dysplasia",0.0,1.0,0.0,0.0,0.0,1839129,Torticollis keloids cryptorchidism renal dysplasia,0.21,0,Biomarker
80771,MCOPCB2,"Microphthalmia, colobomatous, 2",0.0,1.0,0.0,0.0,0.0,1854018,"Microphthalmia, Isolated, with Coloboma 2",0.21,0,Biomarker
71,ACTG1,actin gamma 1,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
111,ADCY5,adenylate cyclase 5,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
118429,ANTXR2,anthrax toxin receptor 2,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
471,ATIC,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
100188853,BMND7,bone mineral density quantiative trait locus 7,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,0,Biomarker
100188854,BMND8,bone mineral density quantiative trait locus 8,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,0,Biomarker
10487,CAP1,"CAP, adenylate cyclase-associated protein 1 (yeast)",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
10576,CCT2,"chaperonin containing TCP1, subunit 2 (beta)",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
2243,FGA,fibrinogen alpha chain,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
2244,FGB,fibrinogen beta chain,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
2820,GPD2,glycerol-3-phosphate dehydrogenase 2 (mitochondrial),0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
2934,GSN,gelsolin,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
3570,IL6R,interleukin 6 receptor,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
11343,MGLL,monoglyceride lipase,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
5019,OXCT1,3-oxoacid CoA transferase 1,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
11315,PARK7,parkinson protein 7,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
25796,PGLS,6-phosphogluconolactonase,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
5315,PKM,"pyruvate kinase, muscle",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
5341,PLEK,pleckstrin,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
4860,PNP,purine nucleoside phosphorylase,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
10935,PRDX3,peroxiredoxin 3,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
5683,PSMA2,"proteasome (prosome, macropain) subunit, alpha type, 2",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
5686,PSMA5,"proteasome (prosome, macropain) subunit, alpha type, 5",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
338382,RAB7B,"RAB7B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
6251,RSU1,Ras suppressor protein 1,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
7094,TLN1,talin 1,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
7171,TPM4,tropomyosin 4,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
10376,TUBA1B,"tubulin, alpha 1b",0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
7307,U2AF1,U2 small nuclear RNA auxiliary factor 1,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
7414,VCL,vinculin,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
9948,WDR1,WD repeat domain 1,0.0,1.0,0.0,0.0,0.0,29456,Osteoporosis,0.21,1,Biomarker
58,ACTA1,"actin, alpha 1, skeletal muscle",0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
1152,CKB,"creatine kinase, brain",0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
1158,CKM,"creatine kinase, muscle",0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
2335,FN1,fibronectin 1,0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
1839,HBEGF,heparin-binding EGF-like growth factor,0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
5530,PPP3CA,"protein phosphatase 3, catalytic subunit, alpha isozyme",0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
6198,RPS6KB1,"ribosomal protein S6 kinase, 70kDa, polypeptide 1",0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
6794,STK11,serine/threonine kinase 11,0.0,1.0,0.0,0.0,0.0,149721,"Hypertrophy, Left Ventricular",0.21,1,Biomarker
25878,MXRA5,matrix-remodelling associated 5,0.0,0.0,1.0,0.0,0.0,684249,Carcinoma of lung,0.21,1,GeneticVariation
100192312,IBD21,Inflammatory bowel disease-21,0.0,1.0,0.0,0.0,0.0,2676507,Inflammatory Bowel Disease 21,0.21,0,Biomarker
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
2782,GNB1,"guanine nucleotide binding protein (G protein), beta polypeptide 1",0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
4192,MDK,midkine (neurite growth-promoting factor 2),0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
4886,NPY1R,neuropeptide Y receptor Y1,0.0,0.0,0.0,0.0,1.0,3469,Anxiety Disorders,0.21,1,Therapeutic
5066,PAM,peptidylglycine alpha-amidating monooxygenase,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
7349,UCN,urocortin,0.0,1.0,0.0,0.0,0.0,3469,Anxiety Disorders,0.21,1,Biomarker
491,ATP2B2,"ATPase, Ca++ transporting, plasma membrane 2",0.0,1.0,0.0,0.0,0.0,1832394,"Deafness, Autosomal Recessive 12",0.21,0,Biomarker
10758,TRAF3IP2,TRAF3 interacting protein 2,0.0,0.0,1.0,0.0,0.0,3714992,"CANDIDIASIS, FAMILIAL, 8",0.21,0,GeneticVariation
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,13990,Emphysema,0.21,1,Biomarker
10516,FBLN5,fibulin 5,0.0,1.0,0.0,0.0,0.0,13990,Emphysema,0.21,1,Biomarker
9365,KL,klotho,0.0,1.0,0.0,0.0,0.0,13990,Emphysema,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,13990,Emphysema,0.21,1,Therapeutic
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,13990,Emphysema,0.21,1,Biomarker
5520,PPP2R2A,"protein phosphatase 2, regulatory subunit B, alpha",0.0,1.0,0.0,0.0,0.0,13990,Emphysema,0.21,1,Biomarker
5522,PPP2R2C,"protein phosphatase 2, regulatory subunit B, gamma",0.0,1.0,0.0,0.0,0.0,13990,Emphysema,0.21,1,Biomarker
5525,PPP2R5A,"protein phosphatase 2, regulatory subunit B', alpha",0.0,1.0,0.0,0.0,0.0,13990,Emphysema,0.21,1,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,13990,Emphysema,0.21,1,Biomarker
727715,SCAX3,"spinocerebellar ataxia, X-linked 3",0.0,1.0,0.0,0.0,0.0,1844936,"Spinocerebellar ataxia, X-linked, 3",0.21,0,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,0.0,0.0,0.0,2676676,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
2956,MSH6,mutS homolog 6,0.0,1.0,0.0,0.0,0.0,2676676,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
4978,OPCML,opioid binding protein/cell adhesion molecule-like,0.0,1.0,0.0,0.0,0.0,2676676,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,2676676,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,2676676,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
3988,LIPA,"lipase A, lysosomal acid, cholesterol esterase",0.0,0.0,0.0,0.0,1.0,220756,"Niemann-Pick Disease, Type C",0.21,1,Therapeutic
57412,AS3MT,arsenite methyltransferase,0.0,1.0,0.0,0.0,0.0,27660,"Neoplasms, Glandular and Epithelial",0.21,1,Biomarker
9113,LATS1,large tumor suppressor kinase 1,0.0,1.0,0.0,0.0,0.0,27660,"Neoplasms, Glandular and Epithelial",0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,19061,Hemolytic-Uremic Syndrome,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,19061,Hemolytic-Uremic Syndrome,0.21,1,Therapeutic
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,19061,Hemolytic-Uremic Syndrome,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,19061,Hemolytic-Uremic Syndrome,0.21,1,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,0.0,0.0,0.0,19061,Hemolytic-Uremic Syndrome,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,19061,Hemolytic-Uremic Syndrome,0.21,1,Biomarker
114890,MRSS,"Mental retardation, X-linked, with short stature",0.0,1.0,0.0,0.0,0.0,1845845,"Mental Retardation, X-Linked, with Short Stature",0.21,0,Biomarker
4965,OFC3,orofacial cleft 3,0.0,1.0,0.0,0.0,0.0,1833369,Orofacial Cleft 3,0.21,0,Biomarker
252843,AAT2,"Aortic aneurysm, familial thoracic 2",0.0,1.0,0.0,0.0,0.0,1846837,"Aortic Aneurysm, Familial Thoracic 2",0.21,0,Biomarker
80746,TSEN2,TSEN2 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,11168,Deglutition Disorders,0.21,1,Biomarker
79042,TSEN34,TSEN34 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,11168,Deglutition Disorders,0.21,1,Biomarker
283989,TSEN54,TSEN54 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,11168,Deglutition Disorders,0.21,1,Biomarker
83605,CCM2,cerebral cavernous malformation 2,0.0,1.0,0.0,0.0,0.0,752160,"Hemangioma, Cavernous, Central Nervous System",0.21,1,Biomarker
889,KRIT1,"KRIT1, ankyrin repeat containing",0.0,1.0,0.0,0.0,0.0,752160,"Hemangioma, Cavernous, Central Nervous System",0.21,0,Biomarker
30829,IBD3,inflammatory bowel disease 3,0.0,1.0,0.0,0.0,0.0,1858303,Inflammatory Bowel Disease 3,0.21,0,Biomarker
955,ENTPD6,ectonucleoside triphosphate diphosphohydrolase 6 (putative),0.0,1.0,0.0,0.0,0.0,36631,Seminoma,0.21,1,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,37188,Sinoatrial Block,0.21,1,Biomarker
619410,NEDE,"nephropathy, progressive, with deafness",0.0,1.0,0.0,0.0,0.0,1836119,"Nephropathy, Progressive, with Deafness",0.21,0,Biomarker
100381210,CAMPD1,Camptodactyly 1,0.0,1.0,0.0,0.0,0.0,2751430,Camptodactyly 1,0.21,0,Biomarker
551,AVP,arginine vasopressin,0.0,0.0,0.0,0.0,1.0,36974,Shock,0.21,1,Therapeutic
4599,MX1,MX dynamin-like GTPase 1,0.0,1.0,0.0,0.0,0.0,15625,Fanconi Anemia,0.21,1,Biomarker
780898,APMR1,Alopecia-mental retardation syndrome,0.0,1.0,0.0,0.0,0.0,1859878,Alopecia-Mental Retardation Syndrome 1,0.21,0,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,162672,MERRF Syndrome,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,162672,MERRF Syndrome,0.21,1,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,406585,"Tight skin contracture syndrome, lethal",0.21,0,Biomarker
2488,FSHB,"follicle stimulating hormone, beta polypeptide",0.0,1.0,0.0,0.0,0.0,43019,Lateral Medullary Syndrome,0.21,1,Biomarker
2919,CXCL1,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",0.0,1.0,0.0,0.0,0.0,36982,"Shock, Hemorrhagic",0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,36982,"Shock, Hemorrhagic",0.21,1,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,36982,"Shock, Hemorrhagic",0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,36982,"Shock, Hemorrhagic",0.21,1,Biomarker
15,AANAT,aralkylamine N-acetyltransferase,0.0,0.0,1.0,0.0,0.0,3279991,"DELAYED SLEEP PHASE SYNDROME, SUSCEPTIBILITY TO",0.21,1,GeneticVariation
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.21,1,Biomarker
1302,COL11A2,"collagen, type XI, alpha 2",0.0,1.0,0.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.21,1,Biomarker
1297,COL9A1,"collagen, type IX, alpha 1",0.0,1.0,0.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.21,1,Biomarker
8772,FADD,Fas (TNFRSF6)-associated via death domain,0.0,1.0,0.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.21,1,Biomarker
2248,FGF3,fibroblast growth factor 3,0.0,1.0,0.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.21,1,Biomarker
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.21,1,Biomarker
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,0.0,0.0,0.0,18784,"Hearing Loss, Sensorineural",0.21,1,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,2931644,O'Donnell Pappas syndrome,0.21,0,Biomarker
170545,SCA21,spinocerebellar ataxia 21,0.0,1.0,0.0,0.0,0.0,1843891,Spinocerebellar ataxia 21,0.21,0,Biomarker
221692,PHACTR1,phosphatase and actin regulator 1,0.0,1.0,0.0,0.0,0.0,751814,Cerebrovascular Trauma,0.21,1,Biomarker
58484,NLRC4,"NLR family, CARD domain containing 4",0.0,1.0,0.0,0.0,0.0,751422,Hereditary Autoinflammatory Diseases,0.21,2,Biomarker
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",0.0,0.0,1.0,0.0,0.0,3160732,"RENAL CELL CARCINOMA, NONPAPILLARY",0.21,0,GeneticVariation
201163,FLCN,folliculin,0.0,0.0,1.0,0.0,0.0,3160732,"RENAL CELL CARCINOMA, NONPAPILLARY",0.21,0,GeneticVariation
387570,DUH1,Dyschromatosis universalis hereditaria,0.0,1.0,0.0,0.0,0.0,2675711,Dyschromatosis Universalis Hereditaria 1,0.21,0,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,20440,Hypercapnia,0.21,1,Biomarker
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,20440,Hypercapnia,0.21,1,Biomarker
328,APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1,0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,1,Biomarker
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,1,Biomarker
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,1,Biomarker
2072,ERCC4,excision repair cross-complementation group 4,0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,1,Biomarker
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,1,Biomarker
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,1,Biomarker
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,1,Biomarker
7507,XPA,"xeroderma pigmentosum, complementation group A",0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,1,Biomarker
7508,XPC,"xeroderma pigmentosum, complementation group C",0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,1,Biomarker
7515,XRCC1,X-ray repair complementing defective repair in Chinese hamster cells 1,0.0,1.0,0.0,0.0,0.0,1449861,"Micronuclei, Chromosome-Defective",0.21,2,Biomarker
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,0.0,1.0,0.0,0.0,3279690,MOYAMOYA DISEASE 5,0.21,0,GeneticVariation
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,20540,"Hypertension, Malignant",0.21,1,Biomarker
790,CAD,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",0.0,1.0,0.0,0.0,0.0,37889,"Spherocytosis, Hereditary",0.21,1,Biomarker
1723,DHODH,dihydroorotate dehydrogenase (quinone),0.0,1.0,0.0,0.0,0.0,37889,"Spherocytosis, Hereditary",0.21,1,Biomarker
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,0.0,0.0,0.0,37889,"Spherocytosis, Hereditary",0.21,1,Biomarker
4434,MSD,microcephaly with spastic diplegia (Paine syndrome),0.0,1.0,0.0,0.0,0.0,1412041,Paine syndrome,0.21,0,Biomarker
594832,MYP11,"myopia 11 (high grade, autosomal dominant)",0.0,1.0,0.0,0.0,0.0,1864941,Myopia 11,0.21,0,Biomarker
85502,SCAR3,"spinocerebellar ataxia, autosomal recessive 3",0.0,1.0,0.0,0.0,0.0,1849094,"Spinocerebellar ataxia, autosomal recessive 3",0.21,0,Biomarker
2490,FSHMD1B,facioscapulohumeral muscular dystrophy 1B,0.0,1.0,0.0,0.0,0.0,1834671,Facioscapulohumeral Muscular Dystrophy 1B,0.21,0,Biomarker
777645,GLC1N,"glaucoma 1, open angle, N (juvenile-onset)",0.0,1.0,0.0,0.0,0.0,1969812,"Glaucoma 1, Open Angle, N",0.21,0,Biomarker
399516,OTSC7,otosclerosis 7,0.0,1.0,0.0,0.0,0.0,1969044,Otosclerosis 7,0.21,0,Biomarker
6319,SCD,stearoyl-CoA desaturase (delta-9-desaturase),0.0,1.0,0.0,0.0,0.0,339143,Graves Ophthalmopathy,0.21,1,Biomarker
56797,HTGS,"Hypertriglyceridemia, familial",0.0,1.0,0.0,0.0,0.0,20480,Hyperlipoproteinemia Type IV,0.21,0,Biomarker
149998,LIPI,"lipase, member I",0.0,1.0,0.0,0.0,0.0,20480,Hyperlipoproteinemia Type IV,0.21,0,Biomarker
6101,RP1,retinitis pigmentosa 1 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,20480,Hyperlipoproteinemia Type IV,0.21,0,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,0.0,0.0,0.0,1.0,15423,Eyelid Diseases,0.21,1,Therapeutic
3458,IFNG,"interferon, gamma",0.0,0.0,0.0,0.0,1.0,15423,Eyelid Diseases,0.21,1,Therapeutic
1526,CXB3S,coxsackie virus B3 sensitivity,0.0,1.0,0.0,0.0,0.0,1861511,COXSACKIEVIRUS B3 SUSCEPTIBILITY,0.21,0,Biomarker
213,ALB,albumin,0.0,0.0,0.0,0.0,1.0,26848,Muscular Diseases,0.21,1,Therapeutic
383,ARG1,arginase 1,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
1508,CTSB,cathepsin B,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
440275,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
2170,FABP3,"fatty acid binding protein 3, muscle and heart",0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
3094,HINT1,histidine triad nucleotide binding protein 1,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
9177,HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic",0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
729920,ISPD,isoprenoid synthase domain containing,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
4128,MAOA,monoamine oxidase A,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
5837,PYGM,"phosphorylase, glycogen, muscle",0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
5913,RAPSN,receptor-associated protein of the synapse,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
4549,RNR1,s-rRNA,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
4089,SMAD4,SMAD family member 4,0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
7136,TNNI2,"troponin I type 2 (skeletal, fast)",0.0,1.0,0.0,0.0,0.0,26848,Muscular Diseases,0.21,1,Biomarker
2294,FOXF1,forkhead box F1,0.0,1.0,0.0,0.0,0.0,24899,Mastocytosis,0.21,1,Biomarker
91252,SLC39A13,"solute carrier family 39 (zinc transporter), member 13",0.0,1.0,0.0,0.0,0.0,9782,Connective Tissue Diseases,0.21,2,Biomarker
100188864,IH,Hemihypertrophy,0.0,1.0,0.0,0.0,0.0,1856184,"Hemihyperplasia, Isolated",0.21,0,Biomarker
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.21,1,Biomarker
9971,NR1H4,"nuclear receptor subfamily 1, group H, member 4",0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.21,1,Biomarker
5578,PRKCA,"protein kinase C, alpha",0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.21,1,Biomarker
5580,PRKCD,"protein kinase C, delta",0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.21,1,Biomarker
7507,XPA,"xeroderma pigmentosum, complementation group A",0.0,1.0,0.0,0.0,0.0,21841,Intestinal Neoplasms,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,36202,Sarcoidosis,0.21,1,Biomarker
100196919,SS3,"Sarcoidosis, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,36202,Sarcoidosis,0.21,0,Biomarker
65217,PCDH15,protocadherin-related 15,0.0,1.0,0.0,0.0,0.0,2931208,"Usher syndrome, type 1D",0.21,0,Biomarker
78989,COLEC11,collectin sub-family member 11,0.0,1.0,0.0,0.0,0.0,796032,Malpuech facial clefting syndrome,0.21,1,Biomarker
5648,MASP1,mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),0.0,1.0,0.0,0.0,0.0,796032,Malpuech facial clefting syndrome,0.21,1,Biomarker
93,ACVR2B,"activin A receptor, type IIB",0.0,1.0,0.0,0.0,0.0,37221,Situs Inversus,0.21,1,Biomarker
779,CACNA1S,"calcium channel, voltage-dependent, L type, alpha 1S subunit",0.0,0.0,1.0,0.0,0.0,1866077,"MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5",0.21,0,GeneticVariation
3832,KIF11,kinesin family member 11,0.0,1.0,0.0,0.0,0.0,2938,Aneuploidy,0.21,1,Biomarker
3195,TLX1,T-cell leukemia homeobox 1,0.0,1.0,0.0,0.0,0.0,2938,Aneuploidy,0.21,1,Biomarker
285848,PNPLA1,patatin-like phospholipase domain containing 1,0.0,1.0,0.0,0.0,0.0,20757,Ichthyosis,0.21,1,Biomarker
2683,B4GALT1,"UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1",0.0,1.0,0.0,0.0,0.0,2931009,Congenital disorder of glycosylation type 2D,0.21,0,Biomarker
100302515,OFC12,Orofacial cleft 12,0.0,1.0,0.0,0.0,0.0,2748505,Orofacial Cleft 12,0.21,0,Biomarker
2512,FTL,"ferritin, light polypeptide",0.0,1.0,0.0,0.0,0.0,12715,Iron Metabolism Disorders,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,12715,Iron Metabolism Disorders,0.21,1,Biomarker
84315,MON1A,MON1 secretory trafficking family member A,0.0,1.0,0.0,0.0,0.0,12715,Iron Metabolism Disorders,0.21,1,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,12715,Iron Metabolism Disorders,0.21,2,Biomarker
4653,MYOC,"myocilin, trabecular meshwork inducible glucocorticoid response",0.0,0.0,1.0,0.0,0.0,1856439,"Glaucoma 3, Primary Congenital, A",0.21,0,GeneticVariation
8803,SUCLA2,"succinate-CoA ligase, ADP-forming, beta subunit",0.0,1.0,0.0,0.0,0.0,3149750,MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE),0.21,0,Biomarker
859,CAV3,caveolin 3,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
865,CBFB,"core-binding factor, beta subunit",0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
2138,EYA1,EYA transcriptional coactivator and phosphatase 1,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
2776,GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
2812,GP1BB,"glycoprotein Ib (platelet), beta polypeptide",0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
3198,HOXA1,homeobox A1,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
9314,KLF4,Kruppel-like factor 4 (gut),0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
55534,MAML3,mastermind-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
25836,NIPBL,Nipped-B homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
5308,PITX2,paired-like homeodomain 2,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,2,Biomarker
7353,UFD1L,ubiquitin fusion degradation 1 like (yeast),0.0,1.0,0.0,0.0,0.0,18798,"Heart Defects, Congenital",0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,35333,Retinitis,0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,2931229,VACTERL hydrocephaly,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,4610,Bacteremia,0.21,1,Therapeutic
114609,TIRAP,toll-interleukin 1 receptor (TIR) domain containing adaptor protein,0.0,1.0,0.0,0.0,0.0,4610,Bacteremia,0.21,1,Biomarker
490,ATP2B1,"ATPase, Ca++ transporting, plasma membrane 1",0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.21,1,Biomarker
2982,GUCY1A3,"guanylate cyclase 1, soluble, alpha 3",0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.21,1,Biomarker
283450,HECTD4,HECT domain containing E3 ubiquitin protein ligase 4,0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.21,1,Biomarker
574447,MIR146B,microRNA 146b,0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.21,1,Biomarker
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.21,1,Biomarker
5069,PAPPA,"pregnancy-associated plasma protein A, pappalysin 1",0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.21,1,Biomarker
80310,PDGFD,platelet derived growth factor D,0.0,1.0,0.0,0.0,0.0,1956346,Coronary Artery Disease,0.21,1,Biomarker
449489,DFNB47,"deafness, autosomal recessive 47",0.0,1.0,0.0,0.0,0.0,1864964,"Deafness, Autosomal Recessive 47",0.21,0,Biomarker
373073,CLAM,cerebellar atrophy with progressive microcephaly,0.0,1.0,0.0,0.0,0.0,1842687,Pontocerebellar Hypoplasia Type 3,0.21,0,Biomarker
55636,CHD7,chromodomain helicase DNA binding protein 7,0.0,1.0,0.0,0.0,0.0,342384,Idiopathic Hypogonadotropic Hypogonadism,0.21,0,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,342384,Idiopathic Hypogonadotropic Hypogonadism,0.21,0,Biomarker
84634,KISS1R,KISS1 receptor,0.0,1.0,0.0,0.0,0.0,342384,Idiopathic Hypogonadotropic Hypogonadism,0.21,0,Biomarker
26012,NSMF,NMDA receptor synaptonuclear signaling and neuronal migration factor,0.0,1.0,0.0,0.0,0.0,342384,Idiopathic Hypogonadotropic Hypogonadism,0.21,0,Biomarker
60675,PROK2,prokineticin 2,0.0,1.0,0.0,0.0,0.0,342384,Idiopathic Hypogonadotropic Hypogonadism,0.21,0,Biomarker
6866,TAC3,tachykinin 3,0.0,1.0,0.0,0.0,0.0,342384,Idiopathic Hypogonadotropic Hypogonadism,0.21,0,Biomarker
6870,TACR3,tachykinin receptor 3,0.0,1.0,0.0,0.0,0.0,342384,Idiopathic Hypogonadotropic Hypogonadism,0.21,0,Biomarker
668,FOXL2,forkhead box L2,0.0,1.0,0.0,0.0,0.0,2931135,Blepharophimosis syndrome type 1,0.21,3,Biomarker
5818,PVRL1,poliovirus receptor-related 1 (herpesvirus entry mediator C),0.0,1.0,0.0,0.0,0.0,19372,Herpesviridae Infections,0.21,1,Biomarker
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,1.0,0.0,0.0,0.0,19372,Herpesviridae Infections,0.21,1,Biomarker
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,1.0,0.0,0.0,0.0,19372,Herpesviridae Infections,0.21,1,Biomarker
2208,FCER2,"Fc fragment of IgE, low affinity II, receptor for (CD23)",0.0,1.0,0.0,0.0,0.0,20523,"Hypersensitivity, Immediate",0.21,1,Biomarker
90865,IL33,interleukin 33,0.0,1.0,0.0,0.0,0.0,20523,"Hypersensitivity, Immediate",0.21,1,Biomarker
7015,TERT,telomerase reverse transcriptase,0.0,0.0,1.0,0.0,0.0,3151443,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 2",0.21,0,GeneticVariation
23564,DDAH2,dimethylarginine dimethylaminohydrolase 2,0.0,1.0,0.0,0.0,0.0,32914,Pre-Eclampsia,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,32914,Pre-Eclampsia,0.21,1,Biomarker
780908,PEE2,Preeclampsia/eclampsia 2,0.0,1.0,0.0,0.0,0.0,32914,Pre-Eclampsia,0.21,0,Biomarker
780909,PEE3,Preeclampsia/eclampsia 3,0.0,1.0,0.0,0.0,0.0,32914,Pre-Eclampsia,0.21,0,Biomarker
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,0.0,0.0,0.0,32914,Pre-Eclampsia,0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,38273,Stereotypic Movement Disorder,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,38273,Stereotypic Movement Disorder,0.21,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,26633,Mouth Abnormalities,0.21,1,Biomarker
4384,MRX20,"mental retardation, X-linked 20",0.0,1.0,0.0,0.0,0.0,796226,"Mental Retardation, X-Linked 20",0.21,0,Biomarker
1275,COD2,cone dystrophy 2 (X-linked),0.0,1.0,0.0,0.0,0.0,1848139,"Cone-Rod Dystrophy, X-Linked, 2",0.21,0,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,85183,"Neoplasms, Second Primary",0.21,1,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,85183,"Neoplasms, Second Primary",0.21,1,Biomarker
5371,PML,promyelocytic leukemia,0.0,1.0,0.0,0.0,0.0,85183,"Neoplasms, Second Primary",0.21,1,Biomarker
5914,RARA,"retinoic acid receptor, alpha",0.0,1.0,0.0,0.0,0.0,85183,"Neoplasms, Second Primary",0.21,1,Biomarker
2296,FOXC1,forkhead box C1,0.0,1.0,0.0,0.0,0.0,3714873,"AXENFELD-RIEGER SYNDROME, TYPE 1",0.21,1,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,3714873,"AXENFELD-RIEGER SYNDROME, TYPE 1",0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,41956,Ureteral Obstruction,0.21,1,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,41956,Ureteral Obstruction,0.21,1,Biomarker
57393,TMEM27,transmembrane protein 27,0.0,1.0,0.0,0.0,0.0,41956,Ureteral Obstruction,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,37052,Sick Sinus Syndrome,0.21,1,Biomarker
648,BMI1,"BMI1 proto-oncogene, polycomb ring finger",0.0,1.0,0.0,0.0,0.0,27686,"Neovascularization, Pathologic",0.21,1,Biomarker
1191,CLU,clusterin,0.0,0.0,0.0,0.0,1.0,27686,"Neovascularization, Pathologic",0.21,1,Therapeutic
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,0.0,0.0,0.0,1.0,27686,"Neovascularization, Pathologic",0.21,2,Therapeutic
1713,DFNB20,"deafness, autosomal recessive 20",0.0,1.0,0.0,0.0,0.0,1858840,"Deafness, Autosomal Recessive 20",0.21,0,Biomarker
5106,PCK2,phosphoenolpyruvate carboxykinase 2 (mitochondrial),0.0,1.0,0.0,0.0,0.0,2931278,Phosphoenolpyruvate carboxykinase 2 deficiency,0.21,0,Biomarker
4015,LOX,lysyl oxidase,0.0,1.0,0.0,0.0,0.0,19196,Hepatitis C,0.21,1,Biomarker
4017,LOXL2,lysyl oxidase-like 2,0.0,1.0,0.0,0.0,0.0,19196,Hepatitis C,0.21,1,Biomarker
4023,LPL,lipoprotein lipase,0.0,0.0,0.0,0.0,1.0,19196,Hepatitis C,0.21,1,Therapeutic
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,19196,Hepatitis C,0.21,2,Biomarker
59344,ALOXE3,arachidonate lipoxygenase 3,0.0,1.0,0.0,0.0,0.0,1855792,"Ichthyosiform erythroderma, Brocq congenital, nonbullous form",0.21,0,Biomarker
7051,TGM1,transglutaminase 1,0.0,1.0,0.0,0.0,0.0,1855792,"Ichthyosiform erythroderma, Brocq congenital, nonbullous form",0.21,0,Biomarker
1361,CPB2,carboxypeptidase B2 (plasma),0.0,1.0,0.0,0.0,0.0,2453,Amenorrhea,0.21,1,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,2453,Amenorrhea,0.21,1,Biomarker
2488,FSHB,"follicle stimulating hormone, beta polypeptide",0.0,1.0,0.0,0.0,0.0,2453,Amenorrhea,0.21,1,Biomarker
5447,POR,P450 (cytochrome) oxidoreductase,0.0,1.0,0.0,0.0,0.0,2453,Amenorrhea,0.21,1,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,497327,Dementia,0.21,1,Biomarker
23315,SLC9A8,"solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8",0.0,1.0,0.0,0.0,0.0,497327,Dementia,0.21,1,Biomarker
2180,ACSL1,acyl-CoA synthetase long-chain family member 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
71,ACTG1,actin gamma 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
111,ADCY5,adenylate cyclase 5,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
307,ANXA4,annexin A4,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
93974,ATPIF1,ATPase inhibitory factor 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,2,Biomarker
10409,BASP1,"brain abundant, membrane attached signal protein 1",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
832,CAPZB,"capping protein (actin filament) muscle Z-line, beta",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
883,CCBL1,"cysteine conjugate-beta lyase, cytoplasmic",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
902,CCNH,cyclin H,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
1040,CDS1,CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
1266,CNN3,"calponin 3, acidic",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
1289,COL5A1,"collagen, type V, alpha 1",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
1447,CSN2,casein beta,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,2,Biomarker
1448,CSN3,casein kappa,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
1622,DBI,"diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
1848,DUSP6,dual specificity phosphatase 6,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
1984,EIF5A,eukaryotic translation initiation factor 5A,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
50486,G0S2,G0/G1 switch 2,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
2628,GATM,glycine amidinotransferase (L-arginine:glycine amidinotransferase),0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
9615,GDA,guanine deaminase,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
644076,GLYCAM1,glycosylation dependent cell adhesion molecule 1 (pseudogene),0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
2771,GNAI2,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
2937,GSS,glutathione synthetase,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
3021,H3F3B,"H3 histone, family 3B (H3.3B)",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
3178,HNRNPA1,heterogeneous nuclear ribonucleoprotein A1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
3400,ID4,"inhibitor of DNA binding 4, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
3638,INSIG1,insulin induced gene 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
112802,KRT71,"keratin 71, type II",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
8825,LIN7A,lin-7 homolog A (C. elegans),0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
51599,LSR,lipolysis stimulated lipoprotein receptor,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,2,Biomarker
23643,LY96,lymphocyte antigen 96,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
4191,MDH2,"malate dehydrogenase 2, NAD (mitochondrial)",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
10461,MERTK,"MER proto-oncogene, tyrosine kinase",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
9019,MPZL1,myelin protein zero-like 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
9902,MRC2,"mannose receptor, C type 2",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
26012,NSMF,NMDA receptor synaptonuclear signaling and neuronal migration factor,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
5223,PGAM1,phosphoglycerate mutase 1 (brain),0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
5295,PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
7001,PRDX2,peroxiredoxin 2,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
5685,PSMA4,"proteasome (prosome, macropain) subunit, alpha type, 4",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
5720,PSME1,"proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
5901,RAN,"RAN, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,2,Biomarker
5924,RASGRF2,Ras protein-specific guanine nucleotide-releasing factor 2,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
5954,RCN1,"reticulocalbin 1, EF-hand calcium binding domain",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
6122,RPL3,ribosomal protein L3,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
6128,RPL6,ribosomal protein L6,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
6208,RPS14,ribosomal protein S14,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
1901,S1PR1,sphingosine-1-phosphate receptor 1,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
1468,SLC25A10,"solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
6634,SNRPD3,small nuclear ribonucleoprotein D3 polypeptide 18kDa,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
6427,SRSF2,serine/arginine-rich splicing factor 2,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,2,Biomarker
7069,THRSP,thyroid hormone responsive,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
7086,TKT,transketolase,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
140738,TMEM37,transmembrane protein 37,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
347733,TUBB2B,"tubulin, beta 2B class IIb",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
7329,UBE2I,ubiquitin-conjugating enzyme E2I,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
8725,URI1,"URI1, prefoldin-like chaperone",0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
8673,VAMP8,vesicle-associated membrane protein 8,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,7097,Carcinoma,0.21,1,Biomarker
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,0.0,0.0,0.0,28796,"Dermatitis, Occupational",0.21,1,Biomarker
3108,HLA-DMA,"major histocompatibility complex, class II, DM alpha",0.0,1.0,0.0,0.0,0.0,28796,"Dermatitis, Occupational",0.21,1,Biomarker
2969,GTF2I,general transcription factor IIi,0.0,1.0,0.0,0.0,0.0,1266101,Thymic epithelial tumor,0.21,1,Biomarker
150,ADRA2A,adrenoceptor alpha 2A,0.0,0.0,0.0,0.0,1.0,14544,Epilepsy,0.21,1,Therapeutic
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,0.0,0.0,0.0,1.0,14544,Epilepsy,0.21,1,Therapeutic
26053,AUTS2,autism susceptibility candidate 2,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
1128,CHRM1,"cholinergic receptor, muscarinic 1",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
1129,CHRM2,"cholinergic receptor, muscarinic 2",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
2081,ERN1,endoplasmic reticulum to nucleus signaling 1,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
2354,FOSB,FBJ murine osteosarcoma viral oncogene homolog B,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
2911,GRM1,"glutamate receptor, metabotropic 1",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
3611,ILK,integrin-linked kinase,0.0,0.0,0.0,0.0,1.0,14544,Epilepsy,0.21,1,Therapeutic
3756,KCNH1,"potassium channel, voltage gated eag related subfamily H, member 1",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
79944,L2HGDH,L-2-hydroxyglutarate dehydrogenase,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
4887,NPY2R,neuropeptide Y receptor Y2,0.0,0.0,0.0,0.0,1.0,14544,Epilepsy,0.21,1,Therapeutic
4985,OPRD1,"opioid receptor, delta 1",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
22953,P2RX2,"purinergic receptor P2X, ligand gated ion channel, 2",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
5025,P2RX4,"purinergic receptor P2X, ligand gated ion channel, 4",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
116442,RAB39B,"RAB39B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
6415,SEPW1,"selenoprotein W, 1",0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
8404,SPARCL1,SPARC-like 1 (hevin),0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
10617,STAMBP,STAM binding protein,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
7416,VDAC1,voltage-dependent anion channel 1,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
7417,VDAC2,voltage-dependent anion channel 2,0.0,1.0,0.0,0.0,0.0,14544,Epilepsy,0.21,1,Biomarker
10411,RAPGEF3,Rap guanine nucleotide exchange factor (GEF) 3,0.0,1.0,0.0,0.0,0.0,162700,Tick-Borne Diseases,0.21,1,Biomarker
4416,MRX53,"mental retardation, X-linked 53",0.0,1.0,0.0,0.0,0.0,1845889,"Mental Retardation, X-Linked 53",0.21,0,Biomarker
6616,SNAP25,"synaptosomal-associated protein, 25kDa",0.0,1.0,0.0,0.0,0.0,752252,Neuromuscular Manifestations,0.21,1,Biomarker
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,752252,Neuromuscular Manifestations,0.21,2,Biomarker
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,24535,"Malaria, Falciparum",0.21,1,Biomarker
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,0.0,1.0,0.0,0.0,2751778,"Generalized Epilepsy With Febrile Seizures Plus, 7",0.21,0,GeneticVariation
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,39338,Taste Disorders,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,39338,Taste Disorders,0.21,1,Biomarker
727699,LINC00163,long intergenic non-protein coding RNA 163,0.0,1.0,0.0,0.0,0.0,1834372,Narcolepsy 1,0.21,0,Biomarker
100918,NRCLP2,"Narcolepsy, HLA-associated",0.0,1.0,0.0,0.0,0.0,1834372,Narcolepsy 1,0.21,0,Biomarker
7124,TNF,tumor necrosis factor,0.0,0.0,0.0,0.0,1.0,79218,"Fibromatosis, Aggressive",0.21,1,Therapeutic
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,399352,Anodontia,0.21,1,Biomarker
2833,CXCR3,chemokine (C-X-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,2171,Alopecia Areata,0.21,1,Biomarker
154064,RAET1L,retinoic acid early transcript 1L,0.0,1.0,0.0,0.0,0.0,2171,Alopecia Areata,0.21,1,Biomarker
6948,TCN2,transcobalamin II,0.0,1.0,0.0,0.0,0.0,1420653,TRANSCOBALAMIN II,0.21,0,Biomarker
780921,KYPSC1,Kyphoscoliosis 1,0.0,1.0,0.0,0.0,0.0,1857795,Kyphoscoliosis 1,0.21,0,Biomarker
352956,MMVP2,myxomatous mitral valve prolapse 2,0.0,1.0,0.0,0.0,0.0,1843003,"Mitral Valve Prolapse, Myxomatous 2",0.21,0,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,0.0,0.0,0.0,1.0,3460,Anuria,0.21,1,Therapeutic
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,3460,Anuria,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,3460,Anuria,0.21,1,Biomarker
306,ANXA3,annexin A3,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
360,AQP3,aquaporin 3 (Gill blood group),0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
115761,ARL11,ADP-ribosylation factor-like 11,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
467,ATF3,activating transcription factor 3,0.0,0.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.21,1,Therapeutic
607,BCL9,B-cell CLL/lymphoma 9,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
54796,BNC2,basonuclin 2,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
83990,BRIP1,BRCA1 interacting protein C-terminal helicase 1,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
83636,C19orf12,chromosome 19 open reading frame 12,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,0.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.21,1,Therapeutic
894,CCND2,cyclin D2,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
92421,CHMP4C,charged multivesicular body protein 4C,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
51029,DESI2,desumoylating isopeptidase 2,0.0,0.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.21,1,Therapeutic
1796,DOK1,"docking protein 1, 62kDa (downstream of tyrosine kinase 1)",0.0,0.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.21,1,Therapeutic
9149,DYRK1B,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
2069,EREG,epiregulin,0.0,0.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.21,1,Therapeutic
285601,GPR150,G protein-coupled receptor 150,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
10013,HDAC6,histone deacetylase 6,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
3231,HOXD1,homeobox D1,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
3237,HOXD11,homeobox D11,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
3590,IL11RA,"interleukin 11 receptor, alpha",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
3572,IL6ST,interleukin 6 signal transducer,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
8516,ITGA8,"integrin, alpha 8",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
2122,MECOM,MDS1 and EVI1 complex locus,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
574048,OVCAS1,"Ovarian cancer, epithelial, susceptibility to",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,0,Biomarker
79156,PLEKHF1,"pleckstrin homology domain containing, family F (with FYVE domain) member 1",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
10775,POP4,"processing of precursor 4, ribonuclease P/MRP subunit (S. cerevisiae)",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
5501,PPP1CC,"protein phosphatase 1, catalytic subunit, gamma isozyme",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
56952,PRTFDC1,phosphoribosyl transferase domain containing 1,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
5892,RAD51D,RAD51 paralog D,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
5934,RBL2,retinoblastoma-like 2,0.0,0.0,0.0,0.0,1.0,919267,Ovarian Neoplasms,0.21,1,Therapeutic
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
10772,SRSF10,serine/arginine-rich splicing factor 10,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
6765,ST8,suppression of tumorigenicity 8 (ovarian),0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,0,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
8725,URI1,"URI1, prefoldin-like chaperone",0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
79084,WDR77,WD repeat domain 77,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
10413,YAP1,Yes-associated protein 1,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
6935,ZEB1,zinc finger E-box binding homeobox 1,0.0,1.0,0.0,0.0,0.0,919267,Ovarian Neoplasms,0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.21,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.21,1,Biomarker
1839,HBEGF,heparin-binding EGF-like growth factor,0.0,1.0,0.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.21,1,Biomarker
10763,NES,nestin,0.0,1.0,0.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.21,1,Biomarker
4908,NTF3,neurotrophin 3,0.0,1.0,0.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.21,2,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,14549,"Epilepsy, Tonic-Clonic",0.21,1,Biomarker
55971,BAIAP2L1,BAI1-associated protein 2-like 1,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
633,BGN,biglycan,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
800,CALD1,caldesmon 1,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
916,CD3E,"CD3e molecule, epsilon (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
921,CD5,CD5 molecule,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
6372,CXCL6,chemokine (C-X-C motif) ligand 6,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
1656,DDX6,DEAD (Asp-Glu-Ala-Asp) box helicase 6,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
1776,DNASE1L3,deoxyribonuclease I-like 3,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
1404,HAPLN1,hyaluronan and proteoglycan link protein 1,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
3059,HCLS1,hematopoietic cell-specific Lyn substrate 1,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
3236,HOXD10,homeobox D10,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
3237,HOXD11,homeobox D11,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
3934,LCN2,lipocalin 2,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
9355,LHX2,LIM homeobox 2,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
10586,MAB21L2,mab-21-like 2 (C. elegans),0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
84709,MGARP,mitochondria-localized glutamic acid-rich protein,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
4688,NCF2,neutrophil cytosolic factor 2,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
5341,PLEK,pleckstrin,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
5747,PTK2,protein tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
4218,RAB8A,"RAB8A, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
5911,RAP2A,"RAP2A, member of RAS oncogene family",0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
10125,RASGRP1,RAS guanyl releasing protein 1 (calcium and DAG-regulated),0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
1827,RCAN1,regulator of calcineurin 1,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
285704,RGMB,repulsive guidance molecule family member b,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
8604,SLC25A12,"solute carrier family 25 (aspartate/glutamate carrier), member 12",0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
81849,ST6GALNAC5,"ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5",0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
7980,TFPI2,tissue factor pathway inhibitor 2,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
7090,TLE3,transducin-like enhancer of split 3,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
7112,TMPO,thymopoietin,0.0,1.0,0.0,0.0,0.0,3873,"Arthritis, Rheumatoid",0.21,1,Biomarker
23714,DFNB26,"deafness, autosomal recessive 26",0.0,1.0,0.0,0.0,0.0,1854275,"Deafness, Autosomal Recessive 26",0.21,0,Biomarker
100302058,LKMCD,Leukoencephalopathy with metaphyseal chondrodysplasia,0.0,1.0,0.0,0.0,0.0,1970840,Leukoencephalopathy With Metaphyseal Chondrodysplasia,0.21,0,Biomarker
10059,DNM1L,dynamin 1-like,0.0,0.0,1.0,0.0,0.0,3280660,"ENCEPHALOPATHY, LETHAL, DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION",0.21,1,GeneticVariation
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,4936,Mental Disorders,0.21,1,Biomarker
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),0.0,1.0,0.0,0.0,0.0,4936,Mental Disorders,0.21,1,Biomarker
54487,DGCR8,DGCR8 microprocessor complex subunit,0.0,1.0,0.0,0.0,0.0,4936,Mental Disorders,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,4936,Mental Disorders,0.21,1,Biomarker
4010,LMX1B,"LIM homeobox transcription factor 1, beta",0.0,1.0,0.0,0.0,0.0,4936,Mental Disorders,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,4936,Mental Disorders,0.21,1,Biomarker
7225,TRPC6,"transient receptor potential cation channel, subfamily C, member 6",0.0,1.0,0.0,0.0,0.0,4936,Mental Disorders,0.21,1,Biomarker
7504,XK,X-linked Kx blood group,0.0,1.0,0.0,0.0,0.0,4936,Mental Disorders,0.21,1,Biomarker
8011,MROS,Melkersson-Rosenthal syndrome,0.0,1.0,0.0,0.0,0.0,25235,Melkersson-Rosenthal Syndrome,0.21,0,Biomarker
100302560,MUHH2,"Hypotrichosis, hereditary, Marie Unna type, 2",0.0,1.0,0.0,0.0,0.0,2748535,Hypotrichosis 5,0.21,0,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,30200,"Pain, Intractable",0.21,1,Biomarker
619501,HCC,"thyroid carcinoma, Hurthle cell",0.0,1.0,0.0,0.0,0.0,749424,"Thyroid cancer, Hurthle cell",0.21,0,Biomarker
4155,MBP,myelin basic protein,0.0,1.0,0.0,0.0,0.0,27873,Neuromyelitis Optica,0.21,1,Biomarker
57680,CHD8,chromodomain helicase DNA binding protein 8,0.0,1.0,0.0,0.0,0.0,221355,Megalencephaly,0.21,1,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,0.0,0.0,0.0,37917,Spina Bifida Cystica,0.21,1,Biomarker
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,0.0,0.0,0.0,37917,Spina Bifida Cystica,0.21,1,Biomarker
11254,SLC6A14,"solute carrier family 6 (amino acid transporter), member 14",0.0,1.0,0.0,0.0,0.0,2678155,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11,0.21,0,Biomarker
249,ALPL,"alkaline phosphatase, liver/bone/kidney",0.0,1.0,0.0,0.0,0.0,2382,Alveolar Bone Loss,0.21,1,Biomarker
450086,AD9,Alzheimer disease 9,0.0,1.0,0.0,0.0,0.0,1837149,Alzheimer Disease 9,0.21,0,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,34012,"Puberty, Delayed",0.21,1,Biomarker
84634,KISS1R,KISS1 receptor,0.0,1.0,0.0,0.0,0.0,34012,"Puberty, Delayed",0.21,1,Biomarker
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,0.0,0.0,0.0,34012,"Puberty, Delayed",0.21,1,Biomarker
114609,TIRAP,toll-interleukin 1 receptor (TIR) domain containing adaptor protein,0.0,1.0,0.0,0.0,0.0,1835828,"Invasive Pneumococcal Disease, Recurrent Isolated, 1",0.21,0,Biomarker
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,0.0,0.0,0.0,1.0,273058,"Intracranial Hemorrhage, Traumatic",0.21,1,Therapeutic
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,151827,Eye Pain,0.21,1,Biomarker
619477,GCCD3,glucocorticoid deficiency 3,0.0,1.0,0.0,0.0,0.0,1836621,Glucocorticoid Deficiency 3,0.21,0,Biomarker
8842,PROM1,prominin 1,0.0,1.0,0.0,0.0,0.0,206627,"Mixed Tumor, Mullerian",0.21,1,Biomarker
3611,ILK,integrin-linked kinase,0.0,1.0,0.0,0.0,0.0,9376,Colonic Polyps,0.21,1,Biomarker
65217,PCDH15,protocadherin-related 15,0.0,0.0,1.0,0.0,0.0,1832845,"Usher Syndrome, Type ID",0.21,0,GeneticVariation
777778,OPA6,optic atrophy 6 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,1850281,Optic atrophy 6,0.21,0,Biomarker
5836,PYGL,"phosphorylase, glycogen, liver",0.0,0.0,1.0,0.0,0.0,1419156,GLYCOGEN STORAGE DISEASE VI,0.21,1,GeneticVariation
8090,SPPM,"scapuloperoneal syndrome, myopathic type",0.0,1.0,0.0,0.0,0.0,751337,Scapuloperoneal muscular dystrophy,0.21,0,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,2962,Angina Pectoris,0.21,2,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,2962,Angina Pectoris,0.21,1,Therapeutic
23780,APOL2,"apolipoprotein L, 2",0.0,1.0,0.0,0.0,0.0,31391,Phencyclidine Abuse,0.21,1,Biomarker
801,CALM1,"calmodulin 1 (phosphorylase kinase, delta)",0.0,1.0,0.0,0.0,0.0,31391,Phencyclidine Abuse,0.21,1,Biomarker
805,CALM2,"calmodulin 2 (phosphorylase kinase, delta)",0.0,1.0,0.0,0.0,0.0,31391,Phencyclidine Abuse,0.21,1,Biomarker
816,CAMK2B,calcium/calmodulin-dependent protein kinase II beta,0.0,1.0,0.0,0.0,0.0,31391,Phencyclidine Abuse,0.21,1,Biomarker
2222,FDFT1,farnesyl-diphosphate farnesyltransferase 1,0.0,1.0,0.0,0.0,0.0,31391,Phencyclidine Abuse,0.21,1,Biomarker
79571,GCC1,GRIP and coiled-coil domain containing 1,0.0,1.0,0.0,0.0,0.0,31391,Phencyclidine Abuse,0.21,1,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,31391,Phencyclidine Abuse,0.21,1,Biomarker
10142,AKAP9,A kinase (PRKA) anchor protein 9,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
366,AQP9,aquaporin 9,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
6314,ATXN7,ataxin 7,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
6364,CCL20,chemokine (C-C motif) ligand 20,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
414062,CCL3L3,chemokine (C-C motif) ligand 3-like 3,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
9034,CCRL2,chemokine (C-C motif) receptor-like 2,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
9308,CD83,CD83 molecule,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
2921,CXCL3,chemokine (C-X-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
2067,ERCC1,excision repair cross-complementation group 1,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
2071,ERCC3,excision repair cross-complementation group 3,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
2072,ERCC4,excision repair cross-complementation group 4,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
4616,GADD45B,"growth arrest and DNA-damage-inducible, beta",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
2803,GOLGA4,golgin A4,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
3304,HSPA1B,heat shock 70kDa protein 1B,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
3398,ID2,"inhibitor of DNA binding 2, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
8870,IER3,immediate early response 3,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
3759,KCNJ2,"potassium channel, inwardly rectifying subfamily J, member 2",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
3858,KRT10,"keratin 10, type I",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
9562,MINPP1,multiple inositol-polyphosphate phosphatase 1,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
4489,MT1A,metallothionein 1A,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
10443,N4BP2L2,NEDD4 binding protein 2-like 2,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
4714,NDUFB8,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
57162,PELI1,pellino E3 ubiquitin protein ligase 1,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
5209,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
8554,PIAS1,"protein inhibitor of activated STAT, 1",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
4860,PNP,purine nucleoside phosphorylase,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
5806,PTX3,"pentraxin 3, long",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
5991,RFX3,"regulatory factor X, 3 (influences HLA class II expression)",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
5996,RGS1,regulator of G-protein signaling 1,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
22902,RUFY3,RUN and FYVE domain containing 3,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
6421,SFPQ,splicing factor proline/glutamine-rich,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
6498,SKIL,SKI-like proto-oncogene,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
54345,SOX18,SRY (sex determining region Y)-box 18,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
6730,SRP68,signal recognition particle 68kDa,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
6742,SSBP1,"single-stranded DNA binding protein 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
79101,TAF1D,"TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
7130,TNFAIP6,"tumor necrosis factor, alpha-induced protein 6",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
23043,TNIK,TRAF2 and NCK interacting kinase,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
29896,TRA2A,transformer 2 alpha homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
7109,TRAPPC10,trafficking protein particle complex 10,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
7324,UBE2E1,ubiquitin-conjugating enzyme E2E 1,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
8615,USO1,USO1 vesicle transport factor,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
8975,USP13,ubiquitin specific peptidase 13 (isopeptidase T-3),0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
54469,ZFAND6,"zinc finger, AN1-type domain 6",0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
10308,ZNF267,zinc finger protein 267,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
55422,ZNF331,zinc finger protein 331,0.0,1.0,0.0,0.0,0.0,311375,Arsenic Poisoning,0.21,1,Biomarker
317664,DFNA49,"deafness, autosomal dominant 49",0.0,1.0,0.0,0.0,0.0,1842136,"Deafness, Autosomal Dominant 49",0.21,0,Biomarker
50971,ENFL2,"Epilepsy, nocturnal frontal lobe, type 2",0.0,1.0,0.0,0.0,0.0,1864125,"Epilepsy, Nocturnal Frontal Lobe, Type 2",0.21,0,Biomarker
2539,G6PD,glucose-6-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,31306,Phagocyte Bactericidal Dysfunction,0.21,1,Biomarker
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,19080,Hemorrhage,0.21,1,Biomarker
83706,FERMT3,fermitin family member 3,0.0,1.0,0.0,0.0,0.0,19080,Hemorrhage,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,19080,Hemorrhage,0.21,1,Biomarker
3589,IL11,interleukin 11,0.0,0.0,0.0,0.0,1.0,19080,Hemorrhage,0.21,1,Therapeutic
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,19080,Hemorrhage,0.21,8,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,19080,Hemorrhage,0.21,4,Biomarker
5420,PODXL,podocalyxin-like,0.0,1.0,0.0,0.0,0.0,19080,Hemorrhage,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,19080,Hemorrhage,0.21,2,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,19080,Hemorrhage,0.21,1,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,19080,Hemorrhage,0.21,1,Biomarker
450092,KTCN2,Keratoconus 2,0.0,1.0,0.0,0.0,0.0,1837090,Keratoconus 2,0.21,0,Biomarker
2152,F3,"coagulation factor III (thromboplastin, tissue factor)",0.0,1.0,0.0,0.0,0.0,34155,"Purpura, Thrombotic Thrombocytopenic",0.21,1,Biomarker
7035,TFPI,tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor),0.0,1.0,0.0,0.0,0.0,34155,"Purpura, Thrombotic Thrombocytopenic",0.21,1,Biomarker
7056,THBD,thrombomodulin,0.0,1.0,0.0,0.0,0.0,34155,"Purpura, Thrombotic Thrombocytopenic",0.21,1,Biomarker
114610,SAX1,spastic ataxia 1 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1970107,"Ataxia, Spastic, 1, Autosomal Dominant",0.21,0,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,28949,Oligomenorrhea,0.21,1,Biomarker
6583,SLC22A4,"solute carrier family 22 (organic cation/zwitterion transporter), member 4",0.0,1.0,0.0,0.0,0.0,14378,Enterovirus Infections,0.21,1,Biomarker
140625,ACTRT2,actin-related protein T2,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
396,ARHGDIA,Rho GDP dissociation inhibitor (GDI) alpha,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
54829,ASPN,asporin,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
822,CAPG,"capping protein (actin filament), gelsolin-like",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
1192,CLIC1,chloride intracellular channel 1,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
1289,COL5A1,"collagen, type V, alpha 1",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
1381,CRABP1,cellular retinoic acid binding protein 1,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
1984,EIF5A,eukaryotic translation initiation factor 5A,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
2266,FGG,fibrinogen gamma chain,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
2495,FTH1,"ferritin, heavy polypeptide 1",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
2512,FTL,"ferritin, light polypeptide",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
3045,HBD,"hemoglobin, delta",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
3956,LGALS1,"lectin, galactoside-binding, soluble, 1",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
56005,MYDGF,myeloid-derived growth factor,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
140465,MYL6B,"myosin, light chain 6B, alkali, smooth muscle and non-muscle",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
5216,PFN1,profilin 1,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
5052,PRDX1,peroxiredoxin 1,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
7001,PRDX2,peroxiredoxin 2,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
5901,RAN,"RAN, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
6281,S100A10,S100 calcium binding protein A10,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
6275,S100A4,S100 calcium binding protein A4,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
6279,S100A8,S100 calcium binding protein A8,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
6280,S100A9,S100 calcium binding protein A9,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
5268,SERPINB5,"serpin peptidase inhibitor, clade B (ovalbumin), member 5",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
5176,SERPINF1,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1",0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
2810,SFN,stratifin,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
6876,TAGLN,transgelin,0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
7168,TPM1,tropomyosin 1 (alpha),0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
64499,TPSB2,tryptase beta 2 (gene/pseudogene),0.0,1.0,0.0,0.0,0.0,22548,Keloid,0.21,1,Biomarker
378882,MRX84,"mental retardation, X-linked 84",0.0,1.0,0.0,0.0,0.0,1845297,"Mental Retardation, X-Linked 84",0.21,0,Biomarker
2671,GFER,"growth factor, augmenter of liver regeneration",0.0,0.0,0.0,0.0,1.0,392622,Carbon Tetrachloride Poisoning,0.21,1,Therapeutic
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,392622,Carbon Tetrachloride Poisoning,0.21,1,Therapeutic
100302682,PVNH5,Periventricular nodular heterotopia 5,0.0,1.0,0.0,0.0,0.0,2752071,"Heterotopia, Periventricular, Associated With Chromosome 5q Deletion",0.21,0,Biomarker
5953,RCD1,retinal cone dystrophy 1,0.0,1.0,0.0,0.0,0.0,1867326,Retinal Cone Dystrophy 1,0.21,0,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,0.0,1.0,0.0,0.0,2674723,"AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV",0.21,0,GeneticVariation
751798,AUNX1,"auditory neuropathy, X-linked recessive 1",0.0,1.0,0.0,0.0,0.0,1845095,"Deafness, X-Linked 5",0.21,0,Biomarker
100301572,PRBNS,Pierre Robin syndrome,0.0,1.0,0.0,0.0,0.0,31900,Pierre Robin Syndrome,0.21,0,Biomarker
100101423,MRT8,"mental retardation, non-syndromic, autosomal recessive, 8",0.0,1.0,0.0,0.0,0.0,1970196,"Mental Retardation, Autosomal Recessive 8",0.21,0,Biomarker
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,700299,Heinz Body Anemias,0.21,0,Biomarker
3040,HBA2,"hemoglobin, alpha 2",0.0,1.0,0.0,0.0,0.0,700299,Heinz Body Anemias,0.21,0,Biomarker
3043,HBB,"hemoglobin, beta",0.0,1.0,0.0,0.0,0.0,700299,Heinz Body Anemias,0.21,0,Biomarker
8126,MRST,"Mental retardation, severe, with spasticity and tapetoretinal",0.0,1.0,0.0,0.0,0.0,1864549,"Mental Retardation, Severe, With Spasticity And Pigmentary Tapetoretinal Degeneration",0.21,0,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,31039,Pericardial Effusion,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,31039,Pericardial Effusion,0.21,1,Biomarker
4053,LTBP2,latent transforming growth factor beta binding protein 2,0.0,0.0,1.0,0.0,0.0,3553785,WEILL-MARCHESANI SYNDROME 3,0.21,1,GeneticVariation
1184,CLCN5,"chloride channel, voltage-sensitive 5",0.0,1.0,0.0,0.0,0.0,18021,Goiter,0.21,1,Biomarker
100233227,SLI4,Specific language impairment 4,0.0,1.0,0.0,0.0,0.0,2675874,Specific Language Impairment 4,0.21,0,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,950124,Papillomavirus Infections,0.21,1,Biomarker
8900,CCNA1,cyclin A1,0.0,1.0,0.0,0.0,0.0,950124,Papillomavirus Infections,0.21,1,Biomarker
6845,VAMP7,vesicle-associated membrane protein 7,0.0,1.0,0.0,0.0,0.0,950124,Papillomavirus Infections,0.21,1,Biomarker
120,ADD3,adducin 3 (gamma),0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
147,ADRA1B,adrenoceptor alpha 1B,0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
241,ALOX5AP,arachidonate 5-lipoxygenase-activating protein,0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,0.0,0.0,0.0,1.0,235032,Neurotoxicity Syndromes,0.21,1,Therapeutic
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
885,CCK,cholecystokinin,0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
915,CD3D,"CD3d molecule, delta (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
83716,CRISPLD2,cysteine-rich secretory protein LCCL domain containing 2,0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,0.0,0.0,0.0,1.0,235032,Neurotoxicity Syndromes,0.21,1,Therapeutic
2570,GABRR2,"gamma-aminobutyric acid (GABA) A receptor, rho 2",0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
27040,LAT,linker for activation of T cells,0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,235032,Neurotoxicity Syndromes,0.21,1,Therapeutic
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,0.0,0.0,0.0,1.0,235032,Neurotoxicity Syndromes,0.21,1,Therapeutic
5023,P2RX1,"purinergic receptor P2X, ligand gated ion channel, 1",0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
5444,PON1,paraoxonase 1,0.0,0.0,0.0,0.0,1.0,235032,Neurotoxicity Syndromes,0.21,1,Therapeutic
5580,PRKCD,"protein kinase C, delta",0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
6039,RNASE6,"ribonuclease, RNase A family, k6",0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
6430,SRSF5,serine/arginine-rich splicing factor 5,0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
6489,ST8SIA1,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1",0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
7051,TGM1,transglutaminase 1,0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
7078,TIMP3,TIMP metallopeptidase inhibitor 3,0.0,1.0,0.0,0.0,0.0,235032,Neurotoxicity Syndromes,0.21,1,Biomarker
5663,PSEN1,presenilin 1,0.0,1.0,0.0,0.0,0.0,1840560,"Hidradenitis suppurativa, familial",0.21,1,Biomarker
55851,PSENEN,presenilin enhancer gamma secretase subunit,0.0,1.0,0.0,0.0,0.0,1840560,"Hidradenitis suppurativa, familial",0.21,1,Biomarker
545,ATR,ATR serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,42076,Urologic Neoplasms,0.21,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,42076,Urologic Neoplasms,0.21,1,Biomarker
2272,FHIT,fragile histidine triad,0.0,1.0,0.0,0.0,0.0,42076,Urologic Neoplasms,0.21,1,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,42076,Urologic Neoplasms,0.21,1,Biomarker
51741,WWOX,WW domain containing oxidoreductase,0.0,1.0,0.0,0.0,0.0,42076,Urologic Neoplasms,0.21,1,Biomarker
50970,TSG11,Tumor suppressor gene on chromosome 11,0.0,1.0,0.0,0.0,0.0,1864232,TUMOR SUPPRESSOR GENE ON CHROMOSOME 11,0.21,0,Biomarker
1814,DRD3,dopamine receptor D3,0.0,1.0,0.0,0.0,0.0,16995,Gambling,0.21,1,Biomarker
8249,MGR2,"Migraine, familial typical, susceptibility to",0.0,1.0,0.0,0.0,0.0,1848066,"MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2",0.21,0,Biomarker
113189,CHST14,carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14,0.0,1.0,0.0,0.0,0.0,22410,Joint Instability,0.21,1,Biomarker
1311,COMP,cartilage oligomeric matrix protein,0.0,1.0,0.0,0.0,0.0,22410,Joint Instability,0.21,1,Biomarker
84627,ZNF469,zinc finger protein 469,0.0,1.0,0.0,0.0,0.0,22410,Joint Instability,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,0.0,1.0,0.0,0.0,1366550,STIMULATORY G PROTEIN,0.21,1,GeneticVariation
338435,SCA25,spinocerebellar ataxia 25,0.0,1.0,0.0,0.0,0.0,1837518,Spinocerebellar ataxia 25,0.21,0,Biomarker
81620,CDT1,chromatin licensing and DNA replication factor 1,0.0,1.0,0.0,0.0,0.0,1868684,Meier-Gorlin syndrome,0.21,1,Biomarker
23594,ORC6,"origin recognition complex, subunit 6",0.0,1.0,0.0,0.0,0.0,1868684,Meier-Gorlin syndrome,0.21,1,Biomarker
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",0.0,1.0,0.0,0.0,0.0,21603,Sleep Initiation and Maintenance Disorders,0.21,1,Biomarker
4010,LMX1B,"LIM homeobox transcription factor 1, beta",0.0,1.0,0.0,0.0,0.0,21603,Sleep Initiation and Maintenance Disorders,0.21,1,Biomarker
9002,F2RL3,coagulation factor II (thrombin) receptor-like 3,0.0,1.0,0.0,0.0,0.0,30781,Peliosis Hepatis,0.21,1,Biomarker
8493,PPM1D,"protein phosphatase, Mg2+/Mn2+ dependent, 1D",0.0,1.0,0.0,0.0,0.0,677866,Brain Stem Neoplasms,0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,1.0,700359,Organophosphate Poisoning,0.21,3,"Biomarker, Therapeutic"
5184,PEPD,peptidase D,0.0,0.0,0.0,0.0,1.0,700359,Organophosphate Poisoning,0.21,1,Therapeutic
133,ADM,adrenomedullin,0.0,0.0,0.0,0.0,1.0,38358,Stomach Ulcer,0.21,1,Therapeutic
885,CCK,cholecystokinin,0.0,1.0,0.0,0.0,1.0,38358,Stomach Ulcer,0.21,6,"Biomarker, Therapeutic"
1950,EGF,epidermal growth factor,0.0,0.0,0.0,0.0,1.0,38358,Stomach Ulcer,0.21,2,Therapeutic
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,0.0,0.0,0.0,1.0,38358,Stomach Ulcer,0.21,2,Therapeutic
3375,IAPP,islet amyloid polypeptide,0.0,0.0,0.0,0.0,1.0,38358,Stomach Ulcer,0.21,1,Therapeutic
3952,LEP,leptin,0.0,0.0,0.0,0.0,1.0,38358,Stomach Ulcer,0.21,6,Therapeutic
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,38358,Stomach Ulcer,0.21,1,Biomarker
3084,NRG1,neuregulin 1,0.0,1.0,0.0,0.0,0.0,38358,Stomach Ulcer,0.21,1,Biomarker
7425,VGF,VGF nerve growth factor inducible,0.0,0.0,0.0,0.0,1.0,38358,Stomach Ulcer,0.21,1,Therapeutic
6906,SERPINA7,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7",0.0,0.0,1.0,0.0,0.0,1420598,THYROXINE-BINDING GLOBULIN OF SERUM,0.21,6,GeneticVariation
10939,AFG3L2,AFG3-like AAA ATPase 2,0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.21,1,Biomarker
1822,ATN1,atrophin 1,0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.21,0,Biomarker
3746,KCNC1,"potassium channel, voltage gated Shaw related subfamily C, member 1",0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.21,1,Biomarker
4758,NEU1,sialidase 1 (lysosomal sialidase),0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.21,1,Biomarker
5621,PRNP,prion protein,0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.21,1,Biomarker
26278,SACS,sacsin molecular chaperone,0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.21,1,Biomarker
57465,TBC1D24,"TBC1 domain family, member 24",0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.21,1,Biomarker
7248,TSC1,tuberous sclerosis 1,0.0,1.0,0.0,0.0,0.0,751778,"Myoclonic Epilepsies, Progressive",0.21,1,Biomarker
7971,GHS,Goldenhar syndrome,0.0,1.0,0.0,0.0,0.0,265240,Goldenhar Syndrome,0.21,0,Biomarker
100312952,PVOP1,"Pelvic organ prolapse, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,877015,Pelvic Organ Prolapse,0.21,0,Biomarker
100312955,PVOP2,"Pelvic organ prolapse, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,877015,Pelvic Organ Prolapse,0.21,0,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,23897,"Liver Diseases, Parasitic",0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,23897,"Liver Diseases, Parasitic",0.21,1,Biomarker
58508,KMT2C,lysine (K)-specific methyltransferase 2C,0.0,1.0,0.0,0.0,0.0,23897,"Liver Diseases, Parasitic",0.21,1,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,23897,"Liver Diseases, Parasitic",0.21,1,Biomarker
5178,PEG3,paternally expressed 3,0.0,1.0,0.0,0.0,0.0,23897,"Liver Diseases, Parasitic",0.21,1,Biomarker
54894,RNF43,ring finger protein 43,0.0,1.0,0.0,0.0,0.0,23897,"Liver Diseases, Parasitic",0.21,1,Biomarker
6092,ROBO2,"roundabout, axon guidance receptor, homolog 2 (Drosophila)",0.0,1.0,0.0,0.0,0.0,23897,"Liver Diseases, Parasitic",0.21,1,Biomarker
4089,SMAD4,SMAD family member 4,0.0,1.0,0.0,0.0,0.0,23897,"Liver Diseases, Parasitic",0.21,1,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,23897,"Liver Diseases, Parasitic",0.21,1,Biomarker
1639,DCTN1,dynactin 1,0.0,1.0,0.0,0.0,0.0,3203358,Hypoventilation,0.21,1,Biomarker
7535,ZAP70,zeta-chain (TCR) associated protein kinase 70kDa,0.0,1.0,0.0,0.0,0.0,2931320,T cell immunodeficiency primary,0.21,1,Biomarker
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),0.0,1.0,0.0,0.0,0.0,33680,Protein-Losing Enteropathies,0.21,0,Biomarker
337893,BULN,"Bulimia nervosa, susceptibility to",0.0,1.0,0.0,0.0,0.0,2267227,Bulimia Nervosa,0.21,0,Biomarker
3410,IDDM11,insulin-dependent diabetes mellitus 11,0.0,1.0,0.0,0.0,0.0,1832605,"Diabetes Mellitus, Insulin-Dependent, 11",0.21,0,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,21308,Infarction,0.21,1,Therapeutic
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,21308,Infarction,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,3500,"Aortic Stenosis, Subvalvular",0.21,1,Biomarker
493818,MYMY3,moyamoya disease 3,0.0,1.0,0.0,0.0,0.0,1837418,Moyamoya disease 3,0.21,0,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,1,Biomarker
374569,ASPG,asparaginase,0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,1,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,2,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,40034,Thrombocytopenia,0.21,1,Therapeutic
3105,HLA-A,"major histocompatibility complex, class I, A",0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,4,Biomarker
3562,IL3,interleukin 3,0.0,0.0,0.0,0.0,1.0,40034,Thrombocytopenia,0.21,1,Therapeutic
3704,ITPA,inosine triphosphatase (nucleoside triphosphate pyrophosphatase),0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,1,Biomarker
5175,PECAM1,platelet/endothelial cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,1,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,1,Biomarker
9948,WDR1,WD repeat domain 1,0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,1,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,40034,Thrombocytopenia,0.21,1,Biomarker
907,CCT,"cataract, congenital, total",0.0,1.0,0.0,0.0,0.0,2930878,"Cataract, congenital, with microcornea or slight microphthalmia",0.21,0,Biomarker
4810,NHS,Nance-Horan syndrome (congenital cataracts and dental anomalies),0.0,1.0,0.0,0.0,0.0,2930878,"Cataract, congenital, with microcornea or slight microphthalmia",0.21,0,Biomarker
18,ABAT,4-aminobutyrate aminotransferase,0.0,1.0,0.0,0.0,0.0,34933,"Reflex, Abnormal",0.21,1,Biomarker
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,0.0,0.0,0.0,1.0,34933,"Reflex, Abnormal",0.21,1,Therapeutic
7974,HRX,Hyperreflexia,0.0,1.0,0.0,0.0,0.0,34933,"Reflex, Abnormal",0.21,0,Biomarker
5376,PMP22,peripheral myelin protein 22,0.0,1.0,0.0,0.0,0.0,34933,"Reflex, Abnormal",0.21,1,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,34933,"Reflex, Abnormal",0.21,1,Biomarker
3547,IGSF1,"immunoglobulin superfamily, member 1",0.0,1.0,0.0,0.0,0.0,10308,Congenital Hypothyroidism,0.21,1,Biomarker
3258,HPT,hypoparathyroidism,0.0,1.0,0.0,0.0,0.0,342344,"Hypoparathyroidism, X-Linked",0.21,0,Biomarker
5376,PMP22,peripheral myelin protein 22,0.0,1.0,0.0,0.0,0.0,14550,"Epilepsies, Myoclonic",0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,14550,"Epilepsies, Myoclonic",0.21,1,Therapeutic
6812,STXBP1,syntaxin binding protein 1,0.0,1.0,0.0,0.0,0.0,14550,"Epilepsies, Myoclonic",0.21,1,Biomarker
50963,BRKS1,"Telopeptide lysyl hydroxylase, bone-specific",0.0,1.0,0.0,0.0,0.0,1850168,Bruck syndrome 1,0.21,0,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,5138,Berylliosis,0.21,1,Biomarker
940,CD28,CD28 molecule,0.0,1.0,0.0,0.0,0.0,5138,Berylliosis,0.21,1,Biomarker
3116,HLA-DPB2,"major histocompatibility complex, class II, DP beta 2 (pseudogene)",0.0,1.0,0.0,0.0,0.0,5138,Berylliosis,0.21,1,Biomarker
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,0.0,0.0,0.0,5138,Berylliosis,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,5138,Berylliosis,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,0.0,0.0,0.0,1.0,27429,Nasal Obstruction,0.21,1,Therapeutic
100359403,PARK16,Parkinson disease 16 (susceptibility),0.0,1.0,0.0,0.0,0.0,2751012,Parkinson Disease 16,0.21,0,Biomarker
11277,TREX1,three prime repair exonuclease 1,0.0,0.0,1.0,0.0,0.0,3277619,CHILBLAIN LUPUS 1,0.21,0,GeneticVariation
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,3,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,1.0,9241,Cognition Disorders,0.21,2,"Biomarker, Therapeutic"
1312,COMT,catechol-O-methyltransferase,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
1814,DRD3,dopamine receptor D3,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
1965,EIF2S1,"eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa",0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,9241,Cognition Disorders,0.21,1,Therapeutic
3481,IGF2,insulin-like growth factor 2,0.0,0.0,0.0,0.0,1.0,9241,Cognition Disorders,0.21,1,Therapeutic
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
5021,OXTR,oxytocin receptor,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
282808,RAB40AL,"RAB40A, member RAS oncogene family-like",0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
57282,SLC4A10,"solute carrier family 4, sodium bicarbonate transporter, member 10",0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
4089,SMAD4,SMAD family member 4,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
7248,TSC1,tuberous sclerosis 1,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,0.0,0.0,0.0,1.0,9241,Cognition Disorders,0.21,1,Therapeutic
7592,ZNF41,zinc finger protein 41,0.0,1.0,0.0,0.0,0.0,9241,Cognition Disorders,0.21,1,Biomarker
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
10047,CST8,cystatin 8 (cystatin-related epididymal specific),0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
29102,DROSHA,"drosha, ribonuclease type III",0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
54898,ELOVL2,ELOVL fatty acid elongase 2,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
387712,ENO4,enolase family member 4,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
346562,GNAT3,"guanine nucleotide binding protein, alpha transducing 3",0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,0.0,0.0,0.0,1.0,21364,"Infertility, Male",0.21,1,Therapeutic
3237,HOXD11,homeobox D11,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
8085,KMT2D,lysine (K)-specific methyltransferase 2D,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
3948,LDHC,lactate dehydrogenase C,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,2,Biomarker
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,3,Biomarker
79730,NSUN7,"NOP2/Sun domain family, member 7",0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
5887,RAD23B,RAD23 homolog B (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
2054,STX2,syntaxin 2,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
83756,TAS1R3,"taste receptor, type 1, member 3",0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
23424,TDRD7,tudor domain containing 7,0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
1831,TSC22D3,"TSC22 domain family, member 3",0.0,1.0,0.0,0.0,0.0,21364,"Infertility, Male",0.21,1,Biomarker
57790,MRXSL,Lubs X-linked mental retardation syndrome,0.0,1.0,0.0,0.0,0.0,1846058,Lubs X-linked mental retardation syndrome,0.21,0,Biomarker
9619,ABCG1,"ATP-binding cassette, sub-family G (WHITE), member 1",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
34,ACADM,"acyl-CoA dehydrogenase, C-4 to C-12 straight chain",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
11217,AKAP2,A kinase (PRKA) anchor protein 2,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
302,ANXA2,annexin A2,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
308,ANXA5,annexin A5,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
323,APBB2,"amyloid beta (A4) precursor protein-binding, family B, member 2",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
23365,ARHGEF12,Rho guanine nucleotide exchange factor (GEF) 12,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
586,BCAT1,"branched chain amino-acid transaminase 1, cytosolic",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
801,CALM1,"calmodulin 1 (phosphorylase kinase, delta)",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
25932,CLIC4,chloride intracellular channel 4,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
26958,COPG2,"coatomer protein complex, subunit gamma 2",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
1509,CTSD,cathepsin D,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
8701,DNAH11,"dynein, axonemal, heavy chain 11",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
1783,DYNC1LI2,"dynein, cytoplasmic 1, light intermediate chain 2",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
285172,FAM126B,"family with sequence similarity 126, member B",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
2199,FBLN2,fibulin 2,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
23014,FBXO21,F-box protein 21,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
9637,FEZ2,fasciculation and elongation protein zeta 2 (zygin II),0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
2246,FGF1,fibroblast growth factor 1 (acidic),0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
11167,FSTL1,follistatin-like 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
9518,GDF15,growth differentiation factor 15,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
2888,GRB14,growth factor receptor-bound protein 14,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
2934,GSN,gelsolin,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
84064,HDHD2,haloacid dehalogenase-like hydrolase domain containing 2,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
3488,IGFBP5,insulin-like growth factor binding protein 5,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
51194,IPO11,importin 11,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
8826,IQGAP1,IQ motif containing GTPase activating protein 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
9215,LARGE,like-glycosyltransferase,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
3929,LBP,lipopolysaccharide binding protein,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
9926,LPGAT1,lysophosphatidylglycerol acyltransferase 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
4134,MAP4,microtubule-associated protein 4,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
22919,MAPRE1,"microtubule-associated protein, RP/EB family, member 1",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
4199,ME1,"malic enzyme 1, NADP(+)-dependent, cytosolic",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
4232,MEST,mesoderm specific transcript,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
4321,MMP12,matrix metallopeptidase 12 (macrophage elastase),0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
23164,MPRIP,myosin phosphatase Rho interacting protein,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
4651,MYO10,myosin X,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
4430,MYO1B,myosin IB,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
55706,NDC1,NDC1 transmembrane nucleoporin,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
4715,NDUFB9,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
140609,NEK7,NIMA-related kinase 7,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
4811,NID1,nidogen 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
4883,NPR3,natriuretic peptide receptor 3,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
114882,OSBPL8,oxysterol binding protein-like 8,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
23022,PALLD,"palladin, cytoskeletal associated protein",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
51449,PCYOX1,prenylcysteine oxidase 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,2,Biomarker
5467,PPARD,peroxisome proliferator-activated receptor delta,0.0,0.0,0.0,0.0,1.0,43094,Weight Gain,0.21,1,Therapeutic
23683,PRKD3,protein kinase D3,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
5631,PRPS1,phosphoribosyl pyrophosphate synthetase 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
284119,PTRF,polymerase I and transcript release factor,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
10266,RAMP2,receptor (G protein-coupled) activity modifying protein 2,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
5986,RFNG,RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
6158,RPL28,ribosomal protein L28,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
6234,RPS28,ribosomal protein S28,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
6202,RPS8,ribosomal protein S8,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
6259,RYK,receptor-like tyrosine kinase,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
51091,SEPSECS,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
91404,SESTD1,SEC14 and spectrin domains 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
26040,SETBP1,SET binding protein 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
26037,SIPA1L1,signal-induced proliferation-associated 1 like 1,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
10569,SLU7,SLU7 splicing factor homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
8470,SORBS2,sorbin and SH3 domain containing 2,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
6711,SPTBN1,"spectrin, beta, non-erythrocytic 1",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
57620,STIM2,stromal interaction molecule 2,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
412,STS,"steroid sulfatase (microsomal), isozyme S",0.0,0.0,0.0,0.0,1.0,43094,Weight Gain,0.21,1,Therapeutic
7171,TPM4,tropomyosin 4,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
80746,TSEN2,TSEN2 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
55187,VPS13D,vacuolar protein sorting 13 homolog D (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
51201,ZDHHC2,"zinc finger, DHHC-type containing 2",0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
55055,ZWILCH,zwilch kinetochore protein,0.0,1.0,0.0,0.0,0.0,43094,Weight Gain,0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,40028,"Thrombocythemia, Essential",0.21,1,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,0.0,1.0,0.0,0.0,0.0,40028,"Thrombocythemia, Essential",0.21,1,Biomarker
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,1.0,0.0,0.0,0.0,40028,"Thrombocythemia, Essential",0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,25568,Metaplasia,0.21,1,Biomarker
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,0.0,25568,Metaplasia,0.21,1,Biomarker
100187749,ASDP,anal sphincter dysplasia,0.0,1.0,0.0,0.0,0.0,1862936,Anal sphincter dysplasia,0.21,0,Biomarker
431,ASD1,atrial septal defect 1,0.0,1.0,0.0,0.0,0.0,1862389,Atrial Septal Defect 1,0.21,0,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
1269,CNR2,cannabinoid receptor 2 (macrophage),0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
2202,EFEMP1,EGF containing fibulin-like extracellular matrix protein 1,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
2258,FGF13,fibroblast growth factor 13,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
27086,FOXP1,forkhead box P1,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
2543,GAGE1,G antigen 1,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
3439,IFNA1,"interferon, alpha 1",0.0,0.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.21,2,Therapeutic
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.21,1,Therapeutic
3442,IFNA5,"interferon, alpha 5",0.0,0.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.21,1,Therapeutic
4061,LY6E,"lymphocyte antigen 6 complex, locus E",0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
7873,MANF,mesencephalic astrocyte-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,0,Biomarker
6753,SSTR3,somatostatin receptor 3,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
6847,SYCP1,synaptonemal complex protein 1,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
8795,TNFRSF10B,"tumor necrosis factor receptor superfamily, member 10b",0.0,0.0,0.0,0.0,1.0,30297,Pancreatic Neoplasms,0.21,1,Therapeutic
1890,TYMP,thymidine phosphorylase,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
84133,ZNRF3,zinc and ring finger 3,0.0,1.0,0.0,0.0,0.0,30297,Pancreatic Neoplasms,0.21,1,Biomarker
100379201,SPAX3,"Ataxia, spastic, 3, autosomal recessive",0.0,1.0,0.0,0.0,0.0,1969645,"Ataxia, Spastic, 3, Autosomal Recessive",0.21,0,Biomarker
55764,IFT122,intraflagellar transport 122,0.0,1.0,0.0,0.0,0.0,37932,Spinal Curvatures,0.21,1,Biomarker
114086,DBA2,Diamond-Blackfan anemia 2,0.0,1.0,0.0,0.0,0.0,1853666,"Anemia, Diamond-Blackfan, 2",0.21,0,Biomarker
100188805,STBMS1,"Strabismus, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,38379,Strabismus,0.21,0,Biomarker
8104,MCOR,"microcoria, congenital",0.0,1.0,0.0,0.0,0.0,1303009,"Microcoria, congenital",0.21,0,Biomarker
126133,ALDH16A1,"aldehyde dehydrogenase 16 family, member A1",0.0,1.0,0.0,0.0,0.0,18099,Gout,0.21,1,Biomarker
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,1.0,0.0,0.0,0.0,12739,Disseminated Intravascular Coagulation,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,12739,Disseminated Intravascular Coagulation,0.21,1,Biomarker
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,1.0,0.0,0.0,0.0,12739,Disseminated Intravascular Coagulation,0.21,1,Biomarker
5896,RAG1,recombination activating gene 1,0.0,1.0,0.0,0.0,0.0,1832322,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Positive",0.21,0,Biomarker
878,CCA1,"cataract, congenital, cerulean type, 1",0.0,1.0,0.0,0.0,0.0,344523,Cerulean cataract,0.21,0,Biomarker
347737,DFNA31,"deafness, autosomal dominant 31",0.0,1.0,0.0,0.0,0.0,1837617,"Deafness, Autosomal Dominant 31",0.21,0,Biomarker
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10349,ABCA10,"ATP-binding cassette, sub-family A (ABC1), member 10",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
26154,ABCA12,"ATP-binding cassette, sub-family A (ABC1), member 12",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
154664,ABCA13,"ATP-binding cassette, sub-family A (ABC1), member 13",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
21,ABCA3,"ATP-binding cassette, sub-family A (ABC1), member 3",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
24,ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
23461,ABCA5,"ATP-binding cassette, sub-family A (ABC1), member 5",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
23460,ABCA6,"ATP-binding cassette, sub-family A (ABC1), member 6",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10351,ABCA8,"ATP-binding cassette, sub-family A (ABC1), member 8",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10350,ABCA9,"ATP-binding cassette, sub-family A (ABC1), member 9",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
23456,ABCB10,"ATP-binding cassette, sub-family B (MDR/TAP), member 10",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
8647,ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
340273,ABCB5,"ATP-binding cassette, sub-family B (MDR/TAP), member 5",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10058,ABCB6,"ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
150000,ABCC13,"ATP-binding cassette, sub-family C (CFTR/MRP), member 13, pseudogene",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
8714,ABCC3,"ATP-binding cassette, sub-family C (CFTR/MRP), member 3",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10257,ABCC4,"ATP-binding cassette, sub-family C (CFTR/MRP), member 4",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10057,ABCC5,"ATP-binding cassette, sub-family C (CFTR/MRP), member 5",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
368,ABCC6,"ATP-binding cassette, sub-family C (CFTR/MRP), member 6",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
6833,ABCC8,"ATP-binding cassette, sub-family C (CFTR/MRP), member 8",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
225,ABCD2,"ATP-binding cassette, sub-family D (ALD), member 2",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5825,ABCD3,"ATP-binding cassette, sub-family D (ALD), member 3",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5826,ABCD4,"ATP-binding cassette, sub-family D (ALD), member 4",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
6059,ABCE1,"ATP-binding cassette, sub-family E (OABP), member 1",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
9619,ABCG1,"ATP-binding cassette, sub-family G (WHITE), member 1",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
57007,ACKR3,atypical chemokine receptor 3,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10297,APC2,adenomatosis polyposis coli 2,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,3,Biomarker
66037,BOLL,boule-like RNA-binding protein,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
91768,CABLES1,Cdk5 and Abl enzyme substrate 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
26256,CABYR,calcium binding tyrosine-(Y)-phosphorylation regulated,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
811,CALR,calreticulin,0.0,0.0,0.0,0.0,1.0,9404,Colorectal Neoplasms,0.21,1,Therapeutic
135228,CD109,CD109 molecule,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
928,CD9,CD9 molecule,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
1003,CDH5,"cadherin 5, type 2 (vascular endothelium)",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
1005,CDH7,"cadherin 7, type 2",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
26038,CHD5,chromodomain helicase DNA binding protein 5,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
27151,CPAMD8,"C3 and PZP-like, alpha-2-macroglobulin domain containing 8",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
100271691,CRCS10,"Colorectal cancer, susceptibility to, 10",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
100271692,CRCS11,"Colorectal cancer, susceptibility to, 11",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
100188841,CRCS2,"Colorectal cancer, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
100188887,CRCS5,"Colorectal cancer, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
100187710,CRCS6,"colorectal cancer, susceptibility to, 6",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
100187711,CRCS7,"colorectal cancer, susceptibility to, 7",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
100271690,CRCS8,"Colorectal cancer, susceptibility to, 8",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
100329169,CRCS9,"colorectal cancer, susceptibility to, 9",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
1487,CTBP1,C-terminal binding protein 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
9201,DCLK1,doublecortin-like kinase 1,0.0,0.0,0.0,0.0,1.0,9404,Colorectal Neoplasms,0.21,1,Therapeutic
2202,EFEMP1,EGF containing fibulin-like extracellular matrix protein 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
8667,EIF3H,"eukaryotic translation initiation factor 3, subunit H",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
2033,EP300,E1A binding protein p300,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
2070,EYA4,EYA transcriptional coactivator and phosphatase 4,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
3992,FADS1,fatty acid desaturase 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
9415,FADS2,fatty acid desaturase 2,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
2195,FAT1,FAT atypical cadherin 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
2199,FBLN2,fibulin 2,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
2201,FBN2,fibrillin 2,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
2237,FEN1,flap structure-specific endonuclease 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
2318,FLNC,"filamin C, gamma",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
668,FOXL2,forkhead box L2,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10457,GPNMB,glycoprotein (transmembrane) nmb,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
2894,GRID1,"glutamate receptor, ionotropic, delta 1",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
2947,GSTM3,glutathione S-transferase mu 3 (brain),0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
2977,GUCY1A2,"guanylate cyclase 1, soluble, alpha 2",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
1404,HAPLN1,hyaluronan and proteoglycan link protein 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
3231,HOXD1,homeobox D1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
7087,ICAM5,"intercellular adhesion molecule 5, telencephalin",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
3439,IFNA1,"interferon, alpha 1",0.0,0.0,0.0,0.0,1.0,9404,Colorectal Neoplasms,0.21,1,Therapeutic
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,9404,Colorectal Neoplasms,0.21,1,Therapeutic
3572,IL6ST,interleukin 6 signal transducer,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
57338,JPH3,junctophilin 3,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
284217,LAMA1,"laminin, alpha 1",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
59352,LGR6,leucine-rich repeat containing G protein-coupled receptor 6,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
116135,LRRC3B,leucine rich repeat containing 3B,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
23643,LY96,lymphocyte antigen 96,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
406900,MIR106B,microRNA 106b,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
406920,MIR130B,microRNA 130b,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
407017,MIR26B,microRNA 26b,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
407050,MIR93,microRNA 93,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10135,NAMPT,nicotinamide phosphoribosyltransferase,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
9148,NEURL1,neuralized E3 ubiquitin protein ligase 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
4831,NME2,NME/NM23 nucleoside diphosphate kinase 2,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
4897,NRCAM,neuronal cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
30833,NT5C,"5', 3'-nucleotidase, cytosolic",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
22854,NTNG1,netrin G1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
64359,NXN,nucleoredoxin,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5157,PDGFRL,platelet-derived growth factor receptor-like,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,0,Biomarker
10714,POLD3,"polymerase (DNA-directed), delta 3, accessory subunit",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5426,POLE,"polymerase (DNA directed), epsilon, catalytic subunit",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
10631,POSTN,"periostin, osteoblast specific factor",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
22843,PPM1E,"protein phosphatase, Mg2+/Mn2+ dependent, 1E",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
94274,PPP1R14A,"protein phosphatase 1, regulatory (inhibitor) subunit 14A",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5579,PRKCB,"protein kinase C, beta",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5587,PRKD1,protein kinase D1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5789,PTPRD,"protein tyrosine phosphatase, receptor type, D",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
5979,RET,ret proto-oncogene,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
221687,RNF182,ring finger protein 182,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
6241,RRM2,ribonucleotide reductase M2,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
5268,SERPINB5,"serpin peptidase inhibitor, clade B (ovalbumin), member 5",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
54436,SH3TC1,SH3 domain and tetratricopeptide repeats 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
55356,SLC22A15,"solute carrier family 22, member 15",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
9754,STARD8,StAR-related lipid transfer (START) domain containing 8,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
23345,SYNE1,"spectrin repeat containing, nuclear envelope 1",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,2,Biomarker
256536,TCERG1L,transcription elongation regulator 1-like,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
6948,TCN2,transcobalamin II,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
7980,TFPI2,tissue factor pathway inhibitor 2,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
11257,TP53TG1,TP53 target 1 (non-protein coding),0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
143187,VTI1A,vesicle transport through interaction with t-SNAREs 1A,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
54739,XAF1,XIAP associated factor 1,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
57178,ZMIZ1,"zinc finger, MIZ-type containing 1",0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
9668,ZNF432,zinc finger protein 432,0.0,1.0,0.0,0.0,0.0,9404,Colorectal Neoplasms,0.21,1,Biomarker
6928,HNF1B,HNF1 homeobox B,0.0,1.0,0.0,0.0,0.0,2677773,"Prostate Cancer, Hereditary, 11",0.21,0,Biomarker
3704,ITPA,inosine triphosphatase (nucleoside triphosphate pyrophosphatase),0.0,0.0,1.0,0.0,0.0,342800,Inosine Triphosphatase Deficiency,0.21,1,GeneticVariation
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,0.0,0.0,0.0,178324,Vascular System Injuries,0.21,1,Biomarker
538,ATP7A,"ATPase, Cu++ transporting, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,178324,Vascular System Injuries,0.21,1,Biomarker
623,BDKRB1,bradykinin receptor B1,0.0,1.0,0.0,0.0,0.0,178324,Vascular System Injuries,0.21,1,Biomarker
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,178324,Vascular System Injuries,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,0.0,0.0,1.0,178324,Vascular System Injuries,0.21,1,Therapeutic
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,178324,Vascular System Injuries,0.21,1,Therapeutic
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,178324,Vascular System Injuries,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,178324,Vascular System Injuries,0.21,1,Biomarker
168667,BMPER,BMP binding endothelial regulator,0.0,1.0,0.0,0.0,0.0,27412,Opioid-Related Disorders,0.21,1,Biomarker
735,C9,complement component 9,0.0,1.0,0.0,0.0,0.0,27412,Opioid-Related Disorders,0.21,1,Biomarker
1066,CES1,carboxylesterase 1,0.0,0.0,0.0,0.0,1.0,27412,Opioid-Related Disorders,0.21,1,Therapeutic
4200,ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial",0.0,1.0,0.0,0.0,0.0,27412,Opioid-Related Disorders,0.21,0,Biomarker
89795,NAV3,neuron navigator 3,0.0,1.0,0.0,0.0,0.0,27412,Opioid-Related Disorders,0.21,1,Biomarker
100188802,ODS1,"Opioid dependence, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,27412,Opioid-Related Disorders,0.21,0,Biomarker
5179,PENK,proenkephalin,0.0,1.0,0.0,0.0,0.0,27412,Opioid-Related Disorders,0.21,1,Biomarker
23508,TTC9,tetratricopeptide repeat domain 9,0.0,1.0,0.0,0.0,0.0,27412,Opioid-Related Disorders,0.21,1,Biomarker
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,0.0,0.0,0.0,745103,"HYPERCHOLESTEROLEMIA, FAMILIAL",0.21,0,Biomarker
336,APOA2,apolipoprotein A-II,0.0,1.0,0.0,0.0,0.0,745103,"HYPERCHOLESTEROLEMIA, FAMILIAL",0.21,0,Biomarker
2053,EPHX2,"epoxide hydrolase 2, cytoplasmic",0.0,1.0,0.0,0.0,0.0,745103,"HYPERCHOLESTEROLEMIA, FAMILIAL",0.21,0,Biomarker
2690,GHR,growth hormone receptor,0.0,1.0,0.0,0.0,0.0,745103,"HYPERCHOLESTEROLEMIA, FAMILIAL",0.21,0,Biomarker
3700,ITIH4,"inter-alpha-trypsin inhibitor heavy chain family, member 4",0.0,1.0,0.0,0.0,0.0,745103,"HYPERCHOLESTEROLEMIA, FAMILIAL",0.21,0,Biomarker
10842,PPP1R17,"protein phosphatase 1, regulatory subunit 17",0.0,1.0,0.0,0.0,0.0,745103,"HYPERCHOLESTEROLEMIA, FAMILIAL",0.21,0,Biomarker
1878,E11S,"ECHO virus (serotypes 4, 6, 11, 19) sensitivity",0.0,1.0,0.0,0.0,0.0,1851888,Echo Virus 11 Sensitivity,0.21,0,Biomarker
111,ADCY5,adenylate cyclase 5,0.0,1.0,0.0,0.0,0.0,5612,Birth Weight,0.21,1,Biomarker
153,ADRB1,adrenoceptor beta 1,0.0,1.0,0.0,0.0,0.0,5612,Birth Weight,0.21,1,Biomarker
54901,CDKAL1,CDK5 regulatory subunit associated protein 1-like 1,0.0,1.0,0.0,0.0,0.0,5612,Birth Weight,0.21,1,Biomarker
8091,HMGA2,high mobility group AT-hook 2,0.0,1.0,0.0,0.0,0.0,5612,Birth Weight,0.21,1,Biomarker
254251,LCORL,ligand dependent nuclear receptor corepressor-like,0.0,1.0,0.0,0.0,0.0,5612,Birth Weight,0.21,1,Biomarker
4153,MBL2,"mannose-binding lectin (protein C) 2, soluble",0.0,1.0,0.0,0.0,0.0,5612,Birth Weight,0.21,1,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,5612,Birth Weight,0.21,1,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,1.0,0.0,0.0,0.0,33054,Prenatal Exposure Delayed Effects,0.21,1,Biomarker
472,ATM,ATM serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,33054,Prenatal Exposure Delayed Effects,0.21,1,Biomarker
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,33054,Prenatal Exposure Delayed Effects,0.21,1,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,33054,Prenatal Exposure Delayed Effects,0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,33054,Prenatal Exposure Delayed Effects,0.21,1,Biomarker
4654,MYOD1,myogenic differentiation 1,0.0,1.0,0.0,0.0,0.0,33054,Prenatal Exposure Delayed Effects,0.21,1,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,0.0,0.0,0.0,33054,Prenatal Exposure Delayed Effects,0.21,1,Biomarker
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,0.0,0.0,0.0,1.0,33054,Prenatal Exposure Delayed Effects,0.21,1,Therapeutic
8481,OFD1,oral-facial-digital syndrome 1,0.0,1.0,0.0,0.0,0.0,265251,Oto-Palato-digital syndrome type 1,0.21,1,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.21,1,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,0.0,0.0,0.0,1.0,9319,Colitis,0.21,1,Therapeutic
10135,NAMPT,nicotinamide phosphoribosyltransferase,0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.21,1,Biomarker
6714,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.21,1,Biomarker
7263,TST,thiosulfate sulfurtransferase (rhodanese),0.0,1.0,0.0,0.0,0.0,9319,Colitis,0.21,1,Biomarker
619398,5-Feb,febrile convulsions 5,0.0,1.0,0.0,0.0,0.0,1836507,"Febrile Convulsions, Familial, 5",0.21,0,Biomarker
1132,CHRM4,"cholinergic receptor, muscarinic 4",0.0,0.0,0.0,0.0,1.0,7398,Catatonia,0.21,1,Therapeutic
18,ABAT,4-aminobutyrate aminotransferase,0.0,1.0,0.0,0.0,0.0,26827,Muscle Hypotonia,0.21,1,Biomarker
113189,CHST14,carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14,0.0,1.0,0.0,0.0,0.0,26827,Muscle Hypotonia,0.21,1,Biomarker
284058,KANSL1,KAT8 regulatory NSL complex subunit 1,0.0,1.0,0.0,0.0,0.0,26827,Muscle Hypotonia,0.21,2,Biomarker
3954,LETM1,leucine zipper-EF-hand containing transmembrane protein 1,0.0,1.0,0.0,0.0,0.0,26827,Muscle Hypotonia,0.21,1,Biomarker
171514,ANON1,"Anorexia nervosa, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,3125,Anorexia Nervosa,0.21,0,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,2,Biomarker
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
9429,ABCG2,"ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
135,ADORA2A,adenosine A2a receptor,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
8824,CES2,carboxylesterase 2,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
1191,CLU,clusterin,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,0.0,0.0,0.0,1.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Therapeutic
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Therapeutic
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,2,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
1719,DHFR,dihydrofolate reductase,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
2243,FGA,fibrinogen alpha chain,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
26762,HAVCR1,hepatitis A virus cellular receptor 1,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,2,Biomarker
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,5,Biomarker
3107,HLA-C,"major histocompatibility complex, class I, C",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
126393,HSPB6,"heat shock protein, alpha-crystallin-related, B6",0.0,0.0,0.0,0.0,1.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Therapeutic
3357,HTR2B,"5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,0.0,0.0,1.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Therapeutic
3484,IGFBP1,insulin-like growth factor binding protein 1,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
3562,IL3,interleukin 3,0.0,0.0,0.0,0.0,1.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Therapeutic
4254,KITLG,KIT ligand,0.0,0.0,0.0,0.0,1.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Therapeutic
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,9,Biomarker
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,2,Biomarker
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
9,NAT1,N-acetyltransferase 1 (arylamine N-acetyltransferase),0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,2,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Therapeutic
10769,PLK2,polo-like kinase 2,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
6470,SHMT1,serine hydroxymethyltransferase 1 (soluble),0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
10568,SLC34A2,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 2",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
6578,SLCO2A1,"solute carrier organic anion transporter family, member 2A1",0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
6948,TCN2,transcobalamin II,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
7150,TOP1,topoisomerase (DNA) I,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
7298,TYMS,thymidylate synthetase,0.0,1.0,0.0,0.0,0.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Biomarker
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,0.0,0.0,0.0,1.0,3658338,Drug-Related Side Effects and Adverse Reactions,0.21,1,Therapeutic
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,9,Biomarker
241,ALOX5AP,arachidonate 5-lipoxygenase-activating protein,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
1184,CLCN5,"chloride channel, voltage-sensitive 5",0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
1508,CTSB,cathepsin B,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
1514,CTSL,cathepsin L,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
1773,DNASE1,deoxyribonuclease I,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
1803,DPP4,dipeptidyl-peptidase 4,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
2990,GUSB,"glucuronidase, beta",0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
3117,HLA-DQA1,"major histocompatibility complex, class II, DQ alpha 1",0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,2,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,0.0,0.0,0.0,1.0,33687,Proteinuria,0.21,1,Therapeutic
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
4010,LMX1B,"LIM homeobox transcription factor 1, beta",0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,2,Biomarker
4358,MPV17,MpV17 mitochondrial inner membrane protein,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
94025,MUC16,"mucin 16, cell surface associated",0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
4690,NCK1,NCK adaptor protein 1,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
8440,NCK2,NCK adaptor protein 2,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
5058,PAK1,p21 protein (Cdc42/Rac)-activated kinase 1,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
5062,PAK2,p21 protein (Cdc42/Rac)-activated kinase 2,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,2,Biomarker
387,RHOA,ras homolog family member A,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,0.0,0.0,0.0,1.0,33687,Proteinuria,0.21,1,Therapeutic
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,33687,Proteinuria,0.21,1,Biomarker
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,22904,Lacrimal Apparatus Diseases,0.21,1,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,16659,"Fractures, Closed",0.21,1,Biomarker
10800,CYSLTR1,cysteinyl leukotriene receptor 1,0.0,1.0,0.0,0.0,0.0,16659,"Fractures, Closed",0.21,1,Biomarker
11284,PNKP,polynucleotide kinase 3'-phosphatase,0.0,1.0,0.0,0.0,0.0,1563696,DNA Repair-Deficiency Disorders,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,40264,Tinnitus,0.21,1,Biomarker
4549,RNR1,s-rRNA,0.0,1.0,0.0,0.0,0.0,40264,Tinnitus,0.21,1,Biomarker
179,AGMX2,"agammaglobulinemia, X-linked 2 (with growth hormone deficiency)",0.0,1.0,0.0,0.0,0.0,1845903,"Agammaglobulinemia, X-linked, type 2",0.21,0,Biomarker
1373,CPS1,"carbamoyl-phosphate synthase 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,31190,Persistent Fetal Circulation Syndrome,0.21,1,Biomarker
208,AKT2,v-akt murine thymoma viral oncogene homolog 2,0.0,0.0,1.0,0.0,0.0,3278384,HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY,0.21,0,GeneticVariation
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,26766,Multiple Organ Failure,0.21,1,Biomarker
3929,LBP,lipopolysaccharide binding protein,0.0,1.0,0.0,0.0,0.0,26766,Multiple Organ Failure,0.21,1,Biomarker
6750,SST,somatostatin,0.0,0.0,0.0,0.0,1.0,26766,Multiple Organ Failure,0.21,1,Therapeutic
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
226,ALDOA,"aldolase A, fructose-bisphosphate",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
308,ANXA5,annexin A5,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
335,APOA1,apolipoprotein A-I,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
9582,APOBEC3B,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
10476,ATP5H,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
822,CAPG,"capping protein (actin filament), gelsolin-like",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
8890,EIF2B4,"eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
8893,EIF2B5,"eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
10961,ERP29,endoplasmic reticulum protein 29,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
2791,GNG11,"guanine nucleotide binding protein (G protein), gamma 11",0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
3148,HMGB2,high mobility group box 2,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
3028,HSD17B10,hydroxysteroid (17-beta) dehydrogenase 10,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
4437,MSH3,mutS homolog 3,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
2956,MSH6,mutS homolog 6,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,152013,Adenocarcinoma of lung,0.21,1,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,1.0,0.0,0.0,0.0,38525,Subarachnoid Hemorrhage,0.21,1,Biomarker
1910,EDNRB,endothelin receptor type B,0.0,1.0,0.0,0.0,0.0,38525,Subarachnoid Hemorrhage,0.21,1,Biomarker
790,CAD,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",0.0,1.0,0.0,0.0,0.0,949116,"Anemia, Hypoplastic, Congenital",0.21,1,Biomarker
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,0.0,0.0,0.0,949116,"Anemia, Hypoplastic, Congenital",0.21,1,Biomarker
253,ALS3,amyotrophic lateral sclerosis 3 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1847735,Amyotrophic Lateral Sclerosis 3,0.21,0,Biomarker
111,ADCY5,adenylate cyclase 5,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
26,AOC1,"amine oxidase, copper containing 1",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
63036,CELA2A,"chymotrypsin-like elastase family, member 2A",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
1395,CRHR2,corticotropin releasing hormone receptor 2,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
2160,F11,coagulation factor XI,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
486,FXYD2,FXYD domain containing ion transport regulator 2,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
10052,GJC1,"gap junction protein, gamma 1, 45kDa",0.0,0.0,0.0,0.0,1.0,20538,Hypertension,0.21,1,Therapeutic
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
221357,GSTA5,glutathione S-transferase alpha 5,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
2953,GSTT2,glutathione S-transferase theta 2 (gene/pseudogene),0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
2982,GUCY1A3,"guanylate cyclase 1, soluble, alpha 3",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
9445,ITM2B,integral membrane protein 2B,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
4158,MC2R,melanocortin 2 receptor (adrenocorticotropic hormone),0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
4190,MDH1,"malate dehydrogenase 1, NAD (soluble)",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
27020,NPTN,neuroplastin,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
5473,PPBP,pro-platelet basic protein (chemokine (C-X-C motif) ligand 7),0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,2,Biomarker
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
10928,RALBP1,ralA binding protein 1,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
6198,RPS6KB1,"ribosomal protein S6 kinase, 70kDa, polypeptide 1",0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
6786,STIM1,stromal interaction molecule 1,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
6794,STK11,serine/threonine kinase 11,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
6869,TACR1,tachykinin receptor 1,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
7052,TGM2,transglutaminase 2,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
7168,TPM1,tropomyosin 1 (alpha),0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
10451,VAV3,vav 3 guanine nucleotide exchange factor,0.0,1.0,0.0,0.0,0.0,20538,Hypertension,0.21,1,Biomarker
10038,PARP2,poly (ADP-ribose) polymerase 2,0.0,1.0,0.0,0.0,0.0,23787,Lipodystrophy,0.21,1,Biomarker
335,APOA1,apolipoprotein A-I,0.0,1.0,0.0,0.0,0.0,1848533,Ataxia with vitamin E deficiency,0.21,1,Biomarker
338,APOB,apolipoprotein B,0.0,1.0,0.0,0.0,0.0,1848533,Ataxia with vitamin E deficiency,0.21,1,Biomarker
5277,PIGA,"phosphatidylinositol glycan anchor biosynthesis, class A",0.0,0.0,1.0,0.0,0.0,3806670,PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1,0.21,0,GeneticVariation
8322,FZD4,frizzled class receptor 4,0.0,1.0,0.0,0.0,0.0,3706,Arachnodactyly,0.21,1,Biomarker
100188765,CFTDX,"Myopathy, congenital, with fiber-type disproportion, X-linked",0.0,1.0,0.0,0.0,0.0,2749128,"Myopathy, Congenital, With Fiber-Type Disproportion, X-Linked",0.21,0,Biomarker
100529146,DER22T11-22,Emanuel syndrome,0.0,1.0,0.0,0.0,0.0,1836929,Emanuel syndrome,0.21,0,Biomarker
563,AZGP1,"alpha-2-glycoprotein 1, zinc-binding",0.0,1.0,0.0,0.0,0.0,37199,Sinusitis,0.21,1,Biomarker
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,0.0,37199,Sinusitis,0.21,1,Biomarker
5304,PIP,prolactin-induced protein,0.0,1.0,0.0,0.0,0.0,37199,Sinusitis,0.21,1,Biomarker
84687,PPP1R9B,"protein phosphatase 1, regulatory subunit 9B",0.0,1.0,0.0,0.0,0.0,37199,Sinusitis,0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,206681,"Adenocarcinoma, Clear Cell",0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,3615,Appendicitis,0.21,1,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,3615,Appendicitis,0.21,1,Biomarker
378427,AIS3,autoimmune susceptibility 3 (vitiligo specific),0.0,1.0,0.0,0.0,0.0,1842112,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3",0.21,0,Biomarker
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),0.0,1.0,0.0,0.0,0.0,26205,Miosis,0.21,1,Biomarker
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,0.0,1.0,0.0,0.0,3279790,Atrial Septal Defect 3,0.21,0,GeneticVariation
4878,NPPA,natriuretic peptide A,0.0,0.0,1.0,0.0,0.0,3810401,ATRIAL STANDSTILL 2,0.21,1,GeneticVariation
619469,DELYQ11,"Sertoli cell-only syndrome, Y-linked",0.0,1.0,0.0,0.0,0.0,1839073,"Sertoli cell-only syndrome, Y-linked",0.21,0,Biomarker
100415904,HWE2,"Epilepsy, hot water, 2",0.0,1.0,0.0,0.0,0.0,3150536,"EPILEPSY, HOT WATER, 2",0.21,0,Biomarker
1081,CGA,"glycoprotein hormones, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,2931367,"Thyroid cancer, follicular",0.21,1,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,2931367,"Thyroid cancer, follicular",0.21,0,Biomarker
9562,MINPP1,multiple inositol-polyphosphate phosphatase 1,0.0,1.0,0.0,0.0,0.0,2931367,"Thyroid cancer, follicular",0.21,0,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,0.0,0.0,0.0,2931367,"Thyroid cancer, follicular",0.21,1,Biomarker
7849,PAX8,paired box 8,0.0,1.0,0.0,0.0,0.0,2931367,"Thyroid cancer, follicular",0.21,1,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,2931367,"Thyroid cancer, follicular",0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,2931367,"Thyroid cancer, follicular",0.21,0,Biomarker
449488,DFNB46,"deafness, autosomal recessive 46",0.0,1.0,0.0,0.0,0.0,1864815,"Deafness, Autosomal Recessive 46",0.21,0,Biomarker
9313,MMP20,matrix metallopeptidase 20,0.0,1.0,0.0,0.0,0.0,1290537,Amelogenesis imperfecta pigmented hypomaturation type,0.21,0,Biomarker
70,ACTC1,"actin, alpha, cardiac muscle 1",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
95,ACY1,aminoacylase 1,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
8659,ALDH4A1,"aldehyde dehydrogenase 4 family, member A1",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
307,ANXA4,annexin A4,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
506,ATP5B,"ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
587,BCAT2,"branched chain amino-acid transaminase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
84909,C9orf3,chromosome 9 open reading frame 3,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
79879,CCDC134,coiled-coil domain containing 134,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
1050,CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
1072,CFL1,cofilin 1 (non-muscle),0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
1124,CHN2,chimerin 2,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
25839,COG4,component of oligomeric golgi complex 4,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
91522,COL23A1,"collagen, type XXIII, alpha 1",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
1373,CPS1,"carbamoyl-phosphate synthase 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
79039,DDX54,DEAD (Asp-Glu-Ala-Asp) box polypeptide 54,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
57628,DPP10,dipeptidyl-peptidase 10 (non-functional),0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
1948,EFNB2,ephrin-B2,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
23404,EXOSC2,exosome component 2,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
2305,FOXM1,forkhead box M1,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
2495,FTH1,"ferritin, heavy polypeptide 1",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
2705,GJB1,"gap junction protein, beta 1, 32kDa",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
2941,GSTA4,glutathione S-transferase alpha 4,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
9446,GSTO1,glutathione S-transferase omega 1,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
3033,HADH,hydroxyacyl-CoA dehydrogenase,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
192286,HIGD2A,"HIG1 hypoxia inducible domain family, member 2A",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
8100,IFT88,intraflagellar transport 88,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
3484,IGFBP1,insulin-like growth factor binding protein 1,0.0,0.0,0.0,0.0,1.0,32927,Precancerous Conditions,0.21,1,Therapeutic
3667,IRS1,insulin receptor substrate 1,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
3856,KRT8,"keratin 8, type II",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
728239,MAGED4,melanoma antigen family D4,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
5609,MAP2K7,mitogen-activated protein kinase kinase 7,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
5599,MAPK8,mitogen-activated protein kinase 8,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
406910,MIR125A,microRNA 125a,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
406937,MIR145,microRNA 145,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
442920,MIR196B,microRNA 196b,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
406984,MIR200B,microRNA 200b,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
406993,MIR211,microRNA 211,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
406994,MIR212,microRNA 212,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
407017,MIR26B,microRNA 26b,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
407029,MIR30A,microRNA 30a,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
407033,MIR30D,microRNA 30d,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
442898,MIR324,microRNA 324,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
442903,MIR331,microRNA 331,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
442906,MIR338,microRNA 338,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
442908,MIR340,microRNA 340,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
574413,MIR409,microRNA 409,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
619552,MIR483,microRNA 483,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
724022,MIR652,microRNA 652,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
693235,MIR92B,microRNA 92b,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
407054,MIR98,microRNA 98,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
407056,MIR99B,microRNA 99b,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
406884,MIRLET7B,microRNA let-7b,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
406886,MIRLET7D,microRNA let-7d,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
51491,NOP16,NOP16 nucleolar protein,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
9970,NR1I3,"nuclear receptor subfamily 1, group I, member 3",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
64081,PBLD,phenazine biosynthesis-like protein domain containing,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
5037,PEBP1,phosphatidylethanolamine binding protein 1,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
166336,PRICKLE2,prickle homolog 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
5592,PRKG1,"protein kinase, cGMP-dependent, type I",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
84249,PSD2,pleckstrin and Sec7 domain containing 2,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
6317,SERPINB3,"serpin peptidase inhibitor, clade B (ovalbumin), member 3",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
140885,SIRPA,signal-regulatory protein alpha,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
6496,SIX3,SIX homeobox 3,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
121256,TMEM132D,transmembrane protein 132D,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
10188,TNK2,"tyrosine kinase, non-receptor, 2",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
7171,TPM4,tropomyosin 4,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
7204,TRIO,trio Rho guanine nucleotide exchange factor,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
54802,TRIT1,tRNA isopentenyltransferase 1,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
164395,TTLL9,tubulin tyrosine ligase-like family member 9,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
10975,UQCR11,"ubiquinol-cytochrome c reductase, complex III subunit XI",0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
23302,WSCD1,WSC domain containing 1,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
10897,YIF1A,Yip1 interacting factor homolog A (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
339487,ZBTB8OS,zinc finger and BTB domain containing 8 opposite strand,0.0,1.0,0.0,0.0,0.0,32927,Precancerous Conditions,0.21,1,Biomarker
716,C1S,"complement component 1, s subcomponent",0.0,1.0,0.0,0.0,0.0,677607,Hashimoto Disease,0.21,1,Biomarker
147,ADRA1B,adrenoceptor alpha 1B,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,2,Biomarker
150,ADRA2A,adrenoceptor alpha 2A,0.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.21,1,Therapeutic
152,ADRA2C,adrenoceptor alpha 2C,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
156,ADRBK1,"adrenergic, beta, receptor kinase 1",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
9495,AKAP5,A kinase (PRKA) anchor protein 5,0.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.21,1,Therapeutic
26,AOC1,"amine oxidase, copper containing 1",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
23523,CABIN1,calcineurin binding protein 1,0.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.21,1,Therapeutic
859,CAV3,caveolin 3,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
894,CCND2,cyclin D2,0.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.21,1,Therapeutic
1375,CPT1B,carnitine palmitoyltransferase 1B (muscle),0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
1489,CTF1,cardiotrophin 1,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,2,Biomarker
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
2621,GAS6,growth arrest-specific 6,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
2626,GATA4,GATA binding protein 4,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,2,Biomarker
10539,GLRX3,glutaredoxin 3,0.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.21,1,Therapeutic
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
3066,HDAC2,histone deacetylase 2,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.21,1,Therapeutic
3270,HRC,histidine rich calcium binding protein,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
3709,ITPR2,"inositol 1,4,5-trisphosphate receptor, type 2",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
3976,LIF,leukemia inhibitory factor,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
9927,MFN2,mitofusin 2,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
406991,MIR21,microRNA 21,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
4502,MT2A,metallothionein 2A,0.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.21,1,Therapeutic
93649,MYOCD,myocardin,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
4881,NPR1,natriuretic peptide receptor 1,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
5294,PIK3CG,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
5337,PLD1,"phospholipase D1, phosphatidylcholine-specific",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
5338,PLD2,phospholipase D2,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,6,Biomarker
5467,PPARD,peroxisome proliferator-activated receptor delta,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
5563,PRKAA2,"protein kinase, AMP-activated, alpha 2 catalytic subunit",0.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.21,1,Therapeutic
10616,RBCK1,RanBP-type and C3HC4-type zinc finger containing 1,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,2,Biomarker
6464,SHC1,SHC (Src homology 2 domain containing) transforming protein 1,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
6714,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,2,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,3,Biomarker
84676,TRIM63,"tripartite motif containing 63, E3 ubiquitin protein ligase",0.0,0.0,0.0,0.0,1.0,18800,Cardiomegaly,0.21,1,Therapeutic
7220,TRPC1,"transient receptor potential cation channel, subfamily C, member 1",0.0,1.0,0.0,0.0,0.0,18800,Cardiomegaly,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,553730,Chondrocalcinosis,0.21,1,Therapeutic
100233147,ARHI1,Age-related hearing impairment 1,0.0,1.0,0.0,0.0,0.0,2676230,Age-Related Hearing Impairment 1,0.21,0,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,0.0,0.0,0.0,39584,Testicular Diseases,0.21,1,Biomarker
3547,IGSF1,"immunoglobulin superfamily, member 1",0.0,1.0,0.0,0.0,0.0,39584,Testicular Diseases,0.21,1,Biomarker
5530,PPP3CA,"protein phosphatase 3, catalytic subunit, alpha isozyme",0.0,1.0,0.0,0.0,0.0,39584,Testicular Diseases,0.21,1,Biomarker
1831,TSC22D3,"TSC22 domain family, member 3",0.0,1.0,0.0,0.0,0.0,39584,Testicular Diseases,0.21,1,Biomarker
4358,MPV17,MpV17 mitochondrial inner membrane protein,0.0,1.0,0.0,0.0,0.0,9197,Cochlear Diseases,0.21,1,Biomarker
65217,PCDH15,protocadherin-related 15,0.0,1.0,0.0,0.0,0.0,9197,Cochlear Diseases,0.21,1,Biomarker
1828,DSG1,desmoglein 1,0.0,1.0,0.0,0.0,0.0,25517,Metabolic Diseases,0.21,1,Biomarker
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,25517,Metabolic Diseases,0.21,1,Biomarker
51733,UPB1,"ureidopropionase, beta",0.0,1.0,0.0,0.0,0.0,25517,Metabolic Diseases,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,19087,Hemorrhagic Disorders,0.21,1,Biomarker
6915,TBXA2R,thromboxane A2 receptor,0.0,1.0,0.0,0.0,0.0,19087,Hemorrhagic Disorders,0.21,1,Biomarker
2448,FRA12A,"fragile site, folic acid type, rare, fra(12)(q13.1)",0.0,1.0,0.0,0.0,0.0,1969893,"Mental Retardation, Fra12a Type",0.21,0,Biomarker
7466,WFS1,Wolfram syndrome 1 (wolframin),0.0,0.0,1.0,0.0,0.0,3805412,CATARACT 41,0.21,0,GeneticVariation
50987,FPEVF,"Epilepsy, partial, with variable foci",0.0,1.0,0.0,0.0,0.0,1858477,"Epilepsy, Partial, with Variable Foci",0.21,0,Biomarker
81865,BFIC2,Benign familial infantile convulsions-2,0.0,1.0,0.0,0.0,0.0,1853995,"Convulsions, Benign Familial Infantile, 2",0.21,0,Biomarker
4358,MPV17,MpV17 mitochondrial inner membrane protein,0.0,1.0,0.0,0.0,0.0,751651,Mitochondrial Diseases,0.21,1,Biomarker
8996,NOL3,nucleolar protein 3 (apoptosis repressor with CARD domain),0.0,0.0,0.0,0.0,1.0,751651,Mitochondrial Diseases,0.21,1,Therapeutic
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,0.0,0.0,0.0,1.0,751651,Mitochondrial Diseases,0.21,1,Therapeutic
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,751651,Mitochondrial Diseases,0.21,1,Biomarker
100529224,FWS,Forsythe-Wakeling syndrome,0.0,1.0,0.0,0.0,0.0,3150859,FORSYTHE-WAKELING SYNDROME,0.21,0,Biomarker
25978,CHMP2B,charged multivesicular body protein 2B,0.0,0.0,1.0,0.0,0.0,1836076,"Amyotrophic Lateral Sclerosis, Chmp2B-Related",0.21,0,GeneticVariation
7488,WS2B,"Waardenburg syndrome, type 2B",0.0,1.0,0.0,0.0,0.0,1838447,Waardenburg syndrome type 2B,0.21,0,Biomarker
2180,ACSL1,acyl-CoA synthetase long-chain family member 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
71,ACTG1,actin gamma 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
81,ACTN4,"actinin, alpha 4",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
111,ADCY5,adenylate cyclase 5,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
174,AFP,alpha-fetoprotein,0.0,0.0,0.0,0.0,1.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Therapeutic
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
214,ALCAM,activated leukocyte cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
307,ANXA4,annexin A4,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
93974,ATPIF1,ATPase inhibitory factor 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
6790,AURKA,aurora kinase A,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
10409,BASP1,"brain abundant, membrane attached signal protein 1",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
832,CAPZB,"capping protein (actin filament) muscle Z-line, beta",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
998,CDC42,cell division cycle 42,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1040,CDS1,CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1266,CNN3,"calponin 3, acidic",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1289,COL5A1,"collagen, type V, alpha 1",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
4512,COX1,cytochrome c oxidase subunit I,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1447,CSN2,casein beta,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
1448,CSN3,casein kappa,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1622,DBI,"diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
780,DDR1,discoidin domain receptor tyrosine kinase 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1674,DES,desmin,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1848,DUSP6,dual specificity phosphatase 6,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1915,EEF1A1,eukaryotic translation elongation factor 1 alpha 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2202,EFEMP1,EGF containing fibulin-like extracellular matrix protein 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
1984,EIF5A,eukaryotic translation initiation factor 5A,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
4072,EPCAM,epithelial cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7430,EZR,ezrin,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2167,FABP4,"fatty acid binding protein 4, adipocyte",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2335,FN1,fibronectin 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5045,FURIN,furin (paired basic amino acid cleaving enzyme),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
50486,G0S2,G0/G1 switch 2,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2625,GATA3,GATA binding protein 3,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2628,GATM,glycine amidinotransferase (L-arginine:glycine amidinotransferase),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
9615,GDA,guanine deaminase,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2678,GGT1,gamma-glutamyltransferase 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
644076,GLYCAM1,glycosylation dependent cell adhesion molecule 1 (pseudogene),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2771,GNAI2,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
2937,GSS,glutathione synthetase,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3021,H3F3B,"H3 histone, family 3B (H3.3B)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,0.0,0.0,1.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Therapeutic
3178,HNRNPA1,heterogeneous nuclear ribonucleoprotein A1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3182,HNRNPAB,heterogeneous nuclear ribonucleoprotein A/B,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3397,ID1,"inhibitor of DNA binding 1, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3400,ID4,"inhibitor of DNA binding 4, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,3,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3572,IL6ST,interleukin 6 signal transducer,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3638,INSIG1,insulin induced gene 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
4254,KITLG,KIT ligand,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3852,KRT5,"keratin 5, type II",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
112802,KRT71,"keratin 71, type II",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3963,LGALS7,"lectin, galactoside-binding, soluble, 7",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
8825,LIN7A,lin-7 homolog A (C. elegans),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
4023,LPL,lipoprotein lipase,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
51599,LSR,lipolysis stimulated lipoprotein receptor,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
5609,MAP2K7,mitogen-activated protein kinase kinase 7,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
4191,MDH2,"malate dehydrogenase 2, NAD (mitochondrial)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
4256,MGP,matrix Gla protein,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
9019,MPZL1,myelin protein zero-like 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
9902,MRC2,"mannose receptor, C type 2",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
8648,NCOA1,nuclear receptor coactivator 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
26012,NSMF,NMDA receptor synaptonuclear signaling and neuronal migration factor,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,0.0,0.0,0.0,1.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Therapeutic
23569,PADI4,"peptidyl arginine deiminase, type IV",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
5037,PEBP1,phosphatidylethanolamine binding protein 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5223,PGAM1,phosphoglycerate mutase 1 (brain),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5241,PGR,progesterone receptor,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5295,PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5315,PKM,"pyruvate kinase, muscle",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
10769,PLK2,polo-like kinase 2,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7001,PRDX2,peroxiredoxin 2,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5618,PRLR,prolactin receptor,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5685,PSMA4,"proteasome (prosome, macropain) subunit, alpha type, 4",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5720,PSME1,"proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5725,PTBP1,polypyrimidine tract binding protein 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5731,PTGER1,"prostaglandin E receptor 1 (subtype EP1), 42kDa",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5764,PTN,pleiotrophin,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5901,RAN,"RAN, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
5921,RASA1,RAS p21 protein activator (GTPase activating protein) 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5924,RASGRF2,Ras protein-specific guanine nucleotide-releasing factor 2,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5925,RB1,retinoblastoma 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5947,RBP1,"retinol binding protein 1, cellular",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
5954,RCN1,"reticulocalbin 1, EF-hand calcium binding domain",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6122,RPL3,ribosomal protein L3,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6128,RPL6,ribosomal protein L6,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6208,RPS14,ribosomal protein S14,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6277,S100A6,S100 calcium binding protein A6,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1901,S1PR1,sphingosine-1-phosphate receptor 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6319,SCD,stearoyl-CoA desaturase (delta-9-desaturase),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
6446,SGK1,serum/glucocorticoid regulated kinase 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
1468,SLC25A10,"solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6623,SNCG,"synuclein, gamma (breast cancer-specific protein 1)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6634,SNRPD3,small nuclear ribonucleoprotein D3 polypeptide 18kDa,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6662,SOX9,SRY (sex determining region Y)-box 9,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
10653,SPINT2,"serine peptidase inhibitor, Kunitz type, 2",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,0.0,0.0,0.0,1.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Therapeutic
6427,SRSF2,serine/arginine-rich splicing factor 2,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
3925,STMN1,stathmin 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
7031,TFF1,trefoil factor 1,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7069,THRSP,thyroid hormone responsive,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7086,TKT,transketolase,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7091,TLE4,transducin-like enhancer of split 4,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,0.0,0.0,0.0,1.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Therapeutic
7170,TPM3,tropomyosin 3,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,2,Biomarker
7227,TRPS1,trichorhinophalangeal syndrome I,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
8848,TSC22D1,"TSC22 domain family, member 1",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
347733,TUBB2B,"tubulin, beta 2B class IIb",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7329,UBE2I,ubiquitin-conjugating enzyme E2I,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
8673,VAMP8,vesicle-associated membrane protein 8,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
331,XIAP,"X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase",0.0,0.0,0.0,0.0,1.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Therapeutic
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
7534,YWHAZ,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta",0.0,1.0,0.0,0.0,0.0,24668,"Mammary Neoplasms, Experimental",0.21,1,Biomarker
790,CAD,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",0.0,1.0,0.0,0.0,0.0,5283,beta-Thalassemia,0.21,1,Biomarker
1723,DHODH,dihydroorotate dehydrogenase (quinone),0.0,1.0,0.0,0.0,0.0,5283,beta-Thalassemia,0.21,1,Biomarker
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,0.0,0.0,0.0,5283,beta-Thalassemia,0.21,1,Biomarker
107,ADCY1,adenylate cyclase 1 (brain),0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
114,ADCY8,adenylate cyclase 8 (brain),0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
135,ADORA2A,adenosine A2a receptor,0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,1,Therapeutic
590,BCHE,butyrylcholinesterase,0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,1,Therapeutic
796,CALCA,calcitonin-related polypeptide alpha,0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,2,Therapeutic
885,CCK,cholecystokinin,0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,2,Therapeutic
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
1394,CRHR1,corticotropin releasing hormone receptor 1,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
1812,DRD1,dopamine receptor D1,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,2,Biomarker
1814,DRD3,dopamine receptor D3,0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,1,Therapeutic
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
2550,GABBR1,"gamma-aminobutyric acid (GABA) B receptor, 1",0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,1,Therapeutic
28964,GIT1,G protein-coupled receptor kinase interacting ArfGAP 1,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,2,Biomarker
2891,GRIA2,"glutamate receptor, ionotropic, AMPA 2",0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,2,Biomarker
3358,HTR2C,"5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled",0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,1,Therapeutic
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
4135,MAP6,microtubule-associated protein 6,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
4880,NPPC,natriuretic peptide C,0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,1,Therapeutic
594857,NPS,neuropeptide S,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,2,Biomarker
4922,NTS,neurotensin,0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,2,Therapeutic
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,0.0,0.0,0.0,1.0,424295,Hyperkinesis,0.21,1,Therapeutic
6623,SNCG,"synuclein, gamma (breast cancer-specific protein 1)",0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
7054,TH,tyrosine hydroxylase,0.0,1.0,0.0,0.0,0.0,424295,Hyperkinesis,0.21,1,Biomarker
100302716,HTGH,"Hypertrichosis terminalis, generalized, with or without gingival hyperplasia",0.0,1.0,0.0,0.0,0.0,1851120,"Hypertrichosis Terminalis, Generalized, with or without Gingival Hyperplasia",0.21,0,Biomarker
50717,DCAF8,DDB1 and CUL4 associated factor 8,0.0,0.0,1.0,0.0,0.0,1864695,"Giant Axonal Neuropathy, Autosomal Dominant",0.21,1,GeneticVariation
859,CAV3,caveolin 3,0.0,0.0,1.0,0.0,0.0,3280443,"MYOPATHY, DISTAL, TATEYAMA TYPE",0.21,0,GeneticVariation
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,2931037,"Pancreatic cancer, adult",0.21,1,Biomarker
5925,RB1,retinoblastoma 1,0.0,0.0,1.0,0.0,0.0,80113,Retinoblastoma Protein,0.21,9,GeneticVariation
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,20532,Hypersplenism,0.21,1,Biomarker
692222,OPA5,optic atrophy 5 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1853139,Optic atrophy 5,0.21,0,Biomarker
692220,DFNB62,"deafness, autosomal recessive 62",0.0,1.0,0.0,0.0,0.0,1857820,"Deafness, Autosomal Recessive 62",0.21,0,Biomarker
4886,NPY1R,neuropeptide Y receptor Y1,0.0,0.0,0.0,0.0,1.0,40460,Toothache,0.21,1,Therapeutic
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,700201,Dyssomnias,0.21,1,Biomarker
664728,CMD1Q,"cardiomyopathy, dilated 1Q (autosomal dominant)",0.0,1.0,0.0,0.0,0.0,1835926,"Cardiomyopathy, Dilated, 1q",0.21,0,Biomarker
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,0.0,0.0,0.0,22976,"Lameness, Animal",0.21,1,Biomarker
28962,OSTM1,osteopetrosis associated transmembrane protein 1,0.0,1.0,0.0,0.0,0.0,1850127,"Osteopetrosis, Autosomal Recessive 1",0.21,0,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,28797,Occupational Diseases,0.21,1,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,28797,Occupational Diseases,0.21,1,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,28797,Occupational Diseases,0.21,1,Biomarker
724058,ANIB4,"aneurysm, intracranial berry 4",0.0,1.0,0.0,0.0,0.0,1857749,"Aneurysm, Intracranial Berry, 4",0.21,0,Biomarker
4095,MAFD1,major affective disorder 1,0.0,1.0,0.0,0.0,0.0,1852197,Major Affective Disorder 1,0.21,0,Biomarker
7494,XBP1,X-box binding protein 1,0.0,1.0,0.0,0.0,0.0,1852197,Major Affective Disorder 1,0.21,0,Biomarker
2759,GLYS1,"glycosuria 1, renal",0.0,1.0,0.0,0.0,0.0,17980,"Glycosuria, Renal",0.21,0,Biomarker
574043,CDAGS,"Craniosynostosis, anal anomalies, and porokeratosis syndrome",0.0,1.0,0.0,0.0,0.0,1864186,"Craniosynostosis, anal anomalies, and porokeratosis",0.21,0,Biomarker
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,3864,Arthritis,0.21,1,Biomarker
8136,WT3,Wilms tumor-3,0.0,1.0,0.0,0.0,0.0,1860265,Wilms Tumor 3,0.21,0,Biomarker
3263,HPX,hemopexin,0.0,0.0,0.0,0.0,1.0,9492,Compartment Syndromes,0.21,1,Therapeutic
8864,PER2,period circadian clock 2,0.0,1.0,0.0,0.0,0.0,1969,Alcoholic Intoxication,0.21,1,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
952,CD38,CD38 molecule,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
2776,GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
2262,GPC5,glypican 5,0.0,0.0,0.0,0.0,1.0,1925,Albuminuria,0.21,1,Therapeutic
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
406919,MIR130A,microRNA 130a,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
406937,MIR145,microRNA 145,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
406947,MIR155,microRNA 155,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
494336,MIR424,microRNA 424,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
4690,NCK1,NCK adaptor protein 1,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
8440,NCK2,NCK adaptor protein 2,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
4868,NPHS1,"nephrosis 1, congenital, Finnish type (nephrin)",0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,2,Biomarker
85480,TSLP,thymic stromal lymphopoietin,0.0,1.0,0.0,0.0,0.0,1925,Albuminuria,0.21,1,Biomarker
100313948,BRV2,"Vertigo, benign recurrent, 2",0.0,1.0,0.0,0.0,0.0,2751289,"Vertigo, Benign Recurrent, 2",0.21,0,Biomarker
1576,CYP3A4,"cytochrome P450, family 3, subfamily A, polypeptide 4",0.0,1.0,0.0,0.0,0.0,40479,Torsades de Pointes,0.21,1,Biomarker
8130,MCOPCT1,"cataract, congenital, with microphthalmia",0.0,1.0,0.0,0.0,0.0,1834919,"Microphthalmia, Isolated, with Cataract 1",0.21,0,Biomarker
5826,ABCD4,"ATP-binding cassette, sub-family D (ALD), member 4",0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
64902,AGXT2,alanine--glyoxylate aminotransferase 2,0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
1066,CES1,carboxylesterase 1,0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
1719,DHFR,dihydrofolate reductase,0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,2,Biomarker
1733,DIO1,"deiodinase, iodothyronine, type I",0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
3704,ITPA,inosine triphosphatase (nucleoside triphosphate pyrophosphatase),0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,2,Biomarker
3945,LDHB,lactate dehydrogenase B,0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
4645,MYO5B,myosin VB,0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
7941,PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)",0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
6906,SERPINA7,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7",0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,1,Biomarker
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,25521,"Metabolism, Inborn Errors",0.21,2,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,3493,Aortic Diseases,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,3493,Aortic Diseases,0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,0.0,0.0,0.0,1.0,2063,Alkalosis,0.21,1,Therapeutic
1906,EDN1,endothelin 1,0.0,0.0,0.0,0.0,1.0,149745,Oral Ulcer,0.21,1,Therapeutic
3952,LEP,leptin,0.0,0.0,0.0,0.0,1.0,149745,Oral Ulcer,0.21,1,Therapeutic
3261,HPV18I2,human papillomavirus (type 18) integration site 2,0.0,1.0,0.0,0.0,0.0,1415709,HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2,0.21,0,Biomarker
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,0.0,0.0,0.0,2936403,"46, XX Disorders of Sex Development",0.21,1,Biomarker
408259,HPC3,"Prostate cancer, hereditary, 3",0.0,1.0,0.0,0.0,0.0,1837595,"Prostate Cancer, Hereditary, 3",0.21,0,Biomarker
1385,CREB1,cAMP responsive element binding protein 1,0.0,1.0,0.0,0.0,0.0,26552,Morphine Dependence,0.21,1,Biomarker
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",0.0,1.0,0.0,0.0,0.0,26552,Morphine Dependence,0.21,1,Biomarker
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,1.0,0.0,0.0,0.0,26552,Morphine Dependence,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,26552,Morphine Dependence,0.21,1,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,26552,Morphine Dependence,0.21,1,Biomarker
4987,OPRL1,opiate receptor-like 1,0.0,1.0,0.0,0.0,0.0,26552,Morphine Dependence,0.21,1,Biomarker
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,26552,Morphine Dependence,0.21,1,Biomarker
80768,HMNJ,"Distal hereditary motor neuropathy, Jerash type",0.0,1.0,0.0,0.0,0.0,1854023,"Spinal muscular atrophy, Jerash type",0.21,0,Biomarker
553190,MYP7,myopia 7,0.0,1.0,0.0,0.0,0.0,1836506,Myopia 7,0.21,0,Biomarker
1174,AP1S1,"adaptor-related protein complex 1, sigma 1 subunit",0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,1,Biomarker
427,ASAH1,N-acylsphingosine amidohydrolase (acid ceramidase) 1,0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,2,Biomarker
440,ASNS,asparagine synthetase (glutamine-hydrolyzing),0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,1,Biomarker
11067,C10orf10,chromosome 10 open reading frame 10,0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,3,Biomarker
2168,FABP1,"fatty acid binding protein 1, liver",0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,2,Biomarker
9415,FADS2,fatty acid desaturase 2,0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,1,Biomarker
64838,FNDC4,fibronectin type III domain containing 4,0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,3,Biomarker
79153,GDPD3,glycerophosphodiester phosphodiesterase domain containing 3,0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,3,Biomarker
3249,HPN,hepsin,0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,2,Biomarker
83729,INHBE,"inhibin, beta E",0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,1,Biomarker
4047,LSS,"lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)",0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,2,Biomarker
8431,NR0B2,"nuclear receptor subfamily 0, group B, member 2",0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,3,Biomarker
26471,NUPR1,"nuclear protein, transcriptional regulator, 1",0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,1,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,1,Biomarker
6319,SCD,stearoyl-CoA desaturase (delta-9-desaturase),0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,1,Biomarker
12,SERPINA3,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3",0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,3,Biomarker
6515,SLC2A3,"solute carrier family 2 (facilitated glucose transporter), member 3",0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,2,Biomarker
6876,TAGLN,transgelin,0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,3,Biomarker
55062,WIPI1,"WD repeat domain, phosphoinositide interacting 1",0.0,1.0,0.0,0.0,0.0,23794,Lipidoses,0.21,3,Biomarker
100034704,RHDNS1,"Renal hypodysplasia, nonsyndromic, 1",0.0,1.0,0.0,0.0,0.0,1835826,"Renal Hypodysplasia, Nonsyndromic, 1",0.21,0,Biomarker
171014,SLI2,"Specific language impairment QTL, 2",0.0,1.0,0.0,0.0,0.0,1847605,SPECIFIC LANGUAGE IMPAIRMENT 2,0.21,0,Biomarker
79924,ADM2,adrenomedullin 2,0.0,0.0,0.0,0.0,1.0,42373,Vascular Diseases,0.21,1,Therapeutic
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,0.0,0.0,0.0,42373,Vascular Diseases,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,42373,Vascular Diseases,0.21,1,Therapeutic
10516,FBLN5,fibulin 5,0.0,1.0,0.0,0.0,0.0,42373,Vascular Diseases,0.21,1,Biomarker
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,42373,Vascular Diseases,0.21,1,Therapeutic
10398,MYL9,"myosin, light chain 9, regulatory",0.0,1.0,0.0,0.0,0.0,42373,Vascular Diseases,0.21,1,Biomarker
4638,MYLK,myosin light chain kinase,0.0,1.0,0.0,0.0,0.0,42373,Vascular Diseases,0.21,1,Biomarker
6559,SLC12A3,"solute carrier family 12 (sodium/chloride transporter), member 3",0.0,1.0,0.0,0.0,0.0,42373,Vascular Diseases,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,0.0,1.0,0.0,0.0,1857451,Acth-Independent Macronodular Adrenal Hyperplasia,0.21,0,GeneticVariation
619408,PSNP2,"supranuclear palsy, progressive, 2",0.0,1.0,0.0,0.0,0.0,1836148,"Supranuclear Palsy, Progressive, 2",0.21,0,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,24305,"Lymphoma, Non-Hodgkin",0.21,1,Therapeutic
5551,PRF1,perforin 1 (pore forming protein),0.0,1.0,0.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.21,0,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,24305,"Lymphoma, Non-Hodgkin",0.21,1,Biomarker
1889,ECE1,endothelin converting enzyme 1,0.0,1.0,0.0,0.0,0.0,1145628,Autonomic Nervous System Diseases,0.21,1,Biomarker
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
1364,CLDN4,claudin 4,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
100124700,HOTAIR,HOX transcript antisense RNA,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
354,KLK3,kallikrein-related peptidase 3,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
574447,MIR146B,microRNA 146b,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
9874,TLK1,tousled-like kinase 1,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
7298,TYMS,thymidylate synthetase,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
4904,YBX1,Y box binding protein 1,0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
7534,YWHAZ,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta",0.0,1.0,0.0,0.0,0.0,27643,"Neoplasm Recurrence, Local",0.21,1,Biomarker
111,ADCY5,adenylate cyclase 5,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,1,Therapeutic
135,ADORA2A,adenosine A2a receptor,0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,1,Therapeutic
156,ADRBK1,"adrenergic, beta, receptor kinase 1",0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,1,Therapeutic
359,AQP2,aquaporin 2 (collecting duct),0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
467,ATF3,activating transcription factor 3,0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,1,Therapeutic
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
554,AVPR2,arginine vasopressin receptor 2,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
4512,COX1,cytochrome c oxidase subunit I,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
1431,CS,citrate synthase,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
57724,EPG5,ectopic P-granules autophagy protein 5 homolog (C. elegans),0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,4,Therapeutic
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,3,Biomarker
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,1,Therapeutic
3336,HSPE1,heat shock 10kDa protein 1,0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,1,Therapeutic
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
3939,LDHA,lactate dehydrogenase A,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
4217,MAP3K5,mitogen-activated protein kinase kinase kinase 5,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
5600,MAPK11,mitogen-activated protein kinase 11,0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,1,Therapeutic
4973,OLR1,oxidized low density lipoprotein (lectin-like) receptor 1,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
5164,PDK2,"pyruvate dehydrogenase kinase, isozyme 2",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
5467,PPARD,peroxisome proliferator-activated receptor delta,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
5502,PPP1R1A,"protein phosphatase 1, regulatory (inhibitor) subunit 1A",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
57381,RHOJ,ras homolog family member J,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
6443,SGCB,"sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)",0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
7066,THPO,thrombopoietin,0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,1,Therapeutic
7097,TLR2,toll-like receptor 2,0.0,1.0,0.0,0.0,0.0,878544,Cardiomyopathies,0.21,1,Biomarker
7533,YWHAH,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta",0.0,0.0,0.0,0.0,1.0,878544,Cardiomyopathies,0.21,1,Therapeutic
23493,HEY2,hes-related family bHLH transcription factor with YRPW motif 2,0.0,0.0,0.0,0.0,1.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Therapeutic
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Biomarker
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Biomarker
58498,MYL7,"myosin, light chain 7, regulatory",0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Biomarker
4719,NDUFS1,"NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)",0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Biomarker
4830,NME1,NME/NM23 nucleoside diphosphate kinase 1,0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,5,Biomarker
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,0.0,0.0,0.0,1.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Therapeutic
6548,SLC9A1,"solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1",0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Biomarker
6902,TBCA,tubulin folding cofactor A,0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,7194,"Cardiomyopathy, Hypertrophic",0.21,1,Biomarker
1609,DGKQ,"diacylglycerol kinase, theta 110kDa",0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,1,Biomarker
2212,FCGR2A,"Fc fragment of IgG, low affinity IIa, receptor (CD32)",0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,1,Biomarker
2969,GTF2I,general transcription factor IIi,0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,1,Biomarker
134728,IRAK1BP1,interleukin-1 receptor-associated kinase 1 binding protein 1,0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,1,Biomarker
50618,ITSN2,intersectin 2,0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,1,Biomarker
55023,PHIP,pleckstrin homology domain interacting protein,0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,1,Biomarker
639,PRDM1,"PR domain containing 1, with ZNF domain",0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,1,Biomarker
9232,PTTG1,pituitary tumor-transforming 1,0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,1,Biomarker
7128,TNFAIP3,"tumor necrosis factor, alpha-induced protein 3",0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,2,Biomarker
10318,TNIP1,TNFAIP3 interacting protein 1,0.0,1.0,0.0,0.0,0.0,1527336,Sjogren's Syndrome,0.21,1,Biomarker
64585,BOS2,Branchiootic syndrome 2,0.0,1.0,0.0,0.0,0.0,1852718,Branchiootic Syndrome 2,0.21,0,Biomarker
2032,ENUR2,"enuresis, nocturnal 2",0.0,1.0,0.0,0.0,0.0,1833268,"Enuresis, Nocturnal, 2",0.21,0,Biomarker
664780,MYP12,"myopia 12 (high grade, autosomal dominant)",0.0,1.0,0.0,0.0,0.0,1864940,Myopia 12,0.21,0,Biomarker
100302510,XECD,"Corneal dystrophy, endothelial, X-linked",0.0,1.0,0.0,0.0,0.0,2749049,"Corneal Dystrophy, Endothelial, X-Linked",0.21,0,Biomarker
149233,IL23R,interleukin 23 receptor,0.0,1.0,0.0,0.0,0.0,2677091,Inflammatory Bowel Disease 17,0.21,0,Biomarker
57560,IFT80,intraflagellar transport 80,0.0,1.0,0.0,0.0,0.0,4044,Asphyxia,0.21,1,Biomarker
3459,IFNGR1,interferon gamma receptor 1,0.0,0.0,1.0,0.0,0.0,3266863,"Mycobacterial disease, Mendelian susceptibility to",0.21,2,GeneticVariation
81693,AMN,amnion associated transmembrane protein,0.0,0.0,0.0,0.0,1.0,600467,Neurogenic Inflammation,0.21,2,Therapeutic
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,600467,Neurogenic Inflammation,0.21,1,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,600467,Neurogenic Inflammation,0.21,1,Biomarker
1153,CIRBP,cold inducible RNA binding protein,0.0,1.0,0.0,0.0,0.0,600467,Neurogenic Inflammation,0.21,1,Biomarker
4162,MCAM,melanoma cell adhesion molecule,0.0,0.0,0.0,0.0,1.0,600467,Neurogenic Inflammation,0.21,1,Therapeutic
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,600467,Neurogenic Inflammation,0.21,1,Biomarker
5368,PNOC,prepronociceptin,0.0,0.0,0.0,0.0,1.0,600467,Neurogenic Inflammation,0.21,1,Therapeutic
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,600467,Neurogenic Inflammation,0.21,1,Therapeutic
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,600467,Neurogenic Inflammation,0.21,1,Biomarker
100190931,IBD18,Inflammatory bowel disease-18,0.0,1.0,0.0,0.0,0.0,2677090,Inflammatory Bowel Disease 18,0.21,0,Biomarker
406238,ALS7,amyotrophic lateral sclerosis 7,0.0,1.0,0.0,0.0,0.0,1842674,Amyotrophic Lateral Sclerosis 7,0.21,0,Biomarker
100188806,HDLCQ4,High density lipoprotein cholesterol level QTL 4,0.0,1.0,0.0,0.0,0.0,1853253,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4,0.21,0,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
71,ACTG1,actin gamma 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
8092,ALX1,ALX homeobox 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
60529,ALX4,ALX homeobox 4,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
56172,ANKH,ANKH inorganic pyrophosphate transport regulator,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
317,APAF1,apoptotic peptidase activating factor 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
10159,ATP6AP2,"ATPase, H+ transporting, lysosomal accessory protein 2",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
26229,B3GAT3,"beta-1,3-glucuronyltransferase 3",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
11285,B4GALT7,"xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
657,BMPR1A,"bone morphogenetic protein receptor, type IA",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
658,BMPR1B,"bone morphogenetic protein receptor, type IB",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
54796,BNC2,basonuclin 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1055,CECR,cat eye syndrome chromosome region,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
113189,CHST14,carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
152330,CNTN4,contactin 4,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1301,COL11A1,"collagen, type XI, alpha 1",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1302,COL11A2,"collagen, type XI, alpha 2",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
78989,COLEC11,collectin sub-family member 11,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1452,CSNK1A1,"casein kinase 1, alpha 1",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
10238,DCAF7,DDB1 and CUL4 associated factor 7,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
10683,DLL3,delta-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1745,DLX1,distal-less homeobox 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1746,DLX2,distal-less homeobox 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1789,DNMT3B,DNA (cytosine-5-)-methyltransferase 3 beta,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1889,ECE1,endothelin converting enzyme 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,4,Biomarker
1909,EDNRA,endothelin receptor type A,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2077,ERF,Ets2 repressor factor,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2114,ETS2,v-ets avian erythroblastosis virus E26 oncogene homolog 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
8772,FADD,Fas (TNFRSF6)-associated via death domain,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
286077,FAM83H,"family with sequence similarity 83, member H",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2245,FGD1,"FYVE, RhoGEF and PH domain containing 1",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2248,FGF3,fibroblast growth factor 3,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2332,FMR1,fragile X mental retardation 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2303,FOXC2,forkhead box C2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
2299,FOXI1,forkhead box I1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
93986,FOXP2,forkhead box P2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
8322,FZD4,frizzled class receptor 4,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2776,GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2812,GP1BB,"glycoprotein Ib (platelet), beta polypeptide",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
2239,GPC4,glypican 4,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
10082,GPC6,glypican 6,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
145258,GSC,goosecoid homeobox,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1404,HAPLN1,hyaluronan and proteoglycan link protein 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
3166,HMX1,H6 family homeobox 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
3198,HOXA1,homeobox A1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
3200,HOXA3,homeobox A3,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
3211,HOXB1,homeobox B1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
100288805,HYDIN2,"HYDIN2, axonemal central pair apparatus protein (pseudogene)",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
3664,IRF6,interferon regulatory factor 6,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
9270,ITGB1BP1,integrin beta 1 binding protein 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
3714,JAG2,jagged 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
284058,KANSL1,KAT8 regulatory NSL complex subunit 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
9786,KIAA0586,KIAA0586,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
11127,KIF3A,kinesin family member 3A,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
3954,LETM1,leucine zipper-EF-hand containing transmembrane protein 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1902,LPAR1,lysophosphatidic acid receptor 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
4054,LTBP3,latent transforming growth factor beta binding protein 3,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
5648,MASP1,mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
8720,MBTPS1,"membrane-bound transcription factor peptidase, site 1",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
4322,MMP13,matrix metallopeptidase 13 (collagenase 3),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
4335,MNT,MAX network transcriptional repressor,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
4487,MSX1,msh homeobox 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,4,Biomarker
3340,NDST1,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
25836,NIPBL,Nipped-B homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
9378,NRXN1,neurexin 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
5077,PAX3,paired box 3,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
80714,PBX4,pre-B-cell leukemia homeobox 4,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
5251,PHEX,"phosphate regulating endopeptidase homolog, X-linked",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
5308,PITX2,paired-like homeodomain 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
8575,PRKRA,"protein kinase, interferon-inducible double stranded RNA dependent activator",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
5727,PTCH1,patched 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
116442,RAB39B,"RAB39B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
282808,RAB40AL,"RAB40A, member RAS oncogene family-like",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
5887,RAD23B,RAD23 homolog B (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
30062,RAX,retina and anterior neural fold homeobox,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1827,RCAN1,regulator of calcineurin 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
6259,RYK,receptor-like tyrosine kinase,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
27164,SALL3,spalt-like transcription factor 3,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
57167,SALL4,spalt-like transcription factor 4,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
23314,SATB2,SATB homeobox 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
29927,SEC61A1,Sec61 alpha 1 subunit (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
26040,SETBP1,SET binding protein 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
285590,SH3PXD2B,SH3 and PX domains 2B,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
6493,SIM2,single-minded family bHLH transcription factor 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
6495,SIX1,SIX homeobox 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
6497,SKI,SKI proto-oncogene,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
1836,SLC26A2,"solute carrier family 26 (anion exchanger), member 2",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
23169,SLC35D1,"solute carrier family 35 (UDP-GlcA/UDP-GalNAc transporter), member D1",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
4087,SMAD2,SMAD family member 2,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
4088,SMAD3,SMAD family member 3,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
4089,SMAD4,SMAD family member 4,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
10253,SPRY2,sprouty homolog 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
6730,SRP68,signal recognition particle 68kDa,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
6834,SURF1,surfeit 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
6905,TBCE,tubulin folding cofactor E,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
6913,TBX15,T-box 15,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
6925,TCF4,transcription factor 4,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
7020,TFAP2A,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
7021,TFAP2B,transcription factor AP-2 beta (activating enhancer binding protein 2 beta),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,2,Biomarker
7068,THRB,"thyroid hormone receptor, beta",0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
54499,TMCO1,transmembrane and coiled-coil domains 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
4591,TRIM37,tripartite motif containing 37,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
7337,UBE3A,ubiquitin protein ligase E3A,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
7353,UFD1L,ubiquitin fusion degradation 1 like (yeast),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
146862,UNC45B,unc-45 homolog B (C. elegans),0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
80146,UXS1,UDP-glucuronate decarboxylase 1,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
7547,ZIC3,Zic family member 3,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
85416,ZIC5,Zic family member 5,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
10269,ZMPSTE24,zinc metallopeptidase STE24,0.0,1.0,0.0,0.0,0.0,376634,Craniofacial Abnormalities,0.21,1,Biomarker
59331,RFH1,"Renal failure, progressive, with hypertension",0.0,1.0,0.0,0.0,0.0,403443,"Renal Failure, Progressive, with Hypertension",0.21,0,Biomarker
914,CD2,CD2 molecule,0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
1282,COL4A1,"collagen, type IV, alpha 1",0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
1284,COL4A2,"collagen, type IV, alpha 2",0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
3291,HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2,0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
4690,NCK1,NCK adaptor protein 1,0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
8440,NCK2,NCK adaptor protein 2,0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,27726,Nephrotic Syndrome,0.21,1,Biomarker
3146,HMGB1,high mobility group box 1,0.0,1.0,0.0,0.0,0.0,264939,Systemic Vasculitis,0.21,1,Biomarker
404682,MYP5,"myopia 5 (high grade, autosomal dominant)",0.0,1.0,0.0,0.0,0.0,1837972,Myopia 5,0.21,0,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,15930,Fetal Distress,0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,32768,"Neuralgia, Postherpetic",0.21,1,Biomarker
100302509,LECD,"Corneal dystrophy, Lisch epithelial",0.0,1.0,0.0,0.0,0.0,2749050,"Corneal Dystrophy, Lisch Epithelial",0.21,0,Biomarker
9394,HS6ST1,heparan sulfate 6-O-sulfotransferase 1,0.0,0.0,1.0,0.0,0.0,3553977,HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA,0.21,1,GeneticVariation
1814,DRD3,dopamine receptor D3,0.0,1.0,0.0,0.0,0.0,1860861,"Tremor hereditary essential, 1",0.21,0,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,231341,"Aging, Premature",0.21,1,Biomarker
100151644,OTSC8,otosclerosis 8,0.0,1.0,0.0,0.0,0.0,2677515,Otosclerosis 8,0.21,0,Biomarker
54501,CLQTL1,cholesterol-lowering factor,0.0,1.0,0.0,0.0,0.0,1858233,CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1,0.21,0,Biomarker
9582,APOBEC3B,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B",0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
81037,CLPTM1L,CLPTM1-like,0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
3116,HLA-DPB2,"major histocompatibility complex, class II, DP beta 2 (pseudogene)",0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
4853,NOTCH2,notch 2,0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
10401,PIAS3,"protein inhibitor of activated STAT, 3",0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
5457,POU4F1,POU class 4 homeobox 1,0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
5915,RARB,"retinoic acid receptor, beta",0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
7474,WNT5A,"wingless-type MMTV integration site family, member 5A",0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
7528,YY1,YY1 transcription factor,0.0,1.0,0.0,0.0,0.0,7873,Uterine Cervical Neoplasms,0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,18553,"Hamartoma Syndrome, Multiple",0.21,1,Biomarker
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,0.0,0.0,0.0,7642,Cellulitis,0.21,1,Biomarker
5648,MASP1,mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),0.0,1.0,0.0,0.0,0.0,796279,Carnevale syndrome,0.21,1,Biomarker
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,0.0,0.0,0.0,10823,Cytomegalovirus Infections,0.21,1,Biomarker
177,AGER,advanced glycosylation end product-specific receptor,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
199,AIF1,allograft inflammatory factor 1,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
3482,IGF2R,insulin-like growth factor 2 receptor,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
3643,INSR,insulin receptor,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
4099,MAG,myelin associated glycoprotein,0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,752347,Lewy Body Disease,0.21,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,265280,"Spondylometaphyseal dysplasia, Kozlowski type",0.21,0,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,0.0,0.0,0.0,38644,Sudden Infant Death,0.21,1,Biomarker
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,1.0,0.0,0.0,0.0,38644,Sudden Infant Death,0.21,1,Biomarker
6324,SCN1B,"sodium channel, voltage gated, type I beta subunit",0.0,1.0,0.0,0.0,0.0,38644,Sudden Infant Death,0.21,1,Biomarker
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",0.0,1.0,0.0,0.0,0.0,13421,Dystonia,0.21,1,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,13421,Dystonia,0.21,1,Biomarker
791087,HHT4,"Telangiectasia, hereditary hemorrhagic, type 4",0.0,1.0,0.0,0.0,0.0,1857688,"Telangiectasia, Hereditary Hemorrhagic, Type 4",0.21,0,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,38987,Sweat Gland Neoplasms,0.21,1,Biomarker
7547,ZIC3,Zic family member 3,0.0,1.0,0.0,0.0,0.0,11813,Dextrocardia,0.21,1,Biomarker
7201,TRHR,thyrotropin-releasing hormone receptor,0.0,1.0,0.0,0.0,0.0,20676,Hypothyroidism,0.21,1,Biomarker
57502,NLGN4X,"neuroligin 4, X-linked",0.0,1.0,0.0,0.0,0.0,1845539,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 2",0.21,0,Biomarker
100187717,NNO3,nanophthalmos 3,0.0,1.0,0.0,0.0,0.0,2678467,Nanophthalmos 3,0.21,0,Biomarker
10461,MERTK,"MER proto-oncogene, tyrosine kinase",0.0,0.0,0.0,0.0,1.0,40038,Thromboembolism,0.21,1,Therapeutic
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,40038,Thromboembolism,0.21,1,Therapeutic
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,7140,Carcinosarcoma,0.21,1,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,7140,Carcinosarcoma,0.21,1,Biomarker
81861,LPRS,"Leprosy, susceptibility to 1",0.0,1.0,0.0,0.0,0.0,23343,Leprosy,0.21,0,Biomarker
100499166,LPRS6,"Leprosy, susceptiblity to, 6",0.0,1.0,0.0,0.0,0.0,23343,Leprosy,0.21,0,Biomarker
2641,GCG,glucagon,0.0,1.0,0.0,0.0,0.0,9806,Constipation,0.21,1,Biomarker
151306,GPBAR1,G protein-coupled bile acid receptor 1,0.0,1.0,0.0,0.0,0.0,9806,Constipation,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,9806,Constipation,0.21,1,Therapeutic
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,9806,Constipation,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,13238,Dry Eye Syndromes,0.21,1,Biomarker
2245,FGD1,"FYVE, RhoGEF and PH domain containing 1",0.0,1.0,0.0,0.0,0.0,42063,Urogenital Abnormalities,0.21,3,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,42063,Urogenital Abnormalities,0.21,1,Biomarker
4864,NPC1,"Niemann-Pick disease, type C1",0.0,1.0,0.0,0.0,0.0,13362,Dysarthria,0.21,1,Biomarker
8622,PDE8B,phosphodiesterase 8B,0.0,1.0,0.0,0.0,0.0,13362,Dysarthria,0.21,1,Biomarker
70,ACTC1,"actin, alpha, cardiac muscle 1",0.0,1.0,0.0,0.0,0.0,34951,Refractive Errors,0.21,1,Biomarker
5923,RASGRF1,Ras protein-specific guanine nucleotide-releasing factor 1,0.0,1.0,0.0,0.0,0.0,34951,Refractive Errors,0.21,1,Biomarker
619468,RCM2,"cardiomyopathy, familial restrictive, 2",0.0,1.0,0.0,0.0,0.0,1865071,"Cardiomyopathy, Familial Restrictive, 2",0.21,0,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,6434,Burns,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,6434,Burns,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,6434,Burns,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,6434,Burns,0.21,1,Biomarker
2420,FRDA2,Friedreich ataxia 2,0.0,1.0,0.0,0.0,0.0,1856689,Friedreich Ataxia 1,0.21,0,Biomarker
3349,HTOR,5-hydroxytryptamine (serotonin) oxygenase regulator,0.0,1.0,0.0,0.0,0.0,1415802,5-hydroxytryptamine (serotonin) oxygenase regulator,0.21,0,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,15469,Facial Paralysis,0.21,1,Therapeutic
268,AMH,anti-Mullerian hormone,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
269,AMHR2,"anti-Mullerian hormone receptor, type II",0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
657,BMPR1A,"bone morphogenetic protein receptor, type IA",0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
2018,EMX2,empty spiracles homeobox 2,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
3206,HOXA10,homeobox A10,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
3207,HOXA11,homeobox A11,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
3209,HOXA13,homeobox A13,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
3975,LHX1,LIM homeobox 1,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
3976,LIF,leukemia inhibitory factor,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
4488,MSX2,msh homeobox 2,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
5076,PAX2,paired box 2,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
54361,WNT4,"wingless-type MMTV integration site family, member 4",0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
7474,WNT5A,"wingless-type MMTV integration site family, member 5A",0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
7476,WNT7A,"wingless-type MMTV integration site family, member 7A",0.0,1.0,0.0,0.0,0.0,1720887,Female Urogenital Diseases,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,1614,Adrenal Cortex Diseases,0.21,1,Therapeutic
266789,EPPS,"Epilepsy, partial, with pericentral spikes",0.0,1.0,0.0,0.0,0.0,1846609,"Epilepsy, Partial, with Pericentral Spikes",0.21,0,Biomarker
8144,CMS1A1,"myasthenia gravis, familial infantile, 1",0.0,1.0,0.0,0.0,0.0,1853949,"Myasthenia, Familial Infantile, 1",0.21,0,Biomarker
286751,OTSC4,otosclerosis 4,0.0,1.0,0.0,0.0,0.0,1969046,Otosclerosis 4,0.21,0,Biomarker
408257,CILD4,"Ciliary dyskinesia, primary, 4",0.0,1.0,0.0,0.0,0.0,1837616,"Primary ciliary dyskinesia, 4",0.21,0,Biomarker
100188881,MFT2,"Trichoepithelioma, multiple familial, 2",0.0,1.0,0.0,0.0,0.0,2677505,"Trichoepithelioma, Multiple Familial, 2",0.21,0,Biomarker
286,ANK1,"ankyrin 1, erythrocytic",0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
658,BMPR1B,"bone morphogenetic protein receptor, type IB",0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
865,CBFB,"core-binding factor, beta subunit",0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
1146,CHRNG,"cholinergic receptor, nicotinic, gamma (muscle)",0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
1147,CHUK,conserved helix-loop-helix ubiquitous kinase,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
1749,DLX5,distal-less homeobox 5,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
2720,GLB1,"galactosidase, beta 1",0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
3237,HOXD11,homeobox D11,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
57560,IFT80,intraflagellar transport 80,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
9270,ITGB1BP1,integrin beta 1 binding protein 1,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
11127,KIF3A,kinesin family member 3A,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
407975,MIR17HG,miR-17-92 cluster host gene (non-protein coding),0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
25836,NIPBL,Nipped-B homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
4880,NPPC,natriuretic peptide C,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
6197,RPS6KA3,"ribosomal protein S6 kinase, 90kDa, polypeptide 3",0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
285590,SH3PXD2B,SH3 and PX domains 2B,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
1836,SLC26A2,"solute carrier family 26 (anion exchanger), member 2",0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
6569,SLC34A1,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 1",0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
54499,TMCO1,transmembrane and coiled-coil domains 1,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
7547,ZIC3,Zic family member 3,0.0,1.0,0.0,0.0,0.0,5941,"Bone Diseases, Developmental",0.21,1,Biomarker
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,0.0,0.0,0.0,9917,Contracture,0.21,1,Biomarker
118429,ANTXR2,anthrax toxin receptor 2,0.0,1.0,0.0,0.0,0.0,9917,Contracture,0.21,2,Biomarker
10216,PRG4,proteoglycan 4,0.0,1.0,0.0,0.0,0.0,9917,Contracture,0.21,1,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,32226,Pleural Diseases,0.21,1,Biomarker
3371,TNC,tenascin C,0.0,1.0,0.0,0.0,0.0,32226,Pleural Diseases,0.21,1,Biomarker
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,36983,"Shock, Septic",0.21,1,Biomarker
728,C5AR1,complement component 5a receptor 1,0.0,1.0,0.0,0.0,0.0,36983,"Shock, Septic",0.21,1,Biomarker
2638,GC,group-specific component (vitamin D binding protein),0.0,1.0,0.0,0.0,0.0,36983,"Shock, Septic",0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
23305,ACSL6,acyl-CoA synthetase long-chain family member 6,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
26289,AK5,adenylate kinase 5,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
313,AOAH,acyloxyacyl hydrolase (neutrophil),0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
23245,ASTN2,astrotactin 2,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
54535,CCHCR1,coiled-coil alpha-helical rod protein 1,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
1604,CD55,"CD55 molecule, decay accelerating factor for complement (Cromer blood group)",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
1012,CDH13,cadherin 13,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
1061,CENPCP1,centromere protein C pseudogene 1,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
340267,COL28A1,"collagen, type XXVIII, alpha 1",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
64478,CSMD1,CUB and Sushi multiple domains 1,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
8029,CUBN,cubilin (intrinsic factor-cobalamin receptor),0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
81501,DCSTAMP,dendrocyte expressed seven transmembrane protein,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
1812,DRD1,dopamine receptor D1,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,2,Biomarker
1814,DRD3,dopamine receptor D3,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
1815,DRD4,dopamine receptor D4,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
2272,FHIT,fragile histidine triad,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
23307,FKBP15,"FK506 binding protein 15, 133kDa",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
2912,GRM2,"glutamate receptor, metabotropic 2",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
9951,HS3ST4,heparan sulfate (glucosamine) 3-O-sulfotransferase 4,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",0.0,0.0,0.0,0.0,1.0,236733,Amphetamine-Related Disorders,0.21,1,Therapeutic
3359,HTR3A,"5-hydroxytryptamine (serotonin) receptor 3A, ionotropic",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
3362,HTR6,"5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
9215,LARGE,like-glycosyltransferase,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
158038,LINGO2,leucine rich repeat and Ig domain containing 2,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5607,MAP2K5,mitogen-activated protein kinase kinase 5,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
64757,1-Mar,mitochondrial amidoxime reducing component 1,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
54996,2-Mar,mitochondrial amidoxime reducing component 2,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
4645,MYO5B,myosin VB,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
3084,NRG1,neuregulin 1,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
26577,PCOLCE2,procollagen C-endopeptidase enhancer 2,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5144,PDE4D,"phosphodiesterase 4D, cAMP-specific",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5146,PDE6C,"phosphodiesterase 6C, cGMP-specific, cone, alpha prime",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
9463,PICK1,protein interacting with PRKCA 1,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5460,POU5F1,POU class 5 homeobox 1,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
7799,PRDM2,"PR domain containing 2, with ZNF domain",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5592,PRKG1,"protein kinase, cGMP-dependent, type I",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
23362,PSD3,pleckstrin and Sec7 domain containing 3,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
22913,RALY,RALY heterogeneous nuclear ribonucleoprotein,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
9771,RAPGEF5,Rap guanine nucleotide exchange factor (GEF) 5,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
26575,RGS17,regulator of G-protein signaling 17,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
5104,SERPINA5,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
137868,SGCZ,"sarcoglycan, zeta",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
344558,SH3RF3,SH3 domain containing ring finger 3,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
6536,SLC6A9,"solute carrier family 6 (neurotransmitter transporter, glycine), member 9",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
64754,SMYD3,SET and MYND domain containing 3,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
80036,TRPM3,"transient receptor potential cation channel, subfamily M, member 3",0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
84196,USP48,ubiquitin specific peptidase 48,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
79750,ZNF385D,zinc finger protein 385D,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
23090,ZNF423,zinc finger protein 423,0.0,1.0,0.0,0.0,0.0,236733,Amphetamine-Related Disorders,0.21,1,Biomarker
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,0.0,0.0,0.0,1866040,"Diabetes Mellitus, Insulin-Dependent, 10",0.21,0,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,0.0,18818,"Heart Septal Defects, Ventricular",0.21,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,18818,"Heart Septal Defects, Ventricular",0.21,1,Biomarker
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,0.0,0.0,0.0,403823,Asthenozoospermia,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,1421143,THYROTROPIN-RELEASING HORMONE,0.21,0,Biomarker
3239,HOXD13,homeobox D13,0.0,1.0,0.0,0.0,0.0,220708,VATER association,0.21,1,Biomarker
100271686,DELXP11.3,Chromosome Xp11.3 deletion syndrome,0.0,1.0,0.0,0.0,0.0,1845136,Chromosome Xp11.3 Deletion Syndrome,0.21,0,Biomarker
6102,RP2,retinitis pigmentosa 2 (X-linked recessive),0.0,1.0,0.0,0.0,0.0,1845136,Chromosome Xp11.3 Deletion Syndrome,0.21,0,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,206608,Flavivirus Infections,0.21,1,Therapeutic
5602,MAPK10,mitogen-activated protein kinase 10,0.0,1.0,0.0,0.0,0.0,3665601,"Epileptic encephalopathy, Lennox-Gastaut type",0.21,0,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,20461,Hyperkalemia,0.21,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,1.0,20461,Hyperkalemia,0.21,2,"Biomarker, Therapeutic"
6569,SLC34A1,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 1",0.0,1.0,0.0,0.0,0.0,20437,Hypercalcemia,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,1854465,Tuberous Sclerosis 1,0.21,0,Biomarker
23600,AMACR,alpha-methylacyl-CoA racemase,0.0,1.0,0.0,0.0,0.0,27888,Hereditary Sensory and Motor Neuropathy,0.21,1,Biomarker
1959,EGR2,early growth response 2,0.0,1.0,0.0,0.0,0.0,27888,Hereditary Sensory and Motor Neuropathy,0.21,0,Biomarker
5621,PRNP,prion protein,0.0,1.0,0.0,0.0,0.0,1864112,Huntington Disease-Like 1,0.21,0,Biomarker
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.21,1,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.21,1,Biomarker
1675,CFD,complement factor D (adipsin),0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.21,1,Biomarker
2833,CXCR3,chemokine (C-X-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.21,1,Biomarker
1674,DES,desmin,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.21,1,Biomarker
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.21,1,Biomarker
4868,NPHS1,"nephrosis 1, congenital, Finnish type (nephrin)",0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.21,2,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,17658,Glomerulonephritis,0.21,2,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,0.0,0.0,0.0,1.0,17658,Glomerulonephritis,0.21,1,Therapeutic
6328,SCN3A,"sodium channel, voltage gated, type III alpha subunit",0.0,1.0,0.0,0.0,0.0,85417,"Epilepsy, Complex Partial",0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,4604,Back Pain,0.21,1,Biomarker
100188796,GEFSP4,"Epilepsy, generalized, with febrile seizures plus, type 4",0.0,1.0,0.0,0.0,0.0,1853345,"Generalized Epilepsy With Febrile Seizures Plus, Type 4",0.21,0,Biomarker
9619,ABCG1,"ATP-binding cassette, sub-family G (WHITE), member 1",0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
1374,CPT1A,carnitine palmitoyltransferase 1A (liver),0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
2168,FABP1,"fatty acid binding protein 1, liver",0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
2194,FASN,fatty acid synthase,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
1839,HBEGF,heparin-binding EGF-like growth factor,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
51085,MLXIPL,MLX interacting protein-like,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
4481,MSR1,macrophage scavenger receptor 1,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
653361,NCF1,neutrophil cytosolic factor 1,0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,22661,"Kidney Failure, Chronic",0.21,1,Biomarker
5733,PTGER3,prostaglandin E receptor 3 (subtype EP3),0.0,1.0,0.0,0.0,0.0,30804,"Pemphigoid, Benign Mucous Membrane",0.21,1,Biomarker
629,CFB,complement factor B,0.0,1.0,0.0,0.0,0.0,26896,Myasthenia Gravis,0.21,1,Biomarker
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,26896,Myasthenia Gravis,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,26896,Myasthenia Gravis,0.21,1,Therapeutic
100049707,SPG38,"spastic paraplegia 38 (autosomal dominant, Silver syndrome)",0.0,1.0,0.0,0.0,0.0,2676732,"Spastic Paraplegia 38, Autosomal Dominant",0.21,0,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,11991,Diarrhea,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,11991,Diarrhea,0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,11991,Diarrhea,0.21,1,Biomarker
100188857,AAA3,"Aneurysm, familial abdominal 3",0.0,1.0,0.0,0.0,0.0,2678470,"Aortic Aneurysm, Familial Abdominal 3",0.21,0,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,175704,LEOPARD Syndrome,0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,22541,Kearns-Sayre Syndrome,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,22541,Kearns-Sayre Syndrome,0.21,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,35234,Respiratory Sounds,0.21,1,Biomarker
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,35234,Respiratory Sounds,0.21,1,Biomarker
374,AREG,amphiregulin,0.0,1.0,0.0,0.0,0.0,162568,"Protoporphyria, Erythropoietic",0.21,1,Biomarker
685,BTC,betacellulin,0.0,1.0,0.0,0.0,0.0,162568,"Protoporphyria, Erythropoietic",0.21,1,Biomarker
2069,EREG,epiregulin,0.0,1.0,0.0,0.0,0.0,162568,"Protoporphyria, Erythropoietic",0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,3081,Anisometropia,0.21,1,Biomarker
468,ATF4,activating transcription factor 4,0.0,1.0,0.0,0.0,0.0,1134719,"Carcinoma, Ductal, Breast",0.21,1,Biomarker
1364,CLDN4,claudin 4,0.0,1.0,0.0,0.0,0.0,1134719,"Carcinoma, Ductal, Breast",0.21,1,Biomarker
5731,PTGER1,"prostaglandin E receptor 1 (subtype EP1), 42kDa",0.0,1.0,0.0,0.0,0.0,1134719,"Carcinoma, Ductal, Breast",0.21,1,Biomarker
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,1301355,Myelodysplastic-Myeloproliferative Diseases,0.21,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,282612,Prostatic Intraepithelial Neoplasia,0.21,1,Biomarker
4502,MT2A,metallothionein 2A,0.0,1.0,0.0,0.0,0.0,282612,Prostatic Intraepithelial Neoplasia,0.21,1,Biomarker
7155,TOP2B,topoisomerase (DNA) II beta 180kDa,0.0,1.0,0.0,0.0,0.0,282612,Prostatic Intraepithelial Neoplasia,0.21,1,Biomarker
4522,MTHFD1,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase",0.0,1.0,0.0,0.0,0.0,1866558,"Neural tube defect, folate-sensitive",0.21,0,Biomarker
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,0.0,0.0,0.0,1866558,"Neural tube defect, folate-sensitive",0.21,0,Biomarker
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,0.0,0.0,0.0,1866558,"Neural tube defect, folate-sensitive",0.21,0,Biomarker
100188876,IHPS3,"Pyloric stenosis, infantile hypertrophic, 3",0.0,1.0,0.0,0.0,0.0,2677588,"Pyloric Stenosis, Infantile Hypertrophic, 3",0.21,0,Biomarker
84909,C9orf3,chromosome 9 open reading frame 3,0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,2,Biomarker
858,CAV2,caveolin 2,0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
1674,DES,desmin,0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
10021,HCN4,hyperpolarization activated cyclic nucleotide gated potassium channel 4,0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",0.0,0.0,0.0,0.0,1.0,4238,Atrial Fibrillation,0.21,1,Therapeutic
1482,NKX2-5,NK2 homeobox 5,0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
5396,PRRX1,paired related homeobox 1,0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
6336,SCN10A,"sodium channel, voltage gated, type X alpha subunit",0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
6660,SOX5,SRY (sex determining region Y)-box 5,0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
23224,SYNE2,"spectrin repeat containing, nuclear envelope 2",0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
7478,WNT8A,"wingless-type MMTV integration site family, member 8A",0.0,1.0,0.0,0.0,0.0,4238,Atrial Fibrillation,0.21,1,Biomarker
100505390,AAA2,"Aortic aneurysm, familial abdominal 2",0.0,1.0,0.0,0.0,0.0,1853364,"Aortic Aneurysm, Familial Abdominal 2",0.21,0,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,152025,Polyneuropathies,0.21,1,Therapeutic
10908,PNPLA6,patatin-like phospholipase domain containing 6,0.0,1.0,0.0,0.0,0.0,152025,Polyneuropathies,0.21,1,Biomarker
6342,SCP2,sterol carrier protein 2,0.0,1.0,0.0,0.0,0.0,152025,Polyneuropathies,0.21,1,Biomarker
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,0.0,0.0,0.0,78918,"Albinism, Oculocutaneous",0.21,1,Biomarker
84735,CNDP1,carnosine dipeptidase 1 (metallopeptidase M20 family),0.0,1.0,0.0,0.0,0.0,268632,Homocarnosinosis,0.21,1,Biomarker
8173,CNSN,Carnosinemia (carnosinase),0.0,1.0,0.0,0.0,0.0,268632,Homocarnosinosis,0.21,0,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,30554,Paresthesia,0.21,1,Biomarker
4508,ATP6,ATP synthase F0 subunit 6,0.0,0.0,1.0,0.0,0.0,1537983,ATP SYNTHASE 6,0.21,0,GeneticVariation
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,497552,Nervous System Malformations,0.21,1,Biomarker
71,ACTG1,actin gamma 1,0.0,1.0,0.0,0.0,0.0,497552,Nervous System Malformations,0.21,1,Biomarker
2245,FGD1,"FYVE, RhoGEF and PH domain containing 1",0.0,1.0,0.0,0.0,0.0,497552,Nervous System Malformations,0.21,1,Biomarker
3198,HOXA1,homeobox A1,0.0,1.0,0.0,0.0,0.0,497552,Nervous System Malformations,0.21,1,Biomarker
3211,HOXB1,homeobox B1,0.0,1.0,0.0,0.0,0.0,497552,Nervous System Malformations,0.21,1,Biomarker
79944,L2HGDH,L-2-hydroxyglutarate dehydrogenase,0.0,1.0,0.0,0.0,0.0,497552,Nervous System Malformations,0.21,1,Biomarker
5077,PAX3,paired box 3,0.0,1.0,0.0,0.0,0.0,497552,Nervous System Malformations,0.21,1,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,497552,Nervous System Malformations,0.21,1,Biomarker
161742,SPRED1,"sprouty-related, EVH1 domain containing 1",0.0,1.0,0.0,0.0,0.0,497552,Nervous System Malformations,0.21,1,Biomarker
1254,CMTX3,"Charcot-Marie-Tooth neuropathy, X-linked 3 (dominant)",0.0,1.0,0.0,0.0,0.0,1844865,"Charcot-Marie-Tooth disease, X-linked recessive, 3",0.21,0,Biomarker
6777,STAT5B,signal transducer and activator of transcription 5B,0.0,1.0,0.0,0.0,0.0,2931322,T-Lymphocytopenia,0.21,1,Biomarker
57724,EPG5,ectopic P-granules autophagy protein 5 homolog (C. elegans),0.0,1.0,0.0,0.0,0.0,162835,Hypopigmentation,0.21,1,Biomarker
374569,ASPG,asparaginase,0.0,1.0,0.0,0.0,0.0,23530,Leukopenia,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,23530,Leukopenia,0.21,5,Biomarker
3558,IL2,interleukin 2,0.0,0.0,0.0,0.0,1.0,23530,Leukopenia,0.21,1,Therapeutic
3562,IL3,interleukin 3,0.0,0.0,0.0,0.0,1.0,23530,Leukopenia,0.21,1,Therapeutic
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,0.0,0.0,0.0,23530,Leukopenia,0.21,1,Biomarker
7389,UROD,uroporphyrinogen decarboxylase,0.0,0.0,1.0,0.0,0.0,1421374,UROPORPHYRINOGEN DECARBOXYLASE,0.21,14,GeneticVariation
727,C5,complement component 5,0.0,1.0,0.0,0.0,0.0,31154,Peritonitis,0.21,2,Biomarker
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,0.0,0.0,0.0,31154,Peritonitis,0.21,1,Biomarker
51204,TACO1,translational activator of mitochondrially encoded cytochrome c oxidase I,0.0,1.0,0.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,7820,Cerebrovascular Disorders,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,7820,Cerebrovascular Disorders,0.21,2,Therapeutic
404683,BMIQ7,"Obesity, susceptibility to, on chromosome 4",0.0,1.0,0.0,0.0,0.0,2675358,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7,0.21,0,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,598608,Hyperhomocysteinemia,0.21,1,Biomarker
1674,DES,desmin,0.0,1.0,0.0,0.0,0.0,598608,Hyperhomocysteinemia,0.21,1,Biomarker
27232,GNMT,glycine N-methyltransferase,0.0,1.0,0.0,0.0,0.0,598608,Hyperhomocysteinemia,0.21,1,Biomarker
4868,NPHS1,"nephrosis 1, congenital, Finnish type (nephrin)",0.0,1.0,0.0,0.0,0.0,598608,Hyperhomocysteinemia,0.21,1,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,598608,Hyperhomocysteinemia,0.21,1,Biomarker
113235,SLC46A1,"solute carrier family 46 (folate transporter), member 1",0.0,1.0,0.0,0.0,0.0,598608,Hyperhomocysteinemia,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,598608,Hyperhomocysteinemia,0.21,1,Biomarker
100188782,NIDDM4,"Diabetes mellitus, noninsulin-dependent",0.0,1.0,0.0,0.0,0.0,1842642,"Diabetes Mellitus, Noninsulin-Dependent, Type 4",0.21,0,Biomarker
100101424,MRT9,"mental retardation, non-syndromic, autosomal recessive, 9",0.0,1.0,0.0,0.0,0.0,1970195,"Mental Retardation, Autosomal Recessive 9",0.21,0,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,34531,"Radiation Injuries, Experimental",0.21,1,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,34531,"Radiation Injuries, Experimental",0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,34531,"Radiation Injuries, Experimental",0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,0.0,0.0,0.0,1.0,34531,"Radiation Injuries, Experimental",0.21,1,Therapeutic
5595,MAPK3,mitogen-activated protein kinase 3,0.0,0.0,0.0,0.0,1.0,34531,"Radiation Injuries, Experimental",0.21,1,Therapeutic
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,34531,"Radiation Injuries, Experimental",0.21,1,Biomarker
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,0.0,0.0,0.0,34531,"Radiation Injuries, Experimental",0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,0.0,0.0,0.0,1.0,34531,"Radiation Injuries, Experimental",0.21,1,Therapeutic
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,0.0,0.0,0.0,1.0,34531,"Radiation Injuries, Experimental",0.21,2,Therapeutic
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,34531,"Radiation Injuries, Experimental",0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,27697,Nephritis,0.21,6,Biomarker
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,0.0,0.0,0.0,27697,Nephritis,0.21,1,Biomarker
3956,LGALS1,"lectin, galactoside-binding, soluble, 1",0.0,0.0,0.0,0.0,1.0,27697,Nephritis,0.21,1,Therapeutic
3965,LGALS9,"lectin, galactoside-binding, soluble, 9",0.0,0.0,0.0,0.0,1.0,27697,Nephritis,0.21,1,Therapeutic
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,27697,Nephritis,0.21,1,Therapeutic
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
1840,DTX1,"deltex 1, E3 ubiquitin ligase",0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
23220,DTX4,"deltex 4, E3 ubiquitin ligase",0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
23462,HEY1,hes-related family bHLH transcription factor with YRPW motif 1,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
23493,HEY2,hes-related family bHLH transcription factor with YRPW motif 2,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
3303,HSPA1A,heat shock 70kDa protein 1A,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
3304,HSPA1B,heat shock 70kDa protein 1B,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
182,JAG1,jagged 1,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
3714,JAG2,jagged 2,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
4855,NOTCH4,notch 4,0.0,1.0,0.0,0.0,0.0,887833,"Carcinoma, Pancreatic Ductal",0.21,1,Biomarker
57306,CUP2Q35,"Syndactyly, type I",0.0,1.0,0.0,0.0,0.0,1861380,"Syndactyly, Type I",0.21,0,Biomarker
100190788,IBD20,Inflammatory bowel disease-20,0.0,1.0,0.0,0.0,0.0,2676781,Inflammatory Bowel Disease 20,0.21,0,Biomarker
6440,SFTPC,surfactant protein C,0.0,1.0,0.0,0.0,0.0,1968602,"Surfactant Metabolism Dysfunction, Pulmonary, 1",0.21,0,Biomarker
22943,DKK1,dickkopf WNT signaling pathway inhibitor 1,0.0,1.0,0.0,0.0,0.0,16658,"Fractures, Bone",0.21,1,Biomarker
125228,FAM210A,"family with sequence similarity 210, member A",0.0,1.0,0.0,0.0,0.0,16658,"Fractures, Bone",0.21,1,Biomarker
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,16658,"Fractures, Bone",0.21,1,Biomarker
10165,SLC25A13,"solute carrier family 25 (aspartate/glutamate carrier), member 13",0.0,1.0,0.0,0.0,0.0,16658,"Fractures, Bone",0.21,1,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,0.0,0.0,0.0,16658,"Fractures, Bone",0.21,1,Biomarker
716,C1S,"complement component 1, s subcomponent",0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.21,1,Biomarker
1409,CRYAA,"crystallin, alpha A",0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.21,1,Biomarker
1415,CRYBB2,"crystallin, beta B2",0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.21,1,Biomarker
3263,HPX,hemopexin,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.21,1,Biomarker
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.21,1,Biomarker
5196,PF4,platelet factor 4,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.21,1,Biomarker
5913,RAPSN,receptor-associated protein of the synapse,0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,4364,Autoimmune Diseases,0.21,1,Biomarker
8132,PKDTS,"polycystic kidney disease, infantile severe, with tuberous sclerosis",0.0,1.0,0.0,0.0,0.0,1838327,"Polycystic kidneys, severe infantile with tuberous sclerosis",0.21,0,Biomarker
718,C3,complement component 3,0.0,1.0,0.0,0.0,0.0,34152,"Purpura, Schoenlein-Henoch",0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,34152,"Purpura, Schoenlein-Henoch",0.21,2,Therapeutic
3077,HFE,hemochromatosis,0.0,1.0,0.0,0.0,0.0,2936913,"Porphyria, South African type",0.21,0,Biomarker
5498,PPOX,protoporphyrinogen oxidase,0.0,1.0,0.0,0.0,0.0,2936913,"Porphyria, South African type",0.21,0,Biomarker
1957,EGI,"epilepsy, generalized, idiopathic",0.0,1.0,0.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.21,0,Biomarker
353124,EIG2,"Epilepsy, idiopathic generalized, susceptibility to 2",0.0,1.0,0.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.21,0,Biomarker
432400,EIG3,"Epilepsy, idiopathic generalized, susceptibility to 3",0.0,1.0,0.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.21,0,Biomarker
780913,EIG4,"Epilepsy, idiopathic generalized, susceptibility to 4",0.0,1.0,0.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.21,0,Biomarker
100188861,EIG5,"Epilepsy, idiopathic generalized, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.21,0,Biomarker
2563,GABRD,"gamma-aminobutyric acid (GABA) A receptor, delta",0.0,1.0,0.0,0.0,0.0,270850,"Epilepsy, Idiopathic Generalized",0.21,0,Biomarker
150684,COMMD1,copper metabolism (Murr1) domain containing 1,0.0,1.0,0.0,0.0,0.0,12979,Dog Diseases,0.21,1,Biomarker
1759,DNM1,dynamin 1,0.0,1.0,0.0,0.0,0.0,12979,Dog Diseases,0.21,1,Biomarker
7296,TXNRD1,thioredoxin reductase 1,0.0,1.0,0.0,0.0,0.0,243038,"Carcinoma, Lewis Lung",0.21,1,Biomarker
100271837,USH1H,Usher syndrome 1H (autosomal recessive),0.0,1.0,0.0,0.0,0.0,2675458,"Usher Syndrome, Type IH",0.21,0,Biomarker
619404,CTRCT35,"cataract, congenital nuclear, autosomal recessive",0.0,1.0,0.0,0.0,0.0,1836272,"Cataract, Congenital Nuclear, Autosomal Recessive 1",0.21,0,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,26837,Muscle Rigidity,0.21,1,Biomarker
2643,GCH1,GTP cyclohydrolase 1,0.0,1.0,0.0,0.0,0.0,26837,Muscle Rigidity,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,0.0,0.0,0.0,1.0,26837,Muscle Rigidity,0.21,1,Therapeutic
4922,NTS,neurotensin,0.0,0.0,0.0,0.0,1.0,26837,Muscle Rigidity,0.21,1,Therapeutic
8622,PDE8B,phosphodiesterase 8B,0.0,1.0,0.0,0.0,0.0,26837,Muscle Rigidity,0.21,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,0.0,0.0,0.0,1.0,17639,Gliosis,0.21,1,Therapeutic
2247,FGF2,fibroblast growth factor 2 (basic),0.0,0.0,0.0,0.0,1.0,17639,Gliosis,0.21,1,Therapeutic
2918,GRM8,"glutamate receptor, metabotropic 8",0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
3672,ITGA1,"integrin, alpha 1",0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
3673,ITGA2,"integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)",0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
3676,ITGA4,"integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)",0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
3678,ITGA5,"integrin, alpha 5 (fibronectin receptor, alpha polypeptide)",0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
3691,ITGB4,"integrin, beta 4",0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
3777,KCNK3,"potassium channel, two pore domain subfamily K, member 3",0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
7143,TNR,tenascin R,0.0,1.0,0.0,0.0,0.0,17639,Gliosis,0.21,1,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,36439,Scoliosis,0.21,1,Biomarker
308,ANXA5,annexin A5,0.0,1.0,0.0,0.0,0.0,19202,Hepatolenticular Degeneration,0.21,1,Biomarker
100310755,ATOD7,"Dermatitis, atopic, susceptibility to, 7",0.0,1.0,0.0,0.0,0.0,2751599,"Dermatitis, Atopic, 7",0.21,0,Biomarker
7466,WFS1,Wolfram syndrome 1 (wolframin),0.0,0.0,1.0,0.0,0.0,3280358,"Wolfram-Like Syndrome, Autosomal Dominant",0.21,0,GeneticVariation
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,393626,Opsoclonus-Myoclonus Syndrome,0.21,1,Therapeutic
3708,ITPR1,"inositol 1,4,5-trisphosphate receptor, type 1",0.0,1.0,0.0,0.0,0.0,1527348,"Hypoxia, Brain",0.21,1,Biomarker
3709,ITPR2,"inositol 1,4,5-trisphosphate receptor, type 2",0.0,1.0,0.0,0.0,0.0,1527348,"Hypoxia, Brain",0.21,1,Biomarker
998,CDC42,cell division cycle 42,0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.21,1,Biomarker
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.21,1,Biomarker
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,0.0,0.0,0.0,1.0,1624,Adrenal Gland Neoplasms,0.21,1,Therapeutic
2798,GNRHR,gonadotropin-releasing hormone receptor,0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.21,1,Biomarker
5925,RB1,retinoblastoma 1,0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.21,1,Biomarker
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,0.0,0.0,0.0,1624,Adrenal Gland Neoplasms,0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,15799,Feminization,0.21,1,Biomarker
100188880,HPRHP,Hypophosphatemic rickets and hyperparathyroidism,0.0,1.0,0.0,0.0,0.0,2677524,Hypophosphatemic Rickets And Hyperparathyroidism,0.21,0,Biomarker
100307118,BCC1,"Basal cell carcinoma, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21,0,Biomarker
100307119,BCC2,"Basal cell carcinoma, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21,0,Biomarker
100307120,BCC3,"Basal cell carcinoma, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21,0,Biomarker
100307121,BCC4,"Basal cell carcinoma, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21,0,Biomarker
100307122,BCC5,"Basal cell carcinoma, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21,0,Biomarker
100307123,BCC6,"Basal cell carcinoma, susceptibility to, 6",0.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21,0,Biomarker
3872,KRT17,"keratin 17, type I",0.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21,1,Biomarker
8643,PTCH2,patched 2,0.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21,0,Biomarker
5921,RASA1,RAS p21 protein activator (GTPase activating protein) 1,0.0,1.0,0.0,0.0,0.0,7117,"Carcinoma, Basal Cell",0.21,0,Biomarker
7885,CRSA,"Craniosynostosis, Adelaide type",0.0,1.0,0.0,0.0,0.0,1833578,"Craniosynostosis, Adelaide Type",0.21,0,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,2,Biomarker
328,APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
41,ASIC1,acid sensing (proton gated) ion channel 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
460,ASTN1,astrotactin 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
929,CD14,CD14 molecule,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
1051,CEBPB,"CCAAT/enhancer binding protein (C/EBP), beta",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
1066,CES1,carboxylesterase 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
629,CFB,complement factor B,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
1129,CHRM2,"cholinergic receptor, muscarinic 2",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
26253,CLEC4E,"C-type lectin domain family 4, member E",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,0.0,0.0,0.0,1.0,270611,Brain Injuries,0.21,1,Therapeutic
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
2562,GABRB3,"gamma-aminobutyric acid (GABA) A receptor, beta 3",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
2567,GABRG3,"gamma-aminobutyric acid (GABA) A receptor, gamma 3",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
2918,GRM8,"glutamate receptor, metabotropic 8",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
3303,HSPA1A,heat shock 70kDa protein 1A,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
282617,IFNL3,"interferon, lambda 3",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
3595,IL12RB2,"interleukin 12 receptor, beta 2",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
3598,IL13RA2,"interleukin 13 receptor, alpha 2",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
54756,IL17RD,interleukin 17 receptor D,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
8809,IL18R1,interleukin 18 receptor 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
3554,IL1R1,"interleukin 1 receptor, type I",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
133396,IL31RA,interleukin 31 receptor A,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
3574,IL7,interleukin 7,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
3581,IL9R,interleukin 9 receptor,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
55341,LSG1,large 60S subunit nuclear export GTPase 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
9450,LY86,lymphocyte antigen 86,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
406921,MIR132,microRNA 132,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
406959,MIR183,microRNA 183,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
8993,PGLYRP1,peptidoglycan recognition protein 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,0.0,0.0,0.0,1.0,270611,Brain Injuries,0.21,1,Therapeutic
353376,TICAM2,toll-like receptor adaptor molecule 2,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
7096,TLR1,toll-like receptor 1,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
54106,TLR9,toll-like receptor 9,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,2,Biomarker
23495,TNFRSF13B,"tumor necrosis factor receptor superfamily, member 13B",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
115650,TNFRSF13C,"tumor necrosis factor receptor superfamily, member 13C",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
8764,TNFRSF14,"tumor necrosis factor receptor superfamily, member 14",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
9618,TRAF4,TNF receptor-associated factor 4,0.0,1.0,0.0,0.0,0.0,270611,Brain Injuries,0.21,1,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,40715,"Translocation, Genetic",0.21,1,Biomarker
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,40715,"Translocation, Genetic",0.21,1,Biomarker
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,32463,Polycythemia Vera,0.21,1,Biomarker
3043,HBB,"hemoglobin, beta",0.0,1.0,0.0,0.0,0.0,32463,Polycythemia Vera,0.21,1,Biomarker
338333,PAPA3,"Polydactyly, postaxial, type A3",0.0,1.0,0.0,0.0,0.0,1846452,"Polydactyly, Postaxial, Type A3",0.21,0,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,18128,"Graft Occlusion, Vascular",0.21,4,Therapeutic
317682,OTSC5,otosclerosis 5,0.0,1.0,0.0,0.0,0.0,1837422,Otosclerosis 5,0.21,0,Biomarker
23245,ASTN2,astrotactin 2,0.0,1.0,0.0,0.0,0.0,338480,Migraine without Aura,0.21,1,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,338480,Migraine without Aura,0.21,2,Biomarker
4035,LRP1,low density lipoprotein receptor-related protein 1,0.0,1.0,0.0,0.0,0.0,338480,Migraine without Aura,0.21,1,Biomarker
4209,MEF2D,myocyte enhancer factor 2D,0.0,1.0,0.0,0.0,0.0,338480,Migraine without Aura,0.21,1,Biomarker
338342,MGR4,"Migraine, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,338480,Migraine without Aura,0.21,0,Biomarker
221692,PHACTR1,phosphatase and actin regulator 1,0.0,1.0,0.0,0.0,0.0,338480,Migraine without Aura,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,338480,Migraine without Aura,0.21,1,Biomarker
79054,TRPM8,"transient receptor potential cation channel, subfamily M, member 8",0.0,1.0,0.0,0.0,0.0,338480,Migraine without Aura,0.21,1,Biomarker
2192,FBLN1,fibulin 1,0.0,1.0,0.0,0.0,0.0,1842422,Synpolydactyly 2,0.21,0,Biomarker
514,ATP5E,"ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit",0.0,0.0,1.0,0.0,0.0,3279708,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3",0.21,1,GeneticVariation
6326,SCN2A,"sodium channel, voltage gated, type II alpha subunit",0.0,1.0,0.0,0.0,0.0,1842382,"Epilepsy, Benign Neonatal, 3",0.21,0,Biomarker
440854,CAPN14,calpain 14,0.0,1.0,0.0,0.0,0.0,341106,Eosinophilic Esophagitis,0.21,1,Biomarker
100302511,EOE1,"Esophagitis, eosinophilic",0.0,1.0,0.0,0.0,0.0,341106,Eosinophilic Esophagitis,0.21,0,Biomarker
100499167,EOE2,"Esophagitis, eosinophilic, 2",0.0,1.0,0.0,0.0,0.0,341106,Eosinophilic Esophagitis,0.21,0,Biomarker
3378,IBD2,inflammatory bowel disease 2,0.0,1.0,0.0,0.0,0.0,1832321,Inflammatory Bowel Disease 2,0.21,0,Biomarker
2168,FABP1,"fatty acid binding protein 1, liver",0.0,0.0,0.0,0.0,1.0,22672,"Kidney Tubular Necrosis, Acute",0.21,1,Therapeutic
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,22672,"Kidney Tubular Necrosis, Acute",0.21,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,0.0,0.0,0.0,1.0,22672,"Kidney Tubular Necrosis, Acute",0.21,1,Therapeutic
1081,CGA,"glycoprotein hormones, alpha polypeptide",0.0,0.0,0.0,0.0,1.0,42131,Uterine Diseases,0.21,1,Therapeutic
619480,MDBS2,butterfly-shaped pigmentary macular dystrophy 2,0.0,1.0,0.0,0.0,0.0,1868569,Patterned dystrophy of retinal pigment epithelium,0.21,0,Biomarker
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,0.0,1.0,0.0,0.0,1838492,"Spinal Muscular Atrophy, Distal, Congenital Nonprogressive",0.21,0,GeneticVariation
8094,SMAL,"spinal muscular atrophy, congenital nonprogressive, of lower limbs",0.0,1.0,0.0,0.0,0.0,1838492,"Spinal Muscular Atrophy, Distal, Congenital Nonprogressive",0.21,0,Biomarker
7248,TSC1,tuberous sclerosis 1,0.0,1.0,0.0,0.0,0.0,1846385,Focal cortical dysplasia of Taylor,0.21,1,Biomarker
449018,EJM3,"Epilepsy, juvenile myoclonic 3",0.0,1.0,0.0,0.0,0.0,270853,"Myoclonic Epilepsy, Juvenile",0.21,0,Biomarker
100126594,EJM4,"Myoclonic epilepsy, juvenile, 4",0.0,1.0,0.0,0.0,0.0,270853,"Myoclonic Epilepsy, Juvenile",0.21,0,Biomarker
8629,JRK,Jrk homolog (mouse),0.0,1.0,0.0,0.0,0.0,270853,"Myoclonic Epilepsy, Juvenile",0.21,1,Biomarker
246289,DFNA47,"deafness, autosomal dominant 47",0.0,1.0,0.0,0.0,0.0,1837609,"Deafness, Autosomal Dominant 47",0.21,0,Biomarker
10118,EMWX,"episodic muscle weakness, X-linked",0.0,1.0,0.0,0.0,0.0,1846173,"Episodic Muscle Weakness, X-Linked",0.21,0,Biomarker
5734,PTGER4,prostaglandin E receptor 4 (subtype EP4),0.0,0.0,0.0,0.0,1.0,24299,Lymphoma,0.21,1,Therapeutic
5756,TWF1,twinfilin actin-binding protein 1,0.0,1.0,0.0,0.0,0.0,24299,Lymphoma,0.21,1,Biomarker
8639,AOC3,"amine oxidase, copper containing 3",0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.21,1,Biomarker
558,AXL,AXL receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.21,1,Biomarker
160851,DGKH,"diacylglycerol kinase, eta",0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.21,1,Biomarker
406937,MIR145,microRNA 145,0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.21,1,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.21,1,Biomarker
27283,TINAG,tubulointerstitial nephritis antigen,0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.21,1,Biomarker
7126,TNFAIP1,"tumor necrosis factor, alpha-induced protein 1 (endothelial)",0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.21,1,Biomarker
7416,VDAC1,voltage-dependent anion channel 1,0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.21,1,Biomarker
7417,VDAC2,voltage-dependent anion channel 2,0.0,1.0,0.0,0.0,0.0,11881,Diabetic Nephropathies,0.21,1,Biomarker
50975,TCO,"Thyroid carcinoma, nonmedullary, with cell oxyphilia",0.0,1.0,0.0,0.0,0.0,1863925,"Nonmedullary thyroid carcinoma, with or without cell oxyphilia",0.21,0,Biomarker
560,AZF1,azoospermia factor 1,0.0,1.0,0.0,0.0,0.0,1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",0.21,0,Biomarker
5940,RBMY1A1,"RNA binding motif protein, Y-linked, family 1, member A1",0.0,1.0,0.0,0.0,0.0,1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",0.21,0,Biomarker
8105,BRCD1,"cancer, familial, with in vitro radioresistance",0.0,1.0,0.0,0.0,0.0,1861915,"Cancer, Familial, with In Vitro Radioresistance",0.21,0,Biomarker
197322,ACSF3,acyl-CoA synthetase family member 3,0.0,1.0,0.0,0.0,0.0,342793,Malonic aciduria,0.21,1,Biomarker
93991,MRX77,"mental retardation, X-linked 77",0.0,1.0,0.0,0.0,0.0,1845499,"Mental Retardation, X-Linked 77",0.21,0,Biomarker
3759,KCNJ2,"potassium channel, inwardly rectifying subfamily J, member 2",0.0,0.0,1.0,0.0,0.0,3151431,"ATRIAL FIBRILLATION, FAMILIAL, 9",0.21,0,GeneticVariation
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,24312,Lymphopenia,0.21,1,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
2740,GLP1R,glucagon-like peptide 1 receptor,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
3578,IL9,interleukin 9,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
3775,KCNK1,"potassium channel, two pore domain subfamily K, member 1",0.0,0.0,0.0,0.0,1.0,20507,Hyperplasia,0.21,1,Therapeutic
23028,KDM1A,lysine (K)-specific demethylase 1A,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
3949,LDLR,low density lipoprotein receptor,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
5597,MAPK6,mitogen-activated protein kinase 6,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
4143,MAT1A,"methionine adenosyltransferase I, alpha",0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,20507,Hyperplasia,0.21,1,Therapeutic
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
10216,PRG4,proteoglycan 4,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
117579,RLN3,relaxin 3,0.0,0.0,0.0,0.0,1.0,20507,Hyperplasia,0.21,1,Therapeutic
6934,TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box)",0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
7538,ZFP36,ZFP36 ring finger protein,0.0,1.0,0.0,0.0,0.0,20507,Hyperplasia,0.21,1,Biomarker
1301,COL11A1,"collagen, type XI, alpha 1",0.0,0.0,1.0,0.0,0.0,3278138,FIBROCHONDROGENESIS 1,0.21,0,GeneticVariation
6157,RPL27A,ribosomal protein L27a,0.0,1.0,0.0,0.0,0.0,7758,Cerebellar Ataxia,0.21,1,Biomarker
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,1.0,0.0,0.0,0.0,7758,Cerebellar Ataxia,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,2751322,Metaphyseal Anadysplasia 2,0.21,0,Biomarker
8212,AABT,"Beta-amino acids, renal transport of",0.0,1.0,0.0,0.0,0.0,1862289,"BETA-AMINO ACIDS, RENAL TRANSPORT OF",0.21,0,Biomarker
374654,KIF7,kinesin family member 7,0.0,0.0,1.0,0.0,0.0,265220,Pallister-Hall Syndrome,0.21,0,GeneticVariation
6606,SMN1,"survival of motor neuron 1, telomeric",0.0,1.0,0.0,0.0,0.0,2931844,Spinal muscular atrophy 4,0.21,0,Biomarker
100302721,ARHI2,Age-related hearing impairment 2,0.0,1.0,0.0,0.0,0.0,2751814,Presbycusis 2,0.21,0,Biomarker
3630,INS,insulin,0.0,0.0,1.0,0.0,0.0,1337112,INSULIN,0.21,0,GeneticVariation
1415,CRYBB2,"crystallin, beta B2",0.0,1.0,0.0,0.0,0.0,1852438,"Cataract, Coppock-Like",0.21,0,Biomarker
64421,DCLRE1C,DNA cross-link repair 1C,0.0,1.0,0.0,0.0,0.0,2931884,"Reticuloendotheliosis, familial, with eosinophilia",0.21,0,Biomarker
5896,RAG1,recombination activating gene 1,0.0,1.0,0.0,0.0,0.0,2931884,"Reticuloendotheliosis, familial, with eosinophilia",0.21,0,Biomarker
5897,RAG2,recombination activating gene 2,0.0,1.0,0.0,0.0,0.0,2931884,"Reticuloendotheliosis, familial, with eosinophilia",0.21,0,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,18200,"Granuloma, Respiratory Tract",0.21,1,Biomarker
54106,TLR9,toll-like receptor 9,0.0,1.0,0.0,0.0,0.0,18200,"Granuloma, Respiratory Tract",0.21,1,Biomarker
54503,ZDHHC13,"zinc finger, DHHC-type containing 13",0.0,1.0,0.0,0.0,0.0,2726,Amyloidosis,0.21,1,Biomarker
4538,ND4,"NADH dehydrogenase, subunit 4 (complex I)",0.0,0.0,1.0,0.0,0.0,1839040,Marsden syndrome,0.21,0,GeneticVariation
4541,ND6,"NADH dehydrogenase, subunit 6 (complex I)",0.0,0.0,1.0,0.0,0.0,1839040,Marsden syndrome,0.21,0,GeneticVariation
1482,NKX2-5,NK2 homeobox 5,0.0,1.0,0.0,0.0,0.0,27126,Myotonic Dystrophy,0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
330,BIRC3,baculoviral IAP repeat containing 3,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
1051,CEBPB,"CCAAT/enhancer binding protein (C/EBP), beta",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
54205,CYCS,"cytochrome c, somatic",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
9420,CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
2147,F2,coagulation factor II (thrombin),0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
2149,F2R,coagulation factor II (thrombin) receptor,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,3,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
3032,HADHB,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
3087,HHEX,hematopoietically expressed homeobox,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
4143,MAT1A,"methionine adenosyltransferase I, alpha",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
406903,MIR10B,microRNA 10b,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
406924,MIR134,microRNA 134,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
406931,MIR139,microRNA 139,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
442892,MIR148B,microRNA 148b,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
406942,MIR150,microRNA 150,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
406946,MIR154,microRNA 154,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
406952,MIR17,microRNA 17,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
406959,MIR183,microRNA 183,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
406974,MIR197,microRNA 197,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
494333,MIR384,microRNA 384,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
574434,MIR410,microRNA 410,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
100313923,MIR449C,microRNA 449c,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
574506,MIR503,microRNA 503,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
664617,MIR542,microRNA 542,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,0.0,0.0,0.0,1.0,15695,Fatty Liver,0.21,1,Therapeutic
79661,NEIL1,nei endonuclease VIII-like 1 (E. coli),0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,2,Biomarker
123,PLIN2,perilipin 2,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
5757,PTMA,"prothymosin, alpha",0.0,0.0,0.0,0.0,1.0,15695,Fatty Liver,0.21,1,Therapeutic
6514,SLC2A2,"solute carrier family 2 (facilitated glucose transporter), member 2",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,1,Biomarker
412,STS,"steroid sulfatase (microsomal), isozyme S",0.0,0.0,0.0,0.0,1.0,15695,Fatty Liver,0.21,1,Therapeutic
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,15695,Fatty Liver,0.21,2,Biomarker
8245,IDDMX,"Diabetes mellitus, insulin-dependent, X-linked, susceptibility to",0.0,1.0,0.0,0.0,0.0,1848042,"DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO",0.21,0,Biomarker
100303716,PBC2,"Biliary cirrhosis, primary, 2",0.0,1.0,0.0,0.0,0.0,2751696,"Biliary Cirrhosis, Primary, 2",0.21,0,Biomarker
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,85096,Peripheral Vascular Diseases,0.21,1,Biomarker
153090,DAB2IP,DAB2 interacting protein,0.0,1.0,0.0,0.0,0.0,85096,Peripheral Vascular Diseases,0.21,1,Biomarker
100188748,STHAG5,"tooth agenesis, selective, 5",0.0,1.0,0.0,0.0,0.0,1858210,"Tooth Agenesis, Selective, 5",0.21,0,Biomarker
7915,ALDH5A1,"aldehyde dehydrogenase 5 family, member A1",0.0,1.0,0.0,0.0,0.0,393593,Dystonic Disorders,0.21,1,Biomarker
2741,GLRA1,"glycine receptor, alpha 1",0.0,1.0,0.0,0.0,0.0,393593,Dystonic Disorders,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,23176,Lead Poisoning,0.21,1,Biomarker
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
259266,ASPM,"asp (abnormal spindle) homolog, microcephaly associated (Drosophila)",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
53335,BCL11A,B-cell CLL/lymphoma 11A (zinc finger protein),0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
51514,DTL,denticleless E3 ubiquitin protein ligase homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
80303,EFHD1,"EF-hand domain family, member D1",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
2019,EN1,engrailed homeobox 1,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
9700,ESPL1,extra spindle pole bodies homolog 1 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
2175,FANCA,"Fanconi anemia, complementation group A",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
2195,FAT1,FAT atypical cadherin 1,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
2620,GAS2,growth arrest-specific 2,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
2621,GAS6,growth arrest-specific 6,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
51659,GINS2,GINS complex subunit 2 (Psf2 homolog),0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
2982,GUCY1A3,"guanylate cyclase 1, soluble, alpha 3",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
9454,HOMER3,homer homolog 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
3485,IGFBP2,"insulin-like growth factor binding protein 2, 36kDa",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
50805,IRX4,iroquois homeobox 4,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
51477,ISYNA1,inositol-3-phosphate synthase 1,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
3691,ITGB4,"integrin, beta 4",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
182,JAG1,jagged 1,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
3866,KRT15,"keratin 15, type I",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
3852,KRT5,"keratin 5, type II",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
4082,MARCKS,myristoylated alanine-rich protein kinase C substrate,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
2011,MARK2,MAP/microtubule affinity-regulating kinase 2,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
54531,MIER2,"mesoderm induction early response 1, family member 2",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
23209,MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
81831,NETO2,neuropilin (NRP) and tolloid (TLL)-like 2,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
27344,PCSK1N,proprotein convertase subtilisin/kexin type 1 inhibitor,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
5174,PDZK1,PDZ domain containing 1,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
5587,PRKD1,protein kinase D1,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
5834,PYGB,"phosphorylase, glycogen; brain",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
23543,RBFOX2,"RNA binding protein, fox-1 homolog (C. elegans) 2",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
5176,SERPINF1,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
57419,SLC24A3,"solute carrier family 24 (sodium/potassium/calcium exchanger), member 3",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
6651,SON,SON DNA binding protein,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
6664,SOX11,SRY (sex determining region Y)-box 11,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
6659,SOX4,SRY (sex determining region Y)-box 4,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
6484,ST3GAL4,"ST3 beta-galactoside alpha-2,3-sialyltransferase 4",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
54441,STAG3L1,stromal antigen 3-like 1 (pseudogene),0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
7153,TOP2A,topoisomerase (DNA) II alpha 170kDa,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
1462,VCAN,versican,0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
81029,WNT5B,"wingless-type MMTV integration site family, member 5B",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
23619,ZIM2,"zinc finger, imprinted 2",0.0,1.0,0.0,0.0,0.0,36095,Salivary Gland Neoplasms,0.21,1,Biomarker
2723,GLC1C,"glaucoma 1, open angle, C",0.0,1.0,0.0,0.0,0.0,1866483,"Glaucoma 1, Open Angle, C",0.21,0,Biomarker
11311,VPS45,vacuolar protein sorting 45 homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,2931351,Familial myelofibrosis,0.21,1,Biomarker
54,ACP5,"acid phosphatase 5, tartrate resistant",0.0,1.0,0.0,0.0,0.0,432222,Spondyloenchondrodysplasia,0.21,2,Biomarker
1616,DAXX,death-domain associated protein,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.21,1,Biomarker
9968,MED12,mediator complex subunit 12,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.21,1,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.21,1,Biomarker
84133,ZNRF3,zinc and ring finger 3,0.0,1.0,0.0,0.0,0.0,206686,Adrenocortical Carcinoma,0.21,1,Biomarker
208,AKT2,v-akt murine thymoma viral oncogene homolog 2,0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.21,1,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.21,1,Biomarker
8314,BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.21,1,Biomarker
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.21,1,Biomarker
100312951,NPCA2,"Nasopharyngeal carcinoma, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.21,0,Biomarker
23345,SYNE1,"spectrin repeat containing, nuclear envelope 1",0.0,1.0,0.0,0.0,0.0,2931822,Nasopharyngeal carcinoma,0.21,1,Biomarker
10498,CARM1,coactivator-associated arginine methyltransferase 1,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.21,1,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.21,1,Biomarker
23586,DDX58,DEAD (Asp-Glu-Ala-Asp) box polypeptide 58,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.21,1,Biomarker
338442,HCAR2,hydroxycarboxylic acid receptor 2,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.21,1,Biomarker
503613,PSORS10,psoriasis susceptibility 10,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.21,0,Biomarker
100271719,PSORS11,Psoriasis susceptibility 11,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.21,0,Biomarker
864,RUNX3,runt-related transcription factor 3,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.21,1,Biomarker
117289,TAGAP,T-cell activation RhoGTPase activating protein,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.21,1,Biomarker
85463,ZC3H12C,zinc finger CCCH-type containing 12C,0.0,1.0,0.0,0.0,0.0,33860,Psoriasis,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,13295,Duodenal Ulcer,0.21,2,Biomarker
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",0.0,1.0,0.0,0.0,0.0,13295,Duodenal Ulcer,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,13295,Duodenal Ulcer,0.21,1,Biomarker
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,23014,Language Development Disorders,0.21,1,Biomarker
2077,ERF,Ets2 repressor factor,0.0,1.0,0.0,0.0,0.0,23014,Language Development Disorders,0.21,1,Biomarker
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,1.0,0.0,0.0,0.0,23014,Language Development Disorders,0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,23014,Language Development Disorders,0.21,1,Biomarker
26040,SETBP1,SET binding protein 1,0.0,1.0,0.0,0.0,0.0,23014,Language Development Disorders,0.21,1,Biomarker
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,0.0,1.0,0.0,0.0,0.0,23014,Language Development Disorders,0.21,2,Biomarker
406237,PDON2,"Periodontitis, localized aggressive",0.0,1.0,0.0,0.0,0.0,1969478,"Periodontitis, Aggressive, 2",0.21,0,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,25637,Methemoglobinemia,0.21,1,Biomarker
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,25637,Methemoglobinemia,0.21,1,Biomarker
3043,HBB,"hemoglobin, beta",0.0,1.0,0.0,0.0,0.0,25637,Methemoglobinemia,0.21,1,Biomarker
6718,AKR1D1,"aldo-keto reductase family 1, member D1",0.0,1.0,0.0,0.0,0.0,18995,Hemochromatosis,0.21,1,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,152455,Keratomalacia,0.21,1,Biomarker
10309,CCNO,cyclin O,0.0,1.0,0.0,0.0,0.0,600260,"Lung Diseases, Obstructive",0.21,1,Biomarker
2294,FOXF1,forkhead box F1,0.0,1.0,0.0,0.0,0.0,600260,"Lung Diseases, Obstructive",0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,1.0,3578,Apnea,0.21,30,"Biomarker, Therapeutic"
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,0.0,0.0,0.0,1.0,3578,Apnea,0.21,1,Therapeutic
100462676,RCHTS,Roifman-Chitayat syndrome,0.0,1.0,0.0,0.0,0.0,2750068,Roifman-Chitayat Syndrome,0.21,0,Biomarker
283,ANG,"angiogenin, ribonuclease, RNase A family, 5",0.0,1.0,0.0,0.0,0.0,1349,Acute-Phase Reaction,0.21,1,Biomarker
100240733,IBD23,Inflammatory bowel disease-23,0.0,1.0,0.0,0.0,0.0,2676484,Inflammatory Bowel Disease 23,0.21,0,Biomarker
54806,AHI1,Abelson helper integration site 1,0.0,1.0,0.0,0.0,0.0,7760,Cerebellar Diseases,0.21,1,Biomarker
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,1.0,0.0,0.0,0.0,7760,Cerebellar Diseases,0.21,1,Biomarker
256297,PTF1A,"pancreas specific transcription factor, 1a",0.0,1.0,0.0,0.0,0.0,7760,Cerebellar Diseases,0.21,2,Biomarker
23322,RPGRIP1L,RPGRIP1-like,0.0,1.0,0.0,0.0,0.0,7760,Cerebellar Diseases,0.21,2,Biomarker
26277,TINF2,TERF1 (TRF1)-interacting nuclear factor 2,0.0,1.0,0.0,0.0,0.0,7760,Cerebellar Diseases,0.21,1,Biomarker
114902,C1QTNF5,C1q and tumor necrosis factor related protein 5,0.0,1.0,0.0,0.0,0.0,23308,Lens Diseases,0.21,1,Biomarker
406901,MIR107,microRNA 107,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
406902,MIR10A,microRNA 10a,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
406920,MIR130B,microRNA 130b,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
574447,MIR146B,microRNA 146b,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
406959,MIR183,microRNA 183,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
406962,MIR186,microRNA 186,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
100126346,MIR190B,microRNA 190b,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
406985,MIR200C,microRNA 200c,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
407033,MIR30D,microRNA 30d,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
407034,MIR30E,microRNA 30e,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
442899,MIR325,microRNA 325,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
442903,MIR331,microRNA 331,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
442907,MIR339,microRNA 339,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
494330,MIR381,microRNA 381,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
554210,MIR429,microRNA 429,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
693124,MIR532,microRNA 532,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
407056,MIR99B,microRNA 99b,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
57551,TAOK1,TAO kinase 1,0.0,1.0,0.0,0.0,0.0,18781,"Hearing Loss, Noise-Induced",0.21,1,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
147,ADRA1B,adrenoceptor alpha 1B,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
23287,AGTPBP1,ATP/GTP binding protein 1,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
334,APLP2,amyloid beta (A4) precursor-like protein 2,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,9,Biomarker
4287,ATXN3,ataxin 3,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
578,BAK1,BCL2-antagonist/killer 1,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
581,BAX,BCL2-associated X protein,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,2,"Biomarker, Therapeutic"
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,5,"Biomarker, Therapeutic"
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
920,CD4,CD4 molecule,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
928,CD9,CD9 molecule,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
1000,CDH2,"cadherin 2, type 1, N-cadherin (neuronal)",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,2,"Biomarker, Therapeutic"
1270,CNTF,ciliary neurotrophic factor,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
1356,CP,ceruloplasmin (ferroxidase),0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
54541,DDIT4,DNA-damage-inducible transcript 4,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
1965,EIF2S1,"eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,3,Therapeutic
2057,EPOR,erythropoietin receptor,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
2114,ETS2,v-ets avian erythroblastosis virus E26 oncogene homolog 2,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
2147,F2,coagulation factor II (thrombin),0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
2906,GRIN2D,"glutamate receptor, ionotropic, N-methyl D-aspartate 2D",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
2914,GRM4,"glutamate receptor, metabotropic 4",0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
2896,GRN,granulin,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,3,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,2,Therapeutic
3761,KCNJ4,"potassium channel, inwardly rectifying subfamily J, member 4",0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
3763,KCNJ6,"potassium channel, inwardly rectifying subfamily J, member 6",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
3952,LEP,leptin,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
7804,LRP8,"low density lipoprotein receptor-related protein 8, apolipoprotein e receptor",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
120892,LRRK2,leucine-rich repeat kinase 2,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
4359,MPZ,myelin protein zero,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
4804,NGFR,nerve growth factor receptor,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,2,Biomarker
4908,NTF3,neurotrophin 3,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,2,Therapeutic
5015,OTX2,orthodenticle homeobox 2,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
80025,PANK2,pantothenate kinase 2,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
5663,PSEN1,presenilin 1,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
84867,PTPN5,"protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,2,Biomarker
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,2,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
7039,TGFA,"transforming growth factor, alpha",0.0,0.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,1,Therapeutic
7054,TH,tyrosine hydroxylase,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,1.0,27746,Nerve Degeneration,0.21,2,"Biomarker, Therapeutic"
7249,TSC2,tuberous sclerosis 2,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
51542,VPS54,vacuolar protein sorting 54 homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
64393,ZMAT3,"zinc finger, matrin-type 3",0.0,1.0,0.0,0.0,0.0,27746,Nerve Degeneration,0.21,1,Biomarker
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,0.0,1.0,0.0,0.0,3807295,"CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT",0.21,0,GeneticVariation
79809,TTC21B,tetratricopeptide repeat domain 21B,0.0,1.0,0.0,0.0,0.0,265275,Jeune syndrome,0.21,1,Biomarker
29125,C11orf21,chromosome 11 open reading frame 21,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.21,1,Biomarker
100048912,CDKN2B-AS1,CDKN2B antisense RNA 1,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.21,1,Biomarker
100188791,CLLS1,"Leukemia, chronic lymphocytic, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.21,0,Biomarker
100270642,CLLS3,"Leukemia, chronic lymphocytic, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.21,0,Biomarker
100270643,CLLS4,"Leukemia, chronic lymphocytic susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.21,0,Biomarker
100270644,CLLS5,"Leukemia, chronic lymphocytic susceptiblity to, 5",0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.21,0,Biomarker
406937,MIR145,microRNA 145,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.21,1,Biomarker
25797,QPCT,glutaminyl-peptide cyclotransferase,0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.21,1,Biomarker
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,0.0,0.0,0.0,23434,"Leukemia, Lymphocytic, Chronic, B-Cell",0.21,1,Biomarker
362,AQP5,aquaporin 5,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,2,Biomarker
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,0.0,0.0,0.0,1.0,19284,"Hernia, Diaphragmatic",0.21,1,Therapeutic
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,2,Biomarker
1909,EDNRA,endothelin receptor type A,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,2,Biomarker
1910,EDNRB,endothelin receptor type B,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
8817,FGF18,fibroblast growth factor 18,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
3170,FOXA2,forkhead box A2,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
2626,GATA4,GATA binding protein 4,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
2627,GATA6,GATA binding protein 6,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,2,Biomarker
3202,HOXA5,homeobox A5,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
3213,HOXB3,homeobox B3,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,2,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
3737,KCNA2,"potassium channel, voltage gated shaker related subfamily A, member 2",0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
3745,KCNB1,"potassium channel, voltage gated Shab related subfamily B, member 1",0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
3778,KCNMA1,"potassium channel, calcium activated large conductance subfamily M alpha, member 1",0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
7026,NR2F2,"nuclear receptor subfamily 2, group F, member 2",0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
6439,SFTPB,surfactant protein B,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,2,Biomarker
6440,SFTPC,surfactant protein C,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
6586,SLIT3,slit homolog 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
7067,THRA,"thyroid hormone receptor, alpha",0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
7068,THRB,"thyroid hormone receptor, beta",0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
7345,UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase),0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,19284,"Hernia, Diaphragmatic",0.21,1,Biomarker
100188886,ANIB8,"Aneurysm, intracranial berry, 8",0.0,1.0,0.0,0.0,0.0,2677336,"Aneurysm, Intracranial Berry, 8",0.21,0,Biomarker
100188842,ATFB5,"Atrial fibrillation, familial, 5",0.0,1.0,0.0,0.0,0.0,1969099,"Atrial Fibrillation, Familial, 5",0.21,0,Biomarker
204,AK2,adenylate kinase 2,0.0,1.0,0.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.21,2,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,23283,"Leishmaniasis, Cutaneous",0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,23283,"Leishmaniasis, Cutaneous",0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,23283,"Leishmaniasis, Cutaneous",0.21,1,Biomarker
6022,RMD1,rippling muscle disease 1,0.0,1.0,0.0,0.0,0.0,1838254,"Rippling muscle disease, 1",0.21,0,Biomarker
2693,GHSR,growth hormone secretagogue receptor,0.0,1.0,0.0,0.0,0.0,12243,Digestive System Neoplasms,0.21,1,Biomarker
7298,TYMS,thymidylate synthetase,0.0,1.0,0.0,0.0,0.0,12243,Digestive System Neoplasms,0.21,1,Biomarker
431712,CMT2G,"Charcot-Marie-Tooth disease, axonal, type 2G",0.0,1.0,0.0,0.0,0.0,1837805,"Charcot-Marie-Tooth disease, Type 2G",0.21,0,Biomarker
56623,INPP5E,"inositol polyphosphate-5-phosphatase, 72 kDa",0.0,1.0,0.0,0.0,0.0,15398,"Eye Diseases, Hereditary",0.21,1,Biomarker
9227,LRAT,lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase),0.0,1.0,0.0,0.0,0.0,15398,"Eye Diseases, Hereditary",0.21,1,Biomarker
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,0.0,0.0,0.0,15398,"Eye Diseases, Hereditary",0.21,1,Biomarker
10733,PLK4,polo-like kinase 4,0.0,1.0,0.0,0.0,0.0,15398,"Eye Diseases, Hereditary",0.21,1,Biomarker
6017,RLBP1,retinaldehyde binding protein 1,0.0,1.0,0.0,0.0,0.0,15398,"Eye Diseases, Hereditary",0.21,1,Biomarker
6121,RPE65,retinal pigment epithelium-specific protein 65kDa,0.0,0.0,0.0,0.0,1.0,15398,"Eye Diseases, Hereditary",0.21,1,Therapeutic
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.21,1,Biomarker
9474,ATG5,autophagy related 5,0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.21,1,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.21,1,Biomarker
9970,NR1I3,"nuclear receptor subfamily 1, group I, member 3",0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.21,2,Biomarker
5184,PEPD,peptidase D,0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.21,1,Biomarker
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.21,1,Biomarker
4591,TRIM37,tripartite motif containing 37,0.0,1.0,0.0,0.0,0.0,19209,Hepatomegaly,0.21,1,Biomarker
8322,FZD4,frizzled class receptor 4,0.0,1.0,0.0,0.0,0.0,39075,Syndactyly,0.21,1,Biomarker
3714,JAG2,jagged 2,0.0,1.0,0.0,0.0,0.0,39075,Syndactyly,0.21,1,Biomarker
387574,CMTDIA,"Charcot-Marie-Tooth disease, dominant intermediate 2",0.0,1.0,0.0,0.0,0.0,1847896,"Charcot-Marie-Tooth Disease, Dominant Intermediate A",0.21,0,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,37116,Silicosis,0.21,1,Biomarker
692219,DFNB65,"deafness, autosomal recessive 65",0.0,1.0,0.0,0.0,0.0,1853248,"Deafness, Autosomal Recessive 65",0.21,0,Biomarker
387129,NPSR1,neuropeptide S receptor 1,0.0,1.0,0.0,0.0,0.0,1837811,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2",0.21,0,Biomarker
100528027,RJBS,Rajab syndrome,0.0,1.0,0.0,0.0,0.0,3150910,RAJAB SYNDROME,0.21,0,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,20500,Hyperoxaluria,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,20500,Hyperoxaluria,0.21,1,Biomarker
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,0.0,1.0,0.0,0.0,0.0,20500,Hyperoxaluria,0.21,1,Biomarker
18,ABAT,4-aminobutyrate aminotransferase,0.0,1.0,0.0,0.0,0.0,33922,Psychomotor Disorders,0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,0.0,0.0,0.0,1.0,33922,Psychomotor Disorders,0.21,1,Therapeutic
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,0.0,0.0,0.0,33922,Psychomotor Disorders,0.21,1,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,33922,Psychomotor Disorders,0.21,1,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,33922,Psychomotor Disorders,0.21,1,Biomarker
6197,RPS6KA3,"ribosomal protein S6 kinase, 90kDa, polypeptide 3",0.0,1.0,0.0,0.0,0.0,33922,Psychomotor Disorders,0.21,1,Biomarker
7416,VDAC1,voltage-dependent anion channel 1,0.0,1.0,0.0,0.0,0.0,33922,Psychomotor Disorders,0.21,1,Biomarker
606719,DFNB66,"deafness, autosomal recessive 66",0.0,1.0,0.0,0.0,0.0,1857750,"Deafness, Autosomal Recessive 66",0.21,0,Biomarker
6832,SUPV3L1,"suppressor of var1, 3-like 1 (S. cerevisiae)",0.0,1.0,0.0,0.0,0.0,872084,Sarcopenia,0.21,1,Biomarker
9997,SCO2,SCO2 cytochrome c oxidase assembly protein,0.0,0.0,1.0,0.0,0.0,2681911,MYOPIA 6,0.21,0,GeneticVariation
8642,DCHS1,dachsous cadherin-related 1,0.0,1.0,0.0,0.0,0.0,1842563,"Heterotopia, Periventricular, Autosomal Recessive",0.21,1,Biomarker
79633,FAT4,FAT atypical cadherin 4,0.0,1.0,0.0,0.0,0.0,1842563,"Heterotopia, Periventricular, Autosomal Recessive",0.21,1,Biomarker
472,ATM,ATM serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,86543,Cataract,0.21,1,Biomarker
490,ATP2B1,"ATPase, Ca++ transporting, plasma membrane 1",0.0,1.0,0.0,0.0,0.0,86543,Cataract,0.21,1,Biomarker
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,0.0,0.0,0.0,86543,Cataract,0.21,1,Biomarker
57447,NDRG2,NDRG family member 2,0.0,1.0,0.0,0.0,0.0,86543,Cataract,0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,0.0,0.0,0.0,1.0,16978,Gallbladder Neoplasms,0.21,1,Therapeutic
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,16978,Gallbladder Neoplasms,0.21,1,Biomarker
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,16978,Gallbladder Neoplasms,0.21,1,Biomarker
2065,ERBB3,erb-b2 receptor tyrosine kinase 3,0.0,1.0,0.0,0.0,0.0,16978,Gallbladder Neoplasms,0.21,1,Biomarker
2066,ERBB4,erb-b2 receptor tyrosine kinase 4,0.0,1.0,0.0,0.0,0.0,16978,Gallbladder Neoplasms,0.21,1,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,16978,Gallbladder Neoplasms,0.21,1,Biomarker
7345,UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase),0.0,1.0,0.0,0.0,0.0,16978,Gallbladder Neoplasms,0.21,1,Biomarker
117289,TAGAP,T-cell activation RhoGTPase activating protein,0.0,1.0,0.0,0.0,0.0,2675865,"Diabetes Mellitus, Insulin-Dependent, 21",0.21,0,Biomarker
650,BMP2,bone morphogenetic protein 2,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
2321,FLT1,fms-related tyrosine kinase 1,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
4256,MGP,matrix Gla protein,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
6446,SGK1,serum/glucocorticoid regulated kinase 1,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
7046,TGFBR1,"transforming growth factor, beta receptor 1",0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,41948,Uremia,0.21,1,Biomarker
1167,CLA3,cerebellar ataxia 3 (cerebellar parenchyma disorder 1),0.0,1.0,0.0,0.0,0.0,1842676,"Spinocerebellar ataxia, autosomal recessive 6",0.21,0,Biomarker
72,ACTG2,"actin, gamma 2, smooth muscle, enteric",0.0,0.0,1.0,0.0,0.0,1835084,Megaduodenum and/or Megacystis,0.21,3,GeneticVariation
6006,RHCE,"Rh blood group, CcEe antigens",0.0,1.0,0.0,0.0,0.0,2881,"Anemia, Hemolytic, Congenital",0.21,1,Biomarker
6007,RHD,"Rh blood group, D antigen",0.0,1.0,0.0,0.0,0.0,2881,"Anemia, Hemolytic, Congenital",0.21,1,Biomarker
11315,PARK7,parkinson protein 7,0.0,1.0,0.0,0.0,0.0,206160,Reticulocytosis,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,206160,Reticulocytosis,0.21,1,Biomarker
4934,NYS3,"nystagmus 3, congenital autosomal dominant",0.0,1.0,0.0,0.0,0.0,1842186,"Nystagmus 3, congenital, autosomal dominant",0.21,0,Biomarker
85504,BDET,"Bleeding disorder, east Texas type",0.0,1.0,0.0,0.0,0.0,1853831,"Bleeding Disorder, East Texas Type",0.21,0,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.21,1,Biomarker
28514,DLL1,delta-like 1 (Drosophila),0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.21,1,Biomarker
113878,DTX2,"deltex 2, E3 ubiquitin ligase",0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.21,1,Biomarker
27436,EML4,echinoderm microtubule associated protein like 4,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.21,1,Biomarker
388585,HES5,hes family bHLH transcription factor 5,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.21,1,Biomarker
441478,NRARP,NOTCH-regulated ankyrin repeat protein,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.21,1,Biomarker
5727,PTCH1,patched 1,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.21,1,Biomarker
6608,SMO,"smoothened, frizzled class receptor",0.0,1.0,0.0,0.0,0.0,6118,Brain Neoplasms,0.21,1,Biomarker
100188278,FECD2,"corneal dystrophy, Fuchs endothelial 2",0.0,1.0,0.0,0.0,0.0,1857800,"Corneal dystrophy, Fuchs' endothelial, 2",0.21,0,Biomarker
10664,CTCF,CCCTC-binding factor (zinc finger protein),0.0,1.0,0.0,0.0,0.0,1860789,"Leukemia, Megakaryoblastic, of Down Syndrome",0.21,1,Biomarker
10238,DCAF7,DDB1 and CUL4 associated factor 7,0.0,1.0,0.0,0.0,0.0,1860789,"Leukemia, Megakaryoblastic, of Down Syndrome",0.21,1,Biomarker
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,1860789,"Leukemia, Megakaryoblastic, of Down Syndrome",0.21,1,Biomarker
284058,KANSL1,KAT8 regulatory NSL complex subunit 1,0.0,1.0,0.0,0.0,0.0,1860789,"Leukemia, Megakaryoblastic, of Down Syndrome",0.21,1,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,0.0,0.0,0.0,1860789,"Leukemia, Megakaryoblastic, of Down Syndrome",0.21,1,Biomarker
5885,RAD21,RAD21 homolog (S. pombe),0.0,1.0,0.0,0.0,0.0,1860789,"Leukemia, Megakaryoblastic, of Down Syndrome",0.21,1,Biomarker
10735,STAG2,stromal antigen 2,0.0,1.0,0.0,0.0,0.0,1860789,"Leukemia, Megakaryoblastic, of Down Syndrome",0.21,1,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,1860789,"Leukemia, Megakaryoblastic, of Down Syndrome",0.21,1,Biomarker
1083,CGF1,"cognitive function 1, social",0.0,1.0,0.0,0.0,0.0,1848140,"COGNITIVE FUNCTION 1, SOCIAL",0.21,0,Biomarker
338340,MMS,"Malignant mesothelioma, susceptibility to",0.0,1.0,0.0,0.0,0.0,345967,"Mesothelioma, Malignant",0.21,0,Biomarker
100271689,ANIB10,"Aneurysm, intracranial berry, 10",0.0,1.0,0.0,0.0,0.0,2675484,"Aneurysm, Intracranial Berry, 10",0.21,0,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,242597,Leukocyte-Adhesion Deficiency Syndrome,0.21,1,Biomarker
7928,ISCW,Immune suppression to streptococcal antigen,0.0,1.0,0.0,0.0,0.0,1840264,IMMUNE SUPPRESSION,0.21,0,Biomarker
619402,HPC5,"prostate cancer, hereditary, 5",0.0,1.0,0.0,0.0,0.0,1836436,"Prostate Cancer, Hereditary, 5",0.21,0,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,0.0,0.0,0.0,1.0,32343,Poisoning,0.21,1,Therapeutic
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,0.0,0.0,0.0,1.0,32343,Poisoning,0.21,4,Therapeutic
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.21,1,Biomarker
1030,CDKN2B,"cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)",0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,32343,Poisoning,0.21,1,Therapeutic
1471,CST3,cystatin C,0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.21,1,Biomarker
4051,CYP4F3,"cytochrome P450, family 4, subfamily F, polypeptide 3",0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,32343,Poisoning,0.21,1,Therapeutic
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,32343,Poisoning,0.21,1,Therapeutic
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.21,1,Biomarker
9421,HAND1,heart and neural crest derivatives expressed 1,0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.21,1,Biomarker
5591,PRKDC,"protein kinase, DNA-activated, catalytic polypeptide",0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.21,1,Biomarker
6582,SLC22A2,"solute carrier family 22 (organic cation transporter), member 2",0.0,0.0,0.0,0.0,1.0,32343,Poisoning,0.21,1,Therapeutic
165904,XIRP1,xin actin-binding repeat containing 1,0.0,1.0,0.0,0.0,0.0,32343,Poisoning,0.21,1,Biomarker
100049541,STUT1,"Stuttering, familial persistent 1",0.0,1.0,0.0,0.0,0.0,3489627,"STUTTERING, FAMILIAL PERSISTENT, 1",0.21,0,Biomarker
100190786,CILD8,"Ciliary dyskinesia, primary, 8",0.0,1.0,0.0,0.0,0.0,2677085,"Ciliary Dyskinesia, Primary, 8",0.21,0,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
1999,ELF3,"E74-like factor 3 (ets domain transcription factor, epithelial-specific )",0.0,0.0,0.0,0.0,1.0,273115,Lung Injury,0.21,1,Therapeutic
2252,FGF7,fibroblast growth factor 7,0.0,0.0,0.0,0.0,1.0,273115,Lung Injury,0.21,1,Therapeutic
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
4311,MME,membrane metallo-endopeptidase,0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,0.0,0.0,0.0,1.0,273115,Lung Injury,0.21,1,Therapeutic
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,0.0,0.0,0.0,1.0,273115,Lung Injury,0.21,1,Therapeutic
80310,PDGFD,platelet derived growth factor D,0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,0.0,0.0,0.0,1.0,273115,Lung Injury,0.21,1,Therapeutic
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
3371,TNC,tenascin C,0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,0.0,0.0,0.0,273115,Lung Injury,0.21,1,Biomarker
30813,VSX1,visual system homeobox 1,0.0,1.0,0.0,0.0,0.0,10035,"Corneal Dystrophies, Hereditary",0.21,1,Biomarker
1373,CPS1,"carbamoyl-phosphate synthase 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,2677362,Alveolar capillary dysplasia,0.21,0,Biomarker
2294,FOXF1,forkhead box F1,0.0,1.0,0.0,0.0,0.0,2677362,Alveolar capillary dysplasia,0.21,0,Biomarker
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,0.0,0.0,0.0,2677362,Alveolar capillary dysplasia,0.21,1,Biomarker
387578,AITD1,"Autoimmune thyroid disease, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,920350,"Thyroiditis, Autoimmune",0.21,0,Biomarker
387579,AITD2,"Autoimmune thyroid disease, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,920350,"Thyroiditis, Autoimmune",0.21,0,Biomarker
387581,AITD4,"Autoimmune thyroid disease, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,920350,"Thyroiditis, Autoimmune",0.21,0,Biomarker
57623,ZFAT,zinc finger and AT hook domain containing,0.0,1.0,0.0,0.0,0.0,920350,"Thyroiditis, Autoimmune",0.21,0,Biomarker
23723,DFNA24,"deafness, autosomal dominant 24",0.0,1.0,0.0,0.0,0.0,1853451,"Deafness, Autosomal Dominant 24",0.21,0,Biomarker
574078,GLC1J,"glaucoma 1, open angle, J (juvenile-onset)",0.0,1.0,0.0,0.0,0.0,1837528,"Glaucoma 1, Open Angle, J",0.21,0,Biomarker
10000,AKT3,v-akt murine thymoma viral oncogene homolog 3,0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.21,1,Biomarker
26128,KIAA1279,KIAA1279,0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.21,1,Biomarker
3796,KIF2A,kinesin heavy chain member 2A,0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.21,1,Biomarker
3340,NDST1,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.21,1,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.21,1,Biomarker
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",0.0,1.0,0.0,0.0,0.0,1955869,Malformations of Cortical Development,0.21,1,Biomarker
712,C1QA,"complement component 1, q subcomponent, A chain",0.0,1.0,0.0,0.0,0.0,15230,Exanthema,0.21,1,Biomarker
4598,MVK,mevalonate kinase,0.0,1.0,0.0,0.0,0.0,15230,Exanthema,0.21,1,Biomarker
171513,PAOD1,Peripheral arterial occlusive disease 1,0.0,1.0,0.0,0.0,0.0,1847493,Peripheral Arterial Occlusive Disease 1,0.21,0,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,18946,"Hematoma, Subdural",0.21,1,Biomarker
338,APOB,apolipoprotein B,0.0,0.0,1.0,0.0,0.0,1862598,"HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1",0.21,0,GeneticVariation
3691,ITGB4,"integrin, beta 4",0.0,1.0,0.0,0.0,0.0,13575,Ectodermal Dysplasia,0.21,1,Biomarker
91949,COG7,component of oligomeric golgi complex 7,0.0,1.0,0.0,0.0,0.0,2931010,Congenital disorder of glycosylation type 2E,0.21,0,Biomarker
57817,HAMP,hepcidin antimicrobial peptide,0.0,1.0,0.0,0.0,0.0,1865614,"Hemochromatosis, Type 2A",0.21,0,Biomarker
56033,BARX1,BARX homeobox 1,0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.21,1,Biomarker
23373,CRTC1,CREB regulated transcription coactivator 1,0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.21,1,Biomarker
1794,DOCK2,dedicator of cytokinesis 2,0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.21,1,Biomarker
27086,FOXP1,forkhead box P1,0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.21,1,Biomarker
23111,SPG20,spastic paraplegia 20 (Troyer syndrome),0.0,1.0,0.0,0.0,0.0,279628,Adenocarcinoma Of Esophagus,0.21,1,Biomarker
655,BMP7,bone morphogenetic protein 7,0.0,0.0,0.0,0.0,1.0,34069,Pulmonary Fibrosis,0.21,1,Therapeutic
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,2,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
1232,CCR3,chemokine (C-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
3593,IL12B,interleukin 12B,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
5806,PTX3,"pentraxin 3, long",0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
6498,SKIL,SKI-like proto-oncogene,0.0,0.0,0.0,0.0,1.0,34069,Pulmonary Fibrosis,0.21,1,Therapeutic
4092,SMAD7,SMAD family member 7,0.0,0.0,0.0,0.0,1.0,34069,Pulmonary Fibrosis,0.21,1,Therapeutic
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,34069,Pulmonary Fibrosis,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.21,1,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.21,1,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,0.0,0.0,0.0,1.0,30305,Pancreatitis,0.21,1,Therapeutic
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.21,1,Biomarker
26471,NUPR1,"nuclear protein, transcriptional regulator, 1",0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.21,1,Biomarker
5530,PPP3CA,"protein phosphatase 3, catalytic subunit, alpha isozyme",0.0,1.0,0.0,0.0,0.0,30305,Pancreatitis,0.21,1,Biomarker
6750,SST,somatostatin,0.0,0.0,0.0,0.0,1.0,30305,Pancreatitis,0.21,1,Therapeutic
117084,CANDF1,"candidiasis, familial 1",0.0,1.0,0.0,0.0,0.0,2751429,"Candidiasis, Familial, 1",0.21,0,Biomarker
7834,PCAP,predisposing for prostate cancer,0.0,1.0,0.0,0.0,0.0,1864472,"Prostate Cancer, Hereditary, 8",0.21,0,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,21846,Intestinal Polyps,0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,21846,Intestinal Polyps,0.21,2,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,0.0,0.0,0.0,15672,Fatigue,0.21,1,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,15672,Fatigue,0.21,1,Biomarker
353127,HDLCQ2,High density lipoprotein cholesterol level QTL on chromosome 8,0.0,1.0,0.0,0.0,0.0,1846886,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2,0.21,0,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,9759,Conjunctival Diseases,0.21,1,Biomarker
2289,FKBP5,FK506 binding protein 5,0.0,1.0,0.0,0.0,0.0,21290,"Infant, Newborn, Diseases",0.21,1,Biomarker
780916,GINGF3,"gingival fibromatosis, hereditary, 3",0.0,1.0,0.0,0.0,0.0,1864960,"Fibromatosis, gingival, 3",0.21,0,Biomarker
27235,COQ2,coenzyme Q2 4-hydroxybenzoate polyprenyltransferase,0.0,0.0,1.0,0.0,0.0,3714927,"MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO",0.21,0,GeneticVariation
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,85682,Hypophosphatemia,0.21,1,Biomarker
23,ABCF1,"ATP-binding cassette, sub-family F (GCN20), member 1",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6356,CCL11,chemokine (C-C motif) ligand 11,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6361,CCL17,chemokine (C-C motif) ligand 17,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6363,CCL19,chemokine (C-C motif) ligand 19,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6364,CCL20,chemokine (C-C motif) ligand 20,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6369,CCL24,chemokine (C-C motif) ligand 24,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,2,Biomarker
6354,CCL7,chemokine (C-C motif) ligand 7,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6355,CCL8,chemokine (C-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
1230,CCR1,chemokine (C-C motif) receptor 1,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
1235,CCR6,chemokine (C-C motif) receptor 6,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
10803,CCR9,chemokine (C-C motif) receptor 9,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
29126,CD274,CD274 molecule,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
959,CD40LG,CD40 ligand,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6376,CX3CL1,chemokine (C-X3-C motif) ligand 1,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
2919,CXCL1,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6374,CXCL5,chemokine (C-X-C motif) ligand 5,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
4283,CXCL9,chemokine (C-X-C motif) ligand 9,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
2833,CXCR3,chemokine (C-X-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
1828,DSG1,desmoglein 1,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
3126,HLA-DRB4,"major histocompatibility complex, class II, DR beta 4",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
3127,HLA-DRB5,"major histocompatibility complex, class II, DR beta 5",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
3554,IL1R1,"interleukin 1 receptor, type I",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
7850,IL1R2,"interleukin 1 receptor, type II",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
3560,IL2RB,"interleukin 2 receptor, beta",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
3568,IL5RA,"interleukin 5 receptor, alpha",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
3572,IL6ST,interleukin 6 signal transducer,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
4638,MYLK,myosin light chain kinase,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
5196,PF4,platelet factor 4,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6403,SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
10417,SPON2,"spondin 2, extracellular matrix protein",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,0.0,0.0,0.0,20517,Hypersensitivity,0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,268345,"Ehlers-Danlos Syndrome, Type VII, Autosomal Dominant",0.21,0,Biomarker
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,0.0,0.0,0.0,268345,"Ehlers-Danlos Syndrome, Type VII, Autosomal Dominant",0.21,0,Biomarker
450096,PAPA4,"Polydactyly, postaxial, type A4",0.0,1.0,0.0,0.0,0.0,1837868,"Polydactyly, Postaxial, Type A4",0.21,0,Biomarker
100190982,POROK5,"Porokeratosis, disseminated superficial actinic, 3",0.0,1.0,0.0,0.0,0.0,2676769,"Porokeratosis, Disseminated Superficial Actinic, 3",0.21,0,Biomarker
100499260,AMMEC,"Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis",0.0,1.0,0.0,0.0,0.0,1846242,"Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis",0.21,0,Biomarker
9949,AMMECR1,"Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1",0.0,1.0,0.0,0.0,0.0,1846242,"Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis",0.21,0,Biomarker
100144434,ETL4,"epilepsy, occipitotemporal lobe, and migraine with aura",0.0,1.0,0.0,0.0,0.0,1968847,"Epilepsy, Familial Temporal Lobe, 4",0.21,0,Biomarker
353293,SPG23,spastic paraplegia 23 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,796019,Spastic paraplegia 23,0.21,0,Biomarker
2420,FRDA2,Friedreich ataxia 2,0.0,1.0,0.0,0.0,0.0,1865981,Friedreich Ataxia 2,0.21,0,Biomarker
8114,IV,"inversus situs, viscerum",0.0,1.0,0.0,0.0,0.0,3495537,"HETEROTAXY, VISCERAL, 5, AUTOSOMAL",0.21,0,Biomarker
1649,DDIT3,DNA-damage-inducible transcript 3,0.0,1.0,0.0,0.0,0.0,41582,Ulcer,0.21,1,Biomarker
10105,PPIF,peptidylprolyl isomerase F,0.0,1.0,0.0,0.0,0.0,41582,Ulcer,0.21,1,Biomarker
100240702,PLSA1,"Primary lateral sclerosis, adult, 1",0.0,1.0,0.0,0.0,0.0,1968845,"Primary Lateral Sclerosis, Adult, 1",0.21,0,Biomarker
6794,STK11,serine/threonine kinase 11,0.0,1.0,0.0,0.0,0.0,1257915,Intestinal Polyposis,0.21,1,Biomarker
117189,GRDX,"Graves disease, susceptibility to, X-linked",0.0,1.0,0.0,0.0,0.0,2678151,"GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1",0.21,0,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,1837154,"Drug Metabolism, Poor, CYP2D6-Related",0.21,0,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,14324,Entamoebiasis,0.21,1,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,14324,Entamoebiasis,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,14324,Entamoebiasis,0.21,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,14324,Entamoebiasis,0.21,1,Biomarker
3567,IL5,interleukin 5,0.0,1.0,0.0,0.0,0.0,14324,Entamoebiasis,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,14324,Entamoebiasis,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,2677294,"Atrial Fibrillation, Familial, 6",0.21,0,Biomarker
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,0.0,0.0,0.0,206692,"Carcinoma, Lobular",0.21,1,Biomarker
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,0.0,0.0,206692,"Carcinoma, Lobular",0.21,1,Biomarker
7945,PUJO,pelviureteric junction obstruction,0.0,1.0,0.0,0.0,0.0,1840451,"Multicystic renal dysplasia, bilateral",0.21,0,Biomarker
64239,RSCIS,"Radiation sensitivity/chromosome instability syndrome, autosomal dominant",0.0,1.0,0.0,0.0,0.0,1854244,"Radiation Sensitivity Chromosome Instability Syndrome, Autosomal Dominant",0.21,0,Biomarker
10257,ABCC4,"ATP-binding cassette, sub-family C (CFTR/MRP), member 4",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
3983,ABLIM1,actin binding LIM protein 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
105,ADARB2,"adenosine deaminase, RNA-specific, B2 (non-functional)",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
3899,AFF3,"AF4/FMR2 family, member 3",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
84871,AGBL4,ATP/GTP binding protein-like 4,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
9465,AKAP7,A kinase (PRKA) anchor protein 7,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
121601,ANO4,anoctamin 4,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
55198,APPL2,"adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
481,ATP1B1,"ATPase, Na+/K+ transporting, beta 1 polypeptide",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
8412,BCAR3,breast cancer anti-estrogen resistance 3,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
140683,BPIFA2,"BPI fold containing family A, member 2",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
83938,C10orf11,chromosome 10 open reading frame 11,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
143379,C10orf82,chromosome 10 open reading frame 82,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
147685,C19orf18,chromosome 19 open reading frame 18,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
401207,C5orf63,chromosome 5 open reading frame 63,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
93664,CADPS2,Ca++-dependent secretion activator 2,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
55297,CCDC91,coiled-coil domain containing 91,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
29126,CD274,CD274 molecule,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
64866,CDCP1,CUB domain containing protein 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
1012,CDH13,cadherin 13,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
253782,CERS6,ceramide synthase 6,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
54927,CHCHD3,coiled-coil-helix-coiled-coil-helix domain containing 3,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
9557,CHD1L,chromodomain helicase DNA binding protein 1-like,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
1129,CHRM2,"cholinergic receptor, muscarinic 2",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,3,Biomarker
81035,COLEC12,collectin sub-family member 12,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
64478,CSMD1,CUB and Sushi multiple domains 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
114788,CSMD3,CUB and Sushi multiple domains 3,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
80034,CSRNP3,cysteine-serine-rich nuclear protein 3,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
8048,CSRP3,cysteine and glycine-rich protein 3 (cardiac LIM protein),0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
29119,CTNNA3,"catenin (cadherin-associated protein), alpha 3",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
9547,CXCL14,chemokine (C-X-C motif) ligand 14,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
1653,DDX1,DEAD (Asp-Glu-Ala-Asp) box helicase 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
1769,DNAH8,"dynein, axonemal, heavy chain 8",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
1793,DOCK1,dedicator of cytokinesis 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
1826,DSCAM,Down syndrome cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
1962,EHHADH,"enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
2120,ETV6,ets variant 6,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
2166,FAAH,fatty acid amide hydrolase,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,2,Biomarker
84668,FAM126A,"family with sequence similarity 126, member A",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
79632,FAM184A,"family with sequence similarity 184, member A",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
27146,FAM184B,"family with sequence similarity 184, member B",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
10160,FARP1,"FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
2272,FHIT,fragile histidine triad,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
80206,FHOD3,formin homology 2 domain containing 3,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
23307,FKBP15,"FK506 binding protein 15, 133kDa",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
55691,FRMD4A,FERM domain containing 4A,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
57733,GBA3,"glucosidase, beta, acid 3 (gene/pseudogene)",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
2893,GRIA4,"glutamate receptor, ionotropic, AMPA 4",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
2898,GRIK2,"glutamate receptor, ionotropic, kainate 2",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
2915,GRM5,"glutamate receptor, metabotropic 5",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
2917,GRM7,"glutamate receptor, metabotropic 7",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
259217,HSPA12A,heat shock 70kDa protein 12A,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
10207,INADL,InaD-like (Drosophila),0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
3643,INSR,insulin receptor,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
11278,KLF12,Kruppel-like factor 12,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
143458,LDLRAD3,low density lipoprotein receptor class A domain containing 3,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
84247,LDOC1L,"leucine zipper, down-regulated in cancer 1-like",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
22998,LIMCH1,LIM and calponin homology domains 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
140733,MACROD2,MACRO domain containing 2,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
8569,MKNK1,MAP kinase interacting serine/threonine kinase 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
51660,MPC1,mitochondrial pyruvate carrier 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
143098,MPP7,"membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7)",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
4482,MSRA,methionine sulfoxide reductase A,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
55930,MYO5C,myosin VC,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
4646,MYO6,myosin VI,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
29922,NME7,NME/NM23 family member 7,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
4897,NRCAM,neuronal cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
9369,NRXN3,neurexin 3,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
143503,OR51E1,"olfactory receptor, family 51, subfamily E, member 1",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
55690,PACS1,phosphofurin acidic cluster sorting protein 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
55742,PARVA,"parvin, alpha",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
5087,PBX1,pre-B-cell leukemia homeobox 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
65217,PCDH15,protocadherin-related 15,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
5137,PDE1C,"phosphodiesterase 1C, calmodulin-dependent 70kDa",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
9271,PIWIL1,piwi-like RNA-mediated gene silencing 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
22925,PLA2R1,"phospholipase A2 receptor 1, 180kDa",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
5366,PMAIP1,phorbol-12-myristate-13-acetate-induced protein 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
51082,POLR1D,"polymerase (RNA) I polypeptide D, 16kDa",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
5583,PRKCH,"protein kinase C, eta",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
9128,PRPF4,pre-mRNA processing factor 4,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
5768,QSOX1,quiescin Q6 sulfhydryl oxidase 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
5890,RAD51B,RAD51 paralog B,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
25807,RHBDD3,rhomboid domain containing 3,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
23034,SAMD4A,sterile alpha motif domain containing 4A,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
80031,SEMA6D,"sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
6555,SLC10A2,"solute carrier family 10 (sodium/bile acid cotransporter), member 2",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
6581,SLC22A3,"solute carrier family 22 (organic cation transporter), member 3",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
114134,SLC2A13,"solute carrier family 2 (facilitated glucose transporter), member 13",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
51151,SLC45A2,"solute carrier family 45, member 2",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
9748,SLK,STE20-like kinase,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
23345,SYNE1,"spectrin repeat containing, nuclear envelope 1",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
57451,TENM2,teneurin transmembrane protein 2,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
79875,THSD4,"thrombospondin, type I, domain containing 4",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
26230,TIAM2,T-cell lymphoma invasion and metastasis 2,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
344805,TMPRSS7,"transmembrane protease, serine 7",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
7260,TSSC1,tumor suppressing subtransferable candidate 1,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
79809,TTC21B,tetratricopeptide repeat domain 21B,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
55717,WDR11,WD repeat domain 11,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
114786,XKR4,"XK, Kell blood group complex subunit-related family, member 4",0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
23214,XPO6,exportin 6,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
64131,XYLT1,xylosyltransferase I,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
167465,ZNF366,zinc finger protein 366,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
79750,ZNF385D,zinc finger protein 385D,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
80095,ZNF606,zinc finger protein 606,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
91752,ZNF804A,zinc finger protein 804A,0.0,1.0,0.0,0.0,0.0,236969,Substance-Related Disorders,0.21,1,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
335,APOA1,apolipoprotein A-I,0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
344,APOC2,apolipoprotein C-II,0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
345,APOC3,apolipoprotein C-III,0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
721,C4B,complement component 4B (Chido blood group),0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
2205,FCER1A,"Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide",0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,1.0,11609,Drug Eruptions,0.21,2,"Biomarker, Therapeutic"
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
7276,TTR,transthyretin,0.0,1.0,0.0,0.0,0.0,11609,Drug Eruptions,0.21,1,Biomarker
5745,PTH1R,parathyroid hormone 1 receptor,0.0,1.0,0.0,0.0,0.0,35579,Rickets,0.21,1,Biomarker
126410,CYP4F22,"cytochrome P450, family 4, subfamily F, polypeptide 22",0.0,0.0,1.0,0.0,0.0,1858133,"Ichthyosis, Nonlamellar and Nonerythrodermic, Congenital, Autosomal Recessive",0.21,1,GeneticVariation
8151,WT4,Wilms tumor-4,0.0,1.0,0.0,0.0,0.0,1832426,Wilms Tumor 4,0.21,0,Biomarker
126,ADH1C,"alcohol dehydrogenase 1C (class I), gamma polypeptide",0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
1815,DRD4,dopamine receptor D4,0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
26281,FGF20,fibroblast growth factor 20,0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
4729,NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
170534,PARK10,Parkinson disease 10 (susceptibility),0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
677662,PARK12,Parkinson disease 12 (susceptibility),0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
5072,PARK3,"Parkinson disease 3 (autosomal dominant, Lewy body)",0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
9627,SNCAIP,"synuclein, alpha interacting protein",0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
6908,TBP,TATA box binding protein,0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
7345,UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase),0.0,1.0,0.0,0.0,0.0,3160718,"PARKINSON DISEASE, LATE-ONSET",0.21,0,Biomarker
2746,GLUD1,glutamate dehydrogenase 1,0.0,1.0,0.0,0.0,0.0,15934,Fetal Growth Retardation,0.21,1,Biomarker
4998,ORC1,"origin recognition complex, subunit 1",0.0,1.0,0.0,0.0,0.0,15934,Fetal Growth Retardation,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,15934,Fetal Growth Retardation,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,15934,Fetal Growth Retardation,0.21,1,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,0.0,0.0,0.0,1847529,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3",0.21,1,Biomarker
171512,ADIPQTL3,Circulating adiponectin QTL on chromosome 14,0.0,1.0,0.0,0.0,0.0,1847529,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3",0.21,1,Biomarker
100302516,CTEPH1,"Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to",0.0,1.0,0.0,0.0,0.0,2748504,"PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN THROMBOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,0.0,1.0,0.0,0.0,410480,Avascular necrosis of the head of femur,0.21,0,GeneticVariation
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,32290,"Pneumonia, Aspiration",0.21,1,Biomarker
8022,LHX3,LIM homeobox 3,0.0,1.0,0.0,0.0,0.0,878683,"Pituitary Hormone Deficiency, Combined, 2",0.21,0,Biomarker
5449,POU1F1,POU class 1 homeobox 1,0.0,1.0,0.0,0.0,0.0,878683,"Pituitary Hormone Deficiency, Combined, 2",0.21,0,Biomarker
25836,NIPBL,Nipped-B homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,260662,Hearing Disorders,0.21,1,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,260662,Hearing Disorders,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,919532,Genomic Instability,0.21,1,Biomarker
83932,SPRTN,SprT-like N-terminal domain,0.0,1.0,0.0,0.0,0.0,919532,Genomic Instability,0.21,1,Biomarker
383,ARG1,arginase 1,0.0,1.0,0.0,0.0,0.0,21053,Immune System Diseases,0.21,1,Biomarker
1269,CNR2,cannabinoid receptor 2 (macrophage),0.0,1.0,0.0,0.0,0.0,21053,Immune System Diseases,0.21,1,Biomarker
440275,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,0.0,1.0,0.0,0.0,0.0,21053,Immune System Diseases,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,21053,Immune System Diseases,0.21,1,Biomarker
2933,GSM1,geniospasm 1,0.0,1.0,0.0,0.0,0.0,1860972,Geniospasm,0.21,0,Biomarker
5222,PGA5,"pepsinogen 5, group I (pepsinogen A)",0.0,1.0,0.0,0.0,0.0,14868,Esophagitis,0.21,1,Biomarker
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,14868,Esophagitis,0.21,1,Biomarker
619406,HPE8,holoprosencephaly 8,0.0,1.0,0.0,0.0,0.0,1836254,Holoprosencephaly 8,0.21,0,Biomarker
114609,TIRAP,toll-interleukin 1 receptor (TIR) domain containing adaptor protein,0.0,1.0,0.0,0.0,0.0,32269,Pneumococcal Infections,0.21,1,Biomarker
2215,FCGR3B,"Fc fragment of IgG, low affinity IIIb, receptor (CD16b)",0.0,1.0,0.0,0.0,0.0,3495801,Granulomatosis with Polyangiitis,0.21,1,Biomarker
474168,WG,Wegener granulomatosis,0.0,1.0,0.0,0.0,0.0,3495801,Granulomatosis with Polyangiitis,0.21,0,Biomarker
1483,CTAA1,"cataract, anterior polar 1",0.0,1.0,0.0,0.0,0.0,1413785,"CATARACT 32, MULTIPLE TYPES",0.21,0,Biomarker
100499532,ATPLS,"antiphospholipid syndrome, familial",0.0,1.0,0.0,0.0,0.0,2930802,Familial antiphospholipid syndrome,0.21,0,Biomarker
100301527,SYNSTH,Synesthesia,0.0,1.0,0.0,0.0,0.0,233778,Synesthesia,0.21,0,Biomarker
353125,HDLC3,"High density lipoprotein cholesterol, low serum, 3",0.0,1.0,0.0,0.0,0.0,1843212,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3,0.21,0,Biomarker
2444,FRK,fyn-related Src family tyrosine kinase,0.0,1.0,0.0,0.0,0.0,271650,Glucose Intolerance,0.21,1,Biomarker
79661,NEIL1,nei endonuclease VIII-like 1 (E. coli),0.0,1.0,0.0,0.0,0.0,271650,Glucose Intolerance,0.21,1,Biomarker
10549,PRDX4,peroxiredoxin 4,0.0,0.0,0.0,0.0,1.0,271650,Glucose Intolerance,0.21,1,Therapeutic
5562,PRKAA1,"protein kinase, AMP-activated, alpha 1 catalytic subunit",0.0,1.0,0.0,0.0,0.0,271650,Glucose Intolerance,0.21,1,Biomarker
5563,PRKAA2,"protein kinase, AMP-activated, alpha 2 catalytic subunit",0.0,1.0,0.0,0.0,0.0,271650,Glucose Intolerance,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,0.0,0.0,0.0,1.0,271650,Glucose Intolerance,0.21,1,Therapeutic
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,271650,Glucose Intolerance,0.21,1,Biomarker
2234,2-Feb,febrile convulsions 2,0.0,1.0,0.0,0.0,0.0,1865342,"Febrile Convulsions, Familial, 2",0.21,0,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,13922,Embolism,0.21,1,Therapeutic
1738,DLD,dihydrolipoamide dehydrogenase,0.0,1.0,0.0,0.0,0.0,24776,Maple Syrup Urine Disease,0.21,0,Biomarker
2651,GCNT2,"glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)",0.0,1.0,0.0,0.0,0.0,220721,"CATARACT, CONGENITAL OR JUVENILE",0.21,0,Biomarker
100190787,GEFSP6,"Generalized epilepsy with febrile seizures plus, type 6",0.0,1.0,0.0,0.0,0.0,2677078,"Generalized Epilepsy With Febrile Seizures Plus, Type 6",0.21,0,Biomarker
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,32963,"Pregnancy Complications, Cardiovascular",0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,32963,"Pregnancy Complications, Cardiovascular",0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,32963,"Pregnancy Complications, Cardiovascular",0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,32963,"Pregnancy Complications, Cardiovascular",0.21,1,Biomarker
449013,ANIB2,"aneurysm, intracranial berry 2",0.0,1.0,0.0,0.0,0.0,1837894,"Aneurysm, intracranial berry, 2",0.21,0,Biomarker
100190785,IS4,"Scoliosis, idiopathic, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,2677108,"SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 4",0.21,0,Biomarker
9566,HPCX,"hereditary prostate cancer, X-linked",0.0,1.0,0.0,0.0,0.0,1846279,"PROSTATE CANCER, HEREDITARY, X-LINKED 1",0.21,0,Biomarker
939,CD27,CD27 molecule,0.0,1.0,0.0,0.0,0.0,6625,Cachexia,0.21,1,Biomarker
1004,CDH6,"cadherin 6, type 2, K-cadherin (fetal kidney)",0.0,1.0,0.0,0.0,0.0,6625,Cachexia,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,6625,Cachexia,0.21,1,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,1.0,0.0,0.0,0.0,242973,Ventricular Dysfunction,0.21,1,Biomarker
135,ADORA2A,adenosine A2a receptor,0.0,1.0,0.0,0.0,0.0,242973,Ventricular Dysfunction,0.21,1,Biomarker
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,0.0,0.0,0.0,1.0,242973,Ventricular Dysfunction,0.21,1,Therapeutic
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,242973,Ventricular Dysfunction,0.21,1,Biomarker
2548,GAA,"glucosidase, alpha; acid",0.0,1.0,0.0,0.0,0.0,242973,Ventricular Dysfunction,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,242973,Ventricular Dysfunction,0.21,2,Biomarker
51094,ADIPOR1,adiponectin receptor 1,0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
79602,ADIPOR2,adiponectin receptor 2,0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
406,ARNTL,aryl hydrocarbon receptor nuclear translocator-like,0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
9254,CACNA2D2,"calcium channel, voltage-dependent, alpha 2/delta subunit 2",0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
1050,CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
1051,CEBPB,"CCAAT/enhancer binding protein (C/EBP), beta",0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
1719,DHFR,dihydrofolate reductase,0.0,0.0,0.0,0.0,1.0,21361,"Infertility, Female",0.21,1,Therapeutic
2488,FSHB,"follicle stimulating hormone, beta polypeptide",0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
7026,NR2F2,"nuclear receptor subfamily 2, group F, member 2",0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
2494,NR5A2,"nuclear receptor subfamily 5, group A, member 2",0.0,1.0,0.0,0.0,0.0,21361,"Infertility, Female",0.21,1,Biomarker
10084,PQBP1,polyglutamine binding protein 1,0.0,1.0,0.0,0.0,0.0,37773,"Spastic Paraplegia, Hereditary",0.21,1,Biomarker
9895,TECPR2,tectonin beta-propeller repeat containing 2,0.0,1.0,0.0,0.0,0.0,37773,"Spastic Paraplegia, Hereditary",0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,271583,"ACTH Deficiency, Isolated",0.21,0,Biomarker
3458,IFNG,"interferon, gamma",0.0,0.0,0.0,0.0,1.0,23241,Legionnaires' Disease,0.21,1,Therapeutic
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,162671,MELAS Syndrome,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,162671,MELAS Syndrome,0.21,1,Biomarker
100190930,IBD16,Inflammatory bowel disease-16,0.0,1.0,0.0,0.0,0.0,2677093,Inflammatory Bowel Disease 16,0.21,0,Biomarker
64802,NMNAT1,nicotinamide nucleotide adenylyltransferase 1,0.0,1.0,0.0,0.0,0.0,1852767,Hereditary macular coloboma,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,36216,"Sarcoma, Experimental",0.21,1,Therapeutic
8782,MYP3,"myopia 3 (high grade, autosomal dominant)",0.0,1.0,0.0,0.0,0.0,1864111,Myopia 3,0.21,0,Biomarker
476,ATP1A1,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",0.0,1.0,0.0,0.0,0.0,20428,Hyperaldosteronism,0.21,1,Biomarker
492,ATP2B3,"ATPase, Ca++ transporting, plasma membrane 3",0.0,1.0,0.0,0.0,0.0,20428,Hyperaldosteronism,0.21,1,Biomarker
776,CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",0.0,1.0,0.0,0.0,0.0,20428,Hyperaldosteronism,0.21,1,Biomarker
54829,ASPN,asporin,0.0,1.0,0.0,0.0,0.0,158252,Intervertebral disc disease,0.21,0,Biomarker
8483,CILP,"cartilage intermediate layer protein, nucleotide pyrophosphohydrolase",0.0,1.0,0.0,0.0,0.0,158252,Intervertebral disc disease,0.21,0,Biomarker
1301,COL11A1,"collagen, type XI, alpha 1",0.0,1.0,0.0,0.0,0.0,158252,Intervertebral disc disease,0.21,0,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,158252,Intervertebral disc disease,0.21,0,Biomarker
7058,THBS2,thrombospondin 2,0.0,1.0,0.0,0.0,0.0,158252,Intervertebral disc disease,0.21,0,Biomarker
23459,CMD1H,"cardiomyopathy, dilated 1H (autosomal dominant)",0.0,1.0,0.0,0.0,0.0,2931157,Idiopathic dilation cardiomyopathy,0.21,0,Biomarker
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
9429,ABCG2,"ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)",0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
6352,CCL5,chemokine (C-C motif) ligand 5,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
915,CD3D,"CD3d molecule, delta (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
941,CD80,CD80 molecule,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
1003,CDH5,"cadherin 5, type 2 (vascular endothelium)",0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
643,CXCR5,chemokine (C-X-C motif) receptor 5,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
163486,DENND1B,DENN/MADD domain containing 1B,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
3385,ICAM3,intercellular adhesion molecule 3,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
3484,IGFBP1,insulin-like growth factor binding protein 1,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
3593,IL12B,interleukin 12B,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
3575,IL7R,interleukin 7 receptor,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
3855,KRT7,"keratin 7, type II",0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
4015,LOX,lysyl oxidase,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
4017,LOXL2,lysyl oxidase-like 2,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
10412,NSA2,NSA2 ribosome biogenesis homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
200931,SLC51A,"solute carrier family 51, alpha subunit",0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
123264,SLC51B,"solute carrier family 51, beta subunit",0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
6775,STAT4,signal transducer and activator of transcription 4,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
7297,TYK2,tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
10537,UBD,ubiquitin D,0.0,1.0,0.0,0.0,0.0,23892,"Liver Cirrhosis, Biliary",0.21,1,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,8313,"Cholangitis, Sclerosing",0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,8313,"Cholangitis, Sclerosing",0.21,1,Biomarker
2133,EXT3,exostoses (multiple) 3,0.0,1.0,0.0,0.0,0.0,1838420,"Exostoses, Multiple, Type III",0.21,0,Biomarker
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",0.0,1.0,0.0,0.0,0.0,10074,Coronary Vessel Anomalies,0.21,1,Biomarker
4901,NRL,neural retina leucine zipper,0.0,0.0,1.0,0.0,0.0,1417848,NEURAL RETINA LEUCINE ZIPPER,0.21,0,GeneticVariation
59333,NMSR,"Neuropathy, hereditary motor and sensory, Russe type",0.0,1.0,0.0,0.0,0.0,1854449,"Neuropathy, hereditary motor and sensory, Russe type",0.21,0,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,0.0,0.0,0.0,1.0,5396,Bile Duct Neoplasms,0.21,1,Therapeutic
238,ALK,anaplastic lymphoma receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,18199,"Granuloma, Plasma Cell",0.21,3,Biomarker
5903,RANBP2,RAN binding protein 2,0.0,1.0,0.0,0.0,0.0,18199,"Granuloma, Plasma Cell",0.21,1,Biomarker
4004,LMO1,LIM domain only 1 (rhombotin 1),0.0,1.0,0.0,0.0,0.0,23492,"Leukemia, T-Cell",0.21,2,Biomarker
5771,PTPN2,"protein tyrosine phosphatase, non-receptor type 2",0.0,1.0,0.0,0.0,0.0,23492,"Leukemia, T-Cell",0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,25287,Meningism,0.21,1,Biomarker
6750,SST,somatostatin,0.0,0.0,0.0,0.0,1.0,14849,Esophageal and Gastric Varices,0.21,1,Therapeutic
7446,AVSD1,atrioventricular septal defect 1,0.0,1.0,0.0,0.0,0.0,3275750,ATRIOVENTRICULAR SEPTAL DEFECT 3,0.21,0,Biomarker
1555,CYP2B6,"cytochrome P450, family 2, subfamily B, polypeptide 6",0.0,0.0,0.0,0.0,1.0,206726,Gliosarcoma,0.21,2,Therapeutic
1562,CYP2C18,"cytochrome P450, family 2, subfamily C, polypeptide 18",0.0,0.0,0.0,0.0,1.0,206726,Gliosarcoma,0.21,1,Therapeutic
5447,POR,P450 (cytochrome) oxidoreductase,0.0,0.0,0.0,0.0,1.0,206726,Gliosarcoma,0.21,1,Therapeutic
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,206726,Gliosarcoma,0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.21,1,Biomarker
883,CCBL1,"cysteine conjugate-beta lyase, cytoplasmic",0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.21,1,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,22665,Kidney Neoplasms,0.21,1,Biomarker
6528,SLC5A5,"solute carrier family 5 (sodium/iodide cotransporter), member 5",0.0,0.0,0.0,0.0,1.0,22665,Kidney Neoplasms,0.21,1,Therapeutic
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,0.0,0.0,0.0,1.0,22665,Kidney Neoplasms,0.21,1,Therapeutic
100302681,PVNH3,Periventricular nodular heterotopia 3,0.0,1.0,0.0,0.0,0.0,1842562,"Heterotopia, Periventricular, associated with Chromosome 5p Anomalies",0.21,0,Biomarker
100188858,ANIB6,"Aneurysm, intracranial berry, 6",0.0,1.0,0.0,0.0,0.0,2678469,"Aneurysm, Intracranial Berry, 6",0.21,0,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,574960,Sacroiliitis,0.21,1,Therapeutic
6834,SURF1,surfeit 1,0.0,1.0,0.0,0.0,0.0,1857355,"Leigh syndrome , French Canadian type",0.21,1,Biomarker
51750,RTEL1,regulator of telomere elongation helicase 1,0.0,0.0,1.0,0.0,0.0,3554656,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 5",0.21,4,GeneticVariation
1080,CFTR,"cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)",0.0,1.0,0.0,0.0,0.0,2749757,Bronchiectasis With Or Without Elevated Sweat Chloride 1,0.21,0,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,0.0,0.0,0.0,1.0,394016,"Coma, Post-Head Injury",0.21,1,Therapeutic
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,27066,Myoclonus,0.21,1,Biomarker
732,C8B,"complement component 8, beta polypeptide",0.0,1.0,0.0,0.0,0.0,3495559,"Arthritis, Juvenile",0.21,1,Biomarker
1387,CREBBP,CREB binding protein,0.0,1.0,0.0,0.0,0.0,24301,"Lymphoma, Follicular",0.21,1,Biomarker
1879,EBF1,early B-cell factor 1,0.0,1.0,0.0,0.0,0.0,24301,"Lymphoma, Follicular",0.21,1,Biomarker
100306940,FL1,"Follicular lymphoma, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,24301,"Lymphoma, Follicular",0.21,0,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,24301,"Lymphoma, Follicular",0.21,1,Therapeutic
4615,MYD88,myeloid differentiation primary response 88,0.0,1.0,0.0,0.0,0.0,24301,"Lymphoma, Follicular",0.21,1,Biomarker
7128,TNFAIP3,"tumor necrosis factor, alpha-induced protein 3",0.0,1.0,0.0,0.0,0.0,24301,"Lymphoma, Follicular",0.21,1,Biomarker
1253,CMTX2,"Charcot-Marie-Tooth neuropathy, X-linked 2 (recessive)",0.0,1.0,0.0,0.0,0.0,1844873,"Charcot-Marie-Tooth disease, X-linked recessive, 2",0.21,0,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,1.0,3811,"Arrhythmias, Cardiac",0.21,2,"Biomarker, Therapeutic"
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.21,1,Biomarker
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",0.0,1.0,0.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.21,1,Biomarker
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,0.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.21,1,Biomarker
2992,GYG1,glycogenin 1,0.0,1.0,0.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.21,1,Biomarker
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",0.0,1.0,0.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,0.0,0.0,0.0,1.0,3811,"Arrhythmias, Cardiac",0.21,1,Therapeutic
4986,OPRK1,"opioid receptor, kappa 1",0.0,0.0,0.0,0.0,1.0,3811,"Arrhythmias, Cardiac",0.21,1,Therapeutic
4987,OPRL1,opiate receptor-like 1,0.0,0.0,0.0,0.0,1.0,3811,"Arrhythmias, Cardiac",0.21,1,Therapeutic
5502,PPP1R1A,"protein phosphatase 1, regulatory (inhibitor) subunit 1A",0.0,1.0,0.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.21,1,Biomarker
151648,SGOL1,shugoshin-like 1 (S. pombe),0.0,1.0,0.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.21,1,Biomarker
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",0.0,1.0,0.0,0.0,0.0,851578,Sleep Disorders,0.21,1,Biomarker
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,1.0,0.0,0.0,0.0,851578,Sleep Disorders,0.21,1,Biomarker
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",0.0,1.0,0.0,0.0,0.0,851578,Sleep Disorders,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,851578,Sleep Disorders,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,851578,Sleep Disorders,0.21,1,Biomarker
3691,ITGB4,"integrin, beta 4",0.0,1.0,0.0,0.0,0.0,79298,Epidermolysis Bullosa Simplex,0.21,0,Biomarker
266691,DYX6,dyslexia susceptibility 6,0.0,1.0,0.0,0.0,0.0,476254,Dyslexia,0.21,0,Biomarker
474159,DYX9,dyslexia susceptibility 9,0.0,1.0,0.0,0.0,0.0,476254,Dyslexia,0.21,0,Biomarker
50942,IBD6,inflammatory bowel disease 6,0.0,1.0,0.0,0.0,0.0,1847692,Inflammatory Bowel Disease 6,0.21,0,Biomarker
2243,FGA,fibrinogen alpha chain,0.0,1.0,0.0,0.0,0.0,740340,"Amyloidosis, Familial",0.21,2,Biomarker
5979,RET,ret proto-oncogene,0.0,1.0,0.0,0.0,0.0,740340,"Amyloidosis, Familial",0.21,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,18816,Heart Septal Defects,0.21,1,Biomarker
85507,DFNA18,"deafness, autosomal dominant 18",0.0,1.0,0.0,0.0,0.0,1853760,"Deafness, Autosomal Dominant 18",0.21,0,Biomarker
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,0.0,32461,Polycythemia,0.21,1,Biomarker
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,1.0,0.0,0.0,0.0,242852,"Vitreoretinopathy, Proliferative",0.21,1,Biomarker
156,ADRBK1,"adrenergic, beta, receptor kinase 1",0.0,1.0,0.0,0.0,0.0,752351,Embryo Loss,0.21,1,Biomarker
2879,GPX4,glutathione peroxidase 4,0.0,1.0,0.0,0.0,0.0,752351,Embryo Loss,0.21,1,Biomarker
51451,LCMT1,leucine carboxyl methyltransferase 1,0.0,1.0,0.0,0.0,0.0,752351,Embryo Loss,0.21,1,Biomarker
3976,LIF,leukemia inhibitory factor,0.0,1.0,0.0,0.0,0.0,752351,Embryo Loss,0.21,1,Biomarker
8505,PARG,poly (ADP-ribose) glycohydrolase,0.0,1.0,0.0,0.0,0.0,752351,Embryo Loss,0.21,1,Biomarker
1317,SLC31A1,"solute carrier family 31 (copper transporter), member 1",0.0,1.0,0.0,0.0,0.0,752351,Embryo Loss,0.21,1,Biomarker
7334,UBE2N,ubiquitin-conjugating enzyme E2N,0.0,1.0,0.0,0.0,0.0,752351,Embryo Loss,0.21,1,Biomarker
777642,RP34,retinitis pigmentosa 34 (X-linked recessive),0.0,1.0,0.0,0.0,0.0,1845104,Retinitis Pigmentosa 34,0.21,0,Biomarker
3702,ITK,IL2-inducible T-cell kinase,0.0,0.0,1.0,0.0,0.0,3552634,LYMPHOPROLIFERATIVE SYNDROME 1,0.21,1,GeneticVariation
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,2,Biomarker
148,ADRA1A,adrenoceptor alpha 1A,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
203286,ANKS6,ankyrin repeat and sterile alpha motif domain containing 6,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
405,ARNT,aryl hydrocarbon receptor nuclear translocator,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
1131,CHRM3,"cholinergic receptor, muscarinic 3",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
150684,COMMD1,copper metabolism (Murr1) domain containing 1,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
1593,CYP27A1,"cytochrome P450, family 27, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
120227,CYP2R1,"cytochrome P450, family 2, subfamily R, polypeptide 1",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
1717,DHCR7,7-dehydrocholesterol reductase,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
2252,FGF7,fibroblast growth factor 7,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
2638,GC,group-specific component (vitamin D binding protein),0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
3727,JUND,jun D proto-oncogene,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
406997,MIR215,microRNA 215,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
407026,MIR29C,microRNA 29c,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
442895,MIR302C,microRNA 302c,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
407030,MIR30B,microRNA 30b,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
407032,MIR30C2,microRNA 30c-2,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
442913,MIR376C,microRNA 376c,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
574506,MIR503,microRNA 503,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
100313838,MIR764,microRNA 764,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
4864,NPC1,"Niemann-Pick disease, type C1",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
871,SERPINH1,"serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
91147,TMEM67,transmembrane protein 67,0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
54822,TRPM7,"transient receptor potential cation channel, subfamily M, member 7",0.0,1.0,0.0,0.0,0.0,23890,Liver Cirrhosis,0.21,1,Biomarker
5162,PDHB,pyruvate dehydrogenase (lipoamide) beta,0.0,0.0,1.0,0.0,0.0,3279841,Pyruvate Dehydrogenase E1-Beta Deficiency,0.21,1,GeneticVariation
791228,SPG36,spastic paraplegia 36 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,2936879,"Spastic Paraplegia 36, Autosomal Dominant",0.21,0,Biomarker
100322879,SPG45,spastic paraplegia 45 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,2680447,"SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE",0.21,0,Biomarker
8246,MRXS12,"Mental retardation, X-linked, syndromic 12",0.0,1.0,0.0,0.0,0.0,1839792,"Mental Retardation, X-Linked, Syndromic 12",0.21,0,Biomarker
266710,COMA,Cogan-type congential oculomotor apraxia,0.0,1.0,0.0,0.0,0.0,543874,"Apraxia, oculomotor, Cogan type",0.21,0,Biomarker
56801,HDLCQ14,"Hypoalphalipoproteinemia, primary",0.0,1.0,0.0,0.0,0.0,3551749,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 14,0.21,0,Biomarker
27031,NPHP3,nephronophthisis 3 (adolescent),0.0,1.0,0.0,0.0,0.0,2673885,Renal hepatic pancreatic dysplasia Dandy Walker cyst,0.21,0,Biomarker
2303,FOXC2,forkhead box C2,0.0,1.0,0.0,0.0,0.0,221348,Yellow Nail Syndrome,0.21,0,Biomarker
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6059,ABCE1,"ATP-binding cassette, sub-family E (OABP), member 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10006,ABI1,abl-interactor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2180,ACSL1,acyl-CoA synthetase long-chain family member 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10097,ACTR2,ARP2 actin-related protein 2 homolog (yeast),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
90,ACVR1,"activin A receptor, type I",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
102,ADAM10,ADAM metallopeptidase domain 10,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8038,ADAM12,ADAM metallopeptidase domain 12,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8754,ADAM9,ADAM metallopeptidase domain 9,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
27299,ADAMDEC1,"ADAM-like, decysin 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9510,ADAMTS1,"ADAM metallopeptidase with thrombospondin type 1 motif, 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
140,ADORA3,adenosine A3 receptor,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
159,ADSS,adenylosuccinate synthase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
178,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8540,AGPS,alkylglycerone phosphate synthase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9447,AIM2,absent in melanoma 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
79647,AKIRIN1,akirin 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
29929,ALG6,"ALG6, alpha-1,3-glucosyltransferase",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
241,ALOX5AP,arachidonate 5-lipoxygenase-activating protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55608,ANKRD10,ankyrin repeat domain 10,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
308,ANXA5,annexin A5,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
313,AOAH,acyloxyacyl hydrolase (neutrophil),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55435,AP1AR,adaptor-related protein complex 1 associated regulatory protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9582,APOBEC3B,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
341,APOC1,apolipoprotein C-I,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55198,APPL2,"adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10565,ARFGEF1,ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10564,ARFGEF2,ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9824,ARHGAP11A,Rho GTPase activating protein 11A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
58504,ARHGAP22,Rho GTPase activating protein 22,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10550,ARL6IP5,ADP-ribosylation factor-like 6 interacting protein 5,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55156,ARMC1,armadillo repeat containing 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
56938,ARNTL2,aryl hydrocarbon receptor nuclear translocator-like 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10973,ASCC3,activating signal cointegrator 1 complex subunit 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
259266,ASPM,"asp (abnormal spindle) homolog, microcephaly associated (Drosophila)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
29028,ATAD2,"ATPase family, AAA domain containing 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
490,ATP2B1,"ATPase, Ca++ transporting, plasma membrane 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
515,ATP5F1,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10159,ATP6AP2,"ATPase, H+ transporting, lysosomal accessory protein 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
526,ATP6V1B2,"ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6790,AURKA,aurora kinase A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9212,AURKB,aurora kinase B,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51582,AZIN1,antizyme inhibitor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
586,BCAT1,"branched chain amino-acid transaminase 1, cytosolic",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
332,BIRC5,baculoviral IAP repeat containing 5,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
695,BTK,Bruton agammaglobulinemia tyrosine kinase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
699,BUB1,BUB1 mitotic checkpoint serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
57103,C12orf5,chromosome 12 open reading frame 5,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
712,C1QA,"complement component 1, q subcomponent, A chain",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,2,Biomarker
713,C1QB,"complement component 1, q subcomponent, B chain",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
717,C2,complement component 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54149,C21orf91,chromosome 21 open reading frame 91,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54969,C4orf27,chromosome 4 open reading frame 27,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
79624,C6orf211,chromosome 6 open reading frame 211,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51719,CAB39,calcium binding protein 39,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
821,CANX,calnexin,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4076,CAPRIN1,cell cycle associated protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
830,CAPZA2,"capping protein (actin filament) muscle Z-line, alpha 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64170,CARD9,"caspase recruitment domain family, member 9",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
865,CBFB,"core-binding factor, beta subunit",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
891,CCNB1,cyclin B1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9133,CCNB2,cyclin B2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
892,CCNC,cyclin C,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
57018,CCNL1,cyclin L1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1230,CCR1,chemokine (C-C motif) receptor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
729230,CCR2,chemokine (C-C motif) receptor 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
22948,CCT5,"chaperonin containing TCP1, subunit 5 (epsilon)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9332,CD163,CD163 molecule,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
912,CD1D,CD1d molecule,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
951,CD37,CD37 molecule,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
917,CD3G,"CD3g molecule, gamma (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
920,CD4,CD4 molecule,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
963,CD53,CD53 molecule,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
991,CDC20,cell division cycle 20,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64866,CDCP1,CUB domain containing protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8099,CDK2AP1,cyclin-dependent kinase 2 associated protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1033,CDKN3,cyclin-dependent kinase inhibitor 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10659,CELF2,"CUGBP, Elav-like family member 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1058,CENPA,centromere protein A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1063,CENPF,"centromere protein F, 350/400kDa",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55839,CENPN,centromere protein N,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55165,CEP55,centrosomal protein 55kDa,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1111,CHEK1,checkpoint kinase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
25978,CHMP2B,charged multivesicular body protein 2B,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9435,CHST2,carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1147,CHUK,conserved helix-loop-helix ubiquitous kinase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51727,CMPK1,"cytidine monophosphate (UMP-CMP) kinase 1, cytosolic",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
81578,COL21A1,"collagen, type XXI, alpha 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23603,CORO1C,"coronin, actin binding protein, 1C",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
11052,CPSF6,"cleavage and polyadenylation specific factor 6, 68kDa",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51379,CRLF3,cytokine receptor-like factor 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1436,CSF1R,colony stimulating factor 1 receptor,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1520,CTSS,cathepsin S,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8450,CUL4B,cullin 4B,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51167,CYB5R4,cytochrome b5 reductase 4,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9201,DCLK1,doublecortin-like kinase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1654,DDX3X,"DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1670,DEFA5,"defensin, alpha 5, Paneth cell-specific",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,2,Biomarker
8560,DEGS1,"delta(4)-desaturase, sphingolipid 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23405,DICER1,"dicer 1, ribonuclease type III",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9787,DLGAP5,"discs, large (Drosophila) homolog-associated protein 5",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54431,DNAJC10,"DnaJ (Hsp40) homolog, subfamily C, member 10",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55619,DOCK10,dedicator of cytokinesis 10,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1794,DOCK2,dedicator of cytokinesis 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1824,DSC2,desmocollin 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1832,DSP,desmoplakin,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51514,DTL,denticleless E3 ubiquitin protein ligase homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
11221,DUSP10,dual specificity phosphatase 10,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8445,DYRK2,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1894,ECT2,epithelial cell transforming 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23167,EFR3A,EFR3 homolog A (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1965,EIF2S1,"eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
79071,ELOVL6,ELOVL fatty acid elongase 6,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2069,EREG,epiregulin,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51290,ERGIC2,ERGIC and golgi 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10613,ERLIN1,ER lipid raft associated 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
30001,ERO1L,ERO1-like (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55500,ETNK1,ethanolamine kinase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2123,EVI2A,ecotropic viral integration site 2A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2124,EVI2B,ecotropic viral integration site 2B,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2161,F12,coagulation factor XII (Hageman factor),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54491,FAM105A,"family with sequence similarity 105, member A",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51313,FAM198B,"family with sequence similarity 198, member B",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
29902,FAM216A,"family with sequence similarity 216, member A",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
60343,FAM3A,"family with sequence similarity 3, member A",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
81553,FAM49A,"family with sequence similarity 49, member A",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51571,FAM49B,"family with sequence similarity 49, member B",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54478,FAM64A,"family with sequence similarity 64, member A",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55215,FANCI,"Fanconi anemia, complementation group I",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2191,FAP,"fibroblast activation protein, alpha",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
22868,FASTKD2,FAST kinase domains 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
26235,FBXL4,F-box and leucine-rich repeat protein 4,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8061,FOSL1,FOS-like antigen 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2305,FOXM1,forkhead box M1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2359,FPR3,formyl peptide receptor 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2526,FUT4,"fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10146,G3BP1,GTPase activating protein (SH3 domain) binding protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2553,GABPB1,"GA binding protein transcription factor, beta subunit 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2585,GALK2,galactokinase 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2589,GALNT1,polypeptide N-acetylgalactosaminyltransferase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51809,GALNT7,polypeptide N-acetylgalactosaminyltransferase 7,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8522,GAS7,growth arrest-specific 7,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2632,GBE1,"glucan (1,4-alpha-), branching enzyme 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9837,GINS1,GINS complex subunit 1 (Psf1 homolog),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
11010,GLIPR1,GLI pathogenesis-related 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10539,GLRX3,glutaredoxin 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55970,GNG12,"guanine nucleotide binding protein (G protein), gamma 12",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2799,GNS,glucosamine (N-acetyl)-6-sulfatase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10457,GPNMB,glycoprotein (transmembrane) nmb,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
1880,GPR183,G protein-coupled receptor 183,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8477,GPR65,G protein-coupled receptor 65,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9555,H2AFY,"H2A histone family, member Y",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3015,H2AFZ,"H2A histone family, member Z",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3059,HCLS1,hematopoietic cell-specific Lyn substrate 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3074,HEXB,hexosaminidase B (beta polypeptide),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
25994,HIGD1A,"HIG1 hypoxia inducible domain family, member 1A",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55355,HJURP,Holliday junction recognition protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6596,HLTF,helicase-like transcription factor,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10473,HMGN4,high mobility group nucleosomal binding domain 4,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3161,HMMR,hyaluronan-mediated motility receptor (RHAMM),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10855,HPSE,heparanase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3308,HSPA4,heat shock 70kDa protein 4,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55699,IARS2,"isoleucyl-tRNA synthetase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23463,ICMT,isoprenylcysteine carboxyl methyltransferase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3459,IFNGR1,interferon gamma receptor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3587,IL10RA,"interleukin 10 receptor, alpha",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3590,IL11RA,"interleukin 11 receptor, alpha",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3597,IL13RA1,"interleukin 13 receptor, alpha 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3612,IMPA1,inositol(myo)-1(or 4)-monophosphatase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54928,IMPAD1,inositol monophosphatase domain containing 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10527,IPO7,importin 7,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8826,IQGAP1,IQ motif containing GTPase activating protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3394,IRF8,interferon regulatory factor 8,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
83737,ITCH,itchy E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
81533,ITFG1,integrin alpha FG-GAP repeat containing 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3676,ITGA4,"integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3687,ITGAX,"integrin, alpha X (complement component 3 receptor 4 subunit)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3702,ITK,IL2-inducible T-cell kinase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51133,KCTD3,potassium channel tetramerization domain containing 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9768,KIAA0101,KIAA0101,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
80183,KIAA0226L,KIAA0226-like,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3832,KIF11,kinesin family member 11,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9928,KIF14,kinesin family member 14,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
56992,KIF15,kinesin family member 15,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
81930,KIF18A,kinesin family member 18A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10112,KIF20A,kinesin family member 20A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9493,KIF23,kinesin family member 23,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3796,KIF2A,kinesin heavy chain member 2A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
24137,KIF4A,kinesin family member 4A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3838,KPNA2,"karyopherin alpha 2 (RAG cohort 1, importin alpha 1)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8942,KYNU,kynureninase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3903,LAIR1,leukocyte-associated immunoglobulin-like receptor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7805,LAPTM5,lysosomal protein transmembrane 5,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7462,LAT2,"linker for activation of T cells family, member 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3936,LCP1,lymphocyte cytosolic protein 1 (L-plastin),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23484,LEPROTL1,leptin receptor overlapping transcript-like 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10184,LHFPL2,lipoma HMGIC fusion partner-like 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3976,LIF,leukemia inhibitory factor,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10288,LILRB2,"leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10990,LILRB5,"leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3988,LIPA,"lipase A, lysosomal acid, cholesterol esterase",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9516,LITAF,lipopolysaccharide-induced TNF factor,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4001,LMNB1,lamin B1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9926,LPGAT1,lysophosphatidylglycerol acyltransferase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55379,LRRC59,leucine rich repeat containing 59,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10434,LYPLA1,lysophospholipase I,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4085,MAD2L1,MAD2 mitotic arrest deficient-like 1 (yeast),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4121,MAN1A1,"mannosidase, alpha, class 1A, member 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4125,MAN2B1,"mannosidase, alpha, class 2B, member 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6885,MAP3K7,mitogen-activated protein kinase kinase kinase 7,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64844,7-Mar,"membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4082,MARCKS,myristoylated alanine-rich protein kinase C substrate,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4144,MAT2A,"methionine adenosyltransferase II, alpha",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4154,MBNL1,muscleblind-like splicing regulator 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
63933,MCUR1,mitochondrial calcium uniporter regulator 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4200,ME2,"malic enzyme 2, NAD(+)-dependent, mitochondrial",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9833,MELK,maternal embryonic leucine zipper kinase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10461,MERTK,"MER proto-oncogene, tyrosine kinase",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10988,METAP2,methionyl aminopeptidase 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
92342,METTL18,methyltransferase like 18,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64747,MFSD1,major facilitator superfamily domain containing 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
79157,MFSD11,major facilitator superfamily domain containing 11,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9562,MINPP1,multiple inositol-polyphosphate phosphatase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4288,MKI67,marker of proliferation Ki-67,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23531,MMD,monocyte to macrophage differentiation-associated,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4321,MMP12,matrix metallopeptidase 12 (macrophage elastase),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4332,MNDA,myeloid cell nuclear differentiation antigen,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51338,MS4A4A,"membrane-spanning 4-domains, subfamily A, member 4A",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64231,MS4A6A,"membrane-spanning 4-domains, subfamily A, member 6A",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
2956,MSH6,mutS homolog 6,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4481,MSR1,macrophage scavenger receptor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4542,MYO1F,myosin IF,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4644,MYO5A,"myosin VA (heavy chain 12, myoxin)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10135,NAMPT,nicotinamide phosphoribosyltransferase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64151,NCAPG,"non-SMC condensin I complex, subunit G",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4688,NCF2,neutrophil cytosolic factor 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
3071,NCKAP1L,NCK-associated protein 1-like,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55706,NDC1,NDC1 transmembrane nucleoporin,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10403,NDC80,NDC80 kinetochore complex component,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55247,NEIL3,nei endonuclease VIII-like 3 (E. coli),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6787,NEK4,NIMA-related kinase 4,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4811,NID1,nidogen 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
114548,NLRP3,"NLR family, pyrin domain containing 3",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10874,NMU,neuromedin U,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23530,NNT,nicotinamide nucleotide transhydrogenase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64127,NOD2,nucleotide-binding oligomerization domain containing 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
80896,NPL,N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51203,NUSAP1,nucleolar and spindle associated protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55916,NXT2,nuclear transport factor 2-like export factor 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
11339,OIP5,Opa interacting protein 5,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4973,OLR1,oxidized low density lipoprotein (lectin-like) receptor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
114885,OSBPL11,oxysterol binding protein-like 11,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
26031,OSBPL3,oxysterol binding protein-like 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9180,OSMR,oncostatin M receptor,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9943,OXSR1,oxidative stress responsive 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8761,PABPC4,"poly(A) binding protein, cytoplasmic 4 (inducible form)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55010,PARPBP,PARP1 binding protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55872,PBK,PDZ binding kinase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10015,PDCD6IP,programmed cell death 6 interacting protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8050,PDHX,"pyruvate dehydrogenase complex, component X",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23244,PDS5A,PDS5 cohesin associated factor A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23042,PDXDC1,pyridoxal-dependent decarboxylase domain containing 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5229,PGGT1B,"protein geranylgeranyltransferase type I, beta subunit",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10857,PGRMC1,progesterone receptor membrane component 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
22822,PHLDA1,"pleckstrin homology-like domain, family A, member 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,17661,"Glomerulonephritis, IGA",0.21,1,Therapeutic
5341,PLEK,pleckstrin,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
79666,PLEKHF2,"pleckstrin homology domain containing, family F (with FYVE domain) member 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5352,PLOD2,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54107,POLE3,"polymerase (DNA directed), epsilon 3, accessory subunit",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5504,PPP1R2,"protein phosphatase 1, regulatory (inhibitor) subunit 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9055,PRC1,protein regulator of cytokinesis 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10935,PRDX3,peroxiredoxin 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23683,PRKD3,protein kinase D3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5621,PRNP,prion protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5627,PROS1,protein S (alpha),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
133619,PRRC1,proline-rich coiled-coil 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5660,PSAP,prosaposin,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5663,PSEN1,presenilin 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10197,PSME3,"proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9050,PSTPIP2,proline-serine-threonine phosphatase interacting protein 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7803,PTP4A1,"protein tyrosine phosphatase type IVA, member 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
26191,PTPN22,"protein tyrosine phosphatase, non-receptor type 22 (lymphoid)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5788,PTPRC,"protein tyrosine phosphatase, receptor type, C",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5791,PTPRE,"protein tyrosine phosphatase, receptor type, E",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9232,PTTG1,pituitary tumor-transforming 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
22841,RAB11FIP2,RAB11 family interacting protein 2 (class I),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5873,RAB27A,"RAB27A, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10981,RAB32,"RAB32, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51762,RAB8B,"RAB8B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
29127,RACGAP1,Rac GTPase activating protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5888,RAD51,RAD51 recombinase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5917,RARS,arginyl-tRNA synthetase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5921,RASA1,RAS p21 protein activator (GTPase activating protein) 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9770,RASSF2,Ras association (RalGDS/AF-6) domain family member 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5925,RB1,retinoblastoma 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23186,RCOR1,REST corepressor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5965,RECQL,RecQ helicase-like,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10737,RFPL3S,RFPL3 antisense,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55159,RFWD3,ring finger and WD repeat domain 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5999,RGS4,regulator of G-protein signaling 4,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6036,RNASE2,"ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6039,RNASE6,"ribonuclease, RNase A family, k6",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51444,RNF138,"ring finger protein 138, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6120,RPE,ribulose-5-phosphate-3-epimerase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55197,RPRD1A,regulation of nuclear pre-mRNA domain containing 1A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6241,RRM2,ribonucleotide reductase M2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
25939,SAMHD1,SAM domain and HD domain 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64092,SAMSN1,"SAM domain, SH3 domain and nuclear localization signals 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51435,SCARA3,"scavenger receptor class A, member 3",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10484,SEC23A,Sec23 homolog A (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
11196,SEC23IP,SEC23 interacting protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51714,SELT,selenoprotein T,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
26135,SERBP1,SERPINE1 mRNA binding protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
81537,SGPP1,sphingosine-1-phosphate phosphatase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
56833,SLAMF8,SLAM family member 8,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7884,SLBP,stem-loop binding protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6507,SLC1A3,"solute carrier family 1 (glial high affinity glutamate transporter), member 3",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6574,SLC20A1,"solute carrier family 20 (phosphate transporter), member 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
29957,SLC25A24,"solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5250,SLC25A3,"solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64924,SLC30A5,"solute carrier family 30 (zinc transporter), member 5",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54407,SLC38A2,"solute carrier family 38, member 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
64116,SLC39A8,"solute carrier family 39 (zinc transporter), member 8",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
29015,SLC43A3,"solute carrier family 43, member 3",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54716,SLC6A20,"solute carrier family 6 (proline IMINO transporter), member 20",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8140,SLC7A5,"solute carrier family 7 (amino acid transporter light chain, L system), member 5",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10479,SLC9A6,"solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10051,SMC4,structural maintenance of chromosomes 4,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23347,SMCHD1,structural maintenance of chromosomes flexible hinge domain containing 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
29887,SNX10,sorting nexin 10,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6643,SNX2,sorting nexin 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
28966,SNX24,sorting nexin 24,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
57405,SPC25,"SPC25, NDC80 kinetochore complex component",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
5552,SRGN,serglycin,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8406,SRPX,"sushi-repeat containing protein, X-linked",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6745,SSR1,"signal sequence receptor, alpha",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
117178,SSX2IP,"synovial sarcoma, X breakpoint 2 interacting protein",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8869,ST3GAL5,"ST3 beta-galactoside alpha-2,3-sialyltransferase 5",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10228,STX6,syntaxin 6,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10492,SYNCRIP,"synaptotagmin binding, cytoplasmic RNA interacting protein",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6856,SYPL1,synaptophysin-like 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
6880,TAF9,"TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
79718,TBL1XR1,transducin (beta)-like 1 X-linked receptor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51368,TEX264,testis expressed 264,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
22797,TFEC,transcription factor EC,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10342,TFG,TRK-fused gene,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7035,TFPI,tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor),0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8914,TIMELESS,timeless circadian clock,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9874,TLK1,tousled-like kinase 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7097,TLR2,toll-like receptor 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
51311,TLR8,toll-like receptor 8,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9375,TM9SF2,transmembrane 9 superfamily member 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10959,TMED2,transmembrane emp24 domain trafficking protein 2,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55273,TMEM100,transmembrane protein 100,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
65084,TMEM135,transmembrane protein 135,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55754,TMEM30A,transmembrane protein 30A,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7112,TMPO,thymopoietin,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
81542,TMX1,thioredoxin-related transmembrane protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
25816,TNFAIP8,"tumor necrosis factor, alpha-induced protein 8",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
27242,TNFRSF21,"tumor necrosis factor receptor superfamily, member 21",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7153,TOP2A,topoisomerase (DNA) II alpha 170kDa,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
22974,TPX2,"TPX2, microtubule-associated",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
23471,TRAM1,translocation associated membrane protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
4591,TRIM37,tripartite motif containing 37,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7272,TTK,TTK protein kinase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7298,TYMS,thymidylate synthetase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7305,TYROBP,TYRO protein tyrosine kinase binding protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7323,UBE2D3,ubiquitin-conjugating enzyme E2D 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7326,UBE2G1,ubiquitin-conjugating enzyme E2G 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7357,UGCG,UDP-glucose ceramide glucosyltransferase,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
8673,VAMP8,vesicle-associated membrane protein 8,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
10451,VAV3,vav 3 guanine nucleotide exchange factor,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
81671,VMP1,vacuole membrane protein 1,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
11326,VSIG4,V-set and immunoglobulin domain containing 4,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7456,WIPF1,"WAS/WASL interacting protein family, member 1",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7525,YES1,"YES proto-oncogene 1, Src family tyrosine kinase",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
81555,YIPF5,"Yip1 domain family, member 5",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
253943,YTHDF3,YTH N(6)-methyladenosine RNA binding protein 3,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7533,YWHAH,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7534,YWHAZ,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9889,ZBED4,"zinc finger, BED-type containing 4",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
54877,ZCCHC2,"zinc finger, CCHC domain containing 2",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
7690,ZNF131,zinc finger protein 131,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
9326,ZNHIT3,"zinc finger, HIT-type containing 3",0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
11130,ZWINT,ZW10 interacting kinetochore protein,0.0,1.0,0.0,0.0,0.0,17661,"Glomerulonephritis, IGA",0.21,1,Biomarker
55764,IFT122,intraflagellar transport 122,0.0,1.0,0.0,0.0,0.0,20255,Hydrocephalus,0.21,1,Biomarker
729920,ISPD,isoprenoid synthase domain containing,0.0,1.0,0.0,0.0,0.0,20255,Hydrocephalus,0.21,1,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,20255,Hydrocephalus,0.21,1,Biomarker
8772,FADD,Fas (TNFRSF6)-associated via death domain,0.0,1.0,0.0,0.0,0.0,38368,Stomatognathic Diseases,0.21,1,Biomarker
2248,FGF3,fibroblast growth factor 3,0.0,1.0,0.0,0.0,0.0,38368,Stomatognathic Diseases,0.21,1,Biomarker
57282,SLC4A10,"solute carrier family 4, sodium bicarbonate transporter, member 10",0.0,0.0,0.0,0.0,1.0,151740,Intracranial Hypertension,0.21,1,Therapeutic
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,0.0,0.0,0.0,27706,"Nephritis, Hereditary",0.21,1,Biomarker
9495,AKAP5,A kinase (PRKA) anchor protein 5,0.0,1.0,0.0,0.0,0.0,26613,Motor Skills Disorders,0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,26613,Motor Skills Disorders,0.21,1,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,0.0,0.0,0.0,26613,Motor Skills Disorders,0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,26613,Motor Skills Disorders,0.21,1,Biomarker
50944,SHANK1,SH3 and multiple ankyrin repeat domains 1,0.0,1.0,0.0,0.0,0.0,26613,Motor Skills Disorders,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,13274,"Ductus Arteriosus, Patent",0.21,1,Biomarker
116833,ANIB1,"aneurysm, intracranial berry 1",0.0,1.0,0.0,0.0,0.0,1862932,"Aneurysm, Intracranial Berry, 1",0.21,0,Biomarker
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,0.0,1.0,0.0,0.0,1336839,Type 1 Papillary Renal Cell Carcinoma,0.21,0,GeneticVariation
53339,BTBD1,BTB (POZ) domain containing 1,0.0,1.0,0.0,0.0,0.0,520757,Delayed Emergence from Anesthesia,0.21,1,Biomarker
54469,ZFAND6,"zinc finger, AN1-type domain 6",0.0,1.0,0.0,0.0,0.0,520757,Delayed Emergence from Anesthesia,0.21,1,Biomarker
8557,TCAP,titin-cap,0.0,0.0,1.0,0.0,0.0,3495498,"Cardiomyopathy, Familial Hypertrophic, 1",0.21,0,GeneticVariation
88,ACTN2,"actinin, alpha 2",0.0,0.0,1.0,0.0,0.0,3495498,"Cardiomyopathy, Familial Hypertrophic, 1",0.21,0,GeneticVariation
70,ACTC1,"actin, alpha, cardiac muscle 1",0.0,1.0,0.0,0.0,0.0,3495498,"Cardiomyopathy, Familial Hypertrophic, 1",0.21,0,Biomarker
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,1.0,0.0,0.0,0.0,3495498,"Cardiomyopathy, Familial Hypertrophic, 1",0.21,0,Biomarker
291,SLC25A4,"solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4",0.0,1.0,0.0,0.0,0.0,3495498,"Cardiomyopathy, Familial Hypertrophic, 1",0.21,0,Biomarker
7134,TNNC1,troponin C type 1 (slow),0.0,1.0,0.0,0.0,0.0,3495498,"Cardiomyopathy, Familial Hypertrophic, 1",0.21,0,Biomarker
59332,VSPA,Visuospatial/perceptual abilities,0.0,1.0,0.0,0.0,0.0,1839262,"SPATIAL VISUALIZATION, APTITUDE FOR",0.21,0,Biomarker
644096,SDHAF1,succinate dehydrogenase complex assembly factor 1,0.0,1.0,0.0,0.0,0.0,11269,"Dementia, Vascular",0.21,1,Biomarker
26762,HAVCR1,hepatitis A virus cellular receptor 1,0.0,1.0,0.0,0.0,0.0,1840253,"Ige Responsiveness, Atopic",0.21,0,Biomarker
50615,IL21R,interleukin 21 receptor,0.0,1.0,0.0,0.0,0.0,1840253,"Ige Responsiveness, Atopic",0.21,0,Biomarker
3566,IL4R,interleukin 4 receptor,0.0,1.0,0.0,0.0,0.0,1840253,"Ige Responsiveness, Atopic",0.21,0,Biomarker
2206,MS4A2,"membrane-spanning 4-domains, subfamily A, member 2",0.0,1.0,0.0,0.0,0.0,1840253,"Ige Responsiveness, Atopic",0.21,0,Biomarker
51131,PHF11,PHD finger protein 11,0.0,1.0,0.0,0.0,0.0,1840253,"Ige Responsiveness, Atopic",0.21,0,Biomarker
7941,PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)",0.0,1.0,0.0,0.0,0.0,1840253,"Ige Responsiveness, Atopic",0.21,0,Biomarker
6403,SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",0.0,1.0,0.0,0.0,0.0,1840253,"Ige Responsiveness, Atopic",0.21,0,Biomarker
11005,SPINK5,"serine peptidase inhibitor, Kazal type 5",0.0,1.0,0.0,0.0,0.0,1840253,"Ige Responsiveness, Atopic",0.21,0,Biomarker
6037,RNASE3,"ribonuclease, RNase A family, 3",0.0,0.0,0.0,0.0,1.0,85426,Gram-Positive Bacterial Infections,0.21,1,Therapeutic
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,2676832,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
23771,DIANPH,diabetic nephropathy,0.0,1.0,0.0,0.0,0.0,2676832,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
6768,ST14,suppression of tumorigenicity 14 (colon carcinoma),0.0,1.0,0.0,0.0,0.0,265962,Netherton Syndrome,0.21,1,Biomarker
1815,DRD4,dopamine receptor D4,0.0,1.0,0.0,0.0,0.0,236964,Attention Deficit and Disruptive Behavior Disorders,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,8677,"Bronchitis, Chronic",0.21,1,Biomarker
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,2931332,Telomeric 22q13 Monosomy Syndrome,0.21,1,Therapeutic
6868,ADAM17,ADAM metallopeptidase domain 17,0.0,1.0,0.0,0.0,0.0,5758,Blister,0.21,1,Biomarker
23175,LPIN1,lipin 1,0.0,1.0,0.0,0.0,0.0,1849386,"Myoglobinuria, Acute Recurrent, Autosomal Recessive",0.21,0,Biomarker
1958,EGR1,early growth response 1,0.0,1.0,0.0,0.0,0.0,20295,Hydronephrosis,0.21,1,Biomarker
9536,PTGES,prostaglandin E synthase,0.0,1.0,0.0,0.0,0.0,20295,Hydronephrosis,0.21,2,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,20295,Hydronephrosis,0.21,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,1,Biomarker
1136,CHRNA3,"cholinergic receptor, nicotinic, alpha 3 (neuronal)",0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,2,Biomarker
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,0,Biomarker
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,1,Biomarker
8973,CHRNA6,"cholinergic receptor, nicotinic, alpha 6 (neuronal)",0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,1,Biomarker
1142,CHRNB3,"cholinergic receptor, nicotinic, beta 3 (neuronal)",0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,1,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,1.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,2,"Biomarker, Therapeutic"
1555,CYP2B6,"cytochrome P450, family 2, subfamily B, polypeptide 6",0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,1,Biomarker
112398,EGLN2,egl-9 family hypoxia-inducible factor 2,0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,1,Biomarker
3094,HINT1,histidine triad nucleotide binding protein 1,0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,1,Biomarker
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,0.0,0.0,0.0,1861063,"TOBACCO ADDICTION, SUSCEPTIBILITY TO",0.21,0,Biomarker
37,ACADVL,"acyl-CoA dehydrogenase, very long chain",0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
191,AHCY,adenosylhomocysteinase,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
10840,ALDH1L1,"aldehyde dehydrogenase 1 family, member L1",0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
229,ALDOB,"aldolase B, fructose-bisphosphate",0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
335,APOA1,apolipoprotein A-I,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
468,ATF4,activating transcription factor 4,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
506,ATP5B,"ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide",0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
1358,CPA2,carboxypeptidase A2 (pancreatic),0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
1431,CS,citrate synthase,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
1504,CTRB1,chymotrypsinogen B1,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
2098,ESD,esterase D,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
4830,NME1,NME/NM23 nucleoside diphosphate kinase 1,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
5106,PCK2,phosphoenolpyruvate carboxykinase 2 (mitochondrial),0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
6208,RPS14,ribosomal protein S14,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
6187,RPS2,ribosomal protein S2,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
1757,SARDH,sarcosine dehydrogenase,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,2,Biomarker
7035,TFPI,tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor),0.0,0.0,0.0,0.0,1.0,3130,Anoxia,0.21,1,Therapeutic
7086,TKT,transketolase,0.0,1.0,0.0,0.0,0.0,3130,Anoxia,0.21,1,Biomarker
100271697,IDDM23,"Diabetes mellitus, insulin-dependent, 23",0.0,1.0,0.0,0.0,0.0,2675472,"Diabetes Mellitus, Insulin-Dependent, 23",0.21,0,Biomarker
137735,ABRA,actin-binding Rho activating protein,0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.21,1,Biomarker
7840,ALMS1,Alstrom syndrome 1,0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,7193,"Cardiomyopathy, Dilated",0.21,1,Therapeutic
64651,CSRNP1,cysteine-serine-rich nuclear protein 1,0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.21,1,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.21,1,Biomarker
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.21,1,Biomarker
5879,RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.21,1,Biomarker
150094,SIK1,salt-inducible kinase 1,0.0,1.0,0.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.21,1,Biomarker
80871,ANMA,Anisomastia,0.0,1.0,0.0,0.0,0.0,1854013,Anisomastia,0.21,0,Biomarker
100188865,LMPH1B,"Lymphedema, hereditary, IB",0.0,1.0,0.0,0.0,0.0,2677787,"Lymphedema, Hereditary, IB",0.21,0,Biomarker
10935,PRDX3,peroxiredoxin 3,0.0,1.0,0.0,0.0,0.0,85084,Motor Neuron Disease,0.21,1,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,85084,Motor Neuron Disease,0.21,1,Biomarker
249,ALPL,"alkaline phosphatase, liver/bone/kidney",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
632,BGLAP,bone gamma-carboxyglutamate (gla) protein,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
729,C6,complement component 6,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,2,Biomarker
80781,COL18A1,"collagen, type XVIII, alpha 1",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
80169,CTC1,CTS telomere maintenance complex component 1,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
2209,FCGR1A,"Fc fragment of IgG, high affinity Ia, receptor (CD64)",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
3717,JAK2,Janus kinase 2,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
3934,LCN2,lipocalin 2,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
4046,LSP1,lymphocyte-specific protein 1,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
9450,LY86,lymphocyte antigen 86,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,2,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,2,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
5777,PTPN6,"protein tyrosine phosphatase, non-receptor type 6",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
11035,RIPK3,receptor-interacting serine-threonine kinase 3,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
9356,SLC22A6,"solute carrier family 22 (organic anion transporter), member 6",0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
6693,SPN,sialophorin,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,6663,Calcinosis,0.21,1,Biomarker
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,42065,Urogenital Neoplasms,0.21,1,Biomarker
7476,WNT7A,"wingless-type MMTV integration site family, member 7A",0.0,1.0,0.0,0.0,0.0,42065,Urogenital Neoplasms,0.21,1,Biomarker
10297,APC2,adenomatosis polyposis coli 2,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.21,1,Biomarker
55765,C1orf106,chromosome 1 open reading frame 106,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.21,1,Biomarker
317669,IBD9,inflammatory bowel disease 9,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.21,0,Biomarker
283463,MUC19,"mucin 19, oligomeric",0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.21,1,Biomarker
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.21,1,Biomarker
6422,SFRP1,secreted frizzled-related protein 1,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.21,1,Biomarker
6423,SFRP2,secreted frizzled-related protein 2,0.0,1.0,0.0,0.0,0.0,21390,Inflammatory Bowel Diseases,0.21,1,Biomarker
7467,WHCR,Wolf-Hirschhorn syndrome chromosome region,0.0,1.0,0.0,0.0,0.0,1956097,Wolf-Hirschhorn Syndrome,0.21,0,Biomarker
10060,ABCC9,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
231,AKR1B1,"aldo-keto reductase family 1, member B1 (aldose reductase)",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
57016,AKR1B10,"aldo-keto reductase family 1, member B10 (aldose reductase)",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
332,BIRC5,baculoviral IAP repeat containing 5,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
1028,CDKN1C,"cyclin-dependent kinase inhibitor 1C (p57, Kip2)",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
1108,CHD4,chromodomain helicase DNA binding protein 4,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
55743,CHFR,"checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
1634,DCN,decorin,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
55294,FBXW7,"F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
3207,HOXA11,homeobox A11,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
3294,HSD17B2,hydroxysteroid (17-beta) dehydrogenase 2,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
221895,JAZF1,JAZF zinc finger 1,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
4216,MAP3K4,mitogen-activated protein kinase kinase kinase 4,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
406985,MIR200C,microRNA 200c,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
27030,MLH3,mutL homolog 3,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,0,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
5074,PAWR,"PRKC, apoptosis, WT1, regulator",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
55558,PLXNA3,plexin A3,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
5424,POLD1,"polymerase (DNA directed), delta 1, catalytic subunit",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
54894,RNF43,ring finger protein 43,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
7869,SEMA3B,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
6405,SEMA3F,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F",0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
9021,SOCS3,suppressor of cytokine signaling 3,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
8405,SPOP,speckle-type POZ protein,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
10772,SRSF10,serine/arginine-rich splicing factor 10,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
23512,SUZ12,SUZ12 polycomb repressive complex 2 subunit,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
64061,TSPYL2,TSPY-like 2,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
6935,ZEB1,zinc finger E-box binding homeobox 1,0.0,1.0,0.0,0.0,0.0,14170,Endometrial Neoplasms,0.21,1,Biomarker
10965,ACOT2,acyl-CoA thioesterase 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
79924,ADM2,adrenomedullin 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
166,AES,amino-terminal enhancer of split,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
203,AK1,adenylate kinase 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
4329,ALDH6A1,"aldehyde dehydrogenase 6 family, member A1",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
226,ALDOA,"aldolase A, fructose-bisphosphate",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
334,APLP2,amyloid beta (A4) precursor-like protein 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
374,AREG,amphiregulin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
406,ARNTL,aryl hydrocarbon receptor nuclear translocator-like,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
476,ATP1A1,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
8553,BHLHE40,"basic helix-loop-helix family, member e40",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
713,C1QB,"complement component 1, q subcomponent, B chain",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
811,CALR,calreticulin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
817,CAMK2D,calcium/calmodulin-dependent protein kinase II delta,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
821,CANX,calnexin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6348,CCL3,chemokine (C-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
894,CCND2,cyclin D2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1000,CDH2,"cadherin 2, type 1, N-cadherin (neuronal)",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1052,CEBPD,"CCAAT/enhancer binding protein (C/EBP), delta",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
23491,CES3,carboxylesterase 3,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1153,CIRBP,cold inducible RNA binding protein,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
10462,CLEC10A,"C-type lectin domain family 10, member A",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1329,COX5B,cytochrome c oxidase subunit Vb,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1375,CPT1B,carnitine palmitoyltransferase 1B (muscle),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1398,CRK,v-crk avian sarcoma virus CT10 oncogene homolog,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1075,CTSC,cathepsin C,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
83992,CTTNBP2,cortactin binding protein 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6376,CX3CL1,chemokine (C-X3-C motif) ligand 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1634,DCN,decorin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1737,DLAT,dihydrolipoamide S-acetyltransferase,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
10059,DNM1L,dynamin 1-like,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1843,DUSP1,dual specificity phosphatase 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1848,DUSP6,dual specificity phosphatase 6,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1959,EGR2,early growth response 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
83939,EIF2A,"eukaryotic translation initiation factor 2A, 65kDa",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
9451,EIF2AK3,eukaryotic translation initiation factor 2-alpha kinase 3,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2029,ENSA,endosulfine alpha,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2150,F2RL1,coagulation factor II (thrombin) receptor-like 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2171,FABP5,fatty acid binding protein 5 (psoriasis-associated),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
54738,FEV,FEV (ETS oncogene family),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
9637,FEZ2,fasciculation and elongation protein zeta 2 (zygin II),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
60674,GAS5,growth arrest-specific 5 (non-protein coding),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2628,GATM,glycine amidinotransferase (L-arginine:glycine amidinotransferase),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2634,GBP2,"guanylate binding protein 2, interferon-inducible",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2643,GCH1,GTP cyclohydrolase 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
9518,GDF15,growth differentiation factor 15,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2690,GHR,growth hormone receptor,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2710,GK,glycerol kinase,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2768,GNA12,guanine nucleotide binding protein (G protein) alpha 12,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2938,GSTA1,glutathione S-transferase alpha 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2946,GSTM2,glutathione S-transferase mu 2 (muscle),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
2992,GYG1,glycogenin 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3030,HADHA,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3097,HIVEP2,human immunodeficiency virus type I enhancer binding protein 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3098,HK1,hexokinase 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3099,HK2,hexokinase 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3158,HMGCS2,3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3303,HSPA1A,heat shock 70kDa protein 1A,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3306,HSPA2,heat shock 70kDa protein 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3397,ID1,"inhibitor of DNA binding 1, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3459,IFNGR1,interferon gamma receptor 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3572,IL6ST,interleukin 6 signal transducer,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3659,IRF1,interferon regulatory factor 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3726,JUNB,jun B proto-oncogene,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
4254,KITLG,KIT ligand,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
9314,KLF4,Kruppel-like factor 4 (gut),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
1326,MAP3K8,mitogen-activated protein kinase kinase kinase 8,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
22919,MAPRE1,"microtubule-associated protein, RP/EB family, member 1",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
4223,MEOX2,mesenchyme homeobox 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
4478,MSN,moesin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
4599,MX1,MX dynamin-like GTPase 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
4691,NCL,nucleolin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
4734,NEDD4,"neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
4792,NFKBIA,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
27020,NPTN,neuroplastin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
3164,NR4A1,"nuclear receptor subfamily 4, group A, member 1",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5034,P4HB,"prolyl 4-hydroxylase, beta polypeptide",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5160,PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5166,PDK4,"pyruvate dehydrogenase kinase, isozyme 4",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
10611,PDLIM5,PDZ and LIM domain 5,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5037,PEBP1,phosphatidylethanolamine binding protein 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5209,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5213,PFKM,"phosphofructokinase, muscle",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5236,PGM1,phosphoglucomutase 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5320,PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid)",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5471,PPAT,phosphoribosyl pyrophosphate amidotransferase,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5495,PPM1B,"protein phosphatase, Mg2+/Mn2+ dependent, 1B",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5515,PPP2CA,"protein phosphatase 2, catalytic subunit, alpha isozyme",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
9588,PRDX6,peroxiredoxin 6,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5693,PSMB5,"proteasome (prosome, macropain) subunit, beta type, 5",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5786,PTPRA,"protein tyrosine phosphatase, receptor type, A",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5834,PYGB,"phosphorylase, glycogen; brain",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
201475,RAB12,"RAB12, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
81876,RAB1B,"RAB1B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
5868,RAB5A,"RAB5A, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7879,RAB7A,"RAB7A, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
10928,RALBP1,ralA binding protein 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
28984,RGCC,regulator of cell cycle,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
389,RHOC,ras homolog family member C,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
117579,RLN3,relaxin 3,0.0,0.0,0.0,0.0,1.0,151744,Myocardial Ischemia,0.21,1,Therapeutic
6139,RPL17,ribosomal protein L17,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
91543,RSAD2,radical S-adenosyl methionine domain containing 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6252,RTN1,reticulon 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6258,RXRG,"retinoid X receptor, gamma",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6533,SLC6A6,"solute carrier family 6 (neurotransmitter transporter), member 6",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6546,SLC8A1,"solute carrier family 8 (sodium/calcium exchanger), member 1",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
8773,SNAP23,"synaptosomal-associated protein, 23kDa",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
9021,SOCS3,suppressor of cytokine signaling 3,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6817,SULT1A1,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6890,TAP1,"transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7091,TLE4,transducin-like enhancer of split 4,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
10959,TMED2,transmembrane emp24 domain trafficking protein 2,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7112,TMPO,thymopoietin,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7846,TUBA1A,"tubulin, alpha 1a",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7296,TXNRD1,thioredoxin reductase 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7357,UGCG,UDP-glucose ceramide glucosyltransferase,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7386,UQCRFS1,"ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1",0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
6935,ZEB1,zinc finger E-box binding homeobox 1,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
7538,ZFP36,ZFP36 ring finger protein,0.0,1.0,0.0,0.0,0.0,151744,Myocardial Ischemia,0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,30552,Paresis,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,30552,Paresis,0.21,1,Therapeutic
8891,EIF2B3,"eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa",0.0,1.0,0.0,0.0,0.0,1847967,Vanishing White Matter Leukodystrophy with Ovarian Failure,0.21,0,Biomarker
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.21,2,Biomarker
1732,DIH1,diaphragmatic hernia 1,0.0,1.0,0.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.21,0,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.21,2,Biomarker
3482,IGF2R,insulin-like growth factor 2 receptor,0.0,1.0,0.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.21,2,Biomarker
3643,INSR,insulin receptor,0.0,1.0,0.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.21,1,Biomarker
4654,MYOD1,myogenic differentiation 1,0.0,1.0,0.0,0.0,0.0,235833,"Hernias, Diaphragmatic, Congenital",0.21,1,Biomarker
1055,CECR,cat eye syndrome chromosome region,0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
1147,CHUK,conserved helix-loop-helix ubiquitous kinase,0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
2852,GPER1,G protein-coupled estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
7044,LEFTY2,left-right determination factor 2,0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
9378,NRXN1,neurexin 1,0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
5424,POLD1,"polymerase (DNA directed), delta 1, catalytic subunit",0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
26040,SETBP1,SET binding protein 1,0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,772,"Abnormalities, Multiple",0.21,1,Biomarker
779,CACNA1S,"calcium channel, voltage-dependent, L type, alpha 1S subunit",0.0,1.0,0.0,0.0,0.0,35229,Respiratory Insufficiency,0.21,1,Biomarker
10516,FBLN5,fibulin 5,0.0,1.0,0.0,0.0,0.0,35229,Respiratory Insufficiency,0.21,1,Biomarker
57560,IFT80,intraflagellar transport 80,0.0,1.0,0.0,0.0,0.0,35229,Respiratory Insufficiency,0.21,1,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,35229,Respiratory Insufficiency,0.21,1,Biomarker
4137,MAPT,microtubule-associated protein tau,0.0,1.0,0.0,0.0,0.0,35229,Respiratory Insufficiency,0.21,1,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,35229,Respiratory Insufficiency,0.21,1,Biomarker
92667,MGME1,mitochondrial genome maintenance exonuclease 1,0.0,1.0,0.0,0.0,0.0,35229,Respiratory Insufficiency,0.21,1,Biomarker
5173,PDYN,prodynorphin,0.0,0.0,0.0,0.0,1.0,35229,Respiratory Insufficiency,0.21,1,Therapeutic
9963,SLC23A1,"solute carrier family 23 (ascorbic acid transporter), member 1",0.0,1.0,0.0,0.0,0.0,35229,Respiratory Insufficiency,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,0.0,0.0,0.0,1.0,35229,Respiratory Insufficiency,0.21,2,Therapeutic
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,0.0,1.0,0.0,0.0,3806402,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION",0.21,6,GeneticVariation
4010,LMX1B,"LIM homeobox transcription factor 1, beta",0.0,1.0,0.0,0.0,0.0,525040,Mental Disorders Diagnosed in Childhood,0.21,1,Biomarker
780910,PPR2,Photoparoxysmal response 2,0.0,1.0,0.0,0.0,0.0,1835967,PHOTOPAROXYSMAL RESPONSE 2,0.21,0,Biomarker
9518,GDF15,growth differentiation factor 15,0.0,1.0,0.0,0.0,0.0,2896,"Anemia, Sideroblastic",0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,2896,"Anemia, Sideroblastic",0.21,2,Biomarker
170530,MRX78,"mental retardation, X-linked 78",0.0,1.0,0.0,0.0,0.0,1845181,"Mental Retardation, X-Linked 78",0.21,0,Biomarker
221938,MMD2,monocyte to macrophage differentiation-associated 2,0.0,1.0,0.0,0.0,0.0,2750077,Miyoshi Muscular Dystrophy 2,0.21,0,Biomarker
2077,ERF,Ets2 repressor factor,0.0,1.0,0.0,0.0,0.0,3803,Arnold-Chiari Malformation,0.21,1,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,39841,Thiamine Deficiency,0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
1152,CKB,"creatine kinase, brain",0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
1158,CKM,"creatine kinase, muscle",0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,2,Biomarker
1385,CREB1,cAMP responsive element binding protein 1,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
1390,CREM,cAMP responsive element modulator,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
8525,DGKZ,"diacylglycerol kinase, zeta",0.0,0.0,0.0,0.0,1.0,27051,Myocardial Infarction,0.21,1,Therapeutic
2678,GGT1,gamma-glutamyltransferase 1,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
3939,LDHA,lactate dehydrogenase A,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
100233226,MCI2,"Myocardial infarction, susceptiblity to, 2",0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,0,Biomarker
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
5139,PDE3A,"phosphodiesterase 3A, cGMP-inhibited",0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
6402,SELL,selectin L,0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
51330,TNFRSF12A,"tumor necrosis factor receptor superfamily, member 12A",0.0,1.0,0.0,0.0,0.0,27051,Myocardial Infarction,0.21,1,Biomarker
3897,L1CAM,L1 cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,751830,"Gait Disorders, Neurologic",0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,751830,"Gait Disorders, Neurologic",0.21,1,Biomarker
54902,TTC19,tetratricopeptide repeat domain 19,0.0,1.0,0.0,0.0,0.0,751830,"Gait Disorders, Neurologic",0.21,1,Biomarker
203286,ANKS6,ankyrin repeat and sterile alpha motif domain containing 6,0.0,1.0,0.0,0.0,0.0,243050,Cardiovascular Abnormalities,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,243050,Cardiovascular Abnormalities,0.21,1,Biomarker
2253,FGF8,fibroblast growth factor 8 (androgen-induced),0.0,1.0,0.0,0.0,0.0,243050,Cardiovascular Abnormalities,0.21,1,Biomarker
2303,FOXC2,forkhead box C2,0.0,1.0,0.0,0.0,0.0,243050,Cardiovascular Abnormalities,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,243050,Cardiovascular Abnormalities,0.21,1,Biomarker
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,0.0,0.0,0.0,243050,Cardiovascular Abnormalities,0.21,1,Biomarker
140892,TCPT,"thrombocytopenia, Paris-Trousseau type",0.0,1.0,0.0,0.0,0.0,1861178,Thrombocytopenia Paris-Trousseau type,0.21,0,Biomarker
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,0.0,242528,Azotemia,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,242528,Azotemia,0.21,1,Biomarker
317,APAF1,apoptotic peptidase activating factor 1,0.0,1.0,0.0,0.0,0.0,37268,Skin Abnormalities,0.21,1,Biomarker
1147,CHUK,conserved helix-loop-helix ubiquitous kinase,0.0,1.0,0.0,0.0,0.0,37268,Skin Abnormalities,0.21,3,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,37268,Skin Abnormalities,0.21,1,Biomarker
92344,GORAB,"golgin, RAB6-interacting",0.0,1.0,0.0,0.0,0.0,37268,Skin Abnormalities,0.21,1,Biomarker
3664,IRF6,interferon regulatory factor 6,0.0,1.0,0.0,0.0,0.0,37268,Skin Abnormalities,0.21,1,Biomarker
6832,SUPV3L1,"suppressor of var1, 3-like 1 (S. cerevisiae)",0.0,1.0,0.0,0.0,0.0,37268,Skin Abnormalities,0.21,1,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,37268,Skin Abnormalities,0.21,1,Biomarker
84627,ZNF469,zinc finger protein 469,0.0,1.0,0.0,0.0,0.0,37268,Skin Abnormalities,0.21,1,Biomarker
5831,PYCR1,pyrroline-5-carboxylate reductase 1,0.0,1.0,0.0,0.0,0.0,33300,Progeria,0.21,1,Biomarker
83932,SPRTN,SprT-like N-terminal domain,0.0,1.0,0.0,0.0,0.0,33300,Progeria,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,16382,Flushing,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,16382,Flushing,0.21,1,Biomarker
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),0.0,1.0,0.0,0.0,0.0,20452,Hyperemia,0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,20452,Hyperemia,0.21,1,Biomarker
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,20452,Hyperemia,0.21,1,Biomarker
847,CAT,catalase,0.0,0.0,0.0,0.0,1.0,20452,Hyperemia,0.21,1,Therapeutic
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,20452,Hyperemia,0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,20452,Hyperemia,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,20452,Hyperemia,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,20452,Hyperemia,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,0.0,0.0,0.0,1.0,20452,Hyperemia,0.21,2,Therapeutic
8258,GUST,"Gustavson mental retardation syndrome (with microcephaly, optic",0.0,1.0,0.0,0.0,0.0,795965,X-linked mental retardation Gustavson type,0.21,0,Biomarker
859,CAV3,caveolin 3,0.0,1.0,0.0,0.0,0.0,2931337,"Chromosome 3, monosomy 3p25",0.21,1,Biomarker
5021,OXTR,oxytocin receptor,0.0,1.0,0.0,0.0,0.0,2931337,"Chromosome 3, monosomy 3p25",0.21,1,Biomarker
9901,SRGAP3,SLIT-ROBO Rho GTPase activating protein 3,0.0,1.0,0.0,0.0,0.0,2931337,"Chromosome 3, monosomy 3p25",0.21,1,Biomarker
3456,IFNB1,"interferon, beta 1, fibroblast",0.0,0.0,0.0,0.0,1.0,206735,"Melanoma, Amelanotic",0.21,1,Therapeutic
3674,ITGA2B,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)",0.0,1.0,0.0,0.0,0.0,7274,Carotid Artery Thrombosis,0.21,1,Biomarker
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,0.0,0.0,0.0,7274,Carotid Artery Thrombosis,0.21,1,Biomarker
3053,SERPIND1,"serpin peptidase inhibitor, clade D (heparin cofactor), member 1",0.0,0.0,0.0,0.0,1.0,7274,Carotid Artery Thrombosis,0.21,1,Therapeutic
450089,ADHD3,"Attention deficit-hyperactivity disorder, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.21,0,Biomarker
450090,ADHD4,"Attention deficit-hyperactivity disorder, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.21,0,Biomarker
100190790,ADHD5,"Attention deficit-hyperactivity disorder, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.21,0,Biomarker
100190791,ADHD6,"Attention deficit-hyperactivity disorder, susceptibility to, 6",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.21,0,Biomarker
2911,GRM1,"glutamate receptor, metabotropic 1",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.21,1,Biomarker
2918,GRM8,"glutamate receptor, metabotropic 8",0.0,1.0,0.0,0.0,0.0,1263846,Attention Deficit Disorder with Hyperactivity,0.21,1,Biomarker
192644,DFNA21,"deafness, autosomal dominant 21",0.0,1.0,0.0,0.0,0.0,1846922,"Deafness, Autosomal Dominant 21",0.21,0,Biomarker
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,0.0,1.0,0.0,0.0,2751898,"Ventricular Fibrillation, Paroxysmal Familial, 1",0.21,0,GeneticVariation
7915,ALDH5A1,"aldehyde dehydrogenase 5 family, member A1",0.0,1.0,0.0,0.0,0.0,6112,"Brain Diseases, Metabolic",0.21,1,Biomarker
1376,CPT2,carnitine palmitoyltransferase 2,0.0,1.0,0.0,0.0,0.0,6112,"Brain Diseases, Metabolic",0.21,1,Biomarker
4087,SMAD2,SMAD family member 2,0.0,1.0,0.0,0.0,0.0,265287,Acromicric dysplasia,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,265287,Acromicric dysplasia,0.21,1,Biomarker
55331,ACER3,alkaline ceramidase 3,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
80070,ADAMTS20,"ADAM metallopeptidase with thrombospondin type 1 motif, 20",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
57016,AKR1B10,"aldo-keto reductase family 1, member B10 (aldose reductase)",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
402,ARL2,ADP-ribosylation factor-like 2,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
221079,ARL5B,ADP-ribosylation factor-like 5B,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
25842,ASF1A,anti-silencing function 1A histone chaperone,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
9689,BZW1,basic leucine zipper and W2 domains 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
83638,C11orf68,chromosome 11 open reading frame 68,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
51501,C11orf73,chromosome 11 open reading frame 73,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
823,CAPN1,"calpain 1, (mu/I) large subunit",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
160762,CCDC63,coiled-coil domain containing 63,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
283316,CD163L1,CD163 molecule-like 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
1207,CLNS1A,"chloride channel, nucleotide-sensitive, 1A",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
26507,CNNM1,cyclin and CBS domain divalent metal cation transport mediator 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
126129,CPT1C,carnitine palmitoyltransferase 1C,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
1474,CST6,cystatin E/M,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
8029,CUBN,cubilin (intrinsic factor-cobalamin receptor),0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
8452,CUL3,cullin 3,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
285761,DCBLD1,"discoidin, CUB and LCCL domain containing 1",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
1630,DCC,DCC netrin 1 receptor,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
115265,DDIT4L,DNA-damage-inducible transcript 4-like,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
1740,DLG2,"discs, large homolog 2 (Drosophila)",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
64215,DNAJC1,"DnaJ (Hsp40) homolog, subfamily C, member 1",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
29103,DNAJC15,"DnaJ (Hsp40) homolog, subfamily C, member 15",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
10589,DRAP1,DR1-associated protein 1 (negative cofactor 2 alpha),0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
1823,DSC1,desmocollin 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
55862,ECHDC1,ethylmalonyl-CoA decarboxylase 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
1896,EDA,ectodysplasin A,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
84285,EIF1AD,eukaryotic translation initiation factor 1A domain containing,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
2035,EPB41,erythrocyte membrane protein band 4.1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
79852,EPHX3,epoxide hydrolase 3,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
2150,F2RL1,coagulation factor II (thrombin) receptor-like 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
57700,FAM160B1,"family with sequence similarity 160, member B1",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
79633,FAT4,FAT atypical cadherin 4,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
57120,GOPC,golgi-associated PDZ and coiled-coil motif containing,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
57678,GPAM,"glycerol-3-phosphate acyltransferase, mitochondrial",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
170589,GPHA2,glycoprotein hormone alpha 2,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
3066,HDAC2,histone deacetylase 2,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
3205,HOXA9,homeobox A9,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
3238,HOXD12,homeobox D12,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
222537,HS3ST5,heparan sulfate (glucosamine) 3-O-sulfotransferase 5,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
11141,IL1RAPL1,interleukin 1 receptor accessory protein-like 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
3619,INCENP,inner centromere protein antigens 135/155kDa,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
64799,IQCH,IQ motif containing H,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
9832,JAKMIP2,janus kinase and microtubule interacting protein 2,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
202559,KHDRBS2,"KH domain containing, RNA binding, signal transduction associated 2",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
3820,KLRB1,"killer cell lectin-like receptor subfamily B, member 1",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
53353,LRP1B,low density lipoprotein receptor-related protein 1B,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
8028,MLLT10,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
740,MRPL49,mitochondrial ribosomal protein L49,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
55149,MTPAP,mitochondrial poly(A) polymerase,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
23742,NPAP1,nuclear pore associated protein 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,0.0,0.0,0.0,1.0,25202,Melanoma,0.21,1,Therapeutic
221294,NT5DC1,5'-nucleotidase domain containing 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
116150,NUS1,nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
56128,PCDHB8,protocadherin beta 8,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
5305,PIP4K2A,"phosphatidylinositol-5-phosphate 4-kinase, type II, alpha",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
9088,PKMYT1,"protein kinase, membrane associated tyrosine/threonine 1",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
5332,PLCB4,"phospholipase C, beta 4",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
26472,PPP1R14B,"protein phosphatase 1, regulatory (inhibitor) subunit 14B",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
11098,PRSS23,"protease, serine, 23",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
9317,PTER,phosphotriesterase related,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
5800,PTPRO,"protein tyrosine phosphatase, receptor type, O",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
5880,RAC2,"ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
30062,RAX,retina and anterior neural fold homeobox,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
9985,REC8,REC8 meiotic recombination protein,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
222546,RFX6,"regulatory factor X, 6",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
6098,ROS1,"ROS proto-oncogene 1 , receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
10557,RPP38,ribonuclease P/MRP 38kDa subunit,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
6188,RPS3,ribosomal protein S3,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
29901,SAC3D1,SAC3 domain containing 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
7536,SF1,splicing factor 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
6565,SLC15A2,"solute carrier family 15 (oligopeptide transporter), member 2",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
283130,SLC25A45,"solute carrier family 25, member 45",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
80723,SLC35G2,"solute carrier family 35, member G2",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
221074,SLC39A12,"solute carrier family 39 (zinc transporter), member 12",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
6538,SLC6A11,"solute carrier family 6 (neurotransmitter transporter), member 11",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
10963,STIP1,stress-induced phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
6860,SYT4,synaptotagmin IV,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
338398,TAS2R60,"taste receptor, type 2, member 60",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
114795,TMEM132B,transmembrane protein 132B,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
161291,TMEM30B,transmembrane protein 30B,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
23270,TSPYL4,TSPY-like 4,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
7365,UGT2B10,"UDP glucuronosyltransferase 2 family, polypeptide B10",0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
9712,USP6NL,USP6 N-terminal like,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
245806,VGLL2,vestigial-like family member 2,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
54663,WDR74,WD repeat domain 74,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
220929,ZNF438,zinc finger protein 438,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
128611,ZNF831,zinc finger protein 831,0.0,1.0,0.0,0.0,0.0,25202,Melanoma,0.21,1,Biomarker
3848,KRT1,"keratin 1, type II",0.0,1.0,0.0,0.0,0.0,2931123,Keratosis palmoplantaris striata 3,0.21,0,Biomarker
898,CCNE1,cyclin E1,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
79813,EHMT1,euchromatic histone-lysine N-methyltransferase 1,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
2313,FLI1,"Fli-1 proto-oncogene, ETS transcription factor",0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
8660,IRS2,insulin receptor substrate 2,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
7994,KAT6A,K(lysine) acetyltransferase 6A,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
23030,KDM4B,lysine (K)-specific demethylase 4B,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
23081,KDM4C,lysine (K)-specific demethylase 4C,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
83746,L3MBTL2,l(3)mbt-like 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
84456,L3MBTL3,l(3)mbt-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
4352,MPL,"MPL proto-oncogene, thrombopoietin receptor",0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
10389,SCML2,sex comb on midleg-like 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
6502,SKP2,"S-phase kinase-associated protein 2, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
114826,SMYD4,SET and MYND domain containing 4,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
7409,VAV1,vav 1 guanine nucleotide exchange factor,0.0,1.0,0.0,0.0,0.0,25149,Medulloblastoma,0.21,1,Biomarker
100196917,MAFD9,"Major affective disorder-9, susceptibility to",0.0,1.0,0.0,0.0,0.0,2700440,Major Affective Disorder 9,0.21,0,Biomarker
10117,ENAM,enamelin,0.0,1.0,0.0,0.0,0.0,2673923,"Amelogenesis Imperfecta, Type Ic",0.21,0,Biomarker
100302686,MTBS3,"Mycobacterium tuberculosis, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,2752035,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3",0.21,0,Biomarker
100217387,AGA3,"Alopecia, androgenetic, 3",0.0,1.0,0.0,0.0,0.0,2676272,"Alopecia, Androgenetic, 3",0.21,0,Biomarker
100270679,LINC01432,long intergenic non-protein coding RNA 1432,0.0,1.0,0.0,0.0,0.0,2676272,"Alopecia, Androgenetic, 3",0.21,0,Biomarker
6261,RYR1,ryanodine receptor 1 (skeletal),0.0,1.0,0.0,0.0,0.0,2930980,Malignant hyperthermia susceptibility type 1,0.21,0,Biomarker
735,C9,complement component 9,0.0,1.0,0.0,0.0,0.0,25294,"Meningitis, Meningococcal",0.21,1,Biomarker
5199,CFP,complement factor properdin,0.0,1.0,0.0,0.0,0.0,25294,"Meningitis, Meningococcal",0.21,2,Biomarker
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,0.0,0.0,0.0,25294,"Meningitis, Meningococcal",0.21,1,Biomarker
780925,CHMRQ,"Cerebellar hypoplasia, mental retardation, and quadrupedal locomotion",0.0,1.0,0.0,0.0,0.0,2750234,"Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 2",0.21,0,Biomarker
5395,PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,38874,Supratentorial Neoplasms,0.21,1,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,85397,Pasteurellaceae Infections,0.21,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,85397,Pasteurellaceae Infections,0.21,1,Biomarker
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,85397,Pasteurellaceae Infections,0.21,1,Biomarker
4054,LTBP3,latent transforming growth factor beta binding protein 3,0.0,1.0,0.0,0.0,0.0,22821,Kyphosis,0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,22821,Kyphosis,0.21,1,Biomarker
5351,PLOD1,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1",0.0,1.0,0.0,0.0,0.0,22821,Kyphosis,0.21,1,Biomarker
1836,SLC26A2,"solute carrier family 26 (anion exchanger), member 2",0.0,1.0,0.0,0.0,0.0,22821,Kyphosis,0.21,1,Biomarker
91252,SLC39A13,"solute carrier family 39 (zinc transporter), member 13",0.0,1.0,0.0,0.0,0.0,22821,Kyphosis,0.21,1,Biomarker
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
266,AMELY,"amelogenin, Y-linked",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
283,ANG,"angiogenin, ribonuclease, RNase A family, 5",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
245972,ATP6V0D2,"ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
713,C1QB,"complement component 1, q subcomponent, B chain",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
784,CACNB3,"calcium channel, voltage-dependent, beta 3 subunit",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
1001,CDH3,"cadherin 3, type 1, P-cadherin (placental)",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
1675,CFD,complement factor D (adipsin),0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
1301,COL11A1,"collagen, type XI, alpha 1",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
221472,FGD2,"FYVE, RhoGEF and PH domain containing 2",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
56287,GKN1,gastrokine 1,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
2857,GPR34,G protein-coupled receptor 34,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
55699,IARS2,"isoleucyl-tRNA synthetase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
3549,IHH,indian hedgehog,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
8174,MADCAM1,mucosal vascular addressin cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
55110,MAGOHB,mago-nashi homolog B (Drosophila),0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
4237,MFAP2,microfibrillar-associated protein 2,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
931,MS4A1,"membrane-spanning 4-domains, subfamily A, member 1",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
9397,NMT2,N-myristoyltransferase 2,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
7025,NR2F1,"nuclear receptor subfamily 2, group F, member 1",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
11249,NXPH2,neurexophilin 2,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
5195,PEX14,peroxisomal biogenesis factor 14,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
5734,PTGER4,prostaglandin E receptor 4 (subtype EP4),0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
6125,RPL5,ribosomal protein L5,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
6424,SFRP4,secreted frizzled-related protein 4,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
91937,TIMD4,T-cell immunoglobulin and mucin domain containing 4,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
51643,TMBIM4,transmembrane BAX inhibitor motif containing 4,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
25789,TMEM59L,transmembrane protein 59-like,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
7111,TMOD1,tropomodulin 1,0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
391051,UOX,"urate oxidase, pseudogene",0.0,1.0,0.0,0.0,0.0,29927,Ovarian Cysts,0.21,1,Biomarker
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,206663,"Neuroectodermal Tumors, Primitive",0.21,1,Biomarker
23462,HEY1,hes-related family bHLH transcription factor with YRPW motif 1,0.0,1.0,0.0,0.0,0.0,206663,"Neuroectodermal Tumors, Primitive",0.21,1,Biomarker
4853,NOTCH2,notch 2,0.0,1.0,0.0,0.0,0.0,206663,"Neuroectodermal Tumors, Primitive",0.21,1,Biomarker
5395,PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,206663,"Neuroectodermal Tumors, Primitive",0.21,1,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,206663,"Neuroectodermal Tumors, Primitive",0.21,1,Biomarker
6762,ST3,suppression of tumorigenicity 3,0.0,1.0,0.0,0.0,0.0,1860658,SUPPRESSOR OF TUMORIGENICITY 3,0.21,0,Biomarker
6463,SHFM2,split hand/foot malformation (ectrodactyly) type 2,0.0,1.0,0.0,0.0,0.0,1839258,Split-Hand Foot Malformation 2,0.21,0,Biomarker
8068,BRCATA,"Breast cancer, 11;22 translocation associated",0.0,1.0,0.0,0.0,0.0,1332441,"Breast Cancer, 11;22 Translocation Associated Protein",0.21,0,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,33953,"Sexual Dysfunctions, Psychological",0.21,1,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,33953,"Sexual Dysfunctions, Psychological",0.21,2,Biomarker
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",0.0,1.0,0.0,0.0,0.0,33953,"Sexual Dysfunctions, Psychological",0.21,1,Biomarker
2892,GRIA3,"glutamate receptor, ionotropic, AMPA 3",0.0,1.0,0.0,0.0,0.0,33953,"Sexual Dysfunctions, Psychological",0.21,1,Biomarker
2898,GRIK2,"glutamate receptor, ionotropic, kainate 2",0.0,1.0,0.0,0.0,0.0,33953,"Sexual Dysfunctions, Psychological",0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,33953,"Sexual Dysfunctions, Psychological",0.21,2,Biomarker
100188768,SCAX5,"Spinocerebellar ataxia, X-linked 5",0.0,1.0,0.0,0.0,0.0,2678048,"Spinocerebellar Ataxia, X-Linked 5",0.21,0,Biomarker
8000,PSCA,prostate stem cell antigen,0.0,1.0,0.0,0.0,0.0,23743,Linitis Plastica,0.21,1,Biomarker
100101426,MRT11,"mental retardation, non-syndromic, autosomal recessive, 11",0.0,1.0,0.0,0.0,0.0,1970193,"Mental Retardation, Autosomal Recessive 11",0.21,0,Biomarker
100188771,AGA2,"Alopecia, androgenetic, 2",0.0,1.0,0.0,0.0,0.0,2678038,"Alopecia, Androgenetic, 2",0.21,0,Biomarker
10157,AASS,aminoadipate-semialdehyde synthase,0.0,1.0,0.0,0.0,0.0,2936921,Saccharopinuria,0.21,0,Biomarker
118429,ANTXR2,anthrax toxin receptor 2,0.0,1.0,0.0,0.0,0.0,16045,Fibroma,0.21,2,Biomarker
2911,GRM1,"glutamate receptor, metabotropic 1",0.0,1.0,0.0,0.0,0.0,16045,Fibroma,0.21,1,Biomarker
100188859,EA7,"Episodic ataxia, type 7",0.0,1.0,0.0,0.0,0.0,2677843,"Episodic Ataxia, Type 7",0.21,0,Biomarker
50948,OHDS,Orthostatic hypotensive disorder of Streeten,0.0,1.0,0.0,0.0,0.0,1840438,"Orthostatic Hypotensive Disorder, Streeten Type",0.21,0,Biomarker
10133,OPTN,optineurin,0.0,1.0,0.0,0.0,0.0,1847730,"GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO",0.21,0,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,1859972,"Adrenocortical Carcinoma, Hereditary",0.21,0,Biomarker
7491,WT2,Wilms tumor 2,0.0,1.0,0.0,0.0,0.0,1859972,"Adrenocortical Carcinoma, Hereditary",0.21,0,Biomarker
6012,RIEG2,Rieger syndrome 2,0.0,1.0,0.0,0.0,0.0,1832229,Rieger syndrome 2,0.21,0,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,0.0,0.0,1.0,11303,Demyelinating Diseases,0.21,1,Therapeutic
4143,MAT1A,"methionine adenosyltransferase I, alpha",0.0,1.0,0.0,0.0,0.0,11303,Demyelinating Diseases,0.21,1,Biomarker
5376,PMP22,peripheral myelin protein 22,0.0,1.0,0.0,0.0,0.0,11303,Demyelinating Diseases,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,0.0,0.0,0.0,1.0,11303,Demyelinating Diseases,0.21,1,Therapeutic
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,11303,Demyelinating Diseases,0.21,1,Biomarker
550624,KTCN4,Keratoconus 4,0.0,1.0,0.0,0.0,0.0,1836473,Keratoconus 4,0.21,0,Biomarker
4054,LTBP3,latent transforming growth factor beta binding protein 3,0.0,1.0,0.0,0.0,0.0,29464,Osteosclerosis,0.21,2,Biomarker
60500,BRCA3,breast cancer 3,0.0,1.0,0.0,0.0,0.0,1854365,Breast Cancer 3,0.21,0,Biomarker
1733,DIO1,"deiodinase, iodothyronine, type I",0.0,1.0,0.0,0.0,0.0,20551,Hyperthyroxinemia,0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.21,1,Biomarker
11167,FSTL1,follistatin-like 1,0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.21,1,Biomarker
4015,LOX,lysyl oxidase,0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.21,1,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.21,1,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,3504,Aortic Valve Insufficiency,0.21,1,Biomarker
114757,CYGB,cytoglobin,0.0,1.0,0.0,0.0,0.0,751870,"Heredodegenerative Disorders, Nervous System",0.21,1,Biomarker
2512,FTL,"ferritin, light polypeptide",0.0,1.0,0.0,0.0,0.0,751870,"Heredodegenerative Disorders, Nervous System",0.21,1,Biomarker
58157,NGB,neuroglobin,0.0,1.0,0.0,0.0,0.0,751870,"Heredodegenerative Disorders, Nervous System",0.21,1,Biomarker
54119,EIM,Infantile myoclonic epilepsy,0.0,1.0,0.0,0.0,0.0,917800,"MYOCLONIC EPILEPSY, FAMILIAL INFANTILE",0.21,0,Biomarker
291,SLC25A4,"solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4",0.0,1.0,0.0,0.0,0.0,1834846,"Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1",0.21,0,Biomarker
57016,AKR1B10,"aldo-keto reductase family 1, member B10 (aldose reductase)",0.0,0.0,0.0,0.0,1.0,27651,Neoplasms,0.21,1,Therapeutic
57448,BIRC6,baculoviral IAP repeat containing 6,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
823,CAPN1,"calpain 1, (mu/I) large subunit",0.0,0.0,0.0,0.0,1.0,27651,Neoplasms,0.21,1,Therapeutic
10370,CITED2,"Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2",0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
54431,DNAJC10,"DnaJ (Hsp40) homolog, subfamily C, member 10",0.0,0.0,0.0,0.0,1.0,27651,Neoplasms,0.21,1,Therapeutic
2740,GLP1R,glucagon-like peptide 1 receptor,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
2878,GPX3,glutathione peroxidase 3 (plasma),0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
23526,HMHA1,histocompatibility (minor) HA-1,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
7403,KDM6A,lysine (K)-specific demethylase 6A,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
79727,LIN28A,lin-28 homolog A (C. elegans),0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
389421,LIN28B,lin-28 homolog B (C. elegans),0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,27651,Neoplasms,0.21,1,Therapeutic
100506658,OCLN,occludin,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
79949,PLEKHS1,"pleckstrin homology domain containing, family S member 1",0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
6722,SRF,serum response factor (c-fos serum response element-binding transcription factor),0.0,0.0,0.0,0.0,1.0,27651,Neoplasms,0.21,1,Therapeutic
7150,TOP1,topoisomerase (DNA) I,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
54663,WDR74,WD repeat domain 74,0.0,1.0,0.0,0.0,0.0,27651,Neoplasms,0.21,1,Biomarker
284,ANGPT1,angiopoietin 1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
41,ASIC1,acid sensing (proton gated) ion channel 1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
40,ASIC2,acid sensing (proton gated) ion channel 2,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
9311,ASIC3,acid sensing (proton gated) ion channel 3,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
885,CCK,cholecystokinin,0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
916,CD3E,"CD3e molecule, epsilon (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
11221,DUSP10,dual specificity phosphatase 10,0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
1947,EFNB1,ephrin-B1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
1958,EGR1,early growth response 1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
51083,GAL,galanin/GMAP prepropeptide,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
2588,GALNS,galactosamine (N-acetyl)-6-sulfatase,0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
2625,GATA3,GATA binding protein 3,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
3665,IRF7,interferon regulatory factor 7,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
8942,KYNU,kynureninase,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
10747,MASP2,mannan-binding lectin serine peptidase 2,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
4615,MYD88,myeloid differentiation primary response 88,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
4879,NPPB,natriuretic peptide B,0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
9373,PLAA,phospholipase A2-activating protein,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
5734,PTGER4,prostaglandin E receptor 4 (subtype EP4),0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
6097,RORC,RAR-related orphan receptor C,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
10019,SH2B3,SH2B adaptor protein 3,0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
6584,SLC22A5,"solute carrier family 22 (organic cation/carnitine transporter), member 5",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
412,STS,"steroid sulfatase (microsomal), isozyme S",0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
30009,TBX21,T-box 21,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
11277,TREX1,three prime repair exonuclease 1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
8989,TRPA1,"transient receptor potential cation channel, subfamily A, member 1",0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
114131,UCN3,urocortin 3,0.0,0.0,0.0,0.0,1.0,21368,Inflammation,0.21,1,Therapeutic
9948,WDR1,WD repeat domain 1,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
7538,ZFP36,ZFP36 ring finger protein,0.0,1.0,0.0,0.0,0.0,21368,Inflammation,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,3868,"Arthritis, Gouty",0.21,1,Therapeutic
2657,GDF1,growth differentiation factor 1,0.0,0.0,1.0,0.0,0.0,3151221,"TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3",0.21,0,GeneticVariation
5345,SERPINF2,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2",0.0,1.0,0.0,0.0,0.0,3489734,"Anti-plasmin deficiency, congenital",0.21,0,Biomarker
2707,GJB3,"gap junction protein, beta 3, 31kDa",0.0,1.0,0.0,0.0,0.0,2677637,"Deafness, Autosomal Dominant 2A",0.21,0,Biomarker
408221,SCA26,spinocerebellar ataxia 26,0.0,1.0,0.0,0.0,0.0,1836395,Spinocerebellar ataxia 26,0.21,0,Biomarker
3605,IL17A,interleukin 17A,0.0,1.0,0.0,0.0,0.0,24314,Lymphoproliferative Disorders,0.21,1,Biomarker
145226,RDH12,retinol dehydrogenase 12 (all-trans/9-cis/11-cis),0.0,1.0,0.0,0.0,0.0,1858677,Leber Congenital Amaurosis 3,0.21,0,Biomarker
26040,SETBP1,SET binding protein 1,0.0,0.0,1.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.21,0,GeneticVariation
1407,CRY1,cryptochrome circadian clock 1,0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.21,1,Biomarker
1408,CRY2,cryptochrome circadian clock 2,0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.21,1,Biomarker
3309,HSPA5,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.21,1,Biomarker
5187,PER1,period circadian clock 1,0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.21,1,Biomarker
8864,PER2,period circadian clock 2,0.0,1.0,0.0,0.0,0.0,23473,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",0.21,1,Biomarker
10398,MYL9,"myosin, light chain 9, regulatory",0.0,1.0,0.0,0.0,0.0,1527311,Brain Edema,0.21,1,Biomarker
4638,MYLK,myosin light chain kinase,0.0,1.0,0.0,0.0,0.0,1527311,Brain Edema,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,1527311,Brain Edema,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,751895,"Vasospasm, Intracranial",0.21,1,Therapeutic
6271,S100A1,S100 calcium binding protein A1,0.0,1.0,0.0,0.0,0.0,751895,"Vasospasm, Intracranial",0.21,1,Biomarker
6275,S100A4,S100 calcium binding protein A4,0.0,1.0,0.0,0.0,0.0,751895,"Vasospasm, Intracranial",0.21,1,Biomarker
6277,S100A6,S100 calcium binding protein A6,0.0,1.0,0.0,0.0,0.0,751895,"Vasospasm, Intracranial",0.21,1,Biomarker
6285,S100B,S100 calcium binding protein B,0.0,1.0,0.0,0.0,0.0,751895,"Vasospasm, Intracranial",0.21,1,Biomarker
2077,ERF,Ets2 repressor factor,0.0,0.0,1.0,0.0,0.0,3806917,CRANIOSYNOSTOSIS 4,0.21,1,GeneticVariation
57791,MRXSA,Armfield X-linked mental retardation syndrome,0.0,1.0,0.0,0.0,0.0,1846057,Armfield X-Linked Mental Retardation Syndrome,0.21,0,Biomarker
3684,ITGAM,"integrin, alpha M (complement component 3 receptor 3 subunit)",0.0,1.0,0.0,0.0,0.0,20877,Ileitis,0.21,1,Biomarker
8066,ANC,Anal canal carcinoma,0.0,1.0,0.0,0.0,0.0,563211,Anal Canal Carcinoma,0.21,0,Biomarker
4595,MUTYH,mutY homolog,0.0,1.0,0.0,0.0,0.0,206711,Pilomatrixoma,0.21,0,Biomarker
64240,ABCG5,"ATP-binding cassette, sub-family G (WHITE), member 5",0.0,1.0,0.0,0.0,0.0,242339,Dyslipidemias,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,242339,Dyslipidemias,0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,242339,Dyslipidemias,0.21,1,Biomarker
8701,DNAH11,"dynein, axonemal, heavy chain 11",0.0,1.0,0.0,0.0,0.0,242339,Dyslipidemias,0.21,1,Biomarker
79661,NEIL1,nei endonuclease VIII-like 1 (E. coli),0.0,1.0,0.0,0.0,0.0,242339,Dyslipidemias,0.21,1,Biomarker
55219,TMEM57,transmembrane protein 57,0.0,1.0,0.0,0.0,0.0,242339,Dyslipidemias,0.21,1,Biomarker
8876,VNN1,vanin 1,0.0,1.0,0.0,0.0,0.0,242339,Dyslipidemias,0.21,1,Biomarker
486,FXYD2,FXYD domain containing ion transport regulator 2,0.0,1.0,0.0,0.0,0.0,24473,Magnesium Deficiency,0.21,1,Biomarker
4387,MRX23,"mental retardation, X-linked 23",0.0,1.0,0.0,0.0,0.0,796229,"Mental Retardation, X-Linked 23",0.21,0,Biomarker
1645,AKR1C1,"aldo-keto reductase family 1, member C1",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
467,ATF3,activating transcription factor 3,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
57099,AVEN,"apoptosis, caspase activation inhibitor",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
10087,COL4A3BP,"collagen, type IV, alpha 3 (Goodpasture antigen) binding protein",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
23603,CORO1C,"coronin, actin binding protein, 1C",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
1474,CST6,cystatin E/M,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
2309,FOXO3,forkhead box O3,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
2696,GIPR,gastric inhibitory polypeptide receptor,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
100302142,MIR1246,microRNA 1246,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
407021,MIR29A,microRNA 29a,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
407031,MIR30C1,microRNA 30c-1,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
9180,OSMR,oncostatin M receptor,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
5021,OXTR,oxytocin receptor,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
5223,PGAM1,phosphoglycerate mutase 1 (brain),0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
7262,PHLDA2,"pleckstrin homology-like domain, family A, member 2",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
79887,PLBD1,phospholipase B domain containing 1,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
23532,PRAME,preferentially expressed antigen in melanoma,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
10179,RBM7,RNA binding motif protein 7,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
6009,RHEB,Ras homolog enriched in brain,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
6385,SDC4,syndecan 4,0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,1,Biomarker
10568,SLC34A2,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 2",0.0,1.0,0.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.21,2,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,206704,"Carcinoma, Large Cell",0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,6267,Bronchiectasis,0.21,1,Biomarker
474387,OFC4,Orofacial cleft 4,0.0,1.0,0.0,0.0,0.0,1842143,Orofacial Cleft 4,0.21,0,Biomarker
2771,GNAI2,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2",0.0,1.0,0.0,0.0,0.0,4245,Atrioventricular Block,0.21,1,Biomarker
64240,ABCG5,"ATP-binding cassette, sub-family G (WHITE), member 5",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
28,ABO,"ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
84519,ACRBP,acrosin binding protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2182,ACSL4,acyl-CoA synthetase long-chain family member 4,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6296,ACSM3,acyl-CoA synthetase medium-chain family member 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8644,AKR1C3,"aldo-keto reductase family 1, member C3",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,2,Biomarker
59344,ALOXE3,arachidonate lipoxygenase 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
306,ANXA3,annexin A3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
307,ANXA4,annexin A4,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
316,AOX1,aldehyde oxidase 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
328,APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
55198,APPL2,"adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7984,ARHGEF5,Rho guanine nucleotide exchange factor (GEF) 5,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
23204,ARL6IP1,ADP-ribosylation factor-like 6 interacting protein 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
136991,ASZ1,"ankyrin repeat, SAM and basic leucine zipper domain containing 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
55210,ATAD3A,"ATPase family, AAA domain containing 3A",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8702,B4GALT4,"UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
11176,BAZ2A,"bromodomain adjacent to zinc finger domain, 2A",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8537,BCAS1,breast carcinoma amplified sequence 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
826,CAPNS1,"calpain, small subunit 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
858,CAV2,caveolin 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
873,CBR1,carbonyl reductase 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10951,CBX1,chromobox homolog 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1365,CLDN3,claudin 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
9080,CLDN9,claudin 9,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
25932,CLIC4,chloride intracellular channel 4,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
81037,CLPTM1L,CLPTM1-like,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1266,CNN3,"calponin 3, acidic",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1312,COMT,catechol-O-methyltransferase,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8804,CREG1,cellular repressor of E1A-stimulated genes 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1410,CRYAB,"crystallin, alpha B",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
51084,CRYL1,"crystallin, lambda 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1465,CSRP1,cysteine and glycine-rich protein 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1469,CST1,cystatin SN,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1508,CTSB,cathepsin B,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1509,CTSD,cathepsin D,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1562,CYP2C18,"cytochrome P450, family 2, subfamily C, polypeptide 18",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1672,DEFB1,"defensin, beta 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8560,DEGS1,"delta(4)-desaturase, sphingolipid 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
27294,DHDH,dihydrodiol dehydrogenase (dimeric),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
56616,DIABLO,"diablo, IAP-binding mitochondrial protein",0.0,0.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.21,1,Therapeutic
54431,DNAJC10,"DnaJ (Hsp40) homolog, subfamily C, member 10",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5611,DNAJC3,"DnaJ (Hsp40) homolog, subfamily C, member 3",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1775,DNASE1L2,deoxyribonuclease I-like 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
9538,EI24,etoposide induced 2.4,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5610,EIF2AK2,eukaryotic translation initiation factor 2-alpha kinase 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8661,EIF3A,"eukaryotic translation initiation factor 3, subunit A",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2012,EMP1,epithelial membrane protein 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2014,EMP3,epithelial membrane protein 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
59084,ENPP5,ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4072,EPCAM,epithelial cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,2,Biomarker
79574,EPS8L3,EPS8-like 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10961,ERP29,endoplasmic reticulum protein 29,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
23071,ERP44,endoplasmic reticulum protein 44,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
23197,FAF2,Fas associated factor family member 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,0.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.21,1,Therapeutic
2192,FBLN1,fibulin 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10516,FBLN5,fibulin 5,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
93611,FBXO44,F-box protein 44,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3171,FOXA3,forkhead box A3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2296,FOXC1,forkhead box C1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2591,GALNT3,polypeptide N-acetylgalactosaminyltransferase 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2787,GNG5,"guanine nucleotide binding protein (G protein), gamma 5",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2803,GOLGA4,golgin A4,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2878,GPX3,glutathione peroxidase 3 (plasma),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2886,GRB7,growth factor receptor-bound protein 7,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
9380,GRHPR,glyoxylate reductase/hydroxypyruvate reductase,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
79807,GSTCD,"glutathione S-transferase, C-terminal domain containing",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
373156,GSTK1,glutathione S-transferase kappa 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2947,GSTM3,glutathione S-transferase mu 3 (brain),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
9446,GSTO1,glutathione S-transferase omega 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
54363,HAO1,hydroxyacid oxidase (glycolate oxidase) 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3047,HBG1,"hemoglobin, gamma A",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3048,HBG2,"hemoglobin, gamma G",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
9709,HERPUD1,"homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8339,HIST1H2BG,"histone cluster 1, H2bg",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8365,HIST1H4H,"histone cluster 1, H4h",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3187,HNRNPH1,heterogeneous nuclear ribonucleoprotein H1 (H),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3232,HOXD3,homeobox D3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
408259,HPC3,"Prostate cancer, hereditary, 3",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,0,Biomarker
408260,HPC4,"Prostate cancer, hereditary, 4",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,0,Biomarker
619402,HPC5,"prostate cancer, hereditary, 5",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,0,Biomarker
100188789,HPC6,"Prostate cancer, susceptibility to",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,0,Biomarker
347747,HPCQTL19,Prostate cancer aggressiveness quantitative trait locus on chromosome 19,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,0,Biomarker
9566,HPCX,"hereditary prostate cancer, X-linked",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,0,Biomarker
3248,HPGD,hydroxyprostaglandin dehydrogenase 15-(NAD),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3292,HSD17B1,hydroxysteroid (17-beta) dehydrogenase 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3293,HSD17B3,hydroxysteroid (17-beta) dehydrogenase 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3326,HSP90AB1,"heat shock protein 90kDa alpha (cytosolic), class B member 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3303,HSPA1A,heat shock 70kDa protein 1A,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3489,IGFBP6,insulin-like growth factor binding protein 6,0.0,0.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.21,1,Therapeutic
150084,IGSF5,"immunoglobulin superfamily, member 5",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10207,INADL,InaD-like (Drosophila),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
51135,IRAK4,interleukin-1 receptor-associated kinase 4,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10625,IVNS1ABP,influenza virus NS1A binding protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3717,JAK2,Janus kinase 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10945,KDELR1,KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
28999,KLF15,Kruppel-like factor 15,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3913,LAMB2,"laminin, beta 2 (laminin S)",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3945,LDHB,lactate dehydrogenase B,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4074,M6PR,mannose-6-phosphate receptor (cation dependent),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8379,MAD1L1,MAD1 mitotic arrest deficient-like 1 (yeast),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,0,Biomarker
6885,MAP3K7,mitogen-activated protein kinase kinase kinase 7,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8932,MBD2,methyl-CpG binding domain protein 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8720,MBTPS1,"membrane-bound transcription factor peptidase, site 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4158,MC2R,melanocortin 2 receptor (adrenocorticotropic hormone),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4322,MMP13,matrix metallopeptidase 13 (collagenase 3),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4507,MTAP,methylthioadenosine phosphorylase,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
79784,MYH14,"myosin, heavy chain 14, non-muscle",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
55577,NAGK,N-acetylglucosamine kinase,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4669,NAGLU,"N-acetylglucosaminidase, alpha",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4683,NBN,nibrin,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,2,Biomarker
4782,NFIC,nuclear factor I/C (CCAAT-binding transcription factor),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
57185,NIPAL3,NIPA-like domain containing 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,0.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.21,1,Therapeutic
4883,NPR3,natriuretic peptide receptor 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
4925,NUCB2,nucleobindin 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10439,OLFM1,olfactomedin 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5034,P4HB,"prolyl 4-hydroxylase, beta polypeptide",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7834,PCAP,predisposing for prostate cancer,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,0,Biomarker
5100,PCDH8,protocadherin 8,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5144,PDE4D,"phosphodiesterase 4D, cAMP-specific",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5160,PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
2923,PDIA3,"protein disulfide isomerase family A, member 3",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5174,PDZK1,PDZ domain containing 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10158,PDZK1IP1,PDZK1 interacting protein 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5179,PENK,proenkephalin,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5224,PGAM2,phosphoglycerate mutase 2 (muscle),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10857,PGRMC1,progesterone receptor membrane component 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
26227,PHGDH,phosphoglycerate dehydrogenase,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
11187,PKP3,plakophilin 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
26499,PLEK2,pleckstrin 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5530,PPP3CA,"protein phosphatase 3, catalytic subunit, alpha isozyme",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5591,PRKDC,"protein kinase, DNA-activated, catalytic polypeptide",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5396,PRRX1,paired related homeobox 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5652,PRSS8,"protease, serine, 8",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
29893,PSMC3IP,PSMC3 interacting protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5796,PTPRK,"protein tyrosine phosphatase, receptor type, K",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
51651,PTRH2,peptidyl-tRNA hydrolase 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5859,QARS,glutaminyl-tRNA synthetase,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
53916,RAB4B,"RAB4B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5887,RAD23B,RAD23 homolog B (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10928,RALBP1,ralA binding protein 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
51655,RASD1,"RAS, dexamethasone-induced 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
9985,REC8,REC8 meiotic recombination protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
55312,RFK,riboflavin kinase,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
51132,RLIM,"ring finger protein, LIM domain interacting",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6038,RNASE4,"ribonuclease, RNase A family, 4",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
55819,RNF130,ring finger protein 130,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6134,RPL10,ribosomal protein L10,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6136,RPL12,ribosomal protein L12,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6185,RPN2,ribophorin II,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6223,RPS19,ribosomal protein S19,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6237,RRAS,related RAS viral (r-ras) oncogene homolog,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
861,RUNX1,runt-related transcription factor 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
23753,SDF2L1,stromal cell-derived factor 2-like 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10955,SERINC3,serine incorporator 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5273,SERPINB10,"serpin peptidase inhibitor, clade B (ovalbumin), member 10",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6462,SHBG,sex hormone-binding globulin,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,2,Biomarker
64374,SIL1,SIL1 nucleotide exchange factor,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
5172,SLC26A4,"solute carrier family 26 (anion exchanger), member 4",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6541,SLC7A1,"solute carrier family 7 (cationic amino acid transporter, y+ system), member 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
389058,SP5,Sp5 transcription factor,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
11005,SPINK5,"serine peptidase inhibitor, Kazal type 5",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6695,SPOCK1,"sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10417,SPON2,"spondin 2, extracellular matrix protein",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8405,SPOP,speckle-type POZ protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6746,SSR2,"signal sequence receptor, beta (translocon-associated protein beta)",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6757,SSX2,"synovial sarcoma, X breakpoint 2",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10809,STARD10,StAR-related lipid transfer (START) domain containing 10,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10948,STARD3,StAR-related lipid transfer (START) domain containing 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,2,Biomarker
6822,SULT2A1,"sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6820,SULT2B1,"sulfotransferase family, cytosolic, 2B, member 1",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6836,SURF4,surfeit 4,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6916,TBXAS1,thromboxane A synthase 1 (platelet),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
56849,TCEAL7,transcription elongation factor A (SII)-like 7,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6948,TCN2,transcobalamin II,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
6950,TCP1,t-complex 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7012,TERC,telomerase RNA component,0.0,0.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.21,1,Therapeutic
54790,TET2,tet methylcytosine dioxygenase 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
29087,THYN1,thymocyte nuclear protein 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
114609,TIRAP,toll-interleukin 1 receptor (TIR) domain containing adaptor protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
27134,TJP3,tight junction protein 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7100,TLR5,toll-like receptor 5,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7111,TMOD1,tropomodulin 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7114,TMSB4X,"thymosin beta 4, X-linked",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
27242,TNFRSF21,"tumor necrosis factor receptor superfamily, member 21",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10040,TOM1L1,target of myb1 (chicken)-like 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7153,TOP2A,topoisomerase (DNA) II alpha 170kDa,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7162,TPBG,trophoblast glycoprotein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7164,TPD52L1,tumor protein D52-like 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
1200,TPP1,tripeptidyl peptidase I,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7185,TRAF1,TNF receptor-associated factor 1,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7263,TST,thiosulfate sulfurtransferase (rhodanese),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
283237,TTC9C,tetratricopeptide repeat domain 9C,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7991,TUSC3,tumor suppressor candidate 3,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,0,Biomarker
81567,TXNDC5,thioredoxin domain containing 5 (endoplasmic reticulum),0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
10587,TXNRD2,thioredoxin reductase 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7352,UCP3,"uncoupling protein 3 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
8615,USO1,USO1 vesicle transport factor,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
55829,VIMP,VCP-interacting membrane protein,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
54361,WNT4,"wingless-type MMTV integration site family, member 4",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
51341,ZBTB7A,zinc finger and BTB domain containing 7A,0.0,0.0,0.0,0.0,1.0,33578,Prostatic Neoplasms,0.21,1,Therapeutic
7763,ZFAND5,"zinc finger, AN1-type domain 5",0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
678,ZFP36L2,ZFP36 ring finger protein-like 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
7546,ZIC2,Zic family member 2,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
90338,ZNF160,zinc finger protein 160,0.0,1.0,0.0,0.0,0.0,33578,Prostatic Neoplasms,0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,20505,Hyperphagia,0.21,3,Biomarker
2150,F2RL1,coagulation factor II (thrombin) receptor-like 1,0.0,1.0,0.0,0.0,0.0,33774,Pruritus,0.21,1,Biomarker
3269,HRH1,histamine receptor H1,0.0,1.0,0.0,0.0,0.0,33774,Pruritus,0.21,1,Biomarker
59340,HRH4,histamine receptor H4,0.0,1.0,0.0,0.0,0.0,33774,Pruritus,0.21,1,Biomarker
7044,LEFTY2,left-right determination factor 2,0.0,0.0,1.0,0.0,0.0,1537561,LEFT-RIGHT DETERMINATION FACTOR 2,0.21,1,GeneticVariation
3500,IGHG1,immunoglobulin heavy constant gamma 1 (G1m marker),0.0,1.0,0.0,0.0,0.0,27121,Myositis,0.21,1,Biomarker
3501,IGHG2,immunoglobulin heavy constant gamma 2 (G2m marker),0.0,1.0,0.0,0.0,0.0,27121,Myositis,0.21,1,Biomarker
3514,IGKC,immunoglobulin kappa constant,0.0,1.0,0.0,0.0,0.0,27121,Myositis,0.21,1,Biomarker
48,ACO1,"aconitase 1, soluble",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
9510,ADAMTS1,"ADAM metallopeptidase with thrombospondin type 1 motif, 1",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
226,ALDOA,"aldolase A, fructose-bisphosphate",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
259,AMBP,alpha-1-microglobulin/bikunin precursor,0.0,0.0,0.0,0.0,1.0,27626,Neoplasm Invasiveness,0.21,1,Therapeutic
51129,ANGPTL4,angiopoietin-like 4,0.0,0.0,0.0,0.0,1.0,27626,Neoplasm Invasiveness,0.21,1,Therapeutic
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
302,ANXA2,annexin A2,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
9564,BCAR1,breast cancer anti-estrogen resistance 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
682,BSG,basigin (Ok blood group),0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
811,CALR,calreticulin,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
813,CALU,calumenin,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
847,CAT,catalase,0.0,0.0,0.0,0.0,1.0,27626,Neoplasm Invasiveness,0.21,2,Therapeutic
3732,CD82,CD82 molecule,0.0,0.0,0.0,0.0,1.0,27626,Neoplasm Invasiveness,0.21,1,Therapeutic
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,1.0,27626,Neoplasm Invasiveness,0.21,2,"Biomarker, Therapeutic"
1072,CFL1,cofilin 1 (non-muscle),0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
1476,CSTB,cystatin B (stefin B),0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,2,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
1508,CTSB,cathepsin B,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,2,Biomarker
1509,CTSD,cathepsin D,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
1520,CTSS,cathepsin S,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
7913,DEK,DEK proto-oncogene,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
1938,EEF2,eukaryotic translation elongation factor 2,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,2,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
2057,EPOR,erythropoietin receptor,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
2059,EPS8,epidermal growth factor receptor pathway substrate 8,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
8823,FGF16,fibroblast growth factor 16,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
27086,FOXP1,forkhead box P1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
2495,FTH1,"ferritin, heavy polypeptide 1",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
2512,FTL,"ferritin, light polypeptide",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
9846,GAB2,GRB2-associated binding protein 2,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
10855,HPSE,heparanase,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3400,ID4,"inhibitor of DNA binding 4, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3658,IREB2,iron-responsive element binding protein 2,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3678,ITGA5,"integrin, alpha 5 (fibronectin receptor, alpha polypeptide)",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
23028,KDM1A,lysine (K)-specific demethylase 1A,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3880,KRT19,"keratin 19, type I",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3855,KRT7,"keratin 7, type II",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3945,LDHB,lactate dehydrogenase B,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
406984,MIR200B,microRNA 200b,0.0,0.0,0.0,0.0,1.0,27626,Neoplasm Invasiveness,0.21,1,Therapeutic
406985,MIR200C,microRNA 200c,0.0,0.0,0.0,0.0,1.0,27626,Neoplasm Invasiveness,0.21,1,Therapeutic
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,4,Biomarker
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
4502,MT2A,metallothionein 2A,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
4615,MYD88,myeloid differentiation primary response 88,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
4638,MYLK,myosin light chain kinase,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,2,Biomarker
4684,NCAM1,neural cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
4830,NME1,NME/NM23 nucleoside diphosphate kinase 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3084,NRG1,neuregulin 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
27250,PDCD4,programmed cell death 4 (neoplastic transformation inhibitor),0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
5315,PKM,"pyruvate kinase, muscle",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,2,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,0.0,0.0,0.0,1.0,27626,Neoplasm Invasiveness,0.21,1,Therapeutic
5747,PTK2,protein tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
8434,RECK,reversion-inducing-cysteine-rich protein with kazal motifs,0.0,0.0,0.0,0.0,1.0,27626,Neoplasm Invasiveness,0.21,1,Therapeutic
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
387,RHOA,ras homolog family member A,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
6197,RPS6KA3,"ribosomal protein S6 kinase, 90kDa, polypeptide 3",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
3921,RPSA,ribosomal protein SA,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
6275,S100A4,S100 calcium binding protein A4,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
6462,SHBG,sex hormone-binding globulin,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
57181,SLC39A10,"solute carrier family 39 (zinc transporter), member 10",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
6615,SNAI1,snail family zinc finger 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
6591,SNAI2,snail family zinc finger 2,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,6,Biomarker
6714,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,2,Biomarker
7341,SUMO1,small ubiquitin-like modifier 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
7086,TKT,transketolase,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
7094,TLN1,talin 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
7291,TWIST1,twist family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
7295,TXN,thioredoxin,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
6935,ZEB1,zinc finger E-box binding homeobox 1,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
9839,ZEB2,zinc finger E-box binding homeobox 2,0.0,1.0,0.0,0.0,0.0,27626,Neoplasm Invasiveness,0.21,1,Biomarker
4156,MBS1,Moebius syndrome 1,0.0,1.0,0.0,0.0,0.0,2931025,Moebius syndrome 1,0.21,0,Biomarker
100529148,MDNS,Mammary-digital-nail syndrome,0.0,1.0,0.0,0.0,0.0,3150946,MAMMARY-DIGITAL-NAIL SYNDROME,0.21,0,Biomarker
735,C9,complement component 9,0.0,1.0,0.0,0.0,0.0,41834,Erythema,0.21,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,41834,Erythema,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,242216,Gallstones,0.21,1,Biomarker
3156,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,0.0,1.0,0.0,0.0,0.0,242216,Gallstones,0.21,1,Biomarker
54014,BRWD1,bromodomain and WD repeat domain containing 1,0.0,1.0,0.0,0.0,0.0,28960,Oligospermia,0.21,1,Biomarker
1081,CGA,"glycoprotein hormones, alpha polypeptide",0.0,0.0,0.0,0.0,1.0,28960,Oligospermia,0.21,1,Therapeutic
23405,DICER1,"dicer 1, ribonuclease type III",0.0,1.0,0.0,0.0,0.0,28960,Oligospermia,0.21,1,Biomarker
80271,ITPKC,inositol-trisphosphate 3-kinase C,0.0,1.0,0.0,0.0,0.0,2936917,Infantile polyarteritis,0.21,0,Biomarker
38,ACAT1,acetyl-CoA acetyltransferase 1,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
147,ADRA1B,adrenoceptor alpha 1B,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.21,3,"Biomarker, Therapeutic"
1103,CHAT,choline O-acetyltransferase,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
1128,CHRM1,"cholinergic receptor, muscarinic 1",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,5,Biomarker
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,2,Biomarker
1143,CHRNB4,"cholinergic receptor, nicotinic, beta 4 (neuronal)",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,2,Biomarker
1191,CLU,clusterin,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
1583,CYP11A1,"cytochrome P450, family 11, subfamily A, polypeptide 1",0.0,0.0,0.0,0.0,1.0,36572,Seizures,0.21,1,Therapeutic
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,4,Biomarker
2558,GABRA5,"gamma-aminobutyric acid (GABA) A receptor, alpha 5",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
2593,GAMT,guanidinoacetate N-methyltransferase,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,0.0,0.0,0.0,1.0,36572,Seizures,0.21,1,Therapeutic
2784,GNB3,"guanine nucleotide binding protein (G protein), beta polypeptide 3",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.21,3,"Biomarker, Therapeutic"
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
3456,IFNB1,"interferon, beta 1, fibroblast",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
3612,IMPA1,inositol(myo)-1(or 4)-monophosphatase 1,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
54886,LPPR1,lipid phosphate phosphatase-related protein type 1,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
57534,MIB1,mindbomb E3 ubiquitin protein ligase 1,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
4804,NGFR,nerve growth factor receptor,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
8828,NRP2,neuropilin 2,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
4986,OPRK1,"opioid receptor, kappa 1",0.0,1.0,0.0,0.0,1.0,36572,Seizures,0.21,2,"Biomarker, Therapeutic"
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,2,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,6,Biomarker
5066,PAM,peptidylglycine alpha-amidating monooxygenase,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
5816,PVALB,parvalbumin,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
57030,SLC17A7,"solute carrier family 17 (vesicular glutamate transporter), member 7",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
7779,SLC30A1,"solute carrier family 30 (zinc transporter), member 1",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
6529,SLC6A1,"solute carrier family 6 (neurotransmitter transporter), member 1",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
6530,SLC6A2,"solute carrier family 6 (neurotransmitter transporter), member 2",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
6546,SLC8A1,"solute carrier family 8 (sodium/calcium exchanger), member 1",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
6547,SLC8A3,"solute carrier family 8 (sodium/calcium exchanger), member 3",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,36572,Seizures,0.21,1,Biomarker
6752,SSTR2,somatostatin receptor 2,0.0,0.0,0.0,0.0,1.0,36572,Seizures,0.21,1,Therapeutic
6037,RNASE3,"ribonuclease, RNase A family, 3",0.0,0.0,0.0,0.0,1.0,85423,Gram-Negative Bacterial Infections,0.21,1,Therapeutic
4763,NF1,neurofibromin 1,0.0,1.0,0.0,0.0,0.0,23827,Liposarcoma,0.21,1,Biomarker
780906,SLI3,"Specific language impairment QTL, 3",0.0,1.0,0.0,0.0,0.0,1846719,SPECIFIC LANGUAGE IMPAIRMENT 3,0.21,0,Biomarker
6608,SMO,"smoothened, frizzled class receptor",0.0,1.0,0.0,0.0,0.0,2448,Ameloblastoma,0.21,1,Biomarker
8803,SUCLA2,"succinate-CoA ligase, ADP-forming, beta subunit",0.0,1.0,0.0,0.0,0.0,3151513,MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE),0.21,0,Biomarker
7084,TK2,"thymidine kinase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,3151513,MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE),0.21,0,Biomarker
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,1.0,0.0,0.0,0.0,393590,Idiopathic basal ganglia calcification 1,0.21,1,Biomarker
57211,GPR126,G protein-coupled receptor 126,0.0,1.0,0.0,0.0,0.0,2700406,"SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1",0.21,1,Biomarker
260402,IS1,Adolescent idiopathic scoliosis,0.0,1.0,0.0,0.0,0.0,2700406,"SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
4835,NQO2,"NAD(P)H dehydrogenase, quinone 2",0.0,1.0,0.0,0.0,0.0,5956,Bone Marrow Diseases,0.21,1,Biomarker
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,1,Biomarker
1301,COL11A1,"collagen, type XI, alpha 1",0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,1,Biomarker
10683,DLL3,delta-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,1,Biomarker
2316,FLNA,"filamin A, alpha",0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,1,Biomarker
2321,FLT1,fms-related tyrosine kinase 1,0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,1,Biomarker
2720,GLB1,"galactosidase, beta 1",0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,1,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,1,Biomarker
50964,SOST,sclerostin,0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,0,Biomarker
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,0.0,0.0,0.0,29422,Osteochondrodysplasias,0.21,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,0.0,0.0,0.0,1.0,29422,Osteochondrodysplasias,0.21,1,Therapeutic
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,276535,AIDS-related Kaposi sarcoma,0.21,1,Biomarker
63944,SCZD10,schizophrenia disorder 10 (periodic catatonia),0.0,1.0,0.0,0.0,0.0,36344,"Schizophrenia, Catatonic",0.21,0,Biomarker
1591,CYP24A1,"cytochrome P450, family 24, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,1565489,Renal Insufficiency,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,1565489,Renal Insufficiency,0.21,1,Therapeutic
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,1565489,Renal Insufficiency,0.21,1,Biomarker
4311,MME,membrane metallo-endopeptidase,0.0,1.0,0.0,0.0,0.0,1565489,Renal Insufficiency,0.21,1,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,6145,Breast Diseases,0.21,1,Biomarker
378484,MRX82,"mental retardation, X-linked 82",0.0,1.0,0.0,0.0,0.0,1845286,"Mental Retardation, X-Linked 82",0.21,0,Biomarker
10774,DHS,dehydrated hereditary stomatocytosis,0.0,1.0,0.0,0.0,0.0,1863769,"Dehydrated Hereditary Stomatocytosis, Pseudohyperkalemia, and Perinatal Edema",0.21,0,Biomarker
192679,SLEN2,systemic lupus erythematosus with nephritis 2,0.0,1.0,0.0,0.0,0.0,1842756,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2",0.21,0,Biomarker
345,APOC3,apolipoprotein C-III,0.0,1.0,0.0,0.0,0.0,20476,Hyperlipoproteinemias,0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,20476,Hyperlipoproteinemias,0.21,1,Biomarker
2936,GSR,glutathione reductase,0.0,1.0,0.0,0.0,0.0,2736,Amyotrophic Lateral Sclerosis,0.21,1,Biomarker
1433,CSE,"choreoathetosis/spasticity, episodic (paroxysmal choreoathetosis/spasticity)",0.0,1.0,0.0,0.0,0.0,1832855,"Choreoathetosis/Spasticity, Episodic",0.21,0,Biomarker
3548,IHG1,iris hypoplasia with glaucoma 1,0.0,1.0,0.0,0.0,0.0,1839928,Iris hypoplasia and glaucoma,0.21,0,Biomarker
30813,VSX1,visual system homeobox 1,0.0,0.0,1.0,0.0,0.0,3280099,CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME,0.21,0,GeneticVariation
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,80178,Spinal Dysraphism,0.21,1,Biomarker
57216,VANGL2,VANGL planar cell polarity protein 2,0.0,1.0,0.0,0.0,0.0,80178,Spinal Dysraphism,0.21,1,Biomarker
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,0.0,0.0,0.0,40188,Tic Disorders,0.21,1,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,0.0,0.0,0.0,1.0,7787,"Ischemic Attack, Transient",0.21,1,Therapeutic
572,BAD,BCL2-associated agonist of cell death,0.0,1.0,0.0,0.0,0.0,7787,"Ischemic Attack, Transient",0.21,1,Biomarker
842,CASP9,"caspase 9, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,7787,"Ischemic Attack, Transient",0.21,1,Biomarker
54205,CYCS,"cytochrome c, somatic",0.0,1.0,0.0,0.0,0.0,7787,"Ischemic Attack, Transient",0.21,1,Biomarker
27429,HTRA2,HtrA serine peptidase 2,0.0,1.0,0.0,0.0,0.0,7787,"Ischemic Attack, Transient",0.21,1,Biomarker
3611,ILK,integrin-linked kinase,0.0,1.0,0.0,0.0,0.0,7787,"Ischemic Attack, Transient",0.21,1,Biomarker
57447,NDRG2,NDRG family member 2,0.0,1.0,0.0,0.0,0.0,7787,"Ischemic Attack, Transient",0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,0.0,0.0,0.0,1.0,7787,"Ischemic Attack, Transient",0.21,4,Therapeutic
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,7787,"Ischemic Attack, Transient",0.21,1,Biomarker
36,ACADSB,"acyl-CoA dehydrogenase, short/branched chain",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
23394,ADNP,activity-dependent neuroprotector homeobox,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
23245,ASTN2,astrotactin 2,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
100188820,AUTS11,"Autism, susceptibility to, 11",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,0,Biomarker
100188314,AUTS12,"autism, susceptibility to, 12",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,0,Biomarker
100188317,AUTS13,"autism, susceptibility to, 13",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,0,Biomarker
387577,AUTS3,"Autism, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,0,Biomarker
554314,AUTS6,"Autism, susceptibility to, 6",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,0,Biomarker
100188816,AUTS7,"Autism, susceptibility to, 7",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,0,Biomarker
686,BTD,biotinidase,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
5067,CNTN3,contactin 3 (plasmacytoma associated),0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
100187724,DEL16P11.2,"autism, susceptibility to, 14",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,0,Biomarker
51725,FBXO40,F-box protein 40,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
2556,GABRA3,"gamma-aminobutyric acid (GABA) A receptor, alpha 3",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
2690,GHR,growth hormone receptor,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
151556,GPR155,G protein-coupled receptor 155,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3002,GZMB,"granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3346,HTN1,histatin 1,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3486,IGFBP3,insulin-like growth factor binding protein 3,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3600,IL15,interleukin 15,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,2,Biomarker
3567,IL5,interleukin 5,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3628,INPP1,inositol polyphosphate-1-phosphatase,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
152789,JAKMIP1,janus kinase and microtubule interacting protein 1,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3778,KCNMA1,"potassium channel, calcium activated large conductance subfamily M alpha, member 1",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
53615,MBD3,methyl-CpG binding domain protein 3,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
8930,MBD4,methyl-CpG binding domain protein 4,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
4163,MCC,mutated in colorectal cancers,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
4208,MEF2C,myocyte enhancer factor 2C,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
406900,MIR106B,microRNA 106b,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
407010,MIR23A,microRNA 23a,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
4520,MTF1,metal-regulatory transcription factor 1,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
5329,PLAUR,"plasminogen activator, urokinase receptor",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,2,Biomarker
26056,RAB11FIP5,RAB11 family interacting protein 5 (class I),0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
64326,RFWD2,"ring finger and WD repeat domain 2, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
9025,RNF8,"ring finger protein 8, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
6095,RORA,RAR-related orphan receptor A,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,2,Biomarker
6332,SCN7A,"sodium channel, voltage gated, type VII alpha subunit",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
6507,SLC1A3,"solute carrier family 1 (glial high affinity glutamate transporter), member 3",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
30061,SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
6779,STATH,statherin,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
6948,TCN2,transcobalamin II,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
51733,UPB1,"ureidopropionase, beta",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
7508,XPC,"xeroderma pigmentosum, complementation group C",0.0,1.0,0.0,0.0,0.0,4352,Autistic Disorder,0.21,1,Biomarker
100126595,MGS,Mungan syndrome,0.0,1.0,0.0,0.0,0.0,1969653,Mungan Syndrome,0.21,0,Biomarker
25894,PLEKHG4,"pleckstrin homology domain containing, family G (with RhoGef domain) member 4",0.0,1.0,0.0,0.0,0.0,1861736,Spinocerebellar Ataxia 31,0.21,0,Biomarker
4266,MHS6,malignant hyperthermia susceptibility 6,0.0,1.0,0.0,0.0,0.0,2930985,Malignant hyperthermia susceptibility type 6,0.21,0,Biomarker
1050,CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,37286,Skin Neoplasms,0.21,1,Therapeutic
1457,CSNK2A1,"casein kinase 2, alpha 1 polypeptide",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
1459,CSNK2A2,"casein kinase 2, alpha prime polypeptide",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
1460,CSNK2B,"casein kinase 2, beta polypeptide",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
2709,GJB5,"gap junction protein, beta 5, 31.1kDa",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
338442,HCAR2,hydroxycarboxylic acid receptor 2,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
8843,HCAR3,hydroxycarboxylic acid receptor 3,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
3713,IVL,involucrin,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
3858,KRT10,"keratin 10, type I",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
4014,LOR,loricrin,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,0.0,0.0,0.0,1.0,37286,Skin Neoplasms,0.21,1,Therapeutic
25913,POT1,protection of telomeres 1,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
5467,PPARD,peroxisome proliferator-activated receptor delta,0.0,1.0,0.0,0.0,1.0,37286,Skin Neoplasms,0.21,2,"Biomarker, Therapeutic"
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
6608,SMO,"smoothened, frizzled class receptor",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,2,Biomarker
6667,SP1,Sp1 transcription factor,0.0,1.0,0.0,0.0,0.0,37286,Skin Neoplasms,0.21,1,Biomarker
3936,LCP1,lymphocyte cytosolic protein 1 (L-plastin),0.0,1.0,0.0,0.0,0.0,40336,Tobacco Use Disorder,0.21,1,Biomarker
116068,LYSMD3,"LysM, putative peptidoglycan-binding, domain containing 3",0.0,1.0,0.0,0.0,0.0,40336,Tobacco Use Disorder,0.21,1,Biomarker
57521,RPTOR,"regulatory associated protein of MTOR, complex 1",0.0,1.0,0.0,0.0,0.0,40336,Tobacco Use Disorder,0.21,1,Biomarker
619409,MDCMP,"muscular dystrophy, congenital, merosin-positive",0.0,1.0,0.0,0.0,0.0,1836133,"Muscular Dystrophy, Congenital, Merosin-Positive",0.21,0,Biomarker
100009675,MRT4,"mental retardation, non-syndromic, autosomal recessive, 4",0.0,1.0,0.0,0.0,0.0,1970179,"Mental Retardation, Autosomal Recessive 4",0.21,0,Biomarker
54109,CORD8,cone rod dystrophy 8,0.0,1.0,0.0,0.0,0.0,1854180,Cone-Rod Dystrophy 8,0.21,0,Biomarker
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,0.0,0.0,0.0,206720,"Neoplasms, Squamous Cell",0.21,1,Biomarker
11200,CHEK2,checkpoint kinase 2,0.0,1.0,0.0,0.0,0.0,206720,"Neoplasms, Squamous Cell",0.21,1,Biomarker
574077,GLC1K,"glaucoma 1, open angle, K (juvenile-onset)",0.0,1.0,0.0,0.0,0.0,1837527,"Glaucoma 1, Open Angle, K",0.21,0,Biomarker
79633,FAT4,FAT atypical cadherin 4,0.0,1.0,0.0,0.0,0.0,1691228,"Kidney Diseases, Cystic",0.21,1,Biomarker
57560,IFT80,intraflagellar transport 80,0.0,1.0,0.0,0.0,0.0,1691228,"Kidney Diseases, Cystic",0.21,1,Biomarker
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,1691228,"Kidney Diseases, Cystic",0.21,1,Therapeutic
10806,SDCCAG8,serologically defined colon cancer antigen 8,0.0,1.0,0.0,0.0,0.0,1691228,"Kidney Diseases, Cystic",0.21,1,Biomarker
619536,BPPV,"vestibulopathy, familial",0.0,1.0,0.0,0.0,0.0,155502,Benign Paroxysmal Positional Vertigo,0.21,0,Biomarker
2112,ETM2,essential tremor 2,0.0,1.0,0.0,0.0,0.0,1865810,"Tremor hereditary essential, 2",0.21,0,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,2676721,"Thrombophilia, Familial, Due To Decreased Release Of Tissue Plasminogen Activator",0.21,0,Biomarker
7044,LEFTY2,left-right determination factor 2,0.0,1.0,0.0,0.0,0.0,3178805,Heterotaxy Syndrome,0.21,1,Biomarker
6997,TDGF1,teratocarcinoma-derived growth factor 1,0.0,1.0,0.0,0.0,0.0,3178805,Heterotaxy Syndrome,0.21,1,Biomarker
317668,MCDR3,"macular dystrophy, retinal 3",0.0,1.0,0.0,0.0,0.0,1426774,"MACULAR DYSTROPHY, RETINAL, 3",0.21,0,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,162309,Adrenoleukodystrophy,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,162309,Adrenoleukodystrophy,0.21,1,Biomarker
5194,PEX13,peroxisomal biogenesis factor 13,0.0,1.0,0.0,0.0,0.0,162309,Adrenoleukodystrophy,0.21,1,Biomarker
55670,PEX26,peroxisomal biogenesis factor 26,0.0,1.0,0.0,0.0,0.0,162309,Adrenoleukodystrophy,0.21,1,Biomarker
8726,EED,embryonic ectoderm development,0.0,1.0,0.0,0.0,0.0,206727,Nerve Sheath Neoplasms,0.21,1,Biomarker
139628,FOXR2,forkhead box R2,0.0,1.0,0.0,0.0,0.0,206727,Nerve Sheath Neoplasms,0.21,1,Biomarker
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,0.0,0.0,0.0,18566,"Hand Deformities, Congenital",0.21,1,Biomarker
3897,L1CAM,L1 cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,18566,"Hand Deformities, Congenital",0.21,1,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,18566,"Hand Deformities, Congenital",0.21,1,Biomarker
5077,PAX3,paired box 3,0.0,1.0,0.0,0.0,0.0,18566,"Hand Deformities, Congenital",0.21,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,18566,"Hand Deformities, Congenital",0.21,1,Biomarker
6662,SOX9,SRY (sex determining region Y)-box 9,0.0,1.0,0.0,0.0,0.0,18566,"Hand Deformities, Congenital",0.21,1,Biomarker
7021,TFAP2B,transcription factor AP-2 beta (activating enhancer binding protein 2 beta),0.0,1.0,0.0,0.0,0.0,18566,"Hand Deformities, Congenital",0.21,1,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,34885,Rectal Neoplasms,0.21,1,Biomarker
4163,MCC,mutated in colorectal cancers,0.0,1.0,0.0,0.0,0.0,34885,Rectal Neoplasms,0.21,1,Biomarker
4583,MUC2,"mucin 2, oligomeric mucus/gel-forming",0.0,1.0,0.0,0.0,0.0,34885,Rectal Neoplasms,0.21,1,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,0.0,0.0,0.0,34885,Rectal Neoplasms,0.21,1,Biomarker
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,0.0,0.0,0.0,32019,Pituitary Neoplasms,0.21,1,Biomarker
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,0.0,0.0,0.0,19557,Hip Fractures,0.21,1,Biomarker
1902,LPAR1,lysophosphatidic acid receptor 1,0.0,1.0,0.0,0.0,0.0,553757,Olfaction Disorders,0.21,1,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,2931888,Pfeiffer type acrocephalosyndactyly,0.21,0,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,2931888,Pfeiffer type acrocephalosyndactyly,0.21,0,Biomarker
100034705,MMVP3,"Mitral valve prolapse, myxomatous 3",0.0,1.0,0.0,0.0,0.0,1835814,"Mitral Valve Prolapse, Myxomatous 3",0.21,0,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,3869,"Arthritis, Infectious",0.21,1,Biomarker
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,0.0,0.0,0.0,1.0,342257,Diabetes Complications,0.21,1,Therapeutic
34,ACADM,"acyl-CoA dehydrogenase, C-4 to C-12 straight chain",0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
10327,AKR1A1,"aldo-keto reductase family 1, member A1 (aldehyde reductase)",0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
51084,CRYL1,"crystallin, lambda 1",0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
3957,LGALS2,"lectin, galactoside-binding, soluble, 2",0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,520459,"Enterocolitis, Necrotizing",0.21,1,Therapeutic
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
4942,OAT,ornithine aminotransferase,0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
11315,PARK7,parkinson protein 7,0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
333929,SNAI3,snail family zinc finger 3,0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
6652,SORD,sorbitol dehydrogenase,0.0,1.0,0.0,0.0,0.0,520459,"Enterocolitis, Necrotizing",0.21,1,Biomarker
1041,CDSN,corneodesmosin,0.0,1.0,0.0,0.0,0.0,1840299,Hypotrichosis Simplex of Scalp,0.21,0,Biomarker
100380875,FECD7,"Corneal dystrophy, Fuchs endothelial, 7",0.0,1.0,0.0,0.0,0.0,2750447,"Corneal Dystrophy, Fuchs Endothelial, 7",0.21,0,Biomarker
146167,SLC38A8,"solute carrier family 38, member 8",0.0,0.0,1.0,0.0,0.0,3807873,FOVEAL HYPOPLASIA 2,0.21,2,GeneticVariation
207115,LATD,"Laterality defects, autosomal dominant",0.0,1.0,0.0,0.0,0.0,1832813,"Laterality Defects, Autosomal Dominant",0.21,0,Biomarker
652,BMP4,bone morphogenetic protein 4,0.0,1.0,0.0,0.0,0.0,42842,Vitamin A Deficiency,0.21,1,Biomarker
9227,LRAT,lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase),0.0,1.0,0.0,0.0,0.0,42842,Vitamin A Deficiency,0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,42842,Vitamin A Deficiency,0.21,1,Biomarker
7051,TGM1,transglutaminase 1,0.0,1.0,0.0,0.0,0.0,42842,Vitamin A Deficiency,0.21,1,Biomarker
677764,MYP13,myopia 13,0.0,1.0,0.0,0.0,0.0,1845096,Myopia 13,0.21,0,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,43096,Weight Loss,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,43096,Weight Loss,0.21,1,Therapeutic
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,43096,Weight Loss,0.21,1,Biomarker
3976,LIF,leukemia inhibitory factor,0.0,1.0,0.0,0.0,0.0,43096,Weight Loss,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,43096,Weight Loss,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,43096,Weight Loss,0.21,2,Biomarker
1831,TSC22D3,"TSC22 domain family, member 3",0.0,1.0,0.0,0.0,0.0,43096,Weight Loss,0.21,1,Biomarker
550625,ANIC,"Anosmia, isolated congenital",0.0,1.0,0.0,0.0,0.0,393778,Congenital anosmia,0.21,0,Biomarker
50988,WDM,Welander distal myopathy,0.0,1.0,0.0,0.0,0.0,2931290,"Welander distal myopathy, Swedish type",0.21,0,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
1154,CISH,cytokine inducible SH2-containing protein,0.0,1.0,0.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
1522,CTSZ,cathepsin Z,0.0,1.0,0.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
3459,IFNGR1,interferon gamma receptor 1,0.0,1.0,0.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
345611,IRGM,"immunity-related GTPase family, M",0.0,1.0,0.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
4159,MC3R,melanocortin 3 receptor,0.0,1.0,0.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,0.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
114609,TIRAP,toll-interleukin 1 receptor (TIR) domain containing adaptor protein,0.0,1.0,0.0,0.0,0.0,1834752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",0.21,0,Biomarker
100359407,MYP14,myopia 14,0.0,1.0,0.0,0.0,0.0,1853196,Myopia 14,0.21,0,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,20578,Hyperventilation,0.21,1,Biomarker
10451,VAV3,vav 3 guanine nucleotide exchange factor,0.0,1.0,0.0,0.0,0.0,20578,Hyperventilation,0.21,1,Biomarker
1705,DFNB13,"deafness, autosomal recessive 13",0.0,1.0,0.0,0.0,0.0,1864199,"Deafness, Autosomal Recessive 13",0.21,0,Biomarker
100049160,7-Feb,febrile convulsions 7,0.0,1.0,0.0,0.0,0.0,1969087,"Febrile Convulsions, Familial, 7",0.21,0,Biomarker
8314,BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),0.0,1.0,0.0,0.0,0.0,40100,Thymoma,0.21,1,Biomarker
1540,CYLD,cylindromatosis (turban tumor syndrome),0.0,1.0,0.0,0.0,0.0,40100,Thymoma,0.21,1,Biomarker
55193,PBRM1,polybromo 1,0.0,1.0,0.0,0.0,0.0,40100,Thymoma,0.21,1,Biomarker
1283,CTD,Coats disease,0.0,1.0,0.0,0.0,0.0,154832,Retinal Telangiectasis,0.21,0,Biomarker
4967,OGDH,oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide),0.0,1.0,0.0,0.0,0.0,2752074,Alpha-ketoglutarate dehydrogenase deficiency,0.21,0,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,1879526,Aberrant Crypt Foci,0.21,1,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,1879526,Aberrant Crypt Foci,0.21,3,Biomarker
2641,GCG,glucagon,0.0,1.0,0.0,0.0,0.0,1879526,Aberrant Crypt Foci,0.21,1,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,0.0,0.0,0.0,19337,Heroin Dependence,0.21,1,Biomarker
2555,GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",0.0,1.0,0.0,0.0,0.0,19337,Heroin Dependence,0.21,1,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,19337,Heroin Dependence,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,19337,Heroin Dependence,0.21,1,Biomarker
56729,RETN,resistin,0.0,1.0,0.0,0.0,0.0,19337,Heroin Dependence,0.21,1,Biomarker
780920,MPD3,"Myopathy, distal 3",0.0,1.0,0.0,0.0,0.0,751336,Distal Myopathies,0.21,0,Biomarker
2722,GLC1B,"glaucoma 1, open angle, B (adult-onset)",0.0,1.0,0.0,0.0,0.0,1415091,"glaucoma 1, open angle, B (adult-onset)",0.21,0,Biomarker
567,B2M,beta-2-microglobulin,0.0,1.0,0.0,0.0,0.0,79774,"Lymphoma, T-Cell, Peripheral",0.21,1,Biomarker
965,CD58,CD58 molecule,0.0,1.0,0.0,0.0,0.0,79774,"Lymphoma, T-Cell, Peripheral",0.21,1,Biomarker
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,0.0,1.0,0.0,0.0,0.0,79774,"Lymphoma, T-Cell, Peripheral",0.21,2,Biomarker
7161,TP73,tumor protein p73,0.0,1.0,0.0,0.0,0.0,206655,"Rhabdomyosarcoma, Alveolar",0.21,1,Biomarker
171,AFD1,"acrofacial dysostosis 1, Nager type",0.0,1.0,0.0,0.0,0.0,265245,"Acrofacial dysostosis, Nager type",0.21,0,Biomarker
8691,IDDM17,insulin-dependent diabetes mellitus 17,0.0,1.0,0.0,0.0,0.0,1864068,"Diabetes Mellitus, Insulin-Dependent, 17",0.21,0,Biomarker
4854,NOTCH3,notch 3,0.0,0.0,1.0,0.0,0.0,3809084,"MYOFIBROMATOSIS, INFANTILE, 2",0.21,0,GeneticVariation
3402,IDDM3,insulin-dependent diabetes mellitus 3,0.0,1.0,0.0,0.0,0.0,1838262,"Diabetes Mellitus, Insulin-Dependent, 3",0.21,0,Biomarker
114475,AD7,Alzheimer disease 7,0.0,1.0,0.0,0.0,0.0,1853555,Alzheimer Disease 7,0.21,0,Biomarker
1081,CGA,"glycoprotein hormones, alpha polypeptide",0.0,0.0,0.0,0.0,1.0,29928,Ovarian Diseases,0.21,1,Therapeutic
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
6356,CCL11,chemokine (C-C motif) ligand 11,0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
6369,CCL24,chemokine (C-C motif) ligand 24,0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
57105,CYSLTR2,cysteinyl leukotriene receptor 2,0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
2205,FCER1A,"Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide",0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,2,Biomarker
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
3002,GZMB,"granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)",0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
3176,HNMT,histamine N-methyltransferase,0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
3303,HSPA1A,heat shock 70kDa protein 1A,0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
4295,MLN,motilin,0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
10631,POSTN,"periostin, osteoblast specific factor",0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
5733,PTGER3,prostaglandin E receptor 3 (subtype EP3),0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
6916,TBXAS1,thromboxane A synthase 1 (platelet),0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,13182,Drug Hypersensitivity,0.21,1,Biomarker
7941,PLA2G7,"phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)",0.0,0.0,1.0,0.0,0.0,3280315,Platelet-Activating Factor Acetylhydrolase Deficiency,0.21,2,GeneticVariation
567,B2M,beta-2-microglobulin,0.0,0.0,0.0,0.0,1.0,20455,Hypergammaglobulinemia,0.21,1,Therapeutic
898,CCNE1,cyclin E1,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
29126,CD274,CD274 molecule,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
1382,CRABP2,cellular retinoic acid binding protein 2,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
1471,CST3,cystatin C,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
1476,CSTB,cystatin B (stefin B),0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
1514,CTSL,cathepsin L,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
1938,EEF2,eukaryotic translation elongation factor 2,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
2072,ERCC4,excision repair cross-complementation group 4,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
4255,MGMT,O-6-methylguanine-DNA methyltransferase,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
22978,NT5C2,"5'-nucleotidase, cytosolic II",0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
5241,PGR,progesterone receptor,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,2825055,Recurrence,0.21,1,Biomarker
85503,MCOPCB1,"Microphthalmia, colobomatous, 1",0.0,1.0,0.0,0.0,0.0,1845877,"Microphthalmia, Isolated, with Coloboma 1",0.21,0,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,0.0,0.0,0.0,1.0,7370,Catalepsy,0.21,1,Therapeutic
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,0.0,0.0,0.0,1.0,7370,Catalepsy,0.21,1,Therapeutic
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,7370,Catalepsy,0.21,3,Biomarker
885,CCK,cholecystokinin,0.0,0.0,0.0,0.0,1.0,7370,Catalepsy,0.21,2,Therapeutic
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,7370,Catalepsy,0.21,1,Biomarker
1812,DRD1,dopamine receptor D1,0.0,1.0,0.0,0.0,0.0,7370,Catalepsy,0.21,3,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,0.0,0.0,0.0,7370,Catalepsy,0.21,4,Biomarker
2534,FYN,"FYN proto-oncogene, Src family tyrosine kinase",0.0,1.0,0.0,0.0,0.0,7370,Catalepsy,0.21,1,Biomarker
2641,GCG,glucagon,0.0,1.0,0.0,0.0,0.0,7370,Catalepsy,0.21,1,Biomarker
4922,NTS,neurotensin,0.0,0.0,0.0,0.0,1.0,7370,Catalepsy,0.21,1,Therapeutic
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,1.0,7370,Catalepsy,0.21,2,"Biomarker, Therapeutic"
84152,PPP1R1B,"protein phosphatase 1, regulatory (inhibitor) subunit 1B",0.0,0.0,0.0,0.0,1.0,7370,Catalepsy,0.21,1,Therapeutic
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,7370,Catalepsy,0.21,1,Biomarker
7054,TH,tyrosine hydroxylase,0.0,1.0,0.0,0.0,0.0,7370,Catalepsy,0.21,2,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,0.0,0.0,0.0,1.0,7370,Catalepsy,0.21,1,Therapeutic
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,333641,Atrophy,0.21,2,Biomarker
1191,CLU,clusterin,0.0,1.0,0.0,0.0,0.0,333641,Atrophy,0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,333641,Atrophy,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,333641,Atrophy,0.21,1,Biomarker
6198,RPS6KB1,"ribosomal protein S6 kinase, 70kDa, polypeptide 1",0.0,1.0,0.0,0.0,0.0,333641,Atrophy,0.21,1,Biomarker
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",0.0,1.0,0.0,0.0,0.0,333641,Atrophy,0.21,1,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,333641,Atrophy,0.21,1,Biomarker
84676,TRIM63,"tripartite motif containing 63, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,333641,Atrophy,0.21,1,Biomarker
6356,CCL11,chemokine (C-C motif) ligand 11,0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
6355,CCL8,chemokine (C-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
1232,CCR3,chemokine (C-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
2919,CXCL1,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",0.0,0.0,0.0,0.0,1.0,35228,Respiratory Hypersensitivity,0.21,1,Therapeutic
3269,HRH1,histamine receptor H1,0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
3309,HSPA5,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
3600,IL15,interleukin 15,0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
5777,PTPN6,"protein tyrosine phosphatase, non-receptor type 6",0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
7782,SLC30A4,"solute carrier family 30 (zinc transporter), member 4",0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
27173,SLC39A1,"solute carrier family 39 (zinc transporter), member 1",0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
23516,SLC39A14,"solute carrier family 39 (zinc transporter), member 14",0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
55630,SLC39A4,"solute carrier family 39 (zinc transporter), member 4",0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
7378,UPP1,uridine phosphorylase 1,0.0,1.0,0.0,0.0,0.0,35228,Respiratory Hypersensitivity,0.21,1,Biomarker
60529,ALX4,ALX homeobox 4,0.0,1.0,0.0,0.0,0.0,152427,Polydactyly,0.21,1,Biomarker
57560,IFT80,intraflagellar transport 80,0.0,1.0,0.0,0.0,0.0,152427,Polydactyly,0.21,1,Biomarker
8100,IFT88,intraflagellar transport 88,0.0,1.0,0.0,0.0,0.0,152427,Polydactyly,0.21,1,Biomarker
9786,KIAA0586,KIAA0586,0.0,1.0,0.0,0.0,0.0,152427,Polydactyly,0.21,1,Biomarker
11127,KIF3A,kinesin family member 3A,0.0,1.0,0.0,0.0,0.0,152427,Polydactyly,0.21,1,Biomarker
145282,MIPOL1,mirror-image polydactyly 1,0.0,1.0,0.0,0.0,0.0,152427,Polydactyly,0.21,1,Biomarker
79052,PTCPRN,Papillary thyroid carcinoma with papillary renal neoplasia,0.0,1.0,0.0,0.0,0.0,1854104,"Thyroid Carcinoma, Papillary, With Papillary Renal Neoplasia",0.21,0,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,0.0,1.0,0.0,0.0,2675517,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1",0.21,1,GeneticVariation
2724,GLC1D,"glaucoma 1, open angle, D (adult-onset)",0.0,1.0,0.0,0.0,0.0,1865427,"Glaucoma 1, Open Angle, D",0.21,0,Biomarker
5732,PTGER2,"prostaglandin E receptor 2 (subtype EP2), 53kDa",0.0,1.0,0.0,0.0,0.0,1859648,"Asthma, Nasal Polyps, And Aspirin Intolerance",0.21,0,Biomarker
30009,TBX21,T-box 21,0.0,1.0,0.0,0.0,0.0,1859648,"Asthma, Nasal Polyps, And Aspirin Intolerance",0.21,0,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,35455,Rhinitis,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,35455,Rhinitis,0.21,2,Biomarker
100379218,SPDA3,"Spondylarthropathy, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,2750474,"SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3",0.21,0,Biomarker
5193,PEX12,peroxisomal biogenesis factor 12,0.0,0.0,1.0,0.0,0.0,3550693,PEROXISOME BIOGENESIS DISORDER 3B,0.21,0,GeneticVariation
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.21,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.21,1,Biomarker
4088,SMAD3,SMAD family member 3,0.0,1.0,0.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.21,1,Biomarker
7076,TIMP1,TIMP metallopeptidase inhibitor 1,0.0,1.0,0.0,0.0,0.0,23891,"Liver Cirrhosis, Alcoholic",0.21,1,Biomarker
284058,KANSL1,KAT8 regulatory NSL complex subunit 1,0.0,1.0,0.0,0.0,0.0,2931713,Chromosome 17 deletion,0.21,2,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,2931713,Chromosome 17 deletion,0.21,1,Biomarker
100188011,DIP,"interstitial pneumonitis, desquamative, familial",0.0,1.0,0.0,0.0,0.0,238378,"Interstitial Pneumonitis, Desquamative, Familial",0.21,0,Biomarker
100,ADA,adenosine deaminase,0.0,1.0,0.0,0.0,0.0,37928,Spinal Cord Diseases,0.21,1,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,37928,Spinal Cord Diseases,0.21,1,Biomarker
2243,FGA,fibrinogen alpha chain,0.0,1.0,0.0,0.0,0.0,398623,Thrombophilia,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
80169,CTC1,CTS telomere maintenance complex component 1,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,0.0,0.0,0.0,1.0,6111,Brain Diseases,0.21,1,Therapeutic
10319,LAMC3,"laminin, gamma 3",0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
4143,MAT1A,"methionine adenosyltransferase I, alpha",0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
8635,RNASET2,ribonuclease T2,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
10617,STAMBP,STAM binding protein,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
7054,TH,tyrosine hydroxylase,0.0,0.0,0.0,0.0,1.0,6111,Brain Diseases,0.21,1,Therapeutic
7249,TSC2,tuberous sclerosis 2,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
7298,TYMS,thymidylate synthetase,0.0,1.0,0.0,0.0,0.0,6111,Brain Diseases,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,42510,Ventricular Fibrillation,0.21,1,Therapeutic
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,42510,Ventricular Fibrillation,0.21,1,Therapeutic
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,42510,Ventricular Fibrillation,0.21,1,Biomarker
6336,SCN10A,"sodium channel, voltage gated, type X alpha subunit",0.0,1.0,0.0,0.0,0.0,42510,Ventricular Fibrillation,0.21,1,Biomarker
100306979,ATFB8,"Atrial fibrillation, familial, 8",0.0,1.0,0.0,0.0,0.0,2751607,"Atrial Fibrillation, Familial, 8",0.21,0,Biomarker
100271924,DFNA59,"deafness, autosomal dominant 59",0.0,1.0,0.0,0.0,0.0,2675238,"Deafness, Autosomal Dominant 59",0.21,0,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,1450010,"Plagiocephaly, Nonsynostotic",0.21,1,Biomarker
9950,GOLGA5,golgin A5,0.0,1.0,0.0,0.0,0.0,238463,"Thyroid cancer, papillary",0.21,0,Biomarker
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,0.0,0.0,0.0,238463,"Thyroid cancer, papillary",0.21,0,Biomarker
8805,TRIM24,tripartite motif containing 24,0.0,1.0,0.0,0.0,0.0,238463,"Thyroid cancer, papillary",0.21,0,Biomarker
51592,TRIM33,tripartite motif containing 33,0.0,1.0,0.0,0.0,0.0,238463,"Thyroid cancer, papillary",0.21,0,Biomarker
7494,XBP1,X-box binding protein 1,0.0,1.0,0.0,0.0,0.0,2700438,Major Affective Disorder 7,0.21,0,Biomarker
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,0.0,0.0,0.0,1858558,"Rheumatoid Arthritis, Systemic Juvenile",0.21,0,Biomarker
860,RUNX2,runt-related transcription factor 2,0.0,1.0,0.0,0.0,0.0,243057,Stomatognathic System Abnormalities,0.21,1,Biomarker
338331,AZON,"Azoospremia, nonobstructive",0.0,1.0,0.0,0.0,0.0,1847540,"Azoospermia, Nonobstructive",0.21,0,Biomarker
59272,ACE2,angiotensin I converting enzyme 2,0.0,1.0,0.0,0.0,0.0,553980,Endomyocardial Fibrosis,0.21,1,Biomarker
153,ADRB1,adrenoceptor beta 1,0.0,1.0,0.0,0.0,0.0,553980,Endomyocardial Fibrosis,0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,0.0,0.0,0.0,1.0,553980,Endomyocardial Fibrosis,0.21,1,Therapeutic
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,553980,Endomyocardial Fibrosis,0.21,1,Biomarker
2707,GJB3,"gap junction protein, beta 3, 31kDa",0.0,1.0,0.0,0.0,0.0,79153,"Hyperkeratosis, Epidermolytic",0.21,1,Biomarker
127534,GJB4,"gap junction protein, beta 4, 30.3kDa",0.0,1.0,0.0,0.0,0.0,79153,"Hyperkeratosis, Epidermolytic",0.21,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,42512,Ventricular Outflow Obstruction,0.21,1,Biomarker
100049543,STUT2,"Stuttering, familial persistent 2",0.0,1.0,0.0,0.0,0.0,1836484,"Stuttering, Familial Persistent 2",0.21,0,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,10340,Critical Illness,0.21,1,Biomarker
23028,KDM1A,lysine (K)-specific demethylase 1A,0.0,1.0,0.0,0.0,0.0,10340,Critical Illness,0.21,1,Biomarker
100271838,IBD26,Inflammatory bowel disease-26,0.0,1.0,0.0,0.0,0.0,2675249,Inflammatory Bowel Disease 26,0.21,0,Biomarker
5826,ABCD4,"ATP-binding cassette, sub-family D (ALD), member 4",0.0,1.0,0.0,0.0,0.0,42847,Vitamin B 12 Deficiency,0.21,1,Biomarker
3769,KCNJ13,"potassium channel, inwardly rectifying subfamily J, member 13",0.0,0.0,1.0,0.0,0.0,3280062,LEBER CONGENITAL AMAUROSIS 16,0.21,0,GeneticVariation
229,ALDOB,"aldolase B, fructose-bisphosphate",0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
716,C1S,"complement component 1, s subcomponent",0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
6352,CCL5,chemokine (C-C motif) ligand 5,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
2919,CXCL1,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
3596,IL13,interleukin 13,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
50616,IL22,interleukin 22,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
3578,IL9,interleukin 9,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,241910,"Hepatitis, Autoimmune",0.21,1,Biomarker
23552,CDK20,cyclin-dependent kinase 20,0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.21,1,Biomarker
2488,FSHB,"follicle stimulating hormone, beta polypeptide",0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.21,1,Biomarker
10243,GPHN,gephyrin,0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.21,1,Biomarker
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.21,1,Biomarker
55213,RCBTB1,regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1,0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.21,0,Biomarker
6462,SHBG,sex hormone-binding globulin,0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.21,1,Biomarker
9095,TBX19,T-box 19,0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,1973,Alcoholism,0.21,1,Biomarker
81693,AMN,amnion associated transmembrane protein,0.0,0.0,0.0,0.0,1.0,13604,Edema,0.21,1,Therapeutic
335,APOA1,apolipoprotein A-I,0.0,0.0,0.0,0.0,1.0,13604,Edema,0.21,1,Therapeutic
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
842,CASP9,"caspase 9, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
2936,GSR,glutathione reductase,0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
3589,IL11,interleukin 11,0.0,0.0,0.0,0.0,1.0,13604,Edema,0.21,1,Therapeutic
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,2,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,3,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
6548,SLC9A1,"solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1",0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
6549,SLC9A2,"solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2",0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
6550,SLC9A3,"solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3",0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
6778,STAT6,"signal transducer and activator of transcription 6, interleukin-4 induced",0.0,0.0,0.0,0.0,1.0,13604,Edema,0.21,1,Therapeutic
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,13604,Edema,0.21,1,Biomarker
6495,SIX1,SIX homeobox 1,0.0,1.0,0.0,0.0,0.0,1854594,"Deafness, Autosomal Dominant 23",0.21,0,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,162848,Lichenoid Eruptions,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,162848,Lichenoid Eruptions,0.21,1,Biomarker
54968,TMEM70,transmembrane protein 70,0.0,1.0,0.0,0.0,0.0,3276276,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1",0.21,0,Biomarker
6893,TAPVR1,total anomalous pulmonary venous return 1,0.0,1.0,0.0,0.0,0.0,36400,Scimitar Syndrome,0.21,0,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,1969108,"Macular Degeneration, Age-Related, 10",0.21,0,Biomarker
619503,FIQTL1,fasting glucose and specific insulin levels,0.0,1.0,0.0,0.0,0.0,2676369,FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1,0.21,0,Biomarker
260432,SLSN3,Senior-Loken syndrome 3,0.0,1.0,0.0,0.0,0.0,1846980,Senior-Loken Syndrome 3,0.21,0,Biomarker
712,C1QA,"complement component 1, q subcomponent, A chain",0.0,1.0,0.0,0.0,0.0,20951,Immune Complex Diseases,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,20951,Immune Complex Diseases,0.21,1,Biomarker
10747,MASP2,mannan-binding lectin serine peptidase 2,0.0,1.0,0.0,0.0,0.0,20951,Immune Complex Diseases,0.21,1,Biomarker
7020,TFAP2A,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha),0.0,1.0,0.0,0.0,0.0,265234,Branchio-Oto-Renal Syndrome,0.21,1,Biomarker
6335,SCN9A,"sodium channel, voltage gated, type IX alpha subunit",0.0,1.0,0.0,0.0,0.0,1858673,"Generalized Epilepsy With Febrile Seizures Plus, Type 2",0.21,0,Biomarker
10758,TRAF3IP2,TRAF3 interacting protein 2,0.0,0.0,1.0,0.0,0.0,3279754,PSORIASIS SUSCEPTIBILITY 13,0.21,0,GeneticVariation
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,40588,Tracheoesophageal Fistula,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,12655,Disease Susceptibility,0.21,1,Biomarker
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,0.0,0.0,0.0,12655,Disease Susceptibility,0.21,1,Biomarker
4541,ND6,"NADH dehydrogenase, subunit 6 (complex I)",0.0,1.0,0.0,0.0,0.0,12655,Disease Susceptibility,0.21,1,Biomarker
7225,TRPC6,"transient receptor potential cation channel, subfamily C, member 6",0.0,1.0,0.0,0.0,0.0,12655,Disease Susceptibility,0.21,1,Biomarker
23554,TSPAN12,tetraspanin 12,0.0,1.0,0.0,0.0,0.0,12655,Disease Susceptibility,0.21,1,Biomarker
147372,CCBE1,collagen and calcium binding EGF domains 1,0.0,1.0,0.0,0.0,0.0,20305,Hydrops Fetalis,0.21,1,Biomarker
81864,EVR3,exudative vitreoretinopathy 3,0.0,1.0,0.0,0.0,0.0,1854002,Exudative Vitreoretinopathy 3,0.21,0,Biomarker
6546,SLC8A1,"solute carrier family 8 (sodium/calcium exchanger), member 1",0.0,1.0,0.0,0.0,0.0,25160,Megacolon,0.21,2,Biomarker
131,ADH7,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide",0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
302,ANXA2,annexin A2,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
308,ANXA5,annexin A5,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
1410,CRYAB,"crystallin, alpha B",0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
1834,DSPP,dentin sialophosphoprotein,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
2243,FGA,fibrinogen alpha chain,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
10399,GNB2L1,"guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1",0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
3202,HOXA5,homeobox A5,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
3236,HOXD10,homeobox D10,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
3237,HOXD11,homeobox D11,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
3312,HSPA8,heat shock 70kDa protein 8,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
3854,KRT6B,"keratin 6B, type II",0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
3963,LGALS7,"lectin, galactoside-binding, soluble, 7",0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
28998,MRPL13,mitochondrial ribosomal protein L13,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
4489,MT1A,metallothionein 1A,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
5223,PGAM1,phosphoglycerate mutase 1 (brain),0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
5478,PPIA,peptidylprolyl isomerase A (cyclophilin A),0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
56952,PRTFDC1,phosphoribosyl transferase domain containing 1,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
6317,SERPINB3,"serpin peptidase inhibitor, clade B (ovalbumin), member 3",0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
23410,SIRT3,sirtuin 3,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
7248,TSC1,tuberous sclerosis 1,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
7249,TSC2,tuberous sclerosis 2,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
7417,VDAC2,voltage-dependent anion channel 2,0.0,1.0,0.0,0.0,0.0,26640,Mouth Neoplasms,0.21,1,Biomarker
780895,DUPC1,Dupuytren contracture 1,0.0,1.0,0.0,0.0,0.0,13312,Dupuytren Contracture,0.21,0,Biomarker
170508,DFNB33,"deafness, autosomal recessive 33",0.0,1.0,0.0,0.0,0.0,1846576,"Deafness, Autosomal Recessive 33",0.21,0,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,6261,Bronchial Diseases,0.21,1,Biomarker
6869,TACR1,tachykinin receptor 1,0.0,1.0,0.0,0.0,0.0,6261,Bronchial Diseases,0.21,1,Biomarker
6865,TACR2,tachykinin receptor 2,0.0,1.0,0.0,0.0,0.0,6261,Bronchial Diseases,0.21,1,Biomarker
30813,VSX1,visual system homeobox 1,0.0,1.0,0.0,0.0,0.0,14008,Empty Sella Syndrome,0.21,1,Biomarker
100233157,BMIQ13,Body mass index QTL13,0.0,1.0,0.0,0.0,0.0,2675915,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13,0.21,0,Biomarker
2689,GH2,growth hormone 2,0.0,1.0,0.0,0.0,0.0,175693,Silver-Russell Syndrome,0.21,1,Biomarker
6710,SPTB,"spectrin, beta, erythrocytic",0.0,1.0,0.0,0.0,0.0,2891,"Anemia, Neonatal",0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,37769,"Spasms, Infantile",0.21,1,Biomarker
51733,UPB1,"ureidopropionase, beta",0.0,1.0,0.0,0.0,0.0,37769,"Spasms, Infantile",0.21,1,Biomarker
449483,DFNB45,"deafness, autosomal recessive 45",0.0,1.0,0.0,0.0,0.0,1539278,"DEAFNESS, AUTOSOMAL RECESSIVE 45",0.21,0,Biomarker
4508,ATP6,ATP synthase F0 subunit 6,0.0,0.0,1.0,0.0,0.0,1839022,"Striatonigral Degeneration, Infantile, Mitochondrial",0.21,0,GeneticVariation
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,2949,"Aneurysm, Dissecting",0.21,1,Biomarker
4088,SMAD3,SMAD family member 3,0.0,1.0,0.0,0.0,0.0,2949,"Aneurysm, Dissecting",0.21,1,Biomarker
31,ACACA,acetyl-CoA carboxylase alpha,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
47,ACLY,ATP citrate lyase,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
50,ACO2,"aconitase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
118,ADD1,adducin 1 (alpha),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
1646,AKR1C2,"aldo-keto reductase family 1, member C2",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
307,ANXA4,annexin A4,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,3,Biomarker
57492,ARID1B,AT rich interactive domain 1B (SWI1-like),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
10476,ATP5H,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
637,BID,BH3 interacting domain death agonist,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
8900,CCNA1,cyclin A1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
55840,EAF2,ELL associated factor 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
10961,ERP29,endoplasmic reticulum protein 29,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
2108,ETFA,"electron-transfer-flavoprotein, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
2171,FABP5,fatty acid binding protein 5 (psoriasis-associated),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
89885,FATE1,fetal and adult testis expressed 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
2222,FDFT1,farnesyl-diphosphate farnesyltransferase 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
3284,HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
3476,IGBP1,immunoglobulin (CD79A) binding protein 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
3699,ITIH3,inter-alpha-trypsin inhibitor heavy chain 3,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
122953,JDP2,Jun dimerization protein 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
3954,LETM1,leucine zipper-EF-hand containing transmembrane protein 1,0.0,0.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Therapeutic
51360,MBTPS2,"membrane-bound transcription factor peptidase, site 2",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
4199,ME1,"malic enzyme 1, NADP(+)-dependent, cytosolic",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
5469,MED1,mediator complex subunit 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
4502,MT2A,metallothionein 2A,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
5105,PCK1,phosphoenolpyruvate carboxykinase 1 (soluble),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
5317,PKP1,plakophilin 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
87178,PNPT1,polyribonucleotide nucleotidyltransferase 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
5502,PPP1R1A,"protein phosphatase 1, regulatory (inhibitor) subunit 1A",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
9588,PRDX6,peroxiredoxin 6,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
5836,PYGL,"phosphorylase, glycogen, liver",0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
6240,RRM1,ribonucleotide reductase M1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
22937,SCAP,SREBF chaperone,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
5267,SERPINA4,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4",0.0,0.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Therapeutic
6721,SREBF2,sterol regulatory element binding transcription factor 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
6888,TALDO1,transaldolase 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
83940,TATDN1,TatD DNase domain containing 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
117145,THEM4,thioesterase superfamily member 4,0.0,0.0,0.0,0.0,1.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Therapeutic
7263,TST,thiosulfate sulfurtransferase (rhodanese),0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
9099,USP2,ubiquitin specific peptidase 2,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,2239176,"Carcinoma, Hepatocellular",0.21,1,Biomarker
100188772,IHPS4,"Pyloric stenosis, infantile hypertrophic, 4",0.0,1.0,0.0,0.0,0.0,2678037,"Pyloric Stenosis, Infantile Hypertrophic, 4",0.21,0,Biomarker
353147,POROK4,disseminated superficial actinic porokeratosis 2,0.0,1.0,0.0,0.0,0.0,2676508,"Porokeratosis, Disseminated Superficial Actinic, 4",0.21,0,Biomarker
100196911,POROK6,"Porokeratosis, disseminated superficial actinic, 4",0.0,1.0,0.0,0.0,0.0,2676508,"Porokeratosis, Disseminated Superficial Actinic, 4",0.21,0,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,522224,Paralysis,0.21,4,Biomarker
1144,CHRND,"cholinergic receptor, nicotinic, delta (muscle)",0.0,1.0,0.0,0.0,0.0,522224,Paralysis,0.21,1,Biomarker
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,522224,Paralysis,0.21,1,Therapeutic
4340,MOG,myelin oligodendrocyte glycoprotein,0.0,1.0,0.0,0.0,0.0,522224,Paralysis,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,0.0,0.0,0.0,1.0,522224,Paralysis,0.21,1,Therapeutic
54822,TRPM7,"transient receptor potential cation channel, subfamily M, member 7",0.0,1.0,0.0,0.0,0.0,522224,Paralysis,0.21,1,Biomarker
146862,UNC45B,unc-45 homolog B (C. elegans),0.0,1.0,0.0,0.0,0.0,522224,Paralysis,0.21,1,Biomarker
51024,FIS1,fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.21,1,Biomarker
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.21,1,Biomarker
55669,MFN1,mitofusin 1,0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.21,1,Biomarker
10891,PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha",0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.21,1,Biomarker
6198,RPS6KB1,"ribosomal protein S6 kinase, 70kDa, polypeptide 1",0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.21,1,Biomarker
6855,SYP,synaptophysin,0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.21,1,Biomarker
7019,TFAM,"transcription factor A, mitochondrial",0.0,1.0,0.0,0.0,0.0,2931673,"Ceroid lipofuscinosis, neuronal 1, infantile",0.21,1,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.21,2,Biomarker
2919,CXCL1,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",0.0,1.0,0.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.21,1,Biomarker
10417,SPON2,"spondin 2, extracellular matrix protein",0.0,1.0,0.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.21,1,Biomarker
8989,TRPA1,"transient receptor potential cation channel, subfamily A, member 1",0.0,1.0,0.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,85129,Bronchial Hyperreactivity,0.21,2,Biomarker
64851,AD6,Alzheimer disease 6,0.0,1.0,0.0,0.0,0.0,1854187,Alzheimer Disease 6,0.21,0,Biomarker
9782,MATR3,matrin 3,0.0,0.0,1.0,0.0,0.0,3807521,AMYOTROPHIC LATERAL SCLEROSIS 21,0.21,2,GeneticVariation
23722,DFNA27,"deafness, autosomal dominant 27",0.0,1.0,0.0,0.0,0.0,1413996,"DEAFNESS, AUTOSOMAL DOMINANT 27",0.21,0,Biomarker
126133,ALDH16A1,"aldehyde dehydrogenase 16 family, member A1",0.0,1.0,0.0,0.0,0.0,268117,"Gout, HPRT-Related",0.21,1,Biomarker
3200,HOXA3,homeobox A3,0.0,1.0,0.0,0.0,0.0,398368,Lymphatic Abnormalities,0.21,1,Biomarker
9021,SOCS3,suppressor of cytokine signaling 3,0.0,1.0,0.0,0.0,0.0,1853963,"Dermatitis, Atopic, 4",0.21,0,Biomarker
619405,AIS4,"autoimmune disease, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,1836258,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4",0.21,0,Biomarker
282,ANCR,Angelman syndrome chromosome region,0.0,1.0,0.0,0.0,0.0,162635,Angelman Syndrome,0.21,0,Biomarker
100188834,HPC10,"Prostate cancer, hereditary, 10",0.0,1.0,0.0,0.0,0.0,1970192,"Prostate Cancer, Hereditary, 10",0.21,0,Biomarker
100188867,HPC14,"Prostate cancer, hereditary, 14",0.0,1.0,0.0,0.0,0.0,2677772,"Prostate Cancer, Hereditary, 14",0.21,0,Biomarker
6616,SNAP25,"synaptosomal-associated protein, 25kDa",0.0,1.0,0.0,0.0,0.0,278076,Tics,0.21,1,Biomarker
84466,MEGF10,multiple EGF-like-domains 10,0.0,1.0,0.0,0.0,0.0,35220,"Respiratory Distress Syndrome, Newborn",0.21,1,Biomarker
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,0.0,0.0,0.0,35220,"Respiratory Distress Syndrome, Newborn",0.21,1,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,0.0,0.0,0.0,1.0,43251,Wounds and Injuries,0.21,1,Therapeutic
2919,CXCL1,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",0.0,1.0,0.0,0.0,0.0,43251,Wounds and Injuries,0.21,1,Biomarker
2638,GC,group-specific component (vitamin D binding protein),0.0,1.0,0.0,0.0,0.0,43251,Wounds and Injuries,0.21,1,Biomarker
3909,LAMA3,"laminin, alpha 3",0.0,0.0,0.0,0.0,1.0,43251,Wounds and Injuries,0.21,1,Therapeutic
3914,LAMB3,"laminin, beta 3",0.0,0.0,0.0,0.0,1.0,43251,Wounds and Injuries,0.21,1,Therapeutic
3918,LAMC2,"laminin, gamma 2",0.0,0.0,0.0,0.0,1.0,43251,Wounds and Injuries,0.21,1,Therapeutic
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,43251,Wounds and Injuries,0.21,1,Therapeutic
4060,LUM,lumican,0.0,0.0,0.0,0.0,1.0,43251,Wounds and Injuries,0.21,1,Therapeutic
4317,MMP8,matrix metallopeptidase 8 (neutrophil collagenase),0.0,1.0,0.0,0.0,0.0,43251,Wounds and Injuries,0.21,1,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,43251,Wounds and Injuries,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,0.0,0.0,0.0,1.0,43251,Wounds and Injuries,0.21,1,Therapeutic
3105,HLA-A,"major histocompatibility complex, class I, A",0.0,1.0,0.0,0.0,0.0,30491,Parapsoriasis,0.21,1,Biomarker
3133,HLA-E,"major histocompatibility complex, class I, E",0.0,1.0,0.0,0.0,0.0,30491,Parapsoriasis,0.21,1,Biomarker
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,0.0,1.0,0.0,0.0,3280112,"MYASTHENIC SYNDROME, CONGENITAL, ACETAZOLAMIDE-RESPONSIVE",0.21,0,GeneticVariation
3155,HMGCL,3-hydroxymethyl-3-methylglutaryl-CoA lyase,0.0,0.0,1.0,0.0,0.0,1415614,3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY,0.21,9,GeneticVariation
2516,NR5A1,"nuclear receptor subfamily 5, group A, member 1",0.0,0.0,1.0,0.0,0.0,1417838,ADRENOCORTICAL INSUFFICIENCY,0.21,0,GeneticVariation
623,BDKRB1,bradykinin receptor B1,0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
624,BDKRB2,bradykinin receptor B2,0.0,0.0,0.0,0.0,1.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Therapeutic
1268,CNR1,cannabinoid receptor 1 (brain),0.0,0.0,0.0,0.0,1.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Therapeutic
4514,COX3,cytochrome c oxidase III,0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
2913,GRM3,"glutamate receptor, metabotropic 3",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
2914,GRM4,"glutamate receptor, metabotropic 4",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
2915,GRM5,"glutamate receptor, metabotropic 5",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
3749,KCNC4,"potassium channel, voltage gated Shaw related subfamily C, member 4",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
5025,P2RX4,"purinergic receptor P2X, ligand gated ion channel, 4",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
5027,P2RX7,"purinergic receptor P2X, ligand gated ion channel, 7",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,2,Biomarker
7010,TEK,"TEK tyrosine kinase, endothelial",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,14556,"Epilepsy, Temporal Lobe",0.21,1,Biomarker
4981,OPEM,"ophthalmoplegia, external, with myopia",0.0,1.0,0.0,0.0,0.0,1839577,"Ophthalmoplegia, External, and Myopia",0.21,0,Biomarker
10059,DNM1L,dynamin 1-like,0.0,1.0,0.0,0.0,0.0,1125,"Acidosis, Lactic",0.21,1,Biomarker
246751,SMAR,"Spinal muscular atrophy, chronic distal, autosomal recessive",0.0,1.0,0.0,0.0,0.0,1846823,"Spinal Muscular Atrophy, Distal, Autosomal Recessive, 3",0.21,0,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,14072,"Encephalomyelitis, Autoimmune, Experimental",0.21,1,Therapeutic
8184,HBN1,"Progressive familial heart block, type I, locus 1",0.0,1.0,0.0,0.0,0.0,1970298,"Progressive Familial Heart Block, Type Ib",0.21,0,Biomarker
2296,FOXC1,forkhead box C1,0.0,1.0,0.0,0.0,0.0,39685,Tetralogy of Fallot,0.21,1,Biomarker
2303,FOXC2,forkhead box C2,0.0,1.0,0.0,0.0,0.0,39685,Tetralogy of Fallot,0.21,1,Biomarker
8928,FOXH1,forkhead box H1,0.0,1.0,0.0,0.0,0.0,39685,Tetralogy of Fallot,0.21,1,Biomarker
9464,HAND2,heart and neural crest derivatives expressed 2,0.0,1.0,0.0,0.0,0.0,39685,Tetralogy of Fallot,0.21,1,Biomarker
11010,GLIPR1,GLI pathogenesis-related 1,0.0,1.0,0.0,0.0,0.0,27708,Wilms Tumor,0.21,1,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,20635,Hypopituitarism,0.21,1,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,20635,Hypopituitarism,0.21,1,Biomarker
114477,ATOD6,"Dermatitis, atopic, 6",0.0,1.0,0.0,0.0,0.0,1853899,"Dermatitis, Atopic, 6",0.21,0,Biomarker
8255,BZX,Bazex syndrome,0.0,1.0,0.0,0.0,0.0,346104,Bazex-Dupre-Christol syndrome,0.21,0,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,85593,Chills,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,85593,Chills,0.21,1,Biomarker
59344,ALOXE3,arachidonate lipoxygenase 3,0.0,0.0,1.0,0.0,0.0,3539888,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3",0.21,4,GeneticVariation
1363,CPE,carboxypeptidase E,0.0,1.0,0.0,0.0,0.0,14130,Endocrine System Diseases,0.21,1,Biomarker
100233159,WAGRO,WAGRO syndrome,0.0,1.0,0.0,0.0,0.0,2675904,"Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation, and Obesity Syndrome",0.21,0,Biomarker
282631,GCCD2,Glucocorticoid deficiency 2,0.0,1.0,0.0,0.0,0.0,1846284,Glucocorticoid Deficiency 2,0.21,0,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,19156,Hepatic Veno-Occlusive Disease,0.21,1,Biomarker
100506658,OCLN,occludin,0.0,1.0,0.0,0.0,0.0,19156,Hepatic Veno-Occlusive Disease,0.21,1,Biomarker
57582,KCNT1,"potassium channel, sodium activated subfamily T, member 1",0.0,1.0,0.0,0.0,0.0,85541,"Epilepsy, Frontal Lobe",0.21,1,Biomarker
57282,SLC4A10,"solute carrier family 4, sodium bicarbonate transporter, member 10",0.0,1.0,0.0,0.0,0.0,85541,"Epilepsy, Frontal Lobe",0.21,1,Biomarker
65211,FRTS1,Fanconi renotubular syndrome,0.0,1.0,0.0,0.0,0.0,15624,Fanconi Syndrome,0.21,0,Biomarker
2878,GPX3,glutathione peroxidase 3 (plasma),0.0,1.0,0.0,0.0,0.0,15624,Fanconi Syndrome,0.21,1,Biomarker
6514,SLC2A2,"solute carrier family 2 (facilitated glucose transporter), member 2",0.0,1.0,0.0,0.0,0.0,15624,Fanconi Syndrome,0.21,1,Biomarker
6569,SLC34A1,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 1",0.0,1.0,0.0,0.0,0.0,15624,Fanconi Syndrome,0.21,0,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,85602,Polydipsia,0.21,1,Biomarker
50829,HDPA,"Hodgkin disease, susceptibility, pseudoautosomal",0.0,1.0,0.0,0.0,0.0,1846167,"Hodgkin disease, X-linked pseudoautosomal",0.21,0,Biomarker
83706,FERMT3,fermitin family member 3,0.0,1.0,0.0,0.0,0.0,5818,Blood Platelet Disorders,0.21,1,Biomarker
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",0.0,1.0,0.0,0.0,0.0,5818,Blood Platelet Disorders,0.21,1,Biomarker
6915,TBXA2R,thromboxane A2 receptor,0.0,1.0,0.0,0.0,0.0,5818,Blood Platelet Disorders,0.21,2,Biomarker
4535,ND1,"NADH dehydrogenase, subunit 1 (complex I)",0.0,0.0,1.0,0.0,0.0,1838990,"ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL",0.21,0,GeneticVariation
4536,ND2,MTND2,0.0,0.0,1.0,0.0,0.0,1838990,"ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL",0.21,0,GeneticVariation
100534624,LCR-OPSIN,opsin locus control region,0.0,1.0,0.0,0.0,0.0,339537,Blue cone monochromatism,0.21,0,Biomarker
266790,HCA1,"Hypercalciuria, absorptive, 1",0.0,1.0,0.0,0.0,0.0,1846573,"Hypercalciuria, Absorptive, 1",0.21,0,Biomarker
1302,COL11A2,"collagen, type XI, alpha 2",0.0,1.0,0.0,0.0,0.0,7302,Cartilage Diseases,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,7302,Cartilage Diseases,0.21,1,Biomarker
2259,FGF14,fibroblast growth factor 14,0.0,1.0,0.0,0.0,0.0,7302,Cartilage Diseases,0.21,1,Biomarker
4880,NPPC,natriuretic peptide C,0.0,1.0,0.0,0.0,0.0,7302,Cartilage Diseases,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,2994,Angioedema,0.21,1,Biomarker
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,0.0,0.0,0.0,2994,Angioedema,0.21,1,Biomarker
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,0.0,0.0,0.0,2994,Angioedema,0.21,1,Biomarker
3123,HLA-DRB1,"major histocompatibility complex, class II, DR beta 1",0.0,1.0,0.0,0.0,0.0,2994,Angioedema,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,2994,Angioedema,0.21,3,Biomarker
2776,GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",0.0,1.0,0.0,0.0,0.0,5779,Blood Coagulation Disorders,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,5779,Blood Coagulation Disorders,0.21,1,Biomarker
10060,ABCC9,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
25890,ABI3BP,"ABI family, member 3 (NESH) binding protein",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
56172,ANKH,ANKH inorganic pyrophosphate transport regulator,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
27063,ANKRD1,ankyrin repeat domain 1 (cardiac muscle),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
121601,ANO4,anoctamin 4,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
374,AREG,amphiregulin,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
79822,ARHGAP28,Rho GTPase activating protein 28,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
655,BMP7,bone morphogenetic protein 7,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
10902,BRD8,bromodomain containing 8,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
11067,C10orf10,chromosome 10 open reading frame 10,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
715,C1R,"complement component 1, r subcomponent",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9134,CCNE2,cyclin E2,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
10666,CD226,CD226 molecule,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1604,CD55,"CD55 molecule, decay accelerating factor for complement (Cromer blood group)",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1675,CFD,complement factor D (adipsin),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9076,CLDN1,claudin 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
149111,CNIH3,cornichon family AMPA receptor auxiliary protein 3,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9318,COPS2,COP9 signalosome subunit 2,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1368,CPM,carboxypeptidase M,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1528,CYB5A,cytochrome b5 type A (microsomal),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1592,CYP26A1,"cytochrome P450, family 26, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
81501,DCSTAMP,dendrocyte expressed seven transmembrane protein,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1655,DDX5,DEAD (Asp-Glu-Ala-Asp) box helicase 5,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1734,DIO2,"deiodinase, iodothyronine, type II",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
22943,DKK1,dickkopf WNT signaling pathway inhibitor 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1843,DUSP1,dual specificity phosphatase 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1994,ELAVL1,ELAV like RNA binding protein 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
5167,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
54206,ERRFI1,ERBB receptor feedback inhibitor 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
389558,FAM180A,"family with sequence similarity 180, member A",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
2192,FBLN1,fibulin 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
2200,FBN1,fibrillin 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
2289,FKBP5,FK506 binding protein 5,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
2327,FMO2,flavin containing monooxygenase 2 (non-functional),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
2878,GPX3,glutathione peroxidase 3 (plasma),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,2,Biomarker
1839,HBEGF,heparin-binding EGF-like growth factor,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
51191,HERC5,HECT and RLD domain containing E3 ubiquitin protein ligase 5,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9953,HS3ST3B1,heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3434,IFIT1,interferon-induced protein with tetratricopeptide repeats 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3459,IFNGR1,interferon gamma receptor 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3489,IGFBP6,insulin-like growth factor binding protein 6,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3549,IHH,indian hedgehog,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3575,IL7R,interleukin 7 receptor,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3613,IMPA2,inositol(myo)-1(or 4)-monophosphatase 2,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3673,ITGA2,"integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
23421,ITGB3BP,integrin beta 3 binding protein (beta3-endonexin),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3696,ITGB8,"integrin, beta 8",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
51621,KLF13,Kruppel-like factor 13,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3912,LAMB1,"laminin, beta 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
25802,LMOD1,leiomodin 1 (smooth muscle),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
120892,LRRK2,leucine-rich repeat kinase 2,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
4128,MAOA,monoamine oxidase A,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
4129,MAOB,monoamine oxidase B,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
5469,MED1,mediator complex subunit 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9282,MED14,mediator complex subunit 14,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
10025,MED16,mediator complex subunit 16,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9440,MED17,mediator complex subunit 17,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
29079,MED4,mediator complex subunit 4,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
25840,METTL7A,methyltransferase like 7A,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9112,MTA1,metastasis associated 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9219,MTA2,"metastasis associated 1 family, member 2",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
29116,MYLIP,myosin regulatory light chain interacting protein,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
8648,NCOA1,nuclear receptor coactivator 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
23054,NCOA6,nuclear receptor coactivator 6,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9611,NCOR1,nuclear receptor corepressor 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
79625,NDNF,neuron-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
23327,NEDD4L,"neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
4741,NEFM,"neurofilament, medium polypeptide",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9975,NR1D2,"nuclear receptor subfamily 1, group D, member 2",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
7181,NR2C1,"nuclear receptor subfamily 2, group C, member 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
7182,NR2C2,"nuclear receptor subfamily 2, group C, member 2",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
2063,NR2F6,"nuclear receptor subfamily 2, group F, member 6",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3164,NR4A1,"nuclear receptor subfamily 4, group A, member 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
8829,NRP1,neuropilin 1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
4916,NTRK3,"neurotrophic tyrosine kinase, receptor, type 3",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
116039,OSR2,odd-skipped related transciption factor 2,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
10154,PLXNC1,plexin C1,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
5618,PRLR,prolactin receptor,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
5732,PTGER2,"prostaglandin E receptor 2 (subtype EP2), 53kDa",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
5915,RARB,"retinoic acid receptor, beta",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
10125,RASGRP1,RAS guanyl releasing protein 1 (calcium and DAG-regulated),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
387496,RASL11A,"RAS-like, family 11, member A",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
3516,RBPJ,recombination signal binding protein for immunoglobulin kappa J region,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
5999,RGS4,regulator of G-protein signaling 4,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
6096,RORB,RAR-related orphan receptor B,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
92304,SCGB3A1,"secretoglobin, family 3A, member 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
9120,SLC16A6,"solute carrier family 16, member 6",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
6505,SLC1A1,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
6574,SLC20A1,"solute carrier family 20 (phosphate transporter), member 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
30061,SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
23428,SLC7A8,"solute carrier family 7 (amino acid transporter light chain, L system), member 8",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
10924,SMPDL3A,"sphingomyelin phosphodiesterase, acid-like 3A",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
8404,SPARCL1,SPARC-like 1 (hevin),0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,2,Biomarker
6716,SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
8614,STC2,stanniocalcin 2,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
8801,SUCLG2,"succinate-CoA ligase, GDP-forming, beta subunit",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
55959,SULF2,sulfatase 2,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,2,Biomarker
4070,TACSTD2,tumor-associated calcium signal transducer 2,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
7067,THRA,"thyroid hormone receptor, alpha",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
10140,TOB1,"transducer of ERBB2, 1",0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
10090,UST,uronyl-2-sulfotransferase,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
1462,VCAN,versican,0.0,1.0,0.0,0.0,0.0,14175,Endometriosis,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,17612,"Glaucoma, Open-Angle",0.21,1,Biomarker
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
9429,ABCG2,"ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
55738,ARFGAP1,ADP-ribosylation factor GTPase activating protein 1,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
429,ASCL1,achaete-scute family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
467,ATF3,activating transcription factor 3,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,2,Biomarker
6315,ATXN8OS,ATXN8 opposite strand (non-protein coding),0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
84254,CAMKK1,"calcium/calmodulin-dependent protein kinase kinase 1, alpha",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
842,CASP9,"caspase 9, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
1558,CYP2C8,"cytochrome P450, family 2, subfamily C, polypeptide 8",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
2019,EN1,engrailed homeobox 1,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
2290,FOXG1,forkhead box G1,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
2990,GUSB,"glucuronidase, beta",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,2,Biomarker
388585,HES5,hes family bHLH transcription factor 5,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
3785,KCNQ2,"potassium channel, voltage gated KQT-like subfamily Q, member 2",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
4760,NEUROD1,neuronal differentiation 1,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
4773,NFATC2,"nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,0.0,0.0,0.0,1.0,27765,Nervous System Diseases,0.21,1,Therapeutic
10392,NOD1,nucleotide-binding oligomerization domain containing 1,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
10908,PNPLA6,patatin-like phospholipase domain containing 6,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,2,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
6470,SHMT1,serine hydroxymethyltransferase 1 (soluble),0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
6555,SLC10A2,"solute carrier family 10 (sodium/bile acid cotransporter), member 2",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
6571,SLC18A2,"solute carrier family 18 (vesicular monoamine transporter), member 2",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
54902,TTC19,tetratricopeptide repeat domain 19,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
7298,TYMS,thymidylate synthetase,0.0,1.0,0.0,0.0,0.0,27765,Nervous System Diseases,0.21,1,Biomarker
4072,EPCAM,epithelial cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,2931459,Lynch syndrome I (site-specific colonic cancer),0.21,1,Biomarker
4436,MSH2,mutS homolog 2,0.0,1.0,0.0,0.0,0.0,2931459,Lynch syndrome I (site-specific colonic cancer),0.21,1,Biomarker
54106,TLR9,toll-like receptor 9,0.0,1.0,0.0,0.0,0.0,18193,"Granuloma, Foreign-Body",0.21,1,Biomarker
554188,FCMTE2,familial cortical myoclonic tremor with epilepsy 2,0.0,1.0,0.0,0.0,0.0,1842852,"Epilepsy, Myoclonic, Benign Adult Familial, Type 2",0.21,0,Biomarker
7977,MHS3,Malignant hyperthermia susceptibility 3,0.0,1.0,0.0,0.0,0.0,2930982,Malignant hyperthermia susceptibility type 3,0.21,0,Biomarker
34,ACADM,"acyl-CoA dehydrogenase, C-4 to C-12 straight chain",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
47,ACLY,ATP citrate lyase,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
8165,AKAP1,A kinase (PRKA) anchor protein 1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
10840,ALDH1L1,"aldehyde dehydrogenase 1 family, member L1",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
4329,ALDH6A1,"aldehyde dehydrogenase 6 family, member A1",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
64756,ATPAF1,ATP synthase mitochondrial F1 complex assembly factor 1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
353126,BMIQ10,"Obesity, susceptibility to, on chromosome 10q",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,0,Biomarker
404683,BMIQ7,"Obesity, susceptibility to, on chromosome 4",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,0,Biomarker
56694,BMIQ8,body mass index quantitative trait locus 8,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,0,Biomarker
761,CA3,carbonic anhydrase III,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
1350,COX7C,cytochrome c oxidase subunit VIIc,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
1361,CPB2,carboxypeptidase B2 (plasma),0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
1431,CS,citrate synthase,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
1489,CTF1,cardiotrophin 1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
1528,CYB5A,cytochrome b5 type A (microsomal),0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
54205,CYCS,"cytochrome c, somatic",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
56603,CYP26B1,"cytochrome P450, family 26, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
51181,DCXR,dicarbonyl/L-xylulose reductase,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
1892,ECHS1,"enoyl CoA hydratase, short chain, 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
1947,EFNB1,ephrin-B1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
2110,ETFDH,electron-transferring-flavoprotein dehydrogenase,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
2309,FOXO3,forkhead box O3,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
2512,FTL,"ferritin, light polypeptide",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
3148,HMGB2,high mobility group box 2,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
56623,INPP5E,"inositol polyphosphate-5-phosphatase, 72 kDa",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
114294,LACTB,"lactamase, beta",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
4199,ME1,"malic enzyme 1, NADP(+)-dependent, cytosolic",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
406960,MIR184,microRNA 184,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
4594,MUT,methylmalonyl CoA mutase,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
55690,PACS1,phosphofurin acidic cluster sorting protein 1,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
151742,PPM1L,"protein phosphatase, Mg2+/Mn2+ dependent, 1L",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
5577,PRKAR2B,"protein kinase, cAMP-dependent, regulatory, type II, beta",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
5583,PRKCH,"protein kinase C, eta",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
196475,RMST,rhabdomyosarcoma 2 associated transcript (non-protein coding),0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
9194,SLC16A7,"solute carrier family 16 (monocarboxylate transporter), member 7",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
8803,SUCLA2,"succinate-CoA ligase, ADP-forming, beta subunit",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
8801,SUCLG2,"succinate-CoA ligase, GDP-forming, beta subunit",0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,2,Biomarker
7385,UQCRC2,ubiquinol-cytochrome c reductase core protein II,0.0,1.0,0.0,0.0,0.0,28754,Obesity,0.21,1,Biomarker
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,0.0,0.0,0.0,23869,Lithiasis,0.21,1,Biomarker
246750,MYAS1,Myasthenia gravis with thymus hyperplasia,0.0,1.0,0.0,0.0,0.0,1846838,Myasthenia Gravis with Thymus Hyperplasia,0.21,0,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,238461,"Thyroid Carcinoma, Anaplastic",0.21,1,Biomarker
151,ADRA2B,adrenoceptor alpha 2B,0.0,1.0,0.0,0.0,0.0,10520,Cyanosis,0.21,1,Biomarker
3043,HBB,"hemoglobin, beta",0.0,1.0,0.0,0.0,0.0,10520,Cyanosis,0.21,1,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,10520,Cyanosis,0.21,1,Biomarker
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,25427,Mercury Poisoning,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,0.0,0.0,0.0,1.0,36330,Schistosomiasis mansoni,0.21,1,Therapeutic
7911,SM1,"Schistosoma mansoni, susceptibility/resistance to",0.0,1.0,0.0,0.0,0.0,36330,Schistosomiasis mansoni,0.21,0,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,36330,Schistosomiasis mansoni,0.21,1,Biomarker
54106,TLR9,toll-like receptor 9,0.0,1.0,0.0,0.0,0.0,36330,Schistosomiasis mansoni,0.21,1,Biomarker
4413,MRX50,"mental retardation, X-linked 50",0.0,1.0,0.0,0.0,0.0,1848087,"Mental Retardation, X-Linked 50",0.21,0,Biomarker
424,ARVD3,arrhythmogenic right ventricular dysplasia 3,0.0,1.0,0.0,0.0,0.0,1865882,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 3",0.21,0,Biomarker
724107,SPG32,spastic paraplegia 32 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,1970009,"Spastic Paraplegia 32, Autosomal Recessive",0.21,0,Biomarker
360,AQP3,aquaporin 3 (Gill blood group),0.0,1.0,0.0,0.0,0.0,40411,Tongue Neoplasms,0.21,1,Biomarker
1410,CRYAB,"crystallin, alpha B",0.0,1.0,0.0,0.0,0.0,40411,Tongue Neoplasms,0.21,1,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,40411,Tongue Neoplasms,0.21,1,Biomarker
3861,KRT14,"keratin 14, type I",0.0,1.0,0.0,0.0,0.0,40411,Tongue Neoplasms,0.21,1,Biomarker
407007,MIR222,microRNA 222,0.0,1.0,0.0,0.0,0.0,40411,Tongue Neoplasms,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,40411,Tongue Neoplasms,0.21,1,Biomarker
7012,TERC,telomerase RNA component,0.0,0.0,0.0,0.0,1.0,40411,Tongue Neoplasms,0.21,1,Therapeutic
7298,TYMS,thymidylate synthetase,0.0,1.0,0.0,0.0,0.0,40411,Tongue Neoplasms,0.21,1,Biomarker
431710,ASPG1,"Asperger syndrome, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,236792,Asperger Syndrome,0.21,0,Biomarker
431711,ASPG2,"Asperger syndrome, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,236792,Asperger Syndrome,0.21,0,Biomarker
449015,ASPG3,"Asperger syndrome, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,236792,Asperger Syndrome,0.21,0,Biomarker
100188800,ASPG4,"Asperger syndrome, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,236792,Asperger Syndrome,0.21,0,Biomarker
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,0.0,0.0,0.0,236792,Asperger Syndrome,0.21,1,Biomarker
283,ANG,"angiogenin, ribonuclease, RNase A family, 5",0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,0,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
682,BSG,basigin (Ok blood group),0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
794,CALB2,calbindin 2,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
968,CD68,CD68 molecule,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
924,CD7,CD7 molecule,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
1191,CLU,clusterin,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
1387,CREBBP,CREB binding protein,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
1471,CST3,cystatin C,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
1509,CTSD,cathepsin D,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
120237,DBX1,developing brain homeobox 1,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
2251,FGF6,fibroblast growth factor 6,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
2554,GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
2637,GBX2,gastrulation brain homeobox 2,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
2664,GDI1,GDP dissociation inhibitor 1,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
2892,GRIA3,"glutamate receptor, ionotropic, AMPA 3",0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
170825,GSX2,GS homeobox 2,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
9118,INA,"internexin neuronal intermediate filament protein, alpha",0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
3718,JAK3,Janus kinase 3,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
3727,JUND,jun D proto-oncogene,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
3797,KIF3C,kinesin family member 3C,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
27040,LAT,linker for activation of T cells,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
3949,LDLR,low density lipoprotein receptor,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
340990,OTOG,otogelin,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
5179,PENK,proenkephalin,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
5630,PRPH,peripherin,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,0,Biomarker
6256,RXRA,"retinoid X receptor, alpha",0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
6404,SELPLG,selectin P ligand,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
6464,SHC1,SHC (Src homology 2 domain containing) transforming protein 1,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
10736,SIX2,SIX homeobox 2,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
6615,SNAI1,snail family zinc finger 1,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
7074,TIAM1,T-cell lymphoma invasion and metastasis 1,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
7090,TLE3,transducin-like enhancer of split 3,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
7114,TMSB4X,"thymosin beta 4, X-linked",0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
7476,WNT7A,"wingless-type MMTV integration site family, member 7A",0.0,1.0,0.0,0.0,0.0,1862939,Amyotrophic lateral sclerosis 1,0.21,1,Biomarker
1836,SLC26A2,"solute carrier family 26 (anion exchanger), member 2",0.0,1.0,0.0,0.0,0.0,13447,Ear Diseases,0.21,1,Biomarker
2,A2M,alpha-2-macroglobulin,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,3,"Biomarker, Therapeutic"
259,AMBP,alpha-1-microglobulin/bikunin precursor,0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,1,Therapeutic
81693,AMN,amnion associated transmembrane protein,0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,1,Therapeutic
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
1471,CST3,cystatin C,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,1,Therapeutic
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,2,Therapeutic
11167,FSTL1,follistatin-like 1,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
2539,G6PD,glucose-6-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,3,Biomarker
2621,GAS6,growth arrest-specific 6,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
10457,GPNMB,glycoprotein (transmembrane) nmb,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
2946,GSTM2,glutathione S-transferase mu 2 (muscle),0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
1839,HBEGF,heparin-binding EGF-like growth factor,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
3048,HBG2,"hemoglobin, gamma G",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,2,Biomarker
3074,HEXB,hexosaminidase B (beta polypeptide),0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,1,Therapeutic
3303,HSPA1A,heat shock 70kDa protein 1A,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,2,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,1,Therapeutic
3484,IGFBP1,insulin-like growth factor binding protein 1,0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,1,Therapeutic
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
50604,IL20,interleukin 20,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,1,Therapeutic
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
3816,KLK1,kallikrein 1,0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,1,Therapeutic
3827,KNG1,kininogen 1,0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,2,Therapeutic
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
100506658,OCLN,occludin,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
10411,RAPGEF3,Rap guanine nucleotide exchange factor (GEF) 3,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
116085,SLC22A12,"solute carrier family 22 (organic anion/urate transporter), member 12",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
283238,SLC22A24,"solute carrier family 22, member 24",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,2,Biomarker
7033,TFF3,trefoil factor 3 (intestinal),0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,3,Biomarker
51330,TNFRSF12A,"tumor necrosis factor receptor superfamily, member 12A",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
54658,UGT1A1,"UDP glucuronosyltransferase 1 family, polypeptide A1",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
54600,UGT1A9,"UDP glucuronosyltransferase 1 family, polypeptide A9",0.0,1.0,0.0,0.0,0.0,2609414,Acute Kidney Injury,0.21,1,Biomarker
391051,UOX,"urate oxidase, pseudogene",0.0,0.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,1,Therapeutic
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,1.0,2609414,Acute Kidney Injury,0.21,2,"Biomarker, Therapeutic"
100188872,CELIAC10,"Celiac disease, susceptibility to, 10",0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.21,0,Biomarker
100188873,CELIAC11,"Celiac disease, susceptibility to, 11",0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.21,0,Biomarker
100188874,CELIAC12,"Celiac disease, susceptibility to, 12",0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.21,0,Biomarker
100188875,CELIAC13,"Celiac disease, susceptibility to, 13",0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.21,0,Biomarker
338332,CELIAC5,"Celiac disease, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.21,0,Biomarker
100188846,CELIAC6,"Celiac disease, susceptibility to, 6",0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.21,0,Biomarker
100301522,CELIAC7,"Celiac disease, susceptibility to, 7",0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.21,0,Biomarker
100188870,CELIAC8,"Celiac disease, susceptibility to, 8",0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.21,0,Biomarker
100188871,CELIAC9,"Celiac disease, susceptibility to, 9",0.0,1.0,0.0,0.0,0.0,7570,Celiac Disease,0.21,0,Biomarker
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,0.0,0.0,0.0,950123,"Genetic Diseases, Inborn",0.21,1,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,2677101,Inflammatory Bowel Disease 13,0.21,0,Biomarker
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,3860,Arteritis,0.21,1,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,3860,Arteritis,0.21,1,Biomarker
5624,PROC,protein C (inactivator of coagulation factors Va and VIIIa),0.0,1.0,0.0,0.0,0.0,3860,Arteritis,0.21,1,Biomarker
718,C3,complement component 3,0.0,1.0,0.0,0.0,0.0,30807,Pemphigus,0.21,1,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,26851,"Muscular Dystrophy, Animal",0.21,1,Biomarker
10891,PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha",0.0,0.0,0.0,0.0,1.0,26851,"Muscular Dystrophy, Animal",0.21,1,Therapeutic
450095,PLF,Pulmonary function,0.0,1.0,0.0,0.0,0.0,3160731,PULMONARY FUNCTION,0.21,0,Biomarker
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,0.0,0.0,0.0,1.0,151699,Intracranial Hemorrhages,0.21,5,Therapeutic
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,151699,Intracranial Hemorrhages,0.21,14,Biomarker
9963,SLC23A1,"solute carrier family 23 (ascorbic acid transporter), member 1",0.0,1.0,0.0,0.0,0.0,151699,Intracranial Hemorrhages,0.21,1,Biomarker
4183,MCS,Miles-Carpenter X-linked mental retardation syndrome,0.0,1.0,0.0,0.0,0.0,1839735,Miles-Carpenter x-linked mental retardation syndrome,0.21,0,Biomarker
53632,PRKAG3,"protein kinase, AMP-activated, gamma 3 non-catalytic subunit",0.0,1.0,0.0,0.0,0.0,7001,"Carbohydrate Metabolism, Inborn Errors",0.21,2,Biomarker
2153,F5,"coagulation factor V (proaccelerin, labile factor)",0.0,1.0,0.0,0.0,0.0,338575,Sagittal Sinus Thrombosis,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,338575,Sagittal Sinus Thrombosis,0.21,1,Therapeutic
5627,PROS1,protein S (alpha),0.0,1.0,0.0,0.0,0.0,338575,Sagittal Sinus Thrombosis,0.21,1,Biomarker
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,1.0,0.0,0.0,0.0,282488,"Cystitis, Interstitial",0.21,1,Biomarker
6373,CXCL11,chemokine (C-X-C motif) ligand 11,0.0,1.0,0.0,0.0,0.0,282488,"Cystitis, Interstitial",0.21,1,Biomarker
4283,CXCL9,chemokine (C-X-C motif) ligand 9,0.0,1.0,0.0,0.0,0.0,282488,"Cystitis, Interstitial",0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,239981,Hypoalbuminemia,0.21,1,Biomarker
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,0.0,0.0,0.0,239981,Hypoalbuminemia,0.21,1,Biomarker
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,0.0,0.0,0.0,10051,Coronary Aneurysm,0.21,1,Biomarker
100507436,MICA,MHC class I polypeptide-related sequence A,0.0,1.0,0.0,0.0,0.0,10051,Coronary Aneurysm,0.21,1,Biomarker
5781,PTPN11,"protein tyrosine phosphatase, non-receptor type 11",0.0,1.0,0.0,0.0,0.0,15306,"Exostoses, Multiple Hereditary",0.21,1,Biomarker
406215,KTCN3,Keratoconus 3,0.0,1.0,0.0,0.0,0.0,1837809,Keratoconus 3,0.21,0,Biomarker
6662,SOX9,SRY (sex determining region Y)-box 9,0.0,1.0,0.0,0.0,0.0,265998,Anonychia congenita,0.21,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,26936,Mycoplasma Infections,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,26936,Mycoplasma Infections,0.21,1,Biomarker
374569,ASPG,asparaginase,0.0,1.0,0.0,0.0,0.0,2792,Anaphylaxis,0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,2792,Anaphylaxis,0.21,1,Biomarker
1241,LTB4R,leukotriene B4 receptor,0.0,1.0,0.0,0.0,0.0,2792,Anaphylaxis,0.21,1,Biomarker
3717,JAK2,Janus kinase 2,0.0,1.0,0.0,0.0,0.0,25472,Mesenteric Vascular Occlusion,0.21,1,Biomarker
3053,SERPIND1,"serpin peptidase inhibitor, clade D (heparin cofactor), member 1",0.0,1.0,0.0,0.0,0.0,25472,Mesenteric Vascular Occlusion,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,752262,Somatosensory Disorders,0.21,1,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,752262,Somatosensory Disorders,0.21,1,Biomarker
100359399,DFNB85,"deafness, autosomal recessive 85",0.0,1.0,0.0,0.0,0.0,3160740,"DEAFNESS, AUTOSOMAL RECESSIVE 85",0.21,0,Biomarker
751609,DFNB68,"deafness, autosomal recessive 68",0.0,1.0,0.0,0.0,0.0,1835854,"Deafness, Autosomal Recessive 68",0.21,0,Biomarker
6687,SPG7,spastic paraplegia 7 (pure and complicated autosomal recessive),0.0,1.0,0.0,0.0,0.0,30486,Paraplegia,0.21,1,Biomarker
100126593,MAFD4,Major affective disorder 4,0.0,1.0,0.0,0.0,0.0,1970943,Major Affective Disorder 4,0.21,0,Biomarker
23435,TARDBP,TAR DNA binding protein,0.0,1.0,0.0,0.0,0.0,3502417,Amyotrophic Lateral Sclerosis 10,0.21,0,Biomarker
100270800,SHFLD3,Split-hand/foot malformation with long bone deficiency 3,0.0,1.0,0.0,0.0,0.0,2675492,Split-Hand/Foot Malformation With Long Bone Deficiency 3,0.21,0,Biomarker
791121,SHFL1,Split-hand/foot malformation with long bone deficiency 1,0.0,1.0,0.0,0.0,0.0,1861553,Split-hand/foot malformation with long bone deficiency,0.21,0,Biomarker
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,0.0,1.0,0.0,0.0,1334899,GLUCOCORTICOID RECEPTOR,0.21,0,GeneticVariation
51129,ANGPTL4,angiopoietin-like 4,0.0,0.0,0.0,0.0,1.0,24232,Lymphatic Metastasis,0.21,1,Therapeutic
27086,FOXP1,forkhead box P1,0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.21,1,Biomarker
3814,KISS1,KiSS-1 metastasis-suppressor,0.0,0.0,0.0,0.0,1.0,24232,Lymphatic Metastasis,0.21,1,Therapeutic
10232,MSLN,mesothelin,0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.21,1,Biomarker
4489,MT1A,metallothionein 1A,0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.21,1,Biomarker
9770,RASSF2,Ras association (RalGDS/AF-6) domain family member 2,0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.21,1,Biomarker
6462,SHBG,sex hormone-binding globulin,0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.21,3,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.21,1,Biomarker
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,0.0,0.0,0.0,24232,Lymphatic Metastasis,0.21,1,Biomarker
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,22408,Joint Diseases,0.21,1,Therapeutic
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,5974,Bone Resorption,0.21,1,Biomarker
655,BMP7,bone morphogenetic protein 7,0.0,0.0,0.0,0.0,1.0,5974,Bone Resorption,0.21,1,Therapeutic
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,0.0,0.0,0.0,1.0,5974,Bone Resorption,0.21,1,Therapeutic
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,5974,Bone Resorption,0.21,1,Biomarker
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,5974,Bone Resorption,0.21,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,5974,Bone Resorption,0.21,1,Biomarker
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",0.0,1.0,0.0,0.0,1.0,5974,Bone Resorption,0.21,3,"Biomarker, Therapeutic"
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,751792,"Trauma, Nervous System",0.21,1,Biomarker
18,ABAT,4-aminobutyrate aminotransferase,0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
125,ADH1B,"alcohol dehydrogenase 1B (class I), beta polypeptide",0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,2,Biomarker
126,ADH1C,"alcohol dehydrogenase 1C (class I), gamma polypeptide",0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
135,ADORA2A,adenosine A2a receptor,0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
210,ALAD,aminolevulinate dehydratase,0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,2,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
2207,FCER1G,"Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide",0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
3105,HLA-A,"major histocompatibility complex, class I, A",0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
3106,HLA-B,"major histocompatibility complex, class I, B",0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
3764,KCNJ8,"potassium channel, inwardly rectifying subfamily J, member 8",0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
5888,RAD51,RAD51 recombinase,0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
7039,TGFA,"transforming growth factor, alpha",0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
7517,XRCC3,X-ray repair complementing defective repair in Chinese hamster cells 3,0.0,1.0,0.0,0.0,0.0,314657,Genetic Predisposition to Disease,0.21,1,Biomarker
100188695,DA4,"arthrogryposis, distal, type 4",0.0,1.0,0.0,0.0,0.0,1836756,"Arthrogryposis, Distal, Type 4",0.21,0,Biomarker
133,ADM,adrenomedullin,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
213,ALB,albumin,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
551,AVP,arginine vasopressin,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,2,Therapeutic
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
781,CACNA2D1,"calcium channel, voltage-dependent, alpha 2/delta subunit 1",0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
27185,DISC1,disrupted in schizophrenia 1,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
2902,GRIN1,"glutamate receptor, ionotropic, N-methyl D-aspartate 1",0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
3060,HCRT,hypocretin (orexin) neuropeptide precursor,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
3231,HOXD1,homeobox D1,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
3269,HRH1,histamine receptor H1,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,2,Biomarker
9177,HTR3B,"5-hydroxytryptamine (serotonin) receptor 3B, ionotropic",0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
3558,IL2,interleukin 2,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
4878,NPPA,natriuretic peptide A,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
3084,NRG1,neuregulin 1,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
4923,NTSR1,neurotensin receptor 1 (high affinity),0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,2,Biomarker
5179,PENK,proenkephalin,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
23236,PLCB1,"phospholipase C, beta 1 (phosphoinositide-specific)",0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
10887,PROKR1,prokineticin receptor 1,0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
6548,SLC9A1,"solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1",0.0,1.0,0.0,0.0,0.0,30193,Pain,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
7432,VIP,vasoactive intestinal peptide,0.0,0.0,0.0,0.0,1.0,30193,Pain,0.21,1,Therapeutic
8129,HBHR,"alpha-thalassemia/mental retardation syndrome, type 1",0.0,1.0,0.0,0.0,0.0,795917,"Alpha-Thalassemia Mental Retardation Syndrome, Deletion-Type",0.21,0,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,18790,Heart Arrest,0.21,1,Biomarker
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,18790,Heart Arrest,0.21,1,Therapeutic
2688,GH1,growth hormone 1,0.0,1.0,0.0,0.0,0.0,1858656,"Short Stature, Idiopathic, Autosomal",0.21,0,Biomarker
6473,SHOX,short stature homeobox,0.0,1.0,0.0,0.0,0.0,1858656,"Short Stature, Idiopathic, Autosomal",0.21,0,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,2965,"Angina, Unstable",0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,2965,"Angina, Unstable",0.21,1,Therapeutic
2911,GRM1,"glutamate receptor, metabotropic 1",0.0,1.0,0.0,0.0,0.0,206639,"Neoplasms, Bone Tissue",0.21,1,Biomarker
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,0.0,1.0,0.0,0.0,2931244,"Craniometaphyseal dysplasia, autosomal recessive type",0.21,0,GeneticVariation
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,403447,"Renal Insufficiency, Chronic",0.21,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,3466,"Anus, Imperforate",0.21,1,Biomarker
374569,ASPG,asparaginase,0.0,1.0,0.0,0.0,0.0,701818,Choledocholithiasis,0.21,1,Biomarker
1862,DYT2,"dystonia 2, torsion (autosomal recessive)",0.0,1.0,0.0,0.0,0.0,1857093,Dystonia musculorum deformans type 2,0.21,0,Biomarker
7908,EOS,"eosinophilia, familial",0.0,1.0,0.0,0.0,0.0,272192,"Eosinophilia, Familial",0.21,0,Biomarker
4599,MX1,MX dynamin-like GTPase 1,0.0,0.0,0.0,0.0,1.0,16627,Influenza in Birds,0.21,1,Therapeutic
6498,SKIL,SKI-like proto-oncogene,0.0,0.0,0.0,0.0,1.0,2931434,Paraquat lung,0.21,1,Therapeutic
4092,SMAD7,SMAD family member 7,0.0,0.0,0.0,0.0,1.0,2931434,Paraquat lung,0.21,1,Therapeutic
553195,MYP10,myopia 10,0.0,1.0,0.0,0.0,0.0,1836503,Myopia 10,0.21,0,Biomarker
57822,GRHL3,grainyhead-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,15927,Fetal Death,0.21,1,Biomarker
1902,LPAR1,lysophosphatidic acid receptor 1,0.0,1.0,0.0,0.0,0.0,15927,Fetal Death,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,15927,Fetal Death,0.21,1,Biomarker
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,15927,Fetal Death,0.21,1,Biomarker
408260,HPC4,"Prostate cancer, hereditary, 4",0.0,1.0,0.0,0.0,0.0,1837593,"Prostate Cancer, Hereditary, 4",0.21,0,Biomarker
9119,KRT75,"keratin 75, type II",0.0,0.0,1.0,0.0,0.0,406468,Loose Anagen Hair Syndrome,0.21,1,GeneticVariation
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,5694,Urinary Bladder Neck Obstruction,0.21,1,Biomarker
347,APOD,apolipoprotein D,0.0,1.0,0.0,0.0,0.0,86439,Hypokinesia,0.21,1,Biomarker
2643,GCH1,GTP cyclohydrolase 1,0.0,1.0,0.0,0.0,0.0,86439,Hypokinesia,0.21,1,Biomarker
4987,OPRL1,opiate receptor-like 1,0.0,1.0,0.0,0.0,0.0,86439,Hypokinesia,0.21,1,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,3489795,"Hyper-Ige Recurrent Infection Syndrome, Autosomal Dominant",0.21,0,Biomarker
80746,TSEN2,TSEN2 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,42790,Vision Disorders,0.21,1,Biomarker
79042,TSEN34,TSEN34 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,42790,Vision Disorders,0.21,1,Biomarker
283989,TSEN54,TSEN54 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,42790,Vision Disorders,0.21,1,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,42790,Vision Disorders,0.21,1,Biomarker
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,0.0,0.0,0.0,2674838,"ALCOHOL SENSITIVITY, ACUTE",0.21,1,Biomarker
4010,LMX1B,"LIM homeobox transcription factor 1, beta",0.0,1.0,0.0,0.0,0.0,1842028,"Glaucoma 1, Open Angle, A",0.21,0,Biomarker
289,ANOP1,"anophthalmos 1 (with mental retardation, without limb anomalies or dental or urogenital abnormalities)",0.0,1.0,0.0,0.0,0.0,1844948,"Microphthalmia, Syndromic 4",0.21,0,Biomarker
22953,P2RX2,"purinergic receptor P2X, ligand gated ion channel, 2",0.0,0.0,1.0,0.0,0.0,1842371,"Deafness, Autosomal Dominant 41",0.21,2,GeneticVariation
3091,HIF1A,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",0.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.21,1,Biomarker
3248,HPGD,hydroxyprostaglandin dehydrogenase 15-(NAD),0.0,0.0,0.0,0.0,1.0,40136,Thyroid Neoplasms,0.21,1,Therapeutic
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,40136,Thyroid Neoplasms,0.21,1,Therapeutic
80142,PTGES2,prostaglandin E synthase 2,0.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.21,1,Biomarker
6256,RXRA,"retinoid X receptor, alpha",0.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.21,1,Biomarker
83439,TCF7L1,"transcription factor 7-like 1 (T-cell specific, HMG-box)",0.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.21,1,Biomarker
7175,TPR,"translocated promoter region, nuclear basket protein",0.0,1.0,0.0,0.0,0.0,40136,Thyroid Neoplasms,0.21,1,Biomarker
151,ADRA2B,adrenoceptor alpha 2B,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
683,BST1,bone marrow stromal cell antigen 1,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
976,CD97,CD97 molecule,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
338339,CLEC4D,"C-type lectin domain family 4, member D",0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
26253,CLEC4E,"C-type lectin domain family 4, member E",0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
1395,CRHR2,corticotropin releasing hormone receptor 2,0.0,0.0,0.0,0.0,1.0,24115,Lung Diseases,0.21,1,Therapeutic
83716,CRISPLD2,cysteine-rich secretory protein LCCL domain containing 2,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,2,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,2,Biomarker
3482,IGF2R,insulin-like growth factor 2 receptor,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,2,Biomarker
3643,INSR,insulin receptor,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,2,Biomarker
79192,IRX1,iroquois homeobox 1,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
153572,IRX2,iroquois homeobox 2,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
79191,IRX3,iroquois homeobox 3,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
10365,KLF2,Kruppel-like factor 2,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
3948,LDHC,lactate dehydrogenase C,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
4317,MMP8,matrix metallopeptidase 8 (neutrophil collagenase),0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
5591,PRKDC,"protein kinase, DNA-activated, catalytic polypeptide",0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
5745,PTH1R,parathyroid hormone 1 receptor,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,2,Biomarker
10253,SPRY2,sprouty homolog 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
64220,STRA6,stimulated by retinoic acid 6,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,24115,Lung Diseases,0.21,1,Biomarker
114131,UCN3,urocortin 3,0.0,0.0,0.0,0.0,1.0,24115,Lung Diseases,0.21,1,Therapeutic
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,282609,Bone Marrow Neoplasms,0.21,1,Biomarker
727714,SCAX2,"spinocerebellar ataxia, X-linked 2",0.0,1.0,0.0,0.0,0.0,1844885,"Spinocerebellar ataxia, X-linked, 2",0.21,0,Biomarker
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,30846,Penile Diseases,0.21,1,Biomarker
56623,INPP5E,"inositol polyphosphate-5-phosphatase, 72 kDa",0.0,1.0,0.0,0.0,0.0,30846,Penile Diseases,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,30846,Penile Diseases,0.21,3,Biomarker
6999,TDO2,"tryptophan 2,3-dioxygenase",0.0,1.0,0.0,0.0,0.0,38187,Starvation,0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,86468,Prenatal Injuries,0.21,1,Biomarker
4015,LOX,lysyl oxidase,0.0,1.0,0.0,0.0,0.0,86468,Prenatal Injuries,0.21,1,Biomarker
4016,LOXL1,lysyl oxidase-like 1,0.0,1.0,0.0,0.0,0.0,86468,Prenatal Injuries,0.21,1,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,0.0,0.0,0.0,86468,Prenatal Injuries,0.21,1,Biomarker
5652,PRSS8,"protease, serine, 8",0.0,0.0,0.0,0.0,1.0,86468,Prenatal Injuries,0.21,1,Therapeutic
6093,ROCK1,"Rho-associated, coiled-coil containing protein kinase 1",0.0,1.0,0.0,0.0,0.0,86468,Prenatal Injuries,0.21,1,Biomarker
9475,ROCK2,"Rho-associated, coiled-coil containing protein kinase 2",0.0,1.0,0.0,0.0,0.0,86468,Prenatal Injuries,0.21,1,Biomarker
55630,SLC39A4,"solute carrier family 39 (zinc transporter), member 4",0.0,1.0,0.0,0.0,0.0,86468,Prenatal Injuries,0.21,1,Biomarker
10653,SPINT2,"serine peptidase inhibitor, Kunitz type, 2",0.0,1.0,0.0,0.0,0.0,86468,Prenatal Injuries,0.21,1,Biomarker
2524,FUT2,fucosyltransferase 2 (secretor status included),0.0,1.0,0.0,0.0,0.0,2674252,VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1,0.21,0,Biomarker
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
1147,CHUK,conserved helix-loop-helix ubiquitous kinase,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,4,Biomarker
1302,COL11A2,"collagen, type XI, alpha 2",0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
10082,GPC6,glypican 6,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
1404,HAPLN1,hyaluronan and proteoglycan link protein 1,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
3207,HOXA11,homeobox A11,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
3237,HOXD11,homeobox D11,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,3,Biomarker
3238,HOXD12,homeobox D12,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,2,Biomarker
3664,IRF6,interferon regulatory factor 6,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
407975,MIR17HG,miR-17-92 cluster host gene (non-protein coding),0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
6926,TBX3,T-box 3,0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,206762,"Limb Deformities, Congenital",0.21,1,Biomarker
8113,MCOP1,"microphthalmia, autosomal recessive",0.0,1.0,0.0,0.0,0.0,1855052,"Microphthalmia, Isolated 1",0.21,0,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,13384,Dyskinesias,0.21,1,Biomarker
4763,NF1,neurofibromin 1,0.0,1.0,0.0,0.0,0.0,16057,Fibrosarcoma,0.21,1,Biomarker
57788,RFMN,Roifman syndrome,0.0,1.0,0.0,0.0,0.0,1846059,Roifman syndrome,0.21,0,Biomarker
100359402,SPG41,spastic paraplegia 41 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,2680445,"SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT",0.21,0,Biomarker
6905,TBCE,tubulin folding cofactor E,0.0,1.0,0.0,0.0,0.0,4623,Bacterial Infections,0.21,1,Biomarker
100381211,ARCODS,Ariculocondylar syndrome,0.0,1.0,0.0,0.0,0.0,1865295,Auriculo-condylar syndrome,0.21,0,Biomarker
928,CD9,CD9 molecule,0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.21,1,Biomarker
359787,DPPA3,developmental pluripotency associated 3,0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.21,1,Biomarker
2067,ERCC1,excision repair cross-complementation group 1,0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.21,1,Biomarker
2072,ERCC4,excision repair cross-complementation group 4,0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.21,1,Biomarker
9573,GDF3,growth differentiation factor 3,0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.21,1,Biomarker
79923,NANOG,Nanog homeobox,0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.21,1,Biomarker
1911,PHC1,polyhomeotic homolog 1 (Drosophila),0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.21,1,Biomarker
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.21,1,Biomarker
6515,SLC2A3,"solute carrier family 2 (facilitated glucose transporter), member 3",0.0,1.0,0.0,0.0,0.0,27658,"Neoplasms, Germ Cell and Embryonal",0.21,1,Biomarker
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,0.0,0.0,0.0,265201,De Sanctis-Cacchione syndrome,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,35411,Rhabdomyoma,0.21,1,Biomarker
1888,EBVS1,Epstein Barr virus integration site 1,0.0,1.0,0.0,0.0,0.0,1414241,EPSTEIN-BARR VIRUS INSERTION SITE 1,0.21,0,Biomarker
27038,ARVD6,arrhythmogenic right ventricular dysplasia 6,0.0,1.0,0.0,0.0,0.0,1858378,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 6",0.21,0,Biomarker
497188,GLC1I,"glaucoma 1, open angle, I",0.0,1.0,0.0,0.0,0.0,1857852,"Glaucoma 1, Open Angle, I",0.21,0,Biomarker
270,AMPD1,adenosine monophosphate deaminase 1,0.0,1.0,0.0,0.0,0.0,2931781,Adenosine monophosphate deaminase deficiency,0.21,3,Biomarker
9217,VAPB,VAMP (vesicle-associated membrane protein)-associated protein B and C,0.0,1.0,0.0,0.0,0.0,1866777,"Spinal Muscular Atrophy, Proximal, Adult, Autosomal Dominant",0.21,0,Biomarker
23780,APOL2,"apolipoprotein L, 2",0.0,1.0,0.0,0.0,0.0,24809,Marijuana Abuse,0.21,1,Biomarker
801,CALM1,"calmodulin 1 (phosphorylase kinase, delta)",0.0,1.0,0.0,0.0,0.0,24809,Marijuana Abuse,0.21,1,Biomarker
805,CALM2,"calmodulin 2 (phosphorylase kinase, delta)",0.0,1.0,0.0,0.0,0.0,24809,Marijuana Abuse,0.21,1,Biomarker
816,CAMK2B,calcium/calmodulin-dependent protein kinase II beta,0.0,1.0,0.0,0.0,0.0,24809,Marijuana Abuse,0.21,1,Biomarker
2222,FDFT1,farnesyl-diphosphate farnesyltransferase 1,0.0,1.0,0.0,0.0,0.0,24809,Marijuana Abuse,0.21,1,Biomarker
79571,GCC1,GRIP and coiled-coil domain containing 1,0.0,1.0,0.0,0.0,0.0,24809,Marijuana Abuse,0.21,1,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,24809,Marijuana Abuse,0.21,1,Biomarker
94003,PDB4,Paget disease of bone 4,0.0,1.0,0.0,0.0,0.0,1853473,Paget Disease Of Bone 4,0.21,0,Biomarker
551,AVP,arginine vasopressin,0.0,0.0,0.0,0.0,1.0,17181,Gastrointestinal Hemorrhage,0.21,1,Therapeutic
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,17181,Gastrointestinal Hemorrhage,0.21,1,Biomarker
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,17181,Gastrointestinal Hemorrhage,0.21,1,Therapeutic
3458,IFNG,"interferon, gamma",0.0,0.0,0.0,0.0,1.0,1328252,"Leishmaniasis, Mucocutaneous",0.21,1,Therapeutic
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),0.0,1.0,0.0,0.0,0.0,342686,Aromatic amino acid decarboxylase deficiency,0.21,0,Biomarker
7046,TGFBR1,"transforming growth factor, beta receptor 1",0.0,1.0,0.0,0.0,0.0,1836743,"Auditory Neuropathy, Autosomal Dominant, 1",0.21,0,Biomarker
4096,MAFD2,major affective disorder 2,0.0,1.0,0.0,0.0,0.0,1839839,Major Affective Disorder 2,0.21,0,Biomarker
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,271901,"Anemia, hypochromic microcytic",0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,271901,"Anemia, hypochromic microcytic",0.21,1,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,0.0,0.0,0.0,1.0,221406,Pituitary ACTH Hypersecretion,0.21,1,Therapeutic
4126,MANBA,"mannosidase, beta A, lysosomal",0.0,1.0,0.0,0.0,0.0,2931893,Lysosomal beta-mannosidase deficiency,0.21,0,Biomarker
1649,DDIT3,DNA-damage-inducible transcript 3,0.0,1.0,0.0,0.0,0.0,21831,Intestinal Diseases,0.21,1,Biomarker
4645,MYO5B,myosin VB,0.0,1.0,0.0,0.0,0.0,21831,Intestinal Diseases,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,21831,Intestinal Diseases,0.21,1,Biomarker
10105,PPIF,peptidylprolyl isomerase F,0.0,1.0,0.0,0.0,0.0,21831,Intestinal Diseases,0.21,1,Biomarker
151648,SGOL1,shugoshin-like 1 (S. pombe),0.0,1.0,0.0,0.0,0.0,21831,Intestinal Diseases,0.21,1,Biomarker
2120,ETV6,ets variant 6,0.0,1.0,0.0,0.0,0.0,1851585,"Myeloproliferative Disorder, Chronic, with Eosinophilia",0.21,0,Biomarker
5159,PDGFRB,"platelet-derived growth factor receptor, beta polypeptide",0.0,1.0,0.0,0.0,0.0,1851585,"Myeloproliferative Disorder, Chronic, with Eosinophilia",0.21,0,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,20598,Hypocalcemia,0.21,1,Biomarker
3439,IFNA1,"interferon, alpha 1",0.0,0.0,0.0,0.0,1.0,11993,Vipoma,0.21,1,Therapeutic
6750,SST,somatostatin,0.0,0.0,0.0,0.0,1.0,11993,Vipoma,0.21,1,Therapeutic
2936,GSR,glutathione reductase,0.0,1.0,0.0,0.0,0.0,2878,"Anemia, Hemolytic",0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,2878,"Anemia, Hemolytic",0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,2878,"Anemia, Hemolytic",0.21,3,Biomarker
6710,SPTB,"spectrin, beta, erythrocytic",0.0,1.0,0.0,0.0,0.0,2878,"Anemia, Hemolytic",0.21,1,Biomarker
353128,AD8,Alzheimer disease 8,0.0,1.0,0.0,0.0,0.0,1846735,Alzheimer Disease 8,0.21,0,Biomarker
8181,BFIS1,benign familial infantile convulsions,0.0,1.0,0.0,0.0,0.0,270851,"Epilepsy, Benign Neonatal",0.21,0,Biomarker
56997,ADCK3,aarF domain containing kinase 3,0.0,1.0,0.0,0.0,0.0,3551954,"COENZYME Q10 DEFICIENCY, PRIMARY, 1",0.21,1,Biomarker
54840,APTX,aprataxin,0.0,1.0,0.0,0.0,0.0,3551954,"COENZYME Q10 DEFICIENCY, PRIMARY, 1",0.21,0,Biomarker
57017,COQ9,coenzyme Q9,0.0,1.0,0.0,0.0,0.0,3551954,"COENZYME Q10 DEFICIENCY, PRIMARY, 1",0.21,0,Biomarker
23590,PDSS1,"prenyl (decaprenyl) diphosphate synthase, subunit 1",0.0,1.0,0.0,0.0,0.0,3551954,"COENZYME Q10 DEFICIENCY, PRIMARY, 1",0.21,0,Biomarker
2312,FLG,filaggrin,0.0,1.0,0.0,0.0,0.0,1853965,"Dermatitis, Atopic, 2",0.21,0,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,40954,Trichuriasis,0.21,1,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,40954,Trichuriasis,0.21,1,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,37299,Skin Ulcer,0.21,1,Biomarker
3909,LAMA3,"laminin, alpha 3",0.0,1.0,0.0,0.0,0.0,37299,Skin Ulcer,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,0.0,0.0,0.0,1.0,37299,Skin Ulcer,0.21,1,Therapeutic
5184,PEPD,peptidase D,0.0,1.0,0.0,0.0,0.0,37299,Skin Ulcer,0.21,1,Biomarker
780914,ZD1,Zygodactyly 1,0.0,1.0,0.0,0.0,0.0,1853294,Zygodactyly 1,0.21,0,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,0.0,0.0,0.0,1.0,10043,Corneal Ulcer,0.21,1,Therapeutic
5176,SERPINF1,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1",0.0,0.0,0.0,0.0,1.0,10043,Corneal Ulcer,0.21,1,Therapeutic
1829,DSG2,desmoglein 2,0.0,1.0,0.0,0.0,0.0,2752072,"Cardiomyopathy, Dilated, 1BB",0.21,0,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,206617,Cardiovirus Infections,0.21,1,Biomarker
23118,TAB2,TGF-beta activated kinase 1/MAP3K7 binding protein 2,0.0,0.0,1.0,0.0,0.0,3554279,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2",0.21,1,GeneticVariation
100505394,EDSS2,Ectodermal dysplasia-syndactyly syndrome 2,0.0,1.0,0.0,0.0,0.0,3150809,ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2,0.21,0,Biomarker
3990,LIPC,"lipase, hepatic",0.0,1.0,0.0,0.0,0.0,2675071,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12,0.21,0,Biomarker
1146,CHRNG,"cholinergic receptor, nicotinic, gamma (muscle)",0.0,1.0,0.0,0.0,0.0,751882,"Myasthenic Syndromes, Congenital",0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,42029,Urinary Tract Infections,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,42029,Urinary Tract Infections,0.21,1,Biomarker
71,ACTG1,actin gamma 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
1645,AKR1C1,"aldo-keto reductase family 1, member C1",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
1646,AKR1C2,"aldo-keto reductase family 1, member C2",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
8644,AKR1C3,"aldo-keto reductase family 1, member C3",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,3,Biomarker
847,CAT,catalase,0.0,0.0,0.0,0.0,1.0,7621,"Cell Transformation, Neoplastic",0.21,3,Therapeutic
6362,CCL18,chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated),0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,1.0,7621,"Cell Transformation, Neoplastic",0.21,2,"Biomarker, Therapeutic"
947,CD34,CD34 molecule,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
1501,CTNND2,"catenin (cadherin-associated protein), delta 2",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
7852,CXCR4,chemokine (C-X-C motif) receptor 4,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
1879,EBF1,early B-cell factor 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,2,Biomarker
2026,ENO2,"enolase 2 (gamma, neuronal)",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
2034,EPAS1,endothelial PAS domain protein 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3150,HMGN1,high mobility group nucleosome binding domain 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,2,Biomarker
3476,IGBP1,immunoglobulin (CD79A) binding protein 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3575,IL7R,interleukin 7 receptor,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3667,IRS1,insulin receptor substrate 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3861,KRT14,"keratin 14, type I",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3866,KRT15,"keratin 15, type I",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3880,KRT19,"keratin 19, type I",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3852,KRT5,"keratin 5, type II",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3958,LGALS3,"lectin, galactoside-binding, soluble, 3",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
79727,LIN28A,lin-28 homolog A (C. elegans),0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
389421,LIN28B,lin-28 homolog B (C. elegans),0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
5599,MAPK8,mitogen-activated protein kinase 8,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
406899,MIR106A,microRNA 106a,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
100302142,MIR1246,microRNA 1246,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
100302123,MIR1275,microRNA 1275,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
100302258,MIR1469,microRNA 1469,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
406938,MIR146A,microRNA 146a,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
406949,MIR15B,microRNA 15b,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
406961,MIR185,microRNA 185,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
406965,MIR190A,microRNA 190a,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
406966,MIR191,microRNA 191,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
100302129,MIR1915,microRNA 1915,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
406984,MIR200B,microRNA 200b,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
406988,MIR205,microRNA 205,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
407006,MIR221,microRNA 221,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
407014,MIR25,microRNA 25,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
407021,MIR29A,microRNA 29a,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
407033,MIR30D,microRNA 30d,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
407037,MIR320A,microRNA 320a,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
407041,MIR34B,microRNA 34b,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
407042,MIR34C,microRNA 34c,0.0,0.0,0.0,0.0,1.0,7621,"Cell Transformation, Neoplastic",0.21,1,Therapeutic
100126317,MIR374B,microRNA 374b,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
693223,MIR638,microRNA 638,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
100126314,MIR877,microRNA 877,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
693235,MIR92B,microRNA 92b,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
407056,MIR99B,microRNA 99b,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,3,Biomarker
4582,MUC1,"mucin 1, cell surface associated",0.0,0.0,0.0,0.0,1.0,7621,"Cell Transformation, Neoplastic",0.21,1,Therapeutic
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
4613,MYCN,v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
4615,MYD88,myeloid differentiation primary response 88,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
653361,NCF1,neutrophil cytosolic factor 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
4790,NFKB1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,0.0,0.0,0.0,0.0,1.0,7621,"Cell Transformation, Neoplastic",0.21,1,Therapeutic
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3084,NRG1,neuregulin 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
26227,PHGDH,phosphoglycerate dehydrogenase,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
23239,PHLPP1,PH domain and leucine rich repeat protein phosphatase 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
5292,PIM1,"Pim-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
5447,POR,P450 (cytochrome) oxidoreductase,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
5879,RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
6566,SLC16A1,"solute carrier family 16 (monocarboxylate transporter), member 1",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
30061,SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,0.0,0.0,0.0,1.0,7621,"Cell Transformation, Neoplastic",0.21,1,Therapeutic
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,0.0,0.0,0.0,1.0,7621,"Cell Transformation, Neoplastic",0.21,2,Therapeutic
6667,SP1,Sp1 transcription factor,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
3195,TLX1,T-cell leukemia homeobox 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
7128,TNFAIP3,"tumor necrosis factor, alpha-induced protein 3",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
8626,TP63,tumor protein p63,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
8848,TSC22D1,"TSC22 domain family, member 1",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
7468,WHSC1,Wolf-Hirschhorn syndrome candidate 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
7474,WNT5A,"wingless-type MMTV integration site family, member 5A",0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
6935,ZEB1,zinc finger E-box binding homeobox 1,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
9839,ZEB2,zinc finger E-box binding homeobox 2,0.0,1.0,0.0,0.0,0.0,7621,"Cell Transformation, Neoplastic",0.21,1,Biomarker
100271718,AD16,Alzheimer disease 16,0.0,1.0,0.0,0.0,0.0,2677888,Alzheimer Disease 16,0.21,0,Biomarker
387082,SUMO4,small ubiquitin-like modifier 4,0.0,1.0,0.0,0.0,0.0,1838260,"Diabetes Mellitus, Insulin-Dependent, 5",0.21,0,Biomarker
216,ALDH1A1,"aldehyde dehydrogenase 1 family, member A1",0.0,1.0,0.0,0.0,0.0,242422,Parkinsonian Disorders,0.21,1,Biomarker
8854,ALDH1A2,"aldehyde dehydrogenase 1 family, member A2",0.0,1.0,0.0,0.0,0.0,242422,Parkinsonian Disorders,0.21,1,Biomarker
1639,DCTN1,dynactin 1,0.0,1.0,0.0,0.0,0.0,242422,Parkinsonian Disorders,0.21,1,Biomarker
1644,DDC,dopa decarboxylase (aromatic L-amino acid decarboxylase),0.0,0.0,0.0,0.0,1.0,242422,Parkinsonian Disorders,0.21,1,Therapeutic
2936,GSR,glutathione reductase,0.0,0.0,0.0,0.0,1.0,242422,Parkinsonian Disorders,0.21,1,Therapeutic
4803,NGF,nerve growth factor (beta polypeptide),0.0,0.0,0.0,0.0,1.0,242422,Parkinsonian Disorders,0.21,1,Therapeutic
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,242422,Parkinsonian Disorders,0.21,1,Biomarker
5580,PRKCD,"protein kinase C, delta",0.0,0.0,0.0,0.0,1.0,242422,Parkinsonian Disorders,0.21,1,Therapeutic
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,242422,Parkinsonian Disorders,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,37650,Somatoform Disorders,0.21,1,Biomarker
5745,PTH1R,parathyroid hormone 1 receptor,0.0,1.0,0.0,0.0,0.0,20502,Hyperparathyroidism,0.21,1,Biomarker
3972,LHB,luteinizing hormone beta polypeptide,0.0,0.0,1.0,0.0,0.0,1416842,"LUTEINIZING HORMONE, BETA POLYPEPTIDE",0.21,1,GeneticVariation
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,0.0,0.0,0.0,1845069,Albinism ocular late onset sensorineural deafness,0.21,0,Biomarker
4941,OASD,ocular albinism and sensorineural deafness,0.0,1.0,0.0,0.0,0.0,1845069,Albinism ocular late onset sensorineural deafness,0.21,0,Biomarker
7299,TYR,tyrosinase,0.0,1.0,0.0,0.0,0.0,1845069,Albinism ocular late onset sensorineural deafness,0.21,0,Biomarker
27259,HPLH1,hemophagocytic lymphohistiocytosis 1,0.0,1.0,0.0,0.0,0.0,24291,"Lymphohistiocytosis, Hemophagocytic",0.21,0,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
51742,ARID4B,AT rich interactive domain 4B (RBP1-like),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
84159,ARID5B,AT rich interactive domain 5B (MRF1-like),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
259266,ASPM,"asp (abnormal spindle) homolog, microcephaly associated (Drosophila)",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
472,ATM,ATM serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
53335,BCL11A,B-cell CLL/lymphoma 11A (zinc finger protein),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
54880,BCOR,BCL6 corepressor,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
63035,BCORL1,BCL6 corepressor-like 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
23774,BRD1,bromodomain containing 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
55783,CMTR2,cap methyltransferase 2,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
27255,CNTN6,contactin 6,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
1387,CREBBP,CREB binding protein,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
51514,DTL,denticleless E3 ubiquitin protein ligase homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
23220,DTX4,"deltex 4, E3 ubiquitin ligase",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
80303,EFHD1,"EF-hand domain family, member D1",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2019,EN1,engrailed homeobox 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2033,EP300,E1A binding protein p300,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
55914,ERBB2IP,erbb2 interacting protein,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
9700,ESPL1,extra spindle pole bodies homolog 1 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2175,FANCA,"Fanconi anemia, complementation group A",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2195,FAT1,FAT atypical cadherin 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
55294,FBXW7,"F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
8823,FGF16,fibroblast growth factor 16,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2264,FGFR4,fibroblast growth factor receptor 4,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2309,FOXO3,forkhead box O3,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
93986,FOXP2,forkhead box P2,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2620,GAS2,growth arrest-specific 2,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2621,GAS6,growth arrest-specific 6,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
51659,GINS2,GINS complex subunit 2 (Psf2 homolog),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2982,GUCY1A3,"guanylate cyclase 1, soluble, alpha 3",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
3008,HIST1H1E,"histone cluster 1, H1e",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
8332,HIST1H2AL,"histone cluster 1, H2al",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
9454,HOMER3,homer homolog 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
3485,IGFBP2,"insulin-like growth factor binding protein 2, 36kDa",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
54756,IL17RD,interleukin 17 receptor D,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
3645,INSRR,insulin receptor-related receptor,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
50805,IRX4,iroquois homeobox 4,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
51477,ISYNA1,inositol-3-phosphate synthase 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
3691,ITGB4,"integrin, beta 4",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
182,JAG1,jagged 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
221037,JMJD1C,jumonji domain containing 1C,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
284058,KANSL1,KAT8 regulatory NSL complex subunit 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
7994,KAT6A,K(lysine) acetyltransferase 6A,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
7403,KDM6A,lysine (K)-specific demethylase 6A,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
23135,KDM6B,lysine (K)-specific demethylase 6B,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
58508,KMT2C,lysine (K)-specific methyltransferase 2C,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
3866,KRT15,"keratin 15, type I",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
3852,KRT5,"keratin 5, type II",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
9223,MAGI1,"membrane associated guanylate kinase, WW and PDZ domain containing 1",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
9863,MAGI2,"membrane associated guanylate kinase, WW and PDZ domain containing 2",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
55534,MAML3,mastermind-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
5605,MAP2K2,mitogen-activated protein kinase kinase 2,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
4082,MARCKS,myristoylated alanine-rich protein kinase C substrate,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2011,MARK2,MAP/microtubule affinity-regulating kinase 2,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
23269,MGA,"MGA, MAX dimerization protein",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
54531,MIER2,"mesoderm induction early response 1, family member 2",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
23209,MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
10933,MORF4L1,mortality factor 4 like 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
26292,MYCBP,MYC binding protein,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
4613,MYCN,v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
81831,NETO2,neuropilin (NRP) and tolloid (TLL)-like 2,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
64324,NSD1,nuclear receptor binding SET domain protein 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
27344,PCSK1N,proprotein convertase subtilisin/kexin type 1 inhibitor,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
5174,PDZK1,PDZ domain containing 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
5591,PRKDC,"protein kinase, DNA-activated, catalytic polypeptide",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
5834,PYGB,"phosphorylase, glycogen; brain",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
23543,RBFOX2,"RNA binding protein, fox-1 homolog (C. elegans) 2",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
5176,SERPINF1,"serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
29072,SETD2,SET domain containing 2,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
57419,SLC24A3,"solute carrier family 24 (sodium/potassium/calcium exchanger), member 3",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
6595,SMARCA2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
6605,SMARCE1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
8243,SMC1A,structural maintenance of chromosomes 1A,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
6651,SON,SON DNA binding protein,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
6664,SOX11,SRY (sex determining region Y)-box 11,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
10847,SRCAP,Snf2-related CREBBP activator protein,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
6484,ST3GAL4,"ST3 beta-galactoside alpha-2,3-sialyltransferase 4",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
54441,STAG3L1,stromal antigen 3-like 1 (pseudogene),0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
9874,TLK1,tousled-like kinase 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
7153,TOP2A,topoisomerase (DNA) II alpha 170kDa,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
29128,UHRF1,ubiquitin-like with PHD and ring finger domains 1,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
1462,VCAN,versican,0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
81029,WNT5B,"wingless-type MMTV integration site family, member 5B",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
653220,XAGE1B,"X antigen family, member 1B",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
23619,ZIM2,"zinc finger, imprinted 2",0.0,1.0,0.0,0.0,0.0,10606,"Carcinoma, Adenoid Cystic",0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,221263,Cafe-au-Lait Spots,0.21,2,Biomarker
5395,PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,221263,Cafe-au-Lait Spots,0.21,1,Biomarker
107,ADCY1,adenylate cyclase 1 (brain),0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
9774,BCLAF1,BCL2-associated transcription factor 1,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
9425,CDYL,"chromodomain protein, Y-like",0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
26047,CNTNAP2,contactin associated protein-like 2,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
169044,COL22A1,"collagen, type XXII, alpha 1",0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
1284,COL4A2,"collagen, type IV, alpha 2",0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
1387,CREBBP,CREB binding protein,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,149925,Small Cell Lung Carcinoma,0.21,1,Therapeutic
22982,DIP2C,DIP2 disco-interacting protein 2 homolog C (Drosophila),0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
2033,EP300,E1A binding protein p300,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
2045,EPHA7,EPH receptor A7,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
2899,GRIK3,"glutamate receptor, ionotropic, kainate 3",0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
2918,GRM8,"glutamate receptor, metabotropic 8",0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
8570,KHSRP,KH-type splicing regulatory protein,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
55605,KIF21A,kinesin family member 21A,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
201229,LYRM9,LYR motif containing 9,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
57088,PLSCR4,phospholipid scramblase 4,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
11228,RASSF8,Ras association (RalGDS/AF-6) domain family (N-terminal) member 8,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
9699,RIMS2,regulating synaptic membrane exocytosis 2,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
862,RUNX1T1,"runt-related transcription factor 1; translocated to, 1 (cyclin D-related)",0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
23314,SATB2,SATB homeobox 2,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
9353,SLIT2,slit homolog 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
121256,TMEM132D,transmembrane protein 132D,0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
57683,ZDBF2,"zinc finger, DBF-type containing 2",0.0,1.0,0.0,0.0,0.0,149925,Small Cell Lung Carcinoma,0.21,1,Biomarker
1134,CHRNA1,"cholinergic receptor, nicotinic, alpha 1 (muscle)",0.0,1.0,0.0,0.0,0.0,2931107,"Myasthenic syndrome, congenital, postsynaptic slow-channel",0.21,0,Biomarker
1140,CHRNB1,"cholinergic receptor, nicotinic, beta 1 (muscle)",0.0,1.0,0.0,0.0,0.0,2931107,"Myasthenic syndrome, congenital, postsynaptic slow-channel",0.21,0,Biomarker
1144,CHRND,"cholinergic receptor, nicotinic, delta (muscle)",0.0,1.0,0.0,0.0,0.0,2931107,"Myasthenic syndrome, congenital, postsynaptic slow-channel",0.21,0,Biomarker
1145,CHRNE,"cholinergic receptor, nicotinic, epsilon (muscle)",0.0,1.0,0.0,0.0,0.0,2931107,"Myasthenic syndrome, congenital, postsynaptic slow-channel",0.21,0,Biomarker
332,BIRC5,baculoviral IAP repeat containing 5,0.0,0.0,0.0,0.0,1.0,23462,"Leukemia, Megakaryoblastic, Acute",0.21,1,Therapeutic
8496,PPFIBP1,"PTPRF interacting protein, binding protein 1 (liprin beta 1)",0.0,1.0,0.0,0.0,0.0,85269,"Plasma Cell Granuloma, Pulmonary",0.21,1,Biomarker
4538,ND4,"NADH dehydrogenase, subunit 4 (complex I)",0.0,1.0,0.0,0.0,0.0,29125,"Optic Atrophies, Hereditary",0.21,2,Biomarker
4541,ND6,"NADH dehydrogenase, subunit 6 (complex I)",0.0,1.0,0.0,0.0,0.0,29125,"Optic Atrophies, Hereditary",0.21,1,Biomarker
1557,CYP2C19,"cytochrome P450, family 2, subfamily C, polypeptide 19",0.0,1.0,0.0,0.0,0.0,1836023,"Drug Metabolism, Poor, CYP2C19-Related",0.21,0,Biomarker
867,CBL,"Cbl proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,10417,Cryptorchidism,0.21,1,Biomarker
1131,CHRM3,"cholinergic receptor, muscarinic 3",0.0,1.0,0.0,0.0,0.0,10417,Cryptorchidism,0.21,1,Biomarker
4567,TRNL1,tRNA,0.0,1.0,0.0,0.0,0.0,342289,Noninsulin-dependent diabetes mellitus with deafness,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,149649,"Embolism, Cholesterol",0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,149649,"Embolism, Cholesterol",0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,42170,Uveomeningoencephalitic Syndrome,0.21,4,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,7789,Cerebral Palsy,0.21,1,Therapeutic
18,ABAT,4-aminobutyrate aminotransferase,0.0,1.0,0.0,0.0,0.0,23380,Lethargy,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,23380,Lethargy,0.21,1,Biomarker
5550,PREP,prolyl endopeptidase,0.0,1.0,0.0,0.0,0.0,2624,"Amnesia, Retrograde",0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,3838,Arterial Occlusive Diseases,0.21,1,Therapeutic
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,3838,Arterial Occlusive Diseases,0.21,4,Therapeutic
80149,ZC3H12A,zinc finger CCCH-type containing 12A,0.0,1.0,0.0,0.0,0.0,3838,Arterial Occlusive Diseases,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,25290,"Meningitis, Aseptic",0.21,3,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,25290,"Meningitis, Aseptic",0.21,1,Biomarker
10232,MSLN,mesothelin,0.0,1.0,0.0,0.0,0.0,206687,"Carcinoma, Endometrioid",0.21,1,Biomarker
378888,HSN1B,"Hereditary sensory neuropathy, type IB",0.0,1.0,0.0,0.0,0.0,1842586,"Neuropathy, Hereditary Sensory And Autonomic, Type I, With Cough And Gastroesophageal Reflux",0.21,0,Biomarker
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,1.0,0.0,0.0,0.0,949658,"Cardiomyopathy, Hypertrophic, Familial",0.21,1,Biomarker
1475,CSTA,cystatin A (stefin A),0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.21,1,Biomarker
1476,CSTB,cystatin B (stefin B),0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.21,1,Biomarker
1501,CTNND2,"catenin (cadherin-associated protein), delta 2",0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.21,1,Biomarker
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.21,1,Biomarker
8216,LZTR1,leucine-zipper-like transcription regulator 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.21,1,Biomarker
9611,NCOR1,nuclear receptor corepressor 1,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.21,1,Biomarker
4854,NOTCH3,notch 3,0.0,1.0,0.0,0.0,0.0,17636,Glioblastoma,0.21,1,Biomarker
653361,NCF1,neutrophil cytosolic factor 1,0.0,1.0,0.0,0.0,0.0,7766,Intracranial Aneurysm,0.21,1,Biomarker
1680,DFNX3,"deafness, X-linked 3",0.0,1.0,0.0,0.0,0.0,1848294,"Deafness, X-Linked 3",0.21,0,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,23896,"Liver Diseases, Alcoholic",0.21,1,Biomarker
3069,HDLBP,high density lipoprotein binding protein,0.0,1.0,0.0,0.0,0.0,27671,Neoplastic Processes,0.21,1,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,27671,Neoplastic Processes,0.21,1,Biomarker
4976,OPA1,optic atrophy 1 (autosomal dominant),0.0,0.0,1.0,0.0,0.0,3276549,"OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY",0.21,0,GeneticVariation
100188397,HLP,hyperkeratosis lenticularis perstans,0.0,1.0,0.0,0.0,0.0,263420,Hyperkeratosis lenticularis perstans,0.21,0,Biomarker
246319,VAMAS6,Vitiligo,0.0,1.0,0.0,0.0,0.0,3277701,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6,0.21,0,Biomarker
34,ACADM,"acyl-CoA dehydrogenase, C-4 to C-12 straight chain",0.0,1.0,0.0,0.0,0.0,85605,Liver Failure,0.21,1,Biomarker
5004,ORM1,orosomucoid 1,0.0,0.0,0.0,0.0,1.0,85605,Liver Failure,0.21,1,Therapeutic
7422,VEGFA,vascular endothelial growth factor A,0.0,0.0,0.0,0.0,1.0,85605,Liver Failure,0.21,1,Therapeutic
59081,MNG2,multinodular goiter 2,0.0,1.0,0.0,0.0,0.0,1846033,"Goiter, Multinodular 2",0.21,0,Biomarker
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,920269,Microsatellite Instability,0.21,1,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,0.0,0.0,0.0,920269,Microsatellite Instability,0.21,1,Biomarker
100188829,MTBS2,"Mycobacterium tuberculosis, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,1970235,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2",0.21,0,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,1275808,Congenital central hypoventilation syndrome,0.21,1,Biomarker
6391,SDHC,"succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa",0.0,1.0,0.0,0.0,0.0,1847319,Carney-Stratakis Syndrome,0.21,0,Biomarker
1697,DFNB5,"deafness, autosomal recessive 5",0.0,1.0,0.0,0.0,0.0,1833319,"Deafness, Autosomal Recessive 5",0.21,0,Biomarker
3293,HSD17B3,hydroxysteroid (17-beta) dehydrogenase 3,0.0,1.0,0.0,0.0,0.0,36875,Disorders of Sex Development,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,5967,Bone Neoplasms,0.21,1,Biomarker
5352,PLOD2,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2",0.0,1.0,0.0,0.0,0.0,5967,Bone Neoplasms,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,5967,Bone Neoplasms,0.21,1,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,0.0,0.0,0.0,1.0,5967,Bone Neoplasms,0.21,1,Therapeutic
79179,FHII,"Hyperaldosteronism, familial, type II",0.0,1.0,0.0,0.0,0.0,1854107,"Hyperaldosteronism, Familial, Type II",0.21,0,Biomarker
7063,THM,thymoma,0.0,1.0,0.0,0.0,0.0,1848814,"Thymoma, Familial",0.21,0,Biomarker
55687,TRMU,tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase,0.0,1.0,0.0,0.0,0.0,1838854,"Deafness, Aminoglycoside-Induced",0.21,0,Biomarker
2316,FLNA,"filamin A, alpha",0.0,1.0,0.0,0.0,0.0,2746068,Congenital idiopathic intestinal pseudoobstruction,0.21,0,Biomarker
8268,IPOX,"Intestinal pseudoobstruction, neuronal, primary idiopathic",0.0,1.0,0.0,0.0,0.0,2746068,Congenital idiopathic intestinal pseudoobstruction,0.21,0,Biomarker
317669,IBD9,inflammatory bowel disease 9,0.0,1.0,0.0,0.0,0.0,1838019,Inflammatory Bowel Disease 9,0.21,0,Biomarker
1706,DFNB14,"deafness, autosomal recessive 14",0.0,1.0,0.0,0.0,0.0,1863613,"Deafness, Autosomal Recessive 14",0.21,0,Biomarker
58156,OPA4,optic atrophy 4 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1854430,Optic Atrophy 4,0.21,0,Biomarker
23400,ATP13A2,ATPase type 13A2,0.0,1.0,0.0,0.0,0.0,30569,"Parkinson Disease, Secondary",0.21,1,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,0.0,0.0,0.0,1.0,30569,"Parkinson Disease, Secondary",0.21,1,Therapeutic
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,30569,"Parkinson Disease, Secondary",0.21,1,Biomarker
5997,RGS2,regulator of G-protein signaling 2,0.0,1.0,0.0,0.0,0.0,30569,"Parkinson Disease, Secondary",0.21,1,Biomarker
6469,SHH,sonic hedgehog,0.0,0.0,0.0,0.0,1.0,30569,"Parkinson Disease, Secondary",0.21,1,Therapeutic
23400,ATP13A2,ATPase type 13A2,0.0,1.0,0.0,0.0,0.0,677050,Manganese Poisoning,0.21,1,Biomarker
664,BNIP3,BCL2/adenovirus E1B 19kDa interacting protein 3,0.0,1.0,0.0,0.0,0.0,677050,Manganese Poisoning,0.21,1,Biomarker
3064,HTT,huntingtin,0.0,0.0,0.0,0.0,1.0,677050,Manganese Poisoning,0.21,1,Therapeutic
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,677050,Manganese Poisoning,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,677050,Manganese Poisoning,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,677050,Manganese Poisoning,0.21,2,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,0.0,0.0,0.0,1.0,677050,Manganese Poisoning,0.21,1,Therapeutic
1317,SLC31A1,"solute carrier family 31 (copper transporter), member 1",0.0,1.0,0.0,0.0,0.0,677050,Manganese Poisoning,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,677050,Manganese Poisoning,0.21,1,Biomarker
100380873,FECD3,"Corneal dystrophy, Fuchs endothelial, 3",0.0,1.0,0.0,0.0,0.0,2750451,"Corneal Dystrophy, Fuchs Endothelial, 3",0.21,0,Biomarker
10000,AKT3,v-akt murine thymoma viral oncogene homolog 3,0.0,1.0,0.0,0.0,0.0,1863924,Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,26826,Muscle Hypertonia,0.21,1,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,0.0,0.0,0.0,1847530,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2",0.21,1,Biomarker
171511,ADIPQTL2,Circulating adiponectin QTL on chromosome 5,0.0,1.0,0.0,0.0,0.0,1847530,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2",0.21,1,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,20473,Hyperlipidemias,0.21,1,Biomarker
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,20473,Hyperlipidemias,0.21,1,Therapeutic
3667,IRS1,insulin receptor substrate 1,0.0,1.0,0.0,0.0,0.0,20473,Hyperlipidemias,0.21,1,Biomarker
4010,LMX1B,"LIM homeobox transcription factor 1, beta",0.0,1.0,0.0,0.0,0.0,20473,Hyperlipidemias,0.21,1,Biomarker
79661,NEIL1,nei endonuclease VIII-like 1 (E. coli),0.0,1.0,0.0,0.0,0.0,20473,Hyperlipidemias,0.21,1,Biomarker
133522,PPARGC1B,"peroxisome proliferator-activated receptor gamma, coactivator 1 beta",0.0,1.0,0.0,0.0,0.0,20473,Hyperlipidemias,0.21,1,Biomarker
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),0.0,0.0,0.0,0.0,1.0,28840,Ocular Hypertension,0.21,1,Therapeutic
399565,GLC3C,"glaucoma 3, primary congenital, C",0.0,1.0,0.0,0.0,0.0,1428921,"GLAUCOMA 3, PRIMARY CONGENITAL, C",0.21,0,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,7177,Cardiac Tamponade,0.21,1,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,9405,"Colorectal Neoplasms, Hereditary Nonpolyposis",0.21,1,Biomarker
27030,MLH3,mutL homolog 3,0.0,1.0,0.0,0.0,0.0,9405,"Colorectal Neoplasms, Hereditary Nonpolyposis",0.21,1,Biomarker
780912,AD10,Alzheimer disease-10,0.0,1.0,0.0,0.0,0.0,1864828,Alzheimer Disease 10,0.21,0,Biomarker
477,ATP1A2,"ATPase, Na+/K+ transporting, alpha 2 polypeptide",0.0,0.0,1.0,0.0,0.0,3549447,ALTERNATING HEMIPLEGIA OF CHILDHOOD 1,0.21,0,GeneticVariation
100190932,CMM7,"Melanoma, cutaneous malignant, susceptibility to, 7",0.0,1.0,0.0,0.0,0.0,2677089,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7",0.21,0,Biomarker
94003,PDB4,Paget disease of bone 4,0.0,1.0,0.0,0.0,0.0,29401,Osteitis Deformans,0.21,0,Biomarker
80870,DKBI,"Dyskeratosis, hereditary benign intraepithelial",0.0,1.0,0.0,0.0,0.0,265966,"Dyskeratosis, Hereditary Benign Intraepithelial",0.21,0,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
816,CAMK2B,calcium/calmodulin-dependent protein kinase II beta,0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
2912,GRM2,"glutamate receptor, metabotropic 2",0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
3362,HTR6,"5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled",0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
4886,NPY1R,neuropeptide Y receptor Y1,0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
9463,PICK1,protein interacting with PRKCA 1,0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
8787,RGS9,regulator of G-protein signaling 9,0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,33941,"Psychoses, Substance-Induced",0.21,1,Biomarker
56894,AGPAT3,1-acylglycerol-3-phosphate O-acyltransferase 3,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
347,APOD,apolipoprotein D,0.0,0.0,0.0,0.0,1.0,524851,Neurodegenerative Diseases,0.21,1,Therapeutic
2495,FTH1,"ferritin, heavy polypeptide 1",0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
2878,GPX3,glutathione peroxidase 3 (plasma),0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
2936,GSR,glutathione reductase,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
2946,GSTM2,glutathione S-transferase mu 2 (muscle),0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
2948,GSTM4,glutathione S-transferase mu 4,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
2949,GSTM5,glutathione S-transferase mu 5,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
3620,IDO1,"indoleamine 2,3-dioxygenase 1",0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
9118,INA,"internexin neuronal intermediate filament protein, alpha",0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
8942,KYNU,kynureninase,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
4257,MGST1,microsomal glutathione S-transferase 1,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,0.0,0.0,0.0,1.0,524851,Neurodegenerative Diseases,0.21,1,Therapeutic
4804,NGFR,nerve growth factor receptor,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
8622,PDE8B,phosphodiesterase 8B,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
5311,PKD2,polycystic kidney disease 2 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
5413,5-Sep,septin 5,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
6709,SPTAN1,"spectrin, alpha, non-erythrocytic 1",0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,524851,Neurodegenerative Diseases,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,206732,"Hemangioendothelioma, Epithelioid",0.21,1,Therapeutic
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,29445,Osteonecrosis,0.21,1,Biomarker
81858,SHARPIN,SHANK-associated RH domain interactor,0.0,1.0,0.0,0.0,0.0,14457,Eosinophilia,0.21,1,Biomarker
50979,MHW2,Mental health wellness 2,0.0,1.0,0.0,0.0,0.0,1863620,MENTAL HEALTH WELLNESS 2,0.21,0,Biomarker
404684,PHOBS,"Phobia, specific",0.0,1.0,0.0,0.0,0.0,236801,"Phobia, Specific",0.21,0,Biomarker
57465,TBC1D24,"TBC1 domain family, member 24",0.0,0.0,1.0,0.0,0.0,795934,Digitorenocerebral Syndrome,0.21,0,GeneticVariation
100917,VWSM,Van der Woude syndrome modifier,0.0,1.0,0.0,0.0,0.0,1858298,"VAN DER WOUDE SYNDROME 1, MODIFIER OF",0.21,0,Biomarker
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,700345,"Candidiasis, Vulvovaginal",0.21,1,Therapeutic
27247,NFU1,NFU1 iron-sulfur cluster scaffold,0.0,0.0,1.0,0.0,0.0,3276432,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1,0.21,1,GeneticVariation
80767,MMDFS,Multiple mitochondrial dysfunctions syndrome,0.0,1.0,0.0,0.0,0.0,3276432,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1,0.21,0,Biomarker
399564,GLC1H,"glaucoma 1, open angle, H (adult-onset)",0.0,1.0,0.0,0.0,0.0,1969811,"Glaucoma 1, Open Angle, H",0.21,0,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,41955,Ureteral Neoplasms,0.21,1,Biomarker
1081,CGA,"glycoprotein hormones, alpha polypeptide",0.0,0.0,0.0,0.0,1.0,1621,Adrenal Gland Diseases,0.21,1,Therapeutic
1141,CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,20672,Hypothermia,0.21,1,Therapeutic
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
3592,IL12A,interleukin 12A,0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
3593,IL12B,interleukin 12B,0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
7252,TSHB,"thyroid stimulating hormone, beta",0.0,1.0,0.0,0.0,0.0,20672,Hypothermia,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,3862,Arthralgia,0.21,1,Biomarker
8221,OGS2,"Opitz G syndrome, type II",0.0,1.0,0.0,0.0,0.0,1801950,Hypertelorism with esophageal abnormality and hypospadias,0.21,0,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,155862,"Pneumonia, Pneumococcal",0.21,1,Biomarker
1673,DEFB4A,"defensin, beta 4A",0.0,1.0,0.0,0.0,0.0,155862,"Pneumonia, Pneumococcal",0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,155862,"Pneumonia, Pneumococcal",0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,155862,"Pneumonia, Pneumococcal",0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,155862,"Pneumonia, Pneumococcal",0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,36118,"Salmonella Infections, Animal",0.21,1,Biomarker
731,C8A,"complement component 8, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,85396,Neisseriaceae Infections,0.21,1,Biomarker
732,C8B,"complement component 8, beta polypeptide",0.0,1.0,0.0,0.0,0.0,85396,Neisseriaceae Infections,0.21,1,Biomarker
1675,CFD,complement factor D (adipsin),0.0,1.0,0.0,0.0,0.0,85396,Neisseriaceae Infections,0.21,1,Biomarker
5824,PEX19,peroxisomal biogenesis factor 19,0.0,1.0,0.0,0.0,0.0,1832200,Peroxisome biogenesis disorders,0.21,1,Biomarker
641371,ACOT1,acyl-CoA thioesterase 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
51,ACOX1,"acyl-CoA oxidase 1, palmitoyl",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
2180,ACSL1,acyl-CoA synthetase long-chain family member 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,3,Biomarker
9131,AIFM1,"apoptosis-inducing factor, mitochondrion-associated, 1",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
467,ATF3,activating transcription factor 3,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
489,ATP2A3,"ATPase, Ca++ transporting, ubiquitous",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
857,CAV1,"caveolin 1, caveolae protein, 22kDa",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
859,CAV3,caveolin 3,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
6364,CCL20,chemokine (C-C motif) ligand 20,0.0,0.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Therapeutic
968,CD68,CD68 molecule,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
1129,CHRM2,"cholinergic receptor, muscarinic 2",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
4513,COX2,cytochrome c oxidase subunit II,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
1374,CPT1A,carnitine palmitoyltransferase 1A (liver),0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
1375,CPT1B,carnitine palmitoyltransferase 1B (muscle),0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
2101,ESRRA,estrogen-related receptor alpha,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
26291,FGF21,fibroblast growth factor 21,0.0,0.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Therapeutic
2309,FOXO3,forkhead box O3,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
57678,GPAM,"glycerol-3-phosphate acyltransferase, mitochondrial",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
2820,GPD2,glycerol-3-phosphate dehydrogenase 2 (mitochondrial),0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
3098,HK1,hexokinase 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
3375,IAPP,islet amyloid polypeptide,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
3397,ID1,"inhibitor of DNA binding 1, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,3,Biomarker
4217,MAP3K5,mitogen-activated protein kinase kinase kinase 5,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
4240,MFGE8,milk fat globule-EGF factor 8 protein,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
653361,NCF1,neutrophil cytosolic factor 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,2,Biomarker
4535,ND1,"NADH dehydrogenase, subunit 1 (complex I)",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
4760,NEUROD1,neuronal differentiation 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
4825,NKX6-1,NK6 homeobox 1,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,0.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Therapeutic
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
5166,PDK4,"pyruvate dehydrogenase kinase, isozyme 4",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
5213,PFKM,"phosphofructokinase, muscle",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,3,Biomarker
5578,PRKCA,"protein kinase C, alpha",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
6277,S100A6,S100 calcium binding protein A6,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
9294,S1PR2,sphingosine-1-phosphate receptor 2,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
8698,S1PR4,sphingosine-1-phosphate receptor 4,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
53637,S1PR5,sphingosine-1-phosphate receptor 5,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
6548,SLC9A1,"solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
6616,SNAP25,"synaptosomal-associated protein, 25kDa",0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
412,STS,"steroid sulfatase (microsomal), isozyme S",0.0,0.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Therapeutic
7077,TIMP2,TIMP metallopeptidase inhibitor 2,0.0,1.0,0.0,0.0,0.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Biomarker
7533,YWHAH,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta",0.0,0.0,0.0,0.0,1.0,11853,"Diabetes Mellitus, Experimental",0.21,1,Therapeutic
134,ADORA1,adenosine A1 receptor,0.0,0.0,0.0,0.0,1.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Therapeutic
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
467,ATF3,activating transcription factor 3,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
6354,CCL7,chemokine (C-C motif) ligand 7,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
3329,HSPD1,heat shock 60kDa protein 1 (chaperonin),0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
3726,JUNB,jun B proto-oncogene,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,740392,"Infarction, Middle Cerebral Artery",0.21,4,Therapeutic
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,740392,"Infarction, Middle Cerebral Artery",0.21,3,Therapeutic
5337,PLD1,"phospholipase D1, phosphatidylcholine-specific",0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
871,SERPINH1,"serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)",0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
7130,TNFAIP6,"tumor necrosis factor, alpha-induced protein 6",0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,740392,"Infarction, Middle Cerebral Artery",0.21,1,Biomarker
100188328,PNKD2,paroxysmal nonkinesigenic dyskinesia 2,0.0,1.0,0.0,0.0,0.0,1970149,Paroxysmal Nonkinesigenic Dyskinesia 2,0.21,0,Biomarker
379003,DFNB40,"deafness, autosomal recessive 40",0.0,1.0,0.0,0.0,0.0,1842345,"Deafness, Autosomal Recessive 40",0.21,0,Biomarker
15,AANAT,aralkylamine N-acetyltransferase,0.0,1.0,0.0,0.0,0.0,877792,"Sleep Disorders, Circadian Rhythm",0.21,1,Biomarker
25,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
759,CA1,carbonic anhydrase I,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
1028,CDKN1C,"cyclin-dependent kinase inhibitor 1C (p57, Kip2)",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
1938,EEF2,eukaryotic translation elongation factor 2,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
79633,FAT4,FAT atypical cadherin 4,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
2543,GAGE1,G antigen 1,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
51292,GMPR2,guanosine monophosphate reductase 2,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
2886,GRB7,growth factor receptor-bound protein 7,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
59340,HRH4,histamine receptor H4,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
58508,KMT2C,lysine (K)-specific methyltransferase 2C,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
4354,MPP1,"membrane protein, palmitoylated 1, 55kDa",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
8202,NCOA3,nuclear receptor coactivator 3,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
5074,PAWR,"PRKC, apoptosis, WT1, regulator",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
5223,PGAM1,phosphoglycerate mutase 1 (brain),0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
10266,RAMP2,receptor (G protein-coupled) activity modifying protein 2,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
6091,ROBO1,"roundabout, axon guidance receptor, homolog 1 (Drosophila)",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
6599,SMARCC1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1",0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
6847,SYCP1,synaptonemal complex protein 1,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
7170,TPM3,tropomyosin 3,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
7306,TYRP1,tyrosinase-related protein 1,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
143187,VTI1A,vesicle transport through interaction with t-SNAREs 1A,0.0,1.0,0.0,0.0,0.0,1418,Adenocarcinoma,0.21,1,Biomarker
94014,TRICY1,trichilemmal cyst 1,0.0,1.0,0.0,0.0,0.0,1864801,Trichilemmal Cyst 1,0.21,0,Biomarker
197322,ACSF3,acyl-CoA synthetase family member 3,0.0,1.0,0.0,0.0,0.0,268583,Methylmalonic acidemia,0.21,1,Biomarker
1382,CRABP2,cellular retinoic acid binding protein 2,0.0,1.0,0.0,0.0,0.0,268583,Methylmalonic acidemia,0.21,1,Biomarker
54205,CYCS,"cytochrome c, somatic",0.0,1.0,0.0,0.0,0.0,268583,Methylmalonic acidemia,0.21,1,Biomarker
2820,GPD2,glycerol-3-phosphate dehydrogenase 2 (mitochondrial),0.0,1.0,0.0,0.0,0.0,268583,Methylmalonic acidemia,0.21,1,Biomarker
284119,PTRF,polymerase I and transcript release factor,0.0,1.0,0.0,0.0,0.0,268583,Methylmalonic acidemia,0.21,1,Biomarker
55752,11-Sep,septin 11,0.0,1.0,0.0,0.0,0.0,268583,Methylmalonic acidemia,0.21,1,Biomarker
4735,2-Sep,septin 2,0.0,1.0,0.0,0.0,0.0,268583,Methylmalonic acidemia,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,268583,Methylmalonic acidemia,0.21,1,Biomarker
8801,SUCLG2,"succinate-CoA ligase, GDP-forming, beta subunit",0.0,1.0,0.0,0.0,0.0,268583,Methylmalonic acidemia,0.21,1,Biomarker
23719,DFNA30,"deafness, autosomal dominant 30",0.0,1.0,0.0,0.0,0.0,1847972,"Deafness, Autosomal Dominant 30",0.21,0,Biomarker
378426,AIS2,autoimmune susceptibility 2,0.0,1.0,0.0,0.0,0.0,1842113,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2",0.21,0,Biomarker
619496,CMT2H,"Charcot-Marie-Tooth disease, axonal, type 2H",0.0,1.0,0.0,0.0,0.0,1843173,"Charcot-Marie-Tooth disease, Type 2H",0.21,0,Biomarker
100188769,HPCX2,"Prostate cancer, hereditary, X-linked 2",0.0,1.0,0.0,0.0,0.0,2678047,"Prostate Cancer, Hereditary, X-Linked 2",0.21,0,Biomarker
335,APOA1,apolipoprotein A-I,0.0,0.0,0.0,0.0,1.0,11065,Death,0.21,1,Therapeutic
590,BCHE,butyrylcholinesterase,0.0,0.0,0.0,0.0,1.0,11065,Death,0.21,1,Therapeutic
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,206637,"Chondrosarcoma, Mesenchymal",0.21,1,Biomarker
4267,CD99,CD99 molecule,0.0,1.0,0.0,0.0,0.0,206637,"Chondrosarcoma, Mesenchymal",0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,206637,"Chondrosarcoma, Mesenchymal",0.21,1,Biomarker
4288,MKI67,marker of proliferation Ki-67,0.0,1.0,0.0,0.0,0.0,206637,"Chondrosarcoma, Mesenchymal",0.21,1,Biomarker
5156,PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,206637,"Chondrosarcoma, Mesenchymal",0.21,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.21,1,Biomarker
3587,IL10RA,"interleukin 10 receptor, alpha",0.0,0.0,0.0,0.0,1.0,23290,"Leishmaniasis, Visceral",0.21,1,Therapeutic
387582,KAZA1,"Kala-azar (visceral leishmaniasis), susceptibility to",0.0,1.0,0.0,0.0,0.0,23290,"Leishmaniasis, Visceral",0.21,0,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,11071,"Death, Sudden",0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,11071,"Death, Sudden",0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,20557,Hypertriglyceridemia,0.21,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,0.0,0.0,0.0,1.0,20557,Hypertriglyceridemia,0.21,1,Therapeutic
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,20557,Hypertriglyceridemia,0.21,1,Biomarker
64788,LMF1,lipase maturation factor 1,0.0,1.0,0.0,0.0,0.0,20557,Hypertriglyceridemia,0.21,1,Biomarker
3939,LDHA,lactate dehydrogenase A,0.0,1.0,0.0,0.0,0.0,2931743,Lactate dehydrogenase deficiency type A,0.21,0,Biomarker
8989,TRPA1,"transient receptor potential cation channel, subfamily A, member 1",0.0,0.0,1.0,0.0,0.0,3808667,"EPISODIC PAIN SYNDROME, FAMILIAL, 1",0.21,1,GeneticVariation
7962,PBCA,"Pancreatic beta cell, agenesis of",0.0,1.0,0.0,0.0,0.0,1838655,Pancreatic beta cell agenesis with neonatal diabetes mellitus,0.21,0,Biomarker
7399,USH2A,"Usher syndrome 2A (autosomal recessive, mild)",0.0,0.0,1.0,0.0,0.0,3151138,RETINITIS PIGMENTOSA 39,0.21,0,GeneticVariation
94337,MNG3,Multinodular goiter-3,0.0,1.0,0.0,0.0,0.0,1853686,"Goiter, Multinodular 3",0.21,0,Biomarker
1050,CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",0.0,1.0,0.0,0.0,0.0,27666,"Neoplasms, Radiation-Induced",0.21,1,Biomarker
8080,HTNB,hypertension with brachydactyly,0.0,1.0,0.0,0.0,0.0,1862170,Brachydactyly with hypertension,0.21,0,Biomarker
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.21,1,Biomarker
100306937,NBLST4,"Neuroblastoma, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.21,0,Biomarker
100306938,NBLST5,"Neuroblastoma, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.21,0,Biomarker
100306939,NBLST6,"Neuroblastoma, susceptibility to, 6",0.0,1.0,0.0,0.0,0.0,27819,Neuroblastoma,0.21,0,Biomarker
338434,CANDN1,"candidiasis, nail 1 (with ICAM1 deficiency)",0.0,1.0,0.0,0.0,0.0,1843306,"Candidiasis, Familial, 3",0.21,0,Biomarker
717,C2,complement component 2,0.0,1.0,0.0,0.0,0.0,1864205,"Macular Degeneration, Age-Related, 1",0.21,0,Biomarker
629,CFB,complement factor B,0.0,1.0,0.0,0.0,0.0,1864205,"Macular Degeneration, Age-Related, 1",0.21,0,Biomarker
3078,CFHR1,complement factor H-related 1,0.0,1.0,0.0,0.0,0.0,1864205,"Macular Degeneration, Age-Related, 1",0.21,0,Biomarker
10878,CFHR3,complement factor H-related 3,0.0,1.0,0.0,0.0,0.0,1864205,"Macular Degeneration, Age-Related, 1",0.21,0,Biomarker
1524,CX3CR1,chemokine (C-X3-C motif) receptor 1,0.0,1.0,0.0,0.0,0.0,1864205,"Macular Degeneration, Age-Related, 1",0.21,0,Biomarker
59338,PLEKHA1,"pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1",0.0,1.0,0.0,0.0,0.0,1864205,"Macular Degeneration, Age-Related, 1",0.21,0,Biomarker
7098,TLR3,toll-like receptor 3,0.0,1.0,0.0,0.0,0.0,1864205,"Macular Degeneration, Age-Related, 1",0.21,0,Biomarker
8200,GDF5,growth differentiation factor 5,0.0,1.0,0.0,0.0,0.0,1306065,DEVELOPMENTAL DYSPLASIA OF THE HIP 1,0.21,1,Biomarker
1639,DCTN1,dynactin 1,0.0,1.0,0.0,0.0,0.0,525045,Mood Disorders,0.21,1,Biomarker
2743,GLRB,"glycine receptor, beta",0.0,1.0,0.0,0.0,0.0,1835614,Hyperexplexia hereditary,0.21,0,Biomarker
9152,SLC6A5,"solute carrier family 6 (neurotransmitter transporter), member 5",0.0,1.0,0.0,0.0,0.0,1835614,Hyperexplexia hereditary,0.21,0,Biomarker
160728,SLC5A8,"solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8",0.0,1.0,0.0,0.0,0.0,740394,Hyperuricemia,0.21,1,Biomarker
1594,CYP27B1,"cytochrome P450, family 27, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,85655,Polymyositis,0.21,1,Biomarker
2213,FCGR2B,"Fc fragment of IgG, low affinity IIb, receptor (CD32)",0.0,1.0,0.0,0.0,0.0,27947,Neutropenia,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,27947,Neutropenia,0.21,1,Biomarker
84522,JAGN1,jagunal homolog 1 (Drosophila),0.0,1.0,0.0,0.0,0.0,27947,Neutropenia,0.21,2,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,27947,Neutropenia,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,752143,Intracranial Thrombosis,0.21,1,Therapeutic
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,0.0,0.0,0.0,752143,Intracranial Thrombosis,0.21,1,Biomarker
7450,VWF,von Willebrand factor,0.0,1.0,0.0,0.0,0.0,752143,Intracranial Thrombosis,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,559470,Peanut Hypersensitivity,0.21,1,Biomarker
8184,HBN1,"Progressive familial heart block, type I, locus 1",0.0,1.0,0.0,0.0,0.0,1879286,Hereditary bundle branch system defect,0.21,0,Biomarker
1146,CHRNG,"cholinergic receptor, nicotinic, gamma (muscle)",0.0,1.0,0.0,0.0,0.0,3886,Arthrogryposis,0.21,2,Biomarker
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,0.0,0.0,0.0,3886,Arthrogryposis,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,0.0,0.0,0.0,1.0,85628,Stupor,0.21,2,Therapeutic
100302513,DFNB71,"deafness, autosomal recessive 71",0.0,1.0,0.0,0.0,0.0,2748554,"Deafness, Autosomal Recessive 71",0.21,0,Biomarker
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,0.0,0.0,0.0,376628,Chromosome Breakage,0.21,1,Biomarker
2235,FECH,ferrochelatase,0.0,1.0,0.0,0.0,0.0,5395,Bile Duct Diseases,0.21,1,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,0.0,0.0,0.0,1306503,"Hernia, Umbilical",0.21,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,1306503,"Hernia, Umbilical",0.21,1,Biomarker
3159,HMGA1,high mobility group AT-hook 1,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.21,1,Biomarker
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.21,4,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,0.0,0.0,0.0,1.0,20456,Hyperglycemia,0.21,1,Therapeutic
10549,PRDX4,peroxiredoxin 4,0.0,0.0,0.0,0.0,1.0,20456,Hyperglycemia,0.21,1,Therapeutic
6492,SIM1,single-minded family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.21,1,Biomarker
6667,SP1,Sp1 transcription factor,0.0,1.0,0.0,0.0,0.0,20456,Hyperglycemia,0.21,1,Biomarker
5664,PSEN2,presenilin 2,0.0,1.0,0.0,0.0,0.0,3150958,"Cardiomyopathy, Dilated, 1V",0.21,0,Biomarker
23224,SYNE2,"spectrin repeat containing, nuclear envelope 2",0.0,0.0,1.0,0.0,0.0,2751805,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT",0.21,1,GeneticVariation
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
23237,ARC,activity-regulated cytoskeleton-associated protein,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,0.0,0.0,0.0,1.0,26650,Movement Disorders,0.21,1,Therapeutic
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
1812,DRD1,dopamine receptor D1,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
2354,FOSB,FBJ murine osteosarcoma viral oncogene homolog B,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
3084,NRG1,neuregulin 1,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
80746,TSEN2,TSEN2 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
79042,TSEN34,TSEN34 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
283989,TSEN54,TSEN54 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
10911,UTS2,urotensin 2,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
7504,XK,X-linked Kx blood group,0.0,1.0,0.0,0.0,0.0,26650,Movement Disorders,0.21,1,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,0.0,0.0,0.0,1.0,85090,"Lymphoma, AIDS-Related",0.21,2,Therapeutic
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,85090,"Lymphoma, AIDS-Related",0.21,1,Therapeutic
2673,GFPT1,glutamine--fructose-6-phosphate transaminase 1,0.0,0.0,1.0,0.0,0.0,3552335,"MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1",0.21,1,GeneticVariation
7396,USH1E,"Usher syndrome 1E (autosomal recessive, severe)",0.0,1.0,0.0,0.0,0.0,2931209,"Usher syndrome, type 1E",0.21,0,Biomarker
7489,WSN,Waisman syndrome,0.0,1.0,0.0,0.0,0.0,796195,"Parkinsonism, early onset with mental retardation",0.21,0,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,1838568,Sacral defect and anterior sacral meningocele,0.21,1,Biomarker
55738,ARFGAP1,ADP-ribosylation factor GTPase activating protein 1,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
1137,CHRNA4,"cholinergic receptor, nicotinic, alpha 4 (neuronal)",0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
152330,CNTN4,contactin 4,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
3785,KCNQ2,"potassium channel, voltage gated KQT-like subfamily Q, member 2",0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
57582,KCNT1,"potassium channel, sodium activated subfamily T, member 1",0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
4036,LRP2,low density lipoprotein receptor-related protein 2,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
5376,PMP22,peripheral myelin protein 22,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
11284,PNKP,polynucleotide kinase 3'-phosphatase,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,3,Biomarker
8671,SLC4A4,"solute carrier family 4 (sodium bicarbonate cotransporter), member 4",0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
10617,STAMBP,STAM binding protein,0.0,1.0,0.0,0.0,0.0,8073,Developmental Disabilities,0.21,1,Biomarker
46,ACLS,acrocallosal syndrome,0.0,1.0,0.0,0.0,0.0,796147,Acrocallosal Syndrome,0.21,0,Biomarker
2290,FOXG1,forkhead box G1,0.0,1.0,0.0,0.0,0.0,796147,Acrocallosal Syndrome,0.21,1,Biomarker
78989,COLEC11,collectin sub-family member 11,0.0,1.0,0.0,0.0,0.0,796059,Oculopalatoskeletal syndrome,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,42514,"Tachycardia, Ventricular",0.21,1,Therapeutic
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,42514,"Tachycardia, Ventricular",0.21,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,0.0,0.0,0.0,1.0,42514,"Tachycardia, Ventricular",0.21,1,Therapeutic
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,0.0,42514,"Tachycardia, Ventricular",0.21,1,Biomarker
10683,DLL3,delta-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.21,1,Biomarker
23462,HEY1,hes-related family bHLH transcription factor with YRPW motif 1,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.21,1,Biomarker
23493,HEY2,hes-related family bHLH transcription factor with YRPW motif 2,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.21,1,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.21,1,Biomarker
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,4114,Astrocytoma,0.21,1,Biomarker
8205,TAM,"Myeloproliferative syndrome, transient (transient abnormal",0.0,1.0,0.0,0.0,0.0,1834582,"Myeloproliferative Syndrome, Transient",0.21,0,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,2931082,Familial apoceruloplasmin deficiency,0.21,2,Biomarker
30061,SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1",0.0,1.0,0.0,0.0,0.0,2931082,Familial apoceruloplasmin deficiency,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,20625,Hyponatremia,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,20625,Hyponatremia,0.21,3,Biomarker
2303,FOXC2,forkhead box C2,0.0,1.0,0.0,0.0,0.0,151491,Musculoskeletal Abnormalities,0.21,1,Biomarker
5916,RARG,"retinoic acid receptor, gamma",0.0,1.0,0.0,0.0,0.0,151491,Musculoskeletal Abnormalities,0.21,1,Biomarker
6497,SKI,SKI proto-oncogene,0.0,1.0,0.0,0.0,0.0,151491,Musculoskeletal Abnormalities,0.21,1,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,151491,Musculoskeletal Abnormalities,0.21,1,Biomarker
54499,TMCO1,transmembrane and coiled-coil domains 1,0.0,1.0,0.0,0.0,0.0,151491,Musculoskeletal Abnormalities,0.21,1,Biomarker
619478,ATFB2,familial atrial fibrillation 2,0.0,1.0,0.0,0.0,0.0,1837812,"Atrial Fibrillation, Familial, 2",0.21,0,Biomarker
383,ARG1,arginase 1,0.0,1.0,0.0,0.0,0.0,18500,Hair Diseases,0.21,1,Biomarker
440275,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,0.0,1.0,0.0,0.0,0.0,18500,Hair Diseases,0.21,1,Biomarker
8036,SHOC2,soc-2 suppressor of clear homolog (C. elegans),0.0,1.0,0.0,0.0,0.0,18500,Hair Diseases,0.21,1,Biomarker
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),0.0,1.0,0.0,0.0,0.0,85631,Psychomotor Agitation,0.21,1,Biomarker
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,85631,Psychomotor Agitation,0.21,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,0.0,0.0,0.0,1.0,151636,Ventricular Premature Complexes,0.21,1,Therapeutic
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,0.0,0.0,0.0,1.0,43254,"Wounds, Penetrating",0.21,1,Therapeutic
145282,MIPOL1,mirror-image polydactyly 1,0.0,1.0,0.0,0.0,0.0,1851100,Laurin-Sandrow syndrome,0.21,0,Biomarker
1371,CPOX,coproporphyrinogen oxidase,0.0,1.0,0.0,0.0,0.0,162566,Porphyria Cutanea Tarda,0.21,1,Biomarker
7007,TECTA,tectorin alpha,0.0,1.0,0.0,0.0,0.0,1863655,"Deafness, Autosomal Recessive 21",0.21,0,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,20433,Hyperbilirubinemia,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,20433,Hyperbilirubinemia,0.21,1,Biomarker
4618,MYF6,myogenic factor 6 (herculin),0.0,1.0,0.0,0.0,0.0,1834558,"Myopathy, Centronuclear, Autosomal Dominant",0.21,0,Biomarker
3028,HSD17B10,hydroxysteroid (17-beta) dehydrogenase 10,0.0,1.0,0.0,0.0,0.0,796223,"Mental Retardation, X-Linked 17",0.21,0,Biomarker
8289,ARID1A,AT rich interactive domain 1A (SWI-like),0.0,1.0,0.0,0.0,0.0,345905,Intrahepatic cholangiocarcinoma,0.21,1,Biomarker
8314,BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),0.0,1.0,0.0,0.0,0.0,345905,Intrahepatic cholangiocarcinoma,0.21,1,Biomarker
55193,PBRM1,polybromo 1,0.0,1.0,0.0,0.0,0.0,345905,Intrahepatic cholangiocarcinoma,0.21,1,Biomarker
54756,IL17RD,interleukin 17 receptor D,0.0,0.0,1.0,0.0,0.0,3808975,HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA,0.21,1,GeneticVariation
791255,SPDA2,"Spondyloarthropathy, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,1866738,"SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2",0.21,0,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,20224,Polyhydramnios,0.21,1,Biomarker
414058,ACRPV,Acropectorovertebral dysplasia (F syndrome),0.0,1.0,0.0,0.0,0.0,1863307,"Acropectorovertebral Dysplasia, F-Form",0.21,0,Biomarker
3579,CXCR2,chemokine (C-X-C motif) receptor 2,0.0,1.0,0.0,0.0,0.0,24894,Mastitis,0.21,1,Biomarker
10411,RAPGEF3,Rap guanine nucleotide exchange factor (GEF) 3,0.0,1.0,0.0,0.0,0.0,35585,Rickettsia Infections,0.21,1,Biomarker
1028,CDKN1C,"cyclin-dependent kinase inhibitor 1C (p57, Kip2)",0.0,1.0,0.0,0.0,0.0,14173,Endometrial Hyperplasia,0.21,1,Biomarker
1952,CELSR2,"cadherin, EGF LAG seven-pass G-type receptor 2",0.0,1.0,0.0,0.0,0.0,14173,Endometrial Hyperplasia,0.21,1,Biomarker
1465,CSRP1,cysteine and glycine-rich protein 1,0.0,1.0,0.0,0.0,0.0,14173,Endometrial Hyperplasia,0.21,1,Biomarker
1653,DDX1,DEAD (Asp-Glu-Ala-Asp) box helicase 1,0.0,1.0,0.0,0.0,0.0,14173,Endometrial Hyperplasia,0.21,1,Biomarker
30,ACAA1,acetyl-CoA acyltransferase 1,0.0,1.0,0.0,0.0,0.0,342870,Bifunctional peroxisomal enzyme deficiency,0.21,0,Biomarker
374654,KIF7,kinesin family member 7,0.0,0.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.21,0,GeneticVariation
79809,TTC21B,tetratricopeptide repeat domain 21B,0.0,0.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.21,0,GeneticVariation
1129,CHRM2,"cholinergic receptor, muscarinic 2",0.0,0.0,0.0,0.0,1.0,11882,Diabetic Neuropathies,0.21,1,Therapeutic
2915,GRM5,"glutamate receptor, metabotropic 5",0.0,1.0,0.0,0.0,0.0,11882,Diabetic Neuropathies,0.21,1,Biomarker
4311,MME,membrane metallo-endopeptidase,0.0,1.0,0.0,0.0,0.0,11882,Diabetic Neuropathies,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,11882,Diabetic Neuropathies,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,11882,Diabetic Neuropathies,0.21,1,Biomarker
6446,SGK1,serum/glucocorticoid regulated kinase 1,0.0,1.0,0.0,0.0,0.0,11882,Diabetic Neuropathies,0.21,1,Biomarker
201,AIH3,"amelogenesis imperfecta 3, hypomaturation or hypoplastic type",0.0,1.0,0.0,0.0,0.0,1845051,"AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2",0.21,0,Biomarker
7939,LAP,Laryngeal adductor paralysis,0.0,1.0,0.0,0.0,0.0,396060,Laryngeal Adductor Paralysis,0.21,0,Biomarker
5184,PEPD,peptidase D,0.0,1.0,0.0,0.0,0.0,3714514,Infection,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,700501,"Nystagmus, Congenital",0.21,1,Biomarker
51021,MRPS16,mitochondrial ribosomal protein S16,0.0,1.0,0.0,0.0,0.0,1864843,Combined Oxidative Phosphorylation Deficiency 2,0.21,0,Biomarker
2147,F2,coagulation factor II (thrombin),0.0,1.0,0.0,0.0,0.0,162819,"Skin Diseases, Vascular",0.21,1,Biomarker
9131,AIFM1,"apoptosis-inducing factor, mitochondrion-associated, 1",0.0,1.0,0.0,0.0,0.0,35305,Retinal Detachment,0.21,1,Biomarker
317,APAF1,apoptotic peptidase activating factor 1,0.0,1.0,0.0,0.0,0.0,35305,Retinal Detachment,0.21,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,35305,Retinal Detachment,0.21,1,Biomarker
842,CASP9,"caspase 9, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,35305,Retinal Detachment,0.21,1,Biomarker
23418,CRB1,"crumbs family member 1, photoreceptor morphogenesis associated",0.0,1.0,0.0,0.0,0.0,35305,Retinal Detachment,0.21,1,Biomarker
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,35305,Retinal Detachment,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,35305,Retinal Detachment,0.21,2,Biomarker
266678,MRX81,"mental retardation, X-linked 81",0.0,1.0,0.0,0.0,0.0,1845531,"Mental Retardation, X-Linked 81",0.21,0,Biomarker
5621,PRNP,prion protein,0.0,1.0,0.0,0.0,0.0,36457,Scrapie,0.21,4,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,36457,Scrapie,0.21,1,Biomarker
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,0.0,0.0,7124,"Carcinoma, Intraductal, Noninfiltrating",0.21,1,Biomarker
3211,HOXB1,homeobox B1,0.0,1.0,0.0,0.0,0.0,1858717,"Facial paresis, hereditary, congenital",0.21,1,Biomarker
7880,MBS2,Moebius syndrome 2,0.0,1.0,0.0,0.0,0.0,1858717,"Facial paresis, hereditary, congenital",0.21,0,Biomarker
22811,MBS3,Moebius syndrome 3,0.0,1.0,0.0,0.0,0.0,1858717,"Facial paresis, hereditary, congenital",0.21,0,Biomarker
54507,ADAMTSL4,ADAMTS-like 4,0.0,1.0,0.0,0.0,0.0,3541474,"ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE",0.21,0,Biomarker
261,AMCN,"arthrogryposis multiplex congenita, neurogenic",0.0,1.0,0.0,0.0,0.0,1859721,Arthrogryposis multiplex congenita neurogenic type,0.21,0,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,24143,Lupus Nephritis,0.21,1,Biomarker
710,SERPING1,"serpin peptidase inhibitor, clade G (C1 inhibitor), member 1",0.0,1.0,0.0,0.0,0.0,24143,Lupus Nephritis,0.21,1,Biomarker
553991,LGMD1G,limb girdle muscular dystrophy 1G (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1836765,"Limb-Girdle Muscular Dystrophy, Type 1G",0.21,0,Biomarker
53947,A4GALT,"alpha 1,4-galactosyltransferase",0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.21,1,Biomarker
10693,CCT6B,"chaperonin containing TCP1, subunit 6B (zeta 2)",0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.21,1,Biomarker
10841,FTCD,formimidoyltransferase cyclodeaminase,0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.21,1,Biomarker
10672,GNA13,"guanine nucleotide binding protein (G protein), alpha 13",0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.21,1,Biomarker
5091,PC,pyruvate carboxylase,0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.21,1,Biomarker
5295,PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.21,1,Biomarker
5979,RET,ret proto-oncogene,0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.21,1,Biomarker
27164,SALL3,spalt-like transcription factor 3,0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.21,1,Biomarker
6597,SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",0.0,1.0,0.0,0.0,0.0,6413,Burkitt Lymphoma,0.21,1,Biomarker
3939,LDHA,lactate dehydrogenase A,0.0,1.0,0.0,0.0,0.0,27080,Myoglobinuria,0.21,1,Biomarker
1147,CHUK,conserved helix-loop-helix ubiquitous kinase,0.0,1.0,0.0,0.0,0.0,15929,Fetal Diseases,0.21,4,Biomarker
5652,PRSS8,"protease, serine, 8",0.0,1.0,0.0,0.0,0.0,15929,Fetal Diseases,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,0.0,36980,"Shock, Cardiogenic",0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,36980,"Shock, Cardiogenic",0.21,1,Therapeutic
780917,NKCD,"Natural killer cell deficiency, familial isolated",0.0,1.0,0.0,0.0,0.0,1864947,"Natural Killer Cell Deficiency, Familial Isolated",0.21,0,Biomarker
3868,KRT16,"keratin 16, type I",0.0,1.0,0.0,0.0,0.0,1721006,"Keratoderma, Palmoplantar, Epidermolytic",0.21,0,Biomarker
59272,ACE2,angiotensin I converting enzyme 2,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
51554,ACKR4,atypical chemokine receptor 4,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
251,ALPPL2,"alkaline phosphatase, placental-like 2",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
405,ARNT,aryl hydrocarbon receptor nuclear translocator,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
9332,CD163,CD163 molecule,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
8763,CD164,"CD164 molecule, sialomucin",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
10666,CD226,CD226 molecule,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
968,CD68,CD68 molecule,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
969,CD69,CD69 molecule,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
924,CD7,CD7 molecule,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3732,CD82,CD82 molecule,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
8832,CD84,CD84 molecule,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
925,CD8A,CD8a molecule,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
634,CEACAM1,carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein),0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1048,CEACAM5,carcinoembryonic antigen-related cell adhesion molecule 5,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4680,CEACAM6,carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen),0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
27159,CHIA,"chitinase, acidic",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1305,COL13A1,"collagen, type XIII, alpha 1",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1288,COL4A6,"collagen, type IV, alpha 6",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1289,COL5A1,"collagen, type V, alpha 1",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1290,COL5A2,"collagen, type V, alpha 2",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1291,COL6A1,"collagen, type VI, alpha 1",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1293,COL6A3,"collagen, type VI, alpha 3",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1298,COL9A2,"collagen, type IX, alpha 2",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
10321,CRISP3,cysteine-rich secretory protein 3,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
80034,CSRNP3,cysteine-serine-rich nuclear protein 3,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1591,CYP24A1,"cytochrome P450, family 24, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1719,DHFR,dihydrofolate reductase,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
10824,DIAPH2-AS1,DIAPH2 antisense RNA 1,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1893,ECM1,extracellular matrix protein 1,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
1842,ECM2,"extracellular matrix protein 2, female organ and adipocyte specific",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
2012,EMP1,epithelial membrane protein 1,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
26998,FETUB,fetuin B,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
2252,FGF7,fibroblast growth factor 7,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
23767,FLRT3,fibronectin leucine rich transmembrane protein 3,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
2335,FN1,fibronectin 1,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
10468,FST,follistatin,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
2744,GLS,glutaminase,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3026,HABP2,hyaluronan binding protein 2,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3292,HSD17B1,hydroxysteroid (17-beta) dehydrogenase 1,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3430,IFI35,interferon-induced protein 35,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
10561,IFI44,interferon-induced protein 44,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
2537,IFI6,"interferon, alpha-inducible protein 6",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3446,IFNA10,"interferon, alpha 10",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3484,IGFBP1,insulin-like growth factor binding protein 1,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3489,IGFBP6,insulin-like growth factor binding protein 6,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3589,IL11,interleukin 11,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3593,IL12B,interleukin 12B,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3603,IL16,interleukin 16,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
53832,IL20RA,"interleukin 20 receptor, alpha",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
11009,IL24,interleukin 24,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3568,IL5RA,"interleukin 5 receptor, alpha",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3578,IL9,interleukin 9,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3623,INHA,"inhibin, alpha",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3691,ITGB4,"integrin, beta 4",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3694,ITGB6,"integrin, beta 6",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3717,JAK2,Janus kinase 2,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
5655,KLK10,kallikrein-related peptidase 10,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3910,LAMA4,"laminin, alpha 4",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
56891,LGALS14,"lectin, galactoside-binding, soluble, 14",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
3958,LGALS3,"lectin, galactoside-binding, soluble, 3",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4133,MAP2,microtubule-associated protein 2,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
22924,MAPRE3,"microtubule-associated protein, RP/EB family, member 3",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4247,MGAT2,"mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4256,MGP,matrix Gla protein,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4320,MMP11,matrix metallopeptidase 11 (stromelysin 3),0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4321,MMP12,matrix metallopeptidase 12 (macrophage elastase),0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4324,MMP15,matrix metallopeptidase 15 (membrane-inserted),0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4327,MMP19,matrix metallopeptidase 19,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
56547,MMP26,matrix metallopeptidase 26,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4316,MMP7,"matrix metallopeptidase 7 (matrilysin, uterine)",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4585,MUC4,"mucin 4, cell surface associated",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
4684,NCAM1,neural cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
5047,PAEP,progestagen-associated endometrial protein,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
56145,PCDHA3,protocadherin alpha 3,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
5228,PGF,placental growth factor,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
5618,PRLR,prolactin receptor,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
5740,PTGIS,prostaglandin I2 (prostacyclin) synthase,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
23753,SDF2L1,stromal cell-derived factor 2-like 1,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
6317,SERPINB3,"serpin peptidase inhibitor, clade B (ovalbumin), member 3",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
6318,SERPINB4,"serpin peptidase inhibitor, clade B (ovalbumin), member 4",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
10615,SPAG5,sperm associated antigen 5,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
6750,SST,somatostatin,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
7045,TGFBI,"transforming growth factor, beta-induced, 68kDa",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
7046,TGFBR1,"transforming growth factor, beta receptor 1",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
7077,TIMP2,TIMP metallopeptidase inhibitor 2,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
7078,TIMP3,TIMP metallopeptidase inhibitor 3,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
8741,TNFSF13,"tumor necrosis factor (ligand) superfamily, member 13",0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
7143,TNR,tenascin R,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
7185,TRAF1,TNF receptor-associated factor 1,0.0,1.0,0.0,0.0,0.0,786,"Abortion, Spontaneous",0.21,1,Biomarker
93956,AOCH,"Acromegaloid features, overgrowth, cleft palate, and hernia",0.0,1.0,0.0,0.0,0.0,1853757,"Acromegaloid features, overgrowth, cleft palate, and hernia",0.21,0,Biomarker
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",0.0,1.0,0.0,0.0,0.0,20615,Hypoglycemia,0.21,1,Biomarker
2936,GSR,glutathione reductase,0.0,1.0,0.0,0.0,0.0,20615,Hypoglycemia,0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,20615,Hypoglycemia,0.21,1,Biomarker
5265,SERPINA1,"serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1",0.0,1.0,0.0,0.0,0.0,20615,Hypoglycemia,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,20615,Hypoglycemia,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,20615,Hypoglycemia,0.21,1,Biomarker
5105,PCK1,phosphoenolpyruvate carboxykinase 1 (soluble),0.0,1.0,0.0,0.0,0.0,268194,Phosphoenolpyruvate carboxykinase deficiency,0.21,0,Biomarker
100529147,MMRFCGU,"Microcephaly, mental retardation, and distinctive facies, with cardiac and genitourinary malformations",0.0,1.0,0.0,0.0,0.0,3150939,BEAULIEU-BOYCOTT-INNES SYNDROME,0.21,0,Biomarker
335,APOA1,apolipoprotein A-I,0.0,1.0,0.0,0.0,0.0,17665,"Glomerulonephritis, Membranous",0.21,1,Biomarker
2548,GAA,"glucosidase, alpha; acid",0.0,1.0,0.0,0.0,0.0,17665,"Glomerulonephritis, Membranous",0.21,1,Biomarker
374654,KIF7,kinesin family member 7,0.0,1.0,0.0,0.0,0.0,2931104,Hydrolethalus syndrome,0.21,1,Biomarker
170534,PARK10,Parkinson disease 10 (susceptibility),0.0,1.0,0.0,0.0,0.0,1847360,Parkinson Disease 10,0.21,0,Biomarker
100529231,MACST,Macrostomia,0.0,1.0,0.0,0.0,0.0,24433,Macrostomia,0.21,0,Biomarker
8643,PTCH2,patched 2,0.0,1.0,0.0,0.0,0.0,24433,Macrostomia,0.21,0,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,34040,Puerperal Disorders,0.21,1,Biomarker
5080,PAX6,paired box 6,0.0,0.0,1.0,0.0,0.0,3805604,FOVEAL HYPOPLASIA 1,0.21,0,GeneticVariation
353173,ZLS,Zimmerman-Laband Syndrome,0.0,1.0,0.0,0.0,0.0,796013,Zimmerman Laband syndrome,0.21,0,Biomarker
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
1282,COL4A1,"collagen, type IV, alpha 1",0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,2,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
2335,FN1,fibronectin 1,0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
2776,GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
26762,HAVCR1,hepatitis A virus cellular receptor 1,0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
4628,MYH10,"myosin, heavy chain 10, non-muscle",0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
5054,SERPINE1,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,17668,"Glomerulosclerosis, Focal Segmental",0.21,1,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,0.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.21,1,Therapeutic
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.21,2,"Biomarker, Therapeutic"
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
840,CASP7,"caspase 7, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
842,CASP9,"caspase 9, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
1536,CYBB,"cytochrome b-245, beta polypeptide",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
56616,DIABLO,"diablo, IAP-binding mitochondrial protein",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
2697,GJA1,"gap junction protein, alpha 1, 43kDa",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,0.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.21,2,Therapeutic
5601,MAPK9,mitogen-activated protein kinase 9,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406902,MIR10A,microRNA 10a,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406903,MIR10B,microRNA 10b,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406913,MIR126,microRNA 126,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406924,MIR134,microRNA 134,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406928,MIR137,microRNA 137,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406934,MIR142,microRNA 142,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406948,MIR15A,microRNA 15a,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406957,MIR181C,microRNA 181c,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406959,MIR183,microRNA 183,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406962,MIR186,microRNA 186,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406964,MIR188,microRNA 188,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406968,MIR193A,microRNA 193a,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
442920,MIR196B,microRNA 196b,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406974,MIR197,microRNA 197,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406989,MIR206,microRNA 206,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
574032,MIR20B,microRNA 20b,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406991,MIR21,microRNA 21,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
407011,MIR23B,microRNA 23b,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
407018,MIR27A,microRNA 27a,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
407019,MIR27B,microRNA 27b,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
407020,MIR28,microRNA 28,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
407022,MIR296,microRNA 296,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
100126318,MIR301B,microRNA 301b,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
442902,MIR330,microRNA 330,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
442903,MIR331,microRNA 331,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
442904,MIR335,microRNA 335,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
442905,MIR337,microRNA 337,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
442911,MIR346,microRNA 346,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
407042,MIR34C,microRNA 34c,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
494323,MIR361,microRNA 361,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
574030,MIR362,microRNA 362,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
442914,MIR369,microRNA 369,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
494324,MIR375,microRNA 375,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
574435,MIR376B,microRNA 376b,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
693121,MIR411,microRNA 411,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
554210,MIR429,microRNA 429,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
574034,MIR433,microRNA 433,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
574411,MIR451A,microRNA 451a,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
574412,MIR452,microRNA 452,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
574450,MIR493,microRNA 493,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
574506,MIR503,microRNA 503,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
693124,MIR532,microRNA 532,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
664617,MIR542,microRNA 542,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
693167,MIR582,microRNA 582,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
693183,MIR598,microRNA 598,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
100126313,MIR744,microRNA 744,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
768212,MIR758,microRNA 758,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
406891,MIRLET7I,microRNA let-7i,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,0.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.21,1,Therapeutic
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,0.0,0.0,0.0,1.0,27055,Myocardial Reperfusion Injury,0.21,1,Therapeutic
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
331,XIAP,"X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,27055,Myocardial Reperfusion Injury,0.21,1,Biomarker
6792,CDKL5,cyclin-dependent kinase-like 5,0.0,1.0,0.0,0.0,0.0,3463992,"Epileptic Encephalopathy, Early Infantile, 1",0.21,0,Biomarker
348980,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,0.0,1.0,0.0,0.0,0.0,3463992,"Epileptic Encephalopathy, Early Infantile, 1",0.21,1,Biomarker
54822,TRPM7,"transient receptor potential cation channel, subfamily M, member 7",0.0,1.0,0.0,0.0,0.0,543859,AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1,0.21,0,Biomarker
23152,CIC,capicua transcriptional repressor,0.0,1.0,0.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.21,1,Biomarker
2296,FOXC1,forkhead box C1,0.0,1.0,0.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.21,1,Biomarker
2672,GFI1,growth factor independent 1 transcription repressor,0.0,1.0,0.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.21,1,Biomarker
84991,RBM17,RNA binding motif protein 17,0.0,1.0,0.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.21,1,Biomarker
140451,SCA9,spinocerebellar ataxia 9,0.0,1.0,0.0,0.0,0.0,87012,Spinocerebellar Ataxias,0.21,0,Biomarker
58508,KMT2C,lysine (K)-specific methyltransferase 2C,0.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.21,1,Biomarker
5178,PEG3,paternally expressed 3,0.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.21,1,Biomarker
54894,RNF43,ring finger protein 43,0.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.21,1,Biomarker
6092,ROBO2,"roundabout, axon guidance receptor, homolog 2 (Drosophila)",0.0,1.0,0.0,0.0,0.0,206698,Cholangiocarcinoma,0.21,1,Biomarker
920,CD4,CD4 molecule,0.0,1.0,0.0,0.0,0.0,162526,AIDS-Related Opportunistic Infections,0.21,1,Biomarker
6927,HNF1A,HNF1 homeobox A,0.0,1.0,0.0,0.0,0.0,1840646,"Hepatic Adenomas, Familial",0.21,0,Biomarker
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,7222,Cardiovascular Diseases,0.21,1,Biomarker
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,0.0,0.0,0.0,7222,Cardiovascular Diseases,0.21,1,Biomarker
2,A2M,alpha-2-macroglobulin,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
72,ACTG2,"actin, gamma 2, smooth muscle, enteric",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
430,ASCL2,achaete-scute family bHLH transcription factor 2,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
538,ATP7A,"ATPase, Cu++ transporting, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
578,BAK1,BCL2-antagonist/killer 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
781,CACNA2D1,"calcium channel, voltage-dependent, alpha 2/delta subunit 1",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
6364,CCL20,chemokine (C-C motif) ligand 20,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
1158,CKM,"creatine kinase, muscle",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
1410,CRYAB,"crystallin, alpha B",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
1755,DMBT1,deleted in malignant brain tumors 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,2,Biomarker
2535,FZD2,frizzled class receptor 2,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
2596,GAP43,growth associated protein 43,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
2641,GCG,glucagon,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
2949,GSTM5,glutathione S-transferase mu 5,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
2982,GUCY1A3,"guanylate cyclase 1, soluble, alpha 3",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
3158,HMGCS2,3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial),0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
3306,HSPA2,heat shock 70kDa protein 2,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,0.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.21,1,Therapeutic
3484,IGFBP1,insulin-like growth factor binding protein 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
3679,ITGA7,"integrin, alpha 7",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
4023,LPL,lipoprotein lipase,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.21,1,Therapeutic
4129,MAOB,monoamine oxidase B,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
5608,MAP2K6,mitogen-activated protein kinase kinase 6,0.0,0.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.21,1,Therapeutic
2122,MECOM,MDS1 and EVI1 complex locus,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
4224,MEP1A,"meprin A, alpha (PABA peptide hydrolase)",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
4288,MKI67,marker of proliferation Ki-67,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
4321,MMP12,matrix metallopeptidase 12 (macrophage elastase),0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
57447,NDRG2,NDRG family member 2,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,2,Biomarker
4851,NOTCH1,notch 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
50507,NOX4,NADPH oxidase 4,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,0.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.21,1,Therapeutic
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
143,PARP4,"poly (ADP-ribose) polymerase family, member 4",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,2,Biomarker
5121,PCP4,Purkinje cell protein 4,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
23236,PLCB1,"phospholipase C, beta 1 (phosphoinositide-specific)",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
5981,RFC1,"replication factor C (activator 1) 1, 145kDa",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
57381,RHOJ,ras homolog family member J,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
80196,RNF34,"ring finger protein 34, E3 ubiquitin protein ligase",0.0,0.0,0.0,0.0,1.0,9375,Colonic Neoplasms,0.21,1,Therapeutic
6275,S100A4,S100 calcium binding protein A4,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
6280,S100A9,S100 calcium binding protein A9,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
5268,SERPINB5,"serpin peptidase inhibitor, clade B (ovalbumin), member 5",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
29950,SERTAD1,SERTA domain containing 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
30011,SH3KBP1,SH3-domain kinase binding protein 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
6573,SLC19A1,"solute carrier family 19 (folate transporter), member 1",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
6580,SLC22A1,"solute carrier family 22 (organic cation transporter), member 1",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
28234,SLCO1B3,"solute carrier organic anion transporter family, member 1B3",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
6817,SULT1A1,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1",0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
6941,TCF19,transcription factor 19,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
7170,TPM3,tropomyosin 3,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
1890,TYMP,thymidine phosphorylase,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
7490,WT1,Wilms tumor 1,0.0,1.0,0.0,0.0,0.0,9375,Colonic Neoplasms,0.21,1,Biomarker
2672,GFI1,growth factor independent 1 transcription repressor,0.0,1.0,0.0,0.0,0.0,1859966,"Neutropenia, Severe Congenital, Autosomal Dominant 1",0.21,0,Biomarker
2879,GPX4,glutathione peroxidase 4,0.0,1.0,0.0,0.0,0.0,6635,Cadmium Poisoning,0.21,1,Biomarker
3064,HTT,huntingtin,0.0,1.0,0.0,0.0,0.0,6635,Cadmium Poisoning,0.21,1,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,6635,Cadmium Poisoning,0.21,1,Biomarker
100049544,APMR2,Alopecia with mental retardation syndrome 2,0.0,1.0,0.0,0.0,0.0,1835852,Alopecia-Mental Retardation Syndrome 2,0.21,0,Biomarker
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,29227,"Delirium, Dementia, Amnestic, Cognitive Disorders",0.21,1,Therapeutic
619475,PFM3,parietal foramina 3,0.0,1.0,0.0,0.0,0.0,1835980,Parietal Foramina 3,0.21,0,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,3665593,"Nevus, Epidermal",0.21,0,Biomarker
11181,TREH,trehalase (brush-border membrane glycoprotein),0.0,1.0,0.0,0.0,0.0,268187,Trehalase Deficiency,0.21,0,Biomarker
2728,GLC3B,"glaucoma 3, primary infantile, B",0.0,1.0,0.0,0.0,0.0,1832977,"Glaucoma 3, primary infantile, B",0.21,0,Biomarker
7927,IGAT,Immune response to synthetic polypeptide--IRGAT,0.0,1.0,0.0,0.0,0.0,1840267,IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT,0.21,0,Biomarker
100529230,LGMD1H,limb girdle muscular dystrophy 1H (autosomal dominant),0.0,1.0,0.0,0.0,0.0,3150786,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H",0.21,0,Biomarker
8419,BFSP2,"beaded filament structural protein 2, phakinin",0.0,0.0,1.0,0.0,0.0,3808115,"CATARACT 12, MULTIPLE TYPES",0.21,1,GeneticVariation
5621,PRNP,prion protein,0.0,1.0,0.0,0.0,0.0,1847650,Spongiform Encephalopathy with Neuropsychiatric Features,0.21,0,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,26838,Muscle Spasticity,0.21,1,Biomarker
449484,DFNB44,"deafness, autosomal recessive 44",0.0,1.0,0.0,0.0,0.0,1857809,"Deafness, Autosomal Recessive 44",0.21,0,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,37926,Spinal Cord Compression,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,37926,Spinal Cord Compression,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,37926,Spinal Cord Compression,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,39103,Synovitis,0.21,1,Therapeutic
100216344,DYT17,dystonia 17,0.0,1.0,0.0,0.0,0.0,2676281,"Dystonia 17, Torsion, Autosomal Recessive",0.21,0,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,38160,Staphylococcal Infections,0.21,1,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,0.0,0.0,0.0,38160,Staphylococcal Infections,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,34013,"Puberty, Precocious",0.21,1,Biomarker
266979,CTRCT27,"Cataract, congenital, nuclear progressive",0.0,1.0,0.0,0.0,0.0,1846520,"Cataract, Nuclear Progressive",0.21,0,Biomarker
4363,ABCC1,"ATP-binding cassette, sub-family C (CFTR/MRP), member 1",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
1244,ABCC2,"ATP-binding cassette, sub-family C (CFTR/MRP), member 2",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
150,ADRA2A,adrenoceptor alpha 2A,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
328,APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
522,ATP5J,"ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
567,B2M,beta-2-microglobulin,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
8927,BSN,bassoon presynaptic cytomatrix protein,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,18799,Heart Diseases,0.21,1,Therapeutic
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,18799,Heart Diseases,0.21,1,Therapeutic
3032,HADHB,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
3065,HDAC1,histone deacetylase 1,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
8841,HDAC3,histone deacetylase 3,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
4502,MT2A,metallothionein 2A,0.0,0.0,0.0,0.0,1.0,18799,Heart Diseases,0.21,1,Therapeutic
4689,NCF4,"neutrophil cytosolic factor 4, 40kDa",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,0.0,0.0,0.0,1.0,18799,Heart Diseases,0.21,1,Therapeutic
5515,PPP2CA,"protein phosphatase 2, catalytic subunit, alpha isozyme",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
5683,PSMA2,"proteasome (prosome, macropain) subunit, alpha type, 2",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
5739,PTGIR,prostaglandin I2 (prostacyclin) receptor (IP),0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
5880,RAC2,"ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
9294,S1PR2,sphingosine-1-phosphate receptor 2,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
6508,SLC4A3,"solute carrier family 4 (anion exchanger), member 3",0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
6925,TCF4,transcription factor 4,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
7054,TH,tyrosine hydroxylase,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
146862,UNC45B,unc-45 homolog B (C. elegans),0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,18799,Heart Diseases,0.21,1,Biomarker
192,AIC,Aicardi syndrome,0.0,1.0,0.0,0.0,0.0,175713,Aicardi Syndrome,0.21,0,Biomarker
4827,NM,neutrophil migration,0.0,1.0,0.0,0.0,0.0,312860,Neutrophil Chemotactic Response,0.21,0,Biomarker
170507,DFNA52,"deafness, autosomal dominant 52",0.0,1.0,0.0,0.0,0.0,1843232,"Deafness, Autosomal Dominant 52",0.21,0,Biomarker
2664,GDI1,GDP dissociation inhibitor 1,0.0,1.0,0.0,0.0,0.0,796208,"Mental Retardation, X-Linked 3",0.21,0,Biomarker
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,0.0,0.0,0.0,282631,Facies,0.21,1,Biomarker
147372,CCBE1,collagen and calcium binding EGF domains 1,0.0,1.0,0.0,0.0,0.0,282631,Facies,0.21,1,Biomarker
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,0.0,1.0,0.0,0.0,0.0,282631,Facies,0.21,1,Biomarker
2332,FMR1,fragile X mental retardation 1,0.0,1.0,0.0,0.0,0.0,282631,Facies,0.21,1,Biomarker
182,JAG1,jagged 1,0.0,1.0,0.0,0.0,0.0,282631,Facies,0.21,2,Biomarker
282808,RAB40AL,"RAB40A, member RAS oncogene family-like",0.0,1.0,0.0,0.0,0.0,282631,Facies,0.21,1,Biomarker
6905,TBCE,tubulin folding cofactor E,0.0,1.0,0.0,0.0,0.0,282631,Facies,0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,237873,"Sexual Dysfunction, Physiological",0.21,2,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,35457,"Rhinitis, Allergic, Perennial",0.21,1,Biomarker
353347,DFNA53,"deafness, autosomal dominant 53",0.0,1.0,0.0,0.0,0.0,1864957,"Deafness, Autosomal Dominant 53",0.21,0,Biomarker
387700,SLC16A12,"solute carrier family 16, member 12",0.0,1.0,0.0,0.0,0.0,2677587,"Cataract, Juvenile, With Microcornea And Glucosuria",0.21,0,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,559483,Pentalogy of Cantrell,0.21,1,Biomarker
100188844,MAFD6,Major affective disorder 6,0.0,1.0,0.0,0.0,0.0,1970945,Major Affective Disorder 6,0.21,0,Biomarker
54463,FAM134B,"family with sequence similarity 134, member B",0.0,1.0,0.0,0.0,0.0,27889,Hereditary Sensory and Autonomic Neuropathies,0.21,1,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,23510,Leukocyte Disorders,0.21,2,Biomarker
100272225,UAQTL4,"Uric acid concentration, serum, QTL4",0.0,1.0,0.0,0.0,0.0,2675207,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4",0.21,0,Biomarker
84434,THCYTX,"Thrombocytosis, familial X-linked",0.0,1.0,0.0,0.0,0.0,1845888,"THROMBOCYTHEMIA, X-LINKED",0.21,0,Biomarker
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,18939,Hematologic Diseases,0.21,1,Biomarker
54433,GAR1,GAR1 ribonucleoprotein,0.0,1.0,0.0,0.0,0.0,18939,Hematologic Diseases,0.21,1,Biomarker
10661,KLF1,Kruppel-like factor 1 (erythroid),0.0,1.0,0.0,0.0,0.0,18939,Hematologic Diseases,0.21,1,Biomarker
6521,SLC4A1,"solute carrier family 4 (anion exchanger), member 1 (Diego blood group)",0.0,1.0,0.0,0.0,0.0,18939,Hematologic Diseases,0.21,1,Biomarker
7504,XK,X-linked Kx blood group,0.0,1.0,0.0,0.0,0.0,18939,Hematologic Diseases,0.21,2,Biomarker
677662,PARK12,Parkinson disease 12 (susceptibility),0.0,1.0,0.0,0.0,0.0,1845165,Parkinson Disease 12,0.21,0,Biomarker
54362,DFNM1,"deafness (recessive, nonsyndromic) modifier 1",0.0,1.0,0.0,0.0,0.0,1854274,"DEAFNESS, NONSYNDROMIC, MODIFIER 1",0.21,0,Biomarker
2771,GNAI2,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2",0.0,1.0,0.0,0.0,0.0,340485,Familial ventricular tachycardia,0.21,0,Biomarker
64240,ABCG5,"ATP-binding cassette, sub-family G (WHITE), member 5",0.0,1.0,0.0,0.0,0.0,23772,"Lipid Metabolism, Inborn Errors",0.21,1,Biomarker
9420,CYP7B1,"cytochrome P450, family 7, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,23772,"Lipid Metabolism, Inborn Errors",0.21,1,Biomarker
1666,DECR1,"2,4-dienoyl CoA reductase 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,23772,"Lipid Metabolism, Inborn Errors",0.21,1,Biomarker
3990,LIPC,"lipase, hepatic",0.0,1.0,0.0,0.0,0.0,23772,"Lipid Metabolism, Inborn Errors",0.21,3,Biomarker
53632,PRKAG3,"protein kinase, AMP-activated, gamma 3 non-catalytic subunit",0.0,1.0,0.0,0.0,0.0,23772,"Lipid Metabolism, Inborn Errors",0.21,1,Biomarker
84947,SERAC1,serine active site containing 1,0.0,1.0,0.0,0.0,0.0,23772,"Lipid Metabolism, Inborn Errors",0.21,1,Biomarker
53366,SM2,Hepatic fibrosis susceptibility due to Schistosoma mansoni infection,0.0,1.0,0.0,0.0,0.0,1858709,"HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI INFECTION",0.21,0,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,24796,Marfan Syndrome,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,24796,Marfan Syndrome,0.21,1,Biomarker
118429,ANTXR2,anthrax toxin receptor 2,0.0,1.0,0.0,0.0,0.0,17567,Gingival Hypertrophy,0.21,2,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,1968556,"Encephalopathy, Neonatal Severe, Due To Mecp2 Mutations",0.21,0,Biomarker
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,524948,Maxillofacial Abnormalities,0.21,1,Biomarker
2707,GJB3,"gap junction protein, beta 3, 31kDa",0.0,1.0,0.0,0.0,0.0,2673759,"Deafness, Autosomal Recessive 1A",0.21,0,Biomarker
7547,ZIC3,Zic family member 3,0.0,0.0,1.0,0.0,0.0,2931228,"VACTERL association with hydrocephaly, X-linked",0.21,0,GeneticVariation
100188855,MNDEC,Microtia with nasolacrimal duct imperforation and eye coloboma,0.0,1.0,0.0,0.0,0.0,2678482,Microtia With Nasolacrimal Duct Imperforation And Eye Coloboma,0.21,0,Biomarker
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
10036,CHAF1A,"chromatin assembly factor 1, subunit A (p150)",0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
8208,CHAF1B,"chromatin assembly factor 1, subunit B (p60)",0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
56603,CYP26B1,"cytochrome P450, family 26, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
54541,DDIT4,DNA-damage-inducible transcript 4,0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
3301,DNAJA1,"DnaJ (Hsp40) homolog, subfamily A, member 1",0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
2189,FANCG,"Fanconi anemia, complementation group G",0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
9518,GDF15,growth differentiation factor 15,0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
2937,GSS,glutathione synthetase,0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
51182,HSPA14,heat shock 70kDa protein 14,0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
6283,S100A12,S100 calcium binding protein A12,0.0,1.0,0.0,0.0,0.0,26636,Mouth Diseases,0.21,1,Biomarker
493862,CTRCT28,Cataract 28,0.0,1.0,0.0,0.0,0.0,1836942,"Cataract, Age-Related Cortical, 1",0.21,0,Biomarker
2660,MSTN,myostatin,0.0,1.0,0.0,0.0,0.0,2931112,Myostatin-related muscle hypertrophy,0.21,2,Biomarker
780900,FGS5,FG syndrome 5,0.0,1.0,0.0,0.0,0.0,1845119,Fg Syndrome 5,0.21,0,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,37997,Splenic Diseases,0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,37997,Splenic Diseases,0.21,1,Biomarker
3195,TLX1,T-cell leukemia homeobox 1,0.0,1.0,0.0,0.0,0.0,37997,Splenic Diseases,0.21,1,Biomarker
27031,NPHP3,nephronophthisis 3 (adolescent),0.0,1.0,0.0,0.0,0.0,85548,"Polycystic Kidney, Autosomal Recessive",0.21,1,Biomarker
6714,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,85548,"Polycystic Kidney, Autosomal Recessive",0.21,1,Biomarker
4352,MPL,"MPL proto-oncogene, thrombopoietin receptor",0.0,0.0,1.0,0.0,0.0,3275998,THROMBOCYTHEMIA 2,0.21,0,GeneticVariation
574044,EPRPDC,"Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp",0.0,1.0,0.0,0.0,0.0,1842531,"Epilepsy, rolandic with paroxysmal exercise-induced dystonia and writer's cramp",0.21,0,Biomarker
118856,MMP21,matrix metallopeptidase 21,0.0,1.0,0.0,0.0,0.0,206644,"Histiocytoma, Benign Fibrous",0.21,1,Biomarker
551,AVP,arginine vasopressin,0.0,0.0,0.0,0.0,1.0,2622,Amnesia,0.21,1,Therapeutic
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,0.0,0.0,0.0,1.0,2622,Amnesia,0.21,1,Therapeutic
2770,GNAI1,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1",0.0,1.0,0.0,0.0,0.0,2622,Amnesia,0.21,1,Biomarker
2773,GNAI3,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3",0.0,1.0,0.0,0.0,0.0,2622,Amnesia,0.21,1,Biomarker
2922,GRP,gastrin-releasing peptide,0.0,0.0,0.0,0.0,1.0,2622,Amnesia,0.21,1,Therapeutic
3552,IL1A,"interleukin 1, alpha",0.0,0.0,0.0,0.0,1.0,2622,Amnesia,0.21,1,Therapeutic
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,2622,Amnesia,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,0.0,0.0,0.0,1.0,2622,Amnesia,0.21,2,Therapeutic
5173,PDYN,prodynorphin,0.0,0.0,0.0,0.0,1.0,2622,Amnesia,0.21,1,Therapeutic
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,2622,Amnesia,0.21,1,Biomarker
5550,PREP,prolyl endopeptidase,0.0,1.0,0.0,0.0,0.0,2622,Amnesia,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,0.0,0.0,0.0,1.0,2622,Amnesia,0.21,3,Therapeutic
7200,TRH,thyrotropin-releasing hormone,0.0,0.0,0.0,0.0,1.0,2622,Amnesia,0.21,3,Therapeutic
2736,GLI2,GLI family zinc finger 2,0.0,1.0,0.0,0.0,0.0,4779,Basal Cell Nevus Syndrome,0.21,1,Biomarker
553989,LFS3,Li-Fraumeni syndrome 3,0.0,1.0,0.0,0.0,0.0,1836481,Li-Fraumeni Syndrome 3,0.21,0,Biomarker
185,AGTR1,"angiotensin II receptor, type 1",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
226,ALDOA,"aldolase A, fructose-bisphosphate",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
1933,EEF1B2,eukaryotic translation elongation factor 1 beta 2,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
1938,EEF2,eukaryotic translation elongation factor 2,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
10919,EHMT2,euchromatic histone-lysine N-methyltransferase 2,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
2072,ERCC4,excision repair cross-complementation group 4,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
3274,HRH2,histamine receptor H2,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
23643,LY96,lymphocyte antigen 96,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
5601,MAPK9,mitogen-activated protein kinase 9,0.0,0.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.21,1,Therapeutic
80306,MED28,mediator complex subunit 28,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
406919,MIR130A,microRNA 130a,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
442892,MIR148B,microRNA 148b,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
574457,MIR181D,microRNA 181d,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
574032,MIR20B,microRNA 20b,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
407034,MIR30E,microRNA 30e,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
442909,MIR342,microRNA 342,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
407041,MIR34B,microRNA 34b,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
407042,MIR34C,microRNA 34c,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
574466,MIR519C,microRNA 519c,0.0,0.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.21,1,Therapeutic
693124,MIR532,microRNA 532,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
693149,MIR564,microRNA 564,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
693151,MIR566,microRNA 566,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
693180,MIR595,microRNA 595,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
407056,MIR99B,microRNA 99b,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,0.0,0.0,0.0,1.0,27627,Neoplasm Metastasis,0.21,1,Therapeutic
8654,PDE5A,"phosphodiesterase 5A, cGMP-specific",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
23657,SLC7A11,"solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11",0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
9623,TCL1B,T-cell leukemia/lymphoma 1B,0.0,1.0,0.0,0.0,0.0,27627,Neoplasm Metastasis,0.21,1,Biomarker
3063,HCVS,human coronavirus sensitivity,0.0,1.0,0.0,0.0,0.0,10078,Coronaviridae Infections,0.21,0,Biomarker
7792,CCV,"cataract, congenital, Volkmann type",0.0,1.0,0.0,0.0,0.0,1861833,Cataract congenital Volkmann type,0.21,0,Biomarker
100190789,TSHQTL1,Thyroid-stimulating hormone level QTL 1,0.0,1.0,0.0,0.0,0.0,2676758,THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1,0.21,0,Biomarker
150,ADRA2A,adrenoceptor alpha 2A,0.0,0.0,0.0,0.0,1.0,16059,Fibrosis,0.21,1,Therapeutic
152,ADRA2C,adrenoceptor alpha 2C,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
10159,ATP6AP2,"ATPase, H+ transporting, lysosomal accessory protein 2",0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
894,CCND2,cyclin D2,0.0,0.0,0.0,0.0,1.0,16059,Fibrosis,0.21,1,Therapeutic
1134,CHRNA1,"cholinergic receptor, nicotinic, alpha 1 (muscle)",0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,16059,Fibrosis,0.21,2,Therapeutic
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
2235,FECH,ferrochelatase,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,0.0,0.0,0.0,1.0,16059,Fibrosis,0.21,1,Therapeutic
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
3816,KLK1,kallikrein 1,0.0,0.0,0.0,0.0,1.0,16059,Fibrosis,0.21,1,Therapeutic
5609,MAP2K7,mitogen-activated protein kinase kinase 7,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
406991,MIR21,microRNA 21,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
4881,NPR1,natriuretic peptide receptor 1,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
80310,PDGFD,platelet derived growth factor D,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
23411,SIRT1,sirtuin 1,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
8877,SPHK1,sphingosine kinase 1,0.0,0.0,0.0,0.0,1.0,16059,Fibrosis,0.21,1,Therapeutic
7057,THBS1,thrombospondin 1,0.0,1.0,0.0,0.0,0.0,16059,Fibrosis,0.21,1,Biomarker
1769,DNAH8,"dynein, axonemal, heavy chain 8",0.0,1.0,0.0,0.0,0.0,1456784,Paranoid Disorders,0.21,1,Biomarker
3284,HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",0.0,1.0,0.0,0.0,0.0,1456784,Paranoid Disorders,0.21,1,Biomarker
79664,ICE2,interactor of little elongation complex ELL subunit 2,0.0,1.0,0.0,0.0,0.0,1456784,Paranoid Disorders,0.21,1,Biomarker
79694,MANEA,"mannosidase, endo-alpha",0.0,1.0,0.0,0.0,0.0,1456784,Paranoid Disorders,0.21,1,Biomarker
7297,TYK2,tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,1456784,Paranoid Disorders,0.21,1,Biomarker
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
834,CASP1,"caspase 1, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,2,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,1.0,38220,Status Epilepticus,0.21,4,"Biomarker, Therapeutic"
2826,CCR10,chemokine (C-C motif) receptor 10,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
729230,CCR2,chemokine (C-C motif) receptor 2,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,2,Biomarker
1232,CCR3,chemokine (C-C motif) receptor 3,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
1236,CCR7,chemokine (C-C motif) receptor 7,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
1237,CCR8,chemokine (C-C motif) receptor 8,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
10803,CCR9,chemokine (C-C motif) receptor 9,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
958,CD40,"CD40 molecule, TNF receptor superfamily member 5",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
1000,CDH2,"cadherin 2, type 1, N-cadherin (neuronal)",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
5610,EIF2AK2,eukaryotic translation initiation factor 2-alpha kinase 2,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
9451,EIF2AK3,eukaryotic translation initiation factor 2-alpha kinase 3,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
1965,EIF2S1,"eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,0.0,0.0,0.0,1.0,38220,Status Epilepticus,0.21,2,Therapeutic
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,4,Biomarker
2596,GAP43,growth associated protein 43,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,2,Biomarker
2911,GRM1,"glutamate receptor, metabotropic 1",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,2,Biomarker
2915,GRM5,"glutamate receptor, metabotropic 5",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,2,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,0.0,0.0,0.0,1.0,38220,Status Epilepticus,0.21,1,Therapeutic
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
3726,JUNB,jun B proto-oncogene,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
3727,JUND,jun D proto-oncogene,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
8645,KCNK5,"potassium channel, two pore domain subfamily K, member 5",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
3778,KCNMA1,"potassium channel, calcium activated large conductance subfamily M alpha, member 1",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
3920,LAMP2,lysosomal-associated membrane protein 2,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,2,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
4908,NTF3,neurotrophin 3,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,2,Biomarker
4916,NTRK3,"neurotrophic tyrosine kinase, receptor, type 3",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
8566,PDXK,"pyridoxal (pyridoxine, vitamin B6) kinase",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
55163,PNPO,pyridoxamine 5'-phosphate oxidase,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
5979,RET,ret proto-oncogene,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
6751,SSTR1,somatostatin receptor 1,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
6752,SSTR2,somatostatin receptor 2,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
6753,SSTR3,somatostatin receptor 3,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
6755,SSTR5,somatostatin receptor 5,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,38220,Status Epilepticus,0.21,1,Biomarker
270,AMPD1,adenosine monophosphate deaminase 1,0.0,0.0,1.0,0.0,0.0,3714933,MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY,0.21,1,GeneticVariation
574047,MPDMRS,Martin-Probst deafness-mental retardation syndrome,0.0,1.0,0.0,0.0,0.0,1845285,Martin-Probst Deafness-Mental Retardation Syndrome,0.21,0,Biomarker
282617,IFNL3,"interferon, lambda 3",0.0,1.0,0.0,0.0,0.0,16470,Food Hypersensitivity,0.21,1,Biomarker
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,0.0,0.0,0.0,16470,Food Hypersensitivity,0.21,1,Biomarker
404720,HSCR5,"Hirschsprung disease, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,19569,Hirschsprung Disease,0.21,0,Biomarker
246321,HSCR6,"Hirschsprung disease, short-segment, 2",0.0,1.0,0.0,0.0,0.0,19569,Hirschsprung Disease,0.21,0,Biomarker
246322,HSCR7,"Hirschsprung disease, short-segment, 3",0.0,1.0,0.0,0.0,0.0,19569,Hirschsprung Disease,0.21,0,Biomarker
404719,HSCR8,Hirschsprung disease modifier 2,0.0,1.0,0.0,0.0,0.0,19569,Hirschsprung Disease,0.21,0,Biomarker
100188850,HSCR9,"Hirschsprung disease, susceptibility to, 9",0.0,1.0,0.0,0.0,0.0,19569,Hirschsprung Disease,0.21,0,Biomarker
213,ALB,albumin,0.0,0.0,0.0,0.0,1.0,38325,Stevens-Johnson Syndrome,0.21,1,Therapeutic
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,38325,Stevens-Johnson Syndrome,0.21,1,Therapeutic
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,0.0,0.0,0.0,38325,Stevens-Johnson Syndrome,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,38325,Stevens-Johnson Syndrome,0.21,1,Biomarker
5733,PTGER3,prostaglandin E receptor 3 (subtype EP3),0.0,1.0,0.0,0.0,0.0,38325,Stevens-Johnson Syndrome,0.21,1,Biomarker
2180,ACSL1,acyl-CoA synthetase long-chain family member 1,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
2182,ACSL4,acyl-CoA synthetase long-chain family member 4,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
51703,ACSL5,acyl-CoA synthetase long-chain family member 5,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
969,CD69,CD69 molecule,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,3,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,0.0,0.0,0.0,1.0,993582,"Arthritis, Experimental",0.21,1,Therapeutic
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
3952,LEP,leptin,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
5734,PTGER4,prostaglandin E receptor 4 (subtype EP4),0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
6288,SAA1,serum amyloid A1,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
81567,TXNDC5,thioredoxin domain containing 5 (endoplasmic reticulum),0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,993582,"Arthritis, Experimental",0.21,1,Biomarker
791123,SHFLD2,Split-hand/foot malformation with long deficiency 2,0.0,1.0,0.0,0.0,0.0,1853156,Split-Hand/Foot Malformation With Long Bone Deficiency 2,0.21,0,Biomarker
100303717,PBC3,"Biliary cirrhosis, primary, 3",0.0,1.0,0.0,0.0,0.0,2751695,"Biliary Cirrhosis, Primary, 3",0.21,0,Biomarker
1482,NKX2-5,NK2 homeobox 5,0.0,0.0,1.0,0.0,0.0,3280795,HYPOPLASTIC LEFT HEART SYNDROME 2,0.21,0,GeneticVariation
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,35344,Retinopathy of Prematurity,0.21,1,Biomarker
10804,GJB6,"gap junction protein, beta 6, 30kDa",0.0,1.0,0.0,0.0,0.0,2675235,"Deafness, Autosomal Recessive 1b",0.21,0,Biomarker
404716,MTBS1,"mycobacterium tuberculosis, susceptibility to infection by, 1",0.0,1.0,0.0,0.0,0.0,1842762,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
3507,IGHM,immunoglobulin heavy constant mu,0.0,1.0,0.0,0.0,0.0,3152144,"AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE",0.21,0,Biomarker
885,CCK,cholecystokinin,0.0,1.0,0.0,0.0,0.0,41657,Unconsciousness,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,0.0,0.0,0.0,1.0,41657,Unconsciousness,0.21,1,Therapeutic
6581,SLC22A3,"solute carrier family 22 (organic cation transporter), member 3",0.0,1.0,0.0,0.0,0.0,27059,Myocarditis,0.21,1,Biomarker
6583,SLC22A4,"solute carrier family 22 (organic cation/zwitterion transporter), member 4",0.0,1.0,0.0,0.0,0.0,27059,Myocarditis,0.21,1,Biomarker
6584,SLC22A5,"solute carrier family 22 (organic cation/carnitine transporter), member 5",0.0,1.0,0.0,0.0,0.0,27059,Myocarditis,0.21,1,Biomarker
92667,MGME1,mitochondrial genome maintenance exonuclease 1,0.0,1.0,0.0,0.0,0.0,29089,Ophthalmoplegia,0.21,1,Biomarker
4864,NPC1,"Niemann-Pick disease, type C1",0.0,1.0,0.0,0.0,0.0,29089,Ophthalmoplegia,0.21,1,Biomarker
619509,WTRS,Wittwer syndrome,0.0,1.0,0.0,0.0,0.0,796202,Wittwer syndrome,0.21,0,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,1,Biomarker
1233,CCR4,chemokine (C-C motif) receptor 4,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,1,Biomarker
1657,DMXL1,Dmx-like 1,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,1,Biomarker
11170,FAM107A,"family with sequence similarity 107, member A",0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,1,Biomarker
2495,FTH1,"ferritin, heavy polypeptide 1",0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,1,Biomarker
338030,GLM4,"Glioma, familial, 1",0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,0,Biomarker
100415894,GLM5,Glioma susceptibility 5,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,0,Biomarker
100415895,GLM6,Glioma susceptibility 6,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,0,Biomarker
100316847,GLM8,Glioma susceptibility 8,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,0,Biomarker
3592,IL12A,interleukin 12A,0.0,0.0,0.0,0.0,1.0,17638,Glioma,0.21,1,Therapeutic
4638,MYLK,myosin light chain kinase,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,1,Biomarker
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,1,Biomarker
4916,NTRK3,"neurotrophic tyrosine kinase, receptor, type 3",0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,1,Biomarker
23362,PSD3,pleckstrin and Sec7 domain containing 3,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,1,Biomarker
404685,RTE1,repressor of telomerase expression 1,0.0,1.0,0.0,0.0,0.0,17638,Glioma,0.21,0,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,14836,Escherichia coli Infections,0.21,1,Biomarker
23250,ATP11A,"ATPase, class VI, type 11A",0.0,1.0,0.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.21,1,Biomarker
91039,DPP9,dipeptidyl-peptidase 9,0.0,1.0,0.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.21,1,Biomarker
1832,DSP,desmoplakin,0.0,1.0,0.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.21,1,Biomarker
10144,FAM13A,"family with sequence similarity 13, member A",0.0,1.0,0.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.21,1,Biomarker
79991,OBFC1,oligonucleotide/oligosaccharide-binding fold containing 1,0.0,1.0,0.0,0.0,0.0,1800706,Idiopathic Pulmonary Fibrosis,0.21,1,Biomarker
9131,AIFM1,"apoptosis-inducing factor, mitochondrion-associated, 1",0.0,1.0,0.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.21,1,Biomarker
6364,CCL20,chemokine (C-C motif) ligand 20,0.0,0.0,0.0,0.0,1.0,11854,"Diabetes Mellitus, Type 1",0.21,1,Therapeutic
1129,CHRM2,"cholinergic receptor, muscarinic 2",0.0,1.0,0.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.21,1,Biomarker
1649,DDIT3,DNA-damage-inducible transcript 3,0.0,1.0,0.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.21,1,Biomarker
26291,FGF21,fibroblast growth factor 21,0.0,0.0,0.0,0.0,1.0,11854,"Diabetes Mellitus, Type 1",0.21,1,Therapeutic
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,679360,Foodborne Diseases,0.21,1,Biomarker
5649,RELN,reelin,0.0,1.0,0.0,0.0,0.0,1269683,"Depressive Disorder, Major",0.21,1,Biomarker
22995,CEP152,centrosomal protein 152kDa,0.0,1.0,0.0,0.0,0.0,1858516,"Microcephaly, Primary Autosomal Recessive, 4",0.21,0,Biomarker
246230,CMAL,"Capillary malformations, hereditary",0.0,1.0,0.0,0.0,0.0,2931029,"Nevi flammei, familial multiple",0.21,0,Biomarker
50982,NIDDM3,Noninsulin-dependent diabetes mellitus 3,0.0,1.0,0.0,0.0,0.0,1863594,"Diabetes Mellitus, Noninsulin-Dependent, 3",0.21,0,Biomarker
701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
80254,CEP63,centrosomal protein 63kDa,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
10059,DNM1L,dynamin 1-like,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
1778,DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1",0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,2,Biomarker
26128,KIAA1279,KIAA1279,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
407975,MIR17HG,miR-17-92 cluster host gene (non-protein coding),0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
10617,STAMBP,STAM binding protein,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
6925,TCF4,transcription factor 4,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
80746,TSEN2,TSEN2 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
79042,TSEN34,TSEN34 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
283989,TSEN54,TSEN54 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
7283,TUBG1,"tubulin, gamma 1",0.0,1.0,0.0,0.0,0.0,25958,Microcephaly,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,33999,Pterygium,0.21,1,Therapeutic
790,CAD,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",0.0,1.0,0.0,0.0,0.0,2895,"Anemia, Sickle Cell",0.21,1,Biomarker
1723,DHODH,dihydroorotate dehydrogenase (quinone),0.0,1.0,0.0,0.0,0.0,2895,"Anemia, Sickle Cell",0.21,1,Biomarker
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,0.0,2895,"Anemia, Sickle Cell",0.21,1,Biomarker
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,0.0,0.0,0.0,2895,"Anemia, Sickle Cell",0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,24031,Low Back Pain,0.21,1,Therapeutic
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,24031,Low Back Pain,0.21,1,Biomarker
113877,DFNB32,"deafness, autosomal recessive 32",0.0,1.0,0.0,0.0,0.0,1837608,"Deafness, Autosomal Recessive 32",0.21,0,Biomarker
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,13608,"Edema, Cardiac",0.21,1,Biomarker
55764,IFT122,intraflagellar transport 122,0.0,1.0,0.0,0.0,0.0,13608,"Edema, Cardiac",0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,25309,Meningoencephalitis,0.21,1,Therapeutic
2706,GJB2,"gap junction protein, beta 2, 26kDa",0.0,1.0,0.0,0.0,0.0,162836,Hidradenitis Suppurativa,0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.21,1,Biomarker
3202,HOXA5,homeobox A5,0.0,1.0,0.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.21,1,Biomarker
3237,HOXD11,homeobox D11,0.0,1.0,0.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.21,1,Biomarker
282617,IFNL3,"interferon, lambda 3",0.0,0.0,0.0,0.0,1.0,1168401,"Carcinoma, squamous cell of head and neck",0.21,1,Therapeutic
407007,MIR222,microRNA 222,0.0,1.0,0.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.21,1,Biomarker
6845,VAMP7,vesicle-associated membrane protein 7,0.0,1.0,0.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.21,1,Biomarker
10413,YAP1,Yes-associated protein 1,0.0,1.0,0.0,0.0,0.0,1168401,"Carcinoma, squamous cell of head and neck",0.21,1,Biomarker
1153,CIRBP,cold inducible RNA binding protein,0.0,1.0,0.0,0.0,0.0,751865,"Alcohol-Induced Disorders, Nervous System",0.21,1,Biomarker
373071,AIS1,autoimmune susceptibility 1,0.0,1.0,0.0,0.0,0.0,1842979,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
10046,MAMLD1,mastermind-like domain containing 1,0.0,1.0,0.0,0.0,0.0,2678098,"Hypospadias 1, X-Linked",0.21,0,Biomarker
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,0.0,0.0,0.0,1619692,Nephrogenic Fibrosing Dermopathy,0.21,1,Biomarker
6355,CCL8,chemokine (C-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,1619692,Nephrogenic Fibrosing Dermopathy,0.21,1,Biomarker
1277,COL1A1,"collagen, type I, alpha 1",0.0,1.0,0.0,0.0,0.0,1619692,Nephrogenic Fibrosing Dermopathy,0.21,1,Biomarker
317685,NYS4,"nystagmus 4, congenital autosomal dominant",0.0,1.0,0.0,0.0,0.0,1860433,"Nystagmus 4, congenital, autosomal dominant",0.21,0,Biomarker
9563,H6PD,hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase),0.0,0.0,1.0,0.0,0.0,3551716,CORTISONE REDUCTASE DEFICIENCY 1,0.21,2,GeneticVariation
23532,PRAME,preferentially expressed antigen in melanoma,0.0,1.0,0.0,0.0,0.0,1261473,Sarcoma,0.21,1,Biomarker
6114,RP22,retinitis pigmentosa 22 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,35334,Retinitis Pigmentosa,0.21,0,Biomarker
6116,RP24,retinitis pigmentosa 24 (X-linked recessive),0.0,1.0,0.0,0.0,0.0,35334,Retinitis Pigmentosa,0.21,0,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,85307,Embolism and Thrombosis,0.21,1,Therapeutic
3426,CFI,complement factor I,0.0,0.0,1.0,0.0,0.0,3809523,"MACULAR DEGENERATION, AGE-RELATED, 13",0.21,0,GeneticVariation
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,1855794,Bamforth syndrome,0.21,1,Biomarker
3514,IGKC,immunoglobulin kappa constant,0.0,1.0,0.0,0.0,0.0,13374,Dysgammaglobulinemia,0.21,1,Biomarker
60468,BACH2,"BTB and CNC homology 1, basic leucine zipper transcription factor 2",0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
840,CASP7,"caspase 7, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
941,CD80,CD80 molecule,0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
116449,CLNK,cytokine-dependent hematopoietic cell linker,0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
64135,IFIH1,interferon induced with helicase C domain 1,0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
64375,IKZF4,IKAROS family zinc finger 4 (Eos),0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
10019,SH2B3,SH2B adaptor protein 3,0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
6503,SLA,Src-like-adaptor,0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
10766,TOB2,"transducer of ERBB2, 2",0.0,1.0,0.0,0.0,0.0,42900,Vitiligo,0.21,1,Biomarker
414886,SPG27,spastic paraplegia 27 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,1836899,"Spastic Paraplegia 27, Autosomal Recessive",0.21,0,Biomarker
1577,CYP3A5,"cytochrome P450, family 3, subfamily A, polypeptide 5",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.21,0,Biomarker
117191,HYT1,"Hypertension, essential, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.21,0,Biomarker
50986,HYT2,"Hypertension, essential, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.21,0,Biomarker
387575,HYT3,"Hypertension, essential, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.21,0,Biomarker
444980,HYT4,"Hypertension, essential, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.21,0,Biomarker
100188807,HYT5,"Hypertension, essential, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.21,0,Biomarker
100188808,HYT6,"Hypertension, essential, susceptibility to, 6",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.21,0,Biomarker
100188825,HYT7,"Hypertension, essential, susceptibility to, 7",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.21,0,Biomarker
100188321,HYT8,"hypertension, essential, susceptibility to, 8",0.0,1.0,0.0,0.0,0.0,85580,"Hypertension, Essential",0.21,0,Biomarker
51164,DCTN4,dynactin 4 (p62),0.0,1.0,0.0,0.0,0.0,33817,Pseudomonas Infections,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,80274,Urinary Retention,0.21,1,Biomarker
353126,BMIQ10,"Obesity, susceptibility to, on chromosome 10q",0.0,1.0,0.0,0.0,0.0,2675659,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10,0.21,0,Biomarker
4415,MRX52,"mental retardation, X-linked 52",0.0,1.0,0.0,0.0,0.0,1845298,"Mental Retardation, X-Linked 52",0.21,0,Biomarker
2941,GSTA4,glutathione S-transferase alpha 4,0.0,1.0,0.0,0.0,1.0,3850,Arteriosclerosis,0.21,2,"Biomarker, Therapeutic"
4933,NYS2,"nystagmus 2, congenital autosomal dominant",0.0,1.0,0.0,0.0,0.0,1834079,"Nystagmus 2, congenital, autosomal dominant",0.21,0,Biomarker
220296,HEPACAM,hepatic and glial cell adhesion molecule,0.0,0.0,1.0,0.0,0.0,3151356,"MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION",0.21,0,GeneticVariation
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,2390,"Alveolitis, Extrinsic Allergic",0.21,1,Biomarker
3909,LAMA3,"laminin, alpha 3",0.0,1.0,0.0,0.0,0.0,27339,Nail Diseases,0.21,1,Biomarker
26277,TINF2,TERF1 (TRF1)-interacting nuclear factor 2,0.0,1.0,0.0,0.0,0.0,27339,Nail Diseases,0.21,1,Biomarker
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,0.0,0.0,0.0,3150755,SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1,0.21,0,Biomarker
3119,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",0.0,1.0,0.0,0.0,0.0,22336,Creutzfeldt-Jakob Syndrome,0.21,0,Biomarker
50952,HMN7A,"Motor neuronopathy, distal hereditary, type VIIA",0.0,1.0,0.0,0.0,0.0,1834703,"Neuropathy, Distal Hereditary Motor, Type VIIA",0.21,0,Biomarker
10631,POSTN,"periostin, osteoblast specific factor",0.0,1.0,0.0,0.0,0.0,6287,Bronchopulmonary Dysplasia,0.21,1,Biomarker
7295,TXN,thioredoxin,0.0,0.0,0.0,0.0,1.0,6287,Bronchopulmonary Dysplasia,0.21,1,Therapeutic
9582,APOBEC3B,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B",0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
374,AREG,amphiregulin,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
1050,CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,18671,Head and Neck Neoplasms,0.21,1,Therapeutic
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
2195,FAT1,FAT atypical cadherin 1,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
2922,GRP,gastrin-releasing peptide,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
4118,MAL,"mal, T-cell differentiation protein",0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
23532,PRAME,preferentially expressed antigen in melanoma,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
6778,STAT6,"signal transducer and activator of transcription 6, interleukin-4 induced",0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
7389,UROD,uroporphyrinogen decarboxylase,0.0,1.0,0.0,0.0,0.0,18671,Head and Neck Neoplasms,0.21,1,Biomarker
2638,GC,group-specific component (vitamin D binding protein),0.0,1.0,0.0,0.0,0.0,19151,Hepatic Encephalopathy,0.21,1,Biomarker
4049,LTA,lymphotoxin alpha,0.0,1.0,0.0,0.0,0.0,19151,Hepatic Encephalopathy,0.21,1,Biomarker
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,19151,Hepatic Encephalopathy,0.21,1,Biomarker
5591,PRKDC,"protein kinase, DNA-activated, catalytic polypeptide",0.0,1.0,0.0,0.0,0.0,19151,Hepatic Encephalopathy,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,19151,Hepatic Encephalopathy,0.21,2,Biomarker
8156,GPSC,"gliosis, familial progressive subcortical",0.0,1.0,0.0,0.0,0.0,1857300,"Gliosis, Familial Progressive Subcortical",0.21,0,Biomarker
259,AMBP,alpha-1-microglobulin/bikunin precursor,0.0,0.0,0.0,0.0,1.0,7138,"Carcinoma, Transitional Cell",0.21,1,Therapeutic
1387,CREBBP,CREB binding protein,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,7138,"Carcinoma, Transitional Cell",0.21,2,Therapeutic
9700,ESPL1,extra spindle pole bodies homolog 1 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
2876,GPX1,glutathione peroxidase 1,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
3274,HRH2,histamine receptor H2,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
7403,KDM6A,lysine (K)-specific demethylase 6A,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
58508,KMT2C,lysine (K)-specific methyltransferase 2C,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
10735,STAG2,stromal antigen 2,0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
10460,TACC3,"transforming, acidic coiled-coil containing protein 3",0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,0.0,0.0,0.0,7138,"Carcinoma, Transitional Cell",0.21,1,Biomarker
54796,BNC2,basonuclin 2,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
865,CBFB,"core-binding factor, beta subunit",0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
1147,CHUK,conserved helix-loop-helix ubiquitous kinase,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
1739,DLG1,"discs, large homolog 1 (Drosophila)",0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
2248,FGF3,fibroblast growth factor 3,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
2252,FGF7,fibroblast growth factor 7,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
2253,FGF8,fibroblast growth factor 8 (androgen-induced),0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
2254,FGF9,fibroblast growth factor 9,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
2261,FGFR3,fibroblast growth factor receptor 3,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
8322,FZD4,frizzled class receptor 4,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
4335,MNT,MAX network transcriptional repressor,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
5916,RARG,"retinoic acid receptor, gamma",0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
6493,SIM2,single-minded family bHLH transcription factor 2,0.0,1.0,0.0,0.0,0.0,8925,Cleft Palate,0.21,1,Biomarker
100188776,HEY,"hairy ears, Y-linked",0.0,1.0,0.0,0.0,0.0,1839070,"Hairy Ears, Y-Linked",0.21,0,Biomarker
1815,DRD4,dopamine receptor D4,0.0,1.0,0.0,0.0,0.0,1866430,NOVELTY SEEKING PERSONALITY TRAIT,0.21,0,Biomarker
80114,BICC1,BicC family RNA binding protein 1,0.0,0.0,1.0,0.0,0.0,3275898,"RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO",0.21,1,GeneticVariation
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,22593,Keratosis,0.21,1,Biomarker
9817,KEAP1,kelch-like ECH-associated protein 1,0.0,1.0,0.0,0.0,0.0,22593,Keratosis,0.21,1,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,22593,Keratosis,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,22593,Keratosis,0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
9719,ADAMTSL2,ADAMTS-like 2,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
554,AVPR2,arginine vasopressin receptor 2,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
867,CBL,"Cbl proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
152330,CNTN4,contactin 4,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
2245,FGD1,"FYVE, RhoGEF and PH domain containing 1",0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,4,Biomarker
2688,GH1,growth hormone 1,0.0,0.0,0.0,0.0,1.0,18273,Growth Disorders,0.21,1,Therapeutic
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
1902,LPAR1,lysophosphatidic acid receptor 1,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
407975,MIR17HG,miR-17-92 cluster host gene (non-protein coding),0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
4880,NPPC,natriuretic peptide C,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
10084,PQBP1,polyglutamine binding protein 1,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,2,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
282808,RAB40AL,"RAB40A, member RAS oncogene family-like",0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
79048,SECISBP2,SECIS binding protein 2,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
285590,SH3PXD2B,SH3 and PX domains 2B,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
6913,TBX15,T-box 15,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
26277,TINF2,TERF1 (TRF1)-interacting nuclear factor 2,0.0,1.0,0.0,0.0,0.0,18273,Growth Disorders,0.21,1,Biomarker
23,ABCF1,"ATP-binding cassette, sub-family F (GCN20), member 1",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
6363,CCL19,chemokine (C-C motif) ligand 19,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
6364,CCL20,chemokine (C-C motif) ligand 20,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
6355,CCL8,chemokine (C-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
1230,CCR1,chemokine (C-C motif) receptor 1,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
729230,CCR2,chemokine (C-C motif) receptor 2,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
1235,CCR6,chemokine (C-C motif) receptor 6,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
10803,CCR9,chemokine (C-C motif) receptor 9,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
6376,CX3CL1,chemokine (C-X3-C motif) ligand 1,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
4283,CXCL9,chemokine (C-X-C motif) ligand 9,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
3554,IL1R1,"interleukin 1 receptor, type I",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
7850,IL1R2,"interleukin 1 receptor, type II",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
3560,IL2RB,"interleukin 2 receptor, beta",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
3568,IL5RA,"interleukin 5 receptor, alpha",0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
5196,PF4,platelet factor 4,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,32285,Pneumonia,0.21,1,Biomarker
811,CALR,calreticulin,0.0,0.0,0.0,0.0,1.0,25205,"Melanoma, Experimental",0.21,1,Therapeutic
3456,IFNB1,"interferon, beta 1, fibroblast",0.0,0.0,0.0,0.0,1.0,25205,"Melanoma, Experimental",0.21,1,Therapeutic
5829,PXN,paxillin,0.0,1.0,0.0,0.0,0.0,25205,"Melanoma, Experimental",0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,42164,Uveitis,0.21,1,Biomarker
794,CALB2,calbindin 2,0.0,1.0,0.0,0.0,0.0,42164,Uveitis,0.21,1,Biomarker
1409,CRYAA,"crystallin, alpha A",0.0,1.0,0.0,0.0,0.0,42164,Uveitis,0.21,2,Biomarker
1415,CRYBB2,"crystallin, beta B2",0.0,1.0,0.0,0.0,0.0,42164,Uveitis,0.21,2,Biomarker
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),0.0,1.0,0.0,0.0,0.0,42164,Uveitis,0.21,1,Biomarker
6295,SAG,S-antigen; retina and pineal gland (arrestin),0.0,1.0,0.0,0.0,0.0,42164,Uveitis,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,42164,Uveitis,0.21,2,Biomarker
5171,PDR,"pigment disorder, reticulate",0.0,1.0,0.0,0.0,0.0,1845050,"Pigmentary Disorder, Reticulate, with Systemic Manifestations",0.21,0,Biomarker
192677,SLEN1,systemic lupus erythematosus with nephritis 1,0.0,1.0,0.0,0.0,0.0,1842757,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,206669,"Adenoma, Liver Cell",0.21,1,Biomarker
6793,STK10,serine/threonine kinase 10,0.0,0.0,1.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.21,1,GeneticVariation
2261,FGFR3,fibroblast growth factor receptor 3,0.0,0.0,1.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.21,0,GeneticVariation
1618,DAZL,deleted in azoospermia-like,0.0,1.0,0.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.21,1,Biomarker
8093,MGCT,male germ cell tumor,0.0,1.0,0.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.21,0,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.21,1,Biomarker
63978,PRDM14,PR domain containing 14,0.0,1.0,0.0,0.0,0.0,1336708,Testicular Germ Cell Tumor,0.21,1,Biomarker
10617,STAMBP,STAM binding protein,0.0,1.0,0.0,0.0,0.0,1842180,Capillary Malformation-Arteriovenous Malformation,0.21,1,Biomarker
10014,HDAC5,histone deacetylase 5,0.0,1.0,0.0,0.0,0.0,1546,Adjustment Disorders,0.21,1,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,1836302,Carotid Intimal Medial Thickness 1,0.21,0,Biomarker
781,CACNA2D1,"calcium channel, voltage-dependent, alpha 2/delta subunit 1",0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.21,3,Biomarker
7852,CXCR4,chemokine (C-X-C motif) receptor 4,0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.21,1,Biomarker
51083,GAL,galanin/GMAP prepropeptide,0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.21,1,Biomarker
2674,GFRA1,GDNF family receptor alpha 1,0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.21,1,Biomarker
2915,GRM5,"glutamate receptor, metabotropic 5",0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.21,1,Biomarker
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,27796,Neuralgia,0.21,1,Biomarker
1760,DMPK,dystrophia myotonica-protein kinase,0.0,1.0,0.0,0.0,0.0,27125,Myotonia,0.21,1,Biomarker
4154,MBNL1,muscleblind-like splicing regulator 1,0.0,0.0,0.0,0.0,1.0,27125,Myotonia,0.21,1,Therapeutic
84433,CARD11,"caspase recruitment domain family, member 11",0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
151887,CCDC80,coiled-coil domain containing 80,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
1234,CCR5,chemokine (C-C motif) receptor 5 (gene/pseudogene),0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
2720,GLB1,"galactosidase, beta 1",0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
282617,IFNL3,"interferon, lambda 3",0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
5599,MAPK8,mitogen-activated protein kinase 8,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
6556,SLC11A1,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1",0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
8876,VNN1,vanin 1,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
8875,VNN2,vanin 2,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
22891,ZNF365,zinc finger protein 365,0.0,1.0,0.0,0.0,0.0,11615,"Dermatitis, Atopic",0.21,1,Biomarker
3053,SERPIND1,"serpin peptidase inhibitor, clade D (heparin cofactor), member 1",0.0,1.0,0.0,0.0,0.0,1861172,Venous Thromboembolism,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,15397,Eye Diseases,0.21,1,Biomarker
23322,RPGRIP1L,RPGRIP1-like,0.0,1.0,0.0,0.0,0.0,15397,Eye Diseases,0.21,2,Biomarker
199,AIF1,allograft inflammatory factor 1,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
54541,DDIT4,DNA-damage-inducible transcript 4,0.0,0.0,0.0,0.0,1.0,30567,Parkinson Disease,0.21,1,Therapeutic
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
2203,FBP1,"fructose-1,6-bisphosphatase 1",0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
2244,FGB,fibrinogen beta chain,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,0.0,0.0,0.0,1.0,30567,Parkinson Disease,0.21,1,Therapeutic
3482,IGF2R,insulin-like growth factor 2 receptor,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
3643,INSR,insulin receptor,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
3761,KCNJ4,"potassium channel, inwardly rectifying subfamily J, member 4",0.0,0.0,0.0,0.0,1.0,30567,Parkinson Disease,0.21,1,Therapeutic
4099,MAG,myelin associated glycoprotein,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
9045,RPL14,ribosomal protein L14,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
6147,RPL23A,ribosomal protein L23a,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
6128,RPL6,ribosomal protein L6,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
6202,RPS8,ribosomal protein S8,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
6888,TALDO1,transaldolase 1,0.0,1.0,0.0,0.0,0.0,30567,Parkinson Disease,0.21,1,Biomarker
1815,DRD4,dopamine receptor D4,0.0,1.0,0.0,0.0,0.0,1527281,"Anxiety, Separation",0.21,1,Biomarker
5189,PEX1,peroxisomal biogenesis factor 1,0.0,1.0,0.0,0.0,0.0,3550234,PEROXISOME BIOGENESIS DISORDER 2B,0.21,0,Biomarker
5192,PEX10,peroxisomal biogenesis factor 10,0.0,1.0,0.0,0.0,0.0,3550234,PEROXISOME BIOGENESIS DISORDER 2B,0.21,0,Biomarker
5194,PEX13,peroxisomal biogenesis factor 13,0.0,1.0,0.0,0.0,0.0,3550234,PEROXISOME BIOGENESIS DISORDER 2B,0.21,0,Biomarker
55670,PEX26,peroxisomal biogenesis factor 26,0.0,1.0,0.0,0.0,0.0,3550234,PEROXISOME BIOGENESIS DISORDER 2B,0.21,0,Biomarker
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,1,Biomarker
598,BCL2L1,BCL2-like 1,0.0,0.0,0.0,0.0,1.0,1384666,Hearing Loss,0.21,1,Therapeutic
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,1,Biomarker
407053,MIR96,microRNA 96,0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,2,Biomarker
253827,MSRB3,methionine sulfoxide reductase B3,0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,1,Biomarker
4908,NTF3,neurotrophin 3,0.0,0.0,0.0,0.0,1.0,1384666,Hearing Loss,0.21,1,Therapeutic
6103,RPGR,retinitis pigmentosa GTPase regulator,0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,1,Biomarker
285590,SH3PXD2B,SH3 and PX domains 2B,0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,1,Biomarker
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,1,Biomarker
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,1,Biomarker
9414,TJP2,tight junction protein 2,0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,1,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,1384666,Hearing Loss,0.21,1,Biomarker
7937,RWS,Ragweed sensitivity,0.0,1.0,0.0,0.0,0.0,1867394,Ragweed Sensitivity,0.21,0,Biomarker
1297,COL9A1,"collagen, type IX, alpha 1",0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.21,1,Biomarker
2893,GRIA4,"glutamate receptor, ionotropic, AMPA 4",0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.21,1,Biomarker
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.21,1,Biomarker
56479,KCNQ5,"potassium channel, voltage gated KQT-like subfamily Q, member 5",0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.21,1,Biomarker
3908,LAMA2,"laminin, alpha 2",0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.21,1,Biomarker
100359401,MYP17,myopia 17,0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.21,0,Biomarker
393093,MYP4,"myopia 4 (high grade, autosomal dominant)",0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.21,0,Biomarker
646960,PRSS56,"protease, serine, 56",0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.21,1,Biomarker
4990,SIX6,SIX homeobox 6,0.0,1.0,0.0,0.0,0.0,27092,Myopia,0.21,1,Biomarker
10189,ALYREF,Aly/REF export factor,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
64411,ARAP3,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
393,ARHGAP4,Rho GTPase activating protein 4,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
396,ARHGDIA,Rho GDP dissociation inhibitor (GDI) alpha,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
329,BIRC2,baculoviral IAP repeat containing 2,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
7203,CCT3,"chaperonin containing TCP1, subunit 3 (gamma)",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
22948,CCT5,"chaperonin containing TCP1, subunit 5 (epsilon)",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10574,CCT7,"chaperonin containing TCP1, subunit 7 (eta)",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
1192,CLIC1,chloride intracellular channel 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10980,COPS6,COP9 signalosome subunit 6,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
7266,DNAJC7,"DnaJ (Hsp40) homolog, subfamily C, member 7",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
8662,EIF3B,"eukaryotic translation initiation factor 3, subunit B",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
1973,EIF4A1,eukaryotic translation initiation factor 4A1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
1978,EIF4EBP1,eukaryotic translation initiation factor 4E binding protein 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
3692,EIF6,eukaryotic translation initiation factor 6,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10436,EMG1,EMG1 N1-specific pseudouridine methyltransferase,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
1647,GADD45A,"growth arrest and DNA-damage-inducible, alpha",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
80273,GRPEL1,"GrpE-like 1, mitochondrial (E. coli)",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
2971,GTF3A,general transcription factor IIIA,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
3068,HDGF,hepatoma-derived growth factor,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10808,HSPH1,heat shock 105kDa/110kDa protein 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
3608,ILF2,interleukin enhancer binding factor 2,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
3837,KPNB1,karyopherin (importin) beta 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
4150,MAZ,MYC-associated zinc finger protein (purine-binding transcription factor),0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
4927,NUP88,nucleoporin 88kDa,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10204,NUTF2,nuclear transport factor 2,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5479,PPIB,peptidylprolyl isomerase B (cyclophilin B),0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10594,PRPF8,pre-mRNA processing factor 8,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5685,PSMA4,"proteasome (prosome, macropain) subunit, alpha type, 4",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5686,PSMA5,"proteasome (prosome, macropain) subunit, alpha type, 5",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5687,PSMA6,"proteasome (prosome, macropain) subunit, alpha type, 6",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5699,PSMB10,"proteasome (prosome, macropain) subunit, beta type, 10",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5692,PSMB4,"proteasome (prosome, macropain) subunit, beta type, 4",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5705,PSMC5,"proteasome (prosome, macropain) 26S subunit, ATPase, 5",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5719,PSMD13,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 13",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5709,PSMD3,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 3",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
9861,PSMD6,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 6",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5714,PSMD8,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 8",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5720,PSME1,"proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5721,PSME2,"proteasome (prosome, macropain) activator subunit 2 (PA28 beta)",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10197,PSME3,"proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
23198,PSME4,"proteasome (prosome, macropain) activator subunit 4",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5727,PTCH1,patched 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
9230,RAB11B,"RAB11B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10981,RAB32,"RAB32, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5901,RAN,"RAN, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
5902,RANBP1,RAN binding protein 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10946,SF3A3,"splicing factor 3a, subunit 3, 60kDa",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
6421,SFPQ,splicing factor proline/glutamine-rich,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
6634,SNRPD3,small nuclear ribonucleoprotein D3 polypeptide 18kDa,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
6722,SRF,serum response factor (c-fos serum response element-binding transcription factor),0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
6426,SRSF1,serine/arginine-rich splicing factor 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
8683,SRSF9,serine/arginine-rich splicing factor 9,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
6880,TAF9,"TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa",0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
7307,U2AF1,U2 small nuclear RNA auxiliary factor 1,0.0,1.0,0.0,0.0,0.0,19693,HIV Infections,0.21,1,Biomarker
79051,RPY,"Retinitis pigmentosa, Y-linked",0.0,1.0,0.0,0.0,0.0,1839079,"Retinitis Pigmentosa, Y-Linked",0.21,0,Biomarker
170595,IBD8,inflammatory bowel disease 8,0.0,1.0,0.0,0.0,0.0,1847719,Inflammatory Bowel Disease 8,0.21,0,Biomarker
3274,HRH2,histamine receptor H2,0.0,1.0,0.0,0.0,0.0,242231,Coronary Stenosis,0.21,1,Biomarker
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,0.0,0.0,0.0,242231,Coronary Stenosis,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,242231,Coronary Stenosis,0.21,1,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,242231,Coronary Stenosis,0.21,1,Biomarker
50823,HMU,"Hypotrichosis, Marie Unna type",0.0,1.0,0.0,0.0,0.0,2931059,Marie Unna congenital hypotrichosis,0.21,0,Biomarker
915,CD3D,"CD3d molecule, delta (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,1833275,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative",0.21,0,Biomarker
3575,IL7R,interleukin 7 receptor,0.0,1.0,0.0,0.0,0.0,1833275,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative",0.21,0,Biomarker
3236,HOXD10,homeobox D10,0.0,1.0,0.0,0.0,0.0,431943,"Lower Extremity Deformities, Congenital",0.21,1,Biomarker
5125,PCSK5,proprotein convertase subtilisin/kexin type 5,0.0,1.0,0.0,0.0,0.0,431943,"Lower Extremity Deformities, Congenital",0.21,1,Biomarker
5737,PTGFR,prostaglandin F receptor (FP),0.0,1.0,0.0,0.0,0.0,1883,Airway Obstruction,0.21,1,Biomarker
10449,ACAA2,acetyl-CoA acyltransferase 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
48,ACO1,"aconitase 1, soluble",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
205,AK4,adenylate kinase 4,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
1645,AKR1C1,"aldo-keto reductase family 1, member C1",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
1646,AKR1C2,"aldo-keto reductase family 1, member C2",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
8854,ALDH1A2,"aldehyde dehydrogenase 1 family, member A2",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
526,ATP6V1B2,"ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
1192,CLIC1,chloride intracellular channel 1,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
25932,CLIC4,chloride intracellular channel 4,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
1292,COL6A2,"collagen, type VI, alpha 2",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
27071,DAPP1,dual adaptor of phosphotyrosine and 3-phosphoinositides,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
1654,DDX3X,"DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
1808,DPYSL2,dihydropyrimidinase-like 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
1938,EEF2,eukaryotic translation elongation factor 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
2098,ESD,esterase D,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
2108,ETFA,"electron-transfer-flavoprotein, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
7430,EZR,ezrin,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
2512,FTL,"ferritin, light polypeptide",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
2744,GLS,glutaminase,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
10149,GPR64,G protein-coupled receptor 64,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
373156,GSTK1,glutathione S-transferase kappa 1,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
3030,HADHA,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
26275,HIBCH,3-hydroxyisobutyryl-CoA hydrolase,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
3418,IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
3419,IDH3A,isocitrate dehydrogenase 3 (NAD+) alpha,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
10989,IMMT,"inner membrane protein, mitochondrial",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
79763,ISOC2,isochorismatase domain containing 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
10536,P3H3,prolyl 3-hydroxylase 3,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
4054,LTBP3,latent transforming growth factor beta binding protein 3,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,2,Biomarker
4478,MSN,moesin,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
9961,MVP,major vault protein,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
8735,MYH13,"myosin, heavy chain 13, skeletal muscle",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
4728,NDUFS8,"NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase)",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
4831,NME2,NME/NM23 nucleoside diphosphate kinase 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
4976,OPA1,optic atrophy 1 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
100188821,OS4,"Osteoarthritis, generalized, without dysplasia, susceptibility to",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,0,Biomarker
100286836,OS6,Osteoarthritis susceptibility 6,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,0,Biomarker
10015,PDCD6IP,programmed cell death 6 interacting protein,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
5160,PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
5333,PLCD1,"phospholipase C, delta 1",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
5358,PLS3,plastin 3,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
5455,POU3F3,POU class 3 homeobox 3,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
5518,PPP2R1A,"protein phosphatase 2, regulatory subunit A, alpha",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
5689,PSMB1,"proteasome (prosome, macropain) subunit, beta type, 1",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
5901,RAN,"RAN, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
57333,RCN3,"reticulocalbin 3, EF-hand calcium binding domain",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
9805,SCRN1,secernin 1,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
6386,SDCBP,syndecan binding protein (syntenin),0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
6389,SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
10484,SEC23A,Sec23 homolog A (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
6445,SGCG,"sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
6513,SLC2A1,"solute carrier family 2 (facilitated glucose transporter), member 1",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
10131,TRAP1,TNF receptor-associated protein 1,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
7296,TXNRD1,thioredoxin reductase 1,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
7417,VDAC2,voltage-dependent anion channel 2,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,2,Biomarker
10971,YWHAQ,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta",0.0,1.0,0.0,0.0,0.0,29408,Osteoarthritis,0.21,1,Biomarker
2006,ELN,elastin,0.0,1.0,0.0,0.0,0.0,3276539,"CUTIS LAXA, AUTOSOMAL DOMINANT 1",0.21,0,Biomarker
10516,FBLN5,fibulin 5,0.0,1.0,0.0,0.0,0.0,3276539,"CUTIS LAXA, AUTOSOMAL DOMINANT 1",0.21,0,Biomarker
404677,CIMT,Carotid intimal medial thickness,0.0,1.0,0.0,0.0,0.0,1838020,CAROTID INTIMAL MEDIAL THICKNESS 2,0.21,0,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.21,1,Biomarker
64434,NOM1,nucleolar protein with MIF4G domain 1,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.21,1,Biomarker
10935,PRDX3,peroxiredoxin 3,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.21,1,Biomarker
10549,PRDX4,peroxiredoxin 4,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.21,1,Biomarker
22872,SEC31A,SEC31 homolog A (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.21,1,Biomarker
6649,SOD3,"superoxide dismutase 3, extracellular",0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.21,1,Biomarker
10628,TXNIP,thioredoxin interacting protein,0.0,1.0,0.0,0.0,0.0,79744,"Lymphoma, Large B-Cell, Diffuse",0.21,1,Biomarker
619538,OMS,"otitis media, susceptibility to",0.0,1.0,0.0,0.0,0.0,29882,Otitis Media,0.21,0,Biomarker
653361,NCF1,neutrophil cytosolic factor 1,0.0,1.0,0.0,0.0,0.0,162871,"Aortic Aneurysm, Abdominal",0.21,1,Biomarker
100188840,ASRT6,"Asthma-related traits, susceptibility to, 6",0.0,1.0,0.0,0.0,0.0,1969640,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6",0.21,0,Biomarker
283120,H19,"H19, imprinted maternally expressed transcript (non-protein coding)",0.0,1.0,0.0,0.0,0.0,1853800,Familial Wilms tumor 2,0.21,0,Biomarker
7491,WT2,Wilms tumor 2,0.0,1.0,0.0,0.0,0.0,1853800,Familial Wilms tumor 2,0.21,0,Biomarker
9970,NR1I3,"nuclear receptor subfamily 1, group I, member 3",0.0,1.0,0.0,0.0,0.0,524620,Metabolic Syndrome X,0.21,1,Biomarker
1670,DEFA5,"defensin, alpha 5, Paneth cell-specific",0.0,1.0,0.0,0.0,0.0,206677,Adenomatous Polyps,0.21,1,Biomarker
2031,ENUR1,"enuresis, nocturnal 1",0.0,1.0,0.0,0.0,0.0,270327,Nocturnal Enuresis,0.21,0,Biomarker
668,FOXL2,forkhead box L2,0.0,1.0,0.0,0.0,0.0,1862264,Bpes With Duane Retraction Syndrome,0.21,1,Biomarker
2572,GAD2,"glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)",0.0,1.0,0.0,0.0,0.0,11884,Diabetic Retinopathy,0.21,1,Biomarker
4264,MHS2,malignant hyperthermia susceptibility 2,0.0,1.0,0.0,0.0,0.0,2930981,Malignant hyperthermia susceptibility type 2,0.21,0,Biomarker
619399,ETL2,"epilepsy, familial temporal lobe",0.0,1.0,0.0,0.0,0.0,1842564,"Temporal epilepsy, familial",0.21,0,Biomarker
3260,HPV18I1,human papilloma virus (type 18) integration site 1,0.0,1.0,0.0,0.0,0.0,1415708,human papilloma virus (type 18) integration site 1,0.21,0,Biomarker
100188885,ANIB7,"Aneurysm, intracranial berry, 7",0.0,1.0,0.0,0.0,0.0,2677337,"Aneurysm, Intracranial Berry, 7",0.21,0,Biomarker
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,0.0,0.0,0.0,19618,Histiocytosis,0.21,1,Biomarker
84320,ACBD6,acyl-CoA binding domain containing 6,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
132,ADK,adenosine kinase,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
151,ADRA2B,adrenoceptor alpha 2B,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
54806,AHI1,Abelson helper integration site 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
7915,ALDH5A1,"aldehyde dehydrogenase 5 family, member A1",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
23431,AP4E1,"adaptor-related protein complex 4, epsilon 1 subunit",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
9179,AP4M1,"adaptor-related protein complex 4, mu 1 subunit",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
120534,ARL14EP,ADP-ribosylation factor-like 14 effector protein,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
10973,ASCC3,activating signal cointegrator 1 complex subunit 3,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
429,ASCL1,achaete-scute family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
55212,BBS7,Bardet-Biedl syndrome 7,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
113246,C12orf57,chromosome 12 open reading frame 57,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
767,CA8,carbonic anhydrase VIII,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
8913,CACNA1G,"calcium channel, voltage-dependent, T type, alpha 1G subunit",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
11132,CAPN10,calpain 10,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
835,CASP2,"caspase 2, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
147372,CCBE1,collagen and calcium binding EGF domains 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
890,CCNA2,cyclin A2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
23152,CIC,capicua transcriptional repressor,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
84735,CNDP1,carnosine dipeptidase 1 (metallopeptidase M20 family),0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,2,Biomarker
10256,CNKSR1,connector enhancer of kinase suppressor of Ras 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
80781,COL18A1,"collagen, type XVIII, alpha 1",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
84274,COQ5,"coenzyme Q5 homolog, methyltransferase (S. cerevisiae)",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
27185,DISC1,disrupted in schizophrenia 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
1933,EEF1B2,eukaryotic translation elongation factor 1 beta 2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
55250,ELP2,elongator acetyltransferase complex subunit 2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
953,ENTPD1,ectonucleoside triphosphate diphosphohydrolase 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
84668,FAM126A,"family with sequence similarity 126, member A",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
2194,FASN,fatty acid synthase,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
2290,FOXG1,forkhead box G1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
10129,FRY,furry homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
2593,GAMT,guanidinoacetate N-methyltransferase,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
54856,GON4L,gon-4-like (C. elegans),0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
3073,HEXA,hexosaminidase A (alpha polypeptide),0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
8366,HIST1H4B,"histone cluster 1, H4b",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
8290,HIST3H3,"histone cluster 3, H3",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
3631,INPP4A,"inositol polyphosphate-4-phosphatase, type I, 107kDa",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
56623,INPP5E,"inositol polyphosphate-5-phosphatase, 72 kDa",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
5927,KDM5A,lysine (K)-specific demethylase 5A,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
23135,KDM6B,lysine (K)-specific demethylase 6B,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
26128,KIAA1279,KIAA1279,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
374654,KIF7,kinesin family member 7,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
79944,L2HGDH,L-2-hydroxyglutarate dehydrogenase,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
284217,LAMA1,"laminin, alpha 1",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
51574,LARP7,"La ribonucleoprotein domain family, member 7",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
3954,LETM1,leucine zipper-EF-hand containing transmembrane protein 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
4163,MCC,mutated in colorectal cancers,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
4669,NAGLU,"N-acetylglucosaminidase, alpha",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
3340,NDST1,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
4763,NF1,neurofibromin 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
4909,NTF4,neurotrophin 4,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
8050,PDHX,"pyruvate dehydrogenase complex, component X",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
55825,PECR,peroxisomal trans-2-enoyl-CoA reductase,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
5190,PEX6,peroxisomal biogenesis factor 6,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
5373,PMM2,phosphomannomutase 2,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
55703,POLR3B,polymerase (RNA) III (DNA directed) polypeptide B,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
5582,PRKCG,"protein kinase C, gamma",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
8575,PRKRA,"protein kinase, interferon-inducible double stranded RNA dependent activator",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,5,Biomarker
116442,RAB39B,"RAB39B, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
55684,RABL6,"RAB, member RAS oncogene family-like 6",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
5900,RALGDS,ral guanine nucleotide dissociation stimulator,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
6000,RGS7,regulator of G-protein signaling 7,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
6309,SC5D,sterol-C5-desaturase,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
49855,SCAPER,S-phase cyclin A-associated protein in the ER,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
6334,SCN8A,"sodium channel, voltage gated, type VIII alpha subunit",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
1317,SLC31A1,"solute carrier family 31 (copper transporter), member 1",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
57282,SLC4A10,"solute carrier family 4, sodium bicarbonate transporter, member 10",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
79644,SRD5A3,steroid 5 alpha-reductase 3,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
6834,SURF1,surfeit 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
7054,TH,tyrosine hydroxylase,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
54499,TMCO1,transmembrane and coiled-coil domains 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
65084,TMEM135,transmembrane protein 135,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
55621,TRMT1,tRNA methyltransferase 1 homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
80746,TSEN2,TSEN2 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
79042,TSEN34,TSEN34 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
283989,TSEN54,TSEN54 tRNA splicing endonuclease subunit,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
55148,UBR7,ubiquitin protein ligase E3 component n-recognin 7 (putative),0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
131669,UROC1,urocanate hydratase 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
7443,VRK1,vaccinia related kinase 1,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
56270,WDR45B,WD repeat domain 45B,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
284403,WDR62,WD repeat domain 62,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
7528,YY1,YY1 transcription factor,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
9923,ZBTB40,zinc finger and BTB domain containing 40,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
55596,ZCCHC8,"zinc finger, CCHC domain containing 8",0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
116115,ZNF526,zinc finger protein 526,0.0,1.0,0.0,0.0,0.0,3714756,Intellectual Disability,0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
90,ACVR1,"activin A receptor, type I",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
102,ADAM10,ADAM metallopeptidase domain 10,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
174,AFP,alpha-fetoprotein,0.0,0.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21,1,Therapeutic
9590,AKAP12,A kinase (PRKA) anchor protein 12,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
226,ALDOA,"aldolase A, fructose-bisphosphate",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
10297,APC2,adenomatosis polyposis coli 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
200315,APOBEC3A,"apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
369,ARAF,"A-Raf proto-oncogene, serine/threonine kinase",0.0,0.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21,1,Therapeutic
396,ARHGDIA,Rho GDP dissociation inhibitor (GDI) alpha,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
57561,ARRDC3,arrestin domain containing 3,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
9048,ARTN,artemin,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
11067,C10orf10,chromosome 10 open reading frame 10,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
708,C1QBP,"complement component 1, q subcomponent binding protein",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
840,CASP7,"caspase 7, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6364,CCL20,chemokine (C-C motif) ligand 20,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
22948,CCT5,"chaperonin containing TCP1, subunit 5 (epsilon)",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
135228,CD109,CD109 molecule,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
978,CDA,cytidine deaminase,0.0,0.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21,1,Therapeutic
1072,CFL1,cofilin 1 (non-muscle),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
1192,CLIC1,chloride intracellular channel 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
27098,CLUL1,clusterin-like 1 (retinal),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
56942,CMC2,C-x(9)-C motif containing 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
1269,CNR2,cannabinoid receptor 2 (macrophage),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
1294,COL7A1,"collagen, type VII, alpha 1",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
23406,COTL1,coactosin-like F-actin binding protein 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
1374,CPT1A,carnitine palmitoyltransferase 1A (liver),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21,8,"Biomarker, Therapeutic"
7818,DAP3,death associated protein 3,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
28514,DLL1,delta-like 1 (Drosophila),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
1788,DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
196403,DTX3,"deltex 3, E3 ubiquitin ligase",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
1933,EEF1B2,eukaryotic translation elongation factor 1 beta 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
1942,EFNA1,ephrin-A1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
8894,EIF2S2,"eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
2004,ELK3,"ELK3, ETS-domain protein (SRF accessory protein 2)",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
2173,FABP7,"fatty acid binding protein 7, brain",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
151647,FAM19A4,"family with sequence similarity 19 (chemokine (C-C motif)-like), member A4",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
2091,FBL,fibrillarin,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
152273,FGD5,"FYVE, RhoGEF and PH domain containing 5",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
63943,FKBPL,FK506 binding protein like,0.0,0.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21,1,Therapeutic
79068,FTO,fat mass and obesity associated,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
2662,GDF10,growth differentiation factor 10,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
2821,GPI,glucose-6-phosphate isomerase,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
2877,GPX2,glutathione peroxidase 2 (gastrointestinal),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
2977,GUCY1A2,"guanylate cyclase 1, soluble, alpha 2",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3032,HADHB,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
23462,HEY1,hes-related family bHLH transcription factor with YRPW motif 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
23493,HEY2,hes-related family bHLH transcription factor with YRPW motif 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3087,HHEX,hematopoietically expressed homeobox,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3090,HIC1,hypermethylated in cancer 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3006,HIST1H1C,"histone cluster 1, H1c",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
8347,HIST1H2BC,"histone cluster 1, H2bc",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
85236,HIST1H2BK,"histone cluster 1, H2bk",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3190,HNRNPK,heterogeneous nuclear ribonucleoprotein K,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3191,HNRNPL,heterogeneous nuclear ribonucleoprotein L,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
10236,HNRNPR,heterogeneous nuclear ribonucleoprotein R,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3237,HOXD11,homeobox D11,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3304,HSPA1B,heat shock 70kDa protein 1B,0.0,0.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21,1,Therapeutic
3476,IGBP1,immunoglobulin (CD79A) binding protein 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3714,JAG2,jagged 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
92483,LDHAL6B,lactate dehydrogenase A-like 6B,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
3945,LDHB,lactate dehydrogenase B,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
59352,LGR6,leucine-rich repeat containing G protein-coupled receptor 6,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,2,Biomarker
3996,LLGL1,lethal giant larvae homolog 1 (Drosophila),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
4046,LSP1,lymphocyte-specific protein 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,2,Biomarker
2122,MECOM,MDS1 and EVI1 complex locus,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
9968,MED12,mediator complex subunit 12,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
4211,MEIS1,Meis homeobox 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
131965,METTL6,methyltransferase like 6,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
406894,MIR101-2,microRNA 101-2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
406902,MIR10A,microRNA 10a,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
406914,MIR127,microRNA 127,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
406921,MIR132,microRNA 132,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
406933,MIR141,microRNA 141,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
406937,MIR145,microRNA 145,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
406984,MIR200B,microRNA 200b,0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21,2,"Biomarker, Therapeutic"
406985,MIR200C,microRNA 200c,0.0,1.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21,2,"Biomarker, Therapeutic"
407021,MIR29A,microRNA 29a,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
442910,MIR345,microRNA 345,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
554210,MIR429,microRNA 429,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
574442,MIR489,microRNA 489,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
28998,MRPL13,mitochondrial ribosomal protein L13,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
65005,MRPL9,mitochondrial ribosomal protein L9,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
56945,MRPS22,mitochondrial ribosomal protein S22,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
51649,MRPS23,mitochondrial ribosomal protein S23,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
28957,MRPS28,mitochondrial ribosomal protein S28,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
51081,MRPS7,mitochondrial ribosomal protein S7,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
4722,NDUFS3,"NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
4792,NFKBIA,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
4829,NMBR,neuromedin B receptor,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
161424,NOP9,NOP9 nucleolar protein,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
4835,NQO2,"NAD(P)H dehydrogenase, quinone 2",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,0,Biomarker
2063,NR2F6,"nuclear receptor subfamily 2, group F, member 6",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
4897,NRCAM,neuronal cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
318,NUDT2,nudix (nucleoside diphosphate linked moiety X)-type motif 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
26986,PABPC1,"poly(A) binding protein, cytoplasmic 1",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
56100,PCDHGB6,"protocadherin gamma subfamily B, 6",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
5138,PDE2A,"phosphodiesterase 2A, cGMP-stimulated",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
8863,PER3,period circadian clock 3,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
5789,PTPRD,"protein tyrosine phosphatase, receptor type, D",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
5889,RAD51C,RAD51 paralog C,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
138046,RALYL,RALY RNA binding protein-like,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
9185,REPS2,RALBP1 associated Eps domain containing 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
5997,RGS2,regulator of G-protein signaling 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
26150,RIBC2,RIB43A domain with coiled-coils 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
221687,RNF182,ring finger protein 182,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6147,RPL23A,ribosomal protein L23a,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6160,RPL31,ribosomal protein L31,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6191,RPS4X,"ribosomal protein S4, X-linked",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6194,RPS6,ribosomal protein S6,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6201,RPS7,ribosomal protein S7,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6202,RPS8,ribosomal protein S8,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6236,RRAD,Ras-related associated with diabetes,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
84870,RSPO3,R-spondin 3,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6257,RXRB,"retinoid X receptor, beta",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
5055,SERPINB2,"serpin peptidase inhibitor, clade B (ovalbumin), member 2",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6492,SIM1,single-minded family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
6514,SLC2A2,"solute carrier family 2 (facilitated glucose transporter), member 2",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
10599,SLCO1B1,"solute carrier organic anion transporter family, member 1B1",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
9754,STARD8,StAR-related lipid transfer (START) domain containing 8,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
23345,SYNE1,"spectrin repeat containing, nuclear envelope 1",0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
8871,SYNJ2,synaptojanin 2,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
10010,TANK,TRAF family member-associated NFKB activator,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
9623,TCL1B,T-cell leukemia/lymphoma 1B,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
9473,THEMIS2,thymocyte selection associated family member 2,0.0,0.0,0.0,0.0,1.0,1458155,Breast Neoplasms,0.21,1,Therapeutic
7090,TLE3,transducin-like enhancer of split 3,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
84866,TMEM25,transmembrane protein 25,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
10318,TNIP1,TNFAIP3 interacting protein 1,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
11065,UBE2C,ubiquitin-conjugating enzyme E2C,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,2,Biomarker
23339,VPS39,vacuolar protein sorting 39 homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
9877,ZC3H11A,zinc finger CCCH-type containing 11A,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
22891,ZNF365,zinc finger protein 365,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
9668,ZNF432,zinc finger protein 432,0.0,1.0,0.0,0.0,0.0,1458155,Breast Neoplasms,0.21,1,Biomarker
84634,KISS1R,KISS1 receptor,0.0,0.0,1.0,0.0,0.0,3805879,"PRECOCIOUS PUBERTY, CENTRAL, 1",0.21,0,GeneticVariation
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,33575,Prostatic Diseases,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,23269,Leiomyosarcoma,0.21,1,Therapeutic
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,23269,Leiomyosarcoma,0.21,1,Biomarker
1540,CYLD,cylindromatosis (turban tumor syndrome),0.0,1.0,0.0,0.0,0.0,23860,Listeriosis,0.21,1,Biomarker
9457,FHL5,four and a half LIM domains 5,0.0,1.0,0.0,0.0,0.0,149931,Migraine Disorders,0.21,1,Biomarker
192115,MGR1,"Migraine with aura, susceptibility to",0.0,1.0,0.0,0.0,0.0,149931,Migraine Disorders,0.21,0,Biomarker
100188851,MGR12,"Migraine, with or without aura, susceptibility to, 12",0.0,1.0,0.0,0.0,0.0,149931,Migraine Disorders,0.21,0,Biomarker
337892,MGR3,"Migraine, familial, with or without aura, susceptibility to",0.0,1.0,0.0,0.0,0.0,149931,Migraine Disorders,0.21,0,Biomarker
387576,MGR5,"Migraine with or without aura, susceptibility to, 5",0.0,1.0,0.0,0.0,0.0,149931,Migraine Disorders,0.21,0,Biomarker
100188790,MGR8,"Migraine, susceptibility to, 8",0.0,1.0,0.0,0.0,0.0,149931,Migraine Disorders,0.21,0,Biomarker
79783,SUGCT,succinyl-CoA:glutarate-CoA transferase,0.0,1.0,0.0,0.0,0.0,149931,Migraine Disorders,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,19212,Hepatorenal Syndrome,0.21,1,Biomarker
4330,MN1,meningioma (disrupted in balanced translocation) 1,0.0,1.0,0.0,0.0,0.0,1333989,"Meningioma, familial",0.21,0,Biomarker
4771,NF2,neurofibromin 2 (merlin),0.0,1.0,0.0,0.0,0.0,1333989,"Meningioma, familial",0.21,0,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,1333989,"Meningioma, familial",0.21,0,Biomarker
641433,RP32,retinitis pigmentosa 32 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,1835927,Retinitis Pigmentosa 32,0.21,0,Biomarker
9896,FIG4,FIG4 phosphoinositide 5-phosphatase,0.0,0.0,1.0,0.0,0.0,2675191,"Polymicrogyria, Bilateral Occipital",0.21,0,GeneticVariation
100294715,BOP,"Polymicrogyria, bilateral occipital",0.0,1.0,0.0,0.0,0.0,2675191,"Polymicrogyria, Bilateral Occipital",0.21,0,Biomarker
386616,SCKL3,Seckel syndrome 3,0.0,1.0,0.0,0.0,0.0,1837590,Seckel Syndrome 3,0.21,0,Biomarker
10324,KLHL41,kelch-like family member 41,0.0,0.0,1.0,0.0,0.0,3810384,NEMALINE MYOPATHY 9,0.21,1,GeneticVariation
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,282193,Iron Overload,0.21,1,Biomarker
93999,OTSC2,otosclerosis 2,0.0,1.0,0.0,0.0,0.0,1854022,Otosclerosis 2,0.21,0,Biomarker
2641,GCG,glucagon,0.0,1.0,0.0,0.0,0.0,37763,Spasm,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,37763,Spasm,0.21,4,Biomarker
100240736,DEL11P15P14,Chromosome 11p15-p14 deletion syndrome,0.0,1.0,0.0,0.0,0.0,1847866,Homozygous 11p15-p14 Deletion Syndrome,0.21,0,Biomarker
442913,MIR376C,microRNA 376c,0.0,1.0,0.0,0.0,0.0,677886,Ovarian epithelial cancer,0.21,1,Biomarker
50830,TGCT1,testicular germ cell tumor susceptibility 1,0.0,1.0,0.0,0.0,0.0,1846164,Testicular Germ Cell Tumor 1,0.21,0,Biomarker
1493,CTLA4,cytotoxic T-lymphocyte-associated protein 4,0.0,1.0,0.0,0.0,0.0,1832392,"Diabetes Mellitus, Insulin-Dependent, 12",0.21,0,Biomarker
55534,MAML3,mastermind-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,1710096,Sinonasal undifferentiated carcinoma,0.21,1,Biomarker
5077,PAX3,paired box 3,0.0,1.0,0.0,0.0,0.0,1710096,Sinonasal undifferentiated carcinoma,0.21,1,Biomarker
6104,RP6,retinitis pigmentosa 6 (X-linked recessive),0.0,1.0,0.0,0.0,0.0,1839368,Retinitis Pigmentosa 6,0.21,0,Biomarker
100240731,DEL15Q15.3,Deafness and male infertility,0.0,1.0,0.0,0.0,0.0,1970187,"Deafness, Sensorineural, And Male Infertility",0.21,0,Biomarker
3248,HPGD,hydroxyprostaglandin dehydrogenase 15-(NAD),0.0,0.0,0.0,0.0,1.0,206693,"Carcinoma, Medullary",0.21,1,Therapeutic
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,18681,Headache,0.21,1,Biomarker
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,1.0,0.0,0.0,0.0,18681,Headache,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,18681,Headache,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,18681,Headache,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,242706,Hyperoxia,0.21,1,Biomarker
7132,TNFRSF1A,"tumor necrosis factor receptor superfamily, member 1A",0.0,1.0,0.0,0.0,0.0,242706,Hyperoxia,0.21,1,Biomarker
325,APCS,"amyloid P component, serum",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
487,ATP2A1,"ATPase, Ca++ transporting, cardiac muscle, fast twitch 1",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
1431,CS,citrate synthase,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
10516,FBLN5,fibulin 5,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,18801,Heart Failure,0.21,1,Therapeutic
2879,GPX4,glutathione peroxidase 4,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
2932,GSK3B,glycogen synthase kinase 3 beta,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
3315,HSPB1,heat shock 27kDa protein 1,0.0,0.0,0.0,0.0,1.0,18801,Heart Failure,0.21,1,Therapeutic
3357,HTR2B,"5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
3688,ITGB1,"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
5609,MAP2K7,mitogen-activated protein kinase kinase 7,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
27035,NOX1,NADPH oxidase 1,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
8204,NRIP1,nuclear receptor interacting protein 1,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
4973,OLR1,oxidized low density lipoprotein (lectin-like) receptor 1,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,5,Biomarker
6649,SOD3,"superoxide dismutase 3, extracellular",0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
90226,UCN2,urocortin 2,0.0,0.0,0.0,0.0,1.0,18801,Heart Failure,0.21,1,Therapeutic
7450,VWF,von Willebrand factor,0.0,1.0,0.0,0.0,0.0,18801,Heart Failure,0.21,1,Biomarker
100188801,ASRT3,"Asthma-related traits, susceptibility to, 3",0.0,1.0,0.0,0.0,0.0,1864959,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3",0.21,0,Biomarker
255,ALS5,amyotrophic lateral sclerosis 5,0.0,1.0,0.0,0.0,0.0,1865864,Amyotrophic Lateral Sclerosis 5,0.21,0,Biomarker
404715,PAFC,"Preauricular fistulae, congenital",0.0,1.0,0.0,0.0,0.0,546969,"Preauricular Fistulae, Congenital",0.21,0,Biomarker
100359393,SCA30,spinocerebellar ataxia 30,0.0,1.0,0.0,0.0,0.0,2936793,Spinocerebellar ataxia 30,0.21,0,Biomarker
354,KLK3,kallikrein-related peptidase 3,0.0,1.0,0.0,0.0,0.0,1334615,Phyllodes Tumor of the Prostate,0.21,1,Biomarker
9215,LARGE,like-glycosyltransferase,0.0,1.0,0.0,0.0,0.0,265221,Walker-Warburg Syndrome,0.21,0,Biomarker
100312954,GRD1,"Graves disease, susceptiblity to, 1",0.0,1.0,0.0,0.0,0.0,18213,Graves Disease,0.21,0,Biomarker
117189,GRDX,"Graves disease, susceptibility to, X-linked",0.0,1.0,0.0,0.0,0.0,18213,Graves Disease,0.21,0,Biomarker
1012,CDH13,cadherin 13,0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
1592,CYP26A1,"cytochrome P450, family 26, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
2520,GAST,gastrin,0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
4170,MCL1,myeloid cell leukemia 1,0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
8856,NR1I2,"nuclear receptor subfamily 1, group I, member 2",0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
56475,RPRM,"reprimo, TP53 dependent G2 arrest mediator candidate",0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
6548,SLC9A1,"solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1",0.0,1.0,0.0,0.0,0.0,4763,Barrett Esophagus,0.21,1,Biomarker
2252,FGF7,fibroblast growth factor 7,0.0,1.0,0.0,0.0,0.0,17566,Gingival Hyperplasia,0.21,1,Biomarker
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,1.0,0.0,0.0,0.0,17566,Gingival Hyperplasia,0.21,1,Biomarker
100529149,DER22T8-22,Supernumerary der(22)t(8-22) syndrome,0.0,1.0,0.0,0.0,0.0,3150966,SUPERNUMERARY DER(22)t(8,0.21,0,Biomarker
140907,SPG19,spastic paraplegia 19 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1846685,"Spastic paraplegia 19, autosomal dominant",0.21,0,Biomarker
3624,INHBA,"inhibin, beta A",0.0,1.0,0.0,0.0,0.0,23267,Leiomyoma,0.21,1,Biomarker
7249,TSC2,tuberous sclerosis 2,0.0,1.0,0.0,0.0,0.0,23267,Leiomyoma,0.21,1,Biomarker
78989,COLEC11,collectin sub-family member 11,0.0,1.0,0.0,0.0,0.0,549567,Pigmentation Disorders,0.21,1,Biomarker
3861,KRT14,"keratin 14, type I",0.0,1.0,0.0,0.0,0.0,549567,Pigmentation Disorders,0.21,1,Biomarker
5648,MASP1,mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor),0.0,1.0,0.0,0.0,0.0,549567,Pigmentation Disorders,0.21,1,Biomarker
4358,MPV17,MpV17 mitochondrial inner membrane protein,0.0,1.0,0.0,0.0,0.0,549567,Pigmentation Disorders,0.21,1,Biomarker
51251,NT5C3A,"5'-nucleotidase, cytosolic IIIA",0.0,1.0,0.0,0.0,0.0,2882,"Anemia, Hemolytic, Congenital Nonspherocytic",0.21,1,Biomarker
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,2882,"Anemia, Hemolytic, Congenital Nonspherocytic",0.21,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,38833,Superior Vena Cava Syndrome,0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
239,ALOX12,arachidonate 12-lipoxygenase,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
8912,CACNA1H,"calcium channel, voltage-dependent, T type, alpha 1H subunit",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
781,CACNA2D1,"calcium channel, voltage-dependent, alpha 2/delta subunit 1",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,2,Biomarker
815,CAMK2A,calcium/calmodulin-dependent protein kinase II alpha,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
9607,CARTPT,CART prepropeptide,0.0,0.0,0.0,0.0,1.0,20429,Hyperalgesia,0.21,1,Therapeutic
1268,CNR1,cannabinoid receptor 1 (brain),0.0,0.0,0.0,0.0,1.0,20429,Hyperalgesia,0.21,1,Therapeutic
1445,CSK,c-src tyrosine kinase,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,2,Biomarker
51083,GAL,galanin/GMAP prepropeptide,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
3231,HOXD1,homeobox D1,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,0.0,0.0,1.0,20429,Hyperalgesia,0.21,1,Therapeutic
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,20429,Hyperalgesia,0.21,1,Therapeutic
3643,INSR,insulin receptor,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
3673,ITGA2,"integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
5598,MAPK7,mitogen-activated protein kinase 7,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
4157,MC1R,melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor),0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
4359,MPZ,myelin protein zero,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,2,Biomarker
4908,NTF3,neurotrophin 3,0.0,0.0,0.0,0.0,1.0,20429,Hyperalgesia,0.21,1,Therapeutic
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
22953,P2RX2,"purinergic receptor P2X, ligand gated ion channel, 2",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
5024,P2RX3,"purinergic receptor P2X, ligand gated ion channel, 3",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
5582,PRKCG,"protein kinase C, gamma",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
60675,PROK2,prokineticin 2,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
10887,PROKR1,prokineticin receptor 1,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
5731,PTGER1,"prostaglandin E receptor 1 (subtype EP1), 42kDa",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
5894,RAF1,"Raf-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
11280,SCN11A,"sodium channel, voltage gated, type XI alpha subunit",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
57468,SLC12A5,"solute carrier family 12 (potassium/chloride transporter), member 5",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
6854,SYN2,synapsin II,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,9,Biomarker
6869,TACR1,tachykinin receptor 1,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,2,Biomarker
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",0.0,0.0,0.0,0.0,1.0,20429,Hyperalgesia,0.21,1,Therapeutic
8989,TRPA1,"transient receptor potential cation channel, subfamily A, member 1",0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,3,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,20429,Hyperalgesia,0.21,1,Biomarker
100415903,HWE1,"Epilepsy, hot water, 1",0.0,1.0,0.0,0.0,0.0,393729,Aquagenic epilepsy,0.21,0,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,15644,Fasciculation,0.21,1,Biomarker
478,ATP1A3,"ATPase, Na+/K+ transporting, alpha 3 polypeptide",0.0,1.0,0.0,0.0,0.0,242698,"Ventricular Dysfunction, Left",0.21,1,Biomarker
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,0.0,0.0,0.0,1.0,242698,"Ventricular Dysfunction, Left",0.21,1,Therapeutic
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,1.0,242698,"Ventricular Dysfunction, Left",0.21,2,"Biomarker, Therapeutic"
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,242698,"Ventricular Dysfunction, Left",0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,242698,"Ventricular Dysfunction, Left",0.21,1,Biomarker
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,242698,"Ventricular Dysfunction, Left",0.21,1,Therapeutic
55600,ITLN1,intelectin 1 (galactofuranose binding),0.0,0.0,0.0,0.0,1.0,242698,"Ventricular Dysfunction, Left",0.21,1,Therapeutic
4306,NR3C2,"nuclear receptor subfamily 3, group C, member 2",0.0,1.0,0.0,0.0,0.0,242698,"Ventricular Dysfunction, Left",0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,242698,"Ventricular Dysfunction, Left",0.21,1,Biomarker
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,0.0,0.0,0.0,242698,"Ventricular Dysfunction, Left",0.21,1,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,30849,Penile Neoplasms,0.21,1,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,30849,Penile Neoplasms,0.21,1,Biomarker
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,0.0,0.0,0.0,30849,Penile Neoplasms,0.21,1,Biomarker
25913,POT1,protection of telomeres 1,0.0,1.0,0.0,0.0,0.0,8626,Chromosome Disorders,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,4045,Asphyxia Neonatorum,0.21,1,Biomarker
5663,PSEN1,presenilin 1,0.0,1.0,0.0,0.0,0.0,4045,Asphyxia Neonatorum,0.21,1,Biomarker
5664,PSEN2,presenilin 2,0.0,1.0,0.0,0.0,0.0,4045,Asphyxia Neonatorum,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,4045,Asphyxia Neonatorum,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,4045,Asphyxia Neonatorum,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,4045,Asphyxia Neonatorum,0.21,1,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,20651,"Hypotension, Orthostatic",0.21,1,Biomarker
4985,OPRD1,"opioid receptor, delta 1",0.0,1.0,0.0,0.0,0.0,20651,"Hypotension, Orthostatic",0.21,1,Biomarker
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,20651,"Hypotension, Orthostatic",0.21,1,Biomarker
3439,IFNA1,"interferon, alpha 1",0.0,1.0,0.0,0.0,0.0,1175,Acquired Immunodeficiency Syndrome,0.21,1,Biomarker
2034,EPAS1,endothelial PAS domain protein 1,0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,1,Biomarker
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,1,Biomarker
2952,GSTT1,glutathione S-transferase theta 1,0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,3,Biomarker
9,NAT1,N-acetyltransferase 1 (arylamine N-acetyltransferase),0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,1,Biomarker
25913,POT1,protection of telomeres 1,0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,1,Biomarker
6817,SULT1A1,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1",0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,1,Biomarker
6799,SULT1A2,"sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2",0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,1,Biomarker
7508,XPC,"xeroderma pigmentosum, complementation group C",0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,1,Biomarker
7518,XRCC4,X-ray repair complementing defective repair in Chinese hamster cells 4,0.0,1.0,0.0,0.0,0.0,8625,Chromosome Aberrations,0.21,1,Biomarker
55636,CHD7,chromodomain helicase DNA binding protein 7,0.0,0.0,1.0,0.0,0.0,3552553,HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA,0.21,0,GeneticVariation
553192,MYP8,myopia 8,0.0,1.0,0.0,0.0,0.0,1836505,Myopia 8,0.21,0,Biomarker
4256,MGP,matrix Gla protein,0.0,1.0,0.0,0.0,0.0,342649,Vascular Calcification,0.21,1,Biomarker
118429,ANTXR2,anthrax toxin receptor 2,0.0,1.0,0.0,0.0,0.0,221204,Osteolysis,0.21,1,Biomarker
3381,IBSP,integrin-binding sialoprotein,0.0,1.0,0.0,0.0,0.0,221204,Osteolysis,0.21,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,221204,Osteolysis,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,221204,Osteolysis,0.21,1,Biomarker
4982,TNFRSF11B,"tumor necrosis factor receptor superfamily, member 11b",0.0,0.0,0.0,0.0,1.0,221204,Osteolysis,0.21,1,Therapeutic
8600,TNFSF11,"tumor necrosis factor (ligand) superfamily, member 11",0.0,1.0,0.0,0.0,0.0,221204,Osteolysis,0.21,1,Biomarker
80169,CTC1,CTS telomere maintenance complex component 1,0.0,1.0,0.0,0.0,0.0,267211,Gastric Antral Vascular Ectasia,0.21,1,Biomarker
768,CA9,carbonic anhydrase IX,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.21,1,Biomarker
147381,CBLN2,cerebellin 2 precursor,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.21,1,Biomarker
6346,CCL1,chemokine (C-C motif) ligand 1,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.21,1,Biomarker
959,CD40LG,CD40 ligand,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.21,1,Biomarker
10516,FBLN5,fibulin 5,0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.21,1,Biomarker
5592,PRKG1,"protein kinase, cGMP-dependent, type I",0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,20542,"Hypertension, Pulmonary",0.21,1,Biomarker
10232,MSLN,mesothelin,0.0,1.0,0.0,0.0,0.0,3714739,"Neoplasms, Mesothelial",0.21,2,Biomarker
246260,BDA1B,"Brachydactyly, type A1, locus B",0.0,1.0,0.0,0.0,0.0,1862151,Brachydactyly type A1,0.21,0,Biomarker
6389,SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",0.0,0.0,1.0,0.0,0.0,3150898,"CARDIOMYOPATHY, DILATED, 1GG",0.21,0,GeneticVariation
5885,RAD21,RAD21 homolog (S. pombe),0.0,1.0,0.0,0.0,0.0,23470,"Leukemia, Myeloid",0.21,1,Biomarker
26040,SETBP1,SET binding protein 1,0.0,1.0,0.0,0.0,0.0,23470,"Leukemia, Myeloid",0.21,1,Biomarker
8243,SMC1A,structural maintenance of chromosomes 1A,0.0,1.0,0.0,0.0,0.0,23470,"Leukemia, Myeloid",0.21,1,Biomarker
9126,SMC3,structural maintenance of chromosomes 3,0.0,1.0,0.0,0.0,0.0,23470,"Leukemia, Myeloid",0.21,1,Biomarker
10735,STAG2,stromal antigen 2,0.0,1.0,0.0,0.0,0.0,23470,"Leukemia, Myeloid",0.21,1,Biomarker
7155,TOP2B,topoisomerase (DNA) II beta 180kDa,0.0,0.0,0.0,0.0,1.0,23470,"Leukemia, Myeloid",0.21,1,Therapeutic
1866,DYT7,"dystonia 7, torsion (autosomal dominant)",0.0,1.0,0.0,0.0,0.0,1865818,Torsion dystonia 7,0.21,0,Biomarker
10142,AKAP9,A kinase (PRKA) anchor protein 9,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
239,ALOX12,arachidonate 12-lipoxygenase,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
6314,ATXN7,ataxin 7,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
6364,CCL20,chemokine (C-C motif) ligand 20,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
414062,CCL3L3,chemokine (C-C motif) ligand 3-like 3,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
6351,CCL4,chemokine (C-C motif) ligand 4,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
2921,CXCL3,chemokine (C-X-C motif) ligand 3,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
4616,GADD45B,"growth arrest and DNA-damage-inducible, beta",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
2803,GOLGA4,golgin A4,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
3398,ID2,"inhibitor of DNA binding 2, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
8870,IER3,immediate early response 3,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
3759,KCNJ2,"potassium channel, inwardly rectifying subfamily J, member 2",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
9562,MINPP1,multiple inositol-polyphosphate phosphatase 1,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
118856,MMP21,matrix metallopeptidase 21,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
10443,N4BP2L2,NEDD4 binding protein 2-like 2,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
4714,NDUFB8,"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
4929,NR4A2,"nuclear receptor subfamily 4, group A, member 2",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
57162,PELI1,pellino E3 ubiquitin protein ligase 1,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
5209,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
8554,PIAS1,"protein inhibitor of activated STAT, 1",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
5652,PRSS8,"protease, serine, 8",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
5806,PTX3,"pentraxin 3, long",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
5991,RFX3,"regulatory factor X, 3 (influences HLA class II expression)",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
5996,RGS1,regulator of G-protein signaling 1,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
22902,RUFY3,RUN and FYVE domain containing 3,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
6421,SFPQ,splicing factor proline/glutamine-rich,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
6498,SKIL,SKI-like proto-oncogene,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
54345,SOX18,SRY (sex determining region Y)-box 18,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
6730,SRP68,signal recognition particle 68kDa,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
6742,SSBP1,"single-stranded DNA binding protein 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
79101,TAF1D,"TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
7130,TNFAIP6,"tumor necrosis factor, alpha-induced protein 6",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
23043,TNIK,TRAF2 and NCK interacting kinase,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
29896,TRA2A,transformer 2 alpha homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
7109,TRAPPC10,trafficking protein particle complex 10,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
7324,UBE2E1,ubiquitin-conjugating enzyme E2E 1,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
8615,USO1,USO1 vesicle transport factor,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
8975,USP13,ubiquitin specific peptidase 13 (isopeptidase T-3),0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
54469,ZFAND6,"zinc finger, AN1-type domain 6",0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
10308,ZNF267,zinc finger protein 267,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
55422,ZNF331,zinc finger protein 331,0.0,1.0,0.0,0.0,0.0,37274,Skin Diseases,0.21,1,Biomarker
117187,ATOD3,"Dermatitis, atopic, 3",0.0,1.0,0.0,0.0,0.0,1853964,"Dermatitis, Atopic, 3",0.21,0,Biomarker
7439,BEST1,bestrophin 1,0.0,1.0,0.0,0.0,0.0,1828210,"Macular dystrophy, concentric annular",0.21,0,Biomarker
256297,PTF1A,"pancreas specific transcription factor, 1a",0.0,1.0,0.0,0.0,0.0,1850096,"Pancreatic Agenesis, Congenital",0.21,2,Biomarker
9855,FARP2,"FERM, RhoGEF and pleckstrin domain protein 2",0.0,1.0,0.0,0.0,0.0,2931817,Chromosome 2q37 deletion syndrome,0.21,1,Biomarker
3069,HDLBP,high density lipoprotein binding protein,0.0,1.0,0.0,0.0,0.0,2931817,Chromosome 2q37 deletion syndrome,0.21,1,Biomarker
23178,PASK,PAS domain containing serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,2931817,Chromosome 2q37 deletion syndrome,0.21,1,Biomarker
5770,PTPN1,"protein tyrosine phosphatase, non-receptor type 1",0.0,1.0,0.0,0.0,0.0,25063,Mediastinal Neoplasms,0.21,1,Biomarker
93983,DYT13,"dystonia 13, torsion",0.0,1.0,0.0,0.0,0.0,1843264,"Dystonia 13, Torsion",0.21,0,Biomarker
10512,SEMA3C,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C",0.0,1.0,0.0,0.0,0.0,41207,"Truncus Arteriosus, Persistent",0.21,1,Biomarker
100271923,10-Feb,"Febrile convulsions, familial, 10",0.0,1.0,0.0,0.0,0.0,2675251,"Febrile Convulsions, Familial, 10",0.21,0,Biomarker
5961,PRPH2,"peripherin 2 (retinal degeneration, slow)",0.0,1.0,0.0,0.0,0.0,311338,Fundus Albipunctatus,0.21,0,Biomarker
23646,PLD3,"phospholipase D family, member 3",0.0,0.0,1.0,0.0,0.0,3810349,ALZHEIMER DISEASE 19,0.21,1,GeneticVariation
2233,1-Feb,febrile convulsions 1,0.0,1.0,0.0,0.0,0.0,3501856,"Febrile Convulsions, Familial, 1",0.21,0,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,32787,Postoperative Complications,0.21,1,Biomarker
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,0.0,0.0,0.0,1.0,32787,Postoperative Complications,0.21,1,Therapeutic
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,0.0,32787,Postoperative Complications,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,32787,Postoperative Complications,0.21,1,Biomarker
100380874,FECD5,"Corneal dystrophy, Fuchs endothelial, 5",0.0,1.0,0.0,0.0,0.0,2750449,"Corneal Dystrophy, Fuchs Endothelial, 5",0.21,0,Biomarker
694,BTG1,"B-cell translocation gene 1, anti-proliferative",0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.21,1,Biomarker
23492,CBX7,chromobox homolog 7,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.21,1,Biomarker
170680,PSORS1C2,psoriasis susceptibility 1 candidate 2,0.0,1.0,0.0,0.0,0.0,26764,Multiple Myeloma,0.21,1,Biomarker
8314,BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),0.0,1.0,0.0,0.0,0.0,206769,Nevi and Melanomas,0.21,1,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,2,Biomarker
229,ALDOB,"aldolase B, fructose-bisphosphate",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
259,AMBP,alpha-1-microglobulin/bikunin precursor,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
335,APOA1,apolipoprotein A-I,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
350,APOH,apolipoprotein H (beta-2-glycoprotein I),0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
383,ARG1,arginase 1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
405,ARNT,aryl hydrocarbon receptor nuclear translocator,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
9474,ATG5,autophagy related 5,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
686,BTD,biotinidase,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
718,C3,complement component 3,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
729230,CCR2,chemokine (C-C motif) receptor 2,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
1131,CHRM3,"cholinergic receptor, muscarinic 3",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
1191,CLU,clusterin,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
2919,CXCL1,"chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
3627,CXCL10,chemokine (C-X-C motif) ligand 10,0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
84649,DGAT2,diacylglycerol O-acyltransferase 2,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
9002,F2RL3,coagulation factor II (thrombin) receptor-like 3,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
2243,FGA,fibrinogen alpha chain,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
2321,FLT1,fms-related tyrosine kinase 1,0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
2328,FMO3,flavin containing monooxygenase 3,0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
1647,GADD45A,"growth arrest and DNA-damage-inducible, alpha",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
2638,GC,group-specific component (vitamin D binding protein),0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
2875,GPT,glutamic-pyruvate transaminase (alanine aminotransferase),0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,2,Biomarker
2934,GSN,gelsolin,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
2946,GSTM2,glutathione S-transferase mu 2 (muscle),0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
26762,HAVCR1,hepatitis A virus cellular receptor 1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
3146,HMGB1,high mobility group box 1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,2,"Biomarker, Therapeutic"
3242,HPD,4-hydroxyphenylpyruvate dioxygenase,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,2,Biomarker
3263,HPX,hemopexin,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
3274,HRH2,histamine receptor H2,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,2,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
3589,IL11,interleukin 11,0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
3605,IL17A,interleukin 17A,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,2,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
7850,IL1R2,"interleukin 1 receptor, type II",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
50616,IL22,interleukin 22,0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,3,Therapeutic
3934,LCN2,lipocalin 2,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,2,Biomarker
3958,LGALS3,"lectin, galactoside-binding, soluble, 3",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
4217,MAP3K5,mitogen-activated protein kinase kinase kinase 5,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
4190,MDH1,"malate dehydrogenase 1, NAD (soluble)",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
5469,MED1,mediator complex subunit 1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406902,MIR10A,microRNA 10a,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406903,MIR10B,microRNA 10b,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406906,MIR122,microRNA 122,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406921,MIR132,microRNA 132,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406933,MIR141,microRNA 141,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406941,MIR149,microRNA 149,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406957,MIR181C,microRNA 181c,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406979,MIR19A,microRNA 19a,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406985,MIR200C,microRNA 200c,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
406999,MIR217,microRNA 217,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
407000,MIR218-1,microRNA 218-1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
407025,MIR29B2,microRNA 29b-2,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
407029,MIR30A,microRNA 30a,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
442905,MIR337,microRNA 337,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
407042,MIR34C,microRNA 34c,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
442912,MIR367,microRNA 367,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
574434,MIR410,microRNA 410,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
574506,MIR503,microRNA 503,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
693177,MIR592,microRNA 592,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
100126313,MIR744,microRNA 744,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
100313838,MIR764,microRNA 764,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
4486,MST1R,macrophage stimulating 1 receptor (c-met-related tyrosine kinase),0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,3,Therapeutic
10062,NR1H3,"nuclear receptor subfamily 1, group H, member 3",0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
9971,NR1H4,"nuclear receptor subfamily 1, group H, member 4",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
9970,NR1I3,"nuclear receptor subfamily 1, group I, member 3",0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
5340,PLG,plasminogen,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
4860,PNP,purine nucleoside phosphorylase,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,2,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
5591,PRKDC,"protein kinase, DNA-activated, catalytic polypeptide",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
5858,PZP,pregnancy-zone protein,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
5947,RBP1,"retinol binding protein 1, cellular",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
8991,SELENBP1,selenium binding protein 1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
6590,SLPI,secretory leukocyte peptidase inhibitor,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
112574,SNX18,sorting nexin 18,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
6649,SOD3,"superoxide dismutase 3, extracellular",0.0,0.0,0.0,0.0,1.0,860207,Drug-Induced Liver Injury,0.21,1,Therapeutic
54466,SPIN2A,"spindlin family, member 2A",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
6888,TALDO1,transaldolase 1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
6915,TBXA2R,thromboxane A2 receptor,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
79600,TCTN1,tectonic family member 1,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
7276,TTR,transthyretin,0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
54600,UGT1A9,"UDP glucuronosyltransferase 1 family, polypeptide A9",0.0,1.0,0.0,0.0,0.0,860207,Drug-Induced Liver Injury,0.21,1,Biomarker
5548,PRD,primary retinal dysplasia,0.0,1.0,0.0,0.0,0.0,1418874,"RETINAL DYSPLASIA, PRIMARY",0.21,0,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,0.0,1.0,0.0,0.0,544862,Neurocutaneous melanosis,0.21,0,GeneticVariation
1131,CHRM3,"cholinergic receptor, muscarinic 3",0.0,1.0,0.0,0.0,0.0,3962,Ascites,0.21,1,Biomarker
100271688,ANIB9,"Aneurysm, intracranial berry, 9",0.0,1.0,0.0,0.0,0.0,2675485,"Aneurysm, Intracranial Berry, 9",0.21,0,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,1.0,0.0,0.0,0.0,13080,Down Syndrome,0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,13080,Down Syndrome,0.21,1,Biomarker
2946,GSTM2,glutathione S-transferase mu 2 (muscle),0.0,1.0,0.0,0.0,0.0,13080,Down Syndrome,0.21,1,Biomarker
4908,NTF3,neurotrophin 3,0.0,1.0,0.0,0.0,0.0,13080,Down Syndrome,0.21,1,Biomarker
81693,AMN,amnion associated transmembrane protein,0.0,0.0,0.0,0.0,1.0,15379,Extravasation of Diagnostic and Therapeutic Materials,0.21,1,Therapeutic
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,15379,Extravasation of Diagnostic and Therapeutic Materials,0.21,1,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,0.0,0.0,0.0,15379,Extravasation of Diagnostic and Therapeutic Materials,0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,15379,Extravasation of Diagnostic and Therapeutic Materials,0.21,1,Biomarker
9971,NR1H4,"nuclear receptor subfamily 1, group H, member 4",0.0,1.0,0.0,0.0,0.0,15379,Extravasation of Diagnostic and Therapeutic Materials,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,15379,Extravasation of Diagnostic and Therapeutic Materials,0.21,2,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,20522,"Hypersensitivity, Delayed",0.21,1,Biomarker
10381,TUBB3,"tubulin, beta 3 class III",0.0,0.0,1.0,0.0,0.0,3808397,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1",0.21,0,GeneticVariation
50989,HMSNO,"Neuropathy, hereditary motor and sensory, Okinawa type",0.0,1.0,0.0,0.0,0.0,1858338,"Neuropathy, hereditary motor and sensory, Okinawa type",0.21,0,Biomarker
387281,LCRB,"locus control region, beta",0.0,1.0,0.0,0.0,0.0,2312,alpha-Thalassemia,0.21,0,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,35258,Restless Legs Syndrome,0.21,1,Biomarker
100302561,RLS7,Restless legs syndrome 7,0.0,1.0,0.0,0.0,0.0,35258,Restless Legs Syndrome,0.21,0,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,35258,Restless Legs Syndrome,0.21,1,Biomarker
374569,ASPG,asparaginase,0.0,1.0,0.0,0.0,0.0,42963,Vomiting,0.21,1,Biomarker
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,1.0,0.0,0.0,0.0,42963,Vomiting,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,42963,Vomiting,0.21,2,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,42963,Vomiting,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,42109,Urticaria,0.21,1,Biomarker
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,0.0,0.0,0.0,42109,Urticaria,0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,42109,Urticaria,0.21,1,Biomarker
4353,MPO,myeloperoxidase,0.0,1.0,0.0,0.0,0.0,42109,Urticaria,0.21,1,Biomarker
6401,SELE,selectin E,0.0,1.0,0.0,0.0,0.0,42109,Urticaria,0.21,1,Biomarker
7412,VCAM1,vascular cell adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,42109,Urticaria,0.21,1,Biomarker
5351,PLOD1,"procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1",0.0,1.0,0.0,0.0,0.0,2936777,Nevo syndrome,0.21,1,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,13393,Dysostoses,0.21,1,Biomarker
1234,CCR5,chemokine (C-C motif) receptor 5 (gene/pseudogene),0.0,1.0,0.0,0.0,0.0,2675864,"Diabetes Mellitus, Insulin-Dependent, 22",0.21,0,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,3090,Ankylosis,0.21,1,Biomarker
57044,IDDM18,insulin-dependent diabetes mellitus 18,0.0,1.0,0.0,0.0,0.0,1854125,"Diabetes Mellitus, Insulin-Dependent, 18",0.21,0,Biomarker
121391,KRT74,"keratin 74, type II",0.0,0.0,1.0,0.0,0.0,3554117,"ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE",0.21,0,GeneticVariation
5726,TAS2R38,"taste receptor, type 2, member 38",0.0,1.0,0.0,0.0,0.0,1868397,THIOUREA TASTING,0.21,0,Biomarker
5640,PRS,Prieto X-linked mental retardation syndrome,0.0,1.0,0.0,0.0,0.0,1839730,Prieto X-linked mental retardation syndrome,0.21,0,Biomarker
240,ALOX5,arachidonate 5-lipoxygenase,0.0,1.0,0.0,0.0,0.0,376618,Endotoxemia,0.21,1,Biomarker
498,ATP5A1,"ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle",0.0,1.0,0.0,0.0,0.0,376618,Endotoxemia,0.21,1,Biomarker
1373,CPS1,"carbamoyl-phosphate synthase 1, mitochondrial",0.0,1.0,0.0,0.0,0.0,376618,Endotoxemia,0.21,1,Biomarker
3313,HSPA9,heat shock 70kDa protein 9 (mortalin),0.0,1.0,0.0,0.0,0.0,376618,Endotoxemia,0.21,1,Biomarker
5009,OTC,ornithine carbamoyltransferase,0.0,1.0,0.0,0.0,0.0,376618,Endotoxemia,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,376618,Endotoxemia,0.21,1,Biomarker
5745,PTH1R,parathyroid hormone 1 receptor,0.0,1.0,0.0,0.0,0.0,1838779,Eiken Skeletal Dysplasia,0.21,0,Biomarker
2,A2M,alpha-2-macroglobulin,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,2,Biomarker
116285,ACSM1,acyl-CoA synthetase medium-chain family member 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
100,ADA,adenosine deaminase,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
253650,ANKRD18A,ankyrin repeat domain 18A,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
345,APOC3,apolipoprotein C-III,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
563,AZGP1,"alpha-2-glycoprotein 1, zinc-binding",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
8678,BECN1,"beclin 1, autophagy related",0.0,0.0,0.0,0.0,1.0,24121,Lung Neoplasms,0.21,2,Therapeutic
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
6362,CCL18,chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated),0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
900,CCNG1,cyclin G1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
1028,CDKN1C,"cyclin-dependent kinase inhibitor 1C (p57, Kip2)",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,2,Biomarker
1066,CES1,carboxylesterase 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,2,Biomarker
1143,CHRNB4,"cholinergic receptor, nicotinic, beta 4 (neuronal)",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
1291,COL6A1,"collagen, type VI, alpha 1",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
1490,CTGF,connective tissue growth factor,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
1776,DNASE1L3,deoxyribonuclease I-like 3,0.0,0.0,0.0,0.0,1.0,24121,Lung Neoplasms,0.21,1,Therapeutic
1796,DOK1,"docking protein 1, 62kDa (downstream of tyrosine kinase 1)",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
55840,EAF2,ELL associated factor 2,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
1938,EEF2,eukaryotic translation elongation factor 2,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
10919,EHMT2,euchromatic histone-lysine N-methyltransferase 2,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
2018,EMX2,empty spiracles homeobox 2,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
2254,FGF9,fibroblast growth factor 9,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
2260,FGFR1,fibroblast growth factor receptor 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
2627,GATA6,GATA binding protein 6,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
2638,GC,group-specific component (vitamin D binding protein),0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
2878,GPX3,glutathione peroxidase 3 (plasma),0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,2,Biomarker
2886,GRB7,growth factor receptor-bound protein 7,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
23462,HEY1,hes-related family bHLH transcription factor with YRPW motif 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,2,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
3476,IGBP1,immunoglobulin (CD79A) binding protein 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
8517,IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
3659,IRF1,interferon regulatory factor 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,0,Biomarker
182,JAG1,jagged 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
3726,JUNB,jun B proto-oncogene,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
450093,LNCR1,Lung cancer 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,0,Biomarker
100271687,LNCR3,Lung cancer susceptibility 3,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,0,Biomarker
100271693,LNCR4,Lung cancer susceptibility 4,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,0,Biomarker
84864,MINA,MYC induced nuclear antigen,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
407035,MIR31,microRNA 31,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
407041,MIR34B,microRNA 34b,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
4354,MPP1,"membrane protein, palmitoylated 1, 55kDa",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
4800,NFYA,"nuclear transcription factor Y, alpha",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,2,Biomarker
4853,NOTCH2,notch 2,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,0.0,0.0,0.0,1.0,24121,Lung Neoplasms,0.21,1,Therapeutic
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
5757,PTMA,"prothymosin, alpha",0.0,0.0,0.0,0.0,1.0,24121,Lung Neoplasms,0.21,1,Therapeutic
29108,PYCARD,PYD and CARD domain containing,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
8991,SELENBP1,selenium binding protein 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
5002,SLC22A18,"solute carrier family 22, member 18",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,0,Biomarker
28234,SLCO1B3,"solute carrier organic anion transporter family, member 1B3",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
6599,SMARCC1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
7253,TSHR,thyroid stimulating hormone receptor,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
7306,TYRP1,tyrosinase-related protein 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
7367,UGT2B17,"UDP glucuronosyltransferase 2 family, polypeptide B17",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
7474,WNT5A,"wingless-type MMTV integration site family, member 5A",0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
7490,WT1,Wilms tumor 1,0.0,1.0,0.0,0.0,0.0,24121,Lung Neoplasms,0.21,1,Biomarker
3077,HFE,hemochromatosis,0.0,1.0,0.0,0.0,0.0,2673520,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7",0.21,0,Biomarker
27161,AGO2,argonaute RISC catalytic component 2,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
23780,APOL2,"apolipoprotein L, 2",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
23237,ARC,activity-regulated cytoskeleton-associated protein,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
374868,ATP9B,"ATPase, class II, type 9B",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,0.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,7,Therapeutic
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,7,"Biomarker, Therapeutic"
801,CALM1,"calmodulin 1 (phosphorylase kinase, delta)",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
805,CALM2,"calmodulin 2 (phosphorylase kinase, delta)",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
815,CAMK2A,calcium/calmodulin-dependent protein kinase II alpha,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
816,CAMK2B,calcium/calmodulin-dependent protein kinase II beta,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
814,CAMK4,calcium/calmodulin-dependent protein kinase IV,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
887,CCKBR,cholecystokinin B receptor,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
401145,CCSER1,coiled-coil serine-rich protein 1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
1066,CES1,carboxylesterase 1,0.0,0.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,2,Therapeutic
8824,CES2,carboxylesterase 2,0.0,0.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,1,Therapeutic
1133,CHRM5,"cholinergic receptor, muscarinic 5",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
81578,COL21A1,"collagen, type XXI, alpha 1",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
1385,CREB1,cAMP responsive element binding protein 1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,3,Biomarker
1393,CRHBP,corticotropin releasing hormone binding protein,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
1395,CRHR2,corticotropin releasing hormone receptor 2,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
1769,DNAH8,"dynein, axonemal, heavy chain 8",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
1812,DRD1,dopamine receptor D1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,4,Biomarker
1958,EGR1,early growth response 1,0.0,1.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,3,"Biomarker, Therapeutic"
10919,EHMT2,euchromatic histone-lysine N-methyltransferase 2,0.0,0.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,1,Therapeutic
2100,ESR2,estrogen receptor 2 (ER beta),0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
2222,FDFT1,farnesyl-diphosphate farnesyltransferase 1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,3,Biomarker
2354,FOSB,FBJ murine osteosarcoma viral oncogene homolog B,0.0,1.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,4,"Biomarker, Therapeutic"
2550,GABBR1,"gamma-aminobutyric acid (GABA) B receptor, 1",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
2555,GABRA2,"gamma-aminobutyric acid (GABA) A receptor, alpha 2",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,2,Biomarker
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
2572,GAD2,"glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
79571,GCC1,GRIP and coiled-coil domain containing 1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,0.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,2,Therapeutic
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
10243,GPHN,gephyrin,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
26086,GPSM1,G-protein signaling modulator 1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",0.0,1.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,5,"Biomarker, Therapeutic"
2891,GRIA2,"glutamate receptor, ionotropic, AMPA 2",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
2902,GRIN1,"glutamate receptor, ionotropic, N-methyl D-aspartate 1",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,2,Biomarker
2915,GRM5,"glutamate receptor, metabotropic 5",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
3060,HCRT,hypocretin (orexin) neuropeptide precursor,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
3061,HCRTR1,hypocretin (orexin) receptor 1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,3,Biomarker
9759,HDAC4,histone deacetylase 4,0.0,0.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,1,Therapeutic
10014,HDAC5,histone deacetylase 5,0.0,0.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,1,Therapeutic
9456,HOMER1,homer homolog 1 (Drosophila),0.0,1.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,2,"Biomarker, Therapeutic"
9455,HOMER2,homer homolog 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",0.0,1.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,2,"Biomarker, Therapeutic"
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,3,Biomarker
79664,ICE2,interactor of little elongation complex ELL subunit 2,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
3611,ILK,integrin-linked kinase,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,2,Biomarker
3727,JUND,jun D proto-oncogene,0.0,0.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,1,Therapeutic
51088,KLHL5,kelch-like family member 5,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
57554,LRRC7,leucine rich repeat containing 7,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,2,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
406919,MIR130A,microRNA 130a,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
406927,MIR136,microRNA 136,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
406928,MIR137,microRNA 137,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
406929,MIR138-1,microRNA 138-1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
442892,MIR148B,microRNA 148b,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
406946,MIR154,microRNA 154,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
406995,MIR181A1,microRNA 181a-1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
406962,MIR186,microRNA 186,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
406994,MIR212,microRNA 212,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,2,Biomarker
100126318,MIR301B,microRNA 301b,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
442898,MIR324,microRNA 324,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
442905,MIR337,microRNA 337,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
442914,MIR369,microRNA 369,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
442913,MIR376C,microRNA 376c,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
494329,MIR380,microRNA 380,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
494333,MIR384,microRNA 384,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
574441,MIR488,microRNA 488,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
100126315,MIR665,microRNA 665,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
594857,NPS,neuropeptide S,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,3,Biomarker
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,2,Biomarker
4915,NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,2,Biomarker
4988,OPRM1,"opioid receptor, mu 1",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,3,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,4,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
9252,RPS6KA5,"ribosomal protein S6 kinase, 90kDa, polypeptide 5",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,2,Biomarker
6506,SLC1A2,"solute carrier family 1 (glial high affinity glutamate transporter), member 2",0.0,0.0,0.0,0.0,1.0,236736,Cocaine-Related Disorders,0.21,1,Therapeutic
6532,SLC6A4,"solute carrier family 6 (neurotransmitter transporter), member 4",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
57586,SYT13,synaptotagmin XIII,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
55714,TENM3,teneurin transmembrane protein 3,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
7297,TYK2,tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,236736,Cocaine-Related Disorders,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,38002,Splenomegaly,0.21,1,Biomarker
348,APOE,apolipoprotein E,0.0,1.0,0.0,0.0,0.0,38002,Splenomegaly,0.21,1,Biomarker
623,BDKRB1,bradykinin receptor B1,0.0,1.0,0.0,0.0,0.0,38002,Splenomegaly,0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,38002,Splenomegaly,0.21,1,Biomarker
100506658,OCLN,occludin,0.0,1.0,0.0,0.0,0.0,38002,Splenomegaly,0.21,1,Biomarker
5184,PEPD,peptidase D,0.0,1.0,0.0,0.0,0.0,38002,Splenomegaly,0.21,1,Biomarker
501,ALDH7A1,"aldehyde dehydrogenase 7 family, member A1",0.0,1.0,0.0,0.0,0.0,5940,Bone Diseases,0.21,1,Biomarker
650,BMP2,bone morphogenetic protein 2,0.0,0.0,0.0,0.0,1.0,5940,Bone Diseases,0.21,1,Therapeutic
182,JAG1,jagged 1,0.0,1.0,0.0,0.0,0.0,5940,Bone Diseases,0.21,1,Biomarker
91252,SLC39A13,"solute carrier family 39 (zinc transporter), member 13",0.0,1.0,0.0,0.0,0.0,5940,Bone Diseases,0.21,1,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,0.0,0.0,0.0,5940,Bone Diseases,0.21,1,Biomarker
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,0.0,0.0,0.0,5940,Bone Diseases,0.21,2,Biomarker
1719,DHFR,dihydrofolate reductase,0.0,1.0,0.0,0.0,0.0,30312,Pancytopenia,0.21,1,Biomarker
6157,RPL27A,ribosomal protein L27a,0.0,1.0,0.0,0.0,0.0,30312,Pancytopenia,0.21,1,Biomarker
113235,SLC46A1,"solute carrier family 46 (folate transporter), member 1",0.0,1.0,0.0,0.0,0.0,30312,Pancytopenia,0.21,1,Biomarker
285,ANGPT2,angiopoietin 2,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.21,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.21,1,Biomarker
80781,COL18A1,"collagen, type XVIII, alpha 1",0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,18923,Hemangiosarcoma,0.21,1,Therapeutic
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.21,1,Biomarker
2321,FLT1,fms-related tyrosine kinase 1,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.21,1,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.21,1,Biomarker
7424,VEGFC,vascular endothelial growth factor C,0.0,1.0,0.0,0.0,0.0,18923,Hemangiosarcoma,0.21,1,Biomarker
50960,MYMY1,moyamoya disease 1,0.0,1.0,0.0,0.0,0.0,2931384,Moyamoya disease 1,0.21,0,Biomarker
10058,ABCB6,"ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
11173,ADAMTS7,"ADAM metallopeptidase with thrombospondin type 1 motif, 7",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
104,ADARB1,"adenosine deaminase, RNA-specific, B1",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
1645,AKR1C1,"aldo-keto reductase family 1, member C1",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
1646,AKR1C2,"aldo-keto reductase family 1, member C2",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
54443,ANLN,"anillin, actin binding protein",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
57636,ARHGAP23,Rho GTPase activating protein 23,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
257106,ARHGAP30,Rho GTPase activating protein 30,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
259266,ASPM,"asp (abnormal spindle) homolog, microcephaly associated (Drosophila)",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
466,ATF1,activating transcription factor 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
563,AZGP1,"alpha-2-glycoprotein 1, zinc-binding",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
53335,BCL11A,B-cell CLL/lymphoma 11A (zinc finger protein),0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
388552,BLOC1S3,"biogenesis of lysosomal organelles complex-1, subunit 3",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
56946,C11orf30,chromosome 11 open reading frame 30,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
144577,C12orf66,chromosome 12 open reading frame 66,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
374920,C19orf68,chromosome 19 open reading frame 68,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
817,CAMK2D,calcium/calmodulin-dependent protein kinase II delta,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
80127,CCDC176,coiled-coil domain containing 176,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
891,CCNB1,cyclin B1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
9134,CCNE2,cyclin E2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
990,CDC6,cell division cycle 6,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
1013,CDH15,"cadherin 15, type 1, M-cadherin (myotubule)",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
55165,CEP55,centrosomal protein 55kDa,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
1164,CKS2,CDC28 protein kinase regulatory subunit 2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
1364,CLDN4,claudin 4,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
55783,CMTR2,cap methyltransferase 2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
116840,CNTROB,"centrobin, centrosomal BRCA2 interacting protein",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
147906,DACT3,dishevelled-binding antagonist of beta-catenin 3,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
131566,DCBLD2,"discoidin, CUB and LCCL domain containing 2",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
79039,DDX54,DEAD (Asp-Glu-Ala-Asp) box polypeptide 54,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
1742,DLG4,"discs, large homolog 4 (Drosophila)",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
653545,DUX4L5,double homeobox 4 like 5,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
1995,ELAVL3,ELAV like neuron-specific RNA binding protein 3,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
54206,ERRFI1,ERBB receptor feedback inhibitor 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
151354,FAM84A,"family with sequence similarity 84, member A",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
93611,FBXO44,F-box protein 44,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
8817,FGF18,fibroblast growth factor 18,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
2324,FLT4,fms-related tyrosine kinase 4,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
50943,FOXP3,forkhead box P3,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
2529,FUT7,"fucosyltransferase 7 (alpha (1,3) fucosyltransferase)",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
29997,GLTSCR2,glioma tumor suppressor candidate region gene 2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
2812,GP1BB,"glycoprotein Ib (platelet), beta polypeptide",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
347088,GPR144,G protein-coupled receptor 144,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
3070,HELLS,"helicase, lymphoid-specific",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
3161,HMMR,hyaluronan-mediated motility receptor (RHAMM),0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
84376,HOOK3,hook microtubule-tethering protein 3,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
3500,IGHG1,immunoglobulin heavy constant gamma 1 (G1m marker),0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
146433,IL34,interleukin 34,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
55721,IQCC,IQ motif containing C,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
51477,ISYNA1,inositol-3-phosphate synthase 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
126306,JSRP1,junctional sarcoplasmic reticulum protein 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
3850,KRT3,"keratin 3, type II",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
113251,LARP4,"La ribonucleoprotein domain family, member 4",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
3976,LIF,leukemia inhibitory factor,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
3977,LIFR,leukemia inhibitory factor receptor alpha,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
158314,LINC00475,long intergenic non-protein coding RNA 475,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
54947,LPCAT2,lysophosphatidylcholine acyltransferase 2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
90668,LRRC16B,leucine rich repeat containing 16B,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
23658,LSM5,"LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae)",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
4058,LTK,leukocyte receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
4085,MAD2L1,MAD2 mitotic arrest deficient-like 1 (yeast),0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
378938,MALAT1,metastasis associated lung adenocarcinoma transcript 1 (non-protein coding),0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
79694,MANEA,"mannosidase, endo-alpha",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
23162,MAPK8IP3,mitogen-activated protein kinase 8 interacting protein 3,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
22924,MAPRE3,"microtubule-associated protein, RP/EB family, member 3",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
146664,MGAT5B,"mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
79906,MORN1,MORN repeat containing 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
4603,MYBL1,v-myb avian myeloblastosis viral oncogene homolog-like 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
349565,NMNAT3,nicotinamide nucleotide adenylyltransferase 3,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
256933,NPB,neuropeptide B,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
3084,NRG1,neuregulin 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
440836,ODF3B,outer dense fiber of sperm tails 3B,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
55872,PBK,PDZ binding kinase,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
5140,PDE3B,"phosphodiesterase 3B, cGMP-inhibited",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
8572,PDLIM4,PDZ and LIM domain 4,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
57449,PLEKHG5,"pleckstrin homology domain containing, family G (with RhoGef domain) member 5",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
57104,PNPLA2,patatin-like phospholipase domain containing 2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
25865,PRKD2,protein kinase D2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
5724,PTAFR,platelet-activating factor receptor,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
171558,PTCRA,pre T-cell antigen receptor alpha,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
5733,PTGER3,prostaglandin E receptor 3 (subtype EP3),0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
9200,HACD1,3-hydroxyacyl-CoA dehydratase 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
170394,PWWP2B,PWWP domain containing 2B,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
5862,RAB2A,"RAB2A, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
29127,RACGAP1,Rac GTPase activating protein 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
91608,RASL10B,"RAS-like, family 10, member B",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
57455,REXO1,"REX1, RNA exonuclease 1 homolog (S. cerevisiae)",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
114822,RHPN1,"rhophilin, Rho GTPase binding protein 1",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6102,RP2,retinitis pigmentosa 2 (X-linked recessive),0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6168,RPL37A,ribosomal protein L37a,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6241,RRM2,ribonucleotide reductase M2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
864,RUNX3,runt-related transcription factor 3,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
338324,S100A7A,S100 calcium binding protein A7A,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6286,S100P,S100 calcium binding protein P,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
79685,SAP30L,SAP30-like,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6337,SCNN1A,"sodium channel, non voltage gated 1 alpha subunit",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6343,SCT,secretin,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6440,SFTPC,surfactant protein C,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6665,SOX15,SRY (sex determining region Y)-box 15,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
374955,SPATA21,spermatogenesis associated 21,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
57731,SPTBN4,"spectrin, beta, non-erythrocytic 4",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
10772,SRSF10,serine/arginine-rich splicing factor 10,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
10454,TAB1,TGF-beta activated kinase 1/MAP3K7 binding protein 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6899,TBX1,T-box 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
6939,TCF15,transcription factor 15 (basic helix-loop-helix),0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
8463,TEAD2,TEA domain family member 2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
90326,THAP3,"THAP domain containing, apoptosis associated protein 3",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
23671,TMEFF2,transmembrane protein with EGF-like and two follistatin-like domains 2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
256472,TMEM151A,transmembrane protein 151A,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
441151,TMEM151B,transmembrane protein 151B,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
7110,TMF1,TATA element modulatory factor 1,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
30000,TNPO2,transportin 2,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
23112,TNRC6B,trinucleotide repeat containing 6B,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
4796,TONSL,"tonsoku-like, DNA repair protein",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
7153,TOP2A,topoisomerase (DNA) II alpha 170kDa,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
55503,TRPV6,"transient receptor potential cation channel, subfamily V, member 6",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
7272,TTK,TTK protein kinase,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
164395,TTLL9,tubulin tyrosine ligase-like family member 9,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
7328,UBE2H,ubiquitin-conjugating enzyme E2H,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
9205,ZMYM5,"zinc finger, MYM-type 5",0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
7755,ZNF205,zinc finger protein 205,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
80264,ZNF430,zinc finger protein 430,0.0,1.0,0.0,0.0,0.0,32460,Polycystic Ovary Syndrome,0.21,1,Biomarker
1816,DRD5,dopamine receptor D5,0.0,1.0,0.0,0.0,0.0,40485,Torticollis,0.21,1,Biomarker
94008,SCA18,spinocerebellar ataxia 18 (sensory with neurogenic muscular atrophy),0.0,1.0,0.0,0.0,0.0,1843884,"Sensorimotor neuropathy with ataxia, autosomal dominant",0.21,0,Biomarker
59,ACTA2,"actin, alpha 2, smooth muscle, aorta",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,2,Biomarker
241,ALOX5AP,arachidonate 5-lipoxygenase-activating protein,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
23600,AMACR,alpha-methylacyl-CoA racemase,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
56624,ASAH2,N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,0.0,0.0,0.0,0.0,1.0,23895,Liver Diseases,0.21,1,Therapeutic
885,CCK,cholecystokinin,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
1230,CCR1,chemokine (C-C motif) receptor 1,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
915,CD3D,"CD3d molecule, delta (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
974,CD79B,"CD79b molecule, immunoglobulin-associated beta",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
942,CD86,CD86 molecule,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
83716,CRISPLD2,cysteine-rich secretory protein LCCL domain containing 2,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,23895,Liver Diseases,0.21,1,Therapeutic
23576,DDAH1,dimethylarginine dimethylaminohydrolase 1,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
2027,ENO3,"enolase 3 (beta, muscle)",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
2570,GABRR2,"gamma-aminobutyric acid (GABA) A receptor, rho 2",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
94235,GNG8,"guanine nucleotide binding protein (G protein), gamma 8",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
2869,GRK5,G protein-coupled receptor kinase 5,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
3101,HK3,hexokinase 3 (white cell),0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
3303,HSPA1A,heat shock 70kDa protein 1A,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
3589,IL11,interleukin 11,0.0,0.0,0.0,0.0,1.0,23895,Liver Diseases,0.21,1,Therapeutic
7850,IL1R2,"interleukin 1 receptor, type II",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
3556,IL1RAP,interleukin 1 receptor accessory protein,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
3581,IL9R,interleukin 9 receptor,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
3694,ITGB6,"integrin, beta 6",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
3728,JUP,junction plakoglobin,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
27040,LAT,linker for activation of T cells,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
1241,LTB4R,leukotriene B4 receptor,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,2,Biomarker
8829,NRP1,neuropilin 1,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
5879,RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
6039,RNASE6,"ribonuclease, RNase A family, k6",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
6309,SC5D,sterol-C5-desaturase,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
8651,SOCS1,suppressor of cytokine signaling 1,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
9021,SOCS3,suppressor of cytokine signaling 3,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
6430,SRSF5,serine/arginine-rich splicing factor 5,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
6489,ST8SIA1,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1",0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
7051,TGM1,transglutaminase 1,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
7078,TIMP3,TIMP metallopeptidase inhibitor 3,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
7104,TM4SF4,transmembrane 4 L six family member 4,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
54210,TREM1,triggering receptor expressed on myeloid cells 1,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
7305,TYROBP,TYRO protein tyrosine kinase binding protein,0.0,1.0,0.0,0.0,0.0,23895,Liver Diseases,0.21,1,Biomarker
100188952,IBD12,Inflammatory bowel disease 12,0.0,1.0,0.0,0.0,0.0,2677105,Inflammatory Bowel Disease 12,0.21,0,Biomarker
170682,SLEH1,systemic lupus erythematosus with hemolytic anemia 1,0.0,1.0,0.0,0.0,0.0,1846533,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY TO, 1",0.21,0,Biomarker
553992,MGR7,"Migraine with aura, susceptibility to, 7",0.0,1.0,0.0,0.0,0.0,154723,Migraine with Aura,0.21,0,Biomarker
100415943,MGR9,"Migraine with aura, susceptibility to, 9",0.0,1.0,0.0,0.0,0.0,154723,Migraine with Aura,0.21,0,Biomarker
79026,AHNAK,AHNAK nucleoprotein,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
79722,ANKRD55,ankyrin repeat domain 55,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
55726,ASUN,asunder spermatogenesis regulator,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
7832,BTG2,"BTG family, member 2",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
940,CD28,CD28 molecule,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
1021,CDK6,cyclin-dependent kinase 6,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
1390,CREM,cAMP responsive element modulator,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
1524,CX3CR1,chemokine (C-X3-C motif) receptor 1,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
54205,CYCS,"cytochrome c, somatic",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
83481,EPPK1,epiplakin 1,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
257019,FRMD3,FERM domain containing 3,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
1647,GADD45A,"growth arrest and DNA-damage-inducible, alpha",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
2947,GSTM3,glutathione S-transferase mu 3 (brain),0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
3040,HBA2,"hemoglobin, alpha 2",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
3043,HBB,"hemoglobin, beta",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
3045,HBD,"hemoglobin, delta",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
3047,HBG1,"hemoglobin, gamma A",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
3689,ITGB2,"integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
3872,KRT17,"keratin 17, type I",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
51251,NT5C3A,"5'-nucleotidase, cytosolic IIIA",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
5008,OSM,oncostatin M,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
5734,PTGER4,prostaglandin E receptor 4 (subtype EP4),0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
8766,RAB11A,"RAB11A, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
6117,RPA1,"replication protein A1, 70kDa",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
6251,RSU1,Ras suppressor protein 1,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
5272,SERPINB9,"serpin peptidase inhibitor, clade B (ovalbumin), member 9",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
10140,TOB1,"transducer of ERBB2, 1",0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
257101,ZNF683,zinc finger protein 683,0.0,1.0,0.0,0.0,0.0,263454,Chloracne,0.21,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,7528,Cecal Neoplasms,0.21,1,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,7528,Cecal Neoplasms,0.21,1,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,7528,Cecal Neoplasms,0.21,1,Biomarker
54474,KRT20,"keratin 20, type I",0.0,1.0,0.0,0.0,0.0,7528,Cecal Neoplasms,0.21,1,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
368,ABCC6,"ATP-binding cassette, sub-family C (CFTR/MRP), member 6",0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,2,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,2,Biomarker
538,ATP7A,"ATPase, Cu++ transporting, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,4,Biomarker
1756,DMD,dystrophin,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
2155,F7,coagulation factor VII (serum prothrombin conversion accelerator),0.0,0.0,0.0,0.0,1.0,12644,"Disease Models, Animal",0.21,1,Therapeutic
355,FAS,Fas cell surface death receptor,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
3043,HBB,"hemoglobin, beta",0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
1839,HBEGF,heparin-binding EGF-like growth factor,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
348980,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,0.0,0.0,0.0,1.0,12644,"Disease Models, Animal",0.21,1,Therapeutic
27031,NPHP3,nephronophthisis 3 (adolescent),0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
5158,PDE6B,"phosphodiesterase 6B, cGMP-specific, rod, beta",0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
5663,PSEN1,presenilin 1,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
6285,S100B,S100 calcium binding protein B,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
6622,SNCA,"synuclein, alpha (non A4 component of amyloid precursor)",0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,6,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,2,Biomarker
7431,VIM,vimentin,0.0,1.0,0.0,0.0,0.0,12644,"Disease Models, Animal",0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.21,0,Biomarker
149775,GNAS-AS1,GNAS antisense RNA 1,0.0,1.0,0.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.21,0,Biomarker
7830,PHA2A,Pseudohypoaldosteronism type II (gene A),0.0,1.0,0.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.21,0,Biomarker
8675,STX16,syntaxin 16,0.0,1.0,0.0,0.0,0.0,33805,Pseudohypoaldosteronism,0.21,0,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,206062,"Lung Diseases, Interstitial",0.21,1,Biomarker
53369,HDL3,Huntington-like neurodegenerative disorder 2,0.0,1.0,0.0,0.0,0.0,1858114,Huntington Disease-Like 3,0.21,0,Biomarker
8323,FZD6,frizzled class receptor 6,0.0,0.0,1.0,0.0,0.0,3279974,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10",0.21,1,GeneticVariation
8639,AOC3,"amine oxidase, copper containing 3",0.0,1.0,0.0,0.0,0.0,30524,Paratuberculosis,0.21,1,Biomarker
715,C1R,"complement component 1, r subcomponent",0.0,1.0,0.0,0.0,0.0,30524,Paratuberculosis,0.21,1,Biomarker
718,C3,complement component 3,0.0,1.0,0.0,0.0,0.0,30524,Paratuberculosis,0.21,1,Biomarker
2147,F2,coagulation factor II (thrombin),0.0,1.0,0.0,0.0,0.0,30524,Paratuberculosis,0.21,1,Biomarker
2934,GSN,gelsolin,0.0,1.0,0.0,0.0,0.0,30524,Paratuberculosis,0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,30524,Paratuberculosis,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,33626,Protein Deficiency,0.21,1,Biomarker
2936,GSR,glutathione reductase,0.0,1.0,0.0,0.0,0.0,33626,Protein Deficiency,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,0.0,0.0,0.0,1.0,33626,Protein Deficiency,0.21,1,Therapeutic
406214,LRSL,Larsen-like syndrome,0.0,1.0,0.0,0.0,0.0,1837884,Larsen-Like Syndrome,0.21,0,Biomarker
374291,NDUFS7,"NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)",0.0,0.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.21,1,GeneticVariation
4537,ND3,"NADH dehydrogenase, subunit 3 (complex I)",0.0,0.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.21,0,GeneticVariation
4540,ND5,"NADH dehydrogenase, subunit 5 (complex I)",0.0,0.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.21,0,GeneticVariation
4541,ND6,"NADH dehydrogenase, subunit 6 (complex I)",0.0,0.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.21,0,GeneticVariation
137682,NDUFAF6,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6",0.0,0.0,1.0,0.0,0.0,1838979,Mitochondrial complex I deficiency,0.21,1,GeneticVariation
5160,PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1,0.0,1.0,0.0,0.0,0.0,34350,"Pyruvate Metabolism, Inborn Errors",0.21,1,Biomarker
2180,ACSL1,acyl-CoA synthetase long-chain family member 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
71,ACTG1,actin gamma 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
81,ACTN4,"actinin, alpha 4",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
111,ADCY5,adenylate cyclase 5,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
214,ALCAM,activated leukocyte cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
301,ANXA1,annexin A1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,3,Biomarker
302,ANXA2,annexin A2,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
307,ANXA4,annexin A4,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
358,AQP1,aquaporin 1 (Colton blood group),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
93974,ATPIF1,ATPase inhibitory factor 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
10409,BASP1,"brain abundant, membrane attached signal protein 1",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
832,CAPZB,"capping protein (actin filament) muscle Z-line, beta",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
8573,CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,4,Biomarker
902,CCNH,cyclin H,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
998,CDC42,cell division cycle 42,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1040,CDS1,CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1266,CNN3,"calponin 3, acidic",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1289,COL5A1,"collagen, type V, alpha 1",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
11151,CORO1A,"coronin, actin binding protein, 1A",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
4512,COX1,cytochrome c oxidase subunit I,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1447,CSN2,casein beta,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
1448,CSN3,casein kappa,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1622,DBI,"diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1674,DES,desmin,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1848,DUSP6,dual specificity phosphatase 6,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1915,EEF1A1,eukaryotic translation elongation factor 1 alpha 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2202,EFEMP1,EGF containing fibulin-like extracellular matrix protein 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1984,EIF5A,eukaryotic translation initiation factor 5A,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2023,ENO1,"enolase 1, (alpha)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
4072,EPCAM,epithelial cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7430,EZR,ezrin,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2167,FABP4,"fatty acid binding protein 4, adipocyte",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2335,FN1,fibronectin 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5045,FURIN,furin (paired basic amino acid cleaving enzyme),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
50486,G0S2,G0/G1 switch 2,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2625,GATA3,GATA binding protein 3,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2628,GATM,glycine amidinotransferase (L-arginine:glycine amidinotransferase),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
9615,GDA,guanine deaminase,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2678,GGT1,gamma-glutamyltransferase 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
644076,GLYCAM1,glycosylation dependent cell adhesion molecule 1 (pseudogene),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2771,GNAI2,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
2937,GSS,glutathione synthetase,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3021,H3F3B,"H3 histone, family 3B (H3.3B)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3178,HNRNPA1,heterogeneous nuclear ribonucleoprotein A1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3400,ID4,"inhibitor of DNA binding 4, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3572,IL6ST,interleukin 6 signal transducer,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3638,INSIG1,insulin induced gene 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
4254,KITLG,KIT ligand,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3852,KRT5,"keratin 5, type II",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
112802,KRT71,"keratin 71, type II",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
3963,LGALS7,"lectin, galactoside-binding, soluble, 7",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
8825,LIN7A,lin-7 homolog A (C. elegans),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
4023,LPL,lipoprotein lipase,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
51599,LSR,lipolysis stimulated lipoprotein receptor,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
4191,MDH2,"malate dehydrogenase 2, NAD (mitochondrial)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
4256,MGP,matrix Gla protein,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
9019,MPZL1,myelin protein zero-like 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
9902,MRC2,"mannose receptor, C type 2",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
4692,NDN,"necdin, melanoma antigen (MAGE) family member",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
26012,NSMF,NMDA receptor synaptonuclear signaling and neuronal migration factor,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
23569,PADI4,"peptidyl arginine deiminase, type IV",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
5037,PEBP1,phosphatidylethanolamine binding protein 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5223,PGAM1,phosphoglycerate mutase 1 (brain),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5295,PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5315,PKM,"pyruvate kinase, muscle",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
10769,PLK2,polo-like kinase 2,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7001,PRDX2,peroxiredoxin 2,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
5618,PRLR,prolactin receptor,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
5685,PSMA4,"proteasome (prosome, macropain) subunit, alpha type, 4",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5720,PSME1,"proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5725,PTBP1,polypyrimidine tract binding protein 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5731,PTGER1,"prostaglandin E receptor 1 (subtype EP1), 42kDa",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5764,PTN,pleiotrophin,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5901,RAN,"RAN, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
5921,RASA1,RAS p21 protein activator (GTPase activating protein) 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5924,RASGRF2,Ras protein-specific guanine nucleotide-releasing factor 2,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5925,RB1,retinoblastoma 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5947,RBP1,"retinol binding protein 1, cellular",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5950,RBP4,"retinol binding protein 4, plasma",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
5954,RCN1,"reticulocalbin 1, EF-hand calcium binding domain",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6122,RPL3,ribosomal protein L3,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6128,RPL6,ribosomal protein L6,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6208,RPS14,ribosomal protein S14,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6277,S100A6,S100 calcium binding protein A6,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6279,S100A8,S100 calcium binding protein A8,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1901,S1PR1,sphingosine-1-phosphate receptor 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6319,SCD,stearoyl-CoA desaturase (delta-9-desaturase),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
6414,SEPP1,"selenoprotein P, plasma, 1",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
6446,SGK1,serum/glucocorticoid regulated kinase 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6558,SLC12A2,"solute carrier family 12 (sodium/potassium/chloride transporter), member 2",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
1468,SLC25A10,"solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6623,SNCG,"synuclein, gamma (breast cancer-specific protein 1)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6634,SNRPD3,small nuclear ribonucleoprotein D3 polypeptide 18kDa,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6662,SOX9,SRY (sex determining region Y)-box 9,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
10653,SPINT2,"serine peptidase inhibitor, Kunitz type, 2",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6427,SRSF2,serine/arginine-rich splicing factor 2,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
6776,STAT5A,signal transducer and activator of transcription 5A,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,5,Biomarker
3925,STMN1,stathmin 1,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7018,TF,transferrin,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
7069,THRSP,thyroid hormone responsive,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7086,TKT,transketolase,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7091,TLE4,transducin-like enhancer of split 4,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
140738,TMEM37,transmembrane protein 37,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
9540,TP53I3,tumor protein p53 inducible protein 3,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7170,TPM3,tropomyosin 3,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,2,Biomarker
7227,TRPS1,trichorhinophalangeal syndrome I,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
8848,TSC22D1,"TSC22 domain family, member 1",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
347733,TUBB2B,"tubulin, beta 2B class IIb",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7329,UBE2I,ubiquitin-conjugating enzyme E2I,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7351,UCP2,"uncoupling protein 2 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
8673,VAMP8,vesicle-associated membrane protein 8,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7498,XDH,xanthine dehydrogenase,0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
7534,YWHAZ,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta",0.0,1.0,0.0,0.0,0.0,24667,"Mammary Neoplasms, Animal",0.21,1,Biomarker
55729,ATF7IP,activating transcription factor 7 interacting protein,0.0,1.0,0.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
64109,CRLF2,cytokine receptor-like factor 2,0.0,1.0,0.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
2625,GATA3,GATA binding protein 3,0.0,1.0,0.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
23269,MGA,"MGA, MAX dimerization protein",0.0,1.0,0.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,1.0,0.0,0.0,0.0,23485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
716,C1S,"complement component 1, s subcomponent",0.0,1.0,0.0,0.0,0.0,2717905,Hereditary Angioedema Types I and II,0.21,1,Biomarker
710,SERPING1,"serpin peptidase inhibitor, clade G (C1 inhibitor), member 1",0.0,1.0,0.0,0.0,0.0,2717905,Hereditary Angioedema Types I and II,0.21,3,Biomarker
7933,OPLL,ossification of posterior longitudinal ligament of spine,0.0,1.0,0.0,0.0,0.0,1865343,Ossification of the posterior longitudinal ligament of the spine,0.21,0,Biomarker
54657,UGT1A4,"UDP glucuronosyltransferase 1 family, polypeptide A4",0.0,0.0,1.0,0.0,0.0,2931132,"Crigler Najjar syndrome, type 2",0.21,0,GeneticVariation
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,270612,Leukoencephalopathies,0.21,1,Biomarker
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H),0.0,1.0,0.0,0.0,0.0,270612,Leukoencephalopathies,0.21,1,Biomarker
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,0.0,0.0,0.0,270612,Leukoencephalopathies,0.21,1,Biomarker
6342,SCP2,sterol carrier protein 2,0.0,1.0,0.0,0.0,0.0,270612,Leukoencephalopathies,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,270612,Leukoencephalopathies,0.21,1,Biomarker
6948,TCN2,transcobalamin II,0.0,1.0,0.0,0.0,0.0,270612,Leukoencephalopathies,0.21,1,Biomarker
81866,NDIC,"Nail dysplasia, isolated congenital",0.0,1.0,0.0,0.0,0.0,1853984,"Nail dysplasia, isolated congenital",0.21,0,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,0.0,0.0,0.0,1.0,20649,Hypotension,0.21,1,Therapeutic
134,ADORA1,adenosine A1 receptor,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
135,ADORA2A,adenosine A2a receptor,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,3,Biomarker
147,ADRA1B,adrenoceptor alpha 1B,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
150,ADRA2A,adrenoceptor alpha 2A,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,0.0,0.0,0.0,1.0,20649,Hypotension,0.21,3,Therapeutic
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
847,CAT,catalase,0.0,0.0,0.0,0.0,1.0,20649,Hypotension,0.21,1,Therapeutic
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
1489,CTF1,cardiotrophin 1,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
1812,DRD1,dopamine receptor D1,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,4,Biomarker
1907,EDN2,endothelin 2,0.0,0.0,0.0,0.0,1.0,20649,Hypotension,0.21,1,Therapeutic
1908,EDN3,endothelin 3,0.0,1.0,0.0,0.0,1.0,20649,Hypotension,0.21,2,"Biomarker, Therapeutic"
2246,FGF1,fibroblast growth factor 1 (acidic),0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,20649,Hypotension,0.21,2,Therapeutic
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
2904,GRIN2B,"glutamate receptor, ionotropic, N-methyl D-aspartate 2B",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
3269,HRH1,histamine receptor H1,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
3351,HTR1B,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
3352,HTR1D,"5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,1.0,20649,Hypotension,0.21,3,"Biomarker, Therapeutic"
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,8,Biomarker
4057,LTF,lactotransferrin,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
4128,MAOA,monoamine oxidase A,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
4129,MAOB,monoamine oxidase B,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
11188,NISCH,nischarin,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,4,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
5368,PNOC,prepronociceptin,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,4,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,1.0,20649,Hypotension,0.21,3,"Biomarker, Therapeutic"
6340,SCNN1G,"sodium channel, non voltage gated 1 gamma subunit",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,2,Biomarker
7349,UCN,urocortin,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,20649,Hypotension,0.21,1,Biomarker
100188767,AGSPX,Angio serpiginosum,0.0,1.0,0.0,0.0,0.0,263637,"Angioma serpiginosum, X-linked",0.21,0,Biomarker
4010,LMX1B,"LIM homeobox transcription factor 1, beta",0.0,1.0,0.0,0.0,0.0,9081,Clubfoot,0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,20459,Hyperinsulinism,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,0.0,0.0,1.0,20459,Hyperinsulinism,0.21,1,Therapeutic
79661,NEIL1,nei endonuclease VIII-like 1 (E. coli),0.0,1.0,0.0,0.0,0.0,20459,Hyperinsulinism,0.21,1,Biomarker
1831,TSC22D3,"TSC22 domain family, member 3",0.0,1.0,0.0,0.0,0.0,20459,Hyperinsulinism,0.21,1,Biomarker
4509,ATP8,ATP synthase F0 subunit 8,0.0,0.0,1.0,0.0,0.0,1537984,ATP SYNTHASE 8,0.21,1,GeneticVariation
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
1270,CNTF,ciliary neurotrophic factor,0.0,0.0,0.0,0.0,1.0,2937358,Cerebral Hemorrhage,0.21,1,Therapeutic
2321,FLT1,fms-related tyrosine kinase 1,0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
3163,HMOX2,heme oxygenase (decycling) 2,0.0,0.0,0.0,0.0,1.0,2937358,Cerebral Hemorrhage,0.21,1,Therapeutic
3674,ITGA2B,"integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
3685,ITGAV,"integrin, alpha V",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
3690,ITGB3,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,1.0,2937358,Cerebral Hemorrhage,0.21,5,"Biomarker, Therapeutic"
4879,NPPB,natriuretic peptide B,0.0,0.0,0.0,0.0,1.0,2937358,Cerebral Hemorrhage,0.21,1,Therapeutic
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,21,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,5,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,0.0,0.0,0.0,1.0,2937358,Cerebral Hemorrhage,0.21,1,Therapeutic
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,0.0,2937358,Cerebral Hemorrhage,0.21,1,Biomarker
116629,HTX3,"Heterotaxy, visceral, 3",0.0,1.0,0.0,0.0,0.0,1853444,"Heterotaxy, Visceral, 3, Autosomal",0.21,0,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,162316,"Anemia, Iron-Deficiency",0.21,1,Biomarker
50968,FCMTE1,familial cortical myoclonic tremor with epilepsy 1,0.0,1.0,0.0,0.0,0.0,1832841,"Epilepsy, Myoclonic, Benign Adult Familial, Type 1",0.21,0,Biomarker
389015,SLC9A4,"solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4",0.0,1.0,0.0,0.0,0.0,1122,Acidosis,0.21,1,Biomarker
2166,FAAH,fatty acid amide hydrolase,0.0,1.0,0.0,0.0,0.0,32962,Pregnancy Complications,0.21,1,Biomarker
3291,HSD11B2,hydroxysteroid (11-beta) dehydrogenase 2,0.0,1.0,0.0,0.0,0.0,32962,Pregnancy Complications,0.21,1,Biomarker
100359400,DFNB83,"deafness, autosomal recessive 83",0.0,1.0,0.0,0.0,0.0,2829263,"DEAFNESS, AUTOSOMAL RECESSIVE 83",0.21,0,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,0.0,0.0,1.0,152020,Gastroparesis,0.21,1,Therapeutic
2563,GABRD,"gamma-aminobutyric acid (GABA) A receptor, delta",0.0,1.0,0.0,0.0,0.0,1858672,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",0.21,0,Biomarker
2566,GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.0,1.0,0.0,0.0,0.0,1858672,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",0.21,0,Biomarker
84168,ANTXR1,anthrax toxin receptor 1,0.0,1.0,0.0,0.0,0.0,1865871,"Hemangioma, capillary infantile",0.21,0,Biomarker
3439,IFNA1,"interferon, alpha 1",0.0,0.0,0.0,0.0,1.0,42258,Vaginal Neoplasms,0.21,1,Therapeutic
3558,IL2,interleukin 2,0.0,0.0,0.0,0.0,1.0,42258,Vaginal Neoplasms,0.21,1,Therapeutic
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,751674,Lymphangioleiomyomatosis,0.21,1,Biomarker
3714,JAG2,jagged 2,0.0,1.0,0.0,0.0,0.0,751674,Lymphangioleiomyomatosis,0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,162670,Mitochondrial Myopathies,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,162670,Mitochondrial Myopathies,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,162670,Mitochondrial Myopathies,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,162670,Mitochondrial Myopathies,0.21,1,Biomarker
7416,VDAC1,voltage-dependent anion channel 1,0.0,1.0,0.0,0.0,0.0,162670,Mitochondrial Myopathies,0.21,1,Biomarker
100038248,PSNP3,"Supranuclear palsy, progressive, 3",0.0,1.0,0.0,0.0,0.0,1970476,"Supranuclear Palsy, Progressive, 3",0.21,0,Biomarker
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.21,1,Biomarker
6698,SPRR1A,small proline-rich protein 1A,0.0,1.0,0.0,0.0,0.0,30354,Papilloma,0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,0.0,1.0,0.0,0.0,1853365,"Aortic Aneurysm, Familial Abdominal 1",0.21,0,GeneticVariation
100329167,AAA1,"aortic aneurysm, familial abdominal 1",0.0,1.0,0.0,0.0,0.0,1853365,"Aortic Aneurysm, Familial Abdominal 1",0.21,0,Biomarker
60,ACTB,"actin, beta",0.0,1.0,0.0,0.0,0.0,9363,Coloboma,0.21,1,Biomarker
71,ACTG1,actin gamma 1,0.0,1.0,0.0,0.0,0.0,9363,Coloboma,0.21,1,Biomarker
501,ALDH7A1,"aldehyde dehydrogenase 7 family, member A1",0.0,1.0,0.0,0.0,0.0,9363,Coloboma,0.21,1,Biomarker
3912,LAMB1,"laminin, beta 1",0.0,1.0,0.0,0.0,0.0,9363,Coloboma,0.21,1,Biomarker
100188818,HDLCQ5,High density lipoprotein cholesterol level QTL 5,0.0,1.0,0.0,0.0,0.0,1853097,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5,0.21,0,Biomarker
54716,SLC6A20,"solute carrier family 6 (proline IMINO transporter), member 20",0.0,1.0,0.0,0.0,0.0,268654,Iminoglycinuria,0.21,1,Biomarker
5617,PRL,prolactin,0.0,0.0,0.0,0.0,1.0,23601,Leydig Cell Tumor,0.21,1,Therapeutic
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,29172,Oral Submucous Fibrosis,0.21,1,Biomarker
9365,KL,klotho,0.0,1.0,0.0,0.0,0.0,21359,Infertility,0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,21359,Infertility,0.21,1,Biomarker
5732,PTGER2,"prostaglandin E receptor 2 (subtype EP2), 53kDa",0.0,1.0,0.0,0.0,0.0,21359,Infertility,0.21,1,Biomarker
54902,TTC19,tetratricopeptide repeat domain 19,0.0,1.0,0.0,0.0,0.0,21359,Infertility,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,29458,"Osteoporosis, Postmenopausal",0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,20438,Hypercalciuria,0.21,2,Biomarker
338411,TELAB1,"telangiectasia, benign 1",0.0,1.0,0.0,0.0,0.0,406502,"Telangiectasia, Hereditary Benign",0.21,0,Biomarker
1255,CNA1,cornea plana 1 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1852557,Cornea Plana 1,0.21,0,Biomarker
2720,GLB1,"galactosidase, beta 1",0.0,1.0,0.0,0.0,0.0,10038,Corneal Opacity,0.21,1,Biomarker
182,JAG1,jagged 1,0.0,1.0,0.0,0.0,0.0,10038,Corneal Opacity,0.21,1,Biomarker
8671,SLC4A4,"solute carrier family 4 (sodium bicarbonate cotransporter), member 4",0.0,1.0,0.0,0.0,0.0,10038,Corneal Opacity,0.21,1,Biomarker
4129,MAOB,monoamine oxidase B,0.0,1.0,0.0,0.0,0.0,31511,Pheochromocytoma,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,23493,"Leukemia-Lymphoma, Adult T-Cell",0.21,2,Therapeutic
4195,MDRV,"muscular dystrophy, with rimmed vacuoles",0.0,1.0,0.0,0.0,0.0,1866139,Vacuolar Neuromyopathy,0.21,0,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,3537,Aphasia,0.21,1,Therapeutic
100302680,DELXQ28,Chromosome Xq28 microdeletion syndrome,0.0,1.0,0.0,0.0,0.0,1845408,Contiguous Abcd1/Dxs1375e Deletion Syndrome,0.21,0,Biomarker
1636,ACE,angiotensin I converting enzyme,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
27087,B3GAT1,"beta-1,3-glucuronyltransferase 1",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
929,CD14,CD14 molecule,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
2147,F2,coagulation factor II (thrombin),0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
8517,IKBKG,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
3562,IL3,interleukin 3,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
3565,IL4,interleukin 4,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
284217,LAMA1,"laminin, alpha 1",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
3976,LIF,leukemia inhibitory factor,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
100380876,NAFLD1,"Fatty liver disease 1, susceptiblity to",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,0,Biomarker
100462725,NAFLD2,"Fatty liver disease, nonalcoholic, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,0,Biomarker
5897,RAG2,recombination activating gene 2,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
5055,SERPINB2,"serpin peptidase inhibitor, clade B (ovalbumin), member 2",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
8614,STC2,stanniocalcin 2,0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
7040,TGFB1,"transforming growth factor, beta 1",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
7133,TNFRSF1B,"tumor necrosis factor receptor superfamily, member 1B",0.0,1.0,0.0,0.0,0.0,400966,Non-alcoholic Fatty Liver Disease,0.21,1,Biomarker
4018,LPA,"lipoprotein, Lp(a)",0.0,1.0,0.0,0.0,0.0,20623,Hypolipoproteinemias,0.21,1,Biomarker
1459,CSNK2A2,"casein kinase 2, alpha prime polypeptide",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
1460,CSNK2B,"casein kinase 2, beta polypeptide",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
1834,DSPP,dentin sialophosphoprotein,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
338442,HCAR2,hydroxycarboxylic acid receptor 2,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
8843,HCAR3,hydroxycarboxylic acid receptor 3,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
3312,HSPA8,heat shock 70kDa protein 8,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
3848,KRT1,"keratin 1, type II",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
3854,KRT6B,"keratin 6B, type II",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
28998,MRPL13,mitochondrial ribosomal protein L13,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
4489,MT1A,metallothionein 1A,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
5223,PGAM1,phosphoglycerate mutase 1 (brain),0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
5478,PPIA,peptidylprolyl isomerase A (cyclophilin A),0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
56952,PRTFDC1,phosphoribosyl transferase domain containing 1,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
5731,PTGER1,"prostaglandin E receptor 1 (subtype EP1), 42kDa",0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
6698,SPRR1A,small proline-rich protein 1A,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
7417,VDAC2,voltage-dependent anion channel 2,0.0,1.0,0.0,0.0,0.0,7137,"Carcinoma, Squamous Cell",0.21,1,Biomarker
785,CACNB4,"calcium channel, voltage-dependent, beta 4 subunit",0.0,1.0,0.0,0.0,0.0,14548,"Epilepsy, Generalized",0.21,1,Biomarker
8629,JRK,Jrk homolog (mouse),0.0,1.0,0.0,0.0,0.0,14548,"Epilepsy, Generalized",0.21,1,Biomarker
2489,FSHMD1A,facioscapulohumeral muscular dystrophy 1A,0.0,1.0,0.0,0.0,0.0,1834673,Facioscapulohumeral muscular dystrophy 1a,0.21,0,Biomarker
4406,MRX42,"mental retardation, X-linked 42",0.0,1.0,0.0,0.0,0.0,1845810,"Mental Retardation, X-Linked 42",0.21,0,Biomarker
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,0.0,0.0,0.0,1861537,Orofacial Cleft 1,0.21,0,Biomarker
100188838,AD15,Alzheimer disease-15,0.0,1.0,0.0,0.0,0.0,1970143,Alzheimer Disease 15,0.21,0,Biomarker
550626,FHASD,Foveal hypoplasia and anterior segment dysgenesis,0.0,1.0,0.0,0.0,0.0,1836603,Foveal Hypoplasia and Anterior Segment Dysgenesis,0.21,0,Biomarker
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,17416,"Genital Neoplasms, Female",0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
9495,AKAP5,A kinase (PRKA) anchor protein 5,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,7,Biomarker
551,AVP,arginine vasopressin,0.0,0.0,0.0,0.0,1.0,25261,Memory Disorders,0.21,1,Therapeutic
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
1128,CHRM1,"cholinergic receptor, muscarinic 1",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,0.0,0.0,0.0,1.0,25261,Memory Disorders,0.21,1,Therapeutic
2558,GABRA5,"gamma-aminobutyric acid (GABA) A receptor, alpha 5",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
28964,GIT1,G protein-coupled receptor kinase interacting ArfGAP 1,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
2925,GRPR,gastrin-releasing peptide receptor,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
3115,HLA-DPB1,"major histocompatibility complex, class II, DP beta 1",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
11255,HRH3,histamine receptor H3,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
3362,HTR6,"5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
3481,IGF2,insulin-like growth factor 2,0.0,0.0,0.0,0.0,1.0,25261,Memory Disorders,0.21,1,Therapeutic
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,25261,Memory Disorders,0.21,1,Therapeutic
4012,LNPEP,leucyl/cystinyl aminopeptidase,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
4192,MDK,midkine (neurite growth-promoting factor 2),0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
4835,NQO2,"NAD(P)H dehydrogenase, quinone 2",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
5368,PNOC,prepronociceptin,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
5966,REL,v-rel avian reticuloendotheliosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,0.0,0.0,0.0,1.0,25261,Memory Disorders,0.21,1,Therapeutic
57084,SLC17A6,"solute carrier family 17 (vesicular glutamate transporter), member 6",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
57030,SLC17A7,"solute carrier family 17 (vesicular glutamate transporter), member 7",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
6531,SLC6A3,"solute carrier family 6 (neurotransmitter transporter), member 3",0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
6774,STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),0.0,0.0,0.0,0.0,1.0,25261,Memory Disorders,0.21,1,Therapeutic
6855,SYP,synaptophysin,0.0,1.0,0.0,0.0,0.0,25261,Memory Disorders,0.21,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,0.0,0.0,0.0,1.0,25261,Memory Disorders,0.21,1,Therapeutic
3663,IRF5,interferon regulatory factor 5,0.0,1.0,0.0,0.0,0.0,2677100,Inflammatory Bowel Disease 14,0.21,0,Biomarker
780923,IHPS2,"Pyloric stenosis, infantile hypertrophic, 2",0.0,1.0,0.0,0.0,0.0,1853228,"Pyloric Stenosis, Infantile Hypertrophic, 2",0.21,0,Biomarker
23534,TNPO3,transportin 3,0.0,0.0,1.0,0.0,0.0,1842062,"Muscular Dystrophy, Limb-Girdle, Type 1F",0.21,1,GeneticVariation
6595,SMARCA2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",0.0,1.0,0.0,0.0,0.0,265338,Coffin-Siris syndrome,0.21,1,Biomarker
6597,SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",0.0,1.0,0.0,0.0,0.0,265338,Coffin-Siris syndrome,0.21,1,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,1.0,0.0,0.0,0.0,10346,Crohn Disease,0.21,1,Biomarker
151306,GPBAR1,G protein-coupled bile acid receptor 1,0.0,1.0,0.0,0.0,0.0,10346,Crohn Disease,0.21,1,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,10346,Crohn Disease,0.21,1,Biomarker
7448,VTN,vitronectin,0.0,1.0,0.0,0.0,0.0,10346,Crohn Disease,0.21,1,Biomarker
1066,CES1,carboxylesterase 1,0.0,0.0,0.0,0.0,1.0,20443,Hypercholesterolemia,0.21,1,Therapeutic
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.21,1,Biomarker
1489,CTF1,cardiotrophin 1,0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.21,1,Biomarker
4638,MYLK,myosin light chain kinase,0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.21,1,Biomarker
653361,NCF1,neutrophil cytosolic factor 1,0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.21,1,Biomarker
27035,NOX1,NADPH oxidase 1,0.0,1.0,0.0,0.0,0.0,20443,Hypercholesterolemia,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,38362,Stomatitis,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,38362,Stomatitis,0.21,1,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,42487,Venous Thrombosis,0.21,1,Biomarker
2152,F3,"coagulation factor III (thromboplastin, tissue factor)",0.0,1.0,0.0,0.0,0.0,42487,Venous Thrombosis,0.21,1,Biomarker
4018,LPA,"lipoprotein, Lp(a)",0.0,1.0,0.0,0.0,0.0,42487,Venous Thrombosis,0.21,1,Biomarker
93183,PIGM,"phosphatidylinositol glycan anchor biosynthesis, class M",0.0,1.0,0.0,0.0,0.0,42487,Venous Thrombosis,0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,0.0,0.0,0.0,1.0,42487,Venous Thrombosis,0.21,3,Therapeutic
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,42487,Venous Thrombosis,0.21,4,Therapeutic
5340,PLG,plasminogen,0.0,0.0,0.0,0.0,1.0,42487,Venous Thrombosis,0.21,1,Therapeutic
10084,PQBP1,polyglutamine binding protein 1,0.0,1.0,0.0,0.0,0.0,18817,"Heart Septal Defects, Atrial",0.21,1,Biomarker
407973,SCA20,spinocerebellar ataxia 20,0.0,1.0,0.0,0.0,0.0,1837541,Spinocerebellar ataxia 20,0.21,0,Biomarker
284403,WDR62,WD repeat domain 62,0.0,1.0,0.0,0.0,0.0,1838491,Kuzniecky syndrome,0.21,0,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,1,Therapeutic
1129,CHRM2,"cholinergic receptor, muscarinic 2",0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,1,Biomarker
1813,DRD2,dopamine receptor D2,0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,2,Biomarker
1906,EDN1,endothelin 1,0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,2,Therapeutic
1907,EDN2,endothelin 2,0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,1,Therapeutic
1908,EDN3,endothelin 3,0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,1,Therapeutic
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,5,Therapeutic
2771,GNAI2,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2",0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,1,Biomarker
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,1,Therapeutic
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,1,Biomarker
3972,LHB,luteinizing hormone beta polypeptide,0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,1,Therapeutic
11188,NISCH,nischarin,0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,1,Biomarker
4922,NTS,neurotensin,0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,1,Therapeutic
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,3,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,3,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,1,Biomarker
6869,TACR1,tachykinin receptor 1,0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,1,Therapeutic
7200,TRH,thyrotropin-releasing hormone,0.0,0.0,0.0,0.0,1.0,428977,Bradycardia,0.21,2,Therapeutic
10911,UTS2,urotensin 2,0.0,1.0,0.0,0.0,0.0,428977,Bradycardia,0.21,1,Biomarker
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,5686,Urinary Bladder Diseases,0.21,1,Therapeutic
11186,RASSF1,Ras association (RalGDS/AF-6) domain family member 1,0.0,1.0,0.0,0.0,0.0,5686,Urinary Bladder Diseases,0.21,1,Biomarker
7078,TIMP3,TIMP metallopeptidase inhibitor 3,0.0,1.0,0.0,0.0,0.0,5686,Urinary Bladder Diseases,0.21,1,Biomarker
7432,VIP,vasoactive intestinal peptide,0.0,1.0,0.0,0.0,0.0,5686,Urinary Bladder Diseases,0.21,1,Biomarker
1858,DWS,dandy-walker syndrome,0.0,1.0,0.0,0.0,0.0,10964,Dandy-Walker Syndrome,0.21,0,Biomarker
4286,MITF,microphthalmia-associated transcription factor,0.0,1.0,0.0,0.0,0.0,151779,"Melanoma, Cutaneous Malignant",0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,11603,Dermatitis,0.21,1,Biomarker
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",0.0,1.0,0.0,0.0,0.0,11603,Dermatitis,0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,32231,Pleurisy,0.21,1,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,32231,Pleurisy,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,32231,Pleurisy,0.21,1,Biomarker
6403,SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",0.0,1.0,0.0,0.0,0.0,32231,Pleurisy,0.21,1,Biomarker
619397,6-Feb,febrile convulsions 6,0.0,1.0,0.0,0.0,0.0,1836518,"Febrile Convulsions, Familial, 6",0.21,0,Biomarker
23460,ABCA6,"ATP-binding cassette, sub-family A (ABC1), member 6",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
156,ADRBK1,"adrenergic, beta, receptor kinase 1",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
80150,ASRGL1,asparaginase like 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
654,BMP6,bone morphogenetic protein 6,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
10203,CALCRL,calcitonin receptor-like,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
729230,CCR2,chemokine (C-C motif) receptor 2,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
948,CD36,CD36 molecule (thrombospondin receptor),0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
915,CD3D,"CD3d molecule, delta (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
63924,CIDEC,cell death-inducing DFFA-like effector c,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
1154,CISH,cytokine inducible SH2-containing protein,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
5067,CNTN3,contactin 3 (plasmacytoma associated),0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
1390,CREM,cAMP responsive element modulator,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
1075,CTSC,cathepsin C,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
2920,CXCL2,chemokine (C-X-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
1543,CYP1A1,"cytochrome P450, family 1, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
133418,EMB,embigin,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
2114,ETS2,v-ets avian erythroblastosis virus E26 oncogene homolog 2,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
2162,F13A1,"coagulation factor XIII, A1 polypeptide",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
2215,FCGR3B,"Fc fragment of IgG, low affinity IIIb, receptor (CD16b)",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
10875,FGL2,fibrinogen-like 2,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
2533,FYB,FYN binding protein,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
3290,HSD11B1,hydroxysteroid (11-beta) dehydrogenase 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
10437,IFI30,"interferon, gamma-inducible protein 30",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
10261,IGSF6,"immunoglobulin superfamily, member 6",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
3559,IL2RA,"interleukin 2 receptor, alpha",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
9235,IL32,interleukin 32,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
3567,IL5,interleukin 5,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
26034,IPCEF1,interaction protein for cytohesin exchange factors 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
3684,ITGAM,"integrin, alpha M (complement component 3 receptor 3 subunit)",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
8564,KMO,kynurenine 3-monooxygenase (kynurenine 3-hydroxylase),0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
4222,MEOX1,mesenchyme homeobox 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
4360,MRC1,"mannose receptor, C type 1",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
4084,MXD1,MAX dimerization protein 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
10135,NAMPT,nicotinamide phosphoribosyltransferase,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
4814,NINJ1,ninjurin 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
4926,NUMA1,nuclear mitotic apparatus protein 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
22822,PHLDA1,"pleckstrin homology-like domain, family A, member 1",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
5292,PIM1,"Pim-1 proto-oncogene, serine/threonine kinase",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
5327,PLAT,"plasminogen activator, tissue",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
10549,PRDX4,peroxiredoxin 4,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
25797,QPCT,glutaminyl-peptide cyclotransferase,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
10981,RAB32,"RAB32, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
5996,RGS1,regulator of G-protein signaling 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
6303,SAT1,spermidine/spermine N1-acetyltransferase 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
6401,SELE,selectin E,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
6515,SLC2A3,"solute carrier family 2 (facilitated glucose transporter), member 3",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
8140,SLC7A5,"solute carrier family 7 (amino acid transporter light chain, L system), member 5",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
8651,SOCS1,suppressor of cytokine signaling 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
8835,SOCS2,suppressor of cytokine signaling 2,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
6769,STAC,SH3 and cysteine rich domain,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
51284,TLR7,toll-like receptor 7,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
9168,TMSB10,thymosin beta 10,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
7130,TNFAIP6,"tumor necrosis factor, alpha-induced protein 6",0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,2,Biomarker
7378,UPP1,uridine phosphorylase 1,0.0,1.0,0.0,0.0,0.0,162820,"Dermatitis, Allergic Contact",0.21,1,Biomarker
10167,CFM1,cystic fibrosis modifier 1,0.0,1.0,0.0,0.0,0.0,1859047,"CYSTIC FIBROSIS, MODIFIER OF, 1",0.21,0,Biomarker
115019,SLC26A9,"solute carrier family 26 (anion exchanger), member 9",0.0,1.0,0.0,0.0,0.0,1859047,"CYSTIC FIBROSIS, MODIFIER OF, 1",0.21,1,Biomarker
11254,SLC6A14,"solute carrier family 6 (amino acid transporter), member 14",0.0,1.0,0.0,0.0,0.0,1859047,"CYSTIC FIBROSIS, MODIFIER OF, 1",0.21,1,Biomarker
6550,SLC9A3,"solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3",0.0,1.0,0.0,0.0,0.0,1859047,"CYSTIC FIBROSIS, MODIFIER OF, 1",0.21,1,Biomarker
5002,SLC22A18,"solute carrier family 22, member 18",0.0,1.0,0.0,0.0,0.0,1849385,Rhabdomyosarcoma 1,0.21,0,Biomarker
9254,CACNA2D2,"calcium channel, voltage-dependent, alpha 2/delta subunit 2",0.0,1.0,0.0,0.0,0.0,8489,Chorea,0.21,1,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,333355,Mucositis,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,333355,Mucositis,0.21,2,Biomarker
3586,IL10,interleukin 10,0.0,1.0,0.0,0.0,0.0,333355,Mucositis,0.21,1,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,0.0,0.0,0.0,1.0,333355,Mucositis,0.21,1,Therapeutic
7033,TFF3,trefoil factor 3 (intestinal),0.0,0.0,0.0,0.0,1.0,333355,Mucositis,0.21,1,Therapeutic
85505,ACRPS,Acropectoral syndrome,0.0,1.0,0.0,0.0,0.0,1853812,Acropectoral syndrome,0.21,0,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,7192,"Cardiomyopathy, Alcoholic",0.21,1,Biomarker
171013,SLI1,"Specific language impairment QTL, 1",0.0,1.0,0.0,0.0,0.0,1847614,SPECIFIC LANGUAGE IMPAIRMENT 1,0.21,0,Biomarker
4311,MME,membrane metallo-endopeptidase,0.0,1.0,0.0,0.0,0.0,2316212,Cryopyrin-Associated Periodic Syndromes,0.21,1,Biomarker
780919,HRPT3,Hyperparathyroidism 3,0.0,1.0,0.0,0.0,0.0,1864729,Hyperparathyroidism 3,0.21,0,Biomarker
266719,RRDX,Radial ray deficiency,0.0,1.0,0.0,0.0,0.0,1845717,"Radial Ray Deficiency, X-Linked",0.21,0,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,41105,Trismus,0.21,1,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,22354,"Jaundice, Obstructive",0.21,1,Biomarker
208,AKT2,v-akt murine thymoma viral oncogene homolog 2,0.0,1.0,0.0,0.0,0.0,271694,"Lipodystrophy, Familial Partial",0.21,1,Biomarker
5506,PPP1R3A,"protein phosphatase 1, regulatory subunit 3A",0.0,1.0,0.0,0.0,0.0,271694,"Lipodystrophy, Familial Partial",0.21,0,Biomarker
260415,SCASI,spinocerebellar ataxia with saccadic intrusions,0.0,1.0,0.0,0.0,0.0,1846492,"Spinocerebellar ataxia, autosomal recessive 4",0.21,0,Biomarker
4412,MRX49,"mental retardation, X-linked 49",0.0,1.0,0.0,0.0,0.0,1417292,"MENTAL RETARDATION, X-LINKED 49",0.21,0,Biomarker
100294716,MYP15,myopia 15,0.0,1.0,0.0,0.0,0.0,2675180,Myopia 15,0.21,0,Biomarker
5591,PRKDC,"protein kinase, DNA-activated, catalytic polypeptide",0.0,1.0,0.0,0.0,0.0,1364,Massive Hepatic Necrosis,0.21,1,Biomarker
7380,UPK3A,uroplakin 3A,0.0,1.0,0.0,0.0,0.0,1609433,Hereditary renal agenesis,0.21,0,Biomarker
92667,MGME1,mitochondrial genome maintenance exonuclease 1,0.0,1.0,0.0,0.0,0.0,13911,Emaciation,0.21,1,Biomarker
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
127,ADH4,"alcohol dehydrogenase 4 (class II), pi polypeptide",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
135,ADORA2A,adenosine A2a receptor,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
174,AFP,alpha-fetoprotein,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,2,Biomarker
216,ALDH1A1,"aldehyde dehydrogenase 1 family, member A1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
219,ALDH1B1,"aldehyde dehydrogenase 1 family, member B1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
10840,ALDH1L1,"aldehyde dehydrogenase 1 family, member L1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
23600,AMACR,alpha-methylacyl-CoA racemase,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
364,AQP7,aquaporin 7,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
622,BDH1,"3-hydroxybutyrate dehydrogenase, type 1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
655,BMP7,bone morphogenetic protein 7,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
761,CA3,carbonic anhydrase III,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
1036,CDO1,cysteine dioxygenase type 1,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
8824,CES2,carboxylesterase 2,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
23491,CES3,carboxylesterase 3,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
1268,CNR1,cannabinoid receptor 1 (brain),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
51380,CSAD,cysteine sulfinic acid decarboxylase,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
114757,CYGB,cytoglobin,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
1733,DIO1,"deiodinase, iodothyronine, type I",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
2173,FABP7,"fatty acid binding protein 7, brain",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
2326,FMO1,flavin containing monooxygenase 1,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
2645,GCK,glucokinase (hexokinase 4),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
2688,GH1,growth hormone 1,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
2805,GOT1,"glutamic-oxaloacetic transaminase 1, soluble",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
2875,GPT,glutamic-pyruvate transaminase (alanine aminotransferase),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
2939,GSTA2,glutathione S-transferase alpha 2,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
2944,GSTM1,glutathione S-transferase mu 1,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
51179,HAO2,hydroxyacid oxidase 2 (long chain),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,7,Therapeutic
10855,HPSE,heparanase,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,2,Biomarker
3294,HSD17B2,hydroxysteroid (17-beta) dehydrogenase 2,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
8630,HSD17B6,hydroxysteroid (17-beta) dehydrogenase 6,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
3398,ID2,"inhibitor of DNA binding 2, dominant negative helix-loop-helix protein",0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
3439,IFNA1,"interferon, alpha 1",0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,3,Therapeutic
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
3458,IFNG,"interferon, gamma",0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,4,Therapeutic
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,2,Therapeutic
3484,IGFBP1,insulin-like growth factor binding protein 1,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
3485,IGFBP2,"insulin-like growth factor binding protein 2, 36kDa",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
3611,ILK,integrin-linked kinase,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
83729,INHBE,"inhibin, beta E",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
3827,KNG1,kininogen 1,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
3875,KRT18,"keratin 18, type I",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,3,Biomarker
3856,KRT8,"keratin 8, type II",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
3929,LBP,lipopolysaccharide binding protein,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
3934,LCN2,lipocalin 2,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
4249,MGAT5,"mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
4311,MME,membrane metallo-endopeptidase,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
4312,MMP1,matrix metallopeptidase 1 (interstitial collagenase),0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
4317,MMP8,matrix metallopeptidase 8 (neutrophil collagenase),0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
4489,MT1A,metallothionein 1A,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
4780,NFE2L2,"nuclear factor, erythroid 2-like 2",0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
8431,NR0B2,"nuclear receptor subfamily 0, group B, member 2",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
4907,NT5E,"5'-nucleotidase, ecto (CD73)",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
5008,OSM,oncostatin M,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
5091,PC,pyruvate carboxylase,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
5105,PCK1,phosphoenolpyruvate carboxykinase 1 (soluble),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
5340,PLG,plasminogen,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,2,Therapeutic
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,2,Biomarker
9104,RGN,regucalcin,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
6038,RNASE4,"ribonuclease, RNase A family, 4",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
9501,RPH3AL,rabphilin 3A-like (without C2 domains),0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
871,SERPINH1,"serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
6554,SLC10A1,"solute carrier family 10 (sodium/bile acid cotransporter), member 1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
6568,SLC17A1,"solute carrier family 17 (organic anion transporter), member 1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
2542,SLC37A4,"solute carrier family 37 (glucose-6-phosphate transporter), member 4",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
4087,SMAD2,SMAD family member 2,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
4089,SMAD4,SMAD family member 4,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
8651,SOCS1,suppressor of cytokine signaling 1,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
54466,SPIN2A,"spindlin family, member 2A",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
6783,SULT1E1,"sulfotransferase family 1E, estrogen-preferring, member 1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
6822,SULT2A1,"sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Biomarker
7422,VEGFA,vascular endothelial growth factor A,0.0,1.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,2,"Biomarker, Therapeutic"
4904,YBX1,Y box binding protein 1,0.0,0.0,0.0,0.0,1.0,23893,"Liver Cirrhosis, Experimental",0.21,1,Therapeutic
9370,ADIPOQ,"adiponectin, C1Q and collagen domain containing",0.0,0.0,0.0,0.0,1.0,948480,Coronary Restenosis,0.21,1,Therapeutic
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,2,Biomarker
54901,CDKAL1,CDK5 regulatory subunit associated protein 1-like 1,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,2,Biomarker
79068,FTO,fat mass and obesity associated,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,2,Biomarker
2696,GIPR,gastric inhibitory polypeptide receptor,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,1,Biomarker
132789,GNPDA2,glucosamine-6-phosphate deaminase 2,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,1,Biomarker
2813,GP2,glycoprotein 2 (zymogen granule membrane),0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,1,Biomarker
3270,HRC,histidine rich calcium binding protein,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,1,Biomarker
687,KLF9,Kruppel-like factor 9,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,1,Biomarker
5607,MAP2K5,mitogen-activated protein kinase kinase 5,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,1,Biomarker
4160,MC4R,melanocortin 4 receptor,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,2,Biomarker
5122,PCSK1,proprotein convertase subtilisin/kexin type 1,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,1,Biomarker
89866,SEC16B,SEC16 homolog B (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,2,Biomarker
7021,TFAP2B,transcription factor AP-2 beta (activating enhancer binding protein 2 beta),0.0,1.0,0.0,0.0,0.0,5910,Body Weight,0.21,1,Biomarker
57760,SPG16,"spastic paraplegia 16 (complicated, X-linked recessive)",0.0,1.0,0.0,0.0,0.0,1846046,"Spastic paraplegia 16, X-linked",0.21,0,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,0.0,1860707,Tuberous Sclerosis 2,0.21,0,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,737,Abdominal Pain,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,0.0,0.0,0.0,1.0,30920,Peptic Ulcer,0.21,1,Therapeutic
718,C3,complement component 3,0.0,0.0,1.0,0.0,0.0,3151071,"Complement Component 3 Deficiency, Autosomal Recessive",0.21,0,GeneticVariation
142680,SLC34A3,"solute carrier family 34 (type II sodium/phosphate cotransporter), member 3",0.0,1.0,0.0,0.0,0.0,1853271,"Hypophosphatemic Rickets with Hypercalciuria, Hereditary",0.21,0,Biomarker
617,BCS1L,BC1 (ubiquinol-cytochrome c reductase) synthesis-like,0.0,0.0,1.0,0.0,0.0,3541471,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1",0.21,0,GeneticVariation
6390,SDHB,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",0.0,1.0,0.0,0.0,0.0,2676500,Cowden-Like Syndrome,0.21,0,Biomarker
6392,SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein",0.0,1.0,0.0,0.0,0.0,2676500,Cowden-Like Syndrome,0.21,0,Biomarker
54114,ODPF,"Osseous dysplasia, digital, with facial pigmentary defects and multiple frenula",0.0,1.0,0.0,0.0,0.0,1846129,Terminal Osseous Dysplasia and Pigmentary Defects,0.21,0,Biomarker
3832,KIF11,kinesin family member 11,0.0,1.0,0.0,0.0,0.0,1257806,Chromosomal Instability,0.21,1,Biomarker
282552,IS2,"Scoliosis, idiopathic 2",0.0,1.0,0.0,0.0,0.0,1846366,"SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 2",0.21,0,Biomarker
1913,EEC1,"ectrodactyly, ectodermal dysplasia and cleft lip/palate syndrome 1",0.0,1.0,0.0,0.0,0.0,1851841,"Ectrodactyly, Ectodermal Dysplasia, And Cleft Lip/Palate Syndrome 1",0.21,0,Biomarker
23405,DICER1,"dicer 1, ribonuclease type III",0.0,0.0,1.0,0.0,0.0,3165522,"GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS",0.21,0,GeneticVariation
192144,HDLCQ1,high density lipoprotein cholesterol level QTL 1,0.0,1.0,0.0,0.0,0.0,1847758,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1,0.21,0,Biomarker
3360,HTR4,"5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled",0.0,0.0,0.0,0.0,1.0,38454,Stroke,0.21,1,Therapeutic
3659,IRF1,interferon regulatory factor 1,0.0,1.0,0.0,0.0,0.0,38454,Stroke,0.21,1,Biomarker
3685,ITGAV,"integrin, alpha V",0.0,1.0,0.0,0.0,0.0,38454,Stroke,0.21,1,Biomarker
196743,PAOX,polyamine oxidase (exo-N4-amino),0.0,1.0,0.0,0.0,0.0,38454,Stroke,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,1.0,0.0,0.0,0.0,38454,Stroke,0.21,1,Biomarker
5563,PRKAA2,"protein kinase, AMP-activated, alpha 2 catalytic subunit",0.0,0.0,0.0,0.0,1.0,38454,Stroke,0.21,1,Therapeutic
54498,SMOX,spermine oxidase,0.0,1.0,0.0,0.0,0.0,38454,Stroke,0.21,1,Biomarker
217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),0.0,0.0,0.0,0.0,1.0,18805,Heart Injuries,0.21,1,Therapeutic
4632,MYL1,"myosin, light chain 1, alkali; skeletal, fast",0.0,1.0,0.0,0.0,0.0,18805,Heart Injuries,0.21,1,Biomarker
7139,TNNT2,troponin T type 2 (cardiac),0.0,1.0,0.0,0.0,0.0,18805,Heart Injuries,0.21,1,Biomarker
100381207,CIHL,"hearing loss, cisplatin-induced, susceptibility to",0.0,1.0,0.0,0.0,0.0,2750088,"HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO",0.21,0,Biomarker
1312,COMT,catechol-O-methyltransferase,0.0,1.0,0.0,0.0,0.0,2750088,"HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO",0.21,1,Biomarker
7172,TPMT,thiopurine S-methyltransferase,0.0,1.0,0.0,0.0,0.0,2750088,"HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO",0.21,1,Biomarker
10075,HUWE1,"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,1846168,"Mental Retardation, X-Linked, Syndromic 10",0.21,0,Biomarker
8419,BFSP2,"beaded filament structural protein 2, phakinin",0.0,1.0,0.0,0.0,0.0,1969032,"Cataract, Autosomal Dominant, Multiple Types 1",0.21,0,Biomarker
25,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
641371,ACOT1,acyl-CoA thioesterase 1,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
170691,ADAMTS17,"ADAM metallopeptidase with thrombospondin type 1 motif, 17",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
307,ANXA4,annexin A4,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
310,ANXA7,annexin A7,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
325,APCS,"amyloid P component, serum",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
467,ATF3,activating transcription factor 3,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
121551,BTBD11,BTB (POZ) domain containing 11,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
79879,CCDC134,coiled-coil domain containing 134,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
1233,CCR4,chemokine (C-C motif) receptor 4,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
1124,CHN2,chimerin 2,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
1149,CIDEA,cell death-inducing DFFA-like effector a,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
64084,CLSTN2,calsyntenin 2,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
1375,CPT1B,carnitine palmitoyltransferase 1B (muscle),0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
1381,CRABP1,cellular retinoic acid binding protein 1,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
168002,DACT2,dishevelled-binding antagonist of beta-catenin 2,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
79039,DDX54,DEAD (Asp-Glu-Ala-Asp) box polypeptide 54,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
57628,DPP10,dipeptidyl-peptidase 10 (non-functional),0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
23404,EXOSC2,exosome component 2,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
201163,FLCN,folliculin,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
339896,GADL1,glutamate decarboxylase-like 1,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
23593,HEBP2,heme binding protein 2,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
8916,HERC3,HECT and RLD domain containing E3 ubiquitin protein ligase 3,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
192286,HIGD2A,"HIG1 hypoxia inducible domain family, member 2A",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
84263,HSDL2,hydroxysteroid dehydrogenase like 2,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
3593,IL12B,interleukin 12B,0.0,0.0,0.0,0.0,1.0,23903,Liver Neoplasms,0.21,1,Therapeutic
3697,ITIH1,inter-alpha-trypsin inhibitor heavy chain 1,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
9215,LARGE,like-glycosyltransferase,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
158038,LINGO2,leucine rich repeat and Ig domain containing 2,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
4057,LTF,lactotransferrin,0.0,0.0,0.0,0.0,1.0,23903,Liver Neoplasms,0.21,1,Therapeutic
4645,MYO5B,myosin VB,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
51491,NOP16,NOP16 nucleolar protein,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
23386,NUDCD3,NudC domain containing 3,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
283927,NUDT7,nudix (nucleoside diphosphate linked moiety X)-type motif 7,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
81572,PDRG1,p53 and DNA-damage regulated 1,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
5357,PLS1,plastin 1,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
130814,PQLC3,PQ loop repeat containing 3,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
166336,PRICKLE2,prickle homolog 2 (Drosophila),0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
5685,PSMA4,"proteasome (prosome, macropain) subunit, alpha type, 4",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
9317,PTER,phosphotriesterase related,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
5800,PTPRO,"protein tyrosine phosphatase, receptor type, O",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,2,Biomarker
83597,RTP3,receptor (chemosensory) transporter protein 3,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
6319,SCD,stearoyl-CoA desaturase (delta-9-desaturase),0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
6496,SIX3,SIX homeobox 3,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
4891,SLC11A2,"solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
153129,SLC38A9,"solute carrier family 38, member 9",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
30061,SLC40A1,"solute carrier family 40 (iron-regulated transporter), member 1",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
128439,SNHG11,small nucleolar RNA host gene 11 (non-protein coding),0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
374955,SPATA21,spermatogenesis associated 21,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
6725,SRMS,src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
6925,TCF4,transcription factor 4,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
121256,TMEM132D,transmembrane protein 132D,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
10188,TNK2,"tyrosine kinase, non-receptor, 2",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
7204,TRIO,trio Rho guanine nucleotide exchange factor,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
22996,TTC39A,tetratricopeptide repeat domain 39A,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
164395,TTLL9,tubulin tyrosine ligase-like family member 9,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
7358,UGDH,UDP-glucose 6-dehydrogenase,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
116966,WDR17,WD repeat domain 17,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
23302,WSCD1,WSC domain containing 1,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
10897,YIF1A,Yip1 interacting factor homolog A (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
51201,ZDHHC2,"zinc finger, DHHC-type containing 2",0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
342945,ZSCAN22,zinc finger and SCAN domain containing 22,0.0,1.0,0.0,0.0,0.0,23903,Liver Neoplasms,0.21,1,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,2674665,"MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5",0.21,0,Biomarker
541461,PSHK2,"Pseudohyperkalemia, familial, 2, due to red cell leak",0.0,1.0,0.0,0.0,0.0,1836705,"Pseudohyperkalemia, Familial, 2, due to Red Cell Leak",0.21,0,Biomarker
60675,PROK2,prokineticin 2,0.0,0.0,1.0,0.0,0.0,3552343,HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA,0.21,3,GeneticVariation
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,34734,Raynaud Disease,0.21,1,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
635,BHMT,betaine--homocysteine S-methyltransferase,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
836,CASP3,"caspase 3, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
841,CASP8,"caspase 8, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
1036,CDO1,cysteine dioxygenase type 1,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
1889,ECE1,endothelin converting enzyme 1,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
3263,HPX,hemopexin,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
3397,ID1,"inhibitor of DNA binding 1, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
4143,MAT1A,"methionine adenosyltransferase I, alpha",0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
50982,NIDDM3,Noninsulin-dependent diabetes mellitus 3,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,0,Biomarker
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
6277,S100A6,S100 calcium binding protein A6,0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
6616,SNAP25,"synaptosomal-associated protein, 25kDa",0.0,1.0,0.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,23976,Long QT Syndrome,0.21,1,Biomarker
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,0.0,0.0,0.0,23976,Long QT Syndrome,0.21,1,Biomarker
1958,EGR1,early growth response 1,0.0,1.0,0.0,0.0,0.0,8372,"Cholestasis, Intrahepatic",0.21,2,Biomarker
4094,MAF,v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog,0.0,1.0,0.0,0.0,0.0,8372,"Cholestasis, Intrahepatic",0.21,1,Biomarker
4097,MAFG,v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G,0.0,1.0,0.0,0.0,0.0,8372,"Cholestasis, Intrahepatic",0.21,1,Biomarker
9414,TJP2,tight junction protein 2,0.0,1.0,0.0,0.0,0.0,8372,"Cholestasis, Intrahepatic",0.21,1,Biomarker
9518,GDF15,growth differentiation factor 15,0.0,0.0,0.0,0.0,1.0,17185,Gastrointestinal Neoplasms,0.21,1,Therapeutic
3090,HIC1,hypermethylated in cancer 1,0.0,1.0,0.0,0.0,0.0,17185,Gastrointestinal Neoplasms,0.21,1,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
163882,CNST,"consortin, connexin sorting protein",0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
1733,DIO1,"deiodinase, iodothyronine, type I",0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
1734,DIO2,"deiodinase, iodothyronine, type II",0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
51454,GULP1,"GULP, engulfment adaptor PTB domain containing 1",0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
3398,ID2,"inhibitor of DNA binding 2, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
3693,ITGB5,"integrin, beta 5",0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
687,KLF9,Kruppel-like factor 9,0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
6926,TBX3,T-box 3,0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
10618,TGOLN2,trans-golgi network protein 2,0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
163223,ZNF676,zinc finger protein 676,0.0,1.0,0.0,0.0,0.0,40128,Thyroid Diseases,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,17662,"Glomerulonephritis, Membranoproliferative",0.21,1,Biomarker
712,C1QA,"complement component 1, q subcomponent, A chain",0.0,1.0,0.0,0.0,0.0,17662,"Glomerulonephritis, Membranoproliferative",0.21,1,Biomarker
154664,ABCA13,"ATP-binding cassette, sub-family A (ABC1), member 13",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
10347,ABCA7,"ATP-binding cassette, sub-family A (ABC1), member 7",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5244,ABCB4,"ATP-binding cassette, sub-family B (MDR/TAP), member 4",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
4363,ABCC1,"ATP-binding cassette, sub-family C (CFTR/MRP), member 1",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
85320,ABCC11,"ATP-binding cassette, sub-family C (CFTR/MRP), member 11",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
368,ABCC6,"ATP-binding cassette, sub-family C (CFTR/MRP), member 6",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5826,ABCD4,"ATP-binding cassette, sub-family D (ALD), member 4",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
23,ABCF1,"ATP-binding cassette, sub-family F (GCN20), member 1",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
10061,ABCF2,"ATP-binding cassette, sub-family F (GCN20), member 2",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
29777,ABT1,activator of basal transcription 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
27034,ACAD8,"acyl-CoA dehydrogenase family, member 8",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
501,ALDH7A1,"aldehyde dehydrogenase 7 family, member A1",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
267,AMFR,"autocrine motility factor receptor, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
328,APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
84364,ARFGAP2,ADP-ribosylation factor GTPase activating protein 2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
384,ARG2,arginase 2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1386,ATF2,activating transcription factor 2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,3,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
23246,BOP1,block of proliferation 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
51501,C11orf73,chromosome 11 open reading frame 73,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
55739,CARKD,carbohydrate kinase domain containing,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,1.0,242656,Disease Progression,0.21,3,"Biomarker, Therapeutic"
898,CCNE1,cyclin E1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
10574,CCT7,"chaperonin containing TCP1, subunit 7 (eta)",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1000,CDH2,"cadherin 2, type 1, N-cadherin (neuronal)",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1081,CGA,"glycoprotein hormones, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
11200,CHEK2,checkpoint kinase 2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1182,CLCN3,"chloride channel, voltage-sensitive 3",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1201,CLN3,"ceroid-lipofuscinosis, neuronal 3",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
10330,CNPY2,canopy FGF signaling regulator 2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
50813,COPS7A,COP9 signalosome subunit 7A,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
29894,CPSF1,"cleavage and polyadenylation specific factor 1, 160kDa",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1475,CSTA,cystatin A (stefin A),0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,2,Biomarker
1508,CTSB,cathepsin B,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1075,CTSC,cathepsin C,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1642,DDB1,"damage-specific DNA binding protein 1, 127kDa",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
23586,DDX58,DEAD (Asp-Glu-Ala-Asp) box polypeptide 58,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1798,DPAGT1,dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
1969,EPHA2,EPH receptor A2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
56915,EXOSC5,exosome component 5,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
23201,FAM168A,"family with sequence similarity 168, member A",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
2247,FGF2,fibroblast growth factor 2 (basic),0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
2286,FKBP2,"FK506 binding protein 2, 13kDa",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
2950,GSTP1,glutathione S-transferase pi 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
3191,HNRNPL,heterogeneous nuclear ribonucleoprotein L,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
3420,IDH3B,isocitrate dehydrogenase 3 (NAD+) beta,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
3621,ING1,"inhibitor of growth family, member 1",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
23028,KDM1A,lysine (K)-specific demethylase 1A,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
9817,KEAP1,kelch-like ECH-associated protein 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
354,KLK3,kallikrein-related peptidase 3,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
4074,M6PR,mannose-6-phosphate receptor (cation dependent),0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
406984,MIR200B,microRNA 200b,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
406985,MIR200C,microRNA 200c,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
28998,MRPL13,mitochondrial ribosomal protein L13,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
64963,MRPS11,mitochondrial ribosomal protein S11,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
28973,MRPS18B,mitochondrial ribosomal protein S18B,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
51594,NBAS,neuroblastoma amplified sequence,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
4695,NDUFA2,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
4719,NDUFS1,"NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
4723,NDUFV1,"NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
10528,NOP56,NOP56 ribonucleoprotein,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5036,PA2G4,"proliferation-associated 2G4, 38kDa",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5160,PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5245,PHB,prohibitin,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
51728,POLR3K,"polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
8611,PPAP2A,phosphatidic acid phosphatase type 2A,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5518,PPP2R1A,"protein phosphatase 2, regulatory subunit A, alpha",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5524,PPP2R4,"protein phosphatase 2A activator, regulatory subunit 4",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
10935,PRDX3,peroxiredoxin 3,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
10549,PRDX4,peroxiredoxin 4,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5550,PREP,prolyl endopeptidase,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5564,PRKAB1,"protein kinase, AMP-activated, beta 1 non-catalytic subunit",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
27339,PRPF19,pre-mRNA processing factor 19,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
53635,PTOV1,prostate tumor overexpressed 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5792,PTPRF,"protein tyrosine phosphatase, receptor type, F",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
80324,PUS1,pseudouridylate synthase 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5886,RAD23A,RAD23 homolog A (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
57610,RANBP10,RAN binding protein 10,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
5909,RAP1GAP,RAP1 GTPase activating protein,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6137,RPL13,ribosomal protein L13,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6138,RPL15,ribosomal protein L15,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6141,RPL18,ribosomal protein L18,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6209,RPS15,ribosomal protein S15,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6223,RPS19,ribosomal protein S19,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6227,RPS21,ribosomal protein S21,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6231,RPS26,ribosomal protein S26,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6194,RPS6,ribosomal protein S6,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6240,RRM1,ribonucleotide reductase M1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
9136,RRP9,"ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast)",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6257,RXRB,"retinoid X receptor, beta",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
26135,SERBP1,SERPINE1 mRNA binding protein 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6628,SNRPB,small nuclear ribonucleoprotein polypeptides B and B1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
27131,SNX5,sorting nexin 5,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,1.0,242656,Disease Progression,0.21,7,"Biomarker, Therapeutic"
6649,SOD3,"superoxide dismutase 3, extracellular",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6721,SREBF2,sterol regulatory element binding transcription factor 2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
8802,SUCLG1,"succinate-CoA ligase, alpha subunit",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
8189,SYMPK,symplekin,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
8148,TAF15,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa",0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
7015,TERT,telomerase reverse transcriptase,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
9725,TMEM63A,transmembrane protein 63A,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
10131,TRAP1,TNF receptor-associated protein 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
10628,TXNIP,thioredoxin interacting protein,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
51035,UBXN1,UBX domain protein 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
81605,URM1,ubiquitin related modifier 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
9277,WDR46,WD repeat domain 46,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
7528,YY1,YY1 transcription factor,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
6935,ZEB1,zinc finger E-box binding homeobox 1,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
9839,ZEB2,zinc finger E-box binding homeobox 2,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
51042,ZNF593,zinc finger protein 593,0.0,1.0,0.0,0.0,0.0,242656,Disease Progression,0.21,1,Biomarker
23767,FLRT3,fibronectin leucine rich transmembrane protein 3,0.0,0.0,1.0,0.0,0.0,3808986,HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA,0.21,1,GeneticVariation
4055,LTBR,"lymphotoxin beta receptor (TNFR superfamily, member 3)",0.0,1.0,0.0,0.0,0.0,24530,Malaria,0.21,1,Biomarker
9992,KCNE2,"potassium channel, voltage gated subfamily E regulatory beta subunit 2",0.0,1.0,0.0,0.0,0.0,1837014,"Atrial Fibrillation, Familial, 3",0.21,0,Biomarker
474388,CMM4,"Melanoma, cutaneous malignant, 4",0.0,1.0,0.0,0.0,0.0,1842643,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4",0.21,0,Biomarker
641372,ACOT6,acyl-CoA thioesterase 6,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
9508,ADAMTS3,"ADAM metallopeptidase with thrombospondin type 1 motif, 3",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
113,ADCY7,adenylate cyclase 7,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
259173,ALS2CL,ALS2 C-terminal like,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
694,BTG1,"B-cell translocation gene 1, anti-proliferative",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
837,CASP4,"caspase 4, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
255101,CCDC108,coiled-coil domain containing 108,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
339230,CCDC137,coiled-coil domain containing 137,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
10659,CELF2,"CUGBP, Elav-like family member 2",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
1108,CHD4,chromodomain helicase DNA binding protein 4,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
1281,COL3A1,"collagen, type III, alpha 1",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
1806,DPYD,dihydropyrimidine dehydrogenase,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,2,Biomarker
55741,EDEM2,"ER degradation enhancer, mannosidase alpha-like 2",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
1983,EIF5,eukaryotic translation initiation factor 5,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
90952,ESAM,endothelial cell adhesion molecule,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
131177,FAM3D,"family with sequence similarity 3, member D",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
60493,FASTKD5,FAST kinase domains 5,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
2563,GABRD,"gamma-aminobutyric acid (GABA) A receptor, delta",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
2694,GIF,gastric intrinsic factor (vitamin B synthesis),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
221393,GPR115,G protein-coupled receptor 115,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
387509,GPR153,G protein-coupled receptor 153,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
220988,HNRNPA3,heterogeneous nuclear ribonucleoprotein A3,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
3632,INPP5A,"inositol polyphosphate-5-phosphatase, 40kDa",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
84678,KDM2B,lysine (K)-specific demethylase 2B,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
11278,KLF12,Kruppel-like factor 12,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
3836,KPNA1,karyopherin alpha 1 (importin alpha 5),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
284217,LAMA1,"laminin, alpha 1",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
3908,LAMA2,"laminin, alpha 2",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,2,Biomarker
55366,LGR4,leucine-rich repeat containing G protein-coupled receptor 4,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,0,Biomarker
4035,LRP1,low density lipoprotein receptor-related protein 1,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
9947,MAGEC1,melanoma antigen family C1,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
2475,MTOR,mechanistic target of rapamycin (serine/threonine kinase),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
10641,NPRL2,nitrogen permease regulator-like 2 (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
8204,NRIP1,nuclear receptor interacting protein 1,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
119749,OR4C46,"olfactory receptor, family 4, subfamily C, member 46",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
55824,PAG1,phosphoprotein membrane anchor with glycosphingolipid microdomains 1,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
9600,PITPNM1,"phosphatidylinositol transfer protein, membrane-associated 1",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
23228,PLCL2,phospholipase C-like 2,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
5371,PML,promyelocytic leukemia,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
9821,RB1CC1,RB1-inducible coiled-coil 1,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
6002,RGS12,regulator of G-protein signaling 12,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
29115,SAP30BP,SAP30 binding protein,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
55206,SBNO1,strawberry notch homolog 1 (Drosophila),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
404686,SCZD11,"Schizophrenia susceptibility locus, chromosome 10q-related",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,0,Biomarker
619488,SCZD12,schizophrenia 12,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,0,Biomarker
100196913,SCZD14,"schizophrenia, susceptibility to, 14",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,0,Biomarker
6365,SCZD3,schizophrenia disorder 3,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,0,Biomarker
8400,SCZD6,schizophrenia disorder 6,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,0,Biomarker
8401,SCZD7,schizophrenia disorder 7,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,0,Biomarker
8806,SCZD8,schizophrenia disorder 8,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,0,Biomarker
115111,SLC26A7,"solute carrier family 26 (anion exchanger), member 7",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
116369,SLC26A8,"solute carrier family 26 (anion exchanger), member 8",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
166378,SPATA5,spermatogenesis associated 5,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
6426,SRSF1,serine/arginine-rich splicing factor 1,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
146279,TEKT5,tektin 5,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
22906,TRAK1,"trafficking protein, kinesin binding 1",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
8295,TRRAP,transformation/transcription domain-associated protein,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,2,Biomarker
54659,UGT1A3,"UDP glucuronosyltransferase 1 family, polypeptide A3",0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
55737,VPS35,vacuolar protein sorting 35 homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
23339,VPS39,vacuolar protein sorting 39 homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
55717,WDR11,WD repeat domain 11,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
147657,ZNF480,zinc finger protein 480,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
348327,ZNF530,zinc finger protein 530,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
147929,ZNF565,zinc finger protein 565,0.0,1.0,0.0,0.0,0.0,36341,Schizophrenia,0.21,1,Biomarker
100188774,DFCTRPS,"Deafness, cataract, retinitis pigmentosa, and sperm abnormalities",0.0,1.0,0.0,0.0,0.0,2678011,"Deafness, Cataract, Retinitis Pigmentosa, And Sperm Abnormalities",0.21,0,Biomarker
6647,SOD1,"superoxide dismutase 1, soluble",0.0,1.0,0.0,0.0,0.0,15696,"Fatty Liver, Alcoholic",0.21,1,Biomarker
3284,HSD3B2,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2",0.0,1.0,0.0,0.0,0.0,2931782,Adrenal hyperplasia 2,0.21,0,Biomarker
282551,ITS,Insulinoma tumor suppressor gene locus,0.0,1.0,0.0,0.0,0.0,21670,Insulinoma,0.21,0,Biomarker
2524,FUT2,fucosyltransferase 2 (secretor status included),0.0,1.0,0.0,0.0,0.0,162677,Caliciviridae Infections,0.21,1,Biomarker
116,ADCYAP1,adenylate cyclase activating polypeptide 1 (pituitary),0.0,0.0,0.0,0.0,1.0,878773,"Urinary Bladder, Overactive",0.21,1,Therapeutic
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,878773,"Urinary Bladder, Overactive",0.21,1,Biomarker
8989,TRPA1,"transient receptor potential cation channel, subfamily A, member 1",0.0,1.0,0.0,0.0,1.0,878773,"Urinary Bladder, Overactive",0.21,2,"Biomarker, Therapeutic"
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,0.0,0.0,0.0,1.0,4310,Auditory Perceptual Disorders,0.21,1,Therapeutic
30813,VSX1,visual system homeobox 1,0.0,1.0,0.0,0.0,0.0,4310,Auditory Perceptual Disorders,0.21,1,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,0.0,0.0,0.0,525041,Neurobehavioral Manifestations,0.21,1,Biomarker
2289,FKBP5,FK506 binding protein 5,0.0,1.0,0.0,0.0,0.0,525041,Neurobehavioral Manifestations,0.21,1,Biomarker
407046,MIR9-1,microRNA 9-1,0.0,1.0,0.0,0.0,0.0,525041,Neurobehavioral Manifestations,0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,0.0,0.0,0.0,1.0,525041,Neurobehavioral Manifestations,0.21,1,Therapeutic
10743,RAI1,retinoic acid induced 1,0.0,1.0,0.0,0.0,0.0,525041,Neurobehavioral Manifestations,0.21,1,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,0.0,0.0,0.0,19294,"Hernia, Inguinal",0.21,1,Biomarker
338090,SPG24,spastic paraplegia 24 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,2931354,Spastic paraplegia 24,0.21,0,Biomarker
100049159,SPG37,spastic paraplegia 37 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,2936880,"Spastic Paraplegia 37, Autosomal Dominant",0.21,0,Biomarker
3240,HP,haptoglobin,0.0,1.0,0.0,0.0,0.0,524909,"Hepatitis B, Chronic",0.21,1,Biomarker
7332,UBE2L3,ubiquitin-conjugating enzyme E2L 3,0.0,1.0,0.0,0.0,0.0,524909,"Hepatitis B, Chronic",0.21,1,Biomarker
847,CAT,catalase,0.0,0.0,0.0,0.0,1.0,771,"Abnormalities, Drug-Induced",0.21,1,Therapeutic
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,0.0,0.0,0.0,771,"Abnormalities, Drug-Induced",0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
1558,CYP2C8,"cytochrome P450, family 2, subfamily C, polypeptide 8",0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
3055,HCK,"HCK proto-oncogene, Src family tyrosine kinase",0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
22806,IKZF3,IKAROS family zinc finger 3 (Aiolos),0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
55824,PAG1,phosphoprotein membrane anchor with glycosphingolipid microdomains 1,0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
63978,PRDM14,PR domain containing 14,0.0,1.0,0.0,0.0,0.0,1961102,Precursor Cell Lymphoblastic Leukemia-Lymphoma,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,32617,Polyuria,0.21,1,Biomarker
9536,PTGES,prostaglandin E synthase,0.0,1.0,0.0,0.0,0.0,32617,Polyuria,0.21,1,Biomarker
5818,PVRL1,poliovirus receptor-related 1 (herpesvirus entry mediator C),0.0,1.0,0.0,0.0,0.0,796139,Rosselli-Gulienetti Syndrome,0.21,0,Biomarker
10747,MASP2,mannan-binding lectin serine peptidase 2,0.0,1.0,0.0,0.0,0.0,14742,Erythema Multiforme,0.21,1,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,13390,Dysmenorrhea,0.21,1,Biomarker
5020,OXT,oxytocin/neurophysin I prepropeptide,0.0,1.0,0.0,0.0,0.0,13390,Dysmenorrhea,0.21,1,Biomarker
100124414,GINGF4,"gingival fibromatosis, hereditary, 4",0.0,1.0,0.0,0.0,0.0,1970245,"Fibromatosis, Gingival, 4",0.21,0,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,29106,Opisthorchiasis,0.21,1,Biomarker
619511,MHB,"myopathy, hyaline body, autosomal recessive",0.0,1.0,0.0,0.0,0.0,1850709,"Myopathy, Hyaline Body, Autosomal Recessive",0.21,0,Biomarker
9193,SPG9,spastic paraplegia 9 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,1832669,"Spastic paraplegia 9, autosomal dominant",0.21,0,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,37019,Shy-Drager Syndrome,0.21,1,Biomarker
43,ACHE,acetylcholinesterase (Yt blood group),0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
347,APOD,apolipoprotein D,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
351,APP,amyloid beta (A4) precursor protein,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,4,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
2890,GRIA1,"glutamate receptor, ionotropic, AMPA 1",0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
3363,HTR7,"5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled",0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
4137,MAPT,microtubule-associated protein tau,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
10367,MICU1,mitochondrial calcium uptake 1,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
5153,PDE1B,"phosphodiesterase 1B, calmodulin-dependent",0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
5368,PNOC,prepronociceptin,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
5447,POR,P450 (cytochrome) oxidoreductase,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
10280,SIGMAR1,sigma non-opioid intracellular receptor 1,0.0,0.0,0.0,0.0,1.0,23186,Learning Disorders,0.21,1,Therapeutic
57084,SLC17A6,"solute carrier family 17 (vesicular glutamate transporter), member 6",0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
57030,SLC17A7,"solute carrier family 17 (vesicular glutamate transporter), member 7",0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
6855,SYP,synaptophysin,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,1,Biomarker
7054,TH,tyrosine hydroxylase,0.0,1.0,0.0,0.0,0.0,23186,Learning Disorders,0.21,2,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,0.0,0.0,0.0,1.0,23186,Learning Disorders,0.21,1,Therapeutic
7422,VEGFA,vascular endothelial growth factor A,0.0,0.0,0.0,0.0,1.0,23186,Learning Disorders,0.21,1,Therapeutic
406900,MIR106B,microRNA 106b,0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.21,1,Biomarker
406920,MIR130B,microRNA 130b,0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.21,1,Biomarker
442894,MIR302B,microRNA 302b,0.0,0.0,0.0,0.0,1.0,29463,Osteosarcoma,0.21,1,Therapeutic
4486,MST1R,macrophage stimulating 1 receptor (c-met-related tyrosine kinase),0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.21,1,Biomarker
5996,RGS1,regulator of G-protein signaling 1,0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.21,1,Biomarker
8148,TAF15,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa",0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.21,1,Biomarker
9183,ZW10,zw10 kinetochore protein,0.0,1.0,0.0,0.0,0.0,29463,Osteosarcoma,0.21,1,Biomarker
619411,LVNC2,"noncompaction of left ventricular myocardium, familial isolated, autosomal dominant 2",0.0,1.0,0.0,0.0,0.0,1836118,LEFT VENTRICULAR NONCOMPACTION 2,0.21,0,Biomarker
3459,IFNGR1,interferon gamma receptor 1,0.0,1.0,0.0,0.0,0.0,26919,"Mycobacterium Infections, Nontuberculous",0.21,0,Biomarker
3460,IFNGR2,interferon gamma receptor 2 (interferon gamma transducer 1),0.0,1.0,0.0,0.0,0.0,26919,"Mycobacterium Infections, Nontuberculous",0.21,0,Biomarker
3593,IL12B,interleukin 12B,0.0,1.0,0.0,0.0,0.0,26919,"Mycobacterium Infections, Nontuberculous",0.21,0,Biomarker
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,0.0,0.0,0.0,26919,"Mycobacterium Infections, Nontuberculous",0.21,0,Biomarker
4364,MRSD,mental retardation-skeletal dysplasia,0.0,1.0,0.0,0.0,0.0,1839729,"Mental Retardation, Skeletal Dysplasia, and Abducens Palsy",0.21,0,Biomarker
100188754,AD14,Alzheimer disease 14,0.0,1.0,0.0,0.0,0.0,1970144,Alzheimer Disease 14,0.21,0,Biomarker
4162,MCAM,melanoma cell adhesion molecule,0.0,0.0,0.0,0.0,1.0,751871,Autoimmune Diseases of the Nervous System,0.21,1,Therapeutic
91574,C12orf65,chromosome 12 open reading frame 65,0.0,1.0,0.0,0.0,0.0,162666,Mitochondrial Encephalomyopathies,0.21,1,Biomarker
10059,DNM1L,dynamin 1-like,0.0,1.0,0.0,0.0,0.0,162666,Mitochondrial Encephalomyopathies,0.21,1,Biomarker
55572,FOXRED1,FAD-dependent oxidoreductase domain containing 1,0.0,1.0,0.0,0.0,0.0,162666,Mitochondrial Encephalomyopathies,0.21,1,Biomarker
4720,NDUFS2,"NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase)",0.0,1.0,0.0,0.0,0.0,162666,Mitochondrial Encephalomyopathies,0.21,1,Biomarker
4729,NDUFV2,"NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa",0.0,1.0,0.0,0.0,0.0,162666,Mitochondrial Encephalomyopathies,0.21,1,Biomarker
9997,SCO2,SCO2 cytochrome c oxidase assembly protein,0.0,1.0,0.0,0.0,0.0,162666,Mitochondrial Encephalomyopathies,0.21,1,Biomarker
54968,TMEM70,transmembrane protein 70,0.0,1.0,0.0,0.0,0.0,162666,Mitochondrial Encephalomyopathies,0.21,1,Biomarker
6157,RPL27A,ribosomal protein L27a,0.0,1.0,0.0,0.0,0.0,162834,Hyperpigmentation,0.21,1,Biomarker
55315,SLC29A3,"solute carrier family 29 (equilibrative nucleoside transporter), member 3",0.0,1.0,0.0,0.0,0.0,162834,Hyperpigmentation,0.21,2,Biomarker
51297,BPIFA1,"BPI fold containing family A, member 1",0.0,1.0,0.0,0.0,0.0,2985290,Fetal Alcohol Spectrum Disorders,0.21,1,Biomarker
56694,BMIQ8,body mass index quantitative trait locus 8,0.0,1.0,0.0,0.0,0.0,2676933,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8,0.21,0,Biomarker
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,0.0,0.0,0.0,2931716,"Deafness, autosomal dominant nonsyndromic sensorineural 17",0.21,0,Biomarker
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,0.0,0.0,0.0,15814,Femur Head Necrosis,0.21,0,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,15814,Femur Head Necrosis,0.21,1,Biomarker
4265,MHS4,malignant hyperthermia susceptibility 4,0.0,1.0,0.0,0.0,0.0,2930983,Malignant hyperthermia susceptibility type 4,0.21,0,Biomarker
138050,HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,0.0,1.0,0.0,0.0,0.0,26706,Mucopolysaccharidosis III,0.21,0,Biomarker
367,AR,androgen receptor,0.0,1.0,0.0,0.0,0.0,85207,"Diabetes, Gestational",0.21,1,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,85207,"Diabetes, Gestational",0.21,1,Biomarker
25,ABL1,"ABL proto-oncogene 1, non-receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
405,ARNT,aryl hydrocarbon receptor nuclear translocator,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
613,BCR,breakpoint cluster region,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
682,BSG,basigin (Ok blood group),0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
595,CCND1,cyclin D1,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
1019,CDK4,cyclin-dependent kinase 4,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
2026,ENO2,"enolase 2 (gamma, neuronal)",0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
2149,F2R,coagulation factor II (thrombin) receptor,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,1,Therapeutic
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,2,Biomarker
3274,HRH2,histamine receptor H2,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,1,Therapeutic
3592,IL12A,interleukin 12A,0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,1,Therapeutic
3593,IL12B,interleukin 12B,0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,1,Therapeutic
3558,IL2,interleukin 2,0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,3,Therapeutic
3832,KIF11,kinesin family member 11,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,3,Biomarker
407041,MIR34B,microRNA 34b,0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,1,Therapeutic
574511,MIR506,microRNA 506,0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,1,Therapeutic
1728,NQO1,"NAD(P)H dehydrogenase, quinone 1",0.0,1.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,2,"Biomarker, Therapeutic"
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
5111,PCNA,proliferating cell nuclear antigen,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
5621,PRNP,prion protein,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
22827,PUF60,poly-U binding splicing factor 60KDa,0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,1,Therapeutic
5970,RELA,v-rel avian reticuloendotheliosis viral oncogene homolog A,0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,1,Therapeutic
7124,TNF,tumor necrosis factor,0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,3,Therapeutic
8743,TNFSF10,"tumor necrosis factor (ligand) superfamily, member 10",0.0,0.0,0.0,0.0,1.0,27659,"Neoplasms, Experimental",0.21,1,Therapeutic
10140,TOB1,"transducer of ERBB2, 1",0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
8725,URI1,"URI1, prefoldin-like chaperone",0.0,1.0,0.0,0.0,0.0,27659,"Neoplasms, Experimental",0.21,1,Biomarker
246260,BDA1B,"Brachydactyly, type A1, locus B",0.0,1.0,0.0,0.0,0.0,1846949,"Brachydactyly, Type A1, B",0.21,0,Biomarker
790,CAD,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase",0.0,1.0,0.0,0.0,0.0,23440,"Leukemia, Erythroblastic, Acute",0.21,1,Biomarker
1723,DHODH,dihydroorotate dehydrogenase (quinone),0.0,1.0,0.0,0.0,0.0,23440,"Leukemia, Erythroblastic, Acute",0.21,1,Biomarker
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,0.0,0.0,0.0,23440,"Leukemia, Erythroblastic, Acute",0.21,1,Biomarker
2332,FMR1,fragile X mental retardation 1,0.0,1.0,0.0,0.0,0.0,18051,Gonadal Dysgenesis,0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
644165,BCRP3,breakpoint cluster region pseudogene 3,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
624,BDKRB2,bradykinin receptor B2,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
914,CD2,CD2 molecule,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
2056,EPO,erythropoietin,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,2,Biomarker
2159,F10,coagulation factor X,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
2158,F9,coagulation factor IX,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
2322,FLT3,fms-related tyrosine kinase 3,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
2526,FUT4,"fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)",0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
2982,GUCY1A3,"guanylate cyclase 1, soluble, alpha 3",0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,0.0,0.0,1.0,40053,Thrombosis,0.21,1,Therapeutic
5028,P2RY1,"purinergic receptor P2Y, G-protein coupled, 1",0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
5139,PDE3A,"phosphodiesterase 3A, cGMP-inhibited",0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
5420,PODXL,podocalyxin-like,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
5733,PTGER3,prostaglandin E receptor 3 (subtype EP3),0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
7301,TYRO3,TYRO3 protein tyrosine kinase,0.0,1.0,0.0,0.0,0.0,40053,Thrombosis,0.21,1,Biomarker
8724,SNX3,sorting nexin 3,0.0,1.0,0.0,0.0,0.0,1832440,"Microcephaly, microphthalmia, ectrodactyly of lower limbs, and prognathism",0.21,0,Biomarker
100240732,IBD22,Inflammatory bowel disease-22,0.0,1.0,0.0,0.0,0.0,2676485,Inflammatory Bowel Disease 22,0.21,0,Biomarker
100270641,MYP16,myopia 16,0.0,1.0,0.0,0.0,0.0,2675523,Myopia 16,0.21,0,Biomarker
131,ADH7,"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide",0.0,1.0,0.0,0.0,0.0,31347,Pharyngeal Neoplasms,0.21,1,Biomarker
149465,CFAP57,cilia and flagella associated protein 57,0.0,0.0,1.0,0.0,0.0,1847604,Van der Woude syndrome 2,0.21,1,GeneticVariation
213,ALB,albumin,0.0,0.0,0.0,0.0,1.0,35222,"Respiratory Distress Syndrome, Adult",0.21,1,Therapeutic
56994,CHPT1,choline phosphotransferase 1,0.0,1.0,0.0,0.0,0.0,35222,"Respiratory Distress Syndrome, Adult",0.21,1,Biomarker
5321,PLA2G4A,"phospholipase A2, group IVA (cytosolic, calcium-dependent)",0.0,1.0,0.0,0.0,0.0,35222,"Respiratory Distress Syndrome, Adult",0.21,1,Biomarker
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,0.0,0.0,0.0,35222,"Respiratory Distress Syndrome, Adult",0.21,1,Biomarker
780905,EA3,"Episodic ataxia, type 3",0.0,1.0,0.0,0.0,0.0,1847839,"Episodic Ataxia, Type 3",0.21,0,Biomarker
6392,SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein",0.0,1.0,0.0,0.0,0.0,349535,"Carcinoid Tumors, Intestinal",0.21,0,Biomarker
10572,SIVA1,"SIVA1, apoptosis-inducing factor",0.0,1.0,0.0,0.0,0.0,10246,Coxsackievirus Infections,0.21,1,Biomarker
6581,SLC22A3,"solute carrier family 22 (organic cation transporter), member 3",0.0,1.0,0.0,0.0,0.0,10246,Coxsackievirus Infections,0.21,1,Biomarker
6583,SLC22A4,"solute carrier family 22 (organic cation/zwitterion transporter), member 4",0.0,1.0,0.0,0.0,0.0,10246,Coxsackievirus Infections,0.21,1,Biomarker
6584,SLC22A5,"solute carrier family 22 (organic cation/carnitine transporter), member 5",0.0,1.0,0.0,0.0,0.0,10246,Coxsackievirus Infections,0.21,1,Biomarker
301,ANXA1,annexin A1,0.0,0.0,0.0,0.0,1.0,38354,Stomach Diseases,0.21,1,Therapeutic
2641,GCG,glucagon,0.0,0.0,0.0,0.0,1.0,38354,Stomach Diseases,0.21,1,Therapeutic
8772,FADD,Fas (TNFRSF6)-associated via death domain,0.0,0.0,1.0,0.0,0.0,3151062,"INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS",0.21,1,GeneticVariation
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",0.0,1.0,0.0,0.0,0.0,20514,Hyperprolactinemia,0.21,1,Biomarker
2796,GNRH1,gonadotropin-releasing hormone 1 (luteinizing-releasing hormone),0.0,1.0,0.0,0.0,0.0,20514,Hyperprolactinemia,0.21,1,Biomarker
3972,LHB,luteinizing hormone beta polypeptide,0.0,1.0,0.0,0.0,0.0,20514,Hyperprolactinemia,0.21,1,Biomarker
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,0.0,0.0,0.0,1.0,29944,Drug Overdose,0.21,1,Therapeutic
551,AVP,arginine vasopressin,0.0,0.0,0.0,0.0,1.0,29944,Drug Overdose,0.21,1,Therapeutic
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,343755,HIV Wasting Syndrome,0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,343755,HIV Wasting Syndrome,0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,343755,HIV Wasting Syndrome,0.21,1,Biomarker
162417,NAGS,N-acetylglutamate synthase,0.0,1.0,0.0,0.0,0.0,220994,Hyperammonemia,0.21,2,Biomarker
7298,TYMS,thymidylate synthetase,0.0,1.0,0.0,0.0,0.0,220994,Hyperammonemia,0.21,1,Biomarker
780899,DIH2,"Hernia, congenital diaphragmatic 2",0.0,1.0,0.0,0.0,0.0,1857284,Diaphragmatic Hernia 2,0.21,0,Biomarker
1297,COL9A1,"collagen, type IX, alpha 1",0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.21,1,Biomarker
4543,MTNR1A,melatonin receptor 1A,0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.21,1,Biomarker
100506658,OCLN,occludin,0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.21,1,Biomarker
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,0.0,0.0,0.0,1.0,35309,Retinal Diseases,0.21,1,Therapeutic
5311,PKD2,polycystic kidney disease 2 (autosomal dominant),0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.21,1,Biomarker
5788,PTPRC,"protein tyrosine phosphatase, receptor type, C",0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.21,1,Biomarker
10806,SDCCAG8,serologically defined colon cancer antigen 8,0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.21,1,Biomarker
30813,VSX1,visual system homeobox 1,0.0,1.0,0.0,0.0,0.0,35309,Retinal Diseases,0.21,1,Biomarker
3039,HBA1,"hemoglobin, alpha 1",0.0,1.0,0.0,0.0,0.0,7785,Cerebral Infarction,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,7785,Cerebral Infarction,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,7785,Cerebral Infarction,0.21,3,Therapeutic
6685,SPG5B,spastic paraplegia 5B (autosomal recessive),0.0,1.0,0.0,0.0,0.0,2931357,"Spastic paraplegia type 5B, recessive",0.21,0,Biomarker
260403,MMEDF,Macrocephaly with multiple epiphyseal dysplasia and distinctive facies,0.0,1.0,0.0,0.0,0.0,1846722,Macrocephaly with Multiple Epiphyseal Dysplasia and Distinctive Facies,0.21,0,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,151786,Muscle Weakness,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,151786,Muscle Weakness,0.21,1,Biomarker
2992,GYG1,glycogenin 1,0.0,1.0,0.0,0.0,0.0,151786,Muscle Weakness,0.21,1,Biomarker
7273,TTN,titin,0.0,1.0,0.0,0.0,0.0,151786,Muscle Weakness,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,16063,Fibrous Dysplasia of Bone,0.21,1,Biomarker
4591,TRIM37,tripartite motif containing 37,0.0,1.0,0.0,0.0,0.0,16063,Fibrous Dysplasia of Bone,0.21,1,Biomarker
374569,ASPG,asparaginase,0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
2488,FSHB,"follicle stimulating hormone, beta polypeptide",0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
3356,HTR2A,"5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,2,Biomarker
3458,IFNG,"interferon, gamma",0.0,1.0,0.0,0.0,1.0,15967,Fever,0.21,2,"Biomarker, Therapeutic"
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,0.0,0.0,0.0,1.0,15967,Fever,0.21,1,Therapeutic
121278,TPH2,tryptophan hydroxylase 2,0.0,1.0,0.0,0.0,0.0,15967,Fever,0.21,1,Biomarker
6663,SOX10,SRY (sex determining region Y)-box 10,0.0,0.0,1.0,0.0,0.0,2700405,"WAARDENBURG SYNDROME, TYPE 2E",0.21,0,GeneticVariation
3162,HMOX1,heme oxygenase (decycling) 1,0.0,1.0,0.0,0.0,0.0,221013,"Mastocytosis, Systemic",0.21,1,Biomarker
100270798,IBD24,Inflammatory bowel disease-24,0.0,1.0,0.0,0.0,0.0,2675509,Inflammatory Bowel Disease 24,0.21,0,Biomarker
572,BAD,BCL2-associated agonist of cell death,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.21,1,Biomarker
330,BIRC3,baculoviral IAP repeat containing 3,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.21,1,Biomarker
9446,GSTO1,glutathione S-transferase omega 1,0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.21,1,Biomarker
10848,PPP1R13L,"protein phosphatase 1, regulatory subunit 13 like",0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.21,1,Biomarker
5590,PRKCZ,"protein kinase C, zeta",0.0,1.0,0.0,0.0,0.0,23418,Leukemia,0.21,1,Biomarker
847,CAT,catalase,0.0,0.0,0.0,0.0,1.0,34063,Pulmonary Edema,0.21,1,Therapeutic
2691,GHRH,growth hormone releasing hormone,0.0,0.0,0.0,0.0,1.0,34063,Pulmonary Edema,0.21,1,Therapeutic
7039,TGFA,"transforming growth factor, alpha",0.0,0.0,0.0,0.0,1.0,34063,Pulmonary Edema,0.21,1,Therapeutic
7124,TNF,tumor necrosis factor,0.0,0.0,0.0,0.0,1.0,34063,Pulmonary Edema,0.21,1,Therapeutic
83636,C19orf12,chromosome 19 open reading frame 12,0.0,0.0,1.0,0.0,0.0,2680446,"SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE",0.21,0,GeneticVariation
554,AVPR2,arginine vasopressin receptor 2,0.0,1.0,0.0,0.0,0.0,28961,Oliguria,0.21,1,Biomarker
3048,HBG2,"hemoglobin, gamma G",0.0,1.0,0.0,0.0,0.0,28961,Oliguria,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,28961,Oliguria,0.21,1,Biomarker
391051,UOX,"urate oxidase, pseudogene",0.0,0.0,0.0,0.0,1.0,28961,Oliguria,0.21,1,Therapeutic
486,FXYD2,FXYD domain containing ion transport regulator 2,0.0,1.0,0.0,0.0,0.0,268448,Hypomagnesemia primary,0.21,1,Biomarker
4129,MAOB,monoamine oxidase B,0.0,1.0,0.0,0.0,0.0,2888,"Anemia, Megaloblastic",0.21,1,Biomarker
6947,TCN1,"transcobalamin I (vitamin B12 binding protein, R binder family)",0.0,1.0,0.0,0.0,0.0,2888,"Anemia, Megaloblastic",0.21,1,Biomarker
10306,CTPP,"Cataract, posterior polar",0.0,1.0,0.0,0.0,0.0,1861825,"Cataract, posterior polar, 1",0.21,0,Biomarker
7547,ZIC3,Zic family member 3,0.0,1.0,0.0,0.0,0.0,1306710,Facial Asymmetry,0.21,1,Biomarker
174,AFP,alpha-fetoprotein,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
212,ALAS2,5'-aminolevulinate synthase 2,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
337,APOA4,apolipoprotein A-IV,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
344,APOC2,apolipoprotein C-II,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
596,BCL2,B-cell CLL/lymphoma 2,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
598,BCL2L1,BCL2-like 1,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
23582,CCNDBP1,cyclin D-type binding-protein 1,0.0,0.0,0.0,0.0,1.0,23904,"Liver Neoplasms, Experimental",0.21,1,Therapeutic
967,CD63,CD63 molecule,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,3,Biomarker
4283,CXCL9,chemokine (C-X-C motif) ligand 9,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,2,Biomarker
1571,CYP2E1,"cytochrome P450, family 2, subfamily E, polypeptide 1",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
2026,ENO2,"enolase 2 (gamma, neuronal)",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
2161,F12,coagulation factor XII (Hageman factor),0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
2305,FOXM1,forkhead box M1,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
2752,GLUL,glutamate-ammonia ligase,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,2,Biomarker
2922,GRP,gastrin-releasing peptide,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
283120,H19,"H19, imprinted maternally expressed transcript (non-protein coding)",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
3082,HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
3265,HRAS,Harvey rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,3,Biomarker
3791,KDR,kinase insert domain receptor,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
4240,MFGE8,milk fat globule-EGF factor 8 protein,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406902,MIR10A,microRNA 10a,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406910,MIR125A,microRNA 125a,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406937,MIR145,microRNA 145,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406957,MIR181C,microRNA 181c,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
574457,MIR181D,microRNA 181d,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406959,MIR183,microRNA 183,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406962,MIR186,microRNA 186,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406953,MIR18A,microRNA 18a,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406971,MIR195,microRNA 195,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
442920,MIR196B,microRNA 196b,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406984,MIR200B,microRNA 200b,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406989,MIR206,microRNA 206,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406994,MIR212,microRNA 212,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407006,MIR221,microRNA 221,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407017,MIR26B,microRNA 26b,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
100126297,MIR300,microRNA 300,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407027,MIR301A,microRNA 301a,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407029,MIR30A,microRNA 30a,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407030,MIR30B,microRNA 30b,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407033,MIR30D,microRNA 30d,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407034,MIR30E,microRNA 30e,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
442898,MIR324,microRNA 324,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
442903,MIR331,microRNA 331,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
442904,MIR335,microRNA 335,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
442906,MIR338,microRNA 338,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
442907,MIR339,microRNA 339,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
442908,MIR340,microRNA 340,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407040,MIR34A,microRNA 34a,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
494332,MIR383,microRNA 383,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
574413,MIR409,microRNA 409,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
554210,MIR429,microRNA 429,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
619552,MIR483,microRNA 483,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
574508,MIR505,microRNA 505,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
664612,MIR539,microRNA 539,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
693183,MIR598,microRNA 598,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
724022,MIR652,microRNA 652,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
768213,MIR671,microRNA 671,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
100126333,MIR708,microRNA 708,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
100126348,MIR760,microRNA 760,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
693235,MIR92B,microRNA 92b,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407054,MIR98,microRNA 98,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
407056,MIR99B,microRNA 99b,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406884,MIRLET7B,microRNA let-7b,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406886,MIRLET7D,microRNA let-7d,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406887,MIRLET7E,microRNA let-7e,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
406891,MIRLET7I,microRNA let-7i,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
219972,MPEG1,macrophage expressed 1,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,3,Biomarker
9970,NR1I3,"nuclear receptor subfamily 1, group I, member 3",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,2,Biomarker
5371,PML,promyelocytic leukemia,0.0,0.0,0.0,0.0,1.0,23904,"Liver Neoplasms, Experimental",0.21,1,Therapeutic
5471,PPAT,phosphoribosyl pyrophosphate amidotransferase,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
5925,RB1,retinoblastoma 1,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
9104,RGN,regucalcin,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
22800,RRAS2,related RAS viral (r-ras) oncogene homolog 2,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
8651,SOCS1,suppressor of cytokine signaling 1,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
6659,SOX4,SRY (sex determining region Y)-box 4,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
6713,SQLE,squalene epoxidase,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
7010,TEK,"TEK tyrosine kinase, endothelial",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
7083,TK1,"thymidine kinase 1, soluble",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
8795,TNFRSF10B,"tumor necrosis factor receptor superfamily, member 10b",0.0,0.0,0.0,0.0,1.0,23904,"Liver Neoplasms, Experimental",0.21,1,Therapeutic
7157,TP53,tumor protein p53,0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,1,Biomarker
8848,TSC22D1,"TSC22 domain family, member 1",0.0,1.0,0.0,0.0,0.0,23904,"Liver Neoplasms, Experimental",0.21,2,Biomarker
2984,GUCY2C,guanylate cyclase 2C,0.0,0.0,1.0,0.0,0.0,3553270,DIARRHEA 6,0.21,0,GeneticVariation
57792,MRXSAB,Abidi X-linked mental retardation syndrome,0.0,1.0,0.0,0.0,0.0,1846056,Abidi X-linked mental retardation syndrome,0.21,0,Biomarker
100303715,IDDM24,"Diabetes mellitus, insulin-dependent, 24",0.0,1.0,0.0,0.0,0.0,2751697,"Diabetes Mellitus, Insulin-Dependent, 24",0.21,0,Biomarker
191,AHCY,adenosylhomocysteinase,0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
4329,ALDH6A1,"aldehyde dehydrogenase 6 family, member A1",0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
383,ARG1,arginase 1,0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
728294,D2HGDH,D-2-hydroxyglutarate dehydrogenase,0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
440275,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
2593,GAMT,guanidinoacetate N-methyltransferase,0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
2729,GCLC,"glutamate-cysteine ligase, catalytic subunit",0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
4143,MAT1A,"methionine adenosyltransferase I, alpha",0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,2,Biomarker
5723,PSPH,phosphoserine phosphatase,0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
79048,SECISBP2,SECIS binding protein 2,0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
9056,SLC7A7,"solute carrier family 7 (amino acid transporter light chain, y+L system), member 7",0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
7508,XPC,"xeroderma pigmentosum, complementation group C",0.0,1.0,0.0,0.0,0.0,2514,"Amino Acid Metabolism, Inborn Errors",0.21,1,Biomarker
177,AGER,advanced glycosylation end product-specific receptor,0.0,1.0,0.0,0.0,0.0,30286,Pancreatic Diseases,0.21,1,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,30286,Pancreatic Diseases,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,0.0,0.0,1.0,30286,Pancreatic Diseases,0.21,1,Therapeutic
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,30286,Pancreatic Diseases,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,30286,Pancreatic Diseases,0.21,1,Biomarker
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,30286,Pancreatic Diseases,0.21,1,Biomarker
65076,AOMS1,Abdominal obesity-metabolic syndrome QTL1,0.0,1.0,0.0,0.0,0.0,2930930,Abdominal obesity metabolic syndrome,0.21,0,Biomarker
4547,MTTP,microsomal triglyceride transfer protein,0.0,1.0,0.0,0.0,0.0,2930930,Abdominal obesity metabolic syndrome,0.21,0,Biomarker
5465,PPARA,peroxisome proliferator-activated receptor alpha,0.0,1.0,0.0,0.0,0.0,2930930,Abdominal obesity metabolic syndrome,0.21,1,Biomarker
867,CBL,"Cbl proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,42384,Vasculitis,0.21,1,Biomarker
100188784,AFA1,"Alopecia, androgenetic",0.0,1.0,0.0,0.0,0.0,2170,Alopecia,0.21,0,Biomarker
1392,CRH,corticotropin releasing hormone,0.0,1.0,0.0,0.0,0.0,2170,Alopecia,0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,2170,Alopecia,0.21,1,Biomarker
6716,SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",0.0,1.0,0.0,0.0,0.0,2170,Alopecia,0.21,1,Biomarker
6832,SUPV3L1,"suppressor of var1, 3-like 1 (S. cerevisiae)",0.0,1.0,0.0,0.0,0.0,2170,Alopecia,0.21,1,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,2170,Alopecia,0.21,1,Biomarker
54503,ZDHHC13,"zinc finger, DHHC-type containing 13",0.0,1.0,0.0,0.0,0.0,2170,Alopecia,0.21,1,Biomarker
7538,ZFP36,ZFP36 ring finger protein,0.0,1.0,0.0,0.0,0.0,2170,Alopecia,0.21,1,Biomarker
100271922,BFIS4,"Convulsions, benign familial infantile, 4",0.0,1.0,0.0,0.0,0.0,2675462,"Convulsions, Benign Familial Infantile, 4",0.21,0,Biomarker
780897,HPP1,"hyperpigmentation, progressive, 1",0.0,1.0,0.0,0.0,0.0,1840392,"Hyperpigmentation, Familial Progressive",0.21,0,Biomarker
5765,PTOS1,"ptosis, congenital 1 (autosomal dominant)",0.0,1.0,0.0,0.0,0.0,1867438,"Ptosis, Hereditary Congenital 1",0.21,0,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,21845,Intestinal Perforation,0.21,1,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,21845,Intestinal Perforation,0.21,1,Biomarker
4846,NOS3,nitric oxide synthase 3 (endothelial cell),0.0,1.0,0.0,0.0,0.0,21845,Intestinal Perforation,0.21,1,Biomarker
100101425,MRT10,"mental retardation, non-syndromic, autosomal recessive, 10",0.0,1.0,0.0,0.0,0.0,1970194,"Mental Retardation, Autosomal Recessive 10",0.21,0,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,349231,Phobic Disorders,0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,349231,Phobic Disorders,0.21,1,Biomarker
23513,SCRIB,scribbled planar cell polarity protein,0.0,0.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,GeneticVariation
51339,DACT1,dishevelled-binding antagonist of beta-catenin 1,0.0,0.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,GeneticVariation
9620,CELSR1,"cadherin, EGF LAG seven-pass G-type receptor 1",0.0,0.0,1.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,GeneticVariation
27443,CECR2,"cat eye syndrome chromosome region, candidate 2",0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,0.0,0.0,0.0,1.0,27794,Neural Tube Defects,0.21,1,Therapeutic
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
2350,FOLR2,folate receptor 2 (fetal),0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
51738,GHRL,ghrelin/obestatin prepropeptide,0.0,0.0,0.0,0.0,1.0,27794,Neural Tube Defects,0.21,1,Therapeutic
2737,GLI3,GLI family zinc finger 3,0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
57822,GRHL3,grainyhead-like 3 (Drosophila),0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
3458,IFNG,"interferon, gamma",0.0,0.0,0.0,0.0,1.0,27794,Neural Tube Defects,0.21,1,Therapeutic
3630,INS,insulin,0.0,0.0,0.0,0.0,1.0,27794,Neural Tube Defects,0.21,1,Therapeutic
10,NAT2,N-acetyltransferase 2 (arylamine N-acetyltransferase),0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
4886,NPY1R,neuropeptide Y receptor Y1,0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
5652,PRSS8,"protease, serine, 8",0.0,0.0,0.0,0.0,1.0,27794,Neural Tube Defects,0.21,1,Therapeutic
5697,PYY,peptide YY,0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
6240,RRM1,ribonucleotide reductase M1,0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
6497,SKI,SKI proto-oncogene,0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
10653,SPINT2,"serine peptidase inhibitor, Kunitz type, 2",0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
85416,ZIC5,Zic family member 5,0.0,1.0,0.0,0.0,0.0,27794,Neural Tube Defects,0.21,1,Biomarker
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,0.0,1.0,0.0,0.0,3151464,"ATRIAL FIBRILLATION, FAMILIAL, 10",0.21,0,GeneticVariation
4627,MYH9,"myosin, heavy chain 9, non-muscle",0.0,1.0,0.0,0.0,0.0,20544,"Hypertension, Renal",0.21,1,Biomarker
1027,CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",0.0,1.0,0.0,0.0,0.0,79487,Helicobacter Infections,0.21,1,Biomarker
5803,PTPRZ1,"protein tyrosine phosphatase, receptor-type, Z polypeptide 1",0.0,1.0,0.0,0.0,0.0,79487,Helicobacter Infections,0.21,0,Biomarker
7037,TFRC,transferrin receptor,0.0,1.0,0.0,0.0,0.0,79487,Helicobacter Infections,0.21,2,Biomarker
8647,ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",0.0,1.0,0.0,0.0,0.0,19250,Afibrinogenemia congenital,0.21,1,Biomarker
135,ADORA2A,adenosine A2a receptor,0.0,1.0,0.0,0.0,0.0,40822,Tremor,0.21,1,Biomarker
1132,CHRM4,"cholinergic receptor, muscarinic 4",0.0,1.0,0.0,0.0,0.0,40822,Tremor,0.21,1,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,40822,Tremor,0.21,1,Biomarker
3350,HTR1A,"5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled",0.0,1.0,0.0,0.0,0.0,40822,Tremor,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,1.0,40822,Tremor,0.21,2,"Biomarker, Therapeutic"
1082,CGB,"chorionic gonadotropin, beta polypeptide",0.0,0.0,0.0,0.0,1.0,15951,Fetal Resorption,0.21,1,Therapeutic
5617,PRL,prolactin,0.0,0.0,0.0,0.0,1.0,15951,Fetal Resorption,0.21,1,Therapeutic
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,0.0,1.0,0.0,0.0,3554518,COWDEN SYNDROME 5,0.21,0,GeneticVariation
388552,BLOC1S3,"biogenesis of lysosomal organelles complex-1, subunit 3",0.0,1.0,0.0,0.0,0.0,2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,0.21,0,Biomarker
84062,DTNBP1,dystrobrevin binding protein 1,0.0,1.0,0.0,0.0,0.0,2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,0.21,0,Biomarker
84343,HPS3,Hermansky-Pudlak syndrome 3,0.0,1.0,0.0,0.0,0.0,2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,0.21,0,Biomarker
89781,HPS4,Hermansky-Pudlak syndrome 4,0.0,1.0,0.0,0.0,0.0,2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,0.21,0,Biomarker
11234,HPS5,Hermansky-Pudlak syndrome 5,0.0,1.0,0.0,0.0,0.0,2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,0.21,0,Biomarker
79803,HPS6,Hermansky-Pudlak syndrome 6,0.0,1.0,0.0,0.0,0.0,2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,0.21,0,Biomarker
431708,MDD1,Major depressive disorder,0.0,1.0,0.0,0.0,0.0,1837929,Major Depressive Disorder 1,0.21,0,Biomarker
1187,CLCNKA,"chloride channel, voltage-sensitive Ka",0.0,1.0,0.0,0.0,0.0,1865270,"Bartter Syndrome, Type 4A",0.21,0,Biomarker
1188,CLCNKB,"chloride channel, voltage-sensitive Kb",0.0,1.0,0.0,0.0,0.0,1865270,"Bartter Syndrome, Type 4A",0.21,0,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,0.0,0.0,1.0,10034,Corneal Diseases,0.21,1,Therapeutic
6863,TAC1,"tachykinin, precursor 1",0.0,0.0,0.0,0.0,1.0,10034,Corneal Diseases,0.21,1,Therapeutic
54884,RETSAT,"retinol saturase (all-trans-retinol 13,14-reductase)",0.0,1.0,0.0,0.0,0.0,796154,Simpson-Golabi-Behmel syndrome,0.21,1,Biomarker
100918,NRCLP2,"Narcolepsy, HLA-associated",0.0,1.0,0.0,0.0,0.0,27404,Narcolepsy,0.21,0,Biomarker
494446,NRCLP3,Narcolepsy 3,0.0,1.0,0.0,0.0,0.0,27404,Narcolepsy,0.21,0,Biomarker
100216484,NRCLP4,Narcolepsy 4,0.0,1.0,0.0,0.0,0.0,27404,Narcolepsy,0.21,0,Biomarker
100302514,NRCLP5,Narcolepsy 5,0.0,1.0,0.0,0.0,0.0,27404,Narcolepsy,0.21,0,Biomarker
5179,PENK,proenkephalin,0.0,1.0,0.0,0.0,0.0,27404,Narcolepsy,0.21,1,Biomarker
8835,SOCS2,suppressor of cytokine signaling 2,0.0,1.0,0.0,0.0,0.0,27404,Narcolepsy,0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,27404,Narcolepsy,0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,27404,Narcolepsy,0.21,1,Biomarker
10161,LPAR6,lysophosphatidic acid receptor 6,0.0,0.0,1.0,0.0,0.0,3279470,"Hypotrichosis, Localized, Autosomal Recessive, 3",0.21,1,GeneticVariation
2931,GSK3A,glycogen synthase kinase 3 alpha,0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.21,1,Biomarker
4914,NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.21,1,Biomarker
6526,SLC5A3,"solute carrier family 5 (sodium/myo-inositol cotransporter), member 3",0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.21,1,Biomarker
7252,TSHB,"thyroid stimulating hormone, beta",0.0,1.0,0.0,0.0,0.0,5586,Bipolar Disorder,0.21,1,Biomarker
1694,DFNA16,"deafness, autosomal dominant 16",0.0,1.0,0.0,0.0,0.0,1858916,"Deafness, Autosomal Dominant 16",0.21,0,Biomarker
282849,SLEN3,systemic lupus erythematosus with nephritis 3,0.0,1.0,0.0,0.0,0.0,1842755,"SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3",0.21,0,Biomarker
170594,WS2C,"Waardenburg syndrome, type IIC",0.0,1.0,0.0,0.0,0.0,1847722,"Waardenburg Syndrome, Type 2C",0.21,0,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,35204,Respiration Disorders,0.21,1,Biomarker
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,35204,Respiration Disorders,0.21,1,Biomarker
7356,SCGB1A1,"secretoglobin, family 1A, member 1 (uteroglobin)",0.0,1.0,0.0,0.0,0.0,35204,Respiration Disorders,0.21,1,Biomarker
64802,NMNAT1,nicotinamide nucleotide adenylyltransferase 1,0.0,1.0,0.0,0.0,0.0,242383,Macular Degeneration,0.21,1,Biomarker
8878,SQSTM1,sequestosome 1,0.0,1.0,0.0,0.0,0.0,242383,Macular Degeneration,0.21,1,Biomarker
51780,KDM3B,lysine (K)-specific demethylase 3B,0.0,0.0,0.0,0.0,1.0,274869,Heavy Metal Toxicity,0.21,1,Therapeutic
5116,PCNT,pericentrin,0.0,1.0,0.0,0.0,0.0,1847572,Seckel syndrome 2,0.21,1,Biomarker
2354,FOSB,FBJ murine osteosarcoma viral oncogene homolog B,0.0,1.0,0.0,0.0,0.0,21122,Impulse Control Disorders,0.21,1,Biomarker
4175,MCM6,minichromosome maintenance complex component 6,0.0,1.0,0.0,0.0,0.0,268181,"Lactose Intolerance, Adult Type",0.21,0,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.21,4,Biomarker
6346,CCL1,chemokine (C-C motif) ligand 1,0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.21,1,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.21,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.21,1,Biomarker
1559,CYP2C9,"cytochrome P450, family 2, subfamily C, polypeptide 9",0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.21,1,Biomarker
1565,CYP2D6,"cytochrome P450, family 2, subfamily D, polypeptide 6",0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.21,1,Biomarker
1634,DCN,decorin,0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.21,1,Biomarker
4803,NGF,nerve growth factor (beta polypeptide),0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.21,1,Biomarker
7057,THBS1,thrombospondin 1,0.0,1.0,0.0,0.0,0.0,27707,"Nephritis, Interstitial",0.21,1,Biomarker
915,CD3D,"CD3d molecule, delta (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,1837028,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive",0.21,0,Biomarker
916,CD3E,"CD3e molecule, epsilon (CD3-TCR complex)",0.0,1.0,0.0,0.0,0.0,1837028,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive",0.21,0,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,13386,"Dyskinesia, Drug-Induced",0.21,1,Biomarker
885,CCK,cholecystokinin,0.0,0.0,0.0,0.0,1.0,13386,"Dyskinesia, Drug-Induced",0.21,1,Therapeutic
1812,DRD1,dopamine receptor D1,0.0,1.0,0.0,0.0,0.0,13386,"Dyskinesia, Drug-Induced",0.21,4,Biomarker
2354,FOSB,FBJ murine osteosarcoma viral oncogene homolog B,0.0,1.0,0.0,0.0,0.0,13386,"Dyskinesia, Drug-Induced",0.21,1,Biomarker
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",0.0,1.0,0.0,0.0,0.0,13386,"Dyskinesia, Drug-Induced",0.21,1,Biomarker
2643,GCH1,GTP cyclohydrolase 1,0.0,0.0,0.0,0.0,1.0,13386,"Dyskinesia, Drug-Induced",0.21,1,Therapeutic
2668,GDNF,glial cell derived neurotrophic factor,0.0,0.0,0.0,0.0,1.0,13386,"Dyskinesia, Drug-Induced",0.21,1,Therapeutic
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,13386,"Dyskinesia, Drug-Induced",0.21,2,Biomarker
5179,PENK,proenkephalin,0.0,1.0,0.0,0.0,0.0,13386,"Dyskinesia, Drug-Induced",0.21,1,Biomarker
5923,RASGRF1,Ras protein-specific guanine nucleotide-releasing factor 1,0.0,0.0,0.0,0.0,1.0,13386,"Dyskinesia, Drug-Induced",0.21,1,Therapeutic
8787,RGS9,regulator of G-protein signaling 9,0.0,1.0,0.0,0.0,1.0,13386,"Dyskinesia, Drug-Induced",0.21,2,"Biomarker, Therapeutic"
7054,TH,tyrosine hydroxylase,0.0,0.0,0.0,0.0,1.0,13386,"Dyskinesia, Drug-Induced",0.21,1,Therapeutic
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,1.0,0.0,0.0,0.0,2936380,Neointima,0.21,1,Biomarker
538,ATP7A,"ATPase, Cu++ transporting, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,2936380,Neointima,0.21,1,Biomarker
688,KLF5,Kruppel-like factor 5 (intestinal),0.0,1.0,0.0,0.0,0.0,2936380,Neointima,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,2936380,Neointima,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,2936380,Neointima,0.21,1,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,2902,Anencephaly,0.21,1,Biomarker
617,BCS1L,BC1 (ubiquinol-cytochrome c reductase) synthesis-like,0.0,1.0,0.0,0.0,0.0,23264,Leigh Disease,0.21,0,Biomarker
55572,FOXRED1,FAD-dependent oxidoreductase domain containing 1,0.0,1.0,0.0,0.0,0.0,23264,Leigh Disease,0.21,0,Biomarker
19,ABCA1,"ATP-binding cassette, sub-family A (ABC1), member 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
8647,ABCB11,"ATP-binding cassette, sub-family B (MDR/TAP), member 11",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
8714,ABCC3,"ATP-binding cassette, sub-family C (CFTR/MRP), member 3",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10257,ABCC4,"ATP-binding cassette, sub-family C (CFTR/MRP), member 4",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10057,ABCC5,"ATP-binding cassette, sub-family C (CFTR/MRP), member 5",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
368,ABCC6,"ATP-binding cassette, sub-family C (CFTR/MRP), member 6",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
81569,ACTL8,actin-like 8,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
154,ADRB2,"adrenoceptor beta 2, surface",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
57379,AICDA,activation-induced cytidine deaminase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
216,ALDH1A1,"aldehyde dehydrogenase 1 family, member A1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
239,ALOX12,arachidonate 12-lipoxygenase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
51129,ANGPTL4,angiopoietin-like 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
421,ARVCF,armadillo repeat gene deleted in velocardiofacial syndrome,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
467,ATF3,activating transcription factor 3,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
472,ATM,ATM serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
540,ATP7B,"ATPase, Cu++ transporting, beta polypeptide",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6790,AURKA,aurora kinase A,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
578,BAK1,BCL2-antagonist/killer 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
581,BAX,BCL2-associated X protein,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
658,BMPR1B,"bone morphogenetic protein receptor, type IB",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
100170841,C17orf96,chromosome 17 open reading frame 96,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
774,CACNA1B,"calcium channel, voltage-dependent, N type, alpha 1B subunit",0.0,0.0,0.0,0.0,1.0,31117,Peripheral Nervous System Diseases,0.21,1,Therapeutic
8618,CADPS,Ca++-dependent secretion activator,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
57082,CASC5,cancer susceptibility candidate 5,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
842,CASP9,"caspase 9, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6352,CCL5,chemokine (C-C motif) ligand 5,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
890,CCNA2,cyclin A2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
939,CD27,CD27 molecule,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
960,CD44,CD44 molecule (Indian blood group),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
990,CDC6,cell division cycle 6,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
157313,CDCA2,cell division cycle associated 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1020,CDK5,cyclin-dependent kinase 5,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1022,CDK7,cyclin-dependent kinase 7,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,2,Biomarker
11190,CEP250,centrosomal protein 250kDa,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1066,CES1,carboxylesterase 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1071,CETP,"cholesteryl ester transfer protein, plasma",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1111,CHEK1,checkpoint kinase 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
23563,CHST5,carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1158,CKM,"creatine kinase, muscle",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
23242,COBL,cordon-bleu WH2 repeat protein,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1299,COL9A3,"collagen, type IX, alpha 3",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
126129,CPT1C,carnitine palmitoyltransferase 1C,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1396,CRIP1,cysteine-rich protein 1 (intestinal),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1437,CSF2,colony stimulating factor 2 (granulocyte-macrophage),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1588,CYP19A1,"cytochrome P450, family 19, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1544,CYP1A2,"cytochrome P450, family 1, subfamily A, polypeptide 2",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1591,CYP24A1,"cytochrome P450, family 24, subfamily A, polypeptide 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
66002,CYP4F12,"cytochrome P450, family 4, subfamily F, polypeptide 12",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1582,CYP8B1,"cytochrome P450, family 8, subfamily B, polypeptide 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1612,DAPK1,death-associated protein kinase 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1617,DAZ1,deleted in azoospermia 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
57054,DAZ3,deleted in azoospermia 3,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
57135,DAZ4,deleted in azoospermia 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1621,DBH,dopamine beta-hydroxylase (dopamine beta-monooxygenase),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1633,DCK,deoxycytidine kinase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1649,DDIT3,DNA-damage-inducible transcript 3,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
115265,DDIT4L,DNA-damage-inducible transcript 4-like,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
11056,DDX52,DEAD (Asp-Glu-Ala-Asp) box polypeptide 52,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
22943,DKK1,dickkopf WNT signaling pathway inhibitor 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9046,DOK2,"docking protein 2, 56kDa",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
8110,DPF3,"D4, zinc and double PHD fingers, family 3",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
51207,DUSP13,dual specificity phosphatase 13,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
54935,DUSP23,dual specificity phosphatase 23,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1906,EDN1,endothelin 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1950,EGF,epidermal growth factor,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
79071,ELOVL6,ELOVL fatty acid elongase 6,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2052,EPHX1,"epoxide hydrolase 1, microsomal (xenobiotic)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2068,ERCC2,excision repair cross-complementation group 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2071,ERCC3,excision repair cross-complementation group 3,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2072,ERCC4,excision repair cross-complementation group 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2099,ESR1,estrogen receptor 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9156,EXO1,exonuclease 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
84668,FAM126A,"family with sequence similarity 126, member A",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
55215,FANCI,"Fanconi anemia, complementation group I",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9103,FCGR2C,"Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2264,FGFR4,fibroblast growth factor receptor 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2327,FMO2,flavin containing monooxygenase 2 (non-functional),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2328,FMO3,flavin containing monooxygenase 3,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
23150,FRMD4B,FERM domain containing 4B,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10129,FRY,furry homolog (Drosophila),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2528,FUT6,"fucosyltransferase 6 (alpha (1,3) fucosyltransferase)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2571,GAD1,"glutamate decarboxylase 1 (brain, 67kDa)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
26748,GAGE12I,G antigen 12I,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2574,GAGE2C,G antigen 2C,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2575,GAGE3,G antigen 3,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2576,GAGE4,G antigen 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2578,GAGE6,G antigen 6,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2579,GAGE7,G antigen 7,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
8139,GAN,gigaxonin,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
51608,GET4,golgi to ER traffic protein 4 homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2670,GFAP,glial fibrillary acidic protein,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2690,GHR,growth hormone receptor,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2735,GLI1,GLI family zinc finger 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7918,GPANK1,G patch domain and ankyrin repeats 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2838,GPR15,G protein-coupled receptor 15,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2954,GSTZ1,glutathione S-transferase zeta 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2965,GTF2H1,"general transcription factor IIH, polypeptide 1, 62kDa",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2999,GZMH,"granzyme H (cathepsin G-like 2, protein h-CCPX)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3044,HBBP1,"hemoglobin, beta pseudogene 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3059,HCLS1,hematopoietic cell-specific Lyn substrate 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
113510,HELQ,"helicase, POLQ-like",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9709,HERPUD1,"homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3161,HMMR,hyaluronan-mediated motility receptor (RHAMM),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3364,HUS1,HUS1 checkpoint homolog (S. pombe),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3383,ICAM1,intercellular adhesion molecule 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3399,ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10561,IFI44,interferon-induced protein 44,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3460,IFNGR2,interferon gamma receptor 2 (interferon gamma transducer 1),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,0.0,0.0,1.0,31117,Peripheral Nervous System Diseases,0.21,2,Therapeutic
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10643,IGF2BP3,insulin-like growth factor 2 mRNA binding protein 3,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3500,IGHG1,immunoglobulin heavy constant gamma 1 (G1m marker),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3508,IGHMBP2,immunoglobulin mu binding protein 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
54756,IL17RD,interleukin 17 receptor D,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3606,IL18,interleukin 18,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3557,IL1RN,interleukin 1 receptor antagonist,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3558,IL2,interleukin 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3562,IL3,interleukin 3,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3662,IRF4,interferon regulatory factor 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9358,ITGBL1,"integrin, beta-like 1 (with EGF-like repeat domains)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9452,ITM2A,integral membrane protein 2A,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3725,JUN,jun proto-oncogene,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,2,Biomarker
57535,KIAA1324,KIAA1324,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
55220,KLHDC8A,kelch domain containing 8A,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9757,KMT2B,lysine (K)-specific methyltransferase 2B,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3904,LAIR2,leukocyte-associated immunoglobulin-like receptor 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10859,LILRB1,"leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
11006,LILRB4,"leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
64788,LMF1,lipase maturation factor 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
27257,LSM1,"LSM1, U6 small nuclear RNA associated",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4049,LTA,lymphotoxin alpha,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4058,LTK,leukocyte receptor tyrosine kinase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4101,MAGEA2,melanoma antigen family A2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
266740,MAGEA2B,melanoma antigen family A2B,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
23005,MAPKBP1,mitogen-activated protein kinase binding protein 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
114785,MBD6,methyl-CpG binding domain protein 6,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4153,MBL2,"mannose-binding lectin (protein C) 2, soluble",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4193,MDM2,"MDM2 proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10461,MERTK,"MER proto-oncogene, tyrosine kinase",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9258,MFHAS1,malignant fibrous histiocytoma amplified sequence 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
54842,MFSD6,major facilitator superfamily domain containing 6,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4255,MGMT,O-6-methylguanine-DNA methyltransferase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
440823,MIAT,myocardial infarction associated transcript (non-protein coding),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4288,MKI67,marker of proliferation Ki-67,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4314,MMP3,"matrix metallopeptidase 3 (stromelysin 1, progelatinase)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4330,MN1,meningioma (disrupted in balanced translocation) 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4361,MRE11A,MRE11 meiotic recombination 11 homolog A (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
2956,MSH6,mutS homolog 6,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4595,MUTYH,mutY homolog,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
53904,MYO3A,myosin IIIA,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9,NAT1,N-acetyltransferase 1 (arylamine N-acetyltransferase),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4744,NEFH,"neurofilament, heavy polypeptide",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
55247,NEIL3,nei endonuclease VIII-like 3 (E. coli),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6787,NEK4,NIMA-related kinase 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10577,NPC2,"Niemann-Pick disease, type C2",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
4852,NPY,neuropeptide Y,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
8829,NRP1,neuropilin 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
114880,OSBPL6,oxysterol binding protein-like 6,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
55644,OSGEP,O-sialoglycoprotein endopeptidase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
8712,PAGE1,"P antigen family, member 1 (prostate associated)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
142,PARP1,poly (ADP-ribose) polymerase 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10038,PARP2,poly (ADP-ribose) polymerase 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
23178,PASK,PAS domain containing serine/threonine kinase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5294,PIK3CG,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5329,PLAUR,"plasminogen activator, urokinase receptor",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
25894,PLEKHG4,"pleckstrin homology domain containing, family G (with RhoGef domain) member 4",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
84898,PLXDC2,plexin domain containing 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10908,PNPLA6,patatin-like phospholipase domain containing 6,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5423,POLB,"polymerase (DNA directed), beta",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5445,PON2,paraoxonase 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5452,POU2F2,POU class 2 homeobox 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5467,PPARD,peroxisome proliferator-activated receptor delta,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,2,Biomarker
10891,PPARGC1A,"peroxisome proliferator-activated receptor gamma, coactivator 1 alpha",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5478,PPIA,peptidylprolyl isomerase A (cyclophilin A),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5530,PPP3CA,"protein phosphatase 3, catalytic subunit, alpha isozyme",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9989,PPP4R1,"protein phosphatase 4, regulatory subunit 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5581,PRKCE,"protein kinase C, epsilon",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
23683,PRKD3,protein kinase D3,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5695,PSMB7,"proteasome (prosome, macropain) subunit, beta type, 7",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5740,PTGIS,prostaglandin I2 (prostacyclin) synthase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5742,PTGS1,prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5799,PTPRN2,"protein tyrosine phosphatase, receptor type, N polypeptide 2",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
326624,RAB37,"RAB37, member RAS oncogene family",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
65059,RAPH1,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10125,RASGRP1,RAS guanyl releasing protein 1 (calcium and DAG-regulated),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
159162,RBMY2FP,"RNA binding motif protein, Y-linked, family 2, member F pseudogene",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
201299,RDM1,RAD52 motif containing 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6095,RORA,RAR-related orphan receptor A,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6240,RRM1,ribonucleotide reductase M1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
949,SCARB1,"scavenger receptor class B, member 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
91179,SCARF2,"scavenger receptor class F, member 2",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6401,SELE,selectin E,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6403,SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
5055,SERPINB2,"serpin peptidase inhibitor, clade B (ovalbumin), member 2",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,2,Biomarker
6442,SGCA,"sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
81537,SGPP1,sphingosine-1-phosphate phosphatase 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7979,SHFM1,split hand/foot malformation (ectrodactyly) type 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6492,SIM1,single-minded family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6555,SLC10A2,"solute carrier family 10 (sodium/bile acid cotransporter), member 2",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9376,SLC22A8,"solute carrier family 22 (organic anion transporter), member 8",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
9154,SLC28A1,"solute carrier family 28 (concentrative nucleoside transporter), member 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
28232,SLCO3A1,"solute carrier organic anion transporter family, member 3A1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10592,SMC2,structural maintenance of chromosomes 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6649,SOD3,"superoxide dismutase 3, extracellular",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
54908,SPDL1,spindle apparatus coiled-coil protein 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6715,SRD5A1,"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6716,SRD5A2,"steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6756,SSX1,"synovial sarcoma, X breakpoint 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6757,SSX2,"synovial sarcoma, X breakpoint 2",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6759,SSX4,"synovial sarcoma, X breakpoint 4",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
548313,SSX4B,"synovial sarcoma, X breakpoint 4B",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6778,STAT6,"signal transducer and activator of transcription 6, interleukin-4 induced",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
56164,STK31,serine/threonine kinase 31,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6820,SULT2B1,"sulfotransferase family, cytosolic, 2B, member 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
25830,SULT4A1,"sulfotransferase family 4A, member 1",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
55061,SUSD4,sushi domain containing 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
55530,SVOP,SV2 related protein homolog (rat),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
6891,TAP2,"transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
83439,TCF7L1,"transcription factor 7-like 1 (T-cell specific, HMG-box)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
10732,TCFL5,transcription factor-like 5 (basic helix-loop-helix),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
90381,TICRR,TOPBP1-interacting checkpoint and replication regulator,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
83660,TLN2,talin 2,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
50999,TMED5,transmembrane emp24 protein transport domain containing 5,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
26022,TMEM98,transmembrane protein 98,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
8797,TNFRSF10A,"tumor necrosis factor receptor superfamily, member 10a",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
944,TNFSF8,"tumor necrosis factor (ligand) superfamily, member 8",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7173,TPO,thyroid peroxidase,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
1200,TPP1,tripeptidyl peptidase I,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
55809,TRERF1,transcriptional regulating factor 1,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7223,TRPC4,"transient receptor potential cation channel, subfamily C, member 4",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7227,TRPS1,trichorhinophalangeal syndrome I,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
706,TSPO,translocator protein (18kDa),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
23170,TTLL12,tubulin tyrosine ligase-like family member 12,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
55075,UACA,uveal autoantigen with coiled-coil domains and ankyrin repeats,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7345,UCHL1,ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7350,UCP1,"uncoupling protein 1 (mitochondrial, proton carrier)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7364,UGT2B7,"UDP glucuronosyltransferase 2 family, polypeptide B7",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
440279,UNC13C,unc-13 homolog C (C. elegans),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7380,UPK3A,uroplakin 3A,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
27340,UTP20,"UTP20, small subunit (SSU) processome component, homolog (yeast)",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7450,VWF,von Willebrand factor,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7481,WNT11,"wingless-type MMTV integration site family, member 11",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7486,WRN,"Werner syndrome, RecQ helicase-like",0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7504,XK,X-linked Kx blood group,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
51646,YPEL5,yippee-like 5 (Drosophila),0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
151126,ZNF385B,zinc finger protein 385B,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
169270,ZNF596,zinc finger protein 596,0.0,1.0,0.0,0.0,0.0,31117,Peripheral Nervous System Diseases,0.21,1,Biomarker
7438,VMD1,"vitelliform macular dystrophy, atypical",0.0,1.0,0.0,0.0,0.0,1835178,"Macular dystrophy, atypical vitelliform",0.21,0,Biomarker
554,AVPR2,arginine vasopressin receptor 2,0.0,1.0,0.0,0.0,0.0,1138434,"Genetic Diseases, X-Linked",0.21,1,Biomarker
1081,CGA,"glycoprotein hormones, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,18991,Hemiplegia,0.21,1,Biomarker
3756,KCNH1,"potassium channel, voltage gated eag related subfamily H, member 1",0.0,1.0,0.0,0.0,0.0,2678486,Temple-Baraitser Syndrome,0.21,1,Biomarker
80770,CTRCT25,"Cataract, central pouch-like, with sutural opacities",0.0,1.0,0.0,0.0,0.0,1854021,"Cataract, Central Saccular, With Sutural Opacities",0.21,0,Biomarker
100188849,9-Feb,"Febrile convulsions, familial, 9",0.0,1.0,0.0,0.0,0.0,1968846,"Febrile Convulsions, Familial, 9",0.21,0,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,19572,Hirsutism,0.21,1,Biomarker
590,BCHE,butyrylcholinesterase,0.0,1.0,0.0,0.0,0.0,37315,Sleep Apnea Syndromes,0.21,1,Biomarker
100190926,IBD19,Inflammatory bowel disease 19,0.0,1.0,0.0,0.0,0.0,2677079,Inflammatory Bowel Disease 19,0.21,0,Biomarker
170592,UVM1,"Melanoma, uveal, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,220633,Uveal melanoma,0.21,0,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,79772,"Lymphoma, T-Cell",0.21,1,Biomarker
80830,APOL6,"apolipoprotein L, 6",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
467,ATF3,activating transcription factor 3,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
6355,CCL8,chemokine (C-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
55601,DDX60,DEAD (Asp-Glu-Ala-Asp) box polypeptide 60,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
2633,GBP1,"guanylate binding protein 1, interferon-inducible",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
51191,HERC5,HECT and RLD domain containing E3 ubiquitin protein ligase 5,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
55008,HERC6,HECT and RLD domain containing E3 ubiquitin protein ligase family member 6,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
3429,IFI27,"interferon, alpha-inducible protein 27",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
3430,IFI35,interferon-induced protein 35,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
10561,IFI44,interferon-induced protein 44,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
10964,IFI44L,interferon-induced protein 44-like,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
2537,IFI6,"interferon, alpha-inducible protein 6",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
3433,IFIT2,interferon-induced protein with tetratricopeptide repeats 2,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
3437,IFIT3,interferon-induced protein with tetratricopeptide repeats 3,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
24138,IFIT5,interferon-induced protein with tetratricopeptide repeats 5,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
4061,LY6E,"lymphocyte antigen 6 complex, locus E",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
4600,MX2,MX dynamin-like GTPase 2,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
4938,OAS1,"2'-5'-oligoadenylate synthetase 1, 40/46kDa",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
4939,OAS2,"2'-5'-oligoadenylate synthetase 2, 69/71kDa",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
4940,OAS3,"2'-5'-oligoadenylate synthetase 3, 100kDa",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
8638,OASL,2'-5'-oligoadenylate synthetase-like,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
64761,PARP12,"poly (ADP-ribose) polymerase family, member 12",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
5359,PLSCR1,phospholipid scramblase 1,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
64108,RTP4,receptor (chemosensory) transporter protein 4,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
54809,SAMD9,sterile alpha motif domain containing 9,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
9997,SCO2,SCO2 cytochrome c oxidase assembly protein,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
710,SERPING1,"serpin peptidase inhibitor, clade G (C1 inhibitor), member 1",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
6614,SIGLEC1,"sialic acid binding Ig-like lectin 1, sialoadhesin",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
9376,SLC22A8,"solute carrier family 22 (organic anion transporter), member 8",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
6772,STAT1,"signal transducer and activator of transcription 1, 91kDa",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
23424,TDRD7,tudor domain containing 7,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
7130,TNFAIP6,"tumor necrosis factor, alpha-induced protein 6",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
27348,TOR1B,"torsin family 1, member B (torsin B)",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
11277,TREX1,three prime repair exonuclease 1,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
10346,TRIM22,tripartite motif containing 22,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
9246,UBE2L6,ubiquitin-conjugating enzyme E2L 6,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
54739,XAF1,XIAP associated factor 1,0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
7503,XIST,X inactive specific transcript (non-protein coding),0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
54877,ZCCHC2,"zinc finger, CCHC domain containing 2",0.0,1.0,0.0,0.0,0.0,21400,"Influenza, Human",0.21,1,Biomarker
538,ATP7A,"ATPase, Cu++ transporting, alpha polypeptide",0.0,1.0,0.0,0.0,0.0,3496,Aortic Rupture,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,3496,Aortic Rupture,0.21,1,Biomarker
79001,VKORC1,"vitamin K epoxide reductase complex, subunit 1",0.0,1.0,0.0,0.0,0.0,3496,Aortic Rupture,0.21,1,Biomarker
3094,HINT1,histidine triad nucleotide binding protein 1,0.0,1.0,0.0,0.0,0.0,2932678,Inherited Peripheral Neuropathy,0.21,1,Biomarker
55651,NHP2,NHP2 ribonucleoprotein,0.0,0.0,1.0,0.0,0.0,3151441,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2",0.21,1,GeneticVariation
2074,ERCC6,excision repair cross-complementation group 6,0.0,1.0,0.0,0.0,0.0,3551173,UV-SENSITIVE SYNDROME 1,0.21,0,Biomarker
57654,UVSSA,UV-stimulated scaffold protein A,0.0,1.0,0.0,0.0,0.0,3551173,UV-SENSITIVE SYNDROME 1,0.21,2,Biomarker
4335,MNT,MAX network transcriptional repressor,0.0,1.0,0.0,0.0,0.0,1955870,Classical Lissencephalies and Subcortical Band Heterotopias,0.21,1,Biomarker
7531,YWHAE,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon",0.0,1.0,0.0,0.0,0.0,1955870,Classical Lissencephalies and Subcortical Band Heterotopias,0.21,0,Biomarker
3605,IL17A,interleukin 17A,0.0,1.0,0.0,0.0,0.0,7682,Central Nervous System Diseases,0.21,1,Biomarker
6648,SOD2,"superoxide dismutase 2, mitochondrial",0.0,1.0,0.0,0.0,0.0,7682,Central Nervous System Diseases,0.21,1,Biomarker
27329,ANGPTL3,angiopoietin-like 3,0.0,1.0,0.0,0.0,0.0,1857970,"Hypobetalipoproteinemia, Familial, 2",0.21,0,Biomarker
7986,GPDS1,glaucoma-related pigment dispersion syndrome 1,0.0,1.0,0.0,0.0,0.0,1271398,Glaucoma-Related Pigment Dispersion Syndrome,0.21,0,Biomarker
2348,FOLR1,folate receptor 1 (adult),0.0,1.0,0.0,0.0,0.0,752109,"Brain Diseases, Metabolic, Inborn",0.21,1,Biomarker
2752,GLUL,glutamate-ammonia ligase,0.0,1.0,0.0,0.0,0.0,752109,"Brain Diseases, Metabolic, Inborn",0.21,1,Biomarker
91942,NDUFAF2,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 2",0.0,1.0,0.0,0.0,0.0,752109,"Brain Diseases, Metabolic, Inborn",0.21,1,Biomarker
494028,CVMRF,cubitus valgus with mental retardation and unusual facies,0.0,1.0,0.0,0.0,0.0,1845450,Cubitus Valgus with Mental Retardation and Unusual Facies,0.21,0,Biomarker
8288,EPX,eosinophil peroxidase,0.0,0.0,1.0,0.0,0.0,1850000,Presentey Anomaly,0.21,1,GeneticVariation
831,CAST,calpastatin,0.0,0.0,0.0,0.0,1.0,162557,"Liver Failure, Acute",0.21,1,Therapeutic
972,CD74,"CD74 molecule, major histocompatibility complex, class II invariant chain",0.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.21,1,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.21,1,Biomarker
10468,FST,follistatin,0.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.21,1,Biomarker
10457,GPNMB,glycoprotein (transmembrane) nmb,0.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.21,1,Biomarker
3624,INHBA,"inhibin, beta A",0.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.21,1,Biomarker
5599,MAPK8,mitogen-activated protein kinase 8,0.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,162557,"Liver Failure, Acute",0.21,1,Therapeutic
462,SERPINC1,"serpin peptidase inhibitor, clade C (antithrombin), member 1",0.0,1.0,0.0,0.0,0.0,162557,"Liver Failure, Acute",0.21,1,Biomarker
6563,SLC14A1,"solute carrier family 14 (urea transporter), member 1 (Kidd blood group)",0.0,1.0,0.0,0.0,0.0,2880,"Anemia, Hemolytic, Autoimmune",0.21,1,Biomarker
6863,TAC1,"tachykinin, precursor 1",0.0,1.0,0.0,0.0,0.0,37036,Sialorrhea,0.21,1,Biomarker
3244,HPE1,"holoprosencephaly 1, alobar",0.0,1.0,0.0,0.0,0.0,79541,Holoprosencephaly,0.21,0,Biomarker
117190,HPE6,holoprosencephaly 6,0.0,1.0,0.0,0.0,0.0,79541,Holoprosencephaly,0.21,0,Biomarker
6997,TDGF1,teratocarcinoma-derived growth factor 1,0.0,1.0,0.0,0.0,0.0,79541,Holoprosencephaly,0.21,1,Biomarker
448963,DFNB51,"deafness, autosomal recessive 51",0.0,1.0,0.0,0.0,0.0,1864968,"Deafness, autosomal recessive 51",0.21,0,Biomarker
3273,HRG,histidine-rich glycoprotein,0.0,1.0,0.0,0.0,0.0,2751091,Thrombophilia Due To Elevated Histidine-Rich Glycoprotein,0.21,0,Biomarker
796,CALCA,calcitonin-related polypeptide alpha,0.0,0.0,0.0,0.0,1.0,149940,Sciatic Neuropathy,0.21,1,Therapeutic
5914,RARA,"retinoic acid receptor, alpha",0.0,1.0,0.0,0.0,0.0,149940,Sciatic Neuropathy,0.21,1,Biomarker
5915,RARB,"retinoic acid receptor, beta",0.0,1.0,0.0,0.0,0.0,149940,Sciatic Neuropathy,0.21,1,Biomarker
6256,RXRA,"retinoid X receptor, alpha",0.0,1.0,0.0,0.0,0.0,149940,Sciatic Neuropathy,0.21,1,Biomarker
64581,CLEC7A,"C-type lectin domain family 7, member A",0.0,1.0,0.0,0.0,0.0,1859353,"Candidiasis familial chronic mucocutaneous, autosomal recessive",0.21,0,Biomarker
7167,TPI1,triosephosphate isomerase 1,0.0,1.0,0.0,0.0,0.0,27868,Neuromuscular Diseases,0.21,1,Biomarker
7504,XK,X-linked Kx blood group,0.0,1.0,0.0,0.0,0.0,27868,Neuromuscular Diseases,0.21,2,Biomarker
847,CAT,catalase,0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.21,1,Biomarker
5168,ENPP2,ectonucleotide pyrophosphatase/phosphodiesterase 2,0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.21,1,Biomarker
2149,F2R,coagulation factor II (thrombin) receptor,0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.21,1,Biomarker
27232,GNMT,glycine N-methyltransferase,0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.21,1,Biomarker
3162,HMOX1,heme oxygenase (decycling) 1,0.0,0.0,0.0,0.0,1.0,19158,Hepatitis,0.21,1,Therapeutic
9817,KEAP1,kelch-like ECH-associated protein 1,0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.21,1,Biomarker
6678,SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",0.0,1.0,0.0,0.0,0.0,19158,Hepatitis,0.21,1,Biomarker
117188,ATOD5,"Dermatitis, atopic, 5",0.0,1.0,0.0,0.0,0.0,1853900,"Dermatitis, Atopic, 5",0.21,0,Biomarker
11216,AKAP10,A kinase (PRKA) anchor protein 10,0.0,1.0,0.0,0.0,0.0,264886,Cardiac Conduction Defect,0.21,0,Biomarker
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,21141,Inappropriate ADH Syndrome,0.21,2,Biomarker
100188830,AD12,Alzheimer disease 12,0.0,1.0,0.0,0.0,0.0,1970209,Alzheimer Disease 12,0.21,0,Biomarker
3456,IFNB1,"interferon, beta 1, fibroblast",0.0,0.0,0.0,0.0,1.0,3463,Anus Neoplasms,0.21,2,Therapeutic
939,CD27,CD27 molecule,0.0,0.0,1.0,0.0,0.0,3554540,LYMPHOPROLIFERATIVE SYNDROME 2,0.21,1,GeneticVariation
6911,TBX6,T-box 6,0.0,1.0,0.0,0.0,0.0,1853223,"Deafness, Autosomal Recessive 67",0.21,0,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,1.0,0.0,0.0,0.0,155305,"Optic Neuropathy, Ischemic",0.21,1,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,27439,Nasopharyngeal Neoplasms,0.21,1,Biomarker
1909,EDNRA,endothelin receptor type A,0.0,1.0,0.0,0.0,0.0,27439,Nasopharyngeal Neoplasms,0.21,1,Biomarker
1956,EGFR,epidermal growth factor receptor,0.0,1.0,0.0,0.0,0.0,27439,Nasopharyngeal Neoplasms,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,27439,Nasopharyngeal Neoplasms,0.21,1,Biomarker
9770,RASSF2,Ras association (RalGDS/AF-6) domain family member 2,0.0,1.0,0.0,0.0,0.0,27439,Nasopharyngeal Neoplasms,0.21,1,Biomarker
11197,WIF1,WNT inhibitory factor 1,0.0,1.0,0.0,0.0,0.0,27439,Nasopharyngeal Neoplasms,0.21,1,Biomarker
6295,SAG,S-antigen; retina and pineal gland (arrestin),0.0,1.0,0.0,0.0,0.0,339535,"Night blindness, congenital stationary",0.21,1,Biomarker
113,ADCY7,adenylate cyclase 7,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
375790,AGRN,agrin,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
9163,AMLCR2,acute myeloid leukemia chromosome region 2,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,0,Biomarker
307,ANXA4,annexin A4,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
309,ANXA6,annexin A6,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
366,AQP9,aquaporin 9,0.0,0.0,0.0,0.0,1.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Therapeutic
8623,ASMTL,acetylserotonin O-methyltransferase-like,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
481,ATP1B1,"ATPase, Na+/K+ transporting, beta 1 polypeptide",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
60468,BACH2,"BTB and CNC homology 1, basic leucine zipper transcription factor 2",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
822,CAPG,"capping protein (actin filament), gelsolin-like",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
824,CAPN2,"calpain 2, (m/II) large subunit",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
840,CASP7,"caspase 7, apoptosis-related cysteine peptidase",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
26511,CHIC2,cysteine-rich hydrophobic domain 2,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,0,Biomarker
1512,CTSH,cathepsin H,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
1522,CTSZ,cathepsin Z,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
2026,ENO2,"enolase 2 (gamma, neuronal)",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
53826,FXYD6,FXYD domain containing ion transport regulator 6,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
10634,GAS2L1,growth arrest-specific 2 like 1,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
8833,GMPS,guanine monphosphate synthase,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,0,Biomarker
2969,GTF2I,general transcription factor IIi,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
3005,H1F0,"H1 histone family, member 0",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
3006,HIST1H1C,"histone cluster 1, H1c",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
3398,ID2,"inhibitor of DNA binding 2, dominant negative helix-loop-helix protein",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
10437,IFI30,"interferon, gamma-inducible protein 30",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
1902,LPAR1,lysophosphatidic acid receptor 1,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
4599,MX1,MX dynamin-like GTPase 1,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
5142,PDE4B,"phosphodiesterase 4B, cAMP-specific",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
7837,PXDN,peroxidasin,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
6281,S100A10,S100 calcium binding protein A10,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
6446,SGK1,serum/glucocorticoid regulated kinase 1,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
6840,SVIL,supervillin,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
9145,SYNGR1,synaptogyrin 1,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
6919,TCEA2,"transcription elongation factor A (SII), 2",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
7200,TRH,thyrotropin-releasing hormone,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
7280,TUBB2A,"tubulin, beta 2A class IIa",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
81552,VOPP1,"vesicular, overexpressed in cancer, prosurvival protein 1",0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
11326,VSIG4,V-set and immunoglobulin domain containing 4,0.0,1.0,0.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.21,1,Biomarker
7442,TRPV1,"transient receptor potential cation channel, subfamily V, member 1",0.0,1.0,0.0,0.0,0.0,14852,Esophageal Diseases,0.21,1,Biomarker
55764,IFT122,intraflagellar transport 122,0.0,1.0,0.0,0.0,0.0,8780,Ciliary Motility Disorders,0.21,1,Biomarker
56623,INPP5E,"inositol polyphosphate-5-phosphatase, 72 kDa",0.0,1.0,0.0,0.0,0.0,8780,Ciliary Motility Disorders,0.21,2,Biomarker
23322,RPGRIP1L,RPGRIP1-like,0.0,1.0,0.0,0.0,0.0,8780,Ciliary Motility Disorders,0.21,2,Biomarker
213,ALB,albumin,0.0,1.0,0.0,0.0,0.0,36830,Serum Sickness,0.21,2,Biomarker
100188787,WM1,"Macroglobulinemia, Waldenstrom, susceptibility to, 1",0.0,1.0,0.0,0.0,0.0,24419,Waldenstrom Macroglobulinemia,0.21,0,Biomarker
100188811,WM2,"Macroglobulinemia, Waldenstrom, susceptibility to, 2",0.0,1.0,0.0,0.0,0.0,24419,Waldenstrom Macroglobulinemia,0.21,0,Biomarker
1548,CYP2A6,"cytochrome P450, family 2, subfamily A, polypeptide 6",0.0,1.0,0.0,0.0,0.0,19163,Hepatitis B,0.21,1,Biomarker
4015,LOX,lysyl oxidase,0.0,1.0,0.0,0.0,0.0,19163,Hepatitis B,0.21,1,Biomarker
4017,LOXL2,lysyl oxidase-like 2,0.0,1.0,0.0,0.0,0.0,19163,Hepatitis B,0.21,1,Biomarker
186,AGTR2,"angiotensin II receptor, type 2",0.0,1.0,0.0,0.0,0.0,853897,Diabetic Cardiomyopathies,0.21,2,Biomarker
3479,IGF1,insulin-like growth factor 1 (somatomedin C),0.0,0.0,0.0,0.0,1.0,853897,Diabetic Cardiomyopathies,0.21,1,Therapeutic
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,0.0,0.0,0.0,853897,Diabetic Cardiomyopathies,0.21,1,Biomarker
291,SLC25A4,"solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4",0.0,0.0,0.0,0.0,1.0,853897,Diabetic Cardiomyopathies,0.21,1,Therapeutic
6696,SPP1,secreted phosphoprotein 1,0.0,1.0,0.0,0.0,0.0,853897,Diabetic Cardiomyopathies,0.21,1,Biomarker
7124,TNF,tumor necrosis factor,0.0,1.0,0.0,0.0,0.0,853897,Diabetic Cardiomyopathies,0.21,1,Biomarker
100188823,ASRT4,"Asthma-related traits, susceptibility to, 4",0.0,1.0,0.0,0.0,0.0,1970474,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4",0.21,0,Biomarker
10397,NDRG1,N-myc downstream regulated 1,0.0,1.0,0.0,0.0,0.0,206734,Hemangioblastoma,0.21,1,Biomarker
50644,MRXS11,"mental retardation, X-linked, syndromic 11",0.0,1.0,0.0,0.0,0.0,1846145,"Orofaciodigital syndrome, Shashi type",0.21,0,Biomarker
1840,DTX1,"deltex 1, E3 ubiquitin ligase",0.0,1.0,0.0,0.0,0.0,28945,Oligodendroglioma,0.21,1,Biomarker
2668,GDNF,glial cell derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,28945,Oligodendroglioma,0.21,1,Biomarker
3280,HES1,hes family bHLH transcription factor 1,0.0,1.0,0.0,0.0,0.0,28945,Oligodendroglioma,0.21,1,Biomarker
23462,HEY1,hes-related family bHLH transcription factor with YRPW motif 1,0.0,1.0,0.0,0.0,0.0,28945,Oligodendroglioma,0.21,1,Biomarker
57212,TP73-AS1,TP73 antisense RNA 1,0.0,1.0,0.0,0.0,0.0,28945,Oligodendroglioma,0.21,1,Biomarker
136647,MPLKIP,M-phase specific PLK1 interacting protein,0.0,0.0,1.0,0.0,0.0,1866504,"TRICHOTHIODYSTROPHY, PHOTOSENSITIVE",0.21,1,GeneticVariation
3896,KWE,keratolytic winter erythema (Oudtshoorn skin disease),0.0,1.0,0.0,0.0,0.0,406756,Keratolytic winter erythema,0.21,0,Biomarker
1947,EFNB1,ephrin-B1,0.0,1.0,0.0,0.0,0.0,1876203,Frontonasal dysplasia,0.21,1,Biomarker
10265,IRX5,iroquois homeobox 5,0.0,1.0,0.0,0.0,0.0,1876203,Frontonasal dysplasia,0.21,1,Biomarker
10736,SIX2,SIX homeobox 2,0.0,1.0,0.0,0.0,0.0,1876203,Frontonasal dysplasia,0.21,1,Biomarker
2627,GATA6,GATA binding protein 6,0.0,0.0,1.0,0.0,0.0,3280943,ATRIAL SEPTAL DEFECT 9,0.21,0,GeneticVariation
183,AGT,"angiotensinogen (serpin peptidase inhibitor, clade A, member 8)",0.0,0.0,0.0,0.0,1.0,20621,Hypokalemia,0.21,1,Therapeutic
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,20621,Hypokalemia,0.21,1,Biomarker
4879,NPPB,natriuretic peptide B,0.0,1.0,0.0,0.0,0.0,20621,Hypokalemia,0.21,1,Biomarker
2908,NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.0,1.0,0.0,0.0,0.0,20621,Hypokalemia,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,20621,Hypokalemia,0.21,9,Biomarker
6750,SST,somatostatin,0.0,0.0,0.0,0.0,1.0,20621,Hypokalemia,0.21,1,Therapeutic
2245,FGD1,"FYVE, RhoGEF and PH domain containing 1",0.0,1.0,0.0,0.0,0.0,16508,"Foot Deformities, Congenital",0.21,1,Biomarker
4000,LMNA,lamin A/C,0.0,1.0,0.0,0.0,0.0,16508,"Foot Deformities, Congenital",0.21,1,Biomarker
5744,PTHLH,parathyroid hormone-like hormone,0.0,1.0,0.0,0.0,0.0,16508,"Foot Deformities, Congenital",0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,28433,Nose Neoplasms,0.21,1,Biomarker
3576,CXCL8,chemokine (C-X-C motif) ligand 8,0.0,1.0,0.0,0.0,0.0,30805,"Pemphigoid, Bullous",0.21,1,Biomarker
887,CCKBR,cholecystokinin B receptor,0.0,1.0,0.0,0.0,0.0,28768,Obsessive-Compulsive Disorder,0.21,1,Biomarker
317,APAF1,apoptotic peptidase activating factor 1,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
324,APC,adenomatous polyposis coli,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
657,BMPR1A,"bone morphogenetic protein receptor, type IA",0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
658,BMPR1B,"bone morphogenetic protein receptor, type IB",0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
1055,CECR,cat eye syndrome chromosome region,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
158326,FREM1,FRAS1 related extracellular matrix 1,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
55764,IFT122,intraflagellar transport 122,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
729920,ISPD,isoprenoid synthase domain containing,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
182,JAG1,jagged 1,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,3,Biomarker
3340,NDST1,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
285590,SH3PXD2B,SH3 and PX domains 2B,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
7020,TFAP2A,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha),0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
7042,TGFB2,"transforming growth factor, beta 2",0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
7048,TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
30813,VSX1,visual system homeobox 1,0.0,1.0,0.0,0.0,0.0,15393,Eye Abnormalities,0.21,1,Biomarker
196,AHR,aryl hydrocarbon receptor,0.0,1.0,0.0,0.0,0.0,236811,Chronobiology Disorders,0.21,1,Biomarker
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,0.0,0.0,0.0,236811,Chronobiology Disorders,0.21,1,Biomarker
151648,SGOL1,shugoshin-like 1 (S. pombe),0.0,1.0,0.0,0.0,0.0,236811,Chronobiology Disorders,0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,1.0,0.0,0.0,0.0,22650,Kidney Calculi,0.21,1,Biomarker
54822,TRPM7,"transient receptor potential cation channel, subfamily M, member 7",0.0,1.0,0.0,0.0,0.0,22650,Kidney Calculi,0.21,1,Biomarker
57309,SPG14,spastic paraplegia 14 (autosomal recessive),0.0,1.0,0.0,0.0,0.0,1854568,"Spastic paraplegia 14, autosomal recessive",0.21,0,Biomarker
10516,FBLN5,fibulin 5,0.0,1.0,0.0,0.0,0.0,35243,Respiratory Tract Infections,0.21,1,Biomarker
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,35243,Respiratory Tract Infections,0.21,1,Biomarker
6103,RPGR,retinitis pigmentosa GTPase regulator,0.0,1.0,0.0,0.0,0.0,35243,Respiratory Tract Infections,0.21,1,Biomarker
574049,TUKLS,Tukel syndrome,0.0,1.0,0.0,0.0,0.0,1836217,Tukel syndrome,0.21,0,Biomarker
1484,CTAA2,"cataract, anterior polar 2",0.0,1.0,0.0,0.0,0.0,1832609,Anterior polar cataract 2,0.21,0,Biomarker
100188789,HPC6,"Prostate cancer, susceptibility to",0.0,1.0,0.0,0.0,0.0,1836005,"Prostate Cancer, Hereditary, 6",0.21,0,Biomarker
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,0.0,1.0,0.0,0.0,1842036,Giant pigmented hairy nevus,0.21,0,GeneticVariation
9973,CCS,copper chaperone for superoxide dismutase,0.0,1.0,0.0,0.0,0.0,11156,Deficiency Diseases,0.21,1,Biomarker
1356,CP,ceruloplasmin (ferroxidase),0.0,1.0,0.0,0.0,0.0,11156,Deficiency Diseases,0.21,1,Biomarker
3414,IDDM15,insulin-dependent diabetes mellitus 15,0.0,1.0,0.0,0.0,0.0,1866519,"Diabetes Mellitus, Insulin-Dependent, 15",0.21,0,Biomarker
100188826,HPC9,"Prostate cancer, hereditary, 9",0.0,1.0,0.0,0.0,0.0,1970250,"Prostate Cancer, Hereditary, 9",0.21,0,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,29132,Optic Nerve Diseases,0.21,1,Biomarker
4313,MMP2,"matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,24950,Maxillary Diseases,0.21,1,Biomarker
50608,IBD4,inflammatory bowel disease 4,0.0,1.0,0.0,0.0,0.0,1847691,Inflammatory Bowel Disease 4,0.21,0,Biomarker
3032,HADHB,"hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit",0.0,1.0,0.0,0.0,0.0,154251,Lipid Metabolism Disorders,0.21,1,Biomarker
100270639,IHPS5,"Pyloric stenosis, infantile hypertrophic, 5",0.0,1.0,0.0,0.0,0.0,2675862,"Pyloric Stenosis, Infantile Hypertrophic, 5",0.21,0,Biomarker
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,1.0,0.0,0.0,0.0,37822,Speech Disorders,0.21,1,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,37822,Speech Disorders,0.21,1,Biomarker
5376,PMP22,peripheral myelin protein 22,0.0,1.0,0.0,0.0,0.0,34372,Quadriplegia,0.21,1,Biomarker
10491,CRTAP,cartilage associated protein,0.0,1.0,0.0,0.0,0.0,2931095,"Osteogenesis imperfecta, type 7",0.21,0,Biomarker
5173,PDYN,prodynorphin,0.0,1.0,0.0,0.0,0.0,36659,Sensation Disorders,0.21,1,Biomarker
3309,HSPA5,"heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)",0.0,1.0,0.0,0.0,0.0,376545,Hematologic Neoplasms,0.21,1,Biomarker
5444,PON1,paraoxonase 1,0.0,1.0,0.0,0.0,0.0,376545,Hematologic Neoplasms,0.21,1,Biomarker
158866,ZDHHC15,"zinc finger, DHHC-type containing 15",0.0,1.0,0.0,0.0,0.0,1845142,"Mental Retardation, X-Linked 91",0.21,0,Biomarker
619510,AMCX5,"arthrogryposis, X-linked, type 5",0.0,1.0,0.0,0.0,0.0,1846273,"ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED",0.21,0,Biomarker
6347,CCL2,chemokine (C-C motif) ligand 2,0.0,1.0,0.0,0.0,0.0,13264,"Muscular Dystrophy, Duchenne",0.21,1,Biomarker
920,CD4,CD4 molecule,0.0,1.0,0.0,0.0,0.0,13264,"Muscular Dystrophy, Duchenne",0.21,1,Biomarker
4618,MYF6,myogenic factor 6 (herculin),0.0,1.0,0.0,0.0,0.0,13264,"Muscular Dystrophy, Duchenne",0.21,0,Biomarker
10631,POSTN,"periostin, osteoblast specific factor",0.0,1.0,0.0,0.0,0.0,13264,"Muscular Dystrophy, Duchenne",0.21,1,Biomarker
5154,PDGFA,platelet-derived growth factor alpha polypeptide,0.0,1.0,0.0,0.0,0.0,5942,"Bone Diseases, Endocrine",0.21,1,Biomarker
5741,PTH,parathyroid hormone,0.0,1.0,0.0,0.0,0.0,5942,"Bone Diseases, Endocrine",0.21,1,Biomarker
11093,ADAMTS13,"ADAM metallopeptidase with thrombospondin type 1 motif, 13",0.0,1.0,0.0,0.0,0.0,398650,"Purpura, Thrombocytopenic, Idiopathic",0.21,1,Biomarker
1394,CRHR1,corticotropin releasing hormone receptor 1,0.0,1.0,0.0,0.0,0.0,11616,"Dermatitis, Contact",0.21,1,Biomarker
6288,SAA1,serum amyloid A1,0.0,1.0,0.0,0.0,0.0,11616,"Dermatitis, Contact",0.21,1,Biomarker
6649,SOD3,"superoxide dismutase 3, extracellular",0.0,0.0,0.0,0.0,1.0,11616,"Dermatitis, Contact",0.21,1,Therapeutic
7099,TLR4,toll-like receptor 4,0.0,1.0,0.0,0.0,0.0,11616,"Dermatitis, Contact",0.21,1,Biomarker
5443,POMC,proopiomelanocortin,0.0,0.0,0.0,0.0,1.0,11848,Diabetes Insipidus,0.21,1,Therapeutic
3229,HOXC13,homeobox C13,0.0,1.0,0.0,0.0,0.0,1865951,"Ectodermal Dysplasia, Pure Hair-Nail Type",0.21,1,Biomarker
5205,ATP8B1,"ATPase, aminophospholipid transporter, class I, type 8B, member 1",0.0,0.0,1.0,0.0,0.0,3549845,"CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1",0.21,0,GeneticVariation
1689,DFNA7,"deafness, autosomal dominant 7",0.0,1.0,0.0,0.0,0.0,1832379,"Deafness, Autosomal Dominant 7",0.21,0,Biomarker
546,ATRX,alpha thalassemia/mental retardation syndrome X-linked,0.0,1.0,0.0,0.0,0.0,39978,Thoracic Diseases,0.21,1,Biomarker
57560,IFT80,intraflagellar transport 80,0.0,1.0,0.0,0.0,0.0,39978,Thoracic Diseases,0.21,1,Biomarker
7055,THAS,thoracoabdominal syndrome,0.0,1.0,0.0,0.0,0.0,39978,Thoracic Diseases,0.21,1,Biomarker
9217,VAPB,VAMP (vesicle-associated membrane protein)-associated protein B and C,0.0,0.0,1.0,0.0,0.0,1854058,"Spinal Muscular Atrophy, Late-Onset, Finkel Type",0.21,0,GeneticVariation
107,ADCY1,adenylate cyclase 1 (brain),0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
114,ADCY8,adenylate cyclase 8 (brain),0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
134,ADORA1,adenosine A1 receptor,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
135,ADORA2A,adenosine A2a receptor,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,3,Biomarker
10550,ARL6IP5,ADP-ribosylation factor-like 6 interacting protein 5,0.0,0.0,0.0,0.0,1.0,38587,Substance Withdrawal Syndrome,0.21,1,Therapeutic
551,AVP,arginine vasopressin,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
627,BDNF,brain-derived neurotrophic factor,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
887,CCKBR,cholecystokinin B receptor,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,2,Biomarker
1133,CHRM5,"cholinergic receptor, muscarinic 5",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
1138,CHRNA5,"cholinergic receptor, nicotinic, alpha 5 (neuronal)",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
8973,CHRNA6,"cholinergic receptor, nicotinic, alpha 6 (neuronal)",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
1139,CHRNA7,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
1143,CHRNB4,"cholinergic receptor, nicotinic, beta 4 (neuronal)",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
1385,CREB1,cAMP responsive element binding protein 1,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
1401,CRP,"C-reactive protein, pentraxin-related",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
2353,FOS,FBJ murine osteosarcoma viral oncogene homolog,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,3,Biomarker
2770,GNAI1,"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
2775,GNAO1,"guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
2778,GNAS,GNAS complex locus,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
2891,GRIA2,"glutamate receptor, ionotropic, AMPA 2",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
2903,GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
3060,HCRT,hypocretin (orexin) neuropeptide precursor,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
3061,HCRTR1,hypocretin (orexin) receptor 1,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
3269,HRH1,histamine receptor H1,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
3274,HRH2,histamine receptor H2,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
3440,IFNA2,"interferon, alpha 2",0.0,0.0,0.0,0.0,1.0,38587,Substance Withdrawal Syndrome,0.21,1,Therapeutic
5594,MAPK1,mitogen-activated protein kinase 1,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
5595,MAPK3,mitogen-activated protein kinase 3,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
4318,MMP9,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
4843,NOS2,"nitric oxide synthase 2, inducible",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
4885,NPTX2,neuronal pentraxin II,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
4985,OPRD1,"opioid receptor, delta 1",0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
4987,OPRL1,opiate receptor-like 1,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
5187,PER1,period circadian clock 1,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
8864,PER2,period circadian clock 2,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,2,Biomarker
8863,PER3,period circadian clock 3,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
5368,PNOC,prepronociceptin,0.0,0.0,0.0,0.0,1.0,38587,Substance Withdrawal Syndrome,0.21,1,Therapeutic
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
5972,REN,renin,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
6869,TACR1,tachykinin receptor 1,0.0,1.0,0.0,0.0,0.0,38587,Substance Withdrawal Syndrome,0.21,1,Biomarker
9332,CD163,CD163 molecule,0.0,1.0,0.0,0.0,0.0,7273,Carotid Artery Diseases,0.21,1,Biomarker
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,0.0,0.0,0.0,7273,Carotid Artery Diseases,0.21,1,Biomarker
22808,MRAS,muscle RAS oncogene homolog,0.0,1.0,0.0,0.0,0.0,7273,Carotid Artery Diseases,0.21,1,Biomarker
5328,PLAU,"plasminogen activator, urokinase",0.0,0.0,0.0,0.0,1.0,7273,Carotid Artery Diseases,0.21,1,Therapeutic
5420,PODXL,podocalyxin-like,0.0,1.0,0.0,0.0,0.0,7273,Carotid Artery Diseases,0.21,1,Biomarker
4329,ALDH6A1,"aldehyde dehydrogenase 6 family, member A1",0.0,0.0,1.0,0.0,0.0,3279840,Methylmalonate Semialdehyde Dehydrogenase Deficiency,0.21,1,GeneticVariation
57042,IBD7,inflammatory bowel disease 7,0.0,1.0,0.0,0.0,0.0,1854573,Inflammatory Bowel Disease 7,0.21,0,Biomarker
207,AKT1,v-akt murine thymoma viral oncogene homolog 1,0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.21,1,Biomarker
1668,DEFA3,"defensin, alpha 3, neutrophil-specific",0.0,0.0,0.0,0.0,1.0,23487,"Leukemia, Promyelocytic, Acute",0.21,1,Therapeutic
2735,GLI1,GLI family zinc finger 1,0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.21,1,Biomarker
2736,GLI2,GLI family zinc finger 2,0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.21,1,Biomarker
3605,IL17A,interleukin 17A,0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.21,1,Biomarker
406948,MIR15A,microRNA 15a,0.0,0.0,0.0,0.0,1.0,23487,"Leukemia, Promyelocytic, Acute",0.21,1,Therapeutic
406950,MIR16-1,microRNA 16-1,0.0,0.0,0.0,0.0,1.0,23487,"Leukemia, Promyelocytic, Acute",0.21,1,Therapeutic
5909,RAP1GAP,RAP1 GTPase activating protein,0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.21,1,Biomarker
6608,SMO,"smoothened, frizzled class receptor",0.0,1.0,0.0,0.0,0.0,23487,"Leukemia, Promyelocytic, Acute",0.21,1,Biomarker
3630,INS,insulin,0.0,1.0,0.0,0.0,0.0,30319,Panic Disorder,0.21,1,Biomarker
387572,PAND1,Panic disorder 1,0.0,1.0,0.0,0.0,0.0,30319,Panic Disorder,0.21,0,Biomarker
619493,PAND2,panic disorder 2,0.0,1.0,0.0,0.0,0.0,30319,Panic Disorder,0.21,0,Biomarker
677663,PAND3,panic disorder 3,0.0,1.0,0.0,0.0,0.0,30319,Panic Disorder,0.21,0,Biomarker
4842,NOS1,nitric oxide synthase 1 (neuronal),0.0,1.0,0.0,0.0,0.0,42035,Urination Disorders,0.21,1,Biomarker
4878,NPPA,natriuretic peptide A,0.0,1.0,0.0,0.0,0.0,42035,Urination Disorders,0.21,1,Biomarker
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,0.0,0.0,0.0,42035,Urination Disorders,0.21,1,Biomarker
7274,TTPA,tocopherol (alpha) transfer protein,0.0,1.0,0.0,0.0,0.0,42035,Urination Disorders,0.21,1,Biomarker
3673,ITGA2,"integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)",0.0,1.0,0.0,0.0,0.0,35328,Retinal Vein Occlusion,0.21,1,Biomarker
2989,GULOP,"gulonolactone (L-) oxidase, pseudogene",0.0,1.0,0.0,0.0,0.0,36474,Scurvy,0.21,0,Biomarker
1082,CGB,"chorionic gonadotropin, beta polypeptide",0.0,0.0,0.0,0.0,1.0,20619,Hypogonadism,0.21,2,Therapeutic
2488,FSHB,"follicle stimulating hormone, beta polypeptide",0.0,1.0,0.0,0.0,1.0,20619,Hypogonadism,0.21,2,"Biomarker, Therapeutic"
3953,LEPR,leptin receptor,0.0,1.0,0.0,0.0,0.0,20619,Hypogonadism,0.21,1,Biomarker
5424,POLD1,"polymerase (DNA directed), delta 1, catalytic subunit",0.0,1.0,0.0,0.0,0.0,20619,Hypogonadism,0.21,1,Biomarker
5617,PRL,prolactin,0.0,1.0,0.0,0.0,0.0,20619,Hypogonadism,0.21,1,Biomarker
6866,TAC3,tachykinin 3,0.0,1.0,0.0,0.0,0.0,20619,Hypogonadism,0.21,1,Biomarker
6870,TACR3,tachykinin receptor 3,0.0,1.0,0.0,0.0,0.0,20619,Hypogonadism,0.21,1,Biomarker
1440,CSF3,colony stimulating factor 3 (granulocyte),0.0,0.0,0.0,0.0,1.0,19829,Hodgkin Disease,0.21,1,Therapeutic
100302059,IBD27,Inflammatory bowel disease-27,0.0,1.0,0.0,0.0,0.0,2748550,Inflammatory Bowel Disease 27,0.21,0,Biomarker
239,ALOX12,arachidonate 12-lipoxygenase,0.0,1.0,0.0,0.0,0.0,6435,"Burns, Chemical",0.21,1,Biomarker
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,0.0,0.0,0.0,6435,"Burns, Chemical",0.21,1,Biomarker
3552,IL1A,"interleukin 1, alpha",0.0,1.0,0.0,0.0,0.0,6435,"Burns, Chemical",0.21,1,Biomarker
3553,IL1B,"interleukin 1, beta",0.0,1.0,0.0,0.0,0.0,6435,"Burns, Chemical",0.21,1,Biomarker
3554,IL1R1,"interleukin 1 receptor, type I",0.0,1.0,0.0,0.0,0.0,6435,"Burns, Chemical",0.21,1,Biomarker
3569,IL6,interleukin 6,0.0,1.0,0.0,0.0,0.0,6435,"Burns, Chemical",0.21,1,Biomarker
5080,PAX6,paired box 6,0.0,1.0,0.0,0.0,0.0,344543,"Aniridia, type 2",0.21,0,Biomarker
203547,VMA21,VMA21 vacuolar H+-ATPase homolog (S. cerevisiae),0.0,1.0,0.0,0.0,0.0,1839615,"Myopathy, X-Linked, with Excessive Autophagy",0.21,0,Biomarker
4128,MAOA,monoamine oxidase A,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.21,1,Biomarker
57526,PCDH19,protocadherin 19,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.21,1,Biomarker
139411,PTCHD1,patched domain containing 1,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.21,1,Biomarker
282808,RAB40AL,"RAB40A, member RAS oncogene family-like",0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.21,1,Biomarker
6855,SYP,synaptophysin,0.0,1.0,0.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.21,1,Biomarker
1670,DEFA5,"defensin, alpha 5, Paneth cell-specific",0.0,1.0,0.0,0.0,0.0,31269,Peutz-Jeghers Syndrome,0.21,1,Biomarker
2494,NR5A2,"nuclear receptor subfamily 5, group A, member 2",0.0,1.0,0.0,0.0,0.0,3128,Anovulation,0.21,1,Biomarker
100240730,DUP7Q11.23,Chromosome 7q11.23 duplication syndrome,0.0,1.0,0.0,0.0,0.0,1857844,Williams-Beuren Region Duplication Syndrome,0.21,0,Biomarker
7037,TFRC,transferrin receptor,0.0,0.0,0.0,0.0,1.0,3756,Arenaviridae Infections,0.21,1,Therapeutic
7490,WT1,Wilms tumor 1,0.0,1.0,0.0,0.0,0.0,2931752,Meacham Winn Culler syndrome,0.21,0,Biomarker
1071,CETP,"cholesteryl ester transfer protein, plasma",0.0,1.0,1.0,0.0,0.0,342883,Cholesteryl Ester Transfer Protein Deficiency,0.20992266,35,"Biomarker, GeneticVariation"
2778,GNAS,GNAS complex locus,0.0,1.0,1.0,0.0,0.0,1864100,"PSEUDOHYPOPARATHYROIDISM, TYPE IB",0.20992266,35,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,1141890,Congenital long QT syndrome,0.209639155,34,"Biomarker, GeneticVariation"
7389,UROD,uroporphyrinogen decarboxylase,0.0,1.0,1.0,0.0,0.0,268323,Familial porphyria cutanea tarda,0.209639155,34,"Biomarker, GeneticVariation"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,1282971,von Willebrand disease type 2B,0.209639155,34,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,205710,Alpers' disease,0.208788642,31,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",1.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.208701749,7,"AlteredExpression, Biomarker, GeneticVariation"
11155,LDB3,LIM domain binding 3,0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.208574235,7,"Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,1.0,1.0,1.0,0.0,0.0,23467,"Leukemia, Myeloid, Acute",0.208574235,8,"AlteredExpression, Biomarker, GeneticVariation"
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.208554168,23,"Biomarker, GeneticVariation"
4487,MSX1,msh homeobox 1,0.0,1.0,1.0,0.0,0.0,20608,Hypodontia,0.208505137,30,"Biomarker, GeneticVariation"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,38644,Sudden Infant Death,0.208007226,5,"Biomarker, GeneticVariation"
6448,SGSH,N-sulfoglucosamine sulfohydrolase,0.0,1.0,1.0,0.0,0.0,86647,Mucopolysaccharidosis Type IIIA,0.207938128,28,"Biomarker, GeneticVariation"
6390,SDHB,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",0.0,1.0,1.0,0.0,0.0,238198,Gastrointestinal Stromal Tumors,0.207909164,20,"Biomarker, GeneticVariation"
8322,FZD4,frizzled class receptor 4,0.0,1.0,1.0,0.0,0.0,35344,Retinopathy of Prematurity,0.207801716,4,"Biomarker, GeneticVariation"
3480,IGF1R,insulin-like growth factor 1 receptor,0.0,1.0,1.0,0.0,0.0,11860,"Diabetes Mellitus, Type 2",0.207518212,6,"Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.207518212,5,"Biomarker, GeneticVariation"
348,APOE,apolipoprotein E,0.0,1.0,1.0,0.0,0.0,20476,Hyperlipoproteinemias,0.20742015,19,"Biomarker, GeneticVariation"
3784,KCNQ1,"potassium channel, voltage gated KQT-like subfamily Q, member 1",0.0,1.0,1.0,0.0,0.0,40479,Torsades de Pointes,0.207391186,11,"Biomarker, GeneticVariation"
7287,TULP1,tubby like protein 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.207391186,10,"Biomarker, GeneticVariation"
7389,UROD,uroporphyrinogen decarboxylase,0.0,1.0,1.0,0.0,0.0,162569,"Porphyria, Hepatoerythropoietic",0.207371119,26,"Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,271980,beta^0^ Thalassemia,0.207371119,26,"Biomarker, GeneticVariation"
10210,TOPORS,"topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase",0.0,0.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.207362222,3,GeneticVariation
24,ABCA4,"ATP-binding cassette, sub-family A (ABC1), member 4",0.0,0.0,1.0,0.0,0.0,271093,Stargardt Macular Degeneration,0.206951203,3,GeneticVariation
79188,TMEM43,transmembrane protein 43,0.0,1.0,1.0,0.0,0.0,349788,Arrhythmogenic Right Ventricular Dysplasia,0.206824177,8,"Biomarker, GeneticVariation"
51422,PRKAG2,"protein kinase, AMP-activated, gamma 2 non-catalytic subunit",0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.206746182,8,"Biomarker, GeneticVariation"
5468,PPARG,peroxisome proliferator-activated receptor gamma,0.0,1.0,1.0,0.0,0.0,28756,"Obesity, Morbid",0.206618667,8,"Biomarker, GeneticVariation"
26154,ABCA12,"ATP-binding cassette, sub-family A (ABC1), member 12",0.0,1.0,1.0,0.0,0.0,239849,Harlequin fetus,0.206520605,23,"Biomarker, GeneticVariation"
55624,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",0.0,1.0,1.0,0.0,0.0,457133,Muscle eye brain disease,0.206520605,23,"Biomarker, GeneticVariation"
335,APOA1,apolipoprotein A-I,0.0,1.0,1.0,0.0,0.0,39292,Tangier Disease,0.206491641,14,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,37052,Sick Sinus Syndrome,0.206462677,6,"Biomarker, GeneticVariation"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,1282968,von Willebrand disease type 2A,0.206237101,22,"Biomarker, GeneticVariation"
79728,PALB2,partner and localizer of BRCA2,0.0,1.0,1.0,0.0,0.0,346153,"Breast Cancer, Familial",0.206237101,22,"Biomarker, GeneticVariation"
11200,CHEK2,checkpoint kinase 2,0.0,1.0,1.0,0.0,0.0,346153,"Breast Cancer, Familial",0.206237101,22,"Biomarker, GeneticVariation"
5320,PLA2G2A,"phospholipase A2, group IIA (platelets, synovial fluid)",0.0,1.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.206051658,6,"Biomarker, GeneticVariation"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,1282975,von Willebrand disease type 2N,0.206002627,13,"Biomarker, GeneticVariation"
472,ATM,ATM serine/threonine kinase,0.0,1.0,1.0,0.0,0.0,2363142,"Leukemia, Prolymphocytic, T-Cell",0.205953596,21,"Biomarker, GeneticVariation"
2064,ERBB2,erb-b2 receptor tyrosine kinase 2,0.0,1.0,1.0,0.0,0.0,152013,Adenocarcinoma of lung,0.205953596,21,"Biomarker, GeneticVariation"
3988,LIPA,"lipase A, lysosomal acid, cholesterol esterase",0.0,1.0,1.0,0.0,0.0,43208,Wolman Disease,0.205953596,21,"Biomarker, GeneticVariation"
10682,EBP,emopamil binding protein (sterol isomerase),0.0,1.0,1.0,0.0,0.0,282102,"Chondrodysplasia punctata, X-linked dominant type",0.205953596,21,"Biomarker, GeneticVariation"
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,0.0,1.0,1.0,1.0,0.0,23461,"Leukemia, Mast-Cell",0.205924632,13,"Biomarker, GeneticVariation, PostTranslationalModification"
1392,CRH,corticotropin releasing hormone,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.205768153,5,"Biomarker, GeneticVariation"
3575,IL7R,interleukin 7 receptor,0.0,1.0,1.0,0.0,0.0,85110,Severe Combined Immunodeficiency,0.205719122,12,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,677886,Ovarian epithelial cancer,0.205719122,13,"Biomarker, GeneticVariation"
4758,NEU1,sialidase 1 (lysosomal sialidase),0.0,1.0,1.0,0.0,0.0,268226,Mucolipidosis type I,0.205670091,20,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,1959582,PTEN Hamartoma Tumor Syndrome,0.205670091,20,"Biomarker, GeneticVariation"
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,1.0,0.0,0.0,349788,Arrhythmogenic Right Ventricular Dysplasia,0.205641127,12,"Biomarker, GeneticVariation"
672,BRCA1,"breast cancer 1, early onset",0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.205484649,5,"Biomarker, GeneticVariation"
6017,RLBP1,retinaldehyde binding protein 1,0.0,1.0,1.0,0.0,0.0,1405854,Retinitis punctata albescens (disorder),0.205435618,11,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,38015,spondyloepiphyseal dysplasia,0.205386587,19,"Biomarker, GeneticVariation"
6663,SOX10,SRY (sex determining region Y)-box 10,0.0,1.0,1.0,0.0,0.0,2931876,Hirschsprung disease 1,0.205386587,19,"Biomarker, GeneticVariation"
472,ATM,ATM serine/threonine kinase,0.0,1.0,1.0,0.0,0.0,334634,"Lymphoma, Mantle-Cell",0.205386587,19,"Biomarker, GeneticVariation"
23592,LEMD3,LEM domain containing 3,0.0,1.0,1.0,0.0,0.0,29455,Osteopoikilosis,0.205357623,10,"Biomarker, GeneticVariation"
5071,PARK2,parkin RBR E3 ubiquitin protein ligase,1.0,1.0,1.0,0.0,0.0,919267,Ovarian Neoplasms,0.205328659,3,"AlteredExpression, Biomarker, GeneticVariation"
3845,KRAS,Kirsten rat sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,5684,Malignant neoplasm of bladder,0.205201144,4,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,2675080,Li-Fraumeni-Like Syndrome,0.205103082,18,"Biomarker, GeneticVariation"
4535,ND1,"NADH dehydrogenase, subunit 1 (complex I)",0.0,1.0,1.0,0.0,0.0,2395,Alzheimer Disease,0.20491764,3,"Biomarker, GeneticVariation"
8200,GDF5,growth differentiation factor 5,0.0,0.0,1.0,0.0,0.0,29410,"Osteoarthritis, Hip",0.20491764,3,GeneticVariation
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,17097,Gardner Syndrome,0.204868609,9,"Biomarker, GeneticVariation"
1829,DSG2,desmoglein 2,0.0,0.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.204839645,2,GeneticVariation
2057,EPOR,erythropoietin receptor,1.0,1.0,1.0,0.0,0.0,23440,"Leukemia, Erythroblastic, Acute",0.204790614,9,"AlteredExpression, Biomarker, GeneticVariation"
811,CALR,calreticulin,0.0,1.0,1.0,0.0,0.0,1815,Primary Myelofibrosis,0.204536073,16,"Biomarker, GeneticVariation"
775,CACNA1C,"calcium channel, voltage-dependent, L type, alpha 1C subunit",0.0,1.0,1.0,0.0,0.0,1142166,Brugada Syndrome,0.204507109,8,"Biomarker, GeneticVariation"
2010,EMD,emerin,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.204507109,8,"Biomarker, GeneticVariation"
7428,VHL,"von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.204507109,8,"Biomarker, GeneticVariation"
7099,TLR4,toll-like receptor 4,0.0,1.0,1.0,0.0,0.0,1864267,Endotoxin Hyporesponsiveness,0.2043016,7,"Biomarker, GeneticVariation"
6094,ROM1,retinal outer segment membrane protein 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.2043016,7,"Biomarker, GeneticVariation"
1499,CTNNB1,"catenin (cadherin-associated protein), beta 1, 88kDa",0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.204252569,15,"Biomarker, GeneticVariation"
4566,TRNK,tRNA,0.0,1.0,1.0,0.0,0.0,162672,MERRF Syndrome,0.204018095,6,"Biomarker, GeneticVariation"
2018,EMX2,empty spiracles homeobox 2,0.0,1.0,1.0,0.0,0.0,266484,Schizencephaly,0.204018095,6,"Biomarker, GeneticVariation"
7414,VCL,vinculin,0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.204018095,7,"Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,271979,thalassemia intermedia,0.203969064,14,"Biomarker, GeneticVariation"
410,ARSA,arylsulfatase A,0.0,1.0,1.0,0.0,0.0,751278,"Metachromatic leukodystrophy, congenital type",0.203969064,14,"Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,472767,Beta thalassemia intermedia,0.203969064,14,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,0.0,1.0,1.0,0.0,0.0,25500,Mesothelioma,0.2039401,6,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,206624,Hepatoblastoma,0.203685559,13,"Biomarker, GeneticVariation"
3767,KCNJ11,"potassium channel, inwardly rectifying subfamily J, member 11",0.0,1.0,1.0,0.0,0.0,27773,Nesidioblastosis,0.203685559,13,"Biomarker, GeneticVariation"
5048,PAFAH1B1,"platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)",0.0,1.0,1.0,0.0,0.0,1848201,Double cortex syndrome,0.203685559,13,"Biomarker, GeneticVariation"
6391,SDHC,"succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa",0.0,1.0,1.0,0.0,0.0,238198,Gastrointestinal Stromal Tumors,0.203656595,5,"Biomarker, GeneticVariation"
10194,TSHZ1,teashirt zinc finger homeobox 1,0.0,1.0,1.0,0.0,0.0,1842937,"Aural Atresia, Congenital",0.203402055,12,"Biomarker, GeneticVariation"
4204,MECP2,methyl CpG binding protein 2,0.0,1.0,1.0,0.0,0.0,2748910,"Rett Syndrome, Atypical",0.203402055,12,"Biomarker, GeneticVariation"
5925,RB1,retinoblastoma 1,1.0,1.0,1.0,0.0,0.0,5684,Malignant neoplasm of bladder,0.203402055,12,"AlteredExpression, Biomarker, GeneticVariation"
8675,STX16,syntaxin 16,0.0,1.0,1.0,0.0,0.0,1864100,"PSEUDOHYPOPARATHYROIDISM, TYPE IB",0.203402055,12,"Biomarker, GeneticVariation"
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.203167581,4,"Biomarker, GeneticVariation"
4647,MYO7A,myosin VIIA,0.0,1.0,1.0,0.0,0.0,1848638,"Usher Syndrome, Type Ib",0.20311855,11,"Biomarker, GeneticVariation"
472,ATM,ATM serine/threonine kinase,0.0,1.0,1.0,0.0,0.0,346153,"Breast Cancer, Familial",0.20311855,11,"Biomarker, GeneticVariation"
7450,VWF,von Willebrand factor,0.0,1.0,1.0,0.0,0.0,1282974,von Willebrand disease type 2M,0.20311855,11,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,391826,Lhermitte-Duclos disease,0.20311855,11,"Biomarker, GeneticVariation"
3045,HBD,"hemoglobin, delta",0.0,1.0,1.0,0.0,0.0,271990,delta-Thalassemia,0.20311855,11,"Biomarker, GeneticVariation"
6262,RYR2,ryanodine receptor 2 (cardiac),0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.203089586,2,"Biomarker, GeneticVariation"
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,0.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.202884077,3,GeneticVariation
8915,BCL10,B-cell CLL/lymphoma 10,0.0,1.0,1.0,0.0,0.0,24301,"Lymphoma, Follicular",0.202884077,3,"Biomarker, GeneticVariation"
4519,CYTB,cytochrome b,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.202884077,3,"Biomarker, GeneticVariation"
15,AANAT,aralkylamine N-acetyltransferase,0.0,1.0,1.0,0.0,0.0,393770,delayed sleep phase syndrome,0.202884077,2,"Biomarker, GeneticVariation"
4053,LTBP2,latent transforming growth factor beta binding protein 2,0.0,1.0,1.0,0.0,0.0,206368,Exfoliation Syndrome,0.202884077,3,"Biomarker, GeneticVariation"
779,CACNA1S,"calcium channel, voltage-dependent, L type, alpha 1S subunit",0.0,1.0,1.0,0.0,0.0,268446,Thyrotoxic periodic paralysis,0.202884077,3,"Biomarker, GeneticVariation"
581,BAX,BCL2-associated X protein,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.202835046,10,"Biomarker, GeneticVariation"
1630,DCC,DCC netrin 1 receptor,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.202835046,10,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,431109,Choroid Plexus Carcinoma,0.202835046,10,"Biomarker, GeneticVariation"
2538,G6PC,"glucose-6-phosphatase, catalytic subunit",0.0,1.0,1.0,0.0,0.0,268146,Glycogen Storage Disease IB,0.202835046,10,"Biomarker, GeneticVariation"
353,APRT,adenine phosphoribosyltransferase,0.0,1.0,1.0,0.0,0.0,268120,Adenine phosphoribosyltransferase deficiency,0.202835046,10,"Biomarker, GeneticVariation"
4567,TRNL1,tRNA,0.0,0.0,1.0,0.0,0.0,162672,MERRF Syndrome,0.202600572,1,GeneticVariation
4624,MYH6,"myosin, heavy chain 6, cardiac muscle, alpha",0.0,1.0,1.0,0.0,0.0,18798,"Heart Defects, Congenital",0.202600572,1,"Biomarker, GeneticVariation"
7490,WT1,Wilms tumor 1,0.0,1.0,1.0,0.0,0.0,268747,"Mesangial sclerosis, diffuse",0.202600572,2,"Biomarker, GeneticVariation"
1824,DSC2,desmocollin 2,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.202600572,2,"Biomarker, GeneticVariation"
1482,NKX2-5,NK2 homeobox 5,0.0,1.0,1.0,0.0,0.0,13069,Double Outlet Right Ventricle,0.202600572,2,"Biomarker, GeneticVariation"
611,OPN1SW,"opsin 1 (cone pigments), short-wave-sensitive",0.0,1.0,1.0,0.0,0.0,155017,Tritan defect,0.202600572,1,"Biomarker, GeneticVariation"
4595,MUTYH,mutY homolog,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.202551541,9,"Biomarker, GeneticVariation"
6910,TBX5,T-box 5,0.0,1.0,1.0,0.0,0.0,18798,"Heart Defects, Congenital",0.202551541,9,"Biomarker, GeneticVariation"
8048,CSRP3,cysteine and glycine-rich protein 3 (cardiac LIM protein),0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.202551541,9,"Biomarker, GeneticVariation"
5888,RAD51,RAD51 recombinase,0.0,1.0,1.0,0.0,0.0,346153,"Breast Cancer, Familial",0.202551541,9,"Biomarker, GeneticVariation"
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,1.0,0.0,0.0,2348199,Short Qt Syndrome,0.202551541,9,"Biomarker, GeneticVariation"
4942,OAT,ornithine aminotransferase,0.0,1.0,1.0,0.0,0.0,599035,Hyperornithinemia,0.202551541,9,"Biomarker, GeneticVariation"
2147,F2,coagulation factor II (thrombin),0.0,1.0,1.0,0.0,0.0,272317,Dysprothrombinemia,0.202551541,9,"Biomarker, GeneticVariation"
287,ANK2,"ankyrin 2, neuronal",0.0,1.0,1.0,0.0,0.0,40479,Torsades de Pointes,0.202522577,1,"Biomarker, GeneticVariation"
3759,KCNJ2,"potassium channel, inwardly rectifying subfamily J, member 2",0.0,0.0,1.0,0.0,0.0,4238,Atrial Fibrillation,0.202522577,1,GeneticVariation
287,ANK2,"ankyrin 2, neuronal",0.0,0.0,1.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.202522577,1,GeneticVariation
845,CASQ2,calsequestrin 2 (cardiac muscle),0.0,1.0,1.0,0.0,0.0,3811,"Arrhythmias, Cardiac",0.202522577,1,"Biomarker, GeneticVariation"
6338,SCNN1B,"sodium channel, non voltage gated 1 beta subunit",0.0,0.0,1.0,0.0,0.0,6267,Bronchiectasis,0.202522577,1,GeneticVariation
4634,MYL3,"myosin, light chain 3, alkali; ventricular, skeletal, slow",0.0,0.0,1.0,0.0,0.0,949658,"Cardiomyopathy, Hypertrophic, Familial",0.202522577,1,GeneticVariation
999,CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",0.0,0.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.202522577,1,GeneticVariation
4536,ND2,MTND2,0.0,0.0,1.0,0.0,0.0,23264,Leigh Disease,0.202522577,1,GeneticVariation
8915,BCL10,B-cell CLL/lymphoma 10,0.0,0.0,1.0,0.0,0.0,153594,Testicular Cancer,0.202317068,1,GeneticVariation
7352,UCP3,"uncoupling protein 3 (mitochondrial, proton carrier)",0.0,0.0,1.0,0.0,0.0,28756,"Obesity, Morbid",0.202317068,1,GeneticVariation
153,ADRB1,adrenoceptor beta 1,0.0,0.0,1.0,0.0,0.0,1821417,Resting heart rate,0.202317068,1,GeneticVariation
9049,AIP,aryl hydrocarbon receptor interacting protein,0.0,0.0,1.0,0.0,0.0,221406,Pituitary ACTH Hypersecretion,0.202317068,1,GeneticVariation
4519,CYTB,cytochrome b,0.0,0.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.202317068,1,GeneticVariation
4539,ND4L,"NADH dehydrogenase, subunit 4L (complex I)",0.0,0.0,1.0,0.0,0.0,1527249,Colorectal Cancer,0.202317068,1,GeneticVariation
9227,LRAT,lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase),0.0,0.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.202317068,1,GeneticVariation
2747,GLUD2,glutamate dehydrogenase 2,0.0,0.0,1.0,0.0,0.0,30567,Parkinson Disease,0.202317068,1,GeneticVariation
657,BMPR1A,"bone morphogenetic protein receptor, type IA",0.0,0.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.202317068,1,GeneticVariation
4089,SMAD4,SMAD family member 4,0.0,0.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.202317068,1,GeneticVariation
2296,FOXC1,forkhead box C1,0.0,1.0,1.0,0.0,0.0,266548,Axenfeld anomaly,0.202268037,8,"Biomarker, GeneticVariation"
1586,CYP17A1,"cytochrome P450, family 17, subfamily A, polypeptide 1",0.0,1.0,1.0,0.0,0.0,3277849,"17,20-Lyase Deficiency, Isolated",0.202268037,8,"Biomarker, GeneticVariation"
83990,BRIP1,BRCA1 interacting protein C-terminal helicase 1,0.0,1.0,1.0,0.0,0.0,346153,"Breast Cancer, Familial",0.202268037,8,"Biomarker, GeneticVariation"
3040,HBA2,"hemoglobin, alpha 2",0.0,1.0,1.0,0.0,0.0,472762,Alpha trait thalassemia,0.202268037,8,"Biomarker, GeneticVariation"
4647,MYO7A,myosin VIIA,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.202268037,8,"Biomarker, GeneticVariation"
2200,FBN1,fibrillin 1,0.0,1.0,1.0,0.0,0.0,1851286,Ectopia lentis isolated,0.201984532,7,"Biomarker, GeneticVariation"
3753,KCNE1,"potassium channel, voltage gated subfamily E regulatory beta subunit 1",0.0,1.0,1.0,0.0,0.0,1141890,Congenital long QT syndrome,0.201984532,7,"Biomarker, GeneticVariation"
6794,STK11,serine/threonine kinase 11,0.0,1.0,1.0,0.0,0.0,235974,Pancreatic Carcinoma,0.201984532,7,"Biomarker, GeneticVariation"
10585,POMT1,protein-O-mannosyltransferase 1,0.0,1.0,1.0,0.0,0.0,699743,Congenital muscular dystrophy,0.201984532,7,"Biomarker, GeneticVariation"
29954,POMT2,protein-O-mannosyltransferase 2,0.0,1.0,1.0,0.0,0.0,699743,Congenital muscular dystrophy,0.201984532,7,"Biomarker, GeneticVariation"
91147,TMEM67,transmembrane protein 67,0.0,1.0,1.0,0.0,0.0,265215,Meckel-Gruber syndrome,0.201984532,7,"Biomarker, GeneticVariation"
100151683,RNU4ATAC,"RNA, U4atac small nuclear (U12-dependent splicing)",0.0,1.0,1.0,0.0,0.0,1859452,"Microcephalic osteodysplastic primordial dwarfism, type 1",0.201984532,7,"Biomarker, GeneticVariation"
57716,PRX,periaxin,0.0,1.0,1.0,0.0,0.0,11195,dejerine-sottas disease,0.201984532,7,"Biomarker, GeneticVariation"
335,APOA1,apolipoprotein A-I,0.0,1.0,1.0,0.0,0.0,1704429,Familial hypoalphalipoproteinemia,0.201984532,7,"Biomarker, GeneticVariation"
23322,RPGRIP1L,RPGRIP1-like,0.0,1.0,1.0,0.0,0.0,431399,Agenesis of Cerebellar Vermis,0.201984532,7,"Biomarker, GeneticVariation"
1371,CPOX,coproporphyrinogen oxidase,0.0,1.0,1.0,0.0,0.0,342859,Harderoporphyria,0.201984532,7,"Biomarker, GeneticVariation"
5205,ATP8B1,"ATPase, aminophospholipid transporter, class I, type 8B, member 1",0.0,1.0,1.0,0.0,0.0,268318,Intrahepatic Cholestasis of Pregnancy,0.201701027,6,"Biomarker, GeneticVariation"
8313,AXIN2,axin 2,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.201701027,6,"Biomarker, GeneticVariation"
10002,NR2E3,"nuclear receptor subfamily 2, group E, member 3",0.0,1.0,1.0,0.0,0.0,339541,Goldmann-Favre syndrome,0.201701027,6,"Biomarker, GeneticVariation"
2006,ELN,elastin,0.0,1.0,1.0,0.0,0.0,268350,"Cutis Laxa, Autosomal Dominant",0.201701027,6,"Biomarker, GeneticVariation"
50945,TBX22,T-box 22,0.0,1.0,1.0,0.0,0.0,1844831,Cleft Palate with Ankyloglossia,0.201701027,6,"Biomarker, GeneticVariation"
29123,ANKRD11,ankyrin repeat domain 11,0.0,1.0,1.0,0.0,0.0,220687,KBG syndrome,0.201701027,6,"Biomarker, GeneticVariation"
2334,AFF2,"AF4/FMR2 family, member 2",0.0,1.0,1.0,0.0,0.0,751157,FRAXE,0.201701027,6,"Biomarker, GeneticVariation"
5573,PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha",0.0,1.0,1.0,0.0,0.0,220659,Acrodysostosis,0.201701027,6,"Biomarker, GeneticVariation"
5309,PITX3,paired-like homeodomain 3,0.0,1.0,1.0,0.0,0.0,9691,Congenital cataract,0.201701027,6,"Biomarker, GeneticVariation"
55624,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",0.0,1.0,1.0,0.0,0.0,699743,Congenital muscular dystrophy,0.201701027,6,"Biomarker, GeneticVariation"
203228,C9orf72,chromosome 9 open reading frame 72,0.0,1.0,1.0,0.0,0.0,1862937,Frontotemporal Dementia With Motor Neuron Disease,0.201701027,6,"Biomarker, GeneticVariation"
6662,SOX9,SRY (sex determining region Y)-box 9,0.0,1.0,1.0,0.0,0.0,1861923,Acampomelic Campomelic Dysplasia,0.201701027,6,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,1.0,1.0,0.0,0.0,542428,Hypochondrogenesis,0.201701027,6,"Biomarker, GeneticVariation"
1786,DNMT1,DNA (cytosine-5-)-methyltransferase 1,0.0,1.0,1.0,0.0,0.0,1858804,"Cerebellar Ataxia, Deafness, and Narcolepsy",0.201701027,6,"Biomarker, GeneticVariation"
4437,MSH3,mutS homolog 3,0.0,1.0,1.0,0.0,0.0,476089,Endometrial Carcinoma,0.201701027,6,"Biomarker, GeneticVariation"
1727,CYB5R3,cytochrome b5 reductase 3,0.0,1.0,1.0,0.0,0.0,2749559,"Methemoglobinemia, Type I",0.201701027,6,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,858252,Breast Adenocarcinoma,0.201701027,6,"Biomarker, GeneticVariation"
5155,PDGFB,platelet-derived growth factor beta polypeptide,0.0,1.0,1.0,0.0,0.0,25286,Meningioma,0.201701027,6,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.201701027,6,"Biomarker, GeneticVariation"
10395,DLC1,DLC1 Rho GTPase activating protein,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.201417523,5,"Biomarker, GeneticVariation"
5795,PTPRJ,"protein tyrosine phosphatase, receptor type, J",0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.201417523,5,"Biomarker, GeneticVariation"
3757,KCNH2,"potassium channel, voltage gated eag related subfamily H, member 2",0.0,1.0,1.0,0.0,0.0,2732979,Acquired long QT syndrome,0.201417523,5,"Biomarker, GeneticVariation"
1778,DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1",0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.201417523,5,"Biomarker, GeneticVariation"
80184,CEP290,centrosomal protein 290kDa,0.0,1.0,1.0,0.0,0.0,265215,Meckel-Gruber syndrome,0.201417523,5,"Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,2878,"Anemia, Hemolytic",0.201417523,5,"Biomarker, GeneticVariation"
6392,SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein",0.0,1.0,1.0,0.0,0.0,7279,Carotid Body Tumor,0.201417523,5,"Biomarker, GeneticVariation"
8452,CUL3,cullin 3,0.0,1.0,1.0,0.0,0.0,1449844,"Pseudohypoaldosteronism, type 2",0.201417523,5,"Biomarker, GeneticVariation"
23522,KAT6B,K(lysine) acetyltransferase 6B,0.0,1.0,1.0,0.0,0.0,1853566,Genitopatellar Syndrome,0.201417523,5,"Biomarker, GeneticVariation"
4538,ND4,"NADH dehydrogenase, subunit 4 (complex I)",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.201417523,5,"Biomarker, GeneticVariation"
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.201134018,4,"Biomarker, GeneticVariation"
3766,KCNJ10,"potassium channel, inwardly rectifying subfamily J, member 10",0.0,1.0,1.0,0.0,0.0,1863752,Enlarged Vestibular Aqueduct,0.201134018,4,"Biomarker, GeneticVariation"
9992,KCNE2,"potassium channel, voltage gated subfamily E regulatory beta subunit 2",0.0,1.0,1.0,0.0,0.0,1141890,Congenital long QT syndrome,0.201134018,4,"Biomarker, GeneticVariation"
57190,SEPN1,"selenoprotein N, 1",0.0,1.0,1.0,0.0,0.0,546264,Congenital Fiber-Type Disproportion,0.201134018,4,"Biomarker, GeneticVariation"
1727,CYB5R3,cytochrome b5 reductase 3,1.0,1.0,1.0,0.0,0.0,2749560,"Methemoglobinemia, Type Ii",0.201134018,4,"AlteredExpression, Biomarker, GeneticVariation"
410,ARSA,arylsulfatase A,0.0,1.0,1.0,0.0,0.0,751276,"Metachromatic leukodystrophy, juvenile type",0.201134018,4,"Biomarker, GeneticVariation"
282996,RBM20,RNA binding motif protein 20,0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.201134018,4,"Biomarker, GeneticVariation"
27235,COQ2,coenzyme Q2 4-hydroxybenzoate polyprenyltransferase,0.0,1.0,1.0,0.0,0.0,1843920,Coenzyme Q10 Deficiency,0.201134018,4,"Biomarker, GeneticVariation"
10847,SRCAP,Snf2-related CREBBP activator protein,0.0,1.0,1.0,0.0,0.0,729582,Floating-harbor syndrome,0.201134018,4,"Biomarker, GeneticVariation"
8643,PTCH2,patched 2,0.0,1.0,1.0,0.0,0.0,4779,Basal Cell Nevus Syndrome,0.201134018,4,"Biomarker, GeneticVariation"
768206,PRCD,progressive rod-cone degeneration,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.201134018,4,"Biomarker, GeneticVariation"
4117,MAK,male germ cell-associated kinase,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.201134018,4,"Biomarker, GeneticVariation"
23020,SNRNP200,small nuclear ribonucleoprotein 200kDa (U5),0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.201134018,4,"Biomarker, GeneticVariation"
132884,EVC2,Ellis van Creveld syndrome 2,0.0,1.0,1.0,0.0,0.0,457013,Weyers acrofacial dysostosis,0.201134018,4,"Biomarker, GeneticVariation"
582,BBS1,Bardet-Biedl syndrome 1,0.0,1.0,1.0,0.0,0.0,2936862,Bardet-Biedl syndrome 1,0.201134018,4,"Biomarker, GeneticVariation"
26249,KLHL3,kelch-like family member 3,0.0,1.0,1.0,0.0,0.0,1449844,"Pseudohypoaldosteronism, type 2",0.201134018,4,"Biomarker, GeneticVariation"
406960,MIR184,microRNA 184,0.0,1.0,1.0,0.0,0.0,3280392,EDICT SYNDROME,0.201134018,4,"Biomarker, GeneticVariation"
410,ARSA,arylsulfatase A,0.0,1.0,1.0,0.0,0.0,751279,"Metachromatic leukodystrophy, adult type",0.201134018,4,"Biomarker, GeneticVariation"
7157,TP53,tumor protein p53,0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.201134018,4,"Biomarker, GeneticVariation"
1778,DYNC1H1,"dynein, cytoplasmic 1, heavy chain 1",0.0,1.0,1.0,0.0,0.0,26847,"Muscular Atrophy, Spinal",0.201134018,4,"Biomarker, GeneticVariation"
22852,ANKRD26,ankyrin repeat domain 26,0.0,1.0,1.0,0.0,0.0,1861185,Thrombocytopenia chromosome breakage,0.200850514,3,"Biomarker, GeneticVariation"
2033,EP300,E1A binding protein p300,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.200850514,3,"Biomarker, GeneticVariation"
1261,CNGA3,cyclic nucleotide gated channel alpha 3,0.0,1.0,1.0,0.0,0.0,302129,Achromatopsia 1,0.200850514,3,"Biomarker, GeneticVariation"
3508,IGHMBP2,immunoglobulin mu binding protein 2,0.0,1.0,1.0,0.0,0.0,43116,Werdnig-Hoffmann Disease,0.200850514,3,"Biomarker, GeneticVariation"
57514,ARHGAP31,Rho GTPase activating protein 31,0.0,1.0,1.0,0.0,0.0,265268,Adams Oliver syndrome,0.200850514,3,"Biomarker, GeneticVariation"
4041,LRP5,low density lipoprotein receptor-related protein 5,0.0,1.0,1.0,0.0,0.0,432272,Hyperostosis corticalis generalisata,0.200850514,3,"Biomarker, GeneticVariation"
5243,ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",0.0,1.0,1.0,0.0,0.0,1861502,COLCHICINE RESISTANCE,0.200850514,3,"Biomarker, GeneticVariation"
846,CASR,calcium-sensing receptor,0.0,1.0,1.0,0.0,0.0,1809471,Familial benign hypercalcemia,0.200850514,3,"Biomarker, GeneticVariation"
8929,PHOX2B,paired-like homeobox 2b,0.0,1.0,1.0,0.0,0.0,1859049,CCHS WITH HIRSCHSPRUNG DISEASE,0.200850514,3,"Biomarker, GeneticVariation"
91,ACVR1B,"activin A receptor, type IB",0.0,1.0,1.0,0.0,0.0,235974,Pancreatic Carcinoma,0.200850514,3,"Biomarker, GeneticVariation"
284058,KANSL1,KAT8 regulatory NSL complex subunit 1,0.0,0.0,1.0,0.0,0.0,1864871,Chromosome 17q21.31 Deletion Syndrome,0.200850514,3,GeneticVariation
355,FAS,Fas cell surface death receptor,0.0,1.0,1.0,0.0,0.0,1866119,"Autoimmune Lymphoproliferative Syndrome, Type IA",0.200850514,3,"Biomarker, GeneticVariation"
2263,FGFR2,fibroblast growth factor receptor 2,0.0,1.0,1.0,0.0,0.0,175699,Saethre-Chotzen Syndrome,0.200850514,3,"Biomarker, GeneticVariation"
1301,COL11A1,"collagen, type XI, alpha 1",0.0,1.0,1.0,0.0,0.0,265282,Fibrochondrogenesis,0.200850514,3,"Biomarker, GeneticVariation"
1832,DSP,desmoplakin,0.0,1.0,1.0,0.0,0.0,7193,"Cardiomyopathy, Dilated",0.200850514,3,"Biomarker, GeneticVariation"
4893,NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,0.0,1.0,1.0,0.0,0.0,7131,"Carcinoma, Non-Small-Cell Lung",0.200850514,3,"Biomarker, GeneticVariation"
7251,TSG101,tumor susceptibility 101,0.0,1.0,1.0,0.0,0.0,346153,"Breast Cancer, Familial",0.200850514,3,"Biomarker, GeneticVariation"
10262,SF3B4,"splicing factor 3b, subunit 4, 49kDa",0.0,1.0,1.0,0.0,0.0,265245,"Acrofacial dysostosis, Nager type",0.200850514,3,"Biomarker, GeneticVariation"
23414,ZFPM2,"zinc finger protein, FOG family member 2",0.0,1.0,1.0,0.0,0.0,13069,Double Outlet Right Ventricle,0.200850514,3,"Biomarker, GeneticVariation"
51684,SUFU,suppressor of fused homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,751291,Desmoplastic medulloblastoma,0.200850514,3,"Biomarker, GeneticVariation"
7421,VDR,"vitamin D (1,25- dihydroxyvitamin D3) receptor",0.0,1.0,1.0,0.0,0.0,268690,"Rickets, Hereditary Vitamin D-Resistant",0.200850514,3,"Biomarker, GeneticVariation"
3107,HLA-C,"major histocompatibility complex, class I, C",0.0,1.0,1.0,0.0,0.0,1867449,PSORIASIS SUSCEPTIBILITY 1,0.200850514,3,"Biomarker, GeneticVariation"
5696,PSMB8,"proteasome (prosome, macropain) subunit, beta type, 8",0.0,1.0,1.0,0.0,0.0,1850568,Nakajo syndrome,0.200850514,3,"Biomarker, GeneticVariation"
5290,PIK3CA,"phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha",0.0,1.0,1.0,0.0,0.0,334082,Epidermal Nevus,0.200850514,3,"Biomarker, GeneticVariation"
4968,OGG1,8-oxoguanine DNA glycosylase,0.0,1.0,1.0,0.0,0.0,279702,Hypernephroma,0.200850514,3,"Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,0.0,1.0,0.0,0.0,1960469,Left ventricular noncompaction,0.200850514,3,GeneticVariation
3067,HDC,histidine decarboxylase,0.0,1.0,1.0,0.0,0.0,40517,Tourette Syndrome,0.200850514,3,"Biomarker, GeneticVariation"
9180,OSMR,oncostatin M receptor,0.0,1.0,1.0,0.0,0.0,268397,"Amyloidosis, Primary Cutaneous",0.200850514,3,"Biomarker, GeneticVariation"
4519,CYTB,cytochrome b,0.0,1.0,1.0,0.0,0.0,559758,Multisystem disorder,0.200850514,3,"Biomarker, GeneticVariation"
650,BMP2,bone morphogenetic protein 2,0.0,1.0,1.0,0.0,0.0,1832702,Brachydactyly type A2,0.200850514,3,"Biomarker, GeneticVariation"
178,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1.0,0.0,1.0,0.0,0.0,1968740,Glycogen Storage Disease IIIB,0.200850514,3,"AlteredExpression, GeneticVariation"
27235,COQ2,coenzyme Q2 4-hydroxybenzoate polyprenyltransferase,0.0,1.0,1.0,0.0,0.0,37019,Shy-Drager Syndrome,0.200850514,3,"Biomarker, GeneticVariation"
4541,ND6,"NADH dehydrogenase, subunit 6 (complex I)",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.200850514,3,"Biomarker, GeneticVariation"
178,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1.0,1.0,1.0,0.0,0.0,1968739,Glycogen Storage Disease IIIA,0.200850514,3,"AlteredExpression, Biomarker, GeneticVariation"
2623,GATA1,GATA binding protein 1 (globin transcription factor 1),0.0,1.0,1.0,0.0,0.0,1845837,Dyserythropoietic Anemia with Thrombocytopenia,0.200850514,3,"Biomarker, GeneticVariation"
270,AMPD1,adenosine monophosphate deaminase 1,0.0,1.0,1.0,0.0,0.0,268123,Muscle AMP deaminase deficiency,0.200567009,2,"Biomarker, GeneticVariation"
23522,KAT6B,K(lysine) acetyltransferase 6B,0.0,1.0,1.0,0.0,0.0,1863557,Young Simpson syndrome,0.200567009,2,"Biomarker, GeneticVariation"
8915,BCL10,B-cell CLL/lymphoma 10,0.0,1.0,1.0,0.0,0.0,25500,Mesothelioma,0.200567009,2,"Biomarker, GeneticVariation"
8915,BCL10,B-cell CLL/lymphoma 10,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.200567009,2,"Biomarker, GeneticVariation"
5782,PTPN12,"protein tyrosine phosphatase, non-receptor type 12",0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.200567009,2,"Biomarker, GeneticVariation"
11152,WDR45,WD repeat domain 45,0.0,0.0,1.0,0.0,0.0,3550973,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5,0.200567009,2,GeneticVariation
9244,CRLF1,cytokine receptor-like factor 1,0.0,1.0,1.0,0.0,0.0,1848947,Cold-Induced Sweating Syndrome 1,0.200567009,2,"Biomarker, GeneticVariation"
6794,STK11,serine/threonine kinase 11,0.0,1.0,1.0,0.0,0.0,153594,Testicular Cancer,0.200567009,2,"Biomarker, GeneticVariation"
3815,KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,0.0,1.0,1.0,0.0,0.0,153594,Testicular Cancer,0.200567009,2,"Biomarker, GeneticVariation"
718,C3,complement component 3,0.0,1.0,1.0,0.0,0.0,1332655,C3 Deficiency,0.200567009,2,"Biomarker, GeneticVariation"
55750,AGK,acylglycerol kinase,0.0,1.0,1.0,0.0,0.0,1859317,Cataract and cardiomyopathy,0.200567009,2,"Biomarker, GeneticVariation"
59341,TRPV4,"transient receptor potential cation channel, subfamily V, member 4",0.0,1.0,1.0,0.0,0.0,2079540,"Charcot-Marie-Tooth disease, Type 2C",0.200567009,2,"Biomarker, GeneticVariation"
28234,SLCO1B3,"solute carrier organic anion transporter family, member 1B3",0.0,1.0,1.0,0.0,0.0,220991,Rotor syndrome,0.200567009,2,"Biomarker, GeneticVariation"
3043,HBB,"hemoglobin, beta",0.0,1.0,1.0,0.0,0.0,1527405,Erythrocytosis,0.200567009,2,"Biomarker, GeneticVariation"
3040,HBA2,"hemoglobin, alpha 2",0.0,1.0,1.0,0.0,0.0,1527405,Erythrocytosis,0.200567009,2,"Biomarker, GeneticVariation"
4221,MEN1,multiple endocrine neoplasia I,0.0,1.0,1.0,0.0,0.0,280089,Carcinoid tumor of lung,0.200567009,2,"Biomarker, GeneticVariation"
2760,GM2A,GM2 ganglioside activator,0.0,1.0,1.0,0.0,0.0,39373,Tay-Sachs Disease,0.200567009,2,"Biomarker, GeneticVariation"
4297,KMT2A,lysine (K)-specific methyltransferase 2A,0.0,1.0,1.0,0.0,0.0,1854630,Growth Deficiency and Mental Retardation with Facial Dysmorphism,0.200567009,2,"Biomarker, GeneticVariation"
84168,ANTXR1,anthrax toxin receptor 1,0.0,1.0,1.0,0.0,0.0,406723,"Growth retardation, Alopecia, Pseudoanodontia and Optic atrophy",0.200567009,2,"Biomarker, GeneticVariation"
8398,PLA2G6,"phospholipase A2, group VI (cytosolic, calcium-independent)",0.0,1.0,1.0,0.0,0.0,2750220,Karak Syndrome,0.200567009,2,"Biomarker, GeneticVariation"
79641,ROGDI,rogdi homolog (Drosophila),0.0,1.0,1.0,0.0,0.0,406740,Kohlschutter Tonz syndrome,0.200567009,2,"Biomarker, GeneticVariation"
1785,DNM2,dynamin 2,0.0,1.0,1.0,0.0,0.0,410203,"Myotubular myopathy, X-linked",0.200567009,2,"Biomarker, GeneticVariation"
6331,SCN5A,"sodium channel, voltage gated, type V alpha subunit",0.0,1.0,1.0,0.0,0.0,2732979,Acquired long QT syndrome,0.200567009,2,"Biomarker, GeneticVariation"
9095,TBX19,T-box 19,0.0,1.0,1.0,0.0,0.0,342388,Adrenocorticotropic hormone deficiency,0.200567009,2,"Biomarker, GeneticVariation"
3299,HSF4,heat shock transcription factor 4,0.0,1.0,1.0,0.0,0.0,266537,Congenital lamellar cataract,0.200567009,2,"Biomarker, GeneticVariation"
2643,GCH1,GTP cyclohydrolase 1,0.0,1.0,1.0,0.0,0.0,2673535,"Segawa syndrome, autosomal recessive",0.200567009,2,"Biomarker, GeneticVariation"
145258,GSC,goosecoid homeobox,0.0,1.0,1.0,0.0,0.0,1865361,"Short Stature, Auditory Canal Atresia, Mandibular Hypoplasia, Skeletal Abnormalities",0.200567009,2,"Biomarker, GeneticVariation"
847,CAT,catalase,0.0,1.0,1.0,0.0,0.0,2936847,Acatalasemia Japanese type,0.200567009,2,"Biomarker, GeneticVariation"
4175,MCM6,minichromosome maintenance complex component 6,0.0,1.0,1.0,0.0,0.0,1857231,LACTASE PERSISTENCE,0.200567009,2,"Biomarker, GeneticVariation"
4683,NBN,nibrin,0.0,0.0,1.0,0.0,0.0,2874,"Anemia, Aplastic",0.200567009,2,GeneticVariation
2243,FGA,fibrinogen alpha chain,0.0,0.0,1.0,0.0,0.0,1260903,Dysfibrinogenemia,0.200567009,2,GeneticVariation
54585,LZTFL1,leucine zipper transcription factor-like 1,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.200567009,2,"Biomarker, GeneticVariation"
356,FASLG,"Fas ligand (TNF superfamily, member 6)",0.0,1.0,0.0,0.0,0.0,11854,"Diabetes Mellitus, Type 1",0.200567009,3,Biomarker
154288,KHDC3L,"KH domain containing 3-like, subcortical maternal complex member",0.0,1.0,1.0,0.0,0.0,678213,Complete hydatidiform mole,0.200567009,2,"Biomarker, GeneticVariation"
7439,BEST1,bestrophin 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.200567009,2,"Biomarker, GeneticVariation"
9782,MATR3,matrin 3,0.0,1.0,1.0,0.0,0.0,1853723,"Myopathy, Distal 2",0.200567009,2,"Biomarker, GeneticVariation"
3074,HEXB,hexosaminidase B (beta polypeptide),0.0,1.0,1.0,0.0,0.0,751490,Infantile Sandhoff Disease,0.200567009,2,"Biomarker, GeneticVariation"
2627,GATA6,GATA binding protein 6,0.0,1.0,1.0,0.0,0.0,41207,"Truncus Arteriosus, Persistent",0.200567009,2,"Biomarker, GeneticVariation"
4053,LTBP2,latent transforming growth factor beta binding protein 2,0.0,1.0,1.0,0.0,0.0,339573,"Glaucoma, Primary Open Angle",0.200567009,2,"Biomarker, GeneticVariation"
64327,LMBR1,limb development membrane protein 1,0.0,1.0,1.0,0.0,0.0,241397,Triphalangeal Thumb,0.200567009,2,"Biomarker, GeneticVariation"
51151,SLC45A2,"solute carrier family 45, member 2",0.0,1.0,1.0,0.0,0.0,151779,"Melanoma, Cutaneous Malignant",0.200567009,2,"Biomarker, GeneticVariation"
324,APC,adenomatous polyposis coli,0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.200567009,2,"Biomarker, GeneticVariation"
1029,CDKN2A,cyclin-dependent kinase inhibitor 2A,0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.200567009,2,"Biomarker, GeneticVariation"
4292,MLH1,mutL homolog 1,0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.200567009,2,"Biomarker, GeneticVariation"
4436,MSH2,mutS homolog 2,0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.200567009,2,"Biomarker, GeneticVariation"
54507,ADAMTSL4,ADAMTS-like 4,0.0,1.0,1.0,0.0,0.0,1644196,Ectopia Lentis with Ectopia of Pupil,0.200567009,2,"Biomarker, GeneticVariation"
4566,TRNK,tRNA,0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.200567009,2,"Biomarker, GeneticVariation"
4535,ND1,"NADH dehydrogenase, subunit 1 (complex I)",0.0,0.0,1.0,0.0,0.0,23264,Leigh Disease,0.200567009,2,GeneticVariation
4514,COX3,cytochrome c oxidase III,0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.200567009,2,"Biomarker, GeneticVariation"
100134444,KCNJ18,"potassium channel, inwardly rectifying subfamily J, member 18",0.0,1.0,1.0,0.0,0.0,268446,Thyrotoxic periodic paralysis,0.200567009,2,"Biomarker, GeneticVariation"
2073,ERCC5,excision repair cross-complementation group 5,0.0,1.0,1.0,0.0,0.0,1968561,"Xeroderma Pigmentosum, Type G/Cockayne Syndrome",0.200567009,2,"Biomarker, GeneticVariation"
1641,DCX,doublecortin,0.0,1.0,1.0,0.0,0.0,1848070,Lissencephaly and agenesis of corpus callosum,0.200567009,2,"Biomarker, GeneticVariation"
3198,HOXA1,homeobox A1,0.0,1.0,1.0,0.0,0.0,1832216,Bosley-Salih-Alorainy Syndrome,0.200567009,2,"Biomarker, GeneticVariation"
644,BLVRA,biliverdin reductase A,0.0,1.0,1.0,0.0,0.0,3279964,HYPERBILIVERDINEMIA,0.200283505,1,"Biomarker, GeneticVariation"
10312,TCIRG1,"T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3",0.0,1.0,1.0,0.0,0.0,340970,Congenital neutropenia,0.200283505,1,"Biomarker, GeneticVariation"
92579,G6PC3,"glucose 6 phosphatase, catalytic, 3",0.0,1.0,1.0,0.0,0.0,2751630,Dursun Syndrome,0.200283505,1,"Biomarker, GeneticVariation"
201163,FLCN,folliculin,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.200283505,1,"Biomarker, GeneticVariation"
27030,MLH3,mutL homolog 3,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.200283505,1,"Biomarker, GeneticVariation"
25788,RAD54B,RAD54 homolog B (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.200283505,1,"Biomarker, GeneticVariation"
701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.200283505,1,"Biomarker, GeneticVariation"
4163,MCC,mutated in colorectal cancers,0.0,1.0,1.0,0.0,0.0,699790,Colon Carcinoma,0.200283505,1,"Biomarker, GeneticVariation"
8260,NAA10,"N(alpha)-acetyltransferase 10, NatA catalytic subunit",0.0,1.0,1.0,0.0,0.0,796016,"Microphthalmia, syndromic 1",0.200283505,1,"Biomarker, GeneticVariation"
7372,UMPS,uridine monophosphate synthetase,0.0,1.0,1.0,0.0,0.0,268128,Orotic aciduria,0.200283505,1,"Biomarker, GeneticVariation"
26123,TCTN3,tectonic family member 3,0.0,0.0,1.0,0.0,0.0,406727,Orofaciodigital syndrome 4,0.200283505,1,GeneticVariation
60681,FKBP10,"FK506 binding protein 10, 65 kDa",0.0,1.0,1.0,0.0,0.0,3151218,"OSTEOGENESIS IMPERFECTA, TYPE XI",0.200283505,1,"Biomarker, GeneticVariation"
4558,TRNF,tRNA,0.0,0.0,1.0,0.0,0.0,162672,MERRF Syndrome,0.200283505,1,GeneticVariation
4053,LTBP2,latent transforming growth factor beta binding protein 2,0.0,1.0,1.0,0.0,0.0,1562061,Microspherophakia,0.200283505,1,"Biomarker, GeneticVariation"
249,ALPL,"alkaline phosphatase, liver/bone/kidney",0.0,1.0,1.0,0.0,0.0,1840322,Odontohypophosphatasia,0.200283505,1,"Biomarker, GeneticVariation"
1280,COL2A1,"collagen, type II, alpha 1",0.0,0.0,1.0,0.0,0.0,1836081,"Rhegmatogenous Retinal Detachment, Autosomal Dominant",0.200283505,1,GeneticVariation
51256,TBC1D7,"TBC1 domain family, member 7",0.0,1.0,1.0,0.0,0.0,221355,Megalencephaly,0.200283505,1,"Biomarker, GeneticVariation"
10599,SLCO1B1,"solute carrier organic anion transporter family, member 1B1",0.0,1.0,1.0,0.0,0.0,220991,Rotor syndrome,0.200283505,1,"Biomarker, GeneticVariation"
4851,NOTCH1,notch 1,0.0,1.0,1.0,0.0,0.0,265268,Adams Oliver syndrome,0.200283505,1,"Biomarker, GeneticVariation"
26873,OPLAH,5-oxoprolinase (ATP-hydrolysing),0.0,1.0,1.0,0.0,0.0,268525,5-oxoprolinase deficiency,0.200283505,1,"Biomarker, GeneticVariation"
10019,SH2B3,SH2B adaptor protein 3,0.0,1.0,1.0,0.0,0.0,40028,"Thrombocythemia, Essential",0.200283505,1,"Biomarker, GeneticVariation"
92935,MARS2,"methionyl-tRNA synthetase 2, mitochondrial",0.0,1.0,1.0,0.0,0.0,1969645,"Ataxia, Spastic, 3, Autosomal Recessive",0.200283505,1,"Biomarker, GeneticVariation"
776,CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",0.0,1.0,1.0,0.0,0.0,3554018,SINOATRIAL NODE DYSFUNCTION AND DEAFNESS,0.200283505,1,"Biomarker, GeneticVariation"
79365,BHLHE41,"basic helix-loop-helix family, member e41",0.0,0.0,1.0,0.0,0.0,751509,Short-sleeper,0.200283505,1,GeneticVariation
26610,ELP4,elongator acetyltransferase complex subunit 4,0.0,1.0,1.0,0.0,0.0,3076,Aniridia,0.200283505,1,"Biomarker, GeneticVariation"
4625,MYH7,"myosin, heavy chain 7, cardiac muscle, beta",0.0,1.0,1.0,0.0,0.0,546264,Congenital Fiber-Type Disproportion,0.200283505,1,"Biomarker, GeneticVariation"
88,ACTN2,"actinin, alpha 2",0.0,0.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.200283505,1,GeneticVariation
7840,ALMS1,Alstrom syndrome 1,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.200283505,1,"Biomarker, GeneticVariation"
79188,TMEM43,transmembrane protein 43,0.0,1.0,1.0,0.0,0.0,878544,Cardiomyopathies,0.200283505,1,"Biomarker, GeneticVariation"
581,BAX,BCL2-associated X protein,0.0,1.0,1.0,0.0,0.0,1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.200283505,1,"Biomarker, GeneticVariation"
1373,CPS1,"carbamoyl-phosphate synthase 1, mitochondrial",0.0,1.0,1.0,0.0,0.0,32768,"Neuralgia, Postherpetic",0.200283505,1,"Biomarker, GeneticVariation"
4535,ND1,"NADH dehydrogenase, subunit 1 (complex I)",0.0,1.0,1.0,0.0,0.0,38644,Sudden Infant Death,0.200283505,1,"Biomarker, GeneticVariation"
100131801,PET100,PET100 homolog (S. cerevisiae),0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.200283505,1,"Biomarker, GeneticVariation"
84334,APOPT1,"apoptogenic 1, mitochondrial",0.0,1.0,1.0,0.0,0.0,268237,Cytochrome-c Oxidase Deficiency,0.200283505,1,"Biomarker, GeneticVariation"
201163,FLCN,folliculin,0.0,1.0,1.0,0.0,0.0,1266042,Chromophobe Renal Cell Carcinoma,0.200283505,1,"Biomarker, GeneticVariation"
6928,HNF1B,HNF1 homeobox B,0.0,1.0,1.0,0.0,0.0,1266042,Chromophobe Renal Cell Carcinoma,0.200283505,1,"Biomarker, GeneticVariation"
4053,LTBP2,latent transforming growth factor beta binding protein 2,0.0,1.0,1.0,0.0,0.0,20302,Hydrophthalmos,0.200283505,1,"Biomarker, GeneticVariation"
5376,PMP22,peripheral myelin protein 22,0.0,1.0,1.0,0.0,0.0,1861669,Charcot-Marie-Tooth disease and deafness,0.200283505,1,"Biomarker, GeneticVariation"
6948,TCN2,transcobalamin II,0.0,1.0,1.0,0.0,0.0,342701,Transcobalamin II deficiency,0.200283505,1,"Biomarker, GeneticVariation"
10528,NOP56,NOP56 ribonucleoprotein,0.0,1.0,1.0,0.0,0.0,3472711,SPINOCEREBELLAR ATAXIA 36,0.200283505,1,"Biomarker, GeneticVariation"
1282,COL4A1,"collagen, type IV, alpha 1",0.0,1.0,1.0,0.0,0.0,266484,Schizencephaly,0.200283505,1,"Biomarker, GeneticVariation"
360,AQP3,aquaporin 3 (Gill blood group),0.0,1.0,1.0,0.0,0.0,1843889,GIL BLOOD GROUP,0.200283505,1,"Biomarker, GeneticVariation"
2316,FLNA,"filamin A, alpha",0.0,1.0,1.0,0.0,0.0,2748918,Otopalatodigital Spectrum Disorder,0.200283505,1,"Biomarker, GeneticVariation"
1292,COL6A2,"collagen, type VI, alpha 2",0.0,1.0,1.0,0.0,0.0,699743,Congenital muscular dystrophy,0.200283505,1,"Biomarker, GeneticVariation"
3679,ITGA7,"integrin, alpha 7",0.0,1.0,1.0,0.0,0.0,699743,Congenital muscular dystrophy,0.200283505,1,"Biomarker, GeneticVariation"
860,RUNX2,runt-related transcription factor 2,0.0,1.0,1.0,0.0,0.0,1834969,Metaphyseal Dysplasia with Maxillary Hypoplasia and Brachydactyly,0.200283505,1,"Biomarker, GeneticVariation"
2261,FGFR3,fibroblast growth factor receptor 3,0.0,0.0,1.0,0.0,0.0,175699,Saethre-Chotzen Syndrome,0.200283505,1,GeneticVariation
3239,HOXD13,homeobox D13,0.0,1.0,1.0,0.0,0.0,1735591,VACTERL association,0.200283505,1,"Biomarker, GeneticVariation"
4572,TRNQ,tRNA,0.0,1.0,1.0,0.0,0.0,162671,MELAS Syndrome,0.200283505,1,"Biomarker, GeneticVariation"
5428,POLG,"polymerase (DNA directed), gamma",0.0,1.0,1.0,0.0,0.0,7959,Charcot-Marie-Tooth Disease,0.200283505,1,"Biomarker, GeneticVariation"
1392,CRH,corticotropin releasing hormone,0.0,1.0,1.0,0.0,0.0,342388,Adrenocorticotropic hormone deficiency,0.200283505,1,"Biomarker, GeneticVariation"
3073,HEXA,hexosaminidase A (alpha polypeptide),0.0,1.0,1.0,0.0,0.0,1848913,"Tay-Sachs Disease, Juvenile",0.200283505,1,"Biomarker, GeneticVariation"
2296,FOXC1,forkhead box C1,0.0,1.0,1.0,0.0,0.0,1839928,Iris hypoplasia and glaucoma,0.200283505,1,"Biomarker, GeneticVariation"
9562,MINPP1,multiple inositol-polyphosphate phosphatase 1,0.0,1.0,1.0,0.0,0.0,206682,"Adenocarcinoma, Follicular",0.200283505,1,"Biomarker, GeneticVariation"
5728,PTEN,phosphatase and tensin homolog,0.0,0.0,1.0,0.0,0.0,2749240,Vater Association With Macrocephaly And Ventriculomegaly,0.200283505,1,GeneticVariation
6261,RYR1,ryanodine receptor 1 (skeletal),0.0,1.0,1.0,0.0,0.0,1840365,King Denborough syndrome,0.200283505,1,"Biomarker, GeneticVariation"
6662,SOX9,SRY (sex determining region Y)-box 9,0.0,1.0,1.0,0.0,0.0,1842462,Campomelic Dysplasia with Autosomal Sex Reversal,0.200283505,1,"Biomarker, GeneticVariation"
132158,GLYCTK,glycerate kinase,0.0,1.0,1.0,0.0,0.0,1291386,D-glycericacidemia,0.200283505,1,"Biomarker, GeneticVariation"
112609,MRAP2,melanocortin 2 receptor accessory protein 2,0.0,1.0,1.0,0.0,0.0,28754,Obesity,0.200283505,1,"Biomarker, GeneticVariation"
57545,CC2D2A,coiled-coil and C2 domain containing 2A,0.0,1.0,1.0,0.0,0.0,265215,Meckel-Gruber syndrome,0.200283505,1,"Biomarker, GeneticVariation"
675,BRCA2,"breast cancer 2, early onset",0.0,1.0,1.0,0.0,0.0,342573,Pituitary dwarfism 1,0.200283505,1,"Biomarker, GeneticVariation"
7518,XRCC4,X-ray repair complementing defective repair in Chinese hamster cells 4,0.0,1.0,1.0,0.0,0.0,342573,Pituitary dwarfism 1,0.200283505,1,"Biomarker, GeneticVariation"
9419,CRIPT,cysteine-rich PDZ-binding protein,0.0,1.0,1.0,0.0,0.0,342573,Pituitary dwarfism 1,0.200283505,1,"Biomarker, GeneticVariation"
5426,POLE,"polymerase (DNA directed), epsilon, catalytic subunit",0.0,0.0,1.0,0.0,0.0,3554576,"FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE",0.200283505,1,GeneticVariation
50945,TBX22,T-box 22,0.0,1.0,1.0,0.0,0.0,1844862,Abruzzo Erickson syndrome,0.200283505,1,"Biomarker, GeneticVariation"
1181,CLCN2,"chloride channel, voltage-sensitive 2",0.0,1.0,1.0,0.0,0.0,393697,Epilepsy with grand mal seizures on awakening,0.200283505,1,"Biomarker, GeneticVariation"
2984,GUCY2C,guanylate cyclase 2C,0.0,1.0,1.0,0.0,0.0,270246,Meconium plug syndrome,0.200283505,1,"Biomarker, GeneticVariation"
4854,NOTCH3,notch 3,0.0,1.0,1.0,0.0,0.0,432284,"Fibromatosis, Congenital Generalized",0.200283505,1,"Biomarker, GeneticVariation"
1828,DSG1,desmoglein 1,1.0,0.0,1.0,0.0,0.0,3809719,"ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE",0.200283505,1,"AlteredExpression, GeneticVariation"
4601,MXI1,"MAX interactor 1, dimerization protein",0.0,1.0,1.0,0.0,0.0,206729,Neurofibrosarcoma,0.200283505,1,"Biomarker, GeneticVariation"
4556,TRNE,tRNA,0.0,1.0,1.0,0.0,0.0,342289,Noninsulin-dependent diabetes mellitus with deafness,0.200283505,1,"Biomarker, GeneticVariation"
79644,SRD5A3,steroid 5 alpha-reductase 3,0.0,1.0,1.0,0.0,0.0,2675185,Kahrizi Syndrome,0.200283505,1,"Biomarker, GeneticVariation"
51422,PRKAG2,"protein kinase, AMP-activated, gamma 2 non-catalytic subunit",0.0,1.0,1.0,0.0,0.0,949658,"Cardiomyopathy, Hypertrophic, Familial",0.200283505,1,"Biomarker, GeneticVariation"
4549,RNR1,s-rRNA,0.0,1.0,1.0,0.0,0.0,1838854,"Deafness, Aminoglycoside-Induced",0.200283505,1,"Biomarker, GeneticVariation"
488,ATP2A2,"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2",0.0,1.0,1.0,0.0,0.0,1852297,"Darier Disease, Segmental",0.200283505,1,"Biomarker, GeneticVariation"
477,ATP1A2,"ATPase, Na+/K+ transporting, alpha 2 polypeptide",0.0,1.0,1.0,0.0,0.0,1865323,"Migraine, Familial Basilar",0.200283505,1,"Biomarker, GeneticVariation"
26277,TINF2,TERF1 (TRF1)-interacting nuclear factor 2,0.0,1.0,1.0,0.0,0.0,2874,"Anemia, Aplastic",0.200283505,1,"Biomarker, GeneticVariation"
92482,BBIP1,BBSome interacting protein 1,0.0,1.0,1.0,0.0,0.0,752166,Bardet-Biedl Syndrome,0.200283505,1,"Biomarker, GeneticVariation"
54499,TMCO1,transmembrane and coiled-coil domains 1,0.0,1.0,1.0,0.0,0.0,1859252,Cerebrofaciothoracic Dysplasia,0.200283505,1,"Biomarker, GeneticVariation"
9897,KIAA0196,KIAA0196,0.0,1.0,1.0,0.0,0.0,796137,3C syndrome,0.200283505,1,"Biomarker, GeneticVariation"
8314,BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),0.0,1.0,1.0,0.0,0.0,3280492,TUMOR PREDISPOSITION SYNDROME,0.200283505,1,"Biomarker, GeneticVariation"
4512,COX1,cytochrome c oxidase subunit I,0.0,1.0,1.0,0.0,0.0,1838877,"Myoglobinuria, Recurrent",0.200283505,1,"Biomarker, GeneticVariation"
4053,LTBP2,latent transforming growth factor beta binding protein 2,0.0,1.0,1.0,0.0,0.0,24796,Marfan Syndrome,0.200283505,1,"Biomarker, GeneticVariation"
4758,NEU1,sialidase 1 (lysosomal sialidase),0.0,1.0,1.0,0.0,0.0,1850510,"Sialidosis, Type I",0.200283505,1,"Biomarker, GeneticVariation"
2956,MSH6,mutS homolog 6,0.0,1.0,1.0,0.0,0.0,2936783,"Colorectal cancer, hereditary nonpolyposis, type 1",0.200283505,1,"Biomarker, GeneticVariation"
24148,PRPF6,pre-mRNA processing factor 6,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.200283505,1,"Biomarker, GeneticVariation"
50939,IMPG2,interphotoreceptor matrix proteoglycan 2,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.200283505,1,"Biomarker, GeneticVariation"
94137,RP1L1,retinitis pigmentosa 1-like 1,0.0,1.0,1.0,0.0,0.0,35334,Retinitis Pigmentosa,0.200283505,1,"Biomarker, GeneticVariation"
55033,FKBP14,"FK506 binding protein 14, 22 kDa",0.0,1.0,1.0,0.0,0.0,3281160,"EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY, AND HEARING LOSS",0.200283505,1,"Biomarker, GeneticVariation"
27030,MLH3,mutL homolog 3,0.0,1.0,1.0,0.0,0.0,476089,Endometrial Carcinoma,0.200283505,1,"Biomarker, GeneticVariation"
55065,SLC52A1,"solute carrier family 52 (riboflavin transporter), member 1",0.0,1.0,1.0,0.0,0.0,35528,Riboflavin Deficiency,0.200283505,1,"Biomarker, GeneticVariation"
23317,DNAJC13,"DnaJ (Hsp40) homolog, subfamily C, member 13",0.0,1.0,1.0,0.0,0.0,30567,Parkinson Disease,0.200283505,1,"Biomarker, GeneticVariation"
2690,GHR,growth hormone receptor,0.0,0.0,1.0,0.0,0.0,20445,Hyperlipoproteinemia Type II,0.200283505,1,GeneticVariation
3426,CFI,complement factor I,0.0,1.0,1.0,0.0,0.0,1733,Afibrinogenemia,0.200283505,1,"Biomarker, GeneticVariation"
8547,FCN3,ficolin (collagen/fibrinogen domain containing) 3,0.0,1.0,1.0,0.0,0.0,3151226,IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY,0.200283505,1,"Biomarker, GeneticVariation"
137814,NKX2-6,NK2 homeobox 6,0.0,1.0,1.0,0.0,0.0,41207,"Truncus Arteriosus, Persistent",0.200283505,1,"Biomarker, GeneticVariation"
4569,TRNM,tRNA,0.0,1.0,1.0,0.0,0.0,162670,Mitochondrial Myopathies,0.200283505,1,"Biomarker, GeneticVariation"
1545,CYP1B1,"cytochrome P450, family 1, subfamily B, polypeptide 1",0.0,1.0,1.0,0.0,0.0,9363,Coloboma,0.200283505,1,"Biomarker, GeneticVariation"
10413,YAP1,Yes-associated protein 1,0.0,0.0,1.0,0.0,0.0,9363,Coloboma,0.200283505,1,GeneticVariation
6297,SALL2,spalt-like transcription factor 2,0.0,1.0,1.0,0.0,0.0,9363,Coloboma,0.200283505,1,"Biomarker, GeneticVariation"
55532,SLC30A10,"solute carrier family 30, member 10",0.0,0.0,1.0,0.0,0.0,2750442,Hypermanganesemia with Dystonia Polycythemia and Cirrhosis,0.200283505,1,GeneticVariation
1278,COL1A2,"collagen, type I, alpha 2",0.0,1.0,1.0,0.0,0.0,29458,"Osteoporosis, Postmenopausal",0.200283505,1,"Biomarker, GeneticVariation"
65062,TMEM237,transmembrane protein 237,0.0,1.0,1.0,0.0,0.0,431399,Agenesis of Cerebellar Vermis,0.200283505,1,"Biomarker, GeneticVariation"
2956,MSH6,mutS homolog 6,0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.200283505,1,"Biomarker, GeneticVariation"
2271,FH,fumarate hydratase,0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.200283505,1,"Biomarker, GeneticVariation"
201163,FLCN,folliculin,0.0,1.0,1.0,0.0,0.0,27672,"Neoplastic Syndromes, Hereditary",0.200283505,1,"Biomarker, GeneticVariation"
149775,GNAS-AS1,GNAS antisense RNA 1,0.0,1.0,1.0,0.0,0.0,1864100,"PSEUDOHYPOPARATHYROIDISM, TYPE IB",0.200283505,1,"Biomarker, GeneticVariation"
6329,SCN4A,"sodium channel, voltage gated, type IV alpha subunit",0.0,1.0,1.0,0.0,0.0,1868433,"Normokalemic Periodic Paralysis, Potassium-Sensitive",0.200283505,1,"Biomarker, GeneticVariation"
867,CBL,"Cbl proto-oncogene, E3 ubiquitin protein ligase",0.0,1.0,1.0,0.0,0.0,28326,Noonan Syndrome,0.200283505,1,"Biomarker, GeneticVariation"
4578,TRNW,tRNA,0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.200283505,1,"Biomarker, GeneticVariation"
1892,ECHS1,"enoyl CoA hydratase, short chain, 1, mitochondrial",0.0,1.0,1.0,0.0,0.0,23264,Leigh Disease,0.200283505,1,"Biomarker, GeneticVariation"
3856,KRT8,"keratin 8, type II",0.0,1.0,1.0,0.0,0.0,267809,"Cirrhosis, Cryptogenic",0.200283505,1,"Biomarker, GeneticVariation"
3909,LAMA3,"laminin, alpha 3",0.0,1.0,1.0,0.0,0.0,79683,Epidermolysis bullosa letalis,0.200283505,1,"Biomarker, GeneticVariation"
5830,PEX5,peroxisomal biogenesis factor 5,0.0,1.0,1.0,0.0,0.0,282525,Neonatal adrenoleukodystrophy,0.200283505,1,"Biomarker, GeneticVariation"
585,BBS4,Bardet-Biedl syndrome 4,0.0,1.0,1.0,0.0,0.0,2936864,Bardet-Biedl syndrome 4,0.200283505,1,"Biomarker, GeneticVariation"
57502,NLGN4X,"neuroligin 4, X-linked",0.0,1.0,1.0,0.0,0.0,1136249,"Mental Retardation, X-Linked",0.200283505,1,"Biomarker, GeneticVariation"
